data_5mwv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5mwv _Structure_validation_residue.Date_analyzed 2017-12-22 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.6 t70 . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 120.923 0.392 . . . . 3.6099999999999999 111.092 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -99.64 130.45 45.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.331 -0.395 . . . . 3.9100000000000001 110.358 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -98.86 117.67 33.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.081 0.467 . . . . 3.9399999999999999 110.073 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -119.97 140.01 51.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.576 -0.738 . . . . 3.21 110.569 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 14.3 t-20 -133.71 131.43 39.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.759 -0.655 . . . . 2.6499999999999999 110.2 174.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 84.7 mt -129.03 128.97 67.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.908 -0.587 . . . . 2.0699999999999998 109.577 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.08 135.61 11.77 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.482 -0.866 . . . . 0.92000000000000004 111.347 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.02 135.33 54.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.082 0.441 . . . . 1.6499999999999999 110.516 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 94.6 mmm -136.99 149.97 47.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.757 -0.656 . . . . 2.9700000000000002 110.362 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.31 124.96 43.52 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.949 -0.76 . . . . 3.1499999999999999 108.949 174.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 N--CA 1.455 -0.219 0 C-N-CA 120.881 -0.327 . . . . 5.0899999999999999 111.101 -177.743 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.403 ' HB2' ' HD2' ' A' ' 33' ' ' PRO . 11.9 pt-20 . . . . . 0 CA--C 1.53 0.203 0 N-CA-C 109.887 -0.412 . . . . 3.48 109.887 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 32' ' ' GLU . 31.7 Cg_endo -69.85 147.84 63.19 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 121.689 1.593 . . . . 2.0299999999999998 111.647 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.5 t -129.49 142.83 50.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.448 -0.342 . . . . 2.2799999999999998 111.009 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.04 131.99 65.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.981 -0.554 . . . . 2.4100000000000001 109.615 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 94.7 m-85 -110.02 131.26 55.21 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.883 -0.414 . . . . 4.4400000000000004 109.883 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.7 m-85 -112.99 128.07 56.4 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.927 -0.309 . . . . 3.6200000000000001 110.93 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 10' ' ' ASN . 48.8 m-80 -129.15 132.44 47.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.873 -0.603 . . . . 2.48 109.981 175.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.54 143.36 37.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.593 -0.276 . . . . 1.53 110.261 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.46 122.29 3.15 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.73 0.27 . . . . 1.8 111.73 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.637 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 56.2 t30 -167.53 95.14 0.45 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.393 -0.595 . . . . 3.3799999999999999 109.393 171.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.23 -84.24 0.45 Allowed Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 110.921 -0.871 . . . . 1.8200000000000001 110.921 -173.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.637 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 24.4 Cg_endo -63.62 172.91 5.03 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.862 2.375 . . . . 2.1000000000000001 111.922 169.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -71.05 -174.86 1.03 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.95 -0.568 . . . . 4.0499999999999998 110.914 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -109.61 127.62 54.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.27 0.557 . . . . 3.6000000000000001 109.785 -171.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.2 tt -127.3 135.24 63.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.856 -1.065 . . . . 2.2799999999999998 110.876 -171.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -118.28 129.92 55.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.804 -0.635 . . . . 1.4399999999999999 110.264 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.3 tp -122.74 136.25 54.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.278 -0.419 . . . . 1.75 110.788 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.32 159.94 42.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.738 -0.665 . . . . 1.5900000000000001 109.852 176.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -123.53 139.98 53.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.572 0.225 . . . . 4.4400000000000004 110.416 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -125.45 115.33 20.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 5.0199999999999996 110.926 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -112.28 129.06 56.41 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.844 -0.343 . . . . 3.7400000000000002 110.239 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.484 ' HB2' ' NH2' ' A' ' 69' ' ' ARG . 85.8 tt0 . . . . . 0 C--N 1.319 -0.72 0 CA-C-N 116.48 -0.327 . . . . 5.0499999999999998 110.468 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 96.2 m95 . . . . . 0 C--O 1.228 -0.059 0 CA-C-O 120.939 0.4 . . . . 6.5 110.745 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -86.14 104.81 16.06 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.582 -0.896 . . . . 4.5999999999999996 108.582 170.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -141.86 147.06 36.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.505 -0.316 . . . . 2.4500000000000002 110.317 -166.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.545 ' HG3' ' HA ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -127.43 124.0 23.42 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 109.858 -0.423 . . . . 3.7200000000000002 109.858 172.315 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 67.0 Cg_endo -80.01 135.51 11.17 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.119 1.879 . . . . 1.3200000000000001 110.951 170.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.474 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 8.1 tp10 -115.35 120.0 38.16 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.406 -0.59 . . . . 2.1899999999999999 109.406 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.4 tp -134.54 129.54 35.21 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.267 -0.424 . . . . 1.73 110.315 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -139.7 129.81 25.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.932 0.396 . . . . 2.1800000000000002 110.309 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.4 t -121.55 130.1 74.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.927 -0.579 . . . . 2.0600000000000001 109.773 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -108.81 137.43 46.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.049 0.452 . . . . 4.1900000000000004 110.915 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -119.91 139.89 51.73 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.472 -0.785 . . . . 5.1600000000000001 109.757 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -120.06 138.59 53.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.947 -0.39 . . . . 3.3100000000000001 109.947 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -125.5 127.64 46.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.287 0.565 . . . . 4.6600000000000001 110.496 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.7 tp . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 115.511 -0.768 . . . . 4.8799999999999999 110.097 -178.514 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.608 ' HA ' ' OD2' ' A' ' 120' ' ' ASP . 16.3 m . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.818 0.342 . . . . 2.6400000000000001 111.41 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -112.04 130.29 55.92 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.987 -0.375 . . . . 6.1900000000000004 109.987 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -154.76 156.35 26.83 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.545 -0.836 . . . . 1.54 111.96 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 96.9 mt -132.84 136.89 46.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.821 0.343 . . . . 2.73 110.287 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 60.9 m -119.93 129.94 54.57 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.653 -0.499 . . . . 1.8700000000000001 109.653 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.91 132.58 8.18 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.466 -0.873 . . . . 1.1699999999999999 111.528 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -125.07 128.5 6.67 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.762 -0.733 . . . . 1.4399999999999999 111.989 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -120.26 121.87 39.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.641 -0.503 . . . . 4.6399999999999997 109.641 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.474 ' HD2' ' OE2' ' A' ' 71' ' ' GLU . 38.6 ttt180 -141.96 130.01 22.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.726 -0.472 . . . . 3.2200000000000002 109.726 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.625 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 5.4 t30 -111.07 129.99 55.75 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.036 0.446 . . . . 2.2200000000000002 109.937 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.545 ' HA ' ' HG3' ' A' ' 69' ' ' ARG . 65.8 t80 -100.0 109.78 22.11 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.427 -0.582 . . . . 3.6400000000000001 109.427 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.674 0 C-N-CA 120.519 -0.848 . . . . 2.79 111.934 -175.206 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.442 -0.84 0 N-CA-C 108.819 -0.808 . . . . 3.77 108.819 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -158.07 149.68 21.5 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.629 -0.508 . . . . 2.2000000000000002 109.629 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -114.68 110.34 19.6 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.138 0.494 . . . . 3.1200000000000001 111.553 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 88.6 mtp -127.08 130.44 49.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.936 -0.764 . . . . 2.1200000000000001 108.936 169.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.639 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 95.7 mt-30 -107.43 138.39 43.72 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.094 -0.642 . . . . 2.4900000000000002 110.502 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 29.1 ttt180 -110.42 117.04 32.51 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.546 -0.539 . . . . 4.4699999999999998 109.546 171.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.556 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 61.4 m95 -108.5 127.42 53.91 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.735 -0.666 . . . . 2.9199999999999999 110.156 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -119.67 123.41 43.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.491 -0.322 . . . . 2.5099999999999998 110.795 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.6 mm -123.21 120.55 60.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.043 -0.725 . . . . 2.1299999999999999 109.043 170.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -144.43 106.28 4.72 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 111.716 0.265 . . . . 1.6799999999999999 111.716 -177.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.611 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 87.8 Cg_endo -79.94 149.18 20.11 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.575 2.183 . . . . 1.54 111.604 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -95.45 137.75 34.07 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.219 -0.66 . . . . 2.3500000000000001 109.219 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -135.98 130.49 33.72 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 111.957 0.355 . . . . 5.1500000000000004 111.957 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.608 ' OD2' ' HA ' ' A' ' 85' ' ' SER . 13.0 m-20 -94.36 102.14 14.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.821 -0.807 . . . . 3.04 108.821 168.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 96.3 t -69.9 -42.73 79.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.142 -0.481 . . . . 4.7400000000000002 111.089 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -114.73 132.82 56.31 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.556 -0.535 . . . . 6.3600000000000003 109.556 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.0 mt -107.19 24.84 12.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.202 -0.454 . . . . 4.96 111.019 -173.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 17.4 p -108.89 142.57 39.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.12 -0.491 . . . . 4.0700000000000003 110.758 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -69.5 -39.96 77.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 5.1699999999999999 111.591 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -59.92 -40.11 87.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.006 -0.543 . . . . 3.71 111.248 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.6 tp -139.34 122.39 16.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.002 -0.544 . . . . 2.4500000000000002 109.745 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -119.16 136.29 54.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.991 0.424 . . . . 4.6799999999999997 110.54 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.411 ' CZ ' ' HB ' ' A' ' 156' ' ' THR . 89.1 t80 -139.58 130.87 26.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.826 -0.624 . . . . 4.3600000000000003 109.386 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -127.09 162.17 26.7 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.24 -0.436 . . . . 2.5899999999999999 110.958 -176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -161.39 140.51 6.68 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.276 -0.73 . . . . 1.25 111.276 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.6 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 5.1 p90 -132.26 134.94 45.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.225 0.536 . . . . 5.0899999999999999 110.914 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.611 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 58.8 tp -104.46 124.46 49.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.163 -0.926 . . . . 2.7599999999999998 109.955 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.9 t -119.88 127.31 52.6 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.017 0.437 . . . . 1.99 110.179 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 89.3 mtp -113.04 130.42 56.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.94 -0.573 . . . . 2.7799999999999998 110.043 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 113' ' ' TRP . 70.9 m-85 -121.58 139.98 52.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.92 0.39 . . . . 3.6800000000000002 111.676 -175.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 63.1 mttp -125.95 151.54 46.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.787 -0.642 . . . . 2.1699999999999999 109.7 169.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.639 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 87.8 m-85 -135.56 156.28 49.13 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.422 0.451 . . . . 4.0099999999999998 110.53 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 110' ' ' MET . . . 60.05 -175.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.979 -0.555 . . . . 1.79 111.587 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -76.61 -33.69 58.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.487 0.66 . . . . 3.04 109.766 168.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -60.11 -45.61 92.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.79 -1.095 . . . . 2.4100000000000001 112.421 -169.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.586 ' HB2' ' O ' ' A' ' 138' ' ' PHE . 9.4 mp -69.9 -30.11 67.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.826 0.345 . . . . 2.3599999999999999 110.88 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -67.38 -39.89 85.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.339 0.59 . . . . 2.52 109.955 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.1 m -66.94 -41.34 87.15 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.191 -0.913 . . . . 2.52 111.665 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 34.7 p -80.58 -14.01 58.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.247 0.546 . . . . 2.0099999999999998 111.01 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.404 ' O ' ' HE3' ' A' ' 137' ' ' LYS . . . 71.3 -130.61 18.92 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.622 -0.717 . . . . 1.52 112.955 175.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.449 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 46.5 p90 -70.04 -16.15 63.11 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.53 0.196 . . . . 6.2199999999999998 111.53 -174.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.92 -48.68 80.69 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.208 0.448 . . . . 2.0499999999999998 112.208 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.427 ' HB3' ' HG ' ' A' ' 142' ' ' LEU . 51.3 m-20 -100.22 14.17 31.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.847 0.356 . . . . 2.6400000000000001 111.218 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.449 ' OG1' ' HA ' ' A' ' 147' ' ' TYR . 98.2 m -72.93 129.71 38.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.394 -0.366 . . . . 2.6000000000000001 110.706 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -83.45 134.29 34.87 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.387 -0.598 . . . . 4.0899999999999999 109.387 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 63.0 t -119.6 124.24 72.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.002 0.43 . . . . 2.1499999999999999 110.746 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -127.39 136.18 51.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.63 -0.714 . . . . 2.5600000000000001 109.684 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 16.0 m -135.77 130.05 33.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.804 0.335 . . . . 1.78 110.887 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.6 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 74.4 tt0 -120.29 136.89 54.53 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.525 -0.546 . . . . 2.04 109.525 175.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.546 ' OG1' ' HB2' ' A' ' 172' ' ' TYR . 17.1 p -127.38 140.07 52.43 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.024 -0.535 . . . . 2.0299999999999998 110.375 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -125.02 130.1 7.25 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.694 -0.765 . . . . 1.0800000000000001 112.211 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.8 tp -112.86 128.31 56.42 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 110.196 -0.298 . . . . 2.9300000000000002 110.196 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -108.49 107.43 17.96 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.995 -0.372 . . . . 3.02 109.995 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -121.01 130.08 53.65 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.414 -0.587 . . . . 4.7599999999999998 109.414 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.5 p -88.91 94.15 9.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.877 0.37 . . . . 1.8200000000000001 110.523 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -61.1 -45.73 93.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.971 -0.559 . . . . 3.27 111.271 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -99.95 7.65 44.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.589 -0.278 . . . . 2.4100000000000001 110.482 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 73.57 -46.01 0.62 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.708 0.803 . . . . 2.5800000000000001 111.201 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.4 p -73.88 -24.73 59.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.873 0.368 . . . . 2.6000000000000001 111.623 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.9 m -123.45 144.65 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.385 -0.37 . . . . 2.0600000000000001 110.554 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.22 135.02 49.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.143 -0.48 . . . . 1.8400000000000001 110.66 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 31.4 mt -104.2 134.53 47.28 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.416 -0.587 . . . . 2.1400000000000001 109.416 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.494 ' HD2' ' CE1' ' A' ' 197' ' ' TYR . 96.8 mtt180 -99.95 111.54 23.84 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.844 -0.428 . . . . 3.73 109.844 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.11 119.95 60.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.146 -0.479 . . . . 1.8100000000000001 109.812 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -107.83 128.44 54.6 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.205 0.526 . . . . 2.2400000000000002 110.792 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.546 ' HB2' ' OG1' ' A' ' 156' ' ' THR . 88.2 m-85 -106.81 128.52 54.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.457 -0.792 . . . . 4.8399999999999999 108.898 177.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -104.09 129.98 51.79 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.064 0.459 . . . . 4.4299999999999997 110.697 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.484 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 54.2 tp -118.61 119.94 35.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.699 -0.682 . . . . 2.8500000000000001 110.549 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -122.91 149.24 44.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.182 -0.673 . . . . 3.3100000000000001 109.182 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 . . . . . 0 C--N 1.321 -0.635 0 C-N-CA 120.109 -0.637 . . . . 7.3300000000000001 110.417 178.25 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.838 -0.43 . . . . 4.4000000000000004 109.838 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 87.2 mt -104.09 116.08 47.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.368 -0.378 . . . . 2.6400000000000001 110.089 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -107.61 125.28 51.13 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.182 -0.303 . . . . 4.1100000000000003 110.182 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -122.85 140.3 53.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.64 0.257 . . . . 1.76 111.137 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.494 ' CE1' ' HD2' ' A' ' 169' ' ' ARG . 28.5 p90 -149.73 157.67 43.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.273 -0.421 . . . . 6.1399999999999997 110.101 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.62 143.4 23.51 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.637 0.256 . . . . 3.0800000000000001 110.811 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -88.03 116.08 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.441 2.094 . . . . 1.98 112.168 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 55.0 tp -103.56 129.15 50.74 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.296 -0.631 . . . . 2.7599999999999998 109.296 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 27.4 m -95.67 116.72 29.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.955 0.407 . . . . 2.4199999999999999 111.24 -176.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.1 mt -127.74 81.46 2.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.071 -0.714 . . . . 2.77 109.071 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 75.83 -129.54 10.36 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.76 -0.733 . . . . 1.6200000000000001 111.291 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -90.62 -0.42 57.68 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.057 -0.72 . . . . 2.8599999999999999 109.057 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.519 ' HA ' ' O ' ' A' ' 242' ' ' GLY . 33.3 m170 -102.95 117.4 34.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.679 -0.691 . . . . 3.23 110.082 -176.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -96.02 132.88 40.91 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.877 -0.601 . . . . 2.0499999999999998 109.999 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.483 ' CG1' HD11 ' A' ' 239' ' ' LEU . 58.4 t -110.08 120.04 60.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.289 -0.634 . . . . 1.9299999999999999 109.289 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 45.1 m -131.01 91.95 34.95 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 120.776 0.322 . . . . 1.6699999999999999 111.569 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.06 147.77 18.95 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.314 2.009 . . . . 1.28 111.135 172.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.433 ' CE1' ' HA3' ' A' ' 238' ' ' GLY . 33.8 p90 -132.4 149.54 52.33 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.621 -0.511 . . . . 4.8600000000000003 109.621 172.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 20.6 p -119.0 135.74 54.46 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.715 -0.675 . . . . 2.0899999999999999 109.626 177.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -60.1 -39.81 87.44 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.743 -0.662 . . . . 5.29 110.259 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.444 -0.735 0 CA-C-N 115.861 -0.608 . . . . 4.9400000000000004 109.543 -179.579 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 120.915 0.388 . . . . 2.9700000000000002 110.577 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.433 ' HA3' ' CE1' ' A' ' 210' ' ' TYR . . . -122.01 140.0 13.28 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.065 -0.814 . . . . 1.3999999999999999 111.065 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.483 HD11 ' CG1' ' A' ' 207' ' ' VAL . 52.7 tp -120.58 124.4 45.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.928 0.364 . . . . 2.4300000000000002 110.728 -176.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.47 ' CE1' ' HG2' ' A' ' 254' ' ' GLU . 96.3 m-85 -104.88 132.07 51.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.126 -0.488 . . . . 4.3300000000000001 110.633 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -112.33 126.91 55.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.38 -0.373 . . . . 3.2599999999999998 110.22 171.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 205' ' ' HIS . . . -89.34 118.18 5.13 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.826 -0.91 . . . . 1.3500000000000001 110.826 174.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' TYR . . . . . 0.449 ' HB3' ' CG2' ' A' ' 251' ' ' VAL . 50.1 t80 -107.74 134.7 50.33 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.792 -0.447 . . . . 4.7599999999999998 109.792 -176.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -99.89 145.79 27.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.88 -0.6 . . . . 4.29 111.295 -174.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.68 139.9 52.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.842 -0.617 . . . . 7.5599999999999996 110.004 172.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -64.43 -26.41 68.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.288 -0.869 . . . . 7.0199999999999996 111.168 -174.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -59.82 -40.12 87.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.684 -0.689 . . . . 6.4800000000000004 110.808 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 130.8 21.74 1.09 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.83 -0.7 . . . . 2.9199999999999999 111.937 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 91.8 mt -110.99 151.52 27.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.747 0.308 . . . . 3.5800000000000001 110.351 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 52.8 m -130.07 139.77 50.92 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.703 -0.481 . . . . 2.6000000000000001 109.703 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . 0.449 ' CG2' ' HB3' ' A' ' 243' ' ' TYR . 33.2 m -129.07 142.86 42.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.981 0.419 . . . . 2.2400000000000002 110.827 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 4.2 p -100.07 120.74 40.31 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.999 -0.546 . . . . 2.0 110.165 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 87.9 mt -99.96 125.94 46.04 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.052 -0.522 . . . . 3.4199999999999999 110.154 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 273' ' ' ALA . 45.3 mt-10 -92.81 134.62 34.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.41 -0.359 . . . . 4.0800000000000001 111.018 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -137.04 138.88 40.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.987 -0.552 . . . . 5.1699999999999999 109.564 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.574 0 CA-C-O 120.603 0.24 . . . . 3.5800000000000001 110.432 177.75 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 254' ' ' GLU . . . . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 110.233 -0.284 . . . . 2.4100000000000001 110.233 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -140.81 154.84 24.58 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.958 -0.639 . . . . 1.6200000000000001 111.571 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 58.2 t -119.99 127.98 75.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.13 0.49 . . . . 2.4900000000000002 110.982 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 251' ' ' VAL . . . -117.72 129.84 8.49 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.697 -0.961 . . . . 1.3 110.697 173.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.2 124.92 64.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 117.368 0.584 . . . . 2.3399999999999999 110.758 -175.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -117.43 127.35 53.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.275 0.56 . . . . 2.7999999999999998 111.111 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 44.2 t80 -113.89 119.57 37.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.361 -0.836 . . . . 5.1900000000000004 109.106 171.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 53.4 m -129.98 129.61 43.97 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.752 0.311 . . . . 2.0499999999999998 110.337 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 49.8 t80 . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.319 -0.848 . . . . 4.4199999999999999 108.749 176.568 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 . . . . . 0 CA--C 1.519 -0.226 0 N-CA-C 109.785 -0.45 . . . . 3.6099999999999999 109.785 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -141.31 101.73 4.07 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.128 -0.694 . . . . 3.9100000000000001 109.128 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 44.7 m80 -119.98 137.88 53.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.014 0.435 . . . . 3.9399999999999999 111.119 -175.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -132.84 146.22 51.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.671 -0.695 . . . . 3.21 110.85 -176.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -123.93 131.9 53.64 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.257 -0.428 . . . . 2.6499999999999999 109.969 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -130.0 129.97 65.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.309 -0.405 . . . . 2.0699999999999998 110.404 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -115.2 134.95 11.91 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.448 -0.882 . . . . 0.92000000000000004 111.644 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.97 136.34 54.57 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.94 0.4 . . . . 1.6499999999999999 110.569 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 65.9 mtt -133.14 155.34 49.45 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.881 -0.599 . . . . 2.9700000000000002 109.769 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -111.33 114.49 27.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.769 -0.456 . . . . 3.1499999999999999 109.769 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 116.148 -0.478 . . . . 5.0899999999999999 111.445 -170.776 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.857 0.361 . . . . 3.48 110.229 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 14' ' ' MET . 74.4 Cg_endo -78.01 134.73 13.37 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.443 2.096 . . . . 2.0299999999999998 113.166 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.2 m -109.92 143.25 40.11 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.715 -0.846 . . . . 2.2799999999999998 108.715 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.49 134.4 66.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.357 0.598 . . . . 2.4100000000000001 111.615 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -114.08 134.24 55.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.473 -0.785 . . . . 4.4400000000000004 109.582 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -110.69 139.38 46.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.755 0.312 . . . . 3.6200000000000001 110.986 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -149.79 140.54 22.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.689 -0.485 . . . . 2.48 109.689 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.47 143.51 47.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.415 0.15 . . . . 1.53 110.978 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 8' ' ' HIS . . . -153.95 119.69 5.26 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.49 -0.323 . . . . 1.8 111.338 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.537 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 13.0 p-10 -169.12 95.04 0.32 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.373 -0.376 . . . . 3.3799999999999999 111.046 176.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.06 -98.7 2.47 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.972 -0.633 . . . . 1.8200000000000001 112.034 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.537 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 88.6 Cg_exo -49.23 174.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.893 3.062 . . . . 2.1000000000000001 112.998 170.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.403 ' HZ3' ' O ' ' A' ' 77' ' ' GLN . 93.6 m95 -67.31 176.33 2.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.123 0.487 . . . . 4.0499999999999998 111.108 -172.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -110.41 126.79 54.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.988 0.423 . . . . 3.6000000000000001 110.421 -163.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 83.5 mt -117.18 136.86 52.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.774 -0.648 . . . . 2.2799999999999998 110.715 -173.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.83 133.32 56.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.853 -0.612 . . . . 1.4399999999999999 110.423 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.9 tp -120.35 132.02 55.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.925 -0.58 . . . . 1.75 110.257 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.8 165.08 29.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.172 -0.467 . . . . 1.5900000000000001 110.189 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -138.42 147.97 43.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.057 -0.349 . . . . 4.4400000000000004 110.057 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -124.55 129.82 51.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.276 0.56 . . . . 5.0199999999999996 110.803 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -110.29 155.78 21.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.276 -0.874 . . . . 3.7400000000000002 108.859 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 C--N 1.324 -0.514 0 CA-C-O 120.825 0.345 . . . . 5.0499999999999998 110.658 -175.529 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 88.1 m95 . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 120.875 0.369 . . . . 6.5 111.224 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -110.51 135.33 51.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.031 -0.532 . . . . 4.5999999999999996 110.355 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -149.18 170.02 19.39 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.692 -0.485 . . . . 2.4500000000000002 109.692 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 94' ' ' ASN . 40.8 ttp180 -129.6 123.59 21.35 Favored Pre-proline 0 N--CA 1.451 -0.402 0 C-N-CA 120.682 -0.407 . . . . 3.7200000000000002 111.038 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 92.7 Cg_endo -87.78 152.07 7.36 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.938 2.425 . . . . 1.3200000000000001 110.802 167.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.447 ' OE2' ' HD3' ' A' ' 93' ' ' ARG . 52.7 mt-10 -134.5 125.72 27.94 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.807 -0.357 . . . . 2.1899999999999999 110.383 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.4 tp -133.7 129.96 37.49 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.893 -0.41 . . . . 1.73 109.893 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -128.3 146.62 50.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.083 0.468 . . . . 2.1800000000000002 110.994 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.1 t -114.8 126.87 72.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.786 -0.82 . . . . 2.0600000000000001 108.786 171.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -110.85 119.82 40.36 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.298 -0.41 . . . . 4.1900000000000004 110.227 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -105.59 120.03 40.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.065 -0.516 . . . . 5.1600000000000001 110.429 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.403 ' O ' ' HZ3' ' A' ' 44' ' ' TRP . 53.8 mt-30 -109.45 120.16 41.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.789 -0.448 . . . . 3.3100000000000001 109.789 176.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -104.14 125.45 50.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.151 0.5 . . . . 4.6600000000000001 111.214 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.6 tp . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 115.43 -0.805 . . . . 4.8799999999999999 108.975 174.853 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 121.145 0.498 . . . . 2.6400000000000001 110.711 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -128.52 153.29 47.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.77 -0.65 . . . . 6.1900000000000004 109.816 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -151.62 166.28 30.73 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.499 -0.858 . . . . 1.54 111.608 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 63.6 tp -146.49 120.09 9.14 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.908 0.385 . . . . 2.73 110.403 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.3 m -109.39 116.72 32.37 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.047 -0.524 . . . . 1.8700000000000001 109.763 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -134.96 139.05 10.5 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.44 -0.886 . . . . 1.1699999999999999 111.266 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.78 161.67 32.47 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.072 -1.061 . . . . 1.4399999999999999 112.366 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -122.39 130.96 53.63 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.491 -0.559 . . . . 4.6399999999999997 109.491 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.447 ' HD3' ' OE2' ' A' ' 71' ' ' GLU . 83.6 mtt180 -121.99 124.99 45.3 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.587 -0.894 . . . . 3.2200000000000002 108.587 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.515 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 64.4 t30 -103.75 118.41 36.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.064 0.459 . . . . 2.2200000000000002 110.64 -173.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 109' ' ' ASN . 59.3 t80 -102.34 117.67 35.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.07 -0.514 . . . . 3.6400000000000001 110.452 -175.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.475 0 C-N-CA 120.635 -0.793 . . . . 2.79 113.478 173.334 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 110.228 -0.286 . . . . 3.77 110.228 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -137.6 113.74 9.99 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.96 -0.296 . . . . 2.2000000000000002 110.345 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 95' ' ' TYR . 3.5 t-20 -142.09 108.31 5.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.927 -0.579 . . . . 3.1200000000000001 109.677 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.447 ' HB2' ' HB3' ' A' ' 95' ' ' TYR . 88.4 mtp -111.27 125.69 54.1 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.733 -0.667 . . . . 2.1200000000000001 109.343 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.568 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 81.1 mt-30 -91.66 119.87 31.92 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.527 -0.469 . . . . 2.4900000000000002 109.88 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -106.29 113.06 26.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.873 -0.603 . . . . 4.4699999999999998 110.193 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 137' ' ' LYS . 86.3 m95 -115.81 125.31 52.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.882 -0.784 . . . . 2.9199999999999999 108.882 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -140.1 123.88 17.37 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.452 -0.573 . . . . 2.5099999999999998 109.452 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 134' ' ' SER . 87.4 mt -123.22 128.22 74.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.999 -0.546 . . . . 2.1299999999999999 110.179 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -132.77 104.25 13.03 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.516 -0.311 . . . . 1.6799999999999999 111.278 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.18 141.13 11.44 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.091 2.527 . . . . 1.54 111.356 172.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -93.42 138.51 31.67 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.064 -0.516 . . . . 2.3500000000000001 110.088 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -127.06 128.38 46.19 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.125 -0.324 . . . . 5.1500000000000004 110.125 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -148.64 118.11 6.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.867 -0.42 . . . . 3.04 109.867 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.498 HG13 ' H ' ' A' ' 123' ' ' LEU . 61.1 t -124.6 130.01 73.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.001 0.429 . . . . 4.7400000000000002 111.105 -174.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -114.03 28.48 8.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 6.3600000000000003 110.213 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.498 ' H ' HG13 ' A' ' 121' ' ' VAL . 61.3 tp -68.13 -22.77 64.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 4.96 112.066 -171.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.0 p -108.15 143.84 36.38 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.081 0.467 . . . . 4.0700000000000003 111.789 -174.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -66.93 124.97 24.49 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.527 -0.76 . . . . 5.1699999999999999 110.823 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 60.25 15.6 5.45 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.86 0.725 . . . . 3.71 111.598 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.6 mt -129.25 119.53 24.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.207 -0.451 . . . . 2.4500000000000002 110.062 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.497 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 74.0 ttt180 -112.74 130.36 56.09 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.031 -0.531 . . . . 4.6799999999999997 110.062 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -107.24 125.81 51.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.066 -0.515 . . . . 4.3600000000000003 109.652 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -130.6 130.05 43.52 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.201 -0.666 . . . . 2.5899999999999999 109.201 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -137.53 144.55 16.01 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.139 -1.029 . . . . 1.25 112.8 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 155' ' ' GLU . 61.0 t-105 -118.82 128.44 54.46 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.068 -0.716 . . . . 5.0899999999999999 109.068 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 60.9 tp -126.33 140.51 52.45 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.385 -0.598 . . . . 2.7599999999999998 109.385 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 29.3 t -156.72 169.97 23.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.418 -0.216 . . . . 1.99 110.418 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 92.8 mtp -139.62 149.95 44.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.652 0.263 . . . . 2.7799999999999998 110.663 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -103.74 117.35 34.17 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.378 -0.374 . . . . 3.6800000000000002 111.207 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 113' ' ' TRP . 99.4 mttt -132.92 129.8 38.78 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.066 -0.716 . . . . 2.1699999999999999 109.066 170.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 51.1 p90 -157.02 161.04 39.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.473 -0.331 . . . . 4.0099999999999998 110.618 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.415 ' HB3' ' HE3' ' A' ' 110' ' ' MET . . . 74.72 -178.19 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 O-C-N 124.154 0.908 . . . . 1.79 110.678 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -74.47 -38.64 62.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.533 -0.303 . . . . 3.04 111.019 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -59.86 -51.17 70.86 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.738 0.644 . . . . 2.4100000000000001 112.738 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.595 ' HA ' ' OG1' ' A' ' 145' ' ' THR . 44.2 mt -69.98 -30.01 67.25 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.776 -0.37 . . . . 2.3599999999999999 111.342 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -60.02 -42.16 93.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.029 0.442 . . . . 2.52 109.857 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 30.0 p -80.12 -31.37 39.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.011 -0.541 . . . . 2.52 111.972 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.595 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 61.6 p -71.65 -32.38 67.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.147 0.499 . . . . 2.0099999999999998 110.95 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.407 ' O ' ' HE2' ' A' ' 137' ' ' LYS . . . 68.3 -120.09 11.31 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.692 -0.686 . . . . 1.52 112.61 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -89.89 -9.66 48.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.43 0.157 . . . . 6.2199999999999998 111.067 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.69 -52.97 47.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.874 0.369 . . . . 2.0499999999999998 110.663 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.427 ' O ' HD21 ' A' ' 142' ' ' LEU . 10.9 m-20 -118.11 110.05 17.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.867 -0.606 . . . . 2.6400000000000001 109.666 176.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.6 t -170.24 164.17 8.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.813 -0.63 . . . . 2.6000000000000001 109.616 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -119.89 143.98 47.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.645 0.259 . . . . 4.0899999999999999 110.478 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.0 143.51 25.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.146 -0.479 . . . . 2.1499999999999999 110.984 -172.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 134' ' ' SER . 34.9 mt-10 -110.61 125.5 53.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.56 -0.904 . . . . 2.5600000000000001 108.56 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.8 m -132.22 122.45 25.25 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.464 -0.494 . . . . 1.78 110.97 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.404 ' HB3' ' HB3' ' A' ' 132' ' ' TRP . 85.8 tt0 -119.91 111.98 18.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.301 -0.629 . . . . 2.04 109.301 174.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 31.7 m -108.57 120.32 42.1 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.072 -0.513 . . . . 2.0299999999999998 109.861 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -133.37 149.26 19.61 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 119.71 -1.233 . . . . 1.0800000000000001 113.051 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 59.6 tp -122.47 130.42 53.04 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.983 -0.377 . . . . 2.9300000000000002 109.983 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 51.3 tt0 -95.44 110.89 22.87 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.109 -0.7 . . . . 3.02 109.109 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -122.85 130.08 52.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.566 -0.743 . . . . 4.7599999999999998 110.002 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.2 p -82.28 88.16 6.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.159 0.504 . . . . 1.8200000000000001 109.94 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -60.47 -50.14 74.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.61 -0.723 . . . . 3.27 111.323 -172.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -103.12 16.64 26.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.156 -0.475 . . . . 2.4100000000000001 111.18 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 72.92 -50.22 0.7 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.75 -0.659 . . . . 2.5800000000000001 111.868 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.1 p -74.21 -20.1 60.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.759 0.314 . . . . 2.6000000000000001 111.695 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -125.79 144.19 36.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.366 -0.379 . . . . 2.0600000000000001 110.82 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -105.67 121.63 44.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.036 -0.529 . . . . 1.8400000000000001 110.493 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.41 HD21 ' N ' ' A' ' 168' ' ' LEU . 3.7 mm? -102.88 126.94 50.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.825 -0.625 . . . . 2.1400000000000001 109.761 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -98.11 111.78 23.98 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.303 -0.629 . . . . 3.73 109.303 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.96 119.92 60.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.856 -0.611 . . . . 1.8100000000000001 109.384 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -114.89 131.07 56.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.323 -0.399 . . . . 2.2400000000000002 111.157 -171.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -115.19 119.94 38.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.683 -0.689 . . . . 4.8399999999999999 109.255 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -106.91 130.7 54.54 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.831 0.348 . . . . 4.4299999999999997 110.075 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 64.1 tp -99.5 119.92 38.8 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.982 -0.554 . . . . 2.8500000000000001 110.102 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -66.73 -40.05 88.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.264 -0.88 . . . . 3.3100000000000001 110.638 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 7.3300000000000001 109.766 -178.969 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.354 -0.609 . . . . 4.4000000000000004 109.354 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 85.2 mt -115.39 119.94 63.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.834 -0.432 . . . . 2.6400000000000001 109.834 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 211' ' ' THR . 93.1 mtt180 -117.82 116.19 26.48 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.9 -0.407 . . . . 4.1100000000000003 109.9 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -120.06 138.47 53.52 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.997 -0.547 . . . . 1.76 110.178 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -136.82 140.75 42.68 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.348 0.594 . . . . 6.1399999999999997 111.362 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 55.5 tp -116.69 126.82 27.2 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 114.871 -1.059 . . . . 3.0800000000000001 109.399 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.55 110.18 1.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.942 1.761 . . . . 1.98 111.078 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 60.0 tp -100.12 109.43 21.71 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.275 -0.639 . . . . 2.7599999999999998 109.275 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 78.5 m -121.34 130.07 53.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.331 0.586 . . . . 2.4199999999999999 111.487 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 55.5 tp -133.6 83.86 2.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.507 -0.923 . . . . 2.77 108.507 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.71 -117.79 9.14 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.504 -0.771 . . . . 1.6200000000000001 112.063 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -79.89 -12.68 59.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.729 0.299 . . . . 2.8599999999999999 111.357 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -99.54 117.09 33.16 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.066 -0.346 . . . . 3.23 110.066 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 28.6 t -132.57 138.14 47.35 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.724 -0.473 . . . . 2.0499999999999998 109.724 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 24.5 m -136.61 148.82 26.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.792 0.33 . . . . 1.9299999999999999 110.807 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 26.4 m -119.93 91.73 45.82 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.176 -0.465 . . . . 1.6699999999999999 110.412 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -80.74 126.8 6.05 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.891 2.394 . . . . 1.28 112.455 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -95.27 140.07 30.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.234 -0.439 . . . . 4.8600000000000003 110.0 175.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 195' ' ' ARG . 45.7 p -118.31 130.2 55.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.882 0.372 . . . . 2.0899999999999999 110.447 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 17.7 ttp85 -104.67 110.03 22.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.66 -0.7 . . . . 5.29 109.704 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 30.4 pt . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.262 -0.426 . . . . 4.9400000000000004 110.586 -177.385 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.448 -0.56 0 CA-C-O 121.094 0.473 . . . . 2.9700000000000002 110.228 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -78.28 111.93 3.36 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.854 -0.898 . . . . 1.3999999999999999 110.854 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.556 ' O ' ' HB3' ' A' ' 254' ' ' GLU . 47.7 tp -111.68 125.43 53.96 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.631 -0.507 . . . . 2.4300000000000002 109.631 -175.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.405 ' HB3' ' HA ' ' A' ' 253' ' ' LEU . 85.9 m-85 -124.83 133.34 53.14 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.993 -0.549 . . . . 4.3300000000000001 109.776 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -98.11 131.15 44.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.972 0.415 . . . . 3.2599999999999998 110.471 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -121.12 118.45 3.8 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.726 -0.67 . . . . 1.3500000000000001 112.455 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -140.06 115.39 9.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.286 -0.635 . . . . 4.7599999999999998 109.286 174.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -120.06 130.29 54.61 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.995 -0.372 . . . . 4.29 109.995 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -139.92 129.67 24.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.034 -0.53 . . . . 7.5599999999999996 110.493 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -70.11 140.33 52.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.762 -0.653 . . . . 7.0199999999999996 110.307 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.97 39.63 19.86 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.449 0.468 . . . . 6.4800000000000004 110.984 -178.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -170.39 171.34 43.56 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.815 -0.707 . . . . 2.9199999999999999 111.74 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 86.7 mt -71.12 141.26 50.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.074 0.464 . . . . 3.5800000000000001 110.786 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 278' ' ' ASN . 68.5 m -123.89 149.97 45.21 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.846 -0.615 . . . . 2.6000000000000001 109.972 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 66.7 t -123.15 135.15 64.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.645 0.26 . . . . 2.2400000000000002 111.314 -172.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 22.7 t -136.44 152.98 51.17 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.078 -0.51 . . . . 2.0 109.877 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 240' ' ' PHE . 90.2 mt 73.23 -179.67 0.21 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.251 0.621 . . . . 3.4199999999999999 111.05 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . 0.556 ' HB3' ' O ' ' A' ' 239' ' ' LEU . 38.2 tt0 -177.91 -86.11 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.293 0.042 . . . . 4.0800000000000001 110.991 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' TYR . . . . . 0.548 ' CD2' ' HG2' ' A' ' 254' ' ' GLU . 69.4 m-85 -120.02 135.96 54.73 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.91 -0.494 . . . . 5.1699999999999999 111.589 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.744 -0.662 . . . . 3.5800000000000001 110.248 176.514 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.426 -0.583 . . . . 2.4100000000000001 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -133.3 118.71 2.18 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 119.857 -1.163 . . . . 1.6200000000000001 111.601 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 63.1 t -126.97 130.05 71.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.966 0.413 . . . . 2.4900000000000002 110.428 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -116.15 160.23 13.47 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 111.167 -0.773 . . . . 1.3 111.167 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 250' ' ' SER . 19.0 m -123.25 139.8 48.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 120.919 0.39 . . . . 2.3399999999999999 110.556 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 250' ' ' SER . 94.1 m-20 -105.39 131.8 52.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.989 -0.551 . . . . 2.7999999999999998 110.936 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -115.26 139.97 49.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.454 -0.943 . . . . 5.1900000000000004 108.454 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 15.5 t -144.2 143.03 30.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.109 0.48 . . . . 2.0499999999999998 110.751 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 59.1 t80 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 117.901 -1.047 . . . . 4.4199999999999999 109.116 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.355 0 CA-C-O 121.242 0.544 . . . . 3.6099999999999999 111.713 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -134.85 129.42 34.43 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.314 -1.365 . . . . 3.9100000000000001 107.314 166.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.467 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 96.4 m-70 -124.58 137.04 54.42 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.953 -0.699 . . . . 3.9399999999999999 110.898 -172.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.441 ' CE2' ' HB3' ' A' ' 281' ' ' PHE . 50.4 p90 -140.0 160.61 39.53 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.637 -0.71 . . . . 3.21 110.988 -176.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -134.12 129.85 36.52 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.777 -0.823 . . . . 2.6499999999999999 108.777 173.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.1 tt -130.1 130.05 65.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.962 -0.755 . . . . 2.0699999999999998 108.962 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.509 ' HA3' ' OD1' ' A' ' 278' ' ' ASN . . . -144.61 155.64 26.47 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 119.23 -1.462 . . . . 0.92000000000000004 113.454 -173.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -118.1 135.14 54.39 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.583 -0.525 . . . . 1.6499999999999999 109.583 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 59.7 ttm -130.27 132.16 45.8 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.936 -0.575 . . . . 2.9700000000000002 110.003 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -84.51 120.34 26.22 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.532 -0.544 . . . . 3.1499999999999999 109.532 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 C--N 1.324 -0.537 0 CA-C-O 121.434 0.635 . . . . 5.0899999999999999 111.408 -174.579 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.768 0.318 . . . . 3.48 110.585 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 14' ' ' MET . 85.2 Cg_endo -79.92 134.83 10.88 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.678 2.252 . . . . 2.0299999999999998 112.832 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.3 m -113.32 142.68 45.56 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.292 -0.633 . . . . 2.2799999999999998 109.292 172.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 59.4 t -115.93 134.5 59.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.701 0.286 . . . . 2.4100000000000001 111.295 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -119.65 139.91 51.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.321 -0.399 . . . . 4.4400000000000004 110.056 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -110.59 129.87 55.7 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.567 -0.531 . . . . 3.6200000000000001 109.567 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.53 HD22 ' HD3' ' A' ' 45' ' ' ARG . 51.3 t30 -143.43 127.63 17.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.601 -0.272 . . . . 2.48 110.295 -173.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -143.31 144.18 32.0 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.52 0.563 . . . . 1.53 112.52 -175.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.421 ' HB1' ' CB ' ' A' ' 45' ' ' ARG . . . -163.09 144.53 9.78 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.363 -0.381 . . . . 1.8 111.74 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.676 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 7.5 t30 -169.13 94.15 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 3.3799999999999999 110.14 166.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.57 -81.36 0.31 Allowed Glycine 0 CA--C 1.517 0.185 0 C-N-CA 120.878 -0.677 . . . . 1.8200000000000001 111.47 -176.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 22.9 Cg_endo -61.71 175.73 1.6 Allowed 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.326 2.684 . . . . 2.1000000000000001 111.776 170.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -68.21 174.72 3.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.968 0.413 . . . . 4.0499999999999998 110.159 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.53 ' HD3' HD22 ' A' ' 38' ' ' ASN . 39.0 ttm180 -110.56 124.84 52.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.24 0.543 . . . . 3.6000000000000001 111.078 -166.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.5 mm -113.09 130.01 67.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.414 -0.812 . . . . 2.2799999999999998 110.599 -173.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.406 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -117.95 129.95 55.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.274 -0.421 . . . . 1.4399999999999999 110.064 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.1 tp -128.14 133.98 49.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.112 -0.495 . . . . 1.75 110.661 -176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.02 153.91 37.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.142 -0.481 . . . . 1.5900000000000001 110.244 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -120.11 139.97 51.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.782 0.325 . . . . 4.4400000000000004 110.684 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.59 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 71.1 t80 -99.9 129.96 46.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.088 -0.505 . . . . 5.0199999999999996 110.527 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -133.45 150.47 51.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.336 -0.847 . . . . 3.7400000000000002 109.049 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 . . . . . 0 C--N 1.322 -0.604 0 CA-C-O 120.952 0.406 . . . . 5.0499999999999998 110.627 -178.325 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 77.6 t90 . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.505 -0.554 . . . . 6.5 109.505 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -150.26 159.95 44.06 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.212 -0.449 . . . . 4.5999999999999996 110.266 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -148.65 170.48 18.05 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.051 -0.722 . . . . 2.4500000000000002 109.051 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.59 ' HB3' ' HB3' ' A' ' 51' ' ' TYR . 29.0 ttp180 -135.0 122.16 15.06 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.648 -0.421 . . . . 3.7200000000000002 110.195 171.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.648 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 71.8 Cg_endo -81.91 146.2 14.51 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.756 2.304 . . . . 1.3200000000000001 111.47 169.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -136.57 120.08 17.05 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.699 -0.482 . . . . 2.1899999999999999 109.699 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.406 HD11 ' O ' ' A' ' 47' ' ' ALA . 40.6 tp -136.63 129.82 31.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.0 -0.545 . . . . 1.73 110.338 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -117.93 142.18 47.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.176 -0.466 . . . . 2.1800000000000002 110.216 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.8 t -113.33 120.02 62.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.558 -0.904 . . . . 2.0600000000000001 108.558 173.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.514 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 15.3 m-70 -108.27 120.13 41.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.989 -0.55 . . . . 4.1900000000000004 109.769 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -99.14 141.44 31.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.155 -0.475 . . . . 5.1600000000000001 110.434 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -100.84 132.13 46.39 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.906 -0.405 . . . . 3.3100000000000001 109.906 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -120.02 99.8 6.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.768 0.318 . . . . 4.6600000000000001 111.662 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.6 tp . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 121.359 0.6 . . . . 4.8799999999999999 109.615 171.545 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.7 p . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 110.096 -0.335 . . . . 2.6400000000000001 110.096 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 52.9 t80 71.97 -76.75 0.06 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.982 -0.554 . . . . 6.1900000000000004 111.794 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.13 166.94 34.79 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 118.478 -1.82 . . . . 1.54 114.853 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.1 tp -133.6 130.05 37.82 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.542 -0.91 . . . . 2.73 108.542 173.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.2 m -120.06 127.51 52.64 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.05 0.453 . . . . 1.8700000000000001 110.555 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -132.07 132.57 6.74 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.83 -0.908 . . . . 1.1699999999999999 110.83 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -141.94 156.24 25.86 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.32 -0.943 . . . . 1.4399999999999999 112.343 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -139.31 149.34 44.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.073 0.463 . . . . 4.6399999999999997 110.614 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.403 ' HB2' ' HB3' ' A' ' 112' ' ' ARG . 99.7 mtt180 -131.57 129.85 41.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.447 -0.797 . . . . 3.2200000000000002 109.449 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.648 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 8.5 t30 -115.29 117.58 30.86 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.4 -0.592 . . . . 2.2200000000000002 109.4 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -111.76 120.3 41.55 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.607 0.241 . . . . 3.6400000000000001 110.529 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.436 0 C-N-CA 120.727 -0.749 . . . . 2.79 112.006 179.674 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.427 -0.583 . . . . 3.77 109.427 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.87 130.81 5.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.231 -0.285 . . . . 2.2000000000000002 110.231 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -139.77 108.12 5.82 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.703 -0.48 . . . . 3.1200000000000001 109.703 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 89.7 mtp -116.98 128.1 54.85 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.243 -0.435 . . . . 2.1200000000000001 109.917 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -110.22 133.52 53.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.03 0.443 . . . . 2.4900000000000002 111.127 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 35.2 ttt180 -109.89 117.84 34.89 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.329 -0.619 . . . . 4.4699999999999998 109.329 172.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -113.6 136.32 52.95 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.503 -0.555 . . . . 2.9199999999999999 109.503 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -139.12 128.85 24.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.208 -0.451 . . . . 2.5099999999999998 110.817 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 87.0 mt -120.01 121.01 64.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.952 -0.759 . . . . 2.1299999999999999 108.952 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -137.59 105.3 8.36 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.381 -0.372 . . . . 1.6799999999999999 111.051 -175.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 74.2 Cg_endo -79.64 139.99 14.56 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.075 1.85 . . . . 1.54 110.614 173.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -95.57 136.6 35.75 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.773 -1.195 . . . . 2.3500000000000001 107.773 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -124.51 127.97 48.26 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.118 0.485 . . . . 5.1500000000000004 111.349 -176.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -131.92 120.22 22.22 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.797 -0.816 . . . . 3.04 108.797 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.4 t -132.85 115.83 25.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.438 -0.346 . . . . 4.7400000000000002 110.329 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -107.76 86.45 2.3 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.268 0.556 . . . . 6.3600000000000003 110.513 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.04 -39.95 90.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.437 -0.801 . . . . 4.96 109.696 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.558 ' OG1' ' HB2' ' A' ' 127' ' ' LEU . 24.4 p -129.87 164.01 25.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.218 -0.901 . . . . 4.0700000000000003 109.77 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -73.44 -47.1 44.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.722 0.296 . . . . 5.1699999999999999 111.17 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -70.07 -40.08 75.27 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.133 -0.485 . . . . 3.71 112.027 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.558 ' HB2' ' OG1' ' A' ' 124' ' ' THR . 6.1 mp -102.11 118.45 36.93 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.71 -0.478 . . . . 2.4500000000000002 109.71 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.413 ' HB2' ' HB2' ' A' ' 159' ' ' GLN . 90.6 mtt180 -122.94 134.88 54.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.005 -0.543 . . . . 4.6799999999999997 109.812 -174.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.41 ' CE1' HD12 ' A' ' 158' ' ' LEU . 97.1 m-85 -109.22 129.07 55.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.76 0.314 . . . . 4.3600000000000003 110.519 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -146.32 120.93 9.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.423 -0.584 . . . . 2.5899999999999999 109.423 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -157.13 172.18 34.6 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.565 -0.826 . . . . 1.25 112.047 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.461 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 9.2 p90 -140.23 140.91 35.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.134 0.492 . . . . 5.0899999999999999 111.158 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 66.5 mt -109.41 133.75 52.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.023 -0.732 . . . . 2.7599999999999998 109.023 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 73.9 m -129.9 135.5 48.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.283 0.563 . . . . 1.99 112.14 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 68.6 mtt -119.98 136.76 54.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.443 -0.799 . . . . 2.7799999999999998 108.872 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.505 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 96.1 m-85 -120.05 134.36 55.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.002 0.43 . . . . 3.6800000000000002 111.635 -176.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 98.4 mttt -128.18 138.82 52.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.56 -0.745 . . . . 2.1699999999999999 109.37 173.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.44 ' O ' HD21 ' A' ' 142' ' ' LEU . 96.1 m-85 -129.91 150.76 51.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.687 0.279 . . . . 4.0099999999999998 111.09 -176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 58.99 -165.03 0.19 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.669 -0.696 . . . . 1.79 111.306 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -76.95 -32.81 57.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.29 0.567 . . . . 3.04 110.254 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -60.01 -46.78 88.38 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.046 -0.979 . . . . 2.4100000000000001 113.176 -168.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.44 HD21 ' O ' ' A' ' 138' ' ' PHE . 4.1 mm? -69.92 -29.21 66.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.141 0.496 . . . . 2.3599999999999999 110.545 -177.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -69.76 -40.02 76.37 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.905 -0.589 . . . . 2.52 109.896 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.4 m -63.85 -40.12 95.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.098 -0.955 . . . . 2.52 111.233 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.4 p -75.7 -23.63 56.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.821 0.343 . . . . 2.0099999999999998 111.615 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 60.43 -120.98 25.12 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.757 -0.656 . . . . 1.52 113.327 174.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -69.94 -30.6 68.03 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.4 0.28 . . . . 6.2199999999999998 111.727 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.7 -49.95 75.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 2.0499999999999998 112.054 -174.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -122.93 113.3 18.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.951 0.405 . . . . 2.6400000000000001 110.924 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.9 t -160.01 150.29 18.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.018 -0.734 . . . . 2.6000000000000001 109.018 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.505 ' HB2' ' HB2' ' A' ' 136' ' ' TYR . 98.5 mtt180 -83.7 137.28 33.84 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.075 -0.343 . . . . 4.0899999999999999 110.075 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.6 119.95 60.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.337 -0.392 . . . . 2.1499999999999999 110.493 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -124.29 129.88 51.53 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.731 -0.84 . . . . 2.5600000000000001 108.731 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 50.8 m -136.71 130.17 31.68 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.623 -0.262 . . . . 1.78 111.409 -174.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.461 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 82.4 tt0 -130.76 121.48 25.49 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.125 0.488 . . . . 2.04 109.818 175.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 40.7 p -119.33 139.17 52.38 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.596 -0.729 . . . . 2.0299999999999998 109.993 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -130.05 141.85 13.07 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.243 -0.98 . . . . 1.0800000000000001 113.349 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.41 HD12 ' CE1' ' A' ' 129' ' ' PHE . 63.7 tp -122.21 128.58 51.36 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.733 -0.469 . . . . 2.9300000000000002 109.733 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 168' ' ' LEU . 95.6 mt-30 -100.01 126.78 46.25 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.327 -0.62 . . . . 3.02 109.327 173.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -126.06 128.81 47.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.388 -0.369 . . . . 4.7599999999999998 110.38 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 2.4 p -85.3 88.59 7.51 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.348 0.594 . . . . 1.8200000000000001 111.071 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -60.07 -49.94 75.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.579 -0.737 . . . . 3.27 111.618 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.488 ' HB2' HG21 ' A' ' 166' ' ' VAL . 92.7 m-20 -102.61 14.55 31.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.535 -0.302 . . . . 2.4100000000000001 110.851 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 72.98 -49.03 0.7 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.893 0.746 . . . . 2.5800000000000001 110.487 -176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 27.2 m -72.86 -33.17 65.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.176 -0.465 . . . . 2.6000000000000001 111.037 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.488 HG21 ' HB2' ' A' ' 163' ' ' ASN . 13.7 m -108.75 138.63 34.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.861 0.362 . . . . 2.0600000000000001 110.914 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -109.21 137.21 47.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.085 -0.507 . . . . 1.8400000000000001 110.608 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 159' ' ' GLN . 16.2 mt -103.22 129.96 50.31 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.698 -0.482 . . . . 2.1400000000000001 109.698 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -94.11 105.43 17.43 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.529 -0.545 . . . . 3.73 109.529 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.3 t -119.31 121.99 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.858 -0.423 . . . . 1.8100000000000001 109.858 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.569 ' OD1' ' HB2' ' A' ' 195' ' ' ARG . 30.4 p30 -132.3 156.65 46.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.349 0.595 . . . . 2.2400000000000002 112.086 -177.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.541 ' CE1' ' HB3' ' A' ' 193' ' ' GLU . 67.8 t80 -124.3 131.42 53.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.992 -1.003 . . . . 4.8399999999999999 109.586 177.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -113.2 135.01 54.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.154 0.502 . . . . 4.4299999999999997 110.42 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.7 tp -100.01 116.6 32.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.734 -0.666 . . . . 2.8500000000000001 109.608 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.498 ' OE2' ' HD2' ' A' ' 176' ' ' ARG . 31.7 tt0 -70.02 -40.76 75.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.962 -0.563 . . . . 3.3100000000000001 111.307 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.498 ' HD2' ' OE2' ' A' ' 175' ' ' GLU . 8.8 ptm180 . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.569 -0.741 . . . . 7.3300000000000001 110.525 -169.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.541 ' HB3' ' CE1' ' A' ' 172' ' ' TYR . 36.0 mt-10 . . . . . 0 C--O 1.233 0.234 0 CA-C-O 121.115 0.483 . . . . 4.4000000000000004 110.777 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 48.5 mm -105.76 127.89 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.616 -0.72 . . . . 2.6400000000000001 110.646 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.569 ' HB2' ' OD1' ' A' ' 171' ' ' ASN . 25.2 mtm180 -110.87 129.32 55.9 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.549 -0.537 . . . . 4.1100000000000003 109.549 174.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -118.4 134.49 55.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.085 -0.507 . . . . 1.76 110.924 -177.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -133.59 143.32 48.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.626 -0.715 . . . . 6.1399999999999997 109.56 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 208' ' ' THR . 42.3 tp -119.92 124.22 28.01 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.178 -0.675 . . . . 3.0800000000000001 109.178 171.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -93.28 105.41 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.905 1.737 . . . . 1.98 112.449 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.8 tp -96.11 121.89 38.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.043 -0.526 . . . . 2.7599999999999998 109.648 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 89.6 m -99.9 118.85 37.2 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.275 0.559 . . . . 2.4199999999999999 110.845 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 94.4 mt -125.7 81.07 1.95 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.191 -1.04 . . . . 2.77 108.191 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 74.35 -126.87 9.55 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.705 -0.958 . . . . 1.6200000000000001 110.705 -172.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -95.08 -0.11 53.87 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.304 0.573 . . . . 2.8599999999999999 109.531 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -99.34 119.18 37.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.518 -0.764 . . . . 3.23 109.554 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 32.1 t -112.49 139.93 47.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.935 0.398 . . . . 2.0499999999999998 110.525 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.92 123.12 70.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.658 -0.867 . . . . 1.9299999999999999 108.658 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 198' ' ' LEU . 42.6 m -126.86 93.02 43.18 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-O 120.788 0.327 . . . . 1.6699999999999999 110.721 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 29.0 Cg_endo -69.82 149.87 67.1 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.841 1.694 . . . . 1.28 111.378 175.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -126.0 138.05 53.71 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.729 -0.669 . . . . 4.8600000000000003 109.987 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 59.2 p -130.01 143.57 50.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.204 -0.453 . . . . 2.0899999999999999 110.012 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -95.16 -15.35 23.38 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.939 -0.573 . . . . 5.29 109.922 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.0 mt . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.73 -0.668 . . . . 4.9400000000000004 110.087 170.691 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 62.6 t . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.768 -0.456 . . . . 2.9700000000000002 109.768 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -85.47 138.85 16.83 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.327 -0.939 . . . . 1.3999999999999999 110.987 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.44 ' HB2' ' HB3' ' A' ' 255' ' ' TYR . 92.6 mt -119.69 129.48 54.56 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.494 -0.482 . . . . 2.4300000000000002 110.013 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.431 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 65.2 t80 -107.37 131.19 54.52 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.361 -0.607 . . . . 4.3300000000000001 109.361 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -120.0 140.12 51.46 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.824 -0.435 . . . . 3.2599999999999998 109.824 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -125.91 128.28 6.41 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.247 -0.978 . . . . 1.3500000000000001 112.48 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -111.39 117.0 31.89 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.507 -0.553 . . . . 4.7599999999999998 109.507 173.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.47 133.87 55.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.781 0.324 . . . . 4.29 110.307 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -119.93 139.92 51.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.337 -0.392 . . . . 7.5599999999999996 110.384 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -64.86 -13.24 55.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.757 -0.656 . . . . 7.0199999999999996 110.561 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -69.98 -10.93 60.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.712 -0.676 . . . . 6.4800000000000004 110.567 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 104.7 -2.54 42.06 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.696 -0.764 . . . . 2.9199999999999999 112.259 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 61.8 tp -95.18 120.02 34.68 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.015 -0.365 . . . . 3.5800000000000001 110.015 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 8.6 t -121.6 129.94 53.17 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.437 -0.579 . . . . 2.6000000000000001 109.437 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.6 t -124.37 132.54 71.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.026 0.441 . . . . 2.2400000000000002 110.882 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 51.9 m -110.23 129.06 55.79 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.876 -0.602 . . . . 2.0 109.865 178.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 75.0 mt -120.0 130.34 54.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.312 -0.403 . . . . 3.4199999999999999 111.027 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -101.84 124.85 48.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.438 -0.347 . . . . 4.0800000000000001 110.073 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' TYR . . . . . 0.44 ' HB3' ' HB2' ' A' ' 239' ' ' LEU . 61.2 t80 -104.33 129.97 52.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.547 . . . . 5.1699999999999999 109.588 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.588 0 CA-C-N 116.371 -0.377 . . . . 3.5800000000000001 111.458 -176.12 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 109.833 -0.432 . . . . 2.4100000000000001 109.833 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.1 116.64 1.99 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.897 -1.144 . . . . 1.6200000000000001 111.895 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 62.6 t -129.92 130.0 66.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.638 0.256 . . . . 2.4900000000000002 110.826 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.09 126.97 5.41 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.807 -0.917 . . . . 1.3 110.807 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.6 t -118.19 120.05 63.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 117.099 0.449 . . . . 2.3399999999999999 110.954 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . 0.509 ' OD1' ' HA3' ' A' ' 12' ' ' GLY . 96.3 m-20 -119.3 129.98 55.16 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.579 -0.526 . . . . 2.7999999999999998 109.579 176.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -112.08 116.44 30.52 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.193 -0.669 . . . . 5.1900000000000004 109.193 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 15.3 t -121.71 130.3 53.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.101 -0.499 . . . . 2.0499999999999998 110.382 -176.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 65.1 t80 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.245 -0.883 . . . . 4.4199999999999999 108.939 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 CA--C 1.523 -0.095 0 CA-C-O 120.799 0.333 . . . . 3.6099999999999999 110.698 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -77.56 121.57 24.08 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.598 -0.89 . . . . 3.9100000000000001 108.598 171.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.536 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 32.7 m170 -98.38 131.63 44.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.218 0.532 . . . . 3.9399999999999999 111.246 -174.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -139.65 159.91 41.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.642 -0.708 . . . . 3.21 110.644 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 41.9 t30 -145.88 129.7 17.22 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.48 -0.563 . . . . 2.6499999999999999 109.48 172.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.4 mt -120.56 122.53 68.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.326 -0.62 . . . . 2.0699999999999998 109.326 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -130.15 137.3 9.42 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 119.85 -1.167 . . . . 0.92000000000000004 112.827 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.57 136.29 54.84 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.789 -0.449 . . . . 1.6499999999999999 109.789 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 57.5 ttm -143.44 150.65 39.32 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.746 -0.464 . . . . 2.9700000000000002 109.746 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -106.69 119.99 40.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.115 -0.328 . . . . 3.1499999999999999 110.115 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 116.436 -0.347 . . . . 5.0899999999999999 110.209 -177.916 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.711 -0.477 . . . . 3.48 109.711 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -64.59 134.32 40.63 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.551 2.168 . . . . 2.0299999999999998 112.383 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 m -121.35 142.97 49.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.047 -0.524 . . . . 2.2799999999999998 109.706 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.0 p -135.39 141.87 41.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.065 0.46 . . . . 2.4100000000000001 110.943 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -137.85 147.61 44.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.979 -0.555 . . . . 4.4400000000000004 110.694 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -119.91 140.08 51.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.965 -0.562 . . . . 3.6200000000000001 111.238 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 10' ' ' ASN . 28.6 m-80 -121.52 140.44 52.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.723 -0.671 . . . . 2.48 110.095 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -137.87 140.93 40.69 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.987 -0.285 . . . . 1.53 110.394 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.54 122.04 2.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.124 -0.489 . . . . 1.8 110.669 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.681 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 43.4 t30 -149.95 92.12 1.86 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.23 -0.656 . . . . 3.3799999999999999 109.23 171.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.86 -78.96 0.28 Allowed Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.093 -0.803 . . . . 1.8200000000000001 111.093 -174.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.681 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 24.9 Cg_endo -61.96 175.57 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.526 2.817 . . . . 2.1000000000000001 112.94 171.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.451 ' HB3' ' O ' ' A' ' 75' ' ' HIS . 8.4 m-90 -69.41 -172.99 0.51 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.518 -0.765 . . . . 4.0499999999999998 111.15 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -106.64 122.34 46.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.779 0.8 . . . . 3.6000000000000001 111.237 -167.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 87.5 mt -111.81 136.09 49.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.417 -1.265 . . . . 2.2799999999999998 109.895 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . . . -117.22 132.48 56.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.087 -0.506 . . . . 1.4399999999999999 109.877 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.5 tp -119.49 131.7 55.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.059 -0.519 . . . . 1.75 110.489 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.54 163.64 39.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.763 -0.653 . . . . 1.5900000000000001 109.537 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -157.05 150.6 24.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.644 0.259 . . . . 4.4400000000000004 110.396 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -130.04 150.02 51.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.911 -0.586 . . . . 5.0199999999999996 110.603 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -125.31 124.38 41.48 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.472 -0.785 . . . . 3.7400000000000002 109.301 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.727 -0.67 . . . . 5.0499999999999998 111.073 -175.577 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 75.8 m95 . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 120.963 0.411 . . . . 6.5 110.85 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -120.02 140.02 51.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.839 -0.619 . . . . 4.5999999999999996 110.342 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -134.8 160.05 39.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.574 -0.739 . . . . 2.4500000000000002 109.861 -174.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 17.1 ptp180 -148.48 125.09 5.39 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.871 0.367 . . . . 3.7200000000000002 110.626 171.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.423 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 89.3 Cg_endo -93.02 153.77 2.65 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.941 2.428 . . . . 1.3200000000000001 112.313 171.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.474 ' HG2' ' HG2' ' A' ' 93' ' ' ARG . 43.8 mt-10 -118.91 125.51 49.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.295 -0.411 . . . . 2.1899999999999999 110.123 175.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.407 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 64.0 tp -122.12 112.59 18.4 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.019 -0.537 . . . . 1.73 109.981 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 47' ' ' ALA . 80.0 mt-10 -108.5 132.72 53.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.003 0.43 . . . . 2.1800000000000002 111.28 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.42 124.59 72.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.894 -0.78 . . . . 2.0600000000000001 108.894 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.451 ' O ' ' HB3' ' A' ' 44' ' ' TRP . 28.1 m-70 -106.32 119.1 38.36 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.84 -0.43 . . . . 4.1900000000000004 109.84 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.486 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 79.4 t80 -100.45 122.53 43.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.769 -0.65 . . . . 5.1600000000000001 110.35 -176.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -109.21 128.68 55.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.592 -0.731 . . . . 3.3100000000000001 109.693 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -143.37 129.95 20.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.069 -0.252 . . . . 4.6600000000000001 111.224 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 N--CA 1.465 0.309 0 CA-C-N 115.606 -0.724 . . . . 4.8799999999999999 111.703 177.67 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 120.878 0.37 . . . . 2.6400000000000001 110.747 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -123.06 148.33 45.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.056 -0.52 . . . . 6.1900000000000004 110.292 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.94 163.8 28.28 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.548 -0.834 . . . . 1.54 111.959 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 65.1 tp -145.61 128.6 16.5 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.472 -0.566 . . . . 2.73 109.472 174.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 p -118.31 128.53 54.75 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.308 0.575 . . . . 1.8700000000000001 110.9 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.84 132.63 8.48 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.571 -0.823 . . . . 1.1699999999999999 111.319 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -128.14 127.42 5.71 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 111.497 -0.641 . . . . 1.4399999999999999 111.497 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -111.09 130.28 55.66 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.888 0.375 . . . . 4.6399999999999997 110.483 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.474 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 91.0 mtt180 -122.95 126.88 48.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.615 -0.72 . . . . 3.2200000000000002 109.12 175.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 64.9 t30 -107.33 129.94 54.84 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.337 -0.616 . . . . 2.2200000000000002 109.337 -178.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.43 ' HB3' ' HB3' ' A' ' 110' ' ' MET . 54.5 t80 -137.05 146.05 44.74 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.416 -0.514 . . . . 3.6400000000000001 110.576 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.517 0 C-N-CA 120.622 -0.799 . . . . 2.79 112.495 177.7 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 109.591 -0.522 . . . . 3.77 109.591 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.39 116.38 7.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.667 -0.242 . . . . 2.2000000000000002 110.589 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -117.67 130.54 56.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.443 -0.344 . . . . 3.1200000000000001 110.085 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.496 ' HG3' ' H ' ' A' ' 139' ' ' ALA . 46.3 ttm -132.56 122.34 24.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.831 0.348 . . . . 2.1200000000000001 111.624 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.497 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 56.7 mt-30 -103.54 118.71 37.35 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.036 -0.727 . . . . 2.4900000000000002 109.036 170.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 31.4 ttm180 -113.77 120.73 41.8 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.124 0.488 . . . . 4.4699999999999998 110.168 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -119.14 139.62 51.5 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.728 -0.669 . . . . 2.9199999999999999 110.409 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 135' ' ' MET . 82.0 tttt -128.84 123.68 33.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.717 -0.674 . . . . 2.5099999999999998 109.559 172.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.9 mm -124.21 128.15 73.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.016 -0.538 . . . . 2.1299999999999999 109.698 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -142.71 106.47 5.42 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 120.681 0.277 . . . . 1.6799999999999999 111.493 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 65.2 Cg_endo -76.8 132.53 13.16 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.977 1.784 . . . . 1.54 110.467 172.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -92.38 137.31 32.47 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.538 -0.541 . . . . 2.3500000000000001 109.538 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -128.44 129.99 46.94 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.862 -0.422 . . . . 5.1500000000000004 109.862 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -137.49 119.76 15.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.843 0.354 . . . . 3.04 110.481 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.9 t -129.56 128.28 65.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.732 -0.667 . . . . 4.7400000000000002 109.659 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -114.99 96.86 5.91 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.789 -0.448 . . . . 6.3600000000000003 109.789 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.99 -33.24 71.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.557 0.694 . . . . 4.96 109.683 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 8.6 m -140.35 159.88 41.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.18 -0.918 . . . . 4.0700000000000003 108.75 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -60.14 -41.99 93.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.503 0.668 . . . . 5.1699999999999999 109.361 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -69.92 -40.03 75.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.763 -1.108 . . . . 3.71 111.946 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.9 mt -104.94 119.43 39.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 2.4500000000000002 110.814 -172.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.453 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 79.4 ttt180 -125.71 133.31 52.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.119 -0.491 . . . . 4.6799999999999997 111.453 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -108.98 119.99 41.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 4.3600000000000003 109.332 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -143.81 135.79 26.5 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.802 -0.444 . . . . 2.5899999999999999 109.802 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -171.8 172.13 44.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.445 -0.883 . . . . 1.25 111.689 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -143.0 150.57 39.82 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.991 0.424 . . . . 5.0899999999999999 110.691 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.605 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 47.8 tp -106.0 111.61 24.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.933 -0.576 . . . . 2.7599999999999998 109.511 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.5 t -101.56 121.1 41.37 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.864 0.364 . . . . 1.99 110.631 -173.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.413 ' O ' ' HA ' ' A' ' 114' ' ' LYS . 74.8 mtm -111.83 133.24 54.17 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.345 -0.389 . . . . 2.7799999999999998 110.08 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -118.98 134.88 54.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.95 0.405 . . . . 3.6800000000000002 111.411 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 97.3 mttt -138.55 148.35 44.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.078 -0.712 . . . . 2.1699999999999999 109.078 174.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 54.8 p90 -150.83 160.02 44.15 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.974 -0.38 . . . . 4.0099999999999998 109.974 175.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.496 ' H ' ' HG3' ' A' ' 110' ' ' MET . . . 72.16 -178.69 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.876 0.735 . . . . 1.79 110.334 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -76.82 -39.67 50.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.963 0.411 . . . . 3.04 111.279 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.0 -49.61 77.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.715 -0.675 . . . . 2.4100000000000001 112.532 -171.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.438 HD21 ' H ' ' A' ' 138' ' ' PHE . 9.5 mp -62.59 -36.35 82.45 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.137 0.494 . . . . 2.3599999999999999 111.129 -177.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.497 ' ND2' ' HB2' ' A' ' 111' ' ' GLN . 94.0 m-20 -66.13 -39.93 90.26 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.24 0.543 . . . . 2.52 110.388 175.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 90.9 m -66.75 -42.25 86.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.367 -0.833 . . . . 2.52 111.061 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 33.9 p -72.72 -28.89 62.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.251 0.548 . . . . 2.0099999999999998 110.6 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.05 -118.05 7.84 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.531 -0.759 . . . . 1.52 113.041 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -70.11 -20.05 63.21 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.553 0.205 . . . . 6.2199999999999998 111.553 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.438 ' HB2' ' HB ' ' A' ' 145' ' ' THR . . . -66.25 -57.32 7.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.462 -0.336 . . . . 2.0499999999999998 111.851 -175.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -117.16 83.84 2.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.461 0.648 . . . . 2.6400000000000001 110.945 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.1 t -145.74 142.44 28.94 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.433 -0.803 . . . . 2.6000000000000001 109.502 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.404 ' HB3' ' OE2' ' A' ' 153' ' ' GLU . 15.1 mtp180 -76.59 131.97 39.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.872 0.368 . . . . 4.0899999999999999 110.626 176.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.09 115.85 49.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.744 -0.662 . . . . 2.1499999999999999 109.499 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.404 ' OE2' ' HB3' ' A' ' 151' ' ' ARG . 17.8 mm-40 -113.03 129.1 56.62 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.08 -0.711 . . . . 2.5600000000000001 109.08 -177.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.42 ' HB ' ' HB2' ' A' ' 174' ' ' LEU . 21.4 m -113.34 120.03 39.72 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 121.07 -0.252 . . . . 1.78 110.745 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -116.45 122.13 43.88 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.741 -0.466 . . . . 2.04 109.741 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 55.3 m -119.58 128.22 53.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.182 -0.463 . . . . 2.0299999999999998 110.544 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -115.33 128.47 8.09 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.968 -0.56 . . . . 1.0800000000000001 111.868 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 79.6 mt -118.27 134.66 54.84 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.634 -0.506 . . . . 2.9300000000000002 109.634 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.453 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 63.1 tt0 -115.07 125.85 54.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.941 -0.392 . . . . 3.02 109.941 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -130.3 133.79 46.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.252 -0.431 . . . . 4.7599999999999998 110.255 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.0 p -90.73 87.65 6.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.178 0.513 . . . . 1.8200000000000001 109.617 171.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -60.33 -49.57 77.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.702 -0.681 . . . . 3.27 111.367 -173.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.438 ' HB2' HG23 ' A' ' 166' ' ' VAL . 22.8 m120 -101.84 17.1 23.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.457 -0.338 . . . . 2.4100000000000001 110.499 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 72.4 -53.87 0.69 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 123.908 0.755 . . . . 2.5800000000000001 111.415 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.7 p -75.05 -15.96 60.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.348 -0.387 . . . . 2.6000000000000001 111.94 -176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' A' ' 163' ' ' ASN . 33.2 m -125.53 140.4 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.559 -0.291 . . . . 2.0600000000000001 110.481 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.26 128.35 53.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.951 0.405 . . . . 1.8400000000000001 110.48 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 22.1 mt -105.61 137.16 43.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.901 -0.591 . . . . 2.1400000000000001 109.476 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -110.64 116.12 30.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.961 0.41 . . . . 3.73 110.264 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 63.0 t -124.01 129.87 74.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.886 -0.412 . . . . 1.8100000000000001 109.886 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.404 ' OD1' ' HB2' ' A' ' 195' ' ' ARG . 25.9 p30 -134.09 156.09 48.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.875 0.369 . . . . 2.2400000000000002 110.969 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -145.34 150.02 35.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.183 -0.462 . . . . 4.8399999999999999 111.017 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -105.2 126.38 52.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.725 -0.671 . . . . 4.4299999999999997 111.615 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 154' ' ' THR . 93.3 mt -113.62 130.48 56.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.784 -0.644 . . . . 2.8500000000000001 110.151 175.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -100.39 128.87 46.35 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.272 -0.64 . . . . 3.3100000000000001 109.272 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 . . . . . 0 C--N 1.326 -0.437 0 CA-C-O 120.807 0.337 . . . . 7.3300000000000001 110.562 -179.297 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 121.251 0.548 . . . . 4.4000000000000004 110.892 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 82.2 mt -120.05 129.99 74.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.61 -0.723 . . . . 2.6400000000000001 109.493 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.404 ' HB2' ' OD1' ' A' ' 171' ' ' ASN . 85.1 mtm180 -96.3 115.05 26.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.778 0.323 . . . . 4.1100000000000003 110.6 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -108.39 124.02 49.73 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.599 -0.519 . . . . 1.76 109.599 174.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -147.53 151.93 37.15 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.75 0.31 . . . . 6.1399999999999997 110.612 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.41 ' O ' ' HD2' ' A' ' 209' ' ' PRO . 1.8 pt? -129.66 128.37 23.03 Favored Pre-proline 0 C--N 1.321 -0.668 0 C-N-CA 120.98 -0.288 . . . . 3.0800000000000001 110.538 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.16 105.99 2.14 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.4 2.067 . . . . 1.98 111.427 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 56.9 tp -99.18 120.07 38.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.794 -0.639 . . . . 2.7599999999999998 109.512 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 19.6 p -99.95 123.93 44.73 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.943 0.401 . . . . 2.4199999999999999 111.37 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 62.8 tp -130.29 81.84 2.03 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.032 -0.729 . . . . 2.77 109.032 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 70.03 -125.2 15.29 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.409 -0.814 . . . . 1.6200000000000001 112.283 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -86.82 -0.3 56.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.253 0.549 . . . . 2.8599999999999999 110.051 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -103.0 117.44 34.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.74 -0.664 . . . . 3.23 110.112 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 63.3 m -107.9 123.75 49.08 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.779 -0.452 . . . . 2.0499999999999998 109.779 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 50.6 t -119.3 129.97 74.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 1.9299999999999999 109.854 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 25.3 m -126.62 91.29 47.73 Favored Pre-proline 0 C--N 1.318 -0.769 0 C-N-CA 120.965 -0.294 . . . . 1.6699999999999999 110.722 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 38.4 Cg_endo -70.8 146.33 53.49 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.128 1.885 . . . . 1.28 111.694 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -112.41 139.62 47.83 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.847 0.356 . . . . 4.8600000000000003 110.344 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 21.1 p -134.58 125.25 26.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.762 -0.653 . . . . 2.0899999999999999 110.731 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -70.12 -36.12 74.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.255 -0.884 . . . . 5.29 109.942 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 86.3 mt . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.399 -0.819 . . . . 4.9400000000000004 109.451 176.396 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.994 0.426 . . . . 2.9700000000000002 111.061 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -92.3 146.19 18.06 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.898 -0.668 . . . . 1.3999999999999999 111.999 -177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 89.3 mt -119.47 131.3 55.58 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.306 0.574 . . . . 2.4300000000000002 111.129 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -108.75 130.16 55.37 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.413 -0.812 . . . . 4.3300000000000001 109.767 173.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.48 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 96.1 m-85 -119.67 140.05 51.26 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.498 -0.927 . . . . 3.2599999999999998 108.498 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.44 167.05 33.42 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.64 -1.267 . . . . 1.3500000000000001 112.945 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -121.5 112.24 18.26 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.695 -0.483 . . . . 4.7599999999999998 109.695 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -120.87 13.88 11.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.242 0.544 . . . . 4.29 109.815 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.96 -40.33 88.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.356 -0.838 . . . . 7.5599999999999996 110.391 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -102.88 135.85 43.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.629 -0.714 . . . . 7.0199999999999996 109.747 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -70.01 -19.08 63.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 6.4800000000000004 111.535 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -96.66 2.81 62.66 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.704 -0.76 . . . . 2.9199999999999999 112.718 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 62.8 tp -131.2 129.94 42.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.818 0.342 . . . . 3.5800000000000001 110.648 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 48.9 m -134.94 130.4 35.78 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.399 -0.593 . . . . 2.6000000000000001 109.399 173.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.5 t -130.02 133.1 64.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 120.837 -0.345 . . . . 2.2400000000000002 110.906 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 11.1 p -115.92 109.99 18.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.119 0.485 . . . . 2.0 110.857 176.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 79.3 mt -105.54 120.06 40.69 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.049 -0.723 . . . . 3.4199999999999999 109.049 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -113.64 112.83 24.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.548 -0.296 . . . . 4.0800000000000001 111.173 -172.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -127.15 110.08 12.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.039 -0.528 . . . . 5.1699999999999999 109.76 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.547 0 CA-C-O 120.832 0.349 . . . . 3.5800000000000001 111.619 179.083 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 110.178 -0.305 . . . . 2.4100000000000001 110.178 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -157.69 167.15 34.09 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.32 -0.943 . . . . 1.6200000000000001 112.399 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.9 140.01 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.94 0.4 . . . . 2.4900000000000002 111.133 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.92 140.01 11.41 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.321 -0.712 . . . . 1.3 111.321 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.4 t -128.01 129.94 69.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.908 0.354 . . . . 2.3399999999999999 110.884 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -126.42 130.56 50.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.026 -0.534 . . . . 2.7999999999999998 111.004 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -113.55 129.19 56.6 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.423 -0.584 . . . . 5.1900000000000004 109.423 172.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 50.8 m -120.84 141.25 50.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.319 -0.4 . . . . 2.0499999999999998 110.485 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.536 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 91.0 m-85 . . . . . 0 C--O 1.247 0.96 0 CA-C-O 117.785 -1.103 . . . . 4.4199999999999999 109.584 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 . . . . . 0 CA--C 1.518 -0.267 0 CA-C-O 121.187 0.518 . . . . 3.6099999999999999 110.009 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.43 ' HA ' ' HB2' ' A' ' 41' ' ' ASN . 44.6 m95 -62.72 139.98 58.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.291 -0.868 . . . . 3.9100000000000001 111.471 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.35 135.64 36.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.125 -0.489 . . . . 3.9399999999999999 110.0 175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.92 139.94 51.65 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.854 -0.612 . . . . 3.21 110.683 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -126.64 129.83 49.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.276 -0.42 . . . . 2.6499999999999999 110.468 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.6 mt -121.0 120.09 61.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.058 -0.719 . . . . 2.0699999999999998 109.058 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.3 129.36 9.44 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.23 -0.986 . . . . 0.92000000000000004 111.475 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.1 134.83 54.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.162 0.506 . . . . 1.6499999999999999 110.636 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 68.0 mtt -126.63 141.38 51.87 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.566 -0.743 . . . . 2.9700000000000002 109.492 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -119.32 127.93 53.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.619 -0.264 . . . . 3.1499999999999999 110.586 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 . . . . . 0 C--N 1.329 -0.302 0 O-C-N 123.804 0.69 . . . . 5.0899999999999999 111.26 172.431 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 C--O 1.236 0.348 0 CA-C-O 120.604 0.24 . . . . 3.48 110.559 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.2 135.87 15.6 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.883 2.389 . . . . 2.0299999999999998 111.211 170.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.1 t -140.45 149.88 43.12 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 121.097 -0.241 . . . . 2.2799999999999998 110.848 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.2 m -126.56 139.93 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 2.4100000000000001 110.824 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -119.75 147.04 45.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.989 -0.551 . . . . 4.4400000000000004 110.105 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -119.29 139.36 52.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.792 0.33 . . . . 3.6200000000000001 111.103 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -150.16 142.45 24.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.967 -0.56 . . . . 2.48 110.266 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -148.29 143.73 27.13 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.959 -0.109 . . . . 1.53 110.993 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.56 135.14 7.45 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.972 0.36 . . . . 1.8 111.972 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.587 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 41.4 t30 -168.85 94.64 0.34 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.88 -0.6 . . . . 3.3799999999999999 110.096 170.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.85 -91.75 1.5 Allowed Glycine 0 CA--C 1.517 0.184 0 C-N-CA 120.901 -0.666 . . . . 1.8200000000000001 111.709 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.587 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 72.9 Cg_exo -50.44 176.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.608 2.872 . . . . 2.1000000000000001 113.456 169.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -67.1 170.8 6.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.621 -0.718 . . . . 4.0499999999999998 111.289 -171.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -113.11 130.03 56.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.8 -0.636 . . . . 3.6000000000000001 110.511 -173.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.5 tt -116.58 131.47 69.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.384 -0.825 . . . . 2.2799999999999998 110.492 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.418 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -118.38 128.6 54.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.002 -0.544 . . . . 1.4399999999999999 110.697 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.8 tp -103.65 126.59 50.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.951 -0.568 . . . . 1.75 110.242 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.0 168.39 19.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.098 0.475 . . . . 1.5900000000000001 110.928 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -164.31 160.01 20.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.867 -0.606 . . . . 4.4400000000000004 110.109 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.531 ' HB3' ' CG ' ' A' ' 69' ' ' ARG . 61.8 t80 -130.33 129.77 43.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.87 -0.419 . . . . 5.0199999999999996 109.87 177.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -130.85 159.74 36.49 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.972 -0.558 . . . . 3.7400000000000002 110.601 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 115.302 -0.863 . . . . 5.0499999999999998 109.174 176.719 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 95.2 m95 . . . . . 0 CA--C 1.517 -0.314 0 N-CA-C 110.095 -0.335 . . . . 6.5 110.095 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -116.69 140.04 49.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.243 0.544 . . . . 4.5999999999999996 110.464 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -139.72 170.42 15.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.533 -0.758 . . . . 2.4500000000000002 109.373 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.531 ' CG ' ' HB3' ' A' ' 51' ' ' TYR . 3.2 ptp180 -129.98 125.95 22.23 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 120.419 -0.512 . . . . 3.7200000000000002 111.161 175.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.4 140.03 5.24 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.918 2.412 . . . . 1.3200000000000001 110.835 167.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.468 ' CD ' ' HE ' ' A' ' 93' ' ' ARG . 76.7 mt-10 -126.87 130.0 49.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.738 -0.468 . . . . 2.1899999999999999 109.738 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.418 HD11 ' O ' ' A' ' 47' ' ' ALA . 57.8 tp -133.54 120.85 21.3 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.562 -0.29 . . . . 1.73 110.339 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -119.49 130.02 55.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.994 0.426 . . . . 2.1800000000000002 110.267 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 89' ' ' THR . 62.1 t -120.0 129.52 75.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.931 -0.577 . . . . 2.0600000000000001 110.062 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -113.99 122.26 46.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.155 -0.475 . . . . 4.1900000000000004 111.169 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -108.38 146.22 33.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.642 -0.708 . . . . 5.1600000000000001 109.705 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -117.14 137.39 52.35 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.029 -0.36 . . . . 3.3100000000000001 110.029 173.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.595 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 93.2 m-85 -134.87 91.01 2.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.208 -0.451 . . . . 4.6600000000000001 110.422 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 78' ' ' PHE . 10.0 mt . . . . . 0 N--CA 1.471 0.591 0 C-N-CA 124.786 1.234 . . . . 4.8799999999999999 109.354 171.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 121.0 0.428 . . . . 2.6400000000000001 111.574 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -110.17 150.18 29.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.614 -0.884 . . . . 6.1900000000000004 108.614 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -150.14 169.69 30.17 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.724 -1.227 . . . . 1.54 112.818 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 97.4 mt -131.43 122.47 26.32 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.405 -0.591 . . . . 2.73 109.405 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 92.9 m -120.11 129.98 54.42 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.001 0.429 . . . . 1.8700000000000001 110.254 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -121.67 133.57 9.52 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.771 -0.728 . . . . 1.1699999999999999 111.484 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.58 130.66 8.76 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.655 -0.783 . . . . 1.4399999999999999 112.462 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 68.3 m-85 -112.01 127.24 55.82 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.768 -0.456 . . . . 4.6399999999999997 109.768 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.468 ' HE ' ' CD ' ' A' ' 71' ' ' GLU . 40.1 ttm180 -142.71 124.87 15.38 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.561 -0.163 . . . . 3.2200000000000002 110.561 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.5 ' OD1' ' HA ' ' A' ' 111' ' ' GLN . 93.5 m-20 -132.65 129.83 39.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.293 -0.262 . . . . 2.2200000000000002 110.293 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -126.69 135.39 51.08 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.306 -0.627 . . . . 3.6400000000000001 109.306 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.439 0 C-N-CA 120.745 -0.74 . . . . 2.79 112.414 -178.364 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.5 p . . . . . 0 N--CA 1.447 -0.602 0 CA-C-O 120.951 0.405 . . . . 3.77 110.514 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.16 160.94 33.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.793 -0.639 . . . . 2.2000000000000002 109.775 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -120.12 129.99 54.42 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.572 -0.529 . . . . 3.1200000000000001 109.572 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 89.0 mtp -104.52 129.44 52.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.742 0.306 . . . . 2.1200000000000001 110.413 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.5 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 99.5 mt-30 -95.66 123.14 39.08 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.823 -0.626 . . . . 2.4900000000000002 111.047 -176.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 85.7 mtt180 -116.29 114.3 24.17 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.659 -0.497 . . . . 4.4699999999999998 109.659 173.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.442 ' NE1' ' HB3' ' A' ' 111' ' ' GLN . 83.8 m95 -107.44 136.88 46.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.68 -0.691 . . . . 2.9199999999999999 110.86 -173.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -120.53 123.36 42.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.823 -0.626 . . . . 2.5099999999999998 110.196 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 134' ' ' SER . 88.2 mt -120.07 120.35 62.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.077 -0.712 . . . . 2.1299999999999999 109.077 174.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -145.76 108.05 4.36 Favored Pre-proline 0 C--N 1.325 -0.488 0 C-N-CA 120.723 -0.391 . . . . 1.6799999999999999 111.814 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 69.3 Cg_endo -77.64 139.93 18.4 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.067 1.845 . . . . 1.54 110.185 171.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.88 137.44 32.36 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.229 -0.442 . . . . 2.3500000000000001 110.045 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -127.16 127.54 44.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.302 -0.408 . . . . 5.1500000000000004 109.968 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -126.82 109.59 12.16 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.347 -0.612 . . . . 3.04 109.347 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.7 t -120.58 117.62 53.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.128 -0.487 . . . . 4.7400000000000002 110.321 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -117.34 96.09 5.26 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.651 -0.499 . . . . 6.3600000000000003 109.651 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.42 -39.95 85.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.647 -0.706 . . . . 4.96 110.694 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.1 t -149.71 170.0 19.74 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.381 -0.827 . . . . 4.0700000000000003 108.865 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.98 -39.24 85.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.404 0.621 . . . . 5.1699999999999999 110.046 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.15 -31.11 68.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.627 -1.169 . . . . 3.71 111.57 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 159' ' ' GLN . 85.0 mt -119.98 119.79 34.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 2.4500000000000002 112.061 -171.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.45 ' HB2' ' HB3' ' A' ' 159' ' ' GLN . 89.8 mtt180 -111.6 109.61 19.6 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.855 -0.794 . . . . 4.6799999999999997 108.855 170.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -109.43 122.4 47.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.187 0.518 . . . . 4.3600000000000003 111.037 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.12 139.91 53.35 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.764 -0.653 . . . . 2.5899999999999999 109.522 173.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -147.65 133.6 4.77 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.576 -0.821 . . . . 1.25 111.573 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 29.3 m-90 -120.03 127.61 52.75 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.936 0.398 . . . . 5.0899999999999999 111.062 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.649 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 58.2 tp -101.3 118.57 37.24 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.438 -0.949 . . . . 2.7599999999999998 108.438 173.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 42.9 m -120.49 130.01 54.1 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.036 0.446 . . . . 1.99 111.177 -175.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.638 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 76.5 mtm -106.3 130.24 54.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.595 -0.729 . . . . 2.7799999999999998 109.394 173.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -120.07 139.9 51.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.35 -0.386 . . . . 3.6800000000000002 111.346 -175.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 96.7 mttt -129.55 160.04 34.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.71 -0.677 . . . . 2.1699999999999999 109.271 174.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.414 ' H ' HD21 ' A' ' 142' ' ' LEU . 53.0 p90 -143.96 160.07 41.47 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.487 -0.56 . . . . 4.0099999999999998 109.487 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 63.56 -178.57 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.893 0.746 . . . . 1.79 111.504 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -74.99 -39.93 60.98 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.117 0.484 . . . . 3.04 111.343 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -59.98 -41.93 93.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.529 -0.759 . . . . 2.4100000000000001 113.034 -168.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.414 HD21 ' H ' ' A' ' 138' ' ' PHE . 9.4 mp -69.98 -30.13 67.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.878 0.37 . . . . 2.3599999999999999 111.352 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -70.03 -40.07 75.4 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.805 -0.358 . . . . 2.52 110.101 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 33.7 p -73.48 -31.15 63.6 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.569 0.581 . . . . 2.52 112.569 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 35.1 p -79.46 -10.03 59.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.898 0.38 . . . . 2.0099999999999998 111.412 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 91.14 -137.06 13.66 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.689 -0.767 . . . . 1.52 112.449 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -89.93 -1.27 57.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.842 0.353 . . . . 6.2199999999999998 110.379 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.56 -47.7 82.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.934 -0.576 . . . . 2.0499999999999998 111.153 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -108.43 81.96 1.55 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.073 0.463 . . . . 2.6400000000000001 110.477 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.5 t -149.5 150.01 31.64 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.2 -0.455 . . . . 2.6000000000000001 109.996 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.638 ' O ' ' HA ' ' A' ' 135' ' ' MET . 42.8 mtt180 -80.84 134.89 35.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.355 -0.384 . . . . 4.0899999999999999 110.309 174.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.83 102.85 14.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.055 -0.72 . . . . 2.1499999999999999 109.055 173.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.584 ' OE1' ' HD3' ' A' ' 151' ' ' ARG . 83.9 mt-10 -124.74 141.51 52.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.112 -0.495 . . . . 2.5600000000000001 110.248 -174.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 174' ' ' LEU . 21.8 m -130.08 139.91 50.89 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 121.014 -0.274 . . . . 1.78 110.844 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -119.85 131.44 55.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.18 -0.674 . . . . 2.04 109.18 171.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.2 p -117.82 121.12 39.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.224 -0.444 . . . . 2.0299999999999998 110.906 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -113.38 120.1 5.05 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.123 -0.791 . . . . 1.0800000000000001 111.123 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 68.8 tp -123.5 129.44 51.23 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.966 0.412 . . . . 2.9300000000000002 110.941 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.45 ' HB3' ' HB2' ' A' ' 128' ' ' ARG . 53.4 tt0 -102.87 118.37 36.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.718 -0.845 . . . . 3.02 108.718 171.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -122.26 137.52 54.81 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.915 0.388 . . . . 4.7599999999999998 110.039 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . 1.6 m -98.26 89.22 4.4 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.33 0.586 . . . . 1.8200000000000001 109.835 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -67.58 -48.75 65.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.377 -0.828 . . . . 3.27 112.218 -171.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.429 ' HB2' HG22 ' A' ' 166' ' ' VAL . 93.6 m-20 -99.9 8.98 43.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.424 -0.353 . . . . 2.4100000000000001 110.98 -175.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 73.6 -39.71 0.44 Allowed 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.865 0.728 . . . . 2.5800000000000001 110.727 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 163' ' ' ASN . 21.4 p -75.32 -40.13 58.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.194 -0.457 . . . . 2.6000000000000001 111.235 175.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 163' ' ' ASN . 31.3 m -120.17 144.48 28.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.115 0.483 . . . . 2.0600000000000001 111.536 -175.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 161' ' ' THR . . . -119.98 139.47 52.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.463 -0.789 . . . . 1.8400000000000001 110.591 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 159' ' ' GLN . 3.1 mm? -108.49 130.49 55.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.828 -0.624 . . . . 2.1400000000000001 109.648 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -101.77 113.0 25.79 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.598 -0.519 . . . . 3.73 109.598 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 195' ' ' ARG . 63.1 t -120.13 129.8 75.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.338 -0.392 . . . . 1.8100000000000001 111.257 -177.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -110.88 126.36 54.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.906 -0.588 . . . . 2.2400000000000002 110.065 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -119.2 140.06 50.83 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.813 -0.631 . . . . 4.8399999999999999 109.941 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -97.52 137.0 37.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.057 0.456 . . . . 4.4299999999999997 111.032 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 154' ' ' THR . 3.4 mm? -106.73 120.02 40.86 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.131 -0.692 . . . . 2.8500000000000001 109.131 173.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.61 -42.55 97.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.603 -0.726 . . . . 3.3100000000000001 110.352 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 . . . . . 0 N--CA 1.446 -0.645 0 CA-C-N 115.136 -0.938 . . . . 7.3300000000000001 110.453 -178.566 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 C--O 1.234 0.277 0 CA-C-O 121.374 0.607 . . . . 4.4000000000000004 111.902 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 85.8 mt -119.98 120.54 63.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.226 -0.897 . . . . 2.6400000000000001 109.831 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 72.3 mtm180 -102.86 120.15 40.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.752 -0.204 . . . . 4.1100000000000003 110.745 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -117.26 128.7 55.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.657 0.265 . . . . 1.76 110.498 175.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -150.05 159.95 44.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.152 -0.476 . . . . 6.1399999999999997 110.078 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.415 ' N ' HD21 ' A' ' 198' ' ' LEU . 1.8 pt? -147.05 128.5 7.3 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 110.233 -0.284 . . . . 3.0800000000000001 110.233 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.84 106.72 2.18 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.393 2.062 . . . . 1.98 111.89 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 62.6 tp -112.46 140.06 47.51 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.175 -0.676 . . . . 2.7599999999999998 109.175 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 28.6 p -119.97 140.43 50.94 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.466 -0.494 . . . . 2.4199999999999999 111.658 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 58.9 tp -130.0 81.71 2.03 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.825 -0.806 . . . . 2.77 108.825 176.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 75.72 -120.01 5.9 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.512 -0.767 . . . . 1.6200000000000001 112.3 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -96.72 0.0 48.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.238 0.542 . . . . 2.8599999999999999 110.324 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -111.24 140.28 45.94 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.768 -0.651 . . . . 3.23 109.367 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 19.6 p -114.77 151.74 33.26 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.528 -0.305 . . . . 2.0499999999999998 110.731 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 5.3 p -138.78 130.15 35.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.999 0.428 . . . . 1.9299999999999999 110.67 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 56.9 m -122.3 96.72 45.94 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 120.932 0.396 . . . . 1.6699999999999999 110.518 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -60.54 148.11 92.18 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.972 2.448 . . . . 1.28 112.62 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -119.9 139.95 51.62 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.357 -0.608 . . . . 4.8600000000000003 109.357 174.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 14.0 t -159.41 173.59 16.0 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.591 -0.522 . . . . 2.0899999999999999 109.591 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 212' ' ' ARG . 50.9 mtt180 -126.71 129.57 48.67 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.884 -0.413 . . . . 5.29 109.884 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 16.0 tt . . . . . 0 C--N 1.323 -0.571 0 CA-C-N 116.133 -0.485 . . . . 4.9400000000000004 110.355 -177.722 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 63.4 t . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 108.686 -0.857 . . . . 2.9700000000000002 108.686 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -150.25 166.45 30.05 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.005 -1.093 . . . . 1.3999999999999999 112.098 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.4 mt -134.33 129.13 35.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.921 0.391 . . . . 2.4300000000000002 110.749 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.496 ' HE2' ' OG ' ' A' ' 252' ' ' SER . 61.2 t80 -108.07 131.95 54.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.938 -0.574 . . . . 4.3300000000000001 110.234 174.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -119.97 134.01 55.38 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.973 -0.38 . . . . 3.2599999999999998 109.973 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -110.13 121.76 6.09 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.754 -0.736 . . . . 1.3500000000000001 111.749 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' TYR . . . . . 0.423 ' CD1' HD12 ' A' ' 253' ' ' LEU . 91.9 m-85 -121.62 112.13 18.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.821 0.344 . . . . 4.7599999999999998 110.559 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -99.07 97.91 8.99 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.798 -0.445 . . . . 4.29 109.798 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -69.97 -37.0 75.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.015 -0.539 . . . . 7.5599999999999996 111.986 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 96.0 mt-30 -137.31 170.54 15.91 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.861 -0.422 . . . . 7.0199999999999996 109.861 -175.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -59.91 -40.17 87.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.159 0.504 . . . . 6.4800000000000004 111.003 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.19 10.9 51.44 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.742 -0.742 . . . . 2.9199999999999999 113.014 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.489 ' HB3' ' HB2' ' A' ' 246' ' ' GLN . 58.5 tp -122.46 115.19 21.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.021 0.411 . . . . 3.5800000000000001 111.499 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 50.0 m -120.24 130.44 54.51 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.695 -0.684 . . . . 2.6000000000000001 109.814 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 99.2 t -113.26 132.14 62.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.189 0.519 . . . . 2.2400000000000002 110.351 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' SER . . . . . 0.496 ' OG ' ' HE2' ' A' ' 240' ' ' PHE . 42.5 t -101.33 118.77 37.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.242 -0.89 . . . . 2.0 110.196 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.423 HD12 ' CD1' ' A' ' 243' ' ' TYR . 84.2 mt -119.6 100.96 7.59 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.0 -0.37 . . . . 3.4199999999999999 110.0 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -109.5 130.04 55.53 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.034 -0.358 . . . . 4.0800000000000001 110.034 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.0 129.04 56.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.312 -0.404 . . . . 5.1699999999999999 110.405 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 3.5800000000000001 110.852 -179.398 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.833 0.349 . . . . 2.4100000000000001 111.182 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.66 131.54 6.23 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.588 -1.005 . . . . 1.6200000000000001 110.588 174.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.03 128.51 75.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.116 0.484 . . . . 2.4900000000000002 111.207 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -132.75 138.33 10.06 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.337 -0.705 . . . . 1.3 111.337 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.0 t -116.36 120.69 65.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.618 -0.512 . . . . 2.3399999999999999 109.618 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -116.21 129.94 56.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.139 0.495 . . . . 2.7999999999999998 111.069 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.428 ' CE2' HD11 ' A' ' 249' ' ' LEU . 97.8 m-85 -109.35 111.58 23.23 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.548 -0.908 . . . . 5.1900000000000004 108.548 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.9 t -132.0 139.97 48.78 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.517 -0.473 . . . . 2.0499999999999998 110.683 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 57.5 t80 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.085 -0.959 . . . . 4.4199999999999999 108.784 178.825 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 109.12 -0.696 . . . . 3.6099999999999999 109.12 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -69.88 119.83 14.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.956 0.408 . . . . 3.9100000000000001 111.549 -173.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -100.99 125.05 47.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.806 -0.634 . . . . 3.9399999999999999 109.661 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -114.92 139.68 49.6 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.26 -0.427 . . . . 3.21 110.0 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -126.48 130.5 50.75 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.386 -0.598 . . . . 2.6499999999999999 109.386 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.1 mt -127.89 129.97 69.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.273 -0.421 . . . . 2.0699999999999998 110.681 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.29 140.0 11.46 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.173 -0.771 . . . . 0.92000000000000004 111.173 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.4 135.58 54.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.014 0.407 . . . . 1.6499999999999999 110.947 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 96.6 mmm -130.1 157.09 43.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.496 -0.774 . . . . 2.9700000000000002 109.702 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -114.56 142.22 46.71 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.436 0.636 . . . . 3.1499999999999999 110.374 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 114.697 -1.138 . . . . 5.0899999999999999 111.754 -175.015 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 110.012 -0.366 . . . . 3.48 110.012 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.73 142.09 47.12 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.153 1.902 . . . . 2.0299999999999998 111.58 173.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.3 t -119.97 143.49 47.99 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.618 -0.512 . . . . 2.2799999999999998 109.618 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.34 133.73 61.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.392 0.615 . . . . 2.4100000000000001 111.453 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -111.64 126.2 54.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.275 -0.875 . . . . 4.4400000000000004 108.711 174.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -133.51 130.08 38.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.568 0.223 . . . . 3.6200000000000001 111.212 -174.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.431 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . 9.9 p30 -145.59 156.48 43.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.513 -0.312 . . . . 2.48 110.584 173.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.446 ' O ' ' HG3' ' A' ' 45' ' ' ARG . . . -137.01 143.94 43.01 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.966 -0.561 . . . . 1.53 110.678 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.98 136.2 33.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.832 -0.622 . . . . 1.8 110.766 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.608 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 40.8 t30 -165.95 95.37 0.59 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.023 -0.535 . . . . 3.3799999999999999 109.708 176.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.57 -98.62 1.41 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.051 -0.595 . . . . 1.8200000000000001 111.818 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.608 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 85.7 Cg_exo -45.12 175.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 124.12 3.213 . . . . 2.1000000000000001 114.078 168.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.544 ' HB2' ' O ' ' A' ' 75' ' ' HIS . 41.3 p90 -68.46 171.93 6.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.152 -0.931 . . . . 4.0499999999999998 112.054 -169.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 39' ' ' ALA . 57.7 ttp180 -113.1 133.32 55.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.839 -0.618 . . . . 3.6000000000000001 111.117 -168.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.2 mt -119.66 129.97 74.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.224 -0.898 . . . . 2.2799999999999998 110.387 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 38' ' ' ASN . . . -118.09 144.42 45.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.012 -0.54 . . . . 1.4399999999999999 111.169 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.0 tp -133.41 134.91 44.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.248 -0.433 . . . . 1.75 110.814 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.34 167.48 24.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.8 -0.636 . . . . 1.5900000000000001 109.4 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -134.04 148.71 51.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.339 . . . . 4.4400000000000004 111.639 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -132.1 149.94 52.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.834 -0.621 . . . . 5.0199999999999996 110.014 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -120.49 139.97 52.11 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.212 -0.292 . . . . 3.7400000000000002 110.212 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 67' ' ' PHE . 49.6 mt-10 . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.754 0.311 . . . . 5.0499999999999998 111.793 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 110.18 -0.304 . . . . 6.5 110.18 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.561 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 93.8 m-85 -122.46 125.29 45.51 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.896 -0.779 . . . . 4.5999999999999996 108.896 174.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -156.41 160.41 39.59 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.077 0.465 . . . . 2.4500000000000002 110.907 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 94' ' ' ASN . 27.6 mtm180 -140.71 125.27 10.75 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 115.355 -0.839 . . . . 3.7200000000000002 110.565 175.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.63 140.18 11.65 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.848 2.365 . . . . 1.3200000000000001 112.096 174.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -106.06 120.09 40.88 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.858 -0.793 . . . . 2.1899999999999999 108.858 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.0 tp -128.03 106.67 9.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.848 0.356 . . . . 1.73 110.363 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -101.61 128.68 47.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.144 -0.48 . . . . 2.1800000000000002 110.284 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.8 t -120.03 120.01 61.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.306 -0.627 . . . . 2.0600000000000001 109.306 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.544 ' O ' ' HB2' ' A' ' 44' ' ' TRP . 80.1 t60 -119.59 118.22 30.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.118 0.485 . . . . 4.1900000000000004 110.253 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -117.62 138.54 51.89 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.186 -0.916 . . . . 5.1600000000000001 109.9 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -130.09 149.17 51.92 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.855 -0.424 . . . . 3.3100000000000001 109.855 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -137.11 132.68 34.42 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.614 -0.513 . . . . 4.6600000000000001 109.614 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 C--N 1.322 -0.628 0 CA-C-N 116.416 -0.356 . . . . 4.8799999999999999 110.49 -178.152 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.2 p . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 120.915 0.388 . . . . 2.6400000000000001 110.552 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -135.84 160.06 39.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.318 -0.401 . . . . 6.1900000000000004 110.357 -175.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.97 176.88 41.87 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.393 -0.908 . . . . 1.54 112.587 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.12 125.21 27.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.785 -0.45 . . . . 2.73 109.785 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.9 m -120.11 129.95 54.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.157 0.503 . . . . 1.8700000000000001 110.183 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -131.59 146.76 18.24 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.556 -0.831 . . . . 1.1699999999999999 112.577 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -123.92 122.2 4.75 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.908 -0.877 . . . . 1.4399999999999999 110.908 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -111.54 122.22 47.24 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.234 -0.654 . . . . 4.6399999999999997 109.234 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.547 ' HB2' ' HB2' ' A' ' 112' ' ' ARG . 97.8 mtt180 -134.97 137.36 42.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.914 0.388 . . . . 3.2200000000000002 110.907 -173.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.601 ' O ' ' HG2' ' A' ' 69' ' ' ARG . 92.6 m-20 -114.51 130.13 56.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.071 -0.513 . . . . 2.2200000000000002 109.972 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.505 ' HA ' ' HG2' ' A' ' 69' ' ' ARG . 58.8 t80 -106.93 119.94 40.7 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.848 -0.427 . . . . 3.6400000000000001 109.848 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.511 0 C-N-CA 120.55 -0.833 . . . . 2.79 112.243 178.178 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.9 p . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 109.991 -0.374 . . . . 3.77 109.991 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.41 148.56 47.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.583 0.23 . . . . 2.2000000000000002 110.676 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -132.58 135.74 46.11 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.368 0.604 . . . . 3.1200000000000001 111.077 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.47 ' HB2' ' HB3' ' A' ' 95' ' ' TYR . 89.7 mtp -136.55 141.45 43.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.784 -1.191 . . . . 2.1200000000000001 107.784 175.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 16.2 mm100 -108.95 139.97 43.08 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.022 -0.671 . . . . 2.4900000000000002 111.546 -172.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.547 ' HB2' ' HB2' ' A' ' 93' ' ' ARG . 76.2 mtt180 -120.37 128.95 53.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.004 -0.544 . . . . 4.4699999999999998 109.864 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -127.72 133.03 49.54 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.004 -0.544 . . . . 2.9199999999999999 110.849 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -121.55 125.22 46.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.958 -0.565 . . . . 2.5099999999999998 109.947 171.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 86.6 mt -120.08 124.0 71.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.978 -0.556 . . . . 2.1299999999999999 109.612 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -147.05 105.24 3.86 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.617 0.246 . . . . 1.6799999999999999 111.121 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.98 139.95 13.97 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.38 2.053 . . . . 1.54 110.922 175.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.51 137.19 33.48 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.285 -0.416 . . . . 2.3500000000000001 109.916 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -130.88 129.79 42.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.445 -0.343 . . . . 5.1500000000000004 110.493 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -94.28 113.87 25.85 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.17 -0.678 . . . . 3.04 109.17 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.6 t -120.08 119.99 61.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.778 -0.453 . . . . 4.7400000000000002 109.778 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.5 ' HG2' ' HA ' ' A' ' 128' ' ' ARG . 36.4 mtmm -126.84 118.78 25.31 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.745 -0.465 . . . . 6.3600000000000003 109.745 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.3 tp -90.15 -79.01 0.35 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 4.96 110.79 -174.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 47.4 p -142.67 171.77 13.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.371 -0.377 . . . . 4.0700000000000003 110.662 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 62.37 26.27 15.69 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 124.057 0.848 . . . . 5.1699999999999999 112.071 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 57.82 33.54 23.34 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.046 -0.525 . . . . 3.71 110.692 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.1 mt -98.99 130.0 45.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.058 -0.519 . . . . 2.4500000000000002 109.983 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.5 ' HA ' ' HG2' ' A' ' 122' ' ' LYS . 47.9 ttt180 -105.07 127.83 53.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.207 0.527 . . . . 4.6799999999999997 111.02 -174.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.444 ' CE2' HD12 ' A' ' 158' ' ' LEU . 96.7 m-85 -108.18 129.09 55.2 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.521 -0.918 . . . . 4.3600000000000003 108.521 174.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -111.65 113.9 26.58 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.756 -0.831 . . . . 2.5899999999999999 108.756 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -123.1 137.72 11.26 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.204 -0.998 . . . . 1.25 111.908 -175.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.519 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 8.8 p90 -134.45 140.91 46.58 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.115 0.484 . . . . 5.0899999999999999 110.315 177.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 64.3 tp -99.96 111.14 23.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.596 -0.729 . . . . 2.7599999999999998 109.258 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.8 m -100.83 118.0 36.04 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.306 0.574 . . . . 1.99 111.121 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 87.1 mtp -101.09 125.39 47.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.195 -0.911 . . . . 2.7799999999999998 109.26 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.479 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 95.5 m-85 -109.94 127.59 54.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.93 0.395 . . . . 3.6800000000000002 110.988 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -129.9 144.62 51.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.787 -0.642 . . . . 2.1699999999999999 109.986 174.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.437 ' O ' ' HB2' ' A' ' 142' ' ' LEU . 46.9 p90 -148.01 165.52 30.49 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.063 -0.717 . . . . 4.0099999999999998 109.063 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.439 ' HA ' ' HB3' ' A' ' 110' ' ' MET . . . 64.42 170.09 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.673 0.608 . . . . 1.79 110.733 -174.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -76.05 -20.1 58.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.457 0.646 . . . . 3.04 109.572 173.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -66.65 -49.53 65.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.022 -0.99 . . . . 2.4100000000000001 111.997 -175.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.465 ' HA ' ' OG1' ' A' ' 145' ' ' THR . 10.0 mp -68.38 -30.32 69.22 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.888 0.375 . . . . 2.3599999999999999 111.458 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -60.55 -40.21 90.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.394 0.616 . . . . 2.52 109.884 171.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 57.6 m -69.97 -40.38 75.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.956 -1.02 . . . . 2.52 111.366 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 40.8 p -69.99 -36.57 75.26 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.959 0.409 . . . . 2.0099999999999998 110.632 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 62.19 -114.66 7.02 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.484 -0.78 . . . . 1.52 113.044 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -70.07 -31.3 68.82 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.549 0.34 . . . . 6.2199999999999998 111.149 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.9 -48.93 79.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.318 0.488 . . . . 2.0499999999999998 112.318 -172.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -138.98 111.72 7.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.132 0.491 . . . . 2.6400000000000001 110.738 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.3 t -160.01 149.66 18.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.341 -0.845 . . . . 2.6000000000000001 109.102 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 67.5 ttt180 -79.55 125.24 29.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.778 0.323 . . . . 4.0899999999999999 110.26 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.425 ' CG1' HD13 ' A' ' 133' ' ' LEU . 62.1 t -119.92 120.1 62.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.928 -0.578 . . . . 2.1499999999999999 110.082 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -140.06 141.19 36.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.183 -0.303 . . . . 2.5600000000000001 110.183 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 m -115.24 128.39 56.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.683 0.278 . . . . 1.78 110.766 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.519 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 83.3 tt0 -108.68 130.7 55.34 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.786 -0.45 . . . . 2.04 109.786 176.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 44.0 m -118.1 121.11 39.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.283 -0.417 . . . . 2.0299999999999998 110.18 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -111.02 118.12 4.79 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.938 -0.649 . . . . 1.0800000000000001 111.903 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.444 HD12 ' CE2' ' A' ' 129' ' ' PHE . 41.5 tp -95.37 128.36 42.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.889 0.376 . . . . 2.9300000000000002 110.68 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -101.8 108.98 20.64 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.276 -0.638 . . . . 3.02 109.276 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -120.2 126.67 51.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.459 -0.791 . . . . 4.7599999999999998 109.244 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.1 p -99.21 88.81 4.03 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.279 -0.569 . . . . 1.8200000000000001 110.225 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -60.24 -49.67 76.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.412 -0.813 . . . . 3.27 111.292 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.404 ' HB2' HG21 ' A' ' 166' ' ' VAL . 94.0 m-20 -103.01 15.82 28.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.456 -0.338 . . . . 2.4100000000000001 110.824 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 72.52 -53.83 0.69 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.888 0.743 . . . . 2.5800000000000001 111.617 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.6 p -74.38 -18.77 60.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.372 -0.377 . . . . 2.6000000000000001 111.496 -177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.404 HG21 ' HB2' ' A' ' 163' ' ' ASN . 35.7 m -110.6 136.93 45.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.373 -0.376 . . . . 2.0600000000000001 110.3 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.57 123.62 48.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.062 -0.517 . . . . 1.8400000000000001 109.788 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 35.7 mt -102.48 127.43 49.53 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.265 -0.643 . . . . 2.1400000000000001 109.265 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -99.99 108.83 21.13 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.723 -0.473 . . . . 3.73 109.723 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 50.2 t -109.98 119.7 59.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.32 -0.622 . . . . 1.8100000000000001 109.32 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.434 ' HB2' ' HD3' ' A' ' 195' ' ' ARG . 15.5 m120 -109.81 131.55 54.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.012 0.434 . . . . 2.2400000000000002 110.879 -172.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -119.88 139.6 52.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.88 -0.6 . . . . 4.8399999999999999 109.683 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -106.37 122.69 46.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.672 0.272 . . . . 4.4299999999999997 110.387 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 55.7 tp -108.63 114.92 29.13 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.172 -0.467 . . . . 2.8500000000000001 109.963 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -108.59 138.52 44.77 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.013 -0.54 . . . . 3.3100000000000001 110.007 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 . . . . . 0 C--N 1.323 -0.566 0 N-CA-C 109.626 -0.509 . . . . 7.3300000000000001 109.626 177.064 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 110.044 -0.354 . . . . 4.4000000000000004 110.044 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 88.0 mt -100.62 120.04 49.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.986 0.422 . . . . 2.6400000000000001 110.384 -176.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.434 ' HD3' ' HB2' ' A' ' 171' ' ' ASN . 31.4 ttt180 -98.93 119.37 37.59 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.692 -0.686 . . . . 4.1100000000000003 110.754 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -119.6 123.46 43.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.916 0.389 . . . . 1.76 110.72 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -130.86 118.75 21.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.615 -0.721 . . . . 6.1399999999999997 109.751 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 1.3 pt? -136.83 126.82 15.9 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.753 -0.379 . . . . 3.0800000000000001 111.103 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 198' ' ' LEU . 27.7 Cg_endo -94.49 117.44 0.25 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.965 2.443 . . . . 1.98 112.499 175.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 50.8 tp -104.31 116.41 32.1 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.19 -0.67 . . . . 2.7599999999999998 109.19 176.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 96.7 m -99.58 120.07 39.07 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.167 0.508 . . . . 2.4199999999999999 110.881 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 89.7 mt -114.56 80.38 1.39 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.948 -0.76 . . . . 2.77 108.948 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 72.59 -112.85 4.15 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.151 -0.931 . . . . 1.6200000000000001 112.228 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -100.09 10.35 41.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.11 0.481 . . . . 2.8599999999999999 110.948 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -134.42 117.71 16.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.195 -0.457 . . . . 3.23 109.864 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 74.3 m -102.66 134.19 46.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.197 0.522 . . . . 2.0499999999999998 111.227 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 59.1 t -115.45 122.67 69.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.575 -0.739 . . . . 1.9299999999999999 109.239 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 23.5 m -118.3 94.28 46.68 Favored Pre-proline 0 C--N 1.318 -0.767 0 C-N-CA 121.031 -0.268 . . . . 1.6699999999999999 111.37 -176.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.401 ' HA ' HD21 ' A' ' 239' ' ' LEU . 15.6 Cg_exo -69.41 139.97 42.8 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.902 2.401 . . . . 1.28 111.795 173.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.47 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 64.9 t80 -137.68 140.23 40.68 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.074 -0.512 . . . . 4.8600000000000003 110.408 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 28.7 p -135.34 147.73 49.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.268 -0.424 . . . . 2.0899999999999999 110.866 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -102.42 -0.03 33.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.437 0.637 . . . . 5.29 109.995 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 48.5 mm . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.452 -0.795 . . . . 4.9400000000000004 109.505 175.825 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.434 -0.58 . . . . 2.9700000000000002 109.434 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -78.14 137.61 20.1 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.418 -0.896 . . . . 1.3999999999999999 111.283 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.401 HD21 ' HA ' ' A' ' 209' ' ' PRO . 94.5 mt -134.45 124.47 25.67 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.759 -0.46 . . . . 2.4300000000000002 109.759 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.489 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 64.5 t80 -118.52 118.4 31.59 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.158 -0.682 . . . . 4.3300000000000001 109.158 175.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -104.79 129.72 53.01 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.127 -0.488 . . . . 3.2599999999999998 110.379 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -114.45 143.34 17.99 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 115.576 -0.738 . . . . 1.3500000000000001 111.533 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -107.28 112.35 25.16 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.484 -0.562 . . . . 4.7599999999999998 109.484 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -105.42 28.4 7.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.337 -0.847 . . . . 4.29 110.31 -172.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -59.89 -40.12 87.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.013 -0.994 . . . . 7.5599999999999996 110.741 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . 0.421 ' OE1' ' HB3' ' A' ' 249' ' ' LEU . 62.4 tt0 -133.05 133.79 43.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.948 -0.569 . . . . 7.0199999999999996 110.358 -176.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -63.38 -39.86 95.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.788 -0.642 . . . . 6.4800000000000004 110.595 176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -68.19 -50.07 42.02 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.539 -0.839 . . . . 2.9199999999999999 112.535 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.421 ' HB3' ' OE1' ' A' ' 246' ' ' GLN . 59.1 tp -118.51 124.15 46.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.94 0.4 . . . . 3.5800000000000001 111.046 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 46.9 p -126.78 148.21 49.94 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.91 -0.587 . . . . 2.6000000000000001 110.082 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 57.7 t -116.43 137.67 49.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.434 -0.348 . . . . 2.2400000000000002 110.3 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 43.4 m -111.76 139.76 46.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.327 -0.397 . . . . 2.0 110.628 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.421 ' HG ' ' HG3' ' A' ' 254' ' ' GLU . 59.3 tp -132.65 143.42 49.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.544 -0.298 . . . . 3.4199999999999999 111.31 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . 0.421 ' HG3' ' HG ' ' A' ' 253' ' ' LEU . 43.9 mt-10 60.34 -159.99 0.3 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.886 0.741 . . . . 4.0800000000000001 111.108 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -144.47 137.05 26.66 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.05 0.453 . . . . 5.1699999999999999 111.529 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 210' ' ' TYR . . . . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 115.637 -0.71 . . . . 3.5800000000000001 109.221 172.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.193 0 CA-C-O 120.503 0.192 . . . . 2.4100000000000001 110.516 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -138.4 158.62 24.99 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 119.529 -1.32 . . . . 1.6200000000000001 112.489 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.19 127.17 68.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.17 -0.678 . . . . 2.4900000000000002 109.17 176.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.68 157.23 21.74 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.757 -0.735 . . . . 1.3 111.638 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 6.2 p -119.96 121.31 65.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.116 0.484 . . . . 2.3399999999999999 110.344 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -122.21 123.71 42.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.895 -0.593 . . . . 2.7999999999999998 110.517 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -118.08 130.03 55.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.745 -0.465 . . . . 5.1900000000000004 109.745 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 8.9 p -117.5 129.44 55.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.953 0.406 . . . . 2.0499999999999998 110.498 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 61.4 t80 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.395 -0.812 . . . . 4.4199999999999999 109.572 -176.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.866 0.365 . . . . 3.6099999999999999 110.811 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.474 ' HA ' ' HB2' ' A' ' 41' ' ' ASN . 70.0 m95 -88.59 107.35 18.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.131 0.491 . . . . 3.9100000000000001 111.171 -176.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -94.87 130.44 41.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.619 -0.719 . . . . 3.9399999999999999 110.592 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.34 139.48 52.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.165 -0.925 . . . . 3.21 110.244 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 15.6 m120 -122.67 132.03 54.07 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.94 -0.573 . . . . 2.6499999999999999 110.105 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.0 mt -120.06 119.83 61.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.021 -0.733 . . . . 2.0699999999999998 109.021 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.428 ' HA3' ' CZ ' ' A' ' 36' ' ' TYR . . . -115.77 134.43 11.49 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.103 -1.046 . . . . 0.92000000000000004 112.453 -176.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -121.78 134.41 54.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.91 0.386 . . . . 1.6499999999999999 110.147 175.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 91.0 mtp -140.66 157.09 45.95 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.268 -0.641 . . . . 2.9700000000000002 109.268 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -100.19 121.98 42.3 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.834 -0.346 . . . . 3.1499999999999999 110.99 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--N 1.323 -0.568 0 N-CA-C 109.751 -0.462 . . . . 5.0899999999999999 109.751 178.232 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 N--CA 1.451 -0.413 0 N-CA-C 110.083 -0.339 . . . . 3.48 110.083 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.9 134.0 41.39 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 121.914 1.743 . . . . 2.0299999999999998 111.132 173.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 28.3 t -124.59 142.4 51.38 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.603 -0.888 . . . . 2.2799999999999998 108.603 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 62.5 t -130.01 133.61 64.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.893 0.378 . . . . 2.4100000000000001 111.002 -174.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.428 ' CZ ' ' HA3' ' A' ' 12' ' ' GLY . 53.8 p90 -130.22 151.82 50.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.675 -0.491 . . . . 4.4400000000000004 109.675 175.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 93.2 m-85 -119.55 139.95 51.31 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.517 -0.31 . . . . 3.6200000000000001 111.051 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 18.5 m-80 -129.65 141.37 50.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.801 -0.636 . . . . 2.48 109.995 174.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.11 142.67 38.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.68 -0.236 . . . . 1.53 110.439 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.61 139.21 11.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.197 0.443 . . . . 1.8 112.197 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.643 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 34.3 t30 -167.68 94.14 0.41 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.346 -0.843 . . . . 3.3799999999999999 109.186 171.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.92 -91.89 1.73 Allowed Glycine 0 N--CA 1.454 -0.144 0 N-CA-C 111.276 -0.73 . . . . 1.8200000000000001 111.276 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.643 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 72.6 Cg_exo -50.51 173.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.331 2.687 . . . . 2.1000000000000001 113.06 167.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.511 ' CD1' HG11 ' A' ' 74' ' ' VAL . 48.9 p90 -68.4 176.65 2.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.737 -0.665 . . . . 4.0499999999999998 111.951 -170.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -112.83 129.31 56.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.515 -0.766 . . . . 3.6000000000000001 110.069 -173.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 45.6 pt -110.92 143.56 20.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.271 -0.422 . . . . 2.2799999999999998 110.939 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 72' ' ' LEU . . . -118.52 127.12 53.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.746 -0.661 . . . . 1.4399999999999999 110.352 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.7 tp -119.95 128.75 53.87 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.889 0.376 . . . . 1.75 111.176 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.53 157.1 42.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.589 -0.732 . . . . 1.5900000000000001 109.423 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -120.09 140.0 51.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.083 0.468 . . . . 4.4400000000000004 111.141 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -112.14 133.28 54.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.657 -0.701 . . . . 5.0199999999999996 111.289 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -122.56 127.04 48.95 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.38 -0.6 . . . . 3.7400000000000002 109.38 174.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.624 ' HB2' ' OH ' ' A' ' 95' ' ' TYR . 39.0 tt0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 121.238 0.542 . . . . 5.0499999999999998 110.021 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 78.1 m95 . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 121.287 0.565 . . . . 6.5 111.517 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -139.99 137.43 34.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.205 -0.907 . . . . 4.5999999999999996 109.309 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -159.96 168.38 25.82 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.433 -0.349 . . . . 2.4500000000000002 110.518 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.489 ' HD2' ' HB3' ' A' ' 93' ' ' ARG . 58.6 ttp85 -142.43 123.73 8.59 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.817 -0.629 . . . . 3.7200000000000002 110.267 169.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.611 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 72.9 Cg_endo -80.07 139.98 13.85 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.14 1.893 . . . . 1.3200000000000001 110.54 167.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.489 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 33.5 tt0 -124.15 113.87 18.92 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.227 0.537 . . . . 2.1899999999999999 110.077 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.554 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 40.8 tp -120.21 119.73 34.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.172 -0.922 . . . . 1.73 110.209 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 34.2 mt-10 -104.21 147.03 27.93 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.289 0.566 . . . . 2.1800000000000002 111.08 174.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.511 HG11 ' CD1' ' A' ' 44' ' ' TRP . 63.8 t -113.41 120.08 62.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.95 -1.023 . . . . 2.0600000000000001 108.83 174.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.563 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 93.4 m-70 -122.27 127.19 49.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.88 0.371 . . . . 4.1900000000000004 110.28 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.407 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 84.5 t80 -139.94 139.09 36.07 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.114 -0.493 . . . . 5.1600000000000001 110.43 -178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -99.17 119.87 38.57 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.587 -0.523 . . . . 3.3100000000000001 109.587 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -100.02 120.03 39.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.289 -0.414 . . . . 4.6600000000000001 109.963 -174.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.9 tp . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 116.267 -0.424 . . . . 4.8799999999999999 112.077 -172.169 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.487 ' HB3' ' CD1' ' A' ' 119' ' ' TRP . 22.7 m . . . . . 0 N--CA 1.448 -0.554 0 CA-C-O 120.899 0.38 . . . . 2.6400000000000001 110.651 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -135.64 159.53 41.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.135 -0.484 . . . . 6.1900000000000004 110.257 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -141.0 -178.52 17.4 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.983 -1.247 . . . . 1.54 109.983 174.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 75' ' ' HIS . 64.7 tp -140.18 121.78 15.24 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 117.515 0.657 . . . . 2.73 110.953 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.44 HG22 ' CE1' ' A' ' 75' ' ' HIS . 92.9 m -120.08 116.61 26.05 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.689 -0.687 . . . . 1.8700000000000001 109.595 169.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 73' ' ' GLU . . . -125.99 154.63 18.88 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.837 -0.905 . . . . 1.1699999999999999 110.837 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.81 124.3 2.23 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.669 -0.777 . . . . 1.4399999999999999 112.102 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -111.35 121.77 46.09 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.843 -0.799 . . . . 4.6399999999999997 108.843 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 112' ' ' ARG . 34.8 mtm180 -142.59 126.87 17.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.392 -0.367 . . . . 3.2200000000000002 111.208 -172.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.611 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 57.6 t30 -122.16 130.01 52.83 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.445 -0.576 . . . . 2.2200000000000002 109.445 174.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.624 ' OH ' ' HB2' ' A' ' 53' ' ' GLU . 3.3 t80 -121.95 115.95 23.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.804 -0.18 . . . . 3.6400000000000001 110.955 -172.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 C-N-CA 120.473 -0.87 . . . . 2.79 111.167 176.227 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.2 m . . . . . 0 N--CA 1.447 -0.605 0 CA-C-O 120.931 0.396 . . . . 3.77 110.578 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.95 144.25 33.64 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.681 -0.859 . . . . 2.2000000000000002 108.681 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.431 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 95.8 m-20 -129.06 127.0 40.65 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.87 0.367 . . . . 3.1200000000000001 110.739 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.482 ' HB3' ' HA ' ' A' ' 139' ' ' ALA . 41.8 mtm -108.59 130.03 55.31 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.043 -0.725 . . . . 2.1200000000000001 109.043 175.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -102.99 137.22 41.48 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.093 -0.643 . . . . 2.4900000000000002 111.241 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 53.7 mtp85 -119.98 109.97 16.14 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.978 -0.749 . . . . 4.4699999999999998 108.978 177.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -110.02 140.02 44.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.342 0.592 . . . . 2.9199999999999999 112.046 -175.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -129.03 124.42 34.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.588 -1.187 . . . . 2.5099999999999998 109.854 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 80.3 mt -140.46 120.03 12.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.471 -0.196 . . . . 2.1299999999999999 110.471 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.38 106.24 2.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.649 -0.25 . . . . 1.6799999999999999 111.425 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.716 ' HD2' ' CD1' ' A' ' 132' ' ' TRP . 13.3 Cg_exo -71.48 88.06 0.76 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.461 2.108 . . . . 1.54 111.045 168.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 119' ' ' TRP . 12.1 p-10 -108.5 139.38 43.34 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.211 0.449 . . . . 2.3500000000000001 112.211 -166.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.487 ' CD1' ' HB3' ' A' ' 85' ' ' SER . 7.3 t-105 176.61 -176.59 0.13 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.34 -0.845 . . . . 5.1500000000000004 108.993 174.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.603 ' OD1' ' HB3' ' A' ' 128' ' ' ARG . 30.1 t70 -80.24 117.44 21.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.135 0.493 . . . . 3.04 111.277 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.4 t -107.01 120.04 57.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.019 -0.734 . . . . 4.7400000000000002 109.019 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -93.08 72.01 4.63 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.932 -0.577 . . . . 6.3600000000000003 110.636 -171.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.2 tp -67.32 -40.04 85.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.753 -0.658 . . . . 4.96 110.709 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 24.4 p -123.28 150.16 43.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.756 -0.657 . . . . 4.0700000000000003 110.03 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -69.93 -40.26 75.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.793 0.33 . . . . 5.1699999999999999 111.279 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -70.24 -40.26 74.57 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.103 -0.498 . . . . 3.71 112.212 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.0 mt -119.95 139.16 52.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.919 0.39 . . . . 2.4500000000000002 111.339 -171.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.603 ' HB3' ' OD1' ' A' ' 120' ' ' ASP . 62.0 mtt180 -103.26 139.26 38.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.013 -0.539 . . . . 4.6799999999999997 110.097 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -112.74 107.82 16.61 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.436 -0.579 . . . . 4.3600000000000003 109.436 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 2.9 t-20 -110.83 114.3 27.53 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 120.797 0.332 . . . . 2.5899999999999999 110.495 -174.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 142.52 -163.18 27.24 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.326 -0.71 . . . . 1.25 111.326 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.716 ' CD1' ' HD2' ' A' ' 117' ' ' PRO . 47.8 t-105 -161.34 168.53 23.78 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.977 0.389 . . . . 5.0899999999999999 110.799 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 46.9 tp -100.5 119.93 39.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.741 -0.663 . . . . 2.7599999999999998 109.596 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.1 p -122.97 158.46 30.43 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.182 0.438 . . . . 1.99 112.182 -172.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 75.0 mtm -118.39 136.74 53.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.047 -0.524 . . . . 2.7799999999999998 109.976 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -120.04 140.41 51.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.2 0.524 . . . . 3.6800000000000002 111.518 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -124.39 136.34 53.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.365 -0.834 . . . . 2.1699999999999999 109.503 176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.474 ' H ' HD23 ' A' ' 142' ' ' LEU . 42.2 m-85 -128.46 146.65 50.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.155 -0.475 . . . . 4.0099999999999998 110.1 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 110' ' ' MET . . . 59.99 -164.87 0.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.714 -0.675 . . . . 1.79 111.642 177.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -77.39 -31.33 54.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.033 0.444 . . . . 3.04 110.766 172.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -60.0 -50.28 74.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.622 -0.717 . . . . 2.4100000000000001 112.328 -169.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.474 HD23 ' H ' ' A' ' 138' ' ' PHE . 8.8 mp -70.7 -29.91 66.33 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.769 -0.373 . . . . 2.3599999999999999 111.219 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -61.11 -43.61 98.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.857 0.36 . . . . 2.52 110.704 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.3 p -70.4 -31.1 68.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 2.52 111.468 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 75.8 p -97.78 9.94 41.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.583 -0.28 . . . . 2.0099999999999998 110.542 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -60.0 -24.66 60.88 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.906 -0.588 . . . . 1.52 114.06 -172.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -69.87 -38.49 76.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.851 0.358 . . . . 6.2199999999999998 110.415 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -107.62 -55.93 2.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.451 0.537 . . . . 2.0499999999999998 112.451 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -109.2 117.41 34.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.424 0.631 . . . . 2.6400000000000001 111.963 -171.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 24.4 p -130.1 147.01 51.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.061 -0.972 . . . . 2.6000000000000001 110.186 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -77.18 132.77 38.94 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.517 -0.549 . . . . 4.0899999999999999 109.517 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.99 129.57 64.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.297 -0.41 . . . . 2.1499999999999999 110.899 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.62 137.96 54.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.084 -0.507 . . . . 2.5600000000000001 110.397 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.465 ' HB ' ' HB2' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -133.38 101.04 5.01 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.281 -0.418 . . . . 1.78 110.179 175.132 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -99.52 110.45 22.9 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.289 -1.004 . . . . 2.04 108.289 172.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 32.1 m -129.14 121.05 26.95 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.013 0.435 . . . . 2.0299999999999998 111.183 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 171' ' ' ASN . . . -101.12 120.1 6.76 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.896 -0.882 . . . . 1.0800000000000001 110.896 174.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 92.5 mt -97.11 129.54 44.5 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.502 -0.555 . . . . 2.9300000000000002 109.502 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.435 ' HG2' ' HG2' ' A' ' 169' ' ' ARG . 69.9 mt-30 -102.0 119.12 38.28 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.644 -0.422 . . . . 3.02 110.625 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -118.81 133.11 56.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.513 -0.767 . . . . 4.7599999999999998 109.3 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.5 p -103.57 92.15 4.33 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.405 -0.518 . . . . 1.8200000000000001 110.767 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -60.01 -48.96 79.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.593 -0.731 . . . . 3.27 111.204 -176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.425 ' HB2' HG21 ' A' ' 166' ' ' VAL . 10.9 m120 -101.96 13.18 35.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.486 -0.324 . . . . 2.4100000000000001 111.331 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 73.88 -53.41 0.69 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.367 0.667 . . . . 2.5800000000000001 111.915 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.5 p -74.51 -18.77 60.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.985 0.422 . . . . 2.6000000000000001 111.564 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.425 HG21 ' HB2' ' A' ' 163' ' ' ASN . 16.7 m -119.93 144.48 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.297 -0.41 . . . . 2.0600000000000001 110.175 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -114.83 132.74 56.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.3 -0.409 . . . . 1.8400000000000001 111.127 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 27.3 mt -104.35 129.98 52.21 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.718 -0.845 . . . . 2.1400000000000001 108.718 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.435 ' HG2' ' HG2' ' A' ' 159' ' ' GLN . 81.0 mtt180 -110.08 112.81 25.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.994 0.426 . . . . 3.73 110.633 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.57 119.75 60.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.975 -0.557 . . . . 1.8100000000000001 109.87 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.426 ' HA ' ' HA2' ' A' ' 157' ' ' GLY . 47.9 t30 -119.51 133.9 55.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.0 0.428 . . . . 2.2400000000000002 110.674 -172.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -138.9 150.92 46.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.768 -0.651 . . . . 4.8399999999999999 110.835 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -106.29 129.7 54.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.024 -0.534 . . . . 4.4299999999999997 110.381 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.465 ' HB2' ' HB ' ' A' ' 154' ' ' THR . 86.6 mt -114.75 131.99 56.59 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.466 -0.568 . . . . 2.8500000000000001 109.466 171.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -113.47 177.21 4.71 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.564 -0.289 . . . . 3.3100000000000001 110.532 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 . . . . . 0 C--N 1.327 -0.407 0 CA-C-O 121.208 0.528 . . . . 7.3300000000000001 110.083 -178.714 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.273 0.559 . . . . 4.4000000000000004 109.718 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 32.4 mm -116.98 139.92 41.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.623 -0.717 . . . . 2.6400000000000001 111.184 -164.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 48.3 mtm105 -114.02 139.98 48.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.334 -0.247 . . . . 4.1100000000000003 110.334 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -132.22 137.99 47.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.776 0.322 . . . . 1.76 110.653 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -150.16 160.01 43.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.35 -0.386 . . . . 6.1399999999999997 110.281 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -137.93 139.13 25.28 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 120.69 0.281 . . . . 3.0800000000000001 110.394 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.33 135.65 22.84 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.401 2.067 . . . . 1.98 112.43 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 67.3 tp -137.76 134.15 34.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.685 -0.689 . . . . 2.7599999999999998 109.559 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 85.4 m -119.92 129.56 54.4 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.814 0.34 . . . . 2.4199999999999999 110.333 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.1 mt -131.45 81.71 2.0 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.283 0.563 . . . . 2.77 109.523 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 71.42 -121.47 8.94 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.429 -0.805 . . . . 1.6200000000000001 112.483 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -96.54 9.13 42.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.592 0.71 . . . . 2.8599999999999999 109.725 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -120.01 129.99 54.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.198 -0.91 . . . . 3.23 109.615 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 7.0 p -103.71 146.28 28.84 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.297 -0.41 . . . . 2.0499999999999998 110.661 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 58.0 t -133.4 140.08 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 1.9299999999999999 110.119 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 46.1 m -138.49 95.48 10.14 Favored Pre-proline 0 C--N 1.319 -0.742 0 O-C-N 122.13 -0.356 . . . . 1.6699999999999999 110.533 173.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.11 139.97 90.11 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.43 2.087 . . . . 1.28 111.477 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -109.5 137.23 47.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.033 -0.53 . . . . 4.8600000000000003 109.65 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 33.1 p -144.67 162.1 37.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.177 -0.465 . . . . 2.0899999999999999 110.731 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -138.29 142.02 39.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.26 -0.645 . . . . 5.29 109.26 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 84.3 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 121.11 0.481 . . . . 4.9400000000000004 110.423 -178.436 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 62.4 t . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 120.791 0.329 . . . . 2.9700000000000002 110.886 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -85.51 165.98 39.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.781 -0.723 . . . . 1.3999999999999999 111.438 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 89.4 mt -134.33 129.92 36.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.471 0.636 . . . . 2.4300000000000002 112.04 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.494 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 57.5 t80 -100.67 131.29 46.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.333 -0.848 . . . . 4.3300000000000001 109.845 171.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.438 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 91.0 m-85 -113.97 130.01 56.56 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.453 -0.573 . . . . 3.2599999999999998 109.453 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -123.3 134.24 9.35 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.7 -0.762 . . . . 1.3500000000000001 111.67 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.43 110.98 23.08 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.156 -0.683 . . . . 4.7599999999999998 109.156 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -107.06 102.12 11.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.908 -0.587 . . . . 4.29 110.37 -176.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.421 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 91.3 m-85 -120.0 135.98 54.72 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.13 -0.486 . . . . 7.5599999999999996 109.817 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -84.8 9.65 13.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.448 0.642 . . . . 7.0199999999999996 110.107 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -90.71 6.26 44.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.186 -0.916 . . . . 6.4800000000000004 110.268 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 99.94 5.13 55.22 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.791 -0.718 . . . . 2.9199999999999999 112.816 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 245' ' ' PHE . 65.9 tp -102.95 120.1 40.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.927 0.394 . . . . 3.5800000000000001 111.254 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 23.9 t -130.72 129.24 42.29 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.699 -0.852 . . . . 2.6000000000000001 108.699 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.51 133.17 64.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.932 -0.307 . . . . 2.2400000000000002 110.643 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 15.5 m -116.65 120.1 37.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.069 -0.514 . . . . 2.0 110.057 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 86.0 mt -125.2 127.51 46.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.753 -0.203 . . . . 3.4199999999999999 110.515 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -120.55 111.33 17.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.854 0.359 . . . . 4.0800000000000001 110.487 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -120.1 140.09 51.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.963 0.411 . . . . 5.1699999999999999 111.316 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 115.899 -0.591 . . . . 3.5800000000000001 110.491 175.614 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.661 0.267 . . . . 2.4100000000000001 110.464 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.76 132.56 6.64 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.001 -0.619 . . . . 1.6200000000000001 111.698 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 29.6 m -138.01 140.17 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.862 0.363 . . . . 2.4900000000000002 111.103 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -163.96 140.58 6.55 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.7 -0.762 . . . . 1.3 112.394 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.5 t -120.29 130.07 74.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.728 0.299 . . . . 2.3399999999999999 110.3 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -118.59 126.37 51.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.25 -0.432 . . . . 2.7999999999999998 110.286 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -100.3 123.69 44.85 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.699 -0.852 . . . . 5.1900000000000004 108.699 174.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 37.7 t -117.75 130.02 56.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.986 0.422 . . . . 2.0499999999999998 110.673 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.2 t80 . . . . . 0 C--O 1.243 0.724 0 CA-C-O 118.336 -0.84 . . . . 4.4199999999999999 109.182 176.836 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 . . . . . 0 CA--C 1.519 -0.228 0 CA-C-O 121.416 0.627 . . . . 3.6099999999999999 109.43 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -73.22 149.28 42.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.143 -0.935 . . . . 3.9100000000000001 110.534 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -104.08 131.08 51.71 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.96 -0.385 . . . . 3.9399999999999999 109.96 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.83 149.76 42.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.81 -0.632 . . . . 3.21 111.791 -171.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -131.54 129.43 41.01 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.677 -0.86 . . . . 2.6499999999999999 108.677 166.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 85.4 mt -132.5 120.23 41.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.598 -0.519 . . . . 2.0699999999999998 109.598 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -117.08 147.8 18.87 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.352 -0.927 . . . . 0.92000000000000004 112.505 -176.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.584 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -138.09 135.03 35.4 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.093 -0.336 . . . . 1.6499999999999999 110.093 175.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.623 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 67.8 mtt -134.0 146.42 50.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.406 -0.361 . . . . 2.9700000000000002 110.482 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -97.63 129.46 44.72 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.895 -0.78 . . . . 3.1499999999999999 108.895 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 . . . . . 0 C--N 1.328 -0.355 0 N-CA-C 112.187 0.44 . . . . 5.0899999999999999 112.187 -173.365 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 N--CA 1.449 -0.519 0 CA-C-O 120.943 0.402 . . . . 3.48 110.326 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 14' ' ' MET . 73.8 Cg_endo -77.39 134.81 14.34 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.354 2.036 . . . . 2.0299999999999998 113.127 -177.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.584 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 34.8 p -84.42 157.71 21.3 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.992 -0.744 . . . . 2.2799999999999998 108.992 171.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.99 132.56 69.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.213 0.53 . . . . 2.4100000000000001 111.005 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 53.0 t80 -122.76 130.85 53.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.361 -0.836 . . . . 4.4400000000000004 110.303 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -120.02 135.24 55.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.764 0.316 . . . . 3.6200000000000001 110.75 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -149.9 127.96 11.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.243 -0.651 . . . . 2.48 109.243 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.44 147.95 28.86 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.078 -0.249 . . . . 1.53 111.316 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.72 139.12 9.96 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.131 -0.486 . . . . 1.8 111.443 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.673 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 27.3 t-20 -168.28 94.97 0.39 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.963 -0.755 . . . . 3.3799999999999999 108.963 169.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.05 -85.62 0.55 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.93 -0.652 . . . . 1.8200000000000001 111.496 -173.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 19.6 Cg_endo -59.59 176.66 0.57 Allowed 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 123.643 2.895 . . . . 2.1000000000000001 112.55 171.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -67.77 175.25 3.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.932 -0.576 . . . . 4.0499999999999998 110.527 -173.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -110.99 117.08 32.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.478 0.656 . . . . 3.6000000000000001 109.706 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 84.3 mt -116.24 130.23 71.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.438 -1.256 . . . . 2.2799999999999998 110.436 -170.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.22 130.7 56.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.261 -0.427 . . . . 1.4399999999999999 110.21 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 61.2 tp -130.59 132.57 45.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 1.75 110.886 -177.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -146.59 168.92 20.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.56 -0.745 . . . . 1.5900000000000001 109.56 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -120.07 140.0 51.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.703 0.287 . . . . 4.4400000000000004 110.567 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -119.86 122.62 41.69 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.758 -0.46 . . . . 5.0199999999999996 109.758 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -123.1 139.98 53.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.941 0.401 . . . . 3.7400000000000002 110.091 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.685 -0.689 . . . . 5.0499999999999998 110.212 -179.608 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 . . . . . 0 N--CA 1.456 -0.161 0 CA-C-O 120.866 0.365 . . . . 6.5 110.644 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -102.22 111.64 24.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.465 -0.569 . . . . 4.5999999999999996 109.465 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -125.34 169.96 11.81 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.267 -0.424 . . . . 2.4500000000000002 110.098 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.502 ' NE ' ' HB2' ' A' ' 95' ' ' TYR . 12.5 ttm180 -139.31 122.41 10.62 Favored Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 120.874 -0.33 . . . . 3.7200000000000002 110.134 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 85.3 Cg_endo -91.41 151.69 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.872 2.382 . . . . 1.3200000000000001 112.184 171.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.543 ' HA ' ' HG2' ' A' ' 93' ' ' ARG . 37.8 tt0 -118.04 115.61 25.21 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.17 -0.678 . . . . 2.1899999999999999 109.17 174.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.4 tp -132.56 114.74 14.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.883 -0.599 . . . . 1.73 110.758 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.488 ' HG2' ' HA3' ' A' ' 91' ' ' GLY . 46.9 mt-10 -123.9 140.47 52.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.263 -0.426 . . . . 2.1800000000000002 110.108 174.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -123.03 129.8 74.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.203 -0.453 . . . . 2.0600000000000001 109.965 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -112.48 119.9 39.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.008 0.432 . . . . 4.1900000000000004 110.444 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . 64.8 t80 -93.08 129.14 39.14 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.554 -0.748 . . . . 5.1600000000000001 109.26 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -103.02 119.83 39.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.079 -0.509 . . . . 3.3100000000000001 110.099 -177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.448 ' CD2' ' HG ' ' A' ' 79' ' ' LEU . 69.7 t80 -120.1 119.35 33.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.522 -0.308 . . . . 4.6600000000000001 110.633 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.448 ' HG ' ' CD2' ' A' ' 78' ' ' PHE . 85.4 mt . . . . . 0 N--CA 1.466 0.336 0 O-C-N 124.136 0.897 . . . . 4.8799999999999999 112.817 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 109.996 -0.372 . . . . 2.6400000000000001 109.996 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -119.92 135.84 54.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.924 0.392 . . . . 6.1900000000000004 110.748 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.21 143.42 15.01 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.029 -0.828 . . . . 1.54 111.029 175.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 76' ' ' TYR . 88.6 mt -120.27 113.72 20.82 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.767 -0.457 . . . . 2.73 109.767 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.1 m -116.58 122.64 45.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.05 0.452 . . . . 1.8700000000000001 110.882 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -137.86 140.33 11.14 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.443 -0.663 . . . . 1.1699999999999999 111.443 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.488 ' HA3' ' HG2' ' A' ' 73' ' ' GLU . . . -169.63 170.03 42.44 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.219 -0.991 . . . . 1.4399999999999999 112.455 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 112' ' ' ARG . 53.3 p90 -156.75 160.01 38.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.986 0.422 . . . . 4.6399999999999997 111.201 -176.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.543 ' HG2' ' HA ' ' A' ' 71' ' ' GLU . 30.1 mtm180 -121.27 127.96 51.89 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.743 -0.662 . . . . 3.2200000000000002 109.228 169.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.476 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 52.0 t30 -107.3 119.13 38.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.189 -0.46 . . . . 2.2200000000000002 110.134 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.502 ' HB2' ' NE ' ' A' ' 69' ' ' ARG . 69.9 t80 -116.85 129.31 56.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.793 0.33 . . . . 3.6400000000000001 111.006 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.783 0 C-N-CA 120.333 -0.936 . . . . 2.79 113.179 172.751 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 109.4 -0.593 . . . . 3.77 109.4 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -164.78 129.12 2.52 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.632 -0.427 . . . . 2.2000000000000002 111.159 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -138.47 126.88 23.13 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.195 0.522 . . . . 3.1200000000000001 110.034 173.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 89.5 mtp -131.35 126.91 36.48 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.925 -0.579 . . . . 2.1200000000000001 109.462 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.481 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 26.3 mt-30 -118.92 134.23 55.31 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.327 -0.549 . . . . 2.4900000000000002 110.528 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 92' ' ' PHE . 47.3 ttt-85 -111.77 119.44 38.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.682 -0.69 . . . . 4.4699999999999998 109.439 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -119.94 140.21 51.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.545 -0.298 . . . . 2.9199999999999999 110.901 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 135' ' ' MET . 21.8 pttp -139.94 135.29 32.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.023 0.44 . . . . 2.5099999999999998 110.184 168.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 134' ' ' SER . 48.5 mm -120.02 119.85 61.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.827 -0.805 . . . . 2.1299999999999999 108.827 173.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -140.55 106.58 6.5 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 120.553 0.216 . . . . 1.6799999999999999 111.197 -174.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.94 139.87 13.98 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.757 2.305 . . . . 1.54 110.776 174.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -88.03 138.4 31.48 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.29 -0.634 . . . . 2.3500000000000001 109.29 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -125.86 132.32 52.21 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.547 0.203 . . . . 5.1500000000000004 111.547 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 55.78 37.53 28.98 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.251 0.97 . . . . 3.04 112.451 171.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 92.9 t -64.19 119.32 8.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.638 -0.255 . . . . 4.7400000000000002 110.926 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 59.93 43.11 15.22 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.583 -0.735 . . . . 6.3600000000000003 110.948 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.1 tp -60.15 -39.9 87.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.147 -0.479 . . . . 4.96 111.872 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 127' ' ' LEU . 32.6 m -117.3 138.14 51.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.923 0.392 . . . . 4.0700000000000003 110.318 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -61.42 -44.66 96.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.147 -0.479 . . . . 5.1699999999999999 111.025 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -70.97 -40.83 71.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.794 -0.639 . . . . 3.71 111.492 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.52 ' O ' ' HB ' ' A' ' 124' ' ' THR . 86.5 mt -126.59 125.48 42.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.924 -0.58 . . . . 2.4500000000000002 110.523 -173.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.484 ' HD2' ' OE1' ' A' ' 159' ' ' GLN . 64.9 mtt180 -92.67 133.83 35.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.098 0.475 . . . . 4.6799999999999997 110.623 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -119.8 122.0 40.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.367 -0.833 . . . . 4.3600000000000003 109.565 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.456 ' HB3' ' CZ3' ' A' ' 132' ' ' TRP . 94.4 m-20 -133.32 120.06 20.55 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.883 -0.414 . . . . 2.5899999999999999 109.883 174.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -148.18 140.27 8.25 Favored Glycine 0 CA--C 1.507 -0.416 0 C-N-CA 120.2 -1.0 . . . . 1.25 111.43 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.456 ' CZ3' ' HB3' ' A' ' 130' ' ' ASN . 0.9 OUTLIER -142.72 147.67 36.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.302 0.573 . . . . 5.0899999999999999 112.153 -177.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 91.4 mt -104.43 120.01 40.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.987 -1.006 . . . . 2.7599999999999998 109.09 176.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 26.6 t -107.39 124.56 50.01 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.54 -0.464 . . . . 1.99 110.974 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 114' ' ' LYS . 69.7 mtm -93.95 120.06 33.7 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.324 -0.991 . . . . 2.7799999999999998 108.324 171.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -115.12 132.61 56.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.167 0.508 . . . . 3.6800000000000002 112.208 -168.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -130.17 152.86 49.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.415 -0.812 . . . . 2.1699999999999999 109.908 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.464 ' O ' HD22 ' A' ' 142' ' ' LEU . 77.9 t80 -149.7 151.5 33.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.421 -0.354 . . . . 4.0099999999999998 110.248 -177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 60.61 -163.44 0.25 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.546 0.529 . . . . 1.79 111.649 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -75.91 -41.39 52.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.967 0.413 . . . . 3.04 111.786 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -60.14 -46.16 90.59 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.528 -0.76 . . . . 2.4100000000000001 112.959 -165.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.464 HD22 ' O ' ' A' ' 138' ' ' PHE . 3.8 mm? -69.88 -35.66 74.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.071 0.462 . . . . 2.3599999999999999 110.974 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.481 ' ND2' ' HB2' ' A' ' 111' ' ' GLN . 95.6 m-20 -70.78 -40.25 72.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.884 -0.598 . . . . 2.52 111.392 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.1 p -77.0 -35.05 57.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.504 -0.316 . . . . 2.52 111.823 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 149' ' ' ASP . 23.2 p -69.9 -29.9 67.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.986 0.422 . . . . 2.0099999999999998 111.092 177.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 63.28 -109.83 2.98 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.694 -0.685 . . . . 1.52 113.071 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -70.02 -33.94 72.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.594 0.235 . . . . 6.2199999999999998 110.808 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.04 75.26 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.075 -0.512 . . . . 2.0499999999999998 112.256 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.416 ' HB2' ' OG1' ' A' ' 145' ' ' THR . 15.7 m-20 -122.51 127.1 49.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.212 0.53 . . . . 2.6400000000000001 111.003 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.1 t -160.23 157.73 28.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.853 -0.612 . . . . 2.6000000000000001 110.113 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -120.16 148.2 43.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.917 -0.401 . . . . 4.0899999999999999 109.917 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.09 139.81 50.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.867 0.365 . . . . 2.1499999999999999 110.974 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -138.0 141.04 40.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.989 -0.551 . . . . 2.5600000000000001 109.523 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 24.5 m -122.91 131.36 53.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.735 0.302 . . . . 1.78 111.346 -177.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -126.57 130.06 49.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.944 -0.571 . . . . 2.04 110.235 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 93.4 m -128.24 120.78 27.87 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.044 -0.525 . . . . 2.0299999999999998 110.538 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -111.69 117.73 4.56 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.657 -0.977 . . . . 1.0800000000000001 110.657 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 77.4 mt -118.65 130.64 55.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.913 0.387 . . . . 2.9300000000000002 111.024 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.484 ' OE1' ' HD2' ' A' ' 128' ' ' ARG . 53.4 tt0 -100.14 113.43 26.07 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.901 -0.59 . . . . 3.02 110.669 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.454 ' HA ' HD22 ' A' ' 127' ' ' LEU . 86.7 m-85 -120.16 139.8 52.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.889 -0.596 . . . . 4.7599999999999998 110.424 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.4 p -94.25 100.26 12.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.963 0.411 . . . . 1.8200000000000001 110.349 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -60.05 -49.07 79.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.939 -0.573 . . . . 3.27 111.225 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.458 ' HB2' HG23 ' A' ' 166' ' ' VAL . 94.7 m-20 -101.09 10.09 41.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.222 -0.445 . . . . 2.4100000000000001 110.717 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 72.47 -46.92 0.66 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.634 0.774 . . . . 2.5800000000000001 111.235 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.4 p -74.71 -20.42 59.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.397 -0.365 . . . . 2.6000000000000001 111.788 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.458 HG23 ' HB2' ' A' ' 163' ' ' ASN . 34.2 m -124.81 139.95 49.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.368 -0.378 . . . . 2.0600000000000001 110.252 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.83 131.55 53.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.959 0.409 . . . . 1.8400000000000001 111.374 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 31.1 mt -115.31 138.54 50.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.311 -0.626 . . . . 2.1400000000000001 109.311 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -112.17 122.02 46.58 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 110.075 -0.343 . . . . 3.73 110.075 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.94 127.91 75.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.731 0.3 . . . . 1.8100000000000001 110.547 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -107.05 126.69 52.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.249 0.547 . . . . 2.2400000000000002 110.782 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -99.42 124.42 44.54 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.11 -0.95 . . . . 4.8399999999999999 108.648 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -108.77 124.98 51.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.096 0.474 . . . . 4.4299999999999997 110.923 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.474 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 62.0 tp -115.4 115.82 27.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.608 -0.723 . . . . 2.8500000000000001 111.21 -177.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -120.01 145.12 47.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.694 -0.685 . . . . 3.3100000000000001 110.116 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 . . . . . 0 C--N 1.321 -0.656 0 N-CA-C 109.546 -0.538 . . . . 7.3300000000000001 109.546 172.368 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 C--O 1.235 0.314 0 CA-C-O 120.635 0.255 . . . . 4.4000000000000004 110.521 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.481 ' O ' HG13 ' A' ' 194' ' ' ILE . 29.7 pt -93.92 90.72 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.66 0.743 . . . . 2.6400000000000001 109.375 170.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.409 ' HG2' ' HA ' ' A' ' 212' ' ' ARG . 99.1 mtt180 -91.3 120.08 31.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.875 -0.602 . . . . 4.1100000000000003 110.314 -173.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -109.36 147.23 33.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.95 -0.568 . . . . 1.76 111.38 -174.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -155.97 160.02 39.72 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.492 -0.777 . . . . 6.1399999999999997 109.726 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 1.7 pt? -144.51 127.49 8.54 Favored Pre-proline 0 C--N 1.322 -0.619 0 C-N-CA 120.846 -0.342 . . . . 3.0800000000000001 111.006 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 198' ' ' LEU . 9.1 Cg_exo -73.28 127.38 11.88 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.462 2.108 . . . . 1.98 111.674 172.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 33.1 tp -130.83 148.57 52.62 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.565 -0.902 . . . . 2.7599999999999998 108.565 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 11.9 t -129.58 140.18 51.27 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.302 0.572 . . . . 2.4199999999999999 110.954 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 60.0 tp -141.05 82.53 1.84 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.343 -0.844 . . . . 2.77 109.149 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 69.22 -120.04 10.05 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.734 -0.666 . . . . 1.6200000000000001 112.616 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -95.47 10.09 37.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.497 0.665 . . . . 2.8599999999999999 109.778 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -119.2 145.87 45.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.389 -0.823 . . . . 3.23 109.399 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 241' ' ' TYR . 47.5 t -130.03 144.53 51.39 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.851 -0.426 . . . . 2.0499999999999998 109.851 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 47.9 t -119.92 129.95 74.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.639 -0.504 . . . . 1.9299999999999999 109.639 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 20.3 m -139.84 91.03 10.62 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-O 120.867 0.365 . . . . 1.6699999999999999 110.42 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.46 140.6 27.28 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 123.013 2.475 . . . . 1.28 111.826 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -118.99 139.88 50.94 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.858 -0.423 . . . . 4.8600000000000003 109.858 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 61.1 p -133.07 146.15 51.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.789 -0.641 . . . . 2.0899999999999999 109.626 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.409 ' HA ' ' HG2' ' A' ' 195' ' ' ARG . 59.0 mtp180 -80.51 -9.97 59.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.035 0.445 . . . . 5.29 110.255 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 46.5 pt . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.547 -0.751 . . . . 4.9400000000000004 109.932 179.18 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 109.832 -0.433 . . . . 2.9700000000000002 109.832 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -132.92 143.88 15.67 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.62 -0.8 . . . . 1.3999999999999999 111.923 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 81.1 mt -116.94 121.78 42.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.7 0.286 . . . . 2.4300000000000002 110.284 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -106.55 122.26 45.95 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.877 -0.416 . . . . 4.3300000000000001 109.877 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 206' ' ' SER . 95.9 m-85 -112.2 120.37 41.54 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.066 -0.515 . . . . 3.2599999999999998 110.115 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -89.62 129.57 9.76 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.613 -0.803 . . . . 1.3500000000000001 111.533 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -107.58 127.19 53.42 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 110.004 -0.369 . . . . 4.7599999999999998 110.004 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -99.36 133.82 43.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.572 -0.74 . . . . 4.29 110.37 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -124.73 146.16 49.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.499 -0.556 . . . . 7.5599999999999996 109.499 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -56.49 -27.56 57.5 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.272 -0.876 . . . . 7.0199999999999996 112.816 -168.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.98 -34.97 74.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.364 0.602 . . . . 6.4800000000000004 110.742 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 116.2 1.94 20.25 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.21 -1.156 . . . . 2.9199999999999999 110.21 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 53.5 tp -91.08 130.41 36.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.579 -0.811 . . . . 3.5800000000000001 109.792 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 24.3 p -120.08 140.15 51.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.859 0.362 . . . . 2.6000000000000001 110.672 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.2 t -118.71 133.02 66.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.424 -0.353 . . . . 2.2400000000000002 110.211 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 24.7 m -98.4 117.55 33.06 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.782 -0.451 . . . . 2.0 109.782 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 68.6 mt -95.73 119.45 34.26 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.313 -0.625 . . . . 3.4199999999999999 109.313 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -104.43 120.02 40.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.916 0.389 . . . . 4.0800000000000001 110.495 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -116.2 132.25 56.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.885 -0.598 . . . . 5.1699999999999999 110.675 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.474 0 CA-C-O 121.504 0.669 . . . . 3.5800000000000001 109.733 172.948 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.81 0.338 . . . . 2.4100000000000001 110.545 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.91 167.54 23.25 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.917 -0.658 . . . . 1.6200000000000001 111.844 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.05 140.0 39.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.149 0.499 . . . . 2.4900000000000002 111.06 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -126.77 137.08 9.76 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.033 -0.827 . . . . 1.3 111.033 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.99 119.99 60.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.857 -0.423 . . . . 2.3399999999999999 109.857 -176.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -128.25 129.77 46.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.154 0.502 . . . . 2.7999999999999998 111.627 -176.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -120.01 110.62 16.91 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.291 -0.633 . . . . 5.1900000000000004 109.291 173.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 22.9 t -120.6 130.23 54.09 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.53 -0.544 . . . . 2.0499999999999998 109.53 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 46.2 t80 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.112 -0.946 . . . . 4.4199999999999999 109.462 -177.727 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 120.966 0.412 . . . . 3.6099999999999999 111.079 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -120.3 139.99 51.91 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.166 -0.679 . . . . 3.9100000000000001 109.166 172.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -131.83 130.78 42.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.812 0.339 . . . . 3.9399999999999999 110.182 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -137.06 150.35 47.99 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.089 -0.505 . . . . 3.21 110.152 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -132.77 131.39 41.09 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.923 -0.769 . . . . 2.6499999999999999 108.923 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.8 pt -121.34 130.32 74.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.987 0.422 . . . . 2.0699999999999998 110.971 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -114.8 134.53 11.72 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.671 -0.776 . . . . 0.92000000000000004 111.578 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -120.0 135.87 54.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.018 0.437 . . . . 1.6499999999999999 110.636 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 66.7 mtt -139.92 157.26 45.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.714 -0.675 . . . . 2.9700000000000002 109.734 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.02 112.32 24.75 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.007 -0.368 . . . . 3.1499999999999999 110.007 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 C--N 1.324 -0.536 0 CA-C-O 121.084 0.468 . . . . 5.0899999999999999 110.87 -176.789 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.591 0.234 . . . . 3.48 110.835 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.09 134.84 10.67 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.441 2.094 . . . . 2.0299999999999998 111.972 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 19.3 p -123.9 145.78 48.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.241 -0.436 . . . . 2.2799999999999998 110.0 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 8.5 p -130.0 136.79 58.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.02 0.438 . . . . 2.4100000000000001 110.791 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -117.97 143.66 46.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.033 -0.53 . . . . 4.4400000000000004 110.481 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.589 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 91.0 m-85 -102.71 129.28 49.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.976 -0.556 . . . . 3.6200000000000001 111.244 -176.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -119.88 137.43 54.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.137 -0.483 . . . . 2.48 109.948 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -120.69 143.5 48.7 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.988 -0.375 . . . . 1.53 109.988 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.49 117.98 6.97 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.537 0.523 . . . . 1.8 111.226 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.622 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 37.4 t30 -167.24 96.01 0.48 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.01 -0.541 . . . . 3.3799999999999999 110.12 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.3 -98.78 1.89 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.017 -0.611 . . . . 1.8200000000000001 112.266 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 84.1 Cg_exo -47.82 175.0 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.956 3.104 . . . . 2.1000000000000001 113.644 169.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -69.72 -177.44 1.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.265 0.555 . . . . 4.0499999999999998 111.582 -170.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.7 mtp180 -111.97 140.58 46.52 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.609 0.719 . . . . 3.6000000000000001 112.331 -170.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.0 pt -126.52 146.66 32.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 114.397 -1.274 . . . . 2.2799999999999998 110.892 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -119.73 131.22 55.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.791 -0.64 . . . . 1.4399999999999999 110.287 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.8 tp -119.92 131.84 55.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.166 -0.47 . . . . 1.75 110.831 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.98 157.8 42.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 1.5900000000000001 110.551 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -134.48 150.48 50.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.793 0.33 . . . . 4.4400000000000004 110.725 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -135.27 106.94 6.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.019 -0.537 . . . . 5.0199999999999996 111.589 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -98.87 135.84 39.73 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.457 -0.942 . . . . 3.7400000000000002 108.457 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 N--CA 1.462 0.149 0 CA-C-N 116.024 -0.535 . . . . 5.0499999999999998 111.059 -176.175 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 94.5 m95 . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 120.913 0.387 . . . . 6.5 110.507 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -70.54 139.96 51.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.072 -0.513 . . . . 4.5999999999999996 110.804 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -130.65 144.26 51.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.67 -0.696 . . . . 2.4500000000000002 109.704 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.443 ' HD2' ' HB3' ' A' ' 93' ' ' ARG . 39.5 ttp180 -124.34 122.05 26.0 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.926 -0.579 . . . . 3.7200000000000002 110.07 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 2.9 Cg_endo -85.81 150.03 9.81 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.63 2.22 . . . . 1.3200000000000001 111.883 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -128.11 128.95 45.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.054 0.454 . . . . 2.1899999999999999 110.211 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.4 tp -132.03 116.77 17.51 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.616 -0.72 . . . . 1.73 109.442 173.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.436 ' HA ' ' HA2' ' A' ' 91' ' ' GLY . 40.5 tt0 -118.81 131.17 56.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.043 0.449 . . . . 2.1800000000000002 109.868 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.4 m -113.67 141.55 29.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.816 -0.629 . . . . 2.0600000000000001 109.999 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -120.97 127.01 51.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.097 -0.502 . . . . 4.1900000000000004 110.136 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.94 141.43 49.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.365 -0.38 . . . . 5.1600000000000001 110.074 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -114.65 139.91 49.26 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.851 -0.425 . . . . 3.3100000000000001 109.851 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -132.03 149.29 52.46 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.847 0.356 . . . . 4.6600000000000001 110.408 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.6 tp . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 116.039 -0.528 . . . . 4.8799999999999999 110.085 -179.788 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 120' ' ' ASP . 3.9 m . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 120.775 0.321 . . . . 2.6400000000000001 110.889 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -140.05 143.72 36.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.502 -0.555 . . . . 6.1900000000000004 109.502 174.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.65 176.36 23.08 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.255 -0.974 . . . . 1.54 112.539 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 64.0 tp -126.83 130.04 49.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.912 0.387 . . . . 2.73 110.077 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.2 m -120.02 129.91 54.47 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.054 -0.521 . . . . 1.8700000000000001 109.908 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 114' ' ' LYS . . . -138.97 133.6 6.3 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.615 -0.802 . . . . 1.1699999999999999 111.8 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 73' ' ' GLU . . . -135.03 147.99 19.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.591 -0.814 . . . . 1.4399999999999999 112.4 -178.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -129.36 137.74 51.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.957 0.408 . . . . 4.6399999999999997 111.222 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 89.8 mtt180 -129.79 148.46 51.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.437 -0.801 . . . . 3.2200000000000002 109.803 171.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.658 ' HA ' ' O ' ' A' ' 110' ' ' MET . 51.8 t-20 -139.55 118.43 12.47 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.094 -0.336 . . . . 2.2200000000000002 110.094 172.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.42 ' HB2' ' HD3' ' A' ' 69' ' ' ARG . 43.1 t80 -103.0 119.56 39.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.167 -0.309 . . . . 3.6400000000000001 110.167 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.517 0 C-N-CA 120.295 -0.955 . . . . 2.79 112.166 178.46 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.2 p . . . . . 0 N--CA 1.446 -0.645 0 N-CA-C 110.031 -0.359 . . . . 3.77 110.031 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -128.98 133.24 47.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.894 0.378 . . . . 2.2000000000000002 111.232 -174.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.513 ' HB2' ' OD1' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -149.41 149.46 30.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.789 -0.641 . . . . 3.1200000000000001 110.107 177.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.658 ' O ' ' HA ' ' A' ' 94' ' ' ASN . 87.1 mtp -116.07 116.3 27.62 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.025 -0.534 . . . . 2.1200000000000001 110.353 -176.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -94.66 119.87 33.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.903 0.383 . . . . 2.4900000000000002 110.279 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.598 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 55.3 ttt180 -116.9 125.6 51.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.217 -0.447 . . . . 4.4699999999999998 110.767 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -115.89 135.95 53.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.825 -0.625 . . . . 2.9199999999999999 110.239 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.475 ' O ' ' HA2' ' A' ' 90' ' ' GLY . 45.4 tttm -122.24 123.56 41.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.712 -0.676 . . . . 2.5099999999999998 109.97 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.5 mm -120.03 120.34 62.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 109.286 -0.635 . . . . 2.1299999999999999 109.286 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -141.49 105.03 5.93 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 111.863 0.32 . . . . 1.6799999999999999 111.863 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.444 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 85.4 Cg_endo -84.44 157.04 12.53 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.93 2.42 . . . . 1.54 111.263 171.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -126.21 146.77 49.85 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.908 -0.317 . . . . 2.3500000000000001 110.854 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -126.24 130.79 51.62 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.977 -0.556 . . . . 5.1500000000000004 110.796 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 85' ' ' SER . 42.1 t0 -60.06 140.08 57.06 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.207 0.942 . . . . 3.04 111.319 -176.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.787 ' HA ' ' O ' ' A' ' 129' ' ' PHE . 35.9 m -76.5 -22.67 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.944 -1.025 . . . . 4.7400000000000002 111.444 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -82.4 83.52 7.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.79 0.328 . . . . 6.3600000000000003 110.439 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.2 tp -90.39 -79.78 0.34 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.224 -0.444 . . . . 4.96 111.284 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 69.4 p -145.14 158.11 43.91 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.9 -0.136 . . . . 4.0700000000000003 111.101 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 58.49 25.22 12.76 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.774 0.671 . . . . 5.1699999999999999 112.271 170.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.443 ' HA ' HH12 ' A' ' 128' ' ' ARG . 25.1 m-20 57.04 30.0 17.45 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.064 0.459 . . . . 3.71 111.908 -176.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.1 mt -99.02 139.58 34.45 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.231 -1.026 . . . . 2.4500000000000002 108.231 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.632 ' HA ' ' O ' ' A' ' 121' ' ' VAL . 50.7 mmt-85 -107.99 120.17 41.55 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.213 -0.595 . . . . 4.6799999999999997 110.624 -174.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.787 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 90.2 m-85 -118.47 125.11 49.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.6 -0.727 . . . . 4.3600000000000003 109.79 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.472 ' O ' ' HA ' ' A' ' 156' ' ' THR . 24.0 t30 -110.77 126.24 54.39 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.609 -0.268 . . . . 2.5899999999999999 110.282 -175.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.79 117.38 1.85 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.087 -1.054 . . . . 1.25 112.357 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 155' ' ' GLU . 52.8 t-105 -126.6 129.91 49.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.398 -0.593 . . . . 5.0899999999999999 109.398 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 84.3 mt -118.06 138.27 52.35 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.715 -0.476 . . . . 2.7599999999999998 109.715 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' A' ' 153' ' ' GLU . 3.2 p -134.99 117.19 15.51 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.475 0.655 . . . . 1.99 111.153 175.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 95.1 mmm -106.12 134.83 48.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.183 -0.917 . . . . 2.7799999999999998 109.288 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -124.9 133.83 52.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.012 0.434 . . . . 3.6800000000000002 111.888 -173.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 97.7 mttt -118.5 132.66 56.22 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.681 -0.859 . . . . 2.1699999999999999 108.681 171.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.527 ' H ' HD11 ' A' ' 142' ' ' LEU . 54.3 m-85 -123.03 143.04 50.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.508 0.194 . . . . 4.0099999999999998 110.908 -174.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 59.79 -160.19 0.29 Allowed 'General case' 0 C--O 1.226 -0.171 0 O-C-N 123.856 0.722 . . . . 1.79 111.446 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -76.02 -36.06 59.27 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.952 0.406 . . . . 3.04 110.483 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -60.29 -49.74 76.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.379 -0.828 . . . . 2.4100000000000001 113.169 -167.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.551 ' HA ' ' OG1' ' A' ' 145' ' ' THR . 14.7 mt -70.41 -27.18 64.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.74 -0.384 . . . . 2.3599999999999999 111.371 -176.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -60.72 -39.92 90.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.114 0.483 . . . . 2.52 110.343 172.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 85.0 m -70.05 -41.02 74.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.617 -0.72 . . . . 2.52 111.018 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.551 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 56.3 p -74.82 -26.09 59.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 2.0099999999999998 111.718 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 69.0 -112.96 4.91 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.845 -0.693 . . . . 1.52 112.345 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -106.21 -0.19 24.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.691 0.281 . . . . 6.2199999999999998 110.801 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.85 -40.18 75.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.103 0.478 . . . . 2.0499999999999998 110.547 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.445 ' O ' HD22 ' A' ' 142' ' ' LEU . 24.2 t70 -135.94 111.57 9.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.489 -0.778 . . . . 2.6400000000000001 109.083 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.6 t -165.7 147.15 7.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.932 -0.576 . . . . 2.6000000000000001 110.114 -173.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -70.71 135.71 48.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.611 0.243 . . . . 4.0899999999999999 110.508 175.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.91 120.08 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.176 -0.466 . . . . 2.1499999999999999 110.058 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.47 ' HB2' ' OG ' ' A' ' 134' ' ' SER . 96.4 mt-10 -119.97 139.96 51.66 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.444 -0.576 . . . . 2.5600000000000001 109.444 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 89.5 m -139.97 134.41 31.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.972 0.415 . . . . 1.78 111.493 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 132' ' ' TRP . 41.6 tt0 -113.35 127.81 56.25 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.298 -0.63 . . . . 2.04 109.298 173.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 130' ' ' ASN . 35.5 m -129.0 120.46 26.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.847 0.356 . . . . 2.0299999999999998 110.474 177.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -116.21 133.9 11.07 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.709 -0.758 . . . . 1.0800000000000001 111.601 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.493 ' HB2' HG13 ' A' ' 170' ' ' VAL . 52.6 mt -121.28 133.07 55.13 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.508 -0.553 . . . . 2.9300000000000002 109.508 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.534 ' HB3' ' HB2' ' A' ' 128' ' ' ARG . 54.1 tt0 -120.03 120.38 36.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.458 -0.337 . . . . 3.02 110.419 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -121.55 131.0 53.88 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.358 -0.608 . . . . 4.7599999999999998 109.358 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.1 p -99.49 89.81 4.3 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.466 -0.494 . . . . 1.8200000000000001 110.138 177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.07 -49.1 78.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.61 -0.723 . . . . 3.27 111.441 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.471 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.1 m-20 -100.0 12.68 36.26 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 121.119 -0.232 . . . . 2.4100000000000001 110.454 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 71.15 -49.51 0.68 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.725 0.81 . . . . 2.5800000000000001 111.762 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.2 t -74.84 -16.22 60.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.73 0.3 . . . . 2.6000000000000001 111.488 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 163' ' ' ASN . 17.9 m -125.58 141.45 45.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.853 0.359 . . . . 2.0600000000000001 110.439 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.401 ' O ' ' HD2' ' A' ' 199' ' ' PRO . . . -107.23 139.43 41.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 1.8400000000000001 110.909 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 31.2 mt -104.42 136.8 43.32 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.651 -0.87 . . . . 2.1400000000000001 108.651 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -118.34 120.12 36.68 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.444 -0.502 . . . . 3.73 110.477 -176.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.493 HG13 ' HB2' ' A' ' 158' ' ' LEU . 3.5 p -129.69 131.95 66.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.744 -0.662 . . . . 1.8100000000000001 109.752 176.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.443 HD22 ' CG ' ' A' ' 155' ' ' GLU . 26.8 t-20 -127.84 130.05 47.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.002 -0.545 . . . . 2.2400000000000002 110.163 -176.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -101.01 121.67 42.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.009 -0.542 . . . . 4.8399999999999999 109.626 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -97.3 110.0 22.64 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.155 -0.683 . . . . 4.4299999999999997 109.155 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.51 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 61.2 tp -103.63 115.67 30.92 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.084 -0.507 . . . . 2.8500000000000001 110.372 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -122.06 114.21 20.61 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.634 -0.876 . . . . 3.3100000000000001 108.634 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 116.261 -0.427 . . . . 7.3300000000000001 111.068 -176.349 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 . . . . . 0 CA--C 1.522 -0.107 0 CA-C-O 121.081 0.467 . . . . 4.4000000000000004 111.363 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.688 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 18.5 tt -149.27 146.57 17.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.976 -0.556 . . . . 2.6400000000000001 109.645 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' A' ' 210' ' ' TYR . 96.6 mtt180 -121.93 110.08 15.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.723 0.297 . . . . 4.1100000000000003 110.774 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -137.21 141.76 42.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.544 -0.298 . . . . 1.76 111.186 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -163.53 174.99 11.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.647 -0.871 . . . . 6.1399999999999997 108.647 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 7.0 mp -98.64 125.61 42.03 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.045 -0.724 . . . . 3.0800000000000001 109.045 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' A' ' 167' ' ' ALA . 36.5 Cg_exo -60.07 138.75 83.83 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.1 1.867 . . . . 1.98 111.672 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 77.9 mt -116.94 131.81 56.86 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.183 -0.673 . . . . 2.7599999999999998 109.183 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 11.6 t -147.94 139.87 24.05 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.189 0.518 . . . . 2.4199999999999999 110.838 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 57.2 tp -143.89 85.46 1.82 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.542 -0.754 . . . . 2.77 109.354 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 75.92 -112.29 3.55 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.858 -0.686 . . . . 1.6200000000000001 112.487 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -93.94 0.02 55.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.204 0.526 . . . . 2.8599999999999999 110.351 -177.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -110.56 116.56 31.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.725 -0.67 . . . . 3.23 110.105 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 49.2 m -122.6 131.05 53.64 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.842 -0.429 . . . . 2.0499999999999998 109.842 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.27 130.01 72.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.044 -0.354 . . . . 1.9299999999999999 110.044 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.7 m -127.72 90.34 48.38 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-O 120.915 0.388 . . . . 1.6699999999999999 110.484 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 239' ' ' LEU . 5.8 Cg_exo -79.58 150.45 21.79 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.167 2.578 . . . . 1.28 112.081 175.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.511 ' HB3' ' HB3' ' A' ' 195' ' ' ARG . 80.9 m-85 -126.08 139.93 52.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.024 0.44 . . . . 4.8600000000000003 111.316 173.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 7.0 t -154.43 169.22 24.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.368 -0.975 . . . . 2.0899999999999999 108.368 175.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.688 ' HA ' ' O ' ' A' ' 194' ' ' ILE . 67.3 ttt180 -60.29 -49.19 78.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.385 0.539 . . . . 5.29 111.015 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.6 mt . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 109.584 -0.524 . . . . 4.9400000000000004 109.584 179.443 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 109.675 -0.491 . . . . 2.9700000000000002 109.675 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -92.14 117.08 5.19 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.427 -0.892 . . . . 1.3999999999999999 111.265 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 209' ' ' PRO . 6.3 mp -103.49 119.72 39.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.876 0.37 . . . . 2.4300000000000002 110.305 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -99.89 119.92 38.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.76 -0.655 . . . . 4.3300000000000001 109.287 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 252' ' ' SER . 91.1 m-85 -100.53 126.69 47.0 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.813 -0.44 . . . . 3.2599999999999998 109.813 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -116.25 121.46 5.21 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.798 -0.715 . . . . 1.3500000000000001 111.607 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' TYR . . . . . 0.429 ' HB2' ' HB ' ' A' ' 251' ' ' VAL . 89.7 m-85 -119.94 130.25 54.71 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.802 -0.444 . . . . 4.7599999999999998 109.802 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -112.65 128.7 56.46 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.456 -0.572 . . . . 4.29 109.456 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.92 140.19 51.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.159 0.505 . . . . 7.5599999999999996 110.391 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -60.0 -29.49 68.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.058 -0.974 . . . . 7.0199999999999996 112.24 -171.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -69.47 -20.01 63.75 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.607 0.241 . . . . 6.4800000000000004 111.486 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 116.22 0.0 20.76 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.548 -0.834 . . . . 2.9199999999999999 112.259 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.423 HD12 ' CD2' ' A' ' 279' ' ' TYR . 53.5 tp -74.98 129.96 38.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.869 0.366 . . . . 3.5800000000000001 110.256 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 25.8 t -122.06 130.26 53.12 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.261 -0.644 . . . . 2.6000000000000001 109.261 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . 0.429 ' HB ' ' HB2' ' A' ' 243' ' ' TYR . 62.9 t -119.99 132.85 68.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.42 -0.355 . . . . 2.2400000000000002 110.666 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 241' ' ' TYR . 35.2 t -127.73 128.45 45.39 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.068 -0.716 . . . . 2.0 109.068 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 81.6 mt -121.38 139.93 52.79 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.652 -0.249 . . . . 3.4199999999999999 110.82 -178.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -114.35 110.67 20.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.182 -0.463 . . . . 4.0800000000000001 110.536 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -131.92 148.67 52.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.35 -0.386 . . . . 5.1699999999999999 110.34 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.555 0 CA-C-O 121.24 0.543 . . . . 3.5800000000000001 110.087 175.803 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.607 -0.516 . . . . 2.4100000000000001 109.607 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.07 133.61 7.34 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.216 -0.992 . . . . 1.6200000000000001 112.343 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 61.8 t -127.86 129.82 69.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.956 -0.387 . . . . 2.4900000000000002 109.956 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -132.76 111.85 1.06 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.227 -0.749 . . . . 1.3 111.227 176.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 23.8 m -119.98 132.36 69.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.845 0.355 . . . . 2.3399999999999999 110.815 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -119.71 127.75 53.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.153 -0.476 . . . . 2.7999999999999998 110.368 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.423 ' CD2' HD12 ' A' ' 249' ' ' LEU . 89.6 m-85 -105.99 130.27 53.95 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.044 -0.725 . . . . 5.1900000000000004 109.044 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.1 t -117.68 125.05 49.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.841 0.353 . . . . 2.0499999999999998 111.172 -172.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.281 -0.866 . . . . 4.4199999999999999 109.858 179.193 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 . . . . . 0 CA--C 1.518 -0.276 0 N-CA-C 109.816 -0.439 . . . . 3.6099999999999999 109.816 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -71.78 118.18 14.3 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.674 -0.491 . . . . 3.9100000000000001 109.674 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.464 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 96.4 m-70 -104.14 124.94 50.0 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.104 0.478 . . . . 3.9399999999999999 110.671 -176.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.97 139.94 51.7 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.422 -0.808 . . . . 3.21 109.264 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -129.12 129.63 45.42 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.036 -0.728 . . . . 2.6499999999999999 109.036 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.6 mm -120.53 120.08 61.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.901 -0.407 . . . . 2.0699999999999998 109.901 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -102.74 137.69 13.53 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.065 -1.064 . . . . 0.92000000000000004 111.331 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.17 135.36 54.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.921 0.391 . . . . 1.6499999999999999 110.248 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 59.4 ttm -134.6 130.95 37.24 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.696 -0.683 . . . . 2.9700000000000002 110.026 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -99.84 121.64 41.6 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.486 -0.561 . . . . 3.1499999999999999 109.486 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 5.0899999999999999 110.519 179.908 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.897 0.379 . . . . 3.48 111.278 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.38 133.59 28.68 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.088 1.859 . . . . 2.0299999999999998 110.679 171.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.8 m -128.45 147.25 50.65 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.561 -0.29 . . . . 2.2799999999999998 110.654 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 19.5 m -120.13 146.69 24.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.382 -0.372 . . . . 2.4100000000000001 110.475 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -119.96 142.65 48.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.03 -0.532 . . . . 4.4400000000000004 109.608 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 64.4 t80 -101.7 129.87 47.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.863 0.363 . . . . 3.6200000000000001 110.602 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -144.38 134.87 24.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.79 -0.641 . . . . 2.48 109.351 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.74 146.7 39.87 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.309 -0.244 . . . . 1.53 111.425 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 8' ' ' HIS . . . -154.95 122.53 5.7 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 111.936 0.347 . . . . 1.8 111.936 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.643 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 53.8 t30 -167.87 95.56 0.43 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.391 -0.368 . . . . 3.3799999999999999 110.207 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.69 -94.72 2.02 Favored Glycine 0 C--O 1.23 -0.134 0 C-N-CA 121.012 -0.614 . . . . 1.8200000000000001 111.67 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.643 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 80.8 Cg_exo -47.19 175.74 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 123.912 3.075 . . . . 2.1000000000000001 113.357 167.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -66.1 176.68 1.62 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.428 0.632 . . . . 4.0499999999999998 111.441 -172.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -110.62 124.18 51.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.707 -0.678 . . . . 3.6000000000000001 109.649 -171.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 85.3 mt -119.58 130.01 74.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.664 -0.698 . . . . 2.2799999999999998 110.915 -169.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -118.96 130.0 55.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 1.4399999999999999 110.419 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.2 tp -124.57 135.66 53.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.138 -0.483 . . . . 1.75 111.241 -176.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.98 162.47 35.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.663 -0.699 . . . . 1.5900000000000001 110.121 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -137.42 146.87 44.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.821 0.344 . . . . 4.4400000000000004 110.345 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.4 ' HB2' ' HG3' ' A' ' 69' ' ' ARG . 96.1 m-85 -130.05 129.95 44.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.229 -0.441 . . . . 5.0199999999999996 111.306 -175.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -104.54 85.94 2.42 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.281 -0.637 . . . . 3.7400000000000002 109.281 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.549 ' CD ' HH21 ' A' ' 69' ' ' ARG . 42.2 mt-10 . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.857 -0.61 . . . . 5.0499999999999998 110.907 -173.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 87.6 m95 . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.637 0.256 . . . . 6.5 110.616 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -125.66 138.65 53.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.459 -0.337 . . . . 4.5999999999999996 110.153 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -131.99 170.03 15.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.366 -0.379 . . . . 2.4500000000000002 110.173 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.549 HH21 ' CD ' ' A' ' 53' ' ' GLU . 27.9 ptt180 -141.84 125.7 9.96 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.979 0.418 . . . . 3.7200000000000002 111.196 171.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.529 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 90.9 Cg_endo -85.19 156.85 11.15 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.999 2.466 . . . . 1.3200000000000001 112.25 172.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.423 ' HG3' ' HE ' ' A' ' 93' ' ' ARG . 86.1 tt0 -127.09 120.77 29.7 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.123 -0.695 . . . . 2.1899999999999999 109.123 171.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.577 ' O ' ' HA3' ' A' ' 91' ' ' GLY . 64.3 tp -136.21 119.09 16.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.346 -0.388 . . . . 1.73 110.208 -177.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.443 ' CD ' ' HZ3' ' A' ' 114' ' ' LYS . 40.0 mt-10 -128.59 149.22 50.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.122 0.487 . . . . 2.1800000000000002 110.864 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.6 t -119.96 130.04 74.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.447 -0.797 . . . . 2.0600000000000001 109.272 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -93.73 120.51 34.09 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.704 -0.48 . . . . 4.1900000000000004 109.704 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -108.2 134.85 50.47 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.105 -0.702 . . . . 5.1600000000000001 109.105 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -120.0 131.29 55.09 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.68 0.276 . . . . 3.3100000000000001 110.318 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -119.58 138.57 53.13 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.29 0.567 . . . . 4.6600000000000001 111.167 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.0 mt . . . . . 0 C--N 1.324 -0.522 0 N-CA-C 108.684 -0.858 . . . . 4.8799999999999999 108.684 177.433 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 CA--C 1.52 -0.21 0 CA-C-O 120.894 0.378 . . . . 2.6400000000000001 111.698 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -94.43 103.89 15.86 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.271 -0.572 . . . . 6.1900000000000004 109.65 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -113.97 125.65 6.99 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.979 -0.848 . . . . 1.54 110.979 176.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 60.0 tp -119.64 130.53 55.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.837 0.351 . . . . 2.73 111.02 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.2 p -117.04 131.86 56.83 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.788 -0.819 . . . . 1.8700000000000001 108.788 169.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.43 150.46 20.88 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.235 -0.983 . . . . 1.1699999999999999 111.585 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 72' ' ' LEU . . . -173.16 -169.96 36.23 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.632 -0.794 . . . . 1.4399999999999999 112.07 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -120.21 139.98 51.85 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.062 0.458 . . . . 4.6399999999999997 110.819 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.423 ' HE ' ' HG3' ' A' ' 71' ' ' GLU . 98.2 mtt180 -121.04 127.21 51.5 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.492 -0.929 . . . . 3.2200000000000002 108.492 172.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.529 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 10.4 t30 -132.25 124.61 29.26 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.78 -0.368 . . . . 2.2200000000000002 110.674 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.461 ' HA ' ' HB3' ' A' ' 69' ' ' ARG . 72.1 t80 -111.28 129.54 55.95 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.331 -0.395 . . . . 3.6400000000000001 110.435 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.541 0 C-N-CA 120.68 -0.772 . . . . 2.79 112.574 177.499 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.2 t . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 109.049 -0.723 . . . . 3.77 109.049 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.62 113.25 7.02 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.623 -0.431 . . . . 2.2000000000000002 110.864 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -147.02 138.56 24.19 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.045 -0.525 . . . . 3.1200000000000001 110.139 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.477 ' HG3' ' HA ' ' A' ' 139' ' ' ALA . 46.4 ttm -131.65 129.91 41.4 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.622 -0.717 . . . . 2.1200000000000001 110.71 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -101.87 124.96 48.39 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.491 -0.559 . . . . 2.4900000000000002 109.491 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -130.55 130.15 43.71 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.134 0.492 . . . . 4.4699999999999998 110.328 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -112.2 141.73 45.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.742 -0.663 . . . . 2.9199999999999999 110.79 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.443 ' HZ3' ' CD ' ' A' ' 73' ' ' GLU . 62.2 tttm -139.89 123.59 17.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.177 -0.465 . . . . 2.5099999999999998 110.424 173.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 88.0 mt -136.76 130.15 45.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.513 -0.767 . . . . 2.1299999999999999 109.039 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -149.46 104.19 3.28 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.678 0.622 . . . . 1.6799999999999999 112.678 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.411 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 65.0 Cg_endo -94.43 159.77 1.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.463 2.775 . . . . 1.54 113.036 170.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -120.6 142.51 49.33 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.379 -0.971 . . . . 2.3500000000000001 108.379 173.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -125.78 129.92 50.41 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.474 0.176 . . . . 5.1500000000000004 111.474 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -84.1 120.89 26.7 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.576 -0.527 . . . . 3.04 109.576 170.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.57 ' O ' ' HB3' ' A' ' 129' ' ' PHE . 57.3 t -139.88 99.92 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.886 0.375 . . . . 4.7400000000000002 110.282 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -87.61 115.92 25.38 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.113 -0.328 . . . . 6.3600000000000003 110.113 176.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.78 -39.81 95.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.413 0.625 . . . . 4.96 109.322 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.0 p -141.4 169.92 16.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.873 -1.058 . . . . 4.0700000000000003 109.178 172.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.14 -45.44 93.05 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.839 0.311 . . . . 5.1699999999999999 111.839 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -64.94 -39.95 94.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 3.71 111.552 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.5 mt -76.16 142.57 41.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.43 0.634 . . . . 2.4500000000000002 112.11 -172.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.516 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 35.2 ttt180 -110.31 118.07 35.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.252 -0.886 . . . . 4.6799999999999997 109.248 175.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.57 ' HB3' ' O ' ' A' ' 121' ' ' VAL . 65.0 t80 -142.11 138.48 31.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.728 0.299 . . . . 4.3600000000000003 110.372 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -139.87 172.2 13.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 2.5899999999999999 109.913 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -148.23 121.99 1.44 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.776 -0.726 . . . . 1.25 112.072 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -100.02 126.52 46.22 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.389 -0.597 . . . . 5.0899999999999999 109.389 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.602 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 42.6 tp -111.98 130.71 55.76 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.26 -0.427 . . . . 2.7599999999999998 110.117 -178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.1 m -127.0 129.99 49.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.901 0.382 . . . . 1.99 110.308 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.595 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 72.0 mtm -122.91 125.19 44.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.849 -0.614 . . . . 2.7799999999999998 109.958 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -122.17 139.94 53.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.116 -0.493 . . . . 3.6800000000000002 111.774 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -135.78 149.98 49.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.323 -0.991 . . . . 2.1699999999999999 108.323 172.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.467 ' O ' HD23 ' A' ' 142' ' ' LEU . 46.2 p90 -140.5 165.93 26.1 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.095 -0.335 . . . . 4.0099999999999998 110.095 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.477 ' HA ' ' HG3' ' A' ' 110' ' ' MET . . . 63.42 178.15 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.512 0.507 . . . . 1.79 111.018 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -76.1 -36.63 58.82 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.313 0.578 . . . . 3.04 110.6 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -60.07 -40.02 88.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.253 -0.885 . . . . 2.4100000000000001 112.956 -171.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 138' ' ' PHE . 4.2 mm? -69.38 -33.4 72.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.696 0.284 . . . . 2.3599999999999999 111.535 -173.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -66.62 -39.93 88.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.365 0.602 . . . . 2.52 109.517 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 52.4 m -65.77 -39.95 91.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.2 -0.909 . . . . 2.52 111.395 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 22.9 p -71.7 -9.87 58.91 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 111.89 0.33 . . . . 2.0099999999999998 111.89 -177.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 65.43 -120.34 17.19 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.786 -0.721 . . . . 1.52 111.857 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -103.29 10.09 37.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.854 0.327 . . . . 6.2199999999999998 111.016 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.48 -40.12 95.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.885 0.374 . . . . 2.0499999999999998 110.499 176.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -137.14 114.87 11.27 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.298 -0.631 . . . . 2.6400000000000001 109.298 175.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.1 t -159.95 150.05 18.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.918 0.39 . . . . 2.6000000000000001 110.543 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 135' ' ' MET . 19.0 mtp180 -84.47 113.35 21.14 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.051 -0.351 . . . . 4.0899999999999999 110.051 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.9 t -111.15 103.7 15.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.98 -0.748 . . . . 2.1499999999999999 108.98 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -121.99 128.91 52.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.549 -0.75 . . . . 2.5600000000000001 110.016 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 72.7 m -128.49 130.22 47.2 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.033 0.444 . . . . 1.78 111.527 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -110.4 119.22 38.5 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.01 -0.737 . . . . 2.04 109.01 173.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.522 ' OG1' ' HB3' ' A' ' 172' ' ' TYR . 22.7 p -101.36 141.67 33.89 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.726 -0.39 . . . . 2.0299999999999998 110.727 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 129' ' ' PHE . . . -116.7 120.02 4.69 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.723 -0.751 . . . . 1.0800000000000001 112.095 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.6 tp -115.2 129.76 56.73 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.91 0.386 . . . . 2.9300000000000002 110.151 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.516 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 30.1 tt0 -118.98 115.85 25.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.521 -0.548 . . . . 3.02 109.521 174.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -125.39 130.53 52.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.795 -0.638 . . . . 4.7599999999999998 110.218 -175.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 3.7 p -87.58 93.9 9.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.064 0.459 . . . . 1.8200000000000001 110.853 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -59.99 -49.82 76.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 3.27 111.547 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -101.8 16.65 25.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.544 -0.298 . . . . 2.4100000000000001 110.861 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 73.03 -50.19 0.7 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.763 0.664 . . . . 2.5800000000000001 111.419 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.1 p -74.78 -21.41 59.34 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.037 0.384 . . . . 2.6000000000000001 112.037 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 161' ' ' THR . 34.3 m -120.03 138.16 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.776 0.322 . . . . 2.0600000000000001 110.724 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.0 134.4 50.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.215 -0.448 . . . . 1.8400000000000001 110.29 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 43.8 mt -103.55 139.92 38.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.34 -0.391 . . . . 2.1400000000000001 110.024 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 55.6 mtp180 -98.9 114.36 26.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.212 -0.449 . . . . 3.73 109.882 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 195' ' ' ARG . 60.3 t -129.16 132.3 67.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 1.8100000000000001 110.569 -177.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.425 ' O ' HG21 ' A' ' 194' ' ' ILE . 18.9 m120 -122.52 147.91 45.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.971 0.415 . . . . 2.2400000000000002 110.868 173.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.522 ' HB3' ' OG1' ' A' ' 156' ' ' THR . 64.5 t80 -129.09 147.09 50.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.487 -0.779 . . . . 4.8399999999999999 109.811 -173.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -96.63 125.49 41.14 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 120.757 0.313 . . . . 4.4299999999999997 110.714 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 67.7 tp -120.83 114.02 20.99 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.257 -0.645 . . . . 2.8500000000000001 109.257 171.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -125.18 113.43 17.66 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.629 -0.508 . . . . 3.3100000000000001 109.629 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.063 0.459 . . . . 7.3300000000000001 111.021 -176.247 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.43 ' HG3' ' HG3' ' A' ' 212' ' ' ARG . 35.8 tt0 . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.077 -0.342 . . . . 4.4000000000000004 110.077 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.425 HG21 ' O ' ' A' ' 171' ' ' ASN . 87.3 mt -110.2 143.29 20.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 122.358 0.263 . . . . 2.6400000000000001 111.188 -173.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.577 ' HB3' ' CD1' ' A' ' 210' ' ' TYR . 53.9 mtm-85 -98.41 102.84 14.7 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.904 -0.776 . . . . 4.1100000000000003 108.904 169.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 169' ' ' ARG . . . -141.08 121.7 14.22 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.918 -0.313 . . . . 1.76 111.014 177.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -165.76 -179.11 5.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.648 -0.501 . . . . 6.1399999999999997 109.648 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.474 HD13 ' HD2' ' A' ' 199' ' ' PRO . 24.3 tp -99.44 126.58 37.09 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.315 -0.624 . . . . 3.0800000000000001 109.315 173.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.474 ' HD2' HD13 ' A' ' 198' ' ' LEU . 38.3 Cg_endo -70.06 145.79 56.46 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.139 1.892 . . . . 1.98 112.225 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 56.1 mt -118.41 130.72 56.13 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.085 -0.507 . . . . 2.7599999999999998 109.655 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 26.8 m -131.12 125.15 32.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.983 0.42 . . . . 2.4199999999999999 110.996 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 91.8 mt -131.37 80.97 1.96 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.57 -0.741 . . . . 2.77 109.47 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 68.62 -115.83 6.94 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.802 -0.713 . . . . 1.6200000000000001 112.105 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -90.12 -0.59 57.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.209 0.528 . . . . 2.8599999999999999 110.117 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.432 ' CD2' ' HE2' ' A' ' 243' ' ' TYR . 75.7 m80 -99.9 117.23 33.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.539 -0.755 . . . . 3.23 109.01 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 12.5 t -132.14 130.97 41.82 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.629 -0.428 . . . . 2.0499999999999998 110.24 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.8 p -137.56 134.98 46.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.408 0.623 . . . . 1.9299999999999999 110.862 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 29.0 m -128.95 91.78 41.74 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 115.667 -0.697 . . . . 1.6699999999999999 109.846 176.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.74 157.16 61.4 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.599 2.199 . . . . 1.28 110.664 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.577 ' CD1' ' HB3' ' A' ' 195' ' ' ARG . 71.0 m-85 -129.29 139.79 51.66 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.997 -0.372 . . . . 4.8600000000000003 109.997 175.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 39.5 p -124.25 140.02 53.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.987 0.422 . . . . 2.0899999999999999 110.385 176.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.43 ' HG3' ' HG3' ' A' ' 193' ' ' GLU . 37.7 ttt180 -64.27 -39.67 94.41 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 114.795 -1.093 . . . . 5.29 112.748 -170.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.9 mt . . . . . 0 C--N 1.321 -0.643 0 CA-C-O 120.742 0.306 . . . . 4.9400000000000004 110.383 -174.917 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 210' ' ' TYR . 71.0 t . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 120.932 0.396 . . . . 2.9700000000000002 110.031 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -110.39 141.79 16.42 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.599 -0.81 . . . . 1.3999999999999999 111.807 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 88.9 mt -109.72 117.65 34.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.158 -0.312 . . . . 2.4300000000000002 110.158 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -101.09 120.11 39.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.205 -0.452 . . . . 4.3300000000000001 109.95 175.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.514 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 86.8 m-85 -111.94 130.19 55.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.097 0.475 . . . . 3.2599999999999998 110.349 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -121.32 113.7 2.39 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 111.027 -0.829 . . . . 1.3500000000000001 111.027 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' TYR . . . . . 0.432 ' HE2' ' CD2' ' A' ' 205' ' ' HIS . 86.5 m-85 -119.96 135.25 54.98 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.178 0.513 . . . . 4.7599999999999998 111.501 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -110.0 100.82 9.71 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.408 -0.815 . . . . 4.29 109.077 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -77.55 -19.95 54.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.976 0.417 . . . . 7.5599999999999996 110.959 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -149.93 150.46 31.91 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.738 -0.838 . . . . 7.0199999999999996 108.738 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -66.97 121.68 16.06 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.423 -0.511 . . . . 6.4800000000000004 109.682 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 98.53 -9.71 62.65 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.778 -0.646 . . . . 2.9199999999999999 112.43 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 93.1 mt -124.23 133.0 53.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.721 0.296 . . . . 3.5800000000000001 110.616 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 33.7 m -129.98 149.96 51.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.368 -0.378 . . . . 2.6000000000000001 110.772 -176.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 8.5 p -127.41 134.07 66.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.17 0.51 . . . . 2.2400000000000002 109.845 174.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 19.3 t -103.9 119.89 39.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.716 -0.674 . . . . 2.0 109.747 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 77.9 mt -119.42 113.05 20.18 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.145 -0.479 . . . . 3.4199999999999999 110.068 -178.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -109.05 129.55 55.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.945 0.402 . . . . 4.0800000000000001 111.036 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -128.14 151.3 49.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.823 -0.626 . . . . 5.1699999999999999 110.441 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 116.164 -0.471 . . . . 3.5800000000000001 110.568 -179.522 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 110.445 -0.206 . . . . 2.4100000000000001 110.445 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 177.69 -169.74 41.86 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.747 -0.739 . . . . 1.6200000000000001 112.333 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 63.2 t -110.12 128.89 65.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.867 0.365 . . . . 2.4900000000000002 110.667 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.86 141.21 12.46 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.508 -0.637 . . . . 1.3 111.508 176.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 61.6 t -120.02 129.96 74.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 117.093 0.447 . . . . 2.3399999999999999 110.162 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -108.11 109.33 20.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.935 0.398 . . . . 2.7999999999999998 110.058 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -100.02 107.9 19.96 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.872 -0.788 . . . . 5.1900000000000004 108.872 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.6 m -119.54 132.27 55.71 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.998 0.428 . . . . 2.0499999999999998 111.248 -172.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 59.2 t80 . . . . . 0 C--O 1.241 0.617 0 CA-C-O 118.411 -0.804 . . . . 4.4199999999999999 109.225 176.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 121.162 0.506 . . . . 3.6099999999999999 111.322 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.502 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 71.0 m95 -119.79 147.24 44.88 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.151 -0.685 . . . . 3.9100000000000001 109.151 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.651 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 11.6 t-160 -96.44 113.37 24.94 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.624 -0.51 . . . . 3.9399999999999999 109.624 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.502 ' CE1' ' HB2' ' A' ' 7' ' ' TRP . 95.0 m-85 -110.41 158.88 18.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.904 -0.589 . . . . 3.21 111.108 -176.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -141.42 132.3 25.93 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.809 -0.632 . . . . 2.6499999999999999 109.326 170.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.5 mt -119.8 114.09 43.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.974 -0.75 . . . . 2.0699999999999998 108.974 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.81 127.25 8.18 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.265 -0.969 . . . . 0.92000000000000004 112.128 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -115.69 134.45 55.02 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 110.057 -0.349 . . . . 1.6499999999999999 110.057 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 94.8 mmm -124.31 131.03 53.5 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.859 -0.61 . . . . 2.9700000000000002 109.372 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -85.82 109.1 18.44 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.769 -0.456 . . . . 3.1499999999999999 109.769 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 C--N 1.325 -0.492 0 CA-C-O 121.145 0.498 . . . . 5.0899999999999999 110.706 -175.314 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.855 0.359 . . . . 3.48 111.026 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.592 ' HA ' ' O ' ' A' ' 14' ' ' MET . 76.9 Cg_endo -81.2 135.31 9.57 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.669 2.246 . . . . 2.0299999999999998 112.198 172.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 56.2 m -103.21 142.36 34.29 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.421 -0.585 . . . . 2.2799999999999998 109.421 174.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 m -110.87 134.47 53.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.28 0.562 . . . . 2.4100000000000001 111.309 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -119.9 132.08 55.43 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.59 -0.732 . . . . 4.4400000000000004 109.817 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 94.1 m-85 -105.37 127.95 53.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.031 -0.359 . . . . 3.6200000000000001 110.031 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -130.89 138.02 49.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.947 -0.39 . . . . 2.48 109.947 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.57 143.13 50.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.711 -0.222 . . . . 1.53 110.691 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.651 ' O ' ' HB3' ' A' ' 8' ' ' HIS . . . -154.14 117.37 4.54 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.366 -0.379 . . . . 1.8 111.33 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.456 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 25.4 t-20 -163.49 95.42 0.82 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.642 -0.503 . . . . 3.3799999999999999 109.642 173.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.82 -97.59 2.31 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.037 -0.601 . . . . 1.8200000000000001 111.76 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.456 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 51.3 Cg_exo -55.3 174.16 0.26 Allowed 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.52 2.813 . . . . 2.1000000000000001 113.515 172.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.506 ' HB3' ' O ' ' A' ' 75' ' ' HIS . 24.4 m-90 -70.15 -176.24 1.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.551 -0.749 . . . . 4.0499999999999998 111.064 -175.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.7 mtm-85 -112.06 149.96 31.35 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.529 0.68 . . . . 3.6000000000000001 112.732 -163.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.5 pt -128.88 140.05 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 114.606 -1.179 . . . . 2.2799999999999998 110.244 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -120.06 128.88 53.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.189 -0.46 . . . . 1.4399999999999999 110.09 177.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.6 tp -125.19 136.59 53.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.102 0.477 . . . . 1.75 110.922 -176.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.76 168.15 20.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.456 -0.793 . . . . 1.5900000000000001 109.376 176.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -140.02 145.58 37.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.588 0.232 . . . . 4.4400000000000004 110.665 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.55 ' HB2' ' CG ' ' A' ' 69' ' ' ARG . 89.6 m-85 -135.75 148.97 49.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.307 -0.406 . . . . 5.0199999999999996 109.937 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -136.43 170.22 16.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.619 -0.264 . . . . 3.7400000000000002 111.323 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 115.938 -0.574 . . . . 5.0499999999999998 110.774 -179.514 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 35.6 p90 . . . . . 0 N--CA 1.455 -0.184 0 N-CA-C 109.83 -0.433 . . . . 6.5 109.83 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.509 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 95.0 m-85 -109.2 127.64 54.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.039 0.447 . . . . 4.5999999999999996 111.057 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -97.2 166.45 11.56 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.761 -0.654 . . . . 2.4500000000000002 110.637 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.55 ' CG ' ' HB2' ' A' ' 51' ' ' TYR . 6.6 ptp180 -150.48 125.53 4.76 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 121.113 0.483 . . . . 3.7200000000000002 110.577 171.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.454 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 75.6 Cg_endo -89.41 158.78 5.47 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.005 2.47 . . . . 1.3200000000000001 112.268 172.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.637 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 39.5 tt0 -131.25 111.72 12.15 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.351 -0.611 . . . . 2.1899999999999999 109.351 173.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.8 tp -125.01 120.0 30.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.278 -0.419 . . . . 1.73 110.424 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 39.0 tt0 -121.38 130.05 53.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.657 -0.497 . . . . 2.1800000000000002 109.657 177.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 m -112.67 136.38 49.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.986 0.422 . . . . 2.0600000000000001 109.961 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.506 ' O ' ' HB3' ' A' ' 44' ' ' TRP . 63.2 m80 -116.64 119.6 36.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.081 -0.508 . . . . 4.1900000000000004 110.837 -171.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -113.62 126.08 54.88 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.099 -0.704 . . . . 5.1600000000000001 109.099 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -120.3 134.08 55.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.954 0.406 . . . . 3.3100000000000001 110.708 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -90.6 86.49 6.41 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.514 -0.766 . . . . 4.6600000000000001 109.158 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--N 1.32 -0.682 0 N-CA-C 108.439 -0.949 . . . . 4.8799999999999999 108.439 174.209 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.4 m . . . . . 0 N--CA 1.449 -0.496 0 CA-C-O 121.204 0.526 . . . . 2.6400000000000001 110.249 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -130.56 149.65 52.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.587 -0.894 . . . . 6.1900000000000004 108.587 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.23 154.13 21.84 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.033 -1.08 . . . . 1.54 112.708 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.2 mt -134.93 129.87 34.97 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.172 -0.677 . . . . 2.73 109.172 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.1 t -133.96 139.47 46.12 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.111 0.481 . . . . 1.8700000000000001 110.409 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 73' ' ' GLU . . . -132.96 132.79 6.71 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 111.34 -0.704 . . . . 1.1699999999999999 111.34 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.11 123.23 5.6 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.884 -0.674 . . . . 1.4399999999999999 111.892 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -112.01 122.12 46.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.633 0.254 . . . . 4.6399999999999997 110.541 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.637 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 72.1 mtm180 -131.36 129.78 41.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.307 -0.406 . . . . 3.2200000000000002 110.064 173.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.454 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 64.2 t30 -128.51 117.72 21.8 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.958 -0.386 . . . . 2.2200000000000002 109.958 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -109.84 126.67 54.06 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.742 0.306 . . . . 3.6400000000000001 110.372 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.509 ' HA2' ' HB3' ' A' ' 67' ' ' PHE . . . . . . . . 0 N--CA 1.442 -0.947 0 C-N-CA 120.201 -0.999 . . . . 2.79 112.233 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 108.667 -0.864 . . . . 3.77 108.667 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -119.39 115.29 23.79 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 120.631 -0.427 . . . . 2.2000000000000002 110.921 -173.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -153.53 137.41 16.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.887 -0.597 . . . . 3.1200000000000001 111.593 -175.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 44.6 ttm -132.33 123.63 27.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.558 -0.746 . . . . 2.1200000000000001 109.863 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.48 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 78.3 mt-30 -107.25 127.24 53.36 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 120.123 -0.631 . . . . 2.4900000000000002 110.212 175.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.514 ' HB2' ' HB2' ' A' ' 93' ' ' ARG . 95.4 mtt180 -110.13 113.36 25.98 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.999 -0.741 . . . . 4.4699999999999998 108.999 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -107.4 122.56 46.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.965 -0.561 . . . . 2.9199999999999999 111.036 -176.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -114.71 123.77 50.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.651 -0.704 . . . . 2.5099999999999998 109.986 175.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 11.8 tt -131.12 129.82 63.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.932 -0.396 . . . . 2.1299999999999999 109.932 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -149.93 121.16 4.03 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.558 -0.292 . . . . 1.6799999999999999 111.482 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -90.3 135.61 2.22 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 122.916 2.411 . . . . 1.54 111.371 169.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -104.12 139.64 38.91 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.436 -0.579 . . . . 2.3500000000000001 109.436 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -132.21 140.66 48.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.377 0.608 . . . . 5.1500000000000004 111.413 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -134.43 79.14 1.79 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.902 -1.045 . . . . 3.04 108.406 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.518 ' O ' ' HB3' ' A' ' 129' ' ' PHE . 63.1 t -129.99 125.39 60.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.758 -0.655 . . . . 4.7400000000000002 110.518 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.431 ' HD3' ' HB2' ' A' ' 129' ' ' PHE . 59.4 tptt -140.3 135.73 32.54 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.311 -0.626 . . . . 6.3600000000000003 109.311 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.9 tp -60.52 -31.32 70.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.557 -0.747 . . . . 4.96 111.921 -176.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.9 m -108.35 135.3 49.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.941 0.4 . . . . 4.0700000000000003 110.106 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -63.01 -39.79 95.81 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.28 -0.873 . . . . 5.1699999999999999 112.181 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -70.0 -15.47 63.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.906 -0.588 . . . . 3.71 111.234 -176.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.8 mt -111.82 154.22 25.43 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.908 -0.587 . . . . 2.4500000000000002 110.058 -173.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -130.88 136.88 49.03 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.539 -0.464 . . . . 4.6799999999999997 110.985 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.518 ' HB3' ' O ' ' A' ' 121' ' ' VAL . 65.2 t80 -123.31 120.42 33.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.79 -0.641 . . . . 4.3600000000000003 109.73 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -122.81 136.84 55.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.784 0.326 . . . . 2.5899999999999999 111.202 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -160.75 149.98 19.55 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.277 -0.729 . . . . 1.25 111.277 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -148.33 148.03 29.94 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.119 -0.326 . . . . 5.0899999999999999 110.119 176.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 67.9 tp -116.79 117.93 31.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.332 -0.395 . . . . 2.7599999999999998 110.755 -175.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.5 t -104.99 118.41 36.45 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.805 0.336 . . . . 1.99 110.577 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.401 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 64.6 mtt -108.86 121.63 45.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.226 -0.657 . . . . 2.7799999999999998 109.226 171.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.421 ' OH ' ' HD3' ' A' ' 112' ' ' ARG . 64.9 t80 -116.53 136.79 52.69 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.655 -0.702 . . . . 3.6800000000000002 111.068 -171.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -130.17 150.86 51.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.63 -0.713 . . . . 2.1699999999999999 109.813 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -139.55 159.94 41.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.571 0.224 . . . . 4.0099999999999998 110.431 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 60.22 -177.03 0.1 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.552 -0.749 . . . . 1.79 111.001 -175.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -77.65 -24.67 49.37 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.087 0.47 . . . . 3.04 110.515 172.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.95 -51.38 69.93 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.409 -0.814 . . . . 2.4100000000000001 112.575 -172.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.5 mp -70.17 -29.11 65.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.03 0.443 . . . . 2.3599999999999999 111.2 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.48 ' ND2' ' HB2' ' A' ' 111' ' ' GLN . 95.0 m-20 -68.79 -39.75 80.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.532 -0.304 . . . . 2.52 110.809 178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.3 p -70.11 -32.1 69.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.577 -0.283 . . . . 2.52 111.481 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.4 p -80.36 -20.21 44.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.234 0.54 . . . . 2.0099999999999998 110.845 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.84 -114.35 5.26 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.694 -0.684 . . . . 1.52 112.381 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -99.98 3.65 44.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.566 0.222 . . . . 6.2199999999999998 111.162 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.82 -40.04 76.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.022 0.439 . . . . 2.0499999999999998 110.02 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -129.83 99.34 5.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.55 -0.75 . . . . 2.6400000000000001 109.788 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.9 t -148.81 159.06 44.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.06 -0.518 . . . . 2.6000000000000001 109.833 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 135' ' ' MET . 42.1 ttm180 -93.68 123.38 36.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.204 -0.453 . . . . 4.0899999999999999 109.881 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.0 t -112.48 120.58 63.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.493 -0.321 . . . . 2.1499999999999999 110.58 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -143.17 130.03 20.49 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.0 -0.37 . . . . 2.5600000000000001 110.0 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.431 ' HB ' ' CD1' ' A' ' 133' ' ' LEU . 10.1 t -136.58 146.72 46.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.011 0.434 . . . . 1.78 110.965 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -119.98 139.55 52.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.215 -0.448 . . . . 2.04 110.351 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 22.6 m -117.03 122.98 45.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.095 -0.502 . . . . 2.0299999999999998 110.297 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -117.79 121.86 5.23 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.722 -0.551 . . . . 1.0800000000000001 111.722 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 160' ' ' TYR . 92.2 mt -108.38 135.09 50.26 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 122.274 0.23 . . . . 2.9300000000000002 110.382 -177.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 168' ' ' LEU . 63.8 tt0 -123.36 115.89 22.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.758 0.314 . . . . 3.02 110.178 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 158' ' ' LEU . 82.9 m-85 -130.92 139.95 50.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.23 -0.441 . . . . 4.7599999999999998 110.867 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 22.9 p -96.93 92.76 6.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.09 -0.505 . . . . 1.8200000000000001 110.973 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . 0.497 ' CD2' HD11 ' A' ' 168' ' ' LEU . 61.3 m-85 -70.04 -39.91 75.45 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.163 0.431 . . . . 3.27 112.163 -176.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.479 ' HB2' HG23 ' A' ' 166' ' ' VAL . 88.7 m-20 -100.3 13.38 34.55 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.776 -0.37 . . . . 2.4100000000000001 110.908 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 73.12 -52.06 0.71 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.873 0.733 . . . . 2.5800000000000001 111.79 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.2 p -74.66 -20.58 59.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.715 0.293 . . . . 2.6000000000000001 111.705 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 163' ' ' ASN . 35.8 m -116.68 137.91 48.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.89 0.376 . . . . 2.0600000000000001 110.836 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.8 123.07 47.61 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.077 -0.51 . . . . 1.8400000000000001 110.131 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.497 HD11 ' CD2' ' A' ' 162' ' ' PHE . 21.7 mt -103.8 140.53 37.51 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.72 -0.474 . . . . 2.1400000000000001 109.72 -177.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -115.18 125.46 53.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.935 0.398 . . . . 3.73 110.383 -176.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.5 t -128.44 129.57 68.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.561 -0.533 . . . . 1.8100000000000001 109.561 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.523 ' OD1' ' HB2' ' A' ' 195' ' ' ARG . 28.7 p-10 -133.74 148.72 51.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.302 0.572 . . . . 2.2400000000000002 111.575 -177.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -145.36 151.43 38.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.347 -0.842 . . . . 4.8399999999999999 110.071 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -101.18 128.91 47.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.428 0.632 . . . . 4.4299999999999997 111.55 -173.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 48.4 tp -120.06 124.24 45.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.327 -0.851 . . . . 2.8500000000000001 109.499 -176.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -70.01 -43.4 71.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.229 0.537 . . . . 3.3100000000000001 111.061 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.963 -0.562 . . . . 7.3300000000000001 109.979 -172.108 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.131 0.491 . . . . 4.4000000000000004 109.801 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 86.4 mt -117.26 131.54 69.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.968 -0.56 . . . . 2.6400000000000001 110.855 -173.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.523 ' HB2' ' OD1' ' A' ' 171' ' ' ASN . 90.0 mtt180 -95.25 127.36 41.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.814 0.34 . . . . 4.1100000000000003 110.419 176.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -117.78 130.53 56.36 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.571 -0.529 . . . . 1.76 109.571 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -152.85 160.04 43.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.192 0.52 . . . . 6.1399999999999997 111.274 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.436 ' O ' ' HD2' ' A' ' 209' ' ' PRO . 2.5 pt? -137.95 134.25 17.94 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.126 -0.488 . . . . 3.0800000000000001 110.019 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.69 128.05 9.15 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.197 1.931 . . . . 1.98 112.708 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.8 tp -120.43 123.52 43.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.692 -0.686 . . . . 2.7599999999999998 109.538 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 22.7 m -104.9 119.96 40.28 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.454 -0.339 . . . . 2.4199999999999999 110.7 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.92 80.26 1.8 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.472 -0.566 . . . . 2.77 109.472 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.1 -117.26 8.9 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.714 -0.675 . . . . 1.6200000000000001 112.298 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -90.48 0.09 57.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.372 0.606 . . . . 2.8599999999999999 109.651 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -114.69 120.1 38.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.506 -0.77 . . . . 3.23 111.096 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 13.6 p -102.03 142.6 33.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.33 -0.396 . . . . 2.0499999999999998 110.453 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 49.8 t -129.13 129.98 67.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.307 -0.627 . . . . 1.9299999999999999 109.307 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 32.8 m -134.44 91.72 21.73 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-O 120.849 0.357 . . . . 1.6699999999999999 110.37 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 57.0 Cg_endo -74.57 138.47 24.21 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.273 1.982 . . . . 1.28 112.307 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -106.03 139.01 41.23 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.35 -0.611 . . . . 4.8600000000000003 109.35 175.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 38.9 p -132.39 160.53 36.08 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.91 -0.404 . . . . 2.0899999999999999 109.91 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -66.24 -40.52 90.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.416 0.627 . . . . 5.29 109.617 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 44.7 pt . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.484 -0.78 . . . . 4.9400000000000004 109.789 175.417 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 120.85 0.357 . . . . 2.9700000000000002 110.251 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -124.69 138.12 10.95 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.716 -0.754 . . . . 1.3999999999999999 111.298 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.99 126.61 54.12 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.981 0.39 . . . . 2.4300000000000002 110.527 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.483 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 61.7 t80 -99.56 124.42 44.74 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.318 -0.623 . . . . 4.3300000000000001 109.318 173.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.491 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 81.7 m-85 -119.89 140.01 51.51 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.818 -0.438 . . . . 3.2599999999999998 109.818 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -136.77 151.87 21.08 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.074 -1.06 . . . . 1.3500000000000001 112.74 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -129.96 129.85 44.32 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.856 -0.794 . . . . 4.7599999999999998 108.856 172.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -128.1 130.38 48.09 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.193 -0.299 . . . . 4.29 110.193 -176.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -128.52 135.31 49.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.153 -0.476 . . . . 7.5599999999999996 110.429 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -60.09 -30.13 69.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.122 -0.944 . . . . 7.0199999999999996 111.684 -175.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -55.69 -33.64 64.34 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.303 -0.408 . . . . 6.4800000000000004 110.772 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 135.38 31.79 0.31 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.559 -0.829 . . . . 2.9199999999999999 112.797 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 53.0 tp -125.57 127.83 46.98 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.691 -0.3 . . . . 3.5800000000000001 110.4 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 6.1 t -140.09 129.31 23.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.642 -0.873 . . . . 2.6000000000000001 108.642 173.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.94 159.81 41.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.91 0.386 . . . . 2.2400000000000002 111.5 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 35.3 p -131.34 139.96 49.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.523 -0.762 . . . . 2.0 110.166 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 89.0 mt -125.7 135.61 52.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.003 -0.544 . . . . 3.4199999999999999 109.986 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -110.59 120.92 43.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.125 -0.489 . . . . 4.0800000000000001 110.082 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -106.86 129.3 54.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.306 -0.406 . . . . 5.1699999999999999 110.787 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.733 -0.667 . . . . 3.5800000000000001 110.579 179.126 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.171 -0.678 . . . . 2.4100000000000001 109.171 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.75 136.05 8.55 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.224 -0.988 . . . . 1.6200000000000001 112.001 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 62.7 t -130.03 129.7 65.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.982 0.42 . . . . 2.4900000000000002 110.412 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.03 139.99 11.39 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.712 -0.955 . . . . 1.3 110.712 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.16 129.97 54.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 117.102 0.451 . . . . 2.3399999999999999 111.265 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -113.24 123.07 49.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.033 -0.531 . . . . 2.7999999999999998 110.004 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -99.97 107.27 19.19 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.932 -0.766 . . . . 5.1900000000000004 108.932 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 25.6 m -102.12 124.05 47.05 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.144 0.497 . . . . 2.0499999999999998 111.043 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 88.9 m-85 . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.122 -0.942 . . . . 4.4199999999999999 108.722 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 CA--C 1.519 -0.217 0 N-CA-C 109.895 -0.409 . . . . 3.6099999999999999 109.895 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.49 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 20.3 m-90 -70.99 139.98 50.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.987 -0.551 . . . . 3.9100000000000001 110.981 -178.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -99.2 130.0 45.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.001 -0.545 . . . . 3.9399999999999999 110.544 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -115.77 140.31 49.33 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.866 -0.606 . . . . 3.21 110.888 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 94.2 m-20 -121.86 132.33 54.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.556 -0.747 . . . . 2.6499999999999999 109.549 174.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.0 mt -119.76 120.02 62.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.372 -0.603 . . . . 2.0699999999999998 109.372 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.13 142.4 14.95 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.048 -1.072 . . . . 0.92000000000000004 112.68 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.53 134.81 54.71 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.941 -0.762 . . . . 1.6499999999999999 108.941 174.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 49.0 tpp -129.93 129.67 44.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.061 -0.518 . . . . 2.9700000000000002 111.0 -173.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.481 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 56.3 m-85 -93.15 129.77 39.04 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.914 -1.143 . . . . 3.1499999999999999 107.914 169.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 C--N 1.317 -0.822 0 C-N-CA 120.328 -0.549 . . . . 5.0899999999999999 110.534 -177.497 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.649 -0.5 . . . . 3.48 109.649 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.481 ' HD3' ' CE2' ' A' ' 15' ' ' TYR . 59.6 Cg_endo -73.93 134.38 19.68 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.093 1.862 . . . . 2.0299999999999998 112.375 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.7 t -118.13 143.57 46.38 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.797 -0.816 . . . . 2.2799999999999998 108.797 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.5 m -110.11 139.99 31.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.304 0.573 . . . . 2.4100000000000001 111.639 -173.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -135.72 149.77 49.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.425 -0.807 . . . . 4.4400000000000004 109.903 177.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -113.47 130.07 56.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.02 -0.536 . . . . 3.6200000000000001 110.729 -175.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 10' ' ' ASN . 77.6 m-20 -123.44 144.49 49.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.165 -0.471 . . . . 2.48 109.952 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.41 142.34 45.62 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.074 -0.343 . . . . 1.53 110.074 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.01 112.57 1.59 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.151 0.426 . . . . 1.8 112.151 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 7' ' ' TRP . 24.5 t-20 -168.24 94.96 0.39 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.713 -0.477 . . . . 3.3799999999999999 109.713 166.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.89 -83.34 0.43 Allowed Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.212 -0.755 . . . . 1.8200000000000001 111.212 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.13 173.46 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.029 2.486 . . . . 2.1000000000000001 111.797 169.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.451 ' HB3' ' O ' ' A' ' 75' ' ' HIS . 45.3 m95 -70.75 -177.74 1.66 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.143 -0.481 . . . . 4.0499999999999998 110.064 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -109.6 120.42 42.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.657 0.741 . . . . 3.6000000000000001 109.976 -172.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.4 mt -109.94 136.29 46.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.378 -1.283 . . . . 2.2799999999999998 110.326 -174.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.81 128.24 55.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.943 -0.572 . . . . 1.4399999999999999 110.158 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.1 tp -120.45 130.2 54.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.045 -0.525 . . . . 1.75 110.494 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.92 168.42 23.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.236 -0.438 . . . . 1.5900000000000001 110.524 178.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 45.2 p90 -142.4 160.03 41.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.357 -0.383 . . . . 4.4400000000000004 110.342 -177.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -134.28 130.02 36.45 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.82 -0.437 . . . . 5.0199999999999996 109.82 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -135.65 147.21 48.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.404 -0.362 . . . . 3.7400000000000002 110.412 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--N 1.321 -0.641 0 N-CA-C 108.967 -0.753 . . . . 5.0499999999999998 108.967 179.976 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.963 0.411 . . . . 6.5 110.126 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -106.8 99.73 9.29 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.176 -0.676 . . . . 4.5999999999999996 109.176 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -134.23 170.63 15.42 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.511 -0.922 . . . . 2.4500000000000002 108.511 -171.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 39.4 ttp180 -119.14 123.01 29.12 Favored Pre-proline 0 C--N 1.318 -0.787 0 C-N-CA 120.326 -0.55 . . . . 3.7200000000000002 110.697 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -91.74 115.68 0.4 Allowed 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 122.126 1.884 . . . . 1.3200000000000001 110.767 169.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -103.26 112.74 25.76 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.903 -0.777 . . . . 2.1899999999999999 108.903 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.2 tp -124.53 118.66 27.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.652 -0.704 . . . . 1.73 109.496 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -126.03 131.75 52.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.6 -0.518 . . . . 2.1800000000000002 109.6 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.22 121.88 68.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.869 0.366 . . . . 2.0600000000000001 110.116 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.451 ' O ' ' HB3' ' A' ' 44' ' ' TRP . 79.8 t60 -104.64 119.6 39.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.115 -0.493 . . . . 4.1900000000000004 110.503 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -97.16 120.74 38.07 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.984 -1.117 . . . . 5.1600000000000001 107.984 176.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -127.31 113.78 16.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.174 0.511 . . . . 3.3100000000000001 111.671 -174.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -102.61 120.3 40.31 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.673 -0.694 . . . . 4.6600000000000001 109.38 175.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 C--N 1.323 -0.584 0 CA-C-O 121.122 0.486 . . . . 4.8799999999999999 110.777 179.326 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.7 t . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 120.645 0.26 . . . . 2.6400000000000001 110.412 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 69.78 -100.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.512 -0.767 . . . . 6.1900000000000004 111.069 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.27 -82.06 0.35 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.012 -1.089 . . . . 1.54 113.215 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 57.9 tp -144.13 131.25 20.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.22 0.51 . . . . 2.73 111.989 -173.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.5 m -121.36 130.08 53.42 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.575 -0.528 . . . . 1.8700000000000001 109.575 170.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -145.45 141.92 10.26 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.145 -1.026 . . . . 1.1699999999999999 112.238 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.99 171.2 36.26 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.62 -0.8 . . . . 1.4399999999999999 111.993 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -148.47 159.95 43.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.092 0.472 . . . . 4.6399999999999997 111.628 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -134.39 137.29 43.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.324 -0.853 . . . . 3.2200000000000002 109.494 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 63.1 t30 -125.18 122.22 36.42 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.971 -0.381 . . . . 2.2200000000000002 109.971 175.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.505 ' CE1' ' HD3' ' A' ' 69' ' ' ARG . 95.2 m-85 -102.84 120.92 41.45 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.023 -0.362 . . . . 3.6400000000000001 110.023 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.788 0 C-N-CA 120.995 -0.621 . . . . 2.79 113.658 -176.135 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.1 p . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 112.267 0.469 . . . . 3.77 112.267 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.72 119.13 33.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.725 0.774 . . . . 2.2000000000000002 112.85 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -115.19 106.45 14.09 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.595 -0.891 . . . . 3.1200000000000001 108.595 171.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.507 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 89.5 mtp -139.85 117.05 11.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.527 -0.306 . . . . 2.1200000000000001 110.799 -177.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.595 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 54.0 tt0 -117.21 117.96 31.0 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.627 -0.429 . . . . 2.4900000000000002 110.182 176.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -105.6 123.53 48.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.869 -0.605 . . . . 4.4699999999999998 110.14 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -125.53 128.73 48.42 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.814 -0.81 . . . . 2.9199999999999999 108.814 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -130.15 126.03 36.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.408 . . . . 2.5099999999999998 110.558 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 134' ' ' SER . 88.2 mt -120.05 129.61 75.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.709 -0.678 . . . . 2.1299999999999999 109.66 177.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -141.87 108.14 5.91 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 111.954 0.353 . . . . 1.6799999999999999 111.954 -176.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.699 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 61.4 Cg_endo -76.5 131.95 13.05 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.75 1.634 . . . . 1.54 110.21 171.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -102.28 137.02 41.09 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.281 -0.637 . . . . 2.3500000000000001 109.281 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -135.45 129.98 34.05 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.99 -0.284 . . . . 5.1500000000000004 110.942 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -126.25 122.09 34.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.172 -0.467 . . . . 3.04 109.856 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.4 t -120.05 120.49 63.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.09 -0.504 . . . . 4.7400000000000002 110.19 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -104.96 90.75 3.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.296 -0.411 . . . . 6.3600000000000003 110.527 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.6 tp -60.28 -49.74 76.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.284 0.564 . . . . 4.96 110.154 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.5 p -140.79 172.52 12.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.372 -0.831 . . . . 4.0700000000000003 109.358 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -60.16 -39.88 87.95 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.192 -0.603 . . . . 5.1699999999999999 109.605 172.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.1 -40.17 75.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.729 -0.669 . . . . 3.71 111.997 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.0 mt -111.12 119.65 39.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.285 0.564 . . . . 2.4500000000000002 111.436 -173.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -132.63 132.78 42.83 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.719 -0.673 . . . . 4.6799999999999997 110.681 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -111.97 100.03 8.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.326 -0.852 . . . . 4.3600000000000003 109.738 -176.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -113.8 114.65 26.59 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.022 -0.362 . . . . 2.5899999999999999 110.022 -178.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -144.82 152.75 24.71 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.994 -1.098 . . . . 1.25 113.013 -175.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.528 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 56.5 p-90 -141.28 147.85 38.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.783 0.325 . . . . 5.0899999999999999 110.42 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.699 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 10.1 tt -126.27 131.98 51.78 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.314 -0.624 . . . . 2.7599999999999998 109.314 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 116' ' ' ALA . 80.5 p -131.53 150.06 52.29 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.811 -0.355 . . . . 1.99 111.548 -177.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 71.8 mtm -114.38 136.02 53.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.091 -0.504 . . . . 2.7799999999999998 110.415 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.401 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 49.5 m-85 -104.87 120.92 42.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.87 -0.605 . . . . 3.6800000000000002 111.674 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.68 121.79 29.32 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.134 -1.062 . . . . 2.1699999999999999 108.134 166.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.595 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 52.6 p90 -145.85 166.49 25.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.448 -0.342 . . . . 4.0099999999999998 111.49 -171.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 110' ' ' MET . . . 60.0 -164.72 0.22 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.052 -0.976 . . . . 1.79 111.795 177.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -75.3 -39.79 59.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.102 -0.499 . . . . 3.04 111.305 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.69 -54.2 49.11 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.438 0.533 . . . . 2.4100000000000001 112.438 -167.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.73 -40.11 84.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.2 0.524 . . . . 2.3599999999999999 110.492 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.431 HD21 ' C ' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -62.09 -39.38 92.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.783 -0.644 . . . . 2.52 109.96 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.8 m -68.66 -40.11 80.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.886 -0.597 . . . . 2.52 111.912 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 41.9 p -79.9 -20.04 46.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.169 0.509 . . . . 2.0099999999999998 110.865 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.02 -109.82 2.91 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.803 -0.635 . . . . 1.52 113.154 173.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -99.16 0.62 43.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.8 0.333 . . . . 6.2199999999999998 110.661 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.405 ' HB2' ' HB ' ' A' ' 145' ' ' THR . . . -70.04 -40.04 75.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 2.0499999999999998 111.489 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -118.96 124.68 47.62 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.566 -0.288 . . . . 2.6400000000000001 110.569 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.4 p -130.02 140.06 50.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.986 0.422 . . . . 2.6000000000000001 110.9 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.401 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 42.5 ttm180 -113.06 129.98 56.32 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.337 -0.986 . . . . 4.0899999999999999 108.337 173.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.9 p -117.33 132.02 68.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.533 0.683 . . . . 2.1499999999999999 111.697 -173.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.426 ' OE1' ' HH2' ' A' ' 132' ' ' TRP . 38.3 tt0 -119.99 115.69 24.27 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.011 -0.995 . . . . 2.5600000000000001 109.126 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 21.7 m -129.74 127.21 39.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.77 0.319 . . . . 1.78 111.283 -177.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.528 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 42.6 tt0 -122.34 134.49 54.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.966 -0.561 . . . . 2.04 110.032 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.5 m -128.27 120.26 26.78 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.857 0.361 . . . . 2.0299999999999998 110.094 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.72 106.8 3.36 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.861 -0.896 . . . . 1.0800000000000001 110.861 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 82.7 mt -99.79 120.07 39.16 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.668 -0.493 . . . . 2.9300000000000002 109.668 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -100.08 119.13 37.82 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.859 -0.61 . . . . 3.02 110.014 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -121.55 137.94 54.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.532 -0.758 . . . . 4.7599999999999998 109.9 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.3 p -89.9 88.56 7.37 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.077 -0.712 . . . . 1.8200000000000001 109.077 168.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.08 -48.97 79.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.023 -0.989 . . . . 3.27 111.395 -170.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.425 ' C ' ' H ' ' A' ' 165' ' ' THR . 94.6 m-20 -99.96 11.39 39.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.4 -0.364 . . . . 2.4100000000000001 110.52 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 71.88 -43.02 0.55 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.007 0.817 . . . . 2.5800000000000001 111.177 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.425 ' H ' ' C ' ' A' ' 163' ' ' ASN . 24.9 p -73.91 -26.66 60.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.286 -0.416 . . . . 2.6000000000000001 111.428 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.16 143.61 29.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.119 -0.491 . . . . 2.0600000000000001 110.678 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.13 119.52 39.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.206 -0.452 . . . . 1.8400000000000001 110.14 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 22.9 mt -111.57 134.73 52.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.355 -0.384 . . . . 2.1400000000000001 110.182 -175.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -100.06 122.02 42.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.798 -0.445 . . . . 3.73 109.798 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 40.4 t -120.01 120.02 61.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.474 -0.49 . . . . 1.8100000000000001 109.792 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -98.87 120.91 40.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.335 0.588 . . . . 2.2400000000000002 110.389 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -105.85 139.55 40.24 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.054 -0.975 . . . . 4.8399999999999999 109.253 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -113.15 129.79 56.4 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 110.074 -0.343 . . . . 4.4299999999999997 110.074 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 61.5 tp -109.93 129.93 55.59 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.067 0.46 . . . . 2.8500000000000001 110.795 -174.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -112.62 179.45 3.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.393 -0.821 . . . . 3.3100000000000001 110.1 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 . . . . . 0 C--N 1.331 -0.216 0 CA-C-O 121.045 0.45 . . . . 7.3300000000000001 111.705 -179.261 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 120.832 0.348 . . . . 4.4000000000000004 110.669 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 88.0 mt -120.09 98.11 5.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.137 -1.061 . . . . 2.6400000000000001 108.137 171.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.671 ' HA ' ' O ' ' A' ' 211' ' ' THR . 97.7 mtt180 -100.04 118.91 37.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.858 0.361 . . . . 4.1100000000000003 111.173 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.577 ' O ' ' HA ' ' A' ' 210' ' ' TYR . . . -99.98 131.82 45.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.251 -0.431 . . . . 1.76 110.916 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -127.69 129.41 47.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.752 -0.658 . . . . 6.1399999999999997 109.826 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 208' ' ' THR . 1.8 pt? -131.1 127.23 21.9 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.167 -0.309 . . . . 3.0800000000000001 110.167 174.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -89.55 120.31 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.664 2.243 . . . . 1.98 113.626 -177.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 84.1 mt -118.08 128.2 54.52 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.369 -0.604 . . . . 2.7599999999999998 109.369 172.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 24.0 m -100.51 120.13 39.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.807 0.337 . . . . 2.4199999999999999 111.236 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 91.8 mt -122.57 80.78 1.77 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.525 -0.546 . . . . 2.77 109.525 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 72.84 -122.98 8.5 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.65 -0.704 . . . . 1.6200000000000001 111.861 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -93.83 3.56 55.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.293 0.568 . . . . 2.8599999999999999 110.2 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -118.59 130.01 55.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.915 -0.584 . . . . 3.23 110.048 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 241' ' ' TYR . 5.4 p -111.13 139.82 46.19 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.774 -0.37 . . . . 2.0499999999999998 110.557 176.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.419 HG23 ' CE1' ' A' ' 241' ' ' TYR . 31.7 t -109.16 120.91 61.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.378 -0.601 . . . . 1.9299999999999999 109.378 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 198' ' ' LEU . 32.1 m -129.84 90.1 44.07 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.264 -0.426 . . . . 1.6699999999999999 110.0 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -63.17 146.05 93.89 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.45 2.1 . . . . 1.28 111.142 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.577 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 53.0 p90 -133.34 148.28 51.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.156 0.503 . . . . 4.8600000000000003 110.204 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.671 ' O ' ' HA ' ' A' ' 195' ' ' ARG . 32.6 p -129.72 141.29 50.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.539 -0.755 . . . . 2.0899999999999999 110.57 -177.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -69.74 -38.92 77.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.649 -0.705 . . . . 5.29 109.567 177.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.1 mt . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.229 -0.896 . . . . 4.9400000000000004 109.627 174.878 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 108.946 -0.761 . . . . 2.9700000000000002 108.946 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -80.15 134.6 13.72 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.088 -1.053 . . . . 1.3999999999999999 111.737 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 87.0 mt -108.44 118.07 35.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.11 0.455 . . . . 2.4300000000000002 110.627 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' A' ' 208' ' ' THR . 64.8 t80 -110.04 131.23 55.24 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.125 -0.695 . . . . 4.3300000000000001 109.125 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . 0.523 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 96.2 m-85 -120.11 139.2 52.94 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.834 -0.432 . . . . 3.2599999999999998 109.834 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -110.95 129.04 9.03 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.527 -0.844 . . . . 1.3500000000000001 111.682 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -129.31 126.84 39.87 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.939 -0.393 . . . . 4.7599999999999998 109.939 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -120.0 131.7 55.23 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.918 0.389 . . . . 4.29 110.706 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . 0.471 ' HB3' ' HB3' ' A' ' 249' ' ' LEU . 52.2 t80 -102.34 129.95 48.93 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.941 -0.763 . . . . 7.5599999999999996 108.941 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -60.08 -37.17 79.14 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.583 0.957 . . . . 7.0199999999999996 113.583 -167.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -60.11 -39.98 88.09 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.622 0.249 . . . . 6.4800000000000004 111.559 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 151.65 42.04 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.868 -1.158 . . . . 2.9199999999999999 113.233 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 245' ' ' PHE . 49.9 tp -133.48 130.09 38.1 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.031 -0.359 . . . . 3.5800000000000001 110.031 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 21.6 t -117.04 130.03 56.41 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.227 -0.657 . . . . 2.6000000000000001 109.227 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.09 132.72 68.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.057 0.456 . . . . 2.2400000000000002 110.426 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 52.6 m -114.19 128.7 56.49 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.532 -0.544 . . . . 2.0 109.532 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 83.0 mt -118.98 133.57 55.74 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.378 -0.374 . . . . 3.4199999999999999 110.541 -175.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -127.25 121.33 30.87 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.772 -0.455 . . . . 4.0800000000000001 109.772 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -122.97 139.24 54.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.928 0.394 . . . . 5.1699999999999999 111.631 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.673 -0.694 . . . . 3.5800000000000001 110.301 177.98 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.895 0.379 . . . . 2.4100000000000001 111.431 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.99 149.62 19.62 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.87 -0.604 . . . . 1.6200000000000001 112.285 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 61.5 t -130.04 130.07 65.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.673 0.273 . . . . 2.4900000000000002 110.719 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.48 134.69 8.91 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.041 -0.824 . . . . 1.3 111.041 176.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 28.0 m -128.71 139.5 51.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 117.431 0.615 . . . . 2.3399999999999999 111.375 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -129.4 124.31 33.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.855 -0.611 . . . . 2.7999999999999998 110.162 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 97.9 m-85 -96.69 127.92 43.14 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.45 -0.574 . . . . 5.1900000000000004 109.45 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 49.1 m -111.32 124.95 53.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.723 0.297 . . . . 2.0499999999999998 110.73 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 72.6 t80 . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.58 -0.724 . . . . 4.4199999999999999 109.827 179.601 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 N--CA 1.449 -0.502 0 CA-C-O 120.694 0.283 . . . . 3.6099999999999999 110.397 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -119.4 138.52 53.03 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.038 -0.356 . . . . 3.9100000000000001 110.038 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -104.22 128.16 51.92 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.517 -0.549 . . . . 3.9399999999999999 109.517 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -103.23 144.89 30.74 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.687 -0.688 . . . . 3.21 111.033 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 279' ' ' TYR . 35.4 m-80 -119.98 131.26 55.11 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.167 -0.924 . . . . 2.6499999999999999 108.926 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.6 mt -120.29 115.26 46.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 N-CA-C 109.204 -0.665 . . . . 2.0699999999999998 109.204 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -110.02 127.07 8.22 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.551 -0.833 . . . . 0.92000000000000004 111.273 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -120.67 136.01 54.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.713 0.292 . . . . 1.6499999999999999 110.785 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 91.4 mtp -135.35 156.93 48.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.852 -0.613 . . . . 2.9700000000000002 109.415 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -119.95 122.37 41.05 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.641 -0.503 . . . . 3.1499999999999999 109.641 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 C--N 1.34 0.153 0 CA-C-O 121.062 0.458 . . . . 5.0899999999999999 110.345 179.786 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.581 0.229 . . . . 3.48 110.948 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.17 149.99 65.08 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.308 2.005 . . . . 2.0299999999999998 110.916 168.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 22.2 m -125.67 142.19 51.63 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.699 -0.482 . . . . 2.2799999999999998 109.699 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 33.1 m -129.99 160.06 41.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.695 0.284 . . . . 2.4100000000000001 110.512 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -140.2 149.95 43.56 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.68 -0.489 . . . . 4.4400000000000004 109.68 174.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 94.5 m-85 -109.45 128.79 55.42 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.465 -0.334 . . . . 3.6200000000000001 110.217 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -140.32 135.21 31.97 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.992 -0.549 . . . . 2.48 109.753 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.6 141.39 51.14 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.762 -0.375 . . . . 1.53 110.177 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.17 125.82 4.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 1.8 111.675 -177.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -167.46 93.47 0.42 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.507 -0.553 . . . . 3.3799999999999999 109.507 167.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.65 -94.78 1.34 Allowed Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.543 -0.837 . . . . 1.8200000000000001 112.003 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.76 172.95 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.605 2.87 . . . . 2.1000000000000001 113.114 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.8 p-90 -69.78 159.15 34.11 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.197 0.522 . . . . 4.0499999999999998 111.367 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.7 ptt-85 -115.72 146.85 41.52 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.249 0.833 . . . . 3.6000000000000001 113.249 -163.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.4 mm -122.88 131.26 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 114.495 -1.23 . . . . 2.2799999999999998 111.03 -173.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -117.53 139.98 50.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.525 -0.307 . . . . 1.4399999999999999 110.719 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.526 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 56.4 tp -135.83 137.11 41.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 1.75 111.046 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.04 166.94 28.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.743 -0.662 . . . . 1.5900000000000001 109.313 174.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -124.15 130.02 51.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.876 0.37 . . . . 4.4400000000000004 111.122 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.529 ' HB3' ' HB2' ' A' ' 69' ' ' ARG . 47.0 t80 -99.98 119.56 38.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.865 -0.607 . . . . 5.0199999999999996 110.073 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 -133.83 130.17 37.53 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.743 -0.465 . . . . 3.7400000000000002 109.743 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--N 1.323 -0.581 0 CA-C-O 121.015 0.436 . . . . 5.0499999999999998 110.981 177.625 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 97.1 m95 . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 109.032 -0.729 . . . . 6.5 109.032 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.635 ' HB2' ' CZ ' ' A' ' 95' ' ' TYR . 64.8 m-85 -119.73 138.92 53.01 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.534 -0.543 . . . . 4.5999999999999996 109.534 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -123.82 164.94 18.19 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.194 -0.669 . . . . 2.4500000000000002 109.194 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.529 ' HB2' ' HB3' ' A' ' 51' ' ' TYR . 10.4 mtp180 -120.63 124.33 27.64 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.779 -0.452 . . . . 3.7200000000000002 109.779 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 69.9 Cg_endo -80.1 122.76 4.85 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.963 1.775 . . . . 1.3200000000000001 110.952 173.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 36.5 tt0 -99.96 113.03 25.32 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.557 -0.535 . . . . 2.1899999999999999 109.557 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.1 tp -121.9 123.41 41.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.269 -0.423 . . . . 1.73 110.411 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -119.7 135.79 54.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.943 0.401 . . . . 2.1800000000000002 110.262 173.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.1 t -113.67 119.88 62.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.153 -1.054 . . . . 2.0600000000000001 108.153 172.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -117.38 117.38 29.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.752 -0.462 . . . . 4.1900000000000004 109.752 -176.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -120.45 131.2 54.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.815 -0.629 . . . . 5.1600000000000001 109.959 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -121.82 139.95 52.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.306 -0.406 . . . . 3.3100000000000001 110.369 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -116.63 97.92 6.26 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.849 -0.797 . . . . 4.6600000000000001 108.849 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.4 mt . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.842 -0.617 . . . . 4.8799999999999999 110.219 -175.374 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.849 0.356 . . . . 2.6400000000000001 111.657 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -131.56 150.2 52.24 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.948 -0.39 . . . . 6.1900000000000004 109.948 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.55 161.7 28.7 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.645 -0.788 . . . . 1.54 111.828 176.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.0 tp -141.11 112.57 7.48 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.746 -0.464 . . . . 2.73 109.746 176.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.3 m -120.01 129.99 54.52 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.261 -0.427 . . . . 1.8700000000000001 110.562 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -127.23 140.06 11.62 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.727 -0.749 . . . . 1.1699999999999999 111.571 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.47 119.86 1.76 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.631 -0.795 . . . . 1.4399999999999999 111.874 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -126.81 129.72 48.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.001 0.429 . . . . 4.6399999999999997 110.933 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -141.34 134.84 29.84 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.102 -0.703 . . . . 3.2200000000000002 109.102 175.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.522 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 8.6 p30 -134.87 151.65 51.08 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-O 120.468 0.175 . . . . 2.2200000000000002 110.981 -175.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.635 ' CZ ' ' HB2' ' A' ' 67' ' ' PHE . 65.2 t80 -118.74 130.01 55.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.547 -0.297 . . . . 3.6400000000000001 110.371 -176.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.233 0 C-N-CA 120.465 -0.874 . . . . 2.79 112.254 179.191 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 120.736 0.303 . . . . 3.77 110.598 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -132.05 119.45 21.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.498 -0.319 . . . . 2.2000000000000002 111.445 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.553 ' HA ' ' O ' ' A' ' 95' ' ' TYR . 27.5 t-20 -151.8 124.62 8.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.779 -0.646 . . . . 3.1200000000000001 110.121 176.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 43.3 ttm -103.34 121.39 42.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.6 -0.727 . . . . 2.1200000000000001 110.264 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -112.27 141.33 46.11 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.614 -0.434 . . . . 2.4900000000000002 111.434 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 76.4 ttt180 -131.07 110.89 11.53 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.997 -0.742 . . . . 4.4699999999999998 108.997 168.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.556 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 83.2 m95 -98.76 119.95 38.38 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.879 -0.786 . . . . 2.9199999999999999 108.879 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.552 ' HB2' ' HZ1' ' A' ' 114' ' ' LYS . 10.2 mtmp? -121.74 123.81 42.73 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.785 -0.366 . . . . 2.5099999999999998 111.156 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 134' ' ' SER . 87.6 mt -120.62 126.22 74.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.032 -0.531 . . . . 2.1299999999999999 109.976 174.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -138.92 105.78 7.42 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.425 -0.352 . . . . 1.6799999999999999 111.036 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 98.8 Cg_endo -80.06 160.03 23.77 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.98 2.453 . . . . 1.54 111.158 173.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -116.19 137.19 52.35 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.248 -0.433 . . . . 2.3500000000000001 110.25 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -127.03 128.14 45.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.379 -0.373 . . . . 5.1500000000000004 111.495 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -128.64 88.94 2.81 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.553 -0.536 . . . . 3.04 109.553 172.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.0 p -147.5 129.24 6.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.082 0.468 . . . . 4.7400000000000002 111.148 -177.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.624 ' HG3' ' H ' ' A' ' 124' ' ' THR . 55.8 tptt -144.31 142.91 30.72 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.217 -0.66 . . . . 6.3600000000000003 109.217 177.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.3 mt -74.41 -6.77 50.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.137 0.494 . . . . 4.96 110.904 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.624 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 26.3 m -119.96 135.7 54.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.637 -0.71 . . . . 4.0700000000000003 109.561 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -68.15 -39.93 82.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.873 -0.603 . . . . 5.1699999999999999 111.126 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -61.02 -40.27 92.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.244 -0.889 . . . . 3.71 112.078 -176.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -110.95 161.22 16.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.059 0.457 . . . . 2.4500000000000002 111.857 -171.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.53 ' HD2' ' OE1' ' A' ' 159' ' ' GLN . 20.3 ttm180 -125.51 133.66 52.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.88 -0.6 . . . . 4.6799999999999997 111.465 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.489 ' HB2' ' HD3' ' A' ' 122' ' ' LYS . 64.7 t80 -114.88 119.36 36.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.573 -0.739 . . . . 4.3600000000000003 109.21 175.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.41 ' OD1' ' HD3' ' A' ' 128' ' ' ARG . 17.4 m120 -118.45 130.05 55.74 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.018 -0.364 . . . . 2.5899999999999999 110.018 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -134.9 135.75 8.12 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.408 -0.901 . . . . 1.25 111.688 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -124.0 128.28 49.14 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.668 -0.493 . . . . 5.0899999999999999 109.668 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.522 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 63.0 tp -109.95 110.93 22.03 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.188 -0.671 . . . . 2.7599999999999998 109.188 175.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 14.3 t -116.21 130.15 56.65 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.253 -0.579 . . . . 1.99 110.533 -175.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 66.6 mtt -118.99 135.92 54.37 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.651 -0.87 . . . . 2.7799999999999998 108.651 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 113' ' ' TRP . 54.7 p90 -149.83 157.42 43.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.349 0.595 . . . . 3.6800000000000002 111.61 178.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 59.7 mttp -129.82 157.62 41.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.932 -1.031 . . . . 2.1699999999999999 109.849 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.566 ' H ' HD12 ' A' ' 142' ' ' LEU . 64.3 t80 -121.85 139.99 52.94 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.743 -0.662 . . . . 4.0099999999999998 109.824 -173.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 61.12 -175.91 0.12 Allowed 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.685 0.616 . . . . 1.79 110.745 -175.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 63.9 t30 -79.08 -21.63 46.47 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.211 -0.595 . . . . 3.04 110.315 172.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.93 -47.39 85.98 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.496 -0.774 . . . . 2.4100000000000001 112.33 -172.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.566 HD12 ' H ' ' A' ' 138' ' ' PHE . 49.4 mt -69.87 -25.36 63.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.003 0.43 . . . . 2.3599999999999999 110.971 -178.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 140' ' ' ASN . 94.7 m-20 -59.91 -39.98 87.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.974 0.416 . . . . 2.52 110.007 175.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 80.9 p -78.1 -31.1 49.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.012 -0.54 . . . . 2.52 111.54 -177.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.428 ' HG1' ' HB2' ' A' ' 149' ' ' ASP . 34.9 p -70.16 -25.03 63.26 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.105 0.478 . . . . 2.0099999999999998 110.912 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 64.93 -128.08 34.0 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.696 -0.684 . . . . 1.52 112.776 175.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -72.47 -20.69 61.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.514 0.19 . . . . 6.2199999999999998 111.514 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.02 97.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.827 0.346 . . . . 2.0499999999999998 111.155 -176.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.428 ' HB2' ' HG1' ' A' ' 145' ' ' THR . 17.0 m-20 -131.47 92.83 3.23 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.129 -0.693 . . . . 2.6400000000000001 109.129 178.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.2 t -144.85 146.69 32.18 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.048 -0.524 . . . . 2.6000000000000001 110.153 -178.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.463 ' HG2' ' CZ ' ' A' ' 136' ' ' TYR . 32.8 tpt180 -99.77 119.05 37.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.39 -0.368 . . . . 4.0899999999999999 110.492 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.4 t -119.22 119.22 60.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 2.1499999999999999 109.875 178.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -123.49 140.01 53.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.929 0.395 . . . . 2.5600000000000001 111.009 -176.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 33.5 m -119.97 127.03 52.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.141 -0.482 . . . . 1.78 109.737 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.49 ' HG3' HD22 ' A' ' 171' ' ' ASN . 31.0 tt0 -123.51 130.72 53.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.585 -0.524 . . . . 2.04 109.585 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 171' ' ' ASN . 88.3 m -122.07 121.83 37.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.855 0.359 . . . . 2.0299999999999998 111.614 -176.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -102.39 115.23 5.15 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 111.174 -0.77 . . . . 1.0800000000000001 111.174 177.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 89.9 mt -100.34 122.61 43.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.829 0.347 . . . . 2.9300000000000002 110.631 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.53 ' OE1' ' HD2' ' A' ' 128' ' ' ARG . 53.3 tt0 -100.01 107.97 20.05 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.065 -0.717 . . . . 3.02 109.065 176.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -120.44 114.81 22.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.149 -0.478 . . . . 4.7599999999999998 109.714 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.41 ' HB ' ' HA ' ' A' ' 164' ' ' GLU . 6.8 p -88.85 90.5 8.44 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.269 0.557 . . . . 1.8200000000000001 110.535 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -60.23 -49.28 78.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.582 -0.735 . . . . 3.27 111.171 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.434 ' HB2' HG21 ' A' ' 166' ' ' VAL . 94.6 m-20 -101.77 13.13 35.76 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.983 -0.287 . . . . 2.4100000000000001 111.024 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.41 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 41.3 tt0 71.39 -48.7 0.68 Allowed 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.774 0.671 . . . . 2.5800000000000001 111.3 -178.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.7 p -74.69 -19.98 60.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.34 -0.391 . . . . 2.6000000000000001 111.642 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.434 HG21 ' HB2' ' A' ' 163' ' ' ASN . 33.4 m -121.46 140.0 46.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.326 -0.397 . . . . 2.0600000000000001 110.266 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.475 ' O ' ' HD2' ' A' ' 199' ' ' PRO . . . -106.87 129.26 54.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.053 -0.522 . . . . 1.8400000000000001 110.601 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 28.7 mt -103.72 129.22 51.05 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.291 -0.633 . . . . 2.1400000000000001 109.291 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -101.45 107.4 18.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.812 0.339 . . . . 3.73 110.572 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.9 t -113.18 119.98 62.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 109.446 -0.576 . . . . 1.8100000000000001 109.446 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.585 ' HB3' ' HB3' ' A' ' 195' ' ' ARG . 8.5 t30 -106.34 120.73 42.63 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.952 0.406 . . . . 2.2400000000000002 111.123 -176.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -103.18 129.96 50.23 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.562 -0.745 . . . . 4.8399999999999999 109.748 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -102.46 138.71 39.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.225 -0.443 . . . . 4.4299999999999997 110.674 -177.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 62.8 tp -140.08 143.38 36.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.571 . . . . 2.8500000000000001 110.447 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -105.84 141.01 37.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.223 -0.288 . . . . 3.3100000000000001 110.223 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 . . . . . 0 C--N 1.324 -0.5 0 N-CA-C 109.983 -0.376 . . . . 7.3300000000000001 109.983 175.41 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.03 0.443 . . . . 4.4000000000000004 111.071 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 48.9 mm -113.83 125.53 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.781 -0.645 . . . . 2.6400000000000001 110.24 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 171' ' ' ASN . 35.2 ttm180 -99.96 109.37 21.73 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.553 -0.906 . . . . 4.1100000000000003 108.553 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -123.63 131.44 53.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.834 0.349 . . . . 1.76 111.695 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -158.22 165.75 34.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.934 -0.575 . . . . 6.1399999999999997 109.83 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.567 ' O ' ' HD2' ' A' ' 209' ' ' PRO . 1.5 pt? -143.64 137.29 14.31 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 121.126 -0.23 . . . . 3.0800000000000001 110.461 177.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 167' ' ' ALA . 72.3 Cg_endo -79.77 129.67 8.28 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.451 2.101 . . . . 1.98 112.736 176.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 88.1 mt -128.05 135.21 49.55 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.35 -0.611 . . . . 2.7599999999999998 109.35 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 4.4 p -112.45 118.93 36.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.981 0.42 . . . . 2.4199999999999999 111.149 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.9 mt -125.48 82.2 2.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.889 -0.782 . . . . 2.77 108.889 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 69.49 -124.69 16.16 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.338 -0.846 . . . . 1.6200000000000001 111.733 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -91.83 3.98 53.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.18 0.514 . . . . 2.8599999999999999 109.902 175.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -95.9 115.88 28.08 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.61 -0.885 . . . . 3.23 108.61 174.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 47.5 t -100.61 120.37 39.94 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.938 -0.764 . . . . 2.0499999999999998 108.938 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.81 128.07 73.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.932 0.396 . . . . 1.9299999999999999 110.695 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 35.1 m -131.1 91.3 36.47 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-O 120.83 0.347 . . . . 1.6699999999999999 110.093 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 50.1 Cg_endo -70.41 140.58 40.54 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.269 1.979 . . . . 1.28 111.978 176.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -111.85 140.29 46.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.188 -0.46 . . . . 4.8600000000000003 110.587 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 24.0 p -134.0 156.26 48.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 2.0899999999999999 110.314 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -116.57 120.33 38.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.045 0.45 . . . . 5.29 110.656 -177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 84.8 mt . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.907 -0.588 . . . . 4.9400000000000004 110.259 -179.79 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 63.3 t . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 121.044 0.45 . . . . 2.9700000000000002 109.869 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -129.04 156.16 21.07 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.864 -0.684 . . . . 1.3999999999999999 111.701 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.0 130.45 54.75 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.933 -0.395 . . . . 2.4300000000000002 109.933 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -109.89 130.0 55.58 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.989 -0.745 . . . . 4.3300000000000001 108.989 176.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -120.03 139.89 51.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.959 0.409 . . . . 3.2599999999999998 111.0 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -113.66 128.81 8.48 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.797 -0.921 . . . . 1.3500000000000001 110.797 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' TYR . . . . . 0.428 ' O ' ' HB ' ' A' ' 251' ' ' VAL . 73.3 m-85 -130.0 150.11 51.42 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.614 0.207 . . . . 4.7599999999999998 110.772 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 58.12 39.98 25.57 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.082 0.864 . . . . 4.29 110.666 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -77.56 114.06 16.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.554 -0.748 . . . . 7.5599999999999996 109.79 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -143.46 168.22 20.36 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.895 -1.048 . . . . 7.0199999999999996 108.26 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -59.97 -40.06 87.78 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.83 -0.348 . . . . 6.4800000000000004 110.794 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.467 ' HA2' ' HB2' ' A' ' 280' ' ' SER . . . -99.83 -0.27 56.36 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.447 -0.883 . . . . 2.9199999999999999 113.967 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 59.4 tp -145.98 138.52 25.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.65 0.725 . . . . 3.5800000000000001 111.304 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 61.3 p -147.36 134.49 20.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.821 0.343 . . . . 2.6000000000000001 110.963 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 243' ' ' TYR . 59.8 t -122.58 132.47 71.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.799 -0.445 . . . . 2.2400000000000002 109.799 176.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 35.1 t -120.04 127.8 52.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.877 0.37 . . . . 2.0 110.086 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 72.2 mt -117.15 129.24 55.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.112 -0.495 . . . . 3.4199999999999999 110.259 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.12 119.95 41.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.053 -0.521 . . . . 4.0800000000000001 110.633 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.51 135.54 53.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.256 -0.429 . . . . 5.1699999999999999 110.465 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.504 0 CA-C-O 121.276 0.56 . . . . 3.5800000000000001 110.775 175.46 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 109.954 -0.387 . . . . 2.4100000000000001 109.954 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -137.8 144.46 15.8 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.552 -0.832 . . . . 1.6200000000000001 112.541 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 63.0 t -130.06 130.11 65.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.588 0.232 . . . . 2.4900000000000002 110.489 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -141.65 131.07 4.63 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.955 -0.64 . . . . 1.3 111.554 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.96 137.12 54.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.652 0.263 . . . . 2.3399999999999999 110.73 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -119.79 127.52 52.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 2.7999999999999998 110.31 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 89.5 m-85 -109.22 126.71 53.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.259 -0.645 . . . . 5.1900000000000004 109.259 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' SER . . . . . 0.467 ' HB2' ' HA2' ' A' ' 248' ' ' GLY . 37.7 m -114.17 129.35 56.63 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.903 0.383 . . . . 2.0499999999999998 110.554 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.178 -0.915 . . . . 4.4199999999999999 109.608 179.503 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 . . . . . 0 CA--C 1.517 -0.315 0 N-CA-C 109.609 -0.515 . . . . 3.6099999999999999 109.609 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.431 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 92.2 m95 -71.25 115.97 11.02 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.642 -0.708 . . . . 3.9100000000000001 110.053 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.408 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 53.1 t60 -114.57 122.16 45.67 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.071 -0.513 . . . . 3.9399999999999999 109.964 175.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 7' ' ' TRP . 98.9 m-85 -120.21 140.07 51.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.944 -0.571 . . . . 3.21 110.731 -178.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -122.0 129.47 52.49 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.078 -0.712 . . . . 2.6499999999999999 109.078 171.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 279' ' ' TYR . 86.2 mt -125.12 129.37 73.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.292 -0.413 . . . . 2.0699999999999998 110.736 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.13 122.79 5.95 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.093 -0.803 . . . . 0.92000000000000004 111.093 175.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -120.01 136.66 54.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.935 0.367 . . . . 1.6499999999999999 110.858 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 68.4 mtt -133.43 156.68 47.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.305 -0.407 . . . . 2.9700000000000002 110.347 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -114.65 139.93 49.25 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.782 -0.451 . . . . 3.1499999999999999 109.782 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 112.762 0.652 . . . . 5.0899999999999999 112.762 -175.276 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 109.796 -0.446 . . . . 3.48 109.796 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.97 150.01 66.32 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.347 2.031 . . . . 2.0299999999999998 112.267 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 14.3 p -124.46 143.67 50.51 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.038 -0.528 . . . . 2.2799999999999998 109.733 175.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.0 m -129.96 139.23 52.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.19 0.519 . . . . 2.4100000000000001 111.252 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -120.33 139.44 52.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.616 -0.72 . . . . 4.4400000000000004 109.631 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -119.9 138.34 53.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.882 0.373 . . . . 3.6200000000000001 111.625 -174.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -140.07 130.01 24.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.733 -0.667 . . . . 2.48 109.222 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.62 143.46 49.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.884 0.373 . . . . 1.53 111.573 -174.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.01 125.09 12.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.607 -0.724 . . . . 1.8 111.354 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.584 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 27.8 p-10 -166.96 95.24 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.278 0.561 . . . . 3.3799999999999999 110.502 171.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.97 -95.52 2.1 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.05 -0.595 . . . . 1.8200000000000001 111.871 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.584 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 54.2 Cg_exo -52.5 174.47 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.624 2.883 . . . . 2.1000000000000001 113.178 171.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.598 ' HB2' ' O ' ' A' ' 75' ' ' HIS . 48.9 p90 -69.14 -176.02 0.84 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.83 -0.623 . . . . 4.0499999999999998 111.289 -175.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -111.0 136.37 50.1 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 121.786 0.803 . . . . 3.6000000000000001 112.42 -167.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 87.1 mt -120.06 129.95 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 114.113 -1.403 . . . . 2.2799999999999998 109.931 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . . . -117.85 138.22 52.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.43 -0.35 . . . . 1.4399999999999999 110.065 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.0 tp -114.22 130.93 56.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.945 -0.57 . . . . 1.75 110.423 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.85 169.25 20.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.52 -0.764 . . . . 1.5900000000000001 109.332 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.422 ' CD2' ' HA ' ' A' ' 70' ' ' PRO . 92.9 m-85 -139.75 157.52 45.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.642 0.258 . . . . 4.4400000000000004 110.386 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -120.42 131.71 54.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.114 -0.494 . . . . 5.0199999999999996 110.645 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -113.61 127.86 56.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.079 -0.51 . . . . 3.7400000000000002 109.816 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.459 ' CD ' HH12 ' A' ' 69' ' ' ARG . 93.6 mt-10 . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 116.308 -0.405 . . . . 5.0499999999999998 109.973 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 89.2 m95 . . . . . 0 CA--C 1.527 0.082 0 CA-C-O 120.793 0.33 . . . . 6.5 110.863 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.416 ' CD2' ' HA2' ' A' ' 96' ' ' GLY . 37.2 m-85 -119.02 120.02 35.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.731 -0.47 . . . . 4.5999999999999996 109.731 173.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -145.05 150.82 37.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.866 -0.607 . . . . 2.4500000000000002 109.634 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.459 HH12 ' CD ' ' A' ' 53' ' ' GLU . 41.0 ttp180 -119.99 124.42 27.87 Favored Pre-proline 0 C--N 1.328 -0.341 0 C-N-CA 120.662 -0.415 . . . . 3.7200000000000002 110.98 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.422 ' HA ' ' CD2' ' A' ' 50' ' ' TYR . 88.2 Cg_endo -84.02 149.15 12.18 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.843 2.362 . . . . 1.3200000000000001 112.921 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.443 ' CD ' ' HE ' ' A' ' 93' ' ' ARG . 3.7 tp10 -115.46 118.55 33.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.572 -0.899 . . . . 2.1899999999999999 108.572 168.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.453 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 59.5 tp -122.34 101.8 7.73 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.251 -0.431 . . . . 1.73 110.15 -178.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 47' ' ' ALA . 34.7 mt-10 -90.14 125.59 35.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.04 -0.527 . . . . 2.1800000000000002 111.31 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.8 m -114.0 121.99 67.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.524 -0.917 . . . . 2.0600000000000001 108.524 168.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.598 ' O ' ' HB2' ' A' ' 44' ' ' TRP . 63.0 m80 -109.67 118.11 35.69 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.662 -0.495 . . . . 4.1900000000000004 109.662 -174.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -114.52 130.07 56.72 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.859 -0.793 . . . . 5.1600000000000001 108.859 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -128.04 129.74 47.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.953 0.406 . . . . 3.3100000000000001 110.399 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 89.0 m-85 -100.23 109.54 21.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.95 -0.568 . . . . 4.6600000000000001 109.941 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 C--N 1.324 -0.541 0 N-CA-C 109.323 -0.621 . . . . 4.8799999999999999 109.323 177.258 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 108.407 -0.96 . . . . 2.6400000000000001 108.407 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 78' ' ' PHE . 98.9 m-85 -79.55 129.8 34.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.107 -0.497 . . . . 6.1900000000000004 110.344 -175.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.08 153.22 17.89 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.318 -0.944 . . . . 1.54 111.903 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.8 tp -139.3 117.32 11.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.92 0.39 . . . . 2.73 110.079 176.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.6 m -110.8 117.65 34.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.138 -0.483 . . . . 1.8700000000000001 110.368 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.57 133.9 10.8 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.508 -0.853 . . . . 1.1699999999999999 112.059 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -136.04 126.11 3.76 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.548 -0.621 . . . . 1.4399999999999999 111.548 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -112.35 131.29 55.61 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.054 -0.35 . . . . 4.6399999999999997 110.054 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HE ' ' CD ' ' A' ' 71' ' ' GLU . 85.8 mtt180 -135.28 131.33 36.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.088 -0.506 . . . . 3.2200000000000002 110.177 -172.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -133.92 129.21 35.99 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.052 -0.259 . . . . 2.2200000000000002 110.958 175.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -114.85 125.13 53.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.525 -0.307 . . . . 3.6400000000000001 110.252 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.416 ' HA2' ' CD2' ' A' ' 67' ' ' PHE . . . . . . . . 0 N--CA 1.443 -0.856 0 C-N-CA 120.527 -0.845 . . . . 2.79 112.928 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 N--CA 1.445 -0.677 0 CA-C-O 121.155 0.502 . . . . 3.77 110.835 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.64 124.67 16.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.928 -0.578 . . . . 2.2000000000000002 110.095 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -139.54 107.93 5.83 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.245 -0.65 . . . . 3.1200000000000001 109.245 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 91.6 mtp -119.95 115.52 23.94 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.471 -0.331 . . . . 2.1200000000000001 110.297 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.625 ' HB2' ' OD1' ' A' ' 143' ' ' ASN . 49.4 mt-30 -100.19 129.09 46.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.949 0.404 . . . . 2.4900000000000002 110.113 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.672 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 40.5 ttm180 -120.24 111.02 17.28 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.87 -0.789 . . . . 4.4699999999999998 108.87 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -108.02 130.83 55.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.06 -0.518 . . . . 2.9199999999999999 109.703 -175.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.65 ' HA ' ' O ' ' A' ' 135' ' ' MET . 87.6 tttt -130.23 124.12 31.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.045 0.45 . . . . 2.5099999999999998 110.884 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 75.9 mt -129.82 130.03 66.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.022 -0.535 . . . . 2.1299999999999999 109.557 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -134.01 116.41 13.42 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.393 -0.367 . . . . 1.6799999999999999 111.151 -177.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.606 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 87.3 Cg_endo -80.01 140.05 13.99 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.277 1.984 . . . . 1.54 110.579 171.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -87.77 137.75 32.06 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.202 -0.454 . . . . 2.3500000000000001 110.985 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -101.13 127.53 47.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.24 -0.652 . . . . 5.1500000000000004 109.24 172.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -71.43 160.39 32.82 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 124.092 0.87 . . . . 3.04 111.61 -171.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.473 ' HB ' ' HG3' ' A' ' 128' ' ' ARG . 34.6 m -115.04 173.94 3.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.304 -0.862 . . . . 4.7400000000000002 110.841 -173.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 60.13 39.07 19.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.854 -0.612 . . . . 6.3600000000000003 111.576 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.7 tp -63.08 -40.19 96.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.759 -0.655 . . . . 4.96 110.436 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.9 p -118.02 159.98 22.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.752 -0.658 . . . . 4.0700000000000003 110.446 177.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -70.27 129.91 40.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.061 -0.518 . . . . 5.1699999999999999 111.402 -174.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 59.86 28.37 17.85 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.081 -0.963 . . . . 3.71 111.368 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.8 mt -137.77 144.44 41.6 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.21 -0.663 . . . . 2.4500000000000002 109.21 175.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.473 ' HG3' ' HB ' ' A' ' 121' ' ' VAL . 56.8 ttt180 -130.2 128.99 42.81 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.427 -0.509 . . . . 4.6799999999999997 111.104 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.43 ' O ' HG11 ' A' ' 121' ' ' VAL . 90.0 m-85 -120.01 123.05 42.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.273 -0.876 . . . . 4.3600000000000003 108.882 176.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 156' ' ' THR . 21.8 m-80 -116.16 130.98 57.06 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.078 -0.712 . . . . 2.5899999999999999 109.078 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.36 129.61 4.62 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 118.965 -1.588 . . . . 1.25 113.232 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -123.57 127.8 48.81 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.943 -0.392 . . . . 5.0899999999999999 109.943 173.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.606 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 87.9 mt -112.75 109.72 19.39 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.031 -0.729 . . . . 2.7599999999999998 109.031 174.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 152' ' ' VAL . 52.6 m -105.88 124.95 50.39 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.565 -0.454 . . . . 1.99 111.469 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.65 ' O ' ' HA ' ' A' ' 114' ' ' LYS . 95.4 mmm -93.32 126.2 38.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.507 -0.77 . . . . 2.7799999999999998 109.295 176.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -120.68 126.14 49.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.177 0.513 . . . . 3.6800000000000002 111.953 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.672 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 61.7 mttp -130.31 143.72 50.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.387 -0.968 . . . . 2.1699999999999999 108.387 167.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.471 ' H ' HD23 ' A' ' 142' ' ' LEU . 53.1 p90 -141.48 160.0 41.06 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 121.201 -0.2 . . . . 4.0099999999999998 110.76 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 62.75 178.66 0.14 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.94 0.775 . . . . 1.79 110.601 -177.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -75.73 -24.36 56.13 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.93 0.395 . . . . 3.04 110.584 173.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -59.96 -50.85 72.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.951 -0.568 . . . . 2.4100000000000001 111.599 -174.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 149' ' ' ASP . 9.5 mp -70.81 -29.86 66.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.436 -0.347 . . . . 2.3599999999999999 111.24 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.625 ' OD1' ' HB2' ' A' ' 111' ' ' GLN . 12.7 m120 -61.58 -41.49 97.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.006 0.432 . . . . 2.52 110.456 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.1 p -80.22 -39.9 28.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.595 -0.73 . . . . 2.52 111.832 -173.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.437 ' HG1' ' HB2' ' A' ' 149' ' ' ASP . 24.6 p -74.07 -32.88 63.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.321 . . . . 2.0099999999999998 111.207 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.71 -108.75 2.59 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.933 -0.576 . . . . 1.52 113.149 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -59.97 -40.07 87.83 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 122.687 0.395 . . . . 6.2199999999999998 111.503 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.424 ' HB3' ' HB ' ' A' ' 145' ' ' THR . . . -60.04 -44.27 94.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.173 -0.467 . . . . 2.0499999999999998 111.857 -175.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.496 ' HB3' ' HG ' ' A' ' 142' ' ' LEU . 43.3 m-20 -118.01 98.25 6.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.125 0.488 . . . . 2.6400000000000001 110.966 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.5 t -149.93 144.56 25.96 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.406 -0.59 . . . . 2.6000000000000001 109.406 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -110.16 151.71 26.94 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.335 -0.393 . . . . 4.0899999999999999 110.078 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.513 HG11 ' SD ' ' A' ' 135' ' ' MET . 16.1 m -136.41 134.4 49.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.984 0.421 . . . . 2.1499999999999999 111.504 -177.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -113.72 140.51 48.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.199 -0.455 . . . . 2.5600000000000001 109.832 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 78.6 m -128.42 118.63 23.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.163 -0.471 . . . . 1.78 109.936 175.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -120.68 120.16 34.9 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.774 -0.454 . . . . 2.04 109.774 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 130' ' ' ASN . 27.0 m -108.3 119.93 40.92 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.669 -0.696 . . . . 2.0299999999999998 110.026 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.97 111.81 4.33 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.92 -0.872 . . . . 1.0800000000000001 110.92 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 91.7 mt -104.23 129.98 52.03 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 110.263 -0.273 . . . . 2.9300000000000002 110.263 -176.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 65.9 tt0 -114.92 113.55 24.31 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.832 -0.433 . . . . 3.02 109.832 176.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -115.65 130.57 56.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.573 -0.74 . . . . 4.7599999999999998 109.458 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -92.58 90.18 7.02 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.404 0.621 . . . . 1.8200000000000001 109.907 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -60.24 -49.62 76.88 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.934 -1.03 . . . . 3.27 111.715 -171.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.437 ' C ' ' H ' ' A' ' 165' ' ' THR . 17.4 m120 -99.87 2.62 44.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.381 -0.372 . . . . 2.4100000000000001 110.353 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 71.88 -36.11 0.35 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.356 -0.838 . . . . 2.5800000000000001 111.263 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.437 ' H ' ' C ' ' A' ' 163' ' ' ASN . 21.8 p -75.36 -34.97 61.19 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.859 0.362 . . . . 2.6000000000000001 111.206 174.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.9 m -121.08 140.56 44.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 120.94 0.4 . . . . 2.0600000000000001 110.734 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 161' ' ' THR . . . -107.74 139.94 41.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.928 -0.578 . . . . 1.8400000000000001 111.237 -175.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 159' ' ' GLN . 17.9 mt -104.53 125.59 50.84 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.429 -0.582 . . . . 2.1400000000000001 109.429 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -109.22 115.72 30.54 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.727 -0.472 . . . . 3.73 109.727 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.0 132.09 65.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.063 0.459 . . . . 1.8100000000000001 110.855 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.471 ' O ' ' HB ' ' A' ' 194' ' ' ILE . 3.2 m-20 -107.23 122.57 46.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.048 0.451 . . . . 2.2400000000000002 111.025 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -98.28 121.51 40.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.512 -0.767 . . . . 4.8399999999999999 110.052 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -99.49 120.42 39.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.953 0.406 . . . . 4.4299999999999997 110.119 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 63.9 tp -104.91 129.14 53.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.806 -0.634 . . . . 2.8500000000000001 110.95 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -98.68 138.63 35.57 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.641 -0.874 . . . . 3.3100000000000001 108.641 175.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.992 0.425 . . . . 7.3300000000000001 110.842 179.793 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 109.554 -0.535 . . . . 4.4000000000000004 109.554 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 171' ' ' ASN . 28.5 pt -120.09 169.1 11.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.761 -0.654 . . . . 2.6400000000000001 111.062 -172.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -101.68 119.94 39.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.85 -0.614 . . . . 4.1100000000000003 110.553 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -112.87 129.44 56.46 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.512 -0.551 . . . . 1.76 109.512 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 209' ' ' PRO . 31.1 p90 -145.42 149.93 35.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.264 0.554 . . . . 6.1399999999999997 111.528 -178.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.9 mp -112.26 127.74 26.44 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.689 -0.687 . . . . 3.0800000000000001 110.279 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.22 106.23 1.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.287 1.991 . . . . 1.98 111.581 175.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 89.9 mt -114.47 140.09 49.0 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.941 -0.572 . . . . 2.7599999999999998 109.93 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 94.0 m -119.93 130.05 54.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.126 0.488 . . . . 2.4199999999999999 111.134 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.1 mt -129.8 80.29 1.95 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.533 -0.914 . . . . 2.77 108.533 173.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 70.06 -120.96 9.96 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.863 -0.684 . . . . 1.6200000000000001 111.78 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -91.87 -0.03 57.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.259 0.552 . . . . 2.8599999999999999 109.536 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -93.67 118.98 32.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.327 -0.852 . . . . 3.23 109.291 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 47.6 m -104.62 131.97 51.42 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.782 -0.451 . . . . 2.0499999999999998 109.782 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 63.2 t -120.07 130.03 74.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.908 -0.405 . . . . 1.9299999999999999 109.908 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 48.1 m -138.1 94.65 11.04 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 116.503 -0.317 . . . . 1.6699999999999999 110.987 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.413 ' O ' ' HA ' ' A' ' 197' ' ' TYR . 16.5 Cg_exo -69.17 131.22 21.6 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.525 2.15 . . . . 1.28 111.635 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -108.43 139.97 42.4 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.823 -0.436 . . . . 4.8600000000000003 109.823 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 11.1 t -168.53 166.93 11.9 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.191 -0.459 . . . . 2.0899999999999999 110.426 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -98.97 139.87 33.97 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.048 -1.093 . . . . 5.29 108.048 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 83.7 mt . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.03 0.443 . . . . 4.9400000000000004 110.871 -175.74 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 C--O 1.233 0.234 0 N-CA-C 109.337 -0.616 . . . . 2.9700000000000002 109.337 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 172.43 177.03 41.59 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.024 -1.084 . . . . 1.3999999999999999 112.995 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 83.0 mt -120.04 129.97 54.48 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.104 -0.332 . . . . 2.4300000000000002 110.104 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -101.45 133.64 45.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.061 -0.348 . . . . 4.3300000000000001 110.061 175.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -120.08 139.96 51.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.061 -0.518 . . . . 3.2599999999999998 110.262 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 251' ' ' VAL . . . -127.13 132.16 7.49 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.251 -0.739 . . . . 1.3500000000000001 111.251 176.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 250' ' ' SER . 91.3 m-85 -120.83 144.24 48.45 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.067 -0.346 . . . . 4.7599999999999998 110.067 -177.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 56.5 40.04 29.69 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.846 0.716 . . . . 4.29 110.507 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -62.72 -40.11 96.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.534 -0.757 . . . . 7.5599999999999996 110.867 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -111.21 129.99 55.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.636 -0.256 . . . . 7.0199999999999996 111.289 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 55.51 39.92 31.11 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.704 -0.68 . . . . 6.4800000000000004 112.229 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -161.82 -174.44 31.7 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.521 -0.632 . . . . 2.9199999999999999 111.521 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 86.2 mt -89.1 109.1 20.0 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.863 -0.791 . . . . 3.5800000000000001 108.863 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 243' ' ' TYR . 17.7 m -78.88 130.92 36.17 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.113 0.482 . . . . 2.6000000000000001 111.26 -169.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . 0.41 ' O ' ' HA2' ' A' ' 242' ' ' GLY . 62.9 t -107.57 133.24 52.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.667 -0.697 . . . . 2.2400000000000002 109.78 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 3.0 p -108.3 113.28 26.25 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.064 0.459 . . . . 2.0 110.485 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 64.8 tp -119.57 115.73 24.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.087 -0.506 . . . . 3.4199999999999999 110.635 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -101.77 115.47 30.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.181 -0.463 . . . . 4.0800000000000001 110.371 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -106.21 120.04 40.81 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 110.259 -0.275 . . . . 5.1699999999999999 110.259 175.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.684 0 N-CA-C 108.487 -0.931 . . . . 3.5800000000000001 108.487 172.62 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.467 0 N-CA-C 109.617 -0.512 . . . . 2.4100000000000001 109.617 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.35 137.57 9.54 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.937 -0.649 . . . . 1.6200000000000001 111.659 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 61.9 t -129.4 129.97 67.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.953 0.406 . . . . 2.4900000000000002 110.874 -175.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -152.44 163.66 30.36 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.873 -0.603 . . . . 1.3 111.686 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.19 140.01 32.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.885 0.374 . . . . 2.3399999999999999 110.163 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -113.5 127.01 55.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.196 0.522 . . . . 2.7999999999999998 110.929 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.484 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 65.0 t80 -105.96 124.71 50.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.655 -0.702 . . . . 5.1900000000000004 109.402 176.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 7.7 p -117.44 130.51 56.51 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.037 0.446 . . . . 2.0499999999999998 110.858 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 59.2 t80 . . . . . 0 C--O 1.244 0.783 0 CA-C-O 118.508 -0.758 . . . . 4.4199999999999999 109.084 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 120.572 0.225 . . . . 3.6099999999999999 111.059 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -96.93 108.2 20.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.6 -0.889 . . . . 3.9100000000000001 108.6 171.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -110.7 137.16 48.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.341 0.591 . . . . 3.9399999999999999 111.778 -175.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -125.21 142.89 51.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.619 -1.173 . . . . 3.21 109.536 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -120.98 129.99 53.64 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.962 -0.384 . . . . 2.6499999999999999 109.962 176.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.7 mt -120.03 122.52 68.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.921 -0.581 . . . . 2.0699999999999998 109.919 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.38 142.1 13.53 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 119.799 -1.191 . . . . 0.92000000000000004 112.601 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.26 136.23 53.19 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.624 -0.509 . . . . 1.6499999999999999 109.624 176.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 70.1 mtm -127.75 151.28 49.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.184 -0.462 . . . . 2.9700000000000002 110.944 -175.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 33' ' ' PRO . 59.3 m-85 -129.93 138.25 50.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.251 -0.886 . . . . 3.1499999999999999 108.69 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 121.124 0.488 . . . . 5.0899999999999999 110.049 176.841 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.426 ' CD ' ' HG ' ' A' ' 34' ' ' SER . 0.4 OUTLIER . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 120.548 0.213 . . . . 3.48 110.552 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.429 ' HB3' ' CE1' ' A' ' 15' ' ' TYR . 87.8 Cg_endo -90.09 133.2 1.97 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.627 2.218 . . . . 2.0299999999999998 113.192 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.426 ' HG ' ' CD ' ' A' ' 32' ' ' GLU . 7.2 m -140.03 162.7 34.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.984 0.421 . . . . 2.2799999999999998 111.619 176.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -125.19 134.91 65.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.791 -0.64 . . . . 2.4100000000000001 110.775 -177.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -113.07 162.23 16.16 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.321 -0.622 . . . . 4.4400000000000004 109.321 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -139.87 146.72 39.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.056 0.455 . . . . 3.6200000000000001 111.231 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.597 ' OD1' ' HD3' ' A' ' 45' ' ' ARG . 11.3 p30 -151.4 160.86 43.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.773 -0.649 . . . . 2.48 109.526 174.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.15 155.28 39.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.49 -0.323 . . . . 1.53 110.576 -178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.37 146.03 16.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.369 -0.378 . . . . 1.8 110.8 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.607 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 6.1 p-10 -167.08 94.73 0.47 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.773 -0.649 . . . . 3.3799999999999999 109.787 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.95 -94.07 1.95 Allowed Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 111.114 -0.794 . . . . 1.8200000000000001 111.114 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.607 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 77.0 Cg_exo -52.24 174.03 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.385 2.723 . . . . 2.1000000000000001 113.092 168.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.484 ' HB2' ' O ' ' A' ' 75' ' ' HIS . 48.9 p90 -70.07 -176.89 1.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.742 -0.663 . . . . 4.0499999999999998 112.155 -170.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.597 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 18.0 ttm180 -113.69 129.41 56.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.908 -0.587 . . . . 3.6000000000000001 111.29 -168.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.9 mt -113.22 129.92 68.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.37 -0.832 . . . . 2.2799999999999998 110.274 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.491 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -118.9 132.14 56.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.492 -0.322 . . . . 1.4399999999999999 110.576 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.5 tp -124.23 131.0 53.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.777 0.322 . . . . 1.75 110.413 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.37 160.87 42.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.846 -0.616 . . . . 1.5900000000000001 110.349 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -120.03 139.96 51.72 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.4 -0.593 . . . . 4.4400000000000004 109.4 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.407 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 45.4 t80 -98.89 128.16 45.0 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.651 0.738 . . . . 5.0199999999999996 111.808 -175.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -150.02 155.06 39.24 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.392 -1.707 . . . . 3.7400000000000002 106.392 171.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 . . . . . 0 C--N 1.317 -0.838 0 N-CA-C 109.393 -0.595 . . . . 5.0499999999999998 109.393 178.537 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 47.0 m95 . . . . . 0 CA--C 1.521 -0.173 0 N-CA-C 109.416 -0.587 . . . . 6.5 109.416 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -119.1 119.95 35.72 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.58 -0.526 . . . . 4.5999999999999996 109.58 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -159.36 169.27 24.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.116 0.484 . . . . 2.4500000000000002 110.912 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.511 ' HG3' ' O ' ' A' ' 94' ' ' ASN . 41.5 ttp180 -149.87 123.24 4.43 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 115.293 -0.867 . . . . 3.7200000000000002 109.602 171.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.644 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 71.4 Cg_endo -79.81 140.56 14.66 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.292 1.995 . . . . 1.3200000000000001 110.733 169.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.523 ' CD ' ' HE ' ' A' ' 93' ' ' ARG . 72.2 tt0 -135.87 124.66 23.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.332 0.587 . . . . 2.1899999999999999 110.699 -178.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.491 HD11 ' O ' ' A' ' 47' ' ' ALA . 41.0 tp -120.17 130.02 54.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.408 -0.814 . . . . 1.73 109.994 -178.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -125.04 128.02 47.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.019 0.438 . . . . 2.1800000000000002 110.1 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.03 129.93 74.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.172 -0.467 . . . . 2.0600000000000001 110.743 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.484 ' O ' ' HB2' ' A' ' 44' ' ' TRP . 64.4 m170 -116.61 120.08 37.53 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.786 0.327 . . . . 4.1900000000000004 110.636 177.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -114.45 124.13 51.16 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.82 -0.627 . . . . 5.1600000000000001 109.38 174.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -119.55 137.97 53.49 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.27 -0.27 . . . . 3.3100000000000001 110.27 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -134.54 130.31 36.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.931 0.396 . . . . 4.6600000000000001 110.269 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.4 tp . . . . . 0 C--N 1.321 -0.647 0 N-CA-C 109.405 -0.591 . . . . 4.8799999999999999 109.405 177.145 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 120' ' ' ASP . 47.8 m . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 120.995 0.426 . . . . 2.6400000000000001 110.651 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -147.78 161.4 41.31 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.626 -0.509 . . . . 6.1900000000000004 109.626 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.61 176.94 34.62 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.463 -0.875 . . . . 1.54 112.04 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 92.3 mt -127.69 123.92 36.63 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.118 -0.327 . . . . 2.73 110.118 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.2 m -119.93 130.02 54.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.138 -0.483 . . . . 1.8700000000000001 110.528 176.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -137.07 144.69 16.35 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.804 -0.713 . . . . 1.1699999999999999 111.768 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -137.66 143.98 15.23 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.987 -0.625 . . . . 1.4399999999999999 112.112 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -130.48 130.0 43.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.871 0.367 . . . . 4.6399999999999997 110.753 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.523 ' HE ' ' CD ' ' A' ' 71' ' ' GLU . 99.3 mtt180 -130.29 127.36 39.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.738 -0.665 . . . . 3.2200000000000002 109.809 175.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.644 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 61.2 t30 -111.27 117.95 34.57 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.441 -0.577 . . . . 2.2200000000000002 109.441 174.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -106.54 125.31 50.84 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.564 -0.289 . . . . 3.6400000000000001 110.881 -172.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.572 0 C-N-CA 120.0 -1.095 . . . . 2.79 111.584 175.486 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.874 -0.417 . . . . 3.77 109.874 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.29 157.8 25.46 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.451 -0.203 . . . . 2.2000000000000002 110.451 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -119.91 126.73 51.63 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.643 0.735 . . . . 3.1200000000000001 111.163 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.448 ' HE2' ' HB1' ' A' ' 139' ' ' ALA . 88.7 mtp -104.7 117.96 35.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.308 -0.86 . . . . 2.1200000000000001 109.491 176.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.536 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 96.5 mt-30 -94.2 118.44 31.56 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.503 -0.479 . . . . 2.4900000000000002 110.911 -174.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 84.4 mtt180 -105.5 115.94 31.1 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.012 -0.54 . . . . 4.4699999999999998 109.683 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 35.5 t-105 -118.35 120.8 38.69 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.999 -0.741 . . . . 2.9199999999999999 108.999 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -126.32 130.01 49.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.445 -0.343 . . . . 2.5099999999999998 110.719 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.2 pt -132.59 144.51 36.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.89 0.376 . . . . 2.1299999999999999 110.953 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.47 123.84 3.17 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.775 -0.648 . . . . 1.6799999999999999 110.351 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.6 130.52 3.8 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.459 2.106 . . . . 1.54 111.059 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -80.04 137.41 36.79 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.712 -0.477 . . . . 2.3500000000000001 109.712 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -132.91 128.41 36.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.008 0.432 . . . . 5.1500000000000004 111.496 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 85' ' ' SER . 0.8 OUTLIER -103.57 110.26 22.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.795 -0.638 . . . . 3.04 109.461 171.172 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.73 119.98 61.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.145 0.498 . . . . 4.7400000000000002 110.817 -175.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -102.7 84.53 2.42 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.303 0.573 . . . . 6.3600000000000003 110.137 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.02 -39.98 75.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.261 -0.881 . . . . 4.96 111.598 -177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 81.5 m -123.8 139.18 54.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.073 -0.512 . . . . 4.0700000000000003 110.443 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -59.94 140.05 56.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.816 -0.629 . . . . 5.1699999999999999 111.272 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 66.1 14.31 9.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.271 -0.877 . . . . 3.71 111.964 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.6 mt -131.85 148.94 52.58 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.486 -0.561 . . . . 2.4500000000000002 109.486 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -130.81 137.58 49.49 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.719 -0.392 . . . . 4.6799999999999997 110.057 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -127.01 128.28 46.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.188 -0.46 . . . . 4.3600000000000003 109.78 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -119.77 129.91 54.7 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.473 -0.566 . . . . 2.5899999999999999 109.473 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -160.91 161.19 32.65 Favored Glycine 0 CA--C 1.504 -0.647 0 C-N-CA 119.908 -1.139 . . . . 1.25 112.108 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -145.13 149.81 35.66 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.994 0.426 . . . . 5.0899999999999999 110.942 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.9 tp -101.34 120.98 41.09 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.925 -0.769 . . . . 2.7599999999999998 108.925 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.3 t -113.48 136.74 52.46 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.772 -0.649 . . . . 1.99 111.099 -172.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 67.3 mtm -140.0 140.2 36.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.803 -0.635 . . . . 2.7799999999999998 109.727 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -145.29 156.52 43.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.271 0.558 . . . . 3.6800000000000002 111.555 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 62.2 mttp -130.95 157.0 44.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.879 -1.055 . . . . 2.1699999999999999 108.904 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.536 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 48.1 p90 -142.2 163.78 31.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.645 -0.252 . . . . 4.0099999999999998 110.425 -175.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.448 ' HB1' ' HE2' ' A' ' 110' ' ' MET . . . 65.09 -172.5 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.948 -0.569 . . . . 1.79 111.154 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -76.79 -47.34 21.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.169 0.509 . . . . 3.04 110.89 174.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -60.17 -45.59 92.58 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.196 -0.911 . . . . 2.4100000000000001 113.455 -167.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 138' ' ' PHE . 3.1 mm? -62.02 -39.99 94.17 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.185 0.517 . . . . 2.3599999999999999 110.561 -176.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -67.36 -39.86 85.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.635 -0.711 . . . . 2.52 110.551 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.4 m -62.73 -44.36 96.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.675 -0.693 . . . . 2.52 112.008 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 31.0 p -76.87 -19.9 56.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.992 0.425 . . . . 2.0099999999999998 111.156 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.21 -125.86 21.96 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.789 -0.641 . . . . 1.52 113.196 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -65.73 -19.39 65.88 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.647 0.24 . . . . 6.2199999999999998 111.647 -174.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.43 98.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.424 -0.353 . . . . 2.0499999999999998 111.675 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.495 ' O ' ' HE3' ' A' ' 137' ' ' LYS . 68.1 m-20 -119.69 117.18 27.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.044 0.45 . . . . 2.6400000000000001 110.572 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.4 t -154.3 153.92 32.5 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.863 -0.421 . . . . 2.6000000000000001 109.863 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -108.27 140.06 42.07 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.742 -0.466 . . . . 4.0899999999999999 109.742 175.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.88 119.97 59.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.149 0.5 . . . . 2.1499999999999999 110.295 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -119.63 130.43 55.09 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.363 -0.835 . . . . 2.5600000000000001 109.122 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 21.8 m -129.54 129.79 44.94 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 121.923 -0.486 . . . . 1.78 111.267 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -128.76 128.9 44.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.12 -0.491 . . . . 2.04 109.849 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 27.2 p -130.32 140.3 50.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.074 -0.512 . . . . 2.0299999999999998 110.773 -177.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -125.63 122.44 4.55 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.599 -0.601 . . . . 1.0800000000000001 111.599 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.9 mt -102.29 128.25 48.92 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.988 -0.375 . . . . 2.9300000000000002 109.988 -176.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -107.66 111.05 23.08 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.617 -0.433 . . . . 3.02 110.379 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.98 139.8 51.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.737 -0.665 . . . . 4.7599999999999998 109.75 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 164' ' ' GLU . 18.0 p -100.75 102.22 13.26 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.187 0.518 . . . . 1.8200000000000001 110.368 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -60.01 -48.51 81.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.289 -0.869 . . . . 3.27 110.992 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.405 ' C ' ' H ' ' A' ' 165' ' ' THR . 21.5 m120 -102.64 9.77 39.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.336 -0.393 . . . . 2.4100000000000001 110.553 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.452 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 42.6 tt0 72.13 -42.93 0.55 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.597 0.759 . . . . 2.5800000000000001 111.131 -175.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.405 ' H ' ' C ' ' A' ' 163' ' ' ASN . 25.5 p -74.79 -24.44 58.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.448 -0.342 . . . . 2.6000000000000001 111.816 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.4 m -125.09 140.44 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.403 -0.362 . . . . 2.0600000000000001 110.627 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.06 130.57 54.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.15 0.5 . . . . 1.8400000000000001 111.389 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 21.9 mt -104.26 136.33 44.06 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.556 -0.905 . . . . 2.1400000000000001 108.556 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -114.07 113.45 24.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.169 0.509 . . . . 3.73 110.7 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 63.2 t -115.05 120.11 63.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.5 -0.773 . . . . 1.8100000000000001 110.217 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -104.69 124.08 48.74 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.01 0.433 . . . . 2.2400000000000002 110.773 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -105.17 130.39 53.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.785 -0.643 . . . . 4.8399999999999999 109.821 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.436 ' CE2' ' HD3' ' A' ' 195' ' ' ARG . 68.2 m-85 -110.99 136.65 49.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.971 -0.558 . . . . 4.4299999999999997 110.468 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 61.5 tp -122.39 118.51 28.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.21 -0.45 . . . . 2.8500000000000001 110.398 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -120.11 179.98 4.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.889 -0.596 . . . . 3.3100000000000001 109.695 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 . . . . . 0 C--N 1.323 -0.546 0 C-N-CA 120.884 -0.326 . . . . 7.3300000000000001 111.042 -178.702 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.824 0.345 . . . . 4.4000000000000004 111.251 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' A' ' 213' ' ' ILE . 86.4 mt -120.3 120.0 61.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.347 -0.388 . . . . 2.6400000000000001 110.395 176.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.436 ' HD3' ' CE2' ' A' ' 173' ' ' TYR . 69.4 mtp180 -111.58 116.62 31.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.242 -0.651 . . . . 4.1100000000000003 109.242 177.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -120.0 138.97 53.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.839 0.352 . . . . 1.76 111.048 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -160.02 159.99 32.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.902 -0.59 . . . . 6.1399999999999997 110.425 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -129.14 128.43 23.31 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.377 -0.374 . . . . 3.0800000000000001 110.116 178.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.83 133.04 11.08 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.414 2.076 . . . . 1.98 112.359 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 56.9 tp -135.66 131.14 35.35 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.027 -0.731 . . . . 2.7599999999999998 109.027 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 33.3 m -120.05 130.08 54.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.701 0.286 . . . . 2.4199999999999999 110.548 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 58.3 tp -137.69 86.04 2.16 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.575 -0.528 . . . . 2.77 109.575 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 69.93 -120.89 10.05 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.822 -0.704 . . . . 1.6200000000000001 112.52 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -90.27 2.55 55.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 2.8599999999999999 110.248 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -112.65 130.08 56.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.099 -0.501 . . . . 3.23 110.491 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 68.3 m -115.32 136.93 52.58 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.951 -0.568 . . . . 2.0499999999999998 109.73 173.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 45.9 t -119.93 130.01 74.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.751 -0.463 . . . . 1.9299999999999999 109.751 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.9 m -137.61 95.41 11.27 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-O 120.582 0.229 . . . . 1.6699999999999999 110.57 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.67 130.05 19.96 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.217 1.945 . . . . 1.28 110.659 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -110.79 138.66 46.9 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.287 -0.415 . . . . 4.8600000000000003 110.171 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 71.1 p -133.68 151.66 51.7 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.133 -0.485 . . . . 2.0899999999999999 110.067 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.429 ' HG3' HG21 ' A' ' 237' ' ' VAL . 27.4 mtm180 -108.31 120.86 43.61 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.395 -0.595 . . . . 5.29 109.395 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.504 ' O ' ' HB ' ' A' ' 194' ' ' ILE . 48.6 mm . . . . . 0 C--N 1.321 -0.662 0 N-CA-C 109.899 -0.408 . . . . 4.9400000000000004 109.899 -177.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.429 HG21 ' HG3' ' A' ' 212' ' ' ARG . 54.2 t . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 121.062 0.458 . . . . 2.9700000000000002 110.942 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -162.06 155.11 26.27 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.429 -0.891 . . . . 1.3999999999999999 112.117 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 90.7 mt -112.83 126.24 55.23 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.708 -0.478 . . . . 2.4300000000000002 109.708 176.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -106.19 128.64 54.07 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.649 -0.5 . . . . 4.3300000000000001 109.649 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -119.93 139.97 51.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.247 -0.433 . . . . 3.2599999999999998 110.89 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -111.67 116.05 4.06 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.962 -0.855 . . . . 1.3500000000000001 110.962 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 250' ' ' SER . 59.1 t80 -112.06 114.87 27.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.492 0.187 . . . . 4.7599999999999998 110.884 -177.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -101.34 115.7 31.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.233 0.54 . . . . 4.29 110.074 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -61.1 -49.88 75.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.877 -1.056 . . . . 7.5599999999999996 110.895 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -177.34 78.35 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.177 -0.465 . . . . 7.0199999999999996 110.825 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 56.13 63.43 2.01 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.225 0.536 . . . . 6.4800000000000004 111.956 170.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 153.7 -42.73 0.63 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 119.829 -1.177 . . . . 2.9199999999999999 112.767 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 61.9 tp -99.21 108.69 21.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.875 0.369 . . . . 3.5800000000000001 110.021 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 243' ' ' TYR . 47.0 m -119.9 133.42 55.58 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.988 -0.551 . . . . 2.6000000000000001 110.227 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.9 t -119.34 133.06 67.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 116.017 -0.538 . . . . 2.2400000000000002 110.095 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 22.9 t -98.55 129.83 45.11 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.005 -0.739 . . . . 2.0 109.005 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 91.7 mt -118.86 128.42 54.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.314 -0.403 . . . . 3.4199999999999999 110.782 -176.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' GLU . . . . . 0.421 ' HB2' ' H ' ' A' ' 274' ' ' GLY . 97.5 mt-10 -101.45 114.42 28.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.948 -0.569 . . . . 4.0800000000000001 109.8 176.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -120.3 140.03 51.84 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.849 -0.341 . . . . 5.1699999999999999 110.771 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.655 0 CA-C-N 116.151 -0.477 . . . . 3.5800000000000001 110.425 175.647 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 110.112 -0.329 . . . . 2.4100000000000001 110.112 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . 0.421 ' H ' ' HB2' ' A' ' 254' ' ' GLU . . . -132.69 149.86 19.61 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.338 -0.705 . . . . 1.6200000000000001 111.338 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.56 143.31 40.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.698 0.285 . . . . 2.4900000000000002 110.597 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -139.89 130.58 4.75 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 111.205 -0.758 . . . . 1.3 111.205 174.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 63.2 t -110.13 120.71 61.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.871 0.336 . . . . 2.3399999999999999 110.383 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -127.73 119.95 26.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.068 0.461 . . . . 2.7999999999999998 111.044 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -103.72 122.06 44.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.775 -0.648 . . . . 5.1900000000000004 109.266 175.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.7 t -111.34 129.69 55.92 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.069 -0.514 . . . . 2.0499999999999998 109.92 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 C--O 1.246 0.877 0 CA-C-O 118.407 -0.806 . . . . 4.4199999999999999 109.957 -179.379 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.5 ttm . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 110.212 -0.292 . . . . 11.970000000000001 110.212 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -60.1 -40.16 88.68 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.046 -0.525 . . . . 10.35 111.134 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.47 -39.8 92.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.783 -0.644 . . . . 9.3100000000000005 111.568 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -76.42 146.03 38.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.064 0.459 . . . . 9.4399999999999995 111.47 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -109.76 20.92 17.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.747 -0.661 . . . . 7.75 110.569 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.95 -41.69 92.43 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.736 -0.666 . . . . 3.6099999999999999 111.092 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -99.64 130.45 45.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.331 -0.395 . . . . 3.9100000000000001 110.358 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -98.86 117.67 33.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.081 0.467 . . . . 3.9399999999999999 110.073 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -119.97 140.01 51.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.576 -0.738 . . . . 3.21 110.569 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 14.3 t-20 -133.71 131.43 39.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.759 -0.655 . . . . 2.6499999999999999 110.2 174.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 84.7 mt -129.03 128.97 67.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.908 -0.587 . . . . 2.0699999999999998 109.577 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.08 135.61 11.77 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.482 -0.866 . . . . 0.92000000000000004 111.347 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.02 135.33 54.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.082 0.441 . . . . 1.6499999999999999 110.516 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 94.6 mmm -136.99 149.97 47.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.757 -0.656 . . . . 2.9700000000000002 110.362 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.31 124.96 43.52 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.949 -0.76 . . . . 3.1499999999999999 108.949 174.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.402 ' OE1' ' HA ' ' A' ' 31' ' ' ALA . 46.2 mt-10 -70.15 -33.58 71.97 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 120.881 -0.327 . . . . 5.0899999999999999 111.101 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.1 tt -130.21 131.25 65.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.377 -0.374 . . . . 5.3300000000000001 110.552 174.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -120.64 141.46 50.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.389 0.614 . . . . 8.2799999999999994 110.732 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -86.14 0.25 54.01 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.542 -0.754 . . . . 10.0 110.905 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.2 t -60.18 -50.89 78.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 11.380000000000001 111.224 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.547 ' OE1' ' HB3' ' A' ' 271' ' ' HIS . 62.2 mm-40 -70.5 -33.3 71.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.082 0.467 . . . . 13.1 111.257 177.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.11 8.34 56.75 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.68 -0.771 . . . . 12.52 112.652 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.0 140.01 45.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.738 0.304 . . . . 15.18 110.539 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.99 -156.92 9.08 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 121.011 -0.614 . . . . 12.279999999999999 111.981 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -132.71 172.26 12.78 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.6 -0.148 . . . . 12.82 110.6 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.76 -49.97 74.26 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.573 0.583 . . . . 10.81 112.573 -176.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.428 ' HE1' ' O ' ' A' ' 55' ' ' PRO . 88.5 mtp -109.96 134.34 52.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.155 0.502 . . . . 10.210000000000001 112.268 -172.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -70.01 -39.97 75.52 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.185 -0.916 . . . . 8.0600000000000005 111.726 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.95 14.82 4.37 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-N 116.104 -0.498 . . . . 6.0800000000000001 113.713 -173.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.4 mt -109.88 -0.44 18.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.982 0.391 . . . . 5.96 111.289 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.402 ' HA ' ' OE1' ' A' ' 16' ' ' GLU . . . -146.94 129.47 15.94 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 111.751 0.278 . . . . 3.2400000000000002 111.751 -176.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.403 ' HB2' ' HD2' ' A' ' 33' ' ' PRO . 11.9 pt-20 -150.42 160.3 33.2 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.887 -0.412 . . . . 3.48 109.887 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 32' ' ' GLU . 31.7 Cg_endo -69.85 147.84 63.19 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 121.689 1.593 . . . . 2.0299999999999998 111.647 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.5 t -129.49 142.83 50.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.448 -0.342 . . . . 2.2799999999999998 111.009 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.04 131.99 65.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.981 -0.554 . . . . 2.4100000000000001 109.615 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 94.7 m-85 -110.02 131.26 55.21 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.883 -0.414 . . . . 4.4400000000000004 109.883 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.7 m-85 -112.99 128.07 56.4 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.927 -0.309 . . . . 3.6200000000000001 110.93 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 10' ' ' ASN . 48.8 m-80 -129.15 132.44 47.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.873 -0.603 . . . . 2.48 109.981 175.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.54 143.36 37.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.593 -0.276 . . . . 1.53 110.261 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.46 122.29 3.15 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.73 0.27 . . . . 1.8 111.73 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.637 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 56.2 t30 -167.53 95.14 0.45 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.393 -0.595 . . . . 3.3799999999999999 109.393 171.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.23 -84.24 0.45 Allowed Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 110.921 -0.871 . . . . 1.8200000000000001 110.921 -173.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.637 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 24.4 Cg_endo -63.62 172.91 5.03 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.862 2.375 . . . . 2.1000000000000001 111.922 169.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -71.05 -174.86 1.03 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.95 -0.568 . . . . 4.0499999999999998 110.914 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -109.61 127.62 54.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.27 0.557 . . . . 3.6000000000000001 109.785 -171.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.2 tt -127.3 135.24 63.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.856 -1.065 . . . . 2.2799999999999998 110.876 -171.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -118.28 129.92 55.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.804 -0.635 . . . . 1.4399999999999999 110.264 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.3 tp -122.74 136.25 54.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.278 -0.419 . . . . 1.75 110.788 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.32 159.94 42.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.738 -0.665 . . . . 1.5900000000000001 109.852 176.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -123.53 139.98 53.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.572 0.225 . . . . 4.4400000000000004 110.416 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -125.45 115.33 20.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 5.0199999999999996 110.926 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -112.28 129.06 56.41 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.844 -0.343 . . . . 3.7400000000000002 110.239 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.484 ' HB2' ' NH2' ' A' ' 69' ' ' ARG . 85.8 tt0 -127.26 130.19 49.14 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.48 -0.327 . . . . 5.0499999999999998 110.468 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' HA2' ' HD2' ' A' ' 55' ' ' PRO . . . -112.27 100.64 1.16 Allowed Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.585 -0.817 . . . . 4.3700000000000001 112.122 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.428 ' O ' ' HE1' ' A' ' 27' ' ' MET . 23.3 Cg_endo -60.01 -26.56 82.75 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.631 2.221 . . . . 7.0899999999999999 111.034 175.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.8 t -128.4 130.08 69.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.623 -1.171 . . . . 8.5700000000000003 108.122 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -59.96 -32.28 70.66 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.838 0.351 . . . . 10.039999999999999 111.23 -176.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -65.78 -29.4 69.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.027 -0.533 . . . . 11.890000000000001 110.875 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.6 p -93.6 15.0 17.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 9.7899999999999991 111.359 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.53 143.65 34.34 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.895 -0.409 . . . . 8.7799999999999994 109.895 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.61 131.0 10.14 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.573 -0.822 . . . . 7.7300000000000004 112.688 -175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -69.87 -42.47 73.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.071 0.463 . . . . 10.300000000000001 110.429 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -70.22 -40.05 74.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.506 -0.77 . . . . 10.960000000000001 110.181 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.23 116.51 0.37 Allowed Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 114.812 -1.085 . . . . 5.5599999999999996 110.805 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.484 HG21 ' H ' ' A' ' 67' ' ' PHE . 21.7 m -70.69 130.97 43.16 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.998 0.428 . . . . 5.6900000000000004 111.039 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -65.2 -25.74 67.83 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.842 -0.617 . . . . 6.5 110.745 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.484 ' H ' HG21 ' A' ' 65' ' ' THR . 91.6 m-85 -86.14 104.81 16.06 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.582 -0.896 . . . . 4.5999999999999996 108.582 170.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -141.86 147.06 36.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.505 -0.316 . . . . 2.4500000000000002 110.317 -166.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.545 ' HG3' ' HA ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -127.43 124.0 23.42 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 109.858 -0.423 . . . . 3.7200000000000002 109.858 172.315 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 67.0 Cg_endo -80.01 135.51 11.17 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.119 1.879 . . . . 1.3200000000000001 110.951 170.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.474 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 8.1 tp10 -115.35 120.0 38.16 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.406 -0.59 . . . . 2.1899999999999999 109.406 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.4 tp -134.54 129.54 35.21 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.267 -0.424 . . . . 1.73 110.315 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -139.7 129.81 25.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.932 0.396 . . . . 2.1800000000000002 110.309 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.4 t -121.55 130.1 74.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.927 -0.579 . . . . 2.0600000000000001 109.773 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -108.81 137.43 46.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.049 0.452 . . . . 4.1900000000000004 110.915 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -119.91 139.89 51.73 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.472 -0.785 . . . . 5.1600000000000001 109.757 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -120.06 138.59 53.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.947 -0.39 . . . . 3.3100000000000001 109.947 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -125.5 127.64 46.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.287 0.565 . . . . 4.6600000000000001 110.496 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.7 tp -95.22 67.24 2.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.511 -0.768 . . . . 4.8799999999999999 110.097 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.592 ' HB2' ' CD1' ' A' ' 86' ' ' PHE . 45.3 mt-10 -89.97 -1.12 57.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.521 0.677 . . . . 6.1900000000000004 109.541 176.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -130.25 174.26 10.0 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.028 -1.101 . . . . 6.0999999999999996 108.028 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -60.05 -39.98 87.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 118.491 0.587 . . . . 5.2699999999999996 109.826 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -101.19 165.67 11.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.331 -0.849 . . . . 6.3300000000000001 109.467 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -79.22 66.67 4.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.028 0.442 . . . . 8.3499999999999996 110.281 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.608 ' HA ' ' OD2' ' A' ' 120' ' ' ASP . 16.3 m -80.0 -10.76 59.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.549 -0.75 . . . . 2.6400000000000001 111.41 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.592 ' CD1' ' HB2' ' A' ' 80' ' ' GLU . 97.8 m-85 -112.04 130.29 55.92 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.987 -0.375 . . . . 6.1900000000000004 109.987 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -154.76 156.35 26.83 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.545 -0.836 . . . . 1.54 111.96 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 96.9 mt -132.84 136.89 46.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.821 0.343 . . . . 2.73 110.287 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 60.9 m -119.93 129.94 54.57 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.653 -0.499 . . . . 1.8700000000000001 109.653 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.91 132.58 8.18 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.466 -0.873 . . . . 1.1699999999999999 111.528 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -125.07 128.5 6.67 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.762 -0.733 . . . . 1.4399999999999999 111.989 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -120.26 121.87 39.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.641 -0.503 . . . . 4.6399999999999997 109.641 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.474 ' HD2' ' OE2' ' A' ' 71' ' ' GLU . 38.6 ttt180 -141.96 130.01 22.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.726 -0.472 . . . . 3.2200000000000002 109.726 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.625 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 5.4 t30 -111.07 129.99 55.75 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.036 0.446 . . . . 2.2200000000000002 109.937 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.545 ' HA ' ' HG3' ' A' ' 69' ' ' ARG . 65.8 t80 -100.0 109.78 22.11 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.427 -0.582 . . . . 3.6400000000000001 109.427 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.9 -163.95 30.99 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.519 -0.848 . . . . 2.79 111.934 -175.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -130.9 152.77 49.87 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.372 -0.233 . . . . 7.8499999999999996 110.372 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -123.17 14.46 9.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.551 -0.295 . . . . 7.6900000000000004 111.345 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -70.15 -36.28 74.62 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.945 -0.302 . . . . 10.289999999999999 111.339 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.04 159.94 41.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.114 0.483 . . . . 10.19 111.28 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -120.19 30.96 6.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.544 -0.753 . . . . 12.220000000000001 110.243 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.29 150.39 79.95 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.667 -0.697 . . . . 10.48 111.95 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -59.84 150.07 79.8 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.323 2.682 . . . . 9.6799999999999997 113.103 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.18 -26.97 12.37 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.825 -0.625 . . . . 6.5099999999999998 111.748 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 59.8 33.54 21.72 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.145 0.578 . . . . 8.1099999999999994 112.062 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -76.21 -22.23 55.5 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.137 -1.06 . . . . 4.1399999999999997 108.137 170.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.5 m -96.4 131.93 42.46 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.457 -1.247 . . . . 3.77 108.819 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -158.07 149.68 21.5 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.629 -0.508 . . . . 2.2000000000000002 109.629 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -114.68 110.34 19.6 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.138 0.494 . . . . 3.1200000000000001 111.553 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 88.6 mtp -127.08 130.44 49.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.936 -0.764 . . . . 2.1200000000000001 108.936 169.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.639 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 95.7 mt-30 -107.43 138.39 43.72 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.094 -0.642 . . . . 2.4900000000000002 110.502 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 29.1 ttt180 -110.42 117.04 32.51 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.546 -0.539 . . . . 4.4699999999999998 109.546 171.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.556 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 61.4 m95 -108.5 127.42 53.91 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.735 -0.666 . . . . 2.9199999999999999 110.156 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -119.67 123.41 43.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.491 -0.322 . . . . 2.5099999999999998 110.795 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.6 mm -123.21 120.55 60.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.043 -0.725 . . . . 2.1299999999999999 109.043 170.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.604 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -144.43 106.28 4.72 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 111.716 0.265 . . . . 1.6799999999999999 111.716 -177.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.611 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 87.8 Cg_endo -79.94 149.18 20.11 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.575 2.183 . . . . 1.54 111.604 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -95.45 137.75 34.07 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.219 -0.66 . . . . 2.3500000000000001 109.219 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -135.98 130.49 33.72 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 111.957 0.355 . . . . 5.1500000000000004 111.957 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.608 ' OD2' ' HA ' ' A' ' 85' ' ' SER . 13.0 m-20 -94.36 102.14 14.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.821 -0.807 . . . . 3.04 108.821 168.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 96.3 t -69.9 -42.73 79.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.142 -0.481 . . . . 4.7400000000000002 111.089 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -114.73 132.82 56.31 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.556 -0.535 . . . . 6.3600000000000003 109.556 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.0 mt -107.19 24.84 12.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.202 -0.454 . . . . 4.96 111.019 -173.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 17.4 p -108.89 142.57 39.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.12 -0.491 . . . . 4.0700000000000003 110.758 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -69.5 -39.96 77.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 5.1699999999999999 111.591 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -59.92 -40.11 87.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.006 -0.543 . . . . 3.71 111.248 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.6 tp -139.34 122.39 16.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.002 -0.544 . . . . 2.4500000000000002 109.745 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -119.16 136.29 54.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.991 0.424 . . . . 4.6799999999999997 110.54 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.411 ' CZ ' ' HB ' ' A' ' 156' ' ' THR . 89.1 t80 -139.58 130.87 26.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.826 -0.624 . . . . 4.3600000000000003 109.386 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -127.09 162.17 26.7 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.24 -0.436 . . . . 2.5899999999999999 110.958 -176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -161.39 140.51 6.68 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.276 -0.73 . . . . 1.25 111.276 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.6 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 5.1 p90 -132.26 134.94 45.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.225 0.536 . . . . 5.0899999999999999 110.914 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.611 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 58.8 tp -104.46 124.46 49.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.163 -0.926 . . . . 2.7599999999999998 109.955 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.9 t -119.88 127.31 52.6 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.017 0.437 . . . . 1.99 110.179 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 89.3 mtp -113.04 130.42 56.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.94 -0.573 . . . . 2.7799999999999998 110.043 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 113' ' ' TRP . 70.9 m-85 -121.58 139.98 52.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.92 0.39 . . . . 3.6800000000000002 111.676 -175.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 63.1 mttp -125.95 151.54 46.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.787 -0.642 . . . . 2.1699999999999999 109.7 169.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.639 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 87.8 m-85 -135.56 156.28 49.13 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.422 0.451 . . . . 4.0099999999999998 110.53 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 110' ' ' MET . . . 60.05 -175.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.979 -0.555 . . . . 1.79 111.587 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -76.61 -33.69 58.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.487 0.66 . . . . 3.04 109.766 168.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -60.11 -45.61 92.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.79 -1.095 . . . . 2.4100000000000001 112.421 -169.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.586 ' HB2' ' O ' ' A' ' 138' ' ' PHE . 9.4 mp -69.9 -30.11 67.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.826 0.345 . . . . 2.3599999999999999 110.88 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -67.38 -39.89 85.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.339 0.59 . . . . 2.52 109.955 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.1 m -66.94 -41.34 87.15 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.191 -0.913 . . . . 2.52 111.665 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 34.7 p -80.58 -14.01 58.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.247 0.546 . . . . 2.0099999999999998 111.01 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.404 ' O ' ' HE3' ' A' ' 137' ' ' LYS . . . 71.3 -130.61 18.92 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.622 -0.717 . . . . 1.52 112.955 175.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.449 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 46.5 p90 -70.04 -16.15 63.11 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.53 0.196 . . . . 6.2199999999999998 111.53 -174.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.92 -48.68 80.69 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.208 0.448 . . . . 2.0499999999999998 112.208 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.427 ' HB3' ' HG ' ' A' ' 142' ' ' LEU . 51.3 m-20 -100.22 14.17 31.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.847 0.356 . . . . 2.6400000000000001 111.218 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.449 ' OG1' ' HA ' ' A' ' 147' ' ' TYR . 98.2 m -72.93 129.71 38.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.394 -0.366 . . . . 2.6000000000000001 110.706 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -83.45 134.29 34.87 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.387 -0.598 . . . . 4.0899999999999999 109.387 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 63.0 t -119.6 124.24 72.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.002 0.43 . . . . 2.1499999999999999 110.746 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -127.39 136.18 51.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.63 -0.714 . . . . 2.5600000000000001 109.684 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 16.0 m -135.77 130.05 33.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.804 0.335 . . . . 1.78 110.887 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.6 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 74.4 tt0 -120.29 136.89 54.53 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.525 -0.546 . . . . 2.04 109.525 175.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.546 ' OG1' ' HB2' ' A' ' 172' ' ' TYR . 17.1 p -127.38 140.07 52.43 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.024 -0.535 . . . . 2.0299999999999998 110.375 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -125.02 130.1 7.25 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.694 -0.765 . . . . 1.0800000000000001 112.211 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.8 tp -112.86 128.31 56.42 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 110.196 -0.298 . . . . 2.9300000000000002 110.196 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -108.49 107.43 17.96 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.995 -0.372 . . . . 3.02 109.995 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -121.01 130.08 53.65 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.414 -0.587 . . . . 4.7599999999999998 109.414 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.5 p -88.91 94.15 9.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.877 0.37 . . . . 1.8200000000000001 110.523 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -61.1 -45.73 93.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.971 -0.559 . . . . 3.27 111.271 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -99.95 7.65 44.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.589 -0.278 . . . . 2.4100000000000001 110.482 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 73.57 -46.01 0.62 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.708 0.803 . . . . 2.5800000000000001 111.201 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.4 p -73.88 -24.73 59.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.873 0.368 . . . . 2.6000000000000001 111.623 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.9 m -123.45 144.65 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.385 -0.37 . . . . 2.0600000000000001 110.554 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.22 135.02 49.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.143 -0.48 . . . . 1.8400000000000001 110.66 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 31.4 mt -104.2 134.53 47.28 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.416 -0.587 . . . . 2.1400000000000001 109.416 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.494 ' HD2' ' CE1' ' A' ' 197' ' ' TYR . 96.8 mtt180 -99.95 111.54 23.84 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.844 -0.428 . . . . 3.73 109.844 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.11 119.95 60.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.146 -0.479 . . . . 1.8100000000000001 109.812 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -107.83 128.44 54.6 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.205 0.526 . . . . 2.2400000000000002 110.792 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.546 ' HB2' ' OG1' ' A' ' 156' ' ' THR . 88.2 m-85 -106.81 128.52 54.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.457 -0.792 . . . . 4.8399999999999999 108.898 177.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -104.09 129.98 51.79 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.064 0.459 . . . . 4.4299999999999997 110.697 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.484 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 54.2 tp -118.61 119.94 35.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.699 -0.682 . . . . 2.8500000000000001 110.549 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -122.91 149.24 44.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.182 -0.673 . . . . 3.3100000000000001 109.182 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -94.06 113.09 25.0 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.109 -0.637 . . . . 7.3300000000000001 110.417 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -110.07 -156.33 15.74 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 110.224 -1.15 . . . . 5.0599999999999996 110.224 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -69.99 -28.53 65.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.638 0.732 . . . . 8.0199999999999996 109.452 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 59.9 29.97 19.52 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.197 -1.365 . . . . 9.4900000000000002 111.12 174.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 75.2 mtm -125.62 133.42 52.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.562 -0.745 . . . . 11.1 109.713 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -70.77 146.47 49.76 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.053 -0.521 . . . . 10.470000000000001 110.377 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -137.8 144.91 41.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.172 -0.467 . . . . 13.06 109.753 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 19.2 p -70.01 -18.03 63.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 12.890000000000001 111.456 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -80.56 -10.17 59.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.019 -0.537 . . . . 15.720000000000001 110.648 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -102.83 122.06 43.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.949 -0.569 . . . . 13.470000000000001 109.699 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -70.74 -24.9 62.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.11 -0.496 . . . . 13.15 111.413 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 82.69 10.04 83.79 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.034 -0.603 . . . . 10.050000000000001 111.743 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.32 -39.95 94.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.993 0.425 . . . . 10.699999999999999 110.857 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -107.85 146.4 32.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.797 -0.638 . . . . 11.34 110.135 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 32.2 p -81.26 147.84 29.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.084 0.469 . . . . 6.7800000000000002 110.77 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 23.4 p -70.06 -20.03 63.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.742 -0.663 . . . . 5.3600000000000003 111.056 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -127.25 149.85 49.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.852 -0.613 . . . . 7.8700000000000001 109.543 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -117.59 139.23 51.26 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.838 -0.43 . . . . 4.4000000000000004 109.838 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 87.2 mt -104.09 116.08 47.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.368 -0.378 . . . . 2.6400000000000001 110.089 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -107.61 125.28 51.13 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.182 -0.303 . . . . 4.1100000000000003 110.182 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -122.85 140.3 53.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.64 0.257 . . . . 1.76 111.137 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.494 ' CE1' ' HD2' ' A' ' 169' ' ' ARG . 28.5 p90 -149.73 157.67 43.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.273 -0.421 . . . . 6.1399999999999997 110.101 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.62 143.4 23.51 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.637 0.256 . . . . 3.0800000000000001 110.811 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -88.03 116.08 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.441 2.094 . . . . 1.98 112.168 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 55.0 tp -103.56 129.15 50.74 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.296 -0.631 . . . . 2.7599999999999998 109.296 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 27.4 m -95.67 116.72 29.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.955 0.407 . . . . 2.4199999999999999 111.24 -176.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.1 mt -127.74 81.46 2.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.071 -0.714 . . . . 2.77 109.071 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 75.83 -129.54 10.36 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.76 -0.733 . . . . 1.6200000000000001 111.291 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -90.62 -0.42 57.68 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.057 -0.72 . . . . 2.8599999999999999 109.057 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.519 ' HA ' ' O ' ' A' ' 242' ' ' GLY . 33.3 m170 -102.95 117.4 34.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.679 -0.691 . . . . 3.23 110.082 -176.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -96.02 132.88 40.91 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.877 -0.601 . . . . 2.0499999999999998 109.999 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.483 ' CG1' HD11 ' A' ' 239' ' ' LEU . 58.4 t -110.08 120.04 60.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.289 -0.634 . . . . 1.9299999999999999 109.289 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 45.1 m -131.01 91.95 34.95 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 120.776 0.322 . . . . 1.6699999999999999 111.569 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.06 147.77 18.95 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.314 2.009 . . . . 1.28 111.135 172.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.433 ' CE1' ' HA3' ' A' ' 238' ' ' GLY . 33.8 p90 -132.4 149.54 52.33 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.621 -0.511 . . . . 4.8600000000000003 109.621 172.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 20.6 p -119.0 135.74 54.46 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.715 -0.675 . . . . 2.0899999999999999 109.626 177.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -60.1 -39.81 87.44 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.743 -0.662 . . . . 5.29 110.259 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.424 ' HB ' ' ND2' ' A' ' 235' ' ' ASN . 84.5 mt -119.91 118.9 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 115.861 -0.608 . . . . 4.9400000000000004 109.543 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -72.73 -43.4 43.02 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.153 -0.546 . . . . 4.9800000000000004 112.088 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 96.6 mt -120.04 104.82 10.45 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.498 -0.556 . . . . 8.4399999999999995 109.498 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -63.99 151.73 42.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.151 -0.477 . . . . 7.9699999999999998 110.921 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -60.79 -40.03 91.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 11.1 111.078 -177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -132.26 161.12 34.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.147 -0.479 . . . . 12.24 110.396 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.2 p -60.86 -40.0 91.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.33 0.586 . . . . 10.220000000000001 111.035 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -160.05 -177.73 6.51 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.717 -1.216 . . . . 11.92 107.717 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -59.95 -39.38 85.35 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.421 -0.955 . . . . 14.460000000000001 108.421 168.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 50.99 47.04 25.57 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.727 0.642 . . . . 14.529999999999999 111.805 172.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -113.65 161.29 17.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.446 -0.797 . . . . 17.07 109.199 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -93.75 8.69 40.06 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.349 0.595 . . . . 15.779999999999999 109.998 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -146.23 119.96 9.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.944 -1.025 . . . . 15.67 108.936 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -126.81 145.75 50.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.912 0.387 . . . . 14.5 111.34 -172.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 86.1 mt -109.9 129.95 63.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.169 -0.678 . . . . 15.380000000000001 109.169 173.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -60.69 -38.53 85.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.701 -0.681 . . . . 14.73 111.699 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -94.38 119.21 32.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.994 0.426 . . . . 16.969999999999999 110.88 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -99.71 138.88 36.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.486 -0.779 . . . . 12.779999999999999 109.1 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -60.03 -39.99 96.44 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.379 -0.828 . . . . 11.369999999999999 113.224 -173.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -161.03 159.77 29.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.987 -0.375 . . . . 12.81 109.987 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -83.16 110.84 18.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.067 -0.515 . . . . 9.9900000000000002 110.209 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -69.31 -40.15 77.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.843 -0.617 . . . . 11.32 109.541 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.424 ' ND2' ' HB ' ' A' ' 213' ' ' ILE . 50.0 t-20 -111.19 109.89 20.14 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.399 -0.963 . . . . 6.8799999999999999 108.399 174.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -97.07 137.56 35.95 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.337 -0.392 . . . . 8.9399999999999995 110.626 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 60.5 t -120.17 124.88 73.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.977 -0.556 . . . . 2.9700000000000002 110.577 -174.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.433 ' HA3' ' CE1' ' A' ' 210' ' ' TYR . . . -122.01 140.0 13.28 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.065 -0.814 . . . . 1.3999999999999999 111.065 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.483 HD11 ' CG1' ' A' ' 207' ' ' VAL . 52.7 tp -120.58 124.4 45.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.928 0.364 . . . . 2.4300000000000002 110.728 -176.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.47 ' CE1' ' HG2' ' A' ' 254' ' ' GLU . 96.3 m-85 -104.88 132.07 51.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.126 -0.488 . . . . 4.3300000000000001 110.633 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -112.33 126.91 55.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.38 -0.373 . . . . 3.2599999999999998 110.22 171.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 205' ' ' HIS . . . -89.34 118.18 5.13 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.826 -0.91 . . . . 1.3500000000000001 110.826 174.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' TYR . . . . . 0.449 ' HB3' ' CG2' ' A' ' 251' ' ' VAL . 50.1 t80 -107.74 134.7 50.33 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.792 -0.447 . . . . 4.7599999999999998 109.792 -176.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -99.89 145.79 27.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.88 -0.6 . . . . 4.29 111.295 -174.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.68 139.9 52.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.842 -0.617 . . . . 7.5599999999999996 110.004 172.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -64.43 -26.41 68.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.288 -0.869 . . . . 7.0199999999999996 111.168 -174.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -59.82 -40.12 87.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.684 -0.689 . . . . 6.4800000000000004 110.808 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 130.8 21.74 1.09 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.83 -0.7 . . . . 2.9199999999999999 111.937 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 91.8 mt -110.99 151.52 27.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.747 0.308 . . . . 3.5800000000000001 110.351 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 52.8 m -130.07 139.77 50.92 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.703 -0.481 . . . . 2.6000000000000001 109.703 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.449 ' CG2' ' HB3' ' A' ' 243' ' ' TYR . 33.2 m -129.07 142.86 42.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.981 0.419 . . . . 2.2400000000000002 110.827 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 4.2 p -100.07 120.74 40.31 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.999 -0.546 . . . . 2.0 110.165 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 87.9 mt -99.96 125.94 46.04 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.052 -0.522 . . . . 3.4199999999999999 110.154 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 273' ' ' ALA . 45.3 mt-10 -92.81 134.62 34.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.41 -0.359 . . . . 4.0800000000000001 111.018 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -137.04 138.88 40.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.987 -0.552 . . . . 5.1699999999999999 109.564 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -111.84 129.67 56.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.603 0.24 . . . . 3.5800000000000001 110.432 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -119.95 139.5 52.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.598 -0.274 . . . . 7.5800000000000001 110.489 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -76.59 152.83 35.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.963 -0.562 . . . . 8.5399999999999991 110.077 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -60.13 -39.88 87.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 12.720000000000001 110.642 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -84.92 133.4 34.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.193 -0.458 . . . . 11.09 110.607 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.09 141.62 55.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.673 -0.694 . . . . 11.41 111.195 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -109.24 111.35 22.9 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.932 -0.576 . . . . 12.49 111.066 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -68.63 -39.84 80.6 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.091 -0.707 . . . . 12.460000000000001 109.091 172.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -100.12 101.51 12.57 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.104 -0.953 . . . . 13.779999999999999 110.044 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -82.43 -4.25 90.22 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.883 -0.675 . . . . 11.300000000000001 111.538 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -70.73 -20.65 62.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.549 -0.325 . . . . 12.59 111.58 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 33.5 t -140.04 122.15 15.76 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.082 -0.34 . . . . 11.1 110.082 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . 0.504 ' HB2' ' CE1' ' A' ' 271' ' ' HIS . 66.3 m-20 -130.04 151.04 51.02 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.564 -0.532 . . . . 12.42 109.564 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -69.91 -39.46 76.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.907 0.384 . . . . 11.82 110.925 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.36 149.97 52.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.047 -0.524 . . . . 9.5999999999999996 110.955 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . 0.547 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 22.4 m80 -138.85 103.33 4.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.005 -0.543 . . . . 7.7999999999999998 110.253 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -121.0 107.47 12.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.248 -0.433 . . . . 6.9900000000000002 110.236 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 254' ' ' GLU . . . -133.59 129.69 37.33 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.338 -0.392 . . . . 2.4100000000000001 110.233 176.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -140.81 154.84 24.58 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.958 -0.639 . . . . 1.6200000000000001 111.571 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 58.2 t -119.99 127.98 75.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.13 0.49 . . . . 2.4900000000000002 110.982 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 251' ' ' VAL . . . -117.72 129.84 8.49 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.697 -0.961 . . . . 1.3 110.697 173.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.2 124.92 64.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 117.368 0.584 . . . . 2.3399999999999999 110.758 -175.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -117.43 127.35 53.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.275 0.56 . . . . 2.7999999999999998 111.111 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 44.2 t80 -113.89 119.57 37.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.361 -0.836 . . . . 5.1900000000000004 109.106 171.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 53.4 m -129.98 129.61 43.97 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.752 0.311 . . . . 2.0499999999999998 110.337 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 49.8 t80 . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.319 -0.848 . . . . 4.4199999999999999 108.749 176.568 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.8 tpp . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 110.278 -0.267 . . . . 11.970000000000001 110.278 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -122.65 139.87 53.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.291 -0.413 . . . . 10.35 109.891 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -116.01 135.65 53.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.098 0.475 . . . . 9.3100000000000005 109.745 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -68.55 -39.98 80.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.441 -0.8 . . . . 9.4399999999999995 111.691 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -129.02 133.65 47.82 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.761 0.315 . . . . 7.75 111.158 -175.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -74.52 143.66 44.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.982 -0.554 . . . . 3.6099999999999999 109.785 174.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -141.31 101.73 4.07 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.128 -0.694 . . . . 3.9100000000000001 109.128 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 44.7 m80 -119.98 137.88 53.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.014 0.435 . . . . 3.9399999999999999 111.119 -175.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -132.84 146.22 51.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.671 -0.695 . . . . 3.21 110.85 -176.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -123.93 131.9 53.64 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.257 -0.428 . . . . 2.6499999999999999 109.969 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -130.0 129.97 65.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.309 -0.405 . . . . 2.0699999999999998 110.404 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -115.2 134.95 11.91 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.448 -0.882 . . . . 0.92000000000000004 111.644 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.97 136.34 54.57 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.94 0.4 . . . . 1.6499999999999999 110.569 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 65.9 mtt -133.14 155.34 49.45 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.881 -0.599 . . . . 2.9700000000000002 109.769 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -111.33 114.49 27.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.769 -0.456 . . . . 3.1499999999999999 109.769 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -114.21 134.17 55.1 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.148 -0.478 . . . . 5.0899999999999999 111.445 -170.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.3 mt -117.04 129.93 72.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.626 -0.715 . . . . 5.3300000000000001 109.448 175.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.407 ' CD ' ' HD2' ' A' ' 55' ' ' PRO . 45.4 mt-10 -82.55 137.89 34.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.889 0.376 . . . . 8.2799999999999994 110.571 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -84.45 110.05 18.35 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.406 -0.59 . . . . 10.0 109.406 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.9 t -70.16 -40.09 77.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.423 0.63 . . . . 11.380000000000001 110.489 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 59.93 23.1 12.16 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.597 -1.183 . . . . 13.1 111.81 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.02 -42.68 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.811 -0.709 . . . . 12.52 112.569 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -159.89 160.04 33.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.61 0.243 . . . . 15.18 110.397 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.1 23.05 53.4 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.574 -0.822 . . . . 12.279999999999999 112.168 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -60.03 -39.72 86.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.917 0.389 . . . . 12.82 111.431 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -60.22 -39.97 88.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.818 -0.628 . . . . 10.81 111.939 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 58.4 ttm -103.67 122.99 46.19 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.962 0.41 . . . . 10.210000000000001 111.172 -174.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -60.25 -39.86 88.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.662 -0.699 . . . . 8.0600000000000005 110.386 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.8 -143.79 16.79 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.839 -0.696 . . . . 6.0800000000000001 112.544 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.4 mt -119.59 140.84 49.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.129 -0.323 . . . . 5.96 110.129 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.08 118.53 37.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.244 -0.435 . . . . 3.2400000000000002 110.96 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -85.55 138.51 35.9 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.857 0.361 . . . . 3.48 110.229 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 14' ' ' MET . 74.4 Cg_endo -78.01 134.73 13.37 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.443 2.096 . . . . 2.0299999999999998 113.166 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.2 m -109.92 143.25 40.11 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.715 -0.846 . . . . 2.2799999999999998 108.715 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.49 134.4 66.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.357 0.598 . . . . 2.4100000000000001 111.615 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -114.08 134.24 55.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.473 -0.785 . . . . 4.4400000000000004 109.582 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -110.69 139.38 46.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.755 0.312 . . . . 3.6200000000000001 110.986 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -149.79 140.54 22.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.689 -0.485 . . . . 2.48 109.689 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.47 143.51 47.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.415 0.15 . . . . 1.53 110.978 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 8' ' ' HIS . . . -153.95 119.69 5.26 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.49 -0.323 . . . . 1.8 111.338 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.537 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 13.0 p-10 -169.12 95.04 0.32 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.373 -0.376 . . . . 3.3799999999999999 111.046 176.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.06 -98.7 2.47 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.972 -0.633 . . . . 1.8200000000000001 112.034 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.537 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 88.6 Cg_exo -49.23 174.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.893 3.062 . . . . 2.1000000000000001 112.998 170.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.403 ' HZ3' ' O ' ' A' ' 77' ' ' GLN . 93.6 m95 -67.31 176.33 2.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.123 0.487 . . . . 4.0499999999999998 111.108 -172.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -110.41 126.79 54.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.988 0.423 . . . . 3.6000000000000001 110.421 -163.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 83.5 mt -117.18 136.86 52.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.774 -0.648 . . . . 2.2799999999999998 110.715 -173.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.83 133.32 56.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.853 -0.612 . . . . 1.4399999999999999 110.423 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.9 tp -120.35 132.02 55.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.925 -0.58 . . . . 1.75 110.257 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.8 165.08 29.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.172 -0.467 . . . . 1.5900000000000001 110.189 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -138.42 147.97 43.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.057 -0.349 . . . . 4.4400000000000004 110.057 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -124.55 129.82 51.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.276 0.56 . . . . 5.0199999999999996 110.803 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -110.29 155.78 21.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.276 -0.874 . . . . 3.7400000000000002 108.859 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -59.98 -47.14 87.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.825 0.345 . . . . 5.0499999999999998 110.658 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -130.04 104.94 0.64 Allowed Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.79 -0.641 . . . . 4.3700000000000001 111.951 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.407 ' HD2' ' CD ' ' A' ' 18' ' ' GLU . 50.9 Cg_exo -55.69 -40.02 87.69 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.622 2.214 . . . . 7.0899999999999999 112.382 176.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.4 t -93.59 -29.97 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 8.5700000000000003 111.064 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -87.86 109.45 19.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.253 0.549 . . . . 10.039999999999999 110.615 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -97.86 119.24 36.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.884 -0.598 . . . . 11.890000000000001 110.664 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.5 p -78.35 126.65 31.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.931 -0.577 . . . . 9.7899999999999991 110.568 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.09 155.37 39.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.862 -0.608 . . . . 8.7799999999999994 109.519 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.94 18.18 73.05 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.693 -0.765 . . . . 7.7300000000000004 111.64 -177.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -129.01 144.6 51.24 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.136 -0.32 . . . . 10.300000000000001 110.136 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -125.89 131.49 52.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.698 0.285 . . . . 10.960000000000001 110.82 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.2 -160.89 30.45 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.796 -0.716 . . . . 5.5599999999999996 112.235 175.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.2 p -95.68 156.06 16.48 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.545 -0.539 . . . . 5.6900000000000004 109.545 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -131.35 160.02 36.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.875 0.369 . . . . 6.5 111.224 -172.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -110.51 135.33 51.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.031 -0.532 . . . . 4.5999999999999996 110.355 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -149.18 170.02 19.39 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.692 -0.485 . . . . 2.4500000000000002 109.692 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 94' ' ' ASN . 40.8 ttp180 -129.6 123.59 21.35 Favored Pre-proline 0 N--CA 1.451 -0.402 0 C-N-CA 120.682 -0.407 . . . . 3.7200000000000002 111.038 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 92.7 Cg_endo -87.78 152.07 7.36 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.938 2.425 . . . . 1.3200000000000001 110.802 167.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.447 ' OE2' ' HD3' ' A' ' 93' ' ' ARG . 52.7 mt-10 -134.5 125.72 27.94 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.807 -0.357 . . . . 2.1899999999999999 110.383 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.4 tp -133.7 129.96 37.49 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.893 -0.41 . . . . 1.73 109.893 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -128.3 146.62 50.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.083 0.468 . . . . 2.1800000000000002 110.994 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.1 t -114.8 126.87 72.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.786 -0.82 . . . . 2.0600000000000001 108.786 171.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -110.85 119.82 40.36 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.298 -0.41 . . . . 4.1900000000000004 110.227 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -105.59 120.03 40.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.065 -0.516 . . . . 5.1600000000000001 110.429 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.403 ' O ' ' HZ3' ' A' ' 44' ' ' TRP . 53.8 mt-30 -109.45 120.16 41.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.789 -0.448 . . . . 3.3100000000000001 109.789 176.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -104.14 125.45 50.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.151 0.5 . . . . 4.6600000000000001 111.214 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.6 tp -120.73 112.83 19.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.43 -0.805 . . . . 4.8799999999999999 108.975 174.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -113.74 170.35 8.32 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.88 -0.328 . . . . 6.1900000000000004 111.276 -173.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -60.51 -40.09 90.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.934 0.397 . . . . 6.0999999999999996 110.736 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -69.87 146.89 50.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.905 -0.589 . . . . 5.2699999999999996 109.497 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -79.98 66.68 5.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.797 0.808 . . . . 6.3300000000000001 110.32 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -138.61 150.54 46.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.863 -1.062 . . . . 8.3499999999999996 108.156 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.8 t -124.07 130.08 51.95 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.444 -0.503 . . . . 2.6400000000000001 110.711 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -128.52 153.29 47.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.77 -0.65 . . . . 6.1900000000000004 109.816 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -151.62 166.28 30.73 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.499 -0.858 . . . . 1.54 111.608 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 63.6 tp -146.49 120.09 9.14 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.908 0.385 . . . . 2.73 110.403 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.3 m -109.39 116.72 32.37 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.047 -0.524 . . . . 1.8700000000000001 109.763 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -134.96 139.05 10.5 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.44 -0.886 . . . . 1.1699999999999999 111.266 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.78 161.67 32.47 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.072 -1.061 . . . . 1.4399999999999999 112.366 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -122.39 130.96 53.63 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.491 -0.559 . . . . 4.6399999999999997 109.491 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.447 ' HD3' ' OE2' ' A' ' 71' ' ' GLU . 83.6 mtt180 -121.99 124.99 45.3 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.587 -0.894 . . . . 3.2200000000000002 108.587 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.515 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 64.4 t30 -103.75 118.41 36.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.064 0.459 . . . . 2.2200000000000002 110.64 -173.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 109' ' ' ASN . 59.3 t80 -102.34 117.67 35.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.07 -0.514 . . . . 3.6400000000000001 110.452 -175.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.46 -167.97 49.44 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.635 -0.793 . . . . 2.79 113.478 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -137.89 139.65 39.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.96 0.409 . . . . 7.8499999999999996 111.154 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -150.29 100.07 2.85 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.638 -0.875 . . . . 7.6900000000000004 108.638 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -99.51 126.39 45.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.978 0.418 . . . . 10.289999999999999 110.733 -176.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.7 t -70.24 -40.06 77.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.69 -0.686 . . . . 10.19 110.491 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -65.12 -40.05 93.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.733 -0.667 . . . . 12.220000000000001 111.111 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -129.94 74.95 80.15 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.0 -0.545 . . . . 10.48 110.549 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -79.98 159.76 24.04 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.814 2.343 . . . . 9.6799999999999997 113.243 -176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -130.02 169.47 21.02 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.968 -0.853 . . . . 6.5099999999999998 110.968 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -69.58 -40.02 76.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.32 0.56 . . . . 8.1099999999999994 110.174 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -111.55 109.98 20.17 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.846 -0.615 . . . . 4.1399999999999997 109.641 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.0 p -128.48 145.36 51.13 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.254 -0.43 . . . . 3.77 110.228 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -137.6 113.74 9.99 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.96 -0.296 . . . . 2.2000000000000002 110.345 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 95' ' ' TYR . 3.5 t-20 -142.09 108.31 5.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.927 -0.579 . . . . 3.1200000000000001 109.677 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.447 ' HB2' ' HB3' ' A' ' 95' ' ' TYR . 88.4 mtp -111.27 125.69 54.1 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.733 -0.667 . . . . 2.1200000000000001 109.343 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.568 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 81.1 mt-30 -91.66 119.87 31.92 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.527 -0.469 . . . . 2.4900000000000002 109.88 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -106.29 113.06 26.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.873 -0.603 . . . . 4.4699999999999998 110.193 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 137' ' ' LYS . 86.3 m95 -115.81 125.31 52.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.882 -0.784 . . . . 2.9199999999999999 108.882 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -140.1 123.88 17.37 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.452 -0.573 . . . . 2.5099999999999998 109.452 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 134' ' ' SER . 87.4 mt -123.22 128.22 74.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.999 -0.546 . . . . 2.1299999999999999 110.179 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -132.77 104.25 13.03 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.516 -0.311 . . . . 1.6799999999999999 111.278 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.18 141.13 11.44 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.091 2.527 . . . . 1.54 111.356 172.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -93.42 138.51 31.67 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.064 -0.516 . . . . 2.3500000000000001 110.088 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -127.06 128.38 46.19 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.125 -0.324 . . . . 5.1500000000000004 110.125 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -148.64 118.11 6.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.867 -0.42 . . . . 3.04 109.867 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.498 HG13 ' H ' ' A' ' 123' ' ' LEU . 61.1 t -124.6 130.01 73.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.001 0.429 . . . . 4.7400000000000002 111.105 -174.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -114.03 28.48 8.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 6.3600000000000003 110.213 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.498 ' H ' HG13 ' A' ' 121' ' ' VAL . 61.3 tp -68.13 -22.77 64.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 4.96 112.066 -171.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.0 p -108.15 143.84 36.38 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.081 0.467 . . . . 4.0700000000000003 111.789 -174.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -66.93 124.97 24.49 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.527 -0.76 . . . . 5.1699999999999999 110.823 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 60.25 15.6 5.45 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.86 0.725 . . . . 3.71 111.598 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.6 mt -129.25 119.53 24.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.207 -0.451 . . . . 2.4500000000000002 110.062 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.497 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 74.0 ttt180 -112.74 130.36 56.09 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.031 -0.531 . . . . 4.6799999999999997 110.062 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -107.24 125.81 51.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.066 -0.515 . . . . 4.3600000000000003 109.652 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -130.6 130.05 43.52 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.201 -0.666 . . . . 2.5899999999999999 109.201 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -137.53 144.55 16.01 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.139 -1.029 . . . . 1.25 112.8 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.404 ' HB3' ' HB3' ' A' ' 155' ' ' GLU . 61.0 t-105 -118.82 128.44 54.46 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.068 -0.716 . . . . 5.0899999999999999 109.068 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 60.9 tp -126.33 140.51 52.45 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.385 -0.598 . . . . 2.7599999999999998 109.385 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 29.3 t -156.72 169.97 23.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.418 -0.216 . . . . 1.99 110.418 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 92.8 mtp -139.62 149.95 44.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.652 0.263 . . . . 2.7799999999999998 110.663 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -103.74 117.35 34.17 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.378 -0.374 . . . . 3.6800000000000002 111.207 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 113' ' ' TRP . 99.4 mttt -132.92 129.8 38.78 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.066 -0.716 . . . . 2.1699999999999999 109.066 170.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 51.1 p90 -157.02 161.04 39.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.473 -0.331 . . . . 4.0099999999999998 110.618 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.415 ' HB3' ' HE3' ' A' ' 110' ' ' MET . . . 74.72 -178.19 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 O-C-N 124.154 0.908 . . . . 1.79 110.678 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -74.47 -38.64 62.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.533 -0.303 . . . . 3.04 111.019 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -59.86 -51.17 70.86 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.738 0.644 . . . . 2.4100000000000001 112.738 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.595 ' HA ' ' OG1' ' A' ' 145' ' ' THR . 44.2 mt -69.98 -30.01 67.25 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.776 -0.37 . . . . 2.3599999999999999 111.342 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -60.02 -42.16 93.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.029 0.442 . . . . 2.52 109.857 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 30.0 p -80.12 -31.37 39.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.011 -0.541 . . . . 2.52 111.972 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.595 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 61.6 p -71.65 -32.38 67.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.147 0.499 . . . . 2.0099999999999998 110.95 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.407 ' O ' ' HE2' ' A' ' 137' ' ' LYS . . . 68.3 -120.09 11.31 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.692 -0.686 . . . . 1.52 112.61 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -89.89 -9.66 48.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.43 0.157 . . . . 6.2199999999999998 111.067 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.69 -52.97 47.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.874 0.369 . . . . 2.0499999999999998 110.663 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.427 ' O ' HD21 ' A' ' 142' ' ' LEU . 10.9 m-20 -118.11 110.05 17.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.867 -0.606 . . . . 2.6400000000000001 109.666 176.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.6 t -170.24 164.17 8.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.813 -0.63 . . . . 2.6000000000000001 109.616 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -119.89 143.98 47.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.645 0.259 . . . . 4.0899999999999999 110.478 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.0 143.51 25.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.146 -0.479 . . . . 2.1499999999999999 110.984 -172.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 134' ' ' SER . 34.9 mt-10 -110.61 125.5 53.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.56 -0.904 . . . . 2.5600000000000001 108.56 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.8 m -132.22 122.45 25.25 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.464 -0.494 . . . . 1.78 110.97 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.404 ' HB3' ' HB3' ' A' ' 132' ' ' TRP . 85.8 tt0 -119.91 111.98 18.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.301 -0.629 . . . . 2.04 109.301 174.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 31.7 m -108.57 120.32 42.1 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.072 -0.513 . . . . 2.0299999999999998 109.861 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -133.37 149.26 19.61 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 119.71 -1.233 . . . . 1.0800000000000001 113.051 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 59.6 tp -122.47 130.42 53.04 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.983 -0.377 . . . . 2.9300000000000002 109.983 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 51.3 tt0 -95.44 110.89 22.87 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.109 -0.7 . . . . 3.02 109.109 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -122.85 130.08 52.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.566 -0.743 . . . . 4.7599999999999998 110.002 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.2 p -82.28 88.16 6.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.159 0.504 . . . . 1.8200000000000001 109.94 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -60.47 -50.14 74.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.61 -0.723 . . . . 3.27 111.323 -172.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -103.12 16.64 26.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.156 -0.475 . . . . 2.4100000000000001 111.18 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 72.92 -50.22 0.7 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.75 -0.659 . . . . 2.5800000000000001 111.868 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.1 p -74.21 -20.1 60.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.759 0.314 . . . . 2.6000000000000001 111.695 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -125.79 144.19 36.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.366 -0.379 . . . . 2.0600000000000001 110.82 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -105.67 121.63 44.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.036 -0.529 . . . . 1.8400000000000001 110.493 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.41 HD21 ' N ' ' A' ' 168' ' ' LEU . 3.7 mm? -102.88 126.94 50.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.825 -0.625 . . . . 2.1400000000000001 109.761 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -98.11 111.78 23.98 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.303 -0.629 . . . . 3.73 109.303 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.96 119.92 60.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.856 -0.611 . . . . 1.8100000000000001 109.384 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -114.89 131.07 56.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.323 -0.399 . . . . 2.2400000000000002 111.157 -171.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -115.19 119.94 38.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.683 -0.689 . . . . 4.8399999999999999 109.255 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -106.91 130.7 54.54 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.831 0.348 . . . . 4.4299999999999997 110.075 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 64.1 tp -99.5 119.92 38.8 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.982 -0.554 . . . . 2.8500000000000001 110.102 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -66.73 -40.05 88.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.264 -0.88 . . . . 3.3100000000000001 110.638 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -173.85 135.23 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 7.3300000000000001 109.766 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 130.13 -144.77 16.02 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.324 -0.941 . . . . 5.0599999999999996 113.319 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -138.5 128.78 25.85 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.348 -0.612 . . . . 8.0199999999999996 109.348 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -60.2 -40.26 89.43 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.75 -0.659 . . . . 9.4900000000000002 111.655 -173.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' MET . . . . . 0.537 ' O ' ' HG3' ' A' ' 184' ' ' ARG . 98.9 mmm -70.0 -40.43 75.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.466 -0.334 . . . . 11.1 111.197 -178.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -77.0 -50.0 14.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.162 -0.472 . . . . 10.470000000000001 111.72 -176.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -62.82 -39.73 95.21 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.201 0.445 . . . . 13.06 112.201 -176.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.6 m -68.33 -14.81 63.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.635 0.255 . . . . 12.890000000000001 111.488 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 180' ' ' MET . 99.7 mtt180 -70.02 -31.54 69.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.967 0.413 . . . . 15.720000000000001 110.304 177.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -101.63 117.89 35.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.048 -0.524 . . . . 13.470000000000001 110.128 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -134.05 156.79 47.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.723 0.297 . . . . 13.15 110.371 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 162.04 -166.28 36.24 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.624 -0.798 . . . . 10.050000000000001 112.096 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -60.21 -40.04 88.74 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.092 0.405 . . . . 10.699999999999999 112.092 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -90.7 -18.79 24.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.094 0.473 . . . . 11.34 110.803 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.3 m -89.96 65.24 6.54 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.108 -0.496 . . . . 6.7800000000000002 110.053 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 22.5 p -79.44 153.8 29.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.474 -0.785 . . . . 5.3600000000000003 112.107 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -129.48 154.94 46.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.647 -0.706 . . . . 7.8700000000000001 110.069 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -118.36 139.23 51.68 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.354 -0.609 . . . . 4.4000000000000004 109.354 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 85.2 mt -115.39 119.94 63.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.834 -0.432 . . . . 2.6400000000000001 109.834 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 211' ' ' THR . 93.1 mtt180 -117.82 116.19 26.48 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.9 -0.407 . . . . 4.1100000000000003 109.9 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -120.06 138.47 53.52 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.997 -0.547 . . . . 1.76 110.178 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -136.82 140.75 42.68 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.348 0.594 . . . . 6.1399999999999997 111.362 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 55.5 tp -116.69 126.82 27.2 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 114.871 -1.059 . . . . 3.0800000000000001 109.399 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.55 110.18 1.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.942 1.761 . . . . 1.98 111.078 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 60.0 tp -100.12 109.43 21.71 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.275 -0.639 . . . . 2.7599999999999998 109.275 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 78.5 m -121.34 130.07 53.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.331 0.586 . . . . 2.4199999999999999 111.487 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 55.5 tp -133.6 83.86 2.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.507 -0.923 . . . . 2.77 108.507 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.71 -117.79 9.14 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.504 -0.771 . . . . 1.6200000000000001 112.063 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -79.89 -12.68 59.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.729 0.299 . . . . 2.8599999999999999 111.357 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -99.54 117.09 33.16 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.066 -0.346 . . . . 3.23 110.066 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 28.6 t -132.57 138.14 47.35 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.724 -0.473 . . . . 2.0499999999999998 109.724 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 24.5 m -136.61 148.82 26.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.792 0.33 . . . . 1.9299999999999999 110.807 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 26.4 m -119.93 91.73 45.82 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.176 -0.465 . . . . 1.6699999999999999 110.412 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -80.74 126.8 6.05 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.891 2.394 . . . . 1.28 112.455 177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -95.27 140.07 30.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.234 -0.439 . . . . 4.8600000000000003 110.0 175.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 195' ' ' ARG . 45.7 p -118.31 130.2 55.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.882 0.372 . . . . 2.0899999999999999 110.447 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.617 HH22 ' HG3' ' A' ' 264' ' ' GLU . 17.7 ttp85 -104.67 110.03 22.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.66 -0.7 . . . . 5.29 109.704 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 30.4 pt -139.38 170.44 15.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.262 -0.426 . . . . 4.9400000000000004 110.586 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 125.29 -1.26 8.24 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.281 -0.962 . . . . 4.9800000000000004 113.473 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.0 mt -123.5 153.25 40.81 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.391 0.615 . . . . 8.4399999999999995 110.562 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -58.27 -35.43 71.77 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 114.545 -1.207 . . . . 7.9699999999999998 113.038 -166.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -59.81 -39.98 86.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.834 0.35 . . . . 11.1 110.878 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -89.12 -11.44 43.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.973 0.415 . . . . 12.24 110.798 -176.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 42.1 m -74.6 -39.98 61.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.077 -0.51 . . . . 10.220000000000001 111.301 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -80.5 147.64 30.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.148 -0.478 . . . . 11.92 111.136 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -93.64 120.87 34.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.19 -0.459 . . . . 14.460000000000001 109.898 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -75.6 152.45 37.66 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.352 -0.61 . . . . 14.529999999999999 109.352 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -101.75 -0.01 35.14 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.834 0.309 . . . . 17.07 111.834 -171.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -95.93 116.68 29.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.912 0.386 . . . . 15.779999999999999 110.623 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -74.18 152.35 39.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.94 -0.573 . . . . 15.67 110.701 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -78.35 94.8 4.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.939 -0.573 . . . . 14.5 110.082 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 48.5 mm -70.1 -39.96 77.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.258 0.551 . . . . 15.380000000000001 109.883 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -94.64 42.62 1.09 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.675 -0.693 . . . . 14.73 109.77 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -66.24 126.04 27.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.059 -0.973 . . . . 16.969999999999999 110.367 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -70.15 -39.88 75.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.953 -0.567 . . . . 12.779999999999999 110.385 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 168.36 -129.41 1.88 Allowed Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.584 -0.735 . . . . 11.369999999999999 111.845 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -100.15 9.5 42.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.833 0.349 . . . . 12.81 110.397 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -80.77 134.25 35.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.922 -0.581 . . . . 9.9900000000000002 111.357 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -130.11 129.63 43.78 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.662 -0.496 . . . . 11.32 109.662 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -84.23 -23.61 30.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.656 -0.247 . . . . 6.8799999999999999 111.42 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -75.55 -9.93 59.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.082 -0.508 . . . . 8.9399999999999995 111.795 -173.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 18.7 m -113.22 129.98 67.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.094 0.473 . . . . 2.9700000000000002 110.228 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -78.28 111.93 3.36 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.854 -0.898 . . . . 1.3999999999999999 110.854 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.556 ' O ' ' HB3' ' A' ' 254' ' ' GLU . 47.7 tp -111.68 125.43 53.96 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.631 -0.507 . . . . 2.4300000000000002 109.631 -175.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.405 ' HB3' ' HA ' ' A' ' 253' ' ' LEU . 85.9 m-85 -124.83 133.34 53.14 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.993 -0.549 . . . . 4.3300000000000001 109.776 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -98.11 131.15 44.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.972 0.415 . . . . 3.2599999999999998 110.471 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -121.12 118.45 3.8 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.726 -0.67 . . . . 1.3500000000000001 112.455 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -140.06 115.39 9.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.286 -0.635 . . . . 4.7599999999999998 109.286 174.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -120.06 130.29 54.61 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.995 -0.372 . . . . 4.29 109.995 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -139.92 129.67 24.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.034 -0.53 . . . . 7.5599999999999996 110.493 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -70.11 140.33 52.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.762 -0.653 . . . . 7.0199999999999996 110.307 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.97 39.63 19.86 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.449 0.468 . . . . 6.4800000000000004 110.984 -178.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -170.39 171.34 43.56 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.815 -0.707 . . . . 2.9199999999999999 111.74 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 86.7 mt -71.12 141.26 50.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.074 0.464 . . . . 3.5800000000000001 110.786 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 278' ' ' ASN . 68.5 m -123.89 149.97 45.21 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.846 -0.615 . . . . 2.6000000000000001 109.972 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 66.7 t -123.15 135.15 64.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.645 0.26 . . . . 2.2400000000000002 111.314 -172.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 22.7 t -136.44 152.98 51.17 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.078 -0.51 . . . . 2.0 109.877 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 240' ' ' PHE . 90.2 mt 73.23 -179.67 0.21 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.251 0.621 . . . . 3.4199999999999999 111.05 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.556 ' HB3' ' O ' ' A' ' 239' ' ' LEU . 38.2 tt0 -177.91 -86.11 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.293 0.042 . . . . 4.0800000000000001 110.991 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' TYR . . . . . 0.548 ' CD2' ' HG2' ' A' ' 254' ' ' GLU . 69.4 m-85 -120.02 135.96 54.73 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.91 -0.494 . . . . 5.1699999999999999 111.589 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -161.46 159.97 28.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.744 -0.662 . . . . 3.5800000000000001 110.248 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -113.77 139.98 48.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.923 0.392 . . . . 7.5800000000000001 110.393 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.77 -39.87 90.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.412 -0.813 . . . . 8.5399999999999991 110.935 175.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -127.48 136.13 51.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.329 -0.396 . . . . 12.720000000000001 110.423 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.418 ' NE2' ' HD3' ' A' ' 212' ' ' ARG . 97.7 mt-30 -69.74 -30.52 68.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.863 -0.608 . . . . 11.09 110.934 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.05 -39.91 87.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.86 -0.609 . . . . 11.41 110.277 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . 0.534 ' CE1' ' HB2' ' A' ' 270' ' ' PHE . 86.0 t60 -60.25 -38.48 83.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.413 -0.812 . . . . 12.49 111.32 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.53 -50.07 75.34 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.396 0.435 . . . . 12.460000000000001 111.861 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.617 ' HG3' HH22 ' A' ' 212' ' ' ARG . 41.6 mt-10 -70.09 -31.37 68.91 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.088 -0.245 . . . . 13.779999999999999 111.23 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -68.68 -65.07 2.77 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.897 -0.668 . . . . 11.300000000000001 113.001 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -160.02 140.18 11.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.736 0.268 . . . . 12.59 110.369 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 18.7 p -108.33 -9.88 15.41 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.361 0.504 . . . . 11.1 112.361 -174.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -109.97 -34.05 6.53 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.028 0.381 . . . . 12.42 112.028 -169.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -60.45 -40.12 90.02 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.401 -0.363 . . . . 11.82 110.364 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . 0.534 ' HB2' ' CE1' ' A' ' 262' ' ' HIS . 89.8 m-85 -133.68 130.0 37.59 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.127 -0.694 . . . . 9.5999999999999996 109.127 171.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -128.33 131.16 48.62 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.558 -0.534 . . . . 7.7999999999999998 109.558 -174.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -120.31 140.05 51.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.243 0.544 . . . . 6.9900000000000002 111.93 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -144.61 130.35 19.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.69 -0.686 . . . . 2.4100000000000001 109.426 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -133.3 118.71 2.18 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 119.857 -1.163 . . . . 1.6200000000000001 111.601 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 63.1 t -126.97 130.05 71.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.966 0.413 . . . . 2.4900000000000002 110.428 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -116.15 160.23 13.47 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 111.167 -0.773 . . . . 1.3 111.167 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 250' ' ' SER . 19.0 m -123.25 139.8 48.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 120.919 0.39 . . . . 2.3399999999999999 110.556 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . 0.507 ' HB2' ' HB2' ' A' ' 250' ' ' SER . 94.1 m-20 -105.39 131.8 52.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.989 -0.551 . . . . 2.7999999999999998 110.936 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -115.26 139.97 49.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.454 -0.943 . . . . 5.1900000000000004 108.454 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 15.5 t -144.2 143.03 30.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.109 0.48 . . . . 2.0499999999999998 110.751 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 59.1 t80 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 117.901 -1.047 . . . . 4.4199999999999999 109.116 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.2 mtm . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 110.789 -0.078 . . . . 11.970000000000001 110.789 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -60.07 -41.65 92.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.576 -0.898 . . . . 10.35 108.576 171.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -131.11 159.97 36.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.848 -1.069 . . . . 9.3100000000000005 108.723 170.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -109.24 140.09 43.32 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.682 0.277 . . . . 9.4399999999999995 110.26 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -95.89 102.82 14.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.084 -0.507 . . . . 7.75 110.101 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.98 120.19 40.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.904 -0.589 . . . . 3.6099999999999999 111.713 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -134.85 129.42 34.43 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.314 -1.365 . . . . 3.9100000000000001 107.314 166.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.467 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 96.4 m-70 -124.58 137.04 54.42 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.953 -0.699 . . . . 3.9399999999999999 110.898 -172.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.441 ' CE2' ' HB3' ' A' ' 281' ' ' PHE . 50.4 p90 -140.0 160.61 39.53 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.637 -0.71 . . . . 3.21 110.988 -176.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -134.12 129.85 36.52 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.777 -0.823 . . . . 2.6499999999999999 108.777 173.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.1 tt -130.1 130.05 65.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.962 -0.755 . . . . 2.0699999999999998 108.962 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.509 ' HA3' ' OD1' ' A' ' 278' ' ' ASN . . . -144.61 155.64 26.47 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 119.23 -1.462 . . . . 0.92000000000000004 113.454 -173.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -118.1 135.14 54.39 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.583 -0.525 . . . . 1.6499999999999999 109.583 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.407 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 59.7 ttm -130.27 132.16 45.8 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.936 -0.575 . . . . 2.9700000000000002 110.003 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -84.51 120.34 26.22 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.532 -0.544 . . . . 3.1499999999999999 109.532 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -83.31 132.74 35.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.434 0.635 . . . . 5.0899999999999999 111.408 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 86.3 mt -117.57 130.11 72.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.058 -0.974 . . . . 5.3300000000000001 109.988 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -63.44 134.38 55.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.006 -0.543 . . . . 8.2799999999999994 111.151 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -107.59 114.81 29.05 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.356 -0.609 . . . . 10.0 109.356 174.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.3 t -119.85 130.05 74.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.057 0.456 . . . . 11.380000000000001 109.96 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.89 -39.89 90.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.066 -0.97 . . . . 13.1 112.048 -174.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -152.46 178.68 29.5 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.509 -0.853 . . . . 12.52 112.481 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -87.67 6.69 33.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.787 0.327 . . . . 15.18 111.349 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.73 -10.07 70.55 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.918 -0.658 . . . . 12.279999999999999 113.329 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -139.95 141.2 36.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.097 0.448 . . . . 12.82 110.552 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -123.96 156.12 36.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.208 -0.451 . . . . 10.81 110.837 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 70.8 mtm -130.87 160.05 35.59 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.223 -0.658 . . . . 10.210000000000001 109.223 175.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -105.95 55.38 0.68 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.934 0.397 . . . . 8.0600000000000005 110.768 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.52 176.05 47.85 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.814 -0.708 . . . . 6.0800000000000001 112.604 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.6 tp -140.01 140.21 36.18 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.424 -0.584 . . . . 5.96 109.424 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.21 76.0 3.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.027 0.441 . . . . 3.2400000000000002 110.814 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -101.26 147.23 33.47 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.816 -0.629 . . . . 3.48 110.585 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 14' ' ' MET . 85.2 Cg_endo -79.92 134.83 10.88 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.678 2.252 . . . . 2.0299999999999998 112.832 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.3 m -113.32 142.68 45.56 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.292 -0.633 . . . . 2.2799999999999998 109.292 172.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 59.4 t -115.93 134.5 59.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.701 0.286 . . . . 2.4100000000000001 111.295 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -119.65 139.91 51.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.321 -0.399 . . . . 4.4400000000000004 110.056 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -110.59 129.87 55.7 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.567 -0.531 . . . . 3.6200000000000001 109.567 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.53 HD22 ' HD3' ' A' ' 45' ' ' ARG . 51.3 t30 -143.43 127.63 17.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.601 -0.272 . . . . 2.48 110.295 -173.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -143.31 144.18 32.0 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.52 0.563 . . . . 1.53 112.52 -175.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.421 ' HB1' ' CB ' ' A' ' 45' ' ' ARG . . . -163.09 144.53 9.78 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.363 -0.381 . . . . 1.8 111.74 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.676 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 7.5 t30 -169.13 94.15 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 3.3799999999999999 110.14 166.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.57 -81.36 0.31 Allowed Glycine 0 CA--C 1.517 0.185 0 C-N-CA 120.878 -0.677 . . . . 1.8200000000000001 111.47 -176.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 22.9 Cg_endo -61.71 175.73 1.6 Allowed 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.326 2.684 . . . . 2.1000000000000001 111.776 170.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -68.21 174.72 3.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.968 0.413 . . . . 4.0499999999999998 110.159 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.53 ' HD3' HD22 ' A' ' 38' ' ' ASN . 39.0 ttm180 -110.56 124.84 52.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.24 0.543 . . . . 3.6000000000000001 111.078 -166.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.5 mm -113.09 130.01 67.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.414 -0.812 . . . . 2.2799999999999998 110.599 -173.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.406 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -117.95 129.95 55.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.274 -0.421 . . . . 1.4399999999999999 110.064 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.1 tp -128.14 133.98 49.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.112 -0.495 . . . . 1.75 110.661 -176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.02 153.91 37.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.142 -0.481 . . . . 1.5900000000000001 110.244 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -120.11 139.97 51.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.782 0.325 . . . . 4.4400000000000004 110.684 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.59 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 71.1 t80 -99.9 129.96 46.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.088 -0.505 . . . . 5.0199999999999996 110.527 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -133.45 150.47 51.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.336 -0.847 . . . . 3.7400000000000002 109.049 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -79.78 -9.95 59.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.952 0.406 . . . . 5.0499999999999998 110.627 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -149.89 167.35 29.94 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.6 -0.6 . . . . 4.3700000000000001 111.6 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -59.91 -28.9 88.19 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.136 2.557 . . . . 7.0899999999999999 112.257 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.96 160.14 40.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.885 -0.598 . . . . 8.5700000000000003 110.193 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -129.54 152.16 49.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.116 -0.493 . . . . 10.039999999999999 110.085 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -120.25 139.96 51.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.88 0.371 . . . . 11.890000000000001 110.633 -175.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.5 m -77.57 -13.95 59.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.03 -0.532 . . . . 9.7899999999999991 111.328 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -139.23 132.81 30.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.568 -0.287 . . . . 8.7799999999999994 110.35 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.87 160.02 28.05 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.517 -0.849 . . . . 7.7300000000000004 112.416 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -61.31 -40.04 92.7 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.762 0.425 . . . . 10.300000000000001 111.623 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -60.26 -39.91 88.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 10.960000000000001 110.653 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.25 -26.79 4.83 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.626 -0.716 . . . . 5.5599999999999996 112.345 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 29.4 m -83.33 121.54 27.28 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.272 -0.269 . . . . 5.6900000000000004 110.272 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -118.53 135.01 54.64 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.505 -0.554 . . . . 6.5 109.505 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -150.26 159.95 44.06 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.212 -0.449 . . . . 4.5999999999999996 110.266 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -148.65 170.48 18.05 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.051 -0.722 . . . . 2.4500000000000002 109.051 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.59 ' HB3' ' HB3' ' A' ' 51' ' ' TYR . 29.0 ttp180 -135.0 122.16 15.06 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.648 -0.421 . . . . 3.7200000000000002 110.195 171.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.648 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 71.8 Cg_endo -81.91 146.2 14.51 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.756 2.304 . . . . 1.3200000000000001 111.47 169.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -136.57 120.08 17.05 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.699 -0.482 . . . . 2.1899999999999999 109.699 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.406 HD11 ' O ' ' A' ' 47' ' ' ALA . 40.6 tp -136.63 129.82 31.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.0 -0.545 . . . . 1.73 110.338 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -117.93 142.18 47.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.176 -0.466 . . . . 2.1800000000000002 110.216 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.8 t -113.33 120.02 62.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.558 -0.904 . . . . 2.0600000000000001 108.558 173.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.514 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 15.3 m-70 -108.27 120.13 41.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.989 -0.55 . . . . 4.1900000000000004 109.769 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -99.14 141.44 31.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.155 -0.475 . . . . 5.1600000000000001 110.434 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -100.84 132.13 46.39 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.906 -0.405 . . . . 3.3100000000000001 109.906 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -120.02 99.8 6.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.768 0.318 . . . . 4.6600000000000001 111.662 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.6 tp -70.04 -39.99 75.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.359 0.6 . . . . 4.8799999999999999 109.615 171.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -92.03 137.08 32.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.157 -0.929 . . . . 6.1900000000000004 109.096 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 82.4 m-20 -110.03 20.02 18.38 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.973 0.36 . . . . 6.0999999999999996 111.973 -169.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -67.91 -40.73 83.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.004 0.372 . . . . 5.2699999999999996 112.004 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -106.09 -49.42 3.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.996 0.427 . . . . 6.3300000000000001 110.386 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' A' ' 81' ' ' ASN . 97.0 m-85 -130.39 153.27 48.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.862 -0.608 . . . . 8.3499999999999996 109.622 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.7 p -120.03 143.49 48.06 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.096 -0.335 . . . . 2.6400000000000001 110.096 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 52.9 t80 71.97 -76.75 0.06 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.982 -0.554 . . . . 6.1900000000000004 111.794 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.13 166.94 34.79 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 118.478 -1.82 . . . . 1.54 114.853 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.1 tp -133.6 130.05 37.82 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.542 -0.91 . . . . 2.73 108.542 173.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.2 m -120.06 127.51 52.64 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.05 0.453 . . . . 1.8700000000000001 110.555 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -132.07 132.57 6.74 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.83 -0.908 . . . . 1.1699999999999999 110.83 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -141.94 156.24 25.86 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.32 -0.943 . . . . 1.4399999999999999 112.343 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -139.31 149.34 44.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.073 0.463 . . . . 4.6399999999999997 110.614 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.403 ' HB2' ' HB3' ' A' ' 112' ' ' ARG . 99.7 mtt180 -131.57 129.85 41.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.447 -0.797 . . . . 3.2200000000000002 109.449 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.648 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 8.5 t30 -115.29 117.58 30.86 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.4 -0.592 . . . . 2.2200000000000002 109.4 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -111.76 120.3 41.55 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.607 0.241 . . . . 3.6400000000000001 110.529 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.83 -170.76 32.36 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.727 -0.749 . . . . 2.79 112.006 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -125.05 139.98 53.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.584 0.707 . . . . 7.8499999999999996 112.456 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.441 ' HB2' ' CB ' ' A' ' 109' ' ' ASN . 32.5 t60 -126.54 138.0 53.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.444 -1.253 . . . . 7.6900000000000004 108.108 173.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 63.6 t80 65.29 80.31 0.23 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.451 0.643 . . . . 10.289999999999999 109.412 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.31 129.95 74.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.558 -0.746 . . . . 10.19 110.764 -171.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -68.13 -40.02 82.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.855 -0.611 . . . . 12.220000000000001 111.144 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -70.74 128.55 90.77 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.02 -0.536 . . . . 10.48 110.549 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.31 130.12 24.55 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.414 2.076 . . . . 9.6799999999999997 111.441 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.3 148.34 19.61 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.668 -0.777 . . . . 6.5099999999999998 111.951 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -67.08 -40.08 86.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.849 0.357 . . . . 8.1099999999999994 110.998 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -120.11 133.99 55.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.363 0.601 . . . . 4.1399999999999997 111.56 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.3 p -132.42 139.9 48.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.406 -0.815 . . . . 3.77 109.427 171.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.87 130.81 5.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.231 -0.285 . . . . 2.2000000000000002 110.231 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.441 ' CB ' ' HB2' ' A' ' 98' ' ' HIS . 5.2 t30 -139.77 108.12 5.82 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.703 -0.48 . . . . 3.1200000000000001 109.703 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 89.7 mtp -116.98 128.1 54.85 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.243 -0.435 . . . . 2.1200000000000001 109.917 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -110.22 133.52 53.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.03 0.443 . . . . 2.4900000000000002 111.127 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 35.2 ttt180 -109.89 117.84 34.89 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.329 -0.619 . . . . 4.4699999999999998 109.329 172.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -113.6 136.32 52.95 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.503 -0.555 . . . . 2.9199999999999999 109.503 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -139.12 128.85 24.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.208 -0.451 . . . . 2.5099999999999998 110.817 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 87.0 mt -120.01 121.01 64.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.952 -0.759 . . . . 2.1299999999999999 108.952 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -137.59 105.3 8.36 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.381 -0.372 . . . . 1.6799999999999999 111.051 -175.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 74.2 Cg_endo -79.64 139.99 14.56 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.075 1.85 . . . . 1.54 110.614 173.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -95.57 136.6 35.75 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.773 -1.195 . . . . 2.3500000000000001 107.773 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -124.51 127.97 48.26 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.118 0.485 . . . . 5.1500000000000004 111.349 -176.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -131.92 120.22 22.22 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.797 -0.816 . . . . 3.04 108.797 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.4 t -132.85 115.83 25.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.438 -0.346 . . . . 4.7400000000000002 110.329 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -107.76 86.45 2.3 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.268 0.556 . . . . 6.3600000000000003 110.513 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.04 -39.95 90.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.437 -0.801 . . . . 4.96 109.696 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.558 ' OG1' ' HB2' ' A' ' 127' ' ' LEU . 24.4 p -129.87 164.01 25.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.218 -0.901 . . . . 4.0700000000000003 109.77 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -73.44 -47.1 44.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.722 0.296 . . . . 5.1699999999999999 111.17 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -70.07 -40.08 75.27 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.133 -0.485 . . . . 3.71 112.027 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.558 ' HB2' ' OG1' ' A' ' 124' ' ' THR . 6.1 mp -102.11 118.45 36.93 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.71 -0.478 . . . . 2.4500000000000002 109.71 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.413 ' HB2' ' HB2' ' A' ' 159' ' ' GLN . 90.6 mtt180 -122.94 134.88 54.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.005 -0.543 . . . . 4.6799999999999997 109.812 -174.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.41 ' CE1' HD12 ' A' ' 158' ' ' LEU . 97.1 m-85 -109.22 129.07 55.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.76 0.314 . . . . 4.3600000000000003 110.519 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -146.32 120.93 9.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.423 -0.584 . . . . 2.5899999999999999 109.423 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -157.13 172.18 34.6 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.565 -0.826 . . . . 1.25 112.047 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.461 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 9.2 p90 -140.23 140.91 35.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.134 0.492 . . . . 5.0899999999999999 111.158 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 66.5 mt -109.41 133.75 52.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.023 -0.732 . . . . 2.7599999999999998 109.023 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 73.9 m -129.9 135.5 48.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.283 0.563 . . . . 1.99 112.14 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 68.6 mtt -119.98 136.76 54.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.443 -0.799 . . . . 2.7799999999999998 108.872 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.505 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 96.1 m-85 -120.05 134.36 55.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.002 0.43 . . . . 3.6800000000000002 111.635 -176.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 98.4 mttt -128.18 138.82 52.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.56 -0.745 . . . . 2.1699999999999999 109.37 173.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.44 ' O ' HD21 ' A' ' 142' ' ' LEU . 96.1 m-85 -129.91 150.76 51.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.687 0.279 . . . . 4.0099999999999998 111.09 -176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 58.99 -165.03 0.19 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.669 -0.696 . . . . 1.79 111.306 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -76.95 -32.81 57.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.29 0.567 . . . . 3.04 110.254 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -60.01 -46.78 88.38 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.046 -0.979 . . . . 2.4100000000000001 113.176 -168.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.44 HD21 ' O ' ' A' ' 138' ' ' PHE . 4.1 mm? -69.92 -29.21 66.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.141 0.496 . . . . 2.3599999999999999 110.545 -177.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -69.76 -40.02 76.37 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.905 -0.589 . . . . 2.52 109.896 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.4 m -63.85 -40.12 95.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.098 -0.955 . . . . 2.52 111.233 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.4 p -75.7 -23.63 56.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.821 0.343 . . . . 2.0099999999999998 111.615 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 60.43 -120.98 25.12 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.757 -0.656 . . . . 1.52 113.327 174.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -69.94 -30.6 68.03 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.4 0.28 . . . . 6.2199999999999998 111.727 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.7 -49.95 75.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 2.0499999999999998 112.054 -174.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -122.93 113.3 18.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.951 0.405 . . . . 2.6400000000000001 110.924 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.9 t -160.01 150.29 18.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.018 -0.734 . . . . 2.6000000000000001 109.018 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.505 ' HB2' ' HB2' ' A' ' 136' ' ' TYR . 98.5 mtt180 -83.7 137.28 33.84 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.075 -0.343 . . . . 4.0899999999999999 110.075 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.6 119.95 60.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.337 -0.392 . . . . 2.1499999999999999 110.493 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -124.29 129.88 51.53 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.731 -0.84 . . . . 2.5600000000000001 108.731 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 50.8 m -136.71 130.17 31.68 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.623 -0.262 . . . . 1.78 111.409 -174.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.461 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 82.4 tt0 -130.76 121.48 25.49 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.125 0.488 . . . . 2.04 109.818 175.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 40.7 p -119.33 139.17 52.38 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.596 -0.729 . . . . 2.0299999999999998 109.993 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -130.05 141.85 13.07 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.243 -0.98 . . . . 1.0800000000000001 113.349 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.41 HD12 ' CE1' ' A' ' 129' ' ' PHE . 63.7 tp -122.21 128.58 51.36 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.733 -0.469 . . . . 2.9300000000000002 109.733 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 168' ' ' LEU . 95.6 mt-30 -100.01 126.78 46.25 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.327 -0.62 . . . . 3.02 109.327 173.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -126.06 128.81 47.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.388 -0.369 . . . . 4.7599999999999998 110.38 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 2.4 p -85.3 88.59 7.51 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.348 0.594 . . . . 1.8200000000000001 111.071 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -60.07 -49.94 75.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.579 -0.737 . . . . 3.27 111.618 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.488 ' HB2' HG21 ' A' ' 166' ' ' VAL . 92.7 m-20 -102.61 14.55 31.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.535 -0.302 . . . . 2.4100000000000001 110.851 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 72.98 -49.03 0.7 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.893 0.746 . . . . 2.5800000000000001 110.487 -176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 27.2 m -72.86 -33.17 65.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.176 -0.465 . . . . 2.6000000000000001 111.037 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.488 HG21 ' HB2' ' A' ' 163' ' ' ASN . 13.7 m -108.75 138.63 34.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.861 0.362 . . . . 2.0600000000000001 110.914 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -109.21 137.21 47.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.085 -0.507 . . . . 1.8400000000000001 110.608 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 159' ' ' GLN . 16.2 mt -103.22 129.96 50.31 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.698 -0.482 . . . . 2.1400000000000001 109.698 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -94.11 105.43 17.43 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.529 -0.545 . . . . 3.73 109.529 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.3 t -119.31 121.99 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.858 -0.423 . . . . 1.8100000000000001 109.858 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.569 ' OD1' ' HB2' ' A' ' 195' ' ' ARG . 30.4 p30 -132.3 156.65 46.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.349 0.595 . . . . 2.2400000000000002 112.086 -177.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.541 ' CE1' ' HB3' ' A' ' 193' ' ' GLU . 67.8 t80 -124.3 131.42 53.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.992 -1.003 . . . . 4.8399999999999999 109.586 177.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -113.2 135.01 54.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.154 0.502 . . . . 4.4299999999999997 110.42 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.7 tp -100.01 116.6 32.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.734 -0.666 . . . . 2.8500000000000001 109.608 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.498 ' OE2' ' HD2' ' A' ' 176' ' ' ARG . 31.7 tt0 -70.02 -40.76 75.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.962 -0.563 . . . . 3.3100000000000001 111.307 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.498 ' HD2' ' OE2' ' A' ' 175' ' ' GLU . 8.8 ptm180 -159.98 162.35 34.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.569 -0.741 . . . . 7.3300000000000001 110.525 -169.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.479 ' HA3' ' NH1' ' A' ' 184' ' ' ARG . . . 106.71 -158.85 15.09 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.616 -0.802 . . . . 5.0599999999999996 112.429 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -129.12 151.92 49.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.814 0.34 . . . . 8.0199999999999996 110.507 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -84.26 0.83 47.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.63 -0.714 . . . . 9.4900000000000002 110.126 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 56.1 ttm -60.08 -39.95 87.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.235 -0.893 . . . . 11.1 110.089 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -104.96 114.46 28.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.565 -0.743 . . . . 10.470000000000001 109.497 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -60.11 -39.95 88.02 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.862 -0.608 . . . . 13.06 111.343 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 51.2 m -139.72 149.98 44.27 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.968 -0.56 . . . . 12.890000000000001 109.51 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.479 ' NH1' ' HA3' ' A' ' 177' ' ' GLY . 22.8 mtm180 -123.19 133.46 54.23 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.824 0.345 . . . . 15.720000000000001 110.745 -175.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -78.76 -22.89 45.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.658 -0.701 . . . . 13.470000000000001 110.568 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -62.37 -40.01 95.03 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.927 -0.579 . . . . 13.15 111.743 -176.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -106.23 142.6 15.64 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.48 -0.867 . . . . 10.050000000000001 112.776 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -79.29 130.08 35.1 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.667 -0.494 . . . . 10.699999999999999 109.667 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -72.14 129.81 39.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.316 -0.402 . . . . 11.34 110.49 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 46.5 p -124.54 150.2 46.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.175 -0.466 . . . . 6.7800000000000002 111.054 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 70.6 p -69.97 -19.97 63.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.843 -0.617 . . . . 5.3600000000000003 110.808 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -66.22 -24.23 66.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.802 -0.635 . . . . 7.8700000000000001 110.945 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.541 ' HB3' ' CE1' ' A' ' 172' ' ' TYR . 36.0 mt-10 -70.01 -18.93 63.33 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.463 -0.789 . . . . 4.4000000000000004 110.777 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 48.5 mm -105.76 127.89 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.616 -0.72 . . . . 2.6400000000000001 110.646 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.569 ' HB2' ' OD1' ' A' ' 171' ' ' ASN . 25.2 mtm180 -110.87 129.32 55.9 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.549 -0.537 . . . . 4.1100000000000003 109.549 174.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -118.4 134.49 55.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.085 -0.507 . . . . 1.76 110.924 -177.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -133.59 143.32 48.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.626 -0.715 . . . . 6.1399999999999997 109.56 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.616 ' O ' ' HA ' ' A' ' 208' ' ' THR . 42.3 tp -119.92 124.22 28.01 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.178 -0.675 . . . . 3.0800000000000001 109.178 171.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -93.28 105.41 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.905 1.737 . . . . 1.98 112.449 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.8 tp -96.11 121.89 38.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.043 -0.526 . . . . 2.7599999999999998 109.648 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 89.6 m -99.9 118.85 37.2 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.275 0.559 . . . . 2.4199999999999999 110.845 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 94.4 mt -125.7 81.07 1.95 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.191 -1.04 . . . . 2.77 108.191 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 74.35 -126.87 9.55 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.705 -0.958 . . . . 1.6200000000000001 110.705 -172.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -95.08 -0.11 53.87 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.304 0.573 . . . . 2.8599999999999999 109.531 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -99.34 119.18 37.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.518 -0.764 . . . . 3.23 109.554 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 32.1 t -112.49 139.93 47.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.935 0.398 . . . . 2.0499999999999998 110.525 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.92 123.12 70.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.658 -0.867 . . . . 1.9299999999999999 108.658 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 198' ' ' LEU . 42.6 m -126.86 93.02 43.18 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-O 120.788 0.327 . . . . 1.6699999999999999 110.721 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 29.0 Cg_endo -69.82 149.87 67.1 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.841 1.694 . . . . 1.28 111.378 175.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -126.0 138.05 53.71 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.729 -0.669 . . . . 4.8600000000000003 109.987 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 59.2 p -130.01 143.57 50.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.204 -0.453 . . . . 2.0899999999999999 110.012 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -95.16 -15.35 23.38 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.939 -0.573 . . . . 5.29 109.922 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.0 mt -70.41 -39.99 77.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.73 -0.668 . . . . 4.9400000000000004 110.087 170.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 97.71 -10.09 64.41 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.903 -0.665 . . . . 4.9800000000000004 113.447 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.6 tp -139.93 129.92 24.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.081 0.44 . . . . 8.4399999999999995 111.268 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -80.44 132.55 35.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.96 -0.564 . . . . 7.9699999999999998 110.024 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.05 -39.94 75.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.129 0.49 . . . . 11.1 110.035 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -105.38 133.6 49.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 12.24 109.96 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 23.3 t -97.73 135.96 38.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.528 -0.305 . . . . 10.220000000000001 110.207 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -101.76 130.0 48.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.008 0.432 . . . . 11.92 110.7 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -114.32 149.2 36.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.533 -0.758 . . . . 14.460000000000001 109.907 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.98 -19.9 63.33 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.151 -0.477 . . . . 14.529999999999999 110.396 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -66.29 -27.52 67.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.349 -0.841 . . . . 17.07 110.312 174.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -77.05 110.9 12.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.229 -0.442 . . . . 15.779999999999999 111.138 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -76.58 138.83 40.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.026 -0.534 . . . . 15.67 110.184 174.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -91.98 156.31 17.52 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.724 -0.473 . . . . 14.5 109.724 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 87.9 mt -119.96 126.56 75.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.27 -0.423 . . . . 15.380000000000001 110.017 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.11 -40.0 88.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.599 -0.728 . . . . 14.73 111.01 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -64.26 -39.96 95.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.698 -0.683 . . . . 16.969999999999999 110.909 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -70.73 136.19 48.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.737 -0.665 . . . . 12.779999999999999 111.292 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -117.73 150.68 18.26 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.553 -0.619 . . . . 11.369999999999999 111.553 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -119.79 134.52 55.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.846 0.355 . . . . 12.81 110.355 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -96.0 114.98 26.74 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.928 -0.578 . . . . 9.9900000000000002 110.423 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.447 ' HB3' ' HB ' ' A' ' 237' ' ' VAL . 96.4 m-85 -100.01 109.99 22.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.013 -0.54 . . . . 11.32 110.374 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -99.87 117.68 34.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.019 -0.537 . . . . 6.8799999999999999 110.299 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.48 ' HA ' ' CE1' ' A' ' 257' ' ' PHE . 66.5 mtt180 52.19 39.17 26.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.793 -0.64 . . . . 8.9399999999999995 112.077 -177.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 234' ' ' PHE . 62.6 t -119.79 124.21 72.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.958 -0.565 . . . . 2.9700000000000002 109.768 176.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -85.47 138.85 16.83 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.327 -0.939 . . . . 1.3999999999999999 110.987 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.44 ' HB2' ' HB3' ' A' ' 255' ' ' TYR . 92.6 mt -119.69 129.48 54.56 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.494 -0.482 . . . . 2.4300000000000002 110.013 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.431 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 65.2 t80 -107.37 131.19 54.52 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.361 -0.607 . . . . 4.3300000000000001 109.361 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -120.0 140.12 51.46 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.824 -0.435 . . . . 3.2599999999999998 109.824 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -125.91 128.28 6.41 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.247 -0.978 . . . . 1.3500000000000001 112.48 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -111.39 117.0 31.89 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.507 -0.553 . . . . 4.7599999999999998 109.507 173.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.47 133.87 55.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.781 0.324 . . . . 4.29 110.307 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -119.93 139.92 51.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.337 -0.392 . . . . 7.5599999999999996 110.384 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -64.86 -13.24 55.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.757 -0.656 . . . . 7.0199999999999996 110.561 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -69.98 -10.93 60.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.712 -0.676 . . . . 6.4800000000000004 110.567 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 104.7 -2.54 42.06 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.696 -0.764 . . . . 2.9199999999999999 112.259 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 61.8 tp -95.18 120.02 34.68 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.015 -0.365 . . . . 3.5800000000000001 110.015 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 8.6 t -121.6 129.94 53.17 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.437 -0.579 . . . . 2.6000000000000001 109.437 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.6 t -124.37 132.54 71.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.026 0.441 . . . . 2.2400000000000002 110.882 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 51.9 m -110.23 129.06 55.79 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.876 -0.602 . . . . 2.0 109.865 178.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 75.0 mt -120.0 130.34 54.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.312 -0.403 . . . . 3.4199999999999999 111.027 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -101.84 124.85 48.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.438 -0.347 . . . . 4.0800000000000001 110.073 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' TYR . . . . . 0.44 ' HB3' ' HB2' ' A' ' 239' ' ' LEU . 61.2 t80 -104.33 129.97 52.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.547 . . . . 5.1699999999999999 109.588 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -100.35 127.35 46.68 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.371 -0.377 . . . . 3.5800000000000001 111.458 -176.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . 0.48 ' CE1' ' HA ' ' A' ' 236' ' ' ARG . 51.6 p90 -70.07 -23.58 63.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.01 -0.541 . . . . 7.5800000000000001 109.633 175.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -60.62 -33.93 73.5 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 115.788 -0.642 . . . . 8.5399999999999991 110.753 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 61.0 t90 -69.52 -25.49 64.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.705 -0.68 . . . . 12.720000000000001 111.105 -178.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -68.18 116.31 8.63 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.346 -0.388 . . . . 11.09 111.335 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -85.43 130.01 34.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.208 0.528 . . . . 11.41 109.873 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -70.06 -39.94 75.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.53 -0.759 . . . . 12.49 112.827 -176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -97.43 -176.98 3.66 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.934 -0.307 . . . . 12.460000000000001 111.267 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -60.06 -39.91 87.65 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.0 0.37 . . . . 13.779999999999999 112.0 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -73.75 80.16 0.81 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.994 -0.622 . . . . 11.300000000000001 113.096 -173.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -78.91 159.77 27.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.017 0.437 . . . . 12.59 110.987 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 12.1 p -119.98 137.71 53.91 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.56 0.695 . . . . 11.1 111.448 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -70.1 -39.93 75.23 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 114.942 -1.026 . . . . 12.42 111.695 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.87 139.58 58.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.218 -0.446 . . . . 11.82 110.796 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -99.01 117.1 32.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.177 -0.465 . . . . 9.5999999999999996 111.232 -174.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -59.93 -40.08 87.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.594 -0.73 . . . . 7.7999999999999998 111.046 173.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -145.33 137.45 25.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.905 -0.589 . . . . 6.9900000000000002 110.276 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -139.93 131.47 27.09 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.144 -0.48 . . . . 2.4100000000000001 109.833 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.1 116.64 1.99 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.897 -1.144 . . . . 1.6200000000000001 111.895 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 62.6 t -129.92 130.0 66.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.638 0.256 . . . . 2.4900000000000002 110.826 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.09 126.97 5.41 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.807 -0.917 . . . . 1.3 110.807 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.6 t -118.19 120.05 63.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 117.099 0.449 . . . . 2.3399999999999999 110.954 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . 0.509 ' OD1' ' HA3' ' A' ' 12' ' ' GLY . 96.3 m-20 -119.3 129.98 55.16 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.579 -0.526 . . . . 2.7999999999999998 109.579 176.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -112.08 116.44 30.52 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.193 -0.669 . . . . 5.1900000000000004 109.193 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 15.3 t -121.71 130.3 53.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.101 -0.499 . . . . 2.0499999999999998 110.382 -176.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 65.1 t80 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.245 -0.883 . . . . 4.4199999999999999 108.939 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.8 mtm . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 121.664 0.745 . . . . 11.970000000000001 109.378 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -80.09 -9.57 59.71 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.944 -1.025 . . . . 10.35 111.217 -166.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -80.19 -9.97 59.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.255 -0.43 . . . . 9.3100000000000005 111.197 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 60.5 mtp85 -89.54 141.17 28.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.602 0.593 . . . . 9.4399999999999995 112.602 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -107.43 73.22 0.91 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.432 -0.804 . . . . 7.75 109.363 170.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -60.27 -39.62 87.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 3.6099999999999999 110.698 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -77.56 121.57 24.08 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.598 -0.89 . . . . 3.9100000000000001 108.598 171.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.536 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 32.7 m170 -98.38 131.63 44.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.218 0.532 . . . . 3.9399999999999999 111.246 -174.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -139.65 159.91 41.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.642 -0.708 . . . . 3.21 110.644 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 41.9 t30 -145.88 129.7 17.22 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.48 -0.563 . . . . 2.6499999999999999 109.48 172.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.4 mt -120.56 122.53 68.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.326 -0.62 . . . . 2.0699999999999998 109.326 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -130.15 137.3 9.42 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 119.85 -1.167 . . . . 0.92000000000000004 112.827 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.57 136.29 54.84 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.789 -0.449 . . . . 1.6499999999999999 109.789 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 57.5 ttm -143.44 150.65 39.32 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.746 -0.464 . . . . 2.9700000000000002 109.746 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -106.69 119.99 40.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.115 -0.328 . . . . 3.1499999999999999 110.115 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -112.06 143.48 43.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.436 -0.347 . . . . 5.0899999999999999 110.209 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.7 pt -118.26 132.11 69.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.291 0.567 . . . . 5.3300000000000001 111.243 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -100.36 -0.57 38.05 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.692 -0.855 . . . . 8.2799999999999994 108.692 172.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -73.66 129.79 38.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.983 -1.008 . . . . 10.0 110.947 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.9 p -139.99 145.84 25.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.513 -0.767 . . . . 11.380000000000001 109.382 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 64.81 39.86 5.89 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.659 0.6 . . . . 13.1 111.079 -176.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.56 -12.99 83.36 Favored Glycine 0 C--O 1.225 -0.409 0 CA-C-N 115.324 -0.853 . . . . 12.52 112.209 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -70.22 -30.12 67.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.903 0.382 . . . . 15.18 110.472 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.46 -43.78 76.26 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.144 -0.55 . . . . 12.279999999999999 113.089 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 27' ' ' MET . 41.4 tt0 -128.32 138.56 52.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.749 0.309 . . . . 12.82 110.261 -177.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -63.19 -16.38 59.94 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.695 -0.684 . . . . 10.81 112.397 -172.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.404 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 95.4 mmm -75.54 65.1 1.72 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.875 0.369 . . . . 10.210000000000001 111.349 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.65 140.19 58.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.017 -0.538 . . . . 8.0600000000000005 110.533 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.34 142.03 20.96 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.776 -0.726 . . . . 6.0800000000000001 112.226 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.5 tp -70.07 139.96 52.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.613 0.244 . . . . 5.96 110.364 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.64 131.22 37.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.661 0.267 . . . . 3.2400000000000002 110.532 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.52 125.03 61.01 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.711 -0.477 . . . . 3.48 109.711 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -64.59 134.32 40.63 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.551 2.168 . . . . 2.0299999999999998 112.383 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 m -121.35 142.97 49.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.047 -0.524 . . . . 2.2799999999999998 109.706 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.0 p -135.39 141.87 41.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.065 0.46 . . . . 2.4100000000000001 110.943 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -137.85 147.61 44.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.979 -0.555 . . . . 4.4400000000000004 110.694 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -119.91 140.08 51.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.965 -0.562 . . . . 3.6200000000000001 111.238 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 10' ' ' ASN . 28.6 m-80 -121.52 140.44 52.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.723 -0.671 . . . . 2.48 110.095 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -137.87 140.93 40.69 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.987 -0.285 . . . . 1.53 110.394 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.54 122.04 2.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.124 -0.489 . . . . 1.8 110.669 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.681 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 43.4 t30 -149.95 92.12 1.86 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.23 -0.656 . . . . 3.3799999999999999 109.23 171.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.86 -78.96 0.28 Allowed Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.093 -0.803 . . . . 1.8200000000000001 111.093 -174.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.681 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 24.9 Cg_endo -61.96 175.57 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.526 2.817 . . . . 2.1000000000000001 112.94 171.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.451 ' HB3' ' O ' ' A' ' 75' ' ' HIS . 8.4 m-90 -69.41 -172.99 0.51 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.518 -0.765 . . . . 4.0499999999999998 111.15 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -106.64 122.34 46.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.779 0.8 . . . . 3.6000000000000001 111.237 -167.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 87.5 mt -111.81 136.09 49.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.417 -1.265 . . . . 2.2799999999999998 109.895 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . . . -117.22 132.48 56.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.087 -0.506 . . . . 1.4399999999999999 109.877 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.5 tp -119.49 131.7 55.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.059 -0.519 . . . . 1.75 110.489 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.54 163.64 39.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.763 -0.653 . . . . 1.5900000000000001 109.537 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -157.05 150.6 24.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.644 0.259 . . . . 4.4400000000000004 110.396 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -130.04 150.02 51.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.911 -0.586 . . . . 5.0199999999999996 110.603 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -125.31 124.38 41.48 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.472 -0.785 . . . . 3.7400000000000002 109.301 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.83 -40.84 75.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.727 -0.67 . . . . 5.0499999999999998 111.073 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 47.15 59.91 5.41 Favored Glycine 0 CA--C 1.52 0.382 0 O-C-N 123.596 0.56 . . . . 4.3700000000000001 112.832 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.14 141.58 94.16 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.387 2.058 . . . . 7.0899999999999999 112.39 -174.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.99 119.96 61.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.033 -0.53 . . . . 8.5700000000000003 110.283 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.408 ' OD2' ' HD3' ' A' ' 62' ' ' LYS . 17.0 m-20 -79.2 159.49 27.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.136 -0.484 . . . . 10.039999999999999 110.155 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -65.99 -40.16 90.96 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.033 0.444 . . . . 11.890000000000001 110.356 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.6 m -81.44 139.18 35.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.825 -0.625 . . . . 9.7899999999999991 110.452 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.7 149.44 21.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.262 -0.427 . . . . 8.7799999999999994 110.924 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.4 10.73 37.93 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.748 -0.739 . . . . 7.7300000000000004 112.061 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.408 ' HD3' ' OD2' ' A' ' 57' ' ' ASP . 63.0 tttp -108.27 120.0 41.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.774 0.321 . . . . 10.300000000000001 110.513 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -70.03 -40.19 75.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.129 -0.487 . . . . 10.960000000000001 110.244 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.97 -147.84 50.78 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.292 -0.867 . . . . 5.5599999999999996 112.728 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.5 p -131.4 141.98 49.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.728 0.299 . . . . 5.6900000000000004 110.564 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -99.79 130.52 46.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.963 0.411 . . . . 6.5 110.85 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -120.02 140.02 51.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.839 -0.619 . . . . 4.5999999999999996 110.342 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -134.8 160.05 39.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.574 -0.739 . . . . 2.4500000000000002 109.861 -174.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 17.1 ptp180 -148.48 125.09 5.39 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.871 0.367 . . . . 3.7200000000000002 110.626 171.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.423 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 89.3 Cg_endo -93.02 153.77 2.65 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.941 2.428 . . . . 1.3200000000000001 112.313 171.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.474 ' HG2' ' HG2' ' A' ' 93' ' ' ARG . 43.8 mt-10 -118.91 125.51 49.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.295 -0.411 . . . . 2.1899999999999999 110.123 175.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.407 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 64.0 tp -122.12 112.59 18.4 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.019 -0.537 . . . . 1.73 109.981 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 47' ' ' ALA . 80.0 mt-10 -108.5 132.72 53.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.003 0.43 . . . . 2.1800000000000002 111.28 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.42 124.59 72.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.894 -0.78 . . . . 2.0600000000000001 108.894 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.451 ' O ' ' HB3' ' A' ' 44' ' ' TRP . 28.1 m-70 -106.32 119.1 38.36 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.84 -0.43 . . . . 4.1900000000000004 109.84 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.486 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 79.4 t80 -100.45 122.53 43.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.769 -0.65 . . . . 5.1600000000000001 110.35 -176.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -109.21 128.68 55.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.592 -0.731 . . . . 3.3100000000000001 109.693 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -143.37 129.95 20.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.069 -0.252 . . . . 4.6600000000000001 111.224 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.1 mt 60.12 42.21 15.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.606 -0.724 . . . . 4.8799999999999999 111.703 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -67.17 -37.76 84.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.132 0.491 . . . . 6.1900000000000004 110.815 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -87.31 0.1 55.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.77 -0.65 . . . . 6.0999999999999996 110.925 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -107.02 169.26 8.66 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.101 -0.5 . . . . 5.2699999999999996 110.913 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -60.3 -43.73 96.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.794 0.331 . . . . 6.3300000000000001 111.671 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -95.79 117.54 30.74 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.417 -0.356 . . . . 8.3499999999999996 110.402 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.6 p -99.86 123.95 44.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.345 -0.389 . . . . 2.6400000000000001 110.747 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -123.06 148.33 45.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.056 -0.52 . . . . 6.1900000000000004 110.292 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.94 163.8 28.28 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.548 -0.834 . . . . 1.54 111.959 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 65.1 tp -145.61 128.6 16.5 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.472 -0.566 . . . . 2.73 109.472 174.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 p -118.31 128.53 54.75 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.308 0.575 . . . . 1.8700000000000001 110.9 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.84 132.63 8.48 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.571 -0.823 . . . . 1.1699999999999999 111.319 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -128.14 127.42 5.71 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 111.497 -0.641 . . . . 1.4399999999999999 111.497 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -111.09 130.28 55.66 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.888 0.375 . . . . 4.6399999999999997 110.483 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.474 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 91.0 mtt180 -122.95 126.88 48.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.615 -0.72 . . . . 3.2200000000000002 109.12 175.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 64.9 t30 -107.33 129.94 54.84 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.337 -0.616 . . . . 2.2200000000000002 109.337 -178.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.43 ' HB3' ' HB3' ' A' ' 110' ' ' MET . 54.5 t80 -137.05 146.05 44.74 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.416 -0.514 . . . . 3.6400000000000001 110.576 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.81 169.66 36.85 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.622 -0.799 . . . . 2.79 112.495 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -145.86 157.26 43.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.28 0.562 . . . . 7.8499999999999996 111.656 -177.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -142.57 153.79 43.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.961 -1.018 . . . . 7.6900000000000004 108.69 171.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -134.06 100.02 4.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.861 0.362 . . . . 10.289999999999999 111.043 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 98.1 t -70.49 -39.85 76.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.216 0.532 . . . . 10.19 109.902 175.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -60.09 -40.24 88.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.156 -0.929 . . . . 12.220000000000001 111.641 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -145.86 85.17 7.8 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.772 -0.455 . . . . 10.48 109.772 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.97 139.68 89.06 Favored 'Trans proline' 0 C--N 1.339 0.072 0 C-N-CA 122.89 2.394 . . . . 9.6799999999999997 112.498 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -104.19 179.06 24.78 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.735 -0.745 . . . . 6.5099999999999998 112.08 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -60.06 -42.2 94.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.166 0.508 . . . . 8.1099999999999994 110.334 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -122.46 160.26 25.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.52 -0.764 . . . . 4.1399999999999997 110.471 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.1 m -147.79 140.31 24.56 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.696 -0.684 . . . . 3.77 109.591 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.39 116.38 7.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.667 -0.242 . . . . 2.2000000000000002 110.589 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -117.67 130.54 56.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.443 -0.344 . . . . 3.1200000000000001 110.085 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.496 ' HG3' ' H ' ' A' ' 139' ' ' ALA . 46.3 ttm -132.56 122.34 24.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.831 0.348 . . . . 2.1200000000000001 111.624 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.497 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 56.7 mt-30 -103.54 118.71 37.35 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.036 -0.727 . . . . 2.4900000000000002 109.036 170.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 31.4 ttm180 -113.77 120.73 41.8 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.124 0.488 . . . . 4.4699999999999998 110.168 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -119.14 139.62 51.5 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.728 -0.669 . . . . 2.9199999999999999 110.409 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 135' ' ' MET . 82.0 tttt -128.84 123.68 33.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.717 -0.674 . . . . 2.5099999999999998 109.559 172.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.9 mm -124.21 128.15 73.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.016 -0.538 . . . . 2.1299999999999999 109.698 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -142.71 106.47 5.42 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 120.681 0.277 . . . . 1.6799999999999999 111.493 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 65.2 Cg_endo -76.8 132.53 13.16 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.977 1.784 . . . . 1.54 110.467 172.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -92.38 137.31 32.47 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.538 -0.541 . . . . 2.3500000000000001 109.538 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -128.44 129.99 46.94 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.862 -0.422 . . . . 5.1500000000000004 109.862 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -137.49 119.76 15.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.843 0.354 . . . . 3.04 110.481 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.9 t -129.56 128.28 65.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.732 -0.667 . . . . 4.7400000000000002 109.659 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -114.99 96.86 5.91 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.789 -0.448 . . . . 6.3600000000000003 109.789 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.99 -33.24 71.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.557 0.694 . . . . 4.96 109.683 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 8.6 m -140.35 159.88 41.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.18 -0.918 . . . . 4.0700000000000003 108.75 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -60.14 -41.99 93.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.503 0.668 . . . . 5.1699999999999999 109.361 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -69.92 -40.03 75.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.763 -1.108 . . . . 3.71 111.946 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.9 mt -104.94 119.43 39.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 2.4500000000000002 110.814 -172.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.453 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 79.4 ttt180 -125.71 133.31 52.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.119 -0.491 . . . . 4.6799999999999997 111.453 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -108.98 119.99 41.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 4.3600000000000003 109.332 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -143.81 135.79 26.5 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.802 -0.444 . . . . 2.5899999999999999 109.802 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -171.8 172.13 44.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.445 -0.883 . . . . 1.25 111.689 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -143.0 150.57 39.82 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.991 0.424 . . . . 5.0899999999999999 110.691 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.605 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 47.8 tp -106.0 111.61 24.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.933 -0.576 . . . . 2.7599999999999998 109.511 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.5 t -101.56 121.1 41.37 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.864 0.364 . . . . 1.99 110.631 -173.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.413 ' O ' ' HA ' ' A' ' 114' ' ' LYS . 74.8 mtm -111.83 133.24 54.17 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.345 -0.389 . . . . 2.7799999999999998 110.08 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -118.98 134.88 54.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.95 0.405 . . . . 3.6800000000000002 111.411 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 97.3 mttt -138.55 148.35 44.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.078 -0.712 . . . . 2.1699999999999999 109.078 174.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 54.8 p90 -150.83 160.02 44.15 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.974 -0.38 . . . . 4.0099999999999998 109.974 175.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.496 ' H ' ' HG3' ' A' ' 110' ' ' MET . . . 72.16 -178.69 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.876 0.735 . . . . 1.79 110.334 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -76.82 -39.67 50.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.963 0.411 . . . . 3.04 111.279 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.0 -49.61 77.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.715 -0.675 . . . . 2.4100000000000001 112.532 -171.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.438 HD21 ' H ' ' A' ' 138' ' ' PHE . 9.5 mp -62.59 -36.35 82.45 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.137 0.494 . . . . 2.3599999999999999 111.129 -177.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.497 ' ND2' ' HB2' ' A' ' 111' ' ' GLN . 94.0 m-20 -66.13 -39.93 90.26 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.24 0.543 . . . . 2.52 110.388 175.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 90.9 m -66.75 -42.25 86.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.367 -0.833 . . . . 2.52 111.061 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 33.9 p -72.72 -28.89 62.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.251 0.548 . . . . 2.0099999999999998 110.6 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.05 -118.05 7.84 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.531 -0.759 . . . . 1.52 113.041 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -70.11 -20.05 63.21 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.553 0.205 . . . . 6.2199999999999998 111.553 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.438 ' HB2' ' HB ' ' A' ' 145' ' ' THR . . . -66.25 -57.32 7.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.462 -0.336 . . . . 2.0499999999999998 111.851 -175.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -117.16 83.84 2.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.461 0.648 . . . . 2.6400000000000001 110.945 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.1 t -145.74 142.44 28.94 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.433 -0.803 . . . . 2.6000000000000001 109.502 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.404 ' HB3' ' OE2' ' A' ' 153' ' ' GLU . 15.1 mtp180 -76.59 131.97 39.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.872 0.368 . . . . 4.0899999999999999 110.626 176.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.09 115.85 49.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.744 -0.662 . . . . 2.1499999999999999 109.499 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.404 ' OE2' ' HB3' ' A' ' 151' ' ' ARG . 17.8 mm-40 -113.03 129.1 56.62 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.08 -0.711 . . . . 2.5600000000000001 109.08 -177.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.42 ' HB ' ' HB2' ' A' ' 174' ' ' LEU . 21.4 m -113.34 120.03 39.72 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 121.07 -0.252 . . . . 1.78 110.745 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -116.45 122.13 43.88 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.741 -0.466 . . . . 2.04 109.741 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 55.3 m -119.58 128.22 53.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.182 -0.463 . . . . 2.0299999999999998 110.544 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -115.33 128.47 8.09 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.968 -0.56 . . . . 1.0800000000000001 111.868 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 79.6 mt -118.27 134.66 54.84 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.634 -0.506 . . . . 2.9300000000000002 109.634 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.453 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 63.1 tt0 -115.07 125.85 54.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.941 -0.392 . . . . 3.02 109.941 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -130.3 133.79 46.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.252 -0.431 . . . . 4.7599999999999998 110.255 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.0 p -90.73 87.65 6.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.178 0.513 . . . . 1.8200000000000001 109.617 171.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -60.33 -49.57 77.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.702 -0.681 . . . . 3.27 111.367 -173.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.438 ' HB2' HG23 ' A' ' 166' ' ' VAL . 22.8 m120 -101.84 17.1 23.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.457 -0.338 . . . . 2.4100000000000001 110.499 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 72.4 -53.87 0.69 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 123.908 0.755 . . . . 2.5800000000000001 111.415 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.7 p -75.05 -15.96 60.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.348 -0.387 . . . . 2.6000000000000001 111.94 -176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' A' ' 163' ' ' ASN . 33.2 m -125.53 140.4 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.559 -0.291 . . . . 2.0600000000000001 110.481 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.26 128.35 53.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.951 0.405 . . . . 1.8400000000000001 110.48 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 22.1 mt -105.61 137.16 43.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.901 -0.591 . . . . 2.1400000000000001 109.476 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -110.64 116.12 30.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.961 0.41 . . . . 3.73 110.264 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 63.0 t -124.01 129.87 74.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.886 -0.412 . . . . 1.8100000000000001 109.886 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.404 ' OD1' ' HB2' ' A' ' 195' ' ' ARG . 25.9 p30 -134.09 156.09 48.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.875 0.369 . . . . 2.2400000000000002 110.969 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.446 ' HB2' HG23 ' A' ' 191' ' ' THR . 52.1 p90 -145.34 150.02 35.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.183 -0.462 . . . . 4.8399999999999999 111.017 -177.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -105.2 126.38 52.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.725 -0.671 . . . . 4.4299999999999997 111.615 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 154' ' ' THR . 93.3 mt -113.62 130.48 56.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.784 -0.644 . . . . 2.8500000000000001 110.151 175.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -100.39 128.87 46.35 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.272 -0.64 . . . . 3.3100000000000001 109.272 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -94.29 129.14 41.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.807 0.337 . . . . 7.3300000000000001 110.562 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -154.53 178.1 31.5 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.863 -0.895 . . . . 5.0599999999999996 110.863 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -69.24 -27.7 65.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.708 0.289 . . . . 8.0199999999999996 110.488 -177.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -60.12 -40.2 88.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 9.4900000000000002 110.832 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 59.8 ttm -70.13 -41.2 74.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.509 -0.314 . . . . 11.1 111.043 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.06 -39.66 75.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.262 -0.426 . . . . 10.470000000000001 111.95 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -74.14 -7.49 52.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.665 0.269 . . . . 13.06 111.692 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 68.4 m -69.53 124.88 25.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.153 0.502 . . . . 12.890000000000001 110.373 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -70.04 -35.29 74.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.521 -0.763 . . . . 15.720000000000001 109.314 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -79.85 134.42 36.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.359 -0.837 . . . . 13.470000000000001 109.356 176.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -142.05 149.7 40.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.663 -0.244 . . . . 13.15 110.525 -175.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 102.58 -51.28 0.88 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.948 -0.644 . . . . 10.050000000000001 112.737 176.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -100.03 116.79 32.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.0 0.429 . . . . 10.699999999999999 110.599 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -159.87 159.97 33.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.493 -0.776 . . . . 11.34 108.945 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 28.9 p -125.04 155.43 39.75 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.949 0.404 . . . . 6.7800000000000002 111.436 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.446 HG23 ' HB2' ' A' ' 172' ' ' TYR . 19.2 m -106.91 124.93 50.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.794 -0.639 . . . . 5.3600000000000003 109.867 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -61.07 -49.78 75.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.578 -0.737 . . . . 7.8700000000000001 112.21 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -112.4 108.22 17.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.251 0.548 . . . . 4.4000000000000004 110.892 -174.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 82.2 mt -120.05 129.99 74.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.61 -0.723 . . . . 2.6400000000000001 109.493 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.404 ' HB2' ' OD1' ' A' ' 171' ' ' ASN . 85.1 mtm180 -96.3 115.05 26.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.778 0.323 . . . . 4.1100000000000003 110.6 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -108.39 124.02 49.73 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.599 -0.519 . . . . 1.76 109.599 174.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -147.53 151.93 37.15 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.75 0.31 . . . . 6.1399999999999997 110.612 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.41 ' O ' ' HD2' ' A' ' 209' ' ' PRO . 1.8 pt? -129.66 128.37 23.03 Favored Pre-proline 0 C--N 1.321 -0.668 0 C-N-CA 120.98 -0.288 . . . . 3.0800000000000001 110.538 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.16 105.99 2.14 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.4 2.067 . . . . 1.98 111.427 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 56.9 tp -99.18 120.07 38.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.794 -0.639 . . . . 2.7599999999999998 109.512 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 19.6 p -99.95 123.93 44.73 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.943 0.401 . . . . 2.4199999999999999 111.37 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 62.8 tp -130.29 81.84 2.03 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.032 -0.729 . . . . 2.77 109.032 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 70.03 -125.2 15.29 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.409 -0.814 . . . . 1.6200000000000001 112.283 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -86.82 -0.3 56.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.253 0.549 . . . . 2.8599999999999999 110.051 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -103.0 117.44 34.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.74 -0.664 . . . . 3.23 110.112 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 63.3 m -107.9 123.75 49.08 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.779 -0.452 . . . . 2.0499999999999998 109.779 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 50.6 t -119.3 129.97 74.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 1.9299999999999999 109.854 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 25.3 m -126.62 91.29 47.73 Favored Pre-proline 0 C--N 1.318 -0.769 0 C-N-CA 120.965 -0.294 . . . . 1.6699999999999999 110.722 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 38.4 Cg_endo -70.8 146.33 53.49 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.128 1.885 . . . . 1.28 111.694 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -112.41 139.62 47.83 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.847 0.356 . . . . 4.8600000000000003 110.344 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 21.1 p -134.58 125.25 26.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.762 -0.653 . . . . 2.0899999999999999 110.731 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -70.12 -36.12 74.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.255 -0.884 . . . . 5.29 109.942 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 86.3 mt -119.91 120.35 62.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.399 -0.819 . . . . 4.9400000000000004 109.451 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -91.72 138.35 14.22 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.651 -0.785 . . . . 4.9800000000000004 112.804 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.0 mt -114.72 145.9 41.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.166 0.508 . . . . 8.4399999999999995 109.85 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.524 ' HB3' ' CD1' ' A' ' 218' ' ' TRP . 14.2 m-20 -60.2 -40.12 88.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.138 -0.937 . . . . 7.9699999999999998 112.024 -175.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 57.86 70.67 0.63 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.715 0.769 . . . . 11.1 111.729 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' TRP . . . . . 0.524 ' CD1' ' HB3' ' A' ' 216' ' ' ASP . 52.4 m95 -103.38 139.79 38.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.515 -0.766 . . . . 12.24 109.908 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.8 p -76.17 131.03 39.12 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.634 -0.506 . . . . 10.220000000000001 109.634 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -86.43 169.14 13.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 111.898 0.333 . . . . 11.92 111.898 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -59.91 -49.89 75.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.351 -0.386 . . . . 14.460000000000001 111.307 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -114.99 156.31 25.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.299 0.571 . . . . 14.529999999999999 110.971 -175.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -70.04 -21.14 63.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.228 -0.896 . . . . 17.07 111.729 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -69.98 -29.1 66.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.615 -0.266 . . . . 15.779999999999999 110.894 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -67.49 -39.96 85.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 15.67 111.452 -176.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.19 131.59 34.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.198 -0.456 . . . . 14.5 110.809 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 87.3 mt -93.86 109.37 21.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.151 0.501 . . . . 15.380000000000001 110.606 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -70.18 -39.49 75.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.478 -0.783 . . . . 14.73 110.42 175.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -63.16 139.93 58.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.163 -0.926 . . . . 16.969999999999999 112.007 -172.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -79.81 149.39 31.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.291 -0.868 . . . . 12.779999999999999 109.546 175.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -107.67 -150.45 16.01 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.616 -0.802 . . . . 11.369999999999999 111.139 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -70.07 -36.32 74.87 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.687 -0.486 . . . . 12.81 109.687 173.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 50.03 62.83 2.46 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 124.0 0.812 . . . . 9.9900000000000002 111.596 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -60.55 -40.06 90.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.948 -1.024 . . . . 11.32 111.186 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -79.85 119.7 23.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.037 -0.528 . . . . 6.8799999999999999 110.697 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -100.24 137.26 38.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.529 -0.305 . . . . 8.9399999999999995 110.192 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.1 m -106.75 151.76 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.244 -0.435 . . . . 2.9700000000000002 111.061 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -92.3 146.19 18.06 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.898 -0.668 . . . . 1.3999999999999999 111.999 -177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 89.3 mt -119.47 131.3 55.58 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.306 0.574 . . . . 2.4300000000000002 111.129 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -108.75 130.16 55.37 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.413 -0.812 . . . . 4.3300000000000001 109.767 173.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.48 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 96.1 m-85 -119.67 140.05 51.26 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.498 -0.927 . . . . 3.2599999999999998 108.498 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.44 167.05 33.42 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.64 -1.267 . . . . 1.3500000000000001 112.945 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -121.5 112.24 18.26 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.695 -0.483 . . . . 4.7599999999999998 109.695 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -120.87 13.88 11.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.242 0.544 . . . . 4.29 109.815 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.96 -40.33 88.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.356 -0.838 . . . . 7.5599999999999996 110.391 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -102.88 135.85 43.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.629 -0.714 . . . . 7.0199999999999996 109.747 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -70.01 -19.08 63.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 6.4800000000000004 111.535 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -96.66 2.81 62.66 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.704 -0.76 . . . . 2.9199999999999999 112.718 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 62.8 tp -131.2 129.94 42.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.818 0.342 . . . . 3.5800000000000001 110.648 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 48.9 m -134.94 130.4 35.78 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.399 -0.593 . . . . 2.6000000000000001 109.399 173.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.5 t -130.02 133.1 64.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 120.837 -0.345 . . . . 2.2400000000000002 110.906 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 11.1 p -115.92 109.99 18.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.119 0.485 . . . . 2.0 110.857 176.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 79.3 mt -105.54 120.06 40.69 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.049 -0.723 . . . . 3.4199999999999999 109.049 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -113.64 112.83 24.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.548 -0.296 . . . . 4.0800000000000001 111.173 -172.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -127.15 110.08 12.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.039 -0.528 . . . . 5.1699999999999999 109.76 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -70.19 -29.55 66.44 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.832 0.349 . . . . 3.5800000000000001 111.619 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -132.89 159.68 39.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.296 -0.411 . . . . 7.5800000000000001 109.962 -176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -97.19 140.14 32.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.95 0.405 . . . . 8.5399999999999991 110.913 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -69.89 -26.4 64.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.647 -0.706 . . . . 12.720000000000001 110.382 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -60.09 -40.0 88.11 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.814 -0.63 . . . . 11.09 111.279 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -84.47 152.31 24.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.397 -0.365 . . . . 11.41 110.15 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -83.67 75.01 10.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.054 0.454 . . . . 12.49 110.053 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -70.18 156.17 39.6 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.189 -0.914 . . . . 12.460000000000001 109.797 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -88.4 -0.04 56.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.75 -0.205 . . . . 13.779999999999999 111.237 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -75.61 168.37 54.79 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.97 -0.634 . . . . 11.300000000000001 112.75 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . 0.485 ' OD1' ' HD2' ' A' ' 269' ' ' LYS . 38.3 m-20 -70.08 130.84 43.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.802 0.334 . . . . 12.59 110.775 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 20.4 m -69.88 -22.64 63.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.849 -0.614 . . . . 11.1 111.121 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -99.82 10.54 41.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.098 -0.501 . . . . 12.42 111.324 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.485 ' HD2' ' OD1' ' A' ' 266' ' ' ASP . 94.5 mttt -131.21 160.01 36.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.922 -0.399 . . . . 11.82 109.922 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -107.46 97.23 7.0 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.054 -0.35 . . . . 9.5999999999999996 110.054 171.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -97.88 121.84 40.29 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.815 -0.809 . . . . 7.7999999999999998 108.815 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 60.72 40.08 16.68 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.212 0.529 . . . . 6.9900000000000002 111.169 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -140.28 130.12 24.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.606 -0.725 . . . . 2.4100000000000001 110.178 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -157.69 167.15 34.09 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.32 -0.943 . . . . 1.6200000000000001 112.399 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.9 140.01 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.94 0.4 . . . . 2.4900000000000002 111.133 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.92 140.01 11.41 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.321 -0.712 . . . . 1.3 111.321 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.4 t -128.01 129.94 69.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.908 0.354 . . . . 2.3399999999999999 110.884 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -126.42 130.56 50.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.026 -0.534 . . . . 2.7999999999999998 111.004 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -113.55 129.19 56.6 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.423 -0.584 . . . . 5.1900000000000004 109.423 172.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 50.8 m -120.84 141.25 50.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.319 -0.4 . . . . 2.0499999999999998 110.485 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.536 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 91.0 m-85 . . . . . 0 C--O 1.247 0.96 0 CA-C-O 117.785 -1.103 . . . . 4.4199999999999999 109.584 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.6 mtp . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.432 0.158 . . . . 11.970000000000001 110.821 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 55.66 38.31 29.99 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.492 0.663 . . . . 10.35 111.687 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -90.56 0.03 57.5 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.224 -0.898 . . . . 9.3100000000000005 110.262 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -90.18 8.77 31.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.198 -0.91 . . . . 9.4399999999999995 110.669 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -99.56 119.14 37.58 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.508 -0.553 . . . . 7.75 109.508 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -69.88 -39.68 76.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.187 0.518 . . . . 3.6099999999999999 110.009 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.43 ' HA ' ' HB2' ' A' ' 41' ' ' ASN . 44.6 m95 -62.72 139.98 58.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.291 -0.868 . . . . 3.9100000000000001 111.471 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.35 135.64 36.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.125 -0.489 . . . . 3.9399999999999999 110.0 175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.92 139.94 51.65 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.854 -0.612 . . . . 3.21 110.683 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -126.64 129.83 49.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.276 -0.42 . . . . 2.6499999999999999 110.468 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.6 mt -121.0 120.09 61.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.058 -0.719 . . . . 2.0699999999999998 109.058 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.3 129.36 9.44 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.23 -0.986 . . . . 0.92000000000000004 111.475 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.1 134.83 54.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.162 0.506 . . . . 1.6499999999999999 110.636 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 68.0 mtt -126.63 141.38 51.87 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.566 -0.743 . . . . 2.9700000000000002 109.492 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -119.32 127.93 53.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.619 -0.264 . . . . 3.1499999999999999 110.586 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.464 ' HG2' ' HB1' ' A' ' 31' ' ' ALA . 34.9 mt-10 59.78 40.0 20.07 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.804 0.69 . . . . 5.0899999999999999 111.26 172.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.5 mm -107.27 116.22 50.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.383 -0.371 . . . . 5.3300000000000001 110.625 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -85.67 87.43 7.4 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.511 -0.551 . . . . 8.2799999999999994 109.511 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.409 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 91.0 m-20 -60.17 -39.65 87.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.355 -0.839 . . . . 10.0 111.775 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.0 t -105.78 120.15 56.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.837 0.351 . . . . 11.380000000000001 110.232 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.17 133.19 51.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.868 -0.605 . . . . 13.1 109.988 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.63 19.41 26.17 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.881 -0.676 . . . . 12.52 112.052 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -60.16 -39.84 87.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.87 0.367 . . . . 15.18 110.389 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.34 -30.08 69.58 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.104 -0.569 . . . . 12.279999999999999 112.906 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -100.97 7.78 43.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.648 0.261 . . . . 12.82 111.443 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 56.12 39.94 30.26 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.919 -0.582 . . . . 10.81 111.605 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 93.9 mmm -127.76 130.07 48.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.09 -0.505 . . . . 10.210000000000001 111.022 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -155.8 168.37 27.42 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.419 -0.586 . . . . 8.0600000000000005 109.419 176.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.47 28.78 18.54 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.491 -0.862 . . . . 6.0800000000000001 112.257 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.1 mt -100.89 131.79 46.6 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.473 -0.565 . . . . 5.96 109.473 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HB1' ' HG2' ' A' ' 16' ' ' GLU . . . -146.9 123.5 11.12 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.857 -0.337 . . . . 3.2400000000000002 111.803 -176.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -149.07 156.08 40.29 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 116.298 -0.41 . . . . 3.48 110.559 175.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.2 135.87 15.6 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.883 2.389 . . . . 2.0299999999999998 111.211 170.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.1 t -140.45 149.88 43.12 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 121.097 -0.241 . . . . 2.2799999999999998 110.848 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.2 m -126.56 139.93 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 2.4100000000000001 110.824 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -119.75 147.04 45.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.989 -0.551 . . . . 4.4400000000000004 110.105 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -119.29 139.36 52.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.792 0.33 . . . . 3.6200000000000001 111.103 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -150.16 142.45 24.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.967 -0.56 . . . . 2.48 110.266 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -148.29 143.73 27.13 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.959 -0.109 . . . . 1.53 110.993 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.56 135.14 7.45 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.972 0.36 . . . . 1.8 111.972 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.587 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 41.4 t30 -168.85 94.64 0.34 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.88 -0.6 . . . . 3.3799999999999999 110.096 170.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.85 -91.75 1.5 Allowed Glycine 0 CA--C 1.517 0.184 0 C-N-CA 120.901 -0.666 . . . . 1.8200000000000001 111.709 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.587 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 72.9 Cg_exo -50.44 176.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.608 2.872 . . . . 2.1000000000000001 113.456 169.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -67.1 170.8 6.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.621 -0.718 . . . . 4.0499999999999998 111.289 -171.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -113.11 130.03 56.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.8 -0.636 . . . . 3.6000000000000001 110.511 -173.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.5 tt -116.58 131.47 69.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.384 -0.825 . . . . 2.2799999999999998 110.492 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.418 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -118.38 128.6 54.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.002 -0.544 . . . . 1.4399999999999999 110.697 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.8 tp -103.65 126.59 50.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.951 -0.568 . . . . 1.75 110.242 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.0 168.39 19.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.098 0.475 . . . . 1.5900000000000001 110.928 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -164.31 160.01 20.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.867 -0.606 . . . . 4.4400000000000004 110.109 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.531 ' HB3' ' CG ' ' A' ' 69' ' ' ARG . 61.8 t80 -130.33 129.77 43.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.87 -0.419 . . . . 5.0199999999999996 109.87 177.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -130.85 159.74 36.49 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.972 -0.558 . . . . 3.7400000000000002 110.601 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -110.04 23.22 14.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.302 -0.863 . . . . 5.0499999999999998 109.174 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.1 112.37 0.83 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 110.643 -0.983 . . . . 4.3700000000000001 110.643 -171.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.98 168.23 22.45 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.736 2.29 . . . . 7.0899999999999999 112.828 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.6 t -59.87 -40.11 81.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.022 0.439 . . . . 8.5700000000000003 110.558 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -61.14 -35.6 77.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.863 -0.608 . . . . 10.039999999999999 111.473 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -59.99 -40.64 89.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 11.890000000000001 112.283 -173.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 t -129.95 139.98 51.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.031 0.443 . . . . 9.7899999999999991 111.299 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.99 -0.14 57.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.005 -0.543 . . . . 8.7799999999999994 110.499 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.62 73.88 2.34 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.941 -0.647 . . . . 7.7300000000000004 112.11 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -89.95 -2.5 58.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.599 0.238 . . . . 10.300000000000001 111.112 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -90.22 -0.86 57.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.706 0.288 . . . . 10.960000000000001 111.197 -175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.08 173.69 25.67 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.9 -0.667 . . . . 5.5599999999999996 111.982 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.5 m -92.61 116.66 29.21 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.077 -0.342 . . . . 5.6900000000000004 110.077 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -120.07 143.19 48.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.187 -0.46 . . . . 6.5 110.095 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -116.69 140.04 49.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.243 0.544 . . . . 4.5999999999999996 110.464 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -139.72 170.42 15.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.533 -0.758 . . . . 2.4500000000000002 109.373 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.531 ' CG ' ' HB3' ' A' ' 51' ' ' TYR . 3.2 ptp180 -129.98 125.95 22.23 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 120.419 -0.512 . . . . 3.7200000000000002 111.161 175.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.4 140.03 5.24 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.918 2.412 . . . . 1.3200000000000001 110.835 167.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.468 ' CD ' ' HE ' ' A' ' 93' ' ' ARG . 76.7 mt-10 -126.87 130.0 49.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.738 -0.468 . . . . 2.1899999999999999 109.738 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.418 HD11 ' O ' ' A' ' 47' ' ' ALA . 57.8 tp -133.54 120.85 21.3 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.562 -0.29 . . . . 1.73 110.339 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -119.49 130.02 55.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.994 0.426 . . . . 2.1800000000000002 110.267 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 89' ' ' THR . 62.1 t -120.0 129.52 75.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.931 -0.577 . . . . 2.0600000000000001 110.062 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -113.99 122.26 46.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.155 -0.475 . . . . 4.1900000000000004 111.169 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -108.38 146.22 33.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.642 -0.708 . . . . 5.1600000000000001 109.705 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -117.14 137.39 52.35 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.029 -0.36 . . . . 3.3100000000000001 110.029 173.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.595 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 93.2 m-85 -134.87 91.01 2.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.208 -0.451 . . . . 4.6600000000000001 110.422 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 78' ' ' PHE . 10.0 mt 170.02 130.02 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.786 1.234 . . . . 4.8799999999999999 109.354 171.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -98.72 15.06 26.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.759 0.314 . . . . 6.1900000000000004 111.54 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.425 ' ND2' ' HB2' ' A' ' 83' ' ' ASP . 58.8 t30 -118.74 137.51 53.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.894 0.378 . . . . 6.0999999999999996 110.524 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -70.2 -22.3 62.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.815 -0.63 . . . . 5.2699999999999996 112.302 -176.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.425 ' HB2' ' ND2' ' A' ' 81' ' ' ASN . 59.5 m-20 -62.37 -45.15 94.47 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.821 0.343 . . . . 6.3300000000000001 111.792 -176.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -139.97 147.81 41.02 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.613 -0.514 . . . . 8.3499999999999996 109.613 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.9 m -136.33 130.72 33.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.0 0.428 . . . . 2.6400000000000001 111.574 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -110.17 150.18 29.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.614 -0.884 . . . . 6.1900000000000004 108.614 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -150.14 169.69 30.17 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.724 -1.227 . . . . 1.54 112.818 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 97.4 mt -131.43 122.47 26.32 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.405 -0.591 . . . . 2.73 109.405 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 92.9 m -120.11 129.98 54.42 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.001 0.429 . . . . 1.8700000000000001 110.254 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -121.67 133.57 9.52 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.771 -0.728 . . . . 1.1699999999999999 111.484 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.58 130.66 8.76 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.655 -0.783 . . . . 1.4399999999999999 112.462 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 68.3 m-85 -112.01 127.24 55.82 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.768 -0.456 . . . . 4.6399999999999997 109.768 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.468 ' HE ' ' CD ' ' A' ' 71' ' ' GLU . 40.1 ttm180 -142.71 124.87 15.38 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.561 -0.163 . . . . 3.2200000000000002 110.561 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.5 ' OD1' ' HA ' ' A' ' 111' ' ' GLN . 93.5 m-20 -132.65 129.83 39.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.293 -0.262 . . . . 2.2200000000000002 110.293 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -126.69 135.39 51.08 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.306 -0.627 . . . . 3.6400000000000001 109.306 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -72.3 125.94 11.07 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.745 -0.74 . . . . 2.79 112.414 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.468 ' CE2' ' HD1' ' A' ' 99' ' ' TYR . 64.8 t80 -87.19 124.57 33.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.93 0.395 . . . . 7.8499999999999996 111.04 -177.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -150.03 79.94 1.37 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.602 -0.726 . . . . 7.6900000000000004 109.745 172.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.468 ' HD1' ' CE2' ' A' ' 97' ' ' TYR . 67.6 m-85 -120.56 139.95 52.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.376 -0.601 . . . . 10.289999999999999 109.376 174.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.3 m -96.46 -2.76 10.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 112.0 0.37 . . . . 10.19 112.0 -172.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -70.19 -40.05 74.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.051 0.453 . . . . 12.220000000000001 110.342 176.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -98.68 113.4 64.32 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.936 -0.575 . . . . 10.48 110.347 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.0 138.86 75.82 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.487 2.125 . . . . 9.6799999999999997 111.939 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.91 -117.04 0.75 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.62 -0.8 . . . . 6.5099999999999998 112.463 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -105.37 127.47 52.99 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.978 0.418 . . . . 8.1099999999999994 110.853 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.08 -39.83 87.45 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.288 -0.869 . . . . 4.1399999999999997 111.232 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.5 p -116.29 130.09 56.6 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.951 0.405 . . . . 3.77 110.514 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.16 160.94 33.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.793 -0.639 . . . . 2.2000000000000002 109.775 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -120.12 129.99 54.42 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.572 -0.529 . . . . 3.1200000000000001 109.572 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 89.0 mtp -104.52 129.44 52.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.742 0.306 . . . . 2.1200000000000001 110.413 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.5 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 99.5 mt-30 -95.66 123.14 39.08 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.823 -0.626 . . . . 2.4900000000000002 111.047 -176.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 85.7 mtt180 -116.29 114.3 24.17 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.659 -0.497 . . . . 4.4699999999999998 109.659 173.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.442 ' NE1' ' HB3' ' A' ' 111' ' ' GLN . 83.8 m95 -107.44 136.88 46.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.68 -0.691 . . . . 2.9199999999999999 110.86 -173.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -120.53 123.36 42.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.823 -0.626 . . . . 2.5099999999999998 110.196 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 134' ' ' SER . 88.2 mt -120.07 120.35 62.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.077 -0.712 . . . . 2.1299999999999999 109.077 174.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -145.76 108.05 4.36 Favored Pre-proline 0 C--N 1.325 -0.488 0 C-N-CA 120.723 -0.391 . . . . 1.6799999999999999 111.814 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 69.3 Cg_endo -77.64 139.93 18.4 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.067 1.845 . . . . 1.54 110.185 171.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.88 137.44 32.36 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.229 -0.442 . . . . 2.3500000000000001 110.045 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -127.16 127.54 44.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.302 -0.408 . . . . 5.1500000000000004 109.968 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -126.82 109.59 12.16 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.347 -0.612 . . . . 3.04 109.347 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.7 t -120.58 117.62 53.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.128 -0.487 . . . . 4.7400000000000002 110.321 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -117.34 96.09 5.26 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.651 -0.499 . . . . 6.3600000000000003 109.651 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.42 -39.95 85.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.647 -0.706 . . . . 4.96 110.694 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.1 t -149.71 170.0 19.74 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.381 -0.827 . . . . 4.0700000000000003 108.865 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.98 -39.24 85.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.404 0.621 . . . . 5.1699999999999999 110.046 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.15 -31.11 68.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.627 -1.169 . . . . 3.71 111.57 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 159' ' ' GLN . 85.0 mt -119.98 119.79 34.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 2.4500000000000002 112.061 -171.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.45 ' HB2' ' HB3' ' A' ' 159' ' ' GLN . 89.8 mtt180 -111.6 109.61 19.6 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.855 -0.794 . . . . 4.6799999999999997 108.855 170.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -109.43 122.4 47.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.187 0.518 . . . . 4.3600000000000003 111.037 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.12 139.91 53.35 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.764 -0.653 . . . . 2.5899999999999999 109.522 173.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -147.65 133.6 4.77 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.576 -0.821 . . . . 1.25 111.573 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 29.3 m-90 -120.03 127.61 52.75 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.936 0.398 . . . . 5.0899999999999999 111.062 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.649 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 58.2 tp -101.3 118.57 37.24 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.438 -0.949 . . . . 2.7599999999999998 108.438 173.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 42.9 m -120.49 130.01 54.1 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.036 0.446 . . . . 1.99 111.177 -175.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.638 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 76.5 mtm -106.3 130.24 54.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.595 -0.729 . . . . 2.7799999999999998 109.394 173.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -120.07 139.9 51.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.35 -0.386 . . . . 3.6800000000000002 111.346 -175.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 96.7 mttt -129.55 160.04 34.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.71 -0.677 . . . . 2.1699999999999999 109.271 174.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.414 ' H ' HD21 ' A' ' 142' ' ' LEU . 53.0 p90 -143.96 160.07 41.47 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.487 -0.56 . . . . 4.0099999999999998 109.487 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 63.56 -178.57 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.893 0.746 . . . . 1.79 111.504 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -74.99 -39.93 60.98 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.117 0.484 . . . . 3.04 111.343 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -59.98 -41.93 93.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.529 -0.759 . . . . 2.4100000000000001 113.034 -168.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.414 HD21 ' H ' ' A' ' 138' ' ' PHE . 9.4 mp -69.98 -30.13 67.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.878 0.37 . . . . 2.3599999999999999 111.352 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -70.03 -40.07 75.4 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.805 -0.358 . . . . 2.52 110.101 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 33.7 p -73.48 -31.15 63.6 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.569 0.581 . . . . 2.52 112.569 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 35.1 p -79.46 -10.03 59.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.898 0.38 . . . . 2.0099999999999998 111.412 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 91.14 -137.06 13.66 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.689 -0.767 . . . . 1.52 112.449 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -89.93 -1.27 57.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.842 0.353 . . . . 6.2199999999999998 110.379 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.56 -47.7 82.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.934 -0.576 . . . . 2.0499999999999998 111.153 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -108.43 81.96 1.55 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.073 0.463 . . . . 2.6400000000000001 110.477 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.5 t -149.5 150.01 31.64 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.2 -0.455 . . . . 2.6000000000000001 109.996 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.638 ' O ' ' HA ' ' A' ' 135' ' ' MET . 42.8 mtt180 -80.84 134.89 35.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.355 -0.384 . . . . 4.0899999999999999 110.309 174.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.83 102.85 14.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.055 -0.72 . . . . 2.1499999999999999 109.055 173.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.584 ' OE1' ' HD3' ' A' ' 151' ' ' ARG . 83.9 mt-10 -124.74 141.51 52.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.112 -0.495 . . . . 2.5600000000000001 110.248 -174.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 174' ' ' LEU . 21.8 m -130.08 139.91 50.89 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 121.014 -0.274 . . . . 1.78 110.844 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -119.85 131.44 55.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.18 -0.674 . . . . 2.04 109.18 171.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.2 p -117.82 121.12 39.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.224 -0.444 . . . . 2.0299999999999998 110.906 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -113.38 120.1 5.05 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.123 -0.791 . . . . 1.0800000000000001 111.123 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 68.8 tp -123.5 129.44 51.23 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.966 0.412 . . . . 2.9300000000000002 110.941 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.45 ' HB3' ' HB2' ' A' ' 128' ' ' ARG . 53.4 tt0 -102.87 118.37 36.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.718 -0.845 . . . . 3.02 108.718 171.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -122.26 137.52 54.81 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.915 0.388 . . . . 4.7599999999999998 110.039 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . 1.6 m -98.26 89.22 4.4 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.33 0.586 . . . . 1.8200000000000001 109.835 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -67.58 -48.75 65.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.377 -0.828 . . . . 3.27 112.218 -171.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.429 ' HB2' HG22 ' A' ' 166' ' ' VAL . 93.6 m-20 -99.9 8.98 43.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.424 -0.353 . . . . 2.4100000000000001 110.98 -175.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 73.6 -39.71 0.44 Allowed 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.865 0.728 . . . . 2.5800000000000001 110.727 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 163' ' ' ASN . 21.4 p -75.32 -40.13 58.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.194 -0.457 . . . . 2.6000000000000001 111.235 175.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 163' ' ' ASN . 31.3 m -120.17 144.48 28.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.115 0.483 . . . . 2.0600000000000001 111.536 -175.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 161' ' ' THR . . . -119.98 139.47 52.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.463 -0.789 . . . . 1.8400000000000001 110.591 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 159' ' ' GLN . 3.1 mm? -108.49 130.49 55.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.828 -0.624 . . . . 2.1400000000000001 109.648 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -101.77 113.0 25.79 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.598 -0.519 . . . . 3.73 109.598 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 195' ' ' ARG . 63.1 t -120.13 129.8 75.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.338 -0.392 . . . . 1.8100000000000001 111.257 -177.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -110.88 126.36 54.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.906 -0.588 . . . . 2.2400000000000002 110.065 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -119.2 140.06 50.83 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.813 -0.631 . . . . 4.8399999999999999 109.941 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -97.52 137.0 37.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.057 0.456 . . . . 4.4299999999999997 111.032 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 154' ' ' THR . 3.4 mm? -106.73 120.02 40.86 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.131 -0.692 . . . . 2.8500000000000001 109.131 173.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.61 -42.55 97.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.603 -0.726 . . . . 3.3100000000000001 110.352 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -133.93 127.84 33.28 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.136 -0.938 . . . . 7.3300000000000001 110.453 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -98.84 122.66 7.63 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.675 -0.774 . . . . 5.0599999999999996 111.882 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -147.66 149.61 32.8 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.857 0.36 . . . . 8.0199999999999996 110.401 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -100.28 16.55 23.96 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.257 -0.429 . . . . 9.4900000000000002 110.844 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.9 ttm -60.86 -40.11 91.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.798 -0.637 . . . . 11.1 110.577 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -119.14 121.73 40.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.019 -0.537 . . . . 10.470000000000001 109.964 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -70.02 -39.96 75.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.019 -0.537 . . . . 13.06 110.815 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.9 m -104.67 134.85 47.14 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.104 -0.498 . . . . 12.890000000000001 110.707 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -76.5 144.19 39.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.069 -0.514 . . . . 15.720000000000001 110.346 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.425 ' ND2' ' HG3' ' A' ' 188' ' ' GLU . 37.6 t30 -99.53 119.91 38.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.078 0.466 . . . . 13.470000000000001 111.194 -177.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -72.91 -20.05 61.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.574 -0.739 . . . . 13.15 111.434 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.49 -31.6 68.19 Favored Glycine 0 C--N 1.329 0.141 0 C-N-CA 121.165 -0.541 . . . . 10.050000000000001 113.545 -174.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.425 ' HG3' ' ND2' ' A' ' 185' ' ' ASN . 36.0 mt-10 -85.93 146.72 26.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.187 0.517 . . . . 10.699999999999999 111.501 -176.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -95.79 149.06 21.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.714 -0.675 . . . . 11.34 111.314 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.3 p -140.03 154.09 47.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.731 -0.668 . . . . 6.7800000000000002 110.016 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 25.6 p -98.89 2.76 46.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.126 0.488 . . . . 5.3600000000000003 110.639 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -69.0 142.15 54.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.414 -0.812 . . . . 7.8700000000000001 110.987 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -80.07 153.01 29.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.624 -0.716 . . . . 4.4000000000000004 111.902 -173.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 85.8 mt -119.98 120.54 63.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.226 -0.897 . . . . 2.6400000000000001 109.831 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 72.3 mtm180 -102.86 120.15 40.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.752 -0.204 . . . . 4.1100000000000003 110.745 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -117.26 128.7 55.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.657 0.265 . . . . 1.76 110.498 175.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -150.05 159.95 44.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.152 -0.476 . . . . 6.1399999999999997 110.078 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.415 ' N ' HD21 ' A' ' 198' ' ' LEU . 1.8 pt? -147.05 128.5 7.3 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 110.233 -0.284 . . . . 3.0800000000000001 110.233 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.84 106.72 2.18 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.393 2.062 . . . . 1.98 111.89 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 62.6 tp -112.46 140.06 47.51 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.175 -0.676 . . . . 2.7599999999999998 109.175 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 28.6 p -119.97 140.43 50.94 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.466 -0.494 . . . . 2.4199999999999999 111.658 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 58.9 tp -130.0 81.71 2.03 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.825 -0.806 . . . . 2.77 108.825 176.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 75.72 -120.01 5.9 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.512 -0.767 . . . . 1.6200000000000001 112.3 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -96.72 0.0 48.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.238 0.542 . . . . 2.8599999999999999 110.324 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -111.24 140.28 45.94 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.768 -0.651 . . . . 3.23 109.367 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 19.6 p -114.77 151.74 33.26 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.528 -0.305 . . . . 2.0499999999999998 110.731 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 5.3 p -138.78 130.15 35.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.999 0.428 . . . . 1.9299999999999999 110.67 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 56.9 m -122.3 96.72 45.94 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 120.932 0.396 . . . . 1.6699999999999999 110.518 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -60.54 148.11 92.18 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.972 2.448 . . . . 1.28 112.62 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -119.9 139.95 51.62 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.357 -0.608 . . . . 4.8600000000000003 109.357 174.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 236' ' ' ARG . 14.0 t -159.41 173.59 16.0 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.591 -0.522 . . . . 2.0899999999999999 109.591 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 212' ' ' ARG . 50.9 mtt180 -126.71 129.57 48.67 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.884 -0.413 . . . . 5.29 109.884 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 16.0 tt -110.77 141.71 25.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.133 -0.485 . . . . 4.9400000000000004 110.355 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 86.55 15.93 62.94 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.034 -0.603 . . . . 4.9800000000000004 111.626 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 65.3 tp -116.5 117.97 31.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.874 0.369 . . . . 8.4399999999999995 110.645 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -99.97 120.0 39.13 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.282 -0.636 . . . . 7.9699999999999998 109.282 174.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -60.6 -40.94 93.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.776 -0.647 . . . . 11.1 111.24 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -119.34 140.07 50.93 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.806 -0.442 . . . . 12.24 109.806 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 50.4 m -131.47 146.88 52.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.201 -0.454 . . . . 10.220000000000001 110.475 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -70.56 -20.06 62.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.532 -0.758 . . . . 11.92 111.987 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . 0.487 ' HB2' ' NE2' ' A' ' 224' ' ' GLN . 82.9 m95 -75.86 130.0 37.86 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.883 -0.414 . . . . 14.460000000000001 109.883 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -61.94 -40.03 94.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.199 -0.909 . . . . 14.529999999999999 112.645 -172.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 91.1 t90 -97.62 120.02 37.25 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.433 -0.507 . . . . 17.07 110.428 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . 0.487 ' NE2' ' HB2' ' A' ' 221' ' ' TRP . 88.4 mm-40 -128.99 138.46 51.96 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.526 -0.761 . . . . 15.779999999999999 109.616 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -110.06 111.02 22.12 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.065 0.46 . . . . 15.67 109.928 177.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -146.56 165.73 28.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.538 -0.756 . . . . 14.5 109.562 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 86.7 mt -117.52 120.03 63.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.086 0.469 . . . . 15.380000000000001 110.84 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -110.5 137.92 47.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.748 -0.66 . . . . 14.73 109.366 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -108.86 167.08 10.34 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.263 -0.426 . . . . 16.969999999999999 110.134 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -67.9 -40.0 83.54 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.387 -0.597 . . . . 12.779999999999999 109.387 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.61 129.12 39.08 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.478 -0.783 . . . . 11.369999999999999 111.498 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -79.95 -8.65 59.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.63 0.252 . . . . 12.81 111.56 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -82.15 129.9 34.94 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.94 -0.393 . . . . 9.9900000000000002 109.94 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -136.64 159.79 40.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.611 -0.515 . . . . 11.32 109.611 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -105.11 32.48 4.18 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.47 -0.332 . . . . 6.8799999999999999 111.261 -174.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 211' ' ' THR . 98.1 mtt180 -69.97 -39.98 75.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.443 -0.577 . . . . 8.9399999999999995 109.443 173.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 63.4 t -130.07 130.01 65.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.904 -1.044 . . . . 2.9700000000000002 108.686 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -150.25 166.45 30.05 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.005 -1.093 . . . . 1.3999999999999999 112.098 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.4 mt -134.33 129.13 35.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.921 0.391 . . . . 2.4300000000000002 110.749 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.496 ' HE2' ' OG ' ' A' ' 252' ' ' SER . 61.2 t80 -108.07 131.95 54.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.938 -0.574 . . . . 4.3300000000000001 110.234 174.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -119.97 134.01 55.38 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.973 -0.38 . . . . 3.2599999999999998 109.973 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -110.13 121.76 6.09 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.754 -0.736 . . . . 1.3500000000000001 111.749 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' TYR . . . . . 0.423 ' CD1' HD12 ' A' ' 253' ' ' LEU . 91.9 m-85 -121.62 112.13 18.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.821 0.344 . . . . 4.7599999999999998 110.559 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -99.07 97.91 8.99 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.798 -0.445 . . . . 4.29 109.798 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -69.97 -37.0 75.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.015 -0.539 . . . . 7.5599999999999996 111.986 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 96.0 mt-30 -137.31 170.54 15.91 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.861 -0.422 . . . . 7.0199999999999996 109.861 -175.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -59.91 -40.17 87.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.159 0.504 . . . . 6.4800000000000004 111.003 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.19 10.9 51.44 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.742 -0.742 . . . . 2.9199999999999999 113.014 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.489 ' HB3' ' HB2' ' A' ' 246' ' ' GLN . 58.5 tp -122.46 115.19 21.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.021 0.411 . . . . 3.5800000000000001 111.499 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 50.0 m -120.24 130.44 54.51 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.695 -0.684 . . . . 2.6000000000000001 109.814 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 99.2 t -113.26 132.14 62.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.189 0.519 . . . . 2.2400000000000002 110.351 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.496 ' OG ' ' HE2' ' A' ' 240' ' ' PHE . 42.5 t -101.33 118.77 37.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.242 -0.89 . . . . 2.0 110.196 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.423 HD12 ' CD1' ' A' ' 243' ' ' TYR . 84.2 mt -119.6 100.96 7.59 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.0 -0.37 . . . . 3.4199999999999999 110.0 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -109.5 130.04 55.53 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.034 -0.358 . . . . 4.0800000000000001 110.034 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.0 129.04 56.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.312 -0.404 . . . . 5.1699999999999999 110.405 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -86.07 -32.32 21.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 3.5800000000000001 110.852 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -123.03 134.73 54.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.277 -0.42 . . . . 7.5800000000000001 110.407 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -84.67 138.65 32.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.085 -0.507 . . . . 8.5399999999999991 110.664 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . 0.433 ' CZ2' ' HB2' ' A' ' 266' ' ' ASP . 98.4 m95 -112.81 158.23 20.39 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.247 -0.433 . . . . 12.720000000000001 109.934 177.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -105.52 153.34 21.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.13 -0.486 . . . . 11.09 110.521 -173.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -68.26 -39.83 82.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.247 -0.433 . . . . 11.41 110.483 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . 0.428 ' HD2' ' OD1' ' A' ' 263' ' ' ASP . 65.2 t60 -67.74 -47.93 67.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.001 -0.545 . . . . 12.49 110.473 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.428 ' OD1' ' HD2' ' A' ' 262' ' ' HIS . 14.7 m-20 -114.71 103.94 11.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.915 0.388 . . . . 12.460000000000001 110.228 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -69.9 -38.58 76.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.708 -0.678 . . . . 13.779999999999999 111.097 -175.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 68.88 -128.54 23.41 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.888 -0.596 . . . . 11.300000000000001 112.672 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . 0.433 ' HB2' ' CZ2' ' A' ' 259' ' ' TRP . 2.7 m-20 -78.94 130.62 35.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.851 0.358 . . . . 12.59 110.56 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 25.2 m -122.99 132.3 54.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.177 -0.465 . . . . 11.1 110.875 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 60.09 30.45 19.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.604 -0.726 . . . . 12.42 111.496 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -91.58 149.11 21.82 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.229 -0.656 . . . . 11.82 109.229 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -92.83 1.04 57.5 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 111.827 0.306 . . . . 9.5999999999999996 111.827 -171.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 59.8 m170 -93.59 -40.78 10.1 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.185 -0.606 . . . . 7.7999999999999998 112.288 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -79.46 -10.87 59.89 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.463 -0.495 . . . . 6.9900000000000002 111.389 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -133.52 159.97 38.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.427 -0.351 . . . . 2.4100000000000001 111.182 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.66 131.54 6.23 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.588 -1.005 . . . . 1.6200000000000001 110.588 174.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.03 128.51 75.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.116 0.484 . . . . 2.4900000000000002 111.207 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -132.75 138.33 10.06 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.337 -0.705 . . . . 1.3 111.337 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.0 t -116.36 120.69 65.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.618 -0.512 . . . . 2.3399999999999999 109.618 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -116.21 129.94 56.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.139 0.495 . . . . 2.7999999999999998 111.069 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.428 ' CE2' HD11 ' A' ' 249' ' ' LEU . 97.8 m-85 -109.35 111.58 23.23 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.548 -0.908 . . . . 5.1900000000000004 108.548 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.9 t -132.0 139.97 48.78 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.517 -0.473 . . . . 2.0499999999999998 110.683 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 57.5 t80 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.085 -0.959 . . . . 4.4199999999999999 108.784 178.825 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mmm . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.845 0.355 . . . . 11.970000000000001 110.365 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -87.96 72.92 9.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.375 0.607 . . . . 10.35 109.597 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -119.98 144.06 47.7 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.39 -0.823 . . . . 9.3100000000000005 110.359 -173.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -103.89 140.02 38.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.164 -0.471 . . . . 9.4399999999999995 112.068 -174.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 59.5 55.1 4.27 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.166 -0.924 . . . . 7.75 111.29 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -121.44 139.03 53.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.528 -0.76 . . . . 3.6099999999999999 109.12 175.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -69.88 119.83 14.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.956 0.408 . . . . 3.9100000000000001 111.549 -173.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -100.99 125.05 47.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.806 -0.634 . . . . 3.9399999999999999 109.661 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -114.92 139.68 49.6 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.26 -0.427 . . . . 3.21 110.0 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -126.48 130.5 50.75 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.386 -0.598 . . . . 2.6499999999999999 109.386 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.1 mt -127.89 129.97 69.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.273 -0.421 . . . . 2.0699999999999998 110.681 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.29 140.0 11.46 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.173 -0.771 . . . . 0.92000000000000004 111.173 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.4 135.58 54.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.014 0.407 . . . . 1.6499999999999999 110.947 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 96.6 mmm -130.1 157.09 43.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.496 -0.774 . . . . 2.9700000000000002 109.702 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -114.56 142.22 46.71 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.436 0.636 . . . . 3.1499999999999999 110.374 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -59.83 -40.15 87.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.697 -1.138 . . . . 5.0899999999999999 111.754 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' A' ' 31' ' ' ALA . 48.1 mm -117.99 129.93 73.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.826 -0.435 . . . . 5.3300000000000001 109.826 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.538 ' OE2' ' HB3' ' A' ' 272' ' ' TYR . 98.6 mt-10 -65.73 138.01 57.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.087 0.47 . . . . 8.2799999999999994 111.152 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -83.69 139.82 32.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.551 -0.749 . . . . 10.0 110.007 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.81 129.97 74.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.086 -0.506 . . . . 11.380000000000001 110.146 -177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -76.8 106.57 8.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.231 0.538 . . . . 13.1 109.787 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.19 -162.52 9.49 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.519 -0.764 . . . . 12.52 111.284 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -106.7 10.16 31.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.893 0.346 . . . . 15.18 110.744 -176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.23 -168.54 18.54 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.716 -0.754 . . . . 12.279999999999999 112.581 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -133.69 159.55 40.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.244 -0.28 . . . . 12.82 110.244 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -119.75 129.05 54.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.423 -0.353 . . . . 10.81 110.317 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.623 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 67.3 mtt -68.05 -31.41 71.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.209 0.528 . . . . 10.210000000000001 110.121 176.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -70.17 -14.59 62.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.531 -0.759 . . . . 8.0600000000000005 110.994 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.93 19.33 42.51 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.053 -0.594 . . . . 6.0800000000000001 113.452 -175.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 27' ' ' MET . 90.4 mt -61.79 137.36 58.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 117.084 0.442 . . . . 5.96 109.855 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . . . -142.98 149.17 37.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.874 0.368 . . . . 3.2400000000000002 111.861 -174.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -99.63 129.99 27.68 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.863 -0.608 . . . . 3.48 110.012 172.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.73 142.09 47.12 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.153 1.902 . . . . 2.0299999999999998 111.58 173.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.3 t -119.97 143.49 47.99 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.618 -0.512 . . . . 2.2799999999999998 109.618 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.34 133.73 61.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.392 0.615 . . . . 2.4100000000000001 111.453 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -111.64 126.2 54.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.275 -0.875 . . . . 4.4400000000000004 108.711 174.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -133.51 130.08 38.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.568 0.223 . . . . 3.6200000000000001 111.212 -174.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.431 ' HB3' ' CB ' ' A' ' 47' ' ' ALA . 9.9 p30 -145.59 156.48 43.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.513 -0.312 . . . . 2.48 110.584 173.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.446 ' O ' ' HG3' ' A' ' 45' ' ' ARG . . . -137.01 143.94 43.01 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.966 -0.561 . . . . 1.53 110.678 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.98 136.2 33.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.832 -0.622 . . . . 1.8 110.766 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.608 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 40.8 t30 -165.95 95.37 0.59 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.023 -0.535 . . . . 3.3799999999999999 109.708 176.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.57 -98.62 1.41 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.051 -0.595 . . . . 1.8200000000000001 111.818 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.608 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 85.7 Cg_exo -45.12 175.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 124.12 3.213 . . . . 2.1000000000000001 114.078 168.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.544 ' HB2' ' O ' ' A' ' 75' ' ' HIS . 41.3 p90 -68.46 171.93 6.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.152 -0.931 . . . . 4.0499999999999998 112.054 -169.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 39' ' ' ALA . 57.7 ttp180 -113.1 133.32 55.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.839 -0.618 . . . . 3.6000000000000001 111.117 -168.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.2 mt -119.66 129.97 74.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.224 -0.898 . . . . 2.2799999999999998 110.387 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 38' ' ' ASN . . . -118.09 144.42 45.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.012 -0.54 . . . . 1.4399999999999999 111.169 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.0 tp -133.41 134.91 44.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.248 -0.433 . . . . 1.75 110.814 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.34 167.48 24.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.8 -0.636 . . . . 1.5900000000000001 109.4 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -134.04 148.71 51.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.339 . . . . 4.4400000000000004 111.639 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -132.1 149.94 52.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.834 -0.621 . . . . 5.0199999999999996 110.014 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -120.49 139.97 52.11 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.212 -0.292 . . . . 3.7400000000000002 110.212 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 67' ' ' PHE . 49.6 mt-10 -122.48 140.0 53.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.754 0.311 . . . . 5.0499999999999998 111.793 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.17 -177.79 10.65 Favored Glycine 0 C--N 1.331 0.268 0 CA-C-N 115.795 -0.638 . . . . 4.3700000000000001 113.822 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -70.07 138.52 37.03 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.884 2.389 . . . . 7.0899999999999999 111.357 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.03 159.83 41.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.299 -0.41 . . . . 8.5700000000000003 110.985 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -93.95 113.0 24.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.145 -0.48 . . . . 10.039999999999999 110.162 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -60.64 -42.54 97.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.323 -0.399 . . . . 11.890000000000001 111.105 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.0 m -62.82 138.69 58.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.242 -0.435 . . . . 9.7899999999999991 110.481 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.68 61.15 4.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.229 0.538 . . . . 8.7799999999999994 110.221 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.24 156.11 20.35 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.887 -0.673 . . . . 7.7300000000000004 112.134 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -70.11 -26.17 63.84 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.683 0.253 . . . . 10.300000000000001 111.683 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -89.92 0.01 57.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.912 0.387 . . . . 10.960000000000001 110.407 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.45 142.43 37.14 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.773 -0.649 . . . . 5.5599999999999996 111.865 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.4 m -118.36 129.98 55.74 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.025 0.44 . . . . 5.6900000000000004 110.212 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -129.44 136.15 49.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.029 -0.532 . . . . 6.5 110.18 -176.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.561 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 93.8 m-85 -122.46 125.29 45.51 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.896 -0.779 . . . . 4.5999999999999996 108.896 174.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -156.41 160.41 39.59 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.077 0.465 . . . . 2.4500000000000002 110.907 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 94' ' ' ASN . 27.6 mtm180 -140.71 125.27 10.75 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 115.355 -0.839 . . . . 3.7200000000000002 110.565 175.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.63 140.18 11.65 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.848 2.365 . . . . 1.3200000000000001 112.096 174.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -106.06 120.09 40.88 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.858 -0.793 . . . . 2.1899999999999999 108.858 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.0 tp -128.03 106.67 9.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.848 0.356 . . . . 1.73 110.363 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -101.61 128.68 47.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.144 -0.48 . . . . 2.1800000000000002 110.284 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.8 t -120.03 120.01 61.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.306 -0.627 . . . . 2.0600000000000001 109.306 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.544 ' O ' ' HB2' ' A' ' 44' ' ' TRP . 80.1 t60 -119.59 118.22 30.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.118 0.485 . . . . 4.1900000000000004 110.253 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -117.62 138.54 51.89 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.186 -0.916 . . . . 5.1600000000000001 109.9 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -130.09 149.17 51.92 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.855 -0.424 . . . . 3.3100000000000001 109.855 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -137.11 132.68 34.42 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.614 -0.513 . . . . 4.6600000000000001 109.614 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.3 mt -107.54 118.63 37.24 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.416 -0.356 . . . . 4.8799999999999999 110.49 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -96.54 174.62 6.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.23 -0.441 . . . . 6.1900000000000004 110.813 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -69.85 -19.45 63.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.012 -0.54 . . . . 6.0999999999999996 110.284 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -74.33 158.41 34.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.747 -0.661 . . . . 5.2699999999999996 110.303 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -60.13 -40.4 89.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.421 -0.354 . . . . 6.3300000000000001 111.863 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -74.18 149.35 40.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.222 0.534 . . . . 8.3499999999999996 111.47 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.2 p -114.96 150.17 36.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.841 -0.618 . . . . 2.6400000000000001 110.552 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -135.84 160.06 39.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.318 -0.401 . . . . 6.1900000000000004 110.357 -175.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.97 176.88 41.87 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.393 -0.908 . . . . 1.54 112.587 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.12 125.21 27.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.785 -0.45 . . . . 2.73 109.785 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.9 m -120.11 129.95 54.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.157 0.503 . . . . 1.8700000000000001 110.183 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -131.59 146.76 18.24 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.556 -0.831 . . . . 1.1699999999999999 112.577 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -123.92 122.2 4.75 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.908 -0.877 . . . . 1.4399999999999999 110.908 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -111.54 122.22 47.24 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.234 -0.654 . . . . 4.6399999999999997 109.234 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.547 ' HB2' ' HB2' ' A' ' 112' ' ' ARG . 97.8 mtt180 -134.97 137.36 42.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.914 0.388 . . . . 3.2200000000000002 110.907 -173.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.601 ' O ' ' HG2' ' A' ' 69' ' ' ARG . 92.6 m-20 -114.51 130.13 56.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.071 -0.513 . . . . 2.2200000000000002 109.972 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.505 ' HA ' ' HG2' ' A' ' 69' ' ' ARG . 58.8 t80 -106.93 119.94 40.7 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.848 -0.427 . . . . 3.6400000000000001 109.848 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.95 178.59 51.75 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.55 -0.833 . . . . 2.79 112.243 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.72 ' O ' ' HB ' ' A' ' 107' ' ' THR . 58.3 t80 -139.96 146.41 39.1 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.333 -0.618 . . . . 7.8499999999999996 109.333 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -139.97 152.3 46.21 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.208 -0.293 . . . . 7.6900000000000004 110.208 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -101.63 120.09 39.79 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.733 -0.469 . . . . 10.289999999999999 109.733 176.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 88.2 t -70.13 -40.85 78.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.43 -0.805 . . . . 10.19 110.696 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -70.07 -39.9 75.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.749 -0.659 . . . . 12.220000000000001 111.65 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -109.97 109.4 59.17 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.17 -0.468 . . . . 10.48 110.996 -174.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.89 149.92 66.75 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.791 2.328 . . . . 9.6799999999999997 112.732 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.2 150.86 5.94 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.049 -0.596 . . . . 6.5099999999999998 112.145 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -90.05 1.94 55.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.699 0.285 . . . . 8.1099999999999994 111.029 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -60.19 -39.94 88.27 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.281 0.562 . . . . 4.1399999999999997 109.897 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.72 ' HB ' ' O ' ' A' ' 97' ' ' TYR . 32.9 p -105.66 145.96 30.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.488 -0.778 . . . . 3.77 109.991 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.41 148.56 47.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.583 0.23 . . . . 2.2000000000000002 110.676 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -132.58 135.74 46.11 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.368 0.604 . . . . 3.1200000000000001 111.077 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.47 ' HB2' ' HB3' ' A' ' 95' ' ' TYR . 89.7 mtp -136.55 141.45 43.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.784 -1.191 . . . . 2.1200000000000001 107.784 175.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 16.2 mm100 -108.95 139.97 43.08 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.022 -0.671 . . . . 2.4900000000000002 111.546 -172.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.547 ' HB2' ' HB2' ' A' ' 93' ' ' ARG . 76.2 mtt180 -120.37 128.95 53.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.004 -0.544 . . . . 4.4699999999999998 109.864 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -127.72 133.03 49.54 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.004 -0.544 . . . . 2.9199999999999999 110.849 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -121.55 125.22 46.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.958 -0.565 . . . . 2.5099999999999998 109.947 171.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 86.6 mt -120.08 124.0 71.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.978 -0.556 . . . . 2.1299999999999999 109.612 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.608 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -147.05 105.24 3.86 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.617 0.246 . . . . 1.6799999999999999 111.121 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.98 139.95 13.97 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.38 2.053 . . . . 1.54 110.922 175.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.51 137.19 33.48 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.285 -0.416 . . . . 2.3500000000000001 109.916 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -130.88 129.79 42.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.445 -0.343 . . . . 5.1500000000000004 110.493 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -94.28 113.87 25.85 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.17 -0.678 . . . . 3.04 109.17 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.6 t -120.08 119.99 61.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.778 -0.453 . . . . 4.7400000000000002 109.778 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.5 ' HG2' ' HA ' ' A' ' 128' ' ' ARG . 36.4 mtmm -126.84 118.78 25.31 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.745 -0.465 . . . . 6.3600000000000003 109.745 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.3 tp -90.15 -79.01 0.35 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 4.96 110.79 -174.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 47.4 p -142.67 171.77 13.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.371 -0.377 . . . . 4.0700000000000003 110.662 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 62.37 26.27 15.69 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 124.057 0.848 . . . . 5.1699999999999999 112.071 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 57.82 33.54 23.34 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.046 -0.525 . . . . 3.71 110.692 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.1 mt -98.99 130.0 45.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.058 -0.519 . . . . 2.4500000000000002 109.983 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.5 ' HA ' ' HG2' ' A' ' 122' ' ' LYS . 47.9 ttt180 -105.07 127.83 53.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.207 0.527 . . . . 4.6799999999999997 111.02 -174.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.444 ' CE2' HD12 ' A' ' 158' ' ' LEU . 96.7 m-85 -108.18 129.09 55.2 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.521 -0.918 . . . . 4.3600000000000003 108.521 174.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -111.65 113.9 26.58 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.756 -0.831 . . . . 2.5899999999999999 108.756 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -123.1 137.72 11.26 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.204 -0.998 . . . . 1.25 111.908 -175.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.519 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 8.8 p90 -134.45 140.91 46.58 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.115 0.484 . . . . 5.0899999999999999 110.315 177.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 64.3 tp -99.96 111.14 23.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.596 -0.729 . . . . 2.7599999999999998 109.258 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.8 m -100.83 118.0 36.04 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.306 0.574 . . . . 1.99 111.121 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 87.1 mtp -101.09 125.39 47.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.195 -0.911 . . . . 2.7799999999999998 109.26 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.479 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 95.5 m-85 -109.94 127.59 54.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.93 0.395 . . . . 3.6800000000000002 110.988 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -129.9 144.62 51.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.787 -0.642 . . . . 2.1699999999999999 109.986 174.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.437 ' O ' ' HB2' ' A' ' 142' ' ' LEU . 46.9 p90 -148.01 165.52 30.49 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.063 -0.717 . . . . 4.0099999999999998 109.063 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.439 ' HA ' ' HB3' ' A' ' 110' ' ' MET . . . 64.42 170.09 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.673 0.608 . . . . 1.79 110.733 -174.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -76.05 -20.1 58.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.457 0.646 . . . . 3.04 109.572 173.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -66.65 -49.53 65.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.022 -0.99 . . . . 2.4100000000000001 111.997 -175.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.465 ' HA ' ' OG1' ' A' ' 145' ' ' THR . 10.0 mp -68.38 -30.32 69.22 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.888 0.375 . . . . 2.3599999999999999 111.458 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -60.55 -40.21 90.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.394 0.616 . . . . 2.52 109.884 171.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 57.6 m -69.97 -40.38 75.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.956 -1.02 . . . . 2.52 111.366 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 40.8 p -69.99 -36.57 75.26 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.959 0.409 . . . . 2.0099999999999998 110.632 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 62.19 -114.66 7.02 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.484 -0.78 . . . . 1.52 113.044 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -70.07 -31.3 68.82 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.549 0.34 . . . . 6.2199999999999998 111.149 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.9 -48.93 79.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.318 0.488 . . . . 2.0499999999999998 112.318 -172.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.413 ' OD2' ' HG3' ' A' ' 180' ' ' MET . 17.5 t70 -138.98 111.72 7.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.132 0.491 . . . . 2.6400000000000001 110.738 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.3 t -160.01 149.66 18.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.341 -0.845 . . . . 2.6000000000000001 109.102 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 67.5 ttt180 -79.55 125.24 29.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.778 0.323 . . . . 4.0899999999999999 110.26 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.425 ' CG1' HD13 ' A' ' 133' ' ' LEU . 62.1 t -119.92 120.1 62.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.928 -0.578 . . . . 2.1499999999999999 110.082 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -140.06 141.19 36.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.183 -0.303 . . . . 2.5600000000000001 110.183 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 m -115.24 128.39 56.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.683 0.278 . . . . 1.78 110.766 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.519 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 83.3 tt0 -108.68 130.7 55.34 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.786 -0.45 . . . . 2.04 109.786 176.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 44.0 m -118.1 121.11 39.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.283 -0.417 . . . . 2.0299999999999998 110.18 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -111.02 118.12 4.79 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.938 -0.649 . . . . 1.0800000000000001 111.903 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.444 HD12 ' CE2' ' A' ' 129' ' ' PHE . 41.5 tp -95.37 128.36 42.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.889 0.376 . . . . 2.9300000000000002 110.68 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -101.8 108.98 20.64 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.276 -0.638 . . . . 3.02 109.276 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -120.2 126.67 51.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.459 -0.791 . . . . 4.7599999999999998 109.244 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.1 p -99.21 88.81 4.03 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.279 -0.569 . . . . 1.8200000000000001 110.225 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -60.24 -49.67 76.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.412 -0.813 . . . . 3.27 111.292 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.404 ' HB2' HG21 ' A' ' 166' ' ' VAL . 94.0 m-20 -103.01 15.82 28.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.456 -0.338 . . . . 2.4100000000000001 110.824 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 72.52 -53.83 0.69 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.888 0.743 . . . . 2.5800000000000001 111.617 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.6 p -74.38 -18.77 60.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.372 -0.377 . . . . 2.6000000000000001 111.496 -177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.404 HG21 ' HB2' ' A' ' 163' ' ' ASN . 35.7 m -110.6 136.93 45.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.373 -0.376 . . . . 2.0600000000000001 110.3 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.57 123.62 48.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.062 -0.517 . . . . 1.8400000000000001 109.788 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 35.7 mt -102.48 127.43 49.53 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.265 -0.643 . . . . 2.1400000000000001 109.265 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -99.99 108.83 21.13 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.723 -0.473 . . . . 3.73 109.723 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 50.2 t -109.98 119.7 59.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.32 -0.622 . . . . 1.8100000000000001 109.32 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.434 ' HB2' ' HD3' ' A' ' 195' ' ' ARG . 15.5 m120 -109.81 131.55 54.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.012 0.434 . . . . 2.2400000000000002 110.879 -172.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -119.88 139.6 52.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.88 -0.6 . . . . 4.8399999999999999 109.683 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -106.37 122.69 46.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.672 0.272 . . . . 4.4299999999999997 110.387 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 55.7 tp -108.63 114.92 29.13 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.172 -0.467 . . . . 2.8500000000000001 109.963 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -108.59 138.52 44.77 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.013 -0.54 . . . . 3.3100000000000001 110.007 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -105.47 127.83 53.22 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.626 -0.509 . . . . 7.3300000000000001 109.626 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -70.13 153.17 51.8 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.086 -0.578 . . . . 5.0599999999999996 112.519 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.9 139.96 51.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.576 0.227 . . . . 8.0199999999999996 110.611 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -96.54 5.44 50.77 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.162 -0.472 . . . . 9.4900000000000002 110.727 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' MET . . . . . 0.413 ' HG3' ' OD2' ' A' ' 149' ' ' ASP . 98.1 mmm -68.66 -40.11 80.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.999 -0.546 . . . . 11.1 110.104 176.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -149.14 166.59 28.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.397 -0.82 . . . . 10.470000000000001 108.946 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -67.65 129.6 40.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.035 0.445 . . . . 13.06 111.29 -173.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 59.9 m -85.76 117.47 24.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.874 -0.603 . . . . 12.890000000000001 111.516 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -70.21 -39.9 74.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.001 -0.545 . . . . 15.720000000000001 111.884 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -76.79 -28.97 55.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.961 0.41 . . . . 13.470000000000001 111.406 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.429 ' HA ' ' OG ' ' A' ' 190' ' ' SER . 36.0 m-80 -103.3 120.47 40.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.099 -0.501 . . . . 13.15 111.188 -173.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -131.64 -140.69 4.6 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.424 -0.67 . . . . 10.050000000000001 111.424 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -69.77 -40.21 76.2 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.493 -0.558 . . . . 10.699999999999999 109.493 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -140.0 132.03 27.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.334 -0.848 . . . . 11.34 109.376 173.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.429 ' OG ' ' HA ' ' A' ' 186' ' ' ASN . 70.6 m -119.36 156.78 29.44 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.897 0.379 . . . . 6.7800000000000002 110.321 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.1 t -128.26 161.48 29.26 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.949 0.404 . . . . 5.3600000000000003 110.293 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -128.29 144.11 51.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.807 -0.633 . . . . 7.8700000000000001 109.72 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.89 146.54 23.67 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.42 -0.355 . . . . 4.4000000000000004 110.044 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 88.0 mt -100.62 120.04 49.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.986 0.422 . . . . 2.6400000000000001 110.384 -176.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.434 ' HD3' ' HB2' ' A' ' 171' ' ' ASN . 31.4 ttt180 -98.93 119.37 37.59 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.692 -0.686 . . . . 4.1100000000000003 110.754 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -119.6 123.46 43.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.916 0.389 . . . . 1.76 110.72 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -130.86 118.75 21.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.615 -0.721 . . . . 6.1399999999999997 109.751 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 1.3 pt? -136.83 126.82 15.9 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.753 -0.379 . . . . 3.0800000000000001 111.103 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 198' ' ' LEU . 27.7 Cg_endo -94.49 117.44 0.25 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.965 2.443 . . . . 1.98 112.499 175.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 50.8 tp -104.31 116.41 32.1 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.19 -0.67 . . . . 2.7599999999999998 109.19 176.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 96.7 m -99.58 120.07 39.07 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.167 0.508 . . . . 2.4199999999999999 110.881 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 89.7 mt -114.56 80.38 1.39 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.948 -0.76 . . . . 2.77 108.948 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 72.59 -112.85 4.15 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.151 -0.931 . . . . 1.6200000000000001 112.228 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -100.09 10.35 41.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.11 0.481 . . . . 2.8599999999999999 110.948 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -134.42 117.71 16.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.195 -0.457 . . . . 3.23 109.864 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 74.3 m -102.66 134.19 46.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.197 0.522 . . . . 2.0499999999999998 111.227 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 59.1 t -115.45 122.67 69.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.575 -0.739 . . . . 1.9299999999999999 109.239 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 23.5 m -118.3 94.28 46.68 Favored Pre-proline 0 C--N 1.318 -0.767 0 C-N-CA 121.031 -0.268 . . . . 1.6699999999999999 111.37 -176.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.401 ' HA ' HD21 ' A' ' 239' ' ' LEU . 15.6 Cg_exo -69.41 139.97 42.8 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.902 2.401 . . . . 1.28 111.795 173.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.626 ' OH ' ' HB2' ' A' ' 258' ' ' GLU . 64.9 t80 -137.68 140.23 40.68 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.074 -0.512 . . . . 4.8600000000000003 110.408 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 28.7 p -135.34 147.73 49.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.268 -0.424 . . . . 2.0899999999999999 110.866 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -102.42 -0.03 33.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.437 0.637 . . . . 5.29 109.995 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 48.5 mm -110.05 130.01 64.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.452 -0.795 . . . . 4.9400000000000004 109.505 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -73.37 129.36 12.32 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.779 -0.725 . . . . 4.9800000000000004 112.743 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.31 -40.35 89.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.899 0.38 . . . . 8.4399999999999995 111.0 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -70.06 -20.5 63.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 7.9699999999999998 111.603 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -69.03 -39.36 79.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.053 -0.521 . . . . 11.1 111.887 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -115.99 132.89 56.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.811 0.339 . . . . 12.24 111.175 -176.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 17.0 m -100.37 132.06 45.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.11 -0.495 . . . . 10.220000000000001 111.101 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -110.65 109.64 19.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.078 0.466 . . . . 11.92 109.857 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -70.48 -39.84 73.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.404 -0.817 . . . . 14.460000000000001 112.022 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -89.9 138.9 31.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.991 0.424 . . . . 14.529999999999999 110.344 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -105.96 -18.41 14.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.931 -0.577 . . . . 17.07 110.48 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -60.13 -49.01 79.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.269 0.557 . . . . 15.779999999999999 110.092 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -154.62 161.02 41.78 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.361 -0.977 . . . . 15.67 108.361 174.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -145.69 179.6 7.33 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.742 -0.383 . . . . 14.5 111.325 -176.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 8.3 tp -60.2 -40.03 82.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.212 -0.449 . . . . 15.380000000000001 112.106 -174.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -67.66 -31.81 72.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.857 0.36 . . . . 14.73 110.695 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -59.97 -39.6 86.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.156 -0.475 . . . . 16.969999999999999 111.043 -176.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -68.65 129.65 40.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.399 -0.364 . . . . 12.779999999999999 110.949 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 164.8 -171.17 40.16 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.346 -0.701 . . . . 11.369999999999999 111.346 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -92.67 -13.87 28.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.448 0.642 . . . . 12.81 109.783 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.488 ' HA ' ' CD ' ' A' ' 236' ' ' ARG . 97.0 m-20 56.62 37.29 28.7 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.418 -1.264 . . . . 9.9900000000000002 112.502 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -109.48 97.69 7.22 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.741 -0.466 . . . . 11.32 109.741 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.7 39.91 30.85 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.339 -0.846 . . . . 6.8799999999999999 111.666 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.488 ' CD ' ' HA ' ' A' ' 233' ' ' ASP . 83.6 mtp180 -69.85 -39.98 76.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.594 -0.73 . . . . 8.9399999999999995 110.798 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.3 m -115.09 154.32 16.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.354 -0.839 . . . . 2.9700000000000002 109.434 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -78.14 137.61 20.1 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.418 -0.896 . . . . 1.3999999999999999 111.283 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.401 HD21 ' HA ' ' A' ' 209' ' ' PRO . 94.5 mt -134.45 124.47 25.67 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.759 -0.46 . . . . 2.4300000000000002 109.759 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.489 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 64.5 t80 -118.52 118.4 31.59 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.158 -0.682 . . . . 4.3300000000000001 109.158 175.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -104.79 129.72 53.01 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.127 -0.488 . . . . 3.2599999999999998 110.379 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -114.45 143.34 17.99 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 115.576 -0.738 . . . . 1.3500000000000001 111.533 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -107.28 112.35 25.16 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.484 -0.562 . . . . 4.7599999999999998 109.484 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -105.42 28.4 7.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.337 -0.847 . . . . 4.29 110.31 -172.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -59.89 -40.12 87.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.013 -0.994 . . . . 7.5599999999999996 110.741 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . 0.421 ' OE1' ' HB3' ' A' ' 249' ' ' LEU . 62.4 tt0 -133.05 133.79 43.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.948 -0.569 . . . . 7.0199999999999996 110.358 -176.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -63.38 -39.86 95.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.788 -0.642 . . . . 6.4800000000000004 110.595 176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -68.19 -50.07 42.02 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.539 -0.839 . . . . 2.9199999999999999 112.535 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.421 ' HB3' ' OE1' ' A' ' 246' ' ' GLN . 59.1 tp -118.51 124.15 46.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.94 0.4 . . . . 3.5800000000000001 111.046 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 46.9 p -126.78 148.21 49.94 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.91 -0.587 . . . . 2.6000000000000001 110.082 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 57.7 t -116.43 137.67 49.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.434 -0.348 . . . . 2.2400000000000002 110.3 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 43.4 m -111.76 139.76 46.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.327 -0.397 . . . . 2.0 110.628 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.421 ' HG ' ' HG3' ' A' ' 254' ' ' GLU . 59.3 tp -132.65 143.42 49.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.544 -0.298 . . . . 3.4199999999999999 111.31 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.421 ' HG3' ' HG ' ' A' ' 253' ' ' LEU . 43.9 mt-10 60.34 -159.99 0.3 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.886 0.741 . . . . 4.0800000000000001 111.108 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -144.47 137.05 26.66 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.05 0.453 . . . . 5.1699999999999999 111.529 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 210' ' ' TYR . . . -123.67 44.25 2.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.637 -0.71 . . . . 3.5800000000000001 109.221 172.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -120.02 140.59 50.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.558 -0.747 . . . . 7.5800000000000001 110.669 -175.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.626 ' HB2' ' OH ' ' A' ' 210' ' ' TYR . 82.0 tt0 -60.12 -49.94 75.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.167 -0.924 . . . . 8.5399999999999991 110.862 175.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 55.4 p-90 -140.78 159.78 41.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.009 -0.996 . . . . 12.720000000000001 109.973 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -98.29 147.46 24.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.179 -0.464 . . . . 11.09 110.383 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -74.6 53.23 0.54 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.335 0.588 . . . . 11.41 110.792 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -136.45 148.16 47.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.762 -0.653 . . . . 12.49 109.738 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.2 -25.32 63.36 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.179 -0.464 . . . . 12.460000000000001 110.971 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -89.92 70.01 7.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.14 0.495 . . . . 13.779999999999999 109.737 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -165.27 43.29 0.29 Allowed Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.249 -0.887 . . . . 11.300000000000001 111.031 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -59.89 -40.1 87.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.186 0.517 . . . . 12.59 110.5 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 24.4 m -88.87 -66.29 0.93 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.665 -0.698 . . . . 11.1 111.182 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 50.01 39.7 19.53 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.719 0.771 . . . . 12.42 111.113 -173.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -84.43 -39.96 18.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.377 -0.829 . . . . 11.82 110.528 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -81.19 148.86 29.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.735 -0.666 . . . . 9.5999999999999996 110.278 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -84.34 145.33 28.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.186 -0.461 . . . . 7.7999999999999998 111.209 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . 0.538 ' HB3' ' OE2' ' A' ' 18' ' ' GLU . 93.8 m-85 -128.04 163.01 25.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.749 -0.659 . . . . 6.9900000000000002 109.999 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -140.15 125.6 19.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.503 0.192 . . . . 2.4100000000000001 110.516 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -138.4 158.62 24.99 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 119.529 -1.32 . . . . 1.6200000000000001 112.489 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.19 127.17 68.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.17 -0.678 . . . . 2.4900000000000002 109.17 176.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.68 157.23 21.74 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.757 -0.735 . . . . 1.3 111.638 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 6.2 p -119.96 121.31 65.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.116 0.484 . . . . 2.3399999999999999 110.344 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -122.21 123.71 42.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.895 -0.593 . . . . 2.7999999999999998 110.517 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -118.08 130.03 55.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.745 -0.465 . . . . 5.1900000000000004 109.745 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 8.9 p -117.5 129.44 55.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.953 0.406 . . . . 2.0499999999999998 110.498 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 61.4 t80 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.395 -0.812 . . . . 4.4199999999999999 109.572 -176.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.888 0.375 . . . . 11.970000000000001 110.467 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.427 ' HB2' ' ND2' ' A' ' 5' ' ' ASN . 45.0 mt-10 -113.03 138.34 50.04 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.099 -0.5 . . . . 10.35 110.246 -178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -60.2 -36.53 77.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.527 -0.76 . . . . 9.3100000000000005 109.809 176.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -60.13 -39.42 86.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.897 -1.047 . . . . 9.4399999999999995 111.324 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.427 ' ND2' ' HB2' ' A' ' 2' ' ' GLU . 94.1 m-20 -69.4 -40.05 77.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.402 -0.363 . . . . 7.75 111.091 -178.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -69.54 -47.24 64.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.366 -0.379 . . . . 3.6099999999999999 110.811 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.474 ' HA ' ' HB2' ' A' ' 41' ' ' ASN . 70.0 m95 -88.59 107.35 18.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.131 0.491 . . . . 3.9100000000000001 111.171 -176.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -94.87 130.44 41.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.619 -0.719 . . . . 3.9399999999999999 110.592 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.34 139.48 52.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.165 -0.925 . . . . 3.21 110.244 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 15.6 m120 -122.67 132.03 54.07 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.94 -0.573 . . . . 2.6499999999999999 110.105 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.0 mt -120.06 119.83 61.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.021 -0.733 . . . . 2.0699999999999998 109.021 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.428 ' HA3' ' CZ ' ' A' ' 36' ' ' TYR . . . -115.77 134.43 11.49 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.103 -1.046 . . . . 0.92000000000000004 112.453 -176.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -121.78 134.41 54.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.91 0.386 . . . . 1.6499999999999999 110.147 175.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 91.0 mtp -140.66 157.09 45.95 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.268 -0.641 . . . . 2.9700000000000002 109.268 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -100.19 121.98 42.3 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.834 -0.346 . . . . 3.1499999999999999 110.99 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -112.92 143.09 44.79 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.751 -0.462 . . . . 5.0899999999999999 109.751 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 87.2 mt -103.83 127.47 57.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.908 0.385 . . . . 5.3300000000000001 111.275 -171.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.461 ' OE1' HG13 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -120.45 129.93 54.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.815 -0.63 . . . . 8.2799999999999994 109.626 179.347 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -165.23 35.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.399 . . . . 10.0 110.688 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.461 HG13 ' OE1' ' A' ' 18' ' ' GLU . 27.8 m -69.3 -9.33 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.446 -0.343 . . . . 11.380000000000001 111.823 -177.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.16 -39.81 87.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 13.1 110.632 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -87.05 -168.78 45.22 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.826 -0.702 . . . . 12.52 112.275 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -69.17 -29.97 68.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.869 0.366 . . . . 15.18 111.058 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.26 2.29 74.13 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.8 -0.714 . . . . 12.279999999999999 112.538 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.9 -39.94 96.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.198 0.523 . . . . 12.82 110.401 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -114.61 142.01 47.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.517 -0.765 . . . . 10.81 109.118 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 53.0 ttm -102.37 120.07 39.88 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.005 0.431 . . . . 10.210000000000001 110.457 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -72.4 144.79 48.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.843 -0.617 . . . . 8.0600000000000005 110.259 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.31 26.2 5.79 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.086 -0.578 . . . . 6.0800000000000001 112.857 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.9 tp -99.75 119.9 38.87 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.334 -0.617 . . . . 5.96 109.334 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.82 144.3 51.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.133 0.492 . . . . 3.2400000000000002 111.492 -175.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -97.42 137.72 21.13 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.524 -0.762 . . . . 3.48 110.083 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.9 134.0 41.39 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 121.914 1.743 . . . . 2.0299999999999998 111.132 173.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 28.3 t -124.59 142.4 51.38 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.603 -0.888 . . . . 2.2799999999999998 108.603 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 62.5 t -130.01 133.61 64.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.893 0.378 . . . . 2.4100000000000001 111.002 -174.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.428 ' CZ ' ' HA3' ' A' ' 12' ' ' GLY . 53.8 p90 -130.22 151.82 50.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.675 -0.491 . . . . 4.4400000000000004 109.675 175.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 93.2 m-85 -119.55 139.95 51.31 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.517 -0.31 . . . . 3.6200000000000001 111.051 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 18.5 m-80 -129.65 141.37 50.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.801 -0.636 . . . . 2.48 109.995 174.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.11 142.67 38.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.68 -0.236 . . . . 1.53 110.439 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.61 139.21 11.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.197 0.443 . . . . 1.8 112.197 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.643 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 34.3 t30 -167.68 94.14 0.41 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.346 -0.843 . . . . 3.3799999999999999 109.186 171.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.92 -91.89 1.73 Allowed Glycine 0 N--CA 1.454 -0.144 0 N-CA-C 111.276 -0.73 . . . . 1.8200000000000001 111.276 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.643 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 72.6 Cg_exo -50.51 173.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.331 2.687 . . . . 2.1000000000000001 113.06 167.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.511 ' CD1' HG11 ' A' ' 74' ' ' VAL . 48.9 p90 -68.4 176.65 2.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.737 -0.665 . . . . 4.0499999999999998 111.951 -170.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -112.83 129.31 56.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.515 -0.766 . . . . 3.6000000000000001 110.069 -173.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 45.6 pt -110.92 143.56 20.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.271 -0.422 . . . . 2.2799999999999998 110.939 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 72' ' ' LEU . . . -118.52 127.12 53.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.746 -0.661 . . . . 1.4399999999999999 110.352 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.7 tp -119.95 128.75 53.87 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.889 0.376 . . . . 1.75 111.176 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.53 157.1 42.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.589 -0.732 . . . . 1.5900000000000001 109.423 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -120.09 140.0 51.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.083 0.468 . . . . 4.4400000000000004 111.141 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -112.14 133.28 54.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.657 -0.701 . . . . 5.0199999999999996 111.289 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -122.56 127.04 48.95 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.38 -0.6 . . . . 3.7400000000000002 109.38 174.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.624 ' HB2' ' OH ' ' A' ' 95' ' ' TYR . 39.0 tt0 -67.44 -39.94 85.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.238 0.542 . . . . 5.0499999999999998 110.021 178.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -126.69 79.98 0.37 Allowed Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 111.067 -0.813 . . . . 4.3700000000000001 111.067 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.83 149.96 80.36 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.271 2.648 . . . . 7.0899999999999999 111.968 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.4 HG13 ' H ' ' A' ' 58' ' ' TYR . 48.7 t -128.71 129.93 68.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.397 -0.365 . . . . 8.5700000000000003 110.067 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -59.86 -40.02 87.19 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.108 -0.496 . . . . 10.039999999999999 110.854 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.4 ' H ' HG13 ' A' ' 56' ' ' VAL . 98.3 m-85 -70.16 138.96 52.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.897 -0.592 . . . . 11.890000000000001 110.097 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.5 t -119.24 133.48 55.73 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.117 -0.492 . . . . 9.7899999999999991 109.839 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 60.86 40.05 16.22 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 123.657 0.598 . . . . 8.7799999999999994 110.928 -177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.69 -171.84 43.84 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.477 -0.783 . . . . 7.7300000000000004 111.602 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -86.78 118.55 26.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.882 0.372 . . . . 10.300000000000001 110.455 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -141.15 128.08 20.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.063 -0.517 . . . . 10.960000000000001 110.123 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.61 -38.01 9.16 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.023 -0.608 . . . . 5.5599999999999996 113.019 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.6 p -111.02 128.76 55.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.75 0.31 . . . . 5.6900000000000004 110.723 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -119.31 128.47 54.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.287 0.565 . . . . 6.5 111.517 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -139.99 137.43 34.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.205 -0.907 . . . . 4.5999999999999996 109.309 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -159.96 168.38 25.82 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.433 -0.349 . . . . 2.4500000000000002 110.518 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.489 ' HD2' ' HB3' ' A' ' 93' ' ' ARG . 58.6 ttp85 -142.43 123.73 8.59 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.817 -0.629 . . . . 3.7200000000000002 110.267 169.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.611 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 72.9 Cg_endo -80.07 139.98 13.85 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.14 1.893 . . . . 1.3200000000000001 110.54 167.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.489 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 33.5 tt0 -124.15 113.87 18.92 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.227 0.537 . . . . 2.1899999999999999 110.077 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.554 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 40.8 tp -120.21 119.73 34.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.172 -0.922 . . . . 1.73 110.209 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 34.2 mt-10 -104.21 147.03 27.93 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.289 0.566 . . . . 2.1800000000000002 111.08 174.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.511 HG11 ' CD1' ' A' ' 44' ' ' TRP . 63.8 t -113.41 120.08 62.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.95 -1.023 . . . . 2.0600000000000001 108.83 174.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.563 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 93.4 m-70 -122.27 127.19 49.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.88 0.371 . . . . 4.1900000000000004 110.28 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.407 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 84.5 t80 -139.94 139.09 36.07 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.114 -0.493 . . . . 5.1600000000000001 110.43 -178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -99.17 119.87 38.57 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.587 -0.523 . . . . 3.3100000000000001 109.587 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -100.02 120.03 39.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.289 -0.414 . . . . 4.6600000000000001 109.963 -174.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.9 tp -116.51 119.92 37.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.267 -0.424 . . . . 4.8799999999999999 112.077 -172.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -119.54 147.13 44.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.908 -0.587 . . . . 6.1900000000000004 110.169 173.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -89.85 1.21 56.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.229 -0.441 . . . . 6.0999999999999996 111.335 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -96.61 26.94 4.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.117 0.484 . . . . 5.2699999999999996 110.279 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 60.64 40.07 16.97 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.101 -0.954 . . . . 6.3300000000000001 112.279 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -108.91 129.94 55.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.062 -0.517 . . . . 8.3499999999999996 109.891 171.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.487 ' HB3' ' CD1' ' A' ' 119' ' ' TRP . 22.7 m -115.38 117.08 29.42 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.157 -0.474 . . . . 2.6400000000000001 110.651 -178.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -135.64 159.53 41.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.135 -0.484 . . . . 6.1900000000000004 110.257 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -141.0 -178.52 17.4 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.983 -1.247 . . . . 1.54 109.983 174.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 75' ' ' HIS . 64.7 tp -140.18 121.78 15.24 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 117.515 0.657 . . . . 2.73 110.953 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.44 HG22 ' CE1' ' A' ' 75' ' ' HIS . 92.9 m -120.08 116.61 26.05 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.689 -0.687 . . . . 1.8700000000000001 109.595 169.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 73' ' ' GLU . . . -125.99 154.63 18.88 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.837 -0.905 . . . . 1.1699999999999999 110.837 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.81 124.3 2.23 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.669 -0.777 . . . . 1.4399999999999999 112.102 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -111.35 121.77 46.09 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.843 -0.799 . . . . 4.6399999999999997 108.843 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 112' ' ' ARG . 34.8 mtm180 -142.59 126.87 17.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.392 -0.367 . . . . 3.2200000000000002 111.208 -172.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.611 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 57.6 t30 -122.16 130.01 52.83 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.445 -0.576 . . . . 2.2200000000000002 109.445 174.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.624 ' OH ' ' HB2' ' A' ' 53' ' ' GLU . 3.3 t80 -121.95 115.95 23.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.804 -0.18 . . . . 3.6400000000000001 110.955 -172.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.71 129.85 16.83 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.473 -0.87 . . . . 2.79 111.167 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -127.57 138.54 52.91 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.194 -0.298 . . . . 7.8499999999999996 110.194 -174.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -130.09 170.14 14.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 7.6900000000000004 110.595 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -119.87 139.96 51.58 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.878 -0.786 . . . . 10.289999999999999 108.878 174.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.9 t -70.1 -30.52 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.405 . . . . 10.19 110.952 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -69.58 -33.17 72.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.043 -0.526 . . . . 12.220000000000001 110.392 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -74.13 155.49 88.19 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.021 -0.536 . . . . 10.48 110.139 171.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.81 -13.8 39.19 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.408 2.738 . . . . 9.6799999999999997 113.853 -173.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.07 -7.49 81.54 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.622 -0.799 . . . . 6.5099999999999998 112.154 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -89.87 4.12 50.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.537 0.684 . . . . 8.1099999999999994 109.372 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -79.16 170.54 16.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.687 -1.142 . . . . 4.1399999999999997 110.235 177.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.2 m -140.37 130.64 25.12 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.931 0.396 . . . . 3.77 110.578 173.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.95 144.25 33.64 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.681 -0.859 . . . . 2.2000000000000002 108.681 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.431 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 95.8 m-20 -129.06 127.0 40.65 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.87 0.367 . . . . 3.1200000000000001 110.739 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.482 ' HB3' ' HA ' ' A' ' 139' ' ' ALA . 41.8 mtm -108.59 130.03 55.31 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.043 -0.725 . . . . 2.1200000000000001 109.043 175.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -102.99 137.22 41.48 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.093 -0.643 . . . . 2.4900000000000002 111.241 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 53.7 mtp85 -119.98 109.97 16.14 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.978 -0.749 . . . . 4.4699999999999998 108.978 177.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -110.02 140.02 44.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.342 0.592 . . . . 2.9199999999999999 112.046 -175.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -129.03 124.42 34.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.588 -1.187 . . . . 2.5099999999999998 109.854 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 80.3 mt -140.46 120.03 12.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.471 -0.196 . . . . 2.1299999999999999 110.471 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -155.38 106.24 2.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.649 -0.25 . . . . 1.6799999999999999 111.425 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.716 ' HD2' ' CD1' ' A' ' 132' ' ' TRP . 13.3 Cg_exo -71.48 88.06 0.76 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.461 2.108 . . . . 1.54 111.045 168.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 119' ' ' TRP . 12.1 p-10 -108.5 139.38 43.34 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.211 0.449 . . . . 2.3500000000000001 112.211 -166.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.487 ' CD1' ' HB3' ' A' ' 85' ' ' SER . 7.3 t-105 176.61 -176.59 0.13 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.34 -0.845 . . . . 5.1500000000000004 108.993 174.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.603 ' OD1' ' HB3' ' A' ' 128' ' ' ARG . 30.1 t70 -80.24 117.44 21.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.135 0.493 . . . . 3.04 111.277 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.4 t -107.01 120.04 57.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.019 -0.734 . . . . 4.7400000000000002 109.019 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -93.08 72.01 4.63 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.932 -0.577 . . . . 6.3600000000000003 110.636 -171.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.2 tp -67.32 -40.04 85.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.753 -0.658 . . . . 4.96 110.709 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 24.4 p -123.28 150.16 43.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.756 -0.657 . . . . 4.0700000000000003 110.03 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -69.93 -40.26 75.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.793 0.33 . . . . 5.1699999999999999 111.279 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -70.24 -40.26 74.57 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.103 -0.498 . . . . 3.71 112.212 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.0 mt -119.95 139.16 52.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.919 0.39 . . . . 2.4500000000000002 111.339 -171.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.603 ' HB3' ' OD1' ' A' ' 120' ' ' ASP . 62.0 mtt180 -103.26 139.26 38.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.013 -0.539 . . . . 4.6799999999999997 110.097 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -112.74 107.82 16.61 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.436 -0.579 . . . . 4.3600000000000003 109.436 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 2.9 t-20 -110.83 114.3 27.53 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 120.797 0.332 . . . . 2.5899999999999999 110.495 -174.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 142.52 -163.18 27.24 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.326 -0.71 . . . . 1.25 111.326 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.716 ' CD1' ' HD2' ' A' ' 117' ' ' PRO . 47.8 t-105 -161.34 168.53 23.78 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.977 0.389 . . . . 5.0899999999999999 110.799 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 46.9 tp -100.5 119.93 39.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.741 -0.663 . . . . 2.7599999999999998 109.596 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.1 p -122.97 158.46 30.43 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.182 0.438 . . . . 1.99 112.182 -172.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 75.0 mtm -118.39 136.74 53.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.047 -0.524 . . . . 2.7799999999999998 109.976 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -120.04 140.41 51.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.2 0.524 . . . . 3.6800000000000002 111.518 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -124.39 136.34 53.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.365 -0.834 . . . . 2.1699999999999999 109.503 176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.474 ' H ' HD23 ' A' ' 142' ' ' LEU . 42.2 m-85 -128.46 146.65 50.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.155 -0.475 . . . . 4.0099999999999998 110.1 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 110' ' ' MET . . . 59.99 -164.87 0.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.714 -0.675 . . . . 1.79 111.642 177.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -77.39 -31.33 54.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.033 0.444 . . . . 3.04 110.766 172.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -60.0 -50.28 74.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.622 -0.717 . . . . 2.4100000000000001 112.328 -169.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.474 HD23 ' H ' ' A' ' 138' ' ' PHE . 8.8 mp -70.7 -29.91 66.33 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.769 -0.373 . . . . 2.3599999999999999 111.219 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -61.11 -43.61 98.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.857 0.36 . . . . 2.52 110.704 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.3 p -70.4 -31.1 68.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 2.52 111.468 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 75.8 p -97.78 9.94 41.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.583 -0.28 . . . . 2.0099999999999998 110.542 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -60.0 -24.66 60.88 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.906 -0.588 . . . . 1.52 114.06 -172.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -69.87 -38.49 76.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.851 0.358 . . . . 6.2199999999999998 110.415 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -107.62 -55.93 2.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.451 0.537 . . . . 2.0499999999999998 112.451 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -109.2 117.41 34.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.424 0.631 . . . . 2.6400000000000001 111.963 -171.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 24.4 p -130.1 147.01 51.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.061 -0.972 . . . . 2.6000000000000001 110.186 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -77.18 132.77 38.94 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.517 -0.549 . . . . 4.0899999999999999 109.517 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.99 129.57 64.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.297 -0.41 . . . . 2.1499999999999999 110.899 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.62 137.96 54.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.084 -0.507 . . . . 2.5600000000000001 110.397 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.465 ' HB ' ' HB2' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -133.38 101.04 5.01 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.281 -0.418 . . . . 1.78 110.179 175.132 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -99.52 110.45 22.9 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.289 -1.004 . . . . 2.04 108.289 172.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 32.1 m -129.14 121.05 26.95 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.013 0.435 . . . . 2.0299999999999998 111.183 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 171' ' ' ASN . . . -101.12 120.1 6.76 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.896 -0.882 . . . . 1.0800000000000001 110.896 174.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 92.5 mt -97.11 129.54 44.5 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.502 -0.555 . . . . 2.9300000000000002 109.502 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.435 ' HG2' ' HG2' ' A' ' 169' ' ' ARG . 69.9 mt-30 -102.0 119.12 38.28 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.644 -0.422 . . . . 3.02 110.625 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -118.81 133.11 56.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.513 -0.767 . . . . 4.7599999999999998 109.3 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.5 p -103.57 92.15 4.33 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.405 -0.518 . . . . 1.8200000000000001 110.767 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -60.01 -48.96 79.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.593 -0.731 . . . . 3.27 111.204 -176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.425 ' HB2' HG21 ' A' ' 166' ' ' VAL . 10.9 m120 -101.96 13.18 35.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.486 -0.324 . . . . 2.4100000000000001 111.331 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 73.88 -53.41 0.69 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.367 0.667 . . . . 2.5800000000000001 111.915 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.5 p -74.51 -18.77 60.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.985 0.422 . . . . 2.6000000000000001 111.564 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.425 HG21 ' HB2' ' A' ' 163' ' ' ASN . 16.7 m -119.93 144.48 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.297 -0.41 . . . . 2.0600000000000001 110.175 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -114.83 132.74 56.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.3 -0.409 . . . . 1.8400000000000001 111.127 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 27.3 mt -104.35 129.98 52.21 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.718 -0.845 . . . . 2.1400000000000001 108.718 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.435 ' HG2' ' HG2' ' A' ' 159' ' ' GLN . 81.0 mtt180 -110.08 112.81 25.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.994 0.426 . . . . 3.73 110.633 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.57 119.75 60.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.975 -0.557 . . . . 1.8100000000000001 109.87 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.426 ' HA ' ' HA2' ' A' ' 157' ' ' GLY . 47.9 t30 -119.51 133.9 55.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.0 0.428 . . . . 2.2400000000000002 110.674 -172.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -138.9 150.92 46.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.768 -0.651 . . . . 4.8399999999999999 110.835 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -106.29 129.7 54.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.024 -0.534 . . . . 4.4299999999999997 110.381 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.465 ' HB2' ' HB ' ' A' ' 154' ' ' THR . 86.6 mt -114.75 131.99 56.59 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.466 -0.568 . . . . 2.8500000000000001 109.466 171.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -113.47 177.21 4.71 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.564 -0.289 . . . . 3.3100000000000001 110.532 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -59.81 -40.16 87.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.208 0.528 . . . . 7.3300000000000001 110.083 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -173.86 157.43 25.62 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.348 -0.701 . . . . 5.0599999999999996 111.348 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -79.94 129.08 34.2 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.735 -0.469 . . . . 8.0199999999999996 109.735 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -109.62 153.4 24.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.32 -0.4 . . . . 9.4900000000000002 110.275 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 95.8 mmm -99.57 84.21 2.92 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.313 -0.403 . . . . 11.1 110.097 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -77.12 133.09 39.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.098 -0.501 . . . . 10.470000000000001 110.637 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -89.41 -0.07 57.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.118 -0.492 . . . . 13.06 110.019 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 34.7 t -61.93 -39.97 93.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.482 -0.781 . . . . 12.890000000000001 110.25 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -117.45 126.32 52.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.12 -0.491 . . . . 15.720000000000001 110.146 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -70.07 -39.89 75.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.471 0.653 . . . . 13.470000000000001 109.314 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -140.02 178.77 7.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.063 -0.971 . . . . 13.15 109.452 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 142.05 -55.39 0.6 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.533 -0.841 . . . . 10.050000000000001 111.502 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -88.8 119.98 29.79 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.155 -0.683 . . . . 10.699999999999999 109.155 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -104.49 -14.58 15.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.938 0.399 . . . . 11.34 111.113 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 52.3 m -140.31 148.64 41.67 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.759 -0.46 . . . . 6.7800000000000002 109.759 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 24.2 p -70.03 -22.05 63.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.135 -0.484 . . . . 5.3600000000000003 111.031 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -134.04 100.06 4.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.746 -0.661 . . . . 7.8700000000000001 109.369 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -99.13 128.45 45.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.273 0.559 . . . . 4.4000000000000004 109.718 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 32.4 mm -116.98 139.92 41.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.623 -0.717 . . . . 2.6400000000000001 111.184 -164.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 48.3 mtm105 -114.02 139.98 48.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.334 -0.247 . . . . 4.1100000000000003 110.334 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -132.22 137.99 47.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.776 0.322 . . . . 1.76 110.653 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -150.16 160.01 43.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.35 -0.386 . . . . 6.1399999999999997 110.281 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -137.93 139.13 25.28 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 120.69 0.281 . . . . 3.0800000000000001 110.394 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.33 135.65 22.84 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.401 2.067 . . . . 1.98 112.43 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 67.3 tp -137.76 134.15 34.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.685 -0.689 . . . . 2.7599999999999998 109.559 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 85.4 m -119.92 129.56 54.4 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.814 0.34 . . . . 2.4199999999999999 110.333 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.1 mt -131.45 81.71 2.0 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.283 0.563 . . . . 2.77 109.523 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 71.42 -121.47 8.94 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.429 -0.805 . . . . 1.6200000000000001 112.483 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -96.54 9.13 42.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.592 0.71 . . . . 2.8599999999999999 109.725 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -120.01 129.99 54.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.198 -0.91 . . . . 3.23 109.615 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 7.0 p -103.71 146.28 28.84 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.297 -0.41 . . . . 2.0499999999999998 110.661 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 58.0 t -133.4 140.08 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 1.9299999999999999 110.119 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 46.1 m -138.49 95.48 10.14 Favored Pre-proline 0 C--N 1.319 -0.742 0 O-C-N 122.13 -0.356 . . . . 1.6699999999999999 110.533 173.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.11 139.97 90.11 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.43 2.087 . . . . 1.28 111.477 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -109.5 137.23 47.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.033 -0.53 . . . . 4.8600000000000003 109.65 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 33.1 p -144.67 162.1 37.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.177 -0.465 . . . . 2.0899999999999999 110.731 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -138.29 142.02 39.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.26 -0.645 . . . . 5.29 109.26 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 84.3 mt -60.65 -43.66 95.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.11 0.481 . . . . 4.9400000000000004 110.423 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 109.96 -110.12 2.83 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.885 -0.674 . . . . 4.9800000000000004 111.995 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.3 mt -139.67 159.76 41.42 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.336 -0.616 . . . . 8.4399999999999995 109.336 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -59.97 -40.14 88.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.203 0.525 . . . . 7.9699999999999998 110.732 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -67.47 -39.92 85.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.338 -0.846 . . . . 11.1 111.376 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -81.09 153.53 27.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.366 0.603 . . . . 12.24 112.009 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 50.4 m -140.01 153.57 46.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.694 -0.685 . . . . 10.220000000000001 109.588 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -94.68 125.64 39.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.823 -0.436 . . . . 11.92 109.823 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -119.81 139.88 51.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.376 -0.375 . . . . 14.460000000000001 110.276 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -71.65 -19.97 62.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.632 -0.713 . . . . 14.529999999999999 111.571 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 38.5 t90 -88.03 140.29 29.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.099 0.476 . . . . 17.07 110.825 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -75.32 131.93 40.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.482 -0.781 . . . . 15.779999999999999 110.593 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -60.6 -39.98 90.14 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.36 -0.836 . . . . 15.67 111.541 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -146.38 172.75 13.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.898 -0.592 . . . . 14.5 110.377 -177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 10.2 tp -74.43 -25.19 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.36 0.504 . . . . 15.380000000000001 112.36 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -89.91 67.2 7.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.161 0.505 . . . . 14.73 111.662 -173.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -69.84 137.15 51.51 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.272 -0.64 . . . . 16.969999999999999 109.272 174.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -60.18 -39.81 87.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.996 -0.547 . . . . 12.779999999999999 111.743 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 174.16 -175.69 46.59 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.53 -0.843 . . . . 11.369999999999999 112.141 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -66.05 -40.04 90.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.974 0.416 . . . . 12.81 110.098 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -72.9 136.83 45.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.003 -0.544 . . . . 9.9900000000000002 109.752 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -103.61 121.65 43.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.147 -0.479 . . . . 11.32 110.744 -174.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -69.8 -19.51 63.49 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.62 -0.718 . . . . 6.8799999999999999 110.218 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -68.45 -26.73 65.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.346 -0.843 . . . . 8.9399999999999995 111.014 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 62.4 t -116.54 124.22 72.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.298 -0.41 . . . . 2.9700000000000002 110.886 -174.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -85.51 165.98 39.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.781 -0.723 . . . . 1.3999999999999999 111.438 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 89.4 mt -134.33 129.92 36.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.471 0.636 . . . . 2.4300000000000002 112.04 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.494 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 57.5 t80 -100.67 131.29 46.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.333 -0.848 . . . . 4.3300000000000001 109.845 171.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.438 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 91.0 m-85 -113.97 130.01 56.56 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.453 -0.573 . . . . 3.2599999999999998 109.453 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -123.3 134.24 9.35 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.7 -0.762 . . . . 1.3500000000000001 111.67 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.43 110.98 23.08 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.156 -0.683 . . . . 4.7599999999999998 109.156 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -107.06 102.12 11.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.908 -0.587 . . . . 4.29 110.37 -176.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.421 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 91.3 m-85 -120.0 135.98 54.72 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.13 -0.486 . . . . 7.5599999999999996 109.817 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -84.8 9.65 13.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.448 0.642 . . . . 7.0199999999999996 110.107 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -90.71 6.26 44.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.186 -0.916 . . . . 6.4800000000000004 110.268 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 99.94 5.13 55.22 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.791 -0.718 . . . . 2.9199999999999999 112.816 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 245' ' ' PHE . 65.9 tp -102.95 120.1 40.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.927 0.394 . . . . 3.5800000000000001 111.254 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 23.9 t -130.72 129.24 42.29 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.699 -0.852 . . . . 2.6000000000000001 108.699 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.51 133.17 64.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.932 -0.307 . . . . 2.2400000000000002 110.643 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 15.5 m -116.65 120.1 37.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.069 -0.514 . . . . 2.0 110.057 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 86.0 mt -125.2 127.51 46.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.753 -0.203 . . . . 3.4199999999999999 110.515 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -120.55 111.33 17.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.854 0.359 . . . . 4.0800000000000001 110.487 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -120.1 140.09 51.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.963 0.411 . . . . 5.1699999999999999 111.316 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -127.28 36.05 4.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.899 -0.591 . . . . 3.5800000000000001 110.491 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 59.84 34.55 21.82 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.843 -0.617 . . . . 7.5800000000000001 111.762 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 58.76 40.43 23.1 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.734 -0.666 . . . . 8.5399999999999991 111.436 176.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . 0.533 ' CD1' ' HB2' ' A' ' 261' ' ' ASP . 62.2 t-105 -95.87 129.24 43.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.035 -0.529 . . . . 12.720000000000001 111.018 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -83.34 124.53 30.72 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.947 -0.76 . . . . 11.09 108.947 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . 0.533 ' HB2' ' CD1' ' A' ' 259' ' ' TRP . 11.8 t70 -151.06 156.57 41.35 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.221 -0.592 . . . . 11.41 111.468 -174.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -69.65 -19.25 63.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.704 -1.134 . . . . 12.49 112.952 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -55.88 -30.79 62.09 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.247 0.546 . . . . 12.460000000000001 110.493 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -65.19 -30.97 71.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.196 -0.911 . . . . 13.779999999999999 112.292 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -61.81 134.81 46.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.831 -0.699 . . . . 11.300000000000001 113.389 -173.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 59.56 39.44 21.52 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.141 0.577 . . . . 12.59 111.068 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 37.3 t -129.46 148.44 51.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.677 -0.692 . . . . 11.1 109.803 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -78.26 -10.0 59.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.909 -0.587 . . . . 12.42 110.161 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -108.42 161.71 14.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.679 -0.691 . . . . 11.82 110.232 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -110.71 133.3 53.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.001 0.429 . . . . 9.5999999999999996 110.299 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -74.32 -35.01 63.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.536 -0.756 . . . . 7.7999999999999998 110.514 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -59.9 -50.06 75.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 6.9900000000000002 110.256 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -165.18 138.58 4.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.74 -0.664 . . . . 2.4100000000000001 110.464 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.76 132.56 6.64 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.001 -0.619 . . . . 1.6200000000000001 111.698 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 29.6 m -138.01 140.17 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.862 0.363 . . . . 2.4900000000000002 111.103 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -163.96 140.58 6.55 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.7 -0.762 . . . . 1.3 112.394 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.5 t -120.29 130.07 74.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.728 0.299 . . . . 2.3399999999999999 110.3 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -118.59 126.37 51.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.25 -0.432 . . . . 2.7999999999999998 110.286 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -100.3 123.69 44.85 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.699 -0.852 . . . . 5.1900000000000004 108.699 174.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 37.7 t -117.75 130.02 56.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.986 0.422 . . . . 2.0499999999999998 110.673 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.2 t80 . . . . . 0 C--O 1.243 0.724 0 CA-C-O 118.336 -0.84 . . . . 4.4199999999999999 109.182 176.836 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.2 mtp . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.717 0.294 . . . . 11.970000000000001 111.475 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -60.12 -37.72 80.87 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.951 0.501 . . . . 10.35 111.988 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -51.21 -49.98 59.99 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.519 0.563 . . . . 9.3100000000000005 112.519 -173.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 58.89 49.15 10.14 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.481 0.658 . . . . 9.4399999999999995 110.055 -176.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -80.02 145.28 32.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.038 -0.983 . . . . 7.75 110.892 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -69.87 -39.88 76.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.803 -0.635 . . . . 3.6099999999999999 109.43 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -73.22 149.28 42.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.143 -0.935 . . . . 3.9100000000000001 110.534 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -104.08 131.08 51.71 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.96 -0.385 . . . . 3.9399999999999999 109.96 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.83 149.76 42.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.81 -0.632 . . . . 3.21 111.791 -171.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -131.54 129.43 41.01 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.677 -0.86 . . . . 2.6499999999999999 108.677 166.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 85.4 mt -132.5 120.23 41.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.598 -0.519 . . . . 2.0699999999999998 109.598 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -117.08 147.8 18.87 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.352 -0.927 . . . . 0.92000000000000004 112.505 -176.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.584 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -138.09 135.03 35.4 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.093 -0.336 . . . . 1.6499999999999999 110.093 175.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.623 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 67.8 mtt -134.0 146.42 50.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.406 -0.361 . . . . 2.9700000000000002 110.482 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -97.63 129.46 44.72 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.895 -0.78 . . . . 3.1499999999999999 108.895 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -70.11 -32.56 70.64 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.187 0.44 . . . . 5.0899999999999999 112.187 -173.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 30' ' ' LEU . 80.9 mt -110.3 130.03 64.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.774 0.321 . . . . 5.3300000000000001 110.461 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -63.59 139.98 58.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.922 -0.581 . . . . 8.2799999999999994 110.629 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -100.68 108.63 20.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.901 0.381 . . . . 10.0 110.157 -175.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.9 t -119.13 130.01 74.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.096 -0.502 . . . . 11.380000000000001 109.788 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -88.68 119.94 29.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.933 0.397 . . . . 13.1 110.436 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.73 -171.76 39.45 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.926 -0.654 . . . . 12.52 111.82 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -140.4 130.88 25.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.723 0.296 . . . . 15.18 110.489 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -156.18 178.61 32.61 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.549 -0.62 . . . . 12.279999999999999 111.549 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.58 -43.12 97.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.946 0.403 . . . . 12.82 110.884 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -84.13 147.56 27.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.021 -0.536 . . . . 10.81 109.75 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 94.5 mtp -121.17 132.5 54.88 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.468 0.652 . . . . 10.210000000000001 110.654 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -60.16 -39.85 87.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.439 -1.255 . . . . 8.0600000000000005 112.105 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.26 -145.41 16.92 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.584 -0.817 . . . . 6.0800000000000001 111.749 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.525 ' O ' HD12 ' A' ' 17' ' ' ILE . 59.0 tp -120.68 138.8 53.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.385 -0.598 . . . . 5.96 109.385 175.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.436 ' HB1' ' HB ' ' A' ' 17' ' ' ILE . . . -119.99 107.07 12.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.816 0.341 . . . . 3.2400000000000002 110.892 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 57' ' ' ASP . 1.7 pm0 -103.25 140.79 21.39 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 116.249 -0.432 . . . . 3.48 110.326 177.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 14' ' ' MET . 73.8 Cg_endo -77.39 134.81 14.34 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.354 2.036 . . . . 2.0299999999999998 113.127 -177.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.584 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 34.8 p -84.42 157.71 21.3 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.992 -0.744 . . . . 2.2799999999999998 108.992 171.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.99 132.56 69.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.213 0.53 . . . . 2.4100000000000001 111.005 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 53.0 t80 -122.76 130.85 53.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.361 -0.836 . . . . 4.4400000000000004 110.303 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -120.02 135.24 55.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.764 0.316 . . . . 3.6200000000000001 110.75 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -149.9 127.96 11.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.243 -0.651 . . . . 2.48 109.243 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.44 147.95 28.86 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.078 -0.249 . . . . 1.53 111.316 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.72 139.12 9.96 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.131 -0.486 . . . . 1.8 111.443 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.673 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 27.3 t-20 -168.28 94.97 0.39 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.963 -0.755 . . . . 3.3799999999999999 108.963 169.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.05 -85.62 0.55 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.93 -0.652 . . . . 1.8200000000000001 111.496 -173.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 19.6 Cg_endo -59.59 176.66 0.57 Allowed 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 123.643 2.895 . . . . 2.1000000000000001 112.55 171.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -67.77 175.25 3.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.932 -0.576 . . . . 4.0499999999999998 110.527 -173.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -110.99 117.08 32.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.478 0.656 . . . . 3.6000000000000001 109.706 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 84.3 mt -116.24 130.23 71.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.438 -1.256 . . . . 2.2799999999999998 110.436 -170.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.22 130.7 56.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.261 -0.427 . . . . 1.4399999999999999 110.21 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 61.2 tp -130.59 132.57 45.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 1.75 110.886 -177.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -146.59 168.92 20.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.56 -0.745 . . . . 1.5900000000000001 109.56 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -120.07 140.0 51.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.703 0.287 . . . . 4.4400000000000004 110.567 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -119.86 122.62 41.69 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.758 -0.46 . . . . 5.0199999999999996 109.758 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -123.1 139.98 53.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.941 0.401 . . . . 3.7400000000000002 110.091 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.58 -24.64 31.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.685 -0.689 . . . . 5.0499999999999998 110.212 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -133.2 71.23 0.5 Allowed Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.616 -0.72 . . . . 4.3700000000000001 111.342 174.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.03 141.11 47.22 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.393 2.728 . . . . 7.0899999999999999 113.363 -174.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.1 t -130.75 130.01 64.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.541 -0.754 . . . . 8.5700000000000003 109.096 174.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.518 ' HB2' ' HB3' ' A' ' 32' ' ' GLU . 20.9 t70 -60.02 -49.96 75.59 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.276 0.36 . . . . 10.039999999999999 111.524 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -152.2 150.4 29.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.78 0.324 . . . . 11.890000000000001 110.436 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 52.9 m -143.04 150.0 39.0 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.333 -0.394 . . . . 9.7899999999999991 110.346 176.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.77 120.04 41.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.517 -0.311 . . . . 8.7799999999999994 110.274 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.43 21.08 59.07 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.736 -0.745 . . . . 7.7300000000000004 111.756 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.647 ' HE3' ' O ' ' A' ' 64' ' ' GLY . 57.9 tptt -122.56 119.14 29.97 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.044 -0.354 . . . . 10.300000000000001 110.044 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -69.94 -39.74 75.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.27 -0.423 . . . . 10.960000000000001 111.354 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.647 ' O ' ' HE3' ' A' ' 62' ' ' LYS . . . 148.13 -150.33 22.52 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.923 -0.656 . . . . 5.5599999999999996 111.499 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 t -112.38 130.05 56.1 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.239 0.542 . . . . 5.6900000000000004 110.769 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -60.06 -40.05 88.13 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.262 -0.881 . . . . 6.5 110.644 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -102.22 111.64 24.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.465 -0.569 . . . . 4.5999999999999996 109.465 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -125.34 169.96 11.81 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.267 -0.424 . . . . 2.4500000000000002 110.098 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.502 ' NE ' ' HB2' ' A' ' 95' ' ' TYR . 12.5 ttm180 -139.31 122.41 10.62 Favored Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 120.874 -0.33 . . . . 3.7200000000000002 110.134 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 85.3 Cg_endo -91.41 151.69 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.872 2.382 . . . . 1.3200000000000001 112.184 171.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.543 ' HA ' ' HG2' ' A' ' 93' ' ' ARG . 37.8 tt0 -118.04 115.61 25.21 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.17 -0.678 . . . . 2.1899999999999999 109.17 174.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.4 tp -132.56 114.74 14.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.883 -0.599 . . . . 1.73 110.758 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.488 ' HG2' ' HA3' ' A' ' 91' ' ' GLY . 46.9 mt-10 -123.9 140.47 52.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.263 -0.426 . . . . 2.1800000000000002 110.108 174.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -123.03 129.8 74.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.203 -0.453 . . . . 2.0600000000000001 109.965 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -112.48 119.9 39.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.008 0.432 . . . . 4.1900000000000004 110.444 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . 64.8 t80 -93.08 129.14 39.14 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.554 -0.748 . . . . 5.1600000000000001 109.26 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -103.02 119.83 39.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.079 -0.509 . . . . 3.3100000000000001 110.099 -177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.448 ' CD2' ' HG ' ' A' ' 79' ' ' LEU . 69.7 t80 -120.1 119.35 33.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.522 -0.308 . . . . 4.6600000000000001 110.633 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.448 ' HG ' ' CD2' ' A' ' 78' ' ' PHE . 85.4 mt 69.68 106.21 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 124.136 0.897 . . . . 4.8799999999999999 112.817 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -88.4 -7.17 57.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.477 -0.783 . . . . 6.1900000000000004 109.531 170.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -67.76 143.79 55.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.267 -0.879 . . . . 6.0999999999999996 110.462 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -70.14 -20.87 63.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.854 -0.612 . . . . 5.2699999999999996 112.177 -171.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -61.23 -39.95 92.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.018 0.377 . . . . 6.3300000000000001 112.018 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -138.08 155.36 48.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.856 0.36 . . . . 8.3499999999999996 110.815 -176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.3 t -144.27 94.49 2.58 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.222 -0.445 . . . . 2.6400000000000001 109.996 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -119.92 135.84 54.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.924 0.392 . . . . 6.1900000000000004 110.748 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.21 143.42 15.01 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.029 -0.828 . . . . 1.54 111.029 175.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 76' ' ' TYR . 88.6 mt -120.27 113.72 20.82 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.767 -0.457 . . . . 2.73 109.767 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.1 m -116.58 122.64 45.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.05 0.452 . . . . 1.8700000000000001 110.882 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -137.86 140.33 11.14 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.443 -0.663 . . . . 1.1699999999999999 111.443 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.488 ' HA3' ' HG2' ' A' ' 73' ' ' GLU . . . -169.63 170.03 42.44 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.219 -0.991 . . . . 1.4399999999999999 112.455 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 112' ' ' ARG . 53.3 p90 -156.75 160.01 38.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.986 0.422 . . . . 4.6399999999999997 111.201 -176.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.543 ' HG2' ' HA ' ' A' ' 71' ' ' GLU . 30.1 mtm180 -121.27 127.96 51.89 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.743 -0.662 . . . . 3.2200000000000002 109.228 169.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.476 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 52.0 t30 -107.3 119.13 38.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.189 -0.46 . . . . 2.2200000000000002 110.134 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.502 ' HB2' ' NE ' ' A' ' 69' ' ' ARG . 69.9 t80 -116.85 129.31 56.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.793 0.33 . . . . 3.6400000000000001 111.006 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.73 166.89 29.54 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.333 -0.936 . . . . 2.79 113.179 172.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.445 ' O ' ' HB2' ' A' ' 98' ' ' HIS . 3.2 m-85 -118.69 157.67 27.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.637 -0.281 . . . . 7.8499999999999996 110.537 -176.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.484 ' HB3' ' O ' ' A' ' 101' ' ' ASP . 22.6 m-70 69.76 62.03 0.26 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 124.15 0.906 . . . . 7.6900000000000004 110.452 -169.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -70.07 -27.74 64.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.54 -0.755 . . . . 10.289999999999999 110.97 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 79.5 t -70.09 -40.98 79.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 10.19 111.382 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 98' ' ' HIS . 10.3 p-10 -139.3 136.87 35.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.133 0.492 . . . . 12.220000000000001 111.957 -173.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -129.89 71.18 82.23 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.833 -0.621 . . . . 10.48 110.067 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.02 -30.11 56.73 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.896 2.397 . . . . 9.6799999999999997 113.452 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -138.36 -177.3 15.17 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.61 -0.805 . . . . 6.5099999999999998 112.261 -176.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -80.78 -16.12 54.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.686 0.279 . . . . 8.1099999999999994 111.16 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -69.92 -35.7 74.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.35 0.595 . . . . 4.1399999999999997 109.459 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.5 p -87.7 140.66 29.29 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.355 -0.839 . . . . 3.77 109.4 172.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -164.78 129.12 2.52 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.632 -0.427 . . . . 2.2000000000000002 111.159 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -138.47 126.88 23.13 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.195 0.522 . . . . 3.1200000000000001 110.034 173.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 89.5 mtp -131.35 126.91 36.48 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.925 -0.579 . . . . 2.1200000000000001 109.462 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.481 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 26.3 mt-30 -118.92 134.23 55.31 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.327 -0.549 . . . . 2.4900000000000002 110.528 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 92' ' ' PHE . 47.3 ttt-85 -111.77 119.44 38.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.682 -0.69 . . . . 4.4699999999999998 109.439 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -119.94 140.21 51.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.545 -0.298 . . . . 2.9199999999999999 110.901 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 135' ' ' MET . 21.8 pttp -139.94 135.29 32.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.023 0.44 . . . . 2.5099999999999998 110.184 168.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 134' ' ' SER . 48.5 mm -120.02 119.85 61.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.827 -0.805 . . . . 2.1299999999999999 108.827 173.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -140.55 106.58 6.5 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 120.553 0.216 . . . . 1.6799999999999999 111.197 -174.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.94 139.87 13.98 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.757 2.305 . . . . 1.54 110.776 174.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -88.03 138.4 31.48 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.29 -0.634 . . . . 2.3500000000000001 109.29 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -125.86 132.32 52.21 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.547 0.203 . . . . 5.1500000000000004 111.547 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 55.78 37.53 28.98 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.251 0.97 . . . . 3.04 112.451 171.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 92.9 t -64.19 119.32 8.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.638 -0.255 . . . . 4.7400000000000002 110.926 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 59.93 43.11 15.22 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.583 -0.735 . . . . 6.3600000000000003 110.948 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.1 tp -60.15 -39.9 87.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.147 -0.479 . . . . 4.96 111.872 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 127' ' ' LEU . 32.6 m -117.3 138.14 51.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.923 0.392 . . . . 4.0700000000000003 110.318 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -61.42 -44.66 96.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.147 -0.479 . . . . 5.1699999999999999 111.025 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -70.97 -40.83 71.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.794 -0.639 . . . . 3.71 111.492 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.52 ' O ' ' HB ' ' A' ' 124' ' ' THR . 86.5 mt -126.59 125.48 42.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.924 -0.58 . . . . 2.4500000000000002 110.523 -173.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.484 ' HD2' ' OE1' ' A' ' 159' ' ' GLN . 64.9 mtt180 -92.67 133.83 35.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.098 0.475 . . . . 4.6799999999999997 110.623 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -119.8 122.0 40.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.367 -0.833 . . . . 4.3600000000000003 109.565 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.456 ' HB3' ' CZ3' ' A' ' 132' ' ' TRP . 94.4 m-20 -133.32 120.06 20.55 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.883 -0.414 . . . . 2.5899999999999999 109.883 174.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -148.18 140.27 8.25 Favored Glycine 0 CA--C 1.507 -0.416 0 C-N-CA 120.2 -1.0 . . . . 1.25 111.43 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.456 ' CZ3' ' HB3' ' A' ' 130' ' ' ASN . 0.9 OUTLIER -142.72 147.67 36.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.302 0.573 . . . . 5.0899999999999999 112.153 -177.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 91.4 mt -104.43 120.01 40.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.987 -1.006 . . . . 2.7599999999999998 109.09 176.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 26.6 t -107.39 124.56 50.01 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.54 -0.464 . . . . 1.99 110.974 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 114' ' ' LYS . 69.7 mtm -93.95 120.06 33.7 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.324 -0.991 . . . . 2.7799999999999998 108.324 171.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -115.12 132.61 56.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.167 0.508 . . . . 3.6800000000000002 112.208 -168.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -130.17 152.86 49.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.415 -0.812 . . . . 2.1699999999999999 109.908 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.464 ' O ' HD22 ' A' ' 142' ' ' LEU . 77.9 t80 -149.7 151.5 33.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.421 -0.354 . . . . 4.0099999999999998 110.248 -177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 60.61 -163.44 0.25 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.546 0.529 . . . . 1.79 111.649 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -75.91 -41.39 52.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.967 0.413 . . . . 3.04 111.786 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -60.14 -46.16 90.59 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.528 -0.76 . . . . 2.4100000000000001 112.959 -165.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.464 HD22 ' O ' ' A' ' 138' ' ' PHE . 3.8 mm? -69.88 -35.66 74.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.071 0.462 . . . . 2.3599999999999999 110.974 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.481 ' ND2' ' HB2' ' A' ' 111' ' ' GLN . 95.6 m-20 -70.78 -40.25 72.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.884 -0.598 . . . . 2.52 111.392 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.1 p -77.0 -35.05 57.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.504 -0.316 . . . . 2.52 111.823 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 149' ' ' ASP . 23.2 p -69.9 -29.9 67.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.986 0.422 . . . . 2.0099999999999998 111.092 177.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 63.28 -109.83 2.98 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.694 -0.685 . . . . 1.52 113.071 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -70.02 -33.94 72.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.594 0.235 . . . . 6.2199999999999998 110.808 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.04 75.26 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.075 -0.512 . . . . 2.0499999999999998 112.256 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.416 ' HB2' ' OG1' ' A' ' 145' ' ' THR . 15.7 m-20 -122.51 127.1 49.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.212 0.53 . . . . 2.6400000000000001 111.003 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.1 t -160.23 157.73 28.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.853 -0.612 . . . . 2.6000000000000001 110.113 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -120.16 148.2 43.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.917 -0.401 . . . . 4.0899999999999999 109.917 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.09 139.81 50.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.867 0.365 . . . . 2.1499999999999999 110.974 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -138.0 141.04 40.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.989 -0.551 . . . . 2.5600000000000001 109.523 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 24.5 m -122.91 131.36 53.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.735 0.302 . . . . 1.78 111.346 -177.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -126.57 130.06 49.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.944 -0.571 . . . . 2.04 110.235 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 93.4 m -128.24 120.78 27.87 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.044 -0.525 . . . . 2.0299999999999998 110.538 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -111.69 117.73 4.56 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.657 -0.977 . . . . 1.0800000000000001 110.657 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 77.4 mt -118.65 130.64 55.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.913 0.387 . . . . 2.9300000000000002 111.024 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.484 ' OE1' ' HD2' ' A' ' 128' ' ' ARG . 53.4 tt0 -100.14 113.43 26.07 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.901 -0.59 . . . . 3.02 110.669 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.454 ' HA ' HD22 ' A' ' 127' ' ' LEU . 86.7 m-85 -120.16 139.8 52.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.889 -0.596 . . . . 4.7599999999999998 110.424 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.4 p -94.25 100.26 12.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.963 0.411 . . . . 1.8200000000000001 110.349 177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -60.05 -49.07 79.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.939 -0.573 . . . . 3.27 111.225 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.458 ' HB2' HG23 ' A' ' 166' ' ' VAL . 94.7 m-20 -101.09 10.09 41.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.222 -0.445 . . . . 2.4100000000000001 110.717 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 72.47 -46.92 0.66 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.634 0.774 . . . . 2.5800000000000001 111.235 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.4 p -74.71 -20.42 59.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.397 -0.365 . . . . 2.6000000000000001 111.788 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.458 HG23 ' HB2' ' A' ' 163' ' ' ASN . 34.2 m -124.81 139.95 49.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.368 -0.378 . . . . 2.0600000000000001 110.252 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.83 131.55 53.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.959 0.409 . . . . 1.8400000000000001 111.374 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 31.1 mt -115.31 138.54 50.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.311 -0.626 . . . . 2.1400000000000001 109.311 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -112.17 122.02 46.58 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 110.075 -0.343 . . . . 3.73 110.075 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.94 127.91 75.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.731 0.3 . . . . 1.8100000000000001 110.547 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -107.05 126.69 52.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.249 0.547 . . . . 2.2400000000000002 110.782 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -99.42 124.42 44.54 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.11 -0.95 . . . . 4.8399999999999999 108.648 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -108.77 124.98 51.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.096 0.474 . . . . 4.4299999999999997 110.923 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.474 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 62.0 tp -115.4 115.82 27.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.608 -0.723 . . . . 2.8500000000000001 111.21 -177.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -120.01 145.12 47.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.694 -0.685 . . . . 3.3100000000000001 110.116 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -140.35 130.07 24.39 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.546 -0.538 . . . . 7.3300000000000001 109.546 172.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -115.82 129.17 8.37 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.822 -0.704 . . . . 5.0599999999999996 112.051 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -70.01 -40.0 75.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.28 0.562 . . . . 8.0199999999999996 110.104 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -125.13 43.14 3.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.541 -0.754 . . . . 9.4900000000000002 110.011 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.8 ttm -60.22 -40.09 88.94 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.825 -0.625 . . . . 11.1 110.532 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -115.02 168.05 10.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.107 -0.497 . . . . 10.470000000000001 110.299 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -60.31 -40.2 89.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.015 0.436 . . . . 13.06 111.084 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.0 t -153.84 151.04 29.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.219 -0.446 . . . . 12.890000000000001 110.266 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -109.56 23.44 14.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.997 -0.547 . . . . 15.720000000000001 110.847 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -60.08 -40.13 88.49 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.78 0.324 . . . . 13.470000000000001 111.194 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -67.69 -38.38 83.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.166 0.507 . . . . 13.15 110.361 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 147.02 -166.63 28.41 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 111.152 -0.779 . . . . 10.050000000000001 111.152 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -122.43 139.75 53.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.788 0.328 . . . . 10.699999999999999 110.364 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -142.49 155.52 45.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.246 -0.434 . . . . 11.34 110.225 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.1 p -154.77 159.15 40.44 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.838 -0.619 . . . . 6.7800000000000002 109.621 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 23.2 m -140.45 113.63 8.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.841 0.353 . . . . 5.3600000000000003 110.46 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.86 149.98 23.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.283 -0.417 . . . . 7.8700000000000001 110.08 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -104.61 126.57 51.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.518 -0.31 . . . . 4.4000000000000004 110.521 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.481 ' O ' HG13 ' A' ' 194' ' ' ILE . 29.7 pt -93.92 90.72 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.66 0.743 . . . . 2.6400000000000001 109.375 170.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.409 ' HG2' ' HA ' ' A' ' 212' ' ' ARG . 99.1 mtt180 -91.3 120.08 31.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.875 -0.602 . . . . 4.1100000000000003 110.314 -173.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -109.36 147.23 33.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.95 -0.568 . . . . 1.76 111.38 -174.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -155.97 160.02 39.72 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.492 -0.777 . . . . 6.1399999999999997 109.726 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 1.7 pt? -144.51 127.49 8.54 Favored Pre-proline 0 C--N 1.322 -0.619 0 C-N-CA 120.846 -0.342 . . . . 3.0800000000000001 111.006 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 198' ' ' LEU . 9.1 Cg_exo -73.28 127.38 11.88 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.462 2.108 . . . . 1.98 111.674 172.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 33.1 tp -130.83 148.57 52.62 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.565 -0.902 . . . . 2.7599999999999998 108.565 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 11.9 t -129.58 140.18 51.27 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.302 0.572 . . . . 2.4199999999999999 110.954 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 60.0 tp -141.05 82.53 1.84 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.343 -0.844 . . . . 2.77 109.149 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 69.22 -120.04 10.05 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.734 -0.666 . . . . 1.6200000000000001 112.616 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -95.47 10.09 37.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.497 0.665 . . . . 2.8599999999999999 109.778 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -119.2 145.87 45.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.389 -0.823 . . . . 3.23 109.399 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 241' ' ' TYR . 47.5 t -130.03 144.53 51.39 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.851 -0.426 . . . . 2.0499999999999998 109.851 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 47.9 t -119.92 129.95 74.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.639 -0.504 . . . . 1.9299999999999999 109.639 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 20.3 m -139.84 91.03 10.62 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-O 120.867 0.365 . . . . 1.6699999999999999 110.42 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.46 140.6 27.28 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 123.013 2.475 . . . . 1.28 111.826 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -118.99 139.88 50.94 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.858 -0.423 . . . . 4.8600000000000003 109.858 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 61.1 p -133.07 146.15 51.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.789 -0.641 . . . . 2.0899999999999999 109.626 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.409 ' HA ' ' HG2' ' A' ' 195' ' ' ARG . 59.0 mtp180 -80.51 -9.97 59.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.035 0.445 . . . . 5.29 110.255 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 46.5 pt -115.54 150.11 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.547 -0.751 . . . . 4.9400000000000004 109.932 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -109.45 -159.98 18.75 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.778 -0.725 . . . . 4.9800000000000004 112.193 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.2 mt -60.72 -40.11 91.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.018 0.437 . . . . 8.4399999999999995 110.966 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -84.33 102.72 12.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.906 -0.588 . . . . 7.9699999999999998 109.534 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -69.65 -37.93 76.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.883 -0.599 . . . . 11.1 109.942 -177.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -113.22 139.99 48.33 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.015 -0.735 . . . . 12.24 109.015 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 23.0 m -107.56 156.67 18.76 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.596 -0.275 . . . . 10.220000000000001 110.379 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -103.28 119.98 39.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.958 0.408 . . . . 11.92 110.262 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 21.3 m-90 -114.01 142.33 46.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.836 -0.62 . . . . 14.460000000000001 110.035 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -90.52 8.33 34.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.935 -0.575 . . . . 14.529999999999999 110.302 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -104.4 157.0 17.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.788 -0.642 . . . . 17.07 110.374 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . 0.423 ' HB3' ' OD1' ' A' ' 226' ' ' ASP . 99.4 mt-30 -60.18 -53.08 61.95 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.191 0.307 . . . . 15.779999999999999 111.034 -176.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 49.92 40.01 19.9 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.47 0.481 . . . . 15.67 111.705 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.423 ' OD1' ' HB3' ' A' ' 224' ' ' GLN . 18.4 m-20 -70.02 -20.54 63.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.106 -0.497 . . . . 14.5 111.131 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 86.7 mt -120.03 119.95 61.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.396 -0.594 . . . . 15.380000000000001 109.396 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -115.11 149.84 36.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.083 -0.508 . . . . 14.73 110.731 -175.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -100.13 125.48 46.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.006 -0.738 . . . . 16.969999999999999 109.006 172.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -69.81 139.93 53.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.124 0.488 . . . . 12.779999999999999 110.744 -176.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -179.62 178.78 48.78 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.021 -0.832 . . . . 11.369999999999999 111.021 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 57.8 46.24 17.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.315 0.579 . . . . 12.81 109.762 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.08 -40.04 88.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.365 -0.834 . . . . 9.9900000000000002 110.474 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -123.54 140.0 53.44 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.61 -0.723 . . . . 11.32 109.944 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -96.43 116.21 28.69 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.811 -0.44 . . . . 6.8799999999999999 109.811 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -100.21 141.34 33.19 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.383 -0.372 . . . . 8.9399999999999995 110.499 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.86 160.0 41.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.037 -0.529 . . . . 2.9700000000000002 109.832 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -132.92 143.88 15.67 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.62 -0.8 . . . . 1.3999999999999999 111.923 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 81.1 mt -116.94 121.78 42.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.7 0.286 . . . . 2.4300000000000002 110.284 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -106.55 122.26 45.95 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.877 -0.416 . . . . 4.3300000000000001 109.877 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 206' ' ' SER . 95.9 m-85 -112.2 120.37 41.54 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.066 -0.515 . . . . 3.2599999999999998 110.115 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -89.62 129.57 9.76 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.613 -0.803 . . . . 1.3500000000000001 111.533 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -107.58 127.19 53.42 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 110.004 -0.369 . . . . 4.7599999999999998 110.004 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -99.36 133.82 43.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.572 -0.74 . . . . 4.29 110.37 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -124.73 146.16 49.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.499 -0.556 . . . . 7.5599999999999996 109.499 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -56.49 -27.56 57.5 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.272 -0.876 . . . . 7.0199999999999996 112.816 -168.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.98 -34.97 74.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.364 0.602 . . . . 6.4800000000000004 110.742 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 116.2 1.94 20.25 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.21 -1.156 . . . . 2.9199999999999999 110.21 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 53.5 tp -91.08 130.41 36.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.579 -0.811 . . . . 3.5800000000000001 109.792 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 24.3 p -120.08 140.15 51.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.859 0.362 . . . . 2.6000000000000001 110.672 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.2 t -118.71 133.02 66.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.424 -0.353 . . . . 2.2400000000000002 110.211 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 24.7 m -98.4 117.55 33.06 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.782 -0.451 . . . . 2.0 109.782 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 68.6 mt -95.73 119.45 34.26 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.313 -0.625 . . . . 3.4199999999999999 109.313 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -104.43 120.02 40.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.916 0.389 . . . . 4.0800000000000001 110.495 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -116.2 132.25 56.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.885 -0.598 . . . . 5.1699999999999999 110.675 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -99.22 16.45 22.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.504 0.669 . . . . 3.5800000000000001 109.733 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . 0.431 ' HE2' ' CE2' ' A' ' 259' ' ' TRP . 53.2 p90 -150.06 167.4 26.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.205 -0.907 . . . . 7.5800000000000001 110.191 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -121.7 138.55 54.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.969 -0.559 . . . . 8.5399999999999991 109.878 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . 0.431 ' CE2' ' HE2' ' A' ' 257' ' ' PHE . 93.5 m95 -86.6 121.82 29.65 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.365 -0.976 . . . . 12.720000000000001 108.365 170.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -115.14 172.52 7.02 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 121.013 -0.275 . . . . 11.09 110.906 -171.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -60.01 -40.14 88.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.982 0.42 . . . . 11.41 110.562 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -127.64 109.67 11.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.751 -0.659 . . . . 12.49 110.33 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -119.98 130.02 54.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.183 -0.462 . . . . 12.460000000000001 110.132 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -109.67 143.63 39.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.964 0.411 . . . . 13.779999999999999 110.597 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -90.25 -158.24 34.29 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.744 -0.662 . . . . 11.300000000000001 112.064 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 54.3 39.05 30.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.939 0.399 . . . . 12.59 111.246 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 53.6 m -115.15 147.95 39.62 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.919 0.39 . . . . 11.1 110.182 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -89.96 -0.02 57.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.122 -0.49 . . . . 12.42 111.298 -174.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -87.32 70.03 9.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.24 -0.436 . . . . 11.82 110.072 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -66.17 139.69 58.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.986 -0.552 . . . . 9.5999999999999996 110.073 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -110.4 160.38 16.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.083 -0.508 . . . . 7.7999999999999998 111.638 -171.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -125.86 155.72 40.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.319 -0.855 . . . . 6.9900000000000002 109.904 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -150.02 149.82 30.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.324 -0.398 . . . . 2.4100000000000001 110.545 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.91 167.54 23.25 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.917 -0.658 . . . . 1.6200000000000001 111.844 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.05 140.0 39.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.149 0.499 . . . . 2.4900000000000002 111.06 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -126.77 137.08 9.76 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.033 -0.827 . . . . 1.3 111.033 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.99 119.99 60.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.857 -0.423 . . . . 2.3399999999999999 109.857 -176.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -128.25 129.77 46.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.154 0.502 . . . . 2.7999999999999998 111.627 -176.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -120.01 110.62 16.91 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.291 -0.633 . . . . 5.1900000000000004 109.291 173.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 22.9 t -120.6 130.23 54.09 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.53 -0.544 . . . . 2.0499999999999998 109.53 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 46.2 t80 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.112 -0.946 . . . . 4.4199999999999999 109.462 -177.727 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.943 0.402 . . . . 11.970000000000001 110.489 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -98.73 90.79 4.82 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.073 -0.714 . . . . 10.35 109.073 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -123.82 144.62 49.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.542 -0.754 . . . . 9.3100000000000005 110.388 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -125.07 153.5 42.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.385 -0.37 . . . . 9.4399999999999995 110.753 -177.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -111.13 123.96 51.24 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.418 -0.586 . . . . 7.75 109.418 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -59.93 -39.83 86.85 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.493 -0.776 . . . . 3.6099999999999999 111.079 -178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -120.3 139.99 51.91 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.166 -0.679 . . . . 3.9100000000000001 109.166 172.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -131.83 130.78 42.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.812 0.339 . . . . 3.9399999999999999 110.182 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -137.06 150.35 47.99 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.089 -0.505 . . . . 3.21 110.152 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -132.77 131.39 41.09 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.923 -0.769 . . . . 2.6499999999999999 108.923 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.8 pt -121.34 130.32 74.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.987 0.422 . . . . 2.0699999999999998 110.971 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -114.8 134.53 11.72 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.671 -0.776 . . . . 0.92000000000000004 111.578 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -120.0 135.87 54.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.018 0.437 . . . . 1.6499999999999999 110.636 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 66.7 mtt -139.92 157.26 45.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.714 -0.675 . . . . 2.9700000000000002 109.734 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.02 112.32 24.75 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.007 -0.368 . . . . 3.1499999999999999 110.007 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -99.39 133.28 43.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.084 0.468 . . . . 5.0899999999999999 110.87 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.0 pt -130.25 141.22 46.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.471 -0.786 . . . . 5.3300000000000001 110.033 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -119.9 140.05 51.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.764 0.316 . . . . 8.2799999999999994 110.28 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.475 ' ND2' ' HB2' ' A' ' 186' ' ' ASN . 54.4 t30 -80.73 117.38 21.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.976 -177.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.99 124.55 72.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.964 -0.384 . . . . 11.380000000000001 109.964 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -138.87 140.04 38.3 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.615 -0.513 . . . . 13.1 109.615 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.94 -162.28 30.38 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.269 -0.967 . . . . 12.52 112.696 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -64.48 -28.78 69.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.855 0.359 . . . . 15.18 110.899 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.11 160.44 33.0 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.044 -0.598 . . . . 12.279999999999999 111.613 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -100.0 120.04 39.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.741 0.305 . . . . 12.82 110.42 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -82.85 -11.42 58.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 10.81 110.368 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.457 ' HE3' ' O ' ' A' ' 53' ' ' GLU . 97.6 mmm -120.23 131.56 55.0 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.687 -0.688 . . . . 10.210000000000001 110.305 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -99.57 -0.05 41.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.066 -0.516 . . . . 8.0600000000000005 110.932 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.57 84.14 1.58 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.952 -0.642 . . . . 6.0800000000000001 112.296 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.31 -49.99 75.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.812 0.339 . . . . 5.96 111.469 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -157.0 119.61 3.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.101 -0.499 . . . . 3.2400000000000002 110.927 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -128.71 145.18 55.17 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.515 -0.311 . . . . 3.48 110.835 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.09 134.84 10.67 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.441 2.094 . . . . 2.0299999999999998 111.972 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 19.3 p -123.9 145.78 48.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.241 -0.436 . . . . 2.2799999999999998 110.0 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 8.5 p -130.0 136.79 58.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.02 0.438 . . . . 2.4100000000000001 110.791 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -117.97 143.66 46.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.033 -0.53 . . . . 4.4400000000000004 110.481 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.589 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 91.0 m-85 -102.71 129.28 49.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.976 -0.556 . . . . 3.6200000000000001 111.244 -176.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -119.88 137.43 54.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.137 -0.483 . . . . 2.48 109.948 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -120.69 143.5 48.7 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.988 -0.375 . . . . 1.53 109.988 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.49 117.98 6.97 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.537 0.523 . . . . 1.8 111.226 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.622 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 37.4 t30 -167.24 96.01 0.48 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.01 -0.541 . . . . 3.3799999999999999 110.12 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.3 -98.78 1.89 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.017 -0.611 . . . . 1.8200000000000001 112.266 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 84.1 Cg_exo -47.82 175.0 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.956 3.104 . . . . 2.1000000000000001 113.644 169.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -69.72 -177.44 1.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.265 0.555 . . . . 4.0499999999999998 111.582 -170.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.7 mtp180 -111.97 140.58 46.52 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.609 0.719 . . . . 3.6000000000000001 112.331 -170.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.0 pt -126.52 146.66 32.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 114.397 -1.274 . . . . 2.2799999999999998 110.892 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -119.73 131.22 55.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.791 -0.64 . . . . 1.4399999999999999 110.287 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.8 tp -119.92 131.84 55.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.166 -0.47 . . . . 1.75 110.831 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.98 157.8 42.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 1.5900000000000001 110.551 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -134.48 150.48 50.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.793 0.33 . . . . 4.4400000000000004 110.725 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -135.27 106.94 6.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.019 -0.537 . . . . 5.0199999999999996 111.589 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -98.87 135.84 39.73 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.457 -0.942 . . . . 3.7400000000000002 108.457 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.457 ' O ' ' HE3' ' A' ' 27' ' ' MET . 37.5 tt0 -60.12 -34.0 72.9 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.024 -0.535 . . . . 5.0499999999999998 111.059 -176.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.76 131.65 23.8 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.501 -0.856 . . . . 4.3700000000000001 111.262 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.32 168.2 8.24 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.061 2.507 . . . . 7.0899999999999999 113.123 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 65.4 t -60.17 -44.49 95.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.802 0.334 . . . . 8.5700000000000003 110.445 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -65.64 -40.13 92.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.741 -0.663 . . . . 10.039999999999999 111.246 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -124.98 100.04 6.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.584 -0.28 . . . . 11.890000000000001 111.05 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.1 t -64.39 -40.0 94.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.448 0.642 . . . . 9.7899999999999991 109.277 176.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.76 111.09 22.88 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.452 -0.794 . . . . 8.7799999999999994 110.258 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.14 168.3 38.72 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.765 -0.731 . . . . 7.7300000000000004 112.008 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -60.15 -39.94 88.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.845 0.355 . . . . 10.300000000000001 110.663 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.9 mtm105 -69.74 -20.33 63.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 10.960000000000001 111.036 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.89 23.0 62.62 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.995 -0.621 . . . . 5.5599999999999996 113.145 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.1 p -84.94 131.86 34.44 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.215 0.531 . . . . 5.6900000000000004 111.169 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -119.95 29.7 7.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.749 -0.66 . . . . 6.5 110.507 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -70.54 139.96 51.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.072 -0.513 . . . . 4.5999999999999996 110.804 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -130.65 144.26 51.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.67 -0.696 . . . . 2.4500000000000002 109.704 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.443 ' HD2' ' HB3' ' A' ' 93' ' ' ARG . 39.5 ttp180 -124.34 122.05 26.0 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.926 -0.579 . . . . 3.7200000000000002 110.07 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 2.9 Cg_endo -85.81 150.03 9.81 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.63 2.22 . . . . 1.3200000000000001 111.883 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -128.11 128.95 45.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.054 0.454 . . . . 2.1899999999999999 110.211 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.4 tp -132.03 116.77 17.51 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.616 -0.72 . . . . 1.73 109.442 173.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.436 ' HA ' ' HA2' ' A' ' 91' ' ' GLY . 40.5 tt0 -118.81 131.17 56.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.043 0.449 . . . . 2.1800000000000002 109.868 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.4 m -113.67 141.55 29.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.816 -0.629 . . . . 2.0600000000000001 109.999 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -120.97 127.01 51.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.097 -0.502 . . . . 4.1900000000000004 110.136 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.94 141.43 49.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.365 -0.38 . . . . 5.1600000000000001 110.074 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -114.65 139.91 49.26 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.851 -0.425 . . . . 3.3100000000000001 109.851 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -132.03 149.29 52.46 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.847 0.356 . . . . 4.6600000000000001 110.408 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.6 tp -133.22 129.66 38.03 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.039 -0.528 . . . . 4.8799999999999999 110.085 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -140.07 168.72 19.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.269 -0.641 . . . . 6.1900000000000004 109.269 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -60.0 -50.15 74.85 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.535 0.569 . . . . 6.0999999999999996 112.535 -171.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.72 -49.85 10.64 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.146 0.425 . . . . 5.2699999999999996 112.146 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -85.63 117.46 24.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.185 0.517 . . . . 6.3300000000000001 110.545 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -69.42 -47.85 62.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.36 -0.837 . . . . 8.3499999999999996 112.194 -173.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 120' ' ' ASP . 3.9 m -143.63 109.1 5.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.775 0.321 . . . . 2.6400000000000001 110.889 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -140.05 143.72 36.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.502 -0.555 . . . . 6.1900000000000004 109.502 174.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.65 176.36 23.08 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.255 -0.974 . . . . 1.54 112.539 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 64.0 tp -126.83 130.04 49.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.912 0.387 . . . . 2.73 110.077 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.2 m -120.02 129.91 54.47 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.054 -0.521 . . . . 1.8700000000000001 109.908 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 114' ' ' LYS . . . -138.97 133.6 6.3 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.615 -0.802 . . . . 1.1699999999999999 111.8 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 73' ' ' GLU . . . -135.03 147.99 19.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.591 -0.814 . . . . 1.4399999999999999 112.4 -178.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -129.36 137.74 51.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.957 0.408 . . . . 4.6399999999999997 111.222 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 89.8 mtt180 -129.79 148.46 51.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.437 -0.801 . . . . 3.2200000000000002 109.803 171.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.658 ' HA ' ' O ' ' A' ' 110' ' ' MET . 51.8 t-20 -139.55 118.43 12.47 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.094 -0.336 . . . . 2.2200000000000002 110.094 172.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.42 ' HB2' ' HD3' ' A' ' 69' ' ' ARG . 43.1 t80 -103.0 119.56 39.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.167 -0.309 . . . . 3.6400000000000001 110.167 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 122.7 -174.68 16.37 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.295 -0.955 . . . . 2.79 112.166 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.489 ' O ' ' HB ' ' A' ' 107' ' ' THR . 95.2 m-85 -131.45 129.99 41.91 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.814 -0.439 . . . . 7.8499999999999996 109.814 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -120.16 123.83 44.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.576 -0.284 . . . . 7.6900000000000004 110.333 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -125.09 100.22 6.46 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.943 -0.392 . . . . 10.289999999999999 109.943 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.0 p -76.93 -10.16 13.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.174 0.511 . . . . 10.19 110.389 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.85 -40.16 87.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.562 -0.745 . . . . 12.220000000000001 111.223 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -123.69 97.3 41.94 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.137 -0.483 . . . . 10.48 110.767 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.0 -12.15 35.0 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.901 2.4 . . . . 9.6799999999999997 112.597 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.42 -1.54 90.13 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.078 -0.582 . . . . 6.5099999999999998 112.341 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -112.11 144.35 41.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.761 0.315 . . . . 8.1099999999999994 110.63 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -90.0 109.96 20.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.247 -0.433 . . . . 4.1399999999999997 109.979 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 97' ' ' TYR . 82.2 p -118.58 137.72 53.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.393 -0.367 . . . . 3.77 110.031 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -128.98 133.24 47.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.894 0.378 . . . . 2.2000000000000002 111.232 -174.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.513 ' HB2' ' OD1' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -149.41 149.46 30.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.789 -0.641 . . . . 3.1200000000000001 110.107 177.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.658 ' O ' ' HA ' ' A' ' 94' ' ' ASN . 87.1 mtp -116.07 116.3 27.62 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.025 -0.534 . . . . 2.1200000000000001 110.353 -176.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -94.66 119.87 33.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.903 0.383 . . . . 2.4900000000000002 110.279 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.598 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 55.3 ttt180 -116.9 125.6 51.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.217 -0.447 . . . . 4.4699999999999998 110.767 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -115.89 135.95 53.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.825 -0.625 . . . . 2.9199999999999999 110.239 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.475 ' O ' ' HA2' ' A' ' 90' ' ' GLY . 45.4 tttm -122.24 123.56 41.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.712 -0.676 . . . . 2.5099999999999998 109.97 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.5 mm -120.03 120.34 62.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 109.286 -0.635 . . . . 2.1299999999999999 109.286 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -141.49 105.03 5.93 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 111.863 0.32 . . . . 1.6799999999999999 111.863 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.444 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 85.4 Cg_endo -84.44 157.04 12.53 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.93 2.42 . . . . 1.54 111.263 171.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -126.21 146.77 49.85 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.908 -0.317 . . . . 2.3500000000000001 110.854 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -126.24 130.79 51.62 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.977 -0.556 . . . . 5.1500000000000004 110.796 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 85' ' ' SER . 42.1 t0 -60.06 140.08 57.06 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.207 0.942 . . . . 3.04 111.319 -176.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.787 ' HA ' ' O ' ' A' ' 129' ' ' PHE . 35.9 m -76.5 -22.67 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.944 -1.025 . . . . 4.7400000000000002 111.444 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -82.4 83.52 7.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.79 0.328 . . . . 6.3600000000000003 110.439 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.2 tp -90.39 -79.78 0.34 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.224 -0.444 . . . . 4.96 111.284 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 69.4 p -145.14 158.11 43.91 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.9 -0.136 . . . . 4.0700000000000003 111.101 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 58.49 25.22 12.76 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.774 0.671 . . . . 5.1699999999999999 112.271 170.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.443 ' HA ' HH12 ' A' ' 128' ' ' ARG . 25.1 m-20 57.04 30.0 17.45 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.064 0.459 . . . . 3.71 111.908 -176.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.1 mt -99.02 139.58 34.45 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.231 -1.026 . . . . 2.4500000000000002 108.231 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.632 ' HA ' ' O ' ' A' ' 121' ' ' VAL . 50.7 mmt-85 -107.99 120.17 41.55 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.213 -0.595 . . . . 4.6799999999999997 110.624 -174.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.787 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 90.2 m-85 -118.47 125.11 49.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.6 -0.727 . . . . 4.3600000000000003 109.79 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.472 ' O ' ' HA ' ' A' ' 156' ' ' THR . 24.0 t30 -110.77 126.24 54.39 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.609 -0.268 . . . . 2.5899999999999999 110.282 -175.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.79 117.38 1.85 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.087 -1.054 . . . . 1.25 112.357 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 155' ' ' GLU . 52.8 t-105 -126.6 129.91 49.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.398 -0.593 . . . . 5.0899999999999999 109.398 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 84.3 mt -118.06 138.27 52.35 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.715 -0.476 . . . . 2.7599999999999998 109.715 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' A' ' 153' ' ' GLU . 3.2 p -134.99 117.19 15.51 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.475 0.655 . . . . 1.99 111.153 175.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 95.1 mmm -106.12 134.83 48.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.183 -0.917 . . . . 2.7799999999999998 109.288 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -124.9 133.83 52.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.012 0.434 . . . . 3.6800000000000002 111.888 -173.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 97.7 mttt -118.5 132.66 56.22 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.681 -0.859 . . . . 2.1699999999999999 108.681 171.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.527 ' H ' HD11 ' A' ' 142' ' ' LEU . 54.3 m-85 -123.03 143.04 50.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.508 0.194 . . . . 4.0099999999999998 110.908 -174.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 59.79 -160.19 0.29 Allowed 'General case' 0 C--O 1.226 -0.171 0 O-C-N 123.856 0.722 . . . . 1.79 111.446 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -76.02 -36.06 59.27 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.952 0.406 . . . . 3.04 110.483 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -60.29 -49.74 76.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.379 -0.828 . . . . 2.4100000000000001 113.169 -167.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.551 ' HA ' ' OG1' ' A' ' 145' ' ' THR . 14.7 mt -70.41 -27.18 64.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.74 -0.384 . . . . 2.3599999999999999 111.371 -176.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -60.72 -39.92 90.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.114 0.483 . . . . 2.52 110.343 172.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 85.0 m -70.05 -41.02 74.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.617 -0.72 . . . . 2.52 111.018 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.551 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 56.3 p -74.82 -26.09 59.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 2.0099999999999998 111.718 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 69.0 -112.96 4.91 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.845 -0.693 . . . . 1.52 112.345 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -106.21 -0.19 24.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.691 0.281 . . . . 6.2199999999999998 110.801 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.85 -40.18 75.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.103 0.478 . . . . 2.0499999999999998 110.547 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.445 ' O ' HD22 ' A' ' 142' ' ' LEU . 24.2 t70 -135.94 111.57 9.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.489 -0.778 . . . . 2.6400000000000001 109.083 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.6 t -165.7 147.15 7.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.932 -0.576 . . . . 2.6000000000000001 110.114 -173.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -70.71 135.71 48.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.611 0.243 . . . . 4.0899999999999999 110.508 175.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.91 120.08 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.176 -0.466 . . . . 2.1499999999999999 110.058 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.47 ' HB2' ' OG ' ' A' ' 134' ' ' SER . 96.4 mt-10 -119.97 139.96 51.66 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.444 -0.576 . . . . 2.5600000000000001 109.444 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 89.5 m -139.97 134.41 31.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.972 0.415 . . . . 1.78 111.493 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 132' ' ' TRP . 41.6 tt0 -113.35 127.81 56.25 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.298 -0.63 . . . . 2.04 109.298 173.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 130' ' ' ASN . 35.5 m -129.0 120.46 26.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.847 0.356 . . . . 2.0299999999999998 110.474 177.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -116.21 133.9 11.07 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.709 -0.758 . . . . 1.0800000000000001 111.601 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.493 ' HB2' HG13 ' A' ' 170' ' ' VAL . 52.6 mt -121.28 133.07 55.13 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.508 -0.553 . . . . 2.9300000000000002 109.508 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.534 ' HB3' ' HB2' ' A' ' 128' ' ' ARG . 54.1 tt0 -120.03 120.38 36.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.458 -0.337 . . . . 3.02 110.419 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -121.55 131.0 53.88 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.358 -0.608 . . . . 4.7599999999999998 109.358 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.1 p -99.49 89.81 4.3 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.466 -0.494 . . . . 1.8200000000000001 110.138 177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.07 -49.1 78.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.61 -0.723 . . . . 3.27 111.441 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.471 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.1 m-20 -100.0 12.68 36.26 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 121.119 -0.232 . . . . 2.4100000000000001 110.454 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 71.15 -49.51 0.68 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.725 0.81 . . . . 2.5800000000000001 111.762 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.2 t -74.84 -16.22 60.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.73 0.3 . . . . 2.6000000000000001 111.488 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 163' ' ' ASN . 17.9 m -125.58 141.45 45.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.853 0.359 . . . . 2.0600000000000001 110.439 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.401 ' O ' ' HD2' ' A' ' 199' ' ' PRO . . . -107.23 139.43 41.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 1.8400000000000001 110.909 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 31.2 mt -104.42 136.8 43.32 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.651 -0.87 . . . . 2.1400000000000001 108.651 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -118.34 120.12 36.68 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.444 -0.502 . . . . 3.73 110.477 -176.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.493 HG13 ' HB2' ' A' ' 158' ' ' LEU . 3.5 p -129.69 131.95 66.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.744 -0.662 . . . . 1.8100000000000001 109.752 176.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.443 HD22 ' CG ' ' A' ' 155' ' ' GLU . 26.8 t-20 -127.84 130.05 47.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.002 -0.545 . . . . 2.2400000000000002 110.163 -176.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -101.01 121.67 42.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.009 -0.542 . . . . 4.8399999999999999 109.626 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -97.3 110.0 22.64 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.155 -0.683 . . . . 4.4299999999999997 109.155 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.51 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 61.2 tp -103.63 115.67 30.92 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.084 -0.507 . . . . 2.8500000000000001 110.372 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -122.06 114.21 20.61 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.634 -0.876 . . . . 3.3100000000000001 108.634 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -100.03 124.27 45.21 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.261 -0.427 . . . . 7.3300000000000001 111.068 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 141.35 89.45 0.15 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.813 -0.631 . . . . 5.0599999999999996 112.403 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -64.54 -39.71 94.27 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.218 -0.66 . . . . 8.0199999999999996 109.218 175.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -95.68 122.49 38.5 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.379 -0.971 . . . . 9.4900000000000002 108.379 172.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 90.3 mtp -79.23 151.12 31.37 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.05 -0.523 . . . . 11.1 111.3 -171.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -60.09 -43.42 95.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.34 0.591 . . . . 10.470000000000001 109.485 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.569 ' HB2' ' ND2' ' A' ' 185' ' ' ASN . 40.4 m-20 -130.01 130.01 44.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.115 -0.948 . . . . 13.06 109.213 174.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.8 p -73.81 -15.72 61.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.241 0.543 . . . . 12.890000000000001 109.946 175.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -69.76 -39.12 76.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.245 -0.889 . . . . 15.720000000000001 110.907 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.569 ' ND2' ' HB2' ' A' ' 182' ' ' ASP . 81.1 m-20 -64.65 134.82 55.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.993 -0.548 . . . . 13.470000000000001 110.19 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.475 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 10.9 t30 -107.18 119.99 40.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.776 0.322 . . . . 13.15 110.748 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -90.31 -177.5 44.54 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.963 -0.637 . . . . 10.050000000000001 111.868 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -74.39 127.66 33.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.111 0.481 . . . . 10.699999999999999 109.959 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -70.18 -39.47 75.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.712 -0.676 . . . . 11.34 110.476 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 37.7 m -87.34 71.54 9.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.206 -0.452 . . . . 6.7800000000000002 110.18 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 27.3 m -64.6 128.89 37.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.788 -0.642 . . . . 5.3600000000000003 110.302 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -115.96 130.57 56.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.212 0.53 . . . . 7.8700000000000001 110.921 -175.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -59.78 -42.62 93.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.719 -1.128 . . . . 4.4000000000000004 111.363 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.688 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 18.5 tt -149.27 146.57 17.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.976 -0.556 . . . . 2.6400000000000001 109.645 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' A' ' 210' ' ' TYR . 96.6 mtt180 -121.93 110.08 15.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.723 0.297 . . . . 4.1100000000000003 110.774 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -137.21 141.76 42.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.544 -0.298 . . . . 1.76 111.186 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -163.53 174.99 11.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.647 -0.871 . . . . 6.1399999999999997 108.647 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 7.0 mp -98.64 125.61 42.03 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.045 -0.724 . . . . 3.0800000000000001 109.045 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' A' ' 167' ' ' ALA . 36.5 Cg_exo -60.07 138.75 83.83 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.1 1.867 . . . . 1.98 111.672 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 77.9 mt -116.94 131.81 56.86 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.183 -0.673 . . . . 2.7599999999999998 109.183 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 11.6 t -147.94 139.87 24.05 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.189 0.518 . . . . 2.4199999999999999 110.838 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 57.2 tp -143.89 85.46 1.82 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.542 -0.754 . . . . 2.77 109.354 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 75.92 -112.29 3.55 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.858 -0.686 . . . . 1.6200000000000001 112.487 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -93.94 0.02 55.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.204 0.526 . . . . 2.8599999999999999 110.351 -177.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -110.56 116.56 31.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.725 -0.67 . . . . 3.23 110.105 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 49.2 m -122.6 131.05 53.64 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.842 -0.429 . . . . 2.0499999999999998 109.842 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.27 130.01 72.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.044 -0.354 . . . . 1.9299999999999999 110.044 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.7 m -127.72 90.34 48.38 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-O 120.915 0.388 . . . . 1.6699999999999999 110.484 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 239' ' ' LEU . 5.8 Cg_exo -79.58 150.45 21.79 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.167 2.578 . . . . 1.28 112.081 175.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.511 ' HB3' ' HB3' ' A' ' 195' ' ' ARG . 80.9 m-85 -126.08 139.93 52.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.024 0.44 . . . . 4.8600000000000003 111.316 173.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 7.0 t -154.43 169.22 24.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.368 -0.975 . . . . 2.0899999999999999 108.368 175.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.688 ' HA ' ' O ' ' A' ' 194' ' ' ILE . 67.3 ttt180 -60.29 -49.19 78.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.385 0.539 . . . . 5.29 111.015 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.6 mt -120.21 122.26 67.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.584 -0.524 . . . . 4.9400000000000004 109.584 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -86.72 39.06 3.08 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.835 -0.697 . . . . 4.9800000000000004 113.475 -174.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.8 tp -140.01 128.92 23.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.937 0.369 . . . . 8.4399999999999995 110.253 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -80.93 140.06 35.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.089 -0.505 . . . . 7.9699999999999998 111.565 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -131.4 151.9 51.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.439 -0.8 . . . . 11.1 109.353 173.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -111.68 131.22 55.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.597 -0.519 . . . . 12.24 109.597 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.485 ' HB3' ' O ' ' A' ' 222' ' ' ASP . 47.8 t -130.05 139.96 50.91 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.16 -0.473 . . . . 10.220000000000001 109.753 -176.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -69.25 -39.87 78.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.915 -0.584 . . . . 11.92 110.575 175.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -78.0 -39.91 40.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.513 -0.767 . . . . 14.460000000000001 111.901 -174.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 219' ' ' SER . 8.2 p-10 -131.77 150.08 52.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.116 0.484 . . . . 14.529999999999999 111.423 -175.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -132.66 158.76 41.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.768 -0.651 . . . . 17.07 110.478 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -70.02 -37.73 75.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.18 0.514 . . . . 15.779999999999999 109.761 172.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -60.12 -39.91 87.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.045 -0.98 . . . . 15.67 111.264 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -82.44 133.36 35.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.92 -0.582 . . . . 14.5 110.143 -177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.58 120.4 63.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.871 0.367 . . . . 15.380000000000001 110.687 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.22 125.8 33.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.841 -0.618 . . . . 14.73 110.472 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -63.18 -40.02 96.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.766 -0.652 . . . . 16.969999999999999 110.483 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -120.62 130.53 54.2 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.641 -0.709 . . . . 12.779999999999999 109.729 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -173.73 -173.18 39.73 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.505 -0.855 . . . . 11.369999999999999 112.317 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -70.0 -40.21 75.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.073 0.463 . . . . 12.81 110.657 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -151.05 167.81 26.54 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.776 -0.647 . . . . 9.9900000000000002 110.719 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -122.87 108.92 13.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.873 -0.603 . . . . 11.32 109.478 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -82.01 93.09 6.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.145 0.498 . . . . 6.8799999999999999 110.58 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -99.29 139.26 35.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.829 -0.623 . . . . 8.9399999999999995 109.951 172.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 60.0 t -110.76 121.25 63.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.675 -0.491 . . . . 2.9700000000000002 109.675 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -92.14 117.08 5.19 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.427 -0.892 . . . . 1.3999999999999999 111.265 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 209' ' ' PRO . 6.3 mp -103.49 119.72 39.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.876 0.37 . . . . 2.4300000000000002 110.305 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -99.89 119.92 38.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.76 -0.655 . . . . 4.3300000000000001 109.287 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 252' ' ' SER . 91.1 m-85 -100.53 126.69 47.0 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.813 -0.44 . . . . 3.2599999999999998 109.813 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -116.25 121.46 5.21 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.798 -0.715 . . . . 1.3500000000000001 111.607 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' TYR . . . . . 0.429 ' HB2' ' HB ' ' A' ' 251' ' ' VAL . 89.7 m-85 -119.94 130.25 54.71 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.802 -0.444 . . . . 4.7599999999999998 109.802 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -112.65 128.7 56.46 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.456 -0.572 . . . . 4.29 109.456 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.92 140.19 51.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.159 0.505 . . . . 7.5599999999999996 110.391 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -60.0 -29.49 68.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.058 -0.974 . . . . 7.0199999999999996 112.24 -171.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -69.47 -20.01 63.75 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.607 0.241 . . . . 6.4800000000000004 111.486 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 116.22 0.0 20.76 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.548 -0.834 . . . . 2.9199999999999999 112.259 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.423 HD12 ' CD2' ' A' ' 279' ' ' TYR . 53.5 tp -74.98 129.96 38.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.869 0.366 . . . . 3.5800000000000001 110.256 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 25.8 t -122.06 130.26 53.12 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.261 -0.644 . . . . 2.6000000000000001 109.261 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.429 ' HB ' ' HB2' ' A' ' 243' ' ' TYR . 62.9 t -119.99 132.85 68.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.42 -0.355 . . . . 2.2400000000000002 110.666 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 241' ' ' TYR . 35.2 t -127.73 128.45 45.39 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.068 -0.716 . . . . 2.0 109.068 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 81.6 mt -121.38 139.93 52.79 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.652 -0.249 . . . . 3.4199999999999999 110.82 -178.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -114.35 110.67 20.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.182 -0.463 . . . . 4.0800000000000001 110.536 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -131.92 148.67 52.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.35 -0.386 . . . . 5.1699999999999999 110.34 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -111.66 19.97 17.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.24 0.543 . . . . 3.5800000000000001 110.087 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -126.84 113.99 17.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.812 -0.631 . . . . 7.5800000000000001 109.971 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.424 ' HG2' ' CD1' ' A' ' 259' ' ' TRP . 72.4 tt0 -70.18 -41.67 73.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.015 0.436 . . . . 8.5399999999999991 110.443 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . 0.424 ' CD1' ' HG2' ' A' ' 258' ' ' GLU . 90.5 m95 -133.77 93.98 3.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.977 -0.556 . . . . 12.720000000000001 110.544 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.575 ' HA ' ' OD1' ' A' ' 263' ' ' ASP . 97.9 mt-30 -59.85 -39.77 86.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.122 -0.49 . . . . 11.09 111.396 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -63.35 -21.54 66.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.972 -0.558 . . . . 11.41 111.611 -176.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -104.08 7.76 36.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.598 0.237 . . . . 12.49 111.41 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.575 ' OD1' ' HA ' ' A' ' 260' ' ' GLN . 10.4 m-20 -76.58 124.12 27.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.261 0.553 . . . . 12.460000000000001 111.49 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -70.03 -40.01 75.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.378 -0.828 . . . . 13.779999999999999 110.276 175.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 95.39 -22.4 39.02 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.737 -0.665 . . . . 11.300000000000001 112.816 176.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -70.03 -20.32 63.26 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.227 0.454 . . . . 12.59 112.227 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 51.8 m -59.95 -40.12 87.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.822 0.344 . . . . 11.1 111.681 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -127.01 132.79 50.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.297 -0.41 . . . . 12.42 110.03 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -70.12 -36.25 74.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.265 -0.425 . . . . 11.82 111.58 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -119.35 140.05 50.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.299 -0.409 . . . . 9.5999999999999996 110.179 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -130.04 138.17 50.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.145 -0.479 . . . . 7.7999999999999998 110.175 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -151.27 165.4 34.09 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.757 -0.46 . . . . 6.9900000000000002 109.757 176.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -138.94 170.55 15.79 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.607 -0.516 . . . . 2.4100000000000001 109.607 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.07 133.61 7.34 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.216 -0.992 . . . . 1.6200000000000001 112.343 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 61.8 t -127.86 129.82 69.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.956 -0.387 . . . . 2.4900000000000002 109.956 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -132.76 111.85 1.06 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.227 -0.749 . . . . 1.3 111.227 176.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 23.8 m -119.98 132.36 69.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.845 0.355 . . . . 2.3399999999999999 110.815 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -119.71 127.75 53.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.153 -0.476 . . . . 2.7999999999999998 110.368 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.423 ' CD2' HD12 ' A' ' 249' ' ' LEU . 89.6 m-85 -105.99 130.27 53.95 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.044 -0.725 . . . . 5.1900000000000004 109.044 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.1 t -117.68 125.05 49.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.841 0.353 . . . . 2.0499999999999998 111.172 -172.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.281 -0.866 . . . . 4.4199999999999999 109.858 179.193 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.0 mtm . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 109.444 -0.576 . . . . 11.970000000000001 109.444 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.477 ' OE1' ' HB2' ' A' ' 4' ' ' ARG . 37.4 tt0 -151.01 143.94 24.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.048 0.451 . . . . 10.35 110.546 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.19 -39.88 88.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.387 -0.824 . . . . 9.3100000000000005 111.334 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.477 ' HB2' ' OE1' ' A' ' 2' ' ' GLU . 33.9 mtm180 -67.41 129.3 39.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.028 -0.533 . . . . 9.4399999999999995 110.663 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.407 ' HB3' ' OD1' ' A' ' 41' ' ' ASN . 13.4 m120 -127.31 109.18 11.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.898 -0.592 . . . . 7.75 109.815 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -72.51 125.67 28.0 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.816 -0.439 . . . . 3.6099999999999999 109.816 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -71.78 118.18 14.3 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.674 -0.491 . . . . 3.9100000000000001 109.674 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.464 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 96.4 m-70 -104.14 124.94 50.0 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.104 0.478 . . . . 3.9399999999999999 110.671 -176.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.97 139.94 51.7 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.422 -0.808 . . . . 3.21 109.264 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -129.12 129.63 45.42 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.036 -0.728 . . . . 2.6499999999999999 109.036 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.6 mm -120.53 120.08 61.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.901 -0.407 . . . . 2.0699999999999998 109.901 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -102.74 137.69 13.53 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.065 -1.064 . . . . 0.92000000000000004 111.331 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.17 135.36 54.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.921 0.391 . . . . 1.6499999999999999 110.248 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 59.4 ttm -134.6 130.95 37.24 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.696 -0.683 . . . . 2.9700000000000002 110.026 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -99.84 121.64 41.6 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.486 -0.561 . . . . 3.1499999999999999 109.486 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.64 140.17 55.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 5.0899999999999999 110.519 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.0 tt -129.86 138.42 54.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.907 0.384 . . . . 5.3300000000000001 110.102 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -110.03 147.96 32.57 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.033 0.444 . . . . 8.2799999999999994 110.375 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -70.03 -20.59 63.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.322 -0.854 . . . . 10.0 111.593 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.2 t -120.46 129.96 74.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.735 -0.469 . . . . 11.380000000000001 109.735 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.57 -39.8 92.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.364 -0.835 . . . . 13.1 111.183 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.24 151.86 17.94 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.711 -0.757 . . . . 12.52 111.842 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -84.9 122.31 29.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.177 0.513 . . . . 15.18 111.662 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.3 -176.6 38.98 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.471 -0.786 . . . . 12.279999999999999 111.415 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -69.78 -35.65 75.07 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.771 0.32 . . . . 12.82 110.862 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -70.11 -19.9 63.21 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.933 0.397 . . . . 10.81 111.087 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 91.3 mtp -91.38 139.97 30.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.892 -0.594 . . . . 10.210000000000001 111.064 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -156.14 151.94 27.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.082 -0.508 . . . . 8.0600000000000005 110.13 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.27 -177.9 30.1 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.014 -0.612 . . . . 6.0800000000000001 111.614 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.4 mt -134.57 148.6 50.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.814 0.307 . . . . 5.96 110.644 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.42 114.49 25.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.092 -0.504 . . . . 3.2400000000000002 109.804 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -123.49 152.4 64.79 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.897 0.379 . . . . 3.48 111.278 -171.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.38 133.59 28.68 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.088 1.859 . . . . 2.0299999999999998 110.679 171.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.8 m -128.45 147.25 50.65 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.561 -0.29 . . . . 2.2799999999999998 110.654 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 19.5 m -120.13 146.69 24.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.382 -0.372 . . . . 2.4100000000000001 110.475 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -119.96 142.65 48.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.03 -0.532 . . . . 4.4400000000000004 109.608 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 64.4 t80 -101.7 129.87 47.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.863 0.363 . . . . 3.6200000000000001 110.602 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -144.38 134.87 24.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.79 -0.641 . . . . 2.48 109.351 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.74 146.7 39.87 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.309 -0.244 . . . . 1.53 111.425 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 8' ' ' HIS . . . -154.95 122.53 5.7 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 111.936 0.347 . . . . 1.8 111.936 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.643 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 53.8 t30 -167.87 95.56 0.43 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.391 -0.368 . . . . 3.3799999999999999 110.207 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.69 -94.72 2.02 Favored Glycine 0 C--O 1.23 -0.134 0 C-N-CA 121.012 -0.614 . . . . 1.8200000000000001 111.67 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.643 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 80.8 Cg_exo -47.19 175.74 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 123.912 3.075 . . . . 2.1000000000000001 113.357 167.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -66.1 176.68 1.62 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.428 0.632 . . . . 4.0499999999999998 111.441 -172.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -110.62 124.18 51.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.707 -0.678 . . . . 3.6000000000000001 109.649 -171.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 85.3 mt -119.58 130.01 74.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.664 -0.698 . . . . 2.2799999999999998 110.915 -169.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -118.96 130.0 55.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 1.4399999999999999 110.419 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.2 tp -124.57 135.66 53.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.138 -0.483 . . . . 1.75 111.241 -176.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.98 162.47 35.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.663 -0.699 . . . . 1.5900000000000001 110.121 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -137.42 146.87 44.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.821 0.344 . . . . 4.4400000000000004 110.345 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.4 ' HB2' ' HG3' ' A' ' 69' ' ' ARG . 96.1 m-85 -130.05 129.95 44.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.229 -0.441 . . . . 5.0199999999999996 111.306 -175.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -104.54 85.94 2.42 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.281 -0.637 . . . . 3.7400000000000002 109.281 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.549 ' CD ' HH21 ' A' ' 69' ' ' ARG . 42.2 mt-10 -129.04 154.09 46.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.857 -0.61 . . . . 5.0499999999999998 110.907 -173.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 154.96 133.51 1.74 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.707 -0.759 . . . . 4.3700000000000001 112.454 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.21 145.44 60.31 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.328 2.019 . . . . 7.0899999999999999 111.649 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.4 t -130.0 129.94 65.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.353 -0.385 . . . . 8.5700000000000003 110.607 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -124.61 -174.75 3.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.54 -0.541 . . . . 10.039999999999999 109.54 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -60.01 -40.01 87.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.596 0.236 . . . . 11.890000000000001 111.07 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.441 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 10.2 m -63.45 -50.17 70.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.012 0.434 . . . . 9.7899999999999991 110.778 -178.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.25 -38.52 81.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.736 -0.665 . . . . 8.7799999999999994 111.36 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -60.03 -24.18 60.35 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 116.047 -0.524 . . . . 7.7300000000000004 113.523 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 59' ' ' SER . 55.1 mtmt -69.77 -26.31 64.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.544 0.211 . . . . 10.300000000000001 111.559 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -106.2 147.28 29.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.049 0.452 . . . . 10.960000000000001 110.806 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.99 46.3 3.54 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.586 -0.606 . . . . 5.5599999999999996 111.586 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.2 m -93.31 126.83 38.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.621 0.248 . . . . 5.6900000000000004 110.34 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -120.01 139.03 53.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.433 -0.349 . . . . 6.5 110.616 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -125.66 138.65 53.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.459 -0.337 . . . . 4.5999999999999996 110.153 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -131.99 170.03 15.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.366 -0.379 . . . . 2.4500000000000002 110.173 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.549 HH21 ' CD ' ' A' ' 53' ' ' GLU . 27.9 ptt180 -141.84 125.7 9.96 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.979 0.418 . . . . 3.7200000000000002 111.196 171.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.529 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 90.9 Cg_endo -85.19 156.85 11.15 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.999 2.466 . . . . 1.3200000000000001 112.25 172.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.423 ' HG3' ' HE ' ' A' ' 93' ' ' ARG . 86.1 tt0 -127.09 120.77 29.7 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.123 -0.695 . . . . 2.1899999999999999 109.123 171.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.577 ' O ' ' HA3' ' A' ' 91' ' ' GLY . 64.3 tp -136.21 119.09 16.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.346 -0.388 . . . . 1.73 110.208 -177.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.443 ' CD ' ' HZ3' ' A' ' 114' ' ' LYS . 40.0 mt-10 -128.59 149.22 50.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.122 0.487 . . . . 2.1800000000000002 110.864 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.6 t -119.96 130.04 74.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.447 -0.797 . . . . 2.0600000000000001 109.272 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -93.73 120.51 34.09 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.704 -0.48 . . . . 4.1900000000000004 109.704 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -108.2 134.85 50.47 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.105 -0.702 . . . . 5.1600000000000001 109.105 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -120.0 131.29 55.09 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.68 0.276 . . . . 3.3100000000000001 110.318 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -119.58 138.57 53.13 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.29 0.567 . . . . 4.6600000000000001 111.167 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.428 HD23 ' H ' ' A' ' 84' ' ' PHE . 37.0 mt -100.24 94.04 6.0 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.684 -0.858 . . . . 4.8799999999999999 108.684 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -90.02 -81.33 0.29 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.884 0.373 . . . . 6.1900000000000004 110.867 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -109.11 -40.01 5.1 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.994 -0.743 . . . . 6.0999999999999996 108.994 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -114.12 147.3 39.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.988 -1.006 . . . . 5.2699999999999996 108.966 174.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -71.34 125.03 25.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.081 -0.509 . . . . 6.3300000000000001 112.189 -173.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.428 ' H ' HD23 ' A' ' 79' ' ' LEU . 93.2 m-85 70.18 10.46 7.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.981 -1.008 . . . . 8.3499999999999996 112.4 172.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.3 m -60.38 -40.13 89.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.894 0.378 . . . . 2.6400000000000001 111.698 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -94.43 103.89 15.86 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.271 -0.572 . . . . 6.1900000000000004 109.65 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -113.97 125.65 6.99 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.979 -0.848 . . . . 1.54 110.979 176.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 60.0 tp -119.64 130.53 55.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.837 0.351 . . . . 2.73 111.02 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.2 p -117.04 131.86 56.83 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.788 -0.819 . . . . 1.8700000000000001 108.788 169.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.43 150.46 20.88 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.235 -0.983 . . . . 1.1699999999999999 111.585 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 72' ' ' LEU . . . -173.16 -169.96 36.23 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.632 -0.794 . . . . 1.4399999999999999 112.07 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -120.21 139.98 51.85 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.062 0.458 . . . . 4.6399999999999997 110.819 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.423 ' HE ' ' HG3' ' A' ' 71' ' ' GLU . 98.2 mtt180 -121.04 127.21 51.5 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.492 -0.929 . . . . 3.2200000000000002 108.492 172.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.529 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 10.4 t30 -132.25 124.61 29.26 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.78 -0.368 . . . . 2.2200000000000002 110.674 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.461 ' HA ' ' HB3' ' A' ' 69' ' ' ARG . 72.1 t80 -111.28 129.54 55.95 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.331 -0.395 . . . . 3.6400000000000001 110.435 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.3 -176.97 40.72 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.68 -0.772 . . . . 2.79 112.574 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -122.08 129.0 52.0 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.737 -0.468 . . . . 7.8499999999999996 109.737 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -70.27 -40.22 74.47 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.325 -0.62 . . . . 7.6900000000000004 109.325 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -107.67 124.25 49.7 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.364 -0.835 . . . . 10.289999999999999 109.525 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 102' ' ' GLU . 58.8 t -120.04 130.0 74.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.874 -0.417 . . . . 10.19 109.874 -178.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -72.11 -10.05 59.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 12.220000000000001 112.123 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.516 ' H ' HG12 ' A' ' 100' ' ' VAL . 44.7 mt-10 -70.21 145.28 93.39 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.958 -0.386 . . . . 10.48 109.958 173.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.96 -10.59 28.77 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 C-N-CA 123.317 2.678 . . . . 9.6799999999999997 114.104 -172.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.65 141.57 28.71 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.455 -0.878 . . . . 6.5099999999999998 112.331 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.62 -40.08 95.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.702 0.287 . . . . 8.1099999999999994 111.617 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -62.06 139.5 58.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.033 -0.53 . . . . 4.1399999999999997 111.17 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.2 t -141.51 173.51 11.43 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.522 -0.763 . . . . 3.77 109.049 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.62 113.25 7.02 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.623 -0.431 . . . . 2.2000000000000002 110.864 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -147.02 138.56 24.19 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.045 -0.525 . . . . 3.1200000000000001 110.139 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.477 ' HG3' ' HA ' ' A' ' 139' ' ' ALA . 46.4 ttm -131.65 129.91 41.4 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.622 -0.717 . . . . 2.1200000000000001 110.71 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -101.87 124.96 48.39 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.491 -0.559 . . . . 2.4900000000000002 109.491 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -130.55 130.15 43.71 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.134 0.492 . . . . 4.4699999999999998 110.328 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -112.2 141.73 45.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.742 -0.663 . . . . 2.9199999999999999 110.79 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.443 ' HZ3' ' CD ' ' A' ' 73' ' ' GLU . 62.2 tttm -139.89 123.59 17.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.177 -0.465 . . . . 2.5099999999999998 110.424 173.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 88.0 mt -136.76 130.15 45.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.513 -0.767 . . . . 2.1299999999999999 109.039 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -149.46 104.19 3.28 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.678 0.622 . . . . 1.6799999999999999 112.678 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.411 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 65.0 Cg_endo -94.43 159.77 1.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.463 2.775 . . . . 1.54 113.036 170.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -120.6 142.51 49.33 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.379 -0.971 . . . . 2.3500000000000001 108.379 173.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -125.78 129.92 50.41 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.474 0.176 . . . . 5.1500000000000004 111.474 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -84.1 120.89 26.7 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.576 -0.527 . . . . 3.04 109.576 170.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.57 ' O ' ' HB3' ' A' ' 129' ' ' PHE . 57.3 t -139.88 99.92 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.886 0.375 . . . . 4.7400000000000002 110.282 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -87.61 115.92 25.38 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.113 -0.328 . . . . 6.3600000000000003 110.113 176.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.78 -39.81 95.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.413 0.625 . . . . 4.96 109.322 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.0 p -141.4 169.92 16.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.873 -1.058 . . . . 4.0700000000000003 109.178 172.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.14 -45.44 93.05 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.839 0.311 . . . . 5.1699999999999999 111.839 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -64.94 -39.95 94.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 3.71 111.552 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.5 mt -76.16 142.57 41.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.43 0.634 . . . . 2.4500000000000002 112.11 -172.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.516 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 35.2 ttt180 -110.31 118.07 35.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.252 -0.886 . . . . 4.6799999999999997 109.248 175.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.57 ' HB3' ' O ' ' A' ' 121' ' ' VAL . 65.0 t80 -142.11 138.48 31.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.728 0.299 . . . . 4.3600000000000003 110.372 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -139.87 172.2 13.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 2.5899999999999999 109.913 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -148.23 121.99 1.44 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.776 -0.726 . . . . 1.25 112.072 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -100.02 126.52 46.22 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.389 -0.597 . . . . 5.0899999999999999 109.389 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.602 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 42.6 tp -111.98 130.71 55.76 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.26 -0.427 . . . . 2.7599999999999998 110.117 -178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.1 m -127.0 129.99 49.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.901 0.382 . . . . 1.99 110.308 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.595 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 72.0 mtm -122.91 125.19 44.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.849 -0.614 . . . . 2.7799999999999998 109.958 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -122.17 139.94 53.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.116 -0.493 . . . . 3.6800000000000002 111.774 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -135.78 149.98 49.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.323 -0.991 . . . . 2.1699999999999999 108.323 172.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.467 ' O ' HD23 ' A' ' 142' ' ' LEU . 46.2 p90 -140.5 165.93 26.1 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.095 -0.335 . . . . 4.0099999999999998 110.095 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.477 ' HA ' ' HG3' ' A' ' 110' ' ' MET . . . 63.42 178.15 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.512 0.507 . . . . 1.79 111.018 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -76.1 -36.63 58.82 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.313 0.578 . . . . 3.04 110.6 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -60.07 -40.02 88.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.253 -0.885 . . . . 2.4100000000000001 112.956 -171.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 138' ' ' PHE . 4.2 mm? -69.38 -33.4 72.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.696 0.284 . . . . 2.3599999999999999 111.535 -173.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -66.62 -39.93 88.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.365 0.602 . . . . 2.52 109.517 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 52.4 m -65.77 -39.95 91.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.2 -0.909 . . . . 2.52 111.395 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 22.9 p -71.7 -9.87 58.91 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 111.89 0.33 . . . . 2.0099999999999998 111.89 -177.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 65.43 -120.34 17.19 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.786 -0.721 . . . . 1.52 111.857 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -103.29 10.09 37.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.854 0.327 . . . . 6.2199999999999998 111.016 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.48 -40.12 95.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.885 0.374 . . . . 2.0499999999999998 110.499 176.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -137.14 114.87 11.27 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.298 -0.631 . . . . 2.6400000000000001 109.298 175.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.1 t -159.95 150.05 18.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.918 0.39 . . . . 2.6000000000000001 110.543 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 135' ' ' MET . 19.0 mtp180 -84.47 113.35 21.14 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.051 -0.351 . . . . 4.0899999999999999 110.051 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.9 t -111.15 103.7 15.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.98 -0.748 . . . . 2.1499999999999999 108.98 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -121.99 128.91 52.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.549 -0.75 . . . . 2.5600000000000001 110.016 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 72.7 m -128.49 130.22 47.2 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.033 0.444 . . . . 1.78 111.527 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -110.4 119.22 38.5 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.01 -0.737 . . . . 2.04 109.01 173.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.522 ' OG1' ' HB3' ' A' ' 172' ' ' TYR . 22.7 p -101.36 141.67 33.89 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.726 -0.39 . . . . 2.0299999999999998 110.727 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 129' ' ' PHE . . . -116.7 120.02 4.69 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.723 -0.751 . . . . 1.0800000000000001 112.095 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.6 tp -115.2 129.76 56.73 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.91 0.386 . . . . 2.9300000000000002 110.151 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.516 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 30.1 tt0 -118.98 115.85 25.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.521 -0.548 . . . . 3.02 109.521 174.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -125.39 130.53 52.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.795 -0.638 . . . . 4.7599999999999998 110.218 -175.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 3.7 p -87.58 93.9 9.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.064 0.459 . . . . 1.8200000000000001 110.853 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -59.99 -49.82 76.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 3.27 111.547 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -101.8 16.65 25.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.544 -0.298 . . . . 2.4100000000000001 110.861 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 73.03 -50.19 0.7 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.763 0.664 . . . . 2.5800000000000001 111.419 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.1 p -74.78 -21.41 59.34 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.037 0.384 . . . . 2.6000000000000001 112.037 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 161' ' ' THR . 34.3 m -120.03 138.16 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.776 0.322 . . . . 2.0600000000000001 110.724 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.0 134.4 50.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.215 -0.448 . . . . 1.8400000000000001 110.29 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 43.8 mt -103.55 139.92 38.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.34 -0.391 . . . . 2.1400000000000001 110.024 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 55.6 mtp180 -98.9 114.36 26.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.212 -0.449 . . . . 3.73 109.882 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 195' ' ' ARG . 60.3 t -129.16 132.3 67.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 1.8100000000000001 110.569 -177.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.425 ' O ' HG21 ' A' ' 194' ' ' ILE . 18.9 m120 -122.52 147.91 45.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.971 0.415 . . . . 2.2400000000000002 110.868 173.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.522 ' HB3' ' OG1' ' A' ' 156' ' ' THR . 64.5 t80 -129.09 147.09 50.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.487 -0.779 . . . . 4.8399999999999999 109.811 -173.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -96.63 125.49 41.14 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 120.757 0.313 . . . . 4.4299999999999997 110.714 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 67.7 tp -120.83 114.02 20.99 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.257 -0.645 . . . . 2.8500000000000001 109.257 171.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -125.18 113.43 17.66 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.629 -0.508 . . . . 3.3100000000000001 109.629 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.477 ' HD3' ' OE2' ' A' ' 188' ' ' GLU . 47.7 ttp180 -157.17 98.37 1.72 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.063 0.459 . . . . 7.3300000000000001 111.021 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -111.59 -136.56 6.99 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.104 -0.798 . . . . 5.0599999999999996 111.104 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -88.1 130.0 35.14 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.744 -0.465 . . . . 8.0199999999999996 109.744 176.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -79.1 120.9 24.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.808 0.337 . . . . 9.4900000000000002 110.427 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 92.8 mtp -70.02 -40.02 75.47 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.661 -0.866 . . . . 11.1 108.661 173.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -143.0 109.78 5.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.783 -1.099 . . . . 10.470000000000001 109.202 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -60.89 128.94 38.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.972 0.415 . . . . 13.06 110.502 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 12.0 p -117.21 163.91 15.59 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.023 -0.535 . . . . 12.890000000000001 110.698 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -59.93 -40.18 88.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.272 0.558 . . . . 15.720000000000001 110.018 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -119.83 122.41 41.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.503 -0.771 . . . . 13.470000000000001 109.811 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -84.23 -23.62 30.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.262 0.553 . . . . 13.15 109.778 175.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 99.38 7.71 53.9 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.371 -0.831 . . . . 10.050000000000001 111.479 -175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.477 ' OE2' ' HD3' ' A' ' 176' ' ' ARG . 39.2 mt-10 -60.46 -39.98 89.57 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.593 0.357 . . . . 10.699999999999999 111.267 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -101.29 28.15 5.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.167 0.508 . . . . 11.34 110.995 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.7 t -139.73 159.97 40.96 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.134 -0.691 . . . . 6.7800000000000002 109.134 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.4 m -140.64 130.19 24.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.096 0.474 . . . . 5.3600000000000003 110.809 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -63.36 -40.68 97.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.617 -0.72 . . . . 7.8700000000000001 111.165 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.43 ' HG3' ' HG3' ' A' ' 212' ' ' ARG . 35.8 tt0 -158.94 131.13 6.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.299 -0.409 . . . . 4.4000000000000004 110.077 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.425 HG21 ' O ' ' A' ' 171' ' ' ASN . 87.3 mt -110.2 143.29 20.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 122.358 0.263 . . . . 2.6400000000000001 111.188 -173.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.577 ' HB3' ' CD1' ' A' ' 210' ' ' TYR . 53.9 mtm-85 -98.41 102.84 14.7 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.904 -0.776 . . . . 4.1100000000000003 108.904 169.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 169' ' ' ARG . . . -141.08 121.7 14.22 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.918 -0.313 . . . . 1.76 111.014 177.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -165.76 -179.11 5.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.648 -0.501 . . . . 6.1399999999999997 109.648 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.474 HD13 ' HD2' ' A' ' 199' ' ' PRO . 24.3 tp -99.44 126.58 37.09 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.315 -0.624 . . . . 3.0800000000000001 109.315 173.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.474 ' HD2' HD13 ' A' ' 198' ' ' LEU . 38.3 Cg_endo -70.06 145.79 56.46 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.139 1.892 . . . . 1.98 112.225 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 56.1 mt -118.41 130.72 56.13 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.085 -0.507 . . . . 2.7599999999999998 109.655 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 26.8 m -131.12 125.15 32.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.983 0.42 . . . . 2.4199999999999999 110.996 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 91.8 mt -131.37 80.97 1.96 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.57 -0.741 . . . . 2.77 109.47 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 68.62 -115.83 6.94 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.802 -0.713 . . . . 1.6200000000000001 112.105 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -90.12 -0.59 57.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.209 0.528 . . . . 2.8599999999999999 110.117 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.432 ' CD2' ' HE2' ' A' ' 243' ' ' TYR . 75.7 m80 -99.9 117.23 33.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.539 -0.755 . . . . 3.23 109.01 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 12.5 t -132.14 130.97 41.82 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.629 -0.428 . . . . 2.0499999999999998 110.24 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.8 p -137.56 134.98 46.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.408 0.623 . . . . 1.9299999999999999 110.862 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 29.0 m -128.95 91.78 41.74 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 115.667 -0.697 . . . . 1.6699999999999999 109.846 176.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.74 157.16 61.4 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.599 2.199 . . . . 1.28 110.664 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.577 ' CD1' ' HB3' ' A' ' 195' ' ' ARG . 71.0 m-85 -129.29 139.79 51.66 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.997 -0.372 . . . . 4.8600000000000003 109.997 175.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 39.5 p -124.25 140.02 53.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.987 0.422 . . . . 2.0899999999999999 110.385 176.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.653 ' HD3' ' OD1' ' A' ' 235' ' ' ASN . 37.7 ttt180 -64.27 -39.67 94.41 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 114.795 -1.093 . . . . 5.29 112.748 -170.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.9 mt -108.0 129.93 61.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.742 0.306 . . . . 4.9400000000000004 110.383 -174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -70.44 94.87 0.5 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.92 -0.582 . . . . 4.9800000000000004 112.747 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 57.6 tp -60.23 -38.68 84.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.994 0.425 . . . . 8.4399999999999995 110.354 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -80.48 9.33 6.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.673 -0.694 . . . . 7.9699999999999998 111.491 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -115.77 139.9 49.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.952 0.406 . . . . 11.1 110.974 176.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -109.51 132.32 54.24 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.039 -0.528 . . . . 12.24 109.878 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.1 m -95.4 112.53 24.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.465 -0.334 . . . . 10.220000000000001 110.43 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -69.98 -37.28 75.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.318 0.58 . . . . 11.92 109.886 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 21.2 m-90 -120.93 153.02 37.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.648 -0.706 . . . . 14.460000000000001 110.218 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 60.25 39.51 19.02 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.882 0.739 . . . . 14.529999999999999 110.95 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -94.5 119.96 34.0 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.776 -0.824 . . . . 17.07 108.776 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -129.47 146.49 51.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.838 0.351 . . . . 15.779999999999999 111.096 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -60.95 -39.32 89.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.328 -0.851 . . . . 15.67 110.622 176.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -60.04 -39.97 87.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.685 -0.688 . . . . 14.5 111.386 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 88.7 mt -63.74 -25.31 37.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.39 -0.368 . . . . 15.380000000000001 111.356 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -59.97 -39.95 87.4 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.124 0.488 . . . . 14.73 111.22 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -118.17 137.71 52.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.962 -0.563 . . . . 16.969999999999999 110.526 -170.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.506 ' HG2' ' ND2' ' A' ' 235' ' ' ASN . 47.8 mt-10 -69.46 -34.44 74.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.206 -0.906 . . . . 12.779999999999999 111.134 -172.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 77.69 -132.57 12.07 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.624 -0.798 . . . . 11.369999999999999 112.501 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -70.1 -39.96 75.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.818 0.342 . . . . 12.81 111.284 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -89.97 160.16 16.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.09 -0.504 . . . . 9.9900000000000002 111.014 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -119.94 140.08 51.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.022 -0.536 . . . . 11.32 109.937 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.653 ' OD1' ' HD3' ' A' ' 212' ' ' ARG . 48.9 m-80 -79.1 136.75 37.24 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.777 -0.453 . . . . 6.8799999999999999 109.777 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -73.0 121.75 20.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.254 0.55 . . . . 8.9399999999999995 111.251 -174.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 210' ' ' TYR . 71.0 t -113.58 129.34 69.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.285 -0.871 . . . . 2.9700000000000002 110.031 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -110.39 141.79 16.42 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.599 -0.81 . . . . 1.3999999999999999 111.807 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 88.9 mt -109.72 117.65 34.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.158 -0.312 . . . . 2.4300000000000002 110.158 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -101.09 120.11 39.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.205 -0.452 . . . . 4.3300000000000001 109.95 175.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.514 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 86.8 m-85 -111.94 130.19 55.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.097 0.475 . . . . 3.2599999999999998 110.349 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -121.32 113.7 2.39 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 111.027 -0.829 . . . . 1.3500000000000001 111.027 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' TYR . . . . . 0.432 ' HE2' ' CD2' ' A' ' 205' ' ' HIS . 86.5 m-85 -119.96 135.25 54.98 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.178 0.513 . . . . 4.7599999999999998 111.501 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -110.0 100.82 9.71 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.408 -0.815 . . . . 4.29 109.077 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -77.55 -19.95 54.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.976 0.417 . . . . 7.5599999999999996 110.959 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -149.93 150.46 31.91 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.738 -0.838 . . . . 7.0199999999999996 108.738 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -66.97 121.68 16.06 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.423 -0.511 . . . . 6.4800000000000004 109.682 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 98.53 -9.71 62.65 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.778 -0.646 . . . . 2.9199999999999999 112.43 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 93.1 mt -124.23 133.0 53.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.721 0.296 . . . . 3.5800000000000001 110.616 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 33.7 m -129.98 149.96 51.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.368 -0.378 . . . . 2.6000000000000001 110.772 -176.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 8.5 p -127.41 134.07 66.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.17 0.51 . . . . 2.2400000000000002 109.845 174.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 19.3 t -103.9 119.89 39.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.716 -0.674 . . . . 2.0 109.747 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 77.9 mt -119.42 113.05 20.18 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.145 -0.479 . . . . 3.4199999999999999 110.068 -178.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -109.05 129.55 55.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.945 0.402 . . . . 4.0800000000000001 111.036 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -128.14 151.3 49.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.823 -0.626 . . . . 5.1699999999999999 110.441 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -134.49 146.98 50.26 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.164 -0.471 . . . . 3.5800000000000001 110.568 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -78.77 159.94 27.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.092 -0.504 . . . . 7.5800000000000001 110.29 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 60.06 39.57 19.61 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.507 0.504 . . . . 8.5399999999999991 111.134 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -69.98 -30.02 67.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.766 -0.652 . . . . 12.720000000000001 112.467 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -67.92 -40.75 83.32 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.647 0.261 . . . . 11.09 111.409 -173.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -104.32 114.89 29.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.911 -0.403 . . . . 11.41 109.911 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -93.6 74.03 4.37 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.144 -0.48 . . . . 12.49 111.438 -175.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -74.5 124.9 27.45 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.461 -0.57 . . . . 12.460000000000001 109.461 171.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -68.47 -40.0 81.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.637 -0.71 . . . . 13.779999999999999 110.985 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.85 17.32 68.03 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.523 -0.762 . . . . 11.300000000000001 111.972 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 60.04 39.38 19.92 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.305 0.574 . . . . 12.59 110.534 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 34.5 t -146.81 138.16 24.24 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.629 -0.714 . . . . 11.1 110.127 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -80.1 -10.17 59.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.282 0.563 . . . . 12.42 109.979 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -89.12 120.26 30.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.522 -0.763 . . . . 11.82 109.534 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -135.99 160.79 37.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.145 -0.479 . . . . 9.5999999999999996 110.695 -174.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -84.4 113.08 20.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.043 -0.526 . . . . 7.7999999999999998 110.92 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -82.73 130.09 35.07 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.064 -0.717 . . . . 6.9900000000000002 109.064 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -134.62 140.59 46.18 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.445 -0.206 . . . . 2.4100000000000001 110.445 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 177.69 -169.74 41.86 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.747 -0.739 . . . . 1.6200000000000001 112.333 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 63.2 t -110.12 128.89 65.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.867 0.365 . . . . 2.4900000000000002 110.667 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.86 141.21 12.46 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.508 -0.637 . . . . 1.3 111.508 176.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 61.6 t -120.02 129.96 74.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 117.093 0.447 . . . . 2.3399999999999999 110.162 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -108.11 109.33 20.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.935 0.398 . . . . 2.7999999999999998 110.058 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -100.02 107.9 19.96 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.872 -0.788 . . . . 5.1900000000000004 108.872 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.6 m -119.54 132.27 55.71 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.998 0.428 . . . . 2.0499999999999998 111.248 -172.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 59.2 t80 . . . . . 0 C--O 1.241 0.617 0 CA-C-O 118.411 -0.804 . . . . 4.4199999999999999 109.225 176.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.425 0.155 . . . . 11.970000000000001 111.181 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -60.04 -39.55 86.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.392 0.615 . . . . 10.35 110.408 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -85.32 8.16 19.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.524 -0.762 . . . . 9.3100000000000005 111.547 -175.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -126.75 152.78 46.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.786 0.327 . . . . 9.4399999999999995 111.038 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -113.63 164.07 14.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.112 -0.494 . . . . 7.75 110.892 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -60.85 -43.37 98.42 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.162 0.506 . . . . 3.6099999999999999 111.322 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.502 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 71.0 m95 -119.79 147.24 44.88 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.151 -0.685 . . . . 3.9100000000000001 109.151 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.651 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 11.6 t-160 -96.44 113.37 24.94 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.624 -0.51 . . . . 3.9399999999999999 109.624 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.502 ' CE1' ' HB2' ' A' ' 7' ' ' TRP . 95.0 m-85 -110.41 158.88 18.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.904 -0.589 . . . . 3.21 111.108 -176.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -141.42 132.3 25.93 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.809 -0.632 . . . . 2.6499999999999999 109.326 170.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.5 mt -119.8 114.09 43.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.974 -0.75 . . . . 2.0699999999999998 108.974 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.81 127.25 8.18 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.265 -0.969 . . . . 0.92000000000000004 112.128 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -115.69 134.45 55.02 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 110.057 -0.349 . . . . 1.6499999999999999 110.057 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 94.8 mmm -124.31 131.03 53.5 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.859 -0.61 . . . . 2.9700000000000002 109.372 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -85.82 109.1 18.44 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.769 -0.456 . . . . 3.1499999999999999 109.769 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -96.2 114.37 26.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.145 0.498 . . . . 5.0899999999999999 110.706 -175.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 88.2 mt -119.87 121.31 65.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.401 -0.818 . . . . 5.3300000000000001 110.382 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -119.93 138.3 53.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.174 0.511 . . . . 8.2799999999999994 110.042 176.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -60.18 -39.91 88.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.101 -0.954 . . . . 10.0 111.403 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.7 t -83.51 118.97 31.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.936 -0.575 . . . . 11.380000000000001 110.532 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -66.29 -39.87 89.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.271 -0.877 . . . . 13.1 109.975 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.22 -171.88 30.05 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.214 -0.903 . . . . 12.52 112.036 177.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -139.69 150.05 44.42 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.135 -0.32 . . . . 15.18 110.135 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.5 151.88 7.43 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.73 -0.748 . . . . 12.279999999999999 112.453 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -59.9 -40.06 87.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.853 0.359 . . . . 12.82 111.513 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -82.2 0.15 42.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.836 -0.62 . . . . 10.81 111.801 -173.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 93.6 mmm -100.63 109.33 21.39 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.829 0.347 . . . . 10.210000000000001 110.88 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -69.56 -39.68 77.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.967 -0.561 . . . . 8.0600000000000005 110.778 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.82 3.3 74.06 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.948 -0.644 . . . . 6.0800000000000001 111.916 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.4 mt -92.15 137.87 32.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.668 0.27 . . . . 5.96 110.565 -178.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.43 133.9 37.43 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.445 -0.576 . . . . 3.2400000000000002 109.445 175.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -140.29 150.05 59.98 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-O 120.855 0.359 . . . . 3.48 111.026 -173.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.592 ' HA ' ' O ' ' A' ' 14' ' ' MET . 76.9 Cg_endo -81.2 135.31 9.57 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.669 2.246 . . . . 2.0299999999999998 112.198 172.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 56.2 m -103.21 142.36 34.29 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.421 -0.585 . . . . 2.2799999999999998 109.421 174.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 m -110.87 134.47 53.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.28 0.562 . . . . 2.4100000000000001 111.309 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -119.9 132.08 55.43 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.59 -0.732 . . . . 4.4400000000000004 109.817 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 94.1 m-85 -105.37 127.95 53.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.031 -0.359 . . . . 3.6200000000000001 110.031 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -130.89 138.02 49.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.947 -0.39 . . . . 2.48 109.947 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.57 143.13 50.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.711 -0.222 . . . . 1.53 110.691 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.651 ' O ' ' HB3' ' A' ' 8' ' ' HIS . . . -154.14 117.37 4.54 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.366 -0.379 . . . . 1.8 111.33 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.456 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 25.4 t-20 -163.49 95.42 0.82 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.642 -0.503 . . . . 3.3799999999999999 109.642 173.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.82 -97.59 2.31 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.037 -0.601 . . . . 1.8200000000000001 111.76 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.456 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 51.3 Cg_exo -55.3 174.16 0.26 Allowed 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.52 2.813 . . . . 2.1000000000000001 113.515 172.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.506 ' HB3' ' O ' ' A' ' 75' ' ' HIS . 24.4 m-90 -70.15 -176.24 1.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.551 -0.749 . . . . 4.0499999999999998 111.064 -175.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.7 mtm-85 -112.06 149.96 31.35 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.529 0.68 . . . . 3.6000000000000001 112.732 -163.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.5 pt -128.88 140.05 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 114.606 -1.179 . . . . 2.2799999999999998 110.244 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -120.06 128.88 53.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.189 -0.46 . . . . 1.4399999999999999 110.09 177.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.6 tp -125.19 136.59 53.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.102 0.477 . . . . 1.75 110.922 -176.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.76 168.15 20.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.456 -0.793 . . . . 1.5900000000000001 109.376 176.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -140.02 145.58 37.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.588 0.232 . . . . 4.4400000000000004 110.665 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.55 ' HB2' ' CG ' ' A' ' 69' ' ' ARG . 89.6 m-85 -135.75 148.97 49.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.307 -0.406 . . . . 5.0199999999999996 109.937 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -136.43 170.22 16.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.619 -0.264 . . . . 3.7400000000000002 111.323 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.91 -48.87 79.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.938 -0.574 . . . . 5.0499999999999998 110.774 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -169.19 155.83 26.5 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.247 -0.741 . . . . 4.3700000000000001 111.247 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.17 -48.45 11.95 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.631 2.221 . . . . 7.0899999999999999 112.033 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.02 130.12 65.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.935 -0.765 . . . . 8.5700000000000003 108.935 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -96.53 129.9 43.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.782 0.325 . . . . 10.039999999999999 110.728 -176.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -116.43 19.02 14.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.251 -0.431 . . . . 11.890000000000001 111.494 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.6 t -100.13 130.83 46.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.293 0.568 . . . . 9.7899999999999991 110.874 -176.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.64 0.03 57.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.883 -0.599 . . . . 8.7799999999999994 110.678 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.2 -11.15 84.66 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.79 -0.719 . . . . 7.7300000000000004 112.189 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -99.96 122.51 42.98 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.481 -0.562 . . . . 10.300000000000001 109.481 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -62.47 -40.0 95.24 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.66 -0.7 . . . . 10.960000000000001 112.114 -173.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.7 40.65 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.468 -0.872 . . . . 5.5599999999999996 112.09 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.4 t -159.98 151.2 19.46 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.123 -0.695 . . . . 5.6900000000000004 109.123 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 35.6 p90 -133.8 169.97 16.28 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.83 -0.433 . . . . 6.5 109.83 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.509 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 95.0 m-85 -109.2 127.64 54.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.039 0.447 . . . . 4.5999999999999996 111.057 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -97.2 166.45 11.56 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.761 -0.654 . . . . 2.4500000000000002 110.637 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.55 ' CG ' ' HB2' ' A' ' 51' ' ' TYR . 6.6 ptp180 -150.48 125.53 4.76 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 121.113 0.483 . . . . 3.7200000000000002 110.577 171.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.454 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 75.6 Cg_endo -89.41 158.78 5.47 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.005 2.47 . . . . 1.3200000000000001 112.268 172.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.637 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 39.5 tt0 -131.25 111.72 12.15 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.351 -0.611 . . . . 2.1899999999999999 109.351 173.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.8 tp -125.01 120.0 30.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.278 -0.419 . . . . 1.73 110.424 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 39.0 tt0 -121.38 130.05 53.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.657 -0.497 . . . . 2.1800000000000002 109.657 177.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.6 m -112.67 136.38 49.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.986 0.422 . . . . 2.0600000000000001 109.961 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.506 ' O ' ' HB3' ' A' ' 44' ' ' TRP . 63.2 m80 -116.64 119.6 36.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.081 -0.508 . . . . 4.1900000000000004 110.837 -171.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -113.62 126.08 54.88 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.099 -0.704 . . . . 5.1600000000000001 109.099 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -120.3 134.08 55.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.954 0.406 . . . . 3.3100000000000001 110.708 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -90.6 86.49 6.41 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.514 -0.766 . . . . 4.6600000000000001 109.158 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.7 mt -108.28 15.83 23.73 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.439 -0.949 . . . . 4.8799999999999999 108.439 174.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.52 -39.82 94.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.056 -1.429 . . . . 6.1900000000000004 111.345 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -125.02 135.97 53.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.853 0.358 . . . . 6.0999999999999996 110.665 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -70.11 -19.01 63.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.614 -0.721 . . . . 5.2699999999999996 112.811 -174.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -60.04 -40.06 88.09 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.159 0.429 . . . . 6.3300000000000001 112.159 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -153.13 160.1 42.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.676 0.274 . . . . 8.3499999999999996 110.663 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.4 m -118.86 130.11 55.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.204 0.526 . . . . 2.6400000000000001 110.249 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -130.56 149.65 52.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.587 -0.894 . . . . 6.1900000000000004 108.587 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.23 154.13 21.84 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.033 -1.08 . . . . 1.54 112.708 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.2 mt -134.93 129.87 34.97 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.172 -0.677 . . . . 2.73 109.172 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.1 t -133.96 139.47 46.12 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.111 0.481 . . . . 1.8700000000000001 110.409 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 73' ' ' GLU . . . -132.96 132.79 6.71 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 111.34 -0.704 . . . . 1.1699999999999999 111.34 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.11 123.23 5.6 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.884 -0.674 . . . . 1.4399999999999999 111.892 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -112.01 122.12 46.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.633 0.254 . . . . 4.6399999999999997 110.541 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.637 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 72.1 mtm180 -131.36 129.78 41.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.307 -0.406 . . . . 3.2200000000000002 110.064 173.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.454 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 64.2 t30 -128.51 117.72 21.8 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.958 -0.386 . . . . 2.2200000000000002 109.958 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -109.84 126.67 54.06 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.742 0.306 . . . . 3.6400000000000001 110.372 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.509 ' HA2' ' HB3' ' A' ' 67' ' ' PHE . . . 89.03 179.9 45.59 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.201 -0.999 . . . . 2.79 112.233 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -121.39 129.65 53.15 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.032 -0.358 . . . . 7.8499999999999996 110.032 -178.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.486 ' HB2' ' CB ' ' A' ' 109' ' ' ASN . 53.3 t-80 -108.44 110.02 21.44 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.297 -0.631 . . . . 7.6900000000000004 109.297 176.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -101.08 105.95 17.17 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.952 0.406 . . . . 10.289999999999999 110.94 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.7 t -76.28 -22.26 15.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.989 -0.745 . . . . 10.19 108.989 174.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.513 ' C ' ' HD3' ' A' ' 103' ' ' PRO . 28.7 m-20 -69.95 -10.18 57.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.793 -1.094 . . . . 12.220000000000001 111.148 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -119.22 68.13 9.51 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.492 -0.322 . . . . 10.48 110.746 -176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.513 ' HD3' ' C ' ' A' ' 101' ' ' ASP . 12.4 Cg_exo -70.18 134.22 26.59 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.511 2.141 . . . . 9.6799999999999997 111.545 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.03 -3.5 82.65 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.565 -0.826 . . . . 6.5099999999999998 112.374 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -113.86 138.01 50.89 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.783 -0.451 . . . . 8.1099999999999994 109.783 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -64.71 132.36 49.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.097 0.475 . . . . 4.1399999999999997 110.894 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.4 t -131.85 143.56 50.26 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.667 -0.864 . . . . 3.77 108.667 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -119.39 115.29 23.79 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 120.631 -0.427 . . . . 2.2000000000000002 110.921 -173.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.486 ' CB ' ' HB2' ' A' ' 98' ' ' HIS . 29.0 t-20 -153.53 137.41 16.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.887 -0.597 . . . . 3.1200000000000001 111.593 -175.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 44.6 ttm -132.33 123.63 27.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.558 -0.746 . . . . 2.1200000000000001 109.863 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.48 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 78.3 mt-30 -107.25 127.24 53.36 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 120.123 -0.631 . . . . 2.4900000000000002 110.212 175.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.514 ' HB2' ' HB2' ' A' ' 93' ' ' ARG . 95.4 mtt180 -110.13 113.36 25.98 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.999 -0.741 . . . . 4.4699999999999998 108.999 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -107.4 122.56 46.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.965 -0.561 . . . . 2.9199999999999999 111.036 -176.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -114.71 123.77 50.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.651 -0.704 . . . . 2.5099999999999998 109.986 175.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 11.8 tt -131.12 129.82 63.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.932 -0.396 . . . . 2.1299999999999999 109.932 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -149.93 121.16 4.03 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.558 -0.292 . . . . 1.6799999999999999 111.482 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -90.3 135.61 2.22 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 122.916 2.411 . . . . 1.54 111.371 169.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -104.12 139.64 38.91 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.436 -0.579 . . . . 2.3500000000000001 109.436 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -132.21 140.66 48.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.377 0.608 . . . . 5.1500000000000004 111.413 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -134.43 79.14 1.79 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.902 -1.045 . . . . 3.04 108.406 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.518 ' O ' ' HB3' ' A' ' 129' ' ' PHE . 63.1 t -129.99 125.39 60.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.758 -0.655 . . . . 4.7400000000000002 110.518 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.431 ' HD3' ' HB2' ' A' ' 129' ' ' PHE . 59.4 tptt -140.3 135.73 32.54 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.311 -0.626 . . . . 6.3600000000000003 109.311 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.9 tp -60.52 -31.32 70.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.557 -0.747 . . . . 4.96 111.921 -176.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.9 m -108.35 135.3 49.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.941 0.4 . . . . 4.0700000000000003 110.106 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -63.01 -39.79 95.81 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.28 -0.873 . . . . 5.1699999999999999 112.181 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -70.0 -15.47 63.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.906 -0.588 . . . . 3.71 111.234 -176.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.8 mt -111.82 154.22 25.43 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.908 -0.587 . . . . 2.4500000000000002 110.058 -173.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -130.88 136.88 49.03 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.539 -0.464 . . . . 4.6799999999999997 110.985 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.518 ' HB3' ' O ' ' A' ' 121' ' ' VAL . 65.2 t80 -123.31 120.42 33.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.79 -0.641 . . . . 4.3600000000000003 109.73 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -122.81 136.84 55.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.784 0.326 . . . . 2.5899999999999999 111.202 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -160.75 149.98 19.55 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.277 -0.729 . . . . 1.25 111.277 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -148.33 148.03 29.94 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.119 -0.326 . . . . 5.0899999999999999 110.119 176.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 67.9 tp -116.79 117.93 31.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.332 -0.395 . . . . 2.7599999999999998 110.755 -175.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.5 t -104.99 118.41 36.45 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.805 0.336 . . . . 1.99 110.577 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.401 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 64.6 mtt -108.86 121.63 45.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.226 -0.657 . . . . 2.7799999999999998 109.226 171.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.421 ' OH ' ' HD3' ' A' ' 112' ' ' ARG . 64.9 t80 -116.53 136.79 52.69 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.655 -0.702 . . . . 3.6800000000000002 111.068 -171.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -130.17 150.86 51.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.63 -0.713 . . . . 2.1699999999999999 109.813 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -139.55 159.94 41.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.571 0.224 . . . . 4.0099999999999998 110.431 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 60.22 -177.03 0.1 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.552 -0.749 . . . . 1.79 111.001 -175.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -77.65 -24.67 49.37 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.087 0.47 . . . . 3.04 110.515 172.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.95 -51.38 69.93 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.409 -0.814 . . . . 2.4100000000000001 112.575 -172.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.5 mp -70.17 -29.11 65.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.03 0.443 . . . . 2.3599999999999999 111.2 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.48 ' ND2' ' HB2' ' A' ' 111' ' ' GLN . 95.0 m-20 -68.79 -39.75 80.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.532 -0.304 . . . . 2.52 110.809 178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.3 p -70.11 -32.1 69.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.577 -0.283 . . . . 2.52 111.481 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.4 p -80.36 -20.21 44.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.234 0.54 . . . . 2.0099999999999998 110.845 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.84 -114.35 5.26 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.694 -0.684 . . . . 1.52 112.381 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -99.98 3.65 44.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.566 0.222 . . . . 6.2199999999999998 111.162 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.82 -40.04 76.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.022 0.439 . . . . 2.0499999999999998 110.02 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -129.83 99.34 5.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.55 -0.75 . . . . 2.6400000000000001 109.788 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.9 t -148.81 159.06 44.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.06 -0.518 . . . . 2.6000000000000001 109.833 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 135' ' ' MET . 42.1 ttm180 -93.68 123.38 36.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.204 -0.453 . . . . 4.0899999999999999 109.881 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.0 t -112.48 120.58 63.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.493 -0.321 . . . . 2.1499999999999999 110.58 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -143.17 130.03 20.49 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.0 -0.37 . . . . 2.5600000000000001 110.0 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.431 ' HB ' ' CD1' ' A' ' 133' ' ' LEU . 10.1 t -136.58 146.72 46.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.011 0.434 . . . . 1.78 110.965 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -119.98 139.55 52.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.215 -0.448 . . . . 2.04 110.351 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 22.6 m -117.03 122.98 45.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.095 -0.502 . . . . 2.0299999999999998 110.297 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -117.79 121.86 5.23 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.722 -0.551 . . . . 1.0800000000000001 111.722 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 160' ' ' TYR . 92.2 mt -108.38 135.09 50.26 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 122.274 0.23 . . . . 2.9300000000000002 110.382 -177.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 168' ' ' LEU . 63.8 tt0 -123.36 115.89 22.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.758 0.314 . . . . 3.02 110.178 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 158' ' ' LEU . 82.9 m-85 -130.92 139.95 50.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.23 -0.441 . . . . 4.7599999999999998 110.867 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 22.9 p -96.93 92.76 6.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.09 -0.505 . . . . 1.8200000000000001 110.973 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . 0.497 ' CD2' HD11 ' A' ' 168' ' ' LEU . 61.3 m-85 -70.04 -39.91 75.45 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.163 0.431 . . . . 3.27 112.163 -176.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.479 ' HB2' HG23 ' A' ' 166' ' ' VAL . 88.7 m-20 -100.3 13.38 34.55 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.776 -0.37 . . . . 2.4100000000000001 110.908 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 73.12 -52.06 0.71 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.873 0.733 . . . . 2.5800000000000001 111.79 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.2 p -74.66 -20.58 59.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.715 0.293 . . . . 2.6000000000000001 111.705 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 163' ' ' ASN . 35.8 m -116.68 137.91 48.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.89 0.376 . . . . 2.0600000000000001 110.836 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.8 123.07 47.61 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.077 -0.51 . . . . 1.8400000000000001 110.131 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.497 HD11 ' CD2' ' A' ' 162' ' ' PHE . 21.7 mt -103.8 140.53 37.51 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.72 -0.474 . . . . 2.1400000000000001 109.72 -177.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -115.18 125.46 53.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.935 0.398 . . . . 3.73 110.383 -176.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.5 t -128.44 129.57 68.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.561 -0.533 . . . . 1.8100000000000001 109.561 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.523 ' OD1' ' HB2' ' A' ' 195' ' ' ARG . 28.7 p-10 -133.74 148.72 51.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.302 0.572 . . . . 2.2400000000000002 111.575 -177.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -145.36 151.43 38.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.347 -0.842 . . . . 4.8399999999999999 110.071 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -101.18 128.91 47.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.428 0.632 . . . . 4.4299999999999997 111.55 -173.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 48.4 tp -120.06 124.24 45.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.327 -0.851 . . . . 2.8500000000000001 109.499 -176.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -70.01 -43.4 71.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.229 0.537 . . . . 3.3100000000000001 111.061 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -134.29 129.3 35.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.963 -0.562 . . . . 7.3300000000000001 109.979 -172.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -70.03 -44.5 60.83 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.784 -0.644 . . . . 5.0599999999999996 112.321 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -160.06 160.03 32.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.746 0.308 . . . . 8.0199999999999996 110.355 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -159.95 149.69 18.17 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.248 -0.649 . . . . 9.4900000000000002 109.248 173.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 96.6 mmm -79.98 -12.9 59.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.297 -0.41 . . . . 11.1 111.17 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -70.45 -40.19 73.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.924 -0.58 . . . . 10.470000000000001 111.465 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 51.0 30.34 5.25 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.616 0.572 . . . . 13.06 111.0 -173.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 30.2 p -70.01 -38.22 75.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.71 -0.677 . . . . 12.890000000000001 111.337 -177.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 63.74 27.3 14.68 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.225 -0.898 . . . . 15.720000000000001 110.602 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -69.78 -14.42 62.77 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.692 -0.685 . . . . 13.470000000000001 111.291 -176.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -59.79 -35.09 73.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.77 -0.65 . . . . 13.15 110.084 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 100.55 -20.54 47.87 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.599 -0.728 . . . . 10.050000000000001 111.781 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 59.09 32.44 22.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.299 0.571 . . . . 10.699999999999999 111.049 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -70.07 -39.85 75.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.487 -0.779 . . . . 11.34 110.078 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 80.1 p -62.89 -39.9 95.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.805 -0.634 . . . . 6.7800000000000002 110.877 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 6.4 p -74.74 -24.08 58.66 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.039 -0.528 . . . . 5.3600000000000003 111.478 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -70.16 -35.42 74.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.274 0.559 . . . . 7.8700000000000001 109.765 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -81.41 101.51 9.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.599 -0.728 . . . . 4.4000000000000004 109.801 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 86.4 mt -117.26 131.54 69.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.968 -0.56 . . . . 2.6400000000000001 110.855 -173.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.523 ' HB2' ' OD1' ' A' ' 171' ' ' ASN . 90.0 mtt180 -95.25 127.36 41.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.814 0.34 . . . . 4.1100000000000003 110.419 176.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -117.78 130.53 56.36 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.571 -0.529 . . . . 1.76 109.571 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -152.85 160.04 43.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.192 0.52 . . . . 6.1399999999999997 111.274 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.436 ' O ' ' HD2' ' A' ' 209' ' ' PRO . 2.5 pt? -137.95 134.25 17.94 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.126 -0.488 . . . . 3.0800000000000001 110.019 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.69 128.05 9.15 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.197 1.931 . . . . 1.98 112.708 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.8 tp -120.43 123.52 43.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.692 -0.686 . . . . 2.7599999999999998 109.538 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 22.7 m -104.9 119.96 40.28 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.454 -0.339 . . . . 2.4199999999999999 110.7 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.92 80.26 1.8 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.472 -0.566 . . . . 2.77 109.472 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.1 -117.26 8.9 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.714 -0.675 . . . . 1.6200000000000001 112.298 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -90.48 0.09 57.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.372 0.606 . . . . 2.8599999999999999 109.651 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -114.69 120.1 38.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.506 -0.77 . . . . 3.23 111.096 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 13.6 p -102.03 142.6 33.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.33 -0.396 . . . . 2.0499999999999998 110.453 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 49.8 t -129.13 129.98 67.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.307 -0.627 . . . . 1.9299999999999999 109.307 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 32.8 m -134.44 91.72 21.73 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-O 120.849 0.357 . . . . 1.6699999999999999 110.37 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 57.0 Cg_endo -74.57 138.47 24.21 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.273 1.982 . . . . 1.28 112.307 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -106.03 139.01 41.23 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.35 -0.611 . . . . 4.8600000000000003 109.35 175.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 38.9 p -132.39 160.53 36.08 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.91 -0.404 . . . . 2.0899999999999999 109.91 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.467 ' HD2' ' HA ' ' A' ' 235' ' ' ASN . 61.9 ttt180 -66.24 -40.52 90.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.416 0.627 . . . . 5.29 109.617 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 44.7 pt -126.96 144.98 35.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.484 -0.78 . . . . 4.9400000000000004 109.789 175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -116.99 -8.51 11.64 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.739 -0.743 . . . . 4.9800000000000004 112.335 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 61.8 tp -119.66 138.24 53.39 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.828 0.347 . . . . 8.4399999999999995 110.771 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -105.04 141.27 36.91 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.245 -0.65 . . . . 7.9699999999999998 109.245 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -120.04 134.81 55.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.233 0.539 . . . . 11.1 111.344 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 63.5 t-105 -69.99 -39.96 75.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.264 -0.88 . . . . 12.24 109.526 171.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 77.4 p -97.51 155.8 16.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.402 -0.817 . . . . 10.220000000000001 110.335 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 57.9 t30 58.35 40.02 24.83 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.488 0.661 . . . . 11.92 110.283 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -106.68 130.01 54.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.483 -0.78 . . . . 14.460000000000001 109.971 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -80.47 124.45 28.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.835 0.35 . . . . 14.529999999999999 110.369 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -106.82 -9.55 16.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.206 -0.452 . . . . 17.07 110.725 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -119.96 140.07 51.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.028 -0.533 . . . . 15.779999999999999 110.291 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -111.77 111.3 22.16 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.09 -0.337 . . . . 15.67 110.09 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -91.67 -6.54 51.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.083 0.468 . . . . 14.5 110.443 178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 45.7 pt -129.56 168.04 23.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.698 -0.683 . . . . 15.380000000000001 109.735 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.57 125.54 26.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.097 0.475 . . . . 14.73 110.032 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 59.2 mtp85 -63.09 -40.51 97.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.162 -0.926 . . . . 16.969999999999999 111.396 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -72.18 -40.03 68.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.976 0.417 . . . . 12.779999999999999 110.97 176.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.35 -119.98 17.52 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.589 -0.732 . . . . 11.369999999999999 111.993 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -144.04 80.04 1.64 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.883 0.373 . . . . 12.81 110.03 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 58.23 35.44 24.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.322 -0.854 . . . . 9.9900000000000002 111.749 173.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -70.16 -39.94 75.03 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.048 0.451 . . . . 11.32 110.385 174.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.467 ' HA ' ' HD2' ' A' ' 212' ' ' ARG . 19.1 t-20 -90.25 97.4 11.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.284 -0.635 . . . . 6.8799999999999999 109.284 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -98.92 118.56 35.97 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.85 -0.614 . . . . 8.9399999999999995 110.699 -175.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 62.1 t -110.28 120.72 61.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.65 -0.705 . . . . 2.9700000000000002 110.251 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -124.69 138.12 10.95 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.716 -0.754 . . . . 1.3999999999999999 111.298 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.99 126.61 54.12 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.981 0.39 . . . . 2.4300000000000002 110.527 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.483 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 61.7 t80 -99.56 124.42 44.74 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.318 -0.623 . . . . 4.3300000000000001 109.318 173.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.491 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 81.7 m-85 -119.89 140.01 51.51 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.818 -0.438 . . . . 3.2599999999999998 109.818 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -136.77 151.87 21.08 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.074 -1.06 . . . . 1.3500000000000001 112.74 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -129.96 129.85 44.32 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.856 -0.794 . . . . 4.7599999999999998 108.856 172.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -128.1 130.38 48.09 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.193 -0.299 . . . . 4.29 110.193 -176.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -128.52 135.31 49.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.153 -0.476 . . . . 7.5599999999999996 110.429 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -60.09 -30.13 69.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.122 -0.944 . . . . 7.0199999999999996 111.684 -175.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -55.69 -33.64 64.34 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.303 -0.408 . . . . 6.4800000000000004 110.772 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 135.38 31.79 0.31 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.559 -0.829 . . . . 2.9199999999999999 112.797 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 53.0 tp -125.57 127.83 46.98 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.691 -0.3 . . . . 3.5800000000000001 110.4 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 6.1 t -140.09 129.31 23.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.642 -0.873 . . . . 2.6000000000000001 108.642 173.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.94 159.81 41.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.91 0.386 . . . . 2.2400000000000002 111.5 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 35.3 p -131.34 139.96 49.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.523 -0.762 . . . . 2.0 110.166 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 89.0 mt -125.7 135.61 52.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.003 -0.544 . . . . 3.4199999999999999 109.986 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -110.59 120.92 43.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.125 -0.489 . . . . 4.0800000000000001 110.082 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -106.86 129.3 54.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.306 -0.406 . . . . 5.1699999999999999 110.787 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -101.66 140.7 35.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.733 -0.667 . . . . 3.5800000000000001 110.579 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -69.93 -36.18 75.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.521 -0.763 . . . . 7.5800000000000001 111.369 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 261' ' ' ASP . 97.3 mt-10 50.11 40.4 21.61 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.909 0.707 . . . . 8.5399999999999991 112.909 172.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -69.85 -40.11 75.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.914 0.388 . . . . 12.720000000000001 110.553 176.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -59.89 -39.96 87.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.825 -0.625 . . . . 11.09 111.026 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . 0.408 ' HB3' ' HB3' ' A' ' 258' ' ' GLU . 28.2 t70 -69.17 145.9 52.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.456 -0.793 . . . . 11.41 111.649 -172.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -145.96 133.46 20.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.217 -0.901 . . . . 12.49 109.402 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -69.17 -10.48 57.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.399 0.618 . . . . 12.460000000000001 110.012 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -60.15 -39.8 87.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.992 -1.004 . . . . 13.779999999999999 111.336 174.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -94.07 165.66 26.78 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.848 -0.691 . . . . 11.300000000000001 113.495 -172.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -115.19 9.7 15.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.644 -0.278 . . . . 12.59 111.225 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 51.3 m -60.18 -39.93 88.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.291 0.567 . . . . 11.1 110.344 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -121.17 130.23 53.62 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.215 -1.031 . . . . 12.42 108.215 173.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -89.06 -12.61 40.78 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.746 0.647 . . . . 11.82 112.746 -173.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -149.24 151.4 34.19 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.744 -0.382 . . . . 9.5999999999999996 110.908 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -71.77 148.63 46.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.795 -0.639 . . . . 7.7999999999999998 109.946 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -102.76 128.26 49.57 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.343 0.592 . . . . 6.9900000000000002 111.561 -171.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -145.25 169.99 17.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.26 -0.882 . . . . 2.4100000000000001 109.171 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.75 136.05 8.55 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.224 -0.988 . . . . 1.6200000000000001 112.001 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 62.7 t -130.03 129.7 65.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.982 0.42 . . . . 2.4900000000000002 110.412 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.03 139.99 11.39 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.712 -0.955 . . . . 1.3 110.712 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.16 129.97 54.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 117.102 0.451 . . . . 2.3399999999999999 111.265 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -113.24 123.07 49.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.033 -0.531 . . . . 2.7999999999999998 110.004 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -99.97 107.27 19.19 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.932 -0.766 . . . . 5.1900000000000004 108.932 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 25.6 m -102.12 124.05 47.05 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.144 0.497 . . . . 2.0499999999999998 111.043 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 88.9 m-85 . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.122 -0.942 . . . . 4.4199999999999999 108.722 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.4 mtp . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.711 0.291 . . . . 11.970000000000001 110.301 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -136.21 121.54 19.24 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.966 -0.383 . . . . 10.35 109.966 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -125.65 139.01 53.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.293 -0.412 . . . . 9.3100000000000005 109.997 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.435 ' HB3' ' OD2' ' A' ' 6' ' ' ASP . 17.6 mtp180 -99.85 133.21 44.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.038 0.447 . . . . 9.4399999999999995 111.269 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -108.53 61.89 0.61 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.685 -0.688 . . . . 7.75 109.855 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.435 ' OD2' ' HB3' ' A' ' 4' ' ' ARG . 11.6 m-20 -74.79 110.16 8.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.811 -0.631 . . . . 3.6099999999999999 109.895 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.49 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 20.3 m-90 -70.99 139.98 50.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.987 -0.551 . . . . 3.9100000000000001 110.981 -178.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -99.2 130.0 45.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.001 -0.545 . . . . 3.9399999999999999 110.544 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -115.77 140.31 49.33 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.866 -0.606 . . . . 3.21 110.888 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 94.2 m-20 -121.86 132.33 54.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.556 -0.747 . . . . 2.6499999999999999 109.549 174.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.0 mt -119.76 120.02 62.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.372 -0.603 . . . . 2.0699999999999998 109.372 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.13 142.4 14.95 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.048 -1.072 . . . . 0.92000000000000004 112.68 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.53 134.81 54.71 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.941 -0.762 . . . . 1.6499999999999999 108.941 174.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 49.0 tpp -129.93 129.67 44.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.061 -0.518 . . . . 2.9700000000000002 111.0 -173.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.481 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 56.3 m-85 -93.15 129.77 39.04 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.914 -1.143 . . . . 3.1499999999999999 107.914 169.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -134.32 130.12 36.52 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.328 -0.549 . . . . 5.0899999999999999 110.534 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.442 HG23 ' CE1' ' A' ' 271' ' ' HIS . 80.3 mt -115.68 129.5 71.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.057 -0.52 . . . . 5.3300000000000001 110.385 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -80.56 153.71 27.9 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.876 -0.602 . . . . 8.2799999999999994 110.614 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -70.21 -20.29 63.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.892 -0.595 . . . . 10.0 110.549 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.8 t -110.87 120.07 60.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.44 -0.8 . . . . 11.380000000000001 108.908 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -91.9 -9.11 44.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.041 0.448 . . . . 13.1 110.668 -177.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.4 -160.34 43.75 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.706 -0.759 . . . . 12.52 112.444 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -123.69 102.47 7.85 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.385 0.612 . . . . 15.18 111.148 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.99 26.53 67.45 Favored Glycine 0 C--N 1.329 0.162 0 CA-C-N 115.769 -0.651 . . . . 12.279999999999999 112.291 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -96.04 16.29 18.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.428 0.632 . . . . 12.82 110.706 -173.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.43 -28.27 65.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.87 -1.059 . . . . 10.81 109.986 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 94.7 mtp -59.9 -40.22 88.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.125 -0.943 . . . . 10.210000000000001 111.636 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -80.12 -50.25 10.58 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.627 -0.429 . . . . 8.0600000000000005 110.367 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.14 154.19 7.05 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.572 -0.823 . . . . 6.0800000000000001 112.436 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.4 mt -143.61 -26.87 0.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.592 0.234 . . . . 5.96 111.475 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -154.86 70.71 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.08 0.466 . . . . 3.2400000000000002 110.616 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -120.3 150.94 52.69 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 109.649 -0.5 . . . . 3.48 109.649 -175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.481 ' HD3' ' CE2' ' A' ' 15' ' ' TYR . 59.6 Cg_endo -73.93 134.38 19.68 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.093 1.862 . . . . 2.0299999999999998 112.375 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.7 t -118.13 143.57 46.38 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.797 -0.816 . . . . 2.2799999999999998 108.797 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.5 m -110.11 139.99 31.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.304 0.573 . . . . 2.4100000000000001 111.639 -173.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -135.72 149.77 49.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.425 -0.807 . . . . 4.4400000000000004 109.903 177.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -113.47 130.07 56.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.02 -0.536 . . . . 3.6200000000000001 110.729 -175.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 10' ' ' ASN . 77.6 m-20 -123.44 144.49 49.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.165 -0.471 . . . . 2.48 109.952 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.41 142.34 45.62 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.074 -0.343 . . . . 1.53 110.074 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.01 112.57 1.59 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.151 0.426 . . . . 1.8 112.151 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 7' ' ' TRP . 24.5 t-20 -168.24 94.96 0.39 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.713 -0.477 . . . . 3.3799999999999999 109.713 166.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.89 -83.34 0.43 Allowed Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.212 -0.755 . . . . 1.8200000000000001 111.212 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.13 173.46 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.029 2.486 . . . . 2.1000000000000001 111.797 169.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.451 ' HB3' ' O ' ' A' ' 75' ' ' HIS . 45.3 m95 -70.75 -177.74 1.66 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.143 -0.481 . . . . 4.0499999999999998 110.064 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -109.6 120.42 42.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.657 0.741 . . . . 3.6000000000000001 109.976 -172.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.4 mt -109.94 136.29 46.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.378 -1.283 . . . . 2.2799999999999998 110.326 -174.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.81 128.24 55.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.943 -0.572 . . . . 1.4399999999999999 110.158 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.1 tp -120.45 130.2 54.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.045 -0.525 . . . . 1.75 110.494 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.92 168.42 23.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.236 -0.438 . . . . 1.5900000000000001 110.524 178.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 45.2 p90 -142.4 160.03 41.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.357 -0.383 . . . . 4.4400000000000004 110.342 -177.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -134.28 130.02 36.45 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.82 -0.437 . . . . 5.0199999999999996 109.82 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.606 ' NE2' ' HG1' ' A' ' 65' ' ' THR . 96.4 mt-30 -135.65 147.21 48.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.404 -0.362 . . . . 3.7400000000000002 110.412 -177.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -111.61 144.37 40.98 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.967 -0.753 . . . . 5.0499999999999998 108.967 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 159.92 105.62 0.21 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.342 -1.409 . . . . 4.3700000000000001 113.391 -178.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.25 2.77 7.71 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 123.107 2.538 . . . . 7.0899999999999999 111.713 175.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.4 t -109.67 120.85 61.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.896 -0.593 . . . . 8.5700000000000003 110.478 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -70.29 -39.75 74.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.641 -0.709 . . . . 10.039999999999999 110.955 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -81.92 149.31 28.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.908 -0.587 . . . . 11.890000000000001 111.531 -173.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.8 p -119.65 149.2 42.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.918 -0.583 . . . . 9.7899999999999991 109.954 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -141.52 150.08 41.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.584 0.23 . . . . 8.7799999999999994 110.948 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.98 -93.2 1.59 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.823 -0.703 . . . . 7.7300000000000004 112.109 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -124.68 130.82 53.14 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.659 -0.497 . . . . 10.300000000000001 109.659 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -80.66 150.63 29.34 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.861 -0.422 . . . . 10.960000000000001 109.861 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.97 167.83 12.25 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 111.484 -0.646 . . . . 5.5599999999999996 111.484 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.606 ' HG1' ' NE2' ' A' ' 52' ' ' GLN . 6.9 m -129.55 109.46 11.05 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.004 -0.369 . . . . 5.6900000000000004 110.004 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -69.76 -40.06 76.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.203 -0.453 . . . . 6.5 110.126 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 97' ' ' TYR . 53.2 m-85 -106.8 99.73 9.29 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.176 -0.676 . . . . 4.5999999999999996 109.176 177.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -134.23 170.63 15.42 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.511 -0.922 . . . . 2.4500000000000002 108.511 -171.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 39.4 ttp180 -119.14 123.01 29.12 Favored Pre-proline 0 C--N 1.318 -0.787 0 C-N-CA 120.326 -0.55 . . . . 3.7200000000000002 110.697 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -91.74 115.68 0.4 Allowed 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 122.126 1.884 . . . . 1.3200000000000001 110.767 169.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -103.26 112.74 25.76 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.903 -0.777 . . . . 2.1899999999999999 108.903 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.2 tp -124.53 118.66 27.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.652 -0.704 . . . . 1.73 109.496 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -126.03 131.75 52.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.6 -0.518 . . . . 2.1800000000000002 109.6 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.22 121.88 68.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.869 0.366 . . . . 2.0600000000000001 110.116 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.451 ' O ' ' HB3' ' A' ' 44' ' ' TRP . 79.8 t60 -104.64 119.6 39.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.115 -0.493 . . . . 4.1900000000000004 110.503 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -97.16 120.74 38.07 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.984 -1.117 . . . . 5.1600000000000001 107.984 176.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -127.31 113.78 16.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.174 0.511 . . . . 3.3100000000000001 111.671 -174.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -102.61 120.3 40.31 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.673 -0.694 . . . . 4.6600000000000001 109.38 175.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.3 mt -112.46 -29.84 7.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.122 0.486 . . . . 4.8799999999999999 110.777 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -118.44 -16.99 9.5 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.709 -0.678 . . . . 6.1900000000000004 111.525 -173.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -63.41 -49.99 71.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.529 -0.305 . . . . 6.0999999999999996 111.671 -174.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -146.98 -177.04 5.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.196 -0.298 . . . . 5.2699999999999996 110.196 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -60.01 -40.07 87.99 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.408 0.521 . . . . 6.3300000000000001 112.408 -176.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -74.43 138.43 43.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.208 0.528 . . . . 8.3499999999999996 111.324 -176.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.7 t -95.43 159.56 14.94 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.856 -0.611 . . . . 2.6400000000000001 110.412 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 69.78 -100.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.512 -0.767 . . . . 6.1900000000000004 111.069 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.27 -82.06 0.35 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.012 -1.089 . . . . 1.54 113.215 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 57.9 tp -144.13 131.25 20.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.22 0.51 . . . . 2.73 111.989 -173.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.5 m -121.36 130.08 53.42 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.575 -0.528 . . . . 1.8700000000000001 109.575 170.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -145.45 141.92 10.26 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.145 -1.026 . . . . 1.1699999999999999 112.238 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.99 171.2 36.26 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.62 -0.8 . . . . 1.4399999999999999 111.993 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -148.47 159.95 43.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.092 0.472 . . . . 4.6399999999999997 111.628 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -134.39 137.29 43.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.324 -0.853 . . . . 3.2200000000000002 109.494 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 63.1 t30 -125.18 122.22 36.42 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.971 -0.381 . . . . 2.2200000000000002 109.971 175.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.505 ' CE1' ' HD3' ' A' ' 69' ' ' ARG . 95.2 m-85 -102.84 120.92 41.45 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.023 -0.362 . . . . 3.6400000000000001 110.023 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.6 152.59 52.48 Favored Glycine 0 CA--C 1.501 -0.788 0 C-N-CA 120.995 -0.621 . . . . 2.79 113.658 -176.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.668 ' HA ' ' H ' ' A' ' 108' ' ' ALA . 68.7 m-85 -48.52 82.46 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 124.174 0.99 . . . . 7.8499999999999996 113.564 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.472 ' H ' ' HB2' ' A' ' 108' ' ' ALA . 30.9 p80 -114.17 170.36 8.34 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.231 -0.293 . . . . 7.6900000000000004 110.514 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -68.33 141.25 55.85 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.801 -0.444 . . . . 10.289999999999999 109.801 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.85 -177.03 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.651 -0.25 . . . . 10.19 111.564 -175.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -60.25 -39.97 88.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.117 0.484 . . . . 12.220000000000001 110.473 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -72.7 115.48 40.18 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.416 -0.811 . . . . 10.48 110.229 -177.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.73 -19.62 53.26 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.707 2.272 . . . . 9.6799999999999997 112.671 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.56 2.4 85.65 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.834 -0.698 . . . . 6.5099999999999998 112.68 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -139.54 119.96 13.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.966 0.412 . . . . 8.1099999999999994 110.553 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -96.93 0.25 48.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.947 -0.57 . . . . 4.1399999999999997 110.957 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 97' ' ' TYR . 24.1 p -125.68 149.02 48.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.267 0.469 . . . . 3.77 112.267 -175.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.668 ' H ' ' HA ' ' A' ' 97' ' ' TYR . . . -118.72 119.13 33.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.725 0.774 . . . . 2.2000000000000002 112.85 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -115.19 106.45 14.09 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.595 -0.891 . . . . 3.1200000000000001 108.595 171.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.507 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 89.5 mtp -139.85 117.05 11.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.527 -0.306 . . . . 2.1200000000000001 110.799 -177.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.595 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 54.0 tt0 -117.21 117.96 31.0 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.627 -0.429 . . . . 2.4900000000000002 110.182 176.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -105.6 123.53 48.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.869 -0.605 . . . . 4.4699999999999998 110.14 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -125.53 128.73 48.42 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.814 -0.81 . . . . 2.9199999999999999 108.814 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -130.15 126.03 36.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.408 . . . . 2.5099999999999998 110.558 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 134' ' ' SER . 88.2 mt -120.05 129.61 75.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.709 -0.678 . . . . 2.1299999999999999 109.66 177.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -141.87 108.14 5.91 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 111.954 0.353 . . . . 1.6799999999999999 111.954 -176.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.699 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 61.4 Cg_endo -76.5 131.95 13.05 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.75 1.634 . . . . 1.54 110.21 171.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -102.28 137.02 41.09 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.281 -0.637 . . . . 2.3500000000000001 109.281 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -135.45 129.98 34.05 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.99 -0.284 . . . . 5.1500000000000004 110.942 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -126.25 122.09 34.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.172 -0.467 . . . . 3.04 109.856 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.4 t -120.05 120.49 63.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.09 -0.504 . . . . 4.7400000000000002 110.19 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -104.96 90.75 3.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.296 -0.411 . . . . 6.3600000000000003 110.527 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.6 tp -60.28 -49.74 76.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.284 0.564 . . . . 4.96 110.154 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.5 p -140.79 172.52 12.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.372 -0.831 . . . . 4.0700000000000003 109.358 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -60.16 -39.88 87.95 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.192 -0.603 . . . . 5.1699999999999999 109.605 172.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.1 -40.17 75.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.729 -0.669 . . . . 3.71 111.997 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.0 mt -111.12 119.65 39.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.285 0.564 . . . . 2.4500000000000002 111.436 -173.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -132.63 132.78 42.83 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.719 -0.673 . . . . 4.6799999999999997 110.681 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -111.97 100.03 8.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.326 -0.852 . . . . 4.3600000000000003 109.738 -176.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -113.8 114.65 26.59 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.022 -0.362 . . . . 2.5899999999999999 110.022 -178.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -144.82 152.75 24.71 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.994 -1.098 . . . . 1.25 113.013 -175.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.528 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 56.5 p-90 -141.28 147.85 38.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.783 0.325 . . . . 5.0899999999999999 110.42 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.699 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 10.1 tt -126.27 131.98 51.78 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.314 -0.624 . . . . 2.7599999999999998 109.314 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 116' ' ' ALA . 80.5 p -131.53 150.06 52.29 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.811 -0.355 . . . . 1.99 111.548 -177.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 71.8 mtm -114.38 136.02 53.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.091 -0.504 . . . . 2.7799999999999998 110.415 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.401 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 49.5 m-85 -104.87 120.92 42.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.87 -0.605 . . . . 3.6800000000000002 111.674 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.68 121.79 29.32 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.134 -1.062 . . . . 2.1699999999999999 108.134 166.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.595 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 52.6 p90 -145.85 166.49 25.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.448 -0.342 . . . . 4.0099999999999998 111.49 -171.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 110' ' ' MET . . . 60.0 -164.72 0.22 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.052 -0.976 . . . . 1.79 111.795 177.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -75.3 -39.79 59.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.102 -0.499 . . . . 3.04 111.305 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.69 -54.2 49.11 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.438 0.533 . . . . 2.4100000000000001 112.438 -167.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.73 -40.11 84.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.2 0.524 . . . . 2.3599999999999999 110.492 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.431 HD21 ' C ' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -62.09 -39.38 92.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.783 -0.644 . . . . 2.52 109.96 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.8 m -68.66 -40.11 80.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.886 -0.597 . . . . 2.52 111.912 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 148' ' ' ALA . 41.9 p -79.9 -20.04 46.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.169 0.509 . . . . 2.0099999999999998 110.865 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.02 -109.82 2.91 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.803 -0.635 . . . . 1.52 113.154 173.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -99.16 0.62 43.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.8 0.333 . . . . 6.2199999999999998 110.661 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.405 ' HB2' ' HB ' ' A' ' 145' ' ' THR . . . -70.04 -40.04 75.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 2.0499999999999998 111.489 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -118.96 124.68 47.62 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.566 -0.288 . . . . 2.6400000000000001 110.569 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.4 p -130.02 140.06 50.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.986 0.422 . . . . 2.6000000000000001 110.9 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.401 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 42.5 ttm180 -113.06 129.98 56.32 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.337 -0.986 . . . . 4.0899999999999999 108.337 173.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.9 p -117.33 132.02 68.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.533 0.683 . . . . 2.1499999999999999 111.697 -173.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.426 ' OE1' ' HH2' ' A' ' 132' ' ' TRP . 38.3 tt0 -119.99 115.69 24.27 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.011 -0.995 . . . . 2.5600000000000001 109.126 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 21.7 m -129.74 127.21 39.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.77 0.319 . . . . 1.78 111.283 -177.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.528 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 42.6 tt0 -122.34 134.49 54.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.966 -0.561 . . . . 2.04 110.032 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.5 m -128.27 120.26 26.78 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.857 0.361 . . . . 2.0299999999999998 110.094 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.72 106.8 3.36 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.861 -0.896 . . . . 1.0800000000000001 110.861 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 82.7 mt -99.79 120.07 39.16 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.668 -0.493 . . . . 2.9300000000000002 109.668 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -100.08 119.13 37.82 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.859 -0.61 . . . . 3.02 110.014 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -121.55 137.94 54.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.532 -0.758 . . . . 4.7599999999999998 109.9 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.3 p -89.9 88.56 7.37 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.077 -0.712 . . . . 1.8200000000000001 109.077 168.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.08 -48.97 79.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.023 -0.989 . . . . 3.27 111.395 -170.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.425 ' C ' ' H ' ' A' ' 165' ' ' THR . 94.6 m-20 -99.96 11.39 39.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.4 -0.364 . . . . 2.4100000000000001 110.52 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 71.88 -43.02 0.55 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.007 0.817 . . . . 2.5800000000000001 111.177 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.425 ' H ' ' C ' ' A' ' 163' ' ' ASN . 24.9 p -73.91 -26.66 60.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.286 -0.416 . . . . 2.6000000000000001 111.428 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.16 143.61 29.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.119 -0.491 . . . . 2.0600000000000001 110.678 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.13 119.52 39.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.206 -0.452 . . . . 1.8400000000000001 110.14 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 22.9 mt -111.57 134.73 52.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.355 -0.384 . . . . 2.1400000000000001 110.182 -175.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -100.06 122.02 42.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.798 -0.445 . . . . 3.73 109.798 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 40.4 t -120.01 120.02 61.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.474 -0.49 . . . . 1.8100000000000001 109.792 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -98.87 120.91 40.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.335 0.588 . . . . 2.2400000000000002 110.389 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -105.85 139.55 40.24 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.054 -0.975 . . . . 4.8399999999999999 109.253 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -113.15 129.79 56.4 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 110.074 -0.343 . . . . 4.4299999999999997 110.074 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 61.5 tp -109.93 129.93 55.59 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.067 0.46 . . . . 2.8500000000000001 110.795 -174.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -112.62 179.45 3.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.393 -0.821 . . . . 3.3100000000000001 110.1 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -60.11 -40.01 88.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.045 0.45 . . . . 7.3300000000000001 111.705 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.17 22.69 56.71 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.811 -0.631 . . . . 5.0599999999999996 111.857 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -133.31 129.83 38.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.74 0.305 . . . . 8.0199999999999996 110.534 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . 0.508 HD22 ' HB2' ' A' ' 189' ' ' PHE . 5.9 m120 -100.36 118.43 36.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.031 -0.531 . . . . 9.4900000000000002 110.519 177.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 46.7 tpp -71.15 -30.0 65.92 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.549 -0.75 . . . . 11.1 110.262 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -79.93 169.99 17.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.444 -0.798 . . . . 10.470000000000001 111.591 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -114.21 130.34 56.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.598 -0.728 . . . . 13.06 110.958 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 46.9 t -131.14 146.46 52.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.059 -0.519 . . . . 12.890000000000001 110.094 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -89.88 -0.38 57.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.383 -0.372 . . . . 15.720000000000001 111.192 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -108.8 143.06 38.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.155 -0.475 . . . . 13.470000000000001 109.796 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -87.02 136.57 32.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.244 0.545 . . . . 13.15 110.841 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 150.26 -179.71 26.77 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 111.192 -0.763 . . . . 10.050000000000001 111.192 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -114.33 139.98 49.01 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.604 -0.517 . . . . 10.699999999999999 109.604 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.508 ' HB2' HD22 ' A' ' 179' ' ' ASN . 94.9 m-85 -109.75 20.1 18.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.506 -0.316 . . . . 11.34 111.815 -172.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.1 m -61.01 142.81 56.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.438 -0.346 . . . . 6.7800000000000002 110.611 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 16.5 p -99.71 26.6 6.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.174 0.511 . . . . 5.3600000000000003 111.038 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -59.97 139.17 57.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.163 -0.926 . . . . 7.8700000000000001 111.694 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -111.84 154.17 25.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.881 -0.599 . . . . 4.4000000000000004 110.669 175.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 88.0 mt -120.09 98.11 5.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.137 -1.061 . . . . 2.6400000000000001 108.137 171.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.671 ' HA ' ' O ' ' A' ' 211' ' ' THR . 97.7 mtt180 -100.04 118.91 37.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.858 0.361 . . . . 4.1100000000000003 111.173 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.577 ' O ' ' HA ' ' A' ' 210' ' ' TYR . . . -99.98 131.82 45.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.251 -0.431 . . . . 1.76 110.916 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -127.69 129.41 47.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.752 -0.658 . . . . 6.1399999999999997 109.826 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 208' ' ' THR . 1.8 pt? -131.1 127.23 21.9 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.167 -0.309 . . . . 3.0800000000000001 110.167 174.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -89.55 120.31 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.664 2.243 . . . . 1.98 113.626 -177.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 84.1 mt -118.08 128.2 54.52 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.369 -0.604 . . . . 2.7599999999999998 109.369 172.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 24.0 m -100.51 120.13 39.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.807 0.337 . . . . 2.4199999999999999 111.236 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 91.8 mt -122.57 80.78 1.77 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.525 -0.546 . . . . 2.77 109.525 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 72.84 -122.98 8.5 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.65 -0.704 . . . . 1.6200000000000001 111.861 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -93.83 3.56 55.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.293 0.568 . . . . 2.8599999999999999 110.2 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -118.59 130.01 55.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.915 -0.584 . . . . 3.23 110.048 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 241' ' ' TYR . 5.4 p -111.13 139.82 46.19 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.774 -0.37 . . . . 2.0499999999999998 110.557 176.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.419 HG23 ' CE1' ' A' ' 241' ' ' TYR . 31.7 t -109.16 120.91 61.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.378 -0.601 . . . . 1.9299999999999999 109.378 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 198' ' ' LEU . 32.1 m -129.84 90.1 44.07 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.264 -0.426 . . . . 1.6699999999999999 110.0 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -63.17 146.05 93.89 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.45 2.1 . . . . 1.28 111.142 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.577 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 53.0 p90 -133.34 148.28 51.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.156 0.503 . . . . 4.8600000000000003 110.204 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.671 ' O ' ' HA ' ' A' ' 195' ' ' ARG . 32.6 p -129.72 141.29 50.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.539 -0.755 . . . . 2.0899999999999999 110.57 -177.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -69.74 -38.92 77.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.649 -0.705 . . . . 5.29 109.567 177.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.1 mt -120.24 119.96 61.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.229 -0.896 . . . . 4.9400000000000004 109.627 174.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -88.48 37.7 3.27 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.136 -0.554 . . . . 4.9800000000000004 112.558 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.2 mt -126.67 131.14 51.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.579 -0.526 . . . . 8.4399999999999995 109.579 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -96.85 136.5 37.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.969 0.414 . . . . 7.9699999999999998 110.813 -177.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -113.08 107.79 16.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.997 -0.547 . . . . 11.1 111.432 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -71.77 -31.31 66.49 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.75 -0.833 . . . . 12.24 108.75 170.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 35.1 p -135.3 150.61 50.04 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.651 -1.159 . . . . 10.220000000000001 109.077 172.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -97.85 126.74 43.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.063 0.458 . . . . 11.92 111.17 -174.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -70.02 -31.16 68.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.391 -0.822 . . . . 14.460000000000001 110.021 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -82.76 139.97 33.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.795 -0.639 . . . . 14.529999999999999 110.123 178.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -117.62 138.61 51.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.116 0.484 . . . . 17.07 110.783 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -120.64 140.16 51.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.883 -0.598 . . . . 15.779999999999999 110.308 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -66.06 -39.92 90.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.751 -0.659 . . . . 15.67 109.84 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.46 -42.25 87.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.351 -0.841 . . . . 14.5 111.624 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 48.8 mm -120.07 118.45 56.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.396 -0.365 . . . . 15.380000000000001 111.164 -174.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -74.42 -39.89 62.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.905 -0.589 . . . . 14.73 110.86 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -161.5 158.96 27.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.93 -0.577 . . . . 16.969999999999999 110.321 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -107.93 124.97 50.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.249 -0.432 . . . . 12.779999999999999 110.554 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -71.2 -28.75 69.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.873 -0.68 . . . . 11.369999999999999 111.963 175.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 59.77 36.77 22.21 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 122.809 0.444 . . . . 12.81 111.111 -177.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -60.76 -40.11 91.27 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.479 0.657 . . . . 9.9900000000000002 109.498 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -122.64 140.05 53.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.845 -1.07 . . . . 11.32 108.616 171.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -120.08 151.08 39.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.74 0.305 . . . . 6.8799999999999999 110.486 -175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -98.97 111.02 23.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.296 0.57 . . . . 8.9399999999999995 111.026 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.59 139.85 28.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.147 -0.933 . . . . 2.9700000000000002 108.946 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -80.15 134.6 13.72 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.088 -1.053 . . . . 1.3999999999999999 111.737 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 87.0 mt -108.44 118.07 35.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.11 0.455 . . . . 2.4300000000000002 110.627 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' A' ' 208' ' ' THR . 64.8 t80 -110.04 131.23 55.24 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.125 -0.695 . . . . 4.3300000000000001 109.125 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . 0.523 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 96.2 m-85 -120.11 139.2 52.94 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.834 -0.432 . . . . 3.2599999999999998 109.834 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -110.95 129.04 9.03 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.527 -0.844 . . . . 1.3500000000000001 111.682 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -129.31 126.84 39.87 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.939 -0.393 . . . . 4.7599999999999998 109.939 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -120.0 131.7 55.23 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.918 0.389 . . . . 4.29 110.706 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.471 ' HB3' ' HB3' ' A' ' 249' ' ' LEU . 52.2 t80 -102.34 129.95 48.93 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.941 -0.763 . . . . 7.5599999999999996 108.941 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -60.08 -37.17 79.14 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.583 0.957 . . . . 7.0199999999999996 113.583 -167.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -60.11 -39.98 88.09 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.622 0.249 . . . . 6.4800000000000004 111.559 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 151.65 42.04 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.868 -1.158 . . . . 2.9199999999999999 113.233 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 245' ' ' PHE . 49.9 tp -133.48 130.09 38.1 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.031 -0.359 . . . . 3.5800000000000001 110.031 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 21.6 t -117.04 130.03 56.41 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.227 -0.657 . . . . 2.6000000000000001 109.227 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.09 132.72 68.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.057 0.456 . . . . 2.2400000000000002 110.426 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 52.6 m -114.19 128.7 56.49 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.532 -0.544 . . . . 2.0 109.532 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 83.0 mt -118.98 133.57 55.74 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.378 -0.374 . . . . 3.4199999999999999 110.541 -175.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -127.25 121.33 30.87 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.772 -0.455 . . . . 4.0800000000000001 109.772 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -122.97 139.24 54.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.928 0.394 . . . . 5.1699999999999999 111.631 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -148.87 179.95 7.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.673 -0.694 . . . . 3.5800000000000001 110.301 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 60.26 48.5 8.04 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.542 0.526 . . . . 7.5800000000000001 112.262 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.17 -31.79 73.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.548 -0.296 . . . . 8.5399999999999991 110.839 173.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -67.09 140.17 57.58 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.763 -0.458 . . . . 12.720000000000001 109.763 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -77.52 113.57 15.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.378 -0.373 . . . . 11.09 110.636 -174.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.02 170.05 17.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.247 0.546 . . . . 11.41 110.764 176.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -101.69 29.9 4.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.828 -0.623 . . . . 12.49 110.331 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -112.68 179.5 3.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.131 -0.486 . . . . 12.460000000000001 109.939 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -121.05 144.04 48.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.574 0.226 . . . . 13.779999999999999 110.444 -177.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 70.2 31.59 69.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.564 -0.827 . . . . 11.300000000000001 112.105 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -63.73 -38.65 91.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.961 0.41 . . . . 12.59 110.564 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 48.9 m -60.32 -40.06 89.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.541 -0.754 . . . . 11.1 109.969 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -63.05 -38.03 89.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.576 -0.738 . . . . 12.42 111.361 177.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -60.01 134.23 56.85 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.092 -0.503 . . . . 11.82 111.223 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -83.65 -9.92 58.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.024 -0.534 . . . . 9.5999999999999996 110.211 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . 0.442 ' CE1' HG23 ' A' ' 17' ' ' ILE . 94.2 m-70 -61.17 -39.9 91.88 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 108.912 -0.773 . . . . 7.7999999999999998 108.912 169.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -62.38 -49.79 74.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.368 -1.287 . . . . 6.9900000000000002 111.283 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -149.27 148.98 30.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.895 0.379 . . . . 2.4100000000000001 111.431 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.99 149.62 19.62 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.87 -0.604 . . . . 1.6200000000000001 112.285 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 61.5 t -130.04 130.07 65.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.673 0.273 . . . . 2.4900000000000002 110.719 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.48 134.69 8.91 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.041 -0.824 . . . . 1.3 111.041 176.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 28.0 m -128.71 139.5 51.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 117.431 0.615 . . . . 2.3399999999999999 111.375 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -129.4 124.31 33.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.855 -0.611 . . . . 2.7999999999999998 110.162 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 97.9 m-85 -96.69 127.92 43.14 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.45 -0.574 . . . . 5.1900000000000004 109.45 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 49.1 m -111.32 124.95 53.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.723 0.297 . . . . 2.0499999999999998 110.73 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 72.6 t80 . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.58 -0.724 . . . . 4.4199999999999999 109.827 179.601 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mmm . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.763 0.316 . . . . 11.970000000000001 110.659 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.54 ' HB2' ' ND2' ' A' ' 5' ' ' ASN . 48.0 mt-10 -107.9 131.32 54.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.74 0.305 . . . . 10.35 110.37 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -70.13 -28.02 65.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.918 -0.583 . . . . 9.3100000000000005 110.427 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -60.12 -40.16 88.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.53 . . . . 9.4399999999999995 110.743 175.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.54 ' ND2' ' HB2' ' A' ' 2' ' ' GLU . 88.7 m-20 -70.81 129.87 40.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.986 -0.552 . . . . 7.75 109.689 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -119.91 119.47 33.58 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.098 -0.501 . . . . 3.6099999999999999 110.397 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -119.4 138.52 53.03 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.038 -0.356 . . . . 3.9100000000000001 110.038 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -104.22 128.16 51.92 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.517 -0.549 . . . . 3.9399999999999999 109.517 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -103.23 144.89 30.74 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.687 -0.688 . . . . 3.21 111.033 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 279' ' ' TYR . 35.4 m-80 -119.98 131.26 55.11 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.167 -0.924 . . . . 2.6499999999999999 108.926 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.6 mt -120.29 115.26 46.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 N-CA-C 109.204 -0.665 . . . . 2.0699999999999998 109.204 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -110.02 127.07 8.22 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.551 -0.833 . . . . 0.92000000000000004 111.273 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -120.67 136.01 54.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.713 0.292 . . . . 1.6499999999999999 110.785 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 91.4 mtp -135.35 156.93 48.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.852 -0.613 . . . . 2.9700000000000002 109.415 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -119.95 122.37 41.05 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.641 -0.503 . . . . 3.1499999999999999 109.641 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.23 -49.92 75.69 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 121.062 0.458 . . . . 5.0899999999999999 110.345 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 47.6 mm -119.95 120.33 62.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.915 -0.584 . . . . 5.3300000000000001 109.869 171.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -79.71 148.98 31.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.9 -0.591 . . . . 8.2799999999999994 111.028 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -122.52 110.02 15.06 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.12 -0.696 . . . . 10.0 109.12 170.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.7 p -63.58 -29.97 48.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.259 -0.428 . . . . 11.380000000000001 111.492 -177.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -68.19 -40.02 82.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.1 -0.5 . . . . 13.1 110.669 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.32 127.08 1.13 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.086 -0.578 . . . . 12.52 111.917 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -69.47 126.15 28.89 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.883 0.373 . . . . 15.18 110.435 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.81 24.26 65.05 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.85 -0.69 . . . . 12.279999999999999 113.865 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.88 -39.91 94.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.754 0.777 . . . . 12.82 111.072 175.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -76.49 121.61 23.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 10.81 110.435 -177.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 59.9 ttp -69.86 -40.09 75.98 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.661 -0.699 . . . . 10.210000000000001 110.339 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -131.53 136.78 48.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.393 -0.821 . . . . 8.0600000000000005 110.106 -178.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -169.58 164.97 38.44 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.843 -0.694 . . . . 6.0800000000000001 111.688 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -81.09 -9.95 59.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.696 0.284 . . . . 5.96 110.771 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.75 137.58 53.85 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.113 -0.494 . . . . 3.2400000000000002 109.942 175.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -140.02 159.27 65.04 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.581 0.229 . . . . 3.48 110.948 -173.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.17 149.99 65.08 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.308 2.005 . . . . 2.0299999999999998 110.916 168.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 22.2 m -125.67 142.19 51.63 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.699 -0.482 . . . . 2.2799999999999998 109.699 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 33.1 m -129.99 160.06 41.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.695 0.284 . . . . 2.4100000000000001 110.512 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -140.2 149.95 43.56 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.68 -0.489 . . . . 4.4400000000000004 109.68 174.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 94.5 m-85 -109.45 128.79 55.42 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.465 -0.334 . . . . 3.6200000000000001 110.217 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -140.32 135.21 31.97 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.992 -0.549 . . . . 2.48 109.753 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.6 141.39 51.14 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.762 -0.375 . . . . 1.53 110.177 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.17 125.82 4.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 1.8 111.675 -177.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -167.46 93.47 0.42 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.507 -0.553 . . . . 3.3799999999999999 109.507 167.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.65 -94.78 1.34 Allowed Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.543 -0.837 . . . . 1.8200000000000001 112.003 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.76 172.95 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.605 2.87 . . . . 2.1000000000000001 113.114 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.8 p-90 -69.78 159.15 34.11 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.197 0.522 . . . . 4.0499999999999998 111.367 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.7 ptt-85 -115.72 146.85 41.52 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.249 0.833 . . . . 3.6000000000000001 113.249 -163.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.4 mm -122.88 131.26 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 114.495 -1.23 . . . . 2.2799999999999998 111.03 -173.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -117.53 139.98 50.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.525 -0.307 . . . . 1.4399999999999999 110.719 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.526 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 56.4 tp -135.83 137.11 41.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 1.75 111.046 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.04 166.94 28.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.743 -0.662 . . . . 1.5900000000000001 109.313 174.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -124.15 130.02 51.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.876 0.37 . . . . 4.4400000000000004 111.122 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.529 ' HB3' ' HB2' ' A' ' 69' ' ' ARG . 47.0 t80 -99.98 119.56 38.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.865 -0.607 . . . . 5.0199999999999996 110.073 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 -133.83 130.17 37.53 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.743 -0.465 . . . . 3.7400000000000002 109.743 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -146.47 160.03 42.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.015 0.436 . . . . 5.0499999999999998 110.981 177.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.47 79.78 0.35 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.724 -0.671 . . . . 4.3700000000000001 112.157 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.93 149.91 66.48 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.46 2.107 . . . . 7.0899999999999999 111.627 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.0 p -69.9 -26.87 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.053 -0.521 . . . . 8.5700000000000003 110.862 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -66.68 -39.94 88.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.607 -0.724 . . . . 10.039999999999999 112.039 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -117.16 129.96 56.3 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.171 -0.307 . . . . 11.890000000000001 110.171 -173.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.3 p -125.97 149.18 48.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.815 0.34 . . . . 9.7899999999999991 111.24 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.34 -29.24 65.89 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.88 -0.6 . . . . 8.7799999999999994 110.812 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.82 -143.43 47.77 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.224 -0.898 . . . . 7.7300000000000004 113.814 172.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -69.99 -39.43 75.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.009 0.433 . . . . 10.300000000000001 110.709 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -59.94 -40.02 87.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.364 -0.834 . . . . 10.960000000000001 110.961 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.97 10.22 86.38 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.56 -0.745 . . . . 5.5599999999999996 112.17 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.0 p -79.01 129.36 34.36 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 120.93 0.395 . . . . 5.6900000000000004 111.326 -176.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -109.27 146.02 34.98 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.032 -0.729 . . . . 6.5 109.032 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.635 ' HB2' ' CZ ' ' A' ' 95' ' ' TYR . 64.8 m-85 -119.73 138.92 53.01 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.534 -0.543 . . . . 4.5999999999999996 109.534 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -123.82 164.94 18.19 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.194 -0.669 . . . . 2.4500000000000002 109.194 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.529 ' HB2' ' HB3' ' A' ' 51' ' ' TYR . 10.4 mtp180 -120.63 124.33 27.64 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.779 -0.452 . . . . 3.7200000000000002 109.779 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 69.9 Cg_endo -80.1 122.76 4.85 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.963 1.775 . . . . 1.3200000000000001 110.952 173.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 36.5 tt0 -99.96 113.03 25.32 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.557 -0.535 . . . . 2.1899999999999999 109.557 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.1 tp -121.9 123.41 41.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.269 -0.423 . . . . 1.73 110.411 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -119.7 135.79 54.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.943 0.401 . . . . 2.1800000000000002 110.262 173.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.1 t -113.67 119.88 62.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.153 -1.054 . . . . 2.0600000000000001 108.153 172.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -117.38 117.38 29.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.752 -0.462 . . . . 4.1900000000000004 109.752 -176.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -120.45 131.2 54.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.815 -0.629 . . . . 5.1600000000000001 109.959 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -121.82 139.95 52.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.306 -0.406 . . . . 3.3100000000000001 110.369 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -116.63 97.92 6.26 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.849 -0.797 . . . . 4.6600000000000001 108.849 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.598 HD21 ' O ' ' A' ' 83' ' ' ASP . 40.4 mt -114.7 18.35 16.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.842 -0.617 . . . . 4.8799999999999999 110.219 -175.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.84 -39.21 76.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.823 -0.626 . . . . 6.1900000000000004 111.789 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -73.03 -66.78 0.63 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.82 0.343 . . . . 6.0999999999999996 110.921 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -127.1 -173.42 2.89 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.088 -0.505 . . . . 5.2699999999999996 109.646 177.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.598 ' O ' HD21 ' A' ' 79' ' ' LEU . 22.3 m-20 -59.92 -39.92 87.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.553 -0.536 . . . . 6.3300000000000001 109.553 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -132.75 139.26 47.5 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.82 -0.808 . . . . 8.3499999999999996 108.82 170.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.9 m -150.06 -74.45 0.16 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.849 0.356 . . . . 2.6400000000000001 111.657 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -131.56 150.2 52.24 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.948 -0.39 . . . . 6.1900000000000004 109.948 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.55 161.7 28.7 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.645 -0.788 . . . . 1.54 111.828 176.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.0 tp -141.11 112.57 7.48 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.746 -0.464 . . . . 2.73 109.746 176.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.3 m -120.01 129.99 54.52 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.261 -0.427 . . . . 1.8700000000000001 110.562 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -127.23 140.06 11.62 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.727 -0.749 . . . . 1.1699999999999999 111.571 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.47 119.86 1.76 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.631 -0.795 . . . . 1.4399999999999999 111.874 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -126.81 129.72 48.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.001 0.429 . . . . 4.6399999999999997 110.933 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -141.34 134.84 29.84 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.102 -0.703 . . . . 3.2200000000000002 109.102 175.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.522 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 8.6 p30 -134.87 151.65 51.08 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-O 120.468 0.175 . . . . 2.2200000000000002 110.981 -175.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.635 ' CZ ' ' HB2' ' A' ' 67' ' ' PHE . 65.2 t80 -118.74 130.01 55.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.547 -0.297 . . . . 3.6400000000000001 110.371 -176.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.9 -169.76 22.3 Favored Glycine 0 C--O 1.228 -0.233 0 C-N-CA 120.465 -0.874 . . . . 2.79 112.254 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -152.46 159.97 43.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.651 0.226 . . . . 7.8499999999999996 110.533 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -116.31 19.74 14.63 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.267 0.469 . . . . 7.6900000000000004 112.267 -175.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -110.55 125.4 53.32 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.288 -0.258 . . . . 10.289999999999999 110.557 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.97 160.16 41.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.558 -0.292 . . . . 10.19 110.87 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -52.11 -61.56 2.19 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.382 0.427 . . . . 12.220000000000001 111.076 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -135.03 157.05 77.81 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.444 -0.798 . . . . 10.48 109.363 -178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.02 149.86 81.93 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.311 2.007 . . . . 9.6799999999999997 111.713 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.99 -9.96 37.11 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.793 -0.718 . . . . 6.5099999999999998 111.768 -175.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -100.35 122.82 43.73 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.551 -0.537 . . . . 8.1099999999999994 109.551 174.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -64.5 130.26 43.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.052 -0.522 . . . . 4.1399999999999997 110.794 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.1 p -97.64 139.99 32.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.784 -0.643 . . . . 3.77 110.598 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -132.05 119.45 21.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.498 -0.319 . . . . 2.2000000000000002 111.445 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.553 ' HA ' ' O ' ' A' ' 95' ' ' TYR . 27.5 t-20 -151.8 124.62 8.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.779 -0.646 . . . . 3.1200000000000001 110.121 176.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 43.3 ttm -103.34 121.39 42.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.6 -0.727 . . . . 2.1200000000000001 110.264 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -112.27 141.33 46.11 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.614 -0.434 . . . . 2.4900000000000002 111.434 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 76.4 ttt180 -131.07 110.89 11.53 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.997 -0.742 . . . . 4.4699999999999998 108.997 168.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.556 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 83.2 m95 -98.76 119.95 38.38 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.879 -0.786 . . . . 2.9199999999999999 108.879 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.552 ' HB2' ' HZ1' ' A' ' 114' ' ' LYS . 10.2 mtmp? -121.74 123.81 42.73 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.785 -0.366 . . . . 2.5099999999999998 111.156 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 134' ' ' SER . 87.6 mt -120.62 126.22 74.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.032 -0.531 . . . . 2.1299999999999999 109.976 174.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -138.92 105.78 7.42 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.425 -0.352 . . . . 1.6799999999999999 111.036 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 98.8 Cg_endo -80.06 160.03 23.77 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.98 2.453 . . . . 1.54 111.158 173.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -116.19 137.19 52.35 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.248 -0.433 . . . . 2.3500000000000001 110.25 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -127.03 128.14 45.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.379 -0.373 . . . . 5.1500000000000004 111.495 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -128.64 88.94 2.81 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.553 -0.536 . . . . 3.04 109.553 172.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.0 p -147.5 129.24 6.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.082 0.468 . . . . 4.7400000000000002 111.148 -177.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.624 ' HG3' ' H ' ' A' ' 124' ' ' THR . 55.8 tptt -144.31 142.91 30.72 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.217 -0.66 . . . . 6.3600000000000003 109.217 177.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.3 mt -74.41 -6.77 50.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.137 0.494 . . . . 4.96 110.904 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.624 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 26.3 m -119.96 135.7 54.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.637 -0.71 . . . . 4.0700000000000003 109.561 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -68.15 -39.93 82.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.873 -0.603 . . . . 5.1699999999999999 111.126 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -61.02 -40.27 92.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.244 -0.889 . . . . 3.71 112.078 -176.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -110.95 161.22 16.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.059 0.457 . . . . 2.4500000000000002 111.857 -171.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.53 ' HD2' ' OE1' ' A' ' 159' ' ' GLN . 20.3 ttm180 -125.51 133.66 52.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.88 -0.6 . . . . 4.6799999999999997 111.465 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.489 ' HB2' ' HD3' ' A' ' 122' ' ' LYS . 64.7 t80 -114.88 119.36 36.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.573 -0.739 . . . . 4.3600000000000003 109.21 175.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.41 ' OD1' ' HD3' ' A' ' 128' ' ' ARG . 17.4 m120 -118.45 130.05 55.74 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.018 -0.364 . . . . 2.5899999999999999 110.018 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -134.9 135.75 8.12 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.408 -0.901 . . . . 1.25 111.688 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -124.0 128.28 49.14 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.668 -0.493 . . . . 5.0899999999999999 109.668 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.522 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 63.0 tp -109.95 110.93 22.03 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.188 -0.671 . . . . 2.7599999999999998 109.188 175.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 14.3 t -116.21 130.15 56.65 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.253 -0.579 . . . . 1.99 110.533 -175.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 66.6 mtt -118.99 135.92 54.37 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.651 -0.87 . . . . 2.7799999999999998 108.651 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 113' ' ' TRP . 54.7 p90 -149.83 157.42 43.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.349 0.595 . . . . 3.6800000000000002 111.61 178.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 59.7 mttp -129.82 157.62 41.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.932 -1.031 . . . . 2.1699999999999999 109.849 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.566 ' H ' HD12 ' A' ' 142' ' ' LEU . 64.3 t80 -121.85 139.99 52.94 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.743 -0.662 . . . . 4.0099999999999998 109.824 -173.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 61.12 -175.91 0.12 Allowed 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.685 0.616 . . . . 1.79 110.745 -175.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 63.9 t30 -79.08 -21.63 46.47 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.211 -0.595 . . . . 3.04 110.315 172.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.93 -47.39 85.98 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.496 -0.774 . . . . 2.4100000000000001 112.33 -172.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.566 HD12 ' H ' ' A' ' 138' ' ' PHE . 49.4 mt -69.87 -25.36 63.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.003 0.43 . . . . 2.3599999999999999 110.971 -178.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 140' ' ' ASN . 94.7 m-20 -59.91 -39.98 87.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.974 0.416 . . . . 2.52 110.007 175.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 80.9 p -78.1 -31.1 49.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.012 -0.54 . . . . 2.52 111.54 -177.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.428 ' HG1' ' HB2' ' A' ' 149' ' ' ASP . 34.9 p -70.16 -25.03 63.26 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.105 0.478 . . . . 2.0099999999999998 110.912 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 64.93 -128.08 34.0 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.696 -0.684 . . . . 1.52 112.776 175.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -72.47 -20.69 61.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.514 0.19 . . . . 6.2199999999999998 111.514 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.02 97.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.827 0.346 . . . . 2.0499999999999998 111.155 -176.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.428 ' HB2' ' HG1' ' A' ' 145' ' ' THR . 17.0 m-20 -131.47 92.83 3.23 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.129 -0.693 . . . . 2.6400000000000001 109.129 178.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.2 t -144.85 146.69 32.18 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.048 -0.524 . . . . 2.6000000000000001 110.153 -178.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.463 ' HG2' ' CZ ' ' A' ' 136' ' ' TYR . 32.8 tpt180 -99.77 119.05 37.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.39 -0.368 . . . . 4.0899999999999999 110.492 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.4 t -119.22 119.22 60.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 2.1499999999999999 109.875 178.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -123.49 140.01 53.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.929 0.395 . . . . 2.5600000000000001 111.009 -176.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 33.5 m -119.97 127.03 52.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.141 -0.482 . . . . 1.78 109.737 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.49 ' HG3' HD22 ' A' ' 171' ' ' ASN . 31.0 tt0 -123.51 130.72 53.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.585 -0.524 . . . . 2.04 109.585 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 171' ' ' ASN . 88.3 m -122.07 121.83 37.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.855 0.359 . . . . 2.0299999999999998 111.614 -176.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -102.39 115.23 5.15 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 111.174 -0.77 . . . . 1.0800000000000001 111.174 177.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 89.9 mt -100.34 122.61 43.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.829 0.347 . . . . 2.9300000000000002 110.631 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.53 ' OE1' ' HD2' ' A' ' 128' ' ' ARG . 53.3 tt0 -100.01 107.97 20.05 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.065 -0.717 . . . . 3.02 109.065 176.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -120.44 114.81 22.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.149 -0.478 . . . . 4.7599999999999998 109.714 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.41 ' HB ' ' HA ' ' A' ' 164' ' ' GLU . 6.8 p -88.85 90.5 8.44 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.269 0.557 . . . . 1.8200000000000001 110.535 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -60.23 -49.28 78.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.582 -0.735 . . . . 3.27 111.171 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.434 ' HB2' HG21 ' A' ' 166' ' ' VAL . 94.6 m-20 -101.77 13.13 35.76 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.983 -0.287 . . . . 2.4100000000000001 111.024 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.41 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 41.3 tt0 71.39 -48.7 0.68 Allowed 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.774 0.671 . . . . 2.5800000000000001 111.3 -178.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.7 p -74.69 -19.98 60.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.34 -0.391 . . . . 2.6000000000000001 111.642 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.434 HG21 ' HB2' ' A' ' 163' ' ' ASN . 33.4 m -121.46 140.0 46.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.326 -0.397 . . . . 2.0600000000000001 110.266 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.475 ' O ' ' HD2' ' A' ' 199' ' ' PRO . . . -106.87 129.26 54.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.053 -0.522 . . . . 1.8400000000000001 110.601 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 28.7 mt -103.72 129.22 51.05 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.291 -0.633 . . . . 2.1400000000000001 109.291 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -101.45 107.4 18.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.812 0.339 . . . . 3.73 110.572 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.9 t -113.18 119.98 62.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 109.446 -0.576 . . . . 1.8100000000000001 109.446 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.585 ' HB3' ' HB3' ' A' ' 195' ' ' ARG . 8.5 t30 -106.34 120.73 42.63 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.952 0.406 . . . . 2.2400000000000002 111.123 -176.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -103.18 129.96 50.23 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.562 -0.745 . . . . 4.8399999999999999 109.748 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -102.46 138.71 39.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.225 -0.443 . . . . 4.4299999999999997 110.674 -177.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 62.8 tp -140.08 143.38 36.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.571 . . . . 2.8500000000000001 110.447 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -105.84 141.01 37.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.223 -0.288 . . . . 3.3100000000000001 110.223 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -113.05 140.57 47.74 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.983 -0.376 . . . . 7.3300000000000001 109.983 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 180' ' ' MET . . . 103.1 -3.01 47.65 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.625 -0.798 . . . . 5.0599999999999996 111.732 -175.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.88 -40.08 87.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.178 0.513 . . . . 8.0199999999999996 110.013 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -58.62 -31.96 68.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.661 -0.7 . . . . 9.4900000000000002 111.331 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' A' ' 177' ' ' GLY . 25.7 ptm -99.44 8.65 44.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.612 0.244 . . . . 11.1 111.218 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -89.19 95.55 10.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.664 -0.243 . . . . 10.470000000000001 110.372 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -60.12 -45.08 94.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.421 0.629 . . . . 13.06 109.868 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.2 p -160.05 150.26 18.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.211 -0.904 . . . . 12.890000000000001 108.984 173.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -103.28 113.23 26.56 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.343 0.592 . . . . 15.720000000000001 110.643 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -60.39 -39.94 89.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.521 -1.218 . . . . 13.470000000000001 111.826 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -69.69 -19.56 63.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.073 -0.512 . . . . 13.15 110.689 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 101.8 140.23 11.04 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.651 -0.704 . . . . 10.050000000000001 111.479 -175.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.509 ' HG2' ' H ' ' A' ' 190' ' ' SER . 36.6 tt0 -104.59 130.47 52.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.836 0.35 . . . . 10.699999999999999 110.665 -177.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -75.41 -23.08 56.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.151 0.501 . . . . 11.34 110.251 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.509 ' H ' ' HG2' ' A' ' 188' ' ' GLU . 50.1 m 63.59 17.55 10.47 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.889 -1.051 . . . . 6.7800000000000002 112.293 174.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 7.0 p -140.35 150.04 43.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.592 -0.276 . . . . 5.3600000000000003 110.798 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -110.19 142.66 41.43 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.389 -0.967 . . . . 7.8700000000000001 108.389 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -107.52 150.96 26.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.03 0.443 . . . . 4.4000000000000004 111.071 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 48.9 mm -113.83 125.53 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.781 -0.645 . . . . 2.6400000000000001 110.24 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 171' ' ' ASN . 35.2 ttm180 -99.96 109.37 21.73 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.553 -0.906 . . . . 4.1100000000000003 108.553 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -123.63 131.44 53.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.834 0.349 . . . . 1.76 111.695 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -158.22 165.75 34.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.934 -0.575 . . . . 6.1399999999999997 109.83 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.567 ' O ' ' HD2' ' A' ' 209' ' ' PRO . 1.5 pt? -143.64 137.29 14.31 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 121.126 -0.23 . . . . 3.0800000000000001 110.461 177.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 167' ' ' ALA . 72.3 Cg_endo -79.77 129.67 8.28 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.451 2.101 . . . . 1.98 112.736 176.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 88.1 mt -128.05 135.21 49.55 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.35 -0.611 . . . . 2.7599999999999998 109.35 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 4.4 p -112.45 118.93 36.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.981 0.42 . . . . 2.4199999999999999 111.149 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.9 mt -125.48 82.2 2.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.889 -0.782 . . . . 2.77 108.889 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 69.49 -124.69 16.16 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.338 -0.846 . . . . 1.6200000000000001 111.733 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -91.83 3.98 53.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.18 0.514 . . . . 2.8599999999999999 109.902 175.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -95.9 115.88 28.08 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.61 -0.885 . . . . 3.23 108.61 174.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 47.5 t -100.61 120.37 39.94 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.938 -0.764 . . . . 2.0499999999999998 108.938 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.81 128.07 73.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.932 0.396 . . . . 1.9299999999999999 110.695 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 35.1 m -131.1 91.3 36.47 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-O 120.83 0.347 . . . . 1.6699999999999999 110.093 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.567 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 50.1 Cg_endo -70.41 140.58 40.54 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.269 1.979 . . . . 1.28 111.978 176.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -111.85 140.29 46.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.188 -0.46 . . . . 4.8600000000000003 110.587 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 24.0 p -134.0 156.26 48.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 2.0899999999999999 110.314 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -116.57 120.33 38.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.045 0.45 . . . . 5.29 110.656 -177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 84.8 mt -109.97 129.96 64.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.907 -0.588 . . . . 4.9400000000000004 110.259 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -102.09 -171.41 27.37 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.729 -0.748 . . . . 4.9800000000000004 112.451 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 91.1 mt -100.15 133.65 44.23 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.722 -0.473 . . . . 8.4399999999999995 109.722 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -69.93 -16.8 63.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 7.9699999999999998 111.725 -174.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -89.79 0.11 57.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.064 0.459 . . . . 11.1 111.051 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -125.52 149.42 48.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.835 -0.621 . . . . 12.24 109.347 178.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 46.1 m -76.98 -21.67 54.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.122 -0.49 . . . . 10.220000000000001 110.99 -176.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 59.98 25.69 14.91 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.255 -0.884 . . . . 11.92 112.3 170.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 85.6 m95 60.15 22.85 12.14 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.099 0.407 . . . . 14.460000000000001 112.099 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -99.5 137.16 38.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.333 -0.394 . . . . 14.529999999999999 109.995 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -118.85 122.02 41.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.771 0.32 . . . . 17.07 111.092 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -69.61 -21.16 63.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.999 -0.546 . . . . 15.779999999999999 109.964 175.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -60.54 -39.98 89.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.459 -0.792 . . . . 15.67 111.101 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -70.67 140.43 51.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.278 -0.419 . . . . 14.5 110.493 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 86.1 mt -110.04 130.09 63.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.823 -0.626 . . . . 15.380000000000001 110.691 -172.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -62.21 133.06 54.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.029 -0.532 . . . . 14.73 109.864 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 62.2 mtm180 -83.63 165.44 18.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.26 -0.427 . . . . 16.969999999999999 111.814 -173.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -59.95 -40.32 88.59 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.495 -0.557 . . . . 12.779999999999999 109.495 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -74.9 164.31 54.51 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.407 -0.815 . . . . 11.369999999999999 111.812 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -74.75 121.15 21.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.918 0.39 . . . . 12.81 111.692 -176.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -122.01 140.99 51.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.667 -0.697 . . . . 9.9900000000000002 109.867 174.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -134.72 149.86 50.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.827 0.346 . . . . 11.32 110.319 176.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -112.71 106.06 14.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.051 -0.522 . . . . 6.8799999999999999 110.539 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 60.06 47.7 9.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.8 -0.636 . . . . 8.9399999999999995 111.675 174.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 63.3 t -109.9 129.7 64.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.604 -0.725 . . . . 2.9700000000000002 109.869 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -129.04 156.16 21.07 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.864 -0.684 . . . . 1.3999999999999999 111.701 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.452 ' CD1' ' HA ' ' A' ' 258' ' ' GLU . 85.2 mt -120.0 130.45 54.75 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.933 -0.395 . . . . 2.4300000000000002 109.933 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -109.89 130.0 55.58 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.989 -0.745 . . . . 4.3300000000000001 108.989 176.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -120.03 139.89 51.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.959 0.409 . . . . 3.2599999999999998 111.0 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -113.66 128.81 8.48 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.797 -0.921 . . . . 1.3500000000000001 110.797 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' TYR . . . . . 0.428 ' O ' ' HB ' ' A' ' 251' ' ' VAL . 73.3 m-85 -130.0 150.11 51.42 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.614 0.207 . . . . 4.7599999999999998 110.772 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 58.12 39.98 25.57 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.082 0.864 . . . . 4.29 110.666 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -77.56 114.06 16.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.554 -0.748 . . . . 7.5599999999999996 109.79 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -143.46 168.22 20.36 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.895 -1.048 . . . . 7.0199999999999996 108.26 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -59.97 -40.06 87.78 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.83 -0.348 . . . . 6.4800000000000004 110.794 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.467 ' HA2' ' HB2' ' A' ' 280' ' ' SER . . . -99.83 -0.27 56.36 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.447 -0.883 . . . . 2.9199999999999999 113.967 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 59.4 tp -145.98 138.52 25.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.65 0.725 . . . . 3.5800000000000001 111.304 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 61.3 p -147.36 134.49 20.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.821 0.343 . . . . 2.6000000000000001 110.963 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 243' ' ' TYR . 59.8 t -122.58 132.47 71.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.799 -0.445 . . . . 2.2400000000000002 109.799 176.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 35.1 t -120.04 127.8 52.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.877 0.37 . . . . 2.0 110.086 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 72.2 mt -117.15 129.24 55.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.112 -0.495 . . . . 3.4199999999999999 110.259 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.12 119.95 41.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.053 -0.521 . . . . 4.0800000000000001 110.633 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' TYR . . . . . 0.434 ' HD2' ' CZ ' ' A' ' 257' ' ' PHE . 92.6 m-85 -124.51 135.54 53.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.256 -0.429 . . . . 5.1699999999999999 110.465 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.531 ' HB2' ' H ' ' A' ' 272' ' ' TYR . . . -105.34 29.57 6.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.276 0.56 . . . . 3.5800000000000001 110.775 175.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . 0.434 ' CZ ' ' HD2' ' A' ' 255' ' ' TYR . 29.0 p90 -147.2 133.64 19.69 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.751 -0.658 . . . . 7.5800000000000001 110.174 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.452 ' HA ' ' CD1' ' A' ' 239' ' ' LEU . 56.3 mt-10 -69.86 -40.04 76.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.473 -0.785 . . . . 8.5399999999999991 111.174 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -121.05 154.63 35.83 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.834 -0.621 . . . . 12.720000000000001 109.71 -177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -86.96 109.01 19.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.0 0.429 . . . . 11.09 110.582 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -79.59 116.9 20.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.662 -0.699 . . . . 11.41 110.154 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -70.12 -19.94 63.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.031 -0.531 . . . . 12.49 111.775 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -80.75 168.53 18.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.623 -0.262 . . . . 12.460000000000001 111.069 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.1 -40.13 88.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.02 0.438 . . . . 13.779999999999999 111.05 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 136.55 167.18 11.09 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.903 -0.665 . . . . 11.300000000000001 111.649 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -120.35 134.09 55.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.971 -0.381 . . . . 12.59 109.971 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 12.6 p -69.99 -18.54 63.33 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.865 -0.607 . . . . 11.1 111.296 -178.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.2 -39.95 94.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.146 -0.479 . . . . 12.42 111.262 176.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -131.98 105.83 7.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.321 -0.4 . . . . 11.82 110.195 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -80.01 155.78 27.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.961 0.41 . . . . 9.5999999999999996 110.419 -177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -130.09 143.19 50.65 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.338 -0.392 . . . . 7.7999999999999998 110.619 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . 0.531 ' H ' ' HB2' ' A' ' 256' ' ' ALA . 91.9 m-85 -108.45 149.06 29.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.956 -0.565 . . . . 6.9900000000000002 110.158 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -137.57 130.25 29.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.834 -0.621 . . . . 2.4100000000000001 109.954 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -137.8 144.46 15.8 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.552 -0.832 . . . . 1.6200000000000001 112.541 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 63.0 t -130.06 130.11 65.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.588 0.232 . . . . 2.4900000000000002 110.489 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -141.65 131.07 4.63 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.955 -0.64 . . . . 1.3 111.554 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.96 137.12 54.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.652 0.263 . . . . 2.3399999999999999 110.73 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -119.79 127.52 52.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 2.7999999999999998 110.31 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 89.5 m-85 -109.22 126.71 53.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.259 -0.645 . . . . 5.1900000000000004 109.259 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.467 ' HB2' ' HA2' ' A' ' 248' ' ' GLY . 37.7 m -114.17 129.35 56.63 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.903 0.383 . . . . 2.0499999999999998 110.554 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.178 -0.915 . . . . 4.4199999999999999 109.608 179.503 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.7 mtm . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 120.831 0.348 . . . . 11.970000000000001 110.976 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -117.02 112.97 21.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.087 0.47 . . . . 10.35 110.867 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -69.87 -40.02 75.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.53 -0.759 . . . . 9.3100000000000005 110.652 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -116.24 127.31 54.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.052 -0.522 . . . . 9.4399999999999995 109.969 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -120.04 130.59 54.77 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.093 -0.503 . . . . 7.75 109.833 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -70.18 -29.4 66.27 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.609 -0.515 . . . . 3.6099999999999999 109.609 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.431 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 92.2 m95 -71.25 115.97 11.02 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.642 -0.708 . . . . 3.9100000000000001 110.053 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.408 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 53.1 t60 -114.57 122.16 45.67 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.071 -0.513 . . . . 3.9399999999999999 109.964 175.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 7' ' ' TRP . 98.9 m-85 -120.21 140.07 51.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.944 -0.571 . . . . 3.21 110.731 -178.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -122.0 129.47 52.49 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.078 -0.712 . . . . 2.6499999999999999 109.078 171.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 279' ' ' TYR . 86.2 mt -125.12 129.37 73.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.292 -0.413 . . . . 2.0699999999999998 110.736 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.13 122.79 5.95 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.093 -0.803 . . . . 0.92000000000000004 111.093 175.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -120.01 136.66 54.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.935 0.367 . . . . 1.6499999999999999 110.858 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 68.4 mtt -133.43 156.68 47.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.305 -0.407 . . . . 2.9700000000000002 110.347 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -114.65 139.93 49.25 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.782 -0.451 . . . . 3.1499999999999999 109.782 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.499 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 42.2 tt0 -60.34 -50.23 74.46 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.762 0.652 . . . . 5.0899999999999999 112.762 -175.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.8 tt -145.06 146.68 19.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.799 0.333 . . . . 5.3300000000000001 111.048 -174.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.438 ' HB3' HG11 ' A' ' 20' ' ' VAL . 40.5 mt-10 -61.75 -50.16 73.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.628 -0.715 . . . . 8.2799999999999994 112.317 -176.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 51.14 42.78 29.1 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.244 0.545 . . . . 10.0 111.121 -174.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.438 HG11 ' HB3' ' A' ' 18' ' ' GLU . 16.5 m -80.1 -14.74 13.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.836 -0.62 . . . . 11.380000000000001 111.151 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.63 -30.1 67.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 13.1 110.993 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.6 178.56 28.24 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.733 -0.746 . . . . 12.52 112.218 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -130.02 159.97 35.1 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.501 -0.555 . . . . 15.18 109.501 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.19 -131.26 2.88 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.442 -0.885 . . . . 12.279999999999999 112.301 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -69.8 -35.75 75.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.495 0.664 . . . . 12.82 110.094 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 59.84 28.28 17.73 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 114.126 -1.397 . . . . 10.81 111.983 172.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 75.2 mtm -69.9 -40.04 75.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.291 -0.413 . . . . 10.210000000000001 111.369 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -70.18 149.27 47.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.963 0.411 . . . . 8.0600000000000005 111.026 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.73 97.98 0.51 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.988 -0.625 . . . . 6.0800000000000001 111.864 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.1 tp -139.94 140.77 36.43 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.635 -0.505 . . . . 5.96 109.635 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 16' ' ' GLU . . . 64.27 63.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.623 0.577 . . . . 3.2400000000000002 111.506 176.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -100.82 130.7 24.72 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.953 -0.567 . . . . 3.48 109.796 175.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.97 150.01 66.32 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.347 2.031 . . . . 2.0299999999999998 112.267 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 14.3 p -124.46 143.67 50.51 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.038 -0.528 . . . . 2.2799999999999998 109.733 175.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.0 m -129.96 139.23 52.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.19 0.519 . . . . 2.4100000000000001 111.252 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -120.33 139.44 52.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.616 -0.72 . . . . 4.4400000000000004 109.631 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -119.9 138.34 53.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.882 0.373 . . . . 3.6200000000000001 111.625 -174.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -140.07 130.01 24.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.733 -0.667 . . . . 2.48 109.222 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.62 143.46 49.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.884 0.373 . . . . 1.53 111.573 -174.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.01 125.09 12.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.607 -0.724 . . . . 1.8 111.354 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.584 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 27.8 p-10 -166.96 95.24 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.278 0.561 . . . . 3.3799999999999999 110.502 171.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.97 -95.52 2.1 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.05 -0.595 . . . . 1.8200000000000001 111.871 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.584 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 54.2 Cg_exo -52.5 174.47 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.624 2.883 . . . . 2.1000000000000001 113.178 171.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.598 ' HB2' ' O ' ' A' ' 75' ' ' HIS . 48.9 p90 -69.14 -176.02 0.84 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.83 -0.623 . . . . 4.0499999999999998 111.289 -175.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -111.0 136.37 50.1 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 121.786 0.803 . . . . 3.6000000000000001 112.42 -167.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 87.1 mt -120.06 129.95 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 114.113 -1.403 . . . . 2.2799999999999998 109.931 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . . . -117.85 138.22 52.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.43 -0.35 . . . . 1.4399999999999999 110.065 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.0 tp -114.22 130.93 56.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.945 -0.57 . . . . 1.75 110.423 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.85 169.25 20.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.52 -0.764 . . . . 1.5900000000000001 109.332 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.422 ' CD2' ' HA ' ' A' ' 70' ' ' PRO . 92.9 m-85 -139.75 157.52 45.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.642 0.258 . . . . 4.4400000000000004 110.386 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -120.42 131.71 54.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.114 -0.494 . . . . 5.0199999999999996 110.645 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -113.61 127.86 56.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.079 -0.51 . . . . 3.7400000000000002 109.816 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.636 ' O ' ' HE3' ' A' ' 62' ' ' LYS . 93.6 mt-10 -124.03 139.86 53.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.308 -0.405 . . . . 5.0499999999999998 109.973 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -102.12 164.31 17.04 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.703 -0.76 . . . . 4.3700000000000001 112.921 -173.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.98 -40.35 20.97 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.774 2.316 . . . . 7.0899999999999999 112.498 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -101.45 -60.04 3.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.962 0.41 . . . . 8.5700000000000003 110.232 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -83.98 129.78 34.91 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.183 -0.673 . . . . 10.039999999999999 109.183 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -61.37 -39.94 92.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.289 -0.869 . . . . 11.890000000000001 110.94 -172.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.2 t -112.31 100.13 8.56 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.888 -0.412 . . . . 9.7899999999999991 109.888 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.49 160.03 31.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.789 -0.641 . . . . 8.7799999999999994 109.517 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.28 116.96 5.6 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.342 -0.933 . . . . 7.7300000000000004 112.67 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.636 ' HE3' ' O ' ' A' ' 53' ' ' GLU . 97.6 mttt -78.16 146.63 34.95 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.697 -0.483 . . . . 10.300000000000001 109.697 175.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -68.35 -39.96 81.69 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.943 -0.391 . . . . 10.960000000000001 109.943 174.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -78.97 141.36 24.18 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.758 -0.734 . . . . 5.5599999999999996 111.923 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.8 p -108.61 19.98 19.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.956 0.408 . . . . 5.6900000000000004 111.003 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -60.04 -39.99 87.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.797 -0.638 . . . . 6.5 110.863 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.416 ' CD2' ' HA2' ' A' ' 96' ' ' GLY . 37.2 m-85 -119.02 120.02 35.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.731 -0.47 . . . . 4.5999999999999996 109.731 173.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -145.05 150.82 37.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.866 -0.607 . . . . 2.4500000000000002 109.634 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.459 HH12 ' CD ' ' A' ' 53' ' ' GLU . 41.0 ttp180 -119.99 124.42 27.87 Favored Pre-proline 0 C--N 1.328 -0.341 0 C-N-CA 120.662 -0.415 . . . . 3.7200000000000002 110.98 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.422 ' HA ' ' CD2' ' A' ' 50' ' ' TYR . 88.2 Cg_endo -84.02 149.15 12.18 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.843 2.362 . . . . 1.3200000000000001 112.921 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.443 ' CD ' ' HE ' ' A' ' 93' ' ' ARG . 3.7 tp10 -115.46 118.55 33.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.572 -0.899 . . . . 2.1899999999999999 108.572 168.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.453 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 59.5 tp -122.34 101.8 7.73 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.251 -0.431 . . . . 1.73 110.15 -178.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 47' ' ' ALA . 34.7 mt-10 -90.14 125.59 35.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.04 -0.527 . . . . 2.1800000000000002 111.31 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.8 m -114.0 121.99 67.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.524 -0.917 . . . . 2.0600000000000001 108.524 168.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.598 ' O ' ' HB2' ' A' ' 44' ' ' TRP . 63.0 m80 -109.67 118.11 35.69 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.662 -0.495 . . . . 4.1900000000000004 109.662 -174.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -114.52 130.07 56.72 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.859 -0.793 . . . . 5.1600000000000001 108.859 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -128.04 129.74 47.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.953 0.406 . . . . 3.3100000000000001 110.399 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 89.0 m-85 -100.23 109.54 21.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.95 -0.568 . . . . 4.6600000000000001 109.941 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.07 12.9 35.79 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.323 -0.621 . . . . 4.8799999999999999 109.323 177.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -59.98 -38.46 82.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.908 -1.042 . . . . 6.1900000000000004 111.05 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -109.92 130.06 55.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.01 -0.541 . . . . 6.0999999999999996 110.713 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -77.9 -13.73 59.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.247 0.546 . . . . 5.2699999999999996 109.598 172.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -59.97 -49.95 75.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.431 -0.804 . . . . 6.3300000000000001 110.3 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 86' ' ' PHE . 97.4 m-85 -142.83 141.62 31.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.604 -0.725 . . . . 8.3499999999999996 109.349 177.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.9 t -84.11 93.34 8.11 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.407 -0.96 . . . . 2.6400000000000001 108.407 172.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 78' ' ' PHE . 98.9 m-85 -79.55 129.8 34.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.107 -0.497 . . . . 6.1900000000000004 110.344 -175.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.08 153.22 17.89 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.318 -0.944 . . . . 1.54 111.903 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.8 tp -139.3 117.32 11.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.92 0.39 . . . . 2.73 110.079 176.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.6 m -110.8 117.65 34.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.138 -0.483 . . . . 1.8700000000000001 110.368 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.57 133.9 10.8 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.508 -0.853 . . . . 1.1699999999999999 112.059 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -136.04 126.11 3.76 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.548 -0.621 . . . . 1.4399999999999999 111.548 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -112.35 131.29 55.61 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.054 -0.35 . . . . 4.6399999999999997 110.054 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HE ' ' CD ' ' A' ' 71' ' ' GLU . 85.8 mtt180 -135.28 131.33 36.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.088 -0.506 . . . . 3.2200000000000002 110.177 -172.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -133.92 129.21 35.99 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.052 -0.259 . . . . 2.2200000000000002 110.958 175.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -114.85 125.13 53.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.525 -0.307 . . . . 3.6400000000000001 110.252 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.416 ' HA2' ' CD2' ' A' ' 67' ' ' PHE . . . 102.32 178.84 27.4 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.527 -0.845 . . . . 2.79 112.928 175.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -136.65 140.01 42.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.056 0.455 . . . . 7.8499999999999996 110.106 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -77.0 -20.08 56.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.539 -0.755 . . . . 7.6900000000000004 109.74 177.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -116.5 134.17 55.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.782 -0.645 . . . . 10.289999999999999 109.98 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 28.5 m -136.96 -179.85 3.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 110.023 -0.362 . . . . 10.19 110.023 177.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -59.88 -49.13 78.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.861 0.362 . . . . 12.220000000000001 111.067 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -131.15 78.59 72.51 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.071 -0.513 . . . . 10.48 110.481 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.28 118.44 5.32 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.572 2.181 . . . . 9.6799999999999997 112.867 -176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -152.29 59.17 0.41 Allowed Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.596 -0.729 . . . . 6.5099999999999998 111.38 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 63.03 19.97 11.99 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.213 0.53 . . . . 8.1099999999999994 111.025 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -100.94 1.05 39.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.766 -0.652 . . . . 4.1399999999999997 109.892 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.3 p -86.51 141.51 29.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.516 -0.765 . . . . 3.77 110.835 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.64 124.67 16.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.928 -0.578 . . . . 2.2000000000000002 110.095 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -139.54 107.93 5.83 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.245 -0.65 . . . . 3.1200000000000001 109.245 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 91.6 mtp -119.95 115.52 23.94 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.471 -0.331 . . . . 2.1200000000000001 110.297 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.625 ' HB2' ' OD1' ' A' ' 143' ' ' ASN . 49.4 mt-30 -100.19 129.09 46.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.949 0.404 . . . . 2.4900000000000002 110.113 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.672 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 40.5 ttm180 -120.24 111.02 17.28 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.87 -0.789 . . . . 4.4699999999999998 108.87 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -108.02 130.83 55.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.06 -0.518 . . . . 2.9199999999999999 109.703 -175.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.65 ' HA ' ' O ' ' A' ' 135' ' ' MET . 87.6 tttt -130.23 124.12 31.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.045 0.45 . . . . 2.5099999999999998 110.884 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 75.9 mt -129.82 130.03 66.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.022 -0.535 . . . . 2.1299999999999999 109.557 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -134.01 116.41 13.42 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.393 -0.367 . . . . 1.6799999999999999 111.151 -177.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.606 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 87.3 Cg_endo -80.01 140.05 13.99 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.277 1.984 . . . . 1.54 110.579 171.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -87.77 137.75 32.06 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.202 -0.454 . . . . 2.3500000000000001 110.985 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -101.13 127.53 47.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.24 -0.652 . . . . 5.1500000000000004 109.24 172.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -71.43 160.39 32.82 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 124.092 0.87 . . . . 3.04 111.61 -171.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.473 ' HB ' ' HG3' ' A' ' 128' ' ' ARG . 34.6 m -115.04 173.94 3.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.304 -0.862 . . . . 4.7400000000000002 110.841 -173.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 60.13 39.07 19.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.854 -0.612 . . . . 6.3600000000000003 111.576 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.7 tp -63.08 -40.19 96.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.759 -0.655 . . . . 4.96 110.436 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.9 p -118.02 159.98 22.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.752 -0.658 . . . . 4.0700000000000003 110.446 177.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -70.27 129.91 40.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.061 -0.518 . . . . 5.1699999999999999 111.402 -174.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 59.86 28.37 17.85 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.081 -0.963 . . . . 3.71 111.368 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.8 mt -137.77 144.44 41.6 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.21 -0.663 . . . . 2.4500000000000002 109.21 175.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.473 ' HG3' ' HB ' ' A' ' 121' ' ' VAL . 56.8 ttt180 -130.2 128.99 42.81 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.427 -0.509 . . . . 4.6799999999999997 111.104 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.43 ' O ' HG11 ' A' ' 121' ' ' VAL . 90.0 m-85 -120.01 123.05 42.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.273 -0.876 . . . . 4.3600000000000003 108.882 176.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 156' ' ' THR . 21.8 m-80 -116.16 130.98 57.06 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.078 -0.712 . . . . 2.5899999999999999 109.078 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.36 129.61 4.62 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 118.965 -1.588 . . . . 1.25 113.232 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -123.57 127.8 48.81 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.943 -0.392 . . . . 5.0899999999999999 109.943 173.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.606 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 87.9 mt -112.75 109.72 19.39 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.031 -0.729 . . . . 2.7599999999999998 109.031 174.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 152' ' ' VAL . 52.6 m -105.88 124.95 50.39 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.565 -0.454 . . . . 1.99 111.469 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.65 ' O ' ' HA ' ' A' ' 114' ' ' LYS . 95.4 mmm -93.32 126.2 38.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.507 -0.77 . . . . 2.7799999999999998 109.295 176.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -120.68 126.14 49.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.177 0.513 . . . . 3.6800000000000002 111.953 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.672 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 61.7 mttp -130.31 143.72 50.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.387 -0.968 . . . . 2.1699999999999999 108.387 167.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.471 ' H ' HD23 ' A' ' 142' ' ' LEU . 53.1 p90 -141.48 160.0 41.06 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 121.201 -0.2 . . . . 4.0099999999999998 110.76 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 62.75 178.66 0.14 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.94 0.775 . . . . 1.79 110.601 -177.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -75.73 -24.36 56.13 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.93 0.395 . . . . 3.04 110.584 173.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -59.96 -50.85 72.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.951 -0.568 . . . . 2.4100000000000001 111.599 -174.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 149' ' ' ASP . 9.5 mp -70.81 -29.86 66.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.436 -0.347 . . . . 2.3599999999999999 111.24 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.625 ' OD1' ' HB2' ' A' ' 111' ' ' GLN . 12.7 m120 -61.58 -41.49 97.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.006 0.432 . . . . 2.52 110.456 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.1 p -80.22 -39.9 28.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.595 -0.73 . . . . 2.52 111.832 -173.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.437 ' HG1' ' HB2' ' A' ' 149' ' ' ASP . 24.6 p -74.07 -32.88 63.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.321 . . . . 2.0099999999999998 111.207 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.71 -108.75 2.59 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.933 -0.576 . . . . 1.52 113.149 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -59.97 -40.07 87.83 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 122.687 0.395 . . . . 6.2199999999999998 111.503 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.424 ' HB3' ' HB ' ' A' ' 145' ' ' THR . . . -60.04 -44.27 94.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.173 -0.467 . . . . 2.0499999999999998 111.857 -175.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.496 ' HB3' ' HG ' ' A' ' 142' ' ' LEU . 43.3 m-20 -118.01 98.25 6.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.125 0.488 . . . . 2.6400000000000001 110.966 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.5 t -149.93 144.56 25.96 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.406 -0.59 . . . . 2.6000000000000001 109.406 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -110.16 151.71 26.94 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.335 -0.393 . . . . 4.0899999999999999 110.078 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.513 HG11 ' SD ' ' A' ' 135' ' ' MET . 16.1 m -136.41 134.4 49.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.984 0.421 . . . . 2.1499999999999999 111.504 -177.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -113.72 140.51 48.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.199 -0.455 . . . . 2.5600000000000001 109.832 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 78.6 m -128.42 118.63 23.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.163 -0.471 . . . . 1.78 109.936 175.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -120.68 120.16 34.9 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.774 -0.454 . . . . 2.04 109.774 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 130' ' ' ASN . 27.0 m -108.3 119.93 40.92 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.669 -0.696 . . . . 2.0299999999999998 110.026 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.97 111.81 4.33 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.92 -0.872 . . . . 1.0800000000000001 110.92 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 91.7 mt -104.23 129.98 52.03 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 110.263 -0.273 . . . . 2.9300000000000002 110.263 -176.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 65.9 tt0 -114.92 113.55 24.31 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.832 -0.433 . . . . 3.02 109.832 176.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -115.65 130.57 56.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.573 -0.74 . . . . 4.7599999999999998 109.458 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -92.58 90.18 7.02 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.404 0.621 . . . . 1.8200000000000001 109.907 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -60.24 -49.62 76.88 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.934 -1.03 . . . . 3.27 111.715 -171.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.437 ' C ' ' H ' ' A' ' 165' ' ' THR . 17.4 m120 -99.87 2.62 44.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.381 -0.372 . . . . 2.4100000000000001 110.353 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 71.88 -36.11 0.35 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.356 -0.838 . . . . 2.5800000000000001 111.263 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.437 ' H ' ' C ' ' A' ' 163' ' ' ASN . 21.8 p -75.36 -34.97 61.19 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.859 0.362 . . . . 2.6000000000000001 111.206 174.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.9 m -121.08 140.56 44.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 120.94 0.4 . . . . 2.0600000000000001 110.734 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 161' ' ' THR . . . -107.74 139.94 41.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.928 -0.578 . . . . 1.8400000000000001 111.237 -175.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 159' ' ' GLN . 17.9 mt -104.53 125.59 50.84 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.429 -0.582 . . . . 2.1400000000000001 109.429 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -109.22 115.72 30.54 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.727 -0.472 . . . . 3.73 109.727 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.0 132.09 65.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.063 0.459 . . . . 1.8100000000000001 110.855 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.471 ' O ' ' HB ' ' A' ' 194' ' ' ILE . 3.2 m-20 -107.23 122.57 46.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.048 0.451 . . . . 2.2400000000000002 111.025 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -98.28 121.51 40.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.512 -0.767 . . . . 4.8399999999999999 110.052 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -99.49 120.42 39.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.953 0.406 . . . . 4.4299999999999997 110.119 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 63.9 tp -104.91 129.14 53.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.806 -0.634 . . . . 2.8500000000000001 110.95 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -98.68 138.63 35.57 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.641 -0.874 . . . . 3.3100000000000001 108.641 175.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -60.25 -39.92 88.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.992 0.425 . . . . 7.3300000000000001 110.842 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -110.01 -159.03 17.41 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.866 -0.683 . . . . 5.0599999999999996 111.826 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -133.84 51.17 2.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.015 0.436 . . . . 8.0199999999999996 109.859 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -157.55 122.17 4.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 9.4900000000000002 110.445 -175.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 75.9 mtm -95.55 139.98 31.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.101 0.477 . . . . 11.1 110.608 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -62.05 -40.01 94.31 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.041 -0.982 . . . . 10.470000000000001 113.448 -169.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -73.66 117.2 15.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.931 0.396 . . . . 13.06 111.211 -172.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 13.2 p -104.0 -0.04 29.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.857 -0.611 . . . . 12.890000000000001 110.779 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -70.01 -40.0 75.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.425 0.631 . . . . 15.720000000000001 110.368 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -99.09 148.2 24.29 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.071 -0.968 . . . . 13.470000000000001 110.604 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -64.17 137.7 58.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.282 -0.636 . . . . 13.15 109.282 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -170.86 137.36 4.38 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 119.563 -1.304 . . . . 10.050000000000001 113.561 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.2 145.59 51.34 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.99 -0.745 . . . . 10.699999999999999 108.99 170.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -70.07 -34.06 72.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 11.34 111.341 -172.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 53.0 m -125.05 130.07 51.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.753 0.311 . . . . 6.7800000000000002 110.277 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 9.9 t -158.2 154.77 27.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.328 -0.396 . . . . 5.3600000000000003 110.722 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.524 ' O ' ' HB3' ' A' ' 216' ' ' ASP . 48.7 tt0 -120.0 114.2 21.66 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.929 -0.578 . . . . 7.8700000000000001 109.721 175.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -140.77 111.05 6.68 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.554 -0.535 . . . . 4.4000000000000004 109.554 172.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 171' ' ' ASN . 28.5 pt -120.09 169.1 11.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.761 -0.654 . . . . 2.6400000000000001 111.062 -172.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -101.68 119.94 39.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.85 -0.614 . . . . 4.1100000000000003 110.553 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -112.87 129.44 56.46 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.512 -0.551 . . . . 1.76 109.512 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 209' ' ' PRO . 31.1 p90 -145.42 149.93 35.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.264 0.554 . . . . 6.1399999999999997 111.528 -178.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.9 mp -112.26 127.74 26.44 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.689 -0.687 . . . . 3.0800000000000001 110.279 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.22 106.23 1.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.287 1.991 . . . . 1.98 111.581 175.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 89.9 mt -114.47 140.09 49.0 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.941 -0.572 . . . . 2.7599999999999998 109.93 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 94.0 m -119.93 130.05 54.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.126 0.488 . . . . 2.4199999999999999 111.134 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.1 mt -129.8 80.29 1.95 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.533 -0.914 . . . . 2.77 108.533 173.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 70.06 -120.96 9.96 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.863 -0.684 . . . . 1.6200000000000001 111.78 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -91.87 -0.03 57.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.259 0.552 . . . . 2.8599999999999999 109.536 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -93.67 118.98 32.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.327 -0.852 . . . . 3.23 109.291 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 47.6 m -104.62 131.97 51.42 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.782 -0.451 . . . . 2.0499999999999998 109.782 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 63.2 t -120.07 130.03 74.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.908 -0.405 . . . . 1.9299999999999999 109.908 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 48.1 m -138.1 94.65 11.04 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 116.503 -0.317 . . . . 1.6699999999999999 110.987 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.413 ' O ' ' HA ' ' A' ' 197' ' ' TYR . 16.5 Cg_exo -69.17 131.22 21.6 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.525 2.15 . . . . 1.28 111.635 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -108.43 139.97 42.4 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.823 -0.436 . . . . 4.8600000000000003 109.823 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 11.1 t -168.53 166.93 11.9 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.191 -0.459 . . . . 2.0899999999999999 110.426 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -98.97 139.87 33.97 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.048 -1.093 . . . . 5.29 108.048 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.457 ' HB ' ' OD2' ' A' ' 216' ' ' ASP . 83.7 mt -59.85 -40.2 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.03 0.443 . . . . 4.9400000000000004 110.871 -175.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 104.4 -30.28 10.42 Favored Glycine 0 CA--C 1.507 -0.438 0 C-N-CA 120.698 -0.763 . . . . 4.9800000000000004 111.908 176.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.1 tp -69.89 -24.01 63.33 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.922 -0.77 . . . . 8.4399999999999995 108.922 172.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.524 ' HB3' ' O ' ' A' ' 192' ' ' GLN . 17.0 m-20 -59.93 -50.06 75.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.638 -1.164 . . . . 7.9699999999999998 110.39 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -157.8 136.19 11.1 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.096 -0.956 . . . . 11.1 108.776 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -98.8 110.6 23.18 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.105 0.479 . . . . 12.24 110.705 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 84.3 p -146.53 159.49 43.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.775 -0.648 . . . . 10.220000000000001 109.567 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 15.2 m120 60.06 38.45 20.58 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.666 0.603 . . . . 11.92 111.179 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -61.74 -41.33 97.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.654 -0.703 . . . . 14.460000000000001 109.681 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -142.12 -179.61 6.34 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.13 -0.941 . . . . 14.529999999999999 109.251 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -75.16 99.11 3.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.394 0.616 . . . . 17.07 111.974 -175.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -70.03 147.95 49.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.925 -1.034 . . . . 15.779999999999999 109.569 175.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -100.09 14.05 32.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.821 0.343 . . . . 15.67 110.957 -177.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -67.01 150.19 49.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.887 -0.597 . . . . 14.5 110.934 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 10.7 tp -79.25 -7.58 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.738 0.78 . . . . 15.380000000000001 110.423 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 62.06 51.4 3.64 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.612 -1.176 . . . . 14.73 113.076 174.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -61.5 -34.22 75.13 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.044 -0.725 . . . . 16.969999999999999 109.044 171.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -63.6 -39.91 95.59 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.047 -0.978 . . . . 12.779999999999999 110.759 175.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 90.09 -12.7 66.92 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.974 -0.557 . . . . 11.369999999999999 114.239 173.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 25.6 m80 59.97 39.89 19.54 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 117.225 0.513 . . . . 12.81 111.346 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.8 -40.18 87.46 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.202 0.445 . . . . 9.9900000000000002 112.202 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -68.77 -39.85 80.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.669 0.271 . . . . 11.32 111.275 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -82.15 78.28 8.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.361 0.601 . . . . 6.8799999999999999 109.53 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -119.14 135.93 54.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.567 -0.742 . . . . 8.9399999999999995 110.913 -176.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.03 159.99 41.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.337 -0.616 . . . . 2.9700000000000002 109.337 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 172.43 177.03 41.59 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.024 -1.084 . . . . 1.3999999999999999 112.995 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 83.0 mt -120.04 129.97 54.48 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.104 -0.332 . . . . 2.4300000000000002 110.104 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -101.45 133.64 45.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.061 -0.348 . . . . 4.3300000000000001 110.061 175.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -120.08 139.96 51.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.061 -0.518 . . . . 3.2599999999999998 110.262 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 251' ' ' VAL . . . -127.13 132.16 7.49 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.251 -0.739 . . . . 1.3500000000000001 111.251 176.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 250' ' ' SER . 91.3 m-85 -120.83 144.24 48.45 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.067 -0.346 . . . . 4.7599999999999998 110.067 -177.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 56.5 40.04 29.69 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.846 0.716 . . . . 4.29 110.507 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -62.72 -40.11 96.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.534 -0.757 . . . . 7.5599999999999996 110.867 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -111.21 129.99 55.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.636 -0.256 . . . . 7.0199999999999996 111.289 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 55.51 39.92 31.11 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.704 -0.68 . . . . 6.4800000000000004 112.229 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -161.82 -174.44 31.7 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.521 -0.632 . . . . 2.9199999999999999 111.521 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 86.2 mt -89.1 109.1 20.0 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.863 -0.791 . . . . 3.5800000000000001 108.863 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 243' ' ' TYR . 17.7 m -78.88 130.92 36.17 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.113 0.482 . . . . 2.6000000000000001 111.26 -169.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.41 ' O ' ' HA2' ' A' ' 242' ' ' GLY . 62.9 t -107.57 133.24 52.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.667 -0.697 . . . . 2.2400000000000002 109.78 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 3.0 p -108.3 113.28 26.25 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.064 0.459 . . . . 2.0 110.485 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 64.8 tp -119.57 115.73 24.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.087 -0.506 . . . . 3.4199999999999999 110.635 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -101.77 115.47 30.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.181 -0.463 . . . . 4.0800000000000001 110.371 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' TYR . . . . . 0.517 ' CE1' ' HA ' ' A' ' 257' ' ' PHE . 61.0 t80 -106.21 120.04 40.81 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 110.259 -0.275 . . . . 5.1699999999999999 110.259 175.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -80.04 123.34 27.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.487 -0.931 . . . . 3.5800000000000001 108.487 172.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . 0.517 ' HA ' ' CE1' ' A' ' 255' ' ' TYR . 49.2 t80 -71.32 118.46 14.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.859 0.361 . . . . 7.5800000000000001 110.546 -171.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -96.93 123.46 40.65 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 116.005 -0.543 . . . . 8.5399999999999991 110.151 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -80.05 155.65 27.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.756 -0.656 . . . . 12.720000000000001 111.218 -175.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -86.31 129.99 34.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.769 -0.65 . . . . 11.09 109.606 177.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -84.64 170.03 13.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.044 -0.526 . . . . 11.41 110.006 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -100.92 -18.09 16.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.613 -0.267 . . . . 12.49 111.216 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -85.22 122.9 30.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.407 0.623 . . . . 12.460000000000001 110.432 177.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.4 -40.1 93.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.716 -1.129 . . . . 13.779999999999999 111.674 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -60.32 119.37 18.19 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.105 -0.569 . . . . 11.300000000000001 112.671 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -61.45 132.24 52.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.292 0.567 . . . . 12.59 111.546 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 21.2 m -125.61 143.45 51.02 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.555 -0.748 . . . . 11.1 109.004 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.66 120.09 14.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.983 0.421 . . . . 12.42 109.929 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -119.58 140.08 51.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.784 -0.643 . . . . 11.82 110.113 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -80.67 129.33 34.46 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.217 0.532 . . . . 9.5999999999999996 110.319 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -98.1 133.19 42.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.51 -0.768 . . . . 7.7999999999999998 109.936 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -130.07 129.63 43.85 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.04 0.448 . . . . 6.9900000000000002 110.935 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -151.84 173.67 14.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.582 -0.735 . . . . 2.4100000000000001 109.617 174.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.35 137.57 9.54 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.937 -0.649 . . . . 1.6200000000000001 111.659 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 61.9 t -129.4 129.97 67.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.953 0.406 . . . . 2.4900000000000002 110.874 -175.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -152.44 163.66 30.36 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.873 -0.603 . . . . 1.3 111.686 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.19 140.01 32.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.885 0.374 . . . . 2.3399999999999999 110.163 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -113.5 127.01 55.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.196 0.522 . . . . 2.7999999999999998 110.929 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.484 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 65.0 t80 -105.96 124.71 50.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.655 -0.702 . . . . 5.1900000000000004 109.402 176.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 7.7 p -117.44 130.51 56.51 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.037 0.446 . . . . 2.0499999999999998 110.858 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 59.2 t80 . . . . . 0 C--O 1.244 0.783 0 CA-C-O 118.508 -0.758 . . . . 4.4199999999999999 109.084 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.4 mtp . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 120.689 0.28 . . . . 11.970000000000001 110.692 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -132.4 148.34 52.41 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.361 -0.607 . . . . 10.35 109.361 175.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -111.68 149.19 31.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.059 0.457 . . . . 9.3100000000000005 110.493 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -83.13 0.28 45.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.805 -0.634 . . . . 9.4399999999999995 111.092 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -126.72 140.71 52.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.067 -0.515 . . . . 7.75 110.001 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.51 118.75 22.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.351 -0.386 . . . . 3.6099999999999999 111.059 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -96.93 108.2 20.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.6 -0.889 . . . . 3.9100000000000001 108.6 171.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -110.7 137.16 48.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.341 0.591 . . . . 3.9399999999999999 111.778 -175.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -125.21 142.89 51.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.619 -1.173 . . . . 3.21 109.536 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -120.98 129.99 53.64 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.962 -0.384 . . . . 2.6499999999999999 109.962 176.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.7 mt -120.03 122.52 68.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.921 -0.581 . . . . 2.0699999999999998 109.919 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.38 142.1 13.53 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 119.799 -1.191 . . . . 0.92000000000000004 112.601 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.26 136.23 53.19 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.624 -0.509 . . . . 1.6499999999999999 109.624 176.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 70.1 mtm -127.75 151.28 49.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.184 -0.462 . . . . 2.9700000000000002 110.944 -175.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 33' ' ' PRO . 59.3 m-85 -129.93 138.25 50.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.251 -0.886 . . . . 3.1499999999999999 108.69 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 59.87 48.68 8.68 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.124 0.488 . . . . 5.0899999999999999 110.049 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.6 tp -70.02 -40.05 78.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.554 0.576 . . . . 5.3300000000000001 112.554 -169.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.548 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 36.4 tt0 -149.97 117.19 6.02 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.516 -0.473 . . . . 8.2799999999999994 110.897 -174.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -126.95 151.36 48.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.313 0.577 . . . . 10.0 111.29 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 26' ' ' ASP . 62.7 t -129.97 135.74 60.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.459 -0.941 . . . . 11.380000000000001 108.459 176.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.92 -38.67 83.01 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.442 -0.799 . . . . 13.1 112.246 -169.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.87 86.82 0.15 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 119.654 -1.26 . . . . 12.52 113.977 174.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -69.96 -39.4 76.03 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.022 -1.103 . . . . 15.18 108.022 168.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -136.84 -89.3 0.24 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 109.621 -1.392 . . . . 12.279999999999999 109.621 172.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -128.61 96.72 4.47 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.751 -0.833 . . . . 12.82 108.751 168.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.407 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 15.9 m-20 -100.02 0.09 40.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.89 -0.595 . . . . 10.81 111.026 -177.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 70.3 mtm 60.15 47.09 9.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.978 -1.01 . . . . 10.210000000000001 111.747 175.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -59.97 -39.99 87.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.827 -0.624 . . . . 8.0600000000000005 111.339 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.11 18.1 24.17 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.756 -0.735 . . . . 6.0800000000000001 113.104 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.2 tp -137.83 131.16 30.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.901 0.351 . . . . 5.96 110.404 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.07 161.95 36.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.6 -0.273 . . . . 3.2400000000000002 111.052 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.426 ' CD ' ' HG ' ' A' ' 34' ' ' SER . 0.4 OUTLIER -132.48 159.63 71.57 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.525 -0.307 . . . . 3.48 110.552 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.429 ' HB3' ' CE1' ' A' ' 15' ' ' TYR . 87.8 Cg_endo -90.09 133.2 1.97 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.627 2.218 . . . . 2.0299999999999998 113.192 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.426 ' HG ' ' CD ' ' A' ' 32' ' ' GLU . 7.2 m -140.03 162.7 34.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.984 0.421 . . . . 2.2799999999999998 111.619 176.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -125.19 134.91 65.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.791 -0.64 . . . . 2.4100000000000001 110.775 -177.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -113.07 162.23 16.16 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.321 -0.622 . . . . 4.4400000000000004 109.321 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -139.87 146.72 39.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.056 0.455 . . . . 3.6200000000000001 111.231 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.597 ' OD1' ' HD3' ' A' ' 45' ' ' ARG . 11.3 p30 -151.4 160.86 43.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.773 -0.649 . . . . 2.48 109.526 174.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.15 155.28 39.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.49 -0.323 . . . . 1.53 110.576 -178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.37 146.03 16.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.369 -0.378 . . . . 1.8 110.8 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.607 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 6.1 p-10 -167.08 94.73 0.47 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.773 -0.649 . . . . 3.3799999999999999 109.787 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.95 -94.07 1.95 Allowed Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 111.114 -0.794 . . . . 1.8200000000000001 111.114 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.607 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 77.0 Cg_exo -52.24 174.03 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.385 2.723 . . . . 2.1000000000000001 113.092 168.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.484 ' HB2' ' O ' ' A' ' 75' ' ' HIS . 48.9 p90 -70.07 -176.89 1.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.742 -0.663 . . . . 4.0499999999999998 112.155 -170.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.597 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 18.0 ttm180 -113.69 129.41 56.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.908 -0.587 . . . . 3.6000000000000001 111.29 -168.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.9 mt -113.22 129.92 68.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.37 -0.832 . . . . 2.2799999999999998 110.274 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.491 ' O ' HD11 ' A' ' 72' ' ' LEU . . . -118.9 132.14 56.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.492 -0.322 . . . . 1.4399999999999999 110.576 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.5 tp -124.23 131.0 53.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.777 0.322 . . . . 1.75 110.413 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.37 160.87 42.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.846 -0.616 . . . . 1.5900000000000001 110.349 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -120.03 139.96 51.72 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.4 -0.593 . . . . 4.4400000000000004 109.4 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.548 ' CE2' ' HB3' ' A' ' 18' ' ' GLU . 45.4 t80 -98.89 128.16 45.0 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.651 0.738 . . . . 5.0199999999999996 111.808 -175.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -150.02 155.06 39.24 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.392 -1.707 . . . . 3.7400000000000002 106.392 171.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -148.85 119.32 7.39 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.393 -0.595 . . . . 5.0499999999999998 109.393 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.04 -118.52 4.87 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.851 -0.69 . . . . 4.3700000000000001 112.347 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.96 150.34 66.85 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.822 2.348 . . . . 7.0899999999999999 112.79 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -129.19 130.55 67.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.853 -0.612 . . . . 8.5700000000000003 110.307 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -70.59 -29.47 65.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.128 -0.487 . . . . 10.039999999999999 110.892 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -60.41 -15.04 22.51 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.462 0.542 . . . . 11.890000000000001 112.462 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.3 p -68.35 -19.85 64.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.855 0.359 . . . . 9.7899999999999991 110.879 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.35 128.32 55.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.351 -0.386 . . . . 8.7799999999999994 110.786 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.14 55.26 4.95 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.103 -0.799 . . . . 7.7300000000000004 111.103 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -127.08 158.95 35.64 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.962 0.41 . . . . 10.300000000000001 110.645 -173.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -92.2 120.18 32.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.793 -0.64 . . . . 10.960000000000001 109.998 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.47 -151.3 7.61 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.511 -0.852 . . . . 5.5599999999999996 112.057 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.2 p -82.59 140.7 33.08 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.699 0.285 . . . . 5.6900000000000004 110.864 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -120.23 134.18 55.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.416 -0.587 . . . . 6.5 109.416 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -119.1 119.95 35.72 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.58 -0.526 . . . . 4.5999999999999996 109.58 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -159.36 169.27 24.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.116 0.484 . . . . 2.4500000000000002 110.912 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.511 ' HG3' ' O ' ' A' ' 94' ' ' ASN . 41.5 ttp180 -149.87 123.24 4.43 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 115.293 -0.867 . . . . 3.7200000000000002 109.602 171.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.644 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 71.4 Cg_endo -79.81 140.56 14.66 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.292 1.995 . . . . 1.3200000000000001 110.733 169.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.523 ' CD ' ' HE ' ' A' ' 93' ' ' ARG . 72.2 tt0 -135.87 124.66 23.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.332 0.587 . . . . 2.1899999999999999 110.699 -178.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.491 HD11 ' O ' ' A' ' 47' ' ' ALA . 41.0 tp -120.17 130.02 54.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.408 -0.814 . . . . 1.73 109.994 -178.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -125.04 128.02 47.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.019 0.438 . . . . 2.1800000000000002 110.1 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.03 129.93 74.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.172 -0.467 . . . . 2.0600000000000001 110.743 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.484 ' O ' ' HB2' ' A' ' 44' ' ' TRP . 64.4 m170 -116.61 120.08 37.53 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.786 0.327 . . . . 4.1900000000000004 110.636 177.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -114.45 124.13 51.16 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.82 -0.627 . . . . 5.1600000000000001 109.38 174.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -119.55 137.97 53.49 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.27 -0.27 . . . . 3.3100000000000001 110.27 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -134.54 130.31 36.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.931 0.396 . . . . 4.6600000000000001 110.269 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.4 tp -106.69 119.99 40.78 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.405 -0.591 . . . . 4.8799999999999999 109.405 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -97.18 168.93 10.14 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.044 -0.354 . . . . 6.1900000000000004 110.044 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -60.08 -43.43 95.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.713 0.292 . . . . 6.0999999999999996 111.305 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 84' ' ' PHE . 18.8 m-20 -74.48 164.6 26.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 5.2699999999999996 110.785 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -75.98 36.52 0.14 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.297 -0.411 . . . . 6.3300000000000001 112.053 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.421 ' H ' ' C ' ' A' ' 82' ' ' ASP . 87.1 m-85 -119.94 140.02 51.54 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.186 -0.672 . . . . 8.3499999999999996 109.186 174.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 120' ' ' ASP . 47.8 m -124.67 149.43 47.18 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.995 0.426 . . . . 2.6400000000000001 110.651 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -147.78 161.4 41.31 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.626 -0.509 . . . . 6.1900000000000004 109.626 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.61 176.94 34.62 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.463 -0.875 . . . . 1.54 112.04 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 92.3 mt -127.69 123.92 36.63 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.118 -0.327 . . . . 2.73 110.118 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.2 m -119.93 130.02 54.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.138 -0.483 . . . . 1.8700000000000001 110.528 176.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -137.07 144.69 16.35 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.804 -0.713 . . . . 1.1699999999999999 111.768 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -137.66 143.98 15.23 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.987 -0.625 . . . . 1.4399999999999999 112.112 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -130.48 130.0 43.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.871 0.367 . . . . 4.6399999999999997 110.753 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.523 ' HE ' ' CD ' ' A' ' 71' ' ' GLU . 99.3 mtt180 -130.29 127.36 39.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.738 -0.665 . . . . 3.2200000000000002 109.809 175.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.644 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 61.2 t30 -111.27 117.95 34.57 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.441 -0.577 . . . . 2.2200000000000002 109.441 174.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -106.54 125.31 50.84 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.564 -0.289 . . . . 3.6400000000000001 110.881 -172.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.77 109.99 2.92 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.0 -1.095 . . . . 2.79 111.584 175.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -85.48 119.27 25.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.027 0.441 . . . . 7.8499999999999996 109.817 -177.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -109.98 98.22 7.56 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.999 -0.546 . . . . 7.6900000000000004 109.787 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.519 ' CD1' HG12 ' A' ' 100' ' ' VAL . 60.8 t80 -60.23 -50.14 74.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.89 -0.596 . . . . 10.289999999999999 111.522 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.519 HG12 ' CD1' ' A' ' 99' ' ' TYR . 34.3 m -131.93 161.13 41.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.527 -0.306 . . . . 10.19 110.83 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -89.03 10.61 20.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 12.220000000000001 111.465 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -82.96 120.03 75.39 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.518 -0.31 . . . . 10.48 110.689 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -70.07 150.02 65.72 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.602 2.201 . . . . 9.6799999999999997 111.997 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.8 15.45 39.64 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.815 -0.707 . . . . 6.5099999999999998 111.574 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -121.96 139.59 53.48 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.608 -0.516 . . . . 8.1099999999999994 109.608 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -65.17 136.45 56.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.994 0.426 . . . . 4.1399999999999997 110.842 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 m -87.97 157.88 18.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.793 -0.64 . . . . 3.77 109.874 178.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.29 157.8 25.46 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.451 -0.203 . . . . 2.2000000000000002 110.451 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -119.91 126.73 51.63 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.643 0.735 . . . . 3.1200000000000001 111.163 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.448 ' HE2' ' HB1' ' A' ' 139' ' ' ALA . 88.7 mtp -104.7 117.96 35.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.308 -0.86 . . . . 2.1200000000000001 109.491 176.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.536 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 96.5 mt-30 -94.2 118.44 31.56 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.503 -0.479 . . . . 2.4900000000000002 110.911 -174.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 84.4 mtt180 -105.5 115.94 31.1 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.012 -0.54 . . . . 4.4699999999999998 109.683 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 35.5 t-105 -118.35 120.8 38.69 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.999 -0.741 . . . . 2.9199999999999999 108.999 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -126.32 130.01 49.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.445 -0.343 . . . . 2.5099999999999998 110.719 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.2 pt -132.59 144.51 36.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.89 0.376 . . . . 2.1299999999999999 110.953 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.47 123.84 3.17 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.775 -0.648 . . . . 1.6799999999999999 110.351 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.6 130.52 3.8 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.459 2.106 . . . . 1.54 111.059 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -80.04 137.41 36.79 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.712 -0.477 . . . . 2.3500000000000001 109.712 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -132.91 128.41 36.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.008 0.432 . . . . 5.1500000000000004 111.496 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 85' ' ' SER . 0.8 OUTLIER -103.57 110.26 22.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.795 -0.638 . . . . 3.04 109.461 171.172 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.73 119.98 61.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.145 0.498 . . . . 4.7400000000000002 110.817 -175.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -102.7 84.53 2.42 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.303 0.573 . . . . 6.3600000000000003 110.137 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.02 -39.98 75.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.261 -0.881 . . . . 4.96 111.598 -177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 81.5 m -123.8 139.18 54.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.073 -0.512 . . . . 4.0700000000000003 110.443 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -59.94 140.05 56.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.816 -0.629 . . . . 5.1699999999999999 111.272 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 66.1 14.31 9.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.271 -0.877 . . . . 3.71 111.964 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.6 mt -131.85 148.94 52.58 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.486 -0.561 . . . . 2.4500000000000002 109.486 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -130.81 137.58 49.49 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.719 -0.392 . . . . 4.6799999999999997 110.057 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -127.01 128.28 46.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.188 -0.46 . . . . 4.3600000000000003 109.78 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -119.77 129.91 54.7 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.473 -0.566 . . . . 2.5899999999999999 109.473 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -160.91 161.19 32.65 Favored Glycine 0 CA--C 1.504 -0.647 0 C-N-CA 119.908 -1.139 . . . . 1.25 112.108 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -145.13 149.81 35.66 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.994 0.426 . . . . 5.0899999999999999 110.942 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.9 tp -101.34 120.98 41.09 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.925 -0.769 . . . . 2.7599999999999998 108.925 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.3 t -113.48 136.74 52.46 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.772 -0.649 . . . . 1.99 111.099 -172.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 67.3 mtm -140.0 140.2 36.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.803 -0.635 . . . . 2.7799999999999998 109.727 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -145.29 156.52 43.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.271 0.558 . . . . 3.6800000000000002 111.555 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 62.2 mttp -130.95 157.0 44.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.879 -1.055 . . . . 2.1699999999999999 108.904 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.536 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 48.1 p90 -142.2 163.78 31.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.645 -0.252 . . . . 4.0099999999999998 110.425 -175.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.448 ' HB1' ' HE2' ' A' ' 110' ' ' MET . . . 65.09 -172.5 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.948 -0.569 . . . . 1.79 111.154 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -76.79 -47.34 21.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.169 0.509 . . . . 3.04 110.89 174.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -60.17 -45.59 92.58 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.196 -0.911 . . . . 2.4100000000000001 113.455 -167.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 138' ' ' PHE . 3.1 mm? -62.02 -39.99 94.17 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.185 0.517 . . . . 2.3599999999999999 110.561 -176.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -67.36 -39.86 85.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.635 -0.711 . . . . 2.52 110.551 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.4 m -62.73 -44.36 96.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.675 -0.693 . . . . 2.52 112.008 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 31.0 p -76.87 -19.9 56.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.992 0.425 . . . . 2.0099999999999998 111.156 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.21 -125.86 21.96 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.789 -0.641 . . . . 1.52 113.196 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -65.73 -19.39 65.88 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.647 0.24 . . . . 6.2199999999999998 111.647 -174.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.43 98.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.424 -0.353 . . . . 2.0499999999999998 111.675 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.495 ' O ' ' HE3' ' A' ' 137' ' ' LYS . 68.1 m-20 -119.69 117.18 27.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.044 0.45 . . . . 2.6400000000000001 110.572 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.4 t -154.3 153.92 32.5 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.863 -0.421 . . . . 2.6000000000000001 109.863 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -108.27 140.06 42.07 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.742 -0.466 . . . . 4.0899999999999999 109.742 175.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.88 119.97 59.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.149 0.5 . . . . 2.1499999999999999 110.295 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -119.63 130.43 55.09 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.363 -0.835 . . . . 2.5600000000000001 109.122 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 21.8 m -129.54 129.79 44.94 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 121.923 -0.486 . . . . 1.78 111.267 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -128.76 128.9 44.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.12 -0.491 . . . . 2.04 109.849 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 27.2 p -130.32 140.3 50.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.074 -0.512 . . . . 2.0299999999999998 110.773 -177.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -125.63 122.44 4.55 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.599 -0.601 . . . . 1.0800000000000001 111.599 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.9 mt -102.29 128.25 48.92 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.988 -0.375 . . . . 2.9300000000000002 109.988 -176.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -107.66 111.05 23.08 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.617 -0.433 . . . . 3.02 110.379 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.98 139.8 51.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.737 -0.665 . . . . 4.7599999999999998 109.75 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 164' ' ' GLU . 18.0 p -100.75 102.22 13.26 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.187 0.518 . . . . 1.8200000000000001 110.368 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -60.01 -48.51 81.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.289 -0.869 . . . . 3.27 110.992 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.405 ' C ' ' H ' ' A' ' 165' ' ' THR . 21.5 m120 -102.64 9.77 39.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.336 -0.393 . . . . 2.4100000000000001 110.553 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.452 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 42.6 tt0 72.13 -42.93 0.55 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.597 0.759 . . . . 2.5800000000000001 111.131 -175.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.405 ' H ' ' C ' ' A' ' 163' ' ' ASN . 25.5 p -74.79 -24.44 58.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.448 -0.342 . . . . 2.6000000000000001 111.816 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.4 m -125.09 140.44 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.403 -0.362 . . . . 2.0600000000000001 110.627 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.06 130.57 54.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.15 0.5 . . . . 1.8400000000000001 111.389 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 21.9 mt -104.26 136.33 44.06 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.556 -0.905 . . . . 2.1400000000000001 108.556 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -114.07 113.45 24.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.169 0.509 . . . . 3.73 110.7 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 63.2 t -115.05 120.11 63.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.5 -0.773 . . . . 1.8100000000000001 110.217 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -104.69 124.08 48.74 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.01 0.433 . . . . 2.2400000000000002 110.773 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -105.17 130.39 53.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.785 -0.643 . . . . 4.8399999999999999 109.821 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.436 ' CE2' ' HD3' ' A' ' 195' ' ' ARG . 68.2 m-85 -110.99 136.65 49.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.971 -0.558 . . . . 4.4299999999999997 110.468 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 61.5 tp -122.39 118.51 28.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.21 -0.45 . . . . 2.8500000000000001 110.398 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -120.11 179.98 4.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.889 -0.596 . . . . 3.3100000000000001 109.695 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 -67.11 -39.94 86.78 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.884 -0.326 . . . . 7.3300000000000001 111.042 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 66.45 78.33 0.25 Allowed Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.646 -0.788 . . . . 5.0599999999999996 112.643 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -70.05 -39.88 75.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.859 0.361 . . . . 8.0199999999999996 111.145 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -120.34 144.93 47.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.182 -0.463 . . . . 9.4900000000000002 110.285 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 70.6 mtm -120.4 -4.03 9.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.306 0.575 . . . . 11.1 109.668 171.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -122.83 35.38 4.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.127 -0.942 . . . . 10.470000000000001 111.112 -174.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -60.0 -40.09 88.03 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.246 -0.434 . . . . 13.06 110.487 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 59.6 m -130.46 135.81 48.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.818 -0.628 . . . . 12.890000000000001 109.881 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 83.7 mtm-85 -70.08 -28.59 65.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.49 . . . . 15.720000000000001 110.13 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -97.81 115.27 27.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.711 -0.677 . . . . 13.470000000000001 109.41 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -80.31 141.98 34.95 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.045 -0.525 . . . . 13.15 110.937 -174.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 102.12 -9.48 56.37 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.711 -0.757 . . . . 10.050000000000001 112.738 178.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.44 -39.88 92.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.864 0.364 . . . . 10.699999999999999 111.084 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -118.29 139.06 51.91 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.743 -0.465 . . . . 11.34 109.743 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.485 ' OG ' ' HD2' ' A' ' 212' ' ' ARG . 4.7 t -95.48 111.4 23.3 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.135 0.493 . . . . 6.7800000000000002 109.984 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.2 p -76.33 -18.77 58.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.693 -0.685 . . . . 5.3600000000000003 111.143 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 59.56 34.68 22.47 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 114.895 -1.048 . . . . 7.8700000000000001 111.052 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -60.06 -40.8 90.71 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.747 -0.661 . . . . 4.4000000000000004 111.251 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' A' ' 213' ' ' ILE . 86.4 mt -120.3 120.0 61.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.347 -0.388 . . . . 2.6400000000000001 110.395 176.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.436 ' HD3' ' CE2' ' A' ' 173' ' ' TYR . 69.4 mtp180 -111.58 116.62 31.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.242 -0.651 . . . . 4.1100000000000003 109.242 177.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -120.0 138.97 53.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.839 0.352 . . . . 1.76 111.048 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -160.02 159.99 32.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.902 -0.59 . . . . 6.1399999999999997 110.425 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -129.14 128.43 23.31 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.377 -0.374 . . . . 3.0800000000000001 110.116 178.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.83 133.04 11.08 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.414 2.076 . . . . 1.98 112.359 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 56.9 tp -135.66 131.14 35.35 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.027 -0.731 . . . . 2.7599999999999998 109.027 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 33.3 m -120.05 130.08 54.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.701 0.286 . . . . 2.4199999999999999 110.548 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 58.3 tp -137.69 86.04 2.16 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.575 -0.528 . . . . 2.77 109.575 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 69.93 -120.89 10.05 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.822 -0.704 . . . . 1.6200000000000001 112.52 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -90.27 2.55 55.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 2.8599999999999999 110.248 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -112.65 130.08 56.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.099 -0.501 . . . . 3.23 110.491 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 68.3 m -115.32 136.93 52.58 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.951 -0.568 . . . . 2.0499999999999998 109.73 173.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 45.9 t -119.93 130.01 74.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.751 -0.463 . . . . 1.9299999999999999 109.751 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.9 m -137.61 95.41 11.27 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-O 120.582 0.229 . . . . 1.6699999999999999 110.57 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.67 130.05 19.96 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.217 1.945 . . . . 1.28 110.659 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -110.79 138.66 46.9 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.287 -0.415 . . . . 4.8600000000000003 110.171 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 71.1 p -133.68 151.66 51.7 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.133 -0.485 . . . . 2.0899999999999999 110.067 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.485 ' HD2' ' OG ' ' A' ' 190' ' ' SER . 27.4 mtm180 -108.31 120.86 43.61 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.395 -0.595 . . . . 5.29 109.395 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.504 ' O ' ' HB ' ' A' ' 194' ' ' ILE . 48.6 mm -110.05 129.97 64.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.899 -0.408 . . . . 4.9400000000000004 109.899 -177.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -119.62 -129.26 3.84 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.805 -0.712 . . . . 4.9800000000000004 111.876 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 64.6 tp -131.84 136.01 47.15 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.83 -0.433 . . . . 8.4399999999999995 109.83 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -64.68 132.49 49.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.147 -0.479 . . . . 7.9699999999999998 110.2 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -69.8 -37.95 76.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.747 -0.66 . . . . 11.1 109.369 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -125.56 96.08 4.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.439 -0.8 . . . . 12.24 109.228 172.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 72.8 p -85.23 143.83 28.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.998 0.428 . . . . 10.220000000000001 110.672 -178.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 222' ' ' ASP . 94.8 m-20 -88.2 138.82 31.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.846 -0.616 . . . . 11.92 111.26 -177.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 26.7 m-90 -70.05 -36.39 74.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.436 -0.802 . . . . 14.460000000000001 109.158 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 220' ' ' ASN . 19.4 m-20 -116.0 127.52 54.99 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.962 -1.125 . . . . 14.529999999999999 107.962 170.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -83.92 37.82 0.62 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.059 0.457 . . . . 17.07 112.138 -170.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -124.09 114.53 19.83 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.349 -0.611 . . . . 15.779999999999999 109.349 174.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -91.36 166.89 12.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.595 -0.275 . . . . 15.67 110.696 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -62.04 -40.19 94.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.513 0.673 . . . . 14.5 110.054 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.534 HG23 ' H ' ' A' ' 230' ' ' GLU . 87.9 mt -120.13 129.95 74.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.359 -0.837 . . . . 15.380000000000001 109.549 177.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 232' ' ' HIS . 47.1 mt-10 -95.5 -28.52 14.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.689 -0.232 . . . . 14.73 111.043 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 -69.58 -40.1 76.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.774 0.321 . . . . 16.969999999999999 111.469 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.534 ' H ' HG23 ' A' ' 227' ' ' ILE . 50.3 mt-10 -103.68 141.71 35.59 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.827 -0.435 . . . . 12.779999999999999 109.827 178.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 89.98 -9.99 75.44 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.667 -0.778 . . . . 11.369999999999999 111.703 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 228' ' ' GLU . 15.7 m-70 -122.16 132.89 54.69 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.685 -0.857 . . . . 12.81 108.685 175.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -150.0 170.1 19.65 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.309 0.576 . . . . 9.9900000000000002 111.392 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -128.32 48.0 2.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.119 -0.946 . . . . 11.32 109.073 173.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -56.5 129.42 40.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.403 -0.817 . . . . 6.8799999999999999 111.65 -175.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.556 ' HD2' ' OE2' ' A' ' 258' ' ' GLU . 76.2 mtt180 -104.46 117.98 35.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.757 -0.656 . . . . 8.9399999999999995 110.141 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.429 HG21 ' HG3' ' A' ' 212' ' ' ARG . 54.2 t -69.93 -39.99 78.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.486 -0.779 . . . . 2.9700000000000002 110.942 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -162.06 155.11 26.27 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.429 -0.891 . . . . 1.3999999999999999 112.117 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 90.7 mt -112.83 126.24 55.23 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.708 -0.478 . . . . 2.4300000000000002 109.708 176.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -106.19 128.64 54.07 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.649 -0.5 . . . . 4.3300000000000001 109.649 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -119.93 139.97 51.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.247 -0.433 . . . . 3.2599999999999998 110.89 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -111.67 116.05 4.06 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.962 -0.855 . . . . 1.3500000000000001 110.962 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 250' ' ' SER . 59.1 t80 -112.06 114.87 27.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.492 0.187 . . . . 4.7599999999999998 110.884 -177.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -101.34 115.7 31.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.233 0.54 . . . . 4.29 110.074 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -61.1 -49.88 75.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.877 -1.056 . . . . 7.5599999999999996 110.895 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -177.34 78.35 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.177 -0.465 . . . . 7.0199999999999996 110.825 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 56.13 63.43 2.01 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.225 0.536 . . . . 6.4800000000000004 111.956 170.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 153.7 -42.73 0.63 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 119.829 -1.177 . . . . 2.9199999999999999 112.767 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 61.9 tp -99.21 108.69 21.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.875 0.369 . . . . 3.5800000000000001 110.021 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 243' ' ' TYR . 47.0 m -119.9 133.42 55.58 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.988 -0.551 . . . . 2.6000000000000001 110.227 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.9 t -119.34 133.06 67.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 116.017 -0.538 . . . . 2.2400000000000002 110.095 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 22.9 t -98.55 129.83 45.11 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.005 -0.739 . . . . 2.0 109.005 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 91.7 mt -118.86 128.42 54.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.314 -0.403 . . . . 3.4199999999999999 110.782 -176.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.421 ' HB2' ' H ' ' A' ' 274' ' ' GLY . 97.5 mt-10 -101.45 114.42 28.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.948 -0.569 . . . . 4.0800000000000001 109.8 176.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -120.3 140.03 51.84 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.849 -0.341 . . . . 5.1699999999999999 110.771 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -114.97 1.07 13.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.151 -0.477 . . . . 3.5800000000000001 110.425 175.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -110.12 129.89 55.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.034 -0.53 . . . . 7.5800000000000001 111.01 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.556 ' OE2' ' HD2' ' A' ' 236' ' ' ARG . 55.6 mt-10 -120.11 170.38 9.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.108 -0.496 . . . . 8.5399999999999991 110.329 173.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 92.8 t90 -64.91 -39.95 94.31 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.907 -0.775 . . . . 12.720000000000001 108.907 170.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -69.98 -40.32 75.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.0 -1.0 . . . . 11.09 112.01 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -132.05 147.82 52.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.32 -0.4 . . . . 11.41 110.142 -171.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -119.53 143.11 47.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.617 -0.265 . . . . 12.49 111.018 -171.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.03 139.97 57.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.966 -0.561 . . . . 12.460000000000001 110.626 176.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -125.22 150.45 46.99 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.327 -0.62 . . . . 13.779999999999999 109.327 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 70.21 36.7 71.34 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.455 -0.878 . . . . 11.300000000000001 111.833 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -59.96 -36.55 77.37 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 122.575 0.35 . . . . 12.59 111.856 -176.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 53.2 m -60.15 -39.89 87.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.845 0.355 . . . . 11.1 110.967 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -84.96 -21.79 29.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.237 -0.438 . . . . 12.42 111.257 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -89.61 94.02 9.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.275 0.56 . . . . 11.82 110.697 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -70.03 -40.02 75.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.395 -0.821 . . . . 9.5999999999999996 111.57 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -91.94 82.35 5.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.854 0.359 . . . . 7.7999999999999998 110.25 -176.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -69.99 -44.42 69.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.561 0.696 . . . . 6.9900000000000002 110.144 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -147.29 160.27 42.7 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.167 -0.924 . . . . 2.4100000000000001 110.112 -176.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.421 ' H ' ' HB2' ' A' ' 254' ' ' GLU . . . -132.69 149.86 19.61 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.338 -0.705 . . . . 1.6200000000000001 111.338 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.56 143.31 40.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.698 0.285 . . . . 2.4900000000000002 110.597 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -139.89 130.58 4.75 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 111.205 -0.758 . . . . 1.3 111.205 174.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 63.2 t -110.13 120.71 61.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.871 0.336 . . . . 2.3399999999999999 110.383 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -127.73 119.95 26.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.068 0.461 . . . . 2.7999999999999998 111.044 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -103.72 122.06 44.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.775 -0.648 . . . . 5.1900000000000004 109.266 175.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.7 t -111.34 129.69 55.92 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.069 -0.514 . . . . 2.0499999999999998 109.92 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 C--O 1.246 0.877 0 CA-C-O 118.407 -0.806 . . . . 4.4199999999999999 109.957 -179.379 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.6 t70 . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 120.923 0.392 . . . . 3.6099999999999999 111.092 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -99.64 130.45 45.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.331 -0.395 . . . . 3.3300000000000001 110.358 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -98.86 117.67 33.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.081 0.467 . . . . 3.2000000000000002 110.073 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -119.97 140.01 51.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.576 -0.738 . . . . 2.4900000000000002 110.569 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 14.3 t-20 -133.71 131.43 39.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.759 -0.655 . . . . 2.1299999999999999 110.2 174.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 84.7 mt -129.03 128.97 67.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.908 -0.587 . . . . 1.6000000000000001 109.577 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.08 135.61 11.77 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.482 -0.866 . . . . 0.88 111.347 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.02 135.33 54.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.082 0.441 . . . . 1.0800000000000001 110.516 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 94.6 mmm -136.99 149.97 47.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.757 -0.656 . . . . 2.3300000000000001 110.362 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.31 124.96 43.52 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.949 -0.76 . . . . 2.6099999999999999 108.949 174.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 N--CA 1.455 -0.219 0 C-N-CA 120.881 -0.327 . . . . 5.0899999999999999 111.101 -177.743 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HB2' ' HD2' ' A' ' 33' ' ' PRO . 11.9 pt-20 . . . . . 0 CA--C 1.53 0.203 0 N-CA-C 109.887 -0.412 . . . . 3.48 109.887 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 32' ' ' GLU . 31.7 Cg_endo -69.85 147.84 63.19 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 121.689 1.593 . . . . 1.8600000000000001 111.647 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.5 t -129.49 142.83 50.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.448 -0.342 . . . . 1.97 111.009 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.04 131.99 65.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.981 -0.554 . . . . 1.71 109.615 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 94.7 m-85 -110.02 131.26 55.21 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.883 -0.414 . . . . 4.0700000000000003 109.883 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.7 m-85 -112.99 128.07 56.4 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.927 -0.309 . . . . 2.8599999999999999 110.93 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 10' ' ' ASN . 48.8 m-80 -129.15 132.44 47.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.873 -0.603 . . . . 1.8899999999999999 109.981 175.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.54 143.36 37.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.593 -0.276 . . . . 1.0800000000000001 110.261 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.46 122.29 3.15 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.73 0.27 . . . . 1.3899999999999999 111.73 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.652 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 56.2 t30 -167.53 95.14 0.45 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.393 -0.595 . . . . 2.8599999999999999 109.393 171.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.23 -84.24 0.45 Allowed Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 110.921 -0.871 . . . . 1.6799999999999999 110.921 -173.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.652 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 24.4 Cg_endo -63.62 172.91 5.03 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.862 2.375 . . . . 1.6599999999999999 111.922 169.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -71.05 -174.86 1.03 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.95 -0.568 . . . . 3.3999999999999999 110.914 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -109.61 127.62 54.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.27 0.557 . . . . 3.1000000000000001 109.785 -171.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 72' ' ' LEU . 5.2 tt -127.3 135.24 63.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.856 -1.065 . . . . 1.8 110.876 -171.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -118.28 129.92 55.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.804 -0.635 . . . . 0.85999999999999999 110.264 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.3 tp -122.74 136.25 54.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.278 -0.419 . . . . 1.0600000000000001 110.788 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.32 159.94 42.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.738 -0.665 . . . . 1.1399999999999999 109.852 176.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -123.53 139.98 53.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.572 0.225 . . . . 4.0199999999999996 110.416 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -125.45 115.33 20.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 4.6100000000000003 110.926 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -112.28 129.06 56.41 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.844 -0.343 . . . . 3.3799999999999999 110.239 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.501 ' HB2' ' NH2' ' A' ' 69' ' ' ARG . 85.8 tt0 . . . . . 0 C--N 1.319 -0.72 0 CA-C-N 116.48 -0.327 . . . . 5.0499999999999998 110.468 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 96.2 m95 . . . . . 0 C--O 1.228 -0.059 0 CA-C-O 120.939 0.4 . . . . 5.6100000000000003 110.745 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -86.14 104.81 16.06 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.582 -0.896 . . . . 3.7799999999999998 108.582 170.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -141.86 147.06 36.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.505 -0.316 . . . . 2.4500000000000002 110.317 -166.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.59 ' HG3' ' HA ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -127.43 124.0 23.42 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 109.858 -0.423 . . . . 3.2400000000000002 109.858 172.315 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 67.0 Cg_endo -80.01 135.51 11.17 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.119 1.879 . . . . 1.1899999999999999 110.951 170.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.491 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 8.1 tp10 -115.35 120.0 38.16 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.406 -0.59 . . . . 2.1899999999999999 109.406 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.41 HD11 HD11 ' A' ' 46' ' ' ILE . 53.4 tp -134.54 129.54 35.21 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.267 -0.424 . . . . 1.1399999999999999 110.315 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -139.7 129.81 25.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.932 0.396 . . . . 2.1800000000000002 110.309 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.4 t -121.55 130.1 74.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.927 -0.579 . . . . 1.5600000000000001 109.773 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -108.81 137.43 46.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.049 0.452 . . . . 3.4399999999999999 110.915 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -119.91 139.89 51.73 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.472 -0.785 . . . . 4.7999999999999998 109.757 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -120.06 138.59 53.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.947 -0.39 . . . . 2.9399999999999999 109.947 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -125.5 127.64 46.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.287 0.565 . . . . 3.8999999999999999 110.496 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.7 tp . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 115.511 -0.768 . . . . 4.4800000000000004 110.097 -178.514 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.618 ' HA ' ' OD2' ' A' ' 120' ' ' ASP . 16.3 m . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.818 0.342 . . . . 2.5499999999999998 111.41 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -112.04 130.29 55.92 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.987 -0.375 . . . . 5.2999999999999998 109.987 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -154.76 156.35 26.83 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.545 -0.836 . . . . 1.3500000000000001 111.96 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 96.9 mt -132.84 136.89 46.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.821 0.343 . . . . 2.29 110.287 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 60.9 m -119.93 129.94 54.57 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.653 -0.499 . . . . 1.54 109.653 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.91 132.58 8.18 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.466 -0.873 . . . . 1.1699999999999999 111.528 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -125.07 128.5 6.67 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.762 -0.733 . . . . 1.1899999999999999 111.989 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -120.26 121.87 39.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.641 -0.503 . . . . 3.75 109.641 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.491 ' HD2' ' OE2' ' A' ' 71' ' ' GLU . 38.6 ttt180 -141.96 130.01 22.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.726 -0.472 . . . . 2.75 109.726 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.649 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 5.4 t30 -111.07 129.99 55.75 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.036 0.446 . . . . 1.8200000000000001 109.937 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.59 ' HA ' ' HG3' ' A' ' 69' ' ' ARG . 65.8 t80 -100.0 109.78 22.11 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.427 -0.582 . . . . 3.1400000000000001 109.427 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.674 0 C-N-CA 120.519 -0.848 . . . . 2.79 111.934 -175.206 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.442 -0.84 0 N-CA-C 108.819 -0.808 . . . . 3.2999999999999998 108.819 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -158.07 149.68 21.5 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.629 -0.508 . . . . 1.76 109.629 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -114.68 110.34 19.6 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.138 0.494 . . . . 2.5499999999999998 111.553 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.601 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 88.6 mtp -127.08 130.44 49.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.936 -0.764 . . . . 1.77 108.936 169.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.642 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 95.7 mt-30 -107.43 138.39 43.72 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.094 -0.642 . . . . 1.97 110.502 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 29.1 ttt180 -110.42 117.04 32.51 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.546 -0.539 . . . . 3.8500000000000001 109.546 171.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.564 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 61.4 m95 -108.5 127.42 53.91 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.735 -0.666 . . . . 2.2799999999999998 110.156 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -119.67 123.41 43.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.491 -0.322 . . . . 2.1400000000000001 110.795 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.6 mm -123.21 120.55 60.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.043 -0.725 . . . . 1.55 109.043 170.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -144.43 106.28 4.72 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 111.716 0.265 . . . . 1.1899999999999999 111.716 -177.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 87.8 Cg_endo -79.94 149.18 20.11 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.575 2.183 . . . . 1.3700000000000001 111.604 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -95.45 137.75 34.07 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.219 -0.66 . . . . 2.3500000000000001 109.219 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -135.98 130.49 33.72 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 111.957 0.355 . . . . 4.54 111.957 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.618 ' OD2' ' HA ' ' A' ' 85' ' ' SER . 13.0 m-20 -94.36 102.14 14.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.821 -0.807 . . . . 3.04 108.821 168.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 96.3 t -69.9 -42.73 79.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.142 -0.481 . . . . 4.2699999999999996 111.089 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -114.73 132.82 56.31 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.556 -0.535 . . . . 6.04 109.556 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.0 mt -107.19 24.84 12.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.202 -0.454 . . . . 4.5899999999999999 111.019 -173.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 17.4 p -108.89 142.57 39.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.12 -0.491 . . . . 3.6899999999999999 110.758 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -69.5 -39.96 77.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 5.1699999999999999 111.591 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -59.92 -40.11 87.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.006 -0.543 . . . . 3.71 111.248 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.6 tp -139.34 122.39 16.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.002 -0.544 . . . . 2.0499999999999998 109.745 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -119.16 136.29 54.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.991 0.424 . . . . 4.2400000000000002 110.54 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.413 ' CZ ' ' HB ' ' A' ' 156' ' ' THR . 89.1 t80 -139.58 130.87 26.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.826 -0.624 . . . . 3.5499999999999998 109.386 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -127.09 162.17 26.7 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.24 -0.436 . . . . 2.1099999999999999 110.958 -176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -161.39 140.51 6.68 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.276 -0.73 . . . . 1.1799999999999999 111.276 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.608 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 5.1 p90 -132.26 134.94 45.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.225 0.536 . . . . 4.2999999999999998 110.914 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.632 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 58.8 tp -104.46 124.46 49.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.163 -0.926 . . . . 2.2400000000000002 109.955 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.9 t -119.88 127.31 52.6 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.017 0.437 . . . . 1.6899999999999999 110.179 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 89.3 mtp -113.04 130.42 56.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.94 -0.573 . . . . 2.2400000000000002 110.043 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 113' ' ' TRP . 70.9 m-85 -121.58 139.98 52.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.92 0.39 . . . . 3.5600000000000001 111.676 -175.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 63.1 mttp -125.95 151.54 46.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.787 -0.642 . . . . 1.6699999999999999 109.7 169.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.642 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 87.8 m-85 -135.56 156.28 49.13 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.422 0.451 . . . . 3.23 110.53 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 110' ' ' MET . . . 60.05 -175.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.979 -0.555 . . . . 1.24 111.587 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -76.61 -33.69 58.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.487 0.66 . . . . 2.4700000000000002 109.766 168.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -60.11 -45.61 92.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.79 -1.095 . . . . 2.4100000000000001 112.421 -169.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 138' ' ' PHE . 9.4 mp -69.9 -30.11 67.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.826 0.345 . . . . 1.8300000000000001 110.88 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -67.38 -39.89 85.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.339 0.59 . . . . 2.0 109.955 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.1 m -66.94 -41.34 87.15 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.191 -0.913 . . . . 2.0499999999999998 111.665 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 34.7 p -80.58 -14.01 58.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.247 0.546 . . . . 1.5900000000000001 111.01 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.42 ' O ' ' HE3' ' A' ' 137' ' ' LYS . . . 71.3 -130.61 18.92 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.622 -0.717 . . . . 1.52 112.955 175.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.46 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 46.5 p90 -70.04 -16.15 63.11 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.53 0.196 . . . . 5.9400000000000004 111.53 -174.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.92 -48.68 80.69 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.208 0.448 . . . . 1.8300000000000001 112.208 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.449 ' HB3' ' HG ' ' A' ' 142' ' ' LEU . 51.3 m-20 -100.22 14.17 31.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.847 0.356 . . . . 2.6400000000000001 111.218 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.46 ' OG1' ' HA ' ' A' ' 147' ' ' TYR . 98.2 m -72.93 129.71 38.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.394 -0.366 . . . . 2.02 110.706 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -83.45 134.29 34.87 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.387 -0.598 . . . . 3.6699999999999999 109.387 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 63.0 t -119.6 124.24 72.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.002 0.43 . . . . 1.6399999999999999 110.746 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -127.39 136.18 51.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.63 -0.714 . . . . 2.5600000000000001 109.684 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 16.0 m -135.77 130.05 33.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.804 0.335 . . . . 1.3899999999999999 110.887 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.608 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 74.4 tt0 -120.29 136.89 54.53 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.525 -0.546 . . . . 2.04 109.525 175.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 172' ' ' TYR . 17.1 p -127.38 140.07 52.43 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.024 -0.535 . . . . 1.5600000000000001 110.375 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -125.02 130.1 7.25 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.694 -0.765 . . . . 1.04 112.211 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.8 tp -112.86 128.31 56.42 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 110.196 -0.298 . . . . 2.27 110.196 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -108.49 107.43 17.96 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.995 -0.372 . . . . 2.4100000000000001 109.995 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -121.01 130.08 53.65 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.414 -0.587 . . . . 4.5700000000000003 109.414 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.5 p -88.91 94.15 9.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.877 0.37 . . . . 1.46 110.523 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -61.1 -45.73 93.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.971 -0.559 . . . . 2.6299999999999999 111.271 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.413 ' HB2' HG22 ' A' ' 166' ' ' VAL . 19.6 m120 -99.95 7.65 44.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.589 -0.278 . . . . 2.4100000000000001 110.482 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 73.57 -46.01 0.62 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.708 0.803 . . . . 2.5800000000000001 111.201 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.4 p -73.88 -24.73 59.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.873 0.368 . . . . 2.2999999999999998 111.623 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' A' ' 163' ' ' ASN . 28.9 m -123.45 144.65 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.385 -0.37 . . . . 1.71 110.554 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.22 135.02 49.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.143 -0.48 . . . . 1.47 110.66 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 31.4 mt -104.2 134.53 47.28 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.416 -0.587 . . . . 1.6599999999999999 109.416 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.514 ' HD2' ' CE1' ' A' ' 197' ' ' TYR . 96.8 mtt180 -99.95 111.54 23.84 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.844 -0.428 . . . . 3.2999999999999998 109.844 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.11 119.95 60.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.146 -0.479 . . . . 1.3 109.812 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -107.83 128.44 54.6 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.205 0.526 . . . . 2.2200000000000002 110.792 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.562 ' HB2' ' OG1' ' A' ' 156' ' ' THR . 88.2 m-85 -106.81 128.52 54.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.457 -0.792 . . . . 4.6100000000000003 108.898 177.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -104.09 129.98 51.79 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.064 0.459 . . . . 3.98 110.697 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.513 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 54.2 tp -118.61 119.94 35.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.699 -0.682 . . . . 2.3799999999999999 110.549 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -122.91 149.24 44.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.182 -0.673 . . . . 3.3100000000000001 109.182 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 . . . . . 0 C--N 1.321 -0.635 0 C-N-CA 120.109 -0.637 . . . . 6.5300000000000002 110.417 178.25 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.838 -0.43 . . . . 4.4000000000000004 109.838 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 87.2 mt -104.09 116.08 47.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.368 -0.378 . . . . 2.21 110.089 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -107.61 125.28 51.13 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.182 -0.303 . . . . 3.54 110.182 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -122.85 140.3 53.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.64 0.257 . . . . 1.6699999999999999 111.137 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.514 ' CE1' ' HD2' ' A' ' 169' ' ' ARG . 28.5 p90 -149.73 157.67 43.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.273 -0.421 . . . . 5.8300000000000001 110.101 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.62 143.4 23.51 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.637 0.256 . . . . 2.5899999999999999 110.811 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -88.03 116.08 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.441 2.094 . . . . 1.77 112.168 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 55.0 tp -103.56 129.15 50.74 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.296 -0.631 . . . . 2.2599999999999998 109.296 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 27.4 m -95.67 116.72 29.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.955 0.407 . . . . 1.99 111.24 -176.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.1 mt -127.74 81.46 2.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.071 -0.714 . . . . 2.3100000000000001 109.071 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 75.83 -129.54 10.36 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.76 -0.733 . . . . 1.51 111.291 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -90.62 -0.42 57.68 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.057 -0.72 . . . . 2.5699999999999998 109.057 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 242' ' ' GLY . 33.3 m170 -102.95 117.4 34.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.679 -0.691 . . . . 2.6600000000000001 110.082 -176.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -96.02 132.88 40.91 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.877 -0.601 . . . . 1.6200000000000001 109.999 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.507 ' CG1' HD11 ' A' ' 239' ' ' LEU . 58.4 t -110.08 120.04 60.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.289 -0.634 . . . . 1.3799999999999999 109.289 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 45.1 m -131.01 91.95 34.95 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 120.776 0.322 . . . . 1.1799999999999999 111.569 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.06 147.77 18.95 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.314 2.009 . . . . 1.01 111.135 172.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.425 ' CE1' ' HA3' ' A' ' 238' ' ' GLY . 33.8 p90 -132.4 149.54 52.33 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.621 -0.511 . . . . 4.5 109.621 172.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.404 HG22 HG22 ' A' ' 237' ' ' VAL . 20.6 p -119.0 135.74 54.46 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.715 -0.675 . . . . 1.8899999999999999 109.626 177.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -60.1 -39.81 87.44 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.743 -0.662 . . . . 4.7999999999999998 110.259 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.444 -0.735 0 CA-C-N 115.861 -0.608 . . . . 4.5700000000000003 109.543 -179.579 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.404 HG22 HG22 ' A' ' 211' ' ' THR . 60.5 t . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 120.915 0.388 . . . . 2.3999999999999999 110.577 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.425 ' HA3' ' CE1' ' A' ' 210' ' ' TYR . . . -122.01 140.0 13.28 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.065 -0.814 . . . . 1.27 111.065 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.507 HD11 ' CG1' ' A' ' 207' ' ' VAL . 52.7 tp -120.58 124.4 45.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.928 0.364 . . . . 1.97 110.728 -176.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.487 ' CE1' ' HG2' ' A' ' 254' ' ' GLU . 96.3 m-85 -104.88 132.07 51.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.126 -0.488 . . . . 3.54 110.633 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -112.33 126.91 55.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.38 -0.373 . . . . 2.6400000000000001 110.22 171.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 205' ' ' HIS . . . -89.34 118.18 5.13 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.826 -0.91 . . . . 1.3500000000000001 110.826 174.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' TYR . . . . . 0.462 ' HB3' ' CG2' ' A' ' 251' ' ' VAL . 50.1 t80 -107.74 134.7 50.33 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.792 -0.447 . . . . 4.3600000000000003 109.792 -176.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -99.89 145.79 27.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.88 -0.6 . . . . 4.29 111.295 -174.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.68 139.9 52.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.842 -0.617 . . . . 6.6900000000000004 110.004 172.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -64.43 -26.41 68.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.288 -0.869 . . . . 6.3700000000000001 111.168 -174.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -59.82 -40.12 87.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.684 -0.689 . . . . 5.8300000000000001 110.808 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 130.8 21.74 1.09 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.83 -0.7 . . . . 2.6600000000000001 111.937 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 91.8 mt -110.99 151.52 27.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.747 0.308 . . . . 2.9700000000000002 110.351 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 52.8 m -130.07 139.77 50.92 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.703 -0.481 . . . . 2.1699999999999999 109.703 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.462 ' CG2' ' HB3' ' A' ' 243' ' ' TYR . 33.2 m -129.07 142.86 42.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.981 0.419 . . . . 1.79 110.827 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 4.2 p -100.07 120.74 40.31 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.999 -0.546 . . . . 1.6299999999999999 110.165 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 87.9 mt -99.96 125.94 46.04 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.052 -0.522 . . . . 2.96 110.154 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 273' ' ' ALA . 45.3 mt-10 -92.81 134.62 34.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.41 -0.359 . . . . 4.0800000000000001 111.018 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -137.04 138.88 40.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.987 -0.552 . . . . 4.8399999999999999 109.564 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.574 0 CA-C-O 120.603 0.24 . . . . 3.5800000000000001 110.432 177.75 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 254' ' ' GLU . . . . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 110.233 -0.284 . . . . 1.9399999999999999 110.233 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.468 ' H ' ' HB2' ' A' ' 254' ' ' GLU . . . -140.81 154.84 24.58 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.958 -0.639 . . . . 1.4199999999999999 111.571 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 58.2 t -119.99 127.98 75.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.13 0.49 . . . . 1.8100000000000001 110.982 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 251' ' ' VAL . . . -117.72 129.84 8.49 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.697 -0.961 . . . . 1.3 110.697 173.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.2 124.92 64.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 117.368 0.584 . . . . 1.8300000000000001 110.758 -175.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -117.43 127.35 53.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.275 0.56 . . . . 2.3100000000000001 111.111 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 44.2 t80 -113.89 119.57 37.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.361 -0.836 . . . . 4.75 109.106 171.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 53.4 m -129.98 129.61 43.97 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.752 0.311 . . . . 1.6699999999999999 110.337 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 49.8 t80 . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.319 -0.848 . . . . 3.6899999999999999 108.749 176.568 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 . . . . . 0 CA--C 1.519 -0.226 0 N-CA-C 109.785 -0.45 . . . . 3.6099999999999999 109.785 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -141.31 101.73 4.07 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.128 -0.694 . . . . 3.3300000000000001 109.128 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.446 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 44.7 m80 -119.98 137.88 53.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.014 0.435 . . . . 3.2000000000000002 111.119 -175.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -132.84 146.22 51.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.671 -0.695 . . . . 2.4900000000000002 110.85 -176.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -123.93 131.9 53.64 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.257 -0.428 . . . . 2.1299999999999999 109.969 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 279' ' ' TYR . 77.7 mt -130.0 129.97 65.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.309 -0.405 . . . . 1.6000000000000001 110.404 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -115.2 134.95 11.91 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.448 -0.882 . . . . 0.88 111.644 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.97 136.34 54.57 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.94 0.4 . . . . 1.0800000000000001 110.569 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.527 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 65.9 mtt -133.14 155.34 49.45 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.881 -0.599 . . . . 2.3300000000000001 109.769 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -111.33 114.49 27.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.769 -0.456 . . . . 2.6099999999999999 109.769 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 116.148 -0.478 . . . . 5.0899999999999999 111.445 -170.776 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.857 0.361 . . . . 3.48 110.229 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 14' ' ' MET . 74.4 Cg_endo -78.01 134.73 13.37 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.443 2.096 . . . . 1.8600000000000001 113.166 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.2 m -109.92 143.25 40.11 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.715 -0.846 . . . . 1.97 108.715 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.49 134.4 66.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.357 0.598 . . . . 1.71 111.615 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -114.08 134.24 55.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.473 -0.785 . . . . 4.0700000000000003 109.582 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -110.69 139.38 46.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.755 0.312 . . . . 2.8599999999999999 110.986 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.42 HD22 ' HB2' ' A' ' 47' ' ' ALA . 24.5 t-20 -149.79 140.54 22.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.689 -0.485 . . . . 1.8899999999999999 109.689 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.47 143.51 47.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.415 0.15 . . . . 1.0800000000000001 110.978 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.459 ' HB2' ' HG3' ' A' ' 45' ' ' ARG . . . -153.95 119.69 5.26 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.49 -0.323 . . . . 1.3899999999999999 111.338 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.55 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 13.0 p-10 -169.12 95.04 0.32 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.373 -0.376 . . . . 2.8599999999999999 111.046 176.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.06 -98.7 2.47 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.972 -0.633 . . . . 1.6799999999999999 112.034 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.55 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 88.6 Cg_exo -49.23 174.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.893 3.062 . . . . 1.6599999999999999 112.998 170.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.4 ' HZ3' ' O ' ' A' ' 77' ' ' GLN . 93.6 m95 -67.31 176.33 2.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.123 0.487 . . . . 3.3999999999999999 111.108 -172.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.459 ' HG3' ' HB2' ' A' ' 40' ' ' ALA . 21.6 ttm180 -110.41 126.79 54.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.988 0.423 . . . . 3.1000000000000001 110.421 -163.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 83.5 mt -117.18 136.86 52.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.774 -0.648 . . . . 1.8 110.715 -173.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.42 ' HB2' HD22 ' A' ' 38' ' ' ASN . . . -117.83 133.32 56.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.853 -0.612 . . . . 0.85999999999999999 110.423 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.9 tp -120.35 132.02 55.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.925 -0.58 . . . . 1.0600000000000001 110.257 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.8 165.08 29.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.172 -0.467 . . . . 1.1399999999999999 110.189 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -138.42 147.97 43.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.057 -0.349 . . . . 4.0199999999999996 110.057 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -124.55 129.82 51.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.276 0.56 . . . . 4.6100000000000003 110.803 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -110.29 155.78 21.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.276 -0.874 . . . . 3.3799999999999999 108.859 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 C--N 1.324 -0.514 0 CA-C-O 120.825 0.345 . . . . 5.0499999999999998 110.658 -175.529 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 88.1 m95 . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 120.875 0.369 . . . . 5.6100000000000003 111.224 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -110.51 135.33 51.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.031 -0.532 . . . . 3.7799999999999998 110.355 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -149.18 170.02 19.39 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.692 -0.485 . . . . 2.4500000000000002 109.692 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 94' ' ' ASN . 40.8 ttp180 -129.6 123.59 21.35 Favored Pre-proline 0 N--CA 1.451 -0.402 0 C-N-CA 120.682 -0.407 . . . . 3.2400000000000002 111.038 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.538 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 92.7 Cg_endo -87.78 152.07 7.36 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.938 2.425 . . . . 1.1899999999999999 110.802 167.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.46 ' OE2' ' HD3' ' A' ' 93' ' ' ARG . 52.7 mt-10 -134.5 125.72 27.94 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.807 -0.357 . . . . 2.1899999999999999 110.383 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.4 tp -133.7 129.96 37.49 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.893 -0.41 . . . . 1.1399999999999999 109.893 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -128.3 146.62 50.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.083 0.468 . . . . 2.1800000000000002 110.994 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.1 t -114.8 126.87 72.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.786 -0.82 . . . . 1.5600000000000001 108.786 171.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -110.85 119.82 40.36 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.298 -0.41 . . . . 3.4399999999999999 110.227 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -105.59 120.03 40.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.065 -0.516 . . . . 4.7999999999999998 110.429 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.4 ' O ' ' HZ3' ' A' ' 44' ' ' TRP . 53.8 mt-30 -109.45 120.16 41.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.789 -0.448 . . . . 2.9399999999999999 109.789 176.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -104.14 125.45 50.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.151 0.5 . . . . 3.8999999999999999 111.214 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.6 tp . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 115.43 -0.805 . . . . 4.4800000000000004 108.975 174.853 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 121.145 0.498 . . . . 2.5499999999999998 110.711 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -128.52 153.29 47.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.77 -0.65 . . . . 5.2999999999999998 109.816 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -151.62 166.28 30.73 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.499 -0.858 . . . . 1.3500000000000001 111.608 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 63.6 tp -146.49 120.09 9.14 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.908 0.385 . . . . 2.29 110.403 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.3 m -109.39 116.72 32.37 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.047 -0.524 . . . . 1.54 109.763 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -134.96 139.05 10.5 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.44 -0.886 . . . . 1.1699999999999999 111.266 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.78 161.67 32.47 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.072 -1.061 . . . . 1.1899999999999999 112.366 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -122.39 130.96 53.63 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.491 -0.559 . . . . 3.75 109.491 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.46 ' HD3' ' OE2' ' A' ' 71' ' ' GLU . 83.6 mtt180 -121.99 124.99 45.3 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.587 -0.894 . . . . 2.75 108.587 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.538 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 64.4 t30 -103.75 118.41 36.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.064 0.459 . . . . 1.8200000000000001 110.64 -173.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 109' ' ' ASN . 59.3 t80 -102.34 117.67 35.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.07 -0.514 . . . . 3.1400000000000001 110.452 -175.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.475 0 C-N-CA 120.635 -0.793 . . . . 2.79 113.478 173.334 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 110.228 -0.286 . . . . 3.2999999999999998 110.228 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -137.6 113.74 9.99 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.96 -0.296 . . . . 1.76 110.345 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 95' ' ' TYR . 3.5 t-20 -142.09 108.31 5.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.927 -0.579 . . . . 2.5499999999999998 109.677 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.465 ' HB2' ' HB3' ' A' ' 95' ' ' TYR . 88.4 mtp -111.27 125.69 54.1 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.733 -0.667 . . . . 1.77 109.343 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.575 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 81.1 mt-30 -91.66 119.87 31.92 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.527 -0.469 . . . . 1.97 109.88 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -106.29 113.06 26.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.873 -0.603 . . . . 3.8500000000000001 110.193 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 137' ' ' LYS . 86.3 m95 -115.81 125.31 52.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.882 -0.784 . . . . 2.2799999999999998 108.882 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -140.1 123.88 17.37 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.452 -0.573 . . . . 2.1400000000000001 109.452 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 134' ' ' SER . 87.4 mt -123.22 128.22 74.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.999 -0.546 . . . . 1.55 110.179 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -132.77 104.25 13.03 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.516 -0.311 . . . . 1.1899999999999999 111.278 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.18 141.13 11.44 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.091 2.527 . . . . 1.3700000000000001 111.356 172.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -93.42 138.51 31.67 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.064 -0.516 . . . . 2.3500000000000001 110.088 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -127.06 128.38 46.19 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.125 -0.324 . . . . 4.54 110.125 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -148.64 118.11 6.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.867 -0.42 . . . . 3.04 109.867 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 123' ' ' LEU . 61.1 t -124.6 130.01 73.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.001 0.429 . . . . 4.2699999999999996 111.105 -174.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -114.03 28.48 8.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 6.04 110.213 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.597 ' H ' HG12 ' A' ' 121' ' ' VAL . 61.3 tp -68.13 -22.77 64.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 4.5899999999999999 112.066 -171.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.0 p -108.15 143.84 36.38 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.081 0.467 . . . . 3.6899999999999999 111.789 -174.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -66.93 124.97 24.49 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.527 -0.76 . . . . 5.1699999999999999 110.823 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 60.25 15.6 5.45 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.86 0.725 . . . . 3.71 111.598 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.6 mt -129.25 119.53 24.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.207 -0.451 . . . . 2.0499999999999998 110.062 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.518 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 74.0 ttt180 -112.74 130.36 56.09 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.031 -0.531 . . . . 4.2400000000000002 110.062 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -107.24 125.81 51.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.066 -0.515 . . . . 3.5499999999999998 109.652 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -130.6 130.05 43.52 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.201 -0.666 . . . . 2.1099999999999999 109.201 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -137.53 144.55 16.01 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.139 -1.029 . . . . 1.1799999999999999 112.8 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 155' ' ' GLU . 61.0 t-105 -118.82 128.44 54.46 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.068 -0.716 . . . . 4.2999999999999998 109.068 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 60.9 tp -126.33 140.51 52.45 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.385 -0.598 . . . . 2.2400000000000002 109.385 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 29.3 t -156.72 169.97 23.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.418 -0.216 . . . . 1.6899999999999999 110.418 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 92.8 mtp -139.62 149.95 44.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.652 0.263 . . . . 2.2400000000000002 110.663 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -103.74 117.35 34.17 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.378 -0.374 . . . . 3.5600000000000001 111.207 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 113' ' ' TRP . 99.4 mttt -132.92 129.8 38.78 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.066 -0.716 . . . . 1.6699999999999999 109.066 170.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.575 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 51.1 p90 -157.02 161.04 39.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.473 -0.331 . . . . 3.23 110.618 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 74.72 -178.19 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 O-C-N 124.154 0.908 . . . . 1.24 110.678 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -74.47 -38.64 62.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.533 -0.303 . . . . 2.4700000000000002 111.019 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -59.86 -51.17 70.86 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.738 0.644 . . . . 2.4100000000000001 112.738 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.6 ' HA ' ' OG1' ' A' ' 145' ' ' THR . 44.2 mt -69.98 -30.01 67.25 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.776 -0.37 . . . . 1.8300000000000001 111.342 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -60.02 -42.16 93.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.029 0.442 . . . . 2.0 109.857 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 30.0 p -80.12 -31.37 39.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.011 -0.541 . . . . 2.0499999999999998 111.972 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.6 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 61.6 p -71.65 -32.38 67.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.147 0.499 . . . . 1.5900000000000001 110.95 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.414 ' O ' ' HE2' ' A' ' 137' ' ' LYS . . . 68.3 -120.09 11.31 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.692 -0.686 . . . . 1.52 112.61 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -89.89 -9.66 48.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.43 0.157 . . . . 5.9400000000000004 111.067 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.69 -52.97 47.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.874 0.369 . . . . 1.8300000000000001 110.663 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.417 ' O ' HD22 ' A' ' 142' ' ' LEU . 10.9 m-20 -118.11 110.05 17.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.867 -0.606 . . . . 2.6400000000000001 109.666 176.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.6 t -170.24 164.17 8.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.813 -0.63 . . . . 2.02 109.616 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 151' ' ' ARG . 49.9 mtm180 -119.89 143.98 47.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.645 0.259 . . . . 3.6699999999999999 110.478 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.0 143.51 25.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.146 -0.479 . . . . 1.6399999999999999 110.984 -172.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 134' ' ' SER . 34.9 mt-10 -110.61 125.5 53.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.56 -0.904 . . . . 2.5600000000000001 108.56 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.8 m -132.22 122.45 25.25 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.464 -0.494 . . . . 1.3899999999999999 110.97 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 132' ' ' TRP . 85.8 tt0 -119.91 111.98 18.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.301 -0.629 . . . . 2.04 109.301 174.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 31.7 m -108.57 120.32 42.1 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.072 -0.513 . . . . 1.5600000000000001 109.861 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -133.37 149.26 19.61 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 119.71 -1.233 . . . . 1.04 113.051 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 59.6 tp -122.47 130.42 53.04 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.983 -0.377 . . . . 2.27 109.983 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 51.3 tt0 -95.44 110.89 22.87 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.109 -0.7 . . . . 2.4100000000000001 109.109 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -122.85 130.08 52.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.566 -0.743 . . . . 4.5700000000000003 110.002 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.2 p -82.28 88.16 6.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.159 0.504 . . . . 1.46 109.94 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -60.47 -50.14 74.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.61 -0.723 . . . . 2.6299999999999999 111.323 -172.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -103.12 16.64 26.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.156 -0.475 . . . . 2.4100000000000001 111.18 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 72.92 -50.22 0.7 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.75 -0.659 . . . . 2.5800000000000001 111.868 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.1 p -74.21 -20.1 60.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.759 0.314 . . . . 2.2999999999999998 111.695 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -125.79 144.19 36.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.366 -0.379 . . . . 1.71 110.82 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -105.67 121.63 44.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.036 -0.529 . . . . 1.47 110.493 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -102.88 126.94 50.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.825 -0.625 . . . . 1.6599999999999999 109.761 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -98.11 111.78 23.98 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.303 -0.629 . . . . 3.2999999999999998 109.303 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.96 119.92 60.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.856 -0.611 . . . . 1.3 109.384 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -114.89 131.07 56.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.323 -0.399 . . . . 2.2200000000000002 111.157 -171.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -115.19 119.94 38.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.683 -0.689 . . . . 4.6100000000000003 109.255 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -106.91 130.7 54.54 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.831 0.348 . . . . 3.98 110.075 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 64.1 tp -99.5 119.92 38.8 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.982 -0.554 . . . . 2.3799999999999999 110.102 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -66.73 -40.05 88.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.264 -0.88 . . . . 3.3100000000000001 110.638 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 6.5300000000000002 109.766 -178.969 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.354 -0.609 . . . . 4.4000000000000004 109.354 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 85.2 mt -115.39 119.94 63.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.834 -0.432 . . . . 2.21 109.834 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 211' ' ' THR . 93.1 mtt180 -117.82 116.19 26.48 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.9 -0.407 . . . . 3.54 109.9 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -120.06 138.47 53.52 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.997 -0.547 . . . . 1.6699999999999999 110.178 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -136.82 140.75 42.68 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.348 0.594 . . . . 5.8300000000000001 111.362 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.41 HD12 ' HD2' ' A' ' 199' ' ' PRO . 55.5 tp -116.69 126.82 27.2 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 114.871 -1.059 . . . . 2.5899999999999999 109.399 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.41 ' HD2' HD12 ' A' ' 198' ' ' LEU . 21.8 Cg_exo -66.55 110.18 1.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.942 1.761 . . . . 1.77 111.078 174.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 60.0 tp -100.12 109.43 21.71 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.275 -0.639 . . . . 2.2599999999999998 109.275 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 78.5 m -121.34 130.07 53.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.331 0.586 . . . . 1.99 111.487 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 55.5 tp -133.6 83.86 2.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.507 -0.923 . . . . 2.3100000000000001 108.507 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.71 -117.79 9.14 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.504 -0.771 . . . . 1.51 112.063 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -79.89 -12.68 59.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.729 0.299 . . . . 2.5699999999999998 111.357 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -99.54 117.09 33.16 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.066 -0.346 . . . . 2.6600000000000001 110.066 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 28.6 t -132.57 138.14 47.35 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.724 -0.473 . . . . 1.6200000000000001 109.724 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.419 ' HB ' HD11 ' A' ' 239' ' ' LEU . 24.5 m -136.61 148.82 26.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.792 0.33 . . . . 1.3799999999999999 110.807 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 26.4 m -119.93 91.73 45.82 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.176 -0.465 . . . . 1.1799999999999999 110.412 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 2.6 Cg_endo -80.74 126.8 6.05 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.891 2.394 . . . . 1.01 112.455 177.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -95.27 140.07 30.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.234 -0.439 . . . . 4.5 110.0 175.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 195' ' ' ARG . 45.7 p -118.31 130.2 55.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.882 0.372 . . . . 1.8899999999999999 110.447 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 17.7 ttp85 -104.67 110.03 22.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.66 -0.7 . . . . 4.7999999999999998 109.704 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 30.4 pt . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.262 -0.426 . . . . 4.5700000000000003 110.586 -177.385 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.448 -0.56 0 CA-C-O 121.094 0.473 . . . . 2.3999999999999999 110.228 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -78.28 111.93 3.36 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.854 -0.898 . . . . 1.27 110.854 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.565 ' O ' ' HB3' ' A' ' 254' ' ' GLU . 47.7 tp -111.68 125.43 53.96 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.631 -0.507 . . . . 1.97 109.631 -175.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -124.83 133.34 53.14 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.993 -0.549 . . . . 3.54 109.776 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -98.11 131.15 44.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.972 0.415 . . . . 2.6400000000000001 110.471 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -121.12 118.45 3.8 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.726 -0.67 . . . . 1.3500000000000001 112.455 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -140.06 115.39 9.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.286 -0.635 . . . . 4.3600000000000003 109.286 174.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -120.06 130.29 54.61 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.995 -0.372 . . . . 4.29 109.995 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -139.92 129.67 24.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.034 -0.53 . . . . 6.6900000000000004 110.493 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -70.11 140.33 52.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.762 -0.653 . . . . 6.3700000000000001 110.307 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 59.97 39.63 19.86 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.449 0.468 . . . . 5.8300000000000001 110.984 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -170.39 171.34 43.56 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.815 -0.707 . . . . 2.6600000000000001 111.74 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 86.7 mt -71.12 141.26 50.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.074 0.464 . . . . 2.9700000000000002 110.786 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.554 ' HB2' ' HB2' ' A' ' 278' ' ' ASN . 68.5 m -123.89 149.97 45.21 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.846 -0.615 . . . . 2.1699999999999999 109.972 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 66.7 t -123.15 135.15 64.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.645 0.26 . . . . 1.79 111.314 -172.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 22.7 t -136.44 152.98 51.17 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.078 -0.51 . . . . 1.6299999999999999 109.877 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 90.2 mt 73.23 -179.67 0.21 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.251 0.621 . . . . 2.96 111.05 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' GLU . . . . . 0.565 ' HB3' ' O ' ' A' ' 239' ' ' LEU . 38.2 tt0 -177.91 -86.11 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.293 0.042 . . . . 4.0800000000000001 110.991 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' TYR . . . . . 0.554 ' CD2' ' HG2' ' A' ' 254' ' ' GLU . 69.4 m-85 -120.02 135.96 54.73 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.91 -0.494 . . . . 4.8399999999999999 111.589 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.744 -0.662 . . . . 3.5800000000000001 110.248 176.514 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.426 -0.583 . . . . 1.9399999999999999 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -133.3 118.71 2.18 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 119.857 -1.163 . . . . 1.4199999999999999 111.601 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 63.1 t -126.97 130.05 71.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.966 0.413 . . . . 1.8100000000000001 110.428 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -116.15 160.23 13.47 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 111.167 -0.773 . . . . 1.3 111.167 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 250' ' ' SER . 19.0 m -123.25 139.8 48.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 120.919 0.39 . . . . 1.8300000000000001 110.556 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 250' ' ' SER . 94.1 m-20 -105.39 131.8 52.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.989 -0.551 . . . . 2.3100000000000001 110.936 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.405 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 91.9 m-85 -115.26 139.97 49.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.454 -0.943 . . . . 4.75 108.454 173.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 15.5 t -144.2 143.03 30.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.109 0.48 . . . . 1.6699999999999999 110.751 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 59.1 t80 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 117.901 -1.047 . . . . 3.6899999999999999 109.116 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.355 0 CA-C-O 121.242 0.544 . . . . 3.6099999999999999 111.713 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -134.85 129.42 34.43 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.314 -1.365 . . . . 3.3300000000000001 107.314 166.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.488 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 96.4 m-70 -124.58 137.04 54.42 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.953 -0.699 . . . . 3.2000000000000002 110.898 -172.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.45 ' CE2' ' HB3' ' A' ' 281' ' ' PHE . 50.4 p90 -140.0 160.61 39.53 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.637 -0.71 . . . . 2.4900000000000002 110.988 -176.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -134.12 129.85 36.52 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.777 -0.823 . . . . 2.1299999999999999 108.777 173.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.1 tt -130.1 130.05 65.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.962 -0.755 . . . . 1.6000000000000001 108.962 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.522 ' HA3' ' OD1' ' A' ' 278' ' ' ASN . . . -144.61 155.64 26.47 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 119.23 -1.462 . . . . 0.88 113.454 -173.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.423 ' HB2' HG22 ' A' ' 35' ' ' VAL . . . -118.1 135.14 54.39 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.583 -0.525 . . . . 1.0800000000000001 109.583 176.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.444 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 59.7 ttm -130.27 132.16 45.8 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.936 -0.575 . . . . 2.3300000000000001 110.003 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -84.51 120.34 26.22 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.532 -0.544 . . . . 2.6099999999999999 109.532 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 C--N 1.324 -0.537 0 CA-C-O 121.434 0.635 . . . . 5.0899999999999999 111.408 -174.579 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.768 0.318 . . . . 3.48 110.585 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 14' ' ' MET . 85.2 Cg_endo -79.92 134.83 10.88 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.678 2.252 . . . . 1.8600000000000001 112.832 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.3 m -113.32 142.68 45.56 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.292 -0.633 . . . . 1.97 109.292 172.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 59.4 t -115.93 134.5 59.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.701 0.286 . . . . 1.71 111.295 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -119.65 139.91 51.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.321 -0.399 . . . . 4.0700000000000003 110.056 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -110.59 129.87 55.7 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.567 -0.531 . . . . 2.8599999999999999 109.567 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.561 HD21 ' HD3' ' A' ' 45' ' ' ARG . 51.3 t30 -143.43 127.63 17.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.601 -0.272 . . . . 1.8899999999999999 110.295 -173.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -143.31 144.18 32.0 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.52 0.563 . . . . 1.0800000000000001 112.52 -175.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.437 ' HB2' ' CB ' ' A' ' 45' ' ' ARG . . . -163.09 144.53 9.78 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.363 -0.381 . . . . 1.3899999999999999 111.74 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.691 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 7.5 t30 -169.13 94.15 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 2.8599999999999999 110.14 166.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.57 -81.36 0.31 Allowed Glycine 0 CA--C 1.517 0.185 0 C-N-CA 120.878 -0.677 . . . . 1.6799999999999999 111.47 -176.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.691 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 22.9 Cg_endo -61.71 175.73 1.6 Allowed 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.326 2.684 . . . . 1.6599999999999999 111.776 170.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -68.21 174.72 3.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.968 0.413 . . . . 3.3999999999999999 110.159 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.561 ' HD3' HD21 ' A' ' 38' ' ' ASN . 39.0 ttm180 -110.56 124.84 52.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.24 0.543 . . . . 3.1000000000000001 111.078 -166.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.5 mm -113.09 130.01 67.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.414 -0.812 . . . . 1.8 110.599 -173.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 73' ' ' GLU . . . -117.95 129.95 55.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.274 -0.421 . . . . 0.85999999999999999 110.064 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.1 tp -128.14 133.98 49.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.112 -0.495 . . . . 1.0600000000000001 110.661 -176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.02 153.91 37.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.142 -0.481 . . . . 1.1399999999999999 110.244 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -120.11 139.97 51.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.782 0.325 . . . . 4.0199999999999996 110.684 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.614 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 71.1 t80 -99.9 129.96 46.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.088 -0.505 . . . . 4.6100000000000003 110.527 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -133.45 150.47 51.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.336 -0.847 . . . . 3.3799999999999999 109.049 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 . . . . . 0 C--N 1.322 -0.604 0 CA-C-O 120.952 0.406 . . . . 5.0499999999999998 110.627 -178.325 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 77.6 t90 . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.505 -0.554 . . . . 5.6100000000000003 109.505 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -150.26 159.95 44.06 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.212 -0.449 . . . . 3.7799999999999998 110.266 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -148.65 170.48 18.05 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.051 -0.722 . . . . 2.4500000000000002 109.051 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.614 ' HB3' ' HB3' ' A' ' 51' ' ' TYR . 29.0 ttp180 -135.0 122.16 15.06 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.648 -0.421 . . . . 3.2400000000000002 110.195 171.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.67 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 71.8 Cg_endo -81.91 146.2 14.51 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.756 2.304 . . . . 1.1899999999999999 111.47 169.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -136.57 120.08 17.05 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.699 -0.482 . . . . 2.1899999999999999 109.699 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 47' ' ' ALA . 40.6 tp -136.63 129.82 31.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.0 -0.545 . . . . 1.1399999999999999 110.338 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 99.8 mt-10 -117.93 142.18 47.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.176 -0.466 . . . . 2.1800000000000002 110.216 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.8 t -113.33 120.02 62.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.558 -0.904 . . . . 1.5600000000000001 108.558 173.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 15.3 m-70 -108.27 120.13 41.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.989 -0.55 . . . . 3.4399999999999999 109.769 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -99.14 141.44 31.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.155 -0.475 . . . . 4.7999999999999998 110.434 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -100.84 132.13 46.39 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.906 -0.405 . . . . 2.9399999999999999 109.906 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -120.02 99.8 6.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.768 0.318 . . . . 3.8999999999999999 111.662 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.6 tp . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 121.359 0.6 . . . . 4.4800000000000004 109.615 171.545 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.7 p . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 110.096 -0.335 . . . . 2.5499999999999998 110.096 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 52.9 t80 71.97 -76.75 0.06 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.982 -0.554 . . . . 5.2999999999999998 111.794 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.13 166.94 34.79 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 118.478 -1.82 . . . . 1.3500000000000001 114.853 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.1 tp -133.6 130.05 37.82 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.542 -0.91 . . . . 2.29 108.542 173.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.2 m -120.06 127.51 52.64 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.05 0.453 . . . . 1.54 110.555 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -132.07 132.57 6.74 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.83 -0.908 . . . . 1.1699999999999999 110.83 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -141.94 156.24 25.86 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.32 -0.943 . . . . 1.1899999999999999 112.343 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -139.31 149.34 44.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.073 0.463 . . . . 3.75 110.614 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.421 ' HB2' ' HB3' ' A' ' 112' ' ' ARG . 99.7 mtt180 -131.57 129.85 41.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.447 -0.797 . . . . 2.75 109.449 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.67 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 8.5 t30 -115.29 117.58 30.86 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.4 -0.592 . . . . 1.8200000000000001 109.4 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -111.76 120.3 41.55 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.607 0.241 . . . . 3.1400000000000001 110.529 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 108' ' ' ALA . . . . . . . . 0 N--CA 1.449 -0.436 0 C-N-CA 120.727 -0.749 . . . . 2.79 112.006 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.427 -0.583 . . . . 3.2999999999999998 109.427 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.4 ' O ' ' HA3' ' A' ' 96' ' ' GLY . . . -160.87 130.81 5.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.231 -0.285 . . . . 1.76 110.231 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -139.77 108.12 5.82 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.703 -0.48 . . . . 2.5499999999999998 109.703 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 89.7 mtp -116.98 128.1 54.85 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.243 -0.435 . . . . 1.77 109.917 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -110.22 133.52 53.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.03 0.443 . . . . 1.97 111.127 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 35.2 ttt180 -109.89 117.84 34.89 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.329 -0.619 . . . . 3.8500000000000001 109.329 172.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -113.6 136.32 52.95 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.503 -0.555 . . . . 2.2799999999999998 109.503 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 134' ' ' SER . 85.5 tttt -139.12 128.85 24.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.208 -0.451 . . . . 2.1400000000000001 110.817 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 87.0 mt -120.01 121.01 64.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.952 -0.759 . . . . 1.55 108.952 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -137.59 105.3 8.36 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.381 -0.372 . . . . 1.1899999999999999 111.051 -175.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 74.2 Cg_endo -79.64 139.99 14.56 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.075 1.85 . . . . 1.3700000000000001 110.614 173.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -95.57 136.6 35.75 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.773 -1.195 . . . . 2.3500000000000001 107.773 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -124.51 127.97 48.26 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.118 0.485 . . . . 4.54 111.349 -176.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -131.92 120.22 22.22 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.797 -0.816 . . . . 3.04 108.797 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.4 t -132.85 115.83 25.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.438 -0.346 . . . . 4.2699999999999996 110.329 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -107.76 86.45 2.3 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.268 0.556 . . . . 6.04 110.513 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.04 -39.95 90.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.437 -0.801 . . . . 4.5899999999999999 109.696 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 127' ' ' LEU . 24.4 p -129.87 164.01 25.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.218 -0.901 . . . . 3.6899999999999999 109.77 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -73.44 -47.1 44.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.722 0.296 . . . . 5.1699999999999999 111.17 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -70.07 -40.08 75.27 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.133 -0.485 . . . . 3.71 112.027 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.562 ' HB2' ' OG1' ' A' ' 124' ' ' THR . 6.1 mp -102.11 118.45 36.93 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.71 -0.478 . . . . 2.0499999999999998 109.71 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.425 ' HB2' ' HB2' ' A' ' 159' ' ' GLN . 90.6 mtt180 -122.94 134.88 54.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.005 -0.543 . . . . 4.2400000000000002 109.812 -174.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.419 ' CE1' HD13 ' A' ' 158' ' ' LEU . 97.1 m-85 -109.22 129.07 55.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.76 0.314 . . . . 3.5499999999999998 110.519 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -146.32 120.93 9.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.423 -0.584 . . . . 2.1099999999999999 109.423 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -157.13 172.18 34.6 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.565 -0.826 . . . . 1.1799999999999999 112.047 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.471 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 9.2 p90 -140.23 140.91 35.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.134 0.492 . . . . 4.2999999999999998 111.158 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 66.5 mt -109.41 133.75 52.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.023 -0.732 . . . . 2.2400000000000002 109.023 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.4 ' HB3' ' HE3' ' A' ' 114' ' ' LYS . 73.9 m -129.9 135.5 48.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.283 0.563 . . . . 1.6899999999999999 112.14 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 68.6 mtt -119.98 136.76 54.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.443 -0.799 . . . . 2.2400000000000002 108.872 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 96.1 m-85 -120.05 134.36 55.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.002 0.43 . . . . 3.5600000000000001 111.635 -176.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 98.4 mttt -128.18 138.82 52.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.56 -0.745 . . . . 1.6699999999999999 109.37 173.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.45 ' O ' HD23 ' A' ' 142' ' ' LEU . 96.1 m-85 -129.91 150.76 51.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.687 0.279 . . . . 3.23 111.09 -176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 58.99 -165.03 0.19 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.669 -0.696 . . . . 1.24 111.306 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -76.95 -32.81 57.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.29 0.567 . . . . 2.4700000000000002 110.254 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -60.01 -46.78 88.38 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.046 -0.979 . . . . 2.4100000000000001 113.176 -168.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 138' ' ' PHE . 4.1 mm? -69.92 -29.21 66.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.141 0.496 . . . . 1.8300000000000001 110.545 -177.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -69.76 -40.02 76.37 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.905 -0.589 . . . . 2.0 109.896 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.4 m -63.85 -40.12 95.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.098 -0.955 . . . . 2.0499999999999998 111.233 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.4 p -75.7 -23.63 56.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.821 0.343 . . . . 1.5900000000000001 111.615 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 60.43 -120.98 25.12 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.757 -0.656 . . . . 1.52 113.327 174.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -69.94 -30.6 68.03 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.4 0.28 . . . . 5.9400000000000004 111.727 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.7 -49.95 75.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 1.8300000000000001 112.054 -174.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -122.93 113.3 18.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.951 0.405 . . . . 2.6400000000000001 110.924 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.9 t -160.01 150.29 18.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.018 -0.734 . . . . 2.02 109.018 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.532 ' HB2' ' HB2' ' A' ' 136' ' ' TYR . 98.5 mtt180 -83.7 137.28 33.84 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.075 -0.343 . . . . 3.6699999999999999 110.075 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.6 119.95 60.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.337 -0.392 . . . . 1.6399999999999999 110.493 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -124.29 129.88 51.53 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.731 -0.84 . . . . 2.5600000000000001 108.731 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.404 HG23 ' CD2' ' A' ' 133' ' ' LEU . 50.8 m -136.71 130.17 31.68 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.623 -0.262 . . . . 1.3899999999999999 111.409 -174.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.471 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 82.4 tt0 -130.76 121.48 25.49 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.125 0.488 . . . . 2.04 109.818 175.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 40.7 p -119.33 139.17 52.38 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.596 -0.729 . . . . 1.5600000000000001 109.993 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -130.05 141.85 13.07 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.243 -0.98 . . . . 1.04 113.349 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.419 HD13 ' CE1' ' A' ' 129' ' ' PHE . 63.7 tp -122.21 128.58 51.36 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.733 -0.469 . . . . 2.27 109.733 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 168' ' ' LEU . 95.6 mt-30 -100.01 126.78 46.25 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.327 -0.62 . . . . 2.4100000000000001 109.327 173.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -126.06 128.81 47.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.388 -0.369 . . . . 4.5700000000000003 110.38 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 2.4 p -85.3 88.59 7.51 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.348 0.594 . . . . 1.46 111.071 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.414 ' HB2' HD11 ' A' ' 168' ' ' LEU . 58.2 t80 -60.07 -49.94 75.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.579 -0.737 . . . . 2.6299999999999999 111.618 -176.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.616 ' HB2' HG22 ' A' ' 166' ' ' VAL . 92.7 m-20 -102.61 14.55 31.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.535 -0.302 . . . . 2.4100000000000001 110.851 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 72.98 -49.03 0.7 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.893 0.746 . . . . 2.5800000000000001 110.487 -176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 27.2 m -72.86 -33.17 65.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.176 -0.465 . . . . 2.2999999999999998 111.037 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.616 HG22 ' HB2' ' A' ' 163' ' ' ASN . 13.7 m -108.75 138.63 34.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.861 0.362 . . . . 1.71 110.914 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -109.21 137.21 47.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.085 -0.507 . . . . 1.47 110.608 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 159' ' ' GLN . 16.2 mt -103.22 129.96 50.31 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.698 -0.482 . . . . 1.6599999999999999 109.698 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.421 ' HB2' ' HB2' ' A' ' 197' ' ' TYR . 99.1 mtt180 -94.11 105.43 17.43 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.529 -0.545 . . . . 3.2999999999999998 109.529 177.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.3 t -119.31 121.99 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.858 -0.423 . . . . 1.3 109.858 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.578 ' OD1' ' HB2' ' A' ' 195' ' ' ARG . 30.4 p30 -132.3 156.65 46.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.349 0.595 . . . . 2.2200000000000002 112.086 -177.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.555 ' CE1' ' HB3' ' A' ' 193' ' ' GLU . 67.8 t80 -124.3 131.42 53.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.992 -1.003 . . . . 4.6100000000000003 109.586 177.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -113.2 135.01 54.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.154 0.502 . . . . 3.98 110.42 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.7 tp -100.01 116.6 32.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.734 -0.666 . . . . 2.3799999999999999 109.608 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.517 ' OE2' ' HD2' ' A' ' 176' ' ' ARG . 31.7 tt0 -70.02 -40.76 75.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.962 -0.563 . . . . 3.3100000000000001 111.307 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.517 ' HD2' ' OE2' ' A' ' 175' ' ' GLU . 8.8 ptm180 . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.569 -0.741 . . . . 6.5300000000000002 110.525 -169.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.555 ' HB3' ' CE1' ' A' ' 172' ' ' TYR . 36.0 mt-10 . . . . . 0 C--O 1.233 0.234 0 CA-C-O 121.115 0.483 . . . . 4.4000000000000004 110.777 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 48.5 mm -105.76 127.89 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.616 -0.72 . . . . 2.21 110.646 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.578 ' HB2' ' OD1' ' A' ' 171' ' ' ASN . 25.2 mtm180 -110.87 129.32 55.9 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.549 -0.537 . . . . 3.54 109.549 174.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 169' ' ' ARG . . . -118.4 134.49 55.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.085 -0.507 . . . . 1.6699999999999999 110.924 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.421 ' HB2' ' HB2' ' A' ' 169' ' ' ARG . 87.6 m-85 -133.59 143.32 48.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.626 -0.715 . . . . 5.8300000000000001 109.56 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.623 ' O ' ' HA ' ' A' ' 208' ' ' THR . 42.3 tp -119.92 124.22 28.01 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.178 -0.675 . . . . 2.5899999999999999 109.178 171.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -93.28 105.41 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.905 1.737 . . . . 1.77 112.449 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.8 tp -96.11 121.89 38.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.043 -0.526 . . . . 2.2599999999999998 109.648 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 89.6 m -99.9 118.85 37.2 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.275 0.559 . . . . 1.99 110.845 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 94.4 mt -125.7 81.07 1.95 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.191 -1.04 . . . . 2.3100000000000001 108.191 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 74.35 -126.87 9.55 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.705 -0.958 . . . . 1.51 110.705 -172.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -95.08 -0.11 53.87 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.304 0.573 . . . . 2.5699999999999998 109.531 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -99.34 119.18 37.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.518 -0.764 . . . . 2.6600000000000001 109.554 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 32.1 t -112.49 139.93 47.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.935 0.398 . . . . 1.6200000000000001 110.525 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.92 123.12 70.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.658 -0.867 . . . . 1.3799999999999999 108.658 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 198' ' ' LEU . 42.6 m -126.86 93.02 43.18 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-O 120.788 0.327 . . . . 1.1799999999999999 110.721 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 29.0 Cg_endo -69.82 149.87 67.1 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.841 1.694 . . . . 1.01 111.378 175.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -126.0 138.05 53.71 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.729 -0.669 . . . . 4.5 109.987 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 59.2 p -130.01 143.57 50.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.204 -0.453 . . . . 1.8899999999999999 110.012 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -95.16 -15.35 23.38 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.939 -0.573 . . . . 4.7999999999999998 109.922 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.0 mt . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.73 -0.668 . . . . 4.5700000000000003 110.087 170.691 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 62.6 t . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.768 -0.456 . . . . 2.3999999999999999 109.768 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -85.47 138.85 16.83 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.327 -0.939 . . . . 1.27 110.987 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 255' ' ' TYR . 92.6 mt -119.69 129.48 54.56 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.494 -0.482 . . . . 1.97 110.013 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.453 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 65.2 t80 -107.37 131.19 54.52 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.361 -0.607 . . . . 3.54 109.361 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -120.0 140.12 51.46 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.824 -0.435 . . . . 2.6400000000000001 109.824 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -125.91 128.28 6.41 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.247 -0.978 . . . . 1.3500000000000001 112.48 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -111.39 117.0 31.89 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.507 -0.553 . . . . 4.3600000000000003 109.507 173.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.47 133.87 55.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.781 0.324 . . . . 4.29 110.307 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -119.93 139.92 51.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.337 -0.392 . . . . 6.6900000000000004 110.384 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -64.86 -13.24 55.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.757 -0.656 . . . . 6.3700000000000001 110.561 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -69.98 -10.93 60.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.712 -0.676 . . . . 5.8300000000000001 110.567 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 104.7 -2.54 42.06 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.696 -0.764 . . . . 2.6600000000000001 112.259 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 61.8 tp -95.18 120.02 34.68 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.015 -0.365 . . . . 2.9700000000000002 110.015 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 8.6 t -121.6 129.94 53.17 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.437 -0.579 . . . . 2.1699999999999999 109.437 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.6 t -124.37 132.54 71.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.026 0.441 . . . . 1.79 110.882 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 51.9 m -110.23 129.06 55.79 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.876 -0.602 . . . . 1.6299999999999999 109.865 178.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 75.0 mt -120.0 130.34 54.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.312 -0.403 . . . . 2.96 111.027 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -101.84 124.85 48.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.438 -0.347 . . . . 4.0800000000000001 110.073 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' TYR . . . . . 0.454 ' HB3' ' HB2' ' A' ' 239' ' ' LEU . 61.2 t80 -104.33 129.97 52.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.547 . . . . 4.8399999999999999 109.588 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.588 0 CA-C-N 116.371 -0.377 . . . . 3.5800000000000001 111.458 -176.12 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 109.833 -0.432 . . . . 1.9399999999999999 109.833 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.1 116.64 1.99 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.897 -1.144 . . . . 1.4199999999999999 111.895 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 62.6 t -129.92 130.0 66.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.638 0.256 . . . . 1.8100000000000001 110.826 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.09 126.97 5.41 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.807 -0.917 . . . . 1.3 110.807 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.6 t -118.19 120.05 63.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 117.099 0.449 . . . . 1.8300000000000001 110.954 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ASN . . . . . 0.522 ' OD1' ' HA3' ' A' ' 12' ' ' GLY . 96.3 m-20 -119.3 129.98 55.16 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.579 -0.526 . . . . 2.3100000000000001 109.579 176.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -112.08 116.44 30.52 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.193 -0.669 . . . . 4.75 109.193 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 15.3 t -121.71 130.3 53.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.101 -0.499 . . . . 1.6699999999999999 110.382 -176.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 65.1 t80 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.245 -0.883 . . . . 3.6899999999999999 108.939 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 CA--C 1.523 -0.095 0 CA-C-O 120.799 0.333 . . . . 3.6099999999999999 110.698 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -77.56 121.57 24.08 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.598 -0.89 . . . . 3.3300000000000001 108.598 171.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.543 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 32.7 m170 -98.38 131.63 44.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.218 0.532 . . . . 3.2000000000000002 111.246 -174.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -139.65 159.91 41.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.642 -0.708 . . . . 2.4900000000000002 110.644 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.535 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 3.0 t-20 -145.88 129.7 17.22 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.48 -0.563 . . . . 2.1299999999999999 109.48 172.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.4 mt -120.56 122.53 68.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.326 -0.62 . . . . 1.6000000000000001 109.326 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -130.15 137.3 9.42 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 119.85 -1.167 . . . . 0.88 112.827 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.57 136.29 54.84 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.789 -0.449 . . . . 1.0800000000000001 109.789 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 57.5 ttm -143.44 150.65 39.32 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.746 -0.464 . . . . 2.3300000000000001 109.746 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -106.69 119.99 40.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.115 -0.328 . . . . 2.6099999999999999 110.115 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 116.436 -0.347 . . . . 5.0899999999999999 110.209 -177.916 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 9.7 tp10 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.711 -0.477 . . . . 3.48 109.711 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 32' ' ' GLU . 26.8 Cg_exo -64.59 134.32 40.63 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.551 2.168 . . . . 1.8600000000000001 112.383 175.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 m -121.35 142.97 49.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.047 -0.524 . . . . 1.97 109.706 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.0 p -135.39 141.87 41.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.065 0.46 . . . . 1.71 110.943 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -137.85 147.61 44.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.979 -0.555 . . . . 4.0700000000000003 110.694 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -119.91 140.08 51.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.965 -0.562 . . . . 2.8599999999999999 111.238 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.535 ' HB2' ' HB3' ' A' ' 10' ' ' ASN . 28.6 m-80 -121.52 140.44 52.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.723 -0.671 . . . . 1.8899999999999999 110.095 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -137.87 140.93 40.69 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.987 -0.285 . . . . 1.0800000000000001 110.394 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.54 122.04 2.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.124 -0.489 . . . . 1.3899999999999999 110.669 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.694 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 43.4 t30 -149.95 92.12 1.86 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.23 -0.656 . . . . 2.8599999999999999 109.23 171.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.86 -78.96 0.28 Allowed Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.093 -0.803 . . . . 1.6799999999999999 111.093 -174.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.694 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 24.9 Cg_endo -61.96 175.57 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.526 2.817 . . . . 1.6599999999999999 112.94 171.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.454 ' HB3' ' O ' ' A' ' 75' ' ' HIS . 8.4 m-90 -69.41 -172.99 0.51 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.518 -0.765 . . . . 3.3999999999999999 111.15 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -106.64 122.34 46.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.779 0.8 . . . . 3.1000000000000001 111.237 -167.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 87.5 mt -111.81 136.09 49.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.417 -1.265 . . . . 1.8 109.895 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' A' ' 73' ' ' GLU . . . -117.22 132.48 56.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.087 -0.506 . . . . 0.85999999999999999 109.877 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.5 tp -119.49 131.7 55.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.059 -0.519 . . . . 1.0600000000000001 110.489 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.54 163.64 39.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.763 -0.653 . . . . 1.1399999999999999 109.537 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -157.05 150.6 24.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.644 0.259 . . . . 4.0199999999999996 110.396 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -130.04 150.02 51.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.911 -0.586 . . . . 4.6100000000000003 110.603 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -125.31 124.38 41.48 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.472 -0.785 . . . . 3.3799999999999999 109.301 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.727 -0.67 . . . . 5.0499999999999998 111.073 -175.577 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 75.8 m95 . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 120.963 0.411 . . . . 5.6100000000000003 110.85 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -120.02 140.02 51.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.839 -0.619 . . . . 3.7799999999999998 110.342 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -134.8 160.05 39.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.574 -0.739 . . . . 2.4500000000000002 109.861 -174.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 17.1 ptp180 -148.48 125.09 5.39 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.871 0.367 . . . . 3.2400000000000002 110.626 171.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.444 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 89.3 Cg_endo -93.02 153.77 2.65 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.941 2.428 . . . . 1.1899999999999999 112.313 171.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 93' ' ' ARG . 43.8 mt-10 -118.91 125.51 49.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.295 -0.411 . . . . 2.1899999999999999 110.123 175.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.412 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 64.0 tp -122.12 112.59 18.4 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.019 -0.537 . . . . 1.1399999999999999 109.981 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 80.0 mt-10 -108.5 132.72 53.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.003 0.43 . . . . 2.1800000000000002 111.28 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.42 124.59 72.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.894 -0.78 . . . . 1.5600000000000001 108.894 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' A' ' 44' ' ' TRP . 28.1 m-70 -106.32 119.1 38.36 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.84 -0.43 . . . . 3.4399999999999999 109.84 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 79.4 t80 -100.45 122.53 43.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.769 -0.65 . . . . 4.7999999999999998 110.35 -176.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -109.21 128.68 55.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.592 -0.731 . . . . 2.9399999999999999 109.693 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -143.37 129.95 20.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.069 -0.252 . . . . 3.8999999999999999 111.224 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 N--CA 1.465 0.309 0 CA-C-N 115.606 -0.724 . . . . 4.4800000000000004 111.703 177.67 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 120.878 0.37 . . . . 2.5499999999999998 110.747 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -123.06 148.33 45.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.056 -0.52 . . . . 5.2999999999999998 110.292 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.94 163.8 28.28 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.548 -0.834 . . . . 1.3500000000000001 111.959 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.502 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 65.1 tp -145.61 128.6 16.5 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.472 -0.566 . . . . 2.29 109.472 174.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 p -118.31 128.53 54.75 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.308 0.575 . . . . 1.54 110.9 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.84 132.63 8.48 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.571 -0.823 . . . . 1.1699999999999999 111.319 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -128.14 127.42 5.71 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 111.497 -0.641 . . . . 1.1899999999999999 111.497 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -111.09 130.28 55.66 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.888 0.375 . . . . 3.75 110.483 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.516 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 91.0 mtt180 -122.95 126.88 48.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.615 -0.72 . . . . 2.75 109.12 175.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 64.9 t30 -107.33 129.94 54.84 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.337 -0.616 . . . . 1.8200000000000001 109.337 -178.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.424 ' HB3' ' HB3' ' A' ' 110' ' ' MET . 54.5 t80 -137.05 146.05 44.74 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.416 -0.514 . . . . 3.1400000000000001 110.576 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.517 0 C-N-CA 120.622 -0.799 . . . . 2.79 112.495 177.7 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 109.591 -0.522 . . . . 3.2999999999999998 109.591 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.39 116.38 7.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.667 -0.242 . . . . 1.76 110.589 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -117.67 130.54 56.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.443 -0.344 . . . . 2.5499999999999998 110.085 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.611 ' HG3' ' H ' ' A' ' 139' ' ' ALA . 46.3 ttm -132.56 122.34 24.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.831 0.348 . . . . 1.77 111.624 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 56.7 mt-30 -103.54 118.71 37.35 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.036 -0.727 . . . . 1.97 109.036 170.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 31.4 ttm180 -113.77 120.73 41.8 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.124 0.488 . . . . 3.8500000000000001 110.168 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -119.14 139.62 51.5 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.728 -0.669 . . . . 2.2799999999999998 110.409 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 135' ' ' MET . 82.0 tttt -128.84 123.68 33.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.717 -0.674 . . . . 2.1400000000000001 109.559 172.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.9 mm -124.21 128.15 73.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.016 -0.538 . . . . 1.55 109.698 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -142.71 106.47 5.42 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 120.681 0.277 . . . . 1.1899999999999999 111.493 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.63 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 65.2 Cg_endo -76.8 132.53 13.16 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.977 1.784 . . . . 1.3700000000000001 110.467 172.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -92.38 137.31 32.47 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.538 -0.541 . . . . 2.3500000000000001 109.538 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -128.44 129.99 46.94 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.862 -0.422 . . . . 4.54 109.862 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -137.49 119.76 15.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.843 0.354 . . . . 3.04 110.481 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.9 t -129.56 128.28 65.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.732 -0.667 . . . . 4.2699999999999996 109.659 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -114.99 96.86 5.91 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.789 -0.448 . . . . 6.04 109.789 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.99 -33.24 71.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.557 0.694 . . . . 4.5899999999999999 109.683 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.459 ' HB ' ' H ' ' A' ' 127' ' ' LEU . 8.6 m -140.35 159.88 41.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.18 -0.918 . . . . 3.6899999999999999 108.75 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -60.14 -41.99 93.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.503 0.668 . . . . 5.1699999999999999 109.361 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -69.92 -40.03 75.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.763 -1.108 . . . . 3.71 111.946 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.459 ' H ' ' HB ' ' A' ' 124' ' ' THR . 84.9 mt -104.94 119.43 39.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 2.0499999999999998 110.814 -172.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.489 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 79.4 ttt180 -125.71 133.31 52.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.119 -0.491 . . . . 4.2400000000000002 111.453 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -108.98 119.99 41.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 3.5499999999999998 109.332 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -143.81 135.79 26.5 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.802 -0.444 . . . . 2.1099999999999999 109.802 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -171.8 172.13 44.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.445 -0.883 . . . . 1.1799999999999999 111.689 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -143.0 150.57 39.82 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.991 0.424 . . . . 4.2999999999999998 110.691 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.63 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 47.8 tp -106.0 111.61 24.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.933 -0.576 . . . . 2.2400000000000002 109.511 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.5 t -101.56 121.1 41.37 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.864 0.364 . . . . 1.6899999999999999 110.631 -173.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.423 ' O ' ' HA ' ' A' ' 114' ' ' LYS . 74.8 mtm -111.83 133.24 54.17 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.345 -0.389 . . . . 2.2400000000000002 110.08 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -118.98 134.88 54.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.95 0.405 . . . . 3.5600000000000001 111.411 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 97.3 mttt -138.55 148.35 44.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.078 -0.712 . . . . 1.6699999999999999 109.078 174.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.501 ' H ' HD22 ' A' ' 142' ' ' LEU . 54.8 p90 -150.83 160.02 44.15 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.974 -0.38 . . . . 3.23 109.974 175.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.611 ' H ' ' HG3' ' A' ' 110' ' ' MET . . . 72.16 -178.69 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.876 0.735 . . . . 1.24 110.334 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -76.82 -39.67 50.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.963 0.411 . . . . 2.4700000000000002 111.279 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.0 -49.61 77.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.715 -0.675 . . . . 2.4100000000000001 112.532 -171.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.501 HD22 ' H ' ' A' ' 138' ' ' PHE . 9.5 mp -62.59 -36.35 82.45 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.137 0.494 . . . . 1.8300000000000001 111.129 -177.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -66.13 -39.93 90.26 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.24 0.543 . . . . 2.0 110.388 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 90.9 m -66.75 -42.25 86.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.367 -0.833 . . . . 2.0499999999999998 111.061 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 148' ' ' ALA . 33.9 p -72.72 -28.89 62.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.251 0.548 . . . . 1.5900000000000001 110.6 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.05 -118.05 7.84 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.531 -0.759 . . . . 1.52 113.041 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -70.11 -20.05 63.21 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.553 0.205 . . . . 5.9400000000000004 111.553 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.455 ' HB3' ' HB ' ' A' ' 145' ' ' THR . . . -66.25 -57.32 7.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.462 -0.336 . . . . 1.8300000000000001 111.851 -175.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -117.16 83.84 2.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.461 0.648 . . . . 2.6400000000000001 110.945 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.1 t -145.74 142.44 28.94 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.433 -0.803 . . . . 2.02 109.502 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.411 ' HB3' ' OE2' ' A' ' 153' ' ' GLU . 15.1 mtp180 -76.59 131.97 39.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.872 0.368 . . . . 3.6699999999999999 110.626 176.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.09 115.85 49.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.744 -0.662 . . . . 1.6399999999999999 109.499 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.411 ' OE2' ' HB3' ' A' ' 151' ' ' ARG . 17.8 mm-40 -113.03 129.1 56.62 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.08 -0.711 . . . . 2.5600000000000001 109.08 -177.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 174' ' ' LEU . 21.4 m -113.34 120.03 39.72 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 121.07 -0.252 . . . . 1.3899999999999999 110.745 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -116.45 122.13 43.88 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.741 -0.466 . . . . 2.04 109.741 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 55.3 m -119.58 128.22 53.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.182 -0.463 . . . . 1.5600000000000001 110.544 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -115.33 128.47 8.09 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.968 -0.56 . . . . 1.04 111.868 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 79.6 mt -118.27 134.66 54.84 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.634 -0.506 . . . . 2.27 109.634 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 63.1 tt0 -115.07 125.85 54.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.941 -0.392 . . . . 2.4100000000000001 109.941 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -130.3 133.79 46.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.252 -0.431 . . . . 4.5700000000000003 110.255 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.0 p -90.73 87.65 6.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.178 0.513 . . . . 1.46 109.617 171.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -60.33 -49.57 77.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.702 -0.681 . . . . 2.6299999999999999 111.367 -173.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.496 ' HB2' HG22 ' A' ' 166' ' ' VAL . 22.8 m120 -101.84 17.1 23.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.457 -0.338 . . . . 2.4100000000000001 110.499 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 72.4 -53.87 0.69 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 123.908 0.755 . . . . 2.5800000000000001 111.415 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.7 p -75.05 -15.96 60.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.348 -0.387 . . . . 2.2999999999999998 111.94 -176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.496 HG22 ' HB2' ' A' ' 163' ' ' ASN . 33.2 m -125.53 140.4 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.559 -0.291 . . . . 1.71 110.481 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.26 128.35 53.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.951 0.405 . . . . 1.47 110.48 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 22.1 mt -105.61 137.16 43.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.901 -0.591 . . . . 1.6599999999999999 109.476 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -110.64 116.12 30.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.961 0.41 . . . . 3.2999999999999998 110.264 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 63.0 t -124.01 129.87 74.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.886 -0.412 . . . . 1.3 109.886 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.411 ' OD1' ' HB2' ' A' ' 195' ' ' ARG . 25.9 p30 -134.09 156.09 48.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.875 0.369 . . . . 2.2200000000000002 110.969 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -145.34 150.02 35.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.183 -0.462 . . . . 4.6100000000000003 111.017 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -105.2 126.38 52.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.725 -0.671 . . . . 3.98 111.615 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.449 ' HB2' ' HB ' ' A' ' 154' ' ' THR . 93.3 mt -113.62 130.48 56.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.784 -0.644 . . . . 2.3799999999999999 110.151 175.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -100.39 128.87 46.35 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.272 -0.64 . . . . 3.3100000000000001 109.272 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 . . . . . 0 C--N 1.326 -0.437 0 CA-C-O 120.807 0.337 . . . . 6.5300000000000002 110.562 -179.297 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 121.251 0.548 . . . . 4.4000000000000004 110.892 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 82.2 mt -120.05 129.99 74.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.61 -0.723 . . . . 2.21 109.493 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.411 ' HB2' ' OD1' ' A' ' 171' ' ' ASN . 85.1 mtm180 -96.3 115.05 26.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.778 0.323 . . . . 3.54 110.6 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -108.39 124.02 49.73 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.599 -0.519 . . . . 1.6699999999999999 109.599 174.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -147.53 151.93 37.15 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.75 0.31 . . . . 5.8300000000000001 110.612 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 209' ' ' PRO . 1.8 pt? -129.66 128.37 23.03 Favored Pre-proline 0 C--N 1.321 -0.668 0 C-N-CA 120.98 -0.288 . . . . 2.5899999999999999 110.538 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.16 105.99 2.14 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.4 2.067 . . . . 1.77 111.427 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 56.9 tp -99.18 120.07 38.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.794 -0.639 . . . . 2.2599999999999998 109.512 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 19.6 p -99.95 123.93 44.73 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.943 0.401 . . . . 1.99 111.37 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 62.8 tp -130.29 81.84 2.03 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.032 -0.729 . . . . 2.3100000000000001 109.032 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 70.03 -125.2 15.29 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.409 -0.814 . . . . 1.51 112.283 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -86.82 -0.3 56.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.253 0.549 . . . . 2.5699999999999998 110.051 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -103.0 117.44 34.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.74 -0.664 . . . . 2.6600000000000001 110.112 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 63.3 m -107.9 123.75 49.08 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.779 -0.452 . . . . 1.6200000000000001 109.779 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 50.6 t -119.3 129.97 74.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 1.3799999999999999 109.854 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 25.3 m -126.62 91.29 47.73 Favored Pre-proline 0 C--N 1.318 -0.769 0 C-N-CA 120.965 -0.294 . . . . 1.1799999999999999 110.722 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 38.4 Cg_endo -70.8 146.33 53.49 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.128 1.885 . . . . 1.01 111.694 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -112.41 139.62 47.83 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.847 0.356 . . . . 4.5 110.344 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 21.1 p -134.58 125.25 26.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.762 -0.653 . . . . 1.8899999999999999 110.731 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -70.12 -36.12 74.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.255 -0.884 . . . . 4.7999999999999998 109.942 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 86.3 mt . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.399 -0.819 . . . . 4.5700000000000003 109.451 176.396 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.994 0.426 . . . . 2.3999999999999999 111.061 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -92.3 146.19 18.06 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.898 -0.668 . . . . 1.27 111.999 -177.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 89.3 mt -119.47 131.3 55.58 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.306 0.574 . . . . 1.97 111.129 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.416 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 61.9 t80 -108.75 130.16 55.37 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.413 -0.812 . . . . 3.54 109.767 173.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.51 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 96.1 m-85 -119.67 140.05 51.26 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.498 -0.927 . . . . 2.6400000000000001 108.498 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.44 167.05 33.42 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.64 -1.267 . . . . 1.3500000000000001 112.945 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -121.5 112.24 18.26 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.695 -0.483 . . . . 4.3600000000000003 109.695 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -120.87 13.88 11.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.242 0.544 . . . . 4.29 109.815 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.96 -40.33 88.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.356 -0.838 . . . . 6.6900000000000004 110.391 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -102.88 135.85 43.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.629 -0.714 . . . . 6.3700000000000001 109.747 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -70.01 -19.08 63.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 5.8300000000000001 111.535 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -96.66 2.81 62.66 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.704 -0.76 . . . . 2.6600000000000001 112.718 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 62.8 tp -131.2 129.94 42.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.818 0.342 . . . . 2.9700000000000002 110.648 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 48.9 m -134.94 130.4 35.78 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.399 -0.593 . . . . 2.1699999999999999 109.399 173.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.5 t -130.02 133.1 64.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 120.837 -0.345 . . . . 1.79 110.906 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 11.1 p -115.92 109.99 18.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.119 0.485 . . . . 1.6299999999999999 110.857 176.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 79.3 mt -105.54 120.06 40.69 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.049 -0.723 . . . . 2.96 109.049 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -113.64 112.83 24.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.548 -0.296 . . . . 4.0800000000000001 111.173 -172.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -127.15 110.08 12.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.039 -0.528 . . . . 4.8399999999999999 109.76 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.547 0 CA-C-O 120.832 0.349 . . . . 3.5800000000000001 111.619 179.083 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 110.178 -0.305 . . . . 1.9399999999999999 110.178 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -157.69 167.15 34.09 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.32 -0.943 . . . . 1.4199999999999999 112.399 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.452 HG12 HD22 ' A' ' 253' ' ' LEU . 34.7 m -128.9 140.01 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.94 0.4 . . . . 1.8100000000000001 111.133 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.92 140.01 11.41 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.321 -0.712 . . . . 1.3 111.321 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.4 t -128.01 129.94 69.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.908 0.354 . . . . 1.8300000000000001 110.884 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -126.42 130.56 50.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.026 -0.534 . . . . 2.3100000000000001 111.004 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -113.55 129.19 56.6 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.423 -0.584 . . . . 4.75 109.423 172.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 50.8 m -120.84 141.25 50.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.319 -0.4 . . . . 1.6699999999999999 110.485 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 91.0 m-85 . . . . . 0 C--O 1.247 0.96 0 CA-C-O 117.785 -1.103 . . . . 3.6899999999999999 109.584 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 . . . . . 0 CA--C 1.518 -0.267 0 CA-C-O 121.187 0.518 . . . . 3.6099999999999999 110.009 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.452 ' HA ' ' HB2' ' A' ' 41' ' ' ASN . 44.6 m95 -62.72 139.98 58.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.291 -0.868 . . . . 3.3300000000000001 111.471 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.35 135.64 36.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.125 -0.489 . . . . 3.2000000000000002 110.0 175.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.92 139.94 51.65 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.854 -0.612 . . . . 2.4900000000000002 110.683 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -126.64 129.83 49.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.276 -0.42 . . . . 2.1299999999999999 110.468 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.6 mt -121.0 120.09 61.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.058 -0.719 . . . . 1.6000000000000001 109.058 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.3 129.36 9.44 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.23 -0.986 . . . . 0.88 111.475 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.1 134.83 54.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.162 0.506 . . . . 1.0800000000000001 110.636 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 68.0 mtt -126.63 141.38 51.87 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.566 -0.743 . . . . 2.3300000000000001 109.492 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -119.32 127.93 53.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.619 -0.264 . . . . 2.6099999999999999 110.586 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 . . . . . 0 C--N 1.329 -0.302 0 O-C-N 123.804 0.69 . . . . 5.0899999999999999 111.26 172.431 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 C--O 1.236 0.348 0 CA-C-O 120.604 0.24 . . . . 3.48 110.559 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.2 135.87 15.6 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.883 2.389 . . . . 1.8600000000000001 111.211 170.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.1 t -140.45 149.88 43.12 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 121.097 -0.241 . . . . 1.97 110.848 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.2 m -126.56 139.93 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 1.71 110.824 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -119.75 147.04 45.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.989 -0.551 . . . . 4.0700000000000003 110.105 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -119.29 139.36 52.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.792 0.33 . . . . 2.8599999999999999 111.103 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -150.16 142.45 24.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.967 -0.56 . . . . 1.8899999999999999 110.266 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -148.29 143.73 27.13 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.959 -0.109 . . . . 1.0800000000000001 110.993 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.56 135.14 7.45 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.972 0.36 . . . . 1.3899999999999999 111.972 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.61 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 41.4 t30 -168.85 94.64 0.34 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.88 -0.6 . . . . 2.8599999999999999 110.096 170.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.85 -91.75 1.5 Allowed Glycine 0 CA--C 1.517 0.184 0 C-N-CA 120.901 -0.666 . . . . 1.6799999999999999 111.709 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 72.9 Cg_exo -50.44 176.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.608 2.872 . . . . 1.6599999999999999 113.456 169.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -67.1 170.8 6.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.621 -0.718 . . . . 3.3999999999999999 111.289 -171.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -113.11 130.03 56.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.8 -0.636 . . . . 3.1000000000000001 110.511 -173.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.5 tt -116.58 131.47 69.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.384 -0.825 . . . . 1.8 110.492 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -118.38 128.6 54.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.002 -0.544 . . . . 0.85999999999999999 110.697 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.8 tp -103.65 126.59 50.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.951 -0.568 . . . . 1.0600000000000001 110.242 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.0 168.39 19.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.098 0.475 . . . . 1.1399999999999999 110.928 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -164.31 160.01 20.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.867 -0.606 . . . . 4.0199999999999996 110.109 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.551 ' HB3' ' CG ' ' A' ' 69' ' ' ARG . 61.8 t80 -130.33 129.77 43.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.87 -0.419 . . . . 4.6100000000000003 109.87 177.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -130.85 159.74 36.49 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.972 -0.558 . . . . 3.3799999999999999 110.601 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 115.302 -0.863 . . . . 5.0499999999999998 109.174 176.719 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 95.2 m95 . . . . . 0 CA--C 1.517 -0.314 0 N-CA-C 110.095 -0.335 . . . . 5.6100000000000003 110.095 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -116.69 140.04 49.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.243 0.544 . . . . 3.7799999999999998 110.464 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -139.72 170.42 15.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.533 -0.758 . . . . 2.4500000000000002 109.373 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.551 ' CG ' ' HB3' ' A' ' 51' ' ' TYR . 3.2 ptp180 -129.98 125.95 22.23 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 120.419 -0.512 . . . . 3.2400000000000002 111.161 175.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.4 140.03 5.24 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.918 2.412 . . . . 1.1899999999999999 110.835 167.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.486 ' CD ' ' HE ' ' A' ' 93' ' ' ARG . 76.7 mt-10 -126.87 130.0 49.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.738 -0.468 . . . . 2.1899999999999999 109.738 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 47' ' ' ALA . 57.8 tp -133.54 120.85 21.3 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.562 -0.29 . . . . 1.1399999999999999 110.339 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -119.49 130.02 55.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.994 0.426 . . . . 2.1800000000000002 110.267 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 89' ' ' THR . 62.1 t -120.0 129.52 75.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.931 -0.577 . . . . 1.5600000000000001 110.062 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -113.99 122.26 46.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.155 -0.475 . . . . 3.4399999999999999 111.169 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -108.38 146.22 33.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.642 -0.708 . . . . 4.7999999999999998 109.705 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -117.14 137.39 52.35 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.029 -0.36 . . . . 2.9399999999999999 110.029 173.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.617 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 93.2 m-85 -134.87 91.01 2.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.208 -0.451 . . . . 3.8999999999999999 110.422 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 78' ' ' PHE . 10.0 mt . . . . . 0 N--CA 1.471 0.591 0 C-N-CA 124.786 1.234 . . . . 4.4800000000000004 109.354 171.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 121.0 0.428 . . . . 2.5499999999999998 111.574 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -110.17 150.18 29.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.614 -0.884 . . . . 5.2999999999999998 108.614 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -150.14 169.69 30.17 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.724 -1.227 . . . . 1.3500000000000001 112.818 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 97.4 mt -131.43 122.47 26.32 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.405 -0.591 . . . . 2.29 109.405 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 92.9 m -120.11 129.98 54.42 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.001 0.429 . . . . 1.54 110.254 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -121.67 133.57 9.52 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.771 -0.728 . . . . 1.1699999999999999 111.484 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.58 130.66 8.76 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.655 -0.783 . . . . 1.1899999999999999 112.462 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 68.3 m-85 -112.01 127.24 55.82 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.768 -0.456 . . . . 3.75 109.768 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.486 ' HE ' ' CD ' ' A' ' 71' ' ' GLU . 40.1 ttm180 -142.71 124.87 15.38 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.561 -0.163 . . . . 2.75 110.561 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.507 ' OD1' ' HA ' ' A' ' 111' ' ' GLN . 93.5 m-20 -132.65 129.83 39.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.293 -0.262 . . . . 1.8200000000000001 110.293 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -126.69 135.39 51.08 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.306 -0.627 . . . . 3.1400000000000001 109.306 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.439 0 C-N-CA 120.745 -0.74 . . . . 2.79 112.414 -178.364 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.5 p . . . . . 0 N--CA 1.447 -0.602 0 CA-C-O 120.951 0.405 . . . . 3.2999999999999998 110.514 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.16 160.94 33.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.793 -0.639 . . . . 1.76 109.775 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -120.12 129.99 54.42 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.572 -0.529 . . . . 2.5499999999999998 109.572 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 89.0 mtp -104.52 129.44 52.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.742 0.306 . . . . 1.77 110.413 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.507 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 99.5 mt-30 -95.66 123.14 39.08 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.823 -0.626 . . . . 1.97 111.047 -176.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 85.7 mtt180 -116.29 114.3 24.17 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.659 -0.497 . . . . 3.8500000000000001 109.659 173.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.457 ' NE1' ' HB3' ' A' ' 111' ' ' GLN . 83.8 m95 -107.44 136.88 46.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.68 -0.691 . . . . 2.2799999999999998 110.86 -173.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -120.53 123.36 42.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.823 -0.626 . . . . 2.1400000000000001 110.196 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 134' ' ' SER . 88.2 mt -120.07 120.35 62.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.077 -0.712 . . . . 1.55 109.077 174.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -145.76 108.05 4.36 Favored Pre-proline 0 C--N 1.325 -0.488 0 C-N-CA 120.723 -0.391 . . . . 1.1899999999999999 111.814 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.675 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 69.3 Cg_endo -77.64 139.93 18.4 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.067 1.845 . . . . 1.3700000000000001 110.185 171.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.88 137.44 32.36 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.229 -0.442 . . . . 2.3500000000000001 110.045 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -127.16 127.54 44.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.302 -0.408 . . . . 4.54 109.968 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -126.82 109.59 12.16 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.347 -0.612 . . . . 3.04 109.347 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.7 t -120.58 117.62 53.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.128 -0.487 . . . . 4.2699999999999996 110.321 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -117.34 96.09 5.26 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.651 -0.499 . . . . 6.04 109.651 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.42 -39.95 85.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.647 -0.706 . . . . 4.5899999999999999 110.694 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.1 t -149.71 170.0 19.74 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.381 -0.827 . . . . 3.6899999999999999 108.865 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.98 -39.24 85.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.404 0.621 . . . . 5.1699999999999999 110.046 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.15 -31.11 68.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.627 -1.169 . . . . 3.71 111.57 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 159' ' ' GLN . 85.0 mt -119.98 119.79 34.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 2.0499999999999998 112.061 -171.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.478 ' HB2' ' HB3' ' A' ' 159' ' ' GLN . 89.8 mtt180 -111.6 109.61 19.6 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.855 -0.794 . . . . 4.2400000000000002 108.855 170.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -109.43 122.4 47.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.187 0.518 . . . . 3.5499999999999998 111.037 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -125.12 139.91 53.35 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.764 -0.653 . . . . 2.1099999999999999 109.522 173.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -147.65 133.6 4.77 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.576 -0.821 . . . . 1.1799999999999999 111.573 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 29.3 m-90 -120.03 127.61 52.75 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.936 0.398 . . . . 4.2999999999999998 111.062 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.675 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 58.2 tp -101.3 118.57 37.24 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.438 -0.949 . . . . 2.2400000000000002 108.438 173.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 42.9 m -120.49 130.01 54.1 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.036 0.446 . . . . 1.6899999999999999 111.177 -175.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.649 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 76.5 mtm -106.3 130.24 54.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.595 -0.729 . . . . 2.2400000000000002 109.394 173.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -120.07 139.9 51.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.35 -0.386 . . . . 3.5600000000000001 111.346 -175.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 96.7 mttt -129.55 160.04 34.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.71 -0.677 . . . . 1.6699999999999999 109.271 174.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.462 ' H ' HD22 ' A' ' 142' ' ' LEU . 53.0 p90 -143.96 160.07 41.47 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.487 -0.56 . . . . 3.23 109.487 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 63.56 -178.57 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.893 0.746 . . . . 1.24 111.504 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -74.99 -39.93 60.98 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.117 0.484 . . . . 2.4700000000000002 111.343 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -59.98 -41.93 93.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.529 -0.759 . . . . 2.4100000000000001 113.034 -168.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.462 HD22 ' H ' ' A' ' 138' ' ' PHE . 9.4 mp -69.98 -30.13 67.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.878 0.37 . . . . 1.8300000000000001 111.352 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -70.03 -40.07 75.4 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.805 -0.358 . . . . 2.0 110.101 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 33.7 p -73.48 -31.15 63.6 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.569 0.581 . . . . 2.0499999999999998 112.569 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 35.1 p -79.46 -10.03 59.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.898 0.38 . . . . 1.5900000000000001 111.412 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 91.14 -137.06 13.66 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.689 -0.767 . . . . 1.52 112.449 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -89.93 -1.27 57.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.842 0.353 . . . . 5.9400000000000004 110.379 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.56 -47.7 82.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.934 -0.576 . . . . 1.8300000000000001 111.153 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -108.43 81.96 1.55 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.073 0.463 . . . . 2.6400000000000001 110.477 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.5 t -149.5 150.01 31.64 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.2 -0.455 . . . . 2.02 109.996 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 135' ' ' MET . 42.8 mtt180 -80.84 134.89 35.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.355 -0.384 . . . . 3.6699999999999999 110.309 174.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.83 102.85 14.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.055 -0.72 . . . . 1.6399999999999999 109.055 173.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.596 ' OE1' ' HD3' ' A' ' 151' ' ' ARG . 83.9 mt-10 -124.74 141.51 52.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.112 -0.495 . . . . 2.5600000000000001 110.248 -174.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 174' ' ' LEU . 21.8 m -130.08 139.91 50.89 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 121.014 -0.274 . . . . 1.3899999999999999 110.844 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -119.85 131.44 55.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.18 -0.674 . . . . 2.04 109.18 171.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.2 p -117.82 121.12 39.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.224 -0.444 . . . . 1.5600000000000001 110.906 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -113.38 120.1 5.05 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.123 -0.791 . . . . 1.04 111.123 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 68.8 tp -123.5 129.44 51.23 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.966 0.412 . . . . 2.27 110.941 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 128' ' ' ARG . 53.4 tt0 -102.87 118.37 36.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.718 -0.845 . . . . 2.4100000000000001 108.718 171.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -122.26 137.52 54.81 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.915 0.388 . . . . 4.5700000000000003 110.039 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . 1.6 m -98.26 89.22 4.4 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.33 0.586 . . . . 1.46 109.835 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -67.58 -48.75 65.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.377 -0.828 . . . . 2.6299999999999999 112.218 -171.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.477 ' HB2' HG22 ' A' ' 166' ' ' VAL . 93.6 m-20 -99.9 8.98 43.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.424 -0.353 . . . . 2.4100000000000001 110.98 -175.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 73.6 -39.71 0.44 Allowed 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.865 0.728 . . . . 2.5800000000000001 110.727 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.4 p -75.32 -40.13 58.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.194 -0.457 . . . . 2.2999999999999998 111.235 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.477 HG22 ' HB2' ' A' ' 163' ' ' ASN . 31.3 m -120.17 144.48 28.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.115 0.483 . . . . 1.71 111.536 -175.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 161' ' ' THR . . . -119.98 139.47 52.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.463 -0.789 . . . . 1.47 110.591 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 159' ' ' GLN . 3.1 mm? -108.49 130.49 55.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.828 -0.624 . . . . 1.6599999999999999 109.648 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -101.77 113.0 25.79 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.598 -0.519 . . . . 3.2999999999999998 109.598 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 195' ' ' ARG . 63.1 t -120.13 129.8 75.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.338 -0.392 . . . . 1.3 111.257 -177.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -110.88 126.36 54.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.906 -0.588 . . . . 2.2200000000000002 110.065 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -119.2 140.06 50.83 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.813 -0.631 . . . . 4.6100000000000003 109.941 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -97.52 137.0 37.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.057 0.456 . . . . 3.98 111.032 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.494 ' HB2' ' HB ' ' A' ' 154' ' ' THR . 3.4 mm? -106.73 120.02 40.86 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.131 -0.692 . . . . 2.3799999999999999 109.131 173.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.61 -42.55 97.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.603 -0.726 . . . . 3.3100000000000001 110.352 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 . . . . . 0 N--CA 1.446 -0.645 0 CA-C-N 115.136 -0.938 . . . . 6.5300000000000002 110.453 -178.566 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 C--O 1.234 0.277 0 CA-C-O 121.374 0.607 . . . . 4.4000000000000004 111.902 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 85.8 mt -119.98 120.54 63.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.226 -0.897 . . . . 2.21 109.831 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 72.3 mtm180 -102.86 120.15 40.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.752 -0.204 . . . . 3.54 110.745 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -117.26 128.7 55.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.657 0.265 . . . . 1.6699999999999999 110.498 175.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -150.05 159.95 44.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.152 -0.476 . . . . 5.8300000000000001 110.078 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.417 HD23 ' N ' ' A' ' 198' ' ' LEU . 1.8 pt? -147.05 128.5 7.3 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 110.233 -0.284 . . . . 2.5899999999999999 110.233 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.84 106.72 2.18 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.393 2.062 . . . . 1.77 111.89 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 62.6 tp -112.46 140.06 47.51 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.175 -0.676 . . . . 2.2599999999999998 109.175 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 28.6 p -119.97 140.43 50.94 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.466 -0.494 . . . . 1.99 111.658 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 58.9 tp -130.0 81.71 2.03 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.825 -0.806 . . . . 2.3100000000000001 108.825 176.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 75.72 -120.01 5.9 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.512 -0.767 . . . . 1.51 112.3 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -96.72 0.0 48.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.238 0.542 . . . . 2.5699999999999998 110.324 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -111.24 140.28 45.94 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.768 -0.651 . . . . 2.6600000000000001 109.367 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 19.6 p -114.77 151.74 33.26 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.528 -0.305 . . . . 1.6200000000000001 110.731 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 5.3 p -138.78 130.15 35.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.999 0.428 . . . . 1.3799999999999999 110.67 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 56.9 m -122.3 96.72 45.94 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 120.932 0.396 . . . . 1.1799999999999999 110.518 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -60.54 148.11 92.18 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.972 2.448 . . . . 1.01 112.62 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -119.9 139.95 51.62 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.357 -0.608 . . . . 4.5 109.357 174.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 14.0 t -159.41 173.59 16.0 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.591 -0.522 . . . . 1.8899999999999999 109.591 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 212' ' ' ARG . 50.9 mtt180 -126.71 129.57 48.67 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.884 -0.413 . . . . 4.7999999999999998 109.884 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 16.0 tt . . . . . 0 C--N 1.323 -0.571 0 CA-C-N 116.133 -0.485 . . . . 4.5700000000000003 110.355 -177.722 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 63.4 t . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 108.686 -0.857 . . . . 2.3999999999999999 108.686 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -150.25 166.45 30.05 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.005 -1.093 . . . . 1.27 112.098 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.4 mt -134.33 129.13 35.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.921 0.391 . . . . 1.97 110.749 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.496 ' HE2' ' OG ' ' A' ' 252' ' ' SER . 61.2 t80 -108.07 131.95 54.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.938 -0.574 . . . . 3.54 110.234 174.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -119.97 134.01 55.38 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.973 -0.38 . . . . 2.6400000000000001 109.973 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -110.13 121.76 6.09 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.754 -0.736 . . . . 1.3500000000000001 111.749 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' TYR . . . . . 0.441 ' CD1' HD12 ' A' ' 253' ' ' LEU . 91.9 m-85 -121.62 112.13 18.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.821 0.344 . . . . 4.3600000000000003 110.559 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -99.07 97.91 8.99 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.798 -0.445 . . . . 4.29 109.798 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -69.97 -37.0 75.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.015 -0.539 . . . . 6.6900000000000004 111.986 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' GLN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 96.0 mt-30 -137.31 170.54 15.91 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.861 -0.422 . . . . 6.3700000000000001 109.861 -175.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -59.91 -40.17 87.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.159 0.504 . . . . 5.8300000000000001 111.003 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.19 10.9 51.44 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.742 -0.742 . . . . 2.6600000000000001 113.014 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 246' ' ' GLN . 58.5 tp -122.46 115.19 21.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.021 0.411 . . . . 2.9700000000000002 111.499 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 50.0 m -120.24 130.44 54.51 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.695 -0.684 . . . . 2.1699999999999999 109.814 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 99.2 t -113.26 132.14 62.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.189 0.519 . . . . 1.79 110.351 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' SER . . . . . 0.496 ' OG ' ' HE2' ' A' ' 240' ' ' PHE . 42.5 t -101.33 118.77 37.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.242 -0.89 . . . . 1.6299999999999999 110.196 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.441 HD12 ' CD1' ' A' ' 243' ' ' TYR . 84.2 mt -119.6 100.96 7.59 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.0 -0.37 . . . . 2.96 110.0 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -109.5 130.04 55.53 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.034 -0.358 . . . . 4.0800000000000001 110.034 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.0 129.04 56.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.312 -0.404 . . . . 4.8399999999999999 110.405 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 3.5800000000000001 110.852 -179.398 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.833 0.349 . . . . 1.9399999999999999 111.182 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.66 131.54 6.23 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.588 -1.005 . . . . 1.4199999999999999 110.588 174.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.03 128.51 75.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.116 0.484 . . . . 1.8100000000000001 111.207 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -132.75 138.33 10.06 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.337 -0.705 . . . . 1.3 111.337 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.0 t -116.36 120.69 65.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.618 -0.512 . . . . 1.8300000000000001 109.618 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -116.21 129.94 56.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.139 0.495 . . . . 2.3100000000000001 111.069 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.44 ' CE2' HD13 ' A' ' 249' ' ' LEU . 97.8 m-85 -109.35 111.58 23.23 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.548 -0.908 . . . . 4.75 108.548 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.9 t -132.0 139.97 48.78 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.517 -0.473 . . . . 1.6699999999999999 110.683 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 57.5 t80 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.085 -0.959 . . . . 3.6899999999999999 108.784 178.825 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 109.12 -0.696 . . . . 3.6099999999999999 109.12 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 41' ' ' ASN . 82.9 m95 -69.88 119.83 14.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.956 0.408 . . . . 3.3300000000000001 111.549 -173.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -100.99 125.05 47.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.806 -0.634 . . . . 3.2000000000000002 109.661 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -114.92 139.68 49.6 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.26 -0.427 . . . . 2.4900000000000002 110.0 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -126.48 130.5 50.75 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.386 -0.598 . . . . 2.1299999999999999 109.386 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.1 mt -127.89 129.97 69.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.273 -0.421 . . . . 1.6000000000000001 110.681 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.29 140.0 11.46 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.173 -0.771 . . . . 0.88 111.173 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.4 135.58 54.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.014 0.407 . . . . 1.0800000000000001 110.947 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 96.6 mmm -130.1 157.09 43.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.496 -0.774 . . . . 2.3300000000000001 109.702 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -114.56 142.22 46.71 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.436 0.636 . . . . 2.6099999999999999 110.374 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 114.697 -1.138 . . . . 5.0899999999999999 111.754 -175.015 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 110.012 -0.366 . . . . 3.48 110.012 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.73 142.09 47.12 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.153 1.902 . . . . 1.8600000000000001 111.58 173.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.3 t -119.97 143.49 47.99 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.618 -0.512 . . . . 1.97 109.618 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.34 133.73 61.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.392 0.615 . . . . 1.71 111.453 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -111.64 126.2 54.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.275 -0.875 . . . . 4.0700000000000003 108.711 174.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -133.51 130.08 38.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.568 0.223 . . . . 2.8599999999999999 111.212 -174.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 9.9 p30 -145.59 156.48 43.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.513 -0.312 . . . . 1.8899999999999999 110.584 173.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 45' ' ' ARG . . . -137.01 143.94 43.01 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.966 -0.561 . . . . 1.0800000000000001 110.678 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.98 136.2 33.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.832 -0.622 . . . . 1.3899999999999999 110.766 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.613 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 40.8 t30 -165.95 95.37 0.59 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.023 -0.535 . . . . 2.8599999999999999 109.708 176.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.57 -98.62 1.41 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.051 -0.595 . . . . 1.6799999999999999 111.818 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 85.7 Cg_exo -45.12 175.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 124.12 3.213 . . . . 1.6599999999999999 114.078 168.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.561 ' HB2' ' O ' ' A' ' 75' ' ' HIS . 41.3 p90 -68.46 171.93 6.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.152 -0.931 . . . . 3.3999999999999999 112.054 -169.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 39' ' ' ALA . 57.7 ttp180 -113.1 133.32 55.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.839 -0.618 . . . . 3.1000000000000001 111.117 -168.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.2 mt -119.66 129.97 74.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.224 -0.898 . . . . 1.8 110.387 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . . . -118.09 144.42 45.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.012 -0.54 . . . . 0.85999999999999999 111.169 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.0 tp -133.41 134.91 44.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.248 -0.433 . . . . 1.0600000000000001 110.814 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.34 167.48 24.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.8 -0.636 . . . . 1.1399999999999999 109.4 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -134.04 148.71 51.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.339 . . . . 4.0199999999999996 111.639 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -132.1 149.94 52.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.834 -0.621 . . . . 4.6100000000000003 110.014 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -120.49 139.97 52.11 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.212 -0.292 . . . . 3.3799999999999999 110.212 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 67' ' ' PHE . 49.6 mt-10 . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.754 0.311 . . . . 5.0499999999999998 111.793 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 110.18 -0.304 . . . . 5.6100000000000003 110.18 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.574 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 93.8 m-85 -122.46 125.29 45.51 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.896 -0.779 . . . . 3.7799999999999998 108.896 174.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -156.41 160.41 39.59 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.077 0.465 . . . . 2.4500000000000002 110.907 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 94' ' ' ASN . 27.6 mtm180 -140.71 125.27 10.75 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 115.355 -0.839 . . . . 3.2400000000000002 110.565 175.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.63 140.18 11.65 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.848 2.365 . . . . 1.1899999999999999 112.096 174.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -106.06 120.09 40.88 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.858 -0.793 . . . . 2.1899999999999999 108.858 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.0 tp -128.03 106.67 9.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.848 0.356 . . . . 1.1399999999999999 110.363 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 46.5 mt-10 -101.61 128.68 47.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.144 -0.48 . . . . 2.1800000000000002 110.284 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.8 t -120.03 120.01 61.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.306 -0.627 . . . . 1.5600000000000001 109.306 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.561 ' O ' ' HB2' ' A' ' 44' ' ' TRP . 80.1 t60 -119.59 118.22 30.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.118 0.485 . . . . 3.4399999999999999 110.253 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -117.62 138.54 51.89 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.186 -0.916 . . . . 4.7999999999999998 109.9 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -130.09 149.17 51.92 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.855 -0.424 . . . . 2.9399999999999999 109.855 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -137.11 132.68 34.42 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.614 -0.513 . . . . 3.8999999999999999 109.614 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 C--N 1.322 -0.628 0 CA-C-N 116.416 -0.356 . . . . 4.4800000000000004 110.49 -178.152 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.2 p . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 120.915 0.388 . . . . 2.5499999999999998 110.552 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -135.84 160.06 39.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.318 -0.401 . . . . 5.2999999999999998 110.357 -175.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.97 176.88 41.87 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.393 -0.908 . . . . 1.3500000000000001 112.587 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.12 125.21 27.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.785 -0.45 . . . . 2.29 109.785 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.9 m -120.11 129.95 54.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.157 0.503 . . . . 1.54 110.183 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -131.59 146.76 18.24 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.556 -0.831 . . . . 1.1699999999999999 112.577 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -123.92 122.2 4.75 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.908 -0.877 . . . . 1.1899999999999999 110.908 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -111.54 122.22 47.24 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.234 -0.654 . . . . 3.75 109.234 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.614 ' HB2' ' HB2' ' A' ' 112' ' ' ARG . 97.8 mtt180 -134.97 137.36 42.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.914 0.388 . . . . 2.75 110.907 -173.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.593 ' O ' ' HG2' ' A' ' 69' ' ' ARG . 92.6 m-20 -114.51 130.13 56.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.071 -0.513 . . . . 1.8200000000000001 109.972 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.532 ' HA ' ' HG2' ' A' ' 69' ' ' ARG . 58.8 t80 -106.93 119.94 40.7 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.848 -0.427 . . . . 3.1400000000000001 109.848 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.511 0 C-N-CA 120.55 -0.833 . . . . 2.79 112.243 178.178 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.9 p . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 109.991 -0.374 . . . . 3.2999999999999998 109.991 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.41 148.56 47.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.583 0.23 . . . . 1.76 110.676 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -132.58 135.74 46.11 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.368 0.604 . . . . 2.5499999999999998 111.077 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.487 ' HB2' ' HB3' ' A' ' 95' ' ' TYR . 89.7 mtp -136.55 141.45 43.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.784 -1.191 . . . . 1.77 107.784 175.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 16.2 mm100 -108.95 139.97 43.08 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.022 -0.671 . . . . 1.97 111.546 -172.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.614 ' HB2' ' HB2' ' A' ' 93' ' ' ARG . 76.2 mtt180 -120.37 128.95 53.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.004 -0.544 . . . . 3.8500000000000001 109.864 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -127.72 133.03 49.54 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.004 -0.544 . . . . 2.2799999999999998 110.849 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -121.55 125.22 46.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.958 -0.565 . . . . 2.1400000000000001 109.947 171.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 86.6 mt -120.08 124.0 71.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.978 -0.556 . . . . 1.55 109.612 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -147.05 105.24 3.86 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.617 0.246 . . . . 1.1899999999999999 111.121 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.98 139.95 13.97 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.38 2.053 . . . . 1.3700000000000001 110.922 175.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.51 137.19 33.48 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.285 -0.416 . . . . 2.3500000000000001 109.916 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -130.88 129.79 42.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.445 -0.343 . . . . 4.54 110.493 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -94.28 113.87 25.85 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.17 -0.678 . . . . 3.04 109.17 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.6 t -120.08 119.99 61.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.778 -0.453 . . . . 4.2699999999999996 109.778 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 128' ' ' ARG . 36.4 mtmm -126.84 118.78 25.31 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.745 -0.465 . . . . 6.04 109.745 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.3 tp -90.15 -79.01 0.35 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 4.5899999999999999 110.79 -174.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 47.4 p -142.67 171.77 13.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.371 -0.377 . . . . 3.6899999999999999 110.662 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 62.37 26.27 15.69 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 124.057 0.848 . . . . 5.1699999999999999 112.071 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 57.82 33.54 23.34 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.046 -0.525 . . . . 3.71 110.692 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.1 mt -98.99 130.0 45.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.058 -0.519 . . . . 2.0499999999999998 109.983 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.522 ' HA ' ' HG2' ' A' ' 122' ' ' LYS . 47.9 ttt180 -105.07 127.83 53.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.207 0.527 . . . . 4.2400000000000002 111.02 -174.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.451 ' CE2' HD13 ' A' ' 158' ' ' LEU . 96.7 m-85 -108.18 129.09 55.2 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.521 -0.918 . . . . 3.5499999999999998 108.521 174.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -111.65 113.9 26.58 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.756 -0.831 . . . . 2.1099999999999999 108.756 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -123.1 137.72 11.26 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.204 -0.998 . . . . 1.1799999999999999 111.908 -175.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.526 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 8.8 p90 -134.45 140.91 46.58 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.115 0.484 . . . . 4.2999999999999998 110.315 177.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 64.3 tp -99.96 111.14 23.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.596 -0.729 . . . . 2.2400000000000002 109.258 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.8 m -100.83 118.0 36.04 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.306 0.574 . . . . 1.6899999999999999 111.121 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 87.1 mtp -101.09 125.39 47.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.195 -0.911 . . . . 2.2400000000000002 109.26 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 95.5 m-85 -109.94 127.59 54.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.93 0.395 . . . . 3.5600000000000001 110.988 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -129.9 144.62 51.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.787 -0.642 . . . . 1.6699999999999999 109.986 174.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.444 ' H ' HD22 ' A' ' 142' ' ' LEU . 46.9 p90 -148.01 165.52 30.49 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.063 -0.717 . . . . 3.23 109.063 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 110' ' ' MET . . . 64.42 170.09 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.673 0.608 . . . . 1.24 110.733 -174.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -76.05 -20.1 58.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.457 0.646 . . . . 2.4700000000000002 109.572 173.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -66.65 -49.53 65.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.022 -0.99 . . . . 2.4100000000000001 111.997 -175.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.464 ' HA ' ' OG1' ' A' ' 145' ' ' THR . 10.0 mp -68.38 -30.32 69.22 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.888 0.375 . . . . 1.8300000000000001 111.458 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -60.55 -40.21 90.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.394 0.616 . . . . 2.0 109.884 171.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 57.6 m -69.97 -40.38 75.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.956 -1.02 . . . . 2.0499999999999998 111.366 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.464 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 40.8 p -69.99 -36.57 75.26 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.959 0.409 . . . . 1.5900000000000001 110.632 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 62.19 -114.66 7.02 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.484 -0.78 . . . . 1.52 113.044 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -70.07 -31.3 68.82 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.549 0.34 . . . . 5.9400000000000004 111.149 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.9 -48.93 79.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.318 0.488 . . . . 1.8300000000000001 112.318 -172.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -138.98 111.72 7.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.132 0.491 . . . . 2.6400000000000001 110.738 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.3 t -160.01 149.66 18.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.341 -0.845 . . . . 2.02 109.102 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.499 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 67.5 ttt180 -79.55 125.24 29.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.778 0.323 . . . . 3.6699999999999999 110.26 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.461 ' CG1' HD11 ' A' ' 133' ' ' LEU . 62.1 t -119.92 120.1 62.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.928 -0.578 . . . . 1.6399999999999999 110.082 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -140.06 141.19 36.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.183 -0.303 . . . . 2.5600000000000001 110.183 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 m -115.24 128.39 56.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.683 0.278 . . . . 1.3899999999999999 110.766 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.526 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 83.3 tt0 -108.68 130.7 55.34 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.786 -0.45 . . . . 2.04 109.786 176.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 44.0 m -118.1 121.11 39.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.283 -0.417 . . . . 1.5600000000000001 110.18 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -111.02 118.12 4.79 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.938 -0.649 . . . . 1.04 111.903 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.451 HD13 ' CE2' ' A' ' 129' ' ' PHE . 41.5 tp -95.37 128.36 42.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.889 0.376 . . . . 2.27 110.68 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -101.8 108.98 20.64 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.276 -0.638 . . . . 2.4100000000000001 109.276 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -120.2 126.67 51.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.459 -0.791 . . . . 4.5700000000000003 109.244 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.1 p -99.21 88.81 4.03 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.279 -0.569 . . . . 1.46 110.225 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -60.24 -49.67 76.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.412 -0.813 . . . . 2.6299999999999999 111.292 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.503 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.0 m-20 -103.01 15.82 28.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.456 -0.338 . . . . 2.4100000000000001 110.824 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 72.52 -53.83 0.69 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.888 0.743 . . . . 2.5800000000000001 111.617 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.6 p -74.38 -18.77 60.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.372 -0.377 . . . . 2.2999999999999998 111.496 -177.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 163' ' ' ASN . 35.7 m -110.6 136.93 45.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.373 -0.376 . . . . 1.71 110.3 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.57 123.62 48.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.062 -0.517 . . . . 1.47 109.788 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 35.7 mt -102.48 127.43 49.53 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.265 -0.643 . . . . 1.6599999999999999 109.265 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -99.99 108.83 21.13 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.723 -0.473 . . . . 3.2999999999999998 109.723 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 195' ' ' ARG . 50.2 t -109.98 119.7 59.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.32 -0.622 . . . . 1.3 109.32 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.448 ' HB2' ' HD3' ' A' ' 195' ' ' ARG . 15.5 m120 -109.81 131.55 54.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.012 0.434 . . . . 2.2200000000000002 110.879 -172.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -119.88 139.6 52.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.88 -0.6 . . . . 4.6100000000000003 109.683 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -106.37 122.69 46.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.672 0.272 . . . . 3.98 110.387 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 55.7 tp -108.63 114.92 29.13 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.172 -0.467 . . . . 2.3799999999999999 109.963 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -108.59 138.52 44.77 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.013 -0.54 . . . . 3.3100000000000001 110.007 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 . . . . . 0 C--N 1.323 -0.566 0 N-CA-C 109.626 -0.509 . . . . 6.5300000000000002 109.626 177.064 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 110.044 -0.354 . . . . 4.4000000000000004 110.044 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 88.0 mt -100.62 120.04 49.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.986 0.422 . . . . 2.21 110.384 -176.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.448 ' HD3' ' HB2' ' A' ' 171' ' ' ASN . 31.4 ttt180 -98.93 119.37 37.59 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.692 -0.686 . . . . 3.54 110.754 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -119.6 123.46 43.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.916 0.389 . . . . 1.6699999999999999 110.72 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -130.86 118.75 21.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.615 -0.721 . . . . 5.8300000000000001 109.751 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 1.3 pt? -136.83 126.82 15.9 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.753 -0.379 . . . . 2.5899999999999999 111.103 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 198' ' ' LEU . 27.7 Cg_endo -94.49 117.44 0.25 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.965 2.443 . . . . 1.77 112.499 175.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 50.8 tp -104.31 116.41 32.1 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.19 -0.67 . . . . 2.2599999999999998 109.19 176.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 96.7 m -99.58 120.07 39.07 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.167 0.508 . . . . 1.99 110.881 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 89.7 mt -114.56 80.38 1.39 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.948 -0.76 . . . . 2.3100000000000001 108.948 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 72.59 -112.85 4.15 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.151 -0.931 . . . . 1.51 112.228 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -100.09 10.35 41.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.11 0.481 . . . . 2.5699999999999998 110.948 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -134.42 117.71 16.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.195 -0.457 . . . . 2.6600000000000001 109.864 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 74.3 m -102.66 134.19 46.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.197 0.522 . . . . 1.6200000000000001 111.227 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 59.1 t -115.45 122.67 69.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.575 -0.739 . . . . 1.3799999999999999 109.239 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 23.5 m -118.3 94.28 46.68 Favored Pre-proline 0 C--N 1.318 -0.767 0 C-N-CA 121.031 -0.268 . . . . 1.1799999999999999 111.37 -176.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 15.6 Cg_exo -69.41 139.97 42.8 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.902 2.401 . . . . 1.01 111.795 173.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.505 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 64.9 t80 -137.68 140.23 40.68 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.074 -0.512 . . . . 4.5 110.408 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 28.7 p -135.34 147.73 49.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.268 -0.424 . . . . 1.8899999999999999 110.866 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -102.42 -0.03 33.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.437 0.637 . . . . 4.7999999999999998 109.995 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 48.5 mm . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.452 -0.795 . . . . 4.5700000000000003 109.505 175.825 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.434 -0.58 . . . . 2.3999999999999999 109.434 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -78.14 137.61 20.1 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.418 -0.896 . . . . 1.27 111.283 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 94.5 mt -134.45 124.47 25.67 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.759 -0.46 . . . . 1.97 109.759 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.509 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 64.5 t80 -118.52 118.4 31.59 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.158 -0.682 . . . . 3.54 109.158 175.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.422 ' HB2' ' HB3' ' A' ' 253' ' ' LEU . 92.9 m-85 -104.79 129.72 53.01 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.127 -0.488 . . . . 2.6400000000000001 110.379 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -114.45 143.34 17.99 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 115.576 -0.738 . . . . 1.3500000000000001 111.533 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -107.28 112.35 25.16 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.484 -0.562 . . . . 4.3600000000000003 109.484 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -105.42 28.4 7.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.337 -0.847 . . . . 4.29 110.31 -172.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -59.89 -40.12 87.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.013 -0.994 . . . . 6.6900000000000004 110.741 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' GLN . . . . . 0.44 ' OE1' ' HB3' ' A' ' 249' ' ' LEU . 62.4 tt0 -133.05 133.79 43.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.948 -0.569 . . . . 6.3700000000000001 110.358 -176.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -63.38 -39.86 95.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.788 -0.642 . . . . 5.8300000000000001 110.595 176.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -68.19 -50.07 42.02 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.539 -0.839 . . . . 2.6600000000000001 112.535 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.44 ' HB3' ' OE1' ' A' ' 246' ' ' GLN . 59.1 tp -118.51 124.15 46.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.94 0.4 . . . . 2.9700000000000002 111.046 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 46.9 p -126.78 148.21 49.94 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.91 -0.587 . . . . 2.1699999999999999 110.082 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 57.7 t -116.43 137.67 49.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.434 -0.348 . . . . 1.79 110.3 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 43.4 m -111.76 139.76 46.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.327 -0.397 . . . . 1.6299999999999999 110.628 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.427 ' HG ' ' HG3' ' A' ' 254' ' ' GLU . 59.3 tp -132.65 143.42 49.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.544 -0.298 . . . . 2.96 111.31 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' GLU . . . . . 0.427 ' HG3' ' HG ' ' A' ' 253' ' ' LEU . 43.9 mt-10 60.34 -159.99 0.3 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.886 0.741 . . . . 4.0800000000000001 111.108 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -144.47 137.05 26.66 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.05 0.453 . . . . 4.8399999999999999 111.529 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.505 ' HB1' ' HB2' ' A' ' 210' ' ' TYR . . . . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 115.637 -0.71 . . . . 3.5800000000000001 109.221 172.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.193 0 CA-C-O 120.503 0.192 . . . . 1.9399999999999999 110.516 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -138.4 158.62 24.99 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 119.529 -1.32 . . . . 1.4199999999999999 112.489 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.19 127.17 68.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.17 -0.678 . . . . 1.8100000000000001 109.17 176.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.68 157.23 21.74 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.757 -0.735 . . . . 1.3 111.638 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 6.2 p -119.96 121.31 65.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.116 0.484 . . . . 1.8300000000000001 110.344 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -122.21 123.71 42.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.895 -0.593 . . . . 2.3100000000000001 110.517 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -118.08 130.03 55.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.745 -0.465 . . . . 4.75 109.745 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 8.9 p -117.5 129.44 55.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.953 0.406 . . . . 1.6699999999999999 110.498 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 61.4 t80 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.395 -0.812 . . . . 3.6899999999999999 109.572 -176.986 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.866 0.365 . . . . 3.6099999999999999 110.811 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 41' ' ' ASN . 70.0 m95 -88.59 107.35 18.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.131 0.491 . . . . 3.3300000000000001 111.171 -176.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -94.87 130.44 41.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.619 -0.719 . . . . 3.2000000000000002 110.592 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.34 139.48 52.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.165 -0.925 . . . . 2.4900000000000002 110.244 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 15.6 m120 -122.67 132.03 54.07 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.94 -0.573 . . . . 2.1299999999999999 110.105 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.0 mt -120.06 119.83 61.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.021 -0.733 . . . . 1.6000000000000001 109.021 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.437 ' HA3' ' CZ ' ' A' ' 36' ' ' TYR . . . -115.77 134.43 11.49 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.103 -1.046 . . . . 0.88 112.453 -176.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -121.78 134.41 54.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.91 0.386 . . . . 1.0800000000000001 110.147 175.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 91.0 mtp -140.66 157.09 45.95 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.268 -0.641 . . . . 2.3300000000000001 109.268 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -100.19 121.98 42.3 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.834 -0.346 . . . . 2.6099999999999999 110.99 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--N 1.323 -0.568 0 N-CA-C 109.751 -0.462 . . . . 5.0899999999999999 109.751 178.232 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 41.1 mt-10 . . . . . 0 N--CA 1.451 -0.413 0 N-CA-C 110.083 -0.339 . . . . 3.48 110.083 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 32' ' ' GLU . 24.0 Cg_exo -63.9 134.0 41.39 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 121.914 1.743 . . . . 1.8600000000000001 111.132 173.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 28.3 t -124.59 142.4 51.38 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.603 -0.888 . . . . 1.97 108.603 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 62.5 t -130.01 133.61 64.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.893 0.378 . . . . 1.71 111.002 -174.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.437 ' CZ ' ' HA3' ' A' ' 12' ' ' GLY . 53.8 p90 -130.22 151.82 50.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.675 -0.491 . . . . 4.0700000000000003 109.675 175.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.563 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 93.2 m-85 -119.55 139.95 51.31 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.517 -0.31 . . . . 2.8599999999999999 111.051 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 18.5 m-80 -129.65 141.37 50.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.801 -0.636 . . . . 1.8899999999999999 109.995 174.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.11 142.67 38.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.68 -0.236 . . . . 1.0800000000000001 110.439 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 45' ' ' ARG . . . -159.61 139.21 11.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.197 0.443 . . . . 1.3899999999999999 112.197 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.663 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 34.3 t30 -167.68 94.14 0.41 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.346 -0.843 . . . . 2.8599999999999999 109.186 171.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.92 -91.89 1.73 Allowed Glycine 0 N--CA 1.454 -0.144 0 N-CA-C 111.276 -0.73 . . . . 1.6799999999999999 111.276 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.663 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 72.6 Cg_exo -50.51 173.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.331 2.687 . . . . 1.6599999999999999 113.06 167.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.519 ' CD1' HG13 ' A' ' 74' ' ' VAL . 48.9 p90 -68.4 176.65 2.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.737 -0.665 . . . . 3.3999999999999999 111.951 -170.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 17.1 ttm180 -112.83 129.31 56.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.515 -0.766 . . . . 3.1000000000000001 110.069 -173.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 45.6 pt -110.92 143.56 20.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.271 -0.422 . . . . 1.8 110.939 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 72' ' ' LEU . . . -118.52 127.12 53.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.746 -0.661 . . . . 0.85999999999999999 110.352 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.7 tp -119.95 128.75 53.87 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.889 0.376 . . . . 1.0600000000000001 111.176 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.53 157.1 42.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.589 -0.732 . . . . 1.1399999999999999 109.423 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -120.09 140.0 51.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.083 0.468 . . . . 4.0199999999999996 111.141 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -112.14 133.28 54.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.657 -0.701 . . . . 4.6100000000000003 111.289 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -122.56 127.04 48.95 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.38 -0.6 . . . . 3.3799999999999999 109.38 174.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.627 ' HB2' ' OH ' ' A' ' 95' ' ' TYR . 39.0 tt0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 121.238 0.542 . . . . 5.0499999999999998 110.021 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 78.1 m95 . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 121.287 0.565 . . . . 5.6100000000000003 111.517 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -139.99 137.43 34.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.205 -0.907 . . . . 3.7799999999999998 109.309 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -159.96 168.38 25.82 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.433 -0.349 . . . . 2.4500000000000002 110.518 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.516 ' HD2' ' HB3' ' A' ' 93' ' ' ARG . 58.6 ttp85 -142.43 123.73 8.59 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.817 -0.629 . . . . 3.2400000000000002 110.267 169.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.631 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 72.9 Cg_endo -80.07 139.98 13.85 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.14 1.893 . . . . 1.1899999999999999 110.54 167.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.505 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 33.5 tt0 -124.15 113.87 18.92 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.227 0.537 . . . . 2.1899999999999999 110.077 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 40.8 tp -120.21 119.73 34.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.172 -0.922 . . . . 1.1399999999999999 110.209 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 34.2 mt-10 -104.21 147.03 27.93 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.289 0.566 . . . . 2.1800000000000002 111.08 174.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.519 HG13 ' CD1' ' A' ' 44' ' ' TRP . 63.8 t -113.41 120.08 62.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.95 -1.023 . . . . 1.5600000000000001 108.83 174.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.576 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 93.4 m-70 -122.27 127.19 49.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.88 0.371 . . . . 3.4399999999999999 110.28 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.439 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 84.5 t80 -139.94 139.09 36.07 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.114 -0.493 . . . . 4.7999999999999998 110.43 -178.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -99.17 119.87 38.57 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.587 -0.523 . . . . 2.9399999999999999 109.587 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -100.02 120.03 39.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.289 -0.414 . . . . 3.8999999999999999 109.963 -174.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.9 tp . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 116.267 -0.424 . . . . 4.4800000000000004 112.077 -172.169 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.514 ' HB3' ' CD1' ' A' ' 119' ' ' TRP . 22.7 m . . . . . 0 N--CA 1.448 -0.554 0 CA-C-O 120.899 0.38 . . . . 2.5499999999999998 110.651 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -135.64 159.53 41.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.135 -0.484 . . . . 5.2999999999999998 110.257 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -141.0 -178.52 17.4 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.983 -1.247 . . . . 1.3500000000000001 109.983 174.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 75' ' ' HIS . 64.7 tp -140.18 121.78 15.24 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 117.515 0.657 . . . . 2.29 110.953 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.428 HG23 ' CE1' ' A' ' 75' ' ' HIS . 92.9 m -120.08 116.61 26.05 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.689 -0.687 . . . . 1.54 109.595 169.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 73' ' ' GLU . . . -125.99 154.63 18.88 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.837 -0.905 . . . . 1.1699999999999999 110.837 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.81 124.3 2.23 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.669 -0.777 . . . . 1.1899999999999999 112.102 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -111.35 121.77 46.09 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.843 -0.799 . . . . 3.75 108.843 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.516 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 34.8 mtm180 -142.59 126.87 17.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.392 -0.367 . . . . 2.75 111.208 -172.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.631 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 57.6 t30 -122.16 130.01 52.83 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.445 -0.576 . . . . 1.8200000000000001 109.445 174.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.627 ' OH ' ' HB2' ' A' ' 53' ' ' GLU . 3.3 t80 -121.95 115.95 23.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.804 -0.18 . . . . 3.1400000000000001 110.955 -172.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 C-N-CA 120.473 -0.87 . . . . 2.79 111.167 176.227 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.2 m . . . . . 0 N--CA 1.447 -0.605 0 CA-C-O 120.931 0.396 . . . . 3.2999999999999998 110.578 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.95 144.25 33.64 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.681 -0.859 . . . . 1.76 108.681 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.438 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 95.8 m-20 -129.06 127.0 40.65 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.87 0.367 . . . . 2.5499999999999998 110.739 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.478 ' HB3' ' HA ' ' A' ' 139' ' ' ALA . 41.8 mtm -108.59 130.03 55.31 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.043 -0.725 . . . . 1.77 109.043 175.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -102.99 137.22 41.48 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.093 -0.643 . . . . 1.97 111.241 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.505 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 53.7 mtp85 -119.98 109.97 16.14 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.978 -0.749 . . . . 3.8500000000000001 108.978 177.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -110.02 140.02 44.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.342 0.592 . . . . 2.2799999999999998 112.046 -175.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.401 ' HB2' ' NH2' ' A' ' 93' ' ' ARG . 87.0 tttt -129.03 124.42 34.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.588 -1.187 . . . . 2.1400000000000001 109.854 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 80.3 mt -140.46 120.03 12.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.471 -0.196 . . . . 1.55 110.471 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 134' ' ' SER . . . -155.38 106.24 2.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.649 -0.25 . . . . 1.1899999999999999 111.425 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.721 ' HD2' ' CD1' ' A' ' 132' ' ' TRP . 13.3 Cg_exo -71.48 88.06 0.76 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.461 2.108 . . . . 1.3700000000000001 111.045 168.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 119' ' ' TRP . 12.1 p-10 -108.5 139.38 43.34 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.211 0.449 . . . . 2.3500000000000001 112.211 -166.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.514 ' CD1' ' HB3' ' A' ' 85' ' ' SER . 7.3 t-105 176.61 -176.59 0.13 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.34 -0.845 . . . . 4.54 108.993 174.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.609 ' OD1' ' HB3' ' A' ' 128' ' ' ARG . 30.1 t70 -80.24 117.44 21.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.135 0.493 . . . . 3.04 111.277 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.4 t -107.01 120.04 57.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.019 -0.734 . . . . 4.2699999999999996 109.019 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -93.08 72.01 4.63 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.932 -0.577 . . . . 6.04 110.636 -171.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.2 tp -67.32 -40.04 85.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.753 -0.658 . . . . 4.5899999999999999 110.709 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 24.4 p -123.28 150.16 43.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.756 -0.657 . . . . 3.6899999999999999 110.03 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -69.93 -40.26 75.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.793 0.33 . . . . 5.1699999999999999 111.279 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -70.24 -40.26 74.57 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.103 -0.498 . . . . 3.71 112.212 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.0 mt -119.95 139.16 52.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.919 0.39 . . . . 2.0499999999999998 111.339 -171.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.609 ' HB3' ' OD1' ' A' ' 120' ' ' ASP . 62.0 mtt180 -103.26 139.26 38.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.013 -0.539 . . . . 4.2400000000000002 110.097 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -112.74 107.82 16.61 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.436 -0.579 . . . . 3.5499999999999998 109.436 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 43.8 t30 -110.83 114.3 27.53 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 120.797 0.332 . . . . 2.1099999999999999 110.495 -174.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 142.52 -163.18 27.24 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.326 -0.71 . . . . 1.1799999999999999 111.326 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.721 ' CD1' ' HD2' ' A' ' 117' ' ' PRO . 47.8 t-105 -161.34 168.53 23.78 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.977 0.389 . . . . 4.2999999999999998 110.799 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 46.9 tp -100.5 119.93 39.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.741 -0.663 . . . . 2.2400000000000002 109.596 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.434 ' HB3' ' HB2' ' A' ' 116' ' ' ALA . 13.1 p -122.97 158.46 30.43 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.182 0.438 . . . . 1.6899999999999999 112.182 -172.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 75.0 mtm -118.39 136.74 53.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.047 -0.524 . . . . 2.2400000000000002 109.976 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -120.04 140.41 51.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.2 0.524 . . . . 3.5600000000000001 111.518 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -124.39 136.34 53.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.365 -0.834 . . . . 1.6699999999999999 109.503 176.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.505 ' H ' HD22 ' A' ' 142' ' ' LEU . 42.2 m-85 -128.46 146.65 50.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.155 -0.475 . . . . 3.23 110.1 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 110' ' ' MET . . . 59.99 -164.87 0.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.714 -0.675 . . . . 1.24 111.642 177.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -77.39 -31.33 54.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.033 0.444 . . . . 2.4700000000000002 110.766 172.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -60.0 -50.28 74.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.622 -0.717 . . . . 2.4100000000000001 112.328 -169.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.505 HD22 ' H ' ' A' ' 138' ' ' PHE . 8.8 mp -70.7 -29.91 66.33 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.769 -0.373 . . . . 1.8300000000000001 111.219 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -61.11 -43.61 98.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.857 0.36 . . . . 2.0 110.704 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.3 p -70.4 -31.1 68.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 2.0499999999999998 111.468 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 75.8 p -97.78 9.94 41.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.583 -0.28 . . . . 1.5900000000000001 110.542 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -60.0 -24.66 60.88 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.906 -0.588 . . . . 1.52 114.06 -172.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -69.87 -38.49 76.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.851 0.358 . . . . 5.9400000000000004 110.415 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -107.62 -55.93 2.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.451 0.537 . . . . 1.8300000000000001 112.451 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -109.2 117.41 34.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.424 0.631 . . . . 2.6400000000000001 111.963 -171.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 24.4 p -130.1 147.01 51.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.061 -0.972 . . . . 2.02 110.186 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -77.18 132.77 38.94 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.517 -0.549 . . . . 3.6699999999999999 109.517 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.99 129.57 64.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.297 -0.41 . . . . 1.6399999999999999 110.899 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.62 137.96 54.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.084 -0.507 . . . . 2.5600000000000001 110.397 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -133.38 101.04 5.01 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.281 -0.418 . . . . 1.3899999999999999 110.179 175.132 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -99.52 110.45 22.9 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.289 -1.004 . . . . 2.04 108.289 172.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 32.1 m -129.14 121.05 26.95 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.013 0.435 . . . . 1.5600000000000001 111.183 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 171' ' ' ASN . . . -101.12 120.1 6.76 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.896 -0.882 . . . . 1.04 110.896 174.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 92.5 mt -97.11 129.54 44.5 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.502 -0.555 . . . . 2.27 109.502 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.458 ' HG2' ' HG2' ' A' ' 169' ' ' ARG . 69.9 mt-30 -102.0 119.12 38.28 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.644 -0.422 . . . . 2.4100000000000001 110.625 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -118.81 133.11 56.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.513 -0.767 . . . . 4.5700000000000003 109.3 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.5 p -103.57 92.15 4.33 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.405 -0.518 . . . . 1.46 110.767 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -60.01 -48.96 79.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.593 -0.731 . . . . 2.6299999999999999 111.204 -176.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.456 ' HB2' HG22 ' A' ' 166' ' ' VAL . 80.7 m-20 -101.96 13.18 35.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.486 -0.324 . . . . 2.4100000000000001 111.331 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 73.88 -53.41 0.69 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.367 0.667 . . . . 2.5800000000000001 111.915 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.5 p -74.51 -18.77 60.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.985 0.422 . . . . 2.2999999999999998 111.564 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 163' ' ' ASN . 16.7 m -119.93 144.48 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.297 -0.41 . . . . 1.71 110.175 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -114.83 132.74 56.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.3 -0.409 . . . . 1.47 111.127 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 27.3 mt -104.35 129.98 52.21 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.718 -0.845 . . . . 1.6599999999999999 108.718 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.458 ' HG2' ' HG2' ' A' ' 159' ' ' GLN . 81.0 mtt180 -110.08 112.81 25.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.994 0.426 . . . . 3.2999999999999998 110.633 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.57 119.75 60.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.975 -0.557 . . . . 1.3 109.87 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.441 ' HA ' ' HA2' ' A' ' 157' ' ' GLY . 47.9 t30 -119.51 133.9 55.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.0 0.428 . . . . 2.2200000000000002 110.674 -172.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -138.9 150.92 46.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.768 -0.651 . . . . 4.6100000000000003 110.835 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -106.29 129.7 54.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.024 -0.534 . . . . 3.98 110.381 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 154' ' ' THR . 86.6 mt -114.75 131.99 56.59 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.466 -0.568 . . . . 2.3799999999999999 109.466 171.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -113.47 177.21 4.71 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.564 -0.289 . . . . 3.3100000000000001 110.532 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 . . . . . 0 C--N 1.327 -0.407 0 CA-C-O 121.208 0.528 . . . . 6.5300000000000002 110.083 -178.714 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.273 0.559 . . . . 4.4000000000000004 109.718 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 32.4 mm -116.98 139.92 41.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.623 -0.717 . . . . 2.21 111.184 -164.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 48.3 mtm105 -114.02 139.98 48.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.334 -0.247 . . . . 3.54 110.334 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -132.22 137.99 47.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.776 0.322 . . . . 1.6699999999999999 110.653 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -150.16 160.01 43.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.35 -0.386 . . . . 5.8300000000000001 110.281 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -137.93 139.13 25.28 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 120.69 0.281 . . . . 2.5899999999999999 110.394 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.33 135.65 22.84 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.401 2.067 . . . . 1.77 112.43 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 67.3 tp -137.76 134.15 34.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.685 -0.689 . . . . 2.2599999999999998 109.559 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 85.4 m -119.92 129.56 54.4 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.814 0.34 . . . . 1.99 110.333 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.1 mt -131.45 81.71 2.0 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.283 0.563 . . . . 2.3100000000000001 109.523 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 71.42 -121.47 8.94 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.429 -0.805 . . . . 1.51 112.483 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -96.54 9.13 42.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.592 0.71 . . . . 2.5699999999999998 109.725 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -120.01 129.99 54.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.198 -0.91 . . . . 2.6600000000000001 109.615 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 7.0 p -103.71 146.28 28.84 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.297 -0.41 . . . . 1.6200000000000001 110.661 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 58.0 t -133.4 140.08 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 1.3799999999999999 110.119 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 46.1 m -138.49 95.48 10.14 Favored Pre-proline 0 C--N 1.319 -0.742 0 O-C-N 122.13 -0.356 . . . . 1.1799999999999999 110.533 173.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.11 139.97 90.11 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.43 2.087 . . . . 1.01 111.477 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -109.5 137.23 47.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.033 -0.53 . . . . 4.5 109.65 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 33.1 p -144.67 162.1 37.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.177 -0.465 . . . . 1.8899999999999999 110.731 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -138.29 142.02 39.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.26 -0.645 . . . . 4.7999999999999998 109.26 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 84.3 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 121.11 0.481 . . . . 4.5700000000000003 110.423 -178.436 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 62.4 t . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 120.791 0.329 . . . . 2.3999999999999999 110.886 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -85.51 165.98 39.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.781 -0.723 . . . . 1.27 111.438 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 89.4 mt -134.33 129.92 36.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.471 0.636 . . . . 1.97 112.04 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.517 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 57.5 t80 -100.67 131.29 46.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.333 -0.848 . . . . 3.54 109.845 171.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.462 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 91.0 m-85 -113.97 130.01 56.56 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.453 -0.573 . . . . 2.6400000000000001 109.453 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -123.3 134.24 9.35 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.7 -0.762 . . . . 1.3500000000000001 111.67 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.43 110.98 23.08 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.156 -0.683 . . . . 4.3600000000000003 109.156 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -107.06 102.12 11.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.908 -0.587 . . . . 4.29 110.37 -176.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 91.3 m-85 -120.0 135.98 54.72 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.13 -0.486 . . . . 6.6900000000000004 109.817 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -84.8 9.65 13.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.448 0.642 . . . . 6.3700000000000001 110.107 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -90.71 6.26 44.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.186 -0.916 . . . . 5.8300000000000001 110.268 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 99.94 5.13 55.22 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.791 -0.718 . . . . 2.6600000000000001 112.816 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 245' ' ' PHE . 65.9 tp -102.95 120.1 40.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.927 0.394 . . . . 2.9700000000000002 111.254 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 23.9 t -130.72 129.24 42.29 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.699 -0.852 . . . . 2.1699999999999999 108.699 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.51 133.17 64.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.932 -0.307 . . . . 1.79 110.643 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 15.5 m -116.65 120.1 37.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.069 -0.514 . . . . 1.6299999999999999 110.057 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 86.0 mt -125.2 127.51 46.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.753 -0.203 . . . . 2.96 110.515 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -120.55 111.33 17.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.854 0.359 . . . . 4.0800000000000001 110.487 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -120.1 140.09 51.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.963 0.411 . . . . 4.8399999999999999 111.316 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 115.899 -0.591 . . . . 3.5800000000000001 110.491 175.614 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.661 0.267 . . . . 1.9399999999999999 110.464 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.76 132.56 6.64 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.001 -0.619 . . . . 1.4199999999999999 111.698 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 29.6 m -138.01 140.17 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.862 0.363 . . . . 1.8100000000000001 111.103 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -163.96 140.58 6.55 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.7 -0.762 . . . . 1.3 112.394 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.5 t -120.29 130.07 74.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.728 0.299 . . . . 1.8300000000000001 110.3 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -118.59 126.37 51.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.25 -0.432 . . . . 2.3100000000000001 110.286 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -100.3 123.69 44.85 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.699 -0.852 . . . . 4.75 108.699 174.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 37.7 t -117.75 130.02 56.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.986 0.422 . . . . 1.6699999999999999 110.673 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.2 t80 . . . . . 0 C--O 1.243 0.724 0 CA-C-O 118.336 -0.84 . . . . 3.6899999999999999 109.182 176.836 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 . . . . . 0 CA--C 1.519 -0.228 0 CA-C-O 121.416 0.627 . . . . 3.6099999999999999 109.43 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -73.22 149.28 42.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.143 -0.935 . . . . 3.3300000000000001 110.534 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -104.08 131.08 51.71 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.96 -0.385 . . . . 3.2000000000000002 109.96 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.83 149.76 42.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.81 -0.632 . . . . 2.4900000000000002 111.791 -171.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -131.54 129.43 41.01 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.677 -0.86 . . . . 2.1299999999999999 108.677 166.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 85.4 mt -132.5 120.23 41.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.598 -0.519 . . . . 1.6000000000000001 109.598 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -117.08 147.8 18.87 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.352 -0.927 . . . . 0.88 112.505 -176.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -138.09 135.03 35.4 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.093 -0.336 . . . . 1.0800000000000001 110.093 175.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.662 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 67.8 mtt -134.0 146.42 50.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.406 -0.361 . . . . 2.3300000000000001 110.482 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -97.63 129.46 44.72 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.895 -0.78 . . . . 2.6099999999999999 108.895 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 . . . . . 0 C--N 1.328 -0.355 0 N-CA-C 112.187 0.44 . . . . 5.0899999999999999 112.187 -173.365 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 N--CA 1.449 -0.519 0 CA-C-O 120.943 0.402 . . . . 3.48 110.326 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.662 ' HA ' ' O ' ' A' ' 14' ' ' MET . 73.8 Cg_endo -77.39 134.81 14.34 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.354 2.036 . . . . 1.8600000000000001 113.127 -177.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 34.8 p -84.42 157.71 21.3 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.992 -0.744 . . . . 1.97 108.992 171.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.99 132.56 69.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.213 0.53 . . . . 1.71 111.005 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 53.0 t80 -122.76 130.85 53.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.361 -0.836 . . . . 4.0700000000000003 110.303 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -120.02 135.24 55.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.764 0.316 . . . . 2.8599999999999999 110.75 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -149.9 127.96 11.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.243 -0.651 . . . . 1.8899999999999999 109.243 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.44 147.95 28.86 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.078 -0.249 . . . . 1.0800000000000001 111.316 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.72 139.12 9.96 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.131 -0.486 . . . . 1.3899999999999999 111.443 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.689 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 27.3 t-20 -168.28 94.97 0.39 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.963 -0.755 . . . . 2.8599999999999999 108.963 169.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.05 -85.62 0.55 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.93 -0.652 . . . . 1.6799999999999999 111.496 -173.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.689 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 19.6 Cg_endo -59.59 176.66 0.57 Allowed 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 123.643 2.895 . . . . 1.6599999999999999 112.55 171.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -67.77 175.25 3.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.932 -0.576 . . . . 3.3999999999999999 110.527 -173.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -110.99 117.08 32.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.478 0.656 . . . . 3.1000000000000001 109.706 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 84.3 mt -116.24 130.23 71.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.438 -1.256 . . . . 1.8 110.436 -170.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.22 130.7 56.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.261 -0.427 . . . . 0.85999999999999999 110.21 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 61.2 tp -130.59 132.57 45.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 1.0600000000000001 110.886 -177.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -146.59 168.92 20.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.56 -0.745 . . . . 1.1399999999999999 109.56 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -120.07 140.0 51.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.703 0.287 . . . . 4.0199999999999996 110.567 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -119.86 122.62 41.69 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.758 -0.46 . . . . 4.6100000000000003 109.758 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -123.1 139.98 53.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.941 0.401 . . . . 3.3799999999999999 110.091 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.685 -0.689 . . . . 5.0499999999999998 110.212 -179.608 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 . . . . . 0 N--CA 1.456 -0.161 0 CA-C-O 120.866 0.365 . . . . 5.6100000000000003 110.644 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -102.22 111.64 24.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.465 -0.569 . . . . 3.7799999999999998 109.465 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -125.34 169.96 11.81 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.267 -0.424 . . . . 2.4500000000000002 110.098 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.506 ' NE ' ' HB2' ' A' ' 95' ' ' TYR . 12.5 ttm180 -139.31 122.41 10.62 Favored Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 120.874 -0.33 . . . . 3.2400000000000002 110.134 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.508 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 85.3 Cg_endo -91.41 151.69 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.872 2.382 . . . . 1.1899999999999999 112.184 171.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.592 ' HA ' ' HG2' ' A' ' 93' ' ' ARG . 37.8 tt0 -118.04 115.61 25.21 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.17 -0.678 . . . . 2.1899999999999999 109.17 174.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.4 tp -132.56 114.74 14.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.883 -0.599 . . . . 1.1399999999999999 110.758 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.515 ' HG2' ' HA3' ' A' ' 91' ' ' GLY . 46.9 mt-10 -123.9 140.47 52.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.263 -0.426 . . . . 2.1800000000000002 110.108 174.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -123.03 129.8 74.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.203 -0.453 . . . . 1.5600000000000001 109.965 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -112.48 119.9 39.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.008 0.432 . . . . 3.4399999999999999 110.444 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.447 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . 64.8 t80 -93.08 129.14 39.14 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.554 -0.748 . . . . 4.7999999999999998 109.26 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -103.02 119.83 39.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.079 -0.509 . . . . 2.9399999999999999 110.099 -177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.453 ' CD2' ' HG ' ' A' ' 79' ' ' LEU . 69.7 t80 -120.1 119.35 33.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.522 -0.308 . . . . 3.8999999999999999 110.633 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.453 ' HG ' ' CD2' ' A' ' 78' ' ' PHE . 85.4 mt . . . . . 0 N--CA 1.466 0.336 0 O-C-N 124.136 0.897 . . . . 4.4800000000000004 112.817 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.402 ' OG ' ' HB ' ' A' ' 121' ' ' VAL . 21.3 t . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 109.996 -0.372 . . . . 2.5499999999999998 109.996 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -119.92 135.84 54.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.924 0.392 . . . . 5.2999999999999998 110.748 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.21 143.42 15.01 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.029 -0.828 . . . . 1.3500000000000001 111.029 175.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 76' ' ' TYR . 88.6 mt -120.27 113.72 20.82 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.767 -0.457 . . . . 2.29 109.767 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.1 m -116.58 122.64 45.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.05 0.452 . . . . 1.54 110.882 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -137.86 140.33 11.14 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.443 -0.663 . . . . 1.1699999999999999 111.443 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.515 ' HA3' ' HG2' ' A' ' 73' ' ' GLU . . . -169.63 170.03 42.44 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.219 -0.991 . . . . 1.1899999999999999 112.455 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 112' ' ' ARG . 53.3 p90 -156.75 160.01 38.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.986 0.422 . . . . 3.75 111.201 -176.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.592 ' HG2' ' HA ' ' A' ' 71' ' ' GLU . 30.1 mtm180 -121.27 127.96 51.89 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.743 -0.662 . . . . 2.75 109.228 169.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.508 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 52.0 t30 -107.3 119.13 38.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.189 -0.46 . . . . 1.8200000000000001 110.134 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.506 ' HB2' ' NE ' ' A' ' 69' ' ' ARG . 69.9 t80 -116.85 129.31 56.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.793 0.33 . . . . 3.1400000000000001 111.006 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 108' ' ' ALA . . . . . . . . 0 N--CA 1.444 -0.783 0 C-N-CA 120.333 -0.936 . . . . 2.79 113.179 172.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 109.4 -0.593 . . . . 3.2999999999999998 109.4 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.406 ' O ' ' HA3' ' A' ' 96' ' ' GLY . . . -164.78 129.12 2.52 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.632 -0.427 . . . . 1.76 111.159 -178.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -138.47 126.88 23.13 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.195 0.522 . . . . 2.5499999999999998 110.034 173.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 89.5 mtp -131.35 126.91 36.48 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.925 -0.579 . . . . 1.77 109.462 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.496 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 77.4 mt-30 -118.92 134.23 55.31 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.327 -0.549 . . . . 1.97 110.528 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 92' ' ' PHE . 47.3 ttt-85 -111.77 119.44 38.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.682 -0.69 . . . . 3.8500000000000001 109.439 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -119.94 140.21 51.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.545 -0.298 . . . . 2.2799999999999998 110.901 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 135' ' ' MET . 21.8 pttp -139.94 135.29 32.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.023 0.44 . . . . 2.1400000000000001 110.184 168.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 134' ' ' SER . 48.5 mm -120.02 119.85 61.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.827 -0.805 . . . . 1.55 108.827 173.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -140.55 106.58 6.5 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 120.553 0.216 . . . . 1.1899999999999999 111.197 -174.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.94 139.87 13.98 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.757 2.305 . . . . 1.3700000000000001 110.776 174.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -88.03 138.4 31.48 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.29 -0.634 . . . . 2.3500000000000001 109.29 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -125.86 132.32 52.21 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.547 0.203 . . . . 4.54 111.547 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 55.78 37.53 28.98 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.251 0.97 . . . . 3.04 112.451 171.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.402 ' HB ' ' OG ' ' A' ' 85' ' ' SER . 92.9 t -64.19 119.32 8.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.638 -0.255 . . . . 4.2699999999999996 110.926 -176.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 59.93 43.11 15.22 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.583 -0.735 . . . . 6.04 110.948 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.1 tp -60.15 -39.9 87.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.147 -0.479 . . . . 4.5899999999999999 111.872 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 127' ' ' LEU . 32.6 m -117.3 138.14 51.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.923 0.392 . . . . 3.6899999999999999 110.318 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -61.42 -44.66 96.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.147 -0.479 . . . . 5.1699999999999999 111.025 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -70.97 -40.83 71.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.794 -0.639 . . . . 3.71 111.492 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.535 ' O ' ' HB ' ' A' ' 124' ' ' THR . 86.5 mt -126.59 125.48 42.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.924 -0.58 . . . . 2.0499999999999998 110.523 -173.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.488 ' HD2' ' OE1' ' A' ' 159' ' ' GLN . 64.9 mtt180 -92.67 133.83 35.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.098 0.475 . . . . 4.2400000000000002 110.623 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.466 ' CD2' HD22 ' A' ' 158' ' ' LEU . 89.3 m-85 -119.8 122.0 40.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.367 -0.833 . . . . 3.5499999999999998 109.565 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 132' ' ' TRP . 94.4 m-20 -133.32 120.06 20.55 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.883 -0.414 . . . . 2.1099999999999999 109.883 174.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -148.18 140.27 8.25 Favored Glycine 0 CA--C 1.507 -0.416 0 C-N-CA 120.2 -1.0 . . . . 1.1799999999999999 111.43 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.462 ' CZ3' ' HB3' ' A' ' 130' ' ' ASN . 0.9 OUTLIER -142.72 147.67 36.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.302 0.573 . . . . 4.2999999999999998 112.153 -177.182 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 91.4 mt -104.43 120.01 40.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.987 -1.006 . . . . 2.2400000000000002 109.09 176.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 26.6 t -107.39 124.56 50.01 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.54 -0.464 . . . . 1.6899999999999999 110.974 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.472 ' O ' ' HA ' ' A' ' 114' ' ' LYS . 69.7 mtm -93.95 120.06 33.7 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.324 -0.991 . . . . 2.2400000000000002 108.324 171.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -115.12 132.61 56.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.167 0.508 . . . . 3.5600000000000001 112.208 -168.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -130.17 152.86 49.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.415 -0.812 . . . . 1.6699999999999999 109.908 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.459 ' O ' HD23 ' A' ' 142' ' ' LEU . 77.9 t80 -149.7 151.5 33.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.421 -0.354 . . . . 3.23 110.248 -177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 60.61 -163.44 0.25 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.546 0.529 . . . . 1.24 111.649 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -75.91 -41.39 52.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.967 0.413 . . . . 2.4700000000000002 111.786 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -60.14 -46.16 90.59 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.528 -0.76 . . . . 2.4100000000000001 112.959 -165.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 138' ' ' PHE . 3.8 mm? -69.88 -35.66 74.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.071 0.462 . . . . 1.8300000000000001 110.974 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' A' ' 111' ' ' GLN . 95.6 m-20 -70.78 -40.25 72.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.884 -0.598 . . . . 2.0 111.392 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.1 p -77.0 -35.05 57.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.504 -0.316 . . . . 2.0499999999999998 111.823 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 149' ' ' ASP . 23.2 p -69.9 -29.9 67.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.986 0.422 . . . . 1.5900000000000001 111.092 177.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 63.28 -109.83 2.98 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.694 -0.685 . . . . 1.52 113.071 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -70.02 -33.94 72.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.594 0.235 . . . . 5.9400000000000004 110.808 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.04 75.26 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.075 -0.512 . . . . 1.8300000000000001 112.256 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.428 ' HB2' ' OG1' ' A' ' 145' ' ' THR . 15.7 m-20 -122.51 127.1 49.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.212 0.53 . . . . 2.6400000000000001 111.003 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.1 t -160.23 157.73 28.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.853 -0.612 . . . . 2.02 110.113 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -120.16 148.2 43.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.917 -0.401 . . . . 3.6699999999999999 109.917 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.09 139.81 50.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.867 0.365 . . . . 1.6399999999999999 110.974 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -138.0 141.04 40.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.989 -0.551 . . . . 2.5600000000000001 109.523 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 24.5 m -122.91 131.36 53.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.735 0.302 . . . . 1.3899999999999999 111.346 -177.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -126.57 130.06 49.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.944 -0.571 . . . . 2.04 110.235 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 93.4 m -128.24 120.78 27.87 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.044 -0.525 . . . . 1.5600000000000001 110.538 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -111.69 117.73 4.56 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.657 -0.977 . . . . 1.04 110.657 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.466 HD22 ' CD2' ' A' ' 129' ' ' PHE . 77.4 mt -118.65 130.64 55.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.913 0.387 . . . . 2.27 111.024 -176.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.488 ' OE1' ' HD2' ' A' ' 128' ' ' ARG . 53.4 tt0 -100.14 113.43 26.07 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.901 -0.59 . . . . 2.4100000000000001 110.669 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.469 ' HA ' HD22 ' A' ' 127' ' ' LEU . 86.7 m-85 -120.16 139.8 52.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.889 -0.596 . . . . 4.5700000000000003 110.424 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 167' ' ' ALA . 24.4 p -94.25 100.26 12.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.963 0.411 . . . . 1.46 110.349 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -60.05 -49.07 79.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.939 -0.573 . . . . 2.6299999999999999 111.225 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.493 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.7 m-20 -101.09 10.09 41.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.222 -0.445 . . . . 2.4100000000000001 110.717 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 72.47 -46.92 0.66 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.634 0.774 . . . . 2.5800000000000001 111.235 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.4 p -74.71 -20.42 59.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.397 -0.365 . . . . 2.2999999999999998 111.788 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 163' ' ' ASN . 34.2 m -124.81 139.95 49.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.368 -0.378 . . . . 1.71 110.252 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.406 ' HA ' HG22 ' A' ' 161' ' ' THR . . . -106.83 131.55 53.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.959 0.409 . . . . 1.47 111.374 -175.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 31.1 mt -115.31 138.54 50.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.311 -0.626 . . . . 1.6599999999999999 109.311 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -112.17 122.02 46.58 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 110.075 -0.343 . . . . 3.2999999999999998 110.075 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.94 127.91 75.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.731 0.3 . . . . 1.3 110.547 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -107.05 126.69 52.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.249 0.547 . . . . 2.2200000000000002 110.782 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -99.42 124.42 44.54 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.11 -0.95 . . . . 4.6100000000000003 108.648 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -108.77 124.98 51.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.096 0.474 . . . . 3.98 110.923 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.501 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 62.0 tp -115.4 115.82 27.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.608 -0.723 . . . . 2.3799999999999999 111.21 -177.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -120.01 145.12 47.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.694 -0.685 . . . . 3.3100000000000001 110.116 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 . . . . . 0 C--N 1.321 -0.656 0 N-CA-C 109.546 -0.538 . . . . 6.5300000000000002 109.546 172.368 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 C--O 1.235 0.314 0 CA-C-O 120.635 0.255 . . . . 4.4000000000000004 110.521 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.491 ' O ' HG13 ' A' ' 194' ' ' ILE . 29.7 pt -93.92 90.72 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.66 0.743 . . . . 2.21 109.375 170.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.426 ' HG2' ' HA ' ' A' ' 212' ' ' ARG . 99.1 mtt180 -91.3 120.08 31.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.875 -0.602 . . . . 3.54 110.314 -173.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -109.36 147.23 33.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.95 -0.568 . . . . 1.6699999999999999 111.38 -174.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -155.97 160.02 39.72 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.492 -0.777 . . . . 5.8300000000000001 109.726 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 1.7 pt? -144.51 127.49 8.54 Favored Pre-proline 0 C--N 1.322 -0.619 0 C-N-CA 120.846 -0.342 . . . . 2.5899999999999999 111.006 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 198' ' ' LEU . 9.1 Cg_exo -73.28 127.38 11.88 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.462 2.108 . . . . 1.77 111.674 172.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 33.1 tp -130.83 148.57 52.62 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.565 -0.902 . . . . 2.2599999999999998 108.565 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 11.9 t -129.58 140.18 51.27 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.302 0.572 . . . . 1.99 110.954 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 60.0 tp -141.05 82.53 1.84 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.343 -0.844 . . . . 2.3100000000000001 109.149 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 69.22 -120.04 10.05 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.734 -0.666 . . . . 1.51 112.616 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -95.47 10.09 37.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.497 0.665 . . . . 2.5699999999999998 109.778 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -119.2 145.87 45.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.389 -0.823 . . . . 2.6600000000000001 109.399 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 241' ' ' TYR . 47.5 t -130.03 144.53 51.39 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.851 -0.426 . . . . 1.6200000000000001 109.851 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 47.9 t -119.92 129.95 74.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.639 -0.504 . . . . 1.3799999999999999 109.639 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 20.3 m -139.84 91.03 10.62 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-O 120.867 0.365 . . . . 1.1799999999999999 110.42 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.46 140.6 27.28 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 123.013 2.475 . . . . 1.01 111.826 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -118.99 139.88 50.94 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.858 -0.423 . . . . 4.5 109.858 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 61.1 p -133.07 146.15 51.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.789 -0.641 . . . . 1.8899999999999999 109.626 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.426 ' HA ' ' HG2' ' A' ' 195' ' ' ARG . 59.0 mtp180 -80.51 -9.97 59.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.035 0.445 . . . . 4.7999999999999998 110.255 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 46.5 pt . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.547 -0.751 . . . . 4.5700000000000003 109.932 179.18 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 109.832 -0.433 . . . . 2.3999999999999999 109.832 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -132.92 143.88 15.67 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.62 -0.8 . . . . 1.27 111.923 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 81.1 mt -116.94 121.78 42.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.7 0.286 . . . . 1.97 110.284 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -106.55 122.26 45.95 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.877 -0.416 . . . . 3.54 109.877 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 206' ' ' SER . 95.9 m-85 -112.2 120.37 41.54 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.066 -0.515 . . . . 2.6400000000000001 110.115 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -89.62 129.57 9.76 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.613 -0.803 . . . . 1.3500000000000001 111.533 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -107.58 127.19 53.42 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 110.004 -0.369 . . . . 4.3600000000000003 110.004 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -99.36 133.82 43.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.572 -0.74 . . . . 4.29 110.37 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -124.73 146.16 49.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.499 -0.556 . . . . 6.6900000000000004 109.499 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -56.49 -27.56 57.5 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.272 -0.876 . . . . 6.3700000000000001 112.816 -168.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.98 -34.97 74.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.364 0.602 . . . . 5.8300000000000001 110.742 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 116.2 1.94 20.25 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.21 -1.156 . . . . 2.6600000000000001 110.21 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 53.5 tp -91.08 130.41 36.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.579 -0.811 . . . . 2.9700000000000002 109.792 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 24.3 p -120.08 140.15 51.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.859 0.362 . . . . 2.1699999999999999 110.672 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.2 t -118.71 133.02 66.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.424 -0.353 . . . . 1.79 110.211 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 24.7 m -98.4 117.55 33.06 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.782 -0.451 . . . . 1.6299999999999999 109.782 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 68.6 mt -95.73 119.45 34.26 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.313 -0.625 . . . . 2.96 109.313 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -104.43 120.02 40.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.916 0.389 . . . . 4.0800000000000001 110.495 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -116.2 132.25 56.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.885 -0.598 . . . . 4.8399999999999999 110.675 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.474 0 CA-C-O 121.504 0.669 . . . . 3.5800000000000001 109.733 172.948 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.81 0.338 . . . . 1.9399999999999999 110.545 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.91 167.54 23.25 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.917 -0.658 . . . . 1.4199999999999999 111.844 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.05 140.0 39.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.149 0.499 . . . . 1.8100000000000001 111.06 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -126.77 137.08 9.76 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.033 -0.827 . . . . 1.3 111.033 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.99 119.99 60.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.857 -0.423 . . . . 1.8300000000000001 109.857 -176.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -128.25 129.77 46.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.154 0.502 . . . . 2.3100000000000001 111.627 -176.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -120.01 110.62 16.91 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.291 -0.633 . . . . 4.75 109.291 173.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 22.9 t -120.6 130.23 54.09 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.53 -0.544 . . . . 1.6699999999999999 109.53 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 46.2 t80 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.112 -0.946 . . . . 3.6899999999999999 109.462 -177.727 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 120.966 0.412 . . . . 3.6099999999999999 111.079 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -120.3 139.99 51.91 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.166 -0.679 . . . . 3.3300000000000001 109.166 172.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -131.83 130.78 42.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.812 0.339 . . . . 3.2000000000000002 110.182 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -137.06 150.35 47.99 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.089 -0.505 . . . . 2.4900000000000002 110.152 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -132.77 131.39 41.09 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.923 -0.769 . . . . 2.1299999999999999 108.923 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.8 pt -121.34 130.32 74.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.987 0.422 . . . . 1.6000000000000001 110.971 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -114.8 134.53 11.72 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.671 -0.776 . . . . 0.88 111.578 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -120.0 135.87 54.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.018 0.437 . . . . 1.0800000000000001 110.636 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 66.7 mtt -139.92 157.26 45.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.714 -0.675 . . . . 2.3300000000000001 109.734 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.02 112.32 24.75 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.007 -0.368 . . . . 2.6099999999999999 110.007 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 C--N 1.324 -0.536 0 CA-C-O 121.084 0.468 . . . . 5.0899999999999999 110.87 -176.789 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.591 0.234 . . . . 3.48 110.835 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.09 134.84 10.67 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.441 2.094 . . . . 1.8600000000000001 111.972 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 19.3 p -123.9 145.78 48.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.241 -0.436 . . . . 1.97 110.0 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 8.5 p -130.0 136.79 58.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.02 0.438 . . . . 1.71 110.791 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -117.97 143.66 46.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.033 -0.53 . . . . 4.0700000000000003 110.481 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 91.0 m-85 -102.71 129.28 49.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.976 -0.556 . . . . 2.8599999999999999 111.244 -176.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -119.88 137.43 54.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.137 -0.483 . . . . 1.8899999999999999 109.948 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -120.69 143.5 48.7 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.988 -0.375 . . . . 1.0800000000000001 109.988 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.49 117.98 6.97 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.537 0.523 . . . . 1.3899999999999999 111.226 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.631 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 37.4 t30 -167.24 96.01 0.48 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.01 -0.541 . . . . 2.8599999999999999 110.12 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.3 -98.78 1.89 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.017 -0.611 . . . . 1.6799999999999999 112.266 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.631 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 84.1 Cg_exo -47.82 175.0 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.956 3.104 . . . . 1.6599999999999999 113.644 169.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -69.72 -177.44 1.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.265 0.555 . . . . 3.3999999999999999 111.582 -170.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.7 mtp180 -111.97 140.58 46.52 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.609 0.719 . . . . 3.1000000000000001 112.331 -170.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.406 HG22 HG12 ' A' ' 74' ' ' VAL . 47.0 pt -126.52 146.66 32.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 114.397 -1.274 . . . . 1.8 110.892 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -119.73 131.22 55.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.791 -0.64 . . . . 0.85999999999999999 110.287 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.8 tp -119.92 131.84 55.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.166 -0.47 . . . . 1.0600000000000001 110.831 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 71' ' ' GLU . . . -151.98 157.8 42.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 1.1399999999999999 110.551 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -134.48 150.48 50.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.793 0.33 . . . . 4.0199999999999996 110.725 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -135.27 106.94 6.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.019 -0.537 . . . . 4.6100000000000003 111.589 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -98.87 135.84 39.73 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.457 -0.942 . . . . 3.3799999999999999 108.457 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 N--CA 1.462 0.149 0 CA-C-N 116.024 -0.535 . . . . 5.0499999999999998 111.059 -176.175 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 94.5 m95 . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 120.913 0.387 . . . . 5.6100000000000003 110.507 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -70.54 139.96 51.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.072 -0.513 . . . . 3.7799999999999998 110.804 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -130.65 144.26 51.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.67 -0.696 . . . . 2.4500000000000002 109.704 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.458 ' HD2' ' HB3' ' A' ' 93' ' ' ARG . 39.5 ttp180 -124.34 122.05 26.0 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.926 -0.579 . . . . 3.2400000000000002 110.07 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.478 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 2.9 Cg_endo -85.81 150.03 9.81 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.63 2.22 . . . . 1.1899999999999999 111.883 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 46.5 tt0 -128.11 128.95 45.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.054 0.454 . . . . 2.1899999999999999 110.211 173.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.4 tp -132.03 116.77 17.51 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.616 -0.72 . . . . 1.1399999999999999 109.442 173.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.472 ' HA ' ' HA2' ' A' ' 91' ' ' GLY . 40.5 tt0 -118.81 131.17 56.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.043 0.449 . . . . 2.1800000000000002 109.868 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.406 HG12 HG22 ' A' ' 46' ' ' ILE . 32.4 m -113.67 141.55 29.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.816 -0.629 . . . . 1.5600000000000001 109.999 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -120.97 127.01 51.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.097 -0.502 . . . . 3.4399999999999999 110.136 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.94 141.43 49.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.365 -0.38 . . . . 4.7999999999999998 110.074 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -114.65 139.91 49.26 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.851 -0.425 . . . . 2.9399999999999999 109.851 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -132.03 149.29 52.46 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.847 0.356 . . . . 3.8999999999999999 110.408 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.6 tp . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 116.039 -0.528 . . . . 4.4800000000000004 110.085 -179.788 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 120' ' ' ASP . 3.9 m . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 120.775 0.321 . . . . 2.5499999999999998 110.889 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -140.05 143.72 36.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.502 -0.555 . . . . 5.2999999999999998 109.502 174.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.65 176.36 23.08 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.255 -0.974 . . . . 1.3500000000000001 112.539 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 64.0 tp -126.83 130.04 49.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.912 0.387 . . . . 2.29 110.077 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.2 m -120.02 129.91 54.47 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.054 -0.521 . . . . 1.54 109.908 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 114' ' ' LYS . . . -138.97 133.6 6.3 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.615 -0.802 . . . . 1.1699999999999999 111.8 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 73' ' ' GLU . . . -135.03 147.99 19.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.591 -0.814 . . . . 1.1899999999999999 112.4 -178.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -129.36 137.74 51.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.957 0.408 . . . . 3.75 111.222 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 89.8 mtt180 -129.79 148.46 51.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.437 -0.801 . . . . 2.75 109.803 171.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.664 ' HA ' ' O ' ' A' ' 110' ' ' MET . 51.8 t-20 -139.55 118.43 12.47 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.094 -0.336 . . . . 1.8200000000000001 110.094 172.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.444 ' HB2' ' HD3' ' A' ' 69' ' ' ARG . 43.1 t80 -103.0 119.56 39.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.167 -0.309 . . . . 3.1400000000000001 110.167 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.517 0 C-N-CA 120.295 -0.955 . . . . 2.79 112.166 178.46 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.2 p . . . . . 0 N--CA 1.446 -0.645 0 N-CA-C 110.031 -0.359 . . . . 3.2999999999999998 110.031 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -128.98 133.24 47.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.894 0.378 . . . . 1.76 111.232 -174.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.518 ' HB2' ' OD1' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -149.41 149.46 30.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.789 -0.641 . . . . 2.5499999999999998 110.107 177.85 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.664 ' O ' ' HA ' ' A' ' 94' ' ' ASN . 87.1 mtp -116.07 116.3 27.62 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.025 -0.534 . . . . 1.77 110.353 -176.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -94.66 119.87 33.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.903 0.383 . . . . 1.97 110.279 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.61 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 55.3 ttt180 -116.9 125.6 51.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.217 -0.447 . . . . 3.8500000000000001 110.767 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -115.89 135.95 53.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.825 -0.625 . . . . 2.2799999999999998 110.239 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.483 ' O ' ' HA2' ' A' ' 90' ' ' GLY . 45.4 tttm -122.24 123.56 41.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.712 -0.676 . . . . 2.1400000000000001 109.97 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.5 mm -120.03 120.34 62.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 109.286 -0.635 . . . . 1.55 109.286 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -141.49 105.03 5.93 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 111.863 0.32 . . . . 1.1899999999999999 111.863 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 85.4 Cg_endo -84.44 157.04 12.53 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.93 2.42 . . . . 1.3700000000000001 111.263 171.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -126.21 146.77 49.85 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.908 -0.317 . . . . 2.3500000000000001 110.854 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -126.24 130.79 51.62 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.977 -0.556 . . . . 4.54 110.796 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 85' ' ' SER . 42.1 t0 -60.06 140.08 57.06 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.207 0.942 . . . . 3.04 111.319 -176.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.794 ' HA ' ' O ' ' A' ' 129' ' ' PHE . 35.9 m -76.5 -22.67 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.944 -1.025 . . . . 4.2699999999999996 111.444 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -82.4 83.52 7.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.79 0.328 . . . . 6.04 110.439 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.2 tp -90.39 -79.78 0.34 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.224 -0.444 . . . . 4.5899999999999999 111.284 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 69.4 p -145.14 158.11 43.91 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.9 -0.136 . . . . 3.6899999999999999 111.101 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 58.49 25.22 12.76 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.774 0.671 . . . . 5.1699999999999999 112.271 170.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.471 ' HA ' HH12 ' A' ' 128' ' ' ARG . 25.1 m-20 57.04 30.0 17.45 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.064 0.459 . . . . 3.71 111.908 -176.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.1 mt -99.02 139.58 34.45 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.231 -1.026 . . . . 2.0499999999999998 108.231 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.652 ' HA ' ' O ' ' A' ' 121' ' ' VAL . 50.7 mmt-85 -107.99 120.17 41.55 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.213 -0.595 . . . . 4.2400000000000002 110.624 -174.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.794 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 90.2 m-85 -118.47 125.11 49.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.6 -0.727 . . . . 3.5499999999999998 109.79 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.483 ' O ' ' HA ' ' A' ' 156' ' ' THR . 24.0 t30 -110.77 126.24 54.39 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.609 -0.268 . . . . 2.1099999999999999 110.282 -175.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.79 117.38 1.85 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.087 -1.054 . . . . 1.1799999999999999 112.357 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.536 ' HB3' ' HB3' ' A' ' 155' ' ' GLU . 52.8 t-105 -126.6 129.91 49.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.398 -0.593 . . . . 4.2999999999999998 109.398 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 84.3 mt -118.06 138.27 52.35 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.715 -0.476 . . . . 2.2400000000000002 109.715 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.489 ' OG ' ' HB2' ' A' ' 153' ' ' GLU . 3.2 p -134.99 117.19 15.51 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.475 0.655 . . . . 1.6899999999999999 111.153 175.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 95.1 mmm -106.12 134.83 48.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.183 -0.917 . . . . 2.2400000000000002 109.288 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -124.9 133.83 52.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.012 0.434 . . . . 3.5600000000000001 111.888 -173.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 97.7 mttt -118.5 132.66 56.22 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.681 -0.859 . . . . 1.6699999999999999 108.681 171.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.578 ' H ' HD12 ' A' ' 142' ' ' LEU . 54.3 m-85 -123.03 143.04 50.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.508 0.194 . . . . 3.23 110.908 -174.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 59.79 -160.19 0.29 Allowed 'General case' 0 C--O 1.226 -0.171 0 O-C-N 123.856 0.722 . . . . 1.24 111.446 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -76.02 -36.06 59.27 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.952 0.406 . . . . 2.4700000000000002 110.483 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -60.29 -49.74 76.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.379 -0.828 . . . . 2.4100000000000001 113.169 -167.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.578 HD12 ' H ' ' A' ' 138' ' ' PHE . 14.7 mt -70.41 -27.18 64.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.74 -0.384 . . . . 1.8300000000000001 111.371 -176.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -60.72 -39.92 90.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.114 0.483 . . . . 2.0 110.343 172.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 85.0 m -70.05 -41.02 74.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.617 -0.72 . . . . 2.0499999999999998 111.018 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.556 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 56.3 p -74.82 -26.09 59.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 1.5900000000000001 111.718 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 69.0 -112.96 4.91 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.845 -0.693 . . . . 1.52 112.345 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -106.21 -0.19 24.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.691 0.281 . . . . 5.9400000000000004 110.801 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.85 -40.18 75.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.103 0.478 . . . . 1.8300000000000001 110.547 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.454 ' O ' HD22 ' A' ' 142' ' ' LEU . 24.2 t70 -135.94 111.57 9.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.489 -0.778 . . . . 2.6400000000000001 109.083 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.6 t -165.7 147.15 7.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.932 -0.576 . . . . 2.02 110.114 -173.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.421 ' HD3' ' OE2' ' A' ' 153' ' ' GLU . 24.5 ttm180 -70.71 135.71 48.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.611 0.243 . . . . 3.6699999999999999 110.508 175.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.91 120.08 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.176 -0.466 . . . . 1.6399999999999999 110.058 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.489 ' HB2' ' OG ' ' A' ' 134' ' ' SER . 96.4 mt-10 -119.97 139.96 51.66 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.444 -0.576 . . . . 2.5600000000000001 109.444 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 89.5 m -139.97 134.41 31.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.972 0.415 . . . . 1.3899999999999999 111.493 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 132' ' ' TRP . 41.6 tt0 -113.35 127.81 56.25 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.298 -0.63 . . . . 2.04 109.298 173.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 130' ' ' ASN . 35.5 m -129.0 120.46 26.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.847 0.356 . . . . 1.5600000000000001 110.474 177.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -116.21 133.9 11.07 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.709 -0.758 . . . . 1.04 111.601 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.517 ' HB2' HG13 ' A' ' 170' ' ' VAL . 52.6 mt -121.28 133.07 55.13 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.508 -0.553 . . . . 2.27 109.508 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 128' ' ' ARG . 54.1 tt0 -120.03 120.38 36.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.458 -0.337 . . . . 2.4100000000000001 110.419 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -121.55 131.0 53.88 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.358 -0.608 . . . . 4.5700000000000003 109.358 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.405 ' HB ' ' HA ' ' A' ' 164' ' ' GLU . 15.1 p -99.49 89.81 4.3 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.466 -0.494 . . . . 1.46 110.138 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.07 -49.1 78.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.61 -0.723 . . . . 2.6299999999999999 111.441 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.498 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.1 m-20 -100.0 12.68 36.26 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 121.119 -0.232 . . . . 2.4100000000000001 110.454 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.405 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 42.2 tt0 71.15 -49.51 0.68 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.725 0.81 . . . . 2.5800000000000001 111.762 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.2 t -74.84 -16.22 60.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.73 0.3 . . . . 2.2999999999999998 111.488 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 163' ' ' ASN . 17.9 m -125.58 141.45 45.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.853 0.359 . . . . 1.71 110.439 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.423 ' O ' ' HD2' ' A' ' 199' ' ' PRO . . . -107.23 139.43 41.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 1.47 110.909 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 31.2 mt -104.42 136.8 43.32 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.651 -0.87 . . . . 1.6599999999999999 108.651 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -118.34 120.12 36.68 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.444 -0.502 . . . . 3.2999999999999998 110.477 -176.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.517 HG13 ' HB2' ' A' ' 158' ' ' LEU . 3.5 p -129.69 131.95 66.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.744 -0.662 . . . . 1.3 109.752 176.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -127.84 130.05 47.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.002 -0.545 . . . . 2.2200000000000002 110.163 -176.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -101.01 121.67 42.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.009 -0.542 . . . . 4.6100000000000003 109.626 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -97.3 110.0 22.64 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.155 -0.683 . . . . 3.98 109.155 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.541 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 61.2 tp -103.63 115.67 30.92 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.084 -0.507 . . . . 2.3799999999999999 110.372 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -122.06 114.21 20.61 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.634 -0.876 . . . . 3.3100000000000001 108.634 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 116.261 -0.427 . . . . 6.5300000000000002 111.068 -176.349 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 . . . . . 0 CA--C 1.522 -0.107 0 CA-C-O 121.081 0.467 . . . . 4.4000000000000004 111.363 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.699 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 18.5 tt -149.27 146.57 17.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.976 -0.556 . . . . 2.21 109.645 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.517 ' HB3' ' HB3' ' A' ' 210' ' ' TYR . 96.6 mtt180 -121.93 110.08 15.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.723 0.297 . . . . 3.54 110.774 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -137.21 141.76 42.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.544 -0.298 . . . . 1.6699999999999999 111.186 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -163.53 174.99 11.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.647 -0.871 . . . . 5.8300000000000001 108.647 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 7.0 mp -98.64 125.61 42.03 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.045 -0.724 . . . . 2.5899999999999999 109.045 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' A' ' 167' ' ' ALA . 36.5 Cg_exo -60.07 138.75 83.83 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.1 1.867 . . . . 1.77 111.672 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 77.9 mt -116.94 131.81 56.86 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.183 -0.673 . . . . 2.2599999999999998 109.183 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 11.6 t -147.94 139.87 24.05 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.189 0.518 . . . . 1.99 110.838 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 57.2 tp -143.89 85.46 1.82 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.542 -0.754 . . . . 2.3100000000000001 109.354 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 75.92 -112.29 3.55 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.858 -0.686 . . . . 1.51 112.487 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -93.94 0.02 55.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.204 0.526 . . . . 2.5699999999999998 110.351 -177.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -110.56 116.56 31.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.725 -0.67 . . . . 2.6600000000000001 110.105 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 49.2 m -122.6 131.05 53.64 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.842 -0.429 . . . . 1.6200000000000001 109.842 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.27 130.01 72.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.044 -0.354 . . . . 1.3799999999999999 110.044 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.7 m -127.72 90.34 48.38 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-O 120.915 0.388 . . . . 1.1799999999999999 110.484 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 238' ' ' GLY . 5.8 Cg_exo -79.58 150.45 21.79 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.167 2.578 . . . . 1.01 112.081 175.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.517 ' HB3' ' HB3' ' A' ' 195' ' ' ARG . 80.9 m-85 -126.08 139.93 52.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.024 0.44 . . . . 4.5 111.316 173.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 7.0 t -154.43 169.22 24.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.368 -0.975 . . . . 1.8899999999999999 108.368 175.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.699 ' HA ' ' O ' ' A' ' 194' ' ' ILE . 67.3 ttt180 -60.29 -49.19 78.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.385 0.539 . . . . 4.7999999999999998 111.015 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.6 mt . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 109.584 -0.524 . . . . 4.5700000000000003 109.584 179.443 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 109.675 -0.491 . . . . 2.3999999999999999 109.675 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 209' ' ' PRO . . . -92.14 117.08 5.19 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.427 -0.892 . . . . 1.27 111.265 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.49 119.72 39.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.876 0.37 . . . . 1.97 110.305 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -99.89 119.92 38.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.76 -0.655 . . . . 3.54 109.287 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 252' ' ' SER . 91.1 m-85 -100.53 126.69 47.0 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.813 -0.44 . . . . 2.6400000000000001 109.813 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -116.25 121.46 5.21 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.798 -0.715 . . . . 1.3500000000000001 111.607 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' TYR . . . . . 0.442 ' HB2' ' HB ' ' A' ' 251' ' ' VAL . 89.7 m-85 -119.94 130.25 54.71 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.802 -0.444 . . . . 4.3600000000000003 109.802 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -112.65 128.7 56.46 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.456 -0.572 . . . . 4.29 109.456 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.92 140.19 51.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.159 0.505 . . . . 6.6900000000000004 110.391 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -60.0 -29.49 68.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.058 -0.974 . . . . 6.3700000000000001 112.24 -171.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -69.47 -20.01 63.75 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.607 0.241 . . . . 5.8300000000000001 111.486 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 116.22 0.0 20.76 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.548 -0.834 . . . . 2.6600000000000001 112.259 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.433 HD13 ' CD2' ' A' ' 279' ' ' TYR . 53.5 tp -74.98 129.96 38.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.869 0.366 . . . . 2.9700000000000002 110.256 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 25.8 t -122.06 130.26 53.12 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.261 -0.644 . . . . 2.1699999999999999 109.261 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 243' ' ' TYR . 62.9 t -119.99 132.85 68.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.42 -0.355 . . . . 1.79 110.666 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 241' ' ' TYR . 35.2 t -127.73 128.45 45.39 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.068 -0.716 . . . . 1.6299999999999999 109.068 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 81.6 mt -121.38 139.93 52.79 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.652 -0.249 . . . . 2.96 110.82 -178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -114.35 110.67 20.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.182 -0.463 . . . . 4.0800000000000001 110.536 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -131.92 148.67 52.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.35 -0.386 . . . . 4.8399999999999999 110.34 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.555 0 CA-C-O 121.24 0.543 . . . . 3.5800000000000001 110.087 175.803 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.607 -0.516 . . . . 1.9399999999999999 109.607 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.07 133.61 7.34 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.216 -0.992 . . . . 1.4199999999999999 112.343 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 61.8 t -127.86 129.82 69.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.956 -0.387 . . . . 1.8100000000000001 109.956 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -132.76 111.85 1.06 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.227 -0.749 . . . . 1.3 111.227 176.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 23.8 m -119.98 132.36 69.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.845 0.355 . . . . 1.8300000000000001 110.815 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -119.71 127.75 53.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.153 -0.476 . . . . 2.3100000000000001 110.368 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.433 ' CD2' HD13 ' A' ' 249' ' ' LEU . 89.6 m-85 -105.99 130.27 53.95 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.044 -0.725 . . . . 4.75 109.044 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.1 t -117.68 125.05 49.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.841 0.353 . . . . 1.6699999999999999 111.172 -172.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.281 -0.866 . . . . 3.6899999999999999 109.858 179.193 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 . . . . . 0 CA--C 1.518 -0.276 0 N-CA-C 109.816 -0.439 . . . . 3.6099999999999999 109.816 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -71.78 118.18 14.3 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.674 -0.491 . . . . 3.3300000000000001 109.674 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.468 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 96.4 m-70 -104.14 124.94 50.0 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.104 0.478 . . . . 3.2000000000000002 110.671 -176.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.97 139.94 51.7 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.422 -0.808 . . . . 2.4900000000000002 109.264 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -129.12 129.63 45.42 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.036 -0.728 . . . . 2.1299999999999999 109.036 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.6 mm -120.53 120.08 61.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.901 -0.407 . . . . 1.6000000000000001 109.901 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -102.74 137.69 13.53 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.065 -1.064 . . . . 0.88 111.331 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.17 135.36 54.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.921 0.391 . . . . 1.0800000000000001 110.248 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 59.4 ttm -134.6 130.95 37.24 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.696 -0.683 . . . . 2.3300000000000001 110.026 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -99.84 121.64 41.6 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.486 -0.561 . . . . 2.6099999999999999 109.486 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 5.0899999999999999 110.519 179.908 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.897 0.379 . . . . 3.48 111.278 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.38 133.59 28.68 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.088 1.859 . . . . 1.8600000000000001 110.679 171.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.8 m -128.45 147.25 50.65 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.561 -0.29 . . . . 1.97 110.654 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 19.5 m -120.13 146.69 24.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.382 -0.372 . . . . 1.71 110.475 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -119.96 142.65 48.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.03 -0.532 . . . . 4.0700000000000003 109.608 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 64.4 t80 -101.7 129.87 47.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.863 0.363 . . . . 2.8599999999999999 110.602 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -144.38 134.87 24.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.79 -0.641 . . . . 1.8899999999999999 109.351 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.74 146.7 39.87 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.309 -0.244 . . . . 1.0800000000000001 111.425 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 8' ' ' HIS . . . -154.95 122.53 5.7 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 111.936 0.347 . . . . 1.3899999999999999 111.936 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.656 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 53.8 t30 -167.87 95.56 0.43 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.391 -0.368 . . . . 2.8599999999999999 110.207 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.69 -94.72 2.02 Favored Glycine 0 C--O 1.23 -0.134 0 C-N-CA 121.012 -0.614 . . . . 1.6799999999999999 111.67 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.656 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 80.8 Cg_exo -47.19 175.74 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 123.912 3.075 . . . . 1.6599999999999999 113.357 167.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -66.1 176.68 1.62 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.428 0.632 . . . . 3.3999999999999999 111.441 -172.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.401 ' HG3' ' HB2' ' A' ' 40' ' ' ALA . 19.1 ttm180 -110.62 124.18 51.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.707 -0.678 . . . . 3.1000000000000001 109.649 -171.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.44 HG12 HG22 ' A' ' 74' ' ' VAL . 85.3 mt -119.58 130.01 74.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.664 -0.698 . . . . 1.8 110.915 -169.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -118.96 130.0 55.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.85999999999999999 110.419 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 72' ' ' LEU . 65.2 tp -124.57 135.66 53.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.138 -0.483 . . . . 1.0600000000000001 111.241 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.98 162.47 35.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.663 -0.699 . . . . 1.1399999999999999 110.121 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -137.42 146.87 44.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.821 0.344 . . . . 4.0199999999999996 110.345 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.436 ' HB2' ' HG3' ' A' ' 69' ' ' ARG . 96.1 m-85 -130.05 129.95 44.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.229 -0.441 . . . . 4.6100000000000003 111.306 -175.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -104.54 85.94 2.42 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.281 -0.637 . . . . 3.3799999999999999 109.281 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.552 ' CD ' HH21 ' A' ' 69' ' ' ARG . 42.2 mt-10 . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.857 -0.61 . . . . 5.0499999999999998 110.907 -173.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 87.6 m95 . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.637 0.256 . . . . 5.6100000000000003 110.616 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -125.66 138.65 53.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.459 -0.337 . . . . 3.7799999999999998 110.153 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -131.99 170.03 15.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.366 -0.379 . . . . 2.4500000000000002 110.173 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.552 HH21 ' CD ' ' A' ' 53' ' ' GLU . 27.9 ptt180 -141.84 125.7 9.96 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.979 0.418 . . . . 3.2400000000000002 111.196 171.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 90.9 Cg_endo -85.19 156.85 11.15 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.999 2.466 . . . . 1.1899999999999999 112.25 172.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.441 ' HG3' ' HE ' ' A' ' 93' ' ' ARG . 86.1 tt0 -127.09 120.77 29.7 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.123 -0.695 . . . . 2.1899999999999999 109.123 171.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.592 ' O ' ' HA3' ' A' ' 91' ' ' GLY . 64.3 tp -136.21 119.09 16.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.346 -0.388 . . . . 1.1399999999999999 110.208 -177.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.59 149.22 50.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.122 0.487 . . . . 2.1800000000000002 110.864 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 46' ' ' ILE . 50.6 t -119.96 130.04 74.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.447 -0.797 . . . . 1.5600000000000001 109.272 177.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -93.73 120.51 34.09 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.704 -0.48 . . . . 3.4399999999999999 109.704 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -108.2 134.85 50.47 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.105 -0.702 . . . . 4.7999999999999998 109.105 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -120.0 131.29 55.09 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.68 0.276 . . . . 2.9399999999999999 110.318 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -119.58 138.57 53.13 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.29 0.567 . . . . 3.8999999999999999 111.167 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.0 mt . . . . . 0 C--N 1.324 -0.522 0 N-CA-C 108.684 -0.858 . . . . 4.4800000000000004 108.684 177.433 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 CA--C 1.52 -0.21 0 CA-C-O 120.894 0.378 . . . . 2.5499999999999998 111.698 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -94.43 103.89 15.86 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.271 -0.572 . . . . 5.2999999999999998 109.65 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -113.97 125.65 6.99 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.979 -0.848 . . . . 1.3500000000000001 110.979 176.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 60.0 tp -119.64 130.53 55.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.837 0.351 . . . . 2.29 111.02 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.2 p -117.04 131.86 56.83 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.788 -0.819 . . . . 1.54 108.788 169.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.43 150.46 20.88 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.235 -0.983 . . . . 1.1699999999999999 111.585 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 72' ' ' LEU . . . -173.16 -169.96 36.23 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.632 -0.794 . . . . 1.1899999999999999 112.07 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -120.21 139.98 51.85 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.062 0.458 . . . . 3.75 110.819 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.441 ' HE ' ' HG3' ' A' ' 71' ' ' GLU . 98.2 mtt180 -121.04 127.21 51.5 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.492 -0.929 . . . . 2.75 108.492 172.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.553 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 10.4 t30 -132.25 124.61 29.26 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.78 -0.368 . . . . 1.8200000000000001 110.674 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.487 ' HA ' ' HB3' ' A' ' 69' ' ' ARG . 72.1 t80 -111.28 129.54 55.95 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.331 -0.395 . . . . 3.1400000000000001 110.435 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.541 0 C-N-CA 120.68 -0.772 . . . . 2.79 112.574 177.499 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.2 t . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 109.049 -0.723 . . . . 3.2999999999999998 109.049 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.62 113.25 7.02 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.623 -0.431 . . . . 1.76 110.864 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -147.02 138.56 24.19 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.045 -0.525 . . . . 2.5499999999999998 110.139 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.493 ' HG3' ' HA ' ' A' ' 139' ' ' ALA . 46.4 ttm -131.65 129.91 41.4 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.622 -0.717 . . . . 1.77 110.71 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -101.87 124.96 48.39 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.491 -0.559 . . . . 1.97 109.491 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.42 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 80.6 ttt180 -130.55 130.15 43.71 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.134 0.492 . . . . 3.8500000000000001 110.328 -175.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -112.2 141.73 45.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.742 -0.663 . . . . 2.2799999999999998 110.79 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -139.89 123.59 17.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.177 -0.465 . . . . 2.1400000000000001 110.424 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 88.0 mt -136.76 130.15 45.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.513 -0.767 . . . . 1.55 109.039 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -149.46 104.19 3.28 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.678 0.622 . . . . 1.1899999999999999 112.678 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 65.0 Cg_endo -94.43 159.77 1.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.463 2.775 . . . . 1.3700000000000001 113.036 170.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -120.6 142.51 49.33 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.379 -0.971 . . . . 2.3500000000000001 108.379 173.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -125.78 129.92 50.41 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.474 0.176 . . . . 4.54 111.474 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -84.1 120.89 26.7 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.576 -0.527 . . . . 3.04 109.576 170.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.57 ' O ' ' HB3' ' A' ' 129' ' ' PHE . 57.3 t -139.88 99.92 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.886 0.375 . . . . 4.2699999999999996 110.282 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -87.61 115.92 25.38 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.113 -0.328 . . . . 6.04 110.113 176.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.78 -39.81 95.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.413 0.625 . . . . 4.5899999999999999 109.322 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.0 p -141.4 169.92 16.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.873 -1.058 . . . . 3.6899999999999999 109.178 172.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.14 -45.44 93.05 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.839 0.311 . . . . 5.1699999999999999 111.839 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -64.94 -39.95 94.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 3.71 111.552 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.5 mt -76.16 142.57 41.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.43 0.634 . . . . 2.0499999999999998 112.11 -172.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.541 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 35.2 ttt180 -110.31 118.07 35.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.252 -0.886 . . . . 4.2400000000000002 109.248 175.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.57 ' HB3' ' O ' ' A' ' 121' ' ' VAL . 65.0 t80 -142.11 138.48 31.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.728 0.299 . . . . 3.5499999999999998 110.372 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -139.87 172.2 13.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 2.1099999999999999 109.913 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -148.23 121.99 1.44 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.776 -0.726 . . . . 1.1799999999999999 112.072 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -100.02 126.52 46.22 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.389 -0.597 . . . . 4.2999999999999998 109.389 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 42.6 tp -111.98 130.71 55.76 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.26 -0.427 . . . . 2.2400000000000002 110.117 -178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.1 m -127.0 129.99 49.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.901 0.382 . . . . 1.6899999999999999 110.308 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.613 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 72.0 mtm -122.91 125.19 44.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.849 -0.614 . . . . 2.2400000000000002 109.958 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -122.17 139.94 53.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.116 -0.493 . . . . 3.5600000000000001 111.774 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -135.78 149.98 49.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.323 -0.991 . . . . 1.6699999999999999 108.323 172.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.475 ' O ' HD23 ' A' ' 142' ' ' LEU . 46.2 p90 -140.5 165.93 26.1 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.095 -0.335 . . . . 3.23 110.095 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.493 ' HA ' ' HG3' ' A' ' 110' ' ' MET . . . 63.42 178.15 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.512 0.507 . . . . 1.24 111.018 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -76.1 -36.63 58.82 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.313 0.578 . . . . 2.4700000000000002 110.6 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -60.07 -40.02 88.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.253 -0.885 . . . . 2.4100000000000001 112.956 -171.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 138' ' ' PHE . 4.2 mm? -69.38 -33.4 72.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.696 0.284 . . . . 1.8300000000000001 111.535 -173.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -66.62 -39.93 88.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.365 0.602 . . . . 2.0 109.517 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 52.4 m -65.77 -39.95 91.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.2 -0.909 . . . . 2.0499999999999998 111.395 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 22.9 p -71.7 -9.87 58.91 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 111.89 0.33 . . . . 1.5900000000000001 111.89 -177.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 65.43 -120.34 17.19 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.786 -0.721 . . . . 1.52 111.857 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -103.29 10.09 37.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.854 0.327 . . . . 5.9400000000000004 111.016 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.48 -40.12 95.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.885 0.374 . . . . 1.8300000000000001 110.499 176.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -137.14 114.87 11.27 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.298 -0.631 . . . . 2.6400000000000001 109.298 175.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.1 t -159.95 150.05 18.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.918 0.39 . . . . 2.02 110.543 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 135' ' ' MET . 19.0 mtp180 -84.47 113.35 21.14 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.051 -0.351 . . . . 3.6699999999999999 110.051 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.9 t -111.15 103.7 15.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.98 -0.748 . . . . 1.6399999999999999 108.98 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -121.99 128.91 52.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.549 -0.75 . . . . 2.5600000000000001 110.016 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 72.7 m -128.49 130.22 47.2 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.033 0.444 . . . . 1.3899999999999999 111.527 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.403 ' CD ' HH22 ' A' ' 195' ' ' ARG . 37.2 tt0 -110.4 119.22 38.5 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.01 -0.737 . . . . 2.04 109.01 173.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 172' ' ' TYR . 22.7 p -101.36 141.67 33.89 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.726 -0.39 . . . . 1.5600000000000001 110.727 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 129' ' ' PHE . . . -116.7 120.02 4.69 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.723 -0.751 . . . . 1.04 112.095 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.6 tp -115.2 129.76 56.73 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.91 0.386 . . . . 2.27 110.151 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.541 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 30.1 tt0 -118.98 115.85 25.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.521 -0.548 . . . . 2.4100000000000001 109.521 174.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -125.39 130.53 52.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.795 -0.638 . . . . 4.5700000000000003 110.218 -175.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 3.7 p -87.58 93.9 9.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.064 0.459 . . . . 1.46 110.853 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.475 ' HB2' HD11 ' A' ' 168' ' ' LEU . 65.8 t80 -59.99 -49.82 76.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 2.6299999999999999 111.547 -176.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.423 ' HB2' HG22 ' A' ' 166' ' ' VAL . 93.0 m-20 -101.8 16.65 25.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.544 -0.298 . . . . 2.4100000000000001 110.861 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 163' ' ' ASN . 46.0 tt0 73.03 -50.19 0.7 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.763 0.664 . . . . 2.5800000000000001 111.419 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.1 p -74.78 -21.41 59.34 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.037 0.384 . . . . 2.2999999999999998 112.037 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 161' ' ' THR . 34.3 m -120.03 138.16 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.776 0.322 . . . . 1.71 110.724 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.0 134.4 50.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.215 -0.448 . . . . 1.47 110.29 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.475 HD11 ' HB2' ' A' ' 162' ' ' PHE . 43.8 mt -103.55 139.92 38.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.34 -0.391 . . . . 1.6599999999999999 110.024 -176.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 55.6 mtp180 -98.9 114.36 26.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.212 -0.449 . . . . 3.2999999999999998 109.882 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 195' ' ' ARG . 60.3 t -129.16 132.3 67.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 1.3 110.569 -177.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.435 ' O ' HG23 ' A' ' 194' ' ' ILE . 18.9 m120 -122.52 147.91 45.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.971 0.415 . . . . 2.2200000000000002 110.868 173.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.53 ' HB3' ' OG1' ' A' ' 156' ' ' THR . 64.5 t80 -129.09 147.09 50.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.487 -0.779 . . . . 4.6100000000000003 109.811 -173.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -96.63 125.49 41.14 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 120.757 0.313 . . . . 3.98 110.714 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 67.7 tp -120.83 114.02 20.99 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.257 -0.645 . . . . 2.3799999999999999 109.257 171.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -125.18 113.43 17.66 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.629 -0.508 . . . . 3.3100000000000001 109.629 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.063 0.459 . . . . 6.5300000000000002 111.021 -176.247 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.461 ' HA ' ' HG3' ' A' ' 212' ' ' ARG . 35.8 tt0 . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.077 -0.342 . . . . 4.4000000000000004 110.077 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 171' ' ' ASN . 87.3 mt -110.2 143.29 20.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 122.358 0.263 . . . . 2.21 111.188 -173.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.583 ' HB3' ' CD1' ' A' ' 210' ' ' TYR . 53.9 mtm-85 -98.41 102.84 14.7 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.904 -0.776 . . . . 3.54 108.904 169.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 169' ' ' ARG . . . -141.08 121.7 14.22 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.918 -0.313 . . . . 1.6699999999999999 111.014 177.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.405 ' HB3' ' O ' ' A' ' 209' ' ' PRO . 10.2 t80 -165.76 -179.11 5.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.648 -0.501 . . . . 5.8300000000000001 109.648 171.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.551 HD12 ' HD2' ' A' ' 199' ' ' PRO . 24.3 tp -99.44 126.58 37.09 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.315 -0.624 . . . . 2.5899999999999999 109.315 173.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.551 ' HD2' HD12 ' A' ' 198' ' ' LEU . 38.3 Cg_endo -70.06 145.79 56.46 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.139 1.892 . . . . 1.77 112.225 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 56.1 mt -118.41 130.72 56.13 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.085 -0.507 . . . . 2.2599999999999998 109.655 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 26.8 m -131.12 125.15 32.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.983 0.42 . . . . 1.99 110.996 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 91.8 mt -131.37 80.97 1.96 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.57 -0.741 . . . . 2.3100000000000001 109.47 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 68.62 -115.83 6.94 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.802 -0.713 . . . . 1.51 112.105 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -90.12 -0.59 57.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.209 0.528 . . . . 2.5699999999999998 110.117 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.418 ' HA ' ' CE2' ' A' ' 243' ' ' TYR . 72.9 m-70 -99.9 117.23 33.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.539 -0.755 . . . . 2.6600000000000001 109.01 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 12.5 t -132.14 130.97 41.82 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.629 -0.428 . . . . 1.6200000000000001 110.24 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.8 p -137.56 134.98 46.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.408 0.623 . . . . 1.3799999999999999 110.862 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 29.0 m -128.95 91.78 41.74 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 115.667 -0.697 . . . . 1.1799999999999999 109.846 176.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.405 ' O ' ' HB3' ' A' ' 197' ' ' TYR . 14.4 Cg_exo -69.74 157.16 61.4 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.599 2.199 . . . . 1.01 110.664 174.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 195' ' ' ARG . 71.0 m-85 -129.29 139.79 51.66 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.997 -0.372 . . . . 4.5 109.997 175.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 39.5 p -124.25 140.02 53.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.987 0.422 . . . . 1.8899999999999999 110.385 176.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.461 ' HG3' ' HA ' ' A' ' 193' ' ' GLU . 37.7 ttt180 -64.27 -39.67 94.41 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 114.795 -1.093 . . . . 4.7999999999999998 112.748 -170.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.9 mt . . . . . 0 C--N 1.321 -0.643 0 CA-C-O 120.742 0.306 . . . . 4.5700000000000003 110.383 -174.917 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 210' ' ' TYR . 71.0 t . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 120.932 0.396 . . . . 2.3999999999999999 110.031 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -110.39 141.79 16.42 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.599 -0.81 . . . . 1.27 111.807 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 88.9 mt -109.72 117.65 34.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.158 -0.312 . . . . 1.97 110.158 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -101.09 120.11 39.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.205 -0.452 . . . . 3.54 109.95 175.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.555 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 86.8 m-85 -111.94 130.19 55.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.097 0.475 . . . . 2.6400000000000001 110.349 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -121.32 113.7 2.39 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 111.027 -0.829 . . . . 1.3500000000000001 111.027 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' TYR . . . . . 0.418 ' CE2' ' HA ' ' A' ' 205' ' ' HIS . 86.5 m-85 -119.96 135.25 54.98 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.178 0.513 . . . . 4.3600000000000003 111.501 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -110.0 100.82 9.71 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.408 -0.815 . . . . 4.29 109.077 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -77.55 -19.95 54.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.976 0.417 . . . . 6.6900000000000004 110.959 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -149.93 150.46 31.91 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.738 -0.838 . . . . 6.3700000000000001 108.738 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -66.97 121.68 16.06 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.423 -0.511 . . . . 5.8300000000000001 109.682 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 98.53 -9.71 62.65 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.778 -0.646 . . . . 2.6600000000000001 112.43 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 93.1 mt -124.23 133.0 53.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.721 0.296 . . . . 2.9700000000000002 110.616 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 33.7 m -129.98 149.96 51.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.368 -0.378 . . . . 2.1699999999999999 110.772 -176.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 8.5 p -127.41 134.07 66.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.17 0.51 . . . . 1.79 109.845 174.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 19.3 t -103.9 119.89 39.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.716 -0.674 . . . . 1.6299999999999999 109.747 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 77.9 mt -119.42 113.05 20.18 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.145 -0.479 . . . . 2.96 110.068 -178.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -109.05 129.55 55.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.945 0.402 . . . . 4.0800000000000001 111.036 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -128.14 151.3 49.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.823 -0.626 . . . . 4.8399999999999999 110.441 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 116.164 -0.471 . . . . 3.5800000000000001 110.568 -179.522 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 110.445 -0.206 . . . . 1.9399999999999999 110.445 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 177.69 -169.74 41.86 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.747 -0.739 . . . . 1.4199999999999999 112.333 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 63.2 t -110.12 128.89 65.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.867 0.365 . . . . 1.8100000000000001 110.667 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.86 141.21 12.46 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.508 -0.637 . . . . 1.3 111.508 176.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 61.6 t -120.02 129.96 74.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 117.093 0.447 . . . . 1.8300000000000001 110.162 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -108.11 109.33 20.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.935 0.398 . . . . 2.3100000000000001 110.058 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -100.02 107.9 19.96 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.872 -0.788 . . . . 4.75 108.872 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.6 m -119.54 132.27 55.71 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.998 0.428 . . . . 1.6699999999999999 111.248 -172.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 59.2 t80 . . . . . 0 C--O 1.241 0.617 0 CA-C-O 118.411 -0.804 . . . . 3.6899999999999999 109.225 176.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 121.162 0.506 . . . . 3.6099999999999999 111.322 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.517 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 71.0 m95 -119.79 147.24 44.88 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.151 -0.685 . . . . 3.3300000000000001 109.151 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.662 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 25.9 t60 -96.44 113.37 24.94 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.624 -0.51 . . . . 3.2000000000000002 109.624 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.517 ' CE1' ' HB2' ' A' ' 7' ' ' TRP . 95.0 m-85 -110.41 158.88 18.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.904 -0.589 . . . . 2.4900000000000002 111.108 -176.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -141.42 132.3 25.93 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.809 -0.632 . . . . 2.1299999999999999 109.326 170.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.5 mt -119.8 114.09 43.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.974 -0.75 . . . . 1.6000000000000001 108.974 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.81 127.25 8.18 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.265 -0.969 . . . . 0.88 112.128 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -115.69 134.45 55.02 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 110.057 -0.349 . . . . 1.0800000000000001 110.057 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.607 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 94.8 mmm -124.31 131.03 53.5 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.859 -0.61 . . . . 2.3300000000000001 109.372 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -85.82 109.1 18.44 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.769 -0.456 . . . . 2.6099999999999999 109.769 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 C--N 1.325 -0.492 0 CA-C-O 121.145 0.498 . . . . 5.0899999999999999 110.706 -175.314 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.855 0.359 . . . . 3.48 111.026 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 14' ' ' MET . 76.9 Cg_endo -81.2 135.31 9.57 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.669 2.246 . . . . 1.8600000000000001 112.198 172.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 56.2 m -103.21 142.36 34.29 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.421 -0.585 . . . . 1.97 109.421 174.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 m -110.87 134.47 53.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.28 0.562 . . . . 1.71 111.309 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -119.9 132.08 55.43 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.59 -0.732 . . . . 4.0700000000000003 109.817 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 94.1 m-85 -105.37 127.95 53.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.031 -0.359 . . . . 2.8599999999999999 110.031 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.414 HD21 ' HD2' ' A' ' 45' ' ' ARG . 46.3 t30 -130.89 138.02 49.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.947 -0.39 . . . . 1.8899999999999999 109.947 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.57 143.13 50.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.711 -0.222 . . . . 1.0800000000000001 110.691 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.662 ' O ' ' HB3' ' A' ' 8' ' ' HIS . . . -154.14 117.37 4.54 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.366 -0.379 . . . . 1.3899999999999999 111.33 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.479 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 25.4 t-20 -163.49 95.42 0.82 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.642 -0.503 . . . . 2.8599999999999999 109.642 173.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.82 -97.59 2.31 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.037 -0.601 . . . . 1.6799999999999999 111.76 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 51.3 Cg_exo -55.3 174.16 0.26 Allowed 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.52 2.813 . . . . 1.6599999999999999 113.515 172.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.523 ' HB3' ' O ' ' A' ' 75' ' ' HIS . 24.4 m-90 -70.15 -176.24 1.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.551 -0.749 . . . . 3.3999999999999999 111.064 -175.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.536 ' HG2' ' HB2' ' A' ' 40' ' ' ALA . 36.7 mtm-85 -112.06 149.96 31.35 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.529 0.68 . . . . 3.1000000000000001 112.732 -163.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.497 HG22 HG12 ' A' ' 74' ' ' VAL . 47.5 pt -128.88 140.05 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 114.606 -1.179 . . . . 1.8 110.244 175.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -120.06 128.88 53.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.189 -0.46 . . . . 0.85999999999999999 110.09 177.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.6 tp -125.19 136.59 53.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.102 0.477 . . . . 1.0600000000000001 110.922 -176.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.76 168.15 20.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.456 -0.793 . . . . 1.1399999999999999 109.376 176.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -140.02 145.58 37.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.588 0.232 . . . . 4.0199999999999996 110.665 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.572 ' HB2' ' CG ' ' A' ' 69' ' ' ARG . 89.6 m-85 -135.75 148.97 49.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.307 -0.406 . . . . 4.6100000000000003 109.937 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -136.43 170.22 16.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.619 -0.264 . . . . 3.3799999999999999 111.323 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 115.938 -0.574 . . . . 5.0499999999999998 110.774 -179.514 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 35.6 p90 . . . . . 0 N--CA 1.455 -0.184 0 N-CA-C 109.83 -0.433 . . . . 5.6100000000000003 109.83 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.522 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 95.0 m-85 -109.2 127.64 54.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.039 0.447 . . . . 3.7799999999999998 111.057 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -97.2 166.45 11.56 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.761 -0.654 . . . . 2.4500000000000002 110.637 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.572 ' CG ' ' HB2' ' A' ' 51' ' ' TYR . 6.6 ptp180 -150.48 125.53 4.76 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 121.113 0.483 . . . . 3.2400000000000002 110.577 171.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 75.6 Cg_endo -89.41 158.78 5.47 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.005 2.47 . . . . 1.1899999999999999 112.268 172.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.651 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 39.5 tt0 -131.25 111.72 12.15 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.351 -0.611 . . . . 2.1899999999999999 109.351 173.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.8 tp -125.01 120.0 30.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.278 -0.419 . . . . 1.1399999999999999 110.424 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 39.0 tt0 -121.38 130.05 53.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.657 -0.497 . . . . 2.1800000000000002 109.657 177.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.497 HG12 HG22 ' A' ' 46' ' ' ILE . 29.6 m -112.67 136.38 49.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.986 0.422 . . . . 1.5600000000000001 109.961 -177.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.523 ' O ' ' HB3' ' A' ' 44' ' ' TRP . 63.2 m80 -116.64 119.6 36.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.081 -0.508 . . . . 3.4399999999999999 110.837 -171.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -113.62 126.08 54.88 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.099 -0.704 . . . . 4.7999999999999998 109.099 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -120.3 134.08 55.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.954 0.406 . . . . 2.9399999999999999 110.708 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -90.6 86.49 6.41 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.514 -0.766 . . . . 3.8999999999999999 109.158 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--N 1.32 -0.682 0 N-CA-C 108.439 -0.949 . . . . 4.4800000000000004 108.439 174.209 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.4 m . . . . . 0 N--CA 1.449 -0.496 0 CA-C-O 121.204 0.526 . . . . 2.5499999999999998 110.249 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -130.56 149.65 52.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.587 -0.894 . . . . 5.2999999999999998 108.587 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.23 154.13 21.84 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.033 -1.08 . . . . 1.3500000000000001 112.708 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.2 mt -134.93 129.87 34.97 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.172 -0.677 . . . . 2.29 109.172 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.1 t -133.96 139.47 46.12 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.111 0.481 . . . . 1.54 110.409 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 73' ' ' GLU . . . -132.96 132.79 6.71 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 111.34 -0.704 . . . . 1.1699999999999999 111.34 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.11 123.23 5.6 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.884 -0.674 . . . . 1.1899999999999999 111.892 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -112.01 122.12 46.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.633 0.254 . . . . 3.75 110.541 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.651 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 72.1 mtm180 -131.36 129.78 41.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.307 -0.406 . . . . 2.75 110.064 173.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.482 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 64.2 t30 -128.51 117.72 21.8 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.958 -0.386 . . . . 1.8200000000000001 109.958 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -109.84 126.67 54.06 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.742 0.306 . . . . 3.1400000000000001 110.372 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 67' ' ' PHE . . . . . . . . 0 N--CA 1.442 -0.947 0 C-N-CA 120.201 -0.999 . . . . 2.79 112.233 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 108.667 -0.864 . . . . 3.2999999999999998 108.667 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -119.39 115.29 23.79 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 120.631 -0.427 . . . . 1.76 110.921 -173.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -153.53 137.41 16.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.887 -0.597 . . . . 2.5499999999999998 111.593 -175.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 44.6 ttm -132.33 123.63 27.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.558 -0.746 . . . . 1.77 109.863 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.499 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 78.3 mt-30 -107.25 127.24 53.36 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 120.123 -0.631 . . . . 1.97 110.212 175.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.551 ' HB2' ' HB2' ' A' ' 93' ' ' ARG . 95.4 mtt180 -110.13 113.36 25.98 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.999 -0.741 . . . . 3.8500000000000001 108.999 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -107.4 122.56 46.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.965 -0.561 . . . . 2.2799999999999998 111.036 -176.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -114.71 123.77 50.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.651 -0.704 . . . . 2.1400000000000001 109.986 175.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 11.8 tt -131.12 129.82 63.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.932 -0.396 . . . . 1.55 109.932 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -149.93 121.16 4.03 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.558 -0.292 . . . . 1.1899999999999999 111.482 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -90.3 135.61 2.22 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 122.916 2.411 . . . . 1.3700000000000001 111.371 169.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -104.12 139.64 38.91 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.436 -0.579 . . . . 2.3500000000000001 109.436 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -132.21 140.66 48.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.377 0.608 . . . . 4.54 111.413 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -134.43 79.14 1.79 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.902 -1.045 . . . . 3.04 108.406 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.525 ' O ' ' HB3' ' A' ' 129' ' ' PHE . 63.1 t -129.99 125.39 60.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.758 -0.655 . . . . 4.2699999999999996 110.518 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.476 ' HD3' ' HB2' ' A' ' 129' ' ' PHE . 59.4 tptt -140.3 135.73 32.54 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.311 -0.626 . . . . 6.04 109.311 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.9 tp -60.52 -31.32 70.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.557 -0.747 . . . . 4.5899999999999999 111.921 -176.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.414 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 21.9 m -108.35 135.3 49.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.941 0.4 . . . . 3.6899999999999999 110.106 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -63.01 -39.79 95.81 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.28 -0.873 . . . . 5.1699999999999999 112.181 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -70.0 -15.47 63.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.906 -0.588 . . . . 3.71 111.234 -176.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.8 mt -111.82 154.22 25.43 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.908 -0.587 . . . . 2.0499999999999998 110.058 -173.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -130.88 136.88 49.03 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.539 -0.464 . . . . 4.2400000000000002 110.985 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.525 ' HB3' ' O ' ' A' ' 121' ' ' VAL . 65.2 t80 -123.31 120.42 33.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.79 -0.641 . . . . 3.5499999999999998 109.73 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -122.81 136.84 55.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.784 0.326 . . . . 2.1099999999999999 111.202 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -160.75 149.98 19.55 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.277 -0.729 . . . . 1.1799999999999999 111.277 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -148.33 148.03 29.94 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.119 -0.326 . . . . 4.2999999999999998 110.119 176.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 67.9 tp -116.79 117.93 31.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.332 -0.395 . . . . 2.2400000000000002 110.755 -175.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.5 t -104.99 118.41 36.45 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.805 0.336 . . . . 1.6899999999999999 110.577 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 64.6 mtt -108.86 121.63 45.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.226 -0.657 . . . . 2.2400000000000002 109.226 171.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.415 ' OH ' ' HD3' ' A' ' 112' ' ' ARG . 64.9 t80 -116.53 136.79 52.69 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.655 -0.702 . . . . 3.5600000000000001 111.068 -171.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -130.17 150.86 51.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.63 -0.713 . . . . 1.6699999999999999 109.813 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -139.55 159.94 41.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.571 0.224 . . . . 3.23 110.431 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 60.22 -177.03 0.1 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.552 -0.749 . . . . 1.24 111.001 -175.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -77.65 -24.67 49.37 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.087 0.47 . . . . 2.4700000000000002 110.515 172.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.95 -51.38 69.93 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.409 -0.814 . . . . 2.4100000000000001 112.575 -172.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.5 mp -70.17 -29.11 65.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.03 0.443 . . . . 1.8300000000000001 111.2 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.499 ' ND2' ' HB2' ' A' ' 111' ' ' GLN . 95.0 m-20 -68.79 -39.75 80.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.532 -0.304 . . . . 2.0 110.809 178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.3 p -70.11 -32.1 69.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.577 -0.283 . . . . 2.0499999999999998 111.481 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.4 p -80.36 -20.21 44.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.234 0.54 . . . . 1.5900000000000001 110.845 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.84 -114.35 5.26 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.694 -0.684 . . . . 1.52 112.381 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -99.98 3.65 44.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.566 0.222 . . . . 5.9400000000000004 111.162 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.82 -40.04 76.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.022 0.439 . . . . 1.8300000000000001 110.02 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -129.83 99.34 5.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.55 -0.75 . . . . 2.6400000000000001 109.788 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.9 t -148.81 159.06 44.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.06 -0.518 . . . . 2.02 109.833 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 135' ' ' MET . 42.1 ttm180 -93.68 123.38 36.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.204 -0.453 . . . . 3.6699999999999999 109.881 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.0 t -112.48 120.58 63.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.493 -0.321 . . . . 1.6399999999999999 110.58 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -143.17 130.03 20.49 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.0 -0.37 . . . . 2.5600000000000001 110.0 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.437 ' HB ' ' CD1' ' A' ' 133' ' ' LEU . 10.1 t -136.58 146.72 46.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.011 0.434 . . . . 1.3899999999999999 110.965 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -119.98 139.55 52.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.215 -0.448 . . . . 2.04 110.351 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 22.6 m -117.03 122.98 45.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.095 -0.502 . . . . 1.5600000000000001 110.297 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -117.79 121.86 5.23 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.722 -0.551 . . . . 1.04 111.722 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.432 ' HB3' ' CE2' ' A' ' 160' ' ' TYR . 92.2 mt -108.38 135.09 50.26 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 122.274 0.23 . . . . 2.27 110.382 -177.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 168' ' ' LEU . 63.8 tt0 -123.36 115.89 22.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.758 0.314 . . . . 2.4100000000000001 110.178 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 158' ' ' LEU . 82.9 m-85 -130.92 139.95 50.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.23 -0.441 . . . . 4.5700000000000003 110.867 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 22.9 p -96.93 92.76 6.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.09 -0.505 . . . . 1.46 110.973 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' PHE . . . . . 0.506 ' CD2' HD12 ' A' ' 168' ' ' LEU . 61.3 m-85 -70.04 -39.91 75.45 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.163 0.431 . . . . 2.6299999999999999 112.163 -176.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.533 ' HB2' HG22 ' A' ' 166' ' ' VAL . 88.7 m-20 -100.3 13.38 34.55 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.776 -0.37 . . . . 2.4100000000000001 110.908 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 73.12 -52.06 0.71 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.873 0.733 . . . . 2.5800000000000001 111.79 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.2 p -74.66 -20.58 59.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.715 0.293 . . . . 2.2999999999999998 111.705 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.533 HG22 ' HB2' ' A' ' 163' ' ' ASN . 35.8 m -116.68 137.91 48.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.89 0.376 . . . . 1.71 110.836 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.8 123.07 47.61 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.077 -0.51 . . . . 1.47 110.131 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.506 HD12 ' CD2' ' A' ' 162' ' ' PHE . 21.7 mt -103.8 140.53 37.51 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.72 -0.474 . . . . 1.6599999999999999 109.72 -177.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -115.18 125.46 53.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.935 0.398 . . . . 3.2999999999999998 110.383 -176.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.5 t -128.44 129.57 68.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.561 -0.533 . . . . 1.3 109.561 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.543 ' OD1' ' HB2' ' A' ' 195' ' ' ARG . 28.7 p-10 -133.74 148.72 51.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.302 0.572 . . . . 2.2200000000000002 111.575 -177.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -145.36 151.43 38.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.347 -0.842 . . . . 4.6100000000000003 110.071 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -101.18 128.91 47.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.428 0.632 . . . . 3.98 111.55 -173.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.423 ' HB3' HG23 ' A' ' 154' ' ' THR . 48.4 tp -120.06 124.24 45.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.327 -0.851 . . . . 2.3799999999999999 109.499 -176.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -70.01 -43.4 71.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.229 0.537 . . . . 3.3100000000000001 111.061 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.963 -0.562 . . . . 6.5300000000000002 109.979 -172.108 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.131 0.491 . . . . 4.4000000000000004 109.801 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 86.4 mt -117.26 131.54 69.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.968 -0.56 . . . . 2.21 110.855 -173.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.543 ' HB2' ' OD1' ' A' ' 171' ' ' ASN . 90.0 mtt180 -95.25 127.36 41.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.814 0.34 . . . . 3.54 110.419 176.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -117.78 130.53 56.36 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.571 -0.529 . . . . 1.6699999999999999 109.571 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -152.85 160.04 43.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.192 0.52 . . . . 5.8300000000000001 111.274 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.449 ' O ' ' HD2' ' A' ' 209' ' ' PRO . 2.5 pt? -137.95 134.25 17.94 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.126 -0.488 . . . . 2.5899999999999999 110.019 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.69 128.05 9.15 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.197 1.931 . . . . 1.77 112.708 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.8 tp -120.43 123.52 43.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.692 -0.686 . . . . 2.2599999999999998 109.538 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 22.7 m -104.9 119.96 40.28 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.454 -0.339 . . . . 1.99 110.7 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.92 80.26 1.8 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.472 -0.566 . . . . 2.3100000000000001 109.472 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.1 -117.26 8.9 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.714 -0.675 . . . . 1.51 112.298 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -90.48 0.09 57.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.372 0.606 . . . . 2.5699999999999998 109.651 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -114.69 120.1 38.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.506 -0.77 . . . . 2.6600000000000001 111.096 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 13.6 p -102.03 142.6 33.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.33 -0.396 . . . . 1.6200000000000001 110.453 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 49.8 t -129.13 129.98 67.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.307 -0.627 . . . . 1.3799999999999999 109.307 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 32.8 m -134.44 91.72 21.73 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-O 120.849 0.357 . . . . 1.1799999999999999 110.37 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.449 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 57.0 Cg_endo -74.57 138.47 24.21 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.273 1.982 . . . . 1.01 112.307 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -106.03 139.01 41.23 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.35 -0.611 . . . . 4.5 109.35 175.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 38.9 p -132.39 160.53 36.08 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.91 -0.404 . . . . 1.8899999999999999 109.91 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -66.24 -40.52 90.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.416 0.627 . . . . 4.7999999999999998 109.617 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 44.7 pt . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.484 -0.78 . . . . 4.5700000000000003 109.789 175.417 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 120.85 0.357 . . . . 2.3999999999999999 110.251 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -124.69 138.12 10.95 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.716 -0.754 . . . . 1.27 111.298 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.99 126.61 54.12 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.981 0.39 . . . . 1.97 110.527 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.503 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 61.7 t80 -99.56 124.42 44.74 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.318 -0.623 . . . . 3.54 109.318 173.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.526 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 81.7 m-85 -119.89 140.01 51.51 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.818 -0.438 . . . . 2.6400000000000001 109.818 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -136.77 151.87 21.08 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.074 -1.06 . . . . 1.3500000000000001 112.74 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' TYR . . . . . 0.408 ' HB2' HG22 ' A' ' 251' ' ' VAL . 96.3 m-85 -129.96 129.85 44.32 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.856 -0.794 . . . . 4.3600000000000003 108.856 172.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -128.1 130.38 48.09 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.193 -0.299 . . . . 4.29 110.193 -176.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -128.52 135.31 49.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.153 -0.476 . . . . 6.6900000000000004 110.429 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -60.09 -30.13 69.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.122 -0.944 . . . . 6.3700000000000001 111.684 -175.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -55.69 -33.64 64.34 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.303 -0.408 . . . . 5.8300000000000001 110.772 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 135.38 31.79 0.31 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.559 -0.829 . . . . 2.6600000000000001 112.797 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 53.0 tp -125.57 127.83 46.98 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.691 -0.3 . . . . 2.9700000000000002 110.4 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 6.1 t -140.09 129.31 23.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.642 -0.873 . . . . 2.1699999999999999 108.642 173.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 243' ' ' TYR . 33.1 m -129.94 159.81 41.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.91 0.386 . . . . 1.79 111.5 -176.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 35.3 p -131.34 139.96 49.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.523 -0.762 . . . . 1.6299999999999999 110.166 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 89.0 mt -125.7 135.61 52.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.003 -0.544 . . . . 2.96 109.986 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -110.59 120.92 43.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.125 -0.489 . . . . 4.0800000000000001 110.082 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -106.86 129.3 54.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.306 -0.406 . . . . 4.8399999999999999 110.787 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.733 -0.667 . . . . 3.5800000000000001 110.579 179.126 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.171 -0.678 . . . . 1.9399999999999999 109.171 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.75 136.05 8.55 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.224 -0.988 . . . . 1.4199999999999999 112.001 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 62.7 t -130.03 129.7 65.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.982 0.42 . . . . 1.8100000000000001 110.412 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.03 139.99 11.39 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.712 -0.955 . . . . 1.3 110.712 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.16 129.97 54.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 117.102 0.451 . . . . 1.8300000000000001 111.265 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -113.24 123.07 49.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.033 -0.531 . . . . 2.3100000000000001 110.004 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -99.97 107.27 19.19 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.932 -0.766 . . . . 4.75 108.932 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 25.6 m -102.12 124.05 47.05 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.144 0.497 . . . . 1.6699999999999999 111.043 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 88.9 m-85 . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.122 -0.942 . . . . 3.6899999999999999 108.722 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 CA--C 1.519 -0.217 0 N-CA-C 109.895 -0.409 . . . . 3.6099999999999999 109.895 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.53 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 20.3 m-90 -70.99 139.98 50.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.987 -0.551 . . . . 3.3300000000000001 110.981 -178.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -99.2 130.0 45.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.001 -0.545 . . . . 3.2000000000000002 110.544 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -115.77 140.31 49.33 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.866 -0.606 . . . . 2.4900000000000002 110.888 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 94.2 m-20 -121.86 132.33 54.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.556 -0.747 . . . . 2.1299999999999999 109.549 174.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.0 mt -119.76 120.02 62.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.372 -0.603 . . . . 1.6000000000000001 109.372 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.13 142.4 14.95 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.048 -1.072 . . . . 0.88 112.68 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.53 134.81 54.71 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.941 -0.762 . . . . 1.0800000000000001 108.941 174.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 49.0 tpp -129.93 129.67 44.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.061 -0.518 . . . . 2.3300000000000001 111.0 -173.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.469 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 56.3 m-85 -93.15 129.77 39.04 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.914 -1.143 . . . . 2.6099999999999999 107.914 169.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 C--N 1.317 -0.822 0 C-N-CA 120.328 -0.549 . . . . 5.0899999999999999 110.534 -177.497 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.649 -0.5 . . . . 3.48 109.649 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.469 ' HD3' ' CE2' ' A' ' 15' ' ' TYR . 59.6 Cg_endo -73.93 134.38 19.68 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.093 1.862 . . . . 1.8600000000000001 112.375 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.7 t -118.13 143.57 46.38 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.797 -0.816 . . . . 1.97 108.797 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.5 m -110.11 139.99 31.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.304 0.573 . . . . 1.71 111.639 -173.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 49' ' ' ALA . 34.6 p90 -135.72 149.77 49.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.425 -0.807 . . . . 4.0700000000000003 109.903 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -113.47 130.07 56.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.02 -0.536 . . . . 2.8599999999999999 110.729 -175.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 10' ' ' ASN . 77.6 m-20 -123.44 144.49 49.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.165 -0.471 . . . . 1.8899999999999999 109.952 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.41 142.34 45.62 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.074 -0.343 . . . . 1.0800000000000001 110.074 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.01 112.57 1.59 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.151 0.426 . . . . 1.3899999999999999 112.151 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 7' ' ' TRP . 24.5 t-20 -168.24 94.96 0.39 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.713 -0.477 . . . . 2.8599999999999999 109.713 166.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.89 -83.34 0.43 Allowed Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.212 -0.755 . . . . 1.6799999999999999 111.212 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.13 173.46 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.029 2.486 . . . . 1.6599999999999999 111.797 169.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.461 ' HB3' ' O ' ' A' ' 75' ' ' HIS . 45.3 m95 -70.75 -177.74 1.66 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.143 -0.481 . . . . 3.3999999999999999 110.064 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -109.6 120.42 42.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.657 0.741 . . . . 3.1000000000000001 109.976 -172.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.4 mt -109.94 136.29 46.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.378 -1.283 . . . . 1.8 110.326 -174.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.81 128.24 55.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.943 -0.572 . . . . 0.85999999999999999 110.158 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.1 tp -120.45 130.2 54.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.045 -0.525 . . . . 1.0600000000000001 110.494 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 36' ' ' TYR . . . -148.92 168.42 23.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.236 -0.438 . . . . 1.1399999999999999 110.524 178.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 45.2 p90 -142.4 160.03 41.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.357 -0.383 . . . . 4.0199999999999996 110.342 -177.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.429 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 64.3 t80 -134.28 130.02 36.45 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.82 -0.437 . . . . 4.6100000000000003 109.82 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -135.65 147.21 48.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.404 -0.362 . . . . 3.3799999999999999 110.412 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--N 1.321 -0.641 0 N-CA-C 108.967 -0.753 . . . . 5.0499999999999998 108.967 179.976 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.963 0.411 . . . . 5.6100000000000003 110.126 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -106.8 99.73 9.29 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.176 -0.676 . . . . 3.7799999999999998 109.176 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -134.23 170.63 15.42 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.511 -0.922 . . . . 2.4500000000000002 108.511 -171.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.523 ' HD3' ' CE1' ' A' ' 95' ' ' TYR . 39.4 ttp180 -119.14 123.01 29.12 Favored Pre-proline 0 C--N 1.318 -0.787 0 C-N-CA 120.326 -0.55 . . . . 3.2400000000000002 110.697 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -91.74 115.68 0.4 Allowed 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 122.126 1.884 . . . . 1.1899999999999999 110.767 169.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -103.26 112.74 25.76 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.903 -0.777 . . . . 2.1899999999999999 108.903 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.2 tp -124.53 118.66 27.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.652 -0.704 . . . . 1.1399999999999999 109.496 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -126.03 131.75 52.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.6 -0.518 . . . . 2.1800000000000002 109.6 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.22 121.88 68.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.869 0.366 . . . . 1.5600000000000001 110.116 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.461 ' O ' ' HB3' ' A' ' 44' ' ' TRP . 79.8 t60 -104.64 119.6 39.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.115 -0.493 . . . . 3.4399999999999999 110.503 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -97.16 120.74 38.07 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.984 -1.117 . . . . 4.7999999999999998 107.984 176.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.4 ' HG3' ' HA ' ' A' ' 86' ' ' PHE . 29.0 tt0 -127.31 113.78 16.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.174 0.511 . . . . 2.9399999999999999 111.671 -174.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -102.61 120.3 40.31 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.673 -0.694 . . . . 3.8999999999999999 109.38 175.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 C--N 1.323 -0.584 0 CA-C-O 121.122 0.486 . . . . 4.4800000000000004 110.777 179.326 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 120' ' ' ASP . 14.7 t . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 120.645 0.26 . . . . 2.5499999999999998 110.412 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.4 ' HA ' ' HG3' ' A' ' 77' ' ' GLN . 90.1 m-85 69.78 -100.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.512 -0.767 . . . . 5.2999999999999998 111.069 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.27 -82.06 0.35 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.012 -1.089 . . . . 1.3500000000000001 113.215 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 57.9 tp -144.13 131.25 20.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.22 0.51 . . . . 2.29 111.989 -173.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.5 m -121.36 130.08 53.42 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.575 -0.528 . . . . 1.54 109.575 170.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -145.45 141.92 10.26 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.145 -1.026 . . . . 1.1699999999999999 112.238 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.99 171.2 36.26 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.62 -0.8 . . . . 1.1899999999999999 111.993 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -148.47 159.95 43.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.092 0.472 . . . . 3.75 111.628 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -134.39 137.29 43.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.324 -0.853 . . . . 2.75 109.494 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 63.1 t30 -125.18 122.22 36.42 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.971 -0.381 . . . . 1.8200000000000001 109.971 175.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.523 ' CE1' ' HD3' ' A' ' 69' ' ' ARG . 95.2 m-85 -102.84 120.92 41.45 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.023 -0.362 . . . . 3.1400000000000001 110.023 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.788 0 C-N-CA 120.995 -0.621 . . . . 2.79 113.658 -176.135 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.1 p . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 112.267 0.469 . . . . 3.2999999999999998 112.267 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.72 119.13 33.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.725 0.774 . . . . 1.76 112.85 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -115.19 106.45 14.09 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.595 -0.891 . . . . 2.5499999999999998 108.595 171.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.539 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 89.5 mtp -139.85 117.05 11.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.527 -0.306 . . . . 1.77 110.799 -177.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.614 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 54.0 tt0 -117.21 117.96 31.0 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.627 -0.429 . . . . 1.97 110.182 176.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -105.6 123.53 48.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.869 -0.605 . . . . 3.8500000000000001 110.14 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -125.53 128.73 48.42 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.814 -0.81 . . . . 2.2799999999999998 108.814 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -130.15 126.03 36.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.408 . . . . 2.1400000000000001 110.558 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 134' ' ' SER . 88.2 mt -120.05 129.61 75.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.709 -0.678 . . . . 1.55 109.66 177.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 134' ' ' SER . . . -141.87 108.14 5.91 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 111.954 0.353 . . . . 1.1899999999999999 111.954 -176.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.721 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 61.4 Cg_endo -76.5 131.95 13.05 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.75 1.634 . . . . 1.3700000000000001 110.21 171.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -102.28 137.02 41.09 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.281 -0.637 . . . . 2.3500000000000001 109.281 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -135.45 129.98 34.05 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.99 -0.284 . . . . 4.54 110.942 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 32.5 t70 -126.25 122.09 34.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.172 -0.467 . . . . 3.04 109.856 174.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.4 t -120.05 120.49 63.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.09 -0.504 . . . . 4.2699999999999996 110.19 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.405 ' HE2' ' HD3' ' A' ' 128' ' ' ARG . 96.6 mttt -104.96 90.75 3.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.296 -0.411 . . . . 6.04 110.527 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.6 tp -60.28 -49.74 76.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.284 0.564 . . . . 4.5899999999999999 110.154 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.5 p -140.79 172.52 12.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.372 -0.831 . . . . 3.6899999999999999 109.358 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -60.16 -39.88 87.95 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.192 -0.603 . . . . 5.1699999999999999 109.605 172.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.1 -40.17 75.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.729 -0.669 . . . . 3.71 111.997 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.0 mt -111.12 119.65 39.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.285 0.564 . . . . 2.0499999999999998 111.436 -173.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.405 ' HD3' ' HE2' ' A' ' 122' ' ' LYS . 38.1 ttp180 -132.63 132.78 42.83 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.719 -0.673 . . . . 4.2400000000000002 110.681 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -111.97 100.03 8.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.326 -0.852 . . . . 3.5499999999999998 109.738 -176.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -113.8 114.65 26.59 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.022 -0.362 . . . . 2.1099999999999999 110.022 -178.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -144.82 152.75 24.71 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.994 -1.098 . . . . 1.1799999999999999 113.013 -175.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.536 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 56.5 p-90 -141.28 147.85 38.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.783 0.325 . . . . 4.2999999999999998 110.42 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.721 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 10.1 tt -126.27 131.98 51.78 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.314 -0.624 . . . . 2.2400000000000002 109.314 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.604 ' HB3' ' HB2' ' A' ' 116' ' ' ALA . 80.5 p -131.53 150.06 52.29 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.811 -0.355 . . . . 1.6899999999999999 111.548 -177.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 71.8 mtm -114.38 136.02 53.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.091 -0.504 . . . . 2.2400000000000002 110.415 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.428 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 49.5 m-85 -104.87 120.92 42.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.87 -0.605 . . . . 3.5600000000000001 111.674 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.68 121.79 29.32 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.134 -1.062 . . . . 1.6699999999999999 108.134 166.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.614 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 52.6 p90 -145.85 166.49 25.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.448 -0.342 . . . . 3.23 111.49 -171.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 110' ' ' MET . . . 60.0 -164.72 0.22 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.052 -0.976 . . . . 1.24 111.795 177.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -75.3 -39.79 59.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.102 -0.499 . . . . 2.4700000000000002 111.305 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.69 -54.2 49.11 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.438 0.533 . . . . 2.4100000000000001 112.438 -167.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.73 -40.11 84.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.2 0.524 . . . . 1.8300000000000001 110.492 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.438 HD22 ' C ' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -62.09 -39.38 92.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.783 -0.644 . . . . 2.0 109.96 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.8 m -68.66 -40.11 80.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.886 -0.597 . . . . 2.0499999999999998 111.912 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 148' ' ' ALA . 41.9 p -79.9 -20.04 46.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.169 0.509 . . . . 1.5900000000000001 110.865 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.02 -109.82 2.91 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.803 -0.635 . . . . 1.52 113.154 173.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -99.16 0.62 43.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.8 0.333 . . . . 5.9400000000000004 110.661 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' A' ' 145' ' ' THR . . . -70.04 -40.04 75.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 1.8300000000000001 111.489 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -118.96 124.68 47.62 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.566 -0.288 . . . . 2.6400000000000001 110.569 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.4 p -130.02 140.06 50.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.986 0.422 . . . . 2.02 110.9 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.428 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 42.5 ttm180 -113.06 129.98 56.32 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.337 -0.986 . . . . 3.6699999999999999 108.337 173.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.9 p -117.33 132.02 68.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.533 0.683 . . . . 1.6399999999999999 111.697 -173.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.421 ' OE1' ' HH2' ' A' ' 132' ' ' TRP . 38.3 tt0 -119.99 115.69 24.27 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.011 -0.995 . . . . 2.5600000000000001 109.126 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 21.7 m -129.74 127.21 39.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.77 0.319 . . . . 1.3899999999999999 111.283 -177.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.536 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 42.6 tt0 -122.34 134.49 54.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.966 -0.561 . . . . 2.04 110.032 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.5 m -128.27 120.26 26.78 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.857 0.361 . . . . 1.5600000000000001 110.094 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.72 106.8 3.36 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.861 -0.896 . . . . 1.04 110.861 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 82.7 mt -99.79 120.07 39.16 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.668 -0.493 . . . . 2.27 109.668 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -100.08 119.13 37.82 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.859 -0.61 . . . . 2.4100000000000001 110.014 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -121.55 137.94 54.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.532 -0.758 . . . . 4.5700000000000003 109.9 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 7.3 p -89.9 88.56 7.37 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.077 -0.712 . . . . 1.46 109.077 168.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.08 -48.97 79.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.023 -0.989 . . . . 2.6299999999999999 111.395 -170.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.416 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.6 m-20 -99.96 11.39 39.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.4 -0.364 . . . . 2.4100000000000001 110.52 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 71.88 -43.02 0.55 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.007 0.817 . . . . 2.5800000000000001 111.177 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.9 p -73.91 -26.66 60.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.286 -0.416 . . . . 2.2999999999999998 111.428 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 163' ' ' ASN . 33.7 m -119.16 143.61 29.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.119 -0.491 . . . . 1.71 110.678 -177.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.13 119.52 39.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.206 -0.452 . . . . 1.47 110.14 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 22.9 mt -111.57 134.73 52.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.355 -0.384 . . . . 1.6599999999999999 110.182 -175.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -100.06 122.02 42.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.798 -0.445 . . . . 3.2999999999999998 109.798 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 40.4 t -120.01 120.02 61.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.474 -0.49 . . . . 1.3 109.792 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -98.87 120.91 40.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.335 0.588 . . . . 2.2200000000000002 110.389 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -105.85 139.55 40.24 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.054 -0.975 . . . . 4.6100000000000003 109.253 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -113.15 129.79 56.4 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 110.074 -0.343 . . . . 3.98 110.074 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.498 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 61.5 tp -109.93 129.93 55.59 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.067 0.46 . . . . 2.3799999999999999 110.795 -174.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -112.62 179.45 3.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.393 -0.821 . . . . 3.3100000000000001 110.1 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 . . . . . 0 C--N 1.331 -0.216 0 CA-C-O 121.045 0.45 . . . . 6.5300000000000002 111.705 -179.261 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 120.832 0.348 . . . . 4.4000000000000004 110.669 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 88.0 mt -120.09 98.11 5.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.137 -1.061 . . . . 2.21 108.137 171.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.679 ' HA ' ' O ' ' A' ' 211' ' ' THR . 97.7 mtt180 -100.04 118.91 37.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.858 0.361 . . . . 3.54 111.173 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.589 ' O ' ' HA ' ' A' ' 210' ' ' TYR . . . -99.98 131.82 45.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.251 -0.431 . . . . 1.6699999999999999 110.916 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -127.69 129.41 47.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.752 -0.658 . . . . 5.8300000000000001 109.826 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 208' ' ' THR . 1.8 pt? -131.1 127.23 21.9 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.167 -0.309 . . . . 2.5899999999999999 110.167 174.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -89.55 120.31 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.664 2.243 . . . . 1.77 113.626 -177.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 84.1 mt -118.08 128.2 54.52 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.369 -0.604 . . . . 2.2599999999999998 109.369 172.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 24.0 m -100.51 120.13 39.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.807 0.337 . . . . 1.99 111.236 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 91.8 mt -122.57 80.78 1.77 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.525 -0.546 . . . . 2.3100000000000001 109.525 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 72.84 -122.98 8.5 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.65 -0.704 . . . . 1.51 111.861 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -93.83 3.56 55.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.293 0.568 . . . . 2.5699999999999998 110.2 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -118.59 130.01 55.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.915 -0.584 . . . . 2.6600000000000001 110.048 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 241' ' ' TYR . 5.4 p -111.13 139.82 46.19 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.774 -0.37 . . . . 1.6200000000000001 110.557 176.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.448 HG22 ' CE1' ' A' ' 241' ' ' TYR . 31.7 t -109.16 120.91 61.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.378 -0.601 . . . . 1.3799999999999999 109.378 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 198' ' ' LEU . 32.1 m -129.84 90.1 44.07 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.264 -0.426 . . . . 1.1799999999999999 110.0 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -63.17 146.05 93.89 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.45 2.1 . . . . 1.01 111.142 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 53.0 p90 -133.34 148.28 51.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.156 0.503 . . . . 4.5 110.204 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 195' ' ' ARG . 32.6 p -129.72 141.29 50.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.539 -0.755 . . . . 1.8899999999999999 110.57 -177.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -69.74 -38.92 77.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.649 -0.705 . . . . 4.7999999999999998 109.567 177.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.1 mt . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.229 -0.896 . . . . 4.5700000000000003 109.627 174.878 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 108.946 -0.761 . . . . 2.3999999999999999 108.946 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -80.15 134.6 13.72 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.088 -1.053 . . . . 1.27 111.737 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 87.0 mt -108.44 118.07 35.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.11 0.455 . . . . 1.97 110.627 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' A' ' 208' ' ' THR . 64.8 t80 -110.04 131.23 55.24 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.125 -0.695 . . . . 3.54 109.125 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' TYR . . . . . 0.562 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 96.2 m-85 -120.11 139.2 52.94 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.834 -0.432 . . . . 2.6400000000000001 109.834 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -110.95 129.04 9.03 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.527 -0.844 . . . . 1.3500000000000001 111.682 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -129.31 126.84 39.87 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.939 -0.393 . . . . 4.3600000000000003 109.939 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -120.0 131.7 55.23 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.918 0.389 . . . . 4.29 110.706 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 249' ' ' LEU . 52.2 t80 -102.34 129.95 48.93 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.941 -0.763 . . . . 6.6900000000000004 108.941 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -60.08 -37.17 79.14 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.583 0.957 . . . . 6.3700000000000001 113.583 -167.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -60.11 -39.98 88.09 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.622 0.249 . . . . 5.8300000000000001 111.559 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 151.65 42.04 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.868 -1.158 . . . . 2.6600000000000001 113.233 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 245' ' ' PHE . 49.9 tp -133.48 130.09 38.1 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.031 -0.359 . . . . 2.9700000000000002 110.031 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 21.6 t -117.04 130.03 56.41 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.227 -0.657 . . . . 2.1699999999999999 109.227 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.09 132.72 68.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.057 0.456 . . . . 1.79 110.426 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 52.6 m -114.19 128.7 56.49 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.532 -0.544 . . . . 1.6299999999999999 109.532 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 83.0 mt -118.98 133.57 55.74 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.378 -0.374 . . . . 2.96 110.541 -175.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -127.25 121.33 30.87 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.772 -0.455 . . . . 4.0800000000000001 109.772 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -122.97 139.24 54.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.928 0.394 . . . . 4.8399999999999999 111.631 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.673 -0.694 . . . . 3.5800000000000001 110.301 177.98 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.895 0.379 . . . . 1.9399999999999999 111.431 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.99 149.62 19.62 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.87 -0.604 . . . . 1.4199999999999999 112.285 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 61.5 t -130.04 130.07 65.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.673 0.273 . . . . 1.8100000000000001 110.719 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.48 134.69 8.91 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.041 -0.824 . . . . 1.3 111.041 176.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 28.0 m -128.71 139.5 51.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 117.431 0.615 . . . . 1.8300000000000001 111.375 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -129.4 124.31 33.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.855 -0.611 . . . . 2.3100000000000001 110.162 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.416 ' CD1' HD13 ' A' ' 249' ' ' LEU . 97.9 m-85 -96.69 127.92 43.14 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.45 -0.574 . . . . 4.75 109.45 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 49.1 m -111.32 124.95 53.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.723 0.297 . . . . 1.6699999999999999 110.73 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 72.6 t80 . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.58 -0.724 . . . . 3.6899999999999999 109.827 179.601 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 N--CA 1.449 -0.502 0 CA-C-O 120.694 0.283 . . . . 3.6099999999999999 110.397 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -119.4 138.52 53.03 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.038 -0.356 . . . . 3.3300000000000001 110.038 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -104.22 128.16 51.92 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.517 -0.549 . . . . 3.2000000000000002 109.517 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -103.23 144.89 30.74 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.687 -0.688 . . . . 2.4900000000000002 111.033 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 279' ' ' TYR . 35.4 m-80 -119.98 131.26 55.11 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.167 -0.924 . . . . 2.1299999999999999 108.926 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.6 mt -120.29 115.26 46.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 N-CA-C 109.204 -0.665 . . . . 1.6000000000000001 109.204 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -110.02 127.07 8.22 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.551 -0.833 . . . . 0.88 111.273 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -120.67 136.01 54.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.713 0.292 . . . . 1.0800000000000001 110.785 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' MET . . . . . 0.405 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 91.4 mtp -135.35 156.93 48.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.852 -0.613 . . . . 2.3300000000000001 109.415 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -119.95 122.37 41.05 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.641 -0.503 . . . . 2.6099999999999999 109.641 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 C--N 1.34 0.153 0 CA-C-O 121.062 0.458 . . . . 5.0899999999999999 110.345 179.786 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.581 0.229 . . . . 3.48 110.948 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 14' ' ' MET . 36.3 Cg_endo -70.17 149.99 65.08 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.308 2.005 . . . . 1.8600000000000001 110.916 168.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 22.2 m -125.67 142.19 51.63 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.699 -0.482 . . . . 1.97 109.699 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.618 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 33.1 m -129.99 160.06 41.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.695 0.284 . . . . 1.71 110.512 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -140.2 149.95 43.56 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.68 -0.489 . . . . 4.0700000000000003 109.68 174.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 94.5 m-85 -109.45 128.79 55.42 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.465 -0.334 . . . . 2.8599999999999999 110.217 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -140.32 135.21 31.97 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.992 -0.549 . . . . 1.8899999999999999 109.753 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.6 141.39 51.14 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.762 -0.375 . . . . 1.0800000000000001 110.177 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . . . -160.17 125.82 4.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 1.3899999999999999 111.675 -177.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -167.46 93.47 0.42 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.507 -0.553 . . . . 2.8599999999999999 109.507 167.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.65 -94.78 1.34 Allowed Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.543 -0.837 . . . . 1.6799999999999999 112.003 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.76 172.95 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.605 2.87 . . . . 1.6599999999999999 113.114 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.8 p-90 -69.78 159.15 34.11 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.197 0.522 . . . . 3.3999999999999999 111.367 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.454 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 25.7 ptt-85 -115.72 146.85 41.52 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.249 0.833 . . . . 3.1000000000000001 113.249 -163.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.4 mm -122.88 131.26 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 114.495 -1.23 . . . . 1.8 111.03 -173.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -117.53 139.98 50.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.525 -0.307 . . . . 0.85999999999999999 110.719 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 56.4 tp -135.83 137.11 41.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 1.0600000000000001 111.046 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.04 166.94 28.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.743 -0.662 . . . . 1.1399999999999999 109.313 174.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -124.15 130.02 51.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.876 0.37 . . . . 4.0199999999999996 111.122 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.554 ' HB3' ' HB2' ' A' ' 69' ' ' ARG . 47.0 t80 -99.98 119.56 38.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.865 -0.607 . . . . 4.6100000000000003 110.073 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 -133.83 130.17 37.53 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.743 -0.465 . . . . 3.3799999999999999 109.743 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--N 1.323 -0.581 0 CA-C-O 121.015 0.436 . . . . 5.0499999999999998 110.981 177.625 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 97.1 m95 . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 109.032 -0.729 . . . . 5.6100000000000003 109.032 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.65 ' HB2' ' CZ ' ' A' ' 95' ' ' TYR . 64.8 m-85 -119.73 138.92 53.01 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.534 -0.543 . . . . 3.7799999999999998 109.534 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -123.82 164.94 18.19 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.194 -0.669 . . . . 2.4500000000000002 109.194 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.554 ' HB2' ' HB3' ' A' ' 51' ' ' TYR . 10.4 mtp180 -120.63 124.33 27.64 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.779 -0.452 . . . . 3.2400000000000002 109.779 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.548 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 69.9 Cg_endo -80.1 122.76 4.85 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.963 1.775 . . . . 1.1899999999999999 110.952 173.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 36.5 tt0 -99.96 113.03 25.32 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.557 -0.535 . . . . 2.1899999999999999 109.557 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.1 tp -121.9 123.41 41.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.269 -0.423 . . . . 1.1399999999999999 110.411 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -119.7 135.79 54.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.943 0.401 . . . . 2.1800000000000002 110.262 173.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.1 t -113.67 119.88 62.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.153 -1.054 . . . . 1.5600000000000001 108.153 172.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -117.38 117.38 29.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.752 -0.462 . . . . 3.4399999999999999 109.752 -176.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -120.45 131.2 54.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.815 -0.629 . . . . 4.7999999999999998 109.959 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -121.82 139.95 52.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.306 -0.406 . . . . 2.9399999999999999 110.369 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -116.63 97.92 6.26 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.849 -0.797 . . . . 3.8999999999999999 108.849 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.4 mt . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.842 -0.617 . . . . 4.4800000000000004 110.219 -175.374 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.849 0.356 . . . . 2.5499999999999998 111.657 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -131.56 150.2 52.24 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.948 -0.39 . . . . 5.2999999999999998 109.948 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.55 161.7 28.7 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.645 -0.788 . . . . 1.3500000000000001 111.828 176.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.0 tp -141.11 112.57 7.48 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.746 -0.464 . . . . 2.29 109.746 176.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.3 m -120.01 129.99 54.52 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.261 -0.427 . . . . 1.54 110.562 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -127.23 140.06 11.62 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.727 -0.749 . . . . 1.1699999999999999 111.571 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.47 119.86 1.76 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.631 -0.795 . . . . 1.1899999999999999 111.874 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -126.81 129.72 48.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.001 0.429 . . . . 3.75 110.933 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -141.34 134.84 29.84 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.102 -0.703 . . . . 2.75 109.102 175.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.548 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 8.6 p30 -134.87 151.65 51.08 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-O 120.468 0.175 . . . . 1.8200000000000001 110.981 -175.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.65 ' CZ ' ' HB2' ' A' ' 67' ' ' PHE . 65.2 t80 -118.74 130.01 55.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.547 -0.297 . . . . 3.1400000000000001 110.371 -176.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.233 0 C-N-CA 120.465 -0.874 . . . . 2.79 112.254 179.191 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 120.736 0.303 . . . . 3.2999999999999998 110.598 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -132.05 119.45 21.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.498 -0.319 . . . . 1.76 111.445 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' A' ' 95' ' ' TYR . 27.5 t-20 -151.8 124.62 8.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.779 -0.646 . . . . 2.5499999999999998 110.121 176.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.408 ' HG3' ' HA ' ' A' ' 139' ' ' ALA . 43.3 ttm -103.34 121.39 42.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.6 -0.727 . . . . 1.77 110.264 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -112.27 141.33 46.11 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.614 -0.434 . . . . 1.97 111.434 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.626 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 76.4 ttt180 -131.07 110.89 11.53 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.997 -0.742 . . . . 3.8500000000000001 108.997 168.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.563 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 83.2 m95 -98.76 119.95 38.38 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.879 -0.786 . . . . 2.2799999999999998 108.879 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.459 ' NZ ' ' HB2' ' A' ' 114' ' ' LYS . 10.2 mtmp? -121.74 123.81 42.73 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.785 -0.366 . . . . 2.1400000000000001 111.156 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 134' ' ' SER . 87.6 mt -120.62 126.22 74.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.032 -0.531 . . . . 1.55 109.976 174.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -138.92 105.78 7.42 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.425 -0.352 . . . . 1.1899999999999999 111.036 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.548 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 98.8 Cg_endo -80.06 160.03 23.77 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.98 2.453 . . . . 1.3700000000000001 111.158 173.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -116.19 137.19 52.35 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.248 -0.433 . . . . 2.3500000000000001 110.25 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -127.03 128.14 45.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.379 -0.373 . . . . 4.54 111.495 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.411 ' CG ' ' HE ' ' A' ' 128' ' ' ARG . 43.0 t0 -128.64 88.94 2.81 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.553 -0.536 . . . . 3.04 109.553 172.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.0 p -147.5 129.24 6.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.082 0.468 . . . . 4.2699999999999996 111.148 -177.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.711 ' HG3' ' H ' ' A' ' 124' ' ' THR . 55.8 tptt -144.31 142.91 30.72 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.217 -0.66 . . . . 6.04 109.217 177.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.3 mt -74.41 -6.77 50.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.137 0.494 . . . . 4.5899999999999999 110.904 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.711 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 26.3 m -119.96 135.7 54.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.637 -0.71 . . . . 3.6899999999999999 109.561 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -68.15 -39.93 82.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.873 -0.603 . . . . 5.1699999999999999 111.126 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -61.02 -40.27 92.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.244 -0.889 . . . . 3.71 112.078 -176.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -110.95 161.22 16.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.059 0.457 . . . . 2.0499999999999998 111.857 -171.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.541 ' HD2' ' OE1' ' A' ' 159' ' ' GLN . 20.3 ttm180 -125.51 133.66 52.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.88 -0.6 . . . . 4.2400000000000002 111.465 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.541 ' HB2' ' HD3' ' A' ' 122' ' ' LYS . 64.7 t80 -114.88 119.36 36.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.573 -0.739 . . . . 3.5499999999999998 109.21 175.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.412 ' OD1' ' HD3' ' A' ' 128' ' ' ARG . 17.4 m120 -118.45 130.05 55.74 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.018 -0.364 . . . . 2.1099999999999999 110.018 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -134.9 135.75 8.12 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.408 -0.901 . . . . 1.1799999999999999 111.688 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -124.0 128.28 49.14 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.668 -0.493 . . . . 4.2999999999999998 109.668 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.548 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 63.0 tp -109.95 110.93 22.03 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.188 -0.671 . . . . 2.2400000000000002 109.188 175.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 14.3 t -116.21 130.15 56.65 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.253 -0.579 . . . . 1.6899999999999999 110.533 -175.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 66.6 mtt -118.99 135.92 54.37 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.651 -0.87 . . . . 2.2400000000000002 108.651 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.563 ' HA ' ' O ' ' A' ' 113' ' ' TRP . 54.7 p90 -149.83 157.42 43.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.349 0.595 . . . . 3.5600000000000001 111.61 178.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 59.7 mttp -129.82 157.62 41.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.932 -1.031 . . . . 1.6699999999999999 109.849 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.745 ' H ' HD12 ' A' ' 142' ' ' LEU . 64.3 t80 -121.85 139.99 52.94 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.743 -0.662 . . . . 3.23 109.824 -173.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.408 ' HA ' ' HG3' ' A' ' 110' ' ' MET . . . 61.12 -175.91 0.12 Allowed 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.685 0.616 . . . . 1.24 110.745 -175.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 63.9 t30 -79.08 -21.63 46.47 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.211 -0.595 . . . . 2.4700000000000002 110.315 172.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.93 -47.39 85.98 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.496 -0.774 . . . . 2.4100000000000001 112.33 -172.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.745 HD12 ' H ' ' A' ' 138' ' ' PHE . 49.4 mt -69.87 -25.36 63.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.003 0.43 . . . . 1.8300000000000001 110.971 -178.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 140' ' ' ASN . 94.7 m-20 -59.91 -39.98 87.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.974 0.416 . . . . 2.0 110.007 175.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 80.9 p -78.1 -31.1 49.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.012 -0.54 . . . . 2.0499999999999998 111.54 -177.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.42 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 34.9 p -70.16 -25.03 63.26 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.105 0.478 . . . . 1.5900000000000001 110.912 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 64.93 -128.08 34.0 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.696 -0.684 . . . . 1.52 112.776 175.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -72.47 -20.69 61.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.514 0.19 . . . . 5.9400000000000004 111.514 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.02 97.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.827 0.346 . . . . 1.8300000000000001 111.155 -176.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -131.47 92.83 3.23 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.129 -0.693 . . . . 2.6400000000000001 109.129 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.2 t -144.85 146.69 32.18 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.048 -0.524 . . . . 2.02 110.153 -178.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 136' ' ' TYR . 32.8 tpt180 -99.77 119.05 37.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.39 -0.368 . . . . 3.6699999999999999 110.492 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.4 t -119.22 119.22 60.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 1.6399999999999999 109.875 178.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -123.49 140.01 53.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.929 0.395 . . . . 2.5600000000000001 111.009 -176.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 33.5 m -119.97 127.03 52.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.141 -0.482 . . . . 1.3899999999999999 109.737 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.526 ' HG3' HD21 ' A' ' 171' ' ' ASN . 31.0 tt0 -123.51 130.72 53.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.585 -0.524 . . . . 2.04 109.585 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 171' ' ' ASN . 88.3 m -122.07 121.83 37.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.855 0.359 . . . . 1.5600000000000001 111.614 -176.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -102.39 115.23 5.15 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 111.174 -0.77 . . . . 1.04 111.174 177.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 89.9 mt -100.34 122.61 43.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.829 0.347 . . . . 2.27 110.631 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.541 ' OE1' ' HD2' ' A' ' 128' ' ' ARG . 53.3 tt0 -100.01 107.97 20.05 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.065 -0.717 . . . . 2.4100000000000001 109.065 176.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -120.44 114.81 22.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.149 -0.478 . . . . 4.5700000000000003 109.714 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' A' ' 164' ' ' GLU . 6.8 p -88.85 90.5 8.44 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.269 0.557 . . . . 1.46 110.535 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -60.23 -49.28 78.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.582 -0.735 . . . . 2.6299999999999999 111.171 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.479 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.6 m-20 -101.77 13.13 35.76 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.983 -0.287 . . . . 2.4100000000000001 111.024 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.413 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 41.3 tt0 71.39 -48.7 0.68 Allowed 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.774 0.671 . . . . 2.5800000000000001 111.3 -178.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.7 p -74.69 -19.98 60.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.34 -0.391 . . . . 2.2999999999999998 111.642 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' A' ' 163' ' ' ASN . 33.4 m -121.46 140.0 46.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.326 -0.397 . . . . 1.71 110.266 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.488 ' O ' ' HD2' ' A' ' 199' ' ' PRO . . . -106.87 129.26 54.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.053 -0.522 . . . . 1.47 110.601 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 28.7 mt -103.72 129.22 51.05 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.291 -0.633 . . . . 1.6599999999999999 109.291 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -101.45 107.4 18.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.812 0.339 . . . . 3.2999999999999998 110.572 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.9 t -113.18 119.98 62.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 109.446 -0.576 . . . . 1.3 109.446 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.616 ' HB3' ' HB3' ' A' ' 195' ' ' ARG . 8.5 t30 -106.34 120.73 42.63 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.952 0.406 . . . . 2.2200000000000002 111.123 -176.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -103.18 129.96 50.23 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.562 -0.745 . . . . 4.6100000000000003 109.748 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -102.46 138.71 39.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.225 -0.443 . . . . 3.98 110.674 -177.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 62.8 tp -140.08 143.38 36.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.571 . . . . 2.3799999999999999 110.447 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -105.84 141.01 37.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.223 -0.288 . . . . 3.3100000000000001 110.223 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 . . . . . 0 C--N 1.324 -0.5 0 N-CA-C 109.983 -0.376 . . . . 6.5300000000000002 109.983 175.41 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.03 0.443 . . . . 4.4000000000000004 111.071 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 48.9 mm -113.83 125.53 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.781 -0.645 . . . . 2.21 110.24 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.616 ' HB3' ' HB3' ' A' ' 171' ' ' ASN . 35.2 ttm180 -99.96 109.37 21.73 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.553 -0.906 . . . . 3.54 108.553 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -123.63 131.44 53.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.834 0.349 . . . . 1.6699999999999999 111.695 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -158.22 165.75 34.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.934 -0.575 . . . . 5.8300000000000001 109.83 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.577 ' O ' ' HD2' ' A' ' 209' ' ' PRO . 1.5 pt? -143.64 137.29 14.31 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 121.126 -0.23 . . . . 2.5899999999999999 110.461 177.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' A' ' 167' ' ' ALA . 72.3 Cg_endo -79.77 129.67 8.28 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.451 2.101 . . . . 1.77 112.736 176.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 88.1 mt -128.05 135.21 49.55 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.35 -0.611 . . . . 2.2599999999999998 109.35 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 4.4 p -112.45 118.93 36.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.981 0.42 . . . . 1.99 111.149 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.9 mt -125.48 82.2 2.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.889 -0.782 . . . . 2.3100000000000001 108.889 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 69.49 -124.69 16.16 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.338 -0.846 . . . . 1.51 111.733 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -91.83 3.98 53.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.18 0.514 . . . . 2.5699999999999998 109.902 175.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -95.9 115.88 28.08 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.61 -0.885 . . . . 2.6600000000000001 108.61 174.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 47.5 t -100.61 120.37 39.94 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.938 -0.764 . . . . 1.6200000000000001 108.938 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.81 128.07 73.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.932 0.396 . . . . 1.3799999999999999 110.695 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 35.1 m -131.1 91.3 36.47 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-O 120.83 0.347 . . . . 1.1799999999999999 110.093 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.577 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 50.1 Cg_endo -70.41 140.58 40.54 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.269 1.979 . . . . 1.01 111.978 176.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -111.85 140.29 46.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.188 -0.46 . . . . 4.5 110.587 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 24.0 p -134.0 156.26 48.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 1.8899999999999999 110.314 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -116.57 120.33 38.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.045 0.45 . . . . 4.7999999999999998 110.656 -177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 84.8 mt . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.907 -0.588 . . . . 4.5700000000000003 110.259 -179.79 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 63.3 t . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 121.044 0.45 . . . . 2.3999999999999999 109.869 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -129.04 156.16 21.07 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.864 -0.684 . . . . 1.27 111.701 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.0 130.45 54.75 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.933 -0.395 . . . . 1.97 109.933 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -109.89 130.0 55.58 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.989 -0.745 . . . . 3.54 108.989 176.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -120.03 139.89 51.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.959 0.409 . . . . 2.6400000000000001 111.0 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -113.66 128.81 8.48 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.797 -0.921 . . . . 1.3500000000000001 110.797 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' TYR . . . . . 0.439 ' O ' ' HB ' ' A' ' 251' ' ' VAL . 73.3 m-85 -130.0 150.11 51.42 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.614 0.207 . . . . 4.3600000000000003 110.772 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 58.12 39.98 25.57 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.082 0.864 . . . . 4.29 110.666 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -77.56 114.06 16.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.554 -0.748 . . . . 6.6900000000000004 109.79 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -143.46 168.22 20.36 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.895 -1.048 . . . . 6.3700000000000001 108.26 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -59.97 -40.06 87.78 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.83 -0.348 . . . . 5.8300000000000001 110.794 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 280' ' ' SER . . . -99.83 -0.27 56.36 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.447 -0.883 . . . . 2.6600000000000001 113.967 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 59.4 tp -145.98 138.52 25.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.65 0.725 . . . . 2.9700000000000002 111.304 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 61.3 p -147.36 134.49 20.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.821 0.343 . . . . 2.1699999999999999 110.963 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.473 HG22 HG23 ' A' ' 277' ' ' VAL . 59.8 t -122.58 132.47 71.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.799 -0.445 . . . . 1.79 109.799 176.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 35.1 t -120.04 127.8 52.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.877 0.37 . . . . 1.6299999999999999 110.086 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 72.2 mt -117.15 129.24 55.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.112 -0.495 . . . . 2.96 110.259 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.12 119.95 41.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.053 -0.521 . . . . 4.0800000000000001 110.633 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.51 135.54 53.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.256 -0.429 . . . . 4.8399999999999999 110.465 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.504 0 CA-C-O 121.276 0.56 . . . . 3.5800000000000001 110.775 175.46 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 109.954 -0.387 . . . . 1.9399999999999999 109.954 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -137.8 144.46 15.8 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.552 -0.832 . . . . 1.4199999999999999 112.541 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 63.0 t -130.06 130.11 65.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.588 0.232 . . . . 1.8100000000000001 110.489 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -141.65 131.07 4.63 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.955 -0.64 . . . . 1.3 111.554 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.473 HG23 HG22 ' A' ' 251' ' ' VAL . 7.3 p -132.96 137.12 54.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.652 0.263 . . . . 1.8300000000000001 110.73 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -119.79 127.52 52.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 2.3100000000000001 110.31 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 89.5 m-85 -109.22 126.71 53.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.259 -0.645 . . . . 4.75 109.259 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' SER . . . . . 0.498 ' HB2' ' HA2' ' A' ' 248' ' ' GLY . 37.7 m -114.17 129.35 56.63 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.903 0.383 . . . . 1.6699999999999999 110.554 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.178 -0.915 . . . . 3.6899999999999999 109.608 179.503 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 . . . . . 0 CA--C 1.517 -0.315 0 N-CA-C 109.609 -0.515 . . . . 3.6099999999999999 109.609 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.448 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 92.2 m95 -71.25 115.97 11.02 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.642 -0.708 . . . . 3.3300000000000001 110.053 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.427 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 53.1 t60 -114.57 122.16 45.67 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.071 -0.513 . . . . 3.2000000000000002 109.964 175.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' A' ' 7' ' ' TRP . 98.9 m-85 -120.21 140.07 51.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.944 -0.571 . . . . 2.4900000000000002 110.731 -178.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -122.0 129.47 52.49 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.078 -0.712 . . . . 2.1299999999999999 109.078 171.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.511 ' HB ' ' HB3' ' A' ' 279' ' ' TYR . 86.2 mt -125.12 129.37 73.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.292 -0.413 . . . . 1.6000000000000001 110.736 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.13 122.79 5.95 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.093 -0.803 . . . . 0.88 111.093 175.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -120.01 136.66 54.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.935 0.367 . . . . 1.0800000000000001 110.858 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 68.4 mtt -133.43 156.68 47.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.305 -0.407 . . . . 2.3300000000000001 110.347 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -114.65 139.93 49.25 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.782 -0.451 . . . . 2.6099999999999999 109.782 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 112.762 0.652 . . . . 5.0899999999999999 112.762 -175.276 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 109.796 -0.446 . . . . 3.48 109.796 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.97 150.01 66.32 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.347 2.031 . . . . 1.8600000000000001 112.267 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 14.3 p -124.46 143.67 50.51 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.038 -0.528 . . . . 1.97 109.733 175.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.0 m -129.96 139.23 52.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.19 0.519 . . . . 1.71 111.252 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -120.33 139.44 52.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.616 -0.72 . . . . 4.0700000000000003 109.631 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -119.9 138.34 53.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.882 0.373 . . . . 2.8599999999999999 111.625 -174.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -140.07 130.01 24.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.733 -0.667 . . . . 1.8899999999999999 109.222 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.62 143.46 49.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.884 0.373 . . . . 1.0800000000000001 111.573 -174.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.542 ' HB2' ' HG2' ' A' ' 45' ' ' ARG . . . -147.01 125.09 12.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.607 -0.724 . . . . 1.3899999999999999 111.354 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.602 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 27.8 p-10 -166.96 95.24 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.278 0.561 . . . . 2.8599999999999999 110.502 171.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.97 -95.52 2.1 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.05 -0.595 . . . . 1.6799999999999999 111.871 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.602 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 54.2 Cg_exo -52.5 174.47 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.624 2.883 . . . . 1.6599999999999999 113.178 171.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.605 ' HB2' ' O ' ' A' ' 75' ' ' HIS . 48.9 p90 -69.14 -176.02 0.84 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.83 -0.623 . . . . 3.3999999999999999 111.289 -175.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.542 ' HG2' ' HB2' ' A' ' 40' ' ' ALA . 83.3 mtm180 -111.0 136.37 50.1 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 121.786 0.803 . . . . 3.1000000000000001 112.42 -167.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 87.1 mt -120.06 129.95 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 114.113 -1.403 . . . . 1.8 109.931 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 73' ' ' GLU . . . -117.85 138.22 52.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.43 -0.35 . . . . 0.85999999999999999 110.065 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.0 tp -114.22 130.93 56.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.945 -0.57 . . . . 1.0600000000000001 110.423 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 71' ' ' GLU . . . -148.85 169.25 20.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.52 -0.764 . . . . 1.1399999999999999 109.332 177.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -139.75 157.52 45.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.642 0.258 . . . . 4.0199999999999996 110.386 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -120.42 131.71 54.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.114 -0.494 . . . . 4.6100000000000003 110.645 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -113.61 127.86 56.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.079 -0.51 . . . . 3.3799999999999999 109.816 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.455 ' CD ' HH12 ' A' ' 69' ' ' ARG . 93.6 mt-10 . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 116.308 -0.405 . . . . 5.0499999999999998 109.973 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 89.2 m95 . . . . . 0 CA--C 1.527 0.082 0 CA-C-O 120.793 0.33 . . . . 5.6100000000000003 110.863 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.425 ' CD2' ' HA2' ' A' ' 96' ' ' GLY . 37.2 m-85 -119.02 120.02 35.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.731 -0.47 . . . . 3.7799999999999998 109.731 173.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -145.05 150.82 37.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.866 -0.607 . . . . 2.4500000000000002 109.634 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.455 HH12 ' CD ' ' A' ' 53' ' ' GLU . 41.0 ttp180 -119.99 124.42 27.87 Favored Pre-proline 0 C--N 1.328 -0.341 0 C-N-CA 120.662 -0.415 . . . . 3.2400000000000002 110.98 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -84.02 149.15 12.18 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.843 2.362 . . . . 1.1899999999999999 112.921 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.468 ' CD ' ' HE ' ' A' ' 93' ' ' ARG . 3.7 tp10 -115.46 118.55 33.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.572 -0.899 . . . . 2.1899999999999999 108.572 168.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.462 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 59.5 tp -122.34 101.8 7.73 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.251 -0.431 . . . . 1.1399999999999999 110.15 -178.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 34.7 mt-10 -90.14 125.59 35.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.04 -0.527 . . . . 2.1800000000000002 111.31 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.8 m -114.0 121.99 67.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.524 -0.917 . . . . 1.5600000000000001 108.524 168.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.605 ' O ' ' HB2' ' A' ' 44' ' ' TRP . 63.0 m80 -109.67 118.11 35.69 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.662 -0.495 . . . . 3.4399999999999999 109.662 -174.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -114.52 130.07 56.72 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.859 -0.793 . . . . 4.7999999999999998 108.859 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -128.04 129.74 47.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.953 0.406 . . . . 2.9399999999999999 110.399 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 89.0 m-85 -100.23 109.54 21.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.95 -0.568 . . . . 3.8999999999999999 109.941 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 C--N 1.324 -0.541 0 N-CA-C 109.323 -0.621 . . . . 4.4800000000000004 109.323 177.258 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 108.407 -0.96 . . . . 2.5499999999999998 108.407 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 78' ' ' PHE . 98.9 m-85 -79.55 129.8 34.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.107 -0.497 . . . . 5.2999999999999998 110.344 -175.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.08 153.22 17.89 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.318 -0.944 . . . . 1.3500000000000001 111.903 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.8 tp -139.3 117.32 11.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.92 0.39 . . . . 2.29 110.079 176.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.6 m -110.8 117.65 34.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.138 -0.483 . . . . 1.54 110.368 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.57 133.9 10.8 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.508 -0.853 . . . . 1.1699999999999999 112.059 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -136.04 126.11 3.76 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.548 -0.621 . . . . 1.1899999999999999 111.548 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -112.35 131.29 55.61 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.054 -0.35 . . . . 3.75 110.054 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.468 ' HE ' ' CD ' ' A' ' 71' ' ' GLU . 85.8 mtt180 -135.28 131.33 36.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.088 -0.506 . . . . 2.75 110.177 -172.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -133.92 129.21 35.99 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.052 -0.259 . . . . 1.8200000000000001 110.958 175.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.411 ' HB2' ' HD3' ' A' ' 69' ' ' ARG . 71.4 t80 -114.85 125.13 53.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.525 -0.307 . . . . 3.1400000000000001 110.252 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.425 ' HA2' ' CD2' ' A' ' 67' ' ' PHE . . . . . . . . 0 N--CA 1.443 -0.856 0 C-N-CA 120.527 -0.845 . . . . 2.79 112.928 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 N--CA 1.445 -0.677 0 CA-C-O 121.155 0.502 . . . . 3.2999999999999998 110.835 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.64 124.67 16.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.928 -0.578 . . . . 1.76 110.095 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -139.54 107.93 5.83 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.245 -0.65 . . . . 2.5499999999999998 109.245 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 91.6 mtp -119.95 115.52 23.94 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.471 -0.331 . . . . 1.77 110.297 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.63 ' HB2' ' OD1' ' A' ' 143' ' ' ASN . 49.4 mt-30 -100.19 129.09 46.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.949 0.404 . . . . 1.97 110.113 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 40.5 ttm180 -120.24 111.02 17.28 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.87 -0.789 . . . . 3.8500000000000001 108.87 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -108.02 130.83 55.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.06 -0.518 . . . . 2.2799999999999998 109.703 -175.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 135' ' ' MET . 87.6 tttt -130.23 124.12 31.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.045 0.45 . . . . 2.1400000000000001 110.884 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 75.9 mt -129.82 130.03 66.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.022 -0.535 . . . . 1.55 109.557 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -134.01 116.41 13.42 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.393 -0.367 . . . . 1.1899999999999999 111.151 -177.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 87.3 Cg_endo -80.01 140.05 13.99 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.277 1.984 . . . . 1.3700000000000001 110.579 171.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -87.77 137.75 32.06 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.202 -0.454 . . . . 2.3500000000000001 110.985 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -101.13 127.53 47.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.24 -0.652 . . . . 4.54 109.24 172.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -71.43 160.39 32.82 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 124.092 0.87 . . . . 3.04 111.61 -171.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' A' ' 128' ' ' ARG . 34.6 m -115.04 173.94 3.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.304 -0.862 . . . . 4.2699999999999996 110.841 -173.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 60.13 39.07 19.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.854 -0.612 . . . . 6.04 111.576 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.7 tp -63.08 -40.19 96.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.759 -0.655 . . . . 4.5899999999999999 110.436 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.9 p -118.02 159.98 22.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.752 -0.658 . . . . 3.6899999999999999 110.446 177.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -70.27 129.91 40.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.061 -0.518 . . . . 5.1699999999999999 111.402 -174.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 59.86 28.37 17.85 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.081 -0.963 . . . . 3.71 111.368 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.8 mt -137.77 144.44 41.6 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.21 -0.663 . . . . 2.0499999999999998 109.21 175.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.5 ' HG3' ' HB ' ' A' ' 121' ' ' VAL . 56.8 ttt180 -130.2 128.99 42.81 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.427 -0.509 . . . . 4.2400000000000002 111.104 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.441 ' O ' HG12 ' A' ' 121' ' ' VAL . 90.0 m-85 -120.01 123.05 42.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.273 -0.876 . . . . 3.5499999999999998 108.882 176.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 156' ' ' THR . 21.8 m-80 -116.16 130.98 57.06 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.078 -0.712 . . . . 2.1099999999999999 109.078 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.36 129.61 4.62 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 118.965 -1.588 . . . . 1.1799999999999999 113.232 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -123.57 127.8 48.81 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.943 -0.392 . . . . 4.2999999999999998 109.943 173.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.627 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 87.9 mt -112.75 109.72 19.39 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.031 -0.729 . . . . 2.2400000000000002 109.031 174.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 152' ' ' VAL . 52.6 m -105.88 124.95 50.39 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.565 -0.454 . . . . 1.6899999999999999 111.469 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.661 ' O ' ' HA ' ' A' ' 114' ' ' LYS . 95.4 mmm -93.32 126.2 38.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.507 -0.77 . . . . 2.2400000000000002 109.295 176.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -120.68 126.14 49.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.177 0.513 . . . . 3.5600000000000001 111.953 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 61.7 mttp -130.31 143.72 50.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.387 -0.968 . . . . 1.6699999999999999 108.387 167.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.53 ' H ' HD22 ' A' ' 142' ' ' LEU . 53.1 p90 -141.48 160.0 41.06 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 121.201 -0.2 . . . . 3.23 110.76 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 62.75 178.66 0.14 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.94 0.775 . . . . 1.24 110.601 -177.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -75.73 -24.36 56.13 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.93 0.395 . . . . 2.4700000000000002 110.584 173.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -59.96 -50.85 72.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.951 -0.568 . . . . 2.4100000000000001 111.599 -174.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.53 HD22 ' H ' ' A' ' 138' ' ' PHE . 9.5 mp -70.81 -29.86 66.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.436 -0.347 . . . . 1.8300000000000001 111.24 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.63 ' OD1' ' HB2' ' A' ' 111' ' ' GLN . 12.7 m120 -61.58 -41.49 97.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.006 0.432 . . . . 2.0 110.456 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.1 p -80.22 -39.9 28.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.595 -0.73 . . . . 2.0499999999999998 111.832 -173.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 148' ' ' ALA . 24.6 p -74.07 -32.88 63.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.321 . . . . 1.5900000000000001 111.207 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.71 -108.75 2.59 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.933 -0.576 . . . . 1.52 113.149 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -59.97 -40.07 87.83 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 122.687 0.395 . . . . 5.9400000000000004 111.503 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' A' ' 145' ' ' THR . . . -60.04 -44.27 94.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.173 -0.467 . . . . 1.8300000000000001 111.857 -175.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.53 ' HB3' ' HG ' ' A' ' 142' ' ' LEU . 43.3 m-20 -118.01 98.25 6.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.125 0.488 . . . . 2.6400000000000001 110.966 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.5 t -149.93 144.56 25.96 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.406 -0.59 . . . . 2.02 109.406 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -110.16 151.71 26.94 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.335 -0.393 . . . . 3.6699999999999999 110.078 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.519 HG12 ' SD ' ' A' ' 135' ' ' MET . 16.1 m -136.41 134.4 49.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.984 0.421 . . . . 1.6399999999999999 111.504 -177.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -113.72 140.51 48.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.199 -0.455 . . . . 2.5600000000000001 109.832 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 78.6 m -128.42 118.63 23.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.163 -0.471 . . . . 1.3899999999999999 109.936 175.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -120.68 120.16 34.9 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.774 -0.454 . . . . 2.04 109.774 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 130' ' ' ASN . 27.0 m -108.3 119.93 40.92 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.669 -0.696 . . . . 1.5600000000000001 110.026 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.97 111.81 4.33 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.92 -0.872 . . . . 1.04 110.92 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 91.7 mt -104.23 129.98 52.03 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 110.263 -0.273 . . . . 2.27 110.263 -176.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 65.9 tt0 -114.92 113.55 24.31 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.832 -0.433 . . . . 2.4100000000000001 109.832 176.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -115.65 130.57 56.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.573 -0.74 . . . . 4.5700000000000003 109.458 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -92.58 90.18 7.02 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.404 0.621 . . . . 1.46 109.907 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -60.24 -49.62 76.88 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.934 -1.03 . . . . 2.6299999999999999 111.715 -171.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.418 ' C ' ' H ' ' A' ' 165' ' ' THR . 17.4 m120 -99.87 2.62 44.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.381 -0.372 . . . . 2.4100000000000001 110.353 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 71.88 -36.11 0.35 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.356 -0.838 . . . . 2.5800000000000001 111.263 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 163' ' ' ASN . 21.8 p -75.36 -34.97 61.19 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.859 0.362 . . . . 2.2999999999999998 111.206 174.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 163' ' ' ASN . 24.9 m -121.08 140.56 44.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 120.94 0.4 . . . . 1.71 110.734 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 161' ' ' THR . . . -107.74 139.94 41.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.928 -0.578 . . . . 1.47 111.237 -175.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 159' ' ' GLN . 17.9 mt -104.53 125.59 50.84 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.429 -0.582 . . . . 1.6599999999999999 109.429 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -109.22 115.72 30.54 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.727 -0.472 . . . . 3.2999999999999998 109.727 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.0 132.09 65.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.063 0.459 . . . . 1.3 110.855 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.475 ' O ' ' HB ' ' A' ' 194' ' ' ILE . 3.2 m-20 -107.23 122.57 46.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.048 0.451 . . . . 2.2200000000000002 111.025 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -98.28 121.51 40.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.512 -0.767 . . . . 4.6100000000000003 110.052 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -99.49 120.42 39.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.953 0.406 . . . . 3.98 110.119 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 63.9 tp -104.91 129.14 53.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.806 -0.634 . . . . 2.3799999999999999 110.95 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -98.68 138.63 35.57 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.641 -0.874 . . . . 3.3100000000000001 108.641 175.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.992 0.425 . . . . 6.5300000000000002 110.842 179.793 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 109.554 -0.535 . . . . 4.4000000000000004 109.554 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' A' ' 171' ' ' ASN . 28.5 pt -120.09 169.1 11.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.761 -0.654 . . . . 2.21 111.062 -172.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -101.68 119.94 39.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.85 -0.614 . . . . 3.54 110.553 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -112.87 129.44 56.46 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.512 -0.551 . . . . 1.6699999999999999 109.512 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 209' ' ' PRO . 31.1 p90 -145.42 149.93 35.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.264 0.554 . . . . 5.8300000000000001 111.528 -178.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.9 mp -112.26 127.74 26.44 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.689 -0.687 . . . . 2.5899999999999999 110.279 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' A' ' 167' ' ' ALA . 85.6 Cg_endo -81.22 106.23 1.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.287 1.991 . . . . 1.77 111.581 175.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 89.9 mt -114.47 140.09 49.0 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.941 -0.572 . . . . 2.2599999999999998 109.93 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 94.0 m -119.93 130.05 54.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.126 0.488 . . . . 1.99 111.134 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.1 mt -129.8 80.29 1.95 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.533 -0.914 . . . . 2.3100000000000001 108.533 173.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 70.06 -120.96 9.96 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.863 -0.684 . . . . 1.51 111.78 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -91.87 -0.03 57.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.259 0.552 . . . . 2.5699999999999998 109.536 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -93.67 118.98 32.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.327 -0.852 . . . . 2.6600000000000001 109.291 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 47.6 m -104.62 131.97 51.42 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.782 -0.451 . . . . 1.6200000000000001 109.782 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 63.2 t -120.07 130.03 74.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.908 -0.405 . . . . 1.3799999999999999 109.908 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 48.1 m -138.1 94.65 11.04 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 116.503 -0.317 . . . . 1.1799999999999999 110.987 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' A' ' 197' ' ' TYR . 16.5 Cg_exo -69.17 131.22 21.6 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.525 2.15 . . . . 1.01 111.635 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -108.43 139.97 42.4 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.823 -0.436 . . . . 4.5 109.823 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 11.1 t -168.53 166.93 11.9 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.191 -0.459 . . . . 1.8899999999999999 110.426 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -98.97 139.87 33.97 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.048 -1.093 . . . . 4.7999999999999998 108.048 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 83.7 mt . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.03 0.443 . . . . 4.5700000000000003 110.871 -175.74 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 C--O 1.233 0.234 0 N-CA-C 109.337 -0.616 . . . . 2.3999999999999999 109.337 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 172.43 177.03 41.59 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.024 -1.084 . . . . 1.27 112.995 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 83.0 mt -120.04 129.97 54.48 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.104 -0.332 . . . . 1.97 110.104 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -101.45 133.64 45.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.061 -0.348 . . . . 3.54 110.061 175.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -120.08 139.96 51.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.061 -0.518 . . . . 2.6400000000000001 110.262 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 251' ' ' VAL . . . -127.13 132.16 7.49 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.251 -0.739 . . . . 1.3500000000000001 111.251 176.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 250' ' ' SER . 91.3 m-85 -120.83 144.24 48.45 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.067 -0.346 . . . . 4.3600000000000003 110.067 -177.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 56.5 40.04 29.69 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.846 0.716 . . . . 4.29 110.507 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -62.72 -40.11 96.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.534 -0.757 . . . . 6.6900000000000004 110.867 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -111.21 129.99 55.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.636 -0.256 . . . . 6.3700000000000001 111.289 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 55.51 39.92 31.11 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.704 -0.68 . . . . 5.8300000000000001 112.229 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -161.82 -174.44 31.7 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.521 -0.632 . . . . 2.6600000000000001 111.521 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 86.2 mt -89.1 109.1 20.0 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.863 -0.791 . . . . 2.9700000000000002 108.863 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 243' ' ' TYR . 17.7 m -78.88 130.92 36.17 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.113 0.482 . . . . 2.1699999999999999 111.26 -169.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.42 ' O ' ' HA2' ' A' ' 242' ' ' GLY . 62.9 t -107.57 133.24 52.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.667 -0.697 . . . . 1.79 109.78 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 3.0 p -108.3 113.28 26.25 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.064 0.459 . . . . 1.6299999999999999 110.485 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 64.8 tp -119.57 115.73 24.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.087 -0.506 . . . . 2.96 110.635 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -101.77 115.47 30.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.181 -0.463 . . . . 4.0800000000000001 110.371 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -106.21 120.04 40.81 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 110.259 -0.275 . . . . 4.8399999999999999 110.259 175.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.684 0 N-CA-C 108.487 -0.931 . . . . 3.5800000000000001 108.487 172.62 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.467 0 N-CA-C 109.617 -0.512 . . . . 1.9399999999999999 109.617 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.35 137.57 9.54 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.937 -0.649 . . . . 1.4199999999999999 111.659 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 61.9 t -129.4 129.97 67.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.953 0.406 . . . . 1.8100000000000001 110.874 -175.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -152.44 163.66 30.36 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.873 -0.603 . . . . 1.3 111.686 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.19 140.01 32.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.885 0.374 . . . . 1.8300000000000001 110.163 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -113.5 127.01 55.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.196 0.522 . . . . 2.3100000000000001 110.929 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.511 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 65.0 t80 -105.96 124.71 50.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.655 -0.702 . . . . 4.75 109.402 176.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 7.7 p -117.44 130.51 56.51 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.037 0.446 . . . . 1.6699999999999999 110.858 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 59.2 t80 . . . . . 0 C--O 1.244 0.783 0 CA-C-O 118.508 -0.758 . . . . 3.6899999999999999 109.084 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 120.572 0.225 . . . . 3.6099999999999999 111.059 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -96.93 108.2 20.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.6 -0.889 . . . . 3.3300000000000001 108.6 171.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -110.7 137.16 48.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.341 0.591 . . . . 3.2000000000000002 111.778 -175.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -125.21 142.89 51.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.619 -1.173 . . . . 2.4900000000000002 109.536 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -120.98 129.99 53.64 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.962 -0.384 . . . . 2.1299999999999999 109.962 176.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.7 mt -120.03 122.52 68.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.921 -0.581 . . . . 1.6000000000000001 109.919 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.38 142.1 13.53 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 119.799 -1.191 . . . . 0.88 112.601 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.26 136.23 53.19 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.624 -0.509 . . . . 1.0800000000000001 109.624 176.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 70.1 mtm -127.75 151.28 49.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.184 -0.462 . . . . 2.3300000000000001 110.944 -175.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.444 ' CE1' ' HB3' ' A' ' 33' ' ' PRO . 59.3 m-85 -129.93 138.25 50.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.251 -0.886 . . . . 2.6099999999999999 108.69 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 121.124 0.488 . . . . 5.0899999999999999 110.049 176.841 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 120.548 0.213 . . . . 3.48 110.552 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HB3' ' CE1' ' A' ' 15' ' ' TYR . 87.8 Cg_endo -90.09 133.2 1.97 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.627 2.218 . . . . 1.8600000000000001 113.192 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.2 m -140.03 162.7 34.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.984 0.421 . . . . 1.97 111.619 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -125.19 134.91 65.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.791 -0.64 . . . . 1.71 110.775 -177.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -113.07 162.23 16.16 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.321 -0.622 . . . . 4.0700000000000003 109.321 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -139.87 146.72 39.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.056 0.455 . . . . 2.8599999999999999 111.231 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.6 ' OD1' ' HD3' ' A' ' 45' ' ' ARG . 11.3 p30 -151.4 160.86 43.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.773 -0.649 . . . . 1.8899999999999999 109.526 174.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.15 155.28 39.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.49 -0.323 . . . . 1.0800000000000001 110.576 -178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.37 146.03 16.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.369 -0.378 . . . . 1.3899999999999999 110.8 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.626 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 6.1 p-10 -167.08 94.73 0.47 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.773 -0.649 . . . . 2.8599999999999999 109.787 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.95 -94.07 1.95 Allowed Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 111.114 -0.794 . . . . 1.6799999999999999 111.114 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 77.0 Cg_exo -52.24 174.03 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.385 2.723 . . . . 1.6599999999999999 113.092 168.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.497 ' HB2' ' O ' ' A' ' 75' ' ' HIS . 48.9 p90 -70.07 -176.89 1.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.742 -0.663 . . . . 3.3999999999999999 112.155 -170.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.6 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 18.0 ttm180 -113.69 129.41 56.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.908 -0.587 . . . . 3.1000000000000001 111.29 -168.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.9 mt -113.22 129.92 68.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.37 -0.832 . . . . 1.8 110.274 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.499 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -118.9 132.14 56.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.492 -0.322 . . . . 0.85999999999999999 110.576 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.5 tp -124.23 131.0 53.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.777 0.322 . . . . 1.0600000000000001 110.413 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.37 160.87 42.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.846 -0.616 . . . . 1.1399999999999999 110.349 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -120.03 139.96 51.72 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.4 -0.593 . . . . 4.0199999999999996 109.4 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 45.4 t80 -98.89 128.16 45.0 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.651 0.738 . . . . 4.6100000000000003 111.808 -175.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -150.02 155.06 39.24 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.392 -1.707 . . . . 3.3799999999999999 106.392 171.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 . . . . . 0 C--N 1.317 -0.838 0 N-CA-C 109.393 -0.595 . . . . 5.0499999999999998 109.393 178.537 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 47.0 m95 . . . . . 0 CA--C 1.521 -0.173 0 N-CA-C 109.416 -0.587 . . . . 5.6100000000000003 109.416 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -119.1 119.95 35.72 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.58 -0.526 . . . . 3.7799999999999998 109.58 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -159.36 169.27 24.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.116 0.484 . . . . 2.4500000000000002 110.912 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 94' ' ' ASN . 41.5 ttp180 -149.87 123.24 4.43 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 115.293 -0.867 . . . . 3.2400000000000002 109.602 171.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.663 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 71.4 Cg_endo -79.81 140.56 14.66 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.292 1.995 . . . . 1.1899999999999999 110.733 169.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.544 ' CD ' ' HE ' ' A' ' 93' ' ' ARG . 72.2 tt0 -135.87 124.66 23.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.332 0.587 . . . . 2.1899999999999999 110.699 -178.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 47' ' ' ALA . 41.0 tp -120.17 130.02 54.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.408 -0.814 . . . . 1.1399999999999999 109.994 -178.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -125.04 128.02 47.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.019 0.438 . . . . 2.1800000000000002 110.1 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.03 129.93 74.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.172 -0.467 . . . . 1.5600000000000001 110.743 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 44' ' ' TRP . 64.4 m170 -116.61 120.08 37.53 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.786 0.327 . . . . 3.4399999999999999 110.636 177.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.403 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . 65.0 t80 -114.45 124.13 51.16 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.82 -0.627 . . . . 4.7999999999999998 109.38 174.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -119.55 137.97 53.49 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.27 -0.27 . . . . 2.9399999999999999 110.27 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -134.54 130.31 36.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.931 0.396 . . . . 3.8999999999999999 110.269 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.4 tp . . . . . 0 C--N 1.321 -0.647 0 N-CA-C 109.405 -0.591 . . . . 4.4800000000000004 109.405 177.145 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 120' ' ' ASP . 47.8 m . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 120.995 0.426 . . . . 2.5499999999999998 110.651 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -147.78 161.4 41.31 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.626 -0.509 . . . . 5.2999999999999998 109.626 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.61 176.94 34.62 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.463 -0.875 . . . . 1.3500000000000001 112.04 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 76' ' ' TYR . 92.3 mt -127.69 123.92 36.63 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.118 -0.327 . . . . 2.29 110.118 178.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.2 m -119.93 130.02 54.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.138 -0.483 . . . . 1.54 110.528 176.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -137.07 144.69 16.35 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.804 -0.713 . . . . 1.1699999999999999 111.768 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -137.66 143.98 15.23 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.987 -0.625 . . . . 1.1899999999999999 112.112 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 67.6 t80 -130.48 130.0 43.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.871 0.367 . . . . 3.75 110.753 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.544 ' HE ' ' CD ' ' A' ' 71' ' ' GLU . 99.3 mtt180 -130.29 127.36 39.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.738 -0.665 . . . . 2.75 109.809 175.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.663 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 61.2 t30 -111.27 117.95 34.57 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.441 -0.577 . . . . 1.8200000000000001 109.441 174.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -106.54 125.31 50.84 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.564 -0.289 . . . . 3.1400000000000001 110.881 -172.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.572 0 C-N-CA 120.0 -1.095 . . . . 2.79 111.584 175.486 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.874 -0.417 . . . . 3.2999999999999998 109.874 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.29 157.8 25.46 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.451 -0.203 . . . . 1.76 110.451 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -119.91 126.73 51.63 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.643 0.735 . . . . 2.5499999999999998 111.163 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 88.7 mtp -104.7 117.96 35.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.308 -0.86 . . . . 1.77 109.491 176.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 96.5 mt-30 -94.2 118.44 31.56 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.503 -0.479 . . . . 1.97 110.911 -174.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 84.4 mtt180 -105.5 115.94 31.1 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.012 -0.54 . . . . 3.8500000000000001 109.683 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 35.5 t-105 -118.35 120.8 38.69 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.999 -0.741 . . . . 2.2799999999999998 108.999 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.421 ' HE3' ' OG ' ' A' ' 134' ' ' SER . 87.8 tttt -126.32 130.01 49.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.445 -0.343 . . . . 2.1400000000000001 110.719 -176.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.2 pt -132.59 144.51 36.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.89 0.376 . . . . 1.55 110.953 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.47 123.84 3.17 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.775 -0.648 . . . . 1.1899999999999999 110.351 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.6 130.52 3.8 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.459 2.106 . . . . 1.3700000000000001 111.059 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -80.04 137.41 36.79 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.712 -0.477 . . . . 2.3500000000000001 109.712 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -132.91 128.41 36.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.008 0.432 . . . . 4.54 111.496 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 85' ' ' SER . 0.8 OUTLIER -103.57 110.26 22.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.795 -0.638 . . . . 3.04 109.461 171.172 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.73 119.98 61.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.145 0.498 . . . . 4.2699999999999996 110.817 -175.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -102.7 84.53 2.42 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.303 0.573 . . . . 6.04 110.137 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.02 -39.98 75.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.261 -0.881 . . . . 4.5899999999999999 111.598 -177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 81.5 m -123.8 139.18 54.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.073 -0.512 . . . . 3.6899999999999999 110.443 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -59.94 140.05 56.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.816 -0.629 . . . . 5.1699999999999999 111.272 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 66.1 14.31 9.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.271 -0.877 . . . . 3.71 111.964 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.6 mt -131.85 148.94 52.58 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.486 -0.561 . . . . 2.0499999999999998 109.486 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -130.81 137.58 49.49 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.719 -0.392 . . . . 4.2400000000000002 110.057 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -127.01 128.28 46.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.188 -0.46 . . . . 3.5499999999999998 109.78 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -119.77 129.91 54.7 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.473 -0.566 . . . . 2.1099999999999999 109.473 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -160.91 161.19 32.65 Favored Glycine 0 CA--C 1.504 -0.647 0 C-N-CA 119.908 -1.139 . . . . 1.1799999999999999 112.108 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -145.13 149.81 35.66 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.994 0.426 . . . . 4.2999999999999998 110.942 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.9 tp -101.34 120.98 41.09 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.925 -0.769 . . . . 2.2400000000000002 108.925 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.421 ' OG ' ' HE3' ' A' ' 114' ' ' LYS . 18.3 t -113.48 136.74 52.46 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.772 -0.649 . . . . 1.6899999999999999 111.099 -172.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 67.3 mtm -140.0 140.2 36.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.803 -0.635 . . . . 2.2400000000000002 109.727 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -145.29 156.52 43.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.271 0.558 . . . . 3.5600000000000001 111.555 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 62.2 mttp -130.95 157.0 44.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.879 -1.055 . . . . 1.6699999999999999 108.904 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 48.1 p90 -142.2 163.78 31.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.645 -0.252 . . . . 3.23 110.425 -175.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 65.09 -172.5 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.948 -0.569 . . . . 1.24 111.154 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -76.79 -47.34 21.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.169 0.509 . . . . 2.4700000000000002 110.89 174.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -60.17 -45.59 92.58 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.196 -0.911 . . . . 2.4100000000000001 113.455 -167.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 138' ' ' PHE . 3.1 mm? -62.02 -39.99 94.17 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.185 0.517 . . . . 1.8300000000000001 110.561 -176.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -67.36 -39.86 85.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.635 -0.711 . . . . 2.0 110.551 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.4 m -62.73 -44.36 96.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.675 -0.693 . . . . 2.0499999999999998 112.008 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 31.0 p -76.87 -19.9 56.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.992 0.425 . . . . 1.5900000000000001 111.156 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.21 -125.86 21.96 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.789 -0.641 . . . . 1.52 113.196 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -65.73 -19.39 65.88 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.647 0.24 . . . . 5.9400000000000004 111.647 -174.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.43 98.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.424 -0.353 . . . . 1.8300000000000001 111.675 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.503 ' O ' ' HE3' ' A' ' 137' ' ' LYS . 68.1 m-20 -119.69 117.18 27.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.044 0.45 . . . . 2.6400000000000001 110.572 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.4 t -154.3 153.92 32.5 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.863 -0.421 . . . . 2.02 109.863 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -108.27 140.06 42.07 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.742 -0.466 . . . . 3.6699999999999999 109.742 175.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.88 119.97 59.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.149 0.5 . . . . 1.6399999999999999 110.295 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -119.63 130.43 55.09 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.363 -0.835 . . . . 2.5600000000000001 109.122 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 21.8 m -129.54 129.79 44.94 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 121.923 -0.486 . . . . 1.3899999999999999 111.267 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -128.76 128.9 44.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.12 -0.491 . . . . 2.04 109.849 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 27.2 p -130.32 140.3 50.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.074 -0.512 . . . . 1.5600000000000001 110.773 -177.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -125.63 122.44 4.55 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.599 -0.601 . . . . 1.04 111.599 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.9 mt -102.29 128.25 48.92 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.988 -0.375 . . . . 2.27 109.988 -176.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -107.66 111.05 23.08 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.617 -0.433 . . . . 2.4100000000000001 110.379 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.98 139.8 51.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.737 -0.665 . . . . 4.5700000000000003 109.75 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.442 ' HB ' ' HA ' ' A' ' 164' ' ' GLU . 18.0 p -100.75 102.22 13.26 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.187 0.518 . . . . 1.46 110.368 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -60.01 -48.51 81.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.289 -0.869 . . . . 2.6299999999999999 110.992 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -102.64 9.77 39.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.336 -0.393 . . . . 2.4100000000000001 110.553 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.442 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 42.6 tt0 72.13 -42.93 0.55 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.597 0.759 . . . . 2.5800000000000001 111.131 -175.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.5 p -74.79 -24.44 58.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.448 -0.342 . . . . 2.2999999999999998 111.816 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.4 m -125.09 140.44 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.403 -0.362 . . . . 1.71 110.627 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.06 130.57 54.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.15 0.5 . . . . 1.47 111.389 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 21.9 mt -104.26 136.33 44.06 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.556 -0.905 . . . . 1.6599999999999999 108.556 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -114.07 113.45 24.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.169 0.509 . . . . 3.2999999999999998 110.7 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 63.2 t -115.05 120.11 63.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.5 -0.773 . . . . 1.3 110.217 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -104.69 124.08 48.74 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.01 0.433 . . . . 2.2200000000000002 110.773 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -105.17 130.39 53.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.785 -0.643 . . . . 4.6100000000000003 109.821 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.45 ' CE2' ' HD3' ' A' ' 195' ' ' ARG . 68.2 m-85 -110.99 136.65 49.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.971 -0.558 . . . . 3.98 110.468 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.5 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 61.5 tp -122.39 118.51 28.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.21 -0.45 . . . . 2.3799999999999999 110.398 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -120.11 179.98 4.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.889 -0.596 . . . . 3.3100000000000001 109.695 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 . . . . . 0 C--N 1.323 -0.546 0 C-N-CA 120.884 -0.326 . . . . 6.5300000000000002 111.042 -178.702 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.824 0.345 . . . . 4.4000000000000004 111.251 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 213' ' ' ILE . 86.4 mt -120.3 120.0 61.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.347 -0.388 . . . . 2.21 110.395 176.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.45 ' HD3' ' CE2' ' A' ' 173' ' ' TYR . 69.4 mtp180 -111.58 116.62 31.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.242 -0.651 . . . . 3.54 109.242 177.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -120.0 138.97 53.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.839 0.352 . . . . 1.6699999999999999 111.048 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -160.02 159.99 32.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.902 -0.59 . . . . 5.8300000000000001 110.425 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 198' ' ' LEU . 1.9 pt? -129.14 128.43 23.31 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.377 -0.374 . . . . 2.5899999999999999 110.116 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.83 133.04 11.08 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.414 2.076 . . . . 1.77 112.359 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 56.9 tp -135.66 131.14 35.35 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.027 -0.731 . . . . 2.2599999999999998 109.027 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 33.3 m -120.05 130.08 54.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.701 0.286 . . . . 1.99 110.548 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 58.3 tp -137.69 86.04 2.16 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.575 -0.528 . . . . 2.3100000000000001 109.575 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 69.93 -120.89 10.05 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.822 -0.704 . . . . 1.51 112.52 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -90.27 2.55 55.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 2.5699999999999998 110.248 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -112.65 130.08 56.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.099 -0.501 . . . . 2.6600000000000001 110.491 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 68.3 m -115.32 136.93 52.58 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.951 -0.568 . . . . 1.6200000000000001 109.73 173.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 45.9 t -119.93 130.01 74.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.751 -0.463 . . . . 1.3799999999999999 109.751 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.9 m -137.61 95.41 11.27 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-O 120.582 0.229 . . . . 1.1799999999999999 110.57 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.67 130.05 19.96 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.217 1.945 . . . . 1.01 110.659 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -110.79 138.66 46.9 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.287 -0.415 . . . . 4.5 110.171 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 71.1 p -133.68 151.66 51.7 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.133 -0.485 . . . . 1.8899999999999999 110.067 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.444 ' HG3' HG21 ' A' ' 237' ' ' VAL . 27.4 mtm180 -108.31 120.86 43.61 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.395 -0.595 . . . . 4.7999999999999998 109.395 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.514 ' O ' ' HB ' ' A' ' 194' ' ' ILE . 48.6 mm . . . . . 0 C--N 1.321 -0.662 0 N-CA-C 109.899 -0.408 . . . . 4.5700000000000003 109.899 -177.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.444 HG21 ' HG3' ' A' ' 212' ' ' ARG . 54.2 t . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 121.062 0.458 . . . . 2.3999999999999999 110.942 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -162.06 155.11 26.27 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.429 -0.891 . . . . 1.27 112.117 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 90.7 mt -112.83 126.24 55.23 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.708 -0.478 . . . . 1.97 109.708 176.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -106.19 128.64 54.07 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.649 -0.5 . . . . 3.54 109.649 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -119.93 139.97 51.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.247 -0.433 . . . . 2.6400000000000001 110.89 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -111.67 116.05 4.06 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.962 -0.855 . . . . 1.3500000000000001 110.962 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 250' ' ' SER . 59.1 t80 -112.06 114.87 27.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.492 0.187 . . . . 4.3600000000000003 110.884 -177.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -101.34 115.7 31.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.233 0.54 . . . . 4.29 110.074 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -61.1 -49.88 75.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.877 -1.056 . . . . 6.6900000000000004 110.895 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -177.34 78.35 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.177 -0.465 . . . . 6.3700000000000001 110.825 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 49.8 t30 56.13 63.43 2.01 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.225 0.536 . . . . 5.8300000000000001 111.956 170.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 153.7 -42.73 0.63 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 119.829 -1.177 . . . . 2.6600000000000001 112.767 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 61.9 tp -99.21 108.69 21.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.875 0.369 . . . . 2.9700000000000002 110.021 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 243' ' ' TYR . 47.0 m -119.9 133.42 55.58 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.988 -0.551 . . . . 2.1699999999999999 110.227 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.9 t -119.34 133.06 67.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 116.017 -0.538 . . . . 1.79 110.095 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 22.9 t -98.55 129.83 45.11 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.005 -0.739 . . . . 1.6299999999999999 109.005 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 91.7 mt -118.86 128.42 54.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.314 -0.403 . . . . 2.96 110.782 -176.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' GLU . . . . . 0.5 ' HB2' ' H ' ' A' ' 274' ' ' GLY . 97.5 mt-10 -101.45 114.42 28.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.948 -0.569 . . . . 4.0800000000000001 109.8 176.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -120.3 140.03 51.84 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.849 -0.341 . . . . 4.8399999999999999 110.771 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.655 0 CA-C-N 116.151 -0.477 . . . . 3.5800000000000001 110.425 175.647 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 110.112 -0.329 . . . . 1.9399999999999999 110.112 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.5 ' H ' ' HB2' ' A' ' 254' ' ' GLU . . . -132.69 149.86 19.61 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.338 -0.705 . . . . 1.4199999999999999 111.338 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.56 143.31 40.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.698 0.285 . . . . 1.8100000000000001 110.597 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -139.89 130.58 4.75 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 111.205 -0.758 . . . . 1.3 111.205 174.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 63.2 t -110.13 120.71 61.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.871 0.336 . . . . 1.8300000000000001 110.383 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -127.73 119.95 26.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.068 0.461 . . . . 2.3100000000000001 111.044 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -103.72 122.06 44.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.775 -0.648 . . . . 4.75 109.266 175.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.7 t -111.34 129.69 55.92 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.069 -0.514 . . . . 1.6699999999999999 109.92 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 C--O 1.246 0.877 0 CA-C-O 118.407 -0.806 . . . . 3.6899999999999999 109.957 -179.379 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.5 ttm . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 110.212 -0.292 . . . . 11.85 110.212 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -60.1 -40.16 88.68 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.046 -0.525 . . . . 10.35 111.134 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.47 -39.8 92.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.783 -0.644 . . . . 9.3100000000000005 111.568 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -76.42 146.03 38.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.064 0.459 . . . . 8.8399999999999999 111.47 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -109.76 20.92 17.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.747 -0.661 . . . . 7.0099999999999998 110.569 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.95 -41.69 92.43 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.736 -0.666 . . . . 3.6099999999999999 111.092 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -99.64 130.45 45.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.331 -0.395 . . . . 3.3300000000000001 110.358 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -98.86 117.67 33.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.081 0.467 . . . . 3.2000000000000002 110.073 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -119.97 140.01 51.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.576 -0.738 . . . . 2.4900000000000002 110.569 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 14.3 t-20 -133.71 131.43 39.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.759 -0.655 . . . . 2.1299999999999999 110.2 174.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 84.7 mt -129.03 128.97 67.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.908 -0.587 . . . . 1.6000000000000001 109.577 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.08 135.61 11.77 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.482 -0.866 . . . . 0.88 111.347 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.02 135.33 54.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.082 0.441 . . . . 1.0800000000000001 110.516 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 94.6 mmm -136.99 149.97 47.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.757 -0.656 . . . . 2.3300000000000001 110.362 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.31 124.96 43.52 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.949 -0.76 . . . . 2.6099999999999999 108.949 174.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.427 ' OE1' ' HA ' ' A' ' 31' ' ' ALA . 46.2 mt-10 -70.15 -33.58 71.97 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 120.881 -0.327 . . . . 5.0899999999999999 111.101 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.1 tt -130.21 131.25 65.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.377 -0.374 . . . . 5.3300000000000001 110.552 174.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -120.64 141.46 50.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.389 0.614 . . . . 8.2799999999999994 110.732 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -86.14 0.25 54.01 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.542 -0.754 . . . . 9.6999999999999993 110.905 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.2 t -60.18 -50.89 78.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 11.09 111.224 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.551 ' OE1' ' HB3' ' A' ' 271' ' ' HIS . 62.2 mm-40 -70.5 -33.3 71.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.082 0.467 . . . . 13.1 111.257 177.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.11 8.34 56.75 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.68 -0.771 . . . . 11.94 112.652 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.0 140.01 45.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.738 0.304 . . . . 15.18 110.539 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.99 -156.92 9.08 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 121.011 -0.614 . . . . 12.0 111.981 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -132.71 172.26 12.78 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.6 -0.148 . . . . 12.82 110.6 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.76 -49.97 74.26 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.573 0.583 . . . . 10.81 112.573 -176.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 88.5 mtp -109.96 134.34 52.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.155 0.502 . . . . 10.050000000000001 112.268 -172.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -70.01 -39.97 75.52 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.185 -0.916 . . . . 8.0600000000000005 111.726 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.95 14.82 4.37 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-N 116.104 -0.498 . . . . 5.5800000000000001 113.713 -173.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.4 mt -109.88 -0.44 18.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.982 0.391 . . . . 5.5599999999999996 111.289 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.427 ' HA ' ' OE1' ' A' ' 16' ' ' GLU . . . -146.94 129.47 15.94 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 111.751 0.278 . . . . 3.0499999999999998 111.751 -176.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HB2' ' HD2' ' A' ' 33' ' ' PRO . 11.9 pt-20 -150.42 160.3 33.2 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.887 -0.412 . . . . 3.48 109.887 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 32' ' ' GLU . 31.7 Cg_endo -69.85 147.84 63.19 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 121.689 1.593 . . . . 1.8600000000000001 111.647 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.5 t -129.49 142.83 50.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.448 -0.342 . . . . 1.97 111.009 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.04 131.99 65.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.981 -0.554 . . . . 1.71 109.615 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 94.7 m-85 -110.02 131.26 55.21 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.883 -0.414 . . . . 4.0700000000000003 109.883 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.7 m-85 -112.99 128.07 56.4 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.927 -0.309 . . . . 2.8599999999999999 110.93 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 10' ' ' ASN . 48.8 m-80 -129.15 132.44 47.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.873 -0.603 . . . . 1.8899999999999999 109.981 175.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.54 143.36 37.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.593 -0.276 . . . . 1.0800000000000001 110.261 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.46 122.29 3.15 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.73 0.27 . . . . 1.3899999999999999 111.73 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.652 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 56.2 t30 -167.53 95.14 0.45 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.393 -0.595 . . . . 2.8599999999999999 109.393 171.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.23 -84.24 0.45 Allowed Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 110.921 -0.871 . . . . 1.6799999999999999 110.921 -173.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.652 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 24.4 Cg_endo -63.62 172.91 5.03 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.862 2.375 . . . . 1.6599999999999999 111.922 169.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -71.05 -174.86 1.03 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.95 -0.568 . . . . 3.3999999999999999 110.914 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -109.61 127.62 54.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.27 0.557 . . . . 3.1000000000000001 109.785 -171.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 72' ' ' LEU . 5.2 tt -127.3 135.24 63.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.856 -1.065 . . . . 1.8 110.876 -171.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -118.28 129.92 55.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.804 -0.635 . . . . 0.85999999999999999 110.264 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.3 tp -122.74 136.25 54.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.278 -0.419 . . . . 1.0600000000000001 110.788 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.32 159.94 42.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.738 -0.665 . . . . 1.1399999999999999 109.852 176.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -123.53 139.98 53.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.572 0.225 . . . . 4.0199999999999996 110.416 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -125.45 115.33 20.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 4.6100000000000003 110.926 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -112.28 129.06 56.41 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.844 -0.343 . . . . 3.3799999999999999 110.239 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.501 ' HB2' ' NH2' ' A' ' 69' ' ' ARG . 85.8 tt0 -127.26 130.19 49.14 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.48 -0.327 . . . . 5.0499999999999998 110.468 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.434 ' HA2' ' HD2' ' A' ' 55' ' ' PRO . . . -112.27 100.64 1.16 Allowed Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.585 -0.817 . . . . 4.3700000000000001 112.122 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.434 ' HD2' ' HA2' ' A' ' 54' ' ' GLY . 23.3 Cg_endo -60.01 -26.56 82.75 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.631 2.221 . . . . 6.6799999999999997 111.034 175.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.8 t -128.4 130.08 69.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.623 -1.171 . . . . 8.1699999999999999 108.122 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -59.96 -32.28 70.66 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.838 0.351 . . . . 10.039999999999999 111.23 -176.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -65.78 -29.4 69.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.027 -0.533 . . . . 11.609999999999999 110.875 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.6 p -93.6 15.0 17.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 9.7899999999999991 111.359 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.53 143.65 34.34 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.895 -0.409 . . . . 8.5099999999999998 109.895 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.61 131.0 10.14 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.573 -0.822 . . . . 7.5599999999999996 112.688 -175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -69.87 -42.47 73.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.071 0.463 . . . . 10.0 110.429 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -70.22 -40.05 74.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.506 -0.77 . . . . 10.35 110.181 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.23 116.51 0.37 Allowed Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 114.812 -1.085 . . . . 5.3399999999999999 110.805 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 67' ' ' PHE . 21.7 m -70.69 130.97 43.16 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.998 0.428 . . . . 5.3200000000000003 111.039 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -65.2 -25.74 67.83 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.842 -0.617 . . . . 5.6100000000000003 110.745 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.582 ' H ' HG22 ' A' ' 65' ' ' THR . 91.6 m-85 -86.14 104.81 16.06 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.582 -0.896 . . . . 3.7799999999999998 108.582 170.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -141.86 147.06 36.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.505 -0.316 . . . . 2.4500000000000002 110.317 -166.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.59 ' HG3' ' HA ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -127.43 124.0 23.42 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 109.858 -0.423 . . . . 3.2400000000000002 109.858 172.315 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 67.0 Cg_endo -80.01 135.51 11.17 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.119 1.879 . . . . 1.1899999999999999 110.951 170.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.491 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 8.1 tp10 -115.35 120.0 38.16 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.406 -0.59 . . . . 2.1899999999999999 109.406 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.41 HD11 HD11 ' A' ' 46' ' ' ILE . 53.4 tp -134.54 129.54 35.21 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.267 -0.424 . . . . 1.1399999999999999 110.315 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -139.7 129.81 25.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.932 0.396 . . . . 2.1800000000000002 110.309 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.4 t -121.55 130.1 74.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.927 -0.579 . . . . 1.5600000000000001 109.773 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -108.81 137.43 46.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.049 0.452 . . . . 3.4399999999999999 110.915 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -119.91 139.89 51.73 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.472 -0.785 . . . . 4.7999999999999998 109.757 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -120.06 138.59 53.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.947 -0.39 . . . . 2.9399999999999999 109.947 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -125.5 127.64 46.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.287 0.565 . . . . 3.8999999999999999 110.496 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.7 tp -95.22 67.24 2.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.511 -0.768 . . . . 4.4800000000000004 110.097 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.599 ' HB2' ' CD1' ' A' ' 86' ' ' PHE . 45.3 mt-10 -89.97 -1.12 57.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.521 0.677 . . . . 6.1900000000000004 109.541 176.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -130.25 174.26 10.0 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.028 -1.101 . . . . 5.4500000000000002 108.028 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -60.05 -39.98 87.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 118.491 0.587 . . . . 5.2699999999999996 109.826 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -101.19 165.67 11.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.331 -0.849 . . . . 6.3300000000000001 109.467 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -79.22 66.67 4.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.028 0.442 . . . . 7.4800000000000004 110.281 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.618 ' HA ' ' OD2' ' A' ' 120' ' ' ASP . 16.3 m -80.0 -10.76 59.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.549 -0.75 . . . . 2.5499999999999998 111.41 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.599 ' CD1' ' HB2' ' A' ' 80' ' ' GLU . 97.8 m-85 -112.04 130.29 55.92 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.987 -0.375 . . . . 5.2999999999999998 109.987 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -154.76 156.35 26.83 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.545 -0.836 . . . . 1.3500000000000001 111.96 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 96.9 mt -132.84 136.89 46.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.821 0.343 . . . . 2.29 110.287 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 60.9 m -119.93 129.94 54.57 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.653 -0.499 . . . . 1.54 109.653 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.91 132.58 8.18 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.466 -0.873 . . . . 1.1699999999999999 111.528 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -125.07 128.5 6.67 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.762 -0.733 . . . . 1.1899999999999999 111.989 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -120.26 121.87 39.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.641 -0.503 . . . . 3.75 109.641 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.491 ' HD2' ' OE2' ' A' ' 71' ' ' GLU . 38.6 ttt180 -141.96 130.01 22.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.726 -0.472 . . . . 2.75 109.726 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.649 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 5.4 t30 -111.07 129.99 55.75 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.036 0.446 . . . . 1.8200000000000001 109.937 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.59 ' HA ' ' HG3' ' A' ' 69' ' ' ARG . 65.8 t80 -100.0 109.78 22.11 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.427 -0.582 . . . . 3.1400000000000001 109.427 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.9 -163.95 30.99 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.519 -0.848 . . . . 2.79 111.934 -175.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -130.9 152.77 49.87 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.372 -0.233 . . . . 7.6200000000000001 110.372 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -123.17 14.46 9.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.551 -0.295 . . . . 7.0800000000000001 111.345 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -70.15 -36.28 74.62 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.945 -0.302 . . . . 10.16 111.339 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.04 159.94 41.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.114 0.483 . . . . 9.8100000000000005 111.28 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -120.19 30.96 6.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.544 -0.753 . . . . 12.220000000000001 110.243 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.29 150.39 79.95 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.667 -0.697 . . . . 10.48 111.95 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -59.84 150.07 79.8 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.323 2.682 . . . . 9.0999999999999996 113.103 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.18 -26.97 12.37 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.825 -0.625 . . . . 6.46 111.748 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 59.8 33.54 21.72 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.145 0.578 . . . . 7.6699999999999999 112.062 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -76.21 -22.23 55.5 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.137 -1.06 . . . . 4.1399999999999997 108.137 170.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.5 m -96.4 131.93 42.46 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.457 -1.247 . . . . 3.2999999999999998 108.819 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -158.07 149.68 21.5 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.629 -0.508 . . . . 1.76 109.629 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -114.68 110.34 19.6 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.138 0.494 . . . . 2.5499999999999998 111.553 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.601 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 88.6 mtp -127.08 130.44 49.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.936 -0.764 . . . . 1.77 108.936 169.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.642 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 95.7 mt-30 -107.43 138.39 43.72 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.094 -0.642 . . . . 1.97 110.502 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 29.1 ttt180 -110.42 117.04 32.51 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.546 -0.539 . . . . 3.8500000000000001 109.546 171.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.564 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 61.4 m95 -108.5 127.42 53.91 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.735 -0.666 . . . . 2.2799999999999998 110.156 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -119.67 123.41 43.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.491 -0.322 . . . . 2.1400000000000001 110.795 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.6 mm -123.21 120.55 60.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.043 -0.725 . . . . 1.55 109.043 170.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -144.43 106.28 4.72 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 111.716 0.265 . . . . 1.1899999999999999 111.716 -177.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 87.8 Cg_endo -79.94 149.18 20.11 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.575 2.183 . . . . 1.3700000000000001 111.604 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -95.45 137.75 34.07 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.219 -0.66 . . . . 2.3500000000000001 109.219 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -135.98 130.49 33.72 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 111.957 0.355 . . . . 4.54 111.957 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.618 ' OD2' ' HA ' ' A' ' 85' ' ' SER . 13.0 m-20 -94.36 102.14 14.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.821 -0.807 . . . . 3.04 108.821 168.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 96.3 t -69.9 -42.73 79.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.142 -0.481 . . . . 4.2699999999999996 111.089 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -114.73 132.82 56.31 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.556 -0.535 . . . . 6.04 109.556 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.0 mt -107.19 24.84 12.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.202 -0.454 . . . . 4.5899999999999999 111.019 -173.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 17.4 p -108.89 142.57 39.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.12 -0.491 . . . . 3.6899999999999999 110.758 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -69.5 -39.96 77.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 5.1699999999999999 111.591 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -59.92 -40.11 87.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.006 -0.543 . . . . 3.71 111.248 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.6 tp -139.34 122.39 16.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.002 -0.544 . . . . 2.0499999999999998 109.745 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -119.16 136.29 54.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.991 0.424 . . . . 4.2400000000000002 110.54 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.413 ' CZ ' ' HB ' ' A' ' 156' ' ' THR . 89.1 t80 -139.58 130.87 26.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.826 -0.624 . . . . 3.5499999999999998 109.386 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -127.09 162.17 26.7 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.24 -0.436 . . . . 2.1099999999999999 110.958 -176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -161.39 140.51 6.68 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.276 -0.73 . . . . 1.1799999999999999 111.276 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.608 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 5.1 p90 -132.26 134.94 45.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.225 0.536 . . . . 4.2999999999999998 110.914 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.632 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 58.8 tp -104.46 124.46 49.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.163 -0.926 . . . . 2.2400000000000002 109.955 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.9 t -119.88 127.31 52.6 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.017 0.437 . . . . 1.6899999999999999 110.179 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 89.3 mtp -113.04 130.42 56.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.94 -0.573 . . . . 2.2400000000000002 110.043 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 113' ' ' TRP . 70.9 m-85 -121.58 139.98 52.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.92 0.39 . . . . 3.5600000000000001 111.676 -175.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 63.1 mttp -125.95 151.54 46.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.787 -0.642 . . . . 1.6699999999999999 109.7 169.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.642 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 87.8 m-85 -135.56 156.28 49.13 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.422 0.451 . . . . 3.23 110.53 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 110' ' ' MET . . . 60.05 -175.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.979 -0.555 . . . . 1.24 111.587 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -76.61 -33.69 58.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.487 0.66 . . . . 2.4700000000000002 109.766 168.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -60.11 -45.61 92.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.79 -1.095 . . . . 2.4100000000000001 112.421 -169.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 138' ' ' PHE . 9.4 mp -69.9 -30.11 67.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.826 0.345 . . . . 1.8300000000000001 110.88 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -67.38 -39.89 85.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.339 0.59 . . . . 2.0 109.955 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.1 m -66.94 -41.34 87.15 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.191 -0.913 . . . . 2.0499999999999998 111.665 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 34.7 p -80.58 -14.01 58.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.247 0.546 . . . . 1.5900000000000001 111.01 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.42 ' O ' ' HE3' ' A' ' 137' ' ' LYS . . . 71.3 -130.61 18.92 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.622 -0.717 . . . . 1.52 112.955 175.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.46 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 46.5 p90 -70.04 -16.15 63.11 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.53 0.196 . . . . 5.9400000000000004 111.53 -174.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.92 -48.68 80.69 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.208 0.448 . . . . 1.8300000000000001 112.208 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.449 ' HB3' ' HG ' ' A' ' 142' ' ' LEU . 51.3 m-20 -100.22 14.17 31.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.847 0.356 . . . . 2.6400000000000001 111.218 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.46 ' OG1' ' HA ' ' A' ' 147' ' ' TYR . 98.2 m -72.93 129.71 38.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.394 -0.366 . . . . 2.02 110.706 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -83.45 134.29 34.87 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.387 -0.598 . . . . 3.6699999999999999 109.387 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 63.0 t -119.6 124.24 72.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.002 0.43 . . . . 1.6399999999999999 110.746 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -127.39 136.18 51.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.63 -0.714 . . . . 2.5600000000000001 109.684 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 16.0 m -135.77 130.05 33.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.804 0.335 . . . . 1.3899999999999999 110.887 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.608 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 74.4 tt0 -120.29 136.89 54.53 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.525 -0.546 . . . . 2.04 109.525 175.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 172' ' ' TYR . 17.1 p -127.38 140.07 52.43 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.024 -0.535 . . . . 1.5600000000000001 110.375 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -125.02 130.1 7.25 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.694 -0.765 . . . . 1.04 112.211 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.8 tp -112.86 128.31 56.42 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 110.196 -0.298 . . . . 2.27 110.196 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -108.49 107.43 17.96 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.995 -0.372 . . . . 2.4100000000000001 109.995 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -121.01 130.08 53.65 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.414 -0.587 . . . . 4.5700000000000003 109.414 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.5 p -88.91 94.15 9.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.877 0.37 . . . . 1.46 110.523 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -61.1 -45.73 93.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.971 -0.559 . . . . 2.6299999999999999 111.271 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.413 ' HB2' HG22 ' A' ' 166' ' ' VAL . 19.6 m120 -99.95 7.65 44.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.589 -0.278 . . . . 2.4100000000000001 110.482 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 73.57 -46.01 0.62 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.708 0.803 . . . . 2.5800000000000001 111.201 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.4 p -73.88 -24.73 59.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.873 0.368 . . . . 2.2999999999999998 111.623 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' A' ' 163' ' ' ASN . 28.9 m -123.45 144.65 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.385 -0.37 . . . . 1.71 110.554 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.22 135.02 49.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.143 -0.48 . . . . 1.47 110.66 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 31.4 mt -104.2 134.53 47.28 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.416 -0.587 . . . . 1.6599999999999999 109.416 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.514 ' HD2' ' CE1' ' A' ' 197' ' ' TYR . 96.8 mtt180 -99.95 111.54 23.84 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.844 -0.428 . . . . 3.2999999999999998 109.844 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.11 119.95 60.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.146 -0.479 . . . . 1.3 109.812 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -107.83 128.44 54.6 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.205 0.526 . . . . 2.2200000000000002 110.792 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.562 ' HB2' ' OG1' ' A' ' 156' ' ' THR . 88.2 m-85 -106.81 128.52 54.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.457 -0.792 . . . . 4.6100000000000003 108.898 177.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -104.09 129.98 51.79 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.064 0.459 . . . . 3.98 110.697 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.513 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 54.2 tp -118.61 119.94 35.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.699 -0.682 . . . . 2.3799999999999999 110.549 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -122.91 149.24 44.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.182 -0.673 . . . . 3.3100000000000001 109.182 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -94.06 113.09 25.0 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.109 -0.637 . . . . 6.5300000000000002 110.417 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -110.07 -156.33 15.74 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 110.224 -1.15 . . . . 5.0599999999999996 110.224 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -69.99 -28.53 65.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.638 0.732 . . . . 7.3899999999999997 109.452 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 59.9 29.97 19.52 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.197 -1.365 . . . . 9.0700000000000003 111.12 174.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 75.2 mtm -125.62 133.42 52.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.562 -0.745 . . . . 10.869999999999999 109.713 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -70.77 146.47 49.76 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.053 -0.521 . . . . 10.449999999999999 110.377 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -137.8 144.91 41.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.172 -0.467 . . . . 13.06 109.753 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 19.2 p -70.01 -18.03 63.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 12.609999999999999 111.456 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -80.56 -10.17 59.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.019 -0.537 . . . . 15.19 110.648 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -102.83 122.06 43.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.949 -0.569 . . . . 13.18 109.699 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -70.74 -24.9 62.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.11 -0.496 . . . . 12.73 111.413 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 82.69 10.04 83.79 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.034 -0.603 . . . . 9.9800000000000004 111.743 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.32 -39.95 94.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.993 0.425 . . . . 10.699999999999999 110.857 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -107.85 146.4 32.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.797 -0.638 . . . . 10.5 110.135 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 32.2 p -81.26 147.84 29.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.084 0.469 . . . . 6.6399999999999997 110.77 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 23.4 p -70.06 -20.03 63.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.742 -0.663 . . . . 4.9800000000000004 111.056 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -127.25 149.85 49.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.852 -0.613 . . . . 7.0999999999999996 109.543 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -117.59 139.23 51.26 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.838 -0.43 . . . . 4.4000000000000004 109.838 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 87.2 mt -104.09 116.08 47.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.368 -0.378 . . . . 2.21 110.089 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -107.61 125.28 51.13 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.182 -0.303 . . . . 3.54 110.182 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -122.85 140.3 53.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.64 0.257 . . . . 1.6699999999999999 111.137 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.514 ' CE1' ' HD2' ' A' ' 169' ' ' ARG . 28.5 p90 -149.73 157.67 43.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.273 -0.421 . . . . 5.8300000000000001 110.101 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.62 143.4 23.51 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.637 0.256 . . . . 2.5899999999999999 110.811 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -88.03 116.08 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.441 2.094 . . . . 1.77 112.168 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 55.0 tp -103.56 129.15 50.74 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.296 -0.631 . . . . 2.2599999999999998 109.296 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 27.4 m -95.67 116.72 29.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.955 0.407 . . . . 1.99 111.24 -176.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.1 mt -127.74 81.46 2.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.071 -0.714 . . . . 2.3100000000000001 109.071 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 75.83 -129.54 10.36 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.76 -0.733 . . . . 1.51 111.291 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -90.62 -0.42 57.68 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.057 -0.72 . . . . 2.5699999999999998 109.057 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 242' ' ' GLY . 33.3 m170 -102.95 117.4 34.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.679 -0.691 . . . . 2.6600000000000001 110.082 -176.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -96.02 132.88 40.91 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.877 -0.601 . . . . 1.6200000000000001 109.999 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.507 ' CG1' HD11 ' A' ' 239' ' ' LEU . 58.4 t -110.08 120.04 60.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.289 -0.634 . . . . 1.3799999999999999 109.289 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 45.1 m -131.01 91.95 34.95 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 120.776 0.322 . . . . 1.1799999999999999 111.569 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.06 147.77 18.95 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.314 2.009 . . . . 1.01 111.135 172.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.425 ' CE1' ' HA3' ' A' ' 238' ' ' GLY . 33.8 p90 -132.4 149.54 52.33 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.621 -0.511 . . . . 4.5 109.621 172.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.404 HG22 HG22 ' A' ' 237' ' ' VAL . 20.6 p -119.0 135.74 54.46 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.715 -0.675 . . . . 1.8899999999999999 109.626 177.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.425 ' HB3' ' H ' ' A' ' 236' ' ' ARG . 78.3 ttt180 -60.1 -39.81 87.44 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.743 -0.662 . . . . 4.7999999999999998 110.259 177.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.433 ' HB ' ' ND2' ' A' ' 235' ' ' ASN . 84.5 mt -119.91 118.9 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 115.861 -0.608 . . . . 4.5700000000000003 109.543 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -72.73 -43.4 43.02 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.153 -0.546 . . . . 4.9800000000000004 112.088 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 96.6 mt -120.04 104.82 10.45 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.498 -0.556 . . . . 8.1099999999999994 109.498 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -63.99 151.73 42.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.151 -0.477 . . . . 7.6500000000000004 110.921 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -60.79 -40.03 91.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 10.529999999999999 111.078 -177.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -132.26 161.12 34.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.147 -0.479 . . . . 11.56 110.396 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.2 p -60.86 -40.0 91.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.33 0.586 . . . . 10.06 111.035 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -160.05 -177.73 6.51 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.717 -1.216 . . . . 11.92 107.717 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -59.95 -39.38 85.35 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.421 -0.955 . . . . 14.01 108.421 168.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 50.99 47.04 25.57 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.727 0.642 . . . . 14.529999999999999 111.805 172.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -113.65 161.29 17.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.446 -0.797 . . . . 16.609999999999999 109.199 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -93.75 8.69 40.06 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.349 0.595 . . . . 15.460000000000001 109.998 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -146.23 119.96 9.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.944 -1.025 . . . . 15.67 108.936 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -126.81 145.75 50.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.912 0.387 . . . . 14.5 111.34 -172.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 86.1 mt -109.9 129.95 63.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.169 -0.678 . . . . 15.15 109.169 173.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -60.69 -38.53 85.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.701 -0.681 . . . . 14.73 111.699 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -94.38 119.21 32.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.994 0.426 . . . . 16.379999999999999 110.88 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -99.71 138.88 36.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.486 -0.779 . . . . 12.779999999999999 109.1 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -60.03 -39.99 96.44 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.379 -0.828 . . . . 11.1 113.224 -173.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -161.03 159.77 29.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.987 -0.375 . . . . 12.26 109.987 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -83.16 110.84 18.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.067 -0.515 . . . . 9.9900000000000002 110.209 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -69.31 -40.15 77.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.843 -0.617 . . . . 10.43 109.541 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.433 ' ND2' ' HB ' ' A' ' 213' ' ' ILE . 50.0 t-20 -111.19 109.89 20.14 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.399 -0.963 . . . . 6.29 108.399 174.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.425 ' H ' ' HB3' ' A' ' 212' ' ' ARG . 99.0 mtt180 -97.07 137.56 35.95 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.337 -0.392 . . . . 8.1500000000000004 110.626 -175.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.404 HG22 HG22 ' A' ' 211' ' ' THR . 60.5 t -120.17 124.88 73.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.977 -0.556 . . . . 2.3999999999999999 110.577 -174.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.425 ' HA3' ' CE1' ' A' ' 210' ' ' TYR . . . -122.01 140.0 13.28 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.065 -0.814 . . . . 1.27 111.065 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.507 HD11 ' CG1' ' A' ' 207' ' ' VAL . 52.7 tp -120.58 124.4 45.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.928 0.364 . . . . 1.97 110.728 -176.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.487 ' CE1' ' HG2' ' A' ' 254' ' ' GLU . 96.3 m-85 -104.88 132.07 51.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.126 -0.488 . . . . 3.54 110.633 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -112.33 126.91 55.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.38 -0.373 . . . . 2.6400000000000001 110.22 171.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 205' ' ' HIS . . . -89.34 118.18 5.13 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.826 -0.91 . . . . 1.3500000000000001 110.826 174.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' TYR . . . . . 0.462 ' HB3' ' CG2' ' A' ' 251' ' ' VAL . 50.1 t80 -107.74 134.7 50.33 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.792 -0.447 . . . . 4.3600000000000003 109.792 -176.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -99.89 145.79 27.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.88 -0.6 . . . . 4.29 111.295 -174.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.68 139.9 52.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.842 -0.617 . . . . 6.6900000000000004 110.004 172.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -64.43 -26.41 68.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.288 -0.869 . . . . 6.3700000000000001 111.168 -174.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -59.82 -40.12 87.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.684 -0.689 . . . . 5.8300000000000001 110.808 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 130.8 21.74 1.09 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.83 -0.7 . . . . 2.6600000000000001 111.937 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 91.8 mt -110.99 151.52 27.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.747 0.308 . . . . 2.9700000000000002 110.351 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 52.8 m -130.07 139.77 50.92 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.703 -0.481 . . . . 2.1699999999999999 109.703 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.462 ' CG2' ' HB3' ' A' ' 243' ' ' TYR . 33.2 m -129.07 142.86 42.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.981 0.419 . . . . 1.79 110.827 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 4.2 p -100.07 120.74 40.31 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.999 -0.546 . . . . 1.6299999999999999 110.165 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 87.9 mt -99.96 125.94 46.04 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.052 -0.522 . . . . 2.96 110.154 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 273' ' ' ALA . 45.3 mt-10 -92.81 134.62 34.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.41 -0.359 . . . . 4.0800000000000001 111.018 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -137.04 138.88 40.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.987 -0.552 . . . . 4.8399999999999999 109.564 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -111.84 129.67 56.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.603 0.24 . . . . 3.5800000000000001 110.432 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -119.95 139.5 52.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.598 -0.274 . . . . 6.7699999999999996 110.489 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -76.59 152.83 35.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.963 -0.562 . . . . 8.5399999999999991 110.077 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -60.13 -39.88 87.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 11.9 110.642 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -84.92 133.4 34.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.193 -0.458 . . . . 10.57 110.607 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.09 141.62 55.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.673 -0.694 . . . . 11.41 111.195 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -109.24 111.35 22.9 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.932 -0.576 . . . . 11.98 111.066 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -68.63 -39.84 80.6 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.091 -0.707 . . . . 12.460000000000001 109.091 172.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -100.12 101.51 12.57 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.104 -0.953 . . . . 13.779999999999999 110.044 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -82.43 -4.25 90.22 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.883 -0.675 . . . . 11.07 111.538 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -70.73 -20.65 62.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.549 -0.325 . . . . 12.59 111.58 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 33.5 t -140.04 122.15 15.76 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.082 -0.34 . . . . 10.92 110.082 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ASP . . . . . 0.506 ' HB2' ' CE1' ' A' ' 271' ' ' HIS . 66.3 m-20 -130.04 151.04 51.02 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.564 -0.532 . . . . 12.42 109.564 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -69.91 -39.46 76.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.907 0.384 . . . . 11.59 110.925 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.36 149.97 52.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.047 -0.524 . . . . 8.8300000000000001 110.955 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' HIS . . . . . 0.551 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 22.4 m80 -138.85 103.33 4.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.005 -0.543 . . . . 7.0199999999999996 110.253 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -121.0 107.47 12.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.248 -0.433 . . . . 6.5999999999999996 110.236 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 254' ' ' GLU . . . -133.59 129.69 37.33 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.338 -0.392 . . . . 1.9399999999999999 110.233 176.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.468 ' H ' ' HB2' ' A' ' 254' ' ' GLU . . . -140.81 154.84 24.58 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.958 -0.639 . . . . 1.4199999999999999 111.571 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 58.2 t -119.99 127.98 75.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.13 0.49 . . . . 1.8100000000000001 110.982 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 251' ' ' VAL . . . -117.72 129.84 8.49 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.697 -0.961 . . . . 1.3 110.697 173.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.2 124.92 64.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 117.368 0.584 . . . . 1.8300000000000001 110.758 -175.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -117.43 127.35 53.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.275 0.56 . . . . 2.3100000000000001 111.111 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 44.2 t80 -113.89 119.57 37.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.361 -0.836 . . . . 4.75 109.106 171.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 53.4 m -129.98 129.61 43.97 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.752 0.311 . . . . 1.6699999999999999 110.337 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 49.8 t80 . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.319 -0.848 . . . . 3.6899999999999999 108.749 176.568 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.8 tpp . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 110.278 -0.267 . . . . 11.85 110.278 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -122.65 139.87 53.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.291 -0.413 . . . . 10.35 109.891 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -116.01 135.65 53.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.098 0.475 . . . . 9.3100000000000005 109.745 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 4' ' ' ARG . 13.0 ttp180 -68.55 -39.98 80.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.441 -0.8 . . . . 8.8399999999999999 111.691 -176.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -129.02 133.65 47.82 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.761 0.315 . . . . 7.0099999999999998 111.158 -175.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -74.52 143.66 44.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.982 -0.554 . . . . 3.6099999999999999 109.785 174.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -141.31 101.73 4.07 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.128 -0.694 . . . . 3.3300000000000001 109.128 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.446 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 44.7 m80 -119.98 137.88 53.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.014 0.435 . . . . 3.2000000000000002 111.119 -175.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -132.84 146.22 51.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.671 -0.695 . . . . 2.4900000000000002 110.85 -176.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -123.93 131.9 53.64 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.257 -0.428 . . . . 2.1299999999999999 109.969 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 279' ' ' TYR . 77.7 mt -130.0 129.97 65.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.309 -0.405 . . . . 1.6000000000000001 110.404 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -115.2 134.95 11.91 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.448 -0.882 . . . . 0.88 111.644 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.97 136.34 54.57 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.94 0.4 . . . . 1.0800000000000001 110.569 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.527 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 65.9 mtt -133.14 155.34 49.45 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.881 -0.599 . . . . 2.3300000000000001 109.769 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -111.33 114.49 27.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.769 -0.456 . . . . 2.6099999999999999 109.769 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -114.21 134.17 55.1 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.148 -0.478 . . . . 5.0899999999999999 111.445 -170.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.3 mt -117.04 129.93 72.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.626 -0.715 . . . . 5.3300000000000001 109.448 175.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.411 ' CD ' ' HD2' ' A' ' 55' ' ' PRO . 45.4 mt-10 -82.55 137.89 34.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.889 0.376 . . . . 8.2799999999999994 110.571 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -84.45 110.05 18.35 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.406 -0.59 . . . . 9.6999999999999993 109.406 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.9 t -70.16 -40.09 77.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.423 0.63 . . . . 11.09 110.489 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 59.93 23.1 12.16 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.597 -1.183 . . . . 13.1 111.81 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.02 -42.68 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.811 -0.709 . . . . 11.94 112.569 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -159.89 160.04 33.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.61 0.243 . . . . 15.18 110.397 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.1 23.05 53.4 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.574 -0.822 . . . . 12.0 112.168 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -60.03 -39.72 86.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.917 0.389 . . . . 12.82 111.431 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -60.22 -39.97 88.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.818 -0.628 . . . . 10.81 111.939 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 58.4 ttm -103.67 122.99 46.19 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.962 0.41 . . . . 10.050000000000001 111.172 -174.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -60.25 -39.86 88.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.662 -0.699 . . . . 8.0600000000000005 110.386 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.8 -143.79 16.79 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.839 -0.696 . . . . 5.5800000000000001 112.544 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.4 mt -119.59 140.84 49.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.129 -0.323 . . . . 5.5599999999999996 110.129 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.08 118.53 37.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.244 -0.435 . . . . 3.0499999999999998 110.96 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -85.55 138.51 35.9 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.857 0.361 . . . . 3.48 110.229 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 14' ' ' MET . 74.4 Cg_endo -78.01 134.73 13.37 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.443 2.096 . . . . 1.8600000000000001 113.166 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.2 m -109.92 143.25 40.11 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.715 -0.846 . . . . 1.97 108.715 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.49 134.4 66.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.357 0.598 . . . . 1.71 111.615 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -114.08 134.24 55.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.473 -0.785 . . . . 4.0700000000000003 109.582 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -110.69 139.38 46.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.755 0.312 . . . . 2.8599999999999999 110.986 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.42 HD22 ' HB2' ' A' ' 47' ' ' ALA . 24.5 t-20 -149.79 140.54 22.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.689 -0.485 . . . . 1.8899999999999999 109.689 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.47 143.51 47.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.415 0.15 . . . . 1.0800000000000001 110.978 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.459 ' HB2' ' HG3' ' A' ' 45' ' ' ARG . . . -153.95 119.69 5.26 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.49 -0.323 . . . . 1.3899999999999999 111.338 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.55 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 13.0 p-10 -169.12 95.04 0.32 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.373 -0.376 . . . . 2.8599999999999999 111.046 176.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.06 -98.7 2.47 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.972 -0.633 . . . . 1.6799999999999999 112.034 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.55 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 88.6 Cg_exo -49.23 174.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.893 3.062 . . . . 1.6599999999999999 112.998 170.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.4 ' HZ3' ' O ' ' A' ' 77' ' ' GLN . 93.6 m95 -67.31 176.33 2.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.123 0.487 . . . . 3.3999999999999999 111.108 -172.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.459 ' HG3' ' HB2' ' A' ' 40' ' ' ALA . 21.6 ttm180 -110.41 126.79 54.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.988 0.423 . . . . 3.1000000000000001 110.421 -163.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 83.5 mt -117.18 136.86 52.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.774 -0.648 . . . . 1.8 110.715 -173.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.42 ' HB2' HD22 ' A' ' 38' ' ' ASN . . . -117.83 133.32 56.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.853 -0.612 . . . . 0.85999999999999999 110.423 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.9 tp -120.35 132.02 55.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.925 -0.58 . . . . 1.0600000000000001 110.257 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.8 165.08 29.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.172 -0.467 . . . . 1.1399999999999999 110.189 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -138.42 147.97 43.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.057 -0.349 . . . . 4.0199999999999996 110.057 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -124.55 129.82 51.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.276 0.56 . . . . 4.6100000000000003 110.803 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -110.29 155.78 21.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.276 -0.874 . . . . 3.3799999999999999 108.859 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -59.98 -47.14 87.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.825 0.345 . . . . 5.0499999999999998 110.658 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -130.04 104.94 0.64 Allowed Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.79 -0.641 . . . . 4.3700000000000001 111.951 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.411 ' HD2' ' CD ' ' A' ' 18' ' ' GLU . 50.9 Cg_exo -55.69 -40.02 87.69 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.622 2.214 . . . . 6.6799999999999997 112.382 176.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.4 t -93.59 -29.97 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 8.1699999999999999 111.064 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -87.86 109.45 19.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.253 0.549 . . . . 10.039999999999999 110.615 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -97.86 119.24 36.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.884 -0.598 . . . . 11.609999999999999 110.664 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.5 p -78.35 126.65 31.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.931 -0.577 . . . . 9.7899999999999991 110.568 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.09 155.37 39.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.862 -0.608 . . . . 8.5099999999999998 109.519 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.94 18.18 73.05 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.693 -0.765 . . . . 7.5599999999999996 111.64 -177.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -129.01 144.6 51.24 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.136 -0.32 . . . . 10.0 110.136 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -125.89 131.49 52.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.698 0.285 . . . . 10.35 110.82 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.2 -160.89 30.45 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.796 -0.716 . . . . 5.3399999999999999 112.235 175.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.2 p -95.68 156.06 16.48 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.545 -0.539 . . . . 5.3200000000000003 109.545 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -131.35 160.02 36.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.875 0.369 . . . . 5.6100000000000003 111.224 -172.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -110.51 135.33 51.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.031 -0.532 . . . . 3.7799999999999998 110.355 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -149.18 170.02 19.39 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.692 -0.485 . . . . 2.4500000000000002 109.692 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 94' ' ' ASN . 40.8 ttp180 -129.6 123.59 21.35 Favored Pre-proline 0 N--CA 1.451 -0.402 0 C-N-CA 120.682 -0.407 . . . . 3.2400000000000002 111.038 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.538 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 92.7 Cg_endo -87.78 152.07 7.36 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.938 2.425 . . . . 1.1899999999999999 110.802 167.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.46 ' OE2' ' HD3' ' A' ' 93' ' ' ARG . 52.7 mt-10 -134.5 125.72 27.94 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.807 -0.357 . . . . 2.1899999999999999 110.383 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.4 tp -133.7 129.96 37.49 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.893 -0.41 . . . . 1.1399999999999999 109.893 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -128.3 146.62 50.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.083 0.468 . . . . 2.1800000000000002 110.994 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.1 t -114.8 126.87 72.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.786 -0.82 . . . . 1.5600000000000001 108.786 171.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -110.85 119.82 40.36 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.298 -0.41 . . . . 3.4399999999999999 110.227 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -105.59 120.03 40.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.065 -0.516 . . . . 4.7999999999999998 110.429 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.4 ' O ' ' HZ3' ' A' ' 44' ' ' TRP . 53.8 mt-30 -109.45 120.16 41.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.789 -0.448 . . . . 2.9399999999999999 109.789 176.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -104.14 125.45 50.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.151 0.5 . . . . 3.8999999999999999 111.214 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.6 tp -120.73 112.83 19.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.43 -0.805 . . . . 4.4800000000000004 108.975 174.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -113.74 170.35 8.32 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.88 -0.328 . . . . 6.1900000000000004 111.276 -173.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -60.51 -40.09 90.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.934 0.397 . . . . 5.4500000000000002 110.736 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -69.87 146.89 50.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.905 -0.589 . . . . 5.2699999999999996 109.497 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -79.98 66.68 5.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.797 0.808 . . . . 6.3300000000000001 110.32 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -138.61 150.54 46.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.863 -1.062 . . . . 7.4800000000000004 108.156 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.8 t -124.07 130.08 51.95 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.444 -0.503 . . . . 2.5499999999999998 110.711 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -128.52 153.29 47.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.77 -0.65 . . . . 5.2999999999999998 109.816 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -151.62 166.28 30.73 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.499 -0.858 . . . . 1.3500000000000001 111.608 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 63.6 tp -146.49 120.09 9.14 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.908 0.385 . . . . 2.29 110.403 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.3 m -109.39 116.72 32.37 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.047 -0.524 . . . . 1.54 109.763 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -134.96 139.05 10.5 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.44 -0.886 . . . . 1.1699999999999999 111.266 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.78 161.67 32.47 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.072 -1.061 . . . . 1.1899999999999999 112.366 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -122.39 130.96 53.63 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.491 -0.559 . . . . 3.75 109.491 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.46 ' HD3' ' OE2' ' A' ' 71' ' ' GLU . 83.6 mtt180 -121.99 124.99 45.3 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.587 -0.894 . . . . 2.75 108.587 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.538 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 64.4 t30 -103.75 118.41 36.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.064 0.459 . . . . 1.8200000000000001 110.64 -173.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 109' ' ' ASN . 59.3 t80 -102.34 117.67 35.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.07 -0.514 . . . . 3.1400000000000001 110.452 -175.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.46 -167.97 49.44 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.635 -0.793 . . . . 2.79 113.478 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -137.89 139.65 39.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.96 0.409 . . . . 7.6200000000000001 111.154 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -150.29 100.07 2.85 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.638 -0.875 . . . . 7.0800000000000001 108.638 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -99.51 126.39 45.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.978 0.418 . . . . 10.16 110.733 -176.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.7 t -70.24 -40.06 77.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.69 -0.686 . . . . 9.8100000000000005 110.491 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -65.12 -40.05 93.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.733 -0.667 . . . . 12.220000000000001 111.111 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -129.94 74.95 80.15 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.0 -0.545 . . . . 10.48 110.549 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -79.98 159.76 24.04 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.814 2.343 . . . . 9.0999999999999996 113.243 -176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -130.02 169.47 21.02 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.968 -0.853 . . . . 6.46 110.968 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -69.58 -40.02 76.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.32 0.56 . . . . 7.6699999999999999 110.174 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -111.55 109.98 20.17 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.846 -0.615 . . . . 4.1399999999999997 109.641 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.0 p -128.48 145.36 51.13 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.254 -0.43 . . . . 3.2999999999999998 110.228 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -137.6 113.74 9.99 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.96 -0.296 . . . . 1.76 110.345 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 95' ' ' TYR . 3.5 t-20 -142.09 108.31 5.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.927 -0.579 . . . . 2.5499999999999998 109.677 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.465 ' HB2' ' HB3' ' A' ' 95' ' ' TYR . 88.4 mtp -111.27 125.69 54.1 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.733 -0.667 . . . . 1.77 109.343 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.575 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 81.1 mt-30 -91.66 119.87 31.92 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.527 -0.469 . . . . 1.97 109.88 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -106.29 113.06 26.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.873 -0.603 . . . . 3.8500000000000001 110.193 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 137' ' ' LYS . 86.3 m95 -115.81 125.31 52.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.882 -0.784 . . . . 2.2799999999999998 108.882 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -140.1 123.88 17.37 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.452 -0.573 . . . . 2.1400000000000001 109.452 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 134' ' ' SER . 87.4 mt -123.22 128.22 74.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.999 -0.546 . . . . 1.55 110.179 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -132.77 104.25 13.03 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.516 -0.311 . . . . 1.1899999999999999 111.278 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.18 141.13 11.44 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.091 2.527 . . . . 1.3700000000000001 111.356 172.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -93.42 138.51 31.67 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.064 -0.516 . . . . 2.3500000000000001 110.088 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -127.06 128.38 46.19 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.125 -0.324 . . . . 4.54 110.125 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -148.64 118.11 6.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.867 -0.42 . . . . 3.04 109.867 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 123' ' ' LEU . 61.1 t -124.6 130.01 73.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.001 0.429 . . . . 4.2699999999999996 111.105 -174.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -114.03 28.48 8.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 6.04 110.213 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.597 ' H ' HG12 ' A' ' 121' ' ' VAL . 61.3 tp -68.13 -22.77 64.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 4.5899999999999999 112.066 -171.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.0 p -108.15 143.84 36.38 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.081 0.467 . . . . 3.6899999999999999 111.789 -174.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -66.93 124.97 24.49 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.527 -0.76 . . . . 5.1699999999999999 110.823 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 60.25 15.6 5.45 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.86 0.725 . . . . 3.71 111.598 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.6 mt -129.25 119.53 24.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.207 -0.451 . . . . 2.0499999999999998 110.062 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.518 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 74.0 ttt180 -112.74 130.36 56.09 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.031 -0.531 . . . . 4.2400000000000002 110.062 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -107.24 125.81 51.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.066 -0.515 . . . . 3.5499999999999998 109.652 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -130.6 130.05 43.52 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.201 -0.666 . . . . 2.1099999999999999 109.201 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -137.53 144.55 16.01 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.139 -1.029 . . . . 1.1799999999999999 112.8 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 155' ' ' GLU . 61.0 t-105 -118.82 128.44 54.46 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.068 -0.716 . . . . 4.2999999999999998 109.068 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 60.9 tp -126.33 140.51 52.45 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.385 -0.598 . . . . 2.2400000000000002 109.385 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 29.3 t -156.72 169.97 23.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.418 -0.216 . . . . 1.6899999999999999 110.418 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 92.8 mtp -139.62 149.95 44.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.652 0.263 . . . . 2.2400000000000002 110.663 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -103.74 117.35 34.17 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.378 -0.374 . . . . 3.5600000000000001 111.207 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 113' ' ' TRP . 99.4 mttt -132.92 129.8 38.78 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.066 -0.716 . . . . 1.6699999999999999 109.066 170.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.575 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 51.1 p90 -157.02 161.04 39.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.473 -0.331 . . . . 3.23 110.618 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 74.72 -178.19 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 O-C-N 124.154 0.908 . . . . 1.24 110.678 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -74.47 -38.64 62.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.533 -0.303 . . . . 2.4700000000000002 111.019 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -59.86 -51.17 70.86 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.738 0.644 . . . . 2.4100000000000001 112.738 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.6 ' HA ' ' OG1' ' A' ' 145' ' ' THR . 44.2 mt -69.98 -30.01 67.25 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.776 -0.37 . . . . 1.8300000000000001 111.342 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -60.02 -42.16 93.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.029 0.442 . . . . 2.0 109.857 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 30.0 p -80.12 -31.37 39.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.011 -0.541 . . . . 2.0499999999999998 111.972 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.6 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 61.6 p -71.65 -32.38 67.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.147 0.499 . . . . 1.5900000000000001 110.95 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.414 ' O ' ' HE2' ' A' ' 137' ' ' LYS . . . 68.3 -120.09 11.31 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.692 -0.686 . . . . 1.52 112.61 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -89.89 -9.66 48.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.43 0.157 . . . . 5.9400000000000004 111.067 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.69 -52.97 47.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.874 0.369 . . . . 1.8300000000000001 110.663 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.417 ' O ' HD22 ' A' ' 142' ' ' LEU . 10.9 m-20 -118.11 110.05 17.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.867 -0.606 . . . . 2.6400000000000001 109.666 176.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.6 t -170.24 164.17 8.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.813 -0.63 . . . . 2.02 109.616 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 151' ' ' ARG . 49.9 mtm180 -119.89 143.98 47.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.645 0.259 . . . . 3.6699999999999999 110.478 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.0 143.51 25.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.146 -0.479 . . . . 1.6399999999999999 110.984 -172.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 134' ' ' SER . 34.9 mt-10 -110.61 125.5 53.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.56 -0.904 . . . . 2.5600000000000001 108.56 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.8 m -132.22 122.45 25.25 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.464 -0.494 . . . . 1.3899999999999999 110.97 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 132' ' ' TRP . 85.8 tt0 -119.91 111.98 18.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.301 -0.629 . . . . 2.04 109.301 174.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 31.7 m -108.57 120.32 42.1 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.072 -0.513 . . . . 1.5600000000000001 109.861 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -133.37 149.26 19.61 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 119.71 -1.233 . . . . 1.04 113.051 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 59.6 tp -122.47 130.42 53.04 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.983 -0.377 . . . . 2.27 109.983 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 51.3 tt0 -95.44 110.89 22.87 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.109 -0.7 . . . . 2.4100000000000001 109.109 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -122.85 130.08 52.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.566 -0.743 . . . . 4.5700000000000003 110.002 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.2 p -82.28 88.16 6.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.159 0.504 . . . . 1.46 109.94 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -60.47 -50.14 74.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.61 -0.723 . . . . 2.6299999999999999 111.323 -172.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -103.12 16.64 26.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.156 -0.475 . . . . 2.4100000000000001 111.18 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 72.92 -50.22 0.7 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.75 -0.659 . . . . 2.5800000000000001 111.868 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.1 p -74.21 -20.1 60.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.759 0.314 . . . . 2.2999999999999998 111.695 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -125.79 144.19 36.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.366 -0.379 . . . . 1.71 110.82 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -105.67 121.63 44.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.036 -0.529 . . . . 1.47 110.493 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -102.88 126.94 50.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.825 -0.625 . . . . 1.6599999999999999 109.761 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -98.11 111.78 23.98 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.303 -0.629 . . . . 3.2999999999999998 109.303 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.96 119.92 60.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.856 -0.611 . . . . 1.3 109.384 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -114.89 131.07 56.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.323 -0.399 . . . . 2.2200000000000002 111.157 -171.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -115.19 119.94 38.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.683 -0.689 . . . . 4.6100000000000003 109.255 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -106.91 130.7 54.54 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.831 0.348 . . . . 3.98 110.075 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 64.1 tp -99.5 119.92 38.8 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.982 -0.554 . . . . 2.3799999999999999 110.102 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -66.73 -40.05 88.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.264 -0.88 . . . . 3.3100000000000001 110.638 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -173.85 135.23 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 6.5300000000000002 109.766 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 130.13 -144.77 16.02 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.324 -0.941 . . . . 5.0599999999999996 113.319 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -138.5 128.78 25.85 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.348 -0.612 . . . . 7.3899999999999997 109.348 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -60.2 -40.26 89.43 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.75 -0.659 . . . . 9.0700000000000003 111.655 -173.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.543 ' O ' ' HG3' ' A' ' 184' ' ' ARG . 98.9 mmm -70.0 -40.43 75.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.466 -0.334 . . . . 10.869999999999999 111.197 -178.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -77.0 -50.0 14.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.162 -0.472 . . . . 10.449999999999999 111.72 -176.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -62.82 -39.73 95.21 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.201 0.445 . . . . 13.06 112.201 -176.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.6 m -68.33 -14.81 63.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.635 0.255 . . . . 12.609999999999999 111.488 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 180' ' ' MET . 99.7 mtt180 -70.02 -31.54 69.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.967 0.413 . . . . 15.19 110.304 177.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -101.63 117.89 35.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.048 -0.524 . . . . 13.18 110.128 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -134.05 156.79 47.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.723 0.297 . . . . 12.73 110.371 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 162.04 -166.28 36.24 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.624 -0.798 . . . . 9.9800000000000004 112.096 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -60.21 -40.04 88.74 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.092 0.405 . . . . 10.699999999999999 112.092 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -90.7 -18.79 24.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.094 0.473 . . . . 10.5 110.803 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.3 m -89.96 65.24 6.54 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.108 -0.496 . . . . 6.6399999999999997 110.053 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 22.5 p -79.44 153.8 29.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.474 -0.785 . . . . 4.9800000000000004 112.107 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -129.48 154.94 46.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.647 -0.706 . . . . 7.0999999999999996 110.069 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -118.36 139.23 51.68 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.354 -0.609 . . . . 4.4000000000000004 109.354 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 85.2 mt -115.39 119.94 63.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.834 -0.432 . . . . 2.21 109.834 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 211' ' ' THR . 93.1 mtt180 -117.82 116.19 26.48 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.9 -0.407 . . . . 3.54 109.9 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -120.06 138.47 53.52 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.997 -0.547 . . . . 1.6699999999999999 110.178 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -136.82 140.75 42.68 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.348 0.594 . . . . 5.8300000000000001 111.362 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.41 HD12 ' HD2' ' A' ' 199' ' ' PRO . 55.5 tp -116.69 126.82 27.2 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 114.871 -1.059 . . . . 2.5899999999999999 109.399 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.41 ' HD2' HD12 ' A' ' 198' ' ' LEU . 21.8 Cg_exo -66.55 110.18 1.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.942 1.761 . . . . 1.77 111.078 174.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 60.0 tp -100.12 109.43 21.71 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.275 -0.639 . . . . 2.2599999999999998 109.275 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 78.5 m -121.34 130.07 53.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.331 0.586 . . . . 1.99 111.487 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 55.5 tp -133.6 83.86 2.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.507 -0.923 . . . . 2.3100000000000001 108.507 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.71 -117.79 9.14 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.504 -0.771 . . . . 1.51 112.063 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -79.89 -12.68 59.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.729 0.299 . . . . 2.5699999999999998 111.357 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -99.54 117.09 33.16 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.066 -0.346 . . . . 2.6600000000000001 110.066 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 28.6 t -132.57 138.14 47.35 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.724 -0.473 . . . . 1.6200000000000001 109.724 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.419 ' HB ' HD11 ' A' ' 239' ' ' LEU . 24.5 m -136.61 148.82 26.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.792 0.33 . . . . 1.3799999999999999 110.807 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 26.4 m -119.93 91.73 45.82 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.176 -0.465 . . . . 1.1799999999999999 110.412 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 2.6 Cg_endo -80.74 126.8 6.05 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.891 2.394 . . . . 1.01 112.455 177.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -95.27 140.07 30.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.234 -0.439 . . . . 4.5 110.0 175.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 195' ' ' ARG . 45.7 p -118.31 130.2 55.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.882 0.372 . . . . 1.8899999999999999 110.447 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.653 HH22 ' HG3' ' A' ' 264' ' ' GLU . 17.7 ttp85 -104.67 110.03 22.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.66 -0.7 . . . . 4.7999999999999998 109.704 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 30.4 pt -139.38 170.44 15.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.262 -0.426 . . . . 4.5700000000000003 110.586 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 125.29 -1.26 8.24 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.281 -0.962 . . . . 4.9800000000000004 113.473 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.0 mt -123.5 153.25 40.81 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.391 0.615 . . . . 8.1099999999999994 110.562 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -58.27 -35.43 71.77 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 114.545 -1.207 . . . . 7.6500000000000004 113.038 -166.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -59.81 -39.98 86.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.834 0.35 . . . . 10.529999999999999 110.878 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' TRP . . . . . 0.402 ' CH2' ' HB2' ' A' ' 236' ' ' ARG . 15.7 m95 -89.12 -11.44 43.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.973 0.415 . . . . 11.56 110.798 -176.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 42.1 m -74.6 -39.98 61.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.077 -0.51 . . . . 10.06 111.301 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -80.5 147.64 30.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.148 -0.478 . . . . 11.92 111.136 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -93.64 120.87 34.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.19 -0.459 . . . . 14.01 109.898 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -75.6 152.45 37.66 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.352 -0.61 . . . . 14.529999999999999 109.352 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -101.75 -0.01 35.14 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.834 0.309 . . . . 16.609999999999999 111.834 -171.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -95.93 116.68 29.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.912 0.386 . . . . 15.460000000000001 110.623 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -74.18 152.35 39.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.94 -0.573 . . . . 15.67 110.701 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -78.35 94.8 4.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.939 -0.573 . . . . 14.5 110.082 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 48.5 mm -70.1 -39.96 77.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.258 0.551 . . . . 15.15 109.883 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -94.64 42.62 1.09 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.675 -0.693 . . . . 14.73 109.77 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -66.24 126.04 27.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.059 -0.973 . . . . 16.379999999999999 110.367 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -70.15 -39.88 75.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.953 -0.567 . . . . 12.779999999999999 110.385 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 168.36 -129.41 1.88 Allowed Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.584 -0.735 . . . . 11.1 111.845 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -100.15 9.5 42.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.833 0.349 . . . . 12.26 110.397 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -80.77 134.25 35.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.922 -0.581 . . . . 9.9900000000000002 111.357 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -130.11 129.63 43.78 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.662 -0.496 . . . . 10.43 109.662 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -84.23 -23.61 30.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.656 -0.247 . . . . 6.29 111.42 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.402 ' HB2' ' CH2' ' A' ' 218' ' ' TRP . 36.9 ptt180 -75.55 -9.93 59.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.082 -0.508 . . . . 8.1500000000000004 111.795 -173.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 18.7 m -113.22 129.98 67.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.094 0.473 . . . . 2.3999999999999999 110.228 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -78.28 111.93 3.36 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.854 -0.898 . . . . 1.27 110.854 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.565 ' O ' ' HB3' ' A' ' 254' ' ' GLU . 47.7 tp -111.68 125.43 53.96 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.631 -0.507 . . . . 1.97 109.631 -175.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -124.83 133.34 53.14 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.993 -0.549 . . . . 3.54 109.776 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -98.11 131.15 44.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.972 0.415 . . . . 2.6400000000000001 110.471 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -121.12 118.45 3.8 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.726 -0.67 . . . . 1.3500000000000001 112.455 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -140.06 115.39 9.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.286 -0.635 . . . . 4.3600000000000003 109.286 174.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -120.06 130.29 54.61 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.995 -0.372 . . . . 4.29 109.995 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -139.92 129.67 24.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.034 -0.53 . . . . 6.6900000000000004 110.493 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -70.11 140.33 52.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.762 -0.653 . . . . 6.3700000000000001 110.307 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 59.97 39.63 19.86 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.449 0.468 . . . . 5.8300000000000001 110.984 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -170.39 171.34 43.56 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.815 -0.707 . . . . 2.6600000000000001 111.74 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 86.7 mt -71.12 141.26 50.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.074 0.464 . . . . 2.9700000000000002 110.786 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.554 ' HB2' ' HB2' ' A' ' 278' ' ' ASN . 68.5 m -123.89 149.97 45.21 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.846 -0.615 . . . . 2.1699999999999999 109.972 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 66.7 t -123.15 135.15 64.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.645 0.26 . . . . 1.79 111.314 -172.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 22.7 t -136.44 152.98 51.17 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.078 -0.51 . . . . 1.6299999999999999 109.877 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 90.2 mt 73.23 -179.67 0.21 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.251 0.621 . . . . 2.96 111.05 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.565 ' HB3' ' O ' ' A' ' 239' ' ' LEU . 38.2 tt0 -177.91 -86.11 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.293 0.042 . . . . 4.0800000000000001 110.991 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' TYR . . . . . 0.554 ' CD2' ' HG2' ' A' ' 254' ' ' GLU . 69.4 m-85 -120.02 135.96 54.73 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.91 -0.494 . . . . 4.8399999999999999 111.589 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -161.46 159.97 28.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.744 -0.662 . . . . 3.5800000000000001 110.248 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -113.77 139.98 48.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.923 0.392 . . . . 6.7699999999999996 110.393 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.77 -39.87 90.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.412 -0.813 . . . . 8.5399999999999991 110.935 175.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -127.48 136.13 51.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.329 -0.396 . . . . 11.9 110.423 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.436 ' NE2' ' HD3' ' A' ' 212' ' ' ARG . 97.7 mt-30 -69.74 -30.52 68.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.863 -0.608 . . . . 10.57 110.934 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.05 -39.91 87.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.86 -0.609 . . . . 11.41 110.277 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 270' ' ' PHE . 86.0 t60 -60.25 -38.48 83.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.413 -0.812 . . . . 11.98 111.32 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.53 -50.07 75.34 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.396 0.435 . . . . 12.460000000000001 111.861 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.653 ' HG3' HH22 ' A' ' 212' ' ' ARG . 41.6 mt-10 -70.09 -31.37 68.91 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.088 -0.245 . . . . 13.779999999999999 111.23 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -68.68 -65.07 2.77 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.897 -0.668 . . . . 11.07 113.001 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -160.02 140.18 11.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.736 0.268 . . . . 12.59 110.369 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 18.7 p -108.33 -9.88 15.41 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.361 0.504 . . . . 10.92 112.361 -174.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -109.97 -34.05 6.53 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.028 0.381 . . . . 12.42 112.028 -169.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -60.45 -40.12 90.02 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.401 -0.363 . . . . 11.59 110.364 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' PHE . . . . . 0.544 ' HB2' ' CE1' ' A' ' 262' ' ' HIS . 89.8 m-85 -133.68 130.0 37.59 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.127 -0.694 . . . . 8.8300000000000001 109.127 171.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -128.33 131.16 48.62 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.558 -0.534 . . . . 7.0199999999999996 109.558 -174.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -120.31 140.05 51.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.243 0.544 . . . . 6.5999999999999996 111.93 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -144.61 130.35 19.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.69 -0.686 . . . . 1.9399999999999999 109.426 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -133.3 118.71 2.18 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 119.857 -1.163 . . . . 1.4199999999999999 111.601 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 63.1 t -126.97 130.05 71.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.966 0.413 . . . . 1.8100000000000001 110.428 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -116.15 160.23 13.47 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 111.167 -0.773 . . . . 1.3 111.167 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 250' ' ' SER . 19.0 m -123.25 139.8 48.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 120.919 0.39 . . . . 1.8300000000000001 110.556 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 250' ' ' SER . 94.1 m-20 -105.39 131.8 52.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.989 -0.551 . . . . 2.3100000000000001 110.936 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.405 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 91.9 m-85 -115.26 139.97 49.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.454 -0.943 . . . . 4.75 108.454 173.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 15.5 t -144.2 143.03 30.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.109 0.48 . . . . 1.6699999999999999 110.751 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 59.1 t80 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 117.901 -1.047 . . . . 3.6899999999999999 109.116 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.2 mtm . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 110.789 -0.078 . . . . 11.85 110.789 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -60.07 -41.65 92.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.576 -0.898 . . . . 10.35 108.576 171.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -131.11 159.97 36.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.848 -1.069 . . . . 9.3100000000000005 108.723 170.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -109.24 140.09 43.32 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.682 0.277 . . . . 8.8399999999999999 110.26 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -95.89 102.82 14.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.084 -0.507 . . . . 7.0099999999999998 110.101 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.98 120.19 40.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.904 -0.589 . . . . 3.6099999999999999 111.713 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -134.85 129.42 34.43 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.314 -1.365 . . . . 3.3300000000000001 107.314 166.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.488 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 96.4 m-70 -124.58 137.04 54.42 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.953 -0.699 . . . . 3.2000000000000002 110.898 -172.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.45 ' CE2' ' HB3' ' A' ' 281' ' ' PHE . 50.4 p90 -140.0 160.61 39.53 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.637 -0.71 . . . . 2.4900000000000002 110.988 -176.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -134.12 129.85 36.52 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.777 -0.823 . . . . 2.1299999999999999 108.777 173.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.1 tt -130.1 130.05 65.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.962 -0.755 . . . . 1.6000000000000001 108.962 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.522 ' HA3' ' OD1' ' A' ' 278' ' ' ASN . . . -144.61 155.64 26.47 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 119.23 -1.462 . . . . 0.88 113.454 -173.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.423 ' HB2' HG22 ' A' ' 35' ' ' VAL . . . -118.1 135.14 54.39 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.583 -0.525 . . . . 1.0800000000000001 109.583 176.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.444 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 59.7 ttm -130.27 132.16 45.8 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.936 -0.575 . . . . 2.3300000000000001 110.003 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -84.51 120.34 26.22 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.532 -0.544 . . . . 2.6099999999999999 109.532 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -83.31 132.74 35.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.434 0.635 . . . . 5.0899999999999999 111.408 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 86.3 mt -117.57 130.11 72.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.058 -0.974 . . . . 5.3300000000000001 109.988 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -63.44 134.38 55.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.006 -0.543 . . . . 8.2799999999999994 111.151 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -107.59 114.81 29.05 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.356 -0.609 . . . . 9.6999999999999993 109.356 174.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.3 t -119.85 130.05 74.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.057 0.456 . . . . 11.09 109.96 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.89 -39.89 90.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.066 -0.97 . . . . 13.1 112.048 -174.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -152.46 178.68 29.5 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.509 -0.853 . . . . 11.94 112.481 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -87.67 6.69 33.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.787 0.327 . . . . 15.18 111.349 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.73 -10.07 70.55 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.918 -0.658 . . . . 12.0 113.329 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -139.95 141.2 36.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.097 0.448 . . . . 12.82 110.552 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -123.96 156.12 36.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.208 -0.451 . . . . 10.81 110.837 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 70.8 mtm -130.87 160.05 35.59 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.223 -0.658 . . . . 10.050000000000001 109.223 175.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -105.95 55.38 0.68 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.934 0.397 . . . . 8.0600000000000005 110.768 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.52 176.05 47.85 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.814 -0.708 . . . . 5.5800000000000001 112.604 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.6 tp -140.01 140.21 36.18 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.424 -0.584 . . . . 5.5599999999999996 109.424 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.21 76.0 3.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.027 0.441 . . . . 3.0499999999999998 110.814 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -101.26 147.23 33.47 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.816 -0.629 . . . . 3.48 110.585 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 14' ' ' MET . 85.2 Cg_endo -79.92 134.83 10.88 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.678 2.252 . . . . 1.8600000000000001 112.832 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.3 m -113.32 142.68 45.56 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.292 -0.633 . . . . 1.97 109.292 172.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 59.4 t -115.93 134.5 59.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.701 0.286 . . . . 1.71 111.295 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -119.65 139.91 51.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.321 -0.399 . . . . 4.0700000000000003 110.056 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -110.59 129.87 55.7 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.567 -0.531 . . . . 2.8599999999999999 109.567 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.561 HD21 ' HD3' ' A' ' 45' ' ' ARG . 51.3 t30 -143.43 127.63 17.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.601 -0.272 . . . . 1.8899999999999999 110.295 -173.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -143.31 144.18 32.0 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.52 0.563 . . . . 1.0800000000000001 112.52 -175.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.437 ' HB2' ' CB ' ' A' ' 45' ' ' ARG . . . -163.09 144.53 9.78 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.363 -0.381 . . . . 1.3899999999999999 111.74 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.691 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 7.5 t30 -169.13 94.15 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 2.8599999999999999 110.14 166.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.57 -81.36 0.31 Allowed Glycine 0 CA--C 1.517 0.185 0 C-N-CA 120.878 -0.677 . . . . 1.6799999999999999 111.47 -176.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.691 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 22.9 Cg_endo -61.71 175.73 1.6 Allowed 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.326 2.684 . . . . 1.6599999999999999 111.776 170.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -68.21 174.72 3.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.968 0.413 . . . . 3.3999999999999999 110.159 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.561 ' HD3' HD21 ' A' ' 38' ' ' ASN . 39.0 ttm180 -110.56 124.84 52.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.24 0.543 . . . . 3.1000000000000001 111.078 -166.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.5 mm -113.09 130.01 67.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.414 -0.812 . . . . 1.8 110.599 -173.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 73' ' ' GLU . . . -117.95 129.95 55.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.274 -0.421 . . . . 0.85999999999999999 110.064 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.1 tp -128.14 133.98 49.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.112 -0.495 . . . . 1.0600000000000001 110.661 -176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.02 153.91 37.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.142 -0.481 . . . . 1.1399999999999999 110.244 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -120.11 139.97 51.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.782 0.325 . . . . 4.0199999999999996 110.684 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.614 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 71.1 t80 -99.9 129.96 46.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.088 -0.505 . . . . 4.6100000000000003 110.527 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -133.45 150.47 51.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.336 -0.847 . . . . 3.3799999999999999 109.049 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -79.78 -9.95 59.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.952 0.406 . . . . 5.0499999999999998 110.627 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -149.89 167.35 29.94 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.6 -0.6 . . . . 4.3700000000000001 111.6 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -59.91 -28.9 88.19 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.136 2.557 . . . . 6.6799999999999997 112.257 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.96 160.14 40.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.885 -0.598 . . . . 8.1699999999999999 110.193 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -129.54 152.16 49.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.116 -0.493 . . . . 10.039999999999999 110.085 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -120.25 139.96 51.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.88 0.371 . . . . 11.609999999999999 110.633 -175.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.5 m -77.57 -13.95 59.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.03 -0.532 . . . . 9.7899999999999991 111.328 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -139.23 132.81 30.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.568 -0.287 . . . . 8.5099999999999998 110.35 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.87 160.02 28.05 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.517 -0.849 . . . . 7.5599999999999996 112.416 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -61.31 -40.04 92.7 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.762 0.425 . . . . 10.0 111.623 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -60.26 -39.91 88.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 10.35 110.653 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.25 -26.79 4.83 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.626 -0.716 . . . . 5.3399999999999999 112.345 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 29.4 m -83.33 121.54 27.28 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.272 -0.269 . . . . 5.3200000000000003 110.272 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -118.53 135.01 54.64 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.505 -0.554 . . . . 5.6100000000000003 109.505 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -150.26 159.95 44.06 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.212 -0.449 . . . . 3.7799999999999998 110.266 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -148.65 170.48 18.05 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.051 -0.722 . . . . 2.4500000000000002 109.051 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.614 ' HB3' ' HB3' ' A' ' 51' ' ' TYR . 29.0 ttp180 -135.0 122.16 15.06 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.648 -0.421 . . . . 3.2400000000000002 110.195 171.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.67 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 71.8 Cg_endo -81.91 146.2 14.51 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.756 2.304 . . . . 1.1899999999999999 111.47 169.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -136.57 120.08 17.05 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.699 -0.482 . . . . 2.1899999999999999 109.699 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 47' ' ' ALA . 40.6 tp -136.63 129.82 31.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.0 -0.545 . . . . 1.1399999999999999 110.338 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 99.8 mt-10 -117.93 142.18 47.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.176 -0.466 . . . . 2.1800000000000002 110.216 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.8 t -113.33 120.02 62.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.558 -0.904 . . . . 1.5600000000000001 108.558 173.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 15.3 m-70 -108.27 120.13 41.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.989 -0.55 . . . . 3.4399999999999999 109.769 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -99.14 141.44 31.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.155 -0.475 . . . . 4.7999999999999998 110.434 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -100.84 132.13 46.39 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.906 -0.405 . . . . 2.9399999999999999 109.906 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -120.02 99.8 6.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.768 0.318 . . . . 3.8999999999999999 111.662 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.6 tp -70.04 -39.99 75.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.359 0.6 . . . . 4.4800000000000004 109.615 171.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -92.03 137.08 32.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.157 -0.929 . . . . 6.1900000000000004 109.096 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.554 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 82.4 m-20 -110.03 20.02 18.38 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.973 0.36 . . . . 5.4500000000000002 111.973 -169.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -67.91 -40.73 83.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.004 0.372 . . . . 5.2699999999999996 112.004 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -106.09 -49.42 3.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.996 0.427 . . . . 6.3300000000000001 110.386 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 81' ' ' ASN . 97.0 m-85 -130.39 153.27 48.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.862 -0.608 . . . . 7.4800000000000004 109.622 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.7 p -120.03 143.49 48.06 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.096 -0.335 . . . . 2.5499999999999998 110.096 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 52.9 t80 71.97 -76.75 0.06 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.982 -0.554 . . . . 5.2999999999999998 111.794 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.13 166.94 34.79 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 118.478 -1.82 . . . . 1.3500000000000001 114.853 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.1 tp -133.6 130.05 37.82 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.542 -0.91 . . . . 2.29 108.542 173.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.2 m -120.06 127.51 52.64 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.05 0.453 . . . . 1.54 110.555 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -132.07 132.57 6.74 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.83 -0.908 . . . . 1.1699999999999999 110.83 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -141.94 156.24 25.86 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.32 -0.943 . . . . 1.1899999999999999 112.343 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -139.31 149.34 44.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.073 0.463 . . . . 3.75 110.614 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.421 ' HB2' ' HB3' ' A' ' 112' ' ' ARG . 99.7 mtt180 -131.57 129.85 41.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.447 -0.797 . . . . 2.75 109.449 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.67 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 8.5 t30 -115.29 117.58 30.86 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.4 -0.592 . . . . 1.8200000000000001 109.4 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -111.76 120.3 41.55 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.607 0.241 . . . . 3.1400000000000001 110.529 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 108' ' ' ALA . . . 92.83 -170.76 32.36 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.727 -0.749 . . . . 2.79 112.006 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -125.05 139.98 53.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.584 0.707 . . . . 7.6200000000000001 112.456 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.461 ' HB2' ' CB ' ' A' ' 109' ' ' ASN . 32.5 t60 -126.54 138.0 53.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.444 -1.253 . . . . 7.0800000000000001 108.108 173.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 63.6 t80 65.29 80.31 0.23 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.451 0.643 . . . . 10.16 109.412 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.31 129.95 74.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.558 -0.746 . . . . 9.8100000000000005 110.764 -171.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -68.13 -40.02 82.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.855 -0.611 . . . . 12.220000000000001 111.144 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -70.74 128.55 90.77 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.02 -0.536 . . . . 10.48 110.549 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.31 130.12 24.55 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.414 2.076 . . . . 9.0999999999999996 111.441 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.3 148.34 19.61 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.668 -0.777 . . . . 6.46 111.951 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -67.08 -40.08 86.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.849 0.357 . . . . 7.6699999999999999 110.998 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -120.11 133.99 55.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.363 0.601 . . . . 4.1399999999999997 111.56 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.3 p -132.42 139.9 48.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.406 -0.815 . . . . 3.2999999999999998 109.427 171.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.4 ' O ' ' HA3' ' A' ' 96' ' ' GLY . . . -160.87 130.81 5.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.231 -0.285 . . . . 1.76 110.231 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.461 ' CB ' ' HB2' ' A' ' 98' ' ' HIS . 5.2 t30 -139.77 108.12 5.82 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.703 -0.48 . . . . 2.5499999999999998 109.703 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 89.7 mtp -116.98 128.1 54.85 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.243 -0.435 . . . . 1.77 109.917 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -110.22 133.52 53.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.03 0.443 . . . . 1.97 111.127 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 35.2 ttt180 -109.89 117.84 34.89 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.329 -0.619 . . . . 3.8500000000000001 109.329 172.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -113.6 136.32 52.95 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.503 -0.555 . . . . 2.2799999999999998 109.503 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 134' ' ' SER . 85.5 tttt -139.12 128.85 24.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.208 -0.451 . . . . 2.1400000000000001 110.817 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 87.0 mt -120.01 121.01 64.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.952 -0.759 . . . . 1.55 108.952 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -137.59 105.3 8.36 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.381 -0.372 . . . . 1.1899999999999999 111.051 -175.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 74.2 Cg_endo -79.64 139.99 14.56 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.075 1.85 . . . . 1.3700000000000001 110.614 173.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -95.57 136.6 35.75 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.773 -1.195 . . . . 2.3500000000000001 107.773 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -124.51 127.97 48.26 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.118 0.485 . . . . 4.54 111.349 -176.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -131.92 120.22 22.22 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.797 -0.816 . . . . 3.04 108.797 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.4 t -132.85 115.83 25.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.438 -0.346 . . . . 4.2699999999999996 110.329 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -107.76 86.45 2.3 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.268 0.556 . . . . 6.04 110.513 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.04 -39.95 90.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.437 -0.801 . . . . 4.5899999999999999 109.696 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 127' ' ' LEU . 24.4 p -129.87 164.01 25.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.218 -0.901 . . . . 3.6899999999999999 109.77 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -73.44 -47.1 44.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.722 0.296 . . . . 5.1699999999999999 111.17 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -70.07 -40.08 75.27 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.133 -0.485 . . . . 3.71 112.027 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.562 ' HB2' ' OG1' ' A' ' 124' ' ' THR . 6.1 mp -102.11 118.45 36.93 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.71 -0.478 . . . . 2.0499999999999998 109.71 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.425 ' HB2' ' HB2' ' A' ' 159' ' ' GLN . 90.6 mtt180 -122.94 134.88 54.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.005 -0.543 . . . . 4.2400000000000002 109.812 -174.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.419 ' CE1' HD13 ' A' ' 158' ' ' LEU . 97.1 m-85 -109.22 129.07 55.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.76 0.314 . . . . 3.5499999999999998 110.519 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -146.32 120.93 9.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.423 -0.584 . . . . 2.1099999999999999 109.423 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -157.13 172.18 34.6 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.565 -0.826 . . . . 1.1799999999999999 112.047 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.471 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 9.2 p90 -140.23 140.91 35.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.134 0.492 . . . . 4.2999999999999998 111.158 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 66.5 mt -109.41 133.75 52.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.023 -0.732 . . . . 2.2400000000000002 109.023 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.4 ' HB3' ' HE3' ' A' ' 114' ' ' LYS . 73.9 m -129.9 135.5 48.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.283 0.563 . . . . 1.6899999999999999 112.14 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 68.6 mtt -119.98 136.76 54.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.443 -0.799 . . . . 2.2400000000000002 108.872 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 96.1 m-85 -120.05 134.36 55.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.002 0.43 . . . . 3.5600000000000001 111.635 -176.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 98.4 mttt -128.18 138.82 52.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.56 -0.745 . . . . 1.6699999999999999 109.37 173.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.45 ' O ' HD23 ' A' ' 142' ' ' LEU . 96.1 m-85 -129.91 150.76 51.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.687 0.279 . . . . 3.23 111.09 -176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 58.99 -165.03 0.19 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.669 -0.696 . . . . 1.24 111.306 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -76.95 -32.81 57.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.29 0.567 . . . . 2.4700000000000002 110.254 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -60.01 -46.78 88.38 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.046 -0.979 . . . . 2.4100000000000001 113.176 -168.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 138' ' ' PHE . 4.1 mm? -69.92 -29.21 66.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.141 0.496 . . . . 1.8300000000000001 110.545 -177.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -69.76 -40.02 76.37 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.905 -0.589 . . . . 2.0 109.896 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.4 m -63.85 -40.12 95.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.098 -0.955 . . . . 2.0499999999999998 111.233 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.4 p -75.7 -23.63 56.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.821 0.343 . . . . 1.5900000000000001 111.615 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 60.43 -120.98 25.12 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.757 -0.656 . . . . 1.52 113.327 174.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -69.94 -30.6 68.03 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.4 0.28 . . . . 5.9400000000000004 111.727 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.7 -49.95 75.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 1.8300000000000001 112.054 -174.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -122.93 113.3 18.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.951 0.405 . . . . 2.6400000000000001 110.924 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.9 t -160.01 150.29 18.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.018 -0.734 . . . . 2.02 109.018 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.532 ' HB2' ' HB2' ' A' ' 136' ' ' TYR . 98.5 mtt180 -83.7 137.28 33.84 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.075 -0.343 . . . . 3.6699999999999999 110.075 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.6 119.95 60.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.337 -0.392 . . . . 1.6399999999999999 110.493 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -124.29 129.88 51.53 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.731 -0.84 . . . . 2.5600000000000001 108.731 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.404 HG23 ' CD2' ' A' ' 133' ' ' LEU . 50.8 m -136.71 130.17 31.68 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.623 -0.262 . . . . 1.3899999999999999 111.409 -174.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.471 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 82.4 tt0 -130.76 121.48 25.49 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.125 0.488 . . . . 2.04 109.818 175.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 40.7 p -119.33 139.17 52.38 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.596 -0.729 . . . . 1.5600000000000001 109.993 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -130.05 141.85 13.07 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.243 -0.98 . . . . 1.04 113.349 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.419 HD13 ' CE1' ' A' ' 129' ' ' PHE . 63.7 tp -122.21 128.58 51.36 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.733 -0.469 . . . . 2.27 109.733 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 168' ' ' LEU . 95.6 mt-30 -100.01 126.78 46.25 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.327 -0.62 . . . . 2.4100000000000001 109.327 173.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -126.06 128.81 47.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.388 -0.369 . . . . 4.5700000000000003 110.38 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 2.4 p -85.3 88.59 7.51 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.348 0.594 . . . . 1.46 111.071 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.414 ' HB2' HD11 ' A' ' 168' ' ' LEU . 58.2 t80 -60.07 -49.94 75.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.579 -0.737 . . . . 2.6299999999999999 111.618 -176.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.616 ' HB2' HG22 ' A' ' 166' ' ' VAL . 92.7 m-20 -102.61 14.55 31.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.535 -0.302 . . . . 2.4100000000000001 110.851 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 72.98 -49.03 0.7 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.893 0.746 . . . . 2.5800000000000001 110.487 -176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 27.2 m -72.86 -33.17 65.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.176 -0.465 . . . . 2.2999999999999998 111.037 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.616 HG22 ' HB2' ' A' ' 163' ' ' ASN . 13.7 m -108.75 138.63 34.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.861 0.362 . . . . 1.71 110.914 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -109.21 137.21 47.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.085 -0.507 . . . . 1.47 110.608 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 159' ' ' GLN . 16.2 mt -103.22 129.96 50.31 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.698 -0.482 . . . . 1.6599999999999999 109.698 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.421 ' HB2' ' HB2' ' A' ' 197' ' ' TYR . 99.1 mtt180 -94.11 105.43 17.43 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.529 -0.545 . . . . 3.2999999999999998 109.529 177.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.3 t -119.31 121.99 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.858 -0.423 . . . . 1.3 109.858 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.578 ' OD1' ' HB2' ' A' ' 195' ' ' ARG . 30.4 p30 -132.3 156.65 46.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.349 0.595 . . . . 2.2200000000000002 112.086 -177.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.555 ' CE1' ' HB3' ' A' ' 193' ' ' GLU . 67.8 t80 -124.3 131.42 53.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.992 -1.003 . . . . 4.6100000000000003 109.586 177.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -113.2 135.01 54.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.154 0.502 . . . . 3.98 110.42 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.7 tp -100.01 116.6 32.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.734 -0.666 . . . . 2.3799999999999999 109.608 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.517 ' OE2' ' HD2' ' A' ' 176' ' ' ARG . 31.7 tt0 -70.02 -40.76 75.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.962 -0.563 . . . . 3.3100000000000001 111.307 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.517 ' HD2' ' OE2' ' A' ' 175' ' ' GLU . 8.8 ptm180 -159.98 162.35 34.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.569 -0.741 . . . . 6.5300000000000002 110.525 -169.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.489 ' HA3' ' NH1' ' A' ' 184' ' ' ARG . . . 106.71 -158.85 15.09 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.616 -0.802 . . . . 5.0599999999999996 112.429 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -129.12 151.92 49.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.814 0.34 . . . . 7.3899999999999997 110.507 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -84.26 0.83 47.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.63 -0.714 . . . . 9.0700000000000003 110.126 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 56.1 ttm -60.08 -39.95 87.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.235 -0.893 . . . . 10.869999999999999 110.089 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -104.96 114.46 28.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.565 -0.743 . . . . 10.449999999999999 109.497 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -60.11 -39.95 88.02 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.862 -0.608 . . . . 13.06 111.343 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 51.2 m -139.72 149.98 44.27 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.968 -0.56 . . . . 12.609999999999999 109.51 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.489 ' NH1' ' HA3' ' A' ' 177' ' ' GLY . 22.8 mtm180 -123.19 133.46 54.23 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.824 0.345 . . . . 15.19 110.745 -175.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -78.76 -22.89 45.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.658 -0.701 . . . . 13.18 110.568 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -62.37 -40.01 95.03 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.927 -0.579 . . . . 12.73 111.743 -176.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -106.23 142.6 15.64 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.48 -0.867 . . . . 9.9800000000000004 112.776 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -79.29 130.08 35.1 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.667 -0.494 . . . . 10.699999999999999 109.667 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -72.14 129.81 39.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.316 -0.402 . . . . 10.5 110.49 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 46.5 p -124.54 150.2 46.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.175 -0.466 . . . . 6.6399999999999997 111.054 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 70.6 p -69.97 -19.97 63.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.843 -0.617 . . . . 4.9800000000000004 110.808 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -66.22 -24.23 66.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.802 -0.635 . . . . 7.0999999999999996 110.945 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.555 ' HB3' ' CE1' ' A' ' 172' ' ' TYR . 36.0 mt-10 -70.01 -18.93 63.33 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.463 -0.789 . . . . 4.4000000000000004 110.777 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 48.5 mm -105.76 127.89 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.616 -0.72 . . . . 2.21 110.646 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.578 ' HB2' ' OD1' ' A' ' 171' ' ' ASN . 25.2 mtm180 -110.87 129.32 55.9 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.549 -0.537 . . . . 3.54 109.549 174.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 169' ' ' ARG . . . -118.4 134.49 55.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.085 -0.507 . . . . 1.6699999999999999 110.924 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.421 ' HB2' ' HB2' ' A' ' 169' ' ' ARG . 87.6 m-85 -133.59 143.32 48.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.626 -0.715 . . . . 5.8300000000000001 109.56 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.623 ' O ' ' HA ' ' A' ' 208' ' ' THR . 42.3 tp -119.92 124.22 28.01 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.178 -0.675 . . . . 2.5899999999999999 109.178 171.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -93.28 105.41 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.905 1.737 . . . . 1.77 112.449 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.8 tp -96.11 121.89 38.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.043 -0.526 . . . . 2.2599999999999998 109.648 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 89.6 m -99.9 118.85 37.2 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.275 0.559 . . . . 1.99 110.845 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 94.4 mt -125.7 81.07 1.95 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.191 -1.04 . . . . 2.3100000000000001 108.191 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 74.35 -126.87 9.55 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.705 -0.958 . . . . 1.51 110.705 -172.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -95.08 -0.11 53.87 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.304 0.573 . . . . 2.5699999999999998 109.531 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -99.34 119.18 37.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.518 -0.764 . . . . 2.6600000000000001 109.554 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 32.1 t -112.49 139.93 47.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.935 0.398 . . . . 1.6200000000000001 110.525 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.92 123.12 70.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.658 -0.867 . . . . 1.3799999999999999 108.658 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 198' ' ' LEU . 42.6 m -126.86 93.02 43.18 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-O 120.788 0.327 . . . . 1.1799999999999999 110.721 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 29.0 Cg_endo -69.82 149.87 67.1 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.841 1.694 . . . . 1.01 111.378 175.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -126.0 138.05 53.71 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.729 -0.669 . . . . 4.5 109.987 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 59.2 p -130.01 143.57 50.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.204 -0.453 . . . . 1.8899999999999999 110.012 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -95.16 -15.35 23.38 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.939 -0.573 . . . . 4.7999999999999998 109.922 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.0 mt -70.41 -39.99 77.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.73 -0.668 . . . . 4.5700000000000003 110.087 170.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 97.71 -10.09 64.41 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.903 -0.665 . . . . 4.9800000000000004 113.447 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.6 tp -139.93 129.92 24.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.081 0.44 . . . . 8.1099999999999994 111.268 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -80.44 132.55 35.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.96 -0.564 . . . . 7.6500000000000004 110.024 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.05 -39.94 75.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.129 0.49 . . . . 10.529999999999999 110.035 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -105.38 133.6 49.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 11.56 109.96 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 23.3 t -97.73 135.96 38.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.528 -0.305 . . . . 10.06 110.207 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -101.76 130.0 48.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.008 0.432 . . . . 11.92 110.7 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -114.32 149.2 36.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.533 -0.758 . . . . 14.01 109.907 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.98 -19.9 63.33 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.151 -0.477 . . . . 14.529999999999999 110.396 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -66.29 -27.52 67.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.349 -0.841 . . . . 16.609999999999999 110.312 174.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -77.05 110.9 12.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.229 -0.442 . . . . 15.460000000000001 111.138 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -76.58 138.83 40.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.026 -0.534 . . . . 15.67 110.184 174.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -91.98 156.31 17.52 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.724 -0.473 . . . . 14.5 109.724 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 87.9 mt -119.96 126.56 75.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.27 -0.423 . . . . 15.15 110.017 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.11 -40.0 88.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.599 -0.728 . . . . 14.73 111.01 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -64.26 -39.96 95.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.698 -0.683 . . . . 16.379999999999999 110.909 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -70.73 136.19 48.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.737 -0.665 . . . . 12.779999999999999 111.292 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -117.73 150.68 18.26 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.553 -0.619 . . . . 11.1 111.553 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -119.79 134.52 55.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.846 0.355 . . . . 12.26 110.355 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -96.0 114.98 26.74 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.928 -0.578 . . . . 9.9900000000000002 110.423 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.465 ' HB3' ' HB ' ' A' ' 237' ' ' VAL . 96.4 m-85 -100.01 109.99 22.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.013 -0.54 . . . . 10.43 110.374 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -99.87 117.68 34.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.019 -0.537 . . . . 6.29 110.299 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.485 ' HA ' ' CE1' ' A' ' 257' ' ' PHE . 66.5 mtt180 52.19 39.17 26.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.793 -0.64 . . . . 8.1500000000000004 112.077 -177.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 234' ' ' PHE . 62.6 t -119.79 124.21 72.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.958 -0.565 . . . . 2.3999999999999999 109.768 176.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -85.47 138.85 16.83 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.327 -0.939 . . . . 1.27 110.987 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 255' ' ' TYR . 92.6 mt -119.69 129.48 54.56 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.494 -0.482 . . . . 1.97 110.013 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.453 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 65.2 t80 -107.37 131.19 54.52 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.361 -0.607 . . . . 3.54 109.361 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -120.0 140.12 51.46 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.824 -0.435 . . . . 2.6400000000000001 109.824 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -125.91 128.28 6.41 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.247 -0.978 . . . . 1.3500000000000001 112.48 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -111.39 117.0 31.89 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.507 -0.553 . . . . 4.3600000000000003 109.507 173.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.47 133.87 55.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.781 0.324 . . . . 4.29 110.307 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -119.93 139.92 51.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.337 -0.392 . . . . 6.6900000000000004 110.384 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -64.86 -13.24 55.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.757 -0.656 . . . . 6.3700000000000001 110.561 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -69.98 -10.93 60.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.712 -0.676 . . . . 5.8300000000000001 110.567 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 104.7 -2.54 42.06 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.696 -0.764 . . . . 2.6600000000000001 112.259 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 61.8 tp -95.18 120.02 34.68 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.015 -0.365 . . . . 2.9700000000000002 110.015 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 8.6 t -121.6 129.94 53.17 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.437 -0.579 . . . . 2.1699999999999999 109.437 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.6 t -124.37 132.54 71.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.026 0.441 . . . . 1.79 110.882 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 51.9 m -110.23 129.06 55.79 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.876 -0.602 . . . . 1.6299999999999999 109.865 178.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 75.0 mt -120.0 130.34 54.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.312 -0.403 . . . . 2.96 111.027 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -101.84 124.85 48.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.438 -0.347 . . . . 4.0800000000000001 110.073 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' TYR . . . . . 0.454 ' HB3' ' HB2' ' A' ' 239' ' ' LEU . 61.2 t80 -104.33 129.97 52.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.547 . . . . 4.8399999999999999 109.588 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -100.35 127.35 46.68 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.371 -0.377 . . . . 3.5800000000000001 111.458 -176.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' PHE . . . . . 0.485 ' CE1' ' HA ' ' A' ' 236' ' ' ARG . 51.6 p90 -70.07 -23.58 63.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.01 -0.541 . . . . 6.7699999999999996 109.633 175.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -60.62 -33.93 73.5 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 115.788 -0.642 . . . . 8.5399999999999991 110.753 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 61.0 t90 -69.52 -25.49 64.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.705 -0.68 . . . . 11.9 111.105 -178.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -68.18 116.31 8.63 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.346 -0.388 . . . . 10.57 111.335 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -85.43 130.01 34.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.208 0.528 . . . . 11.41 109.873 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -70.06 -39.94 75.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.53 -0.759 . . . . 11.98 112.827 -176.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -97.43 -176.98 3.66 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.934 -0.307 . . . . 12.460000000000001 111.267 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -60.06 -39.91 87.65 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.0 0.37 . . . . 13.779999999999999 112.0 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -73.75 80.16 0.81 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.994 -0.622 . . . . 11.07 113.096 -173.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -78.91 159.77 27.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.017 0.437 . . . . 12.59 110.987 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 12.1 p -119.98 137.71 53.91 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.56 0.695 . . . . 10.92 111.448 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -70.1 -39.93 75.23 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 114.942 -1.026 . . . . 12.42 111.695 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.87 139.58 58.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.218 -0.446 . . . . 11.59 110.796 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -99.01 117.1 32.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.177 -0.465 . . . . 8.8300000000000001 111.232 -174.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -59.93 -40.08 87.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.594 -0.73 . . . . 7.0199999999999996 111.046 173.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -145.33 137.45 25.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.905 -0.589 . . . . 6.5999999999999996 110.276 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -139.93 131.47 27.09 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.144 -0.48 . . . . 1.9399999999999999 109.833 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.1 116.64 1.99 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.897 -1.144 . . . . 1.4199999999999999 111.895 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 62.6 t -129.92 130.0 66.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.638 0.256 . . . . 1.8100000000000001 110.826 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.09 126.97 5.41 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.807 -0.917 . . . . 1.3 110.807 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.6 t -118.19 120.05 63.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 117.099 0.449 . . . . 1.8300000000000001 110.954 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ASN . . . . . 0.522 ' OD1' ' HA3' ' A' ' 12' ' ' GLY . 96.3 m-20 -119.3 129.98 55.16 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.579 -0.526 . . . . 2.3100000000000001 109.579 176.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -112.08 116.44 30.52 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.193 -0.669 . . . . 4.75 109.193 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 15.3 t -121.71 130.3 53.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.101 -0.499 . . . . 1.6699999999999999 110.382 -176.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 65.1 t80 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.245 -0.883 . . . . 3.6899999999999999 108.939 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.8 mtm . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 121.664 0.745 . . . . 11.85 109.378 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -80.09 -9.57 59.71 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.944 -1.025 . . . . 10.35 111.217 -166.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -80.19 -9.97 59.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.255 -0.43 . . . . 9.3100000000000005 111.197 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 60.5 mtp85 -89.54 141.17 28.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.602 0.593 . . . . 8.8399999999999999 112.602 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -107.43 73.22 0.91 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.432 -0.804 . . . . 7.0099999999999998 109.363 170.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -60.27 -39.62 87.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 3.6099999999999999 110.698 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -77.56 121.57 24.08 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.598 -0.89 . . . . 3.3300000000000001 108.598 171.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.543 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 32.7 m170 -98.38 131.63 44.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.218 0.532 . . . . 3.2000000000000002 111.246 -174.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -139.65 159.91 41.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.642 -0.708 . . . . 2.4900000000000002 110.644 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.535 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 3.0 t-20 -145.88 129.7 17.22 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.48 -0.563 . . . . 2.1299999999999999 109.48 172.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.4 mt -120.56 122.53 68.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.326 -0.62 . . . . 1.6000000000000001 109.326 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -130.15 137.3 9.42 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 119.85 -1.167 . . . . 0.88 112.827 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.57 136.29 54.84 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.789 -0.449 . . . . 1.0800000000000001 109.789 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 57.5 ttm -143.44 150.65 39.32 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.746 -0.464 . . . . 2.3300000000000001 109.746 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -106.69 119.99 40.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.115 -0.328 . . . . 2.6099999999999999 110.115 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -112.06 143.48 43.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.436 -0.347 . . . . 5.0899999999999999 110.209 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.7 pt -118.26 132.11 69.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.291 0.567 . . . . 5.3300000000000001 111.243 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -100.36 -0.57 38.05 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.692 -0.855 . . . . 8.2799999999999994 108.692 172.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -73.66 129.79 38.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.983 -1.008 . . . . 9.6999999999999993 110.947 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.9 p -139.99 145.84 25.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.513 -0.767 . . . . 11.09 109.382 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 64.81 39.86 5.89 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.659 0.6 . . . . 13.1 111.079 -176.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.56 -12.99 83.36 Favored Glycine 0 C--O 1.225 -0.409 0 CA-C-N 115.324 -0.853 . . . . 11.94 112.209 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -70.22 -30.12 67.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.903 0.382 . . . . 15.18 110.472 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.46 -43.78 76.26 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.144 -0.55 . . . . 12.0 113.089 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.472 ' HG2' ' H ' ' A' ' 27' ' ' MET . 41.4 tt0 -128.32 138.56 52.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.749 0.309 . . . . 12.82 110.261 -177.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -63.19 -16.38 59.94 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.695 -0.684 . . . . 10.81 112.397 -172.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.472 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 95.4 mmm -75.54 65.1 1.72 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.875 0.369 . . . . 10.050000000000001 111.349 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.65 140.19 58.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.017 -0.538 . . . . 8.0600000000000005 110.533 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.34 142.03 20.96 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.776 -0.726 . . . . 5.5800000000000001 112.226 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.5 tp -70.07 139.96 52.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.613 0.244 . . . . 5.5599999999999996 110.364 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.64 131.22 37.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.661 0.267 . . . . 3.0499999999999998 110.532 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 9.7 tp10 -90.52 125.03 61.01 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.711 -0.477 . . . . 3.48 109.711 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 32' ' ' GLU . 26.8 Cg_exo -64.59 134.32 40.63 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.551 2.168 . . . . 1.8600000000000001 112.383 175.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 m -121.35 142.97 49.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.047 -0.524 . . . . 1.97 109.706 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.0 p -135.39 141.87 41.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.065 0.46 . . . . 1.71 110.943 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -137.85 147.61 44.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.979 -0.555 . . . . 4.0700000000000003 110.694 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -119.91 140.08 51.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.965 -0.562 . . . . 2.8599999999999999 111.238 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.535 ' HB2' ' HB3' ' A' ' 10' ' ' ASN . 28.6 m-80 -121.52 140.44 52.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.723 -0.671 . . . . 1.8899999999999999 110.095 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -137.87 140.93 40.69 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.987 -0.285 . . . . 1.0800000000000001 110.394 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.54 122.04 2.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.124 -0.489 . . . . 1.3899999999999999 110.669 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.694 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 43.4 t30 -149.95 92.12 1.86 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.23 -0.656 . . . . 2.8599999999999999 109.23 171.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.86 -78.96 0.28 Allowed Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.093 -0.803 . . . . 1.6799999999999999 111.093 -174.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.694 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 24.9 Cg_endo -61.96 175.57 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.526 2.817 . . . . 1.6599999999999999 112.94 171.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.454 ' HB3' ' O ' ' A' ' 75' ' ' HIS . 8.4 m-90 -69.41 -172.99 0.51 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.518 -0.765 . . . . 3.3999999999999999 111.15 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -106.64 122.34 46.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.779 0.8 . . . . 3.1000000000000001 111.237 -167.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 87.5 mt -111.81 136.09 49.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.417 -1.265 . . . . 1.8 109.895 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' A' ' 73' ' ' GLU . . . -117.22 132.48 56.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.087 -0.506 . . . . 0.85999999999999999 109.877 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.5 tp -119.49 131.7 55.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.059 -0.519 . . . . 1.0600000000000001 110.489 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.54 163.64 39.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.763 -0.653 . . . . 1.1399999999999999 109.537 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -157.05 150.6 24.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.644 0.259 . . . . 4.0199999999999996 110.396 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -130.04 150.02 51.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.911 -0.586 . . . . 4.6100000000000003 110.603 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -125.31 124.38 41.48 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.472 -0.785 . . . . 3.3799999999999999 109.301 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.83 -40.84 75.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.727 -0.67 . . . . 5.0499999999999998 111.073 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 47.15 59.91 5.41 Favored Glycine 0 CA--C 1.52 0.382 0 O-C-N 123.596 0.56 . . . . 4.3700000000000001 112.832 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.14 141.58 94.16 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.387 2.058 . . . . 6.6799999999999997 112.39 -174.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.99 119.96 61.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.033 -0.53 . . . . 8.1699999999999999 110.283 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.402 ' OD2' ' HD3' ' A' ' 62' ' ' LYS . 17.0 m-20 -79.2 159.49 27.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.136 -0.484 . . . . 10.039999999999999 110.155 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -65.99 -40.16 90.96 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.033 0.444 . . . . 11.609999999999999 110.356 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.6 m -81.44 139.18 35.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.825 -0.625 . . . . 9.7899999999999991 110.452 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.7 149.44 21.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.262 -0.427 . . . . 8.5099999999999998 110.924 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.4 10.73 37.93 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.748 -0.739 . . . . 7.5599999999999996 112.061 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.402 ' HD3' ' OD2' ' A' ' 57' ' ' ASP . 63.0 tttp -108.27 120.0 41.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.774 0.321 . . . . 10.0 110.513 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -70.03 -40.19 75.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.129 -0.487 . . . . 10.35 110.244 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.97 -147.84 50.78 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.292 -0.867 . . . . 5.3399999999999999 112.728 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.5 p -131.4 141.98 49.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.728 0.299 . . . . 5.3200000000000003 110.564 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -99.79 130.52 46.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.963 0.411 . . . . 5.6100000000000003 110.85 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -120.02 140.02 51.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.839 -0.619 . . . . 3.7799999999999998 110.342 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -134.8 160.05 39.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.574 -0.739 . . . . 2.4500000000000002 109.861 -174.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 17.1 ptp180 -148.48 125.09 5.39 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.871 0.367 . . . . 3.2400000000000002 110.626 171.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.444 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 89.3 Cg_endo -93.02 153.77 2.65 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.941 2.428 . . . . 1.1899999999999999 112.313 171.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 93' ' ' ARG . 43.8 mt-10 -118.91 125.51 49.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.295 -0.411 . . . . 2.1899999999999999 110.123 175.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.412 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 64.0 tp -122.12 112.59 18.4 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.019 -0.537 . . . . 1.1399999999999999 109.981 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 80.0 mt-10 -108.5 132.72 53.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.003 0.43 . . . . 2.1800000000000002 111.28 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.42 124.59 72.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.894 -0.78 . . . . 1.5600000000000001 108.894 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' A' ' 44' ' ' TRP . 28.1 m-70 -106.32 119.1 38.36 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.84 -0.43 . . . . 3.4399999999999999 109.84 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 79.4 t80 -100.45 122.53 43.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.769 -0.65 . . . . 4.7999999999999998 110.35 -176.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -109.21 128.68 55.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.592 -0.731 . . . . 2.9399999999999999 109.693 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -143.37 129.95 20.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.069 -0.252 . . . . 3.8999999999999999 111.224 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.1 mt 60.12 42.21 15.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.606 -0.724 . . . . 4.4800000000000004 111.703 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -67.17 -37.76 84.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.132 0.491 . . . . 6.1900000000000004 110.815 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -87.31 0.1 55.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.77 -0.65 . . . . 5.4500000000000002 110.925 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -107.02 169.26 8.66 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.101 -0.5 . . . . 5.2699999999999996 110.913 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -60.3 -43.73 96.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.794 0.331 . . . . 6.3300000000000001 111.671 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -95.79 117.54 30.74 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.417 -0.356 . . . . 7.4800000000000004 110.402 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.6 p -99.86 123.95 44.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.345 -0.389 . . . . 2.5499999999999998 110.747 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -123.06 148.33 45.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.056 -0.52 . . . . 5.2999999999999998 110.292 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.94 163.8 28.28 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.548 -0.834 . . . . 1.3500000000000001 111.959 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.502 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 65.1 tp -145.61 128.6 16.5 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.472 -0.566 . . . . 2.29 109.472 174.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 p -118.31 128.53 54.75 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.308 0.575 . . . . 1.54 110.9 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.84 132.63 8.48 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.571 -0.823 . . . . 1.1699999999999999 111.319 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -128.14 127.42 5.71 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 111.497 -0.641 . . . . 1.1899999999999999 111.497 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -111.09 130.28 55.66 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.888 0.375 . . . . 3.75 110.483 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.516 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 91.0 mtt180 -122.95 126.88 48.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.615 -0.72 . . . . 2.75 109.12 175.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 64.9 t30 -107.33 129.94 54.84 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.337 -0.616 . . . . 1.8200000000000001 109.337 -178.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.424 ' HB3' ' HB3' ' A' ' 110' ' ' MET . 54.5 t80 -137.05 146.05 44.74 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.416 -0.514 . . . . 3.1400000000000001 110.576 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.81 169.66 36.85 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.622 -0.799 . . . . 2.79 112.495 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -145.86 157.26 43.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.28 0.562 . . . . 7.6200000000000001 111.656 -177.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -142.57 153.79 43.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.961 -1.018 . . . . 7.0800000000000001 108.69 171.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -134.06 100.02 4.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.861 0.362 . . . . 10.16 111.043 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 98.1 t -70.49 -39.85 76.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.216 0.532 . . . . 9.8100000000000005 109.902 175.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -60.09 -40.24 88.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.156 -0.929 . . . . 12.220000000000001 111.641 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -145.86 85.17 7.8 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.772 -0.455 . . . . 10.48 109.772 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.97 139.68 89.06 Favored 'Trans proline' 0 C--N 1.339 0.072 0 C-N-CA 122.89 2.394 . . . . 9.0999999999999996 112.498 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -104.19 179.06 24.78 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.735 -0.745 . . . . 6.46 112.08 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -60.06 -42.2 94.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.166 0.508 . . . . 7.6699999999999999 110.334 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -122.46 160.26 25.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.52 -0.764 . . . . 4.1399999999999997 110.471 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.1 m -147.79 140.31 24.56 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.696 -0.684 . . . . 3.2999999999999998 109.591 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.39 116.38 7.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.667 -0.242 . . . . 1.76 110.589 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -117.67 130.54 56.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.443 -0.344 . . . . 2.5499999999999998 110.085 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.611 ' HG3' ' H ' ' A' ' 139' ' ' ALA . 46.3 ttm -132.56 122.34 24.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.831 0.348 . . . . 1.77 111.624 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 56.7 mt-30 -103.54 118.71 37.35 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.036 -0.727 . . . . 1.97 109.036 170.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 31.4 ttm180 -113.77 120.73 41.8 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.124 0.488 . . . . 3.8500000000000001 110.168 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -119.14 139.62 51.5 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.728 -0.669 . . . . 2.2799999999999998 110.409 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 135' ' ' MET . 82.0 tttt -128.84 123.68 33.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.717 -0.674 . . . . 2.1400000000000001 109.559 172.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.9 mm -124.21 128.15 73.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.016 -0.538 . . . . 1.55 109.698 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -142.71 106.47 5.42 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 120.681 0.277 . . . . 1.1899999999999999 111.493 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.63 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 65.2 Cg_endo -76.8 132.53 13.16 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.977 1.784 . . . . 1.3700000000000001 110.467 172.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -92.38 137.31 32.47 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.538 -0.541 . . . . 2.3500000000000001 109.538 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -128.44 129.99 46.94 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.862 -0.422 . . . . 4.54 109.862 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -137.49 119.76 15.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.843 0.354 . . . . 3.04 110.481 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.9 t -129.56 128.28 65.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.732 -0.667 . . . . 4.2699999999999996 109.659 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -114.99 96.86 5.91 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.789 -0.448 . . . . 6.04 109.789 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.99 -33.24 71.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.557 0.694 . . . . 4.5899999999999999 109.683 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.459 ' HB ' ' H ' ' A' ' 127' ' ' LEU . 8.6 m -140.35 159.88 41.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.18 -0.918 . . . . 3.6899999999999999 108.75 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -60.14 -41.99 93.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.503 0.668 . . . . 5.1699999999999999 109.361 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -69.92 -40.03 75.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.763 -1.108 . . . . 3.71 111.946 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.459 ' H ' ' HB ' ' A' ' 124' ' ' THR . 84.9 mt -104.94 119.43 39.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 2.0499999999999998 110.814 -172.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.489 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 79.4 ttt180 -125.71 133.31 52.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.119 -0.491 . . . . 4.2400000000000002 111.453 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -108.98 119.99 41.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 3.5499999999999998 109.332 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -143.81 135.79 26.5 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.802 -0.444 . . . . 2.1099999999999999 109.802 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -171.8 172.13 44.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.445 -0.883 . . . . 1.1799999999999999 111.689 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -143.0 150.57 39.82 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.991 0.424 . . . . 4.2999999999999998 110.691 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.63 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 47.8 tp -106.0 111.61 24.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.933 -0.576 . . . . 2.2400000000000002 109.511 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.5 t -101.56 121.1 41.37 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.864 0.364 . . . . 1.6899999999999999 110.631 -173.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.423 ' O ' ' HA ' ' A' ' 114' ' ' LYS . 74.8 mtm -111.83 133.24 54.17 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.345 -0.389 . . . . 2.2400000000000002 110.08 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -118.98 134.88 54.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.95 0.405 . . . . 3.5600000000000001 111.411 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 97.3 mttt -138.55 148.35 44.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.078 -0.712 . . . . 1.6699999999999999 109.078 174.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.501 ' H ' HD22 ' A' ' 142' ' ' LEU . 54.8 p90 -150.83 160.02 44.15 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.974 -0.38 . . . . 3.23 109.974 175.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.611 ' H ' ' HG3' ' A' ' 110' ' ' MET . . . 72.16 -178.69 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.876 0.735 . . . . 1.24 110.334 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -76.82 -39.67 50.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.963 0.411 . . . . 2.4700000000000002 111.279 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.0 -49.61 77.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.715 -0.675 . . . . 2.4100000000000001 112.532 -171.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.501 HD22 ' H ' ' A' ' 138' ' ' PHE . 9.5 mp -62.59 -36.35 82.45 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.137 0.494 . . . . 1.8300000000000001 111.129 -177.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -66.13 -39.93 90.26 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.24 0.543 . . . . 2.0 110.388 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 90.9 m -66.75 -42.25 86.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.367 -0.833 . . . . 2.0499999999999998 111.061 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 148' ' ' ALA . 33.9 p -72.72 -28.89 62.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.251 0.548 . . . . 1.5900000000000001 110.6 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.05 -118.05 7.84 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.531 -0.759 . . . . 1.52 113.041 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -70.11 -20.05 63.21 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.553 0.205 . . . . 5.9400000000000004 111.553 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.455 ' HB3' ' HB ' ' A' ' 145' ' ' THR . . . -66.25 -57.32 7.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.462 -0.336 . . . . 1.8300000000000001 111.851 -175.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -117.16 83.84 2.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.461 0.648 . . . . 2.6400000000000001 110.945 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.1 t -145.74 142.44 28.94 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.433 -0.803 . . . . 2.02 109.502 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.411 ' HB3' ' OE2' ' A' ' 153' ' ' GLU . 15.1 mtp180 -76.59 131.97 39.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.872 0.368 . . . . 3.6699999999999999 110.626 176.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.09 115.85 49.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.744 -0.662 . . . . 1.6399999999999999 109.499 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.411 ' OE2' ' HB3' ' A' ' 151' ' ' ARG . 17.8 mm-40 -113.03 129.1 56.62 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.08 -0.711 . . . . 2.5600000000000001 109.08 -177.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 174' ' ' LEU . 21.4 m -113.34 120.03 39.72 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 121.07 -0.252 . . . . 1.3899999999999999 110.745 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -116.45 122.13 43.88 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.741 -0.466 . . . . 2.04 109.741 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 55.3 m -119.58 128.22 53.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.182 -0.463 . . . . 1.5600000000000001 110.544 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -115.33 128.47 8.09 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.968 -0.56 . . . . 1.04 111.868 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 79.6 mt -118.27 134.66 54.84 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.634 -0.506 . . . . 2.27 109.634 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 63.1 tt0 -115.07 125.85 54.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.941 -0.392 . . . . 2.4100000000000001 109.941 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -130.3 133.79 46.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.252 -0.431 . . . . 4.5700000000000003 110.255 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.0 p -90.73 87.65 6.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.178 0.513 . . . . 1.46 109.617 171.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -60.33 -49.57 77.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.702 -0.681 . . . . 2.6299999999999999 111.367 -173.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.496 ' HB2' HG22 ' A' ' 166' ' ' VAL . 22.8 m120 -101.84 17.1 23.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.457 -0.338 . . . . 2.4100000000000001 110.499 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 72.4 -53.87 0.69 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 123.908 0.755 . . . . 2.5800000000000001 111.415 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.7 p -75.05 -15.96 60.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.348 -0.387 . . . . 2.2999999999999998 111.94 -176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.496 HG22 ' HB2' ' A' ' 163' ' ' ASN . 33.2 m -125.53 140.4 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.559 -0.291 . . . . 1.71 110.481 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.26 128.35 53.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.951 0.405 . . . . 1.47 110.48 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 22.1 mt -105.61 137.16 43.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.901 -0.591 . . . . 1.6599999999999999 109.476 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -110.64 116.12 30.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.961 0.41 . . . . 3.2999999999999998 110.264 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 63.0 t -124.01 129.87 74.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.886 -0.412 . . . . 1.3 109.886 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.411 ' OD1' ' HB2' ' A' ' 195' ' ' ARG . 25.9 p30 -134.09 156.09 48.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.875 0.369 . . . . 2.2200000000000002 110.969 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.495 ' HB2' HG21 ' A' ' 191' ' ' THR . 52.1 p90 -145.34 150.02 35.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.183 -0.462 . . . . 4.6100000000000003 111.017 -177.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -105.2 126.38 52.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.725 -0.671 . . . . 3.98 111.615 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.449 ' HB2' ' HB ' ' A' ' 154' ' ' THR . 93.3 mt -113.62 130.48 56.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.784 -0.644 . . . . 2.3799999999999999 110.151 175.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -100.39 128.87 46.35 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.272 -0.64 . . . . 3.3100000000000001 109.272 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -94.29 129.14 41.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.807 0.337 . . . . 6.5300000000000002 110.562 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -154.53 178.1 31.5 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.863 -0.895 . . . . 5.0599999999999996 110.863 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -69.24 -27.7 65.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.708 0.289 . . . . 7.3899999999999997 110.488 -177.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -60.12 -40.2 88.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 9.0700000000000003 110.832 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 59.8 ttm -70.13 -41.2 74.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.509 -0.314 . . . . 10.869999999999999 111.043 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.06 -39.66 75.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.262 -0.426 . . . . 10.449999999999999 111.95 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -74.14 -7.49 52.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.665 0.269 . . . . 13.06 111.692 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 68.4 m -69.53 124.88 25.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.153 0.502 . . . . 12.609999999999999 110.373 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -70.04 -35.29 74.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.521 -0.763 . . . . 15.19 109.314 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -79.85 134.42 36.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.359 -0.837 . . . . 13.18 109.356 176.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -142.05 149.7 40.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.663 -0.244 . . . . 12.73 110.525 -175.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 102.58 -51.28 0.88 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.948 -0.644 . . . . 9.9800000000000004 112.737 176.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -100.03 116.79 32.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.0 0.429 . . . . 10.699999999999999 110.599 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -159.87 159.97 33.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.493 -0.776 . . . . 10.5 108.945 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 28.9 p -125.04 155.43 39.75 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.949 0.404 . . . . 6.6399999999999997 111.436 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.495 HG21 ' HB2' ' A' ' 172' ' ' TYR . 19.2 m -106.91 124.93 50.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.794 -0.639 . . . . 4.9800000000000004 109.867 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -61.07 -49.78 75.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.578 -0.737 . . . . 7.0999999999999996 112.21 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -112.4 108.22 17.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.251 0.548 . . . . 4.4000000000000004 110.892 -174.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 82.2 mt -120.05 129.99 74.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.61 -0.723 . . . . 2.21 109.493 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.411 ' HB2' ' OD1' ' A' ' 171' ' ' ASN . 85.1 mtm180 -96.3 115.05 26.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.778 0.323 . . . . 3.54 110.6 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -108.39 124.02 49.73 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.599 -0.519 . . . . 1.6699999999999999 109.599 174.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -147.53 151.93 37.15 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.75 0.31 . . . . 5.8300000000000001 110.612 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 209' ' ' PRO . 1.8 pt? -129.66 128.37 23.03 Favored Pre-proline 0 C--N 1.321 -0.668 0 C-N-CA 120.98 -0.288 . . . . 2.5899999999999999 110.538 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.16 105.99 2.14 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.4 2.067 . . . . 1.77 111.427 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 56.9 tp -99.18 120.07 38.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.794 -0.639 . . . . 2.2599999999999998 109.512 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 19.6 p -99.95 123.93 44.73 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.943 0.401 . . . . 1.99 111.37 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 62.8 tp -130.29 81.84 2.03 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.032 -0.729 . . . . 2.3100000000000001 109.032 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 70.03 -125.2 15.29 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.409 -0.814 . . . . 1.51 112.283 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -86.82 -0.3 56.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.253 0.549 . . . . 2.5699999999999998 110.051 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -103.0 117.44 34.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.74 -0.664 . . . . 2.6600000000000001 110.112 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 63.3 m -107.9 123.75 49.08 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.779 -0.452 . . . . 1.6200000000000001 109.779 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 50.6 t -119.3 129.97 74.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 1.3799999999999999 109.854 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 25.3 m -126.62 91.29 47.73 Favored Pre-proline 0 C--N 1.318 -0.769 0 C-N-CA 120.965 -0.294 . . . . 1.1799999999999999 110.722 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 38.4 Cg_endo -70.8 146.33 53.49 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.128 1.885 . . . . 1.01 111.694 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -112.41 139.62 47.83 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.847 0.356 . . . . 4.5 110.344 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 21.1 p -134.58 125.25 26.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.762 -0.653 . . . . 1.8899999999999999 110.731 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -70.12 -36.12 74.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.255 -0.884 . . . . 4.7999999999999998 109.942 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 86.3 mt -119.91 120.35 62.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.399 -0.819 . . . . 4.5700000000000003 109.451 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -91.72 138.35 14.22 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.651 -0.785 . . . . 4.9800000000000004 112.804 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.0 mt -114.72 145.9 41.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.166 0.508 . . . . 8.1099999999999994 109.85 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.547 ' HB3' ' CD1' ' A' ' 218' ' ' TRP . 14.2 m-20 -60.2 -40.12 88.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.138 -0.937 . . . . 7.6500000000000004 112.024 -175.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 57.86 70.67 0.63 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.715 0.769 . . . . 10.529999999999999 111.729 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' TRP . . . . . 0.547 ' CD1' ' HB3' ' A' ' 216' ' ' ASP . 52.4 m95 -103.38 139.79 38.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.515 -0.766 . . . . 11.56 109.908 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.8 p -76.17 131.03 39.12 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.634 -0.506 . . . . 10.06 109.634 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -86.43 169.14 13.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 111.898 0.333 . . . . 11.92 111.898 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -59.91 -49.89 75.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.351 -0.386 . . . . 14.01 111.307 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -114.99 156.31 25.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.299 0.571 . . . . 14.529999999999999 110.971 -175.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -70.04 -21.14 63.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.228 -0.896 . . . . 16.609999999999999 111.729 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -69.98 -29.1 66.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.615 -0.266 . . . . 15.460000000000001 110.894 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -67.49 -39.96 85.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 15.67 111.452 -176.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.19 131.59 34.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.198 -0.456 . . . . 14.5 110.809 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 87.3 mt -93.86 109.37 21.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.151 0.501 . . . . 15.15 110.606 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -70.18 -39.49 75.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.478 -0.783 . . . . 14.73 110.42 175.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -63.16 139.93 58.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.163 -0.926 . . . . 16.379999999999999 112.007 -172.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -79.81 149.39 31.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.291 -0.868 . . . . 12.779999999999999 109.546 175.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -107.67 -150.45 16.01 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.616 -0.802 . . . . 11.1 111.139 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -70.07 -36.32 74.87 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.687 -0.486 . . . . 12.26 109.687 173.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 50.03 62.83 2.46 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 124.0 0.812 . . . . 9.9900000000000002 111.596 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -60.55 -40.06 90.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.948 -1.024 . . . . 10.43 111.186 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -79.85 119.7 23.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.037 -0.528 . . . . 6.29 110.697 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -100.24 137.26 38.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.529 -0.305 . . . . 8.1500000000000004 110.192 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.1 m -106.75 151.76 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.244 -0.435 . . . . 2.3999999999999999 111.061 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -92.3 146.19 18.06 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.898 -0.668 . . . . 1.27 111.999 -177.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 89.3 mt -119.47 131.3 55.58 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.306 0.574 . . . . 1.97 111.129 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.416 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 61.9 t80 -108.75 130.16 55.37 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.413 -0.812 . . . . 3.54 109.767 173.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.51 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 96.1 m-85 -119.67 140.05 51.26 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.498 -0.927 . . . . 2.6400000000000001 108.498 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.44 167.05 33.42 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.64 -1.267 . . . . 1.3500000000000001 112.945 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -121.5 112.24 18.26 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.695 -0.483 . . . . 4.3600000000000003 109.695 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -120.87 13.88 11.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.242 0.544 . . . . 4.29 109.815 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.96 -40.33 88.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.356 -0.838 . . . . 6.6900000000000004 110.391 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -102.88 135.85 43.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.629 -0.714 . . . . 6.3700000000000001 109.747 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -70.01 -19.08 63.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 5.8300000000000001 111.535 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -96.66 2.81 62.66 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.704 -0.76 . . . . 2.6600000000000001 112.718 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 62.8 tp -131.2 129.94 42.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.818 0.342 . . . . 2.9700000000000002 110.648 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 48.9 m -134.94 130.4 35.78 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.399 -0.593 . . . . 2.1699999999999999 109.399 173.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.5 t -130.02 133.1 64.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 120.837 -0.345 . . . . 1.79 110.906 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 11.1 p -115.92 109.99 18.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.119 0.485 . . . . 1.6299999999999999 110.857 176.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 79.3 mt -105.54 120.06 40.69 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.049 -0.723 . . . . 2.96 109.049 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -113.64 112.83 24.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.548 -0.296 . . . . 4.0800000000000001 111.173 -172.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -127.15 110.08 12.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.039 -0.528 . . . . 4.8399999999999999 109.76 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -70.19 -29.55 66.44 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.832 0.349 . . . . 3.5800000000000001 111.619 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -132.89 159.68 39.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.296 -0.411 . . . . 6.7699999999999996 109.962 -176.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -97.19 140.14 32.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.95 0.405 . . . . 8.5399999999999991 110.913 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -69.89 -26.4 64.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.647 -0.706 . . . . 11.9 110.382 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -60.09 -40.0 88.11 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.814 -0.63 . . . . 10.57 111.279 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -84.47 152.31 24.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.397 -0.365 . . . . 11.41 110.15 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -83.67 75.01 10.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.054 0.454 . . . . 11.98 110.053 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -70.18 156.17 39.6 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.189 -0.914 . . . . 12.460000000000001 109.797 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -88.4 -0.04 56.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.75 -0.205 . . . . 13.779999999999999 111.237 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -75.61 168.37 54.79 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.97 -0.634 . . . . 11.07 112.75 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ASP . . . . . 0.492 ' OD1' ' HD2' ' A' ' 269' ' ' LYS . 38.3 m-20 -70.08 130.84 43.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.802 0.334 . . . . 12.59 110.775 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 20.4 m -69.88 -22.64 63.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.849 -0.614 . . . . 10.92 111.121 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -99.82 10.54 41.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.098 -0.501 . . . . 12.42 111.324 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.492 ' HD2' ' OD1' ' A' ' 266' ' ' ASP . 94.5 mttt -131.21 160.01 36.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.922 -0.399 . . . . 11.59 109.922 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -107.46 97.23 7.0 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.054 -0.35 . . . . 8.8300000000000001 110.054 171.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -97.88 121.84 40.29 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.815 -0.809 . . . . 7.0199999999999996 108.815 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 60.72 40.08 16.68 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.212 0.529 . . . . 6.5999999999999996 111.169 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -140.28 130.12 24.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.606 -0.725 . . . . 1.9399999999999999 110.178 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -157.69 167.15 34.09 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.32 -0.943 . . . . 1.4199999999999999 112.399 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.452 HG12 HD22 ' A' ' 253' ' ' LEU . 34.7 m -128.9 140.01 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.94 0.4 . . . . 1.8100000000000001 111.133 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.92 140.01 11.41 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.321 -0.712 . . . . 1.3 111.321 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.4 t -128.01 129.94 69.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.908 0.354 . . . . 1.8300000000000001 110.884 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -126.42 130.56 50.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.026 -0.534 . . . . 2.3100000000000001 111.004 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -113.55 129.19 56.6 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.423 -0.584 . . . . 4.75 109.423 172.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 50.8 m -120.84 141.25 50.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.319 -0.4 . . . . 1.6699999999999999 110.485 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 91.0 m-85 . . . . . 0 C--O 1.247 0.96 0 CA-C-O 117.785 -1.103 . . . . 3.6899999999999999 109.584 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.6 mtp . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.432 0.158 . . . . 11.85 110.821 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 55.66 38.31 29.99 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.492 0.663 . . . . 10.35 111.687 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -90.56 0.03 57.5 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.224 -0.898 . . . . 9.3100000000000005 110.262 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -90.18 8.77 31.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.198 -0.91 . . . . 8.8399999999999999 110.669 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -99.56 119.14 37.58 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.508 -0.553 . . . . 7.0099999999999998 109.508 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -69.88 -39.68 76.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.187 0.518 . . . . 3.6099999999999999 110.009 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.452 ' HA ' ' HB2' ' A' ' 41' ' ' ASN . 44.6 m95 -62.72 139.98 58.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.291 -0.868 . . . . 3.3300000000000001 111.471 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.35 135.64 36.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.125 -0.489 . . . . 3.2000000000000002 110.0 175.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.92 139.94 51.65 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.854 -0.612 . . . . 2.4900000000000002 110.683 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -126.64 129.83 49.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.276 -0.42 . . . . 2.1299999999999999 110.468 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.6 mt -121.0 120.09 61.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.058 -0.719 . . . . 1.6000000000000001 109.058 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.3 129.36 9.44 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.23 -0.986 . . . . 0.88 111.475 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.1 134.83 54.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.162 0.506 . . . . 1.0800000000000001 110.636 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 68.0 mtt -126.63 141.38 51.87 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.566 -0.743 . . . . 2.3300000000000001 109.492 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -119.32 127.93 53.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.619 -0.264 . . . . 2.6099999999999999 110.586 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.514 ' HG2' ' HB1' ' A' ' 31' ' ' ALA . 34.9 mt-10 59.78 40.0 20.07 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.804 0.69 . . . . 5.0899999999999999 111.26 172.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.5 mm -107.27 116.22 50.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.383 -0.371 . . . . 5.3300000000000001 110.625 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -85.67 87.43 7.4 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.511 -0.551 . . . . 8.2799999999999994 109.511 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.418 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 91.0 m-20 -60.17 -39.65 87.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.355 -0.839 . . . . 9.6999999999999993 111.775 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.0 t -105.78 120.15 56.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.837 0.351 . . . . 11.09 110.232 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.17 133.19 51.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.868 -0.605 . . . . 13.1 109.988 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.63 19.41 26.17 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.881 -0.676 . . . . 11.94 112.052 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -60.16 -39.84 87.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.87 0.367 . . . . 15.18 110.389 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.34 -30.08 69.58 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.104 -0.569 . . . . 12.0 112.906 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -100.97 7.78 43.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.648 0.261 . . . . 12.82 111.443 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 56.12 39.94 30.26 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.919 -0.582 . . . . 10.81 111.605 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 93.9 mmm -127.76 130.07 48.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.09 -0.505 . . . . 10.050000000000001 111.022 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -155.8 168.37 27.42 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.419 -0.586 . . . . 8.0600000000000005 109.419 176.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.47 28.78 18.54 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.491 -0.862 . . . . 5.5800000000000001 112.257 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.1 mt -100.89 131.79 46.6 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.473 -0.565 . . . . 5.5599999999999996 109.473 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.514 ' HB1' ' HG2' ' A' ' 16' ' ' GLU . . . -146.9 123.5 11.12 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.857 -0.337 . . . . 3.0499999999999998 111.803 -176.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.408 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 12.9 pt-20 -149.07 156.08 40.29 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 116.298 -0.41 . . . . 3.48 110.559 175.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.2 135.87 15.6 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.883 2.389 . . . . 1.8600000000000001 111.211 170.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.1 t -140.45 149.88 43.12 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 121.097 -0.241 . . . . 1.97 110.848 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.2 m -126.56 139.93 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 1.71 110.824 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -119.75 147.04 45.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.989 -0.551 . . . . 4.0700000000000003 110.105 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -119.29 139.36 52.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.792 0.33 . . . . 2.8599999999999999 111.103 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -150.16 142.45 24.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.967 -0.56 . . . . 1.8899999999999999 110.266 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -148.29 143.73 27.13 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.959 -0.109 . . . . 1.0800000000000001 110.993 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.56 135.14 7.45 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.972 0.36 . . . . 1.3899999999999999 111.972 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.61 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 41.4 t30 -168.85 94.64 0.34 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.88 -0.6 . . . . 2.8599999999999999 110.096 170.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.85 -91.75 1.5 Allowed Glycine 0 CA--C 1.517 0.184 0 C-N-CA 120.901 -0.666 . . . . 1.6799999999999999 111.709 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 72.9 Cg_exo -50.44 176.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.608 2.872 . . . . 1.6599999999999999 113.456 169.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -67.1 170.8 6.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.621 -0.718 . . . . 3.3999999999999999 111.289 -171.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -113.11 130.03 56.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.8 -0.636 . . . . 3.1000000000000001 110.511 -173.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.5 tt -116.58 131.47 69.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.384 -0.825 . . . . 1.8 110.492 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -118.38 128.6 54.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.002 -0.544 . . . . 0.85999999999999999 110.697 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.8 tp -103.65 126.59 50.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.951 -0.568 . . . . 1.0600000000000001 110.242 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.0 168.39 19.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.098 0.475 . . . . 1.1399999999999999 110.928 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -164.31 160.01 20.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.867 -0.606 . . . . 4.0199999999999996 110.109 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.551 ' HB3' ' CG ' ' A' ' 69' ' ' ARG . 61.8 t80 -130.33 129.77 43.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.87 -0.419 . . . . 4.6100000000000003 109.87 177.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -130.85 159.74 36.49 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.972 -0.558 . . . . 3.3799999999999999 110.601 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -110.04 23.22 14.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.302 -0.863 . . . . 5.0499999999999998 109.174 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.1 112.37 0.83 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 110.643 -0.983 . . . . 4.3700000000000001 110.643 -171.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.408 ' HD3' ' CB ' ' A' ' 32' ' ' GLU . 48.6 Cg_endo -69.98 168.23 22.45 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.736 2.29 . . . . 6.6799999999999997 112.828 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.6 t -59.87 -40.11 81.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.022 0.439 . . . . 8.1699999999999999 110.558 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -61.14 -35.6 77.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.863 -0.608 . . . . 10.039999999999999 111.473 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -59.99 -40.64 89.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 11.609999999999999 112.283 -173.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 t -129.95 139.98 51.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.031 0.443 . . . . 9.7899999999999991 111.299 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.99 -0.14 57.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.005 -0.543 . . . . 8.5099999999999998 110.499 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.62 73.88 2.34 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.941 -0.647 . . . . 7.5599999999999996 112.11 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -89.95 -2.5 58.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.599 0.238 . . . . 10.0 111.112 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -90.22 -0.86 57.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.706 0.288 . . . . 10.35 111.197 -175.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.08 173.69 25.67 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.9 -0.667 . . . . 5.3399999999999999 111.982 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.5 m -92.61 116.66 29.21 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.077 -0.342 . . . . 5.3200000000000003 110.077 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -120.07 143.19 48.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.187 -0.46 . . . . 5.6100000000000003 110.095 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -116.69 140.04 49.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.243 0.544 . . . . 3.7799999999999998 110.464 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -139.72 170.42 15.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.533 -0.758 . . . . 2.4500000000000002 109.373 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.551 ' CG ' ' HB3' ' A' ' 51' ' ' TYR . 3.2 ptp180 -129.98 125.95 22.23 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 120.419 -0.512 . . . . 3.2400000000000002 111.161 175.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.4 140.03 5.24 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.918 2.412 . . . . 1.1899999999999999 110.835 167.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.486 ' CD ' ' HE ' ' A' ' 93' ' ' ARG . 76.7 mt-10 -126.87 130.0 49.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.738 -0.468 . . . . 2.1899999999999999 109.738 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 47' ' ' ALA . 57.8 tp -133.54 120.85 21.3 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.562 -0.29 . . . . 1.1399999999999999 110.339 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -119.49 130.02 55.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.994 0.426 . . . . 2.1800000000000002 110.267 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 89' ' ' THR . 62.1 t -120.0 129.52 75.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.931 -0.577 . . . . 1.5600000000000001 110.062 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -113.99 122.26 46.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.155 -0.475 . . . . 3.4399999999999999 111.169 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -108.38 146.22 33.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.642 -0.708 . . . . 4.7999999999999998 109.705 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -117.14 137.39 52.35 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.029 -0.36 . . . . 2.9399999999999999 110.029 173.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.617 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 93.2 m-85 -134.87 91.01 2.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.208 -0.451 . . . . 3.8999999999999999 110.422 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 78' ' ' PHE . 10.0 mt 170.02 130.02 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.786 1.234 . . . . 4.4800000000000004 109.354 171.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -98.72 15.06 26.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.759 0.314 . . . . 6.1900000000000004 111.54 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.418 ' ND2' ' HB2' ' A' ' 83' ' ' ASP . 58.8 t30 -118.74 137.51 53.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.894 0.378 . . . . 5.4500000000000002 110.524 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -70.2 -22.3 62.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.815 -0.63 . . . . 5.2699999999999996 112.302 -176.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.418 ' HB2' ' ND2' ' A' ' 81' ' ' ASN . 59.5 m-20 -62.37 -45.15 94.47 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.821 0.343 . . . . 6.3300000000000001 111.792 -176.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -139.97 147.81 41.02 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.613 -0.514 . . . . 7.4800000000000004 109.613 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.9 m -136.33 130.72 33.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.0 0.428 . . . . 2.5499999999999998 111.574 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -110.17 150.18 29.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.614 -0.884 . . . . 5.2999999999999998 108.614 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -150.14 169.69 30.17 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.724 -1.227 . . . . 1.3500000000000001 112.818 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 97.4 mt -131.43 122.47 26.32 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.405 -0.591 . . . . 2.29 109.405 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 92.9 m -120.11 129.98 54.42 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.001 0.429 . . . . 1.54 110.254 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -121.67 133.57 9.52 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.771 -0.728 . . . . 1.1699999999999999 111.484 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.58 130.66 8.76 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.655 -0.783 . . . . 1.1899999999999999 112.462 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 68.3 m-85 -112.01 127.24 55.82 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.768 -0.456 . . . . 3.75 109.768 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.486 ' HE ' ' CD ' ' A' ' 71' ' ' GLU . 40.1 ttm180 -142.71 124.87 15.38 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.561 -0.163 . . . . 2.75 110.561 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.507 ' OD1' ' HA ' ' A' ' 111' ' ' GLN . 93.5 m-20 -132.65 129.83 39.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.293 -0.262 . . . . 1.8200000000000001 110.293 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -126.69 135.39 51.08 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.306 -0.627 . . . . 3.1400000000000001 109.306 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -72.3 125.94 11.07 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.745 -0.74 . . . . 2.79 112.414 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.468 ' CE2' ' HD1' ' A' ' 99' ' ' TYR . 64.8 t80 -87.19 124.57 33.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.93 0.395 . . . . 7.6200000000000001 111.04 -177.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -150.03 79.94 1.37 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.602 -0.726 . . . . 7.0800000000000001 109.745 172.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.468 ' HD1' ' CE2' ' A' ' 97' ' ' TYR . 67.6 m-85 -120.56 139.95 52.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.376 -0.601 . . . . 10.16 109.376 174.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.3 m -96.46 -2.76 10.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 112.0 0.37 . . . . 9.8100000000000005 112.0 -172.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -70.19 -40.05 74.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.051 0.453 . . . . 12.220000000000001 110.342 176.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -98.68 113.4 64.32 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.936 -0.575 . . . . 10.48 110.347 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.0 138.86 75.82 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.487 2.125 . . . . 9.0999999999999996 111.939 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.91 -117.04 0.75 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.62 -0.8 . . . . 6.46 112.463 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -105.37 127.47 52.99 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.978 0.418 . . . . 7.6699999999999999 110.853 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.08 -39.83 87.45 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.288 -0.869 . . . . 4.1399999999999997 111.232 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.5 p -116.29 130.09 56.6 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.951 0.405 . . . . 3.2999999999999998 110.514 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.16 160.94 33.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.793 -0.639 . . . . 1.76 109.775 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -120.12 129.99 54.42 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.572 -0.529 . . . . 2.5499999999999998 109.572 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 89.0 mtp -104.52 129.44 52.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.742 0.306 . . . . 1.77 110.413 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.507 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 99.5 mt-30 -95.66 123.14 39.08 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.823 -0.626 . . . . 1.97 111.047 -176.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 85.7 mtt180 -116.29 114.3 24.17 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.659 -0.497 . . . . 3.8500000000000001 109.659 173.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.457 ' NE1' ' HB3' ' A' ' 111' ' ' GLN . 83.8 m95 -107.44 136.88 46.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.68 -0.691 . . . . 2.2799999999999998 110.86 -173.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -120.53 123.36 42.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.823 -0.626 . . . . 2.1400000000000001 110.196 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 134' ' ' SER . 88.2 mt -120.07 120.35 62.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.077 -0.712 . . . . 1.55 109.077 174.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -145.76 108.05 4.36 Favored Pre-proline 0 C--N 1.325 -0.488 0 C-N-CA 120.723 -0.391 . . . . 1.1899999999999999 111.814 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.675 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 69.3 Cg_endo -77.64 139.93 18.4 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.067 1.845 . . . . 1.3700000000000001 110.185 171.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.88 137.44 32.36 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.229 -0.442 . . . . 2.3500000000000001 110.045 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -127.16 127.54 44.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.302 -0.408 . . . . 4.54 109.968 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -126.82 109.59 12.16 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.347 -0.612 . . . . 3.04 109.347 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.7 t -120.58 117.62 53.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.128 -0.487 . . . . 4.2699999999999996 110.321 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -117.34 96.09 5.26 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.651 -0.499 . . . . 6.04 109.651 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.42 -39.95 85.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.647 -0.706 . . . . 4.5899999999999999 110.694 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.1 t -149.71 170.0 19.74 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.381 -0.827 . . . . 3.6899999999999999 108.865 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.98 -39.24 85.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.404 0.621 . . . . 5.1699999999999999 110.046 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.15 -31.11 68.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.627 -1.169 . . . . 3.71 111.57 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 159' ' ' GLN . 85.0 mt -119.98 119.79 34.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 2.0499999999999998 112.061 -171.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.478 ' HB2' ' HB3' ' A' ' 159' ' ' GLN . 89.8 mtt180 -111.6 109.61 19.6 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.855 -0.794 . . . . 4.2400000000000002 108.855 170.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -109.43 122.4 47.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.187 0.518 . . . . 3.5499999999999998 111.037 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -125.12 139.91 53.35 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.764 -0.653 . . . . 2.1099999999999999 109.522 173.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -147.65 133.6 4.77 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.576 -0.821 . . . . 1.1799999999999999 111.573 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 29.3 m-90 -120.03 127.61 52.75 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.936 0.398 . . . . 4.2999999999999998 111.062 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.675 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 58.2 tp -101.3 118.57 37.24 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.438 -0.949 . . . . 2.2400000000000002 108.438 173.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 42.9 m -120.49 130.01 54.1 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.036 0.446 . . . . 1.6899999999999999 111.177 -175.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.649 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 76.5 mtm -106.3 130.24 54.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.595 -0.729 . . . . 2.2400000000000002 109.394 173.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -120.07 139.9 51.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.35 -0.386 . . . . 3.5600000000000001 111.346 -175.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 96.7 mttt -129.55 160.04 34.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.71 -0.677 . . . . 1.6699999999999999 109.271 174.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.462 ' H ' HD22 ' A' ' 142' ' ' LEU . 53.0 p90 -143.96 160.07 41.47 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.487 -0.56 . . . . 3.23 109.487 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 63.56 -178.57 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.893 0.746 . . . . 1.24 111.504 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -74.99 -39.93 60.98 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.117 0.484 . . . . 2.4700000000000002 111.343 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -59.98 -41.93 93.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.529 -0.759 . . . . 2.4100000000000001 113.034 -168.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.462 HD22 ' H ' ' A' ' 138' ' ' PHE . 9.4 mp -69.98 -30.13 67.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.878 0.37 . . . . 1.8300000000000001 111.352 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -70.03 -40.07 75.4 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.805 -0.358 . . . . 2.0 110.101 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 33.7 p -73.48 -31.15 63.6 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.569 0.581 . . . . 2.0499999999999998 112.569 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 35.1 p -79.46 -10.03 59.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.898 0.38 . . . . 1.5900000000000001 111.412 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 91.14 -137.06 13.66 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.689 -0.767 . . . . 1.52 112.449 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -89.93 -1.27 57.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.842 0.353 . . . . 5.9400000000000004 110.379 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.56 -47.7 82.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.934 -0.576 . . . . 1.8300000000000001 111.153 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -108.43 81.96 1.55 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.073 0.463 . . . . 2.6400000000000001 110.477 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.5 t -149.5 150.01 31.64 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.2 -0.455 . . . . 2.02 109.996 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 135' ' ' MET . 42.8 mtt180 -80.84 134.89 35.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.355 -0.384 . . . . 3.6699999999999999 110.309 174.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.83 102.85 14.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.055 -0.72 . . . . 1.6399999999999999 109.055 173.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.596 ' OE1' ' HD3' ' A' ' 151' ' ' ARG . 83.9 mt-10 -124.74 141.51 52.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.112 -0.495 . . . . 2.5600000000000001 110.248 -174.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 174' ' ' LEU . 21.8 m -130.08 139.91 50.89 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 121.014 -0.274 . . . . 1.3899999999999999 110.844 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -119.85 131.44 55.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.18 -0.674 . . . . 2.04 109.18 171.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.2 p -117.82 121.12 39.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.224 -0.444 . . . . 1.5600000000000001 110.906 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -113.38 120.1 5.05 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.123 -0.791 . . . . 1.04 111.123 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 68.8 tp -123.5 129.44 51.23 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.966 0.412 . . . . 2.27 110.941 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 128' ' ' ARG . 53.4 tt0 -102.87 118.37 36.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.718 -0.845 . . . . 2.4100000000000001 108.718 171.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -122.26 137.52 54.81 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.915 0.388 . . . . 4.5700000000000003 110.039 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . 1.6 m -98.26 89.22 4.4 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.33 0.586 . . . . 1.46 109.835 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -67.58 -48.75 65.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.377 -0.828 . . . . 2.6299999999999999 112.218 -171.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.477 ' HB2' HG22 ' A' ' 166' ' ' VAL . 93.6 m-20 -99.9 8.98 43.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.424 -0.353 . . . . 2.4100000000000001 110.98 -175.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 73.6 -39.71 0.44 Allowed 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.865 0.728 . . . . 2.5800000000000001 110.727 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.4 p -75.32 -40.13 58.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.194 -0.457 . . . . 2.2999999999999998 111.235 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.477 HG22 ' HB2' ' A' ' 163' ' ' ASN . 31.3 m -120.17 144.48 28.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.115 0.483 . . . . 1.71 111.536 -175.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 161' ' ' THR . . . -119.98 139.47 52.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.463 -0.789 . . . . 1.47 110.591 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 159' ' ' GLN . 3.1 mm? -108.49 130.49 55.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.828 -0.624 . . . . 1.6599999999999999 109.648 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -101.77 113.0 25.79 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.598 -0.519 . . . . 3.2999999999999998 109.598 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 195' ' ' ARG . 63.1 t -120.13 129.8 75.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.338 -0.392 . . . . 1.3 111.257 -177.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -110.88 126.36 54.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.906 -0.588 . . . . 2.2200000000000002 110.065 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -119.2 140.06 50.83 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.813 -0.631 . . . . 4.6100000000000003 109.941 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -97.52 137.0 37.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.057 0.456 . . . . 3.98 111.032 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.494 ' HB2' ' HB ' ' A' ' 154' ' ' THR . 3.4 mm? -106.73 120.02 40.86 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.131 -0.692 . . . . 2.3799999999999999 109.131 173.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.61 -42.55 97.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.603 -0.726 . . . . 3.3100000000000001 110.352 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -133.93 127.84 33.28 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.136 -0.938 . . . . 6.5300000000000002 110.453 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -98.84 122.66 7.63 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.675 -0.774 . . . . 5.0599999999999996 111.882 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -147.66 149.61 32.8 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.857 0.36 . . . . 7.3899999999999997 110.401 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -100.28 16.55 23.96 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.257 -0.429 . . . . 9.0700000000000003 110.844 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.9 ttm -60.86 -40.11 91.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.798 -0.637 . . . . 10.869999999999999 110.577 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -119.14 121.73 40.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.019 -0.537 . . . . 10.449999999999999 109.964 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -70.02 -39.96 75.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.019 -0.537 . . . . 13.06 110.815 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.9 m -104.67 134.85 47.14 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.104 -0.498 . . . . 12.609999999999999 110.707 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 184' ' ' ARG . 50.4 mtm180 -76.5 144.19 39.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.069 -0.514 . . . . 15.19 110.346 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.422 ' ND2' ' HG3' ' A' ' 188' ' ' GLU . 37.6 t30 -99.53 119.91 38.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.078 0.466 . . . . 13.18 111.194 -177.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -72.91 -20.05 61.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.574 -0.739 . . . . 12.73 111.434 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.49 -31.6 68.19 Favored Glycine 0 C--N 1.329 0.141 0 C-N-CA 121.165 -0.541 . . . . 9.9800000000000004 113.545 -174.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.422 ' HG3' ' ND2' ' A' ' 185' ' ' ASN . 36.0 mt-10 -85.93 146.72 26.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.187 0.517 . . . . 10.699999999999999 111.501 -176.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -95.79 149.06 21.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.714 -0.675 . . . . 10.5 111.314 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.3 p -140.03 154.09 47.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.731 -0.668 . . . . 6.6399999999999997 110.016 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 25.6 p -98.89 2.76 46.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.126 0.488 . . . . 4.9800000000000004 110.639 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -69.0 142.15 54.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.414 -0.812 . . . . 7.0999999999999996 110.987 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -80.07 153.01 29.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.624 -0.716 . . . . 4.4000000000000004 111.902 -173.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 85.8 mt -119.98 120.54 63.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.226 -0.897 . . . . 2.21 109.831 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 72.3 mtm180 -102.86 120.15 40.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.752 -0.204 . . . . 3.54 110.745 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -117.26 128.7 55.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.657 0.265 . . . . 1.6699999999999999 110.498 175.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -150.05 159.95 44.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.152 -0.476 . . . . 5.8300000000000001 110.078 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.417 HD23 ' N ' ' A' ' 198' ' ' LEU . 1.8 pt? -147.05 128.5 7.3 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 110.233 -0.284 . . . . 2.5899999999999999 110.233 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.84 106.72 2.18 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.393 2.062 . . . . 1.77 111.89 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 62.6 tp -112.46 140.06 47.51 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.175 -0.676 . . . . 2.2599999999999998 109.175 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 28.6 p -119.97 140.43 50.94 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.466 -0.494 . . . . 1.99 111.658 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 58.9 tp -130.0 81.71 2.03 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.825 -0.806 . . . . 2.3100000000000001 108.825 176.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 75.72 -120.01 5.9 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.512 -0.767 . . . . 1.51 112.3 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -96.72 0.0 48.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.238 0.542 . . . . 2.5699999999999998 110.324 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -111.24 140.28 45.94 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.768 -0.651 . . . . 2.6600000000000001 109.367 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 19.6 p -114.77 151.74 33.26 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.528 -0.305 . . . . 1.6200000000000001 110.731 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 5.3 p -138.78 130.15 35.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.999 0.428 . . . . 1.3799999999999999 110.67 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 56.9 m -122.3 96.72 45.94 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 120.932 0.396 . . . . 1.1799999999999999 110.518 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -60.54 148.11 92.18 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.972 2.448 . . . . 1.01 112.62 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -119.9 139.95 51.62 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.357 -0.608 . . . . 4.5 109.357 174.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 236' ' ' ARG . 14.0 t -159.41 173.59 16.0 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.591 -0.522 . . . . 1.8899999999999999 109.591 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 212' ' ' ARG . 50.9 mtt180 -126.71 129.57 48.67 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.884 -0.413 . . . . 4.7999999999999998 109.884 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 16.0 tt -110.77 141.71 25.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.133 -0.485 . . . . 4.5700000000000003 110.355 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 86.55 15.93 62.94 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.034 -0.603 . . . . 4.9800000000000004 111.626 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 65.3 tp -116.5 117.97 31.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.874 0.369 . . . . 8.1099999999999994 110.645 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -99.97 120.0 39.13 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.282 -0.636 . . . . 7.6500000000000004 109.282 174.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -60.6 -40.94 93.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.776 -0.647 . . . . 10.529999999999999 111.24 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -119.34 140.07 50.93 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.806 -0.442 . . . . 11.56 109.806 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 50.4 m -131.47 146.88 52.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.201 -0.454 . . . . 10.06 110.475 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -70.56 -20.06 62.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.532 -0.758 . . . . 11.92 111.987 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.503 ' HB2' ' NE2' ' A' ' 224' ' ' GLN . 82.9 m95 -75.86 130.0 37.86 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.883 -0.414 . . . . 14.01 109.883 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -61.94 -40.03 94.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.199 -0.909 . . . . 14.529999999999999 112.645 -172.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 91.1 t90 -97.62 120.02 37.25 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.433 -0.507 . . . . 16.609999999999999 110.428 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.503 ' NE2' ' HB2' ' A' ' 221' ' ' TRP . 88.4 mm-40 -128.99 138.46 51.96 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.526 -0.761 . . . . 15.460000000000001 109.616 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -110.06 111.02 22.12 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.065 0.46 . . . . 15.67 109.928 177.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -146.56 165.73 28.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.538 -0.756 . . . . 14.5 109.562 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 86.7 mt -117.52 120.03 63.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.086 0.469 . . . . 15.15 110.84 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -110.5 137.92 47.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.748 -0.66 . . . . 14.73 109.366 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -108.86 167.08 10.34 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.263 -0.426 . . . . 16.379999999999999 110.134 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -67.9 -40.0 83.54 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.387 -0.597 . . . . 12.779999999999999 109.387 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.61 129.12 39.08 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.478 -0.783 . . . . 11.1 111.498 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -79.95 -8.65 59.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.63 0.252 . . . . 12.26 111.56 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -82.15 129.9 34.94 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.94 -0.393 . . . . 9.9900000000000002 109.94 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -136.64 159.79 40.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.611 -0.515 . . . . 10.43 109.611 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -105.11 32.48 4.18 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.47 -0.332 . . . . 6.29 111.261 -174.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 211' ' ' THR . 98.1 mtt180 -69.97 -39.98 75.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.443 -0.577 . . . . 8.1500000000000004 109.443 173.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 63.4 t -130.07 130.01 65.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.904 -1.044 . . . . 2.3999999999999999 108.686 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -150.25 166.45 30.05 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.005 -1.093 . . . . 1.27 112.098 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.4 mt -134.33 129.13 35.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.921 0.391 . . . . 1.97 110.749 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.496 ' HE2' ' OG ' ' A' ' 252' ' ' SER . 61.2 t80 -108.07 131.95 54.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.938 -0.574 . . . . 3.54 110.234 174.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -119.97 134.01 55.38 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.973 -0.38 . . . . 2.6400000000000001 109.973 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -110.13 121.76 6.09 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.754 -0.736 . . . . 1.3500000000000001 111.749 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' TYR . . . . . 0.441 ' CD1' HD12 ' A' ' 253' ' ' LEU . 91.9 m-85 -121.62 112.13 18.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.821 0.344 . . . . 4.3600000000000003 110.559 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -99.07 97.91 8.99 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.798 -0.445 . . . . 4.29 109.798 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -69.97 -37.0 75.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.015 -0.539 . . . . 6.6900000000000004 111.986 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 96.0 mt-30 -137.31 170.54 15.91 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.861 -0.422 . . . . 6.3700000000000001 109.861 -175.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -59.91 -40.17 87.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.159 0.504 . . . . 5.8300000000000001 111.003 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.19 10.9 51.44 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.742 -0.742 . . . . 2.6600000000000001 113.014 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 246' ' ' GLN . 58.5 tp -122.46 115.19 21.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.021 0.411 . . . . 2.9700000000000002 111.499 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 50.0 m -120.24 130.44 54.51 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.695 -0.684 . . . . 2.1699999999999999 109.814 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 99.2 t -113.26 132.14 62.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.189 0.519 . . . . 1.79 110.351 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.496 ' OG ' ' HE2' ' A' ' 240' ' ' PHE . 42.5 t -101.33 118.77 37.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.242 -0.89 . . . . 1.6299999999999999 110.196 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.441 HD12 ' CD1' ' A' ' 243' ' ' TYR . 84.2 mt -119.6 100.96 7.59 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.0 -0.37 . . . . 2.96 110.0 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -109.5 130.04 55.53 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.034 -0.358 . . . . 4.0800000000000001 110.034 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.0 129.04 56.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.312 -0.404 . . . . 4.8399999999999999 110.405 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -86.07 -32.32 21.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 3.5800000000000001 110.852 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -123.03 134.73 54.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.277 -0.42 . . . . 6.7699999999999996 110.407 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -84.67 138.65 32.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.085 -0.507 . . . . 8.5399999999999991 110.664 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' TRP . . . . . 0.437 ' CZ2' ' HB2' ' A' ' 266' ' ' ASP . 98.4 m95 -112.81 158.23 20.39 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.247 -0.433 . . . . 11.9 109.934 177.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -105.52 153.34 21.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.13 -0.486 . . . . 10.57 110.521 -173.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -68.26 -39.83 82.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.247 -0.433 . . . . 11.41 110.483 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -67.74 -47.93 67.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.001 -0.545 . . . . 11.98 110.473 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -114.71 103.94 11.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.915 0.388 . . . . 12.460000000000001 110.228 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -69.9 -38.58 76.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.708 -0.678 . . . . 13.779999999999999 111.097 -175.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 68.88 -128.54 23.41 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.888 -0.596 . . . . 11.07 112.672 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ASP . . . . . 0.437 ' HB2' ' CZ2' ' A' ' 259' ' ' TRP . 2.7 m-20 -78.94 130.62 35.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.851 0.358 . . . . 12.59 110.56 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 25.2 m -122.99 132.3 54.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.177 -0.465 . . . . 10.92 110.875 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 60.09 30.45 19.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.604 -0.726 . . . . 12.42 111.496 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -91.58 149.11 21.82 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.229 -0.656 . . . . 11.59 109.229 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -92.83 1.04 57.5 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 111.827 0.306 . . . . 8.8300000000000001 111.827 -171.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 59.8 m170 -93.59 -40.78 10.1 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.185 -0.606 . . . . 7.0199999999999996 112.288 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -79.46 -10.87 59.89 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.463 -0.495 . . . . 6.5999999999999996 111.389 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -133.52 159.97 38.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.427 -0.351 . . . . 1.9399999999999999 111.182 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.66 131.54 6.23 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.588 -1.005 . . . . 1.4199999999999999 110.588 174.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.03 128.51 75.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.116 0.484 . . . . 1.8100000000000001 111.207 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -132.75 138.33 10.06 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.337 -0.705 . . . . 1.3 111.337 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.0 t -116.36 120.69 65.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.618 -0.512 . . . . 1.8300000000000001 109.618 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -116.21 129.94 56.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.139 0.495 . . . . 2.3100000000000001 111.069 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.44 ' CE2' HD13 ' A' ' 249' ' ' LEU . 97.8 m-85 -109.35 111.58 23.23 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.548 -0.908 . . . . 4.75 108.548 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.9 t -132.0 139.97 48.78 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.517 -0.473 . . . . 1.6699999999999999 110.683 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 57.5 t80 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.085 -0.959 . . . . 3.6899999999999999 108.784 178.825 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mmm . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.845 0.355 . . . . 11.85 110.365 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -87.96 72.92 9.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.375 0.607 . . . . 10.35 109.597 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -119.98 144.06 47.7 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.39 -0.823 . . . . 9.3100000000000005 110.359 -173.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -103.89 140.02 38.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.164 -0.471 . . . . 8.8399999999999999 112.068 -174.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 59.5 55.1 4.27 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.166 -0.924 . . . . 7.0099999999999998 111.29 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -121.44 139.03 53.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.528 -0.76 . . . . 3.6099999999999999 109.12 175.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 41' ' ' ASN . 82.9 m95 -69.88 119.83 14.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.956 0.408 . . . . 3.3300000000000001 111.549 -173.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -100.99 125.05 47.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.806 -0.634 . . . . 3.2000000000000002 109.661 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -114.92 139.68 49.6 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.26 -0.427 . . . . 2.4900000000000002 110.0 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -126.48 130.5 50.75 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.386 -0.598 . . . . 2.1299999999999999 109.386 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.1 mt -127.89 129.97 69.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.273 -0.421 . . . . 1.6000000000000001 110.681 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.29 140.0 11.46 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.173 -0.771 . . . . 0.88 111.173 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.4 135.58 54.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.014 0.407 . . . . 1.0800000000000001 110.947 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 96.6 mmm -130.1 157.09 43.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.496 -0.774 . . . . 2.3300000000000001 109.702 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -114.56 142.22 46.71 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.436 0.636 . . . . 2.6099999999999999 110.374 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -59.83 -40.15 87.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.697 -1.138 . . . . 5.0899999999999999 111.754 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.433 ' HB ' ' HB2' ' A' ' 31' ' ' ALA . 48.1 mm -117.99 129.93 73.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.826 -0.435 . . . . 5.3300000000000001 109.826 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.548 ' OE2' ' HB3' ' A' ' 272' ' ' TYR . 98.6 mt-10 -65.73 138.01 57.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.087 0.47 . . . . 8.2799999999999994 111.152 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -83.69 139.82 32.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.551 -0.749 . . . . 9.6999999999999993 110.007 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.81 129.97 74.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.086 -0.506 . . . . 11.09 110.146 -177.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -76.8 106.57 8.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.231 0.538 . . . . 13.1 109.787 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.19 -162.52 9.49 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.519 -0.764 . . . . 11.94 111.284 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -106.7 10.16 31.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.893 0.346 . . . . 15.18 110.744 -176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.23 -168.54 18.54 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.716 -0.754 . . . . 12.0 112.581 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -133.69 159.55 40.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.244 -0.28 . . . . 12.82 110.244 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -119.75 129.05 54.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.423 -0.353 . . . . 10.81 110.317 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.632 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 67.3 mtt -68.05 -31.41 71.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.209 0.528 . . . . 10.050000000000001 110.121 176.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -70.17 -14.59 62.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.531 -0.759 . . . . 8.0600000000000005 110.994 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.93 19.33 42.51 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.053 -0.594 . . . . 5.5800000000000001 113.452 -175.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 27' ' ' MET . 90.4 mt -61.79 137.36 58.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 117.084 0.442 . . . . 5.5599999999999996 109.855 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.433 ' HB2' ' HB ' ' A' ' 17' ' ' ILE . . . -142.98 149.17 37.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.874 0.368 . . . . 3.0499999999999998 111.861 -174.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -99.63 129.99 27.68 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.863 -0.608 . . . . 3.48 110.012 172.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.73 142.09 47.12 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.153 1.902 . . . . 1.8600000000000001 111.58 173.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.3 t -119.97 143.49 47.99 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.618 -0.512 . . . . 1.97 109.618 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.34 133.73 61.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.392 0.615 . . . . 1.71 111.453 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -111.64 126.2 54.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.275 -0.875 . . . . 4.0700000000000003 108.711 174.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -133.51 130.08 38.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.568 0.223 . . . . 2.8599999999999999 111.212 -174.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 9.9 p30 -145.59 156.48 43.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.513 -0.312 . . . . 1.8899999999999999 110.584 173.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 45' ' ' ARG . . . -137.01 143.94 43.01 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.966 -0.561 . . . . 1.0800000000000001 110.678 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.98 136.2 33.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.832 -0.622 . . . . 1.3899999999999999 110.766 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.613 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 40.8 t30 -165.95 95.37 0.59 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.023 -0.535 . . . . 2.8599999999999999 109.708 176.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.57 -98.62 1.41 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.051 -0.595 . . . . 1.6799999999999999 111.818 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 85.7 Cg_exo -45.12 175.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 124.12 3.213 . . . . 1.6599999999999999 114.078 168.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.561 ' HB2' ' O ' ' A' ' 75' ' ' HIS . 41.3 p90 -68.46 171.93 6.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.152 -0.931 . . . . 3.3999999999999999 112.054 -169.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 39' ' ' ALA . 57.7 ttp180 -113.1 133.32 55.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.839 -0.618 . . . . 3.1000000000000001 111.117 -168.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.2 mt -119.66 129.97 74.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.224 -0.898 . . . . 1.8 110.387 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . . . -118.09 144.42 45.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.012 -0.54 . . . . 0.85999999999999999 111.169 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.0 tp -133.41 134.91 44.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.248 -0.433 . . . . 1.0600000000000001 110.814 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.34 167.48 24.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.8 -0.636 . . . . 1.1399999999999999 109.4 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -134.04 148.71 51.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.339 . . . . 4.0199999999999996 111.639 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -132.1 149.94 52.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.834 -0.621 . . . . 4.6100000000000003 110.014 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -120.49 139.97 52.11 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.212 -0.292 . . . . 3.3799999999999999 110.212 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 67' ' ' PHE . 49.6 mt-10 -122.48 140.0 53.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.754 0.311 . . . . 5.0499999999999998 111.793 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.17 -177.79 10.65 Favored Glycine 0 C--N 1.331 0.268 0 CA-C-N 115.795 -0.638 . . . . 4.3700000000000001 113.822 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -70.07 138.52 37.03 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.884 2.389 . . . . 6.6799999999999997 111.357 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.03 159.83 41.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.299 -0.41 . . . . 8.1699999999999999 110.985 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -93.95 113.0 24.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.145 -0.48 . . . . 10.039999999999999 110.162 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -60.64 -42.54 97.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.323 -0.399 . . . . 11.609999999999999 111.105 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.0 m -62.82 138.69 58.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.242 -0.435 . . . . 9.7899999999999991 110.481 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.68 61.15 4.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.229 0.538 . . . . 8.5099999999999998 110.221 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.24 156.11 20.35 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.887 -0.673 . . . . 7.5599999999999996 112.134 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -70.11 -26.17 63.84 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.683 0.253 . . . . 10.0 111.683 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -89.92 0.01 57.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.912 0.387 . . . . 10.35 110.407 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.45 142.43 37.14 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.773 -0.649 . . . . 5.3399999999999999 111.865 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.4 m -118.36 129.98 55.74 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.025 0.44 . . . . 5.3200000000000003 110.212 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -129.44 136.15 49.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.029 -0.532 . . . . 5.6100000000000003 110.18 -176.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.574 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 93.8 m-85 -122.46 125.29 45.51 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.896 -0.779 . . . . 3.7799999999999998 108.896 174.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -156.41 160.41 39.59 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.077 0.465 . . . . 2.4500000000000002 110.907 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 94' ' ' ASN . 27.6 mtm180 -140.71 125.27 10.75 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 115.355 -0.839 . . . . 3.2400000000000002 110.565 175.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.63 140.18 11.65 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.848 2.365 . . . . 1.1899999999999999 112.096 174.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -106.06 120.09 40.88 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.858 -0.793 . . . . 2.1899999999999999 108.858 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.0 tp -128.03 106.67 9.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.848 0.356 . . . . 1.1399999999999999 110.363 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 46.5 mt-10 -101.61 128.68 47.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.144 -0.48 . . . . 2.1800000000000002 110.284 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.8 t -120.03 120.01 61.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.306 -0.627 . . . . 1.5600000000000001 109.306 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.561 ' O ' ' HB2' ' A' ' 44' ' ' TRP . 80.1 t60 -119.59 118.22 30.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.118 0.485 . . . . 3.4399999999999999 110.253 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -117.62 138.54 51.89 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.186 -0.916 . . . . 4.7999999999999998 109.9 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -130.09 149.17 51.92 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.855 -0.424 . . . . 2.9399999999999999 109.855 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -137.11 132.68 34.42 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.614 -0.513 . . . . 3.8999999999999999 109.614 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.3 mt -107.54 118.63 37.24 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.416 -0.356 . . . . 4.4800000000000004 110.49 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -96.54 174.62 6.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.23 -0.441 . . . . 6.1900000000000004 110.813 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -69.85 -19.45 63.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.012 -0.54 . . . . 5.4500000000000002 110.284 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -74.33 158.41 34.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.747 -0.661 . . . . 5.2699999999999996 110.303 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -60.13 -40.4 89.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.421 -0.354 . . . . 6.3300000000000001 111.863 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -74.18 149.35 40.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.222 0.534 . . . . 7.4800000000000004 111.47 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.2 p -114.96 150.17 36.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.841 -0.618 . . . . 2.5499999999999998 110.552 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -135.84 160.06 39.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.318 -0.401 . . . . 5.2999999999999998 110.357 -175.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.97 176.88 41.87 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.393 -0.908 . . . . 1.3500000000000001 112.587 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.12 125.21 27.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.785 -0.45 . . . . 2.29 109.785 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.9 m -120.11 129.95 54.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.157 0.503 . . . . 1.54 110.183 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -131.59 146.76 18.24 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.556 -0.831 . . . . 1.1699999999999999 112.577 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -123.92 122.2 4.75 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.908 -0.877 . . . . 1.1899999999999999 110.908 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -111.54 122.22 47.24 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.234 -0.654 . . . . 3.75 109.234 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.614 ' HB2' ' HB2' ' A' ' 112' ' ' ARG . 97.8 mtt180 -134.97 137.36 42.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.914 0.388 . . . . 2.75 110.907 -173.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.593 ' O ' ' HG2' ' A' ' 69' ' ' ARG . 92.6 m-20 -114.51 130.13 56.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.071 -0.513 . . . . 1.8200000000000001 109.972 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.532 ' HA ' ' HG2' ' A' ' 69' ' ' ARG . 58.8 t80 -106.93 119.94 40.7 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.848 -0.427 . . . . 3.1400000000000001 109.848 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.95 178.59 51.75 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.55 -0.833 . . . . 2.79 112.243 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.732 ' O ' ' HB ' ' A' ' 107' ' ' THR . 58.3 t80 -139.96 146.41 39.1 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.333 -0.618 . . . . 7.6200000000000001 109.333 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.406 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 5.7 p80 -139.97 152.3 46.21 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.208 -0.293 . . . . 7.0800000000000001 110.208 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -101.63 120.09 39.79 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.733 -0.469 . . . . 10.16 109.733 176.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 88.2 t -70.13 -40.85 78.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.43 -0.805 . . . . 9.8100000000000005 110.696 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -70.07 -39.9 75.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.749 -0.659 . . . . 12.220000000000001 111.65 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -109.97 109.4 59.17 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.17 -0.468 . . . . 10.48 110.996 -174.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.89 149.92 66.75 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.791 2.328 . . . . 9.0999999999999996 112.732 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.2 150.86 5.94 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.049 -0.596 . . . . 6.46 112.145 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -90.05 1.94 55.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.699 0.285 . . . . 7.6699999999999999 111.029 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -60.19 -39.94 88.27 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.281 0.562 . . . . 4.1399999999999997 109.897 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.732 ' HB ' ' O ' ' A' ' 97' ' ' TYR . 32.9 p -105.66 145.96 30.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.488 -0.778 . . . . 3.2999999999999998 109.991 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.41 148.56 47.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.583 0.23 . . . . 1.76 110.676 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -132.58 135.74 46.11 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.368 0.604 . . . . 2.5499999999999998 111.077 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.487 ' HB2' ' HB3' ' A' ' 95' ' ' TYR . 89.7 mtp -136.55 141.45 43.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.784 -1.191 . . . . 1.77 107.784 175.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 16.2 mm100 -108.95 139.97 43.08 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.022 -0.671 . . . . 1.97 111.546 -172.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.614 ' HB2' ' HB2' ' A' ' 93' ' ' ARG . 76.2 mtt180 -120.37 128.95 53.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.004 -0.544 . . . . 3.8500000000000001 109.864 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -127.72 133.03 49.54 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.004 -0.544 . . . . 2.2799999999999998 110.849 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -121.55 125.22 46.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.958 -0.565 . . . . 2.1400000000000001 109.947 171.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 86.6 mt -120.08 124.0 71.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.978 -0.556 . . . . 1.55 109.612 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -147.05 105.24 3.86 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.617 0.246 . . . . 1.1899999999999999 111.121 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.98 139.95 13.97 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.38 2.053 . . . . 1.3700000000000001 110.922 175.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.51 137.19 33.48 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.285 -0.416 . . . . 2.3500000000000001 109.916 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -130.88 129.79 42.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.445 -0.343 . . . . 4.54 110.493 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -94.28 113.87 25.85 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.17 -0.678 . . . . 3.04 109.17 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.6 t -120.08 119.99 61.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.778 -0.453 . . . . 4.2699999999999996 109.778 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 128' ' ' ARG . 36.4 mtmm -126.84 118.78 25.31 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.745 -0.465 . . . . 6.04 109.745 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.3 tp -90.15 -79.01 0.35 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 4.5899999999999999 110.79 -174.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 47.4 p -142.67 171.77 13.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.371 -0.377 . . . . 3.6899999999999999 110.662 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 62.37 26.27 15.69 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 124.057 0.848 . . . . 5.1699999999999999 112.071 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 57.82 33.54 23.34 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.046 -0.525 . . . . 3.71 110.692 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.1 mt -98.99 130.0 45.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.058 -0.519 . . . . 2.0499999999999998 109.983 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.522 ' HA ' ' HG2' ' A' ' 122' ' ' LYS . 47.9 ttt180 -105.07 127.83 53.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.207 0.527 . . . . 4.2400000000000002 111.02 -174.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.451 ' CE2' HD13 ' A' ' 158' ' ' LEU . 96.7 m-85 -108.18 129.09 55.2 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.521 -0.918 . . . . 3.5499999999999998 108.521 174.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -111.65 113.9 26.58 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.756 -0.831 . . . . 2.1099999999999999 108.756 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -123.1 137.72 11.26 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.204 -0.998 . . . . 1.1799999999999999 111.908 -175.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.526 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 8.8 p90 -134.45 140.91 46.58 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.115 0.484 . . . . 4.2999999999999998 110.315 177.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 64.3 tp -99.96 111.14 23.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.596 -0.729 . . . . 2.2400000000000002 109.258 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.8 m -100.83 118.0 36.04 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.306 0.574 . . . . 1.6899999999999999 111.121 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 87.1 mtp -101.09 125.39 47.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.195 -0.911 . . . . 2.2400000000000002 109.26 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 95.5 m-85 -109.94 127.59 54.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.93 0.395 . . . . 3.5600000000000001 110.988 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -129.9 144.62 51.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.787 -0.642 . . . . 1.6699999999999999 109.986 174.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.444 ' H ' HD22 ' A' ' 142' ' ' LEU . 46.9 p90 -148.01 165.52 30.49 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.063 -0.717 . . . . 3.23 109.063 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 110' ' ' MET . . . 64.42 170.09 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.673 0.608 . . . . 1.24 110.733 -174.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -76.05 -20.1 58.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.457 0.646 . . . . 2.4700000000000002 109.572 173.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -66.65 -49.53 65.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.022 -0.99 . . . . 2.4100000000000001 111.997 -175.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.464 ' HA ' ' OG1' ' A' ' 145' ' ' THR . 10.0 mp -68.38 -30.32 69.22 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.888 0.375 . . . . 1.8300000000000001 111.458 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -60.55 -40.21 90.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.394 0.616 . . . . 2.0 109.884 171.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 57.6 m -69.97 -40.38 75.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.956 -1.02 . . . . 2.0499999999999998 111.366 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.464 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 40.8 p -69.99 -36.57 75.26 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.959 0.409 . . . . 1.5900000000000001 110.632 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 62.19 -114.66 7.02 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.484 -0.78 . . . . 1.52 113.044 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -70.07 -31.3 68.82 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.549 0.34 . . . . 5.9400000000000004 111.149 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.9 -48.93 79.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.318 0.488 . . . . 1.8300000000000001 112.318 -172.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.415 ' OD2' ' HG3' ' A' ' 180' ' ' MET . 17.5 t70 -138.98 111.72 7.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.132 0.491 . . . . 2.6400000000000001 110.738 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.3 t -160.01 149.66 18.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.341 -0.845 . . . . 2.02 109.102 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.499 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 67.5 ttt180 -79.55 125.24 29.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.778 0.323 . . . . 3.6699999999999999 110.26 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.461 ' CG1' HD11 ' A' ' 133' ' ' LEU . 62.1 t -119.92 120.1 62.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.928 -0.578 . . . . 1.6399999999999999 110.082 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -140.06 141.19 36.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.183 -0.303 . . . . 2.5600000000000001 110.183 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 m -115.24 128.39 56.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.683 0.278 . . . . 1.3899999999999999 110.766 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.526 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 83.3 tt0 -108.68 130.7 55.34 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.786 -0.45 . . . . 2.04 109.786 176.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 44.0 m -118.1 121.11 39.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.283 -0.417 . . . . 1.5600000000000001 110.18 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -111.02 118.12 4.79 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.938 -0.649 . . . . 1.04 111.903 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.451 HD13 ' CE2' ' A' ' 129' ' ' PHE . 41.5 tp -95.37 128.36 42.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.889 0.376 . . . . 2.27 110.68 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -101.8 108.98 20.64 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.276 -0.638 . . . . 2.4100000000000001 109.276 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -120.2 126.67 51.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.459 -0.791 . . . . 4.5700000000000003 109.244 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.1 p -99.21 88.81 4.03 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.279 -0.569 . . . . 1.46 110.225 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -60.24 -49.67 76.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.412 -0.813 . . . . 2.6299999999999999 111.292 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.503 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.0 m-20 -103.01 15.82 28.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.456 -0.338 . . . . 2.4100000000000001 110.824 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 72.52 -53.83 0.69 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.888 0.743 . . . . 2.5800000000000001 111.617 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.6 p -74.38 -18.77 60.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.372 -0.377 . . . . 2.2999999999999998 111.496 -177.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 163' ' ' ASN . 35.7 m -110.6 136.93 45.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.373 -0.376 . . . . 1.71 110.3 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.57 123.62 48.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.062 -0.517 . . . . 1.47 109.788 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 35.7 mt -102.48 127.43 49.53 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.265 -0.643 . . . . 1.6599999999999999 109.265 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -99.99 108.83 21.13 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.723 -0.473 . . . . 3.2999999999999998 109.723 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 195' ' ' ARG . 50.2 t -109.98 119.7 59.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.32 -0.622 . . . . 1.3 109.32 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.448 ' HB2' ' HD3' ' A' ' 195' ' ' ARG . 15.5 m120 -109.81 131.55 54.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.012 0.434 . . . . 2.2200000000000002 110.879 -172.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -119.88 139.6 52.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.88 -0.6 . . . . 4.6100000000000003 109.683 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -106.37 122.69 46.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.672 0.272 . . . . 3.98 110.387 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 55.7 tp -108.63 114.92 29.13 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.172 -0.467 . . . . 2.3799999999999999 109.963 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -108.59 138.52 44.77 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.013 -0.54 . . . . 3.3100000000000001 110.007 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -105.47 127.83 53.22 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.626 -0.509 . . . . 6.5300000000000002 109.626 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -70.13 153.17 51.8 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.086 -0.578 . . . . 5.0599999999999996 112.519 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.9 139.96 51.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.576 0.227 . . . . 7.3899999999999997 110.611 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -96.54 5.44 50.77 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.162 -0.472 . . . . 9.0700000000000003 110.727 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.415 ' HG3' ' OD2' ' A' ' 149' ' ' ASP . 98.1 mmm -68.66 -40.11 80.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.999 -0.546 . . . . 10.869999999999999 110.104 176.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -149.14 166.59 28.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.397 -0.82 . . . . 10.449999999999999 108.946 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -67.65 129.6 40.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.035 0.445 . . . . 13.06 111.29 -173.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 59.9 m -85.76 117.47 24.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.874 -0.603 . . . . 12.609999999999999 111.516 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -70.21 -39.9 74.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.001 -0.545 . . . . 15.19 111.884 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -76.79 -28.97 55.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.961 0.41 . . . . 13.18 111.406 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.442 ' HA ' ' OG ' ' A' ' 190' ' ' SER . 36.0 m-80 -103.3 120.47 40.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.099 -0.501 . . . . 12.73 111.188 -173.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -131.64 -140.69 4.6 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.424 -0.67 . . . . 9.9800000000000004 111.424 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -69.77 -40.21 76.2 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.493 -0.558 . . . . 10.699999999999999 109.493 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -140.0 132.03 27.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.334 -0.848 . . . . 10.5 109.376 173.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.442 ' OG ' ' HA ' ' A' ' 186' ' ' ASN . 70.6 m -119.36 156.78 29.44 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.897 0.379 . . . . 6.6399999999999997 110.321 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.1 t -128.26 161.48 29.26 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.949 0.404 . . . . 4.9800000000000004 110.293 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -128.29 144.11 51.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.807 -0.633 . . . . 7.0999999999999996 109.72 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.89 146.54 23.67 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.42 -0.355 . . . . 4.4000000000000004 110.044 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 88.0 mt -100.62 120.04 49.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.986 0.422 . . . . 2.21 110.384 -176.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.448 ' HD3' ' HB2' ' A' ' 171' ' ' ASN . 31.4 ttt180 -98.93 119.37 37.59 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.692 -0.686 . . . . 3.54 110.754 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -119.6 123.46 43.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.916 0.389 . . . . 1.6699999999999999 110.72 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -130.86 118.75 21.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.615 -0.721 . . . . 5.8300000000000001 109.751 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 1.3 pt? -136.83 126.82 15.9 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.753 -0.379 . . . . 2.5899999999999999 111.103 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 198' ' ' LEU . 27.7 Cg_endo -94.49 117.44 0.25 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.965 2.443 . . . . 1.77 112.499 175.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 50.8 tp -104.31 116.41 32.1 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.19 -0.67 . . . . 2.2599999999999998 109.19 176.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 96.7 m -99.58 120.07 39.07 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.167 0.508 . . . . 1.99 110.881 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 89.7 mt -114.56 80.38 1.39 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.948 -0.76 . . . . 2.3100000000000001 108.948 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 72.59 -112.85 4.15 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.151 -0.931 . . . . 1.51 112.228 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -100.09 10.35 41.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.11 0.481 . . . . 2.5699999999999998 110.948 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -134.42 117.71 16.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.195 -0.457 . . . . 2.6600000000000001 109.864 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 74.3 m -102.66 134.19 46.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.197 0.522 . . . . 1.6200000000000001 111.227 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 59.1 t -115.45 122.67 69.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.575 -0.739 . . . . 1.3799999999999999 109.239 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 23.5 m -118.3 94.28 46.68 Favored Pre-proline 0 C--N 1.318 -0.767 0 C-N-CA 121.031 -0.268 . . . . 1.1799999999999999 111.37 -176.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 15.6 Cg_exo -69.41 139.97 42.8 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.902 2.401 . . . . 1.01 111.795 173.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.63 ' OH ' ' HB2' ' A' ' 258' ' ' GLU . 64.9 t80 -137.68 140.23 40.68 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.074 -0.512 . . . . 4.5 110.408 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 28.7 p -135.34 147.73 49.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.268 -0.424 . . . . 1.8899999999999999 110.866 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -102.42 -0.03 33.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.437 0.637 . . . . 4.7999999999999998 109.995 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 48.5 mm -110.05 130.01 64.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.452 -0.795 . . . . 4.5700000000000003 109.505 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -73.37 129.36 12.32 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.779 -0.725 . . . . 4.9800000000000004 112.743 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.31 -40.35 89.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.899 0.38 . . . . 8.1099999999999994 111.0 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -70.06 -20.5 63.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 7.6500000000000004 111.603 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -69.03 -39.36 79.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.053 -0.521 . . . . 10.529999999999999 111.887 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -115.99 132.89 56.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.811 0.339 . . . . 11.56 111.175 -176.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 17.0 m -100.37 132.06 45.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.11 -0.495 . . . . 10.06 111.101 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -110.65 109.64 19.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.078 0.466 . . . . 11.92 109.857 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -70.48 -39.84 73.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.404 -0.817 . . . . 14.01 112.022 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -89.9 138.9 31.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.991 0.424 . . . . 14.529999999999999 110.344 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -105.96 -18.41 14.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.931 -0.577 . . . . 16.609999999999999 110.48 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -60.13 -49.01 79.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.269 0.557 . . . . 15.460000000000001 110.092 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -154.62 161.02 41.78 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.361 -0.977 . . . . 15.67 108.361 174.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -145.69 179.6 7.33 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.742 -0.383 . . . . 14.5 111.325 -176.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 8.3 tp -60.2 -40.03 82.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.212 -0.449 . . . . 15.15 112.106 -174.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -67.66 -31.81 72.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.857 0.36 . . . . 14.73 110.695 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -59.97 -39.6 86.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.156 -0.475 . . . . 16.379999999999999 111.043 -176.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -68.65 129.65 40.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.399 -0.364 . . . . 12.779999999999999 110.949 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 164.8 -171.17 40.16 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.346 -0.701 . . . . 11.1 111.346 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -92.67 -13.87 28.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.448 0.642 . . . . 12.26 109.783 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.595 ' H ' ' HD2' ' A' ' 236' ' ' ARG . 97.0 m-20 56.62 37.29 28.7 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.418 -1.264 . . . . 9.9900000000000002 112.502 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -109.48 97.69 7.22 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.741 -0.466 . . . . 10.43 109.741 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.7 39.91 30.85 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.339 -0.846 . . . . 6.29 111.666 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.595 ' HD2' ' H ' ' A' ' 233' ' ' ASP . 83.6 mtp180 -69.85 -39.98 76.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.594 -0.73 . . . . 8.1500000000000004 110.798 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.3 m -115.09 154.32 16.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.354 -0.839 . . . . 2.3999999999999999 109.434 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -78.14 137.61 20.1 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.418 -0.896 . . . . 1.27 111.283 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 94.5 mt -134.45 124.47 25.67 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.759 -0.46 . . . . 1.97 109.759 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.509 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 64.5 t80 -118.52 118.4 31.59 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.158 -0.682 . . . . 3.54 109.158 175.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.422 ' HB2' ' HB3' ' A' ' 253' ' ' LEU . 92.9 m-85 -104.79 129.72 53.01 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.127 -0.488 . . . . 2.6400000000000001 110.379 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -114.45 143.34 17.99 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 115.576 -0.738 . . . . 1.3500000000000001 111.533 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -107.28 112.35 25.16 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.484 -0.562 . . . . 4.3600000000000003 109.484 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -105.42 28.4 7.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.337 -0.847 . . . . 4.29 110.31 -172.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -59.89 -40.12 87.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.013 -0.994 . . . . 6.6900000000000004 110.741 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLN . . . . . 0.44 ' OE1' ' HB3' ' A' ' 249' ' ' LEU . 62.4 tt0 -133.05 133.79 43.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.948 -0.569 . . . . 6.3700000000000001 110.358 -176.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -63.38 -39.86 95.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.788 -0.642 . . . . 5.8300000000000001 110.595 176.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -68.19 -50.07 42.02 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.539 -0.839 . . . . 2.6600000000000001 112.535 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.44 ' HB3' ' OE1' ' A' ' 246' ' ' GLN . 59.1 tp -118.51 124.15 46.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.94 0.4 . . . . 2.9700000000000002 111.046 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 46.9 p -126.78 148.21 49.94 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.91 -0.587 . . . . 2.1699999999999999 110.082 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 57.7 t -116.43 137.67 49.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.434 -0.348 . . . . 1.79 110.3 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 43.4 m -111.76 139.76 46.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.327 -0.397 . . . . 1.6299999999999999 110.628 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.427 ' HG ' ' HG3' ' A' ' 254' ' ' GLU . 59.3 tp -132.65 143.42 49.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.544 -0.298 . . . . 2.96 111.31 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.427 ' HG3' ' HG ' ' A' ' 253' ' ' LEU . 43.9 mt-10 60.34 -159.99 0.3 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.886 0.741 . . . . 4.0800000000000001 111.108 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -144.47 137.05 26.66 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.05 0.453 . . . . 4.8399999999999999 111.529 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.505 ' HB1' ' HB2' ' A' ' 210' ' ' TYR . . . -123.67 44.25 2.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.637 -0.71 . . . . 3.5800000000000001 109.221 172.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -120.02 140.59 50.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.558 -0.747 . . . . 6.7699999999999996 110.669 -175.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.63 ' HB2' ' OH ' ' A' ' 210' ' ' TYR . 82.0 tt0 -60.12 -49.94 75.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.167 -0.924 . . . . 8.5399999999999991 110.862 175.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 55.4 p-90 -140.78 159.78 41.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.009 -0.996 . . . . 11.9 109.973 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -98.29 147.46 24.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.179 -0.464 . . . . 10.57 110.383 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -74.6 53.23 0.54 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.335 0.588 . . . . 11.41 110.792 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -136.45 148.16 47.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.762 -0.653 . . . . 11.98 109.738 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.2 -25.32 63.36 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.179 -0.464 . . . . 12.460000000000001 110.971 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -89.92 70.01 7.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.14 0.495 . . . . 13.779999999999999 109.737 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -165.27 43.29 0.29 Allowed Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.249 -0.887 . . . . 11.07 111.031 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -59.89 -40.1 87.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.186 0.517 . . . . 12.59 110.5 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' SER . . . . . 0.408 ' HB3' ' HG3' ' A' ' 269' ' ' LYS . 24.4 m -88.87 -66.29 0.93 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.665 -0.698 . . . . 10.92 111.182 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 50.01 39.7 19.53 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.719 0.771 . . . . 12.42 111.113 -173.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.408 ' HG3' ' HB3' ' A' ' 267' ' ' SER . 94.8 mttt -84.43 -39.96 18.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.377 -0.829 . . . . 11.59 110.528 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -81.19 148.86 29.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.735 -0.666 . . . . 8.8300000000000001 110.278 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -84.34 145.33 28.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.186 -0.461 . . . . 7.0199999999999996 111.209 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' TYR . . . . . 0.548 ' HB3' ' OE2' ' A' ' 18' ' ' GLU . 93.8 m-85 -128.04 163.01 25.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.749 -0.659 . . . . 6.5999999999999996 109.999 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -140.15 125.6 19.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.503 0.192 . . . . 1.9399999999999999 110.516 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -138.4 158.62 24.99 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 119.529 -1.32 . . . . 1.4199999999999999 112.489 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.19 127.17 68.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.17 -0.678 . . . . 1.8100000000000001 109.17 176.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.68 157.23 21.74 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.757 -0.735 . . . . 1.3 111.638 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 6.2 p -119.96 121.31 65.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.116 0.484 . . . . 1.8300000000000001 110.344 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -122.21 123.71 42.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.895 -0.593 . . . . 2.3100000000000001 110.517 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -118.08 130.03 55.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.745 -0.465 . . . . 4.75 109.745 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 8.9 p -117.5 129.44 55.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.953 0.406 . . . . 1.6699999999999999 110.498 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 61.4 t80 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.395 -0.812 . . . . 3.6899999999999999 109.572 -176.986 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.888 0.375 . . . . 11.85 110.467 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.427 ' HB2' ' ND2' ' A' ' 5' ' ' ASN . 45.0 mt-10 -113.03 138.34 50.04 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.099 -0.5 . . . . 10.35 110.246 -178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -60.2 -36.53 77.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.527 -0.76 . . . . 9.3100000000000005 109.809 176.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -60.13 -39.42 86.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.897 -1.047 . . . . 8.8399999999999999 111.324 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.427 ' ND2' ' HB2' ' A' ' 2' ' ' GLU . 94.1 m-20 -69.4 -40.05 77.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.402 -0.363 . . . . 7.0099999999999998 111.091 -178.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -69.54 -47.24 64.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.366 -0.379 . . . . 3.6099999999999999 110.811 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 41' ' ' ASN . 70.0 m95 -88.59 107.35 18.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.131 0.491 . . . . 3.3300000000000001 111.171 -176.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -94.87 130.44 41.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.619 -0.719 . . . . 3.2000000000000002 110.592 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.34 139.48 52.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.165 -0.925 . . . . 2.4900000000000002 110.244 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 15.6 m120 -122.67 132.03 54.07 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.94 -0.573 . . . . 2.1299999999999999 110.105 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.0 mt -120.06 119.83 61.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.021 -0.733 . . . . 1.6000000000000001 109.021 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.437 ' HA3' ' CZ ' ' A' ' 36' ' ' TYR . . . -115.77 134.43 11.49 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.103 -1.046 . . . . 0.88 112.453 -176.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -121.78 134.41 54.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.91 0.386 . . . . 1.0800000000000001 110.147 175.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 91.0 mtp -140.66 157.09 45.95 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.268 -0.641 . . . . 2.3300000000000001 109.268 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -100.19 121.98 42.3 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.834 -0.346 . . . . 2.6099999999999999 110.99 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -112.92 143.09 44.79 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.751 -0.462 . . . . 5.0899999999999999 109.751 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 87.2 mt -103.83 127.47 57.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.908 0.385 . . . . 5.3300000000000001 111.275 -171.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.458 ' OE1' HG13 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -120.45 129.93 54.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.815 -0.63 . . . . 8.2799999999999994 109.626 179.347 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -165.23 35.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.399 . . . . 9.6999999999999993 110.688 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.458 HG13 ' OE1' ' A' ' 18' ' ' GLU . 27.8 m -69.3 -9.33 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.446 -0.343 . . . . 11.09 111.823 -177.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.16 -39.81 87.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 13.1 110.632 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -87.05 -168.78 45.22 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.826 -0.702 . . . . 11.94 112.275 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -69.17 -29.97 68.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.869 0.366 . . . . 15.18 111.058 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.26 2.29 74.13 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.8 -0.714 . . . . 12.0 112.538 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.9 -39.94 96.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.198 0.523 . . . . 12.82 110.401 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -114.61 142.01 47.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.517 -0.765 . . . . 10.81 109.118 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 53.0 ttm -102.37 120.07 39.88 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.005 0.431 . . . . 10.050000000000001 110.457 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -72.4 144.79 48.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.843 -0.617 . . . . 8.0600000000000005 110.259 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.31 26.2 5.79 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.086 -0.578 . . . . 5.5800000000000001 112.857 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.9 tp -99.75 119.9 38.87 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.334 -0.617 . . . . 5.5599999999999996 109.334 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.82 144.3 51.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.133 0.492 . . . . 3.0499999999999998 111.492 -175.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 41.1 mt-10 -97.42 137.72 21.13 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.524 -0.762 . . . . 3.48 110.083 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 32' ' ' GLU . 24.0 Cg_exo -63.9 134.0 41.39 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 121.914 1.743 . . . . 1.8600000000000001 111.132 173.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 28.3 t -124.59 142.4 51.38 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.603 -0.888 . . . . 1.97 108.603 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 62.5 t -130.01 133.61 64.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.893 0.378 . . . . 1.71 111.002 -174.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.437 ' CZ ' ' HA3' ' A' ' 12' ' ' GLY . 53.8 p90 -130.22 151.82 50.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.675 -0.491 . . . . 4.0700000000000003 109.675 175.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.563 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 93.2 m-85 -119.55 139.95 51.31 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.517 -0.31 . . . . 2.8599999999999999 111.051 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 18.5 m-80 -129.65 141.37 50.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.801 -0.636 . . . . 1.8899999999999999 109.995 174.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.11 142.67 38.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.68 -0.236 . . . . 1.0800000000000001 110.439 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 45' ' ' ARG . . . -159.61 139.21 11.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.197 0.443 . . . . 1.3899999999999999 112.197 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.663 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 34.3 t30 -167.68 94.14 0.41 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.346 -0.843 . . . . 2.8599999999999999 109.186 171.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.92 -91.89 1.73 Allowed Glycine 0 N--CA 1.454 -0.144 0 N-CA-C 111.276 -0.73 . . . . 1.6799999999999999 111.276 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.663 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 72.6 Cg_exo -50.51 173.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.331 2.687 . . . . 1.6599999999999999 113.06 167.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.519 ' CD1' HG13 ' A' ' 74' ' ' VAL . 48.9 p90 -68.4 176.65 2.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.737 -0.665 . . . . 3.3999999999999999 111.951 -170.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 17.1 ttm180 -112.83 129.31 56.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.515 -0.766 . . . . 3.1000000000000001 110.069 -173.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 45.6 pt -110.92 143.56 20.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.271 -0.422 . . . . 1.8 110.939 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 72' ' ' LEU . . . -118.52 127.12 53.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.746 -0.661 . . . . 0.85999999999999999 110.352 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.7 tp -119.95 128.75 53.87 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.889 0.376 . . . . 1.0600000000000001 111.176 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.53 157.1 42.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.589 -0.732 . . . . 1.1399999999999999 109.423 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -120.09 140.0 51.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.083 0.468 . . . . 4.0199999999999996 111.141 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -112.14 133.28 54.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.657 -0.701 . . . . 4.6100000000000003 111.289 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -122.56 127.04 48.95 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.38 -0.6 . . . . 3.3799999999999999 109.38 174.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.627 ' HB2' ' OH ' ' A' ' 95' ' ' TYR . 39.0 tt0 -67.44 -39.94 85.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.238 0.542 . . . . 5.0499999999999998 110.021 178.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -126.69 79.98 0.37 Allowed Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 111.067 -0.813 . . . . 4.3700000000000001 111.067 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.83 149.96 80.36 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.271 2.648 . . . . 6.6799999999999997 111.968 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 58' ' ' TYR . 48.7 t -128.71 129.93 68.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.397 -0.365 . . . . 8.1699999999999999 110.067 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -59.86 -40.02 87.19 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.108 -0.496 . . . . 10.039999999999999 110.854 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.458 ' H ' HG12 ' A' ' 56' ' ' VAL . 98.3 m-85 -70.16 138.96 52.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.897 -0.592 . . . . 11.609999999999999 110.097 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.5 t -119.24 133.48 55.73 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.117 -0.492 . . . . 9.7899999999999991 109.839 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 60.86 40.05 16.22 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 123.657 0.598 . . . . 8.5099999999999998 110.928 -177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.69 -171.84 43.84 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.477 -0.783 . . . . 7.5599999999999996 111.602 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -86.78 118.55 26.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.882 0.372 . . . . 10.0 110.455 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -141.15 128.08 20.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.063 -0.517 . . . . 10.35 110.123 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.61 -38.01 9.16 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.023 -0.608 . . . . 5.3399999999999999 113.019 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.6 p -111.02 128.76 55.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.75 0.31 . . . . 5.3200000000000003 110.723 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -119.31 128.47 54.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.287 0.565 . . . . 5.6100000000000003 111.517 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -139.99 137.43 34.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.205 -0.907 . . . . 3.7799999999999998 109.309 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -159.96 168.38 25.82 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.433 -0.349 . . . . 2.4500000000000002 110.518 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.516 ' HD2' ' HB3' ' A' ' 93' ' ' ARG . 58.6 ttp85 -142.43 123.73 8.59 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.817 -0.629 . . . . 3.2400000000000002 110.267 169.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.631 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 72.9 Cg_endo -80.07 139.98 13.85 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.14 1.893 . . . . 1.1899999999999999 110.54 167.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.505 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 33.5 tt0 -124.15 113.87 18.92 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.227 0.537 . . . . 2.1899999999999999 110.077 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 40.8 tp -120.21 119.73 34.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.172 -0.922 . . . . 1.1399999999999999 110.209 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 34.2 mt-10 -104.21 147.03 27.93 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.289 0.566 . . . . 2.1800000000000002 111.08 174.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.519 HG13 ' CD1' ' A' ' 44' ' ' TRP . 63.8 t -113.41 120.08 62.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.95 -1.023 . . . . 1.5600000000000001 108.83 174.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.576 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 93.4 m-70 -122.27 127.19 49.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.88 0.371 . . . . 3.4399999999999999 110.28 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.439 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 84.5 t80 -139.94 139.09 36.07 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.114 -0.493 . . . . 4.7999999999999998 110.43 -178.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -99.17 119.87 38.57 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.587 -0.523 . . . . 2.9399999999999999 109.587 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -100.02 120.03 39.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.289 -0.414 . . . . 3.8999999999999999 109.963 -174.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.9 tp -116.51 119.92 37.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.267 -0.424 . . . . 4.4800000000000004 112.077 -172.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -119.54 147.13 44.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.908 -0.587 . . . . 6.1900000000000004 110.169 173.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -89.85 1.21 56.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.229 -0.441 . . . . 5.4500000000000002 111.335 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -96.61 26.94 4.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.117 0.484 . . . . 5.2699999999999996 110.279 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 60.64 40.07 16.97 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.101 -0.954 . . . . 6.3300000000000001 112.279 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -108.91 129.94 55.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.062 -0.517 . . . . 7.4800000000000004 109.891 171.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.514 ' HB3' ' CD1' ' A' ' 119' ' ' TRP . 22.7 m -115.38 117.08 29.42 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.157 -0.474 . . . . 2.5499999999999998 110.651 -178.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -135.64 159.53 41.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.135 -0.484 . . . . 5.2999999999999998 110.257 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -141.0 -178.52 17.4 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.983 -1.247 . . . . 1.3500000000000001 109.983 174.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 75' ' ' HIS . 64.7 tp -140.18 121.78 15.24 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 117.515 0.657 . . . . 2.29 110.953 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.428 HG23 ' CE1' ' A' ' 75' ' ' HIS . 92.9 m -120.08 116.61 26.05 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.689 -0.687 . . . . 1.54 109.595 169.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 73' ' ' GLU . . . -125.99 154.63 18.88 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.837 -0.905 . . . . 1.1699999999999999 110.837 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.81 124.3 2.23 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.669 -0.777 . . . . 1.1899999999999999 112.102 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -111.35 121.77 46.09 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.843 -0.799 . . . . 3.75 108.843 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.516 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 34.8 mtm180 -142.59 126.87 17.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.392 -0.367 . . . . 2.75 111.208 -172.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.631 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 57.6 t30 -122.16 130.01 52.83 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.445 -0.576 . . . . 1.8200000000000001 109.445 174.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.627 ' OH ' ' HB2' ' A' ' 53' ' ' GLU . 3.3 t80 -121.95 115.95 23.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.804 -0.18 . . . . 3.1400000000000001 110.955 -172.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.71 129.85 16.83 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.473 -0.87 . . . . 2.79 111.167 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -127.57 138.54 52.91 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.194 -0.298 . . . . 7.6200000000000001 110.194 -174.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -130.09 170.14 14.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 7.0800000000000001 110.595 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.4 ' HB3' ' OD1' ' A' ' 101' ' ' ASP . 97.7 m-85 -119.87 139.96 51.58 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.878 -0.786 . . . . 10.16 108.878 174.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.9 t -70.1 -30.52 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.405 . . . . 9.8100000000000005 110.952 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' ' 99' ' ' TYR . 6.2 p-10 -69.58 -33.17 72.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.043 -0.526 . . . . 12.220000000000001 110.392 176.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -74.13 155.49 88.19 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.021 -0.536 . . . . 10.48 110.139 171.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.81 -13.8 39.19 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.408 2.738 . . . . 9.0999999999999996 113.853 -173.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.07 -7.49 81.54 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.622 -0.799 . . . . 6.46 112.154 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -89.87 4.12 50.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.537 0.684 . . . . 7.6699999999999999 109.372 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -79.16 170.54 16.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.687 -1.142 . . . . 4.1399999999999997 110.235 177.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.2 m -140.37 130.64 25.12 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.931 0.396 . . . . 3.2999999999999998 110.578 173.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.95 144.25 33.64 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.681 -0.859 . . . . 1.76 108.681 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.438 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 95.8 m-20 -129.06 127.0 40.65 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.87 0.367 . . . . 2.5499999999999998 110.739 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.478 ' HB3' ' HA ' ' A' ' 139' ' ' ALA . 41.8 mtm -108.59 130.03 55.31 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.043 -0.725 . . . . 1.77 109.043 175.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -102.99 137.22 41.48 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.093 -0.643 . . . . 1.97 111.241 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.505 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 53.7 mtp85 -119.98 109.97 16.14 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.978 -0.749 . . . . 3.8500000000000001 108.978 177.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -110.02 140.02 44.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.342 0.592 . . . . 2.2799999999999998 112.046 -175.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.401 ' HB2' ' NH2' ' A' ' 93' ' ' ARG . 87.0 tttt -129.03 124.42 34.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.588 -1.187 . . . . 2.1400000000000001 109.854 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 80.3 mt -140.46 120.03 12.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.471 -0.196 . . . . 1.55 110.471 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 134' ' ' SER . . . -155.38 106.24 2.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.649 -0.25 . . . . 1.1899999999999999 111.425 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.721 ' HD2' ' CD1' ' A' ' 132' ' ' TRP . 13.3 Cg_exo -71.48 88.06 0.76 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.461 2.108 . . . . 1.3700000000000001 111.045 168.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 119' ' ' TRP . 12.1 p-10 -108.5 139.38 43.34 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.211 0.449 . . . . 2.3500000000000001 112.211 -166.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.514 ' CD1' ' HB3' ' A' ' 85' ' ' SER . 7.3 t-105 176.61 -176.59 0.13 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.34 -0.845 . . . . 4.54 108.993 174.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.609 ' OD1' ' HB3' ' A' ' 128' ' ' ARG . 30.1 t70 -80.24 117.44 21.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.135 0.493 . . . . 3.04 111.277 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.4 t -107.01 120.04 57.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.019 -0.734 . . . . 4.2699999999999996 109.019 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -93.08 72.01 4.63 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.932 -0.577 . . . . 6.04 110.636 -171.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.2 tp -67.32 -40.04 85.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.753 -0.658 . . . . 4.5899999999999999 110.709 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 24.4 p -123.28 150.16 43.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.756 -0.657 . . . . 3.6899999999999999 110.03 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -69.93 -40.26 75.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.793 0.33 . . . . 5.1699999999999999 111.279 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -70.24 -40.26 74.57 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.103 -0.498 . . . . 3.71 112.212 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.0 mt -119.95 139.16 52.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.919 0.39 . . . . 2.0499999999999998 111.339 -171.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.609 ' HB3' ' OD1' ' A' ' 120' ' ' ASP . 62.0 mtt180 -103.26 139.26 38.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.013 -0.539 . . . . 4.2400000000000002 110.097 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -112.74 107.82 16.61 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.436 -0.579 . . . . 3.5499999999999998 109.436 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 43.8 t30 -110.83 114.3 27.53 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 120.797 0.332 . . . . 2.1099999999999999 110.495 -174.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 142.52 -163.18 27.24 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.326 -0.71 . . . . 1.1799999999999999 111.326 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.721 ' CD1' ' HD2' ' A' ' 117' ' ' PRO . 47.8 t-105 -161.34 168.53 23.78 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.977 0.389 . . . . 4.2999999999999998 110.799 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 46.9 tp -100.5 119.93 39.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.741 -0.663 . . . . 2.2400000000000002 109.596 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.434 ' HB3' ' HB2' ' A' ' 116' ' ' ALA . 13.1 p -122.97 158.46 30.43 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.182 0.438 . . . . 1.6899999999999999 112.182 -172.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 75.0 mtm -118.39 136.74 53.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.047 -0.524 . . . . 2.2400000000000002 109.976 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -120.04 140.41 51.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.2 0.524 . . . . 3.5600000000000001 111.518 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -124.39 136.34 53.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.365 -0.834 . . . . 1.6699999999999999 109.503 176.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.505 ' H ' HD22 ' A' ' 142' ' ' LEU . 42.2 m-85 -128.46 146.65 50.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.155 -0.475 . . . . 3.23 110.1 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 110' ' ' MET . . . 59.99 -164.87 0.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.714 -0.675 . . . . 1.24 111.642 177.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -77.39 -31.33 54.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.033 0.444 . . . . 2.4700000000000002 110.766 172.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -60.0 -50.28 74.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.622 -0.717 . . . . 2.4100000000000001 112.328 -169.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.505 HD22 ' H ' ' A' ' 138' ' ' PHE . 8.8 mp -70.7 -29.91 66.33 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.769 -0.373 . . . . 1.8300000000000001 111.219 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -61.11 -43.61 98.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.857 0.36 . . . . 2.0 110.704 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.3 p -70.4 -31.1 68.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 2.0499999999999998 111.468 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 75.8 p -97.78 9.94 41.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.583 -0.28 . . . . 1.5900000000000001 110.542 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -60.0 -24.66 60.88 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.906 -0.588 . . . . 1.52 114.06 -172.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -69.87 -38.49 76.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.851 0.358 . . . . 5.9400000000000004 110.415 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -107.62 -55.93 2.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.451 0.537 . . . . 1.8300000000000001 112.451 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -109.2 117.41 34.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.424 0.631 . . . . 2.6400000000000001 111.963 -171.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 24.4 p -130.1 147.01 51.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.061 -0.972 . . . . 2.02 110.186 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -77.18 132.77 38.94 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.517 -0.549 . . . . 3.6699999999999999 109.517 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.99 129.57 64.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.297 -0.41 . . . . 1.6399999999999999 110.899 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.62 137.96 54.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.084 -0.507 . . . . 2.5600000000000001 110.397 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -133.38 101.04 5.01 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.281 -0.418 . . . . 1.3899999999999999 110.179 175.132 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -99.52 110.45 22.9 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.289 -1.004 . . . . 2.04 108.289 172.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 32.1 m -129.14 121.05 26.95 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.013 0.435 . . . . 1.5600000000000001 111.183 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 171' ' ' ASN . . . -101.12 120.1 6.76 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.896 -0.882 . . . . 1.04 110.896 174.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 92.5 mt -97.11 129.54 44.5 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.502 -0.555 . . . . 2.27 109.502 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.458 ' HG2' ' HG2' ' A' ' 169' ' ' ARG . 69.9 mt-30 -102.0 119.12 38.28 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.644 -0.422 . . . . 2.4100000000000001 110.625 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -118.81 133.11 56.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.513 -0.767 . . . . 4.5700000000000003 109.3 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.5 p -103.57 92.15 4.33 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.405 -0.518 . . . . 1.46 110.767 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -60.01 -48.96 79.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.593 -0.731 . . . . 2.6299999999999999 111.204 -176.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.456 ' HB2' HG22 ' A' ' 166' ' ' VAL . 80.7 m-20 -101.96 13.18 35.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.486 -0.324 . . . . 2.4100000000000001 111.331 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 73.88 -53.41 0.69 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.367 0.667 . . . . 2.5800000000000001 111.915 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.5 p -74.51 -18.77 60.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.985 0.422 . . . . 2.2999999999999998 111.564 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 163' ' ' ASN . 16.7 m -119.93 144.48 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.297 -0.41 . . . . 1.71 110.175 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -114.83 132.74 56.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.3 -0.409 . . . . 1.47 111.127 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 27.3 mt -104.35 129.98 52.21 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.718 -0.845 . . . . 1.6599999999999999 108.718 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.458 ' HG2' ' HG2' ' A' ' 159' ' ' GLN . 81.0 mtt180 -110.08 112.81 25.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.994 0.426 . . . . 3.2999999999999998 110.633 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.57 119.75 60.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.975 -0.557 . . . . 1.3 109.87 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.441 ' HA ' ' HA2' ' A' ' 157' ' ' GLY . 47.9 t30 -119.51 133.9 55.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.0 0.428 . . . . 2.2200000000000002 110.674 -172.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -138.9 150.92 46.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.768 -0.651 . . . . 4.6100000000000003 110.835 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -106.29 129.7 54.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.024 -0.534 . . . . 3.98 110.381 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 154' ' ' THR . 86.6 mt -114.75 131.99 56.59 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.466 -0.568 . . . . 2.3799999999999999 109.466 171.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -113.47 177.21 4.71 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.564 -0.289 . . . . 3.3100000000000001 110.532 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -59.81 -40.16 87.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.208 0.528 . . . . 6.5300000000000002 110.083 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -173.86 157.43 25.62 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.348 -0.701 . . . . 5.0599999999999996 111.348 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -79.94 129.08 34.2 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.735 -0.469 . . . . 7.3899999999999997 109.735 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -109.62 153.4 24.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.32 -0.4 . . . . 9.0700000000000003 110.275 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 95.8 mmm -99.57 84.21 2.92 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.313 -0.403 . . . . 10.869999999999999 110.097 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -77.12 133.09 39.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.098 -0.501 . . . . 10.449999999999999 110.637 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -89.41 -0.07 57.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.118 -0.492 . . . . 13.06 110.019 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 34.7 t -61.93 -39.97 93.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.482 -0.781 . . . . 12.609999999999999 110.25 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -117.45 126.32 52.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.12 -0.491 . . . . 15.19 110.146 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -70.07 -39.89 75.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.471 0.653 . . . . 13.18 109.314 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -140.02 178.77 7.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.063 -0.971 . . . . 12.73 109.452 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 142.05 -55.39 0.6 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.533 -0.841 . . . . 9.9800000000000004 111.502 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -88.8 119.98 29.79 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.155 -0.683 . . . . 10.699999999999999 109.155 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -104.49 -14.58 15.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.938 0.399 . . . . 10.5 111.113 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 52.3 m -140.31 148.64 41.67 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.759 -0.46 . . . . 6.6399999999999997 109.759 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 24.2 p -70.03 -22.05 63.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.135 -0.484 . . . . 4.9800000000000004 111.031 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -134.04 100.06 4.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.746 -0.661 . . . . 7.0999999999999996 109.369 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -99.13 128.45 45.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.273 0.559 . . . . 4.4000000000000004 109.718 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 32.4 mm -116.98 139.92 41.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.623 -0.717 . . . . 2.21 111.184 -164.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 48.3 mtm105 -114.02 139.98 48.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.334 -0.247 . . . . 3.54 110.334 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -132.22 137.99 47.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.776 0.322 . . . . 1.6699999999999999 110.653 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -150.16 160.01 43.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.35 -0.386 . . . . 5.8300000000000001 110.281 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -137.93 139.13 25.28 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 120.69 0.281 . . . . 2.5899999999999999 110.394 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.33 135.65 22.84 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.401 2.067 . . . . 1.77 112.43 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 67.3 tp -137.76 134.15 34.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.685 -0.689 . . . . 2.2599999999999998 109.559 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 85.4 m -119.92 129.56 54.4 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.814 0.34 . . . . 1.99 110.333 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.1 mt -131.45 81.71 2.0 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.283 0.563 . . . . 2.3100000000000001 109.523 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 71.42 -121.47 8.94 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.429 -0.805 . . . . 1.51 112.483 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -96.54 9.13 42.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.592 0.71 . . . . 2.5699999999999998 109.725 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -120.01 129.99 54.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.198 -0.91 . . . . 2.6600000000000001 109.615 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 7.0 p -103.71 146.28 28.84 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.297 -0.41 . . . . 1.6200000000000001 110.661 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 58.0 t -133.4 140.08 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 1.3799999999999999 110.119 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 46.1 m -138.49 95.48 10.14 Favored Pre-proline 0 C--N 1.319 -0.742 0 O-C-N 122.13 -0.356 . . . . 1.1799999999999999 110.533 173.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.11 139.97 90.11 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.43 2.087 . . . . 1.01 111.477 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -109.5 137.23 47.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.033 -0.53 . . . . 4.5 109.65 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 33.1 p -144.67 162.1 37.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.177 -0.465 . . . . 1.8899999999999999 110.731 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -138.29 142.02 39.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.26 -0.645 . . . . 4.7999999999999998 109.26 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 84.3 mt -60.65 -43.66 95.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.11 0.481 . . . . 4.5700000000000003 110.423 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 109.96 -110.12 2.83 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.885 -0.674 . . . . 4.9800000000000004 111.995 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.3 mt -139.67 159.76 41.42 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.336 -0.616 . . . . 8.1099999999999994 109.336 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -59.97 -40.14 88.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.203 0.525 . . . . 7.6500000000000004 110.732 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -67.47 -39.92 85.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.338 -0.846 . . . . 10.529999999999999 111.376 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -81.09 153.53 27.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.366 0.603 . . . . 11.56 112.009 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 50.4 m -140.01 153.57 46.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.694 -0.685 . . . . 10.06 109.588 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -94.68 125.64 39.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.823 -0.436 . . . . 11.92 109.823 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -119.81 139.88 51.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.376 -0.375 . . . . 14.01 110.276 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -71.65 -19.97 62.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.632 -0.713 . . . . 14.529999999999999 111.571 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 38.5 t90 -88.03 140.29 29.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.099 0.476 . . . . 16.609999999999999 110.825 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -75.32 131.93 40.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.482 -0.781 . . . . 15.460000000000001 110.593 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -60.6 -39.98 90.14 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.36 -0.836 . . . . 15.67 111.541 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -146.38 172.75 13.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.898 -0.592 . . . . 14.5 110.377 -177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 10.2 tp -74.43 -25.19 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.36 0.504 . . . . 15.15 112.36 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -89.91 67.2 7.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.161 0.505 . . . . 14.73 111.662 -173.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -69.84 137.15 51.51 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.272 -0.64 . . . . 16.379999999999999 109.272 174.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -60.18 -39.81 87.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.996 -0.547 . . . . 12.779999999999999 111.743 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 174.16 -175.69 46.59 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.53 -0.843 . . . . 11.1 112.141 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -66.05 -40.04 90.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.974 0.416 . . . . 12.26 110.098 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -72.9 136.83 45.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.003 -0.544 . . . . 9.9900000000000002 109.752 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -103.61 121.65 43.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.147 -0.479 . . . . 10.43 110.744 -174.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -69.8 -19.51 63.49 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.62 -0.718 . . . . 6.29 110.218 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -68.45 -26.73 65.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.346 -0.843 . . . . 8.1500000000000004 111.014 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 62.4 t -116.54 124.22 72.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.298 -0.41 . . . . 2.3999999999999999 110.886 -174.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -85.51 165.98 39.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.781 -0.723 . . . . 1.27 111.438 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 89.4 mt -134.33 129.92 36.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.471 0.636 . . . . 1.97 112.04 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.517 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 57.5 t80 -100.67 131.29 46.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.333 -0.848 . . . . 3.54 109.845 171.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.462 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 91.0 m-85 -113.97 130.01 56.56 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.453 -0.573 . . . . 2.6400000000000001 109.453 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -123.3 134.24 9.35 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.7 -0.762 . . . . 1.3500000000000001 111.67 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.43 110.98 23.08 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.156 -0.683 . . . . 4.3600000000000003 109.156 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -107.06 102.12 11.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.908 -0.587 . . . . 4.29 110.37 -176.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 91.3 m-85 -120.0 135.98 54.72 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.13 -0.486 . . . . 6.6900000000000004 109.817 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -84.8 9.65 13.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.448 0.642 . . . . 6.3700000000000001 110.107 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -90.71 6.26 44.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.186 -0.916 . . . . 5.8300000000000001 110.268 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 99.94 5.13 55.22 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.791 -0.718 . . . . 2.6600000000000001 112.816 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 245' ' ' PHE . 65.9 tp -102.95 120.1 40.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.927 0.394 . . . . 2.9700000000000002 111.254 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 23.9 t -130.72 129.24 42.29 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.699 -0.852 . . . . 2.1699999999999999 108.699 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.51 133.17 64.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.932 -0.307 . . . . 1.79 110.643 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 15.5 m -116.65 120.1 37.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.069 -0.514 . . . . 1.6299999999999999 110.057 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 86.0 mt -125.2 127.51 46.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.753 -0.203 . . . . 2.96 110.515 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -120.55 111.33 17.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.854 0.359 . . . . 4.0800000000000001 110.487 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -120.1 140.09 51.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.963 0.411 . . . . 4.8399999999999999 111.316 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -127.28 36.05 4.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.899 -0.591 . . . . 3.5800000000000001 110.491 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 59.84 34.55 21.82 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.843 -0.617 . . . . 6.7699999999999996 111.762 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 58.76 40.43 23.1 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.734 -0.666 . . . . 8.5399999999999991 111.436 176.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' TRP . . . . . 0.542 ' CD1' ' HB2' ' A' ' 261' ' ' ASP . 62.2 t-105 -95.87 129.24 43.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.035 -0.529 . . . . 11.9 111.018 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -83.34 124.53 30.72 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.947 -0.76 . . . . 10.57 108.947 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' ASP . . . . . 0.542 ' HB2' ' CD1' ' A' ' 259' ' ' TRP . 11.8 t70 -151.06 156.57 41.35 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.221 -0.592 . . . . 11.41 111.468 -174.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -69.65 -19.25 63.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.704 -1.134 . . . . 11.98 112.952 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -55.88 -30.79 62.09 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.247 0.546 . . . . 12.460000000000001 110.493 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -65.19 -30.97 71.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.196 -0.911 . . . . 13.779999999999999 112.292 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -61.81 134.81 46.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.831 -0.699 . . . . 11.07 113.389 -173.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 59.56 39.44 21.52 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.141 0.577 . . . . 12.59 111.068 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 37.3 t -129.46 148.44 51.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.677 -0.692 . . . . 10.92 109.803 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -78.26 -10.0 59.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.909 -0.587 . . . . 12.42 110.161 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -108.42 161.71 14.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.679 -0.691 . . . . 11.59 110.232 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -110.71 133.3 53.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.001 0.429 . . . . 8.8300000000000001 110.299 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -74.32 -35.01 63.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.536 -0.756 . . . . 7.0199999999999996 110.514 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -59.9 -50.06 75.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 6.5999999999999996 110.256 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -165.18 138.58 4.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.74 -0.664 . . . . 1.9399999999999999 110.464 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.76 132.56 6.64 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.001 -0.619 . . . . 1.4199999999999999 111.698 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 29.6 m -138.01 140.17 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.862 0.363 . . . . 1.8100000000000001 111.103 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -163.96 140.58 6.55 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.7 -0.762 . . . . 1.3 112.394 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.5 t -120.29 130.07 74.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.728 0.299 . . . . 1.8300000000000001 110.3 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -118.59 126.37 51.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.25 -0.432 . . . . 2.3100000000000001 110.286 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -100.3 123.69 44.85 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.699 -0.852 . . . . 4.75 108.699 174.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 37.7 t -117.75 130.02 56.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.986 0.422 . . . . 1.6699999999999999 110.673 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.2 t80 . . . . . 0 C--O 1.243 0.724 0 CA-C-O 118.336 -0.84 . . . . 3.6899999999999999 109.182 176.836 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.2 mtp . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.717 0.294 . . . . 11.85 111.475 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -60.12 -37.72 80.87 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.951 0.501 . . . . 10.35 111.988 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -51.21 -49.98 59.99 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.519 0.563 . . . . 9.3100000000000005 112.519 -173.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 58.89 49.15 10.14 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.481 0.658 . . . . 8.8399999999999999 110.055 -176.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -80.02 145.28 32.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.038 -0.983 . . . . 7.0099999999999998 110.892 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -69.87 -39.88 76.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.803 -0.635 . . . . 3.6099999999999999 109.43 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -73.22 149.28 42.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.143 -0.935 . . . . 3.3300000000000001 110.534 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -104.08 131.08 51.71 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.96 -0.385 . . . . 3.2000000000000002 109.96 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.83 149.76 42.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.81 -0.632 . . . . 2.4900000000000002 111.791 -171.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -131.54 129.43 41.01 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.677 -0.86 . . . . 2.1299999999999999 108.677 166.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 85.4 mt -132.5 120.23 41.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.598 -0.519 . . . . 1.6000000000000001 109.598 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -117.08 147.8 18.87 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.352 -0.927 . . . . 0.88 112.505 -176.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -138.09 135.03 35.4 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.093 -0.336 . . . . 1.0800000000000001 110.093 175.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.662 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 67.8 mtt -134.0 146.42 50.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.406 -0.361 . . . . 2.3300000000000001 110.482 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.406 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 90.2 m-85 -97.63 129.46 44.72 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.895 -0.78 . . . . 2.6099999999999999 108.895 177.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -70.11 -32.56 70.64 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.187 0.44 . . . . 5.0899999999999999 112.187 -173.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.585 ' HB ' ' HB2' ' A' ' 31' ' ' ALA . 80.9 mt -110.3 130.03 64.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.774 0.321 . . . . 5.3300000000000001 110.461 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -63.59 139.98 58.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.922 -0.581 . . . . 8.2799999999999994 110.629 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -100.68 108.63 20.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.901 0.381 . . . . 9.6999999999999993 110.157 -175.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.9 t -119.13 130.01 74.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.096 -0.502 . . . . 11.09 109.788 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -88.68 119.94 29.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.933 0.397 . . . . 13.1 110.436 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.73 -171.76 39.45 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.926 -0.654 . . . . 11.94 111.82 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -140.4 130.88 25.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.723 0.296 . . . . 15.18 110.489 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -156.18 178.61 32.61 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.549 -0.62 . . . . 12.0 111.549 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.58 -43.12 97.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.946 0.403 . . . . 12.82 110.884 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -84.13 147.56 27.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.021 -0.536 . . . . 10.81 109.75 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 94.5 mtp -121.17 132.5 54.88 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.468 0.652 . . . . 10.050000000000001 110.654 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -60.16 -39.85 87.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.439 -1.255 . . . . 8.0600000000000005 112.105 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.26 -145.41 16.92 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.584 -0.817 . . . . 5.5800000000000001 111.749 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.527 ' O ' HD12 ' A' ' 17' ' ' ILE . 59.0 tp -120.68 138.8 53.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.385 -0.598 . . . . 5.5599999999999996 109.385 175.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.585 ' HB2' ' HB ' ' A' ' 17' ' ' ILE . . . -119.99 107.07 12.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.816 0.341 . . . . 3.0499999999999998 110.892 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 57' ' ' ASP . 1.7 pm0 -103.25 140.79 21.39 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 116.249 -0.432 . . . . 3.48 110.326 177.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.662 ' HA ' ' O ' ' A' ' 14' ' ' MET . 73.8 Cg_endo -77.39 134.81 14.34 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.354 2.036 . . . . 1.8600000000000001 113.127 -177.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 34.8 p -84.42 157.71 21.3 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.992 -0.744 . . . . 1.97 108.992 171.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.99 132.56 69.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.213 0.53 . . . . 1.71 111.005 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 53.0 t80 -122.76 130.85 53.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.361 -0.836 . . . . 4.0700000000000003 110.303 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -120.02 135.24 55.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.764 0.316 . . . . 2.8599999999999999 110.75 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -149.9 127.96 11.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.243 -0.651 . . . . 1.8899999999999999 109.243 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.44 147.95 28.86 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.078 -0.249 . . . . 1.0800000000000001 111.316 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.72 139.12 9.96 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.131 -0.486 . . . . 1.3899999999999999 111.443 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.689 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 27.3 t-20 -168.28 94.97 0.39 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.963 -0.755 . . . . 2.8599999999999999 108.963 169.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.05 -85.62 0.55 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.93 -0.652 . . . . 1.6799999999999999 111.496 -173.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.689 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 19.6 Cg_endo -59.59 176.66 0.57 Allowed 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 123.643 2.895 . . . . 1.6599999999999999 112.55 171.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -67.77 175.25 3.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.932 -0.576 . . . . 3.3999999999999999 110.527 -173.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -110.99 117.08 32.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.478 0.656 . . . . 3.1000000000000001 109.706 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 84.3 mt -116.24 130.23 71.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.438 -1.256 . . . . 1.8 110.436 -170.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.22 130.7 56.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.261 -0.427 . . . . 0.85999999999999999 110.21 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 61.2 tp -130.59 132.57 45.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 1.0600000000000001 110.886 -177.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -146.59 168.92 20.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.56 -0.745 . . . . 1.1399999999999999 109.56 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -120.07 140.0 51.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.703 0.287 . . . . 4.0199999999999996 110.567 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -119.86 122.62 41.69 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.758 -0.46 . . . . 4.6100000000000003 109.758 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -123.1 139.98 53.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.941 0.401 . . . . 3.3799999999999999 110.091 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.58 -24.64 31.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.685 -0.689 . . . . 5.0499999999999998 110.212 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -133.2 71.23 0.5 Allowed Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.616 -0.72 . . . . 4.3700000000000001 111.342 174.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.03 141.11 47.22 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.393 2.728 . . . . 6.6799999999999997 113.363 -174.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.1 t -130.75 130.01 64.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.541 -0.754 . . . . 8.1699999999999999 109.096 174.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.548 ' HB2' ' HB3' ' A' ' 32' ' ' GLU . 20.9 t70 -60.02 -49.96 75.59 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.276 0.36 . . . . 10.039999999999999 111.524 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -152.2 150.4 29.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.78 0.324 . . . . 11.609999999999999 110.436 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 52.9 m -143.04 150.0 39.0 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.333 -0.394 . . . . 9.7899999999999991 110.346 176.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.77 120.04 41.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.517 -0.311 . . . . 8.5099999999999998 110.274 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.43 21.08 59.07 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.736 -0.745 . . . . 7.5599999999999996 111.756 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.657 ' HE3' ' O ' ' A' ' 64' ' ' GLY . 57.9 tptt -122.56 119.14 29.97 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.044 -0.354 . . . . 10.0 110.044 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -69.94 -39.74 75.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.27 -0.423 . . . . 10.35 111.354 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.657 ' O ' ' HE3' ' A' ' 62' ' ' LYS . . . 148.13 -150.33 22.52 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.923 -0.656 . . . . 5.3399999999999999 111.499 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 t -112.38 130.05 56.1 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.239 0.542 . . . . 5.3200000000000003 110.769 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -60.06 -40.05 88.13 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.262 -0.881 . . . . 5.6100000000000003 110.644 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -102.22 111.64 24.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.465 -0.569 . . . . 3.7799999999999998 109.465 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -125.34 169.96 11.81 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.267 -0.424 . . . . 2.4500000000000002 110.098 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.506 ' NE ' ' HB2' ' A' ' 95' ' ' TYR . 12.5 ttm180 -139.31 122.41 10.62 Favored Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 120.874 -0.33 . . . . 3.2400000000000002 110.134 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.508 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 85.3 Cg_endo -91.41 151.69 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.872 2.382 . . . . 1.1899999999999999 112.184 171.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.592 ' HA ' ' HG2' ' A' ' 93' ' ' ARG . 37.8 tt0 -118.04 115.61 25.21 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.17 -0.678 . . . . 2.1899999999999999 109.17 174.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.4 tp -132.56 114.74 14.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.883 -0.599 . . . . 1.1399999999999999 110.758 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.515 ' HG2' ' HA3' ' A' ' 91' ' ' GLY . 46.9 mt-10 -123.9 140.47 52.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.263 -0.426 . . . . 2.1800000000000002 110.108 174.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -123.03 129.8 74.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.203 -0.453 . . . . 1.5600000000000001 109.965 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -112.48 119.9 39.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.008 0.432 . . . . 3.4399999999999999 110.444 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.447 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . 64.8 t80 -93.08 129.14 39.14 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.554 -0.748 . . . . 4.7999999999999998 109.26 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -103.02 119.83 39.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.079 -0.509 . . . . 2.9399999999999999 110.099 -177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.453 ' CD2' ' HG ' ' A' ' 79' ' ' LEU . 69.7 t80 -120.1 119.35 33.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.522 -0.308 . . . . 3.8999999999999999 110.633 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.453 ' HG ' ' CD2' ' A' ' 78' ' ' PHE . 85.4 mt 69.68 106.21 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 124.136 0.897 . . . . 4.4800000000000004 112.817 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -88.4 -7.17 57.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.477 -0.783 . . . . 6.1900000000000004 109.531 170.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -67.76 143.79 55.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.267 -0.879 . . . . 5.4500000000000002 110.462 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -70.14 -20.87 63.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.854 -0.612 . . . . 5.2699999999999996 112.177 -171.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -61.23 -39.95 92.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.018 0.377 . . . . 6.3300000000000001 112.018 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -138.08 155.36 48.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.856 0.36 . . . . 7.4800000000000004 110.815 -176.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.402 ' OG ' ' HB ' ' A' ' 121' ' ' VAL . 21.3 t -144.27 94.49 2.58 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.222 -0.445 . . . . 2.5499999999999998 109.996 -177.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -119.92 135.84 54.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.924 0.392 . . . . 5.2999999999999998 110.748 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.21 143.42 15.01 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.029 -0.828 . . . . 1.3500000000000001 111.029 175.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 76' ' ' TYR . 88.6 mt -120.27 113.72 20.82 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.767 -0.457 . . . . 2.29 109.767 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.1 m -116.58 122.64 45.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.05 0.452 . . . . 1.54 110.882 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -137.86 140.33 11.14 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.443 -0.663 . . . . 1.1699999999999999 111.443 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.515 ' HA3' ' HG2' ' A' ' 73' ' ' GLU . . . -169.63 170.03 42.44 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.219 -0.991 . . . . 1.1899999999999999 112.455 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 112' ' ' ARG . 53.3 p90 -156.75 160.01 38.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.986 0.422 . . . . 3.75 111.201 -176.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.592 ' HG2' ' HA ' ' A' ' 71' ' ' GLU . 30.1 mtm180 -121.27 127.96 51.89 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.743 -0.662 . . . . 2.75 109.228 169.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.508 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 52.0 t30 -107.3 119.13 38.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.189 -0.46 . . . . 1.8200000000000001 110.134 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.506 ' HB2' ' NE ' ' A' ' 69' ' ' ARG . 69.9 t80 -116.85 129.31 56.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.793 0.33 . . . . 3.1400000000000001 111.006 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 108' ' ' ALA . . . 99.73 166.89 29.54 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.333 -0.936 . . . . 2.79 113.179 172.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.454 ' O ' ' HB2' ' A' ' 98' ' ' HIS . 3.2 m-85 -118.69 157.67 27.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.637 -0.281 . . . . 7.6200000000000001 110.537 -176.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.498 ' HB3' ' O ' ' A' ' 101' ' ' ASP . 22.6 m-70 69.76 62.03 0.26 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 124.15 0.906 . . . . 7.0800000000000001 110.452 -169.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -70.07 -27.74 64.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.54 -0.755 . . . . 10.16 110.97 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 79.5 t -70.09 -40.98 79.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 9.8100000000000005 111.382 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' A' ' 98' ' ' HIS . 10.3 p-10 -139.3 136.87 35.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.133 0.492 . . . . 12.220000000000001 111.957 -173.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -129.89 71.18 82.23 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.833 -0.621 . . . . 10.48 110.067 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.02 -30.11 56.73 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.896 2.397 . . . . 9.0999999999999996 113.452 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -138.36 -177.3 15.17 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.61 -0.805 . . . . 6.46 112.261 -176.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -80.78 -16.12 54.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.686 0.279 . . . . 7.6699999999999999 111.16 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -69.92 -35.7 74.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.35 0.595 . . . . 4.1399999999999997 109.459 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.5 p -87.7 140.66 29.29 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.355 -0.839 . . . . 3.2999999999999998 109.4 172.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.406 ' O ' ' HA3' ' A' ' 96' ' ' GLY . . . -164.78 129.12 2.52 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.632 -0.427 . . . . 1.76 111.159 -178.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -138.47 126.88 23.13 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.195 0.522 . . . . 2.5499999999999998 110.034 173.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 89.5 mtp -131.35 126.91 36.48 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.925 -0.579 . . . . 1.77 109.462 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.496 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 77.4 mt-30 -118.92 134.23 55.31 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.327 -0.549 . . . . 1.97 110.528 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 92' ' ' PHE . 47.3 ttt-85 -111.77 119.44 38.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.682 -0.69 . . . . 3.8500000000000001 109.439 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -119.94 140.21 51.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.545 -0.298 . . . . 2.2799999999999998 110.901 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 135' ' ' MET . 21.8 pttp -139.94 135.29 32.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.023 0.44 . . . . 2.1400000000000001 110.184 168.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 134' ' ' SER . 48.5 mm -120.02 119.85 61.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.827 -0.805 . . . . 1.55 108.827 173.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -140.55 106.58 6.5 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 120.553 0.216 . . . . 1.1899999999999999 111.197 -174.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.94 139.87 13.98 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.757 2.305 . . . . 1.3700000000000001 110.776 174.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -88.03 138.4 31.48 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.29 -0.634 . . . . 2.3500000000000001 109.29 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -125.86 132.32 52.21 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.547 0.203 . . . . 4.54 111.547 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 55.78 37.53 28.98 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.251 0.97 . . . . 3.04 112.451 171.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.402 ' HB ' ' OG ' ' A' ' 85' ' ' SER . 92.9 t -64.19 119.32 8.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.638 -0.255 . . . . 4.2699999999999996 110.926 -176.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 59.93 43.11 15.22 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.583 -0.735 . . . . 6.04 110.948 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.1 tp -60.15 -39.9 87.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.147 -0.479 . . . . 4.5899999999999999 111.872 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 127' ' ' LEU . 32.6 m -117.3 138.14 51.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.923 0.392 . . . . 3.6899999999999999 110.318 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -61.42 -44.66 96.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.147 -0.479 . . . . 5.1699999999999999 111.025 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -70.97 -40.83 71.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.794 -0.639 . . . . 3.71 111.492 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.535 ' O ' ' HB ' ' A' ' 124' ' ' THR . 86.5 mt -126.59 125.48 42.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.924 -0.58 . . . . 2.0499999999999998 110.523 -173.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.488 ' HD2' ' OE1' ' A' ' 159' ' ' GLN . 64.9 mtt180 -92.67 133.83 35.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.098 0.475 . . . . 4.2400000000000002 110.623 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.466 ' CD2' HD22 ' A' ' 158' ' ' LEU . 89.3 m-85 -119.8 122.0 40.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.367 -0.833 . . . . 3.5499999999999998 109.565 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 132' ' ' TRP . 94.4 m-20 -133.32 120.06 20.55 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.883 -0.414 . . . . 2.1099999999999999 109.883 174.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -148.18 140.27 8.25 Favored Glycine 0 CA--C 1.507 -0.416 0 C-N-CA 120.2 -1.0 . . . . 1.1799999999999999 111.43 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.462 ' CZ3' ' HB3' ' A' ' 130' ' ' ASN . 0.9 OUTLIER -142.72 147.67 36.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.302 0.573 . . . . 4.2999999999999998 112.153 -177.182 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 91.4 mt -104.43 120.01 40.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.987 -1.006 . . . . 2.2400000000000002 109.09 176.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 26.6 t -107.39 124.56 50.01 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.54 -0.464 . . . . 1.6899999999999999 110.974 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.472 ' O ' ' HA ' ' A' ' 114' ' ' LYS . 69.7 mtm -93.95 120.06 33.7 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.324 -0.991 . . . . 2.2400000000000002 108.324 171.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -115.12 132.61 56.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.167 0.508 . . . . 3.5600000000000001 112.208 -168.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -130.17 152.86 49.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.415 -0.812 . . . . 1.6699999999999999 109.908 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.459 ' O ' HD23 ' A' ' 142' ' ' LEU . 77.9 t80 -149.7 151.5 33.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.421 -0.354 . . . . 3.23 110.248 -177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 60.61 -163.44 0.25 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.546 0.529 . . . . 1.24 111.649 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -75.91 -41.39 52.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.967 0.413 . . . . 2.4700000000000002 111.786 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -60.14 -46.16 90.59 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.528 -0.76 . . . . 2.4100000000000001 112.959 -165.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 138' ' ' PHE . 3.8 mm? -69.88 -35.66 74.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.071 0.462 . . . . 1.8300000000000001 110.974 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' A' ' 111' ' ' GLN . 95.6 m-20 -70.78 -40.25 72.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.884 -0.598 . . . . 2.0 111.392 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.1 p -77.0 -35.05 57.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.504 -0.316 . . . . 2.0499999999999998 111.823 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 149' ' ' ASP . 23.2 p -69.9 -29.9 67.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.986 0.422 . . . . 1.5900000000000001 111.092 177.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 63.28 -109.83 2.98 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.694 -0.685 . . . . 1.52 113.071 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -70.02 -33.94 72.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.594 0.235 . . . . 5.9400000000000004 110.808 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.04 75.26 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.075 -0.512 . . . . 1.8300000000000001 112.256 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.428 ' HB2' ' OG1' ' A' ' 145' ' ' THR . 15.7 m-20 -122.51 127.1 49.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.212 0.53 . . . . 2.6400000000000001 111.003 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.1 t -160.23 157.73 28.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.853 -0.612 . . . . 2.02 110.113 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -120.16 148.2 43.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.917 -0.401 . . . . 3.6699999999999999 109.917 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.09 139.81 50.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.867 0.365 . . . . 1.6399999999999999 110.974 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -138.0 141.04 40.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.989 -0.551 . . . . 2.5600000000000001 109.523 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 24.5 m -122.91 131.36 53.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.735 0.302 . . . . 1.3899999999999999 111.346 -177.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -126.57 130.06 49.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.944 -0.571 . . . . 2.04 110.235 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 93.4 m -128.24 120.78 27.87 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.044 -0.525 . . . . 1.5600000000000001 110.538 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -111.69 117.73 4.56 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.657 -0.977 . . . . 1.04 110.657 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.466 HD22 ' CD2' ' A' ' 129' ' ' PHE . 77.4 mt -118.65 130.64 55.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.913 0.387 . . . . 2.27 111.024 -176.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.488 ' OE1' ' HD2' ' A' ' 128' ' ' ARG . 53.4 tt0 -100.14 113.43 26.07 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.901 -0.59 . . . . 2.4100000000000001 110.669 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.469 ' HA ' HD22 ' A' ' 127' ' ' LEU . 86.7 m-85 -120.16 139.8 52.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.889 -0.596 . . . . 4.5700000000000003 110.424 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 167' ' ' ALA . 24.4 p -94.25 100.26 12.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.963 0.411 . . . . 1.46 110.349 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -60.05 -49.07 79.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.939 -0.573 . . . . 2.6299999999999999 111.225 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.493 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.7 m-20 -101.09 10.09 41.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.222 -0.445 . . . . 2.4100000000000001 110.717 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 72.47 -46.92 0.66 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.634 0.774 . . . . 2.5800000000000001 111.235 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.4 p -74.71 -20.42 59.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.397 -0.365 . . . . 2.2999999999999998 111.788 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 163' ' ' ASN . 34.2 m -124.81 139.95 49.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.368 -0.378 . . . . 1.71 110.252 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.406 ' HA ' HG22 ' A' ' 161' ' ' THR . . . -106.83 131.55 53.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.959 0.409 . . . . 1.47 111.374 -175.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 31.1 mt -115.31 138.54 50.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.311 -0.626 . . . . 1.6599999999999999 109.311 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -112.17 122.02 46.58 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 110.075 -0.343 . . . . 3.2999999999999998 110.075 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.94 127.91 75.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.731 0.3 . . . . 1.3 110.547 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -107.05 126.69 52.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.249 0.547 . . . . 2.2200000000000002 110.782 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -99.42 124.42 44.54 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.11 -0.95 . . . . 4.6100000000000003 108.648 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -108.77 124.98 51.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.096 0.474 . . . . 3.98 110.923 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.501 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 62.0 tp -115.4 115.82 27.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.608 -0.723 . . . . 2.3799999999999999 111.21 -177.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -120.01 145.12 47.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.694 -0.685 . . . . 3.3100000000000001 110.116 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -140.35 130.07 24.39 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.546 -0.538 . . . . 6.5300000000000002 109.546 172.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -115.82 129.17 8.37 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.822 -0.704 . . . . 5.0599999999999996 112.051 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -70.01 -40.0 75.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.28 0.562 . . . . 7.3899999999999997 110.104 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -125.13 43.14 3.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.541 -0.754 . . . . 9.0700000000000003 110.011 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.8 ttm -60.22 -40.09 88.94 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.825 -0.625 . . . . 10.869999999999999 110.532 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -115.02 168.05 10.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.107 -0.497 . . . . 10.449999999999999 110.299 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -60.31 -40.2 89.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.015 0.436 . . . . 13.06 111.084 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.0 t -153.84 151.04 29.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.219 -0.446 . . . . 12.609999999999999 110.266 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -109.56 23.44 14.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.997 -0.547 . . . . 15.19 110.847 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -60.08 -40.13 88.49 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.78 0.324 . . . . 13.18 111.194 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -67.69 -38.38 83.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.166 0.507 . . . . 12.73 110.361 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 147.02 -166.63 28.41 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 111.152 -0.779 . . . . 9.9800000000000004 111.152 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -122.43 139.75 53.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.788 0.328 . . . . 10.699999999999999 110.364 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -142.49 155.52 45.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.246 -0.434 . . . . 10.5 110.225 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.1 p -154.77 159.15 40.44 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.838 -0.619 . . . . 6.6399999999999997 109.621 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 23.2 m -140.45 113.63 8.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.841 0.353 . . . . 4.9800000000000004 110.46 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.86 149.98 23.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.283 -0.417 . . . . 7.0999999999999996 110.08 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -104.61 126.57 51.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.518 -0.31 . . . . 4.4000000000000004 110.521 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.491 ' O ' HG13 ' A' ' 194' ' ' ILE . 29.7 pt -93.92 90.72 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.66 0.743 . . . . 2.21 109.375 170.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.426 ' HG2' ' HA ' ' A' ' 212' ' ' ARG . 99.1 mtt180 -91.3 120.08 31.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.875 -0.602 . . . . 3.54 110.314 -173.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -109.36 147.23 33.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.95 -0.568 . . . . 1.6699999999999999 111.38 -174.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -155.97 160.02 39.72 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.492 -0.777 . . . . 5.8300000000000001 109.726 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 1.7 pt? -144.51 127.49 8.54 Favored Pre-proline 0 C--N 1.322 -0.619 0 C-N-CA 120.846 -0.342 . . . . 2.5899999999999999 111.006 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 198' ' ' LEU . 9.1 Cg_exo -73.28 127.38 11.88 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.462 2.108 . . . . 1.77 111.674 172.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 33.1 tp -130.83 148.57 52.62 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.565 -0.902 . . . . 2.2599999999999998 108.565 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 11.9 t -129.58 140.18 51.27 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.302 0.572 . . . . 1.99 110.954 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 60.0 tp -141.05 82.53 1.84 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.343 -0.844 . . . . 2.3100000000000001 109.149 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 69.22 -120.04 10.05 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.734 -0.666 . . . . 1.51 112.616 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -95.47 10.09 37.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.497 0.665 . . . . 2.5699999999999998 109.778 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -119.2 145.87 45.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.389 -0.823 . . . . 2.6600000000000001 109.399 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 241' ' ' TYR . 47.5 t -130.03 144.53 51.39 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.851 -0.426 . . . . 1.6200000000000001 109.851 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 47.9 t -119.92 129.95 74.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.639 -0.504 . . . . 1.3799999999999999 109.639 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 20.3 m -139.84 91.03 10.62 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-O 120.867 0.365 . . . . 1.1799999999999999 110.42 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.46 140.6 27.28 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 123.013 2.475 . . . . 1.01 111.826 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -118.99 139.88 50.94 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.858 -0.423 . . . . 4.5 109.858 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 61.1 p -133.07 146.15 51.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.789 -0.641 . . . . 1.8899999999999999 109.626 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.426 ' HA ' ' HG2' ' A' ' 195' ' ' ARG . 59.0 mtp180 -80.51 -9.97 59.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.035 0.445 . . . . 4.7999999999999998 110.255 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 46.5 pt -115.54 150.11 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.547 -0.751 . . . . 4.5700000000000003 109.932 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -109.45 -159.98 18.75 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.778 -0.725 . . . . 4.9800000000000004 112.193 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.2 mt -60.72 -40.11 91.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.018 0.437 . . . . 8.1099999999999994 110.966 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -84.33 102.72 12.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.906 -0.588 . . . . 7.6500000000000004 109.534 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -69.65 -37.93 76.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.883 -0.599 . . . . 10.529999999999999 109.942 -177.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -113.22 139.99 48.33 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.015 -0.735 . . . . 11.56 109.015 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 23.0 m -107.56 156.67 18.76 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.596 -0.275 . . . . 10.06 110.379 -176.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -103.28 119.98 39.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.958 0.408 . . . . 11.92 110.262 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' TRP . . . . . 0.404 ' CZ2' ' HB2' ' A' ' 219' ' ' SER . 21.3 m-90 -114.01 142.33 46.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.836 -0.62 . . . . 14.01 110.035 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -90.52 8.33 34.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.935 -0.575 . . . . 14.529999999999999 110.302 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -104.4 157.0 17.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.788 -0.642 . . . . 16.609999999999999 110.374 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLN . . . . . 0.434 ' HB3' ' OD1' ' A' ' 226' ' ' ASP . 99.4 mt-30 -60.18 -53.08 61.95 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.191 0.307 . . . . 15.460000000000001 111.034 -176.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 49.92 40.01 19.9 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.47 0.481 . . . . 15.67 111.705 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.434 ' OD1' ' HB3' ' A' ' 224' ' ' GLN . 18.4 m-20 -70.02 -20.54 63.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.106 -0.497 . . . . 14.5 111.131 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 86.7 mt -120.03 119.95 61.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.396 -0.594 . . . . 15.15 109.396 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -115.11 149.84 36.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.083 -0.508 . . . . 14.73 110.731 -175.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -100.13 125.48 46.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.006 -0.738 . . . . 16.379999999999999 109.006 172.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -69.81 139.93 53.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.124 0.488 . . . . 12.779999999999999 110.744 -176.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -179.62 178.78 48.78 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.021 -0.832 . . . . 11.1 111.021 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 57.8 46.24 17.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.315 0.579 . . . . 12.26 109.762 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.08 -40.04 88.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.365 -0.834 . . . . 9.9900000000000002 110.474 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -123.54 140.0 53.44 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.61 -0.723 . . . . 10.43 109.944 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -96.43 116.21 28.69 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.811 -0.44 . . . . 6.29 109.811 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -100.21 141.34 33.19 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.383 -0.372 . . . . 8.1500000000000004 110.499 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.86 160.0 41.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.037 -0.529 . . . . 2.3999999999999999 109.832 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -132.92 143.88 15.67 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.62 -0.8 . . . . 1.27 111.923 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 81.1 mt -116.94 121.78 42.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.7 0.286 . . . . 1.97 110.284 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -106.55 122.26 45.95 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.877 -0.416 . . . . 3.54 109.877 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 206' ' ' SER . 95.9 m-85 -112.2 120.37 41.54 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.066 -0.515 . . . . 2.6400000000000001 110.115 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -89.62 129.57 9.76 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.613 -0.803 . . . . 1.3500000000000001 111.533 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -107.58 127.19 53.42 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 110.004 -0.369 . . . . 4.3600000000000003 110.004 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -99.36 133.82 43.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.572 -0.74 . . . . 4.29 110.37 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -124.73 146.16 49.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.499 -0.556 . . . . 6.6900000000000004 109.499 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -56.49 -27.56 57.5 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.272 -0.876 . . . . 6.3700000000000001 112.816 -168.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.98 -34.97 74.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.364 0.602 . . . . 5.8300000000000001 110.742 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 116.2 1.94 20.25 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.21 -1.156 . . . . 2.6600000000000001 110.21 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 53.5 tp -91.08 130.41 36.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.579 -0.811 . . . . 2.9700000000000002 109.792 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 24.3 p -120.08 140.15 51.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.859 0.362 . . . . 2.1699999999999999 110.672 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.2 t -118.71 133.02 66.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.424 -0.353 . . . . 1.79 110.211 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 24.7 m -98.4 117.55 33.06 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.782 -0.451 . . . . 1.6299999999999999 109.782 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 68.6 mt -95.73 119.45 34.26 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.313 -0.625 . . . . 2.96 109.313 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -104.43 120.02 40.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.916 0.389 . . . . 4.0800000000000001 110.495 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -116.2 132.25 56.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.885 -0.598 . . . . 4.8399999999999999 110.675 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -99.22 16.45 22.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.504 0.669 . . . . 3.5800000000000001 109.733 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' PHE . . . . . 0.431 ' HE2' ' CE2' ' A' ' 259' ' ' TRP . 53.2 p90 -150.06 167.4 26.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.205 -0.907 . . . . 6.7699999999999996 110.191 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -121.7 138.55 54.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.969 -0.559 . . . . 8.5399999999999991 109.878 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' TRP . . . . . 0.431 ' CE2' ' HE2' ' A' ' 257' ' ' PHE . 93.5 m95 -86.6 121.82 29.65 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.365 -0.976 . . . . 11.9 108.365 170.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -115.14 172.52 7.02 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 121.013 -0.275 . . . . 10.57 110.906 -171.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -60.01 -40.14 88.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.982 0.42 . . . . 11.41 110.562 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -127.64 109.67 11.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.751 -0.659 . . . . 11.98 110.33 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -119.98 130.02 54.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.183 -0.462 . . . . 12.460000000000001 110.132 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -109.67 143.63 39.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.964 0.411 . . . . 13.779999999999999 110.597 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -90.25 -158.24 34.29 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.744 -0.662 . . . . 11.07 112.064 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 54.3 39.05 30.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.939 0.399 . . . . 12.59 111.246 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 53.6 m -115.15 147.95 39.62 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.919 0.39 . . . . 10.92 110.182 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -89.96 -0.02 57.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.122 -0.49 . . . . 12.42 111.298 -174.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -87.32 70.03 9.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.24 -0.436 . . . . 11.59 110.072 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -66.17 139.69 58.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.986 -0.552 . . . . 8.8300000000000001 110.073 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -110.4 160.38 16.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.083 -0.508 . . . . 7.0199999999999996 111.638 -171.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -125.86 155.72 40.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.319 -0.855 . . . . 6.5999999999999996 109.904 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -150.02 149.82 30.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.324 -0.398 . . . . 1.9399999999999999 110.545 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.91 167.54 23.25 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.917 -0.658 . . . . 1.4199999999999999 111.844 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.05 140.0 39.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.149 0.499 . . . . 1.8100000000000001 111.06 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -126.77 137.08 9.76 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.033 -0.827 . . . . 1.3 111.033 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.99 119.99 60.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.857 -0.423 . . . . 1.8300000000000001 109.857 -176.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -128.25 129.77 46.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.154 0.502 . . . . 2.3100000000000001 111.627 -176.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -120.01 110.62 16.91 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.291 -0.633 . . . . 4.75 109.291 173.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 22.9 t -120.6 130.23 54.09 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.53 -0.544 . . . . 1.6699999999999999 109.53 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 46.2 t80 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.112 -0.946 . . . . 3.6899999999999999 109.462 -177.727 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.943 0.402 . . . . 11.85 110.489 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -98.73 90.79 4.82 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.073 -0.714 . . . . 10.35 109.073 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -123.82 144.62 49.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.542 -0.754 . . . . 9.3100000000000005 110.388 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -125.07 153.5 42.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.385 -0.37 . . . . 8.8399999999999999 110.753 -177.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -111.13 123.96 51.24 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.418 -0.586 . . . . 7.0099999999999998 109.418 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -59.93 -39.83 86.85 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.493 -0.776 . . . . 3.6099999999999999 111.079 -178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -120.3 139.99 51.91 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.166 -0.679 . . . . 3.3300000000000001 109.166 172.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -131.83 130.78 42.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.812 0.339 . . . . 3.2000000000000002 110.182 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -137.06 150.35 47.99 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.089 -0.505 . . . . 2.4900000000000002 110.152 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -132.77 131.39 41.09 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.923 -0.769 . . . . 2.1299999999999999 108.923 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.8 pt -121.34 130.32 74.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.987 0.422 . . . . 1.6000000000000001 110.971 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -114.8 134.53 11.72 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.671 -0.776 . . . . 0.88 111.578 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -120.0 135.87 54.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.018 0.437 . . . . 1.0800000000000001 110.636 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 66.7 mtt -139.92 157.26 45.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.714 -0.675 . . . . 2.3300000000000001 109.734 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.02 112.32 24.75 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.007 -0.368 . . . . 2.6099999999999999 110.007 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -99.39 133.28 43.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.084 0.468 . . . . 5.0899999999999999 110.87 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.0 pt -130.25 141.22 46.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.471 -0.786 . . . . 5.3300000000000001 110.033 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -119.9 140.05 51.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.764 0.316 . . . . 8.2799999999999994 110.28 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.481 ' ND2' ' HB2' ' A' ' 186' ' ' ASN . 54.4 t30 -80.73 117.38 21.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.909 -0.587 . . . . 9.6999999999999993 110.976 -177.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.99 124.55 72.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.964 -0.384 . . . . 11.09 109.964 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -138.87 140.04 38.3 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.615 -0.513 . . . . 13.1 109.615 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.94 -162.28 30.38 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.269 -0.967 . . . . 11.94 112.696 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -64.48 -28.78 69.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.855 0.359 . . . . 15.18 110.899 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.11 160.44 33.0 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.044 -0.598 . . . . 12.0 111.613 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -100.0 120.04 39.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.741 0.305 . . . . 12.82 110.42 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -82.85 -11.42 58.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 10.81 110.368 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 97.6 mmm -120.23 131.56 55.0 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.687 -0.688 . . . . 10.050000000000001 110.305 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -99.57 -0.05 41.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.066 -0.516 . . . . 8.0600000000000005 110.932 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.57 84.14 1.58 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.952 -0.642 . . . . 5.5800000000000001 112.296 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.31 -49.99 75.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.812 0.339 . . . . 5.5599999999999996 111.469 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -157.0 119.61 3.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.101 -0.499 . . . . 3.0499999999999998 110.927 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -128.71 145.18 55.17 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.515 -0.311 . . . . 3.48 110.835 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.09 134.84 10.67 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.441 2.094 . . . . 1.8600000000000001 111.972 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 19.3 p -123.9 145.78 48.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.241 -0.436 . . . . 1.97 110.0 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 8.5 p -130.0 136.79 58.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.02 0.438 . . . . 1.71 110.791 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -117.97 143.66 46.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.033 -0.53 . . . . 4.0700000000000003 110.481 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 91.0 m-85 -102.71 129.28 49.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.976 -0.556 . . . . 2.8599999999999999 111.244 -176.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -119.88 137.43 54.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.137 -0.483 . . . . 1.8899999999999999 109.948 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -120.69 143.5 48.7 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.988 -0.375 . . . . 1.0800000000000001 109.988 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.49 117.98 6.97 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.537 0.523 . . . . 1.3899999999999999 111.226 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.631 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 37.4 t30 -167.24 96.01 0.48 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.01 -0.541 . . . . 2.8599999999999999 110.12 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.3 -98.78 1.89 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.017 -0.611 . . . . 1.6799999999999999 112.266 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.631 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 84.1 Cg_exo -47.82 175.0 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.956 3.104 . . . . 1.6599999999999999 113.644 169.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -69.72 -177.44 1.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.265 0.555 . . . . 3.3999999999999999 111.582 -170.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.7 mtp180 -111.97 140.58 46.52 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.609 0.719 . . . . 3.1000000000000001 112.331 -170.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.406 HG22 HG12 ' A' ' 74' ' ' VAL . 47.0 pt -126.52 146.66 32.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 114.397 -1.274 . . . . 1.8 110.892 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -119.73 131.22 55.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.791 -0.64 . . . . 0.85999999999999999 110.287 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.8 tp -119.92 131.84 55.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.166 -0.47 . . . . 1.0600000000000001 110.831 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 71' ' ' GLU . . . -151.98 157.8 42.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 1.1399999999999999 110.551 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -134.48 150.48 50.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.793 0.33 . . . . 4.0199999999999996 110.725 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -135.27 106.94 6.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.019 -0.537 . . . . 4.6100000000000003 111.589 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -98.87 135.84 39.73 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.457 -0.942 . . . . 3.3799999999999999 108.457 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -60.12 -34.0 72.9 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.024 -0.535 . . . . 5.0499999999999998 111.059 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.76 131.65 23.8 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.501 -0.856 . . . . 4.3700000000000001 111.262 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.32 168.2 8.24 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.061 2.507 . . . . 6.6799999999999997 113.123 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 65.4 t -60.17 -44.49 95.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.802 0.334 . . . . 8.1699999999999999 110.445 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -65.64 -40.13 92.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.741 -0.663 . . . . 10.039999999999999 111.246 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -124.98 100.04 6.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.584 -0.28 . . . . 11.609999999999999 111.05 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.1 t -64.39 -40.0 94.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.448 0.642 . . . . 9.7899999999999991 109.277 176.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.76 111.09 22.88 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.452 -0.794 . . . . 8.5099999999999998 110.258 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.14 168.3 38.72 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.765 -0.731 . . . . 7.5599999999999996 112.008 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -60.15 -39.94 88.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.845 0.355 . . . . 10.0 110.663 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.9 mtm105 -69.74 -20.33 63.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 10.35 111.036 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.89 23.0 62.62 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.995 -0.621 . . . . 5.3399999999999999 113.145 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.1 p -84.94 131.86 34.44 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.215 0.531 . . . . 5.3200000000000003 111.169 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -119.95 29.7 7.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.749 -0.66 . . . . 5.6100000000000003 110.507 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -70.54 139.96 51.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.072 -0.513 . . . . 3.7799999999999998 110.804 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -130.65 144.26 51.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.67 -0.696 . . . . 2.4500000000000002 109.704 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.458 ' HD2' ' HB3' ' A' ' 93' ' ' ARG . 39.5 ttp180 -124.34 122.05 26.0 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.926 -0.579 . . . . 3.2400000000000002 110.07 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.478 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 2.9 Cg_endo -85.81 150.03 9.81 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.63 2.22 . . . . 1.1899999999999999 111.883 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 46.5 tt0 -128.11 128.95 45.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.054 0.454 . . . . 2.1899999999999999 110.211 173.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.4 tp -132.03 116.77 17.51 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.616 -0.72 . . . . 1.1399999999999999 109.442 173.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.472 ' HA ' ' HA2' ' A' ' 91' ' ' GLY . 40.5 tt0 -118.81 131.17 56.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.043 0.449 . . . . 2.1800000000000002 109.868 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.406 HG12 HG22 ' A' ' 46' ' ' ILE . 32.4 m -113.67 141.55 29.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.816 -0.629 . . . . 1.5600000000000001 109.999 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -120.97 127.01 51.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.097 -0.502 . . . . 3.4399999999999999 110.136 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.94 141.43 49.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.365 -0.38 . . . . 4.7999999999999998 110.074 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -114.65 139.91 49.26 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.851 -0.425 . . . . 2.9399999999999999 109.851 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -132.03 149.29 52.46 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.847 0.356 . . . . 3.8999999999999999 110.408 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.6 tp -133.22 129.66 38.03 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.039 -0.528 . . . . 4.4800000000000004 110.085 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -140.07 168.72 19.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.269 -0.641 . . . . 6.1900000000000004 109.269 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -60.0 -50.15 74.85 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.535 0.569 . . . . 5.4500000000000002 112.535 -171.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.72 -49.85 10.64 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.146 0.425 . . . . 5.2699999999999996 112.146 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -85.63 117.46 24.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.185 0.517 . . . . 6.3300000000000001 110.545 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -69.42 -47.85 62.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.36 -0.837 . . . . 7.4800000000000004 112.194 -173.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 120' ' ' ASP . 3.9 m -143.63 109.1 5.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.775 0.321 . . . . 2.5499999999999998 110.889 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -140.05 143.72 36.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.502 -0.555 . . . . 5.2999999999999998 109.502 174.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.65 176.36 23.08 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.255 -0.974 . . . . 1.3500000000000001 112.539 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 64.0 tp -126.83 130.04 49.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.912 0.387 . . . . 2.29 110.077 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.2 m -120.02 129.91 54.47 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.054 -0.521 . . . . 1.54 109.908 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 114' ' ' LYS . . . -138.97 133.6 6.3 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.615 -0.802 . . . . 1.1699999999999999 111.8 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 73' ' ' GLU . . . -135.03 147.99 19.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.591 -0.814 . . . . 1.1899999999999999 112.4 -178.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -129.36 137.74 51.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.957 0.408 . . . . 3.75 111.222 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 89.8 mtt180 -129.79 148.46 51.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.437 -0.801 . . . . 2.75 109.803 171.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.664 ' HA ' ' O ' ' A' ' 110' ' ' MET . 51.8 t-20 -139.55 118.43 12.47 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.094 -0.336 . . . . 1.8200000000000001 110.094 172.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.444 ' HB2' ' HD3' ' A' ' 69' ' ' ARG . 43.1 t80 -103.0 119.56 39.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.167 -0.309 . . . . 3.1400000000000001 110.167 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 122.7 -174.68 16.37 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.295 -0.955 . . . . 2.79 112.166 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.502 ' O ' ' HB ' ' A' ' 107' ' ' THR . 95.2 m-85 -131.45 129.99 41.91 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.814 -0.439 . . . . 7.6200000000000001 109.814 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -120.16 123.83 44.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.576 -0.284 . . . . 7.0800000000000001 110.333 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -125.09 100.22 6.46 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.943 -0.392 . . . . 10.16 109.943 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.0 p -76.93 -10.16 13.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.174 0.511 . . . . 9.8100000000000005 110.389 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.85 -40.16 87.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.562 -0.745 . . . . 12.220000000000001 111.223 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -123.69 97.3 41.94 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.137 -0.483 . . . . 10.48 110.767 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.0 -12.15 35.0 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.901 2.4 . . . . 9.0999999999999996 112.597 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.42 -1.54 90.13 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.078 -0.582 . . . . 6.46 112.341 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -112.11 144.35 41.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.761 0.315 . . . . 7.6699999999999999 110.63 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -90.0 109.96 20.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.247 -0.433 . . . . 4.1399999999999997 109.979 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 97' ' ' TYR . 82.2 p -118.58 137.72 53.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.393 -0.367 . . . . 3.2999999999999998 110.031 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -128.98 133.24 47.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.894 0.378 . . . . 1.76 111.232 -174.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.518 ' HB2' ' OD1' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -149.41 149.46 30.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.789 -0.641 . . . . 2.5499999999999998 110.107 177.85 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.664 ' O ' ' HA ' ' A' ' 94' ' ' ASN . 87.1 mtp -116.07 116.3 27.62 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.025 -0.534 . . . . 1.77 110.353 -176.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -94.66 119.87 33.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.903 0.383 . . . . 1.97 110.279 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.61 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 55.3 ttt180 -116.9 125.6 51.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.217 -0.447 . . . . 3.8500000000000001 110.767 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -115.89 135.95 53.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.825 -0.625 . . . . 2.2799999999999998 110.239 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.483 ' O ' ' HA2' ' A' ' 90' ' ' GLY . 45.4 tttm -122.24 123.56 41.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.712 -0.676 . . . . 2.1400000000000001 109.97 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.5 mm -120.03 120.34 62.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 109.286 -0.635 . . . . 1.55 109.286 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -141.49 105.03 5.93 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 111.863 0.32 . . . . 1.1899999999999999 111.863 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 85.4 Cg_endo -84.44 157.04 12.53 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.93 2.42 . . . . 1.3700000000000001 111.263 171.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -126.21 146.77 49.85 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.908 -0.317 . . . . 2.3500000000000001 110.854 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -126.24 130.79 51.62 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.977 -0.556 . . . . 4.54 110.796 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 85' ' ' SER . 42.1 t0 -60.06 140.08 57.06 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.207 0.942 . . . . 3.04 111.319 -176.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.794 ' HA ' ' O ' ' A' ' 129' ' ' PHE . 35.9 m -76.5 -22.67 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.944 -1.025 . . . . 4.2699999999999996 111.444 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -82.4 83.52 7.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.79 0.328 . . . . 6.04 110.439 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.2 tp -90.39 -79.78 0.34 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.224 -0.444 . . . . 4.5899999999999999 111.284 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 69.4 p -145.14 158.11 43.91 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.9 -0.136 . . . . 3.6899999999999999 111.101 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 58.49 25.22 12.76 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.774 0.671 . . . . 5.1699999999999999 112.271 170.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.471 ' HA ' HH12 ' A' ' 128' ' ' ARG . 25.1 m-20 57.04 30.0 17.45 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.064 0.459 . . . . 3.71 111.908 -176.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.1 mt -99.02 139.58 34.45 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.231 -1.026 . . . . 2.0499999999999998 108.231 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.652 ' HA ' ' O ' ' A' ' 121' ' ' VAL . 50.7 mmt-85 -107.99 120.17 41.55 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.213 -0.595 . . . . 4.2400000000000002 110.624 -174.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.794 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 90.2 m-85 -118.47 125.11 49.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.6 -0.727 . . . . 3.5499999999999998 109.79 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.483 ' O ' ' HA ' ' A' ' 156' ' ' THR . 24.0 t30 -110.77 126.24 54.39 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.609 -0.268 . . . . 2.1099999999999999 110.282 -175.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.79 117.38 1.85 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.087 -1.054 . . . . 1.1799999999999999 112.357 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.536 ' HB3' ' HB3' ' A' ' 155' ' ' GLU . 52.8 t-105 -126.6 129.91 49.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.398 -0.593 . . . . 4.2999999999999998 109.398 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 84.3 mt -118.06 138.27 52.35 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.715 -0.476 . . . . 2.2400000000000002 109.715 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.489 ' OG ' ' HB2' ' A' ' 153' ' ' GLU . 3.2 p -134.99 117.19 15.51 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.475 0.655 . . . . 1.6899999999999999 111.153 175.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 95.1 mmm -106.12 134.83 48.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.183 -0.917 . . . . 2.2400000000000002 109.288 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -124.9 133.83 52.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.012 0.434 . . . . 3.5600000000000001 111.888 -173.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 97.7 mttt -118.5 132.66 56.22 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.681 -0.859 . . . . 1.6699999999999999 108.681 171.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.578 ' H ' HD12 ' A' ' 142' ' ' LEU . 54.3 m-85 -123.03 143.04 50.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.508 0.194 . . . . 3.23 110.908 -174.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 59.79 -160.19 0.29 Allowed 'General case' 0 C--O 1.226 -0.171 0 O-C-N 123.856 0.722 . . . . 1.24 111.446 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -76.02 -36.06 59.27 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.952 0.406 . . . . 2.4700000000000002 110.483 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -60.29 -49.74 76.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.379 -0.828 . . . . 2.4100000000000001 113.169 -167.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.578 HD12 ' H ' ' A' ' 138' ' ' PHE . 14.7 mt -70.41 -27.18 64.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.74 -0.384 . . . . 1.8300000000000001 111.371 -176.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -60.72 -39.92 90.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.114 0.483 . . . . 2.0 110.343 172.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 85.0 m -70.05 -41.02 74.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.617 -0.72 . . . . 2.0499999999999998 111.018 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.556 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 56.3 p -74.82 -26.09 59.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 1.5900000000000001 111.718 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 69.0 -112.96 4.91 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.845 -0.693 . . . . 1.52 112.345 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -106.21 -0.19 24.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.691 0.281 . . . . 5.9400000000000004 110.801 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.85 -40.18 75.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.103 0.478 . . . . 1.8300000000000001 110.547 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.454 ' O ' HD22 ' A' ' 142' ' ' LEU . 24.2 t70 -135.94 111.57 9.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.489 -0.778 . . . . 2.6400000000000001 109.083 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.6 t -165.7 147.15 7.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.932 -0.576 . . . . 2.02 110.114 -173.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.421 ' HD3' ' OE2' ' A' ' 153' ' ' GLU . 24.5 ttm180 -70.71 135.71 48.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.611 0.243 . . . . 3.6699999999999999 110.508 175.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.91 120.08 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.176 -0.466 . . . . 1.6399999999999999 110.058 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.489 ' HB2' ' OG ' ' A' ' 134' ' ' SER . 96.4 mt-10 -119.97 139.96 51.66 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.444 -0.576 . . . . 2.5600000000000001 109.444 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 89.5 m -139.97 134.41 31.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.972 0.415 . . . . 1.3899999999999999 111.493 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 132' ' ' TRP . 41.6 tt0 -113.35 127.81 56.25 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.298 -0.63 . . . . 2.04 109.298 173.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 130' ' ' ASN . 35.5 m -129.0 120.46 26.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.847 0.356 . . . . 1.5600000000000001 110.474 177.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -116.21 133.9 11.07 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.709 -0.758 . . . . 1.04 111.601 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.517 ' HB2' HG13 ' A' ' 170' ' ' VAL . 52.6 mt -121.28 133.07 55.13 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.508 -0.553 . . . . 2.27 109.508 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 128' ' ' ARG . 54.1 tt0 -120.03 120.38 36.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.458 -0.337 . . . . 2.4100000000000001 110.419 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -121.55 131.0 53.88 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.358 -0.608 . . . . 4.5700000000000003 109.358 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.405 ' HB ' ' HA ' ' A' ' 164' ' ' GLU . 15.1 p -99.49 89.81 4.3 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.466 -0.494 . . . . 1.46 110.138 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.07 -49.1 78.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.61 -0.723 . . . . 2.6299999999999999 111.441 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.498 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.1 m-20 -100.0 12.68 36.26 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 121.119 -0.232 . . . . 2.4100000000000001 110.454 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.405 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 42.2 tt0 71.15 -49.51 0.68 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.725 0.81 . . . . 2.5800000000000001 111.762 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.2 t -74.84 -16.22 60.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.73 0.3 . . . . 2.2999999999999998 111.488 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 163' ' ' ASN . 17.9 m -125.58 141.45 45.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.853 0.359 . . . . 1.71 110.439 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.423 ' O ' ' HD2' ' A' ' 199' ' ' PRO . . . -107.23 139.43 41.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 1.47 110.909 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 31.2 mt -104.42 136.8 43.32 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.651 -0.87 . . . . 1.6599999999999999 108.651 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -118.34 120.12 36.68 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.444 -0.502 . . . . 3.2999999999999998 110.477 -176.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.517 HG13 ' HB2' ' A' ' 158' ' ' LEU . 3.5 p -129.69 131.95 66.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.744 -0.662 . . . . 1.3 109.752 176.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -127.84 130.05 47.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.002 -0.545 . . . . 2.2200000000000002 110.163 -176.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -101.01 121.67 42.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.009 -0.542 . . . . 4.6100000000000003 109.626 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -97.3 110.0 22.64 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.155 -0.683 . . . . 3.98 109.155 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.541 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 61.2 tp -103.63 115.67 30.92 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.084 -0.507 . . . . 2.3799999999999999 110.372 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -122.06 114.21 20.61 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.634 -0.876 . . . . 3.3100000000000001 108.634 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -100.03 124.27 45.21 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.261 -0.427 . . . . 6.5300000000000002 111.068 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 141.35 89.45 0.15 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.813 -0.631 . . . . 5.0599999999999996 112.403 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -64.54 -39.71 94.27 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.218 -0.66 . . . . 7.3899999999999997 109.218 175.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -95.68 122.49 38.5 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.379 -0.971 . . . . 9.0700000000000003 108.379 172.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 90.3 mtp -79.23 151.12 31.37 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.05 -0.523 . . . . 10.869999999999999 111.3 -171.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -60.09 -43.42 95.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.34 0.591 . . . . 10.449999999999999 109.485 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.417 ' HB2' ' OD1' ' A' ' 185' ' ' ASN . 40.4 m-20 -130.01 130.01 44.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.115 -0.948 . . . . 13.06 109.213 174.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.8 p -73.81 -15.72 61.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.241 0.543 . . . . 12.609999999999999 109.946 175.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -69.76 -39.12 76.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.245 -0.889 . . . . 15.19 110.907 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.417 ' OD1' ' HB2' ' A' ' 182' ' ' ASP . 13.3 m120 -64.65 134.82 55.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.993 -0.548 . . . . 13.18 110.19 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.481 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 10.9 t30 -107.18 119.99 40.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.776 0.322 . . . . 12.73 110.748 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -90.31 -177.5 44.54 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.963 -0.637 . . . . 9.9800000000000004 111.868 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -74.39 127.66 33.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.111 0.481 . . . . 10.699999999999999 109.959 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -70.18 -39.47 75.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.712 -0.676 . . . . 10.5 110.476 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 37.7 m -87.34 71.54 9.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.206 -0.452 . . . . 6.6399999999999997 110.18 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 27.3 m -64.6 128.89 37.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.788 -0.642 . . . . 4.9800000000000004 110.302 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -115.96 130.57 56.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.212 0.53 . . . . 7.0999999999999996 110.921 -175.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -59.78 -42.62 93.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.719 -1.128 . . . . 4.4000000000000004 111.363 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.699 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 18.5 tt -149.27 146.57 17.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.976 -0.556 . . . . 2.21 109.645 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.517 ' HB3' ' HB3' ' A' ' 210' ' ' TYR . 96.6 mtt180 -121.93 110.08 15.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.723 0.297 . . . . 3.54 110.774 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -137.21 141.76 42.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.544 -0.298 . . . . 1.6699999999999999 111.186 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -163.53 174.99 11.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.647 -0.871 . . . . 5.8300000000000001 108.647 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 7.0 mp -98.64 125.61 42.03 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.045 -0.724 . . . . 2.5899999999999999 109.045 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' A' ' 167' ' ' ALA . 36.5 Cg_exo -60.07 138.75 83.83 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.1 1.867 . . . . 1.77 111.672 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 77.9 mt -116.94 131.81 56.86 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.183 -0.673 . . . . 2.2599999999999998 109.183 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 11.6 t -147.94 139.87 24.05 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.189 0.518 . . . . 1.99 110.838 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 57.2 tp -143.89 85.46 1.82 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.542 -0.754 . . . . 2.3100000000000001 109.354 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 75.92 -112.29 3.55 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.858 -0.686 . . . . 1.51 112.487 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -93.94 0.02 55.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.204 0.526 . . . . 2.5699999999999998 110.351 -177.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -110.56 116.56 31.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.725 -0.67 . . . . 2.6600000000000001 110.105 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 49.2 m -122.6 131.05 53.64 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.842 -0.429 . . . . 1.6200000000000001 109.842 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.27 130.01 72.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.044 -0.354 . . . . 1.3799999999999999 110.044 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.7 m -127.72 90.34 48.38 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-O 120.915 0.388 . . . . 1.1799999999999999 110.484 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 238' ' ' GLY . 5.8 Cg_exo -79.58 150.45 21.79 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.167 2.578 . . . . 1.01 112.081 175.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.517 ' HB3' ' HB3' ' A' ' 195' ' ' ARG . 80.9 m-85 -126.08 139.93 52.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.024 0.44 . . . . 4.5 111.316 173.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 7.0 t -154.43 169.22 24.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.368 -0.975 . . . . 1.8899999999999999 108.368 175.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.699 ' HA ' ' O ' ' A' ' 194' ' ' ILE . 67.3 ttt180 -60.29 -49.19 78.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.385 0.539 . . . . 4.7999999999999998 111.015 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.6 mt -120.21 122.26 67.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.584 -0.524 . . . . 4.5700000000000003 109.584 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -86.72 39.06 3.08 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.835 -0.697 . . . . 4.9800000000000004 113.475 -174.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.8 tp -140.01 128.92 23.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.937 0.369 . . . . 8.1099999999999994 110.253 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -80.93 140.06 35.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.089 -0.505 . . . . 7.6500000000000004 111.565 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -131.4 151.9 51.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.439 -0.8 . . . . 10.529999999999999 109.353 173.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -111.68 131.22 55.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.597 -0.519 . . . . 11.56 109.597 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 222' ' ' ASP . 47.8 t -130.05 139.96 50.91 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.16 -0.473 . . . . 10.06 109.753 -176.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -69.25 -39.87 78.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.915 -0.584 . . . . 11.92 110.575 175.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -78.0 -39.91 40.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.513 -0.767 . . . . 14.01 111.901 -174.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 219' ' ' SER . 8.2 p-10 -131.77 150.08 52.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.116 0.484 . . . . 14.529999999999999 111.423 -175.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -132.66 158.76 41.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.768 -0.651 . . . . 16.609999999999999 110.478 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -70.02 -37.73 75.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.18 0.514 . . . . 15.460000000000001 109.761 172.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -60.12 -39.91 87.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.045 -0.98 . . . . 15.67 111.264 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -82.44 133.36 35.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.92 -0.582 . . . . 14.5 110.143 -177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.58 120.4 63.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.871 0.367 . . . . 15.15 110.687 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.22 125.8 33.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.841 -0.618 . . . . 14.73 110.472 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -63.18 -40.02 96.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.766 -0.652 . . . . 16.379999999999999 110.483 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -120.62 130.53 54.2 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.641 -0.709 . . . . 12.779999999999999 109.729 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -173.73 -173.18 39.73 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.505 -0.855 . . . . 11.1 112.317 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -70.0 -40.21 75.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.073 0.463 . . . . 12.26 110.657 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -151.05 167.81 26.54 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.776 -0.647 . . . . 9.9900000000000002 110.719 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -122.87 108.92 13.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.873 -0.603 . . . . 10.43 109.478 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -82.01 93.09 6.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.145 0.498 . . . . 6.29 110.58 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -99.29 139.26 35.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.829 -0.623 . . . . 8.1500000000000004 109.951 172.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 60.0 t -110.76 121.25 63.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.675 -0.491 . . . . 2.3999999999999999 109.675 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 209' ' ' PRO . . . -92.14 117.08 5.19 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.427 -0.892 . . . . 1.27 111.265 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.49 119.72 39.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.876 0.37 . . . . 1.97 110.305 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -99.89 119.92 38.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.76 -0.655 . . . . 3.54 109.287 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 252' ' ' SER . 91.1 m-85 -100.53 126.69 47.0 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.813 -0.44 . . . . 2.6400000000000001 109.813 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -116.25 121.46 5.21 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.798 -0.715 . . . . 1.3500000000000001 111.607 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' TYR . . . . . 0.442 ' HB2' ' HB ' ' A' ' 251' ' ' VAL . 89.7 m-85 -119.94 130.25 54.71 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.802 -0.444 . . . . 4.3600000000000003 109.802 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -112.65 128.7 56.46 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.456 -0.572 . . . . 4.29 109.456 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.92 140.19 51.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.159 0.505 . . . . 6.6900000000000004 110.391 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -60.0 -29.49 68.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.058 -0.974 . . . . 6.3700000000000001 112.24 -171.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -69.47 -20.01 63.75 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.607 0.241 . . . . 5.8300000000000001 111.486 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 116.22 0.0 20.76 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.548 -0.834 . . . . 2.6600000000000001 112.259 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.433 HD13 ' CD2' ' A' ' 279' ' ' TYR . 53.5 tp -74.98 129.96 38.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.869 0.366 . . . . 2.9700000000000002 110.256 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 25.8 t -122.06 130.26 53.12 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.261 -0.644 . . . . 2.1699999999999999 109.261 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 243' ' ' TYR . 62.9 t -119.99 132.85 68.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.42 -0.355 . . . . 1.79 110.666 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 241' ' ' TYR . 35.2 t -127.73 128.45 45.39 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.068 -0.716 . . . . 1.6299999999999999 109.068 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 81.6 mt -121.38 139.93 52.79 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.652 -0.249 . . . . 2.96 110.82 -178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -114.35 110.67 20.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.182 -0.463 . . . . 4.0800000000000001 110.536 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -131.92 148.67 52.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.35 -0.386 . . . . 4.8399999999999999 110.34 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -111.66 19.97 17.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.24 0.543 . . . . 3.5800000000000001 110.087 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -126.84 113.99 17.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.812 -0.631 . . . . 6.7699999999999996 109.971 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.411 ' HG2' ' CD1' ' A' ' 259' ' ' TRP . 72.4 tt0 -70.18 -41.67 73.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.015 0.436 . . . . 8.5399999999999991 110.443 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' TRP . . . . . 0.411 ' CD1' ' HG2' ' A' ' 258' ' ' GLU . 90.5 m95 -133.77 93.98 3.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.977 -0.556 . . . . 11.9 110.544 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.59 ' HA ' ' OD1' ' A' ' 263' ' ' ASP . 97.9 mt-30 -59.85 -39.77 86.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.122 -0.49 . . . . 10.57 111.396 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -63.35 -21.54 66.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.972 -0.558 . . . . 11.41 111.611 -176.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -104.08 7.76 36.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.598 0.237 . . . . 11.98 111.41 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.59 ' OD1' ' HA ' ' A' ' 260' ' ' GLN . 10.4 m-20 -76.58 124.12 27.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.261 0.553 . . . . 12.460000000000001 111.49 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -70.03 -40.01 75.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.378 -0.828 . . . . 13.779999999999999 110.276 175.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 95.39 -22.4 39.02 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.737 -0.665 . . . . 11.07 112.816 176.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -70.03 -20.32 63.26 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.227 0.454 . . . . 12.59 112.227 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 51.8 m -59.95 -40.12 87.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.822 0.344 . . . . 10.92 111.681 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -127.01 132.79 50.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.297 -0.41 . . . . 12.42 110.03 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -70.12 -36.25 74.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.265 -0.425 . . . . 11.59 111.58 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -119.35 140.05 50.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.299 -0.409 . . . . 8.8300000000000001 110.179 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -130.04 138.17 50.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.145 -0.479 . . . . 7.0199999999999996 110.175 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -151.27 165.4 34.09 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.757 -0.46 . . . . 6.5999999999999996 109.757 176.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -138.94 170.55 15.79 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.607 -0.516 . . . . 1.9399999999999999 109.607 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.07 133.61 7.34 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.216 -0.992 . . . . 1.4199999999999999 112.343 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 61.8 t -127.86 129.82 69.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.956 -0.387 . . . . 1.8100000000000001 109.956 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -132.76 111.85 1.06 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.227 -0.749 . . . . 1.3 111.227 176.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 23.8 m -119.98 132.36 69.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.845 0.355 . . . . 1.8300000000000001 110.815 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -119.71 127.75 53.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.153 -0.476 . . . . 2.3100000000000001 110.368 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.433 ' CD2' HD13 ' A' ' 249' ' ' LEU . 89.6 m-85 -105.99 130.27 53.95 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.044 -0.725 . . . . 4.75 109.044 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.1 t -117.68 125.05 49.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.841 0.353 . . . . 1.6699999999999999 111.172 -172.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.281 -0.866 . . . . 3.6899999999999999 109.858 179.193 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.0 mtm . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 109.444 -0.576 . . . . 11.85 109.444 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.485 ' OE1' ' HB2' ' A' ' 4' ' ' ARG . 37.4 tt0 -151.01 143.94 24.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.048 0.451 . . . . 10.35 110.546 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.19 -39.88 88.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.387 -0.824 . . . . 9.3100000000000005 111.334 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.485 ' HB2' ' OE1' ' A' ' 2' ' ' GLU . 33.9 mtm180 -67.41 129.3 39.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.028 -0.533 . . . . 8.8399999999999999 110.663 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.418 ' HB3' ' OD1' ' A' ' 41' ' ' ASN . 83.5 m-20 -127.31 109.18 11.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.898 -0.592 . . . . 7.0099999999999998 109.815 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -72.51 125.67 28.0 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.816 -0.439 . . . . 3.6099999999999999 109.816 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -71.78 118.18 14.3 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.674 -0.491 . . . . 3.3300000000000001 109.674 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.468 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 96.4 m-70 -104.14 124.94 50.0 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.104 0.478 . . . . 3.2000000000000002 110.671 -176.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.97 139.94 51.7 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.422 -0.808 . . . . 2.4900000000000002 109.264 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -129.12 129.63 45.42 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.036 -0.728 . . . . 2.1299999999999999 109.036 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.6 mm -120.53 120.08 61.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.901 -0.407 . . . . 1.6000000000000001 109.901 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -102.74 137.69 13.53 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.065 -1.064 . . . . 0.88 111.331 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.17 135.36 54.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.921 0.391 . . . . 1.0800000000000001 110.248 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 59.4 ttm -134.6 130.95 37.24 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.696 -0.683 . . . . 2.3300000000000001 110.026 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -99.84 121.64 41.6 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.486 -0.561 . . . . 2.6099999999999999 109.486 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.64 140.17 55.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 5.0899999999999999 110.519 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.0 tt -129.86 138.42 54.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.907 0.384 . . . . 5.3300000000000001 110.102 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -110.03 147.96 32.57 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.033 0.444 . . . . 8.2799999999999994 110.375 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -70.03 -20.59 63.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.322 -0.854 . . . . 9.6999999999999993 111.593 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.2 t -120.46 129.96 74.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.735 -0.469 . . . . 11.09 109.735 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.57 -39.8 92.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.364 -0.835 . . . . 13.1 111.183 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.24 151.86 17.94 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.711 -0.757 . . . . 11.94 111.842 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -84.9 122.31 29.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.177 0.513 . . . . 15.18 111.662 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.3 -176.6 38.98 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.471 -0.786 . . . . 12.0 111.415 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -69.78 -35.65 75.07 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.771 0.32 . . . . 12.82 110.862 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -70.11 -19.9 63.21 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.933 0.397 . . . . 10.81 111.087 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 91.3 mtp -91.38 139.97 30.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.892 -0.594 . . . . 10.050000000000001 111.064 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -156.14 151.94 27.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.082 -0.508 . . . . 8.0600000000000005 110.13 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.27 -177.9 30.1 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.014 -0.612 . . . . 5.5800000000000001 111.614 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.4 mt -134.57 148.6 50.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.814 0.307 . . . . 5.5599999999999996 110.644 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.42 114.49 25.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.092 -0.504 . . . . 3.0499999999999998 109.804 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -123.49 152.4 64.79 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.897 0.379 . . . . 3.48 111.278 -171.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.38 133.59 28.68 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.088 1.859 . . . . 1.8600000000000001 110.679 171.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.8 m -128.45 147.25 50.65 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.561 -0.29 . . . . 1.97 110.654 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 19.5 m -120.13 146.69 24.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.382 -0.372 . . . . 1.71 110.475 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -119.96 142.65 48.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.03 -0.532 . . . . 4.0700000000000003 109.608 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 64.4 t80 -101.7 129.87 47.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.863 0.363 . . . . 2.8599999999999999 110.602 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -144.38 134.87 24.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.79 -0.641 . . . . 1.8899999999999999 109.351 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.74 146.7 39.87 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.309 -0.244 . . . . 1.0800000000000001 111.425 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 8' ' ' HIS . . . -154.95 122.53 5.7 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 111.936 0.347 . . . . 1.3899999999999999 111.936 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.656 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 53.8 t30 -167.87 95.56 0.43 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.391 -0.368 . . . . 2.8599999999999999 110.207 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.69 -94.72 2.02 Favored Glycine 0 C--O 1.23 -0.134 0 C-N-CA 121.012 -0.614 . . . . 1.6799999999999999 111.67 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.656 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 80.8 Cg_exo -47.19 175.74 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 123.912 3.075 . . . . 1.6599999999999999 113.357 167.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -66.1 176.68 1.62 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.428 0.632 . . . . 3.3999999999999999 111.441 -172.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.401 ' HG3' ' HB2' ' A' ' 40' ' ' ALA . 19.1 ttm180 -110.62 124.18 51.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.707 -0.678 . . . . 3.1000000000000001 109.649 -171.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.44 HG12 HG22 ' A' ' 74' ' ' VAL . 85.3 mt -119.58 130.01 74.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.664 -0.698 . . . . 1.8 110.915 -169.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -118.96 130.0 55.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.85999999999999999 110.419 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 72' ' ' LEU . 65.2 tp -124.57 135.66 53.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.138 -0.483 . . . . 1.0600000000000001 111.241 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.98 162.47 35.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.663 -0.699 . . . . 1.1399999999999999 110.121 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -137.42 146.87 44.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.821 0.344 . . . . 4.0199999999999996 110.345 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.436 ' HB2' ' HG3' ' A' ' 69' ' ' ARG . 96.1 m-85 -130.05 129.95 44.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.229 -0.441 . . . . 4.6100000000000003 111.306 -175.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -104.54 85.94 2.42 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.281 -0.637 . . . . 3.3799999999999999 109.281 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.552 ' CD ' HH21 ' A' ' 69' ' ' ARG . 42.2 mt-10 -129.04 154.09 46.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.857 -0.61 . . . . 5.0499999999999998 110.907 -173.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 154.96 133.51 1.74 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.707 -0.759 . . . . 4.3700000000000001 112.454 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.21 145.44 60.31 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.328 2.019 . . . . 6.6799999999999997 111.649 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.4 t -130.0 129.94 65.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.353 -0.385 . . . . 8.1699999999999999 110.607 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -124.61 -174.75 3.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.54 -0.541 . . . . 10.039999999999999 109.54 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -60.01 -40.01 87.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.596 0.236 . . . . 11.609999999999999 111.07 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.484 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 10.2 m -63.45 -50.17 70.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.012 0.434 . . . . 9.7899999999999991 110.778 -178.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.25 -38.52 81.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.736 -0.665 . . . . 8.5099999999999998 111.36 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -60.03 -24.18 60.35 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 116.047 -0.524 . . . . 7.5599999999999996 113.523 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' A' ' 59' ' ' SER . 55.1 mtmt -69.77 -26.31 64.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.544 0.211 . . . . 10.0 111.559 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -106.2 147.28 29.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.049 0.452 . . . . 10.35 110.806 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.99 46.3 3.54 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.586 -0.606 . . . . 5.3399999999999999 111.586 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.2 m -93.31 126.83 38.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.621 0.248 . . . . 5.3200000000000003 110.34 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -120.01 139.03 53.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.433 -0.349 . . . . 5.6100000000000003 110.616 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -125.66 138.65 53.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.459 -0.337 . . . . 3.7799999999999998 110.153 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -131.99 170.03 15.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.366 -0.379 . . . . 2.4500000000000002 110.173 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.552 HH21 ' CD ' ' A' ' 53' ' ' GLU . 27.9 ptt180 -141.84 125.7 9.96 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.979 0.418 . . . . 3.2400000000000002 111.196 171.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 90.9 Cg_endo -85.19 156.85 11.15 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.999 2.466 . . . . 1.1899999999999999 112.25 172.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.441 ' HG3' ' HE ' ' A' ' 93' ' ' ARG . 86.1 tt0 -127.09 120.77 29.7 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.123 -0.695 . . . . 2.1899999999999999 109.123 171.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.592 ' O ' ' HA3' ' A' ' 91' ' ' GLY . 64.3 tp -136.21 119.09 16.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.346 -0.388 . . . . 1.1399999999999999 110.208 -177.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.59 149.22 50.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.122 0.487 . . . . 2.1800000000000002 110.864 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 46' ' ' ILE . 50.6 t -119.96 130.04 74.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.447 -0.797 . . . . 1.5600000000000001 109.272 177.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -93.73 120.51 34.09 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.704 -0.48 . . . . 3.4399999999999999 109.704 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -108.2 134.85 50.47 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.105 -0.702 . . . . 4.7999999999999998 109.105 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -120.0 131.29 55.09 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.68 0.276 . . . . 2.9399999999999999 110.318 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -119.58 138.57 53.13 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.29 0.567 . . . . 3.8999999999999999 111.167 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 84' ' ' PHE . 37.0 mt -100.24 94.04 6.0 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.684 -0.858 . . . . 4.4800000000000004 108.684 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -90.02 -81.33 0.29 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.884 0.373 . . . . 6.1900000000000004 110.867 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -109.11 -40.01 5.1 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.994 -0.743 . . . . 5.4500000000000002 108.994 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -114.12 147.3 39.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.988 -1.006 . . . . 5.2699999999999996 108.966 174.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -71.34 125.03 25.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.081 -0.509 . . . . 6.3300000000000001 112.189 -173.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.483 ' H ' HD23 ' A' ' 79' ' ' LEU . 93.2 m-85 70.18 10.46 7.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.981 -1.008 . . . . 7.4800000000000004 112.4 172.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.3 m -60.38 -40.13 89.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.894 0.378 . . . . 2.5499999999999998 111.698 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -94.43 103.89 15.86 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.271 -0.572 . . . . 5.2999999999999998 109.65 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -113.97 125.65 6.99 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.979 -0.848 . . . . 1.3500000000000001 110.979 176.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 60.0 tp -119.64 130.53 55.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.837 0.351 . . . . 2.29 111.02 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.2 p -117.04 131.86 56.83 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.788 -0.819 . . . . 1.54 108.788 169.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.43 150.46 20.88 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.235 -0.983 . . . . 1.1699999999999999 111.585 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 72' ' ' LEU . . . -173.16 -169.96 36.23 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.632 -0.794 . . . . 1.1899999999999999 112.07 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -120.21 139.98 51.85 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.062 0.458 . . . . 3.75 110.819 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.441 ' HE ' ' HG3' ' A' ' 71' ' ' GLU . 98.2 mtt180 -121.04 127.21 51.5 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.492 -0.929 . . . . 2.75 108.492 172.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.553 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 10.4 t30 -132.25 124.61 29.26 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.78 -0.368 . . . . 1.8200000000000001 110.674 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.487 ' HA ' ' HB3' ' A' ' 69' ' ' ARG . 72.1 t80 -111.28 129.54 55.95 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.331 -0.395 . . . . 3.1400000000000001 110.435 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.3 -176.97 40.72 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.68 -0.772 . . . . 2.79 112.574 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -122.08 129.0 52.0 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.737 -0.468 . . . . 7.6200000000000001 109.737 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -70.27 -40.22 74.47 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.325 -0.62 . . . . 7.0800000000000001 109.325 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -107.67 124.25 49.7 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.364 -0.835 . . . . 10.16 109.525 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.66 HG12 ' H ' ' A' ' 102' ' ' GLU . 58.8 t -120.04 130.0 74.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.874 -0.417 . . . . 9.8100000000000005 109.874 -178.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -72.11 -10.05 59.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 12.220000000000001 112.123 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.66 ' H ' HG12 ' A' ' 100' ' ' VAL . 44.7 mt-10 -70.21 145.28 93.39 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.958 -0.386 . . . . 10.48 109.958 173.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.96 -10.59 28.77 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 C-N-CA 123.317 2.678 . . . . 9.0999999999999996 114.104 -172.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.65 141.57 28.71 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.455 -0.878 . . . . 6.46 112.331 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.62 -40.08 95.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.702 0.287 . . . . 7.6699999999999999 111.617 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -62.06 139.5 58.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.033 -0.53 . . . . 4.1399999999999997 111.17 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.2 t -141.51 173.51 11.43 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.522 -0.763 . . . . 3.2999999999999998 109.049 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.62 113.25 7.02 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.623 -0.431 . . . . 1.76 110.864 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -147.02 138.56 24.19 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.045 -0.525 . . . . 2.5499999999999998 110.139 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.493 ' HG3' ' HA ' ' A' ' 139' ' ' ALA . 46.4 ttm -131.65 129.91 41.4 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.622 -0.717 . . . . 1.77 110.71 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -101.87 124.96 48.39 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.491 -0.559 . . . . 1.97 109.491 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.42 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 80.6 ttt180 -130.55 130.15 43.71 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.134 0.492 . . . . 3.8500000000000001 110.328 -175.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -112.2 141.73 45.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.742 -0.663 . . . . 2.2799999999999998 110.79 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -139.89 123.59 17.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.177 -0.465 . . . . 2.1400000000000001 110.424 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 88.0 mt -136.76 130.15 45.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.513 -0.767 . . . . 1.55 109.039 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -149.46 104.19 3.28 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.678 0.622 . . . . 1.1899999999999999 112.678 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 65.0 Cg_endo -94.43 159.77 1.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.463 2.775 . . . . 1.3700000000000001 113.036 170.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -120.6 142.51 49.33 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.379 -0.971 . . . . 2.3500000000000001 108.379 173.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -125.78 129.92 50.41 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.474 0.176 . . . . 4.54 111.474 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -84.1 120.89 26.7 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.576 -0.527 . . . . 3.04 109.576 170.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.57 ' O ' ' HB3' ' A' ' 129' ' ' PHE . 57.3 t -139.88 99.92 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.886 0.375 . . . . 4.2699999999999996 110.282 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -87.61 115.92 25.38 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.113 -0.328 . . . . 6.04 110.113 176.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.78 -39.81 95.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.413 0.625 . . . . 4.5899999999999999 109.322 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.0 p -141.4 169.92 16.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.873 -1.058 . . . . 3.6899999999999999 109.178 172.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.14 -45.44 93.05 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.839 0.311 . . . . 5.1699999999999999 111.839 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -64.94 -39.95 94.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 3.71 111.552 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.5 mt -76.16 142.57 41.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.43 0.634 . . . . 2.0499999999999998 112.11 -172.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.541 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 35.2 ttt180 -110.31 118.07 35.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.252 -0.886 . . . . 4.2400000000000002 109.248 175.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.57 ' HB3' ' O ' ' A' ' 121' ' ' VAL . 65.0 t80 -142.11 138.48 31.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.728 0.299 . . . . 3.5499999999999998 110.372 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -139.87 172.2 13.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 2.1099999999999999 109.913 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -148.23 121.99 1.44 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.776 -0.726 . . . . 1.1799999999999999 112.072 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -100.02 126.52 46.22 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.389 -0.597 . . . . 4.2999999999999998 109.389 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 42.6 tp -111.98 130.71 55.76 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.26 -0.427 . . . . 2.2400000000000002 110.117 -178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.1 m -127.0 129.99 49.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.901 0.382 . . . . 1.6899999999999999 110.308 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.613 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 72.0 mtm -122.91 125.19 44.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.849 -0.614 . . . . 2.2400000000000002 109.958 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -122.17 139.94 53.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.116 -0.493 . . . . 3.5600000000000001 111.774 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -135.78 149.98 49.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.323 -0.991 . . . . 1.6699999999999999 108.323 172.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.475 ' O ' HD23 ' A' ' 142' ' ' LEU . 46.2 p90 -140.5 165.93 26.1 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.095 -0.335 . . . . 3.23 110.095 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.493 ' HA ' ' HG3' ' A' ' 110' ' ' MET . . . 63.42 178.15 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.512 0.507 . . . . 1.24 111.018 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -76.1 -36.63 58.82 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.313 0.578 . . . . 2.4700000000000002 110.6 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -60.07 -40.02 88.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.253 -0.885 . . . . 2.4100000000000001 112.956 -171.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 138' ' ' PHE . 4.2 mm? -69.38 -33.4 72.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.696 0.284 . . . . 1.8300000000000001 111.535 -173.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -66.62 -39.93 88.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.365 0.602 . . . . 2.0 109.517 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 52.4 m -65.77 -39.95 91.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.2 -0.909 . . . . 2.0499999999999998 111.395 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 22.9 p -71.7 -9.87 58.91 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 111.89 0.33 . . . . 1.5900000000000001 111.89 -177.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 65.43 -120.34 17.19 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.786 -0.721 . . . . 1.52 111.857 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -103.29 10.09 37.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.854 0.327 . . . . 5.9400000000000004 111.016 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.48 -40.12 95.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.885 0.374 . . . . 1.8300000000000001 110.499 176.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -137.14 114.87 11.27 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.298 -0.631 . . . . 2.6400000000000001 109.298 175.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.1 t -159.95 150.05 18.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.918 0.39 . . . . 2.02 110.543 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 135' ' ' MET . 19.0 mtp180 -84.47 113.35 21.14 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.051 -0.351 . . . . 3.6699999999999999 110.051 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.9 t -111.15 103.7 15.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.98 -0.748 . . . . 1.6399999999999999 108.98 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -121.99 128.91 52.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.549 -0.75 . . . . 2.5600000000000001 110.016 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 72.7 m -128.49 130.22 47.2 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.033 0.444 . . . . 1.3899999999999999 111.527 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.403 ' CD ' HH22 ' A' ' 195' ' ' ARG . 37.2 tt0 -110.4 119.22 38.5 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.01 -0.737 . . . . 2.04 109.01 173.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 172' ' ' TYR . 22.7 p -101.36 141.67 33.89 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.726 -0.39 . . . . 1.5600000000000001 110.727 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 129' ' ' PHE . . . -116.7 120.02 4.69 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.723 -0.751 . . . . 1.04 112.095 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.6 tp -115.2 129.76 56.73 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.91 0.386 . . . . 2.27 110.151 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.541 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 30.1 tt0 -118.98 115.85 25.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.521 -0.548 . . . . 2.4100000000000001 109.521 174.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -125.39 130.53 52.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.795 -0.638 . . . . 4.5700000000000003 110.218 -175.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 3.7 p -87.58 93.9 9.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.064 0.459 . . . . 1.46 110.853 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.475 ' HB2' HD11 ' A' ' 168' ' ' LEU . 65.8 t80 -59.99 -49.82 76.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 2.6299999999999999 111.547 -176.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.423 ' HB2' HG22 ' A' ' 166' ' ' VAL . 93.0 m-20 -101.8 16.65 25.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.544 -0.298 . . . . 2.4100000000000001 110.861 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 163' ' ' ASN . 46.0 tt0 73.03 -50.19 0.7 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.763 0.664 . . . . 2.5800000000000001 111.419 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.1 p -74.78 -21.41 59.34 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.037 0.384 . . . . 2.2999999999999998 112.037 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 161' ' ' THR . 34.3 m -120.03 138.16 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.776 0.322 . . . . 1.71 110.724 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.0 134.4 50.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.215 -0.448 . . . . 1.47 110.29 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.475 HD11 ' HB2' ' A' ' 162' ' ' PHE . 43.8 mt -103.55 139.92 38.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.34 -0.391 . . . . 1.6599999999999999 110.024 -176.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 55.6 mtp180 -98.9 114.36 26.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.212 -0.449 . . . . 3.2999999999999998 109.882 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 195' ' ' ARG . 60.3 t -129.16 132.3 67.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 1.3 110.569 -177.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.435 ' O ' HG23 ' A' ' 194' ' ' ILE . 18.9 m120 -122.52 147.91 45.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.971 0.415 . . . . 2.2200000000000002 110.868 173.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.53 ' HB3' ' OG1' ' A' ' 156' ' ' THR . 64.5 t80 -129.09 147.09 50.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.487 -0.779 . . . . 4.6100000000000003 109.811 -173.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -96.63 125.49 41.14 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 120.757 0.313 . . . . 3.98 110.714 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 67.7 tp -120.83 114.02 20.99 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.257 -0.645 . . . . 2.3799999999999999 109.257 171.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -125.18 113.43 17.66 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.629 -0.508 . . . . 3.3100000000000001 109.629 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.494 ' HD3' ' OE2' ' A' ' 188' ' ' GLU . 47.7 ttp180 -157.17 98.37 1.72 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.063 0.459 . . . . 6.5300000000000002 111.021 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -111.59 -136.56 6.99 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.104 -0.798 . . . . 5.0599999999999996 111.104 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -88.1 130.0 35.14 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.744 -0.465 . . . . 7.3899999999999997 109.744 176.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -79.1 120.9 24.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.808 0.337 . . . . 9.0700000000000003 110.427 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 92.8 mtp -70.02 -40.02 75.47 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.661 -0.866 . . . . 10.869999999999999 108.661 173.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -143.0 109.78 5.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.783 -1.099 . . . . 10.449999999999999 109.202 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -60.89 128.94 38.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.972 0.415 . . . . 13.06 110.502 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 12.0 p -117.21 163.91 15.59 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.023 -0.535 . . . . 12.609999999999999 110.698 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -59.93 -40.18 88.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.272 0.558 . . . . 15.19 110.018 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -119.83 122.41 41.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.503 -0.771 . . . . 13.18 109.811 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -84.23 -23.62 30.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.262 0.553 . . . . 12.73 109.778 175.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 99.38 7.71 53.9 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.371 -0.831 . . . . 9.9800000000000004 111.479 -175.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.494 ' OE2' ' HD3' ' A' ' 176' ' ' ARG . 39.2 mt-10 -60.46 -39.98 89.57 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.593 0.357 . . . . 10.699999999999999 111.267 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -101.29 28.15 5.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.167 0.508 . . . . 10.5 110.995 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.7 t -139.73 159.97 40.96 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.134 -0.691 . . . . 6.6399999999999997 109.134 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.4 m -140.64 130.19 24.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.096 0.474 . . . . 4.9800000000000004 110.809 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -63.36 -40.68 97.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.617 -0.72 . . . . 7.0999999999999996 111.165 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.461 ' HA ' ' HG3' ' A' ' 212' ' ' ARG . 35.8 tt0 -158.94 131.13 6.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.299 -0.409 . . . . 4.4000000000000004 110.077 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 171' ' ' ASN . 87.3 mt -110.2 143.29 20.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 122.358 0.263 . . . . 2.21 111.188 -173.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.583 ' HB3' ' CD1' ' A' ' 210' ' ' TYR . 53.9 mtm-85 -98.41 102.84 14.7 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.904 -0.776 . . . . 3.54 108.904 169.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 169' ' ' ARG . . . -141.08 121.7 14.22 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.918 -0.313 . . . . 1.6699999999999999 111.014 177.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.405 ' HB3' ' O ' ' A' ' 209' ' ' PRO . 10.2 t80 -165.76 -179.11 5.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.648 -0.501 . . . . 5.8300000000000001 109.648 171.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.551 HD12 ' HD2' ' A' ' 199' ' ' PRO . 24.3 tp -99.44 126.58 37.09 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.315 -0.624 . . . . 2.5899999999999999 109.315 173.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.551 ' HD2' HD12 ' A' ' 198' ' ' LEU . 38.3 Cg_endo -70.06 145.79 56.46 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.139 1.892 . . . . 1.77 112.225 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 56.1 mt -118.41 130.72 56.13 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.085 -0.507 . . . . 2.2599999999999998 109.655 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 26.8 m -131.12 125.15 32.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.983 0.42 . . . . 1.99 110.996 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 91.8 mt -131.37 80.97 1.96 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.57 -0.741 . . . . 2.3100000000000001 109.47 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 68.62 -115.83 6.94 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.802 -0.713 . . . . 1.51 112.105 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -90.12 -0.59 57.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.209 0.528 . . . . 2.5699999999999998 110.117 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.418 ' HA ' ' CE2' ' A' ' 243' ' ' TYR . 72.9 m-70 -99.9 117.23 33.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.539 -0.755 . . . . 2.6600000000000001 109.01 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 12.5 t -132.14 130.97 41.82 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.629 -0.428 . . . . 1.6200000000000001 110.24 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.8 p -137.56 134.98 46.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.408 0.623 . . . . 1.3799999999999999 110.862 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 29.0 m -128.95 91.78 41.74 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 115.667 -0.697 . . . . 1.1799999999999999 109.846 176.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.405 ' O ' ' HB3' ' A' ' 197' ' ' TYR . 14.4 Cg_exo -69.74 157.16 61.4 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.599 2.199 . . . . 1.01 110.664 174.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 195' ' ' ARG . 71.0 m-85 -129.29 139.79 51.66 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.997 -0.372 . . . . 4.5 109.997 175.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 39.5 p -124.25 140.02 53.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.987 0.422 . . . . 1.8899999999999999 110.385 176.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.669 ' HD3' ' OD1' ' A' ' 235' ' ' ASN . 37.7 ttt180 -64.27 -39.67 94.41 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 114.795 -1.093 . . . . 4.7999999999999998 112.748 -170.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.9 mt -108.0 129.93 61.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.742 0.306 . . . . 4.5700000000000003 110.383 -174.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -70.44 94.87 0.5 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.92 -0.582 . . . . 4.9800000000000004 112.747 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 57.6 tp -60.23 -38.68 84.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.994 0.425 . . . . 8.1099999999999994 110.354 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -80.48 9.33 6.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.673 -0.694 . . . . 7.6500000000000004 111.491 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -115.77 139.9 49.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.952 0.406 . . . . 10.529999999999999 110.974 176.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -109.51 132.32 54.24 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.039 -0.528 . . . . 11.56 109.878 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.1 m -95.4 112.53 24.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.465 -0.334 . . . . 10.06 110.43 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -69.98 -37.28 75.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.318 0.58 . . . . 11.92 109.886 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 21.2 m-90 -120.93 153.02 37.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.648 -0.706 . . . . 14.01 110.218 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 60.25 39.51 19.02 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.882 0.739 . . . . 14.529999999999999 110.95 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -94.5 119.96 34.0 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.776 -0.824 . . . . 16.609999999999999 108.776 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -129.47 146.49 51.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.838 0.351 . . . . 15.460000000000001 111.096 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -60.95 -39.32 89.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.328 -0.851 . . . . 15.67 110.622 176.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -60.04 -39.97 87.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.685 -0.688 . . . . 14.5 111.386 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 88.7 mt -63.74 -25.31 37.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.39 -0.368 . . . . 15.15 111.356 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -59.97 -39.95 87.4 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.124 0.488 . . . . 14.73 111.22 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -118.17 137.71 52.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.962 -0.563 . . . . 16.379999999999999 110.526 -170.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.507 ' HG2' ' ND2' ' A' ' 235' ' ' ASN . 47.8 mt-10 -69.46 -34.44 74.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.206 -0.906 . . . . 12.779999999999999 111.134 -172.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 77.69 -132.57 12.07 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.624 -0.798 . . . . 11.1 112.501 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -70.1 -39.96 75.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.818 0.342 . . . . 12.26 111.284 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -89.97 160.16 16.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.09 -0.504 . . . . 9.9900000000000002 111.014 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -119.94 140.08 51.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.022 -0.536 . . . . 10.43 109.937 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.669 ' OD1' ' HD3' ' A' ' 212' ' ' ARG . 48.9 m-80 -79.1 136.75 37.24 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.777 -0.453 . . . . 6.29 109.777 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -73.0 121.75 20.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.254 0.55 . . . . 8.1500000000000004 111.251 -174.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 210' ' ' TYR . 71.0 t -113.58 129.34 69.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.285 -0.871 . . . . 2.3999999999999999 110.031 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -110.39 141.79 16.42 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.599 -0.81 . . . . 1.27 111.807 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 88.9 mt -109.72 117.65 34.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.158 -0.312 . . . . 1.97 110.158 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -101.09 120.11 39.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.205 -0.452 . . . . 3.54 109.95 175.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.555 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 86.8 m-85 -111.94 130.19 55.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.097 0.475 . . . . 2.6400000000000001 110.349 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -121.32 113.7 2.39 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 111.027 -0.829 . . . . 1.3500000000000001 111.027 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' TYR . . . . . 0.418 ' CE2' ' HA ' ' A' ' 205' ' ' HIS . 86.5 m-85 -119.96 135.25 54.98 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.178 0.513 . . . . 4.3600000000000003 111.501 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -110.0 100.82 9.71 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.408 -0.815 . . . . 4.29 109.077 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -77.55 -19.95 54.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.976 0.417 . . . . 6.6900000000000004 110.959 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -149.93 150.46 31.91 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.738 -0.838 . . . . 6.3700000000000001 108.738 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -66.97 121.68 16.06 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.423 -0.511 . . . . 5.8300000000000001 109.682 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 98.53 -9.71 62.65 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.778 -0.646 . . . . 2.6600000000000001 112.43 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 93.1 mt -124.23 133.0 53.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.721 0.296 . . . . 2.9700000000000002 110.616 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 33.7 m -129.98 149.96 51.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.368 -0.378 . . . . 2.1699999999999999 110.772 -176.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 8.5 p -127.41 134.07 66.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.17 0.51 . . . . 1.79 109.845 174.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 19.3 t -103.9 119.89 39.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.716 -0.674 . . . . 1.6299999999999999 109.747 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 77.9 mt -119.42 113.05 20.18 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.145 -0.479 . . . . 2.96 110.068 -178.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -109.05 129.55 55.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.945 0.402 . . . . 4.0800000000000001 111.036 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -128.14 151.3 49.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.823 -0.626 . . . . 4.8399999999999999 110.441 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -134.49 146.98 50.26 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.164 -0.471 . . . . 3.5800000000000001 110.568 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -78.77 159.94 27.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.092 -0.504 . . . . 6.7699999999999996 110.29 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 60.06 39.57 19.61 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.507 0.504 . . . . 8.5399999999999991 111.134 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -69.98 -30.02 67.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.766 -0.652 . . . . 11.9 112.467 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -67.92 -40.75 83.32 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.647 0.261 . . . . 10.57 111.409 -173.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -104.32 114.89 29.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.911 -0.403 . . . . 11.41 109.911 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -93.6 74.03 4.37 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.144 -0.48 . . . . 11.98 111.438 -175.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -74.5 124.9 27.45 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.461 -0.57 . . . . 12.460000000000001 109.461 171.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -68.47 -40.0 81.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.637 -0.71 . . . . 13.779999999999999 110.985 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.85 17.32 68.03 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.523 -0.762 . . . . 11.07 111.972 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 60.04 39.38 19.92 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.305 0.574 . . . . 12.59 110.534 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 34.5 t -146.81 138.16 24.24 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.629 -0.714 . . . . 10.92 110.127 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -80.1 -10.17 59.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.282 0.563 . . . . 12.42 109.979 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -89.12 120.26 30.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.522 -0.763 . . . . 11.59 109.534 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -135.99 160.79 37.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.145 -0.479 . . . . 8.8300000000000001 110.695 -174.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -84.4 113.08 20.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.043 -0.526 . . . . 7.0199999999999996 110.92 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -82.73 130.09 35.07 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.064 -0.717 . . . . 6.5999999999999996 109.064 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -134.62 140.59 46.18 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.445 -0.206 . . . . 1.9399999999999999 110.445 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 177.69 -169.74 41.86 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.747 -0.739 . . . . 1.4199999999999999 112.333 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 63.2 t -110.12 128.89 65.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.867 0.365 . . . . 1.8100000000000001 110.667 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.86 141.21 12.46 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.508 -0.637 . . . . 1.3 111.508 176.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 61.6 t -120.02 129.96 74.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 117.093 0.447 . . . . 1.8300000000000001 110.162 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -108.11 109.33 20.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.935 0.398 . . . . 2.3100000000000001 110.058 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -100.02 107.9 19.96 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.872 -0.788 . . . . 4.75 108.872 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.6 m -119.54 132.27 55.71 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.998 0.428 . . . . 1.6699999999999999 111.248 -172.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 59.2 t80 . . . . . 0 C--O 1.241 0.617 0 CA-C-O 118.411 -0.804 . . . . 3.6899999999999999 109.225 176.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.425 0.155 . . . . 11.85 111.181 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -60.04 -39.55 86.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.392 0.615 . . . . 10.35 110.408 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -85.32 8.16 19.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.524 -0.762 . . . . 9.3100000000000005 111.547 -175.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -126.75 152.78 46.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.786 0.327 . . . . 8.8399999999999999 111.038 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -113.63 164.07 14.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.112 -0.494 . . . . 7.0099999999999998 110.892 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -60.85 -43.37 98.42 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.162 0.506 . . . . 3.6099999999999999 111.322 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.517 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 71.0 m95 -119.79 147.24 44.88 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.151 -0.685 . . . . 3.3300000000000001 109.151 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.662 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 25.9 t60 -96.44 113.37 24.94 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.624 -0.51 . . . . 3.2000000000000002 109.624 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.517 ' CE1' ' HB2' ' A' ' 7' ' ' TRP . 95.0 m-85 -110.41 158.88 18.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.904 -0.589 . . . . 2.4900000000000002 111.108 -176.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -141.42 132.3 25.93 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.809 -0.632 . . . . 2.1299999999999999 109.326 170.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.5 mt -119.8 114.09 43.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.974 -0.75 . . . . 1.6000000000000001 108.974 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.81 127.25 8.18 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.265 -0.969 . . . . 0.88 112.128 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -115.69 134.45 55.02 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 110.057 -0.349 . . . . 1.0800000000000001 110.057 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.607 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 94.8 mmm -124.31 131.03 53.5 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.859 -0.61 . . . . 2.3300000000000001 109.372 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -85.82 109.1 18.44 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.769 -0.456 . . . . 2.6099999999999999 109.769 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -96.2 114.37 26.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.145 0.498 . . . . 5.0899999999999999 110.706 -175.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 88.2 mt -119.87 121.31 65.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.401 -0.818 . . . . 5.3300000000000001 110.382 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -119.93 138.3 53.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.174 0.511 . . . . 8.2799999999999994 110.042 176.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -60.18 -39.91 88.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.101 -0.954 . . . . 9.6999999999999993 111.403 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.7 t -83.51 118.97 31.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.936 -0.575 . . . . 11.09 110.532 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -66.29 -39.87 89.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.271 -0.877 . . . . 13.1 109.975 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.22 -171.88 30.05 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.214 -0.903 . . . . 11.94 112.036 177.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -139.69 150.05 44.42 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.135 -0.32 . . . . 15.18 110.135 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.5 151.88 7.43 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.73 -0.748 . . . . 12.0 112.453 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -59.9 -40.06 87.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.853 0.359 . . . . 12.82 111.513 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -82.2 0.15 42.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.836 -0.62 . . . . 10.81 111.801 -173.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 93.6 mmm -100.63 109.33 21.39 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.829 0.347 . . . . 10.050000000000001 110.88 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -69.56 -39.68 77.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.967 -0.561 . . . . 8.0600000000000005 110.778 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.82 3.3 74.06 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.948 -0.644 . . . . 5.5800000000000001 111.916 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.4 mt -92.15 137.87 32.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.668 0.27 . . . . 5.5599999999999996 110.565 -178.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.43 133.9 37.43 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.445 -0.576 . . . . 3.0499999999999998 109.445 175.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -140.29 150.05 59.98 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-O 120.855 0.359 . . . . 3.48 111.026 -173.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 14' ' ' MET . 76.9 Cg_endo -81.2 135.31 9.57 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.669 2.246 . . . . 1.8600000000000001 112.198 172.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 56.2 m -103.21 142.36 34.29 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.421 -0.585 . . . . 1.97 109.421 174.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 m -110.87 134.47 53.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.28 0.562 . . . . 1.71 111.309 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -119.9 132.08 55.43 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.59 -0.732 . . . . 4.0700000000000003 109.817 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 94.1 m-85 -105.37 127.95 53.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.031 -0.359 . . . . 2.8599999999999999 110.031 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.414 HD21 ' HD2' ' A' ' 45' ' ' ARG . 46.3 t30 -130.89 138.02 49.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.947 -0.39 . . . . 1.8899999999999999 109.947 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.57 143.13 50.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.711 -0.222 . . . . 1.0800000000000001 110.691 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.662 ' O ' ' HB3' ' A' ' 8' ' ' HIS . . . -154.14 117.37 4.54 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.366 -0.379 . . . . 1.3899999999999999 111.33 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.479 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 25.4 t-20 -163.49 95.42 0.82 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.642 -0.503 . . . . 2.8599999999999999 109.642 173.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.82 -97.59 2.31 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.037 -0.601 . . . . 1.6799999999999999 111.76 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 51.3 Cg_exo -55.3 174.16 0.26 Allowed 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.52 2.813 . . . . 1.6599999999999999 113.515 172.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.523 ' HB3' ' O ' ' A' ' 75' ' ' HIS . 24.4 m-90 -70.15 -176.24 1.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.551 -0.749 . . . . 3.3999999999999999 111.064 -175.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.536 ' HG2' ' HB2' ' A' ' 40' ' ' ALA . 36.7 mtm-85 -112.06 149.96 31.35 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.529 0.68 . . . . 3.1000000000000001 112.732 -163.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.497 HG22 HG12 ' A' ' 74' ' ' VAL . 47.5 pt -128.88 140.05 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 114.606 -1.179 . . . . 1.8 110.244 175.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -120.06 128.88 53.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.189 -0.46 . . . . 0.85999999999999999 110.09 177.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.6 tp -125.19 136.59 53.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.102 0.477 . . . . 1.0600000000000001 110.922 -176.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.76 168.15 20.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.456 -0.793 . . . . 1.1399999999999999 109.376 176.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -140.02 145.58 37.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.588 0.232 . . . . 4.0199999999999996 110.665 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.572 ' HB2' ' CG ' ' A' ' 69' ' ' ARG . 89.6 m-85 -135.75 148.97 49.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.307 -0.406 . . . . 4.6100000000000003 109.937 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -136.43 170.22 16.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.619 -0.264 . . . . 3.3799999999999999 111.323 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.91 -48.87 79.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.938 -0.574 . . . . 5.0499999999999998 110.774 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -169.19 155.83 26.5 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.247 -0.741 . . . . 4.3700000000000001 111.247 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.17 -48.45 11.95 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.631 2.221 . . . . 6.6799999999999997 112.033 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.02 130.12 65.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.935 -0.765 . . . . 8.1699999999999999 108.935 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -96.53 129.9 43.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.782 0.325 . . . . 10.039999999999999 110.728 -176.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -116.43 19.02 14.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.251 -0.431 . . . . 11.609999999999999 111.494 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.6 t -100.13 130.83 46.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.293 0.568 . . . . 9.7899999999999991 110.874 -176.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.64 0.03 57.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.883 -0.599 . . . . 8.5099999999999998 110.678 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.2 -11.15 84.66 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.79 -0.719 . . . . 7.5599999999999996 112.189 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -99.96 122.51 42.98 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.481 -0.562 . . . . 10.0 109.481 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -62.47 -40.0 95.24 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.66 -0.7 . . . . 10.35 112.114 -173.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.7 40.65 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.468 -0.872 . . . . 5.3399999999999999 112.09 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.4 t -159.98 151.2 19.46 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.123 -0.695 . . . . 5.3200000000000003 109.123 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 35.6 p90 -133.8 169.97 16.28 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.83 -0.433 . . . . 5.6100000000000003 109.83 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.522 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 95.0 m-85 -109.2 127.64 54.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.039 0.447 . . . . 3.7799999999999998 111.057 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -97.2 166.45 11.56 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.761 -0.654 . . . . 2.4500000000000002 110.637 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.572 ' CG ' ' HB2' ' A' ' 51' ' ' TYR . 6.6 ptp180 -150.48 125.53 4.76 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 121.113 0.483 . . . . 3.2400000000000002 110.577 171.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 75.6 Cg_endo -89.41 158.78 5.47 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.005 2.47 . . . . 1.1899999999999999 112.268 172.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.651 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 39.5 tt0 -131.25 111.72 12.15 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.351 -0.611 . . . . 2.1899999999999999 109.351 173.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.8 tp -125.01 120.0 30.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.278 -0.419 . . . . 1.1399999999999999 110.424 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 39.0 tt0 -121.38 130.05 53.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.657 -0.497 . . . . 2.1800000000000002 109.657 177.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.497 HG12 HG22 ' A' ' 46' ' ' ILE . 29.6 m -112.67 136.38 49.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.986 0.422 . . . . 1.5600000000000001 109.961 -177.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.523 ' O ' ' HB3' ' A' ' 44' ' ' TRP . 63.2 m80 -116.64 119.6 36.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.081 -0.508 . . . . 3.4399999999999999 110.837 -171.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -113.62 126.08 54.88 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.099 -0.704 . . . . 4.7999999999999998 109.099 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -120.3 134.08 55.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.954 0.406 . . . . 2.9399999999999999 110.708 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -90.6 86.49 6.41 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.514 -0.766 . . . . 3.8999999999999999 109.158 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.7 mt -108.28 15.83 23.73 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.439 -0.949 . . . . 4.4800000000000004 108.439 174.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.52 -39.82 94.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.056 -1.429 . . . . 6.1900000000000004 111.345 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -125.02 135.97 53.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.853 0.358 . . . . 5.4500000000000002 110.665 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -70.11 -19.01 63.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.614 -0.721 . . . . 5.2699999999999996 112.811 -174.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -60.04 -40.06 88.09 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.159 0.429 . . . . 6.3300000000000001 112.159 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -153.13 160.1 42.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.676 0.274 . . . . 7.4800000000000004 110.663 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.4 m -118.86 130.11 55.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.204 0.526 . . . . 2.5499999999999998 110.249 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -130.56 149.65 52.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.587 -0.894 . . . . 5.2999999999999998 108.587 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.23 154.13 21.84 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.033 -1.08 . . . . 1.3500000000000001 112.708 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.2 mt -134.93 129.87 34.97 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.172 -0.677 . . . . 2.29 109.172 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.1 t -133.96 139.47 46.12 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.111 0.481 . . . . 1.54 110.409 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 73' ' ' GLU . . . -132.96 132.79 6.71 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 111.34 -0.704 . . . . 1.1699999999999999 111.34 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.11 123.23 5.6 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.884 -0.674 . . . . 1.1899999999999999 111.892 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -112.01 122.12 46.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.633 0.254 . . . . 3.75 110.541 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.651 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 72.1 mtm180 -131.36 129.78 41.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.307 -0.406 . . . . 2.75 110.064 173.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.482 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 64.2 t30 -128.51 117.72 21.8 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.958 -0.386 . . . . 1.8200000000000001 109.958 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -109.84 126.67 54.06 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.742 0.306 . . . . 3.1400000000000001 110.372 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 67' ' ' PHE . . . 89.03 179.9 45.59 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.201 -0.999 . . . . 2.79 112.233 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -121.39 129.65 53.15 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.032 -0.358 . . . . 7.6200000000000001 110.032 -178.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.494 ' HB2' ' CB ' ' A' ' 109' ' ' ASN . 53.3 t-80 -108.44 110.02 21.44 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.297 -0.631 . . . . 7.0800000000000001 109.297 176.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -101.08 105.95 17.17 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.952 0.406 . . . . 10.16 110.94 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.7 t -76.28 -22.26 15.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.989 -0.745 . . . . 9.8100000000000005 108.989 174.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.522 ' C ' ' HD3' ' A' ' 103' ' ' PRO . 28.7 m-20 -69.95 -10.18 57.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.793 -1.094 . . . . 12.220000000000001 111.148 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -119.22 68.13 9.51 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.492 -0.322 . . . . 10.48 110.746 -176.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.522 ' HD3' ' C ' ' A' ' 101' ' ' ASP . 12.4 Cg_exo -70.18 134.22 26.59 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.511 2.141 . . . . 9.0999999999999996 111.545 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.03 -3.5 82.65 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.565 -0.826 . . . . 6.46 112.374 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -113.86 138.01 50.89 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.783 -0.451 . . . . 7.6699999999999999 109.783 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -64.71 132.36 49.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.097 0.475 . . . . 4.1399999999999997 110.894 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.4 t -131.85 143.56 50.26 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.667 -0.864 . . . . 3.2999999999999998 108.667 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -119.39 115.29 23.79 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 120.631 -0.427 . . . . 1.76 110.921 -173.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.494 ' CB ' ' HB2' ' A' ' 98' ' ' HIS . 29.0 t-20 -153.53 137.41 16.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.887 -0.597 . . . . 2.5499999999999998 111.593 -175.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 44.6 ttm -132.33 123.63 27.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.558 -0.746 . . . . 1.77 109.863 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.499 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 78.3 mt-30 -107.25 127.24 53.36 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 120.123 -0.631 . . . . 1.97 110.212 175.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.551 ' HB2' ' HB2' ' A' ' 93' ' ' ARG . 95.4 mtt180 -110.13 113.36 25.98 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.999 -0.741 . . . . 3.8500000000000001 108.999 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -107.4 122.56 46.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.965 -0.561 . . . . 2.2799999999999998 111.036 -176.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -114.71 123.77 50.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.651 -0.704 . . . . 2.1400000000000001 109.986 175.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 11.8 tt -131.12 129.82 63.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.932 -0.396 . . . . 1.55 109.932 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -149.93 121.16 4.03 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.558 -0.292 . . . . 1.1899999999999999 111.482 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -90.3 135.61 2.22 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 122.916 2.411 . . . . 1.3700000000000001 111.371 169.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -104.12 139.64 38.91 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.436 -0.579 . . . . 2.3500000000000001 109.436 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -132.21 140.66 48.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.377 0.608 . . . . 4.54 111.413 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -134.43 79.14 1.79 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.902 -1.045 . . . . 3.04 108.406 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.525 ' O ' ' HB3' ' A' ' 129' ' ' PHE . 63.1 t -129.99 125.39 60.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.758 -0.655 . . . . 4.2699999999999996 110.518 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.476 ' HD3' ' HB2' ' A' ' 129' ' ' PHE . 59.4 tptt -140.3 135.73 32.54 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.311 -0.626 . . . . 6.04 109.311 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.9 tp -60.52 -31.32 70.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.557 -0.747 . . . . 4.5899999999999999 111.921 -176.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.414 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 21.9 m -108.35 135.3 49.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.941 0.4 . . . . 3.6899999999999999 110.106 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -63.01 -39.79 95.81 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.28 -0.873 . . . . 5.1699999999999999 112.181 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -70.0 -15.47 63.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.906 -0.588 . . . . 3.71 111.234 -176.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.8 mt -111.82 154.22 25.43 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.908 -0.587 . . . . 2.0499999999999998 110.058 -173.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -130.88 136.88 49.03 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.539 -0.464 . . . . 4.2400000000000002 110.985 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.525 ' HB3' ' O ' ' A' ' 121' ' ' VAL . 65.2 t80 -123.31 120.42 33.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.79 -0.641 . . . . 3.5499999999999998 109.73 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -122.81 136.84 55.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.784 0.326 . . . . 2.1099999999999999 111.202 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -160.75 149.98 19.55 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.277 -0.729 . . . . 1.1799999999999999 111.277 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -148.33 148.03 29.94 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.119 -0.326 . . . . 4.2999999999999998 110.119 176.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 67.9 tp -116.79 117.93 31.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.332 -0.395 . . . . 2.2400000000000002 110.755 -175.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.5 t -104.99 118.41 36.45 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.805 0.336 . . . . 1.6899999999999999 110.577 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 64.6 mtt -108.86 121.63 45.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.226 -0.657 . . . . 2.2400000000000002 109.226 171.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.415 ' OH ' ' HD3' ' A' ' 112' ' ' ARG . 64.9 t80 -116.53 136.79 52.69 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.655 -0.702 . . . . 3.5600000000000001 111.068 -171.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -130.17 150.86 51.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.63 -0.713 . . . . 1.6699999999999999 109.813 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -139.55 159.94 41.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.571 0.224 . . . . 3.23 110.431 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 60.22 -177.03 0.1 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.552 -0.749 . . . . 1.24 111.001 -175.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -77.65 -24.67 49.37 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.087 0.47 . . . . 2.4700000000000002 110.515 172.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.95 -51.38 69.93 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.409 -0.814 . . . . 2.4100000000000001 112.575 -172.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.5 mp -70.17 -29.11 65.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.03 0.443 . . . . 1.8300000000000001 111.2 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.499 ' ND2' ' HB2' ' A' ' 111' ' ' GLN . 95.0 m-20 -68.79 -39.75 80.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.532 -0.304 . . . . 2.0 110.809 178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.3 p -70.11 -32.1 69.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.577 -0.283 . . . . 2.0499999999999998 111.481 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.4 p -80.36 -20.21 44.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.234 0.54 . . . . 1.5900000000000001 110.845 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.84 -114.35 5.26 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.694 -0.684 . . . . 1.52 112.381 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -99.98 3.65 44.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.566 0.222 . . . . 5.9400000000000004 111.162 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.82 -40.04 76.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.022 0.439 . . . . 1.8300000000000001 110.02 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -129.83 99.34 5.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.55 -0.75 . . . . 2.6400000000000001 109.788 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.9 t -148.81 159.06 44.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.06 -0.518 . . . . 2.02 109.833 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 135' ' ' MET . 42.1 ttm180 -93.68 123.38 36.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.204 -0.453 . . . . 3.6699999999999999 109.881 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.0 t -112.48 120.58 63.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.493 -0.321 . . . . 1.6399999999999999 110.58 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -143.17 130.03 20.49 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.0 -0.37 . . . . 2.5600000000000001 110.0 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.437 ' HB ' ' CD1' ' A' ' 133' ' ' LEU . 10.1 t -136.58 146.72 46.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.011 0.434 . . . . 1.3899999999999999 110.965 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -119.98 139.55 52.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.215 -0.448 . . . . 2.04 110.351 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 22.6 m -117.03 122.98 45.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.095 -0.502 . . . . 1.5600000000000001 110.297 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -117.79 121.86 5.23 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.722 -0.551 . . . . 1.04 111.722 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.432 ' HB3' ' CE2' ' A' ' 160' ' ' TYR . 92.2 mt -108.38 135.09 50.26 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 122.274 0.23 . . . . 2.27 110.382 -177.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 168' ' ' LEU . 63.8 tt0 -123.36 115.89 22.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.758 0.314 . . . . 2.4100000000000001 110.178 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 158' ' ' LEU . 82.9 m-85 -130.92 139.95 50.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.23 -0.441 . . . . 4.5700000000000003 110.867 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 22.9 p -96.93 92.76 6.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.09 -0.505 . . . . 1.46 110.973 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PHE . . . . . 0.506 ' CD2' HD12 ' A' ' 168' ' ' LEU . 61.3 m-85 -70.04 -39.91 75.45 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.163 0.431 . . . . 2.6299999999999999 112.163 -176.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.533 ' HB2' HG22 ' A' ' 166' ' ' VAL . 88.7 m-20 -100.3 13.38 34.55 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.776 -0.37 . . . . 2.4100000000000001 110.908 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 73.12 -52.06 0.71 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.873 0.733 . . . . 2.5800000000000001 111.79 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.2 p -74.66 -20.58 59.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.715 0.293 . . . . 2.2999999999999998 111.705 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.533 HG22 ' HB2' ' A' ' 163' ' ' ASN . 35.8 m -116.68 137.91 48.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.89 0.376 . . . . 1.71 110.836 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.8 123.07 47.61 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.077 -0.51 . . . . 1.47 110.131 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.506 HD12 ' CD2' ' A' ' 162' ' ' PHE . 21.7 mt -103.8 140.53 37.51 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.72 -0.474 . . . . 1.6599999999999999 109.72 -177.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -115.18 125.46 53.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.935 0.398 . . . . 3.2999999999999998 110.383 -176.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.5 t -128.44 129.57 68.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.561 -0.533 . . . . 1.3 109.561 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.543 ' OD1' ' HB2' ' A' ' 195' ' ' ARG . 28.7 p-10 -133.74 148.72 51.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.302 0.572 . . . . 2.2200000000000002 111.575 -177.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -145.36 151.43 38.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.347 -0.842 . . . . 4.6100000000000003 110.071 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -101.18 128.91 47.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.428 0.632 . . . . 3.98 111.55 -173.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.423 ' HB3' HG23 ' A' ' 154' ' ' THR . 48.4 tp -120.06 124.24 45.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.327 -0.851 . . . . 2.3799999999999999 109.499 -176.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -70.01 -43.4 71.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.229 0.537 . . . . 3.3100000000000001 111.061 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -134.29 129.3 35.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.963 -0.562 . . . . 6.5300000000000002 109.979 -172.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -70.03 -44.5 60.83 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.784 -0.644 . . . . 5.0599999999999996 112.321 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -160.06 160.03 32.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.746 0.308 . . . . 7.3899999999999997 110.355 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -159.95 149.69 18.17 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.248 -0.649 . . . . 9.0700000000000003 109.248 173.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 96.6 mmm -79.98 -12.9 59.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.297 -0.41 . . . . 10.869999999999999 111.17 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -70.45 -40.19 73.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.924 -0.58 . . . . 10.449999999999999 111.465 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 51.0 30.34 5.25 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.616 0.572 . . . . 13.06 111.0 -173.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 30.2 p -70.01 -38.22 75.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.71 -0.677 . . . . 12.609999999999999 111.337 -177.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 63.74 27.3 14.68 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.225 -0.898 . . . . 15.19 110.602 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -69.78 -14.42 62.77 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.692 -0.685 . . . . 13.18 111.291 -176.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -59.79 -35.09 73.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.77 -0.65 . . . . 12.73 110.084 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 100.55 -20.54 47.87 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.599 -0.728 . . . . 9.9800000000000004 111.781 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 59.09 32.44 22.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.299 0.571 . . . . 10.699999999999999 111.049 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -70.07 -39.85 75.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.487 -0.779 . . . . 10.5 110.078 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 80.1 p -62.89 -39.9 95.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.805 -0.634 . . . . 6.6399999999999997 110.877 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 6.4 p -74.74 -24.08 58.66 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.039 -0.528 . . . . 4.9800000000000004 111.478 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -70.16 -35.42 74.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.274 0.559 . . . . 7.0999999999999996 109.765 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -81.41 101.51 9.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.599 -0.728 . . . . 4.4000000000000004 109.801 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 86.4 mt -117.26 131.54 69.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.968 -0.56 . . . . 2.21 110.855 -173.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.543 ' HB2' ' OD1' ' A' ' 171' ' ' ASN . 90.0 mtt180 -95.25 127.36 41.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.814 0.34 . . . . 3.54 110.419 176.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -117.78 130.53 56.36 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.571 -0.529 . . . . 1.6699999999999999 109.571 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -152.85 160.04 43.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.192 0.52 . . . . 5.8300000000000001 111.274 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.449 ' O ' ' HD2' ' A' ' 209' ' ' PRO . 2.5 pt? -137.95 134.25 17.94 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.126 -0.488 . . . . 2.5899999999999999 110.019 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.69 128.05 9.15 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.197 1.931 . . . . 1.77 112.708 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.8 tp -120.43 123.52 43.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.692 -0.686 . . . . 2.2599999999999998 109.538 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 22.7 m -104.9 119.96 40.28 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.454 -0.339 . . . . 1.99 110.7 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.92 80.26 1.8 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.472 -0.566 . . . . 2.3100000000000001 109.472 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.1 -117.26 8.9 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.714 -0.675 . . . . 1.51 112.298 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -90.48 0.09 57.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.372 0.606 . . . . 2.5699999999999998 109.651 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -114.69 120.1 38.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.506 -0.77 . . . . 2.6600000000000001 111.096 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 13.6 p -102.03 142.6 33.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.33 -0.396 . . . . 1.6200000000000001 110.453 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 49.8 t -129.13 129.98 67.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.307 -0.627 . . . . 1.3799999999999999 109.307 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 32.8 m -134.44 91.72 21.73 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-O 120.849 0.357 . . . . 1.1799999999999999 110.37 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.449 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 57.0 Cg_endo -74.57 138.47 24.21 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.273 1.982 . . . . 1.01 112.307 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -106.03 139.01 41.23 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.35 -0.611 . . . . 4.5 109.35 175.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 38.9 p -132.39 160.53 36.08 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.91 -0.404 . . . . 1.8899999999999999 109.91 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.488 ' HD2' ' HA ' ' A' ' 235' ' ' ASN . 61.9 ttt180 -66.24 -40.52 90.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.416 0.627 . . . . 4.7999999999999998 109.617 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 44.7 pt -126.96 144.98 35.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.484 -0.78 . . . . 4.5700000000000003 109.789 175.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -116.99 -8.51 11.64 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.739 -0.743 . . . . 4.9800000000000004 112.335 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 61.8 tp -119.66 138.24 53.39 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.828 0.347 . . . . 8.1099999999999994 110.771 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -105.04 141.27 36.91 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.245 -0.65 . . . . 7.6500000000000004 109.245 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -120.04 134.81 55.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.233 0.539 . . . . 10.529999999999999 111.344 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 63.5 t-105 -69.99 -39.96 75.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.264 -0.88 . . . . 11.56 109.526 171.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 77.4 p -97.51 155.8 16.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.402 -0.817 . . . . 10.06 110.335 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 57.9 t30 58.35 40.02 24.83 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.488 0.661 . . . . 11.92 110.283 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -106.68 130.01 54.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.483 -0.78 . . . . 14.01 109.971 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -80.47 124.45 28.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.835 0.35 . . . . 14.529999999999999 110.369 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -106.82 -9.55 16.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.206 -0.452 . . . . 16.609999999999999 110.725 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -119.96 140.07 51.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.028 -0.533 . . . . 15.460000000000001 110.291 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -111.77 111.3 22.16 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.09 -0.337 . . . . 15.67 110.09 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -91.67 -6.54 51.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.083 0.468 . . . . 14.5 110.443 178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 45.7 pt -129.56 168.04 23.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.698 -0.683 . . . . 15.15 109.735 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.57 125.54 26.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.097 0.475 . . . . 14.73 110.032 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 59.2 mtp85 -63.09 -40.51 97.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.162 -0.926 . . . . 16.379999999999999 111.396 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -72.18 -40.03 68.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.976 0.417 . . . . 12.779999999999999 110.97 176.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.35 -119.98 17.52 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.589 -0.732 . . . . 11.1 111.993 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -144.04 80.04 1.64 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.883 0.373 . . . . 12.26 110.03 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 58.23 35.44 24.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.322 -0.854 . . . . 9.9900000000000002 111.749 173.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -70.16 -39.94 75.03 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.048 0.451 . . . . 10.43 110.385 174.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.488 ' HA ' ' HD2' ' A' ' 212' ' ' ARG . 19.1 t-20 -90.25 97.4 11.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.284 -0.635 . . . . 6.29 109.284 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -98.92 118.56 35.97 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.85 -0.614 . . . . 8.1500000000000004 110.699 -175.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 62.1 t -110.28 120.72 61.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.65 -0.705 . . . . 2.3999999999999999 110.251 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -124.69 138.12 10.95 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.716 -0.754 . . . . 1.27 111.298 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.99 126.61 54.12 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.981 0.39 . . . . 1.97 110.527 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.503 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 61.7 t80 -99.56 124.42 44.74 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.318 -0.623 . . . . 3.54 109.318 173.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.526 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 81.7 m-85 -119.89 140.01 51.51 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.818 -0.438 . . . . 2.6400000000000001 109.818 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -136.77 151.87 21.08 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.074 -1.06 . . . . 1.3500000000000001 112.74 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' TYR . . . . . 0.408 ' HB2' HG22 ' A' ' 251' ' ' VAL . 96.3 m-85 -129.96 129.85 44.32 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.856 -0.794 . . . . 4.3600000000000003 108.856 172.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -128.1 130.38 48.09 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.193 -0.299 . . . . 4.29 110.193 -176.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -128.52 135.31 49.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.153 -0.476 . . . . 6.6900000000000004 110.429 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -60.09 -30.13 69.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.122 -0.944 . . . . 6.3700000000000001 111.684 -175.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -55.69 -33.64 64.34 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.303 -0.408 . . . . 5.8300000000000001 110.772 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 135.38 31.79 0.31 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.559 -0.829 . . . . 2.6600000000000001 112.797 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 53.0 tp -125.57 127.83 46.98 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.691 -0.3 . . . . 2.9700000000000002 110.4 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 6.1 t -140.09 129.31 23.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.642 -0.873 . . . . 2.1699999999999999 108.642 173.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 243' ' ' TYR . 33.1 m -129.94 159.81 41.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.91 0.386 . . . . 1.79 111.5 -176.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 35.3 p -131.34 139.96 49.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.523 -0.762 . . . . 1.6299999999999999 110.166 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 89.0 mt -125.7 135.61 52.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.003 -0.544 . . . . 2.96 109.986 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -110.59 120.92 43.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.125 -0.489 . . . . 4.0800000000000001 110.082 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -106.86 129.3 54.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.306 -0.406 . . . . 4.8399999999999999 110.787 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -101.66 140.7 35.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.733 -0.667 . . . . 3.5800000000000001 110.579 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -69.93 -36.18 75.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.521 -0.763 . . . . 6.7699999999999996 111.369 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 261' ' ' ASP . 97.3 mt-10 50.11 40.4 21.61 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.909 0.707 . . . . 8.5399999999999991 112.909 172.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -69.85 -40.11 75.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.914 0.388 . . . . 11.9 110.553 176.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -59.89 -39.96 87.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.825 -0.625 . . . . 10.57 111.026 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' ASP . . . . . 0.435 ' HB3' ' HB3' ' A' ' 258' ' ' GLU . 28.2 t70 -69.17 145.9 52.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.456 -0.793 . . . . 11.41 111.649 -172.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -145.96 133.46 20.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.217 -0.901 . . . . 11.98 109.402 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -69.17 -10.48 57.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.399 0.618 . . . . 12.460000000000001 110.012 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -60.15 -39.8 87.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.992 -1.004 . . . . 13.779999999999999 111.336 174.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -94.07 165.66 26.78 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.848 -0.691 . . . . 11.07 113.495 -172.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -115.19 9.7 15.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.644 -0.278 . . . . 12.59 111.225 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 51.3 m -60.18 -39.93 88.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.291 0.567 . . . . 10.92 110.344 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -121.17 130.23 53.62 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.215 -1.031 . . . . 12.42 108.215 173.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -89.06 -12.61 40.78 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.746 0.647 . . . . 11.59 112.746 -173.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -149.24 151.4 34.19 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.744 -0.382 . . . . 8.8300000000000001 110.908 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -71.77 148.63 46.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.795 -0.639 . . . . 7.0199999999999996 109.946 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -102.76 128.26 49.57 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.343 0.592 . . . . 6.5999999999999996 111.561 -171.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -145.25 169.99 17.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.26 -0.882 . . . . 1.9399999999999999 109.171 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.75 136.05 8.55 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.224 -0.988 . . . . 1.4199999999999999 112.001 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 62.7 t -130.03 129.7 65.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.982 0.42 . . . . 1.8100000000000001 110.412 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.03 139.99 11.39 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.712 -0.955 . . . . 1.3 110.712 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.16 129.97 54.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 117.102 0.451 . . . . 1.8300000000000001 111.265 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -113.24 123.07 49.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.033 -0.531 . . . . 2.3100000000000001 110.004 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -99.97 107.27 19.19 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.932 -0.766 . . . . 4.75 108.932 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 25.6 m -102.12 124.05 47.05 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.144 0.497 . . . . 1.6699999999999999 111.043 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 88.9 m-85 . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.122 -0.942 . . . . 3.6899999999999999 108.722 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.4 mtp . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.711 0.291 . . . . 11.85 110.301 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -136.21 121.54 19.24 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.966 -0.383 . . . . 10.35 109.966 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -125.65 139.01 53.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.293 -0.412 . . . . 9.3100000000000005 109.997 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.454 ' HB3' ' OD2' ' A' ' 6' ' ' ASP . 17.6 mtp180 -99.85 133.21 44.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.038 0.447 . . . . 8.8399999999999999 111.269 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -108.53 61.89 0.61 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.685 -0.688 . . . . 7.0099999999999998 109.855 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.454 ' OD2' ' HB3' ' A' ' 4' ' ' ARG . 11.6 m-20 -74.79 110.16 8.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.811 -0.631 . . . . 3.6099999999999999 109.895 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.53 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 20.3 m-90 -70.99 139.98 50.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.987 -0.551 . . . . 3.3300000000000001 110.981 -178.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -99.2 130.0 45.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.001 -0.545 . . . . 3.2000000000000002 110.544 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -115.77 140.31 49.33 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.866 -0.606 . . . . 2.4900000000000002 110.888 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 94.2 m-20 -121.86 132.33 54.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.556 -0.747 . . . . 2.1299999999999999 109.549 174.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.0 mt -119.76 120.02 62.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.372 -0.603 . . . . 1.6000000000000001 109.372 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.13 142.4 14.95 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.048 -1.072 . . . . 0.88 112.68 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.53 134.81 54.71 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.941 -0.762 . . . . 1.0800000000000001 108.941 174.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 49.0 tpp -129.93 129.67 44.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.061 -0.518 . . . . 2.3300000000000001 111.0 -173.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.469 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 56.3 m-85 -93.15 129.77 39.04 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.914 -1.143 . . . . 2.6099999999999999 107.914 169.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -134.32 130.12 36.52 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.328 -0.549 . . . . 5.0899999999999999 110.534 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.45 HG21 ' CE1' ' A' ' 271' ' ' HIS . 80.3 mt -115.68 129.5 71.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.057 -0.52 . . . . 5.3300000000000001 110.385 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -80.56 153.71 27.9 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.876 -0.602 . . . . 8.2799999999999994 110.614 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -70.21 -20.29 63.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.892 -0.595 . . . . 9.6999999999999993 110.549 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.8 t -110.87 120.07 60.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.44 -0.8 . . . . 11.09 108.908 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -91.9 -9.11 44.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.041 0.448 . . . . 13.1 110.668 -177.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.4 -160.34 43.75 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.706 -0.759 . . . . 11.94 112.444 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -123.69 102.47 7.85 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.385 0.612 . . . . 15.18 111.148 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.99 26.53 67.45 Favored Glycine 0 C--N 1.329 0.162 0 CA-C-N 115.769 -0.651 . . . . 12.0 112.291 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -96.04 16.29 18.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.428 0.632 . . . . 12.82 110.706 -173.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.43 -28.27 65.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.87 -1.059 . . . . 10.81 109.986 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 94.7 mtp -59.9 -40.22 88.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.125 -0.943 . . . . 10.050000000000001 111.636 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -80.12 -50.25 10.58 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.627 -0.429 . . . . 8.0600000000000005 110.367 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.14 154.19 7.05 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.572 -0.823 . . . . 5.5800000000000001 112.436 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.4 mt -143.61 -26.87 0.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.592 0.234 . . . . 5.5599999999999996 111.475 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.411 ' HB2' HG12 ' A' ' 17' ' ' ILE . . . -154.86 70.71 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.08 0.466 . . . . 3.0499999999999998 110.616 -175.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -120.3 150.94 52.69 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 109.649 -0.5 . . . . 3.48 109.649 -175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.469 ' HD3' ' CE2' ' A' ' 15' ' ' TYR . 59.6 Cg_endo -73.93 134.38 19.68 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.093 1.862 . . . . 1.8600000000000001 112.375 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.7 t -118.13 143.57 46.38 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.797 -0.816 . . . . 1.97 108.797 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.5 m -110.11 139.99 31.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.304 0.573 . . . . 1.71 111.639 -173.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 49' ' ' ALA . 34.6 p90 -135.72 149.77 49.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.425 -0.807 . . . . 4.0700000000000003 109.903 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -113.47 130.07 56.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.02 -0.536 . . . . 2.8599999999999999 110.729 -175.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 10' ' ' ASN . 77.6 m-20 -123.44 144.49 49.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.165 -0.471 . . . . 1.8899999999999999 109.952 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.41 142.34 45.62 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.074 -0.343 . . . . 1.0800000000000001 110.074 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.01 112.57 1.59 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.151 0.426 . . . . 1.3899999999999999 112.151 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 7' ' ' TRP . 24.5 t-20 -168.24 94.96 0.39 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.713 -0.477 . . . . 2.8599999999999999 109.713 166.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.89 -83.34 0.43 Allowed Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.212 -0.755 . . . . 1.6799999999999999 111.212 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.13 173.46 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.029 2.486 . . . . 1.6599999999999999 111.797 169.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.461 ' HB3' ' O ' ' A' ' 75' ' ' HIS . 45.3 m95 -70.75 -177.74 1.66 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.143 -0.481 . . . . 3.3999999999999999 110.064 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -109.6 120.42 42.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.657 0.741 . . . . 3.1000000000000001 109.976 -172.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.4 mt -109.94 136.29 46.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.378 -1.283 . . . . 1.8 110.326 -174.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.81 128.24 55.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.943 -0.572 . . . . 0.85999999999999999 110.158 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.1 tp -120.45 130.2 54.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.045 -0.525 . . . . 1.0600000000000001 110.494 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 36' ' ' TYR . . . -148.92 168.42 23.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.236 -0.438 . . . . 1.1399999999999999 110.524 178.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 45.2 p90 -142.4 160.03 41.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.357 -0.383 . . . . 4.0199999999999996 110.342 -177.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.429 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 64.3 t80 -134.28 130.02 36.45 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.82 -0.437 . . . . 4.6100000000000003 109.82 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -135.65 147.21 48.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.404 -0.362 . . . . 3.3799999999999999 110.412 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -111.61 144.37 40.98 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.967 -0.753 . . . . 5.0499999999999998 108.967 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 159.92 105.62 0.21 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.342 -1.409 . . . . 4.3700000000000001 113.391 -178.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.25 2.77 7.71 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 123.107 2.538 . . . . 6.6799999999999997 111.713 175.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.4 t -109.67 120.85 61.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.896 -0.593 . . . . 8.1699999999999999 110.478 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -70.29 -39.75 74.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.641 -0.709 . . . . 10.039999999999999 110.955 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -81.92 149.31 28.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.908 -0.587 . . . . 11.609999999999999 111.531 -173.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.8 p -119.65 149.2 42.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.918 -0.583 . . . . 9.7899999999999991 109.954 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -141.52 150.08 41.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.584 0.23 . . . . 8.5099999999999998 110.948 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.98 -93.2 1.59 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.823 -0.703 . . . . 7.5599999999999996 112.109 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -124.68 130.82 53.14 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.659 -0.497 . . . . 10.0 109.659 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -80.66 150.63 29.34 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.861 -0.422 . . . . 10.35 109.861 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.97 167.83 12.25 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 111.484 -0.646 . . . . 5.3399999999999999 111.484 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.9 m -129.55 109.46 11.05 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.004 -0.369 . . . . 5.3200000000000003 110.004 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -69.76 -40.06 76.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.203 -0.453 . . . . 5.6100000000000003 110.126 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 97' ' ' TYR . 53.2 m-85 -106.8 99.73 9.29 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.176 -0.676 . . . . 3.7799999999999998 109.176 177.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -134.23 170.63 15.42 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.511 -0.922 . . . . 2.4500000000000002 108.511 -171.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.523 ' HD3' ' CE1' ' A' ' 95' ' ' TYR . 39.4 ttp180 -119.14 123.01 29.12 Favored Pre-proline 0 C--N 1.318 -0.787 0 C-N-CA 120.326 -0.55 . . . . 3.2400000000000002 110.697 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -91.74 115.68 0.4 Allowed 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 122.126 1.884 . . . . 1.1899999999999999 110.767 169.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -103.26 112.74 25.76 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.903 -0.777 . . . . 2.1899999999999999 108.903 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.2 tp -124.53 118.66 27.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.652 -0.704 . . . . 1.1399999999999999 109.496 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -126.03 131.75 52.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.6 -0.518 . . . . 2.1800000000000002 109.6 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.22 121.88 68.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.869 0.366 . . . . 1.5600000000000001 110.116 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.461 ' O ' ' HB3' ' A' ' 44' ' ' TRP . 79.8 t60 -104.64 119.6 39.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.115 -0.493 . . . . 3.4399999999999999 110.503 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -97.16 120.74 38.07 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.984 -1.117 . . . . 4.7999999999999998 107.984 176.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.4 ' HG3' ' HA ' ' A' ' 86' ' ' PHE . 29.0 tt0 -127.31 113.78 16.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.174 0.511 . . . . 2.9399999999999999 111.671 -174.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -102.61 120.3 40.31 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.673 -0.694 . . . . 3.8999999999999999 109.38 175.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.3 mt -112.46 -29.84 7.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.122 0.486 . . . . 4.4800000000000004 110.777 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -118.44 -16.99 9.5 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.709 -0.678 . . . . 6.1900000000000004 111.525 -173.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -63.41 -49.99 71.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.529 -0.305 . . . . 5.4500000000000002 111.671 -174.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -146.98 -177.04 5.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.196 -0.298 . . . . 5.2699999999999996 110.196 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -60.01 -40.07 87.99 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.408 0.521 . . . . 6.3300000000000001 112.408 -176.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -74.43 138.43 43.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.208 0.528 . . . . 7.4800000000000004 111.324 -176.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 120' ' ' ASP . 14.7 t -95.43 159.56 14.94 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.856 -0.611 . . . . 2.5499999999999998 110.412 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.4 ' HA ' ' HG3' ' A' ' 77' ' ' GLN . 90.1 m-85 69.78 -100.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.512 -0.767 . . . . 5.2999999999999998 111.069 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.27 -82.06 0.35 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.012 -1.089 . . . . 1.3500000000000001 113.215 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 57.9 tp -144.13 131.25 20.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.22 0.51 . . . . 2.29 111.989 -173.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.5 m -121.36 130.08 53.42 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.575 -0.528 . . . . 1.54 109.575 170.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -145.45 141.92 10.26 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.145 -1.026 . . . . 1.1699999999999999 112.238 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.99 171.2 36.26 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.62 -0.8 . . . . 1.1899999999999999 111.993 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -148.47 159.95 43.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.092 0.472 . . . . 3.75 111.628 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -134.39 137.29 43.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.324 -0.853 . . . . 2.75 109.494 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 63.1 t30 -125.18 122.22 36.42 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.971 -0.381 . . . . 1.8200000000000001 109.971 175.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.523 ' CE1' ' HD3' ' A' ' 69' ' ' ARG . 95.2 m-85 -102.84 120.92 41.45 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.023 -0.362 . . . . 3.1400000000000001 110.023 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.6 152.59 52.48 Favored Glycine 0 CA--C 1.501 -0.788 0 C-N-CA 120.995 -0.621 . . . . 2.79 113.658 -176.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.794 ' HA ' ' H ' ' A' ' 108' ' ' ALA . 68.7 m-85 -48.52 82.46 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 124.174 0.99 . . . . 7.6200000000000001 113.564 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.675 ' H ' ' HB3' ' A' ' 108' ' ' ALA . 30.9 p80 -114.17 170.36 8.34 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.231 -0.293 . . . . 7.0800000000000001 110.514 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -68.33 141.25 55.85 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.801 -0.444 . . . . 10.16 109.801 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.85 -177.03 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.651 -0.25 . . . . 9.8100000000000005 111.564 -175.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -60.25 -39.97 88.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.117 0.484 . . . . 12.220000000000001 110.473 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -72.7 115.48 40.18 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.416 -0.811 . . . . 10.48 110.229 -177.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.73 -19.62 53.26 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.707 2.272 . . . . 9.0999999999999996 112.671 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.56 2.4 85.65 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.834 -0.698 . . . . 6.46 112.68 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -139.54 119.96 13.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.966 0.412 . . . . 7.6699999999999999 110.553 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -96.93 0.25 48.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.947 -0.57 . . . . 4.1399999999999997 110.957 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' A' ' 97' ' ' TYR . 24.1 p -125.68 149.02 48.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.267 0.469 . . . . 3.2999999999999998 112.267 -175.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.794 ' H ' ' HA ' ' A' ' 97' ' ' TYR . . . -118.72 119.13 33.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.725 0.774 . . . . 1.76 112.85 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -115.19 106.45 14.09 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.595 -0.891 . . . . 2.5499999999999998 108.595 171.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.539 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 89.5 mtp -139.85 117.05 11.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.527 -0.306 . . . . 1.77 110.799 -177.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.614 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 54.0 tt0 -117.21 117.96 31.0 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.627 -0.429 . . . . 1.97 110.182 176.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -105.6 123.53 48.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.869 -0.605 . . . . 3.8500000000000001 110.14 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -125.53 128.73 48.42 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.814 -0.81 . . . . 2.2799999999999998 108.814 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -130.15 126.03 36.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.408 . . . . 2.1400000000000001 110.558 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 134' ' ' SER . 88.2 mt -120.05 129.61 75.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.709 -0.678 . . . . 1.55 109.66 177.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 134' ' ' SER . . . -141.87 108.14 5.91 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 111.954 0.353 . . . . 1.1899999999999999 111.954 -176.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.721 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 61.4 Cg_endo -76.5 131.95 13.05 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.75 1.634 . . . . 1.3700000000000001 110.21 171.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -102.28 137.02 41.09 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.281 -0.637 . . . . 2.3500000000000001 109.281 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -135.45 129.98 34.05 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.99 -0.284 . . . . 4.54 110.942 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 32.5 t70 -126.25 122.09 34.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.172 -0.467 . . . . 3.04 109.856 174.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.4 t -120.05 120.49 63.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.09 -0.504 . . . . 4.2699999999999996 110.19 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.405 ' HE2' ' HD3' ' A' ' 128' ' ' ARG . 96.6 mttt -104.96 90.75 3.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.296 -0.411 . . . . 6.04 110.527 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.6 tp -60.28 -49.74 76.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.284 0.564 . . . . 4.5899999999999999 110.154 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.5 p -140.79 172.52 12.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.372 -0.831 . . . . 3.6899999999999999 109.358 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -60.16 -39.88 87.95 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.192 -0.603 . . . . 5.1699999999999999 109.605 172.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.1 -40.17 75.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.729 -0.669 . . . . 3.71 111.997 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.0 mt -111.12 119.65 39.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.285 0.564 . . . . 2.0499999999999998 111.436 -173.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.405 ' HD3' ' HE2' ' A' ' 122' ' ' LYS . 38.1 ttp180 -132.63 132.78 42.83 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.719 -0.673 . . . . 4.2400000000000002 110.681 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -111.97 100.03 8.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.326 -0.852 . . . . 3.5499999999999998 109.738 -176.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -113.8 114.65 26.59 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.022 -0.362 . . . . 2.1099999999999999 110.022 -178.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -144.82 152.75 24.71 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.994 -1.098 . . . . 1.1799999999999999 113.013 -175.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.536 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 56.5 p-90 -141.28 147.85 38.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.783 0.325 . . . . 4.2999999999999998 110.42 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.721 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 10.1 tt -126.27 131.98 51.78 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.314 -0.624 . . . . 2.2400000000000002 109.314 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.604 ' HB3' ' HB2' ' A' ' 116' ' ' ALA . 80.5 p -131.53 150.06 52.29 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.811 -0.355 . . . . 1.6899999999999999 111.548 -177.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 71.8 mtm -114.38 136.02 53.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.091 -0.504 . . . . 2.2400000000000002 110.415 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.428 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 49.5 m-85 -104.87 120.92 42.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.87 -0.605 . . . . 3.5600000000000001 111.674 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.68 121.79 29.32 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.134 -1.062 . . . . 1.6699999999999999 108.134 166.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.614 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 52.6 p90 -145.85 166.49 25.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.448 -0.342 . . . . 3.23 111.49 -171.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 110' ' ' MET . . . 60.0 -164.72 0.22 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.052 -0.976 . . . . 1.24 111.795 177.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -75.3 -39.79 59.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.102 -0.499 . . . . 2.4700000000000002 111.305 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.69 -54.2 49.11 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.438 0.533 . . . . 2.4100000000000001 112.438 -167.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.73 -40.11 84.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.2 0.524 . . . . 1.8300000000000001 110.492 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.438 HD22 ' C ' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -62.09 -39.38 92.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.783 -0.644 . . . . 2.0 109.96 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.8 m -68.66 -40.11 80.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.886 -0.597 . . . . 2.0499999999999998 111.912 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 148' ' ' ALA . 41.9 p -79.9 -20.04 46.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.169 0.509 . . . . 1.5900000000000001 110.865 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.02 -109.82 2.91 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.803 -0.635 . . . . 1.52 113.154 173.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -99.16 0.62 43.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.8 0.333 . . . . 5.9400000000000004 110.661 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' A' ' 145' ' ' THR . . . -70.04 -40.04 75.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 1.8300000000000001 111.489 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -118.96 124.68 47.62 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.566 -0.288 . . . . 2.6400000000000001 110.569 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.4 p -130.02 140.06 50.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.986 0.422 . . . . 2.02 110.9 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.428 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 42.5 ttm180 -113.06 129.98 56.32 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.337 -0.986 . . . . 3.6699999999999999 108.337 173.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.9 p -117.33 132.02 68.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.533 0.683 . . . . 1.6399999999999999 111.697 -173.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.421 ' OE1' ' HH2' ' A' ' 132' ' ' TRP . 38.3 tt0 -119.99 115.69 24.27 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.011 -0.995 . . . . 2.5600000000000001 109.126 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 21.7 m -129.74 127.21 39.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.77 0.319 . . . . 1.3899999999999999 111.283 -177.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.536 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 42.6 tt0 -122.34 134.49 54.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.966 -0.561 . . . . 2.04 110.032 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.5 m -128.27 120.26 26.78 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.857 0.361 . . . . 1.5600000000000001 110.094 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.72 106.8 3.36 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.861 -0.896 . . . . 1.04 110.861 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 82.7 mt -99.79 120.07 39.16 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.668 -0.493 . . . . 2.27 109.668 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -100.08 119.13 37.82 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.859 -0.61 . . . . 2.4100000000000001 110.014 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -121.55 137.94 54.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.532 -0.758 . . . . 4.5700000000000003 109.9 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 7.3 p -89.9 88.56 7.37 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.077 -0.712 . . . . 1.46 109.077 168.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.08 -48.97 79.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.023 -0.989 . . . . 2.6299999999999999 111.395 -170.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.416 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.6 m-20 -99.96 11.39 39.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.4 -0.364 . . . . 2.4100000000000001 110.52 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 71.88 -43.02 0.55 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.007 0.817 . . . . 2.5800000000000001 111.177 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.9 p -73.91 -26.66 60.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.286 -0.416 . . . . 2.2999999999999998 111.428 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 163' ' ' ASN . 33.7 m -119.16 143.61 29.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.119 -0.491 . . . . 1.71 110.678 -177.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.13 119.52 39.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.206 -0.452 . . . . 1.47 110.14 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 22.9 mt -111.57 134.73 52.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.355 -0.384 . . . . 1.6599999999999999 110.182 -175.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -100.06 122.02 42.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.798 -0.445 . . . . 3.2999999999999998 109.798 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 40.4 t -120.01 120.02 61.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.474 -0.49 . . . . 1.3 109.792 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -98.87 120.91 40.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.335 0.588 . . . . 2.2200000000000002 110.389 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -105.85 139.55 40.24 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.054 -0.975 . . . . 4.6100000000000003 109.253 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -113.15 129.79 56.4 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 110.074 -0.343 . . . . 3.98 110.074 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.498 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 61.5 tp -109.93 129.93 55.59 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.067 0.46 . . . . 2.3799999999999999 110.795 -174.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -112.62 179.45 3.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.393 -0.821 . . . . 3.3100000000000001 110.1 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -60.11 -40.01 88.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.045 0.45 . . . . 6.5300000000000002 111.705 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.17 22.69 56.71 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.811 -0.631 . . . . 5.0599999999999996 111.857 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -133.31 129.83 38.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.74 0.305 . . . . 7.3899999999999997 110.534 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -100.36 118.43 36.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.031 -0.531 . . . . 9.0700000000000003 110.519 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 46.7 tpp -71.15 -30.0 65.92 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.549 -0.75 . . . . 10.869999999999999 110.262 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -79.93 169.99 17.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.444 -0.798 . . . . 10.449999999999999 111.591 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -114.21 130.34 56.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.598 -0.728 . . . . 13.06 110.958 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 46.9 t -131.14 146.46 52.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.059 -0.519 . . . . 12.609999999999999 110.094 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -89.88 -0.38 57.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.383 -0.372 . . . . 15.19 111.192 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -108.8 143.06 38.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.155 -0.475 . . . . 13.18 109.796 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -87.02 136.57 32.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.244 0.545 . . . . 12.73 110.841 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 150.26 -179.71 26.77 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 111.192 -0.763 . . . . 9.9800000000000004 111.192 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -114.33 139.98 49.01 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.604 -0.517 . . . . 10.699999999999999 109.604 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -109.75 20.1 18.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.506 -0.316 . . . . 10.5 111.815 -172.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.1 m -61.01 142.81 56.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.438 -0.346 . . . . 6.6399999999999997 110.611 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 16.5 p -99.71 26.6 6.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.174 0.511 . . . . 4.9800000000000004 111.038 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -59.97 139.17 57.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.163 -0.926 . . . . 7.0999999999999996 111.694 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -111.84 154.17 25.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.881 -0.599 . . . . 4.4000000000000004 110.669 175.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 88.0 mt -120.09 98.11 5.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.137 -1.061 . . . . 2.21 108.137 171.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.679 ' HA ' ' O ' ' A' ' 211' ' ' THR . 97.7 mtt180 -100.04 118.91 37.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.858 0.361 . . . . 3.54 111.173 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.589 ' O ' ' HA ' ' A' ' 210' ' ' TYR . . . -99.98 131.82 45.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.251 -0.431 . . . . 1.6699999999999999 110.916 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -127.69 129.41 47.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.752 -0.658 . . . . 5.8300000000000001 109.826 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 208' ' ' THR . 1.8 pt? -131.1 127.23 21.9 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.167 -0.309 . . . . 2.5899999999999999 110.167 174.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -89.55 120.31 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.664 2.243 . . . . 1.77 113.626 -177.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 84.1 mt -118.08 128.2 54.52 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.369 -0.604 . . . . 2.2599999999999998 109.369 172.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 24.0 m -100.51 120.13 39.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.807 0.337 . . . . 1.99 111.236 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 91.8 mt -122.57 80.78 1.77 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.525 -0.546 . . . . 2.3100000000000001 109.525 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 72.84 -122.98 8.5 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.65 -0.704 . . . . 1.51 111.861 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -93.83 3.56 55.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.293 0.568 . . . . 2.5699999999999998 110.2 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -118.59 130.01 55.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.915 -0.584 . . . . 2.6600000000000001 110.048 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 241' ' ' TYR . 5.4 p -111.13 139.82 46.19 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.774 -0.37 . . . . 1.6200000000000001 110.557 176.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.448 HG22 ' CE1' ' A' ' 241' ' ' TYR . 31.7 t -109.16 120.91 61.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.378 -0.601 . . . . 1.3799999999999999 109.378 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 198' ' ' LEU . 32.1 m -129.84 90.1 44.07 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.264 -0.426 . . . . 1.1799999999999999 110.0 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -63.17 146.05 93.89 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.45 2.1 . . . . 1.01 111.142 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 53.0 p90 -133.34 148.28 51.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.156 0.503 . . . . 4.5 110.204 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 195' ' ' ARG . 32.6 p -129.72 141.29 50.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.539 -0.755 . . . . 1.8899999999999999 110.57 -177.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -69.74 -38.92 77.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.649 -0.705 . . . . 4.7999999999999998 109.567 177.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.408 HG22 ' H ' ' A' ' 215' ' ' LEU . 87.1 mt -120.24 119.96 61.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.229 -0.896 . . . . 4.5700000000000003 109.627 174.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -88.48 37.7 3.27 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.136 -0.554 . . . . 4.9800000000000004 112.558 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.408 ' H ' HG22 ' A' ' 213' ' ' ILE . 84.2 mt -126.67 131.14 51.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.579 -0.526 . . . . 8.1099999999999994 109.579 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -96.85 136.5 37.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.969 0.414 . . . . 7.6500000000000004 110.813 -177.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -113.08 107.79 16.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.997 -0.547 . . . . 10.529999999999999 111.432 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -71.77 -31.31 66.49 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.75 -0.833 . . . . 11.56 108.75 170.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 35.1 p -135.3 150.61 50.04 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.651 -1.159 . . . . 10.06 109.077 172.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -97.85 126.74 43.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.063 0.458 . . . . 11.92 111.17 -174.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -70.02 -31.16 68.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.391 -0.822 . . . . 14.01 110.021 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -82.76 139.97 33.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.795 -0.639 . . . . 14.529999999999999 110.123 178.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -117.62 138.61 51.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.116 0.484 . . . . 16.609999999999999 110.783 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -120.64 140.16 51.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.883 -0.598 . . . . 15.460000000000001 110.308 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -66.06 -39.92 90.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.751 -0.659 . . . . 15.67 109.84 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.46 -42.25 87.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.351 -0.841 . . . . 14.5 111.624 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 48.8 mm -120.07 118.45 56.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.396 -0.365 . . . . 15.15 111.164 -174.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -74.42 -39.89 62.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.905 -0.589 . . . . 14.73 110.86 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -161.5 158.96 27.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.93 -0.577 . . . . 16.379999999999999 110.321 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -107.93 124.97 50.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.249 -0.432 . . . . 12.779999999999999 110.554 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -71.2 -28.75 69.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.873 -0.68 . . . . 11.1 111.963 175.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 59.77 36.77 22.21 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 122.809 0.444 . . . . 12.26 111.111 -177.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -60.76 -40.11 91.27 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.479 0.657 . . . . 9.9900000000000002 109.498 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -122.64 140.05 53.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.845 -1.07 . . . . 10.43 108.616 171.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -120.08 151.08 39.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.74 0.305 . . . . 6.29 110.486 -175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -98.97 111.02 23.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.296 0.57 . . . . 8.1500000000000004 111.026 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.59 139.85 28.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.147 -0.933 . . . . 2.3999999999999999 108.946 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -80.15 134.6 13.72 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.088 -1.053 . . . . 1.27 111.737 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 87.0 mt -108.44 118.07 35.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.11 0.455 . . . . 1.97 110.627 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' A' ' 208' ' ' THR . 64.8 t80 -110.04 131.23 55.24 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.125 -0.695 . . . . 3.54 109.125 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' TYR . . . . . 0.562 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 96.2 m-85 -120.11 139.2 52.94 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.834 -0.432 . . . . 2.6400000000000001 109.834 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -110.95 129.04 9.03 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.527 -0.844 . . . . 1.3500000000000001 111.682 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -129.31 126.84 39.87 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.939 -0.393 . . . . 4.3600000000000003 109.939 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -120.0 131.7 55.23 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.918 0.389 . . . . 4.29 110.706 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 249' ' ' LEU . 52.2 t80 -102.34 129.95 48.93 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.941 -0.763 . . . . 6.6900000000000004 108.941 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -60.08 -37.17 79.14 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.583 0.957 . . . . 6.3700000000000001 113.583 -167.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -60.11 -39.98 88.09 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.622 0.249 . . . . 5.8300000000000001 111.559 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 151.65 42.04 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.868 -1.158 . . . . 2.6600000000000001 113.233 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 245' ' ' PHE . 49.9 tp -133.48 130.09 38.1 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.031 -0.359 . . . . 2.9700000000000002 110.031 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 21.6 t -117.04 130.03 56.41 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.227 -0.657 . . . . 2.1699999999999999 109.227 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.09 132.72 68.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.057 0.456 . . . . 1.79 110.426 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 52.6 m -114.19 128.7 56.49 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.532 -0.544 . . . . 1.6299999999999999 109.532 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 83.0 mt -118.98 133.57 55.74 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.378 -0.374 . . . . 2.96 110.541 -175.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -127.25 121.33 30.87 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.772 -0.455 . . . . 4.0800000000000001 109.772 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -122.97 139.24 54.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.928 0.394 . . . . 4.8399999999999999 111.631 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -148.87 179.95 7.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.673 -0.694 . . . . 3.5800000000000001 110.301 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 60.26 48.5 8.04 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.542 0.526 . . . . 6.7699999999999996 112.262 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.17 -31.79 73.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.548 -0.296 . . . . 8.5399999999999991 110.839 173.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -67.09 140.17 57.58 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.763 -0.458 . . . . 11.9 109.763 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -77.52 113.57 15.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.378 -0.373 . . . . 10.57 110.636 -174.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.02 170.05 17.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.247 0.546 . . . . 11.41 110.764 176.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -101.69 29.9 4.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.828 -0.623 . . . . 11.98 110.331 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -112.68 179.5 3.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.131 -0.486 . . . . 12.460000000000001 109.939 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -121.05 144.04 48.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.574 0.226 . . . . 13.779999999999999 110.444 -177.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 70.2 31.59 69.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.564 -0.827 . . . . 11.07 112.105 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -63.73 -38.65 91.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.961 0.41 . . . . 12.59 110.564 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 48.9 m -60.32 -40.06 89.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.541 -0.754 . . . . 10.92 109.969 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -63.05 -38.03 89.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.576 -0.738 . . . . 12.42 111.361 177.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -60.01 134.23 56.85 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.092 -0.503 . . . . 11.59 111.223 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -83.65 -9.92 58.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.024 -0.534 . . . . 8.8300000000000001 110.211 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' HIS . . . . . 0.45 ' CE1' HG21 ' A' ' 17' ' ' ILE . 94.2 m-70 -61.17 -39.9 91.88 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 108.912 -0.773 . . . . 7.0199999999999996 108.912 169.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -62.38 -49.79 74.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.368 -1.287 . . . . 6.5999999999999996 111.283 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -149.27 148.98 30.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.895 0.379 . . . . 1.9399999999999999 111.431 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.99 149.62 19.62 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.87 -0.604 . . . . 1.4199999999999999 112.285 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 61.5 t -130.04 130.07 65.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.673 0.273 . . . . 1.8100000000000001 110.719 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.48 134.69 8.91 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.041 -0.824 . . . . 1.3 111.041 176.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 28.0 m -128.71 139.5 51.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 117.431 0.615 . . . . 1.8300000000000001 111.375 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -129.4 124.31 33.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.855 -0.611 . . . . 2.3100000000000001 110.162 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.416 ' CD1' HD13 ' A' ' 249' ' ' LEU . 97.9 m-85 -96.69 127.92 43.14 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.45 -0.574 . . . . 4.75 109.45 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 49.1 m -111.32 124.95 53.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.723 0.297 . . . . 1.6699999999999999 110.73 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 72.6 t80 . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.58 -0.724 . . . . 3.6899999999999999 109.827 179.601 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mmm . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.763 0.316 . . . . 11.85 110.659 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.549 ' HB2' ' ND2' ' A' ' 5' ' ' ASN . 48.0 mt-10 -107.9 131.32 54.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.74 0.305 . . . . 10.35 110.37 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -70.13 -28.02 65.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.918 -0.583 . . . . 9.3100000000000005 110.427 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -60.12 -40.16 88.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.53 . . . . 8.8399999999999999 110.743 175.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.549 ' ND2' ' HB2' ' A' ' 2' ' ' GLU . 88.7 m-20 -70.81 129.87 40.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.986 -0.552 . . . . 7.0099999999999998 109.689 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -119.91 119.47 33.58 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.098 -0.501 . . . . 3.6099999999999999 110.397 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -119.4 138.52 53.03 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.038 -0.356 . . . . 3.3300000000000001 110.038 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -104.22 128.16 51.92 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.517 -0.549 . . . . 3.2000000000000002 109.517 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -103.23 144.89 30.74 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.687 -0.688 . . . . 2.4900000000000002 111.033 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 279' ' ' TYR . 35.4 m-80 -119.98 131.26 55.11 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.167 -0.924 . . . . 2.1299999999999999 108.926 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.6 mt -120.29 115.26 46.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 N-CA-C 109.204 -0.665 . . . . 1.6000000000000001 109.204 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -110.02 127.07 8.22 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.551 -0.833 . . . . 0.88 111.273 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -120.67 136.01 54.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.713 0.292 . . . . 1.0800000000000001 110.785 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.405 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 91.4 mtp -135.35 156.93 48.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.852 -0.613 . . . . 2.3300000000000001 109.415 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -119.95 122.37 41.05 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.641 -0.503 . . . . 2.6099999999999999 109.641 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.23 -49.92 75.69 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 121.062 0.458 . . . . 5.0899999999999999 110.345 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 47.6 mm -119.95 120.33 62.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.915 -0.584 . . . . 5.3300000000000001 109.869 171.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -79.71 148.98 31.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.9 -0.591 . . . . 8.2799999999999994 111.028 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -122.52 110.02 15.06 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.12 -0.696 . . . . 9.6999999999999993 109.12 170.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.7 p -63.58 -29.97 48.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.259 -0.428 . . . . 11.09 111.492 -177.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -68.19 -40.02 82.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.1 -0.5 . . . . 13.1 110.669 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.32 127.08 1.13 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.086 -0.578 . . . . 11.94 111.917 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -69.47 126.15 28.89 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.883 0.373 . . . . 15.18 110.435 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.81 24.26 65.05 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.85 -0.69 . . . . 12.0 113.865 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.88 -39.91 94.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.754 0.777 . . . . 12.82 111.072 175.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -76.49 121.61 23.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 10.81 110.435 -177.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 59.9 ttp -69.86 -40.09 75.98 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.661 -0.699 . . . . 10.050000000000001 110.339 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -131.53 136.78 48.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.393 -0.821 . . . . 8.0600000000000005 110.106 -178.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -169.58 164.97 38.44 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.843 -0.694 . . . . 5.5800000000000001 111.688 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -81.09 -9.95 59.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.696 0.284 . . . . 5.5599999999999996 110.771 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.75 137.58 53.85 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.113 -0.494 . . . . 3.0499999999999998 109.942 175.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -140.02 159.27 65.04 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.581 0.229 . . . . 3.48 110.948 -173.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 14' ' ' MET . 36.3 Cg_endo -70.17 149.99 65.08 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.308 2.005 . . . . 1.8600000000000001 110.916 168.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 22.2 m -125.67 142.19 51.63 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.699 -0.482 . . . . 1.97 109.699 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.618 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 33.1 m -129.99 160.06 41.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.695 0.284 . . . . 1.71 110.512 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -140.2 149.95 43.56 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.68 -0.489 . . . . 4.0700000000000003 109.68 174.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 94.5 m-85 -109.45 128.79 55.42 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.465 -0.334 . . . . 2.8599999999999999 110.217 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -140.32 135.21 31.97 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.992 -0.549 . . . . 1.8899999999999999 109.753 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.6 141.39 51.14 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.762 -0.375 . . . . 1.0800000000000001 110.177 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . . . -160.17 125.82 4.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 1.3899999999999999 111.675 -177.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -167.46 93.47 0.42 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.507 -0.553 . . . . 2.8599999999999999 109.507 167.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.65 -94.78 1.34 Allowed Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.543 -0.837 . . . . 1.6799999999999999 112.003 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.76 172.95 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.605 2.87 . . . . 1.6599999999999999 113.114 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.8 p-90 -69.78 159.15 34.11 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.197 0.522 . . . . 3.3999999999999999 111.367 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.454 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 25.7 ptt-85 -115.72 146.85 41.52 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.249 0.833 . . . . 3.1000000000000001 113.249 -163.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.4 mm -122.88 131.26 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 114.495 -1.23 . . . . 1.8 111.03 -173.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -117.53 139.98 50.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.525 -0.307 . . . . 0.85999999999999999 110.719 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 56.4 tp -135.83 137.11 41.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 1.0600000000000001 111.046 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.04 166.94 28.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.743 -0.662 . . . . 1.1399999999999999 109.313 174.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -124.15 130.02 51.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.876 0.37 . . . . 4.0199999999999996 111.122 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.554 ' HB3' ' HB2' ' A' ' 69' ' ' ARG . 47.0 t80 -99.98 119.56 38.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.865 -0.607 . . . . 4.6100000000000003 110.073 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 -133.83 130.17 37.53 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.743 -0.465 . . . . 3.3799999999999999 109.743 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -146.47 160.03 42.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.015 0.436 . . . . 5.0499999999999998 110.981 177.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.47 79.78 0.35 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.724 -0.671 . . . . 4.3700000000000001 112.157 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.93 149.91 66.48 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.46 2.107 . . . . 6.6799999999999997 111.627 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.0 p -69.9 -26.87 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.053 -0.521 . . . . 8.1699999999999999 110.862 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -66.68 -39.94 88.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.607 -0.724 . . . . 10.039999999999999 112.039 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -117.16 129.96 56.3 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.171 -0.307 . . . . 11.609999999999999 110.171 -173.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.3 p -125.97 149.18 48.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.815 0.34 . . . . 9.7899999999999991 111.24 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.34 -29.24 65.89 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.88 -0.6 . . . . 8.5099999999999998 110.812 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.82 -143.43 47.77 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.224 -0.898 . . . . 7.5599999999999996 113.814 172.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -69.99 -39.43 75.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.009 0.433 . . . . 10.0 110.709 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -59.94 -40.02 87.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.364 -0.834 . . . . 10.35 110.961 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.97 10.22 86.38 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.56 -0.745 . . . . 5.3399999999999999 112.17 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.0 p -79.01 129.36 34.36 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 120.93 0.395 . . . . 5.3200000000000003 111.326 -176.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -109.27 146.02 34.98 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.032 -0.729 . . . . 5.6100000000000003 109.032 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.65 ' HB2' ' CZ ' ' A' ' 95' ' ' TYR . 64.8 m-85 -119.73 138.92 53.01 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.534 -0.543 . . . . 3.7799999999999998 109.534 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -123.82 164.94 18.19 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.194 -0.669 . . . . 2.4500000000000002 109.194 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.554 ' HB2' ' HB3' ' A' ' 51' ' ' TYR . 10.4 mtp180 -120.63 124.33 27.64 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.779 -0.452 . . . . 3.2400000000000002 109.779 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.548 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 69.9 Cg_endo -80.1 122.76 4.85 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.963 1.775 . . . . 1.1899999999999999 110.952 173.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 36.5 tt0 -99.96 113.03 25.32 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.557 -0.535 . . . . 2.1899999999999999 109.557 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.1 tp -121.9 123.41 41.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.269 -0.423 . . . . 1.1399999999999999 110.411 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -119.7 135.79 54.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.943 0.401 . . . . 2.1800000000000002 110.262 173.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.1 t -113.67 119.88 62.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.153 -1.054 . . . . 1.5600000000000001 108.153 172.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -117.38 117.38 29.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.752 -0.462 . . . . 3.4399999999999999 109.752 -176.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -120.45 131.2 54.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.815 -0.629 . . . . 4.7999999999999998 109.959 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -121.82 139.95 52.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.306 -0.406 . . . . 2.9399999999999999 110.369 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -116.63 97.92 6.26 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.849 -0.797 . . . . 3.8999999999999999 108.849 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.611 HD22 ' O ' ' A' ' 83' ' ' ASP . 40.4 mt -114.7 18.35 16.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.842 -0.617 . . . . 4.4800000000000004 110.219 -175.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.84 -39.21 76.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.823 -0.626 . . . . 6.1900000000000004 111.789 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -73.03 -66.78 0.63 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.82 0.343 . . . . 5.4500000000000002 110.921 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -127.1 -173.42 2.89 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.088 -0.505 . . . . 5.2699999999999996 109.646 177.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.611 ' O ' HD22 ' A' ' 79' ' ' LEU . 22.3 m-20 -59.92 -39.92 87.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.553 -0.536 . . . . 6.3300000000000001 109.553 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -132.75 139.26 47.5 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.82 -0.808 . . . . 7.4800000000000004 108.82 170.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.9 m -150.06 -74.45 0.16 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.849 0.356 . . . . 2.5499999999999998 111.657 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -131.56 150.2 52.24 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.948 -0.39 . . . . 5.2999999999999998 109.948 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.55 161.7 28.7 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.645 -0.788 . . . . 1.3500000000000001 111.828 176.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.0 tp -141.11 112.57 7.48 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.746 -0.464 . . . . 2.29 109.746 176.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.3 m -120.01 129.99 54.52 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.261 -0.427 . . . . 1.54 110.562 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -127.23 140.06 11.62 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.727 -0.749 . . . . 1.1699999999999999 111.571 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.47 119.86 1.76 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.631 -0.795 . . . . 1.1899999999999999 111.874 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -126.81 129.72 48.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.001 0.429 . . . . 3.75 110.933 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -141.34 134.84 29.84 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.102 -0.703 . . . . 2.75 109.102 175.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.548 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 8.6 p30 -134.87 151.65 51.08 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-O 120.468 0.175 . . . . 1.8200000000000001 110.981 -175.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.65 ' CZ ' ' HB2' ' A' ' 67' ' ' PHE . 65.2 t80 -118.74 130.01 55.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.547 -0.297 . . . . 3.1400000000000001 110.371 -176.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.9 -169.76 22.3 Favored Glycine 0 C--O 1.228 -0.233 0 C-N-CA 120.465 -0.874 . . . . 2.79 112.254 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -152.46 159.97 43.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.651 0.226 . . . . 7.6200000000000001 110.533 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -116.31 19.74 14.63 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.267 0.469 . . . . 7.0800000000000001 112.267 -175.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -110.55 125.4 53.32 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.288 -0.258 . . . . 10.16 110.557 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.97 160.16 41.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.558 -0.292 . . . . 9.8100000000000005 110.87 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -52.11 -61.56 2.19 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.382 0.427 . . . . 12.220000000000001 111.076 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -135.03 157.05 77.81 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.444 -0.798 . . . . 10.48 109.363 -178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.02 149.86 81.93 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.311 2.007 . . . . 9.0999999999999996 111.713 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.99 -9.96 37.11 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.793 -0.718 . . . . 6.46 111.768 -175.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -100.35 122.82 43.73 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.551 -0.537 . . . . 7.6699999999999999 109.551 174.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -64.5 130.26 43.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.052 -0.522 . . . . 4.1399999999999997 110.794 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.1 p -97.64 139.99 32.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.784 -0.643 . . . . 3.2999999999999998 110.598 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -132.05 119.45 21.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.498 -0.319 . . . . 1.76 111.445 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' A' ' 95' ' ' TYR . 27.5 t-20 -151.8 124.62 8.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.779 -0.646 . . . . 2.5499999999999998 110.121 176.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.408 ' HG3' ' HA ' ' A' ' 139' ' ' ALA . 43.3 ttm -103.34 121.39 42.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.6 -0.727 . . . . 1.77 110.264 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -112.27 141.33 46.11 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.614 -0.434 . . . . 1.97 111.434 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.626 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 76.4 ttt180 -131.07 110.89 11.53 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.997 -0.742 . . . . 3.8500000000000001 108.997 168.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.563 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 83.2 m95 -98.76 119.95 38.38 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.879 -0.786 . . . . 2.2799999999999998 108.879 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.459 ' NZ ' ' HB2' ' A' ' 114' ' ' LYS . 10.2 mtmp? -121.74 123.81 42.73 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.785 -0.366 . . . . 2.1400000000000001 111.156 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 134' ' ' SER . 87.6 mt -120.62 126.22 74.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.032 -0.531 . . . . 1.55 109.976 174.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -138.92 105.78 7.42 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.425 -0.352 . . . . 1.1899999999999999 111.036 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.548 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 98.8 Cg_endo -80.06 160.03 23.77 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.98 2.453 . . . . 1.3700000000000001 111.158 173.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -116.19 137.19 52.35 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.248 -0.433 . . . . 2.3500000000000001 110.25 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -127.03 128.14 45.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.379 -0.373 . . . . 4.54 111.495 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.411 ' CG ' ' HE ' ' A' ' 128' ' ' ARG . 43.0 t0 -128.64 88.94 2.81 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.553 -0.536 . . . . 3.04 109.553 172.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.0 p -147.5 129.24 6.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.082 0.468 . . . . 4.2699999999999996 111.148 -177.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.711 ' HG3' ' H ' ' A' ' 124' ' ' THR . 55.8 tptt -144.31 142.91 30.72 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.217 -0.66 . . . . 6.04 109.217 177.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.3 mt -74.41 -6.77 50.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.137 0.494 . . . . 4.5899999999999999 110.904 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.711 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 26.3 m -119.96 135.7 54.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.637 -0.71 . . . . 3.6899999999999999 109.561 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -68.15 -39.93 82.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.873 -0.603 . . . . 5.1699999999999999 111.126 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -61.02 -40.27 92.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.244 -0.889 . . . . 3.71 112.078 -176.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -110.95 161.22 16.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.059 0.457 . . . . 2.0499999999999998 111.857 -171.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.541 ' HD2' ' OE1' ' A' ' 159' ' ' GLN . 20.3 ttm180 -125.51 133.66 52.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.88 -0.6 . . . . 4.2400000000000002 111.465 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.541 ' HB2' ' HD3' ' A' ' 122' ' ' LYS . 64.7 t80 -114.88 119.36 36.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.573 -0.739 . . . . 3.5499999999999998 109.21 175.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.412 ' OD1' ' HD3' ' A' ' 128' ' ' ARG . 17.4 m120 -118.45 130.05 55.74 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.018 -0.364 . . . . 2.1099999999999999 110.018 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -134.9 135.75 8.12 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.408 -0.901 . . . . 1.1799999999999999 111.688 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -124.0 128.28 49.14 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.668 -0.493 . . . . 4.2999999999999998 109.668 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.548 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 63.0 tp -109.95 110.93 22.03 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.188 -0.671 . . . . 2.2400000000000002 109.188 175.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 14.3 t -116.21 130.15 56.65 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.253 -0.579 . . . . 1.6899999999999999 110.533 -175.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 66.6 mtt -118.99 135.92 54.37 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.651 -0.87 . . . . 2.2400000000000002 108.651 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.563 ' HA ' ' O ' ' A' ' 113' ' ' TRP . 54.7 p90 -149.83 157.42 43.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.349 0.595 . . . . 3.5600000000000001 111.61 178.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 59.7 mttp -129.82 157.62 41.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.932 -1.031 . . . . 1.6699999999999999 109.849 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.745 ' H ' HD12 ' A' ' 142' ' ' LEU . 64.3 t80 -121.85 139.99 52.94 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.743 -0.662 . . . . 3.23 109.824 -173.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.408 ' HA ' ' HG3' ' A' ' 110' ' ' MET . . . 61.12 -175.91 0.12 Allowed 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.685 0.616 . . . . 1.24 110.745 -175.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 63.9 t30 -79.08 -21.63 46.47 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.211 -0.595 . . . . 2.4700000000000002 110.315 172.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.93 -47.39 85.98 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.496 -0.774 . . . . 2.4100000000000001 112.33 -172.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.745 HD12 ' H ' ' A' ' 138' ' ' PHE . 49.4 mt -69.87 -25.36 63.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.003 0.43 . . . . 1.8300000000000001 110.971 -178.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 140' ' ' ASN . 94.7 m-20 -59.91 -39.98 87.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.974 0.416 . . . . 2.0 110.007 175.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 80.9 p -78.1 -31.1 49.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.012 -0.54 . . . . 2.0499999999999998 111.54 -177.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.42 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 34.9 p -70.16 -25.03 63.26 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.105 0.478 . . . . 1.5900000000000001 110.912 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 64.93 -128.08 34.0 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.696 -0.684 . . . . 1.52 112.776 175.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -72.47 -20.69 61.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.514 0.19 . . . . 5.9400000000000004 111.514 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.02 97.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.827 0.346 . . . . 1.8300000000000001 111.155 -176.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -131.47 92.83 3.23 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.129 -0.693 . . . . 2.6400000000000001 109.129 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.2 t -144.85 146.69 32.18 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.048 -0.524 . . . . 2.02 110.153 -178.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 136' ' ' TYR . 32.8 tpt180 -99.77 119.05 37.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.39 -0.368 . . . . 3.6699999999999999 110.492 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.4 t -119.22 119.22 60.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 1.6399999999999999 109.875 178.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -123.49 140.01 53.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.929 0.395 . . . . 2.5600000000000001 111.009 -176.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 33.5 m -119.97 127.03 52.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.141 -0.482 . . . . 1.3899999999999999 109.737 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.526 ' HG3' HD21 ' A' ' 171' ' ' ASN . 31.0 tt0 -123.51 130.72 53.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.585 -0.524 . . . . 2.04 109.585 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 171' ' ' ASN . 88.3 m -122.07 121.83 37.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.855 0.359 . . . . 1.5600000000000001 111.614 -176.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -102.39 115.23 5.15 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 111.174 -0.77 . . . . 1.04 111.174 177.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 89.9 mt -100.34 122.61 43.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.829 0.347 . . . . 2.27 110.631 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.541 ' OE1' ' HD2' ' A' ' 128' ' ' ARG . 53.3 tt0 -100.01 107.97 20.05 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.065 -0.717 . . . . 2.4100000000000001 109.065 176.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -120.44 114.81 22.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.149 -0.478 . . . . 4.5700000000000003 109.714 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' A' ' 164' ' ' GLU . 6.8 p -88.85 90.5 8.44 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.269 0.557 . . . . 1.46 110.535 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -60.23 -49.28 78.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.582 -0.735 . . . . 2.6299999999999999 111.171 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.479 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.6 m-20 -101.77 13.13 35.76 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.983 -0.287 . . . . 2.4100000000000001 111.024 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.413 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 41.3 tt0 71.39 -48.7 0.68 Allowed 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.774 0.671 . . . . 2.5800000000000001 111.3 -178.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.7 p -74.69 -19.98 60.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.34 -0.391 . . . . 2.2999999999999998 111.642 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' A' ' 163' ' ' ASN . 33.4 m -121.46 140.0 46.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.326 -0.397 . . . . 1.71 110.266 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.488 ' O ' ' HD2' ' A' ' 199' ' ' PRO . . . -106.87 129.26 54.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.053 -0.522 . . . . 1.47 110.601 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 28.7 mt -103.72 129.22 51.05 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.291 -0.633 . . . . 1.6599999999999999 109.291 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -101.45 107.4 18.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.812 0.339 . . . . 3.2999999999999998 110.572 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.9 t -113.18 119.98 62.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 109.446 -0.576 . . . . 1.3 109.446 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.616 ' HB3' ' HB3' ' A' ' 195' ' ' ARG . 8.5 t30 -106.34 120.73 42.63 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.952 0.406 . . . . 2.2200000000000002 111.123 -176.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -103.18 129.96 50.23 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.562 -0.745 . . . . 4.6100000000000003 109.748 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -102.46 138.71 39.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.225 -0.443 . . . . 3.98 110.674 -177.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 62.8 tp -140.08 143.38 36.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.571 . . . . 2.3799999999999999 110.447 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -105.84 141.01 37.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.223 -0.288 . . . . 3.3100000000000001 110.223 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -113.05 140.57 47.74 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.983 -0.376 . . . . 6.5300000000000002 109.983 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.459 ' O ' ' HG2' ' A' ' 180' ' ' MET . . . 103.1 -3.01 47.65 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.625 -0.798 . . . . 5.0599999999999996 111.732 -175.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.88 -40.08 87.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.178 0.513 . . . . 7.3899999999999997 110.013 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -58.62 -31.96 68.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.661 -0.7 . . . . 9.0700000000000003 111.331 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 177' ' ' GLY . 25.7 ptm -99.44 8.65 44.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.612 0.244 . . . . 10.869999999999999 111.218 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -89.19 95.55 10.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.664 -0.243 . . . . 10.449999999999999 110.372 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -60.12 -45.08 94.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.421 0.629 . . . . 13.06 109.868 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.2 p -160.05 150.26 18.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.211 -0.904 . . . . 12.609999999999999 108.984 173.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -103.28 113.23 26.56 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.343 0.592 . . . . 15.19 110.643 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -60.39 -39.94 89.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.521 -1.218 . . . . 13.18 111.826 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -69.69 -19.56 63.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.073 -0.512 . . . . 12.73 110.689 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 101.8 140.23 11.04 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.651 -0.704 . . . . 9.9800000000000004 111.479 -175.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.575 ' HG2' ' H ' ' A' ' 190' ' ' SER . 36.6 tt0 -104.59 130.47 52.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.836 0.35 . . . . 10.699999999999999 110.665 -177.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -75.41 -23.08 56.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.151 0.501 . . . . 10.5 110.251 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.575 ' H ' ' HG2' ' A' ' 188' ' ' GLU . 50.1 m 63.59 17.55 10.47 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.889 -1.051 . . . . 6.6399999999999997 112.293 174.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 7.0 p -140.35 150.04 43.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.592 -0.276 . . . . 4.9800000000000004 110.798 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -110.19 142.66 41.43 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.389 -0.967 . . . . 7.0999999999999996 108.389 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -107.52 150.96 26.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.03 0.443 . . . . 4.4000000000000004 111.071 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 48.9 mm -113.83 125.53 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.781 -0.645 . . . . 2.21 110.24 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.616 ' HB3' ' HB3' ' A' ' 171' ' ' ASN . 35.2 ttm180 -99.96 109.37 21.73 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.553 -0.906 . . . . 3.54 108.553 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -123.63 131.44 53.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.834 0.349 . . . . 1.6699999999999999 111.695 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -158.22 165.75 34.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.934 -0.575 . . . . 5.8300000000000001 109.83 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.577 ' O ' ' HD2' ' A' ' 209' ' ' PRO . 1.5 pt? -143.64 137.29 14.31 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 121.126 -0.23 . . . . 2.5899999999999999 110.461 177.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' A' ' 167' ' ' ALA . 72.3 Cg_endo -79.77 129.67 8.28 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.451 2.101 . . . . 1.77 112.736 176.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 88.1 mt -128.05 135.21 49.55 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.35 -0.611 . . . . 2.2599999999999998 109.35 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 4.4 p -112.45 118.93 36.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.981 0.42 . . . . 1.99 111.149 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.9 mt -125.48 82.2 2.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.889 -0.782 . . . . 2.3100000000000001 108.889 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 69.49 -124.69 16.16 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.338 -0.846 . . . . 1.51 111.733 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -91.83 3.98 53.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.18 0.514 . . . . 2.5699999999999998 109.902 175.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -95.9 115.88 28.08 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.61 -0.885 . . . . 2.6600000000000001 108.61 174.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 47.5 t -100.61 120.37 39.94 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.938 -0.764 . . . . 1.6200000000000001 108.938 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.81 128.07 73.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.932 0.396 . . . . 1.3799999999999999 110.695 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 35.1 m -131.1 91.3 36.47 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-O 120.83 0.347 . . . . 1.1799999999999999 110.093 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.577 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 50.1 Cg_endo -70.41 140.58 40.54 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.269 1.979 . . . . 1.01 111.978 176.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -111.85 140.29 46.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.188 -0.46 . . . . 4.5 110.587 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 24.0 p -134.0 156.26 48.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 1.8899999999999999 110.314 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -116.57 120.33 38.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.045 0.45 . . . . 4.7999999999999998 110.656 -177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 84.8 mt -109.97 129.96 64.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.907 -0.588 . . . . 4.5700000000000003 110.259 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -102.09 -171.41 27.37 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.729 -0.748 . . . . 4.9800000000000004 112.451 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 91.1 mt -100.15 133.65 44.23 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.722 -0.473 . . . . 8.1099999999999994 109.722 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -69.93 -16.8 63.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 7.6500000000000004 111.725 -174.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -89.79 0.11 57.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.064 0.459 . . . . 10.529999999999999 111.051 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -125.52 149.42 48.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.835 -0.621 . . . . 11.56 109.347 178.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 46.1 m -76.98 -21.67 54.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.122 -0.49 . . . . 10.06 110.99 -176.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 59.98 25.69 14.91 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.255 -0.884 . . . . 11.92 112.3 170.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 85.6 m95 60.15 22.85 12.14 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.099 0.407 . . . . 14.01 112.099 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -99.5 137.16 38.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.333 -0.394 . . . . 14.529999999999999 109.995 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -118.85 122.02 41.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.771 0.32 . . . . 16.609999999999999 111.092 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -69.61 -21.16 63.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.999 -0.546 . . . . 15.460000000000001 109.964 175.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -60.54 -39.98 89.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.459 -0.792 . . . . 15.67 111.101 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -70.67 140.43 51.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.278 -0.419 . . . . 14.5 110.493 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 86.1 mt -110.04 130.09 63.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.823 -0.626 . . . . 15.15 110.691 -172.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -62.21 133.06 54.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.029 -0.532 . . . . 14.73 109.864 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 62.2 mtm180 -83.63 165.44 18.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.26 -0.427 . . . . 16.379999999999999 111.814 -173.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -59.95 -40.32 88.59 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.495 -0.557 . . . . 12.779999999999999 109.495 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -74.9 164.31 54.51 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.407 -0.815 . . . . 11.1 111.812 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -74.75 121.15 21.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.918 0.39 . . . . 12.26 111.692 -176.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -122.01 140.99 51.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.667 -0.697 . . . . 9.9900000000000002 109.867 174.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -134.72 149.86 50.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.827 0.346 . . . . 10.43 110.319 176.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -112.71 106.06 14.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.051 -0.522 . . . . 6.29 110.539 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 60.06 47.7 9.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.8 -0.636 . . . . 8.1500000000000004 111.675 174.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 63.3 t -109.9 129.7 64.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.604 -0.725 . . . . 2.3999999999999999 109.869 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -129.04 156.16 21.07 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.864 -0.684 . . . . 1.27 111.701 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.463 ' CD1' ' HA ' ' A' ' 258' ' ' GLU . 85.2 mt -120.0 130.45 54.75 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.933 -0.395 . . . . 1.97 109.933 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -109.89 130.0 55.58 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.989 -0.745 . . . . 3.54 108.989 176.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -120.03 139.89 51.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.959 0.409 . . . . 2.6400000000000001 111.0 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -113.66 128.81 8.48 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.797 -0.921 . . . . 1.3500000000000001 110.797 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' TYR . . . . . 0.439 ' O ' ' HB ' ' A' ' 251' ' ' VAL . 73.3 m-85 -130.0 150.11 51.42 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.614 0.207 . . . . 4.3600000000000003 110.772 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 58.12 39.98 25.57 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.082 0.864 . . . . 4.29 110.666 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -77.56 114.06 16.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.554 -0.748 . . . . 6.6900000000000004 109.79 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -143.46 168.22 20.36 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.895 -1.048 . . . . 6.3700000000000001 108.26 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -59.97 -40.06 87.78 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.83 -0.348 . . . . 5.8300000000000001 110.794 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 280' ' ' SER . . . -99.83 -0.27 56.36 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.447 -0.883 . . . . 2.6600000000000001 113.967 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 59.4 tp -145.98 138.52 25.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.65 0.725 . . . . 2.9700000000000002 111.304 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 61.3 p -147.36 134.49 20.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.821 0.343 . . . . 2.1699999999999999 110.963 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.473 HG22 HG23 ' A' ' 277' ' ' VAL . 59.8 t -122.58 132.47 71.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.799 -0.445 . . . . 1.79 109.799 176.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 35.1 t -120.04 127.8 52.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.877 0.37 . . . . 1.6299999999999999 110.086 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 72.2 mt -117.15 129.24 55.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.112 -0.495 . . . . 2.96 110.259 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.12 119.95 41.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.053 -0.521 . . . . 4.0800000000000001 110.633 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' TYR . . . . . 0.435 ' HD2' ' CZ ' ' A' ' 257' ' ' PHE . 92.6 m-85 -124.51 135.54 53.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.256 -0.429 . . . . 4.8399999999999999 110.465 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.644 ' HB3' ' H ' ' A' ' 272' ' ' TYR . . . -105.34 29.57 6.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.276 0.56 . . . . 3.5800000000000001 110.775 175.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' PHE . . . . . 0.435 ' CZ ' ' HD2' ' A' ' 255' ' ' TYR . 29.0 p90 -147.2 133.64 19.69 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.751 -0.658 . . . . 6.7699999999999996 110.174 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.463 ' HA ' ' CD1' ' A' ' 239' ' ' LEU . 56.3 mt-10 -69.86 -40.04 76.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.473 -0.785 . . . . 8.5399999999999991 111.174 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -121.05 154.63 35.83 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.834 -0.621 . . . . 11.9 109.71 -177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -86.96 109.01 19.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.0 0.429 . . . . 10.57 110.582 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -79.59 116.9 20.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.662 -0.699 . . . . 11.41 110.154 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -70.12 -19.94 63.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.031 -0.531 . . . . 11.98 111.775 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -80.75 168.53 18.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.623 -0.262 . . . . 12.460000000000001 111.069 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.1 -40.13 88.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.02 0.438 . . . . 13.779999999999999 111.05 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 136.55 167.18 11.09 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.903 -0.665 . . . . 11.07 111.649 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -120.35 134.09 55.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.971 -0.381 . . . . 12.59 109.971 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 12.6 p -69.99 -18.54 63.33 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.865 -0.607 . . . . 10.92 111.296 -178.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.2 -39.95 94.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.146 -0.479 . . . . 12.42 111.262 176.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -131.98 105.83 7.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.321 -0.4 . . . . 11.59 110.195 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -80.01 155.78 27.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.961 0.41 . . . . 8.8300000000000001 110.419 -177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -130.09 143.19 50.65 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.338 -0.392 . . . . 7.0199999999999996 110.619 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' TYR . . . . . 0.644 ' H ' ' HB3' ' A' ' 256' ' ' ALA . 91.9 m-85 -108.45 149.06 29.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.956 -0.565 . . . . 6.5999999999999996 110.158 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -137.57 130.25 29.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.834 -0.621 . . . . 1.9399999999999999 109.954 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -137.8 144.46 15.8 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.552 -0.832 . . . . 1.4199999999999999 112.541 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 63.0 t -130.06 130.11 65.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.588 0.232 . . . . 1.8100000000000001 110.489 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -141.65 131.07 4.63 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.955 -0.64 . . . . 1.3 111.554 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.473 HG23 HG22 ' A' ' 251' ' ' VAL . 7.3 p -132.96 137.12 54.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.652 0.263 . . . . 1.8300000000000001 110.73 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -119.79 127.52 52.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 2.3100000000000001 110.31 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 89.5 m-85 -109.22 126.71 53.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.259 -0.645 . . . . 4.75 109.259 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.498 ' HB2' ' HA2' ' A' ' 248' ' ' GLY . 37.7 m -114.17 129.35 56.63 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.903 0.383 . . . . 1.6699999999999999 110.554 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.178 -0.915 . . . . 3.6899999999999999 109.608 179.503 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.7 mtm . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 120.831 0.348 . . . . 11.85 110.976 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -117.02 112.97 21.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.087 0.47 . . . . 10.35 110.867 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -69.87 -40.02 75.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.53 -0.759 . . . . 9.3100000000000005 110.652 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -116.24 127.31 54.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.052 -0.522 . . . . 8.8399999999999999 109.969 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -120.04 130.59 54.77 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.093 -0.503 . . . . 7.0099999999999998 109.833 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -70.18 -29.4 66.27 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.609 -0.515 . . . . 3.6099999999999999 109.609 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.448 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 92.2 m95 -71.25 115.97 11.02 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.642 -0.708 . . . . 3.3300000000000001 110.053 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.427 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 53.1 t60 -114.57 122.16 45.67 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.071 -0.513 . . . . 3.2000000000000002 109.964 175.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' A' ' 7' ' ' TRP . 98.9 m-85 -120.21 140.07 51.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.944 -0.571 . . . . 2.4900000000000002 110.731 -178.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -122.0 129.47 52.49 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.078 -0.712 . . . . 2.1299999999999999 109.078 171.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.511 ' HB ' ' HB3' ' A' ' 279' ' ' TYR . 86.2 mt -125.12 129.37 73.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.292 -0.413 . . . . 1.6000000000000001 110.736 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.13 122.79 5.95 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.093 -0.803 . . . . 0.88 111.093 175.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -120.01 136.66 54.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.935 0.367 . . . . 1.0800000000000001 110.858 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 68.4 mtt -133.43 156.68 47.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.305 -0.407 . . . . 2.3300000000000001 110.347 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -114.65 139.93 49.25 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.782 -0.451 . . . . 2.6099999999999999 109.782 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 42.2 tt0 -60.34 -50.23 74.46 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.762 0.652 . . . . 5.0899999999999999 112.762 -175.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.8 tt -145.06 146.68 19.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.799 0.333 . . . . 5.3300000000000001 111.048 -174.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.532 ' HB3' HG13 ' A' ' 20' ' ' VAL . 40.5 mt-10 -61.75 -50.16 73.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.628 -0.715 . . . . 8.2799999999999994 112.317 -176.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 51.14 42.78 29.1 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.244 0.545 . . . . 9.6999999999999993 111.121 -174.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.532 HG13 ' HB3' ' A' ' 18' ' ' GLU . 16.5 m -80.1 -14.74 13.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.836 -0.62 . . . . 11.09 111.151 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.63 -30.1 67.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 13.1 110.993 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.6 178.56 28.24 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.733 -0.746 . . . . 11.94 112.218 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -130.02 159.97 35.1 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.501 -0.555 . . . . 15.18 109.501 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.19 -131.26 2.88 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.442 -0.885 . . . . 12.0 112.301 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -69.8 -35.75 75.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.495 0.664 . . . . 12.82 110.094 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 59.84 28.28 17.73 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 114.126 -1.397 . . . . 10.81 111.983 172.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 75.2 mtm -69.9 -40.04 75.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.291 -0.413 . . . . 10.050000000000001 111.369 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -70.18 149.27 47.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.963 0.411 . . . . 8.0600000000000005 111.026 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.73 97.98 0.51 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.988 -0.625 . . . . 5.5800000000000001 111.864 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.1 tp -139.94 140.77 36.43 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.635 -0.505 . . . . 5.5599999999999996 109.635 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 16' ' ' GLU . . . 64.27 63.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.623 0.577 . . . . 3.0499999999999998 111.506 176.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -100.82 130.7 24.72 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.953 -0.567 . . . . 3.48 109.796 175.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.97 150.01 66.32 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.347 2.031 . . . . 1.8600000000000001 112.267 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 14.3 p -124.46 143.67 50.51 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.038 -0.528 . . . . 1.97 109.733 175.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.0 m -129.96 139.23 52.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.19 0.519 . . . . 1.71 111.252 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -120.33 139.44 52.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.616 -0.72 . . . . 4.0700000000000003 109.631 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -119.9 138.34 53.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.882 0.373 . . . . 2.8599999999999999 111.625 -174.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -140.07 130.01 24.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.733 -0.667 . . . . 1.8899999999999999 109.222 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.62 143.46 49.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.884 0.373 . . . . 1.0800000000000001 111.573 -174.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.542 ' HB2' ' HG2' ' A' ' 45' ' ' ARG . . . -147.01 125.09 12.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.607 -0.724 . . . . 1.3899999999999999 111.354 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.602 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 27.8 p-10 -166.96 95.24 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.278 0.561 . . . . 2.8599999999999999 110.502 171.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.97 -95.52 2.1 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.05 -0.595 . . . . 1.6799999999999999 111.871 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.602 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 54.2 Cg_exo -52.5 174.47 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.624 2.883 . . . . 1.6599999999999999 113.178 171.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.605 ' HB2' ' O ' ' A' ' 75' ' ' HIS . 48.9 p90 -69.14 -176.02 0.84 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.83 -0.623 . . . . 3.3999999999999999 111.289 -175.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.542 ' HG2' ' HB2' ' A' ' 40' ' ' ALA . 83.3 mtm180 -111.0 136.37 50.1 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 121.786 0.803 . . . . 3.1000000000000001 112.42 -167.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 87.1 mt -120.06 129.95 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 114.113 -1.403 . . . . 1.8 109.931 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 73' ' ' GLU . . . -117.85 138.22 52.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.43 -0.35 . . . . 0.85999999999999999 110.065 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.0 tp -114.22 130.93 56.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.945 -0.57 . . . . 1.0600000000000001 110.423 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 71' ' ' GLU . . . -148.85 169.25 20.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.52 -0.764 . . . . 1.1399999999999999 109.332 177.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -139.75 157.52 45.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.642 0.258 . . . . 4.0199999999999996 110.386 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -120.42 131.71 54.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.114 -0.494 . . . . 4.6100000000000003 110.645 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -113.61 127.86 56.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.079 -0.51 . . . . 3.3799999999999999 109.816 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.641 ' O ' ' HE3' ' A' ' 62' ' ' LYS . 93.6 mt-10 -124.03 139.86 53.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.308 -0.405 . . . . 5.0499999999999998 109.973 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -102.12 164.31 17.04 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.703 -0.76 . . . . 4.3700000000000001 112.921 -173.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.98 -40.35 20.97 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.774 2.316 . . . . 6.6799999999999997 112.498 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -101.45 -60.04 3.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.962 0.41 . . . . 8.1699999999999999 110.232 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -83.98 129.78 34.91 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.183 -0.673 . . . . 10.039999999999999 109.183 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -61.37 -39.94 92.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.289 -0.869 . . . . 11.609999999999999 110.94 -172.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.2 t -112.31 100.13 8.56 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.888 -0.412 . . . . 9.7899999999999991 109.888 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.49 160.03 31.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.789 -0.641 . . . . 8.5099999999999998 109.517 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.28 116.96 5.6 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.342 -0.933 . . . . 7.5599999999999996 112.67 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.641 ' HE3' ' O ' ' A' ' 53' ' ' GLU . 97.6 mttt -78.16 146.63 34.95 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 175.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -68.35 -39.96 81.69 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.943 -0.391 . . . . 10.35 109.943 174.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -78.97 141.36 24.18 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.758 -0.734 . . . . 5.3399999999999999 111.923 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.8 p -108.61 19.98 19.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.956 0.408 . . . . 5.3200000000000003 111.003 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -60.04 -39.99 87.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.797 -0.638 . . . . 5.6100000000000003 110.863 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.425 ' CD2' ' HA2' ' A' ' 96' ' ' GLY . 37.2 m-85 -119.02 120.02 35.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.731 -0.47 . . . . 3.7799999999999998 109.731 173.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -145.05 150.82 37.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.866 -0.607 . . . . 2.4500000000000002 109.634 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.455 HH12 ' CD ' ' A' ' 53' ' ' GLU . 41.0 ttp180 -119.99 124.42 27.87 Favored Pre-proline 0 C--N 1.328 -0.341 0 C-N-CA 120.662 -0.415 . . . . 3.2400000000000002 110.98 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -84.02 149.15 12.18 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.843 2.362 . . . . 1.1899999999999999 112.921 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.468 ' CD ' ' HE ' ' A' ' 93' ' ' ARG . 3.7 tp10 -115.46 118.55 33.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.572 -0.899 . . . . 2.1899999999999999 108.572 168.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.462 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 59.5 tp -122.34 101.8 7.73 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.251 -0.431 . . . . 1.1399999999999999 110.15 -178.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 34.7 mt-10 -90.14 125.59 35.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.04 -0.527 . . . . 2.1800000000000002 111.31 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.8 m -114.0 121.99 67.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.524 -0.917 . . . . 1.5600000000000001 108.524 168.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.605 ' O ' ' HB2' ' A' ' 44' ' ' TRP . 63.0 m80 -109.67 118.11 35.69 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.662 -0.495 . . . . 3.4399999999999999 109.662 -174.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -114.52 130.07 56.72 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.859 -0.793 . . . . 4.7999999999999998 108.859 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -128.04 129.74 47.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.953 0.406 . . . . 2.9399999999999999 110.399 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 89.0 m-85 -100.23 109.54 21.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.95 -0.568 . . . . 3.8999999999999999 109.941 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.07 12.9 35.79 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.323 -0.621 . . . . 4.4800000000000004 109.323 177.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -59.98 -38.46 82.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.908 -1.042 . . . . 6.1900000000000004 111.05 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -109.92 130.06 55.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.01 -0.541 . . . . 5.4500000000000002 110.713 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -77.9 -13.73 59.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.247 0.546 . . . . 5.2699999999999996 109.598 172.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -59.97 -49.95 75.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.431 -0.804 . . . . 6.3300000000000001 110.3 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 86' ' ' PHE . 97.4 m-85 -142.83 141.62 31.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.604 -0.725 . . . . 7.4800000000000004 109.349 177.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.9 t -84.11 93.34 8.11 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.407 -0.96 . . . . 2.5499999999999998 108.407 172.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 78' ' ' PHE . 98.9 m-85 -79.55 129.8 34.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.107 -0.497 . . . . 5.2999999999999998 110.344 -175.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.08 153.22 17.89 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.318 -0.944 . . . . 1.3500000000000001 111.903 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.8 tp -139.3 117.32 11.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.92 0.39 . . . . 2.29 110.079 176.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.6 m -110.8 117.65 34.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.138 -0.483 . . . . 1.54 110.368 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.57 133.9 10.8 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.508 -0.853 . . . . 1.1699999999999999 112.059 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -136.04 126.11 3.76 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.548 -0.621 . . . . 1.1899999999999999 111.548 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -112.35 131.29 55.61 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.054 -0.35 . . . . 3.75 110.054 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.468 ' HE ' ' CD ' ' A' ' 71' ' ' GLU . 85.8 mtt180 -135.28 131.33 36.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.088 -0.506 . . . . 2.75 110.177 -172.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -133.92 129.21 35.99 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.052 -0.259 . . . . 1.8200000000000001 110.958 175.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.411 ' HB2' ' HD3' ' A' ' 69' ' ' ARG . 71.4 t80 -114.85 125.13 53.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.525 -0.307 . . . . 3.1400000000000001 110.252 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.425 ' HA2' ' CD2' ' A' ' 67' ' ' PHE . . . 102.32 178.84 27.4 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.527 -0.845 . . . . 2.79 112.928 175.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -136.65 140.01 42.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.056 0.455 . . . . 7.6200000000000001 110.106 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -77.0 -20.08 56.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.539 -0.755 . . . . 7.0800000000000001 109.74 177.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -116.5 134.17 55.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.782 -0.645 . . . . 10.16 109.98 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 28.5 m -136.96 -179.85 3.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 110.023 -0.362 . . . . 9.8100000000000005 110.023 177.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -59.88 -49.13 78.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.861 0.362 . . . . 12.220000000000001 111.067 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -131.15 78.59 72.51 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.071 -0.513 . . . . 10.48 110.481 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.28 118.44 5.32 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.572 2.181 . . . . 9.0999999999999996 112.867 -176.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -152.29 59.17 0.41 Allowed Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.596 -0.729 . . . . 6.46 111.38 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 63.03 19.97 11.99 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.213 0.53 . . . . 7.6699999999999999 111.025 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -100.94 1.05 39.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.766 -0.652 . . . . 4.1399999999999997 109.892 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.3 p -86.51 141.51 29.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.516 -0.765 . . . . 3.2999999999999998 110.835 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.64 124.67 16.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.928 -0.578 . . . . 1.76 110.095 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -139.54 107.93 5.83 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.245 -0.65 . . . . 2.5499999999999998 109.245 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 91.6 mtp -119.95 115.52 23.94 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.471 -0.331 . . . . 1.77 110.297 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.63 ' HB2' ' OD1' ' A' ' 143' ' ' ASN . 49.4 mt-30 -100.19 129.09 46.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.949 0.404 . . . . 1.97 110.113 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 40.5 ttm180 -120.24 111.02 17.28 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.87 -0.789 . . . . 3.8500000000000001 108.87 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -108.02 130.83 55.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.06 -0.518 . . . . 2.2799999999999998 109.703 -175.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 135' ' ' MET . 87.6 tttt -130.23 124.12 31.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.045 0.45 . . . . 2.1400000000000001 110.884 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 75.9 mt -129.82 130.03 66.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.022 -0.535 . . . . 1.55 109.557 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -134.01 116.41 13.42 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.393 -0.367 . . . . 1.1899999999999999 111.151 -177.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 87.3 Cg_endo -80.01 140.05 13.99 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.277 1.984 . . . . 1.3700000000000001 110.579 171.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -87.77 137.75 32.06 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.202 -0.454 . . . . 2.3500000000000001 110.985 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -101.13 127.53 47.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.24 -0.652 . . . . 4.54 109.24 172.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -71.43 160.39 32.82 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 124.092 0.87 . . . . 3.04 111.61 -171.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' A' ' 128' ' ' ARG . 34.6 m -115.04 173.94 3.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.304 -0.862 . . . . 4.2699999999999996 110.841 -173.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 60.13 39.07 19.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.854 -0.612 . . . . 6.04 111.576 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.7 tp -63.08 -40.19 96.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.759 -0.655 . . . . 4.5899999999999999 110.436 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.9 p -118.02 159.98 22.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.752 -0.658 . . . . 3.6899999999999999 110.446 177.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -70.27 129.91 40.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.061 -0.518 . . . . 5.1699999999999999 111.402 -174.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 59.86 28.37 17.85 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.081 -0.963 . . . . 3.71 111.368 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.8 mt -137.77 144.44 41.6 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.21 -0.663 . . . . 2.0499999999999998 109.21 175.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.5 ' HG3' ' HB ' ' A' ' 121' ' ' VAL . 56.8 ttt180 -130.2 128.99 42.81 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.427 -0.509 . . . . 4.2400000000000002 111.104 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.441 ' O ' HG12 ' A' ' 121' ' ' VAL . 90.0 m-85 -120.01 123.05 42.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.273 -0.876 . . . . 3.5499999999999998 108.882 176.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 156' ' ' THR . 21.8 m-80 -116.16 130.98 57.06 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.078 -0.712 . . . . 2.1099999999999999 109.078 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.36 129.61 4.62 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 118.965 -1.588 . . . . 1.1799999999999999 113.232 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -123.57 127.8 48.81 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.943 -0.392 . . . . 4.2999999999999998 109.943 173.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.627 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 87.9 mt -112.75 109.72 19.39 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.031 -0.729 . . . . 2.2400000000000002 109.031 174.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 152' ' ' VAL . 52.6 m -105.88 124.95 50.39 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.565 -0.454 . . . . 1.6899999999999999 111.469 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.661 ' O ' ' HA ' ' A' ' 114' ' ' LYS . 95.4 mmm -93.32 126.2 38.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.507 -0.77 . . . . 2.2400000000000002 109.295 176.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -120.68 126.14 49.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.177 0.513 . . . . 3.5600000000000001 111.953 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 61.7 mttp -130.31 143.72 50.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.387 -0.968 . . . . 1.6699999999999999 108.387 167.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.53 ' H ' HD22 ' A' ' 142' ' ' LEU . 53.1 p90 -141.48 160.0 41.06 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 121.201 -0.2 . . . . 3.23 110.76 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 62.75 178.66 0.14 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.94 0.775 . . . . 1.24 110.601 -177.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -75.73 -24.36 56.13 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.93 0.395 . . . . 2.4700000000000002 110.584 173.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -59.96 -50.85 72.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.951 -0.568 . . . . 2.4100000000000001 111.599 -174.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.53 HD22 ' H ' ' A' ' 138' ' ' PHE . 9.5 mp -70.81 -29.86 66.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.436 -0.347 . . . . 1.8300000000000001 111.24 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.63 ' OD1' ' HB2' ' A' ' 111' ' ' GLN . 12.7 m120 -61.58 -41.49 97.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.006 0.432 . . . . 2.0 110.456 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.1 p -80.22 -39.9 28.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.595 -0.73 . . . . 2.0499999999999998 111.832 -173.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 148' ' ' ALA . 24.6 p -74.07 -32.88 63.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.321 . . . . 1.5900000000000001 111.207 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.71 -108.75 2.59 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.933 -0.576 . . . . 1.52 113.149 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -59.97 -40.07 87.83 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 122.687 0.395 . . . . 5.9400000000000004 111.503 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' A' ' 145' ' ' THR . . . -60.04 -44.27 94.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.173 -0.467 . . . . 1.8300000000000001 111.857 -175.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.53 ' HB3' ' HG ' ' A' ' 142' ' ' LEU . 43.3 m-20 -118.01 98.25 6.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.125 0.488 . . . . 2.6400000000000001 110.966 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.5 t -149.93 144.56 25.96 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.406 -0.59 . . . . 2.02 109.406 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -110.16 151.71 26.94 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.335 -0.393 . . . . 3.6699999999999999 110.078 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.519 HG12 ' SD ' ' A' ' 135' ' ' MET . 16.1 m -136.41 134.4 49.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.984 0.421 . . . . 1.6399999999999999 111.504 -177.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -113.72 140.51 48.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.199 -0.455 . . . . 2.5600000000000001 109.832 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 78.6 m -128.42 118.63 23.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.163 -0.471 . . . . 1.3899999999999999 109.936 175.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -120.68 120.16 34.9 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.774 -0.454 . . . . 2.04 109.774 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 130' ' ' ASN . 27.0 m -108.3 119.93 40.92 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.669 -0.696 . . . . 1.5600000000000001 110.026 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.97 111.81 4.33 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.92 -0.872 . . . . 1.04 110.92 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 91.7 mt -104.23 129.98 52.03 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 110.263 -0.273 . . . . 2.27 110.263 -176.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 65.9 tt0 -114.92 113.55 24.31 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.832 -0.433 . . . . 2.4100000000000001 109.832 176.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -115.65 130.57 56.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.573 -0.74 . . . . 4.5700000000000003 109.458 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -92.58 90.18 7.02 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.404 0.621 . . . . 1.46 109.907 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -60.24 -49.62 76.88 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.934 -1.03 . . . . 2.6299999999999999 111.715 -171.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.418 ' C ' ' H ' ' A' ' 165' ' ' THR . 17.4 m120 -99.87 2.62 44.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.381 -0.372 . . . . 2.4100000000000001 110.353 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 71.88 -36.11 0.35 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.356 -0.838 . . . . 2.5800000000000001 111.263 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 163' ' ' ASN . 21.8 p -75.36 -34.97 61.19 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.859 0.362 . . . . 2.2999999999999998 111.206 174.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 163' ' ' ASN . 24.9 m -121.08 140.56 44.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 120.94 0.4 . . . . 1.71 110.734 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 161' ' ' THR . . . -107.74 139.94 41.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.928 -0.578 . . . . 1.47 111.237 -175.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 159' ' ' GLN . 17.9 mt -104.53 125.59 50.84 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.429 -0.582 . . . . 1.6599999999999999 109.429 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -109.22 115.72 30.54 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.727 -0.472 . . . . 3.2999999999999998 109.727 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.0 132.09 65.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.063 0.459 . . . . 1.3 110.855 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.475 ' O ' ' HB ' ' A' ' 194' ' ' ILE . 3.2 m-20 -107.23 122.57 46.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.048 0.451 . . . . 2.2200000000000002 111.025 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -98.28 121.51 40.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.512 -0.767 . . . . 4.6100000000000003 110.052 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -99.49 120.42 39.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.953 0.406 . . . . 3.98 110.119 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 63.9 tp -104.91 129.14 53.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.806 -0.634 . . . . 2.3799999999999999 110.95 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -98.68 138.63 35.57 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.641 -0.874 . . . . 3.3100000000000001 108.641 175.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -60.25 -39.92 88.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.992 0.425 . . . . 6.5300000000000002 110.842 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -110.01 -159.03 17.41 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.866 -0.683 . . . . 5.0599999999999996 111.826 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -133.84 51.17 2.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.015 0.436 . . . . 7.3899999999999997 109.859 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -157.55 122.17 4.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 9.0700000000000003 110.445 -175.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 75.9 mtm -95.55 139.98 31.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.101 0.477 . . . . 10.869999999999999 110.608 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -62.05 -40.01 94.31 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.041 -0.982 . . . . 10.449999999999999 113.448 -169.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -73.66 117.2 15.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.931 0.396 . . . . 13.06 111.211 -172.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 13.2 p -104.0 -0.04 29.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.857 -0.611 . . . . 12.609999999999999 110.779 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -70.01 -40.0 75.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.425 0.631 . . . . 15.19 110.368 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -99.09 148.2 24.29 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.071 -0.968 . . . . 13.18 110.604 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -64.17 137.7 58.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.282 -0.636 . . . . 12.73 109.282 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -170.86 137.36 4.38 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 119.563 -1.304 . . . . 9.9800000000000004 113.561 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.2 145.59 51.34 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.99 -0.745 . . . . 10.699999999999999 108.99 170.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -70.07 -34.06 72.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 10.5 111.341 -172.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 53.0 m -125.05 130.07 51.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.753 0.311 . . . . 6.6399999999999997 110.277 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 9.9 t -158.2 154.77 27.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.328 -0.396 . . . . 4.9800000000000004 110.722 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.543 ' O ' ' HB3' ' A' ' 216' ' ' ASP . 48.7 tt0 -120.0 114.2 21.66 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.929 -0.578 . . . . 7.0999999999999996 109.721 175.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -140.77 111.05 6.68 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.554 -0.535 . . . . 4.4000000000000004 109.554 172.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' A' ' 171' ' ' ASN . 28.5 pt -120.09 169.1 11.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.761 -0.654 . . . . 2.21 111.062 -172.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -101.68 119.94 39.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.85 -0.614 . . . . 3.54 110.553 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -112.87 129.44 56.46 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.512 -0.551 . . . . 1.6699999999999999 109.512 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 209' ' ' PRO . 31.1 p90 -145.42 149.93 35.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.264 0.554 . . . . 5.8300000000000001 111.528 -178.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.9 mp -112.26 127.74 26.44 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.689 -0.687 . . . . 2.5899999999999999 110.279 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' A' ' 167' ' ' ALA . 85.6 Cg_endo -81.22 106.23 1.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.287 1.991 . . . . 1.77 111.581 175.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 89.9 mt -114.47 140.09 49.0 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.941 -0.572 . . . . 2.2599999999999998 109.93 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 94.0 m -119.93 130.05 54.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.126 0.488 . . . . 1.99 111.134 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.1 mt -129.8 80.29 1.95 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.533 -0.914 . . . . 2.3100000000000001 108.533 173.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 70.06 -120.96 9.96 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.863 -0.684 . . . . 1.51 111.78 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -91.87 -0.03 57.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.259 0.552 . . . . 2.5699999999999998 109.536 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -93.67 118.98 32.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.327 -0.852 . . . . 2.6600000000000001 109.291 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 47.6 m -104.62 131.97 51.42 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.782 -0.451 . . . . 1.6200000000000001 109.782 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 63.2 t -120.07 130.03 74.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.908 -0.405 . . . . 1.3799999999999999 109.908 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 48.1 m -138.1 94.65 11.04 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 116.503 -0.317 . . . . 1.1799999999999999 110.987 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' A' ' 197' ' ' TYR . 16.5 Cg_exo -69.17 131.22 21.6 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.525 2.15 . . . . 1.01 111.635 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -108.43 139.97 42.4 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.823 -0.436 . . . . 4.5 109.823 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 11.1 t -168.53 166.93 11.9 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.191 -0.459 . . . . 1.8899999999999999 110.426 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -98.97 139.87 33.97 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.048 -1.093 . . . . 4.7999999999999998 108.048 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.466 ' HB ' ' OD2' ' A' ' 216' ' ' ASP . 83.7 mt -59.85 -40.2 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.03 0.443 . . . . 4.5700000000000003 110.871 -175.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 104.4 -30.28 10.42 Favored Glycine 0 CA--C 1.507 -0.438 0 C-N-CA 120.698 -0.763 . . . . 4.9800000000000004 111.908 176.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.1 tp -69.89 -24.01 63.33 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.922 -0.77 . . . . 8.1099999999999994 108.922 172.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 192' ' ' GLN . 17.0 m-20 -59.93 -50.06 75.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.638 -1.164 . . . . 7.6500000000000004 110.39 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -157.8 136.19 11.1 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.096 -0.956 . . . . 10.529999999999999 108.776 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -98.8 110.6 23.18 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.105 0.479 . . . . 11.56 110.705 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 84.3 p -146.53 159.49 43.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.775 -0.648 . . . . 10.06 109.567 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 15.2 m120 60.06 38.45 20.58 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.666 0.603 . . . . 11.92 111.179 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -61.74 -41.33 97.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.654 -0.703 . . . . 14.01 109.681 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -142.12 -179.61 6.34 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.13 -0.941 . . . . 14.529999999999999 109.251 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -75.16 99.11 3.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.394 0.616 . . . . 16.609999999999999 111.974 -175.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -70.03 147.95 49.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.925 -1.034 . . . . 15.460000000000001 109.569 175.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -100.09 14.05 32.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.821 0.343 . . . . 15.67 110.957 -177.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -67.01 150.19 49.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.887 -0.597 . . . . 14.5 110.934 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 10.7 tp -79.25 -7.58 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.738 0.78 . . . . 15.15 110.423 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 62.06 51.4 3.64 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.612 -1.176 . . . . 14.73 113.076 174.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -61.5 -34.22 75.13 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.044 -0.725 . . . . 16.379999999999999 109.044 171.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -63.6 -39.91 95.59 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.047 -0.978 . . . . 12.779999999999999 110.759 175.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 90.09 -12.7 66.92 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.974 -0.557 . . . . 11.1 114.239 173.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 25.6 m80 59.97 39.89 19.54 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 117.225 0.513 . . . . 12.26 111.346 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.8 -40.18 87.46 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.202 0.445 . . . . 9.9900000000000002 112.202 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -68.77 -39.85 80.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.669 0.271 . . . . 10.43 111.275 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -82.15 78.28 8.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.361 0.601 . . . . 6.29 109.53 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -119.14 135.93 54.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.567 -0.742 . . . . 8.1500000000000004 110.913 -176.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.424 HG23 ' HB3' ' A' ' 257' ' ' PHE . 33.1 m -130.03 159.99 41.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.337 -0.616 . . . . 2.3999999999999999 109.337 175.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 172.43 177.03 41.59 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.024 -1.084 . . . . 1.27 112.995 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 83.0 mt -120.04 129.97 54.48 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.104 -0.332 . . . . 1.97 110.104 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -101.45 133.64 45.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.061 -0.348 . . . . 3.54 110.061 175.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -120.08 139.96 51.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.061 -0.518 . . . . 2.6400000000000001 110.262 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 251' ' ' VAL . . . -127.13 132.16 7.49 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.251 -0.739 . . . . 1.3500000000000001 111.251 176.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 250' ' ' SER . 91.3 m-85 -120.83 144.24 48.45 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.067 -0.346 . . . . 4.3600000000000003 110.067 -177.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 56.5 40.04 29.69 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.846 0.716 . . . . 4.29 110.507 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -62.72 -40.11 96.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.534 -0.757 . . . . 6.6900000000000004 110.867 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -111.21 129.99 55.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.636 -0.256 . . . . 6.3700000000000001 111.289 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 55.51 39.92 31.11 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.704 -0.68 . . . . 5.8300000000000001 112.229 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -161.82 -174.44 31.7 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.521 -0.632 . . . . 2.6600000000000001 111.521 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 86.2 mt -89.1 109.1 20.0 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.863 -0.791 . . . . 2.9700000000000002 108.863 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 243' ' ' TYR . 17.7 m -78.88 130.92 36.17 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.113 0.482 . . . . 2.1699999999999999 111.26 -169.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.42 ' O ' ' HA2' ' A' ' 242' ' ' GLY . 62.9 t -107.57 133.24 52.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.667 -0.697 . . . . 1.79 109.78 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 3.0 p -108.3 113.28 26.25 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.064 0.459 . . . . 1.6299999999999999 110.485 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 64.8 tp -119.57 115.73 24.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.087 -0.506 . . . . 2.96 110.635 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -101.77 115.47 30.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.181 -0.463 . . . . 4.0800000000000001 110.371 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' TYR . . . . . 0.521 ' CE1' ' HA ' ' A' ' 257' ' ' PHE . 61.0 t80 -106.21 120.04 40.81 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 110.259 -0.275 . . . . 4.8399999999999999 110.259 175.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -80.04 123.34 27.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.487 -0.931 . . . . 3.5800000000000001 108.487 172.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' PHE . . . . . 0.521 ' HA ' ' CE1' ' A' ' 255' ' ' TYR . 49.2 t80 -71.32 118.46 14.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.859 0.361 . . . . 6.7699999999999996 110.546 -171.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -96.93 123.46 40.65 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 116.005 -0.543 . . . . 8.5399999999999991 110.151 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -80.05 155.65 27.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.756 -0.656 . . . . 11.9 111.218 -175.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -86.31 129.99 34.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.769 -0.65 . . . . 10.57 109.606 177.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -84.64 170.03 13.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.044 -0.526 . . . . 11.41 110.006 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -100.92 -18.09 16.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.613 -0.267 . . . . 11.98 111.216 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -85.22 122.9 30.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.407 0.623 . . . . 12.460000000000001 110.432 177.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.4 -40.1 93.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.716 -1.129 . . . . 13.779999999999999 111.674 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -60.32 119.37 18.19 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.105 -0.569 . . . . 11.07 112.671 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -61.45 132.24 52.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.292 0.567 . . . . 12.59 111.546 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 21.2 m -125.61 143.45 51.02 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.555 -0.748 . . . . 10.92 109.004 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.66 120.09 14.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.983 0.421 . . . . 12.42 109.929 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -119.58 140.08 51.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.784 -0.643 . . . . 11.59 110.113 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -80.67 129.33 34.46 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.217 0.532 . . . . 8.8300000000000001 110.319 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -98.1 133.19 42.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.51 -0.768 . . . . 7.0199999999999996 109.936 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -130.07 129.63 43.85 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.04 0.448 . . . . 6.5999999999999996 110.935 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -151.84 173.67 14.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.582 -0.735 . . . . 1.9399999999999999 109.617 174.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.35 137.57 9.54 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.937 -0.649 . . . . 1.4199999999999999 111.659 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 61.9 t -129.4 129.97 67.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.953 0.406 . . . . 1.8100000000000001 110.874 -175.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -152.44 163.66 30.36 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.873 -0.603 . . . . 1.3 111.686 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.19 140.01 32.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.885 0.374 . . . . 1.8300000000000001 110.163 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -113.5 127.01 55.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.196 0.522 . . . . 2.3100000000000001 110.929 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.511 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 65.0 t80 -105.96 124.71 50.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.655 -0.702 . . . . 4.75 109.402 176.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 7.7 p -117.44 130.51 56.51 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.037 0.446 . . . . 1.6699999999999999 110.858 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 59.2 t80 . . . . . 0 C--O 1.244 0.783 0 CA-C-O 118.508 -0.758 . . . . 3.6899999999999999 109.084 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.4 mtp . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 120.689 0.28 . . . . 11.85 110.692 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -132.4 148.34 52.41 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.361 -0.607 . . . . 10.35 109.361 175.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -111.68 149.19 31.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.059 0.457 . . . . 9.3100000000000005 110.493 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -83.13 0.28 45.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.805 -0.634 . . . . 8.8399999999999999 111.092 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -126.72 140.71 52.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.067 -0.515 . . . . 7.0099999999999998 110.001 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.51 118.75 22.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.351 -0.386 . . . . 3.6099999999999999 111.059 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -96.93 108.2 20.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.6 -0.889 . . . . 3.3300000000000001 108.6 171.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -110.7 137.16 48.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.341 0.591 . . . . 3.2000000000000002 111.778 -175.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -125.21 142.89 51.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.619 -1.173 . . . . 2.4900000000000002 109.536 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -120.98 129.99 53.64 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.962 -0.384 . . . . 2.1299999999999999 109.962 176.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.7 mt -120.03 122.52 68.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.921 -0.581 . . . . 1.6000000000000001 109.919 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.38 142.1 13.53 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 119.799 -1.191 . . . . 0.88 112.601 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.26 136.23 53.19 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.624 -0.509 . . . . 1.0800000000000001 109.624 176.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 70.1 mtm -127.75 151.28 49.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.184 -0.462 . . . . 2.3300000000000001 110.944 -175.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.444 ' CE1' ' HB3' ' A' ' 33' ' ' PRO . 59.3 m-85 -129.93 138.25 50.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.251 -0.886 . . . . 2.6099999999999999 108.69 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 59.87 48.68 8.68 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.124 0.488 . . . . 5.0899999999999999 110.049 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.6 tp -70.02 -40.05 78.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.554 0.576 . . . . 5.3300000000000001 112.554 -169.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.564 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 36.4 tt0 -149.97 117.19 6.02 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.516 -0.473 . . . . 8.2799999999999994 110.897 -174.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -126.95 151.36 48.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.313 0.577 . . . . 9.6999999999999993 111.29 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 26' ' ' ASP . 62.7 t -129.97 135.74 60.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.459 -0.941 . . . . 11.09 108.459 176.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.92 -38.67 83.01 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.442 -0.799 . . . . 13.1 112.246 -169.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.87 86.82 0.15 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 119.654 -1.26 . . . . 11.94 113.977 174.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -69.96 -39.4 76.03 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.022 -1.103 . . . . 15.18 108.022 168.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -136.84 -89.3 0.24 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 109.621 -1.392 . . . . 12.0 109.621 172.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -128.61 96.72 4.47 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.751 -0.833 . . . . 12.82 108.751 168.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.43 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 15.9 m-20 -100.02 0.09 40.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.89 -0.595 . . . . 10.81 111.026 -177.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 70.3 mtm 60.15 47.09 9.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.978 -1.01 . . . . 10.050000000000001 111.747 175.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -59.97 -39.99 87.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.827 -0.624 . . . . 8.0600000000000005 111.339 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.11 18.1 24.17 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.756 -0.735 . . . . 5.5800000000000001 113.104 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.2 tp -137.83 131.16 30.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.901 0.351 . . . . 5.5599999999999996 110.404 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.07 161.95 36.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.6 -0.273 . . . . 3.0499999999999998 111.052 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.48 159.63 71.57 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.525 -0.307 . . . . 3.48 110.552 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HB3' ' CE1' ' A' ' 15' ' ' TYR . 87.8 Cg_endo -90.09 133.2 1.97 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.627 2.218 . . . . 1.8600000000000001 113.192 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.2 m -140.03 162.7 34.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.984 0.421 . . . . 1.97 111.619 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -125.19 134.91 65.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.791 -0.64 . . . . 1.71 110.775 -177.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -113.07 162.23 16.16 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.321 -0.622 . . . . 4.0700000000000003 109.321 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -139.87 146.72 39.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.056 0.455 . . . . 2.8599999999999999 111.231 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.6 ' OD1' ' HD3' ' A' ' 45' ' ' ARG . 11.3 p30 -151.4 160.86 43.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.773 -0.649 . . . . 1.8899999999999999 109.526 174.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.15 155.28 39.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.49 -0.323 . . . . 1.0800000000000001 110.576 -178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.37 146.03 16.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.369 -0.378 . . . . 1.3899999999999999 110.8 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.626 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 6.1 p-10 -167.08 94.73 0.47 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.773 -0.649 . . . . 2.8599999999999999 109.787 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.95 -94.07 1.95 Allowed Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 111.114 -0.794 . . . . 1.6799999999999999 111.114 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 77.0 Cg_exo -52.24 174.03 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.385 2.723 . . . . 1.6599999999999999 113.092 168.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.497 ' HB2' ' O ' ' A' ' 75' ' ' HIS . 48.9 p90 -70.07 -176.89 1.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.742 -0.663 . . . . 3.3999999999999999 112.155 -170.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.6 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 18.0 ttm180 -113.69 129.41 56.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.908 -0.587 . . . . 3.1000000000000001 111.29 -168.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.9 mt -113.22 129.92 68.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.37 -0.832 . . . . 1.8 110.274 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.499 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -118.9 132.14 56.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.492 -0.322 . . . . 0.85999999999999999 110.576 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.5 tp -124.23 131.0 53.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.777 0.322 . . . . 1.0600000000000001 110.413 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.37 160.87 42.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.846 -0.616 . . . . 1.1399999999999999 110.349 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -120.03 139.96 51.72 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.4 -0.593 . . . . 4.0199999999999996 109.4 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.564 ' CE2' ' HB3' ' A' ' 18' ' ' GLU . 45.4 t80 -98.89 128.16 45.0 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.651 0.738 . . . . 4.6100000000000003 111.808 -175.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -150.02 155.06 39.24 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.392 -1.707 . . . . 3.3799999999999999 106.392 171.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -148.85 119.32 7.39 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.393 -0.595 . . . . 5.0499999999999998 109.393 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.04 -118.52 4.87 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.851 -0.69 . . . . 4.3700000000000001 112.347 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.96 150.34 66.85 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.822 2.348 . . . . 6.6799999999999997 112.79 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 58' ' ' TYR . 7.5 p -129.19 130.55 67.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.853 -0.612 . . . . 8.1699999999999999 110.307 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -70.59 -29.47 65.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.128 -0.487 . . . . 10.039999999999999 110.892 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.428 ' H ' HG22 ' A' ' 56' ' ' VAL . 41.1 m-85 -60.41 -15.04 22.51 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.462 0.542 . . . . 11.609999999999999 112.462 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.3 p -68.35 -19.85 64.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.855 0.359 . . . . 9.7899999999999991 110.879 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.35 128.32 55.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.351 -0.386 . . . . 8.5099999999999998 110.786 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.14 55.26 4.95 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.103 -0.799 . . . . 7.5599999999999996 111.103 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -127.08 158.95 35.64 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.962 0.41 . . . . 10.0 110.645 -173.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -92.2 120.18 32.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.793 -0.64 . . . . 10.35 109.998 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.47 -151.3 7.61 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.511 -0.852 . . . . 5.3399999999999999 112.057 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.2 p -82.59 140.7 33.08 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.699 0.285 . . . . 5.3200000000000003 110.864 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -120.23 134.18 55.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.416 -0.587 . . . . 5.6100000000000003 109.416 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -119.1 119.95 35.72 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.58 -0.526 . . . . 3.7799999999999998 109.58 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -159.36 169.27 24.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.116 0.484 . . . . 2.4500000000000002 110.912 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 94' ' ' ASN . 41.5 ttp180 -149.87 123.24 4.43 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 115.293 -0.867 . . . . 3.2400000000000002 109.602 171.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.663 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 71.4 Cg_endo -79.81 140.56 14.66 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.292 1.995 . . . . 1.1899999999999999 110.733 169.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.544 ' CD ' ' HE ' ' A' ' 93' ' ' ARG . 72.2 tt0 -135.87 124.66 23.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.332 0.587 . . . . 2.1899999999999999 110.699 -178.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 47' ' ' ALA . 41.0 tp -120.17 130.02 54.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.408 -0.814 . . . . 1.1399999999999999 109.994 -178.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -125.04 128.02 47.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.019 0.438 . . . . 2.1800000000000002 110.1 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.03 129.93 74.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.172 -0.467 . . . . 1.5600000000000001 110.743 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 44' ' ' TRP . 64.4 m170 -116.61 120.08 37.53 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.786 0.327 . . . . 3.4399999999999999 110.636 177.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.403 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . 65.0 t80 -114.45 124.13 51.16 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.82 -0.627 . . . . 4.7999999999999998 109.38 174.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -119.55 137.97 53.49 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.27 -0.27 . . . . 2.9399999999999999 110.27 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -134.54 130.31 36.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.931 0.396 . . . . 3.8999999999999999 110.269 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.4 tp -106.69 119.99 40.78 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.405 -0.591 . . . . 4.4800000000000004 109.405 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -97.18 168.93 10.14 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.044 -0.354 . . . . 6.1900000000000004 110.044 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -60.08 -43.43 95.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.713 0.292 . . . . 5.4500000000000002 111.305 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -74.48 164.6 26.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 5.2699999999999996 110.785 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -75.98 36.52 0.14 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.297 -0.411 . . . . 6.3300000000000001 112.053 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.409 ' HA ' ' OD2' ' A' ' 120' ' ' ASP . 87.1 m-85 -119.94 140.02 51.54 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.186 -0.672 . . . . 7.4800000000000004 109.186 174.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 120' ' ' ASP . 47.8 m -124.67 149.43 47.18 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.995 0.426 . . . . 2.5499999999999998 110.651 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -147.78 161.4 41.31 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.626 -0.509 . . . . 5.2999999999999998 109.626 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.61 176.94 34.62 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.463 -0.875 . . . . 1.3500000000000001 112.04 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 76' ' ' TYR . 92.3 mt -127.69 123.92 36.63 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.118 -0.327 . . . . 2.29 110.118 178.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.2 m -119.93 130.02 54.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.138 -0.483 . . . . 1.54 110.528 176.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -137.07 144.69 16.35 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.804 -0.713 . . . . 1.1699999999999999 111.768 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -137.66 143.98 15.23 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.987 -0.625 . . . . 1.1899999999999999 112.112 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 67.6 t80 -130.48 130.0 43.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.871 0.367 . . . . 3.75 110.753 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.544 ' HE ' ' CD ' ' A' ' 71' ' ' GLU . 99.3 mtt180 -130.29 127.36 39.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.738 -0.665 . . . . 2.75 109.809 175.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.663 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 61.2 t30 -111.27 117.95 34.57 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.441 -0.577 . . . . 1.8200000000000001 109.441 174.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -106.54 125.31 50.84 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.564 -0.289 . . . . 3.1400000000000001 110.881 -172.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.77 109.99 2.92 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.0 -1.095 . . . . 2.79 111.584 175.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.403 ' HB3' ' HB3' ' A' ' 108' ' ' ALA . 64.2 t80 -85.48 119.27 25.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.027 0.441 . . . . 7.6200000000000001 109.817 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -109.98 98.22 7.56 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.999 -0.546 . . . . 7.0800000000000001 109.787 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD1' HG13 ' A' ' 100' ' ' VAL . 60.8 t80 -60.23 -50.14 74.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.89 -0.596 . . . . 10.16 111.522 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.532 HG13 ' CD1' ' A' ' 99' ' ' TYR . 34.3 m -131.93 161.13 41.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.527 -0.306 . . . . 9.8100000000000005 110.83 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -89.03 10.61 20.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 12.220000000000001 111.465 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -82.96 120.03 75.39 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.518 -0.31 . . . . 10.48 110.689 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -70.07 150.02 65.72 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.602 2.201 . . . . 9.0999999999999996 111.997 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.8 15.45 39.64 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.815 -0.707 . . . . 6.46 111.574 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -121.96 139.59 53.48 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.608 -0.516 . . . . 7.6699999999999999 109.608 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -65.17 136.45 56.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.994 0.426 . . . . 4.1399999999999997 110.842 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 m -87.97 157.88 18.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.793 -0.64 . . . . 3.2999999999999998 109.874 178.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 97' ' ' TYR . . . -117.29 157.8 25.46 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.451 -0.203 . . . . 1.76 110.451 -177.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -119.91 126.73 51.63 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.643 0.735 . . . . 2.5499999999999998 111.163 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 88.7 mtp -104.7 117.96 35.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.308 -0.86 . . . . 1.77 109.491 176.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 96.5 mt-30 -94.2 118.44 31.56 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.503 -0.479 . . . . 1.97 110.911 -174.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 84.4 mtt180 -105.5 115.94 31.1 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.012 -0.54 . . . . 3.8500000000000001 109.683 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 35.5 t-105 -118.35 120.8 38.69 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.999 -0.741 . . . . 2.2799999999999998 108.999 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.421 ' HE3' ' OG ' ' A' ' 134' ' ' SER . 87.8 tttt -126.32 130.01 49.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.445 -0.343 . . . . 2.1400000000000001 110.719 -176.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.2 pt -132.59 144.51 36.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.89 0.376 . . . . 1.55 110.953 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.47 123.84 3.17 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.775 -0.648 . . . . 1.1899999999999999 110.351 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.6 130.52 3.8 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.459 2.106 . . . . 1.3700000000000001 111.059 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -80.04 137.41 36.79 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.712 -0.477 . . . . 2.3500000000000001 109.712 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -132.91 128.41 36.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.008 0.432 . . . . 4.54 111.496 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 85' ' ' SER . 0.8 OUTLIER -103.57 110.26 22.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.795 -0.638 . . . . 3.04 109.461 171.172 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.73 119.98 61.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.145 0.498 . . . . 4.2699999999999996 110.817 -175.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -102.7 84.53 2.42 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.303 0.573 . . . . 6.04 110.137 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.02 -39.98 75.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.261 -0.881 . . . . 4.5899999999999999 111.598 -177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 81.5 m -123.8 139.18 54.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.073 -0.512 . . . . 3.6899999999999999 110.443 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -59.94 140.05 56.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.816 -0.629 . . . . 5.1699999999999999 111.272 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 66.1 14.31 9.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.271 -0.877 . . . . 3.71 111.964 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.6 mt -131.85 148.94 52.58 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.486 -0.561 . . . . 2.0499999999999998 109.486 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -130.81 137.58 49.49 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.719 -0.392 . . . . 4.2400000000000002 110.057 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -127.01 128.28 46.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.188 -0.46 . . . . 3.5499999999999998 109.78 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -119.77 129.91 54.7 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.473 -0.566 . . . . 2.1099999999999999 109.473 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -160.91 161.19 32.65 Favored Glycine 0 CA--C 1.504 -0.647 0 C-N-CA 119.908 -1.139 . . . . 1.1799999999999999 112.108 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -145.13 149.81 35.66 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.994 0.426 . . . . 4.2999999999999998 110.942 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.9 tp -101.34 120.98 41.09 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.925 -0.769 . . . . 2.2400000000000002 108.925 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.421 ' OG ' ' HE3' ' A' ' 114' ' ' LYS . 18.3 t -113.48 136.74 52.46 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.772 -0.649 . . . . 1.6899999999999999 111.099 -172.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 67.3 mtm -140.0 140.2 36.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.803 -0.635 . . . . 2.2400000000000002 109.727 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -145.29 156.52 43.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.271 0.558 . . . . 3.5600000000000001 111.555 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 62.2 mttp -130.95 157.0 44.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.879 -1.055 . . . . 1.6699999999999999 108.904 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 48.1 p90 -142.2 163.78 31.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.645 -0.252 . . . . 3.23 110.425 -175.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 65.09 -172.5 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.948 -0.569 . . . . 1.24 111.154 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -76.79 -47.34 21.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.169 0.509 . . . . 2.4700000000000002 110.89 174.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -60.17 -45.59 92.58 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.196 -0.911 . . . . 2.4100000000000001 113.455 -167.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 138' ' ' PHE . 3.1 mm? -62.02 -39.99 94.17 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.185 0.517 . . . . 1.8300000000000001 110.561 -176.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -67.36 -39.86 85.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.635 -0.711 . . . . 2.0 110.551 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.4 m -62.73 -44.36 96.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.675 -0.693 . . . . 2.0499999999999998 112.008 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 31.0 p -76.87 -19.9 56.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.992 0.425 . . . . 1.5900000000000001 111.156 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.21 -125.86 21.96 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.789 -0.641 . . . . 1.52 113.196 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -65.73 -19.39 65.88 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.647 0.24 . . . . 5.9400000000000004 111.647 -174.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.43 98.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.424 -0.353 . . . . 1.8300000000000001 111.675 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.503 ' O ' ' HE3' ' A' ' 137' ' ' LYS . 68.1 m-20 -119.69 117.18 27.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.044 0.45 . . . . 2.6400000000000001 110.572 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.4 t -154.3 153.92 32.5 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.863 -0.421 . . . . 2.02 109.863 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -108.27 140.06 42.07 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.742 -0.466 . . . . 3.6699999999999999 109.742 175.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.88 119.97 59.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.149 0.5 . . . . 1.6399999999999999 110.295 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -119.63 130.43 55.09 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.363 -0.835 . . . . 2.5600000000000001 109.122 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 21.8 m -129.54 129.79 44.94 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 121.923 -0.486 . . . . 1.3899999999999999 111.267 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -128.76 128.9 44.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.12 -0.491 . . . . 2.04 109.849 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 27.2 p -130.32 140.3 50.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.074 -0.512 . . . . 1.5600000000000001 110.773 -177.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -125.63 122.44 4.55 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.599 -0.601 . . . . 1.04 111.599 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.9 mt -102.29 128.25 48.92 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.988 -0.375 . . . . 2.27 109.988 -176.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -107.66 111.05 23.08 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.617 -0.433 . . . . 2.4100000000000001 110.379 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.98 139.8 51.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.737 -0.665 . . . . 4.5700000000000003 109.75 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.442 ' HB ' ' HA ' ' A' ' 164' ' ' GLU . 18.0 p -100.75 102.22 13.26 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.187 0.518 . . . . 1.46 110.368 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -60.01 -48.51 81.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.289 -0.869 . . . . 2.6299999999999999 110.992 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -102.64 9.77 39.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.336 -0.393 . . . . 2.4100000000000001 110.553 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.442 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 42.6 tt0 72.13 -42.93 0.55 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.597 0.759 . . . . 2.5800000000000001 111.131 -175.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.5 p -74.79 -24.44 58.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.448 -0.342 . . . . 2.2999999999999998 111.816 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.4 m -125.09 140.44 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.403 -0.362 . . . . 1.71 110.627 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.06 130.57 54.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.15 0.5 . . . . 1.47 111.389 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 21.9 mt -104.26 136.33 44.06 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.556 -0.905 . . . . 1.6599999999999999 108.556 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -114.07 113.45 24.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.169 0.509 . . . . 3.2999999999999998 110.7 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 63.2 t -115.05 120.11 63.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.5 -0.773 . . . . 1.3 110.217 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -104.69 124.08 48.74 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.01 0.433 . . . . 2.2200000000000002 110.773 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -105.17 130.39 53.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.785 -0.643 . . . . 4.6100000000000003 109.821 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.45 ' CE2' ' HD3' ' A' ' 195' ' ' ARG . 68.2 m-85 -110.99 136.65 49.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.971 -0.558 . . . . 3.98 110.468 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.5 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 61.5 tp -122.39 118.51 28.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.21 -0.45 . . . . 2.3799999999999999 110.398 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -120.11 179.98 4.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.889 -0.596 . . . . 3.3100000000000001 109.695 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 -67.11 -39.94 86.78 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.884 -0.326 . . . . 6.5300000000000002 111.042 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 66.45 78.33 0.25 Allowed Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.646 -0.788 . . . . 5.0599999999999996 112.643 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -70.05 -39.88 75.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.859 0.361 . . . . 7.3899999999999997 111.145 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -120.34 144.93 47.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.182 -0.463 . . . . 9.0700000000000003 110.285 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 70.6 mtm -120.4 -4.03 9.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.306 0.575 . . . . 10.869999999999999 109.668 171.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -122.83 35.38 4.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.127 -0.942 . . . . 10.449999999999999 111.112 -174.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -60.0 -40.09 88.03 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.246 -0.434 . . . . 13.06 110.487 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 59.6 m -130.46 135.81 48.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.818 -0.628 . . . . 12.609999999999999 109.881 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 83.7 mtm-85 -70.08 -28.59 65.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.49 . . . . 15.19 110.13 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -97.81 115.27 27.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.711 -0.677 . . . . 13.18 109.41 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -80.31 141.98 34.95 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.045 -0.525 . . . . 12.73 110.937 -174.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 102.12 -9.48 56.37 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.711 -0.757 . . . . 9.9800000000000004 112.738 178.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.44 -39.88 92.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.864 0.364 . . . . 10.699999999999999 111.084 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -118.29 139.06 51.91 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.743 -0.465 . . . . 10.5 109.743 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.493 ' OG ' ' HD2' ' A' ' 212' ' ' ARG . 4.7 t -95.48 111.4 23.3 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.135 0.493 . . . . 6.6399999999999997 109.984 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.2 p -76.33 -18.77 58.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.693 -0.685 . . . . 4.9800000000000004 111.143 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 59.56 34.68 22.47 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 114.895 -1.048 . . . . 7.0999999999999996 111.052 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -60.06 -40.8 90.71 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.747 -0.661 . . . . 4.4000000000000004 111.251 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 213' ' ' ILE . 86.4 mt -120.3 120.0 61.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.347 -0.388 . . . . 2.21 110.395 176.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.45 ' HD3' ' CE2' ' A' ' 173' ' ' TYR . 69.4 mtp180 -111.58 116.62 31.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.242 -0.651 . . . . 3.54 109.242 177.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -120.0 138.97 53.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.839 0.352 . . . . 1.6699999999999999 111.048 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -160.02 159.99 32.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.902 -0.59 . . . . 5.8300000000000001 110.425 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 198' ' ' LEU . 1.9 pt? -129.14 128.43 23.31 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.377 -0.374 . . . . 2.5899999999999999 110.116 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.83 133.04 11.08 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.414 2.076 . . . . 1.77 112.359 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 56.9 tp -135.66 131.14 35.35 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.027 -0.731 . . . . 2.2599999999999998 109.027 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 33.3 m -120.05 130.08 54.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.701 0.286 . . . . 1.99 110.548 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 58.3 tp -137.69 86.04 2.16 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.575 -0.528 . . . . 2.3100000000000001 109.575 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 69.93 -120.89 10.05 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.822 -0.704 . . . . 1.51 112.52 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -90.27 2.55 55.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 2.5699999999999998 110.248 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -112.65 130.08 56.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.099 -0.501 . . . . 2.6600000000000001 110.491 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 68.3 m -115.32 136.93 52.58 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.951 -0.568 . . . . 1.6200000000000001 109.73 173.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 45.9 t -119.93 130.01 74.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.751 -0.463 . . . . 1.3799999999999999 109.751 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.9 m -137.61 95.41 11.27 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-O 120.582 0.229 . . . . 1.1799999999999999 110.57 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.67 130.05 19.96 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.217 1.945 . . . . 1.01 110.659 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -110.79 138.66 46.9 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.287 -0.415 . . . . 4.5 110.171 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 71.1 p -133.68 151.66 51.7 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.133 -0.485 . . . . 1.8899999999999999 110.067 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.493 ' HD2' ' OG ' ' A' ' 190' ' ' SER . 27.4 mtm180 -108.31 120.86 43.61 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.395 -0.595 . . . . 4.7999999999999998 109.395 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.514 ' O ' ' HB ' ' A' ' 194' ' ' ILE . 48.6 mm -110.05 129.97 64.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.899 -0.408 . . . . 4.5700000000000003 109.899 -177.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -119.62 -129.26 3.84 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.805 -0.712 . . . . 4.9800000000000004 111.876 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 64.6 tp -131.84 136.01 47.15 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.83 -0.433 . . . . 8.1099999999999994 109.83 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -64.68 132.49 49.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.147 -0.479 . . . . 7.6500000000000004 110.2 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -69.8 -37.95 76.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.747 -0.66 . . . . 10.529999999999999 109.369 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -125.56 96.08 4.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.439 -0.8 . . . . 11.56 109.228 172.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 72.8 p -85.23 143.83 28.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.998 0.428 . . . . 10.06 110.672 -178.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.491 ' HB3' ' O ' ' A' ' 222' ' ' ASP . 94.8 m-20 -88.2 138.82 31.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.846 -0.616 . . . . 11.92 111.26 -177.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 26.7 m-90 -70.05 -36.39 74.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.436 -0.802 . . . . 14.01 109.158 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 220' ' ' ASN . 19.4 m-20 -116.0 127.52 54.99 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.962 -1.125 . . . . 14.529999999999999 107.962 170.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -83.92 37.82 0.62 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.059 0.457 . . . . 16.609999999999999 112.138 -170.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -124.09 114.53 19.83 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.349 -0.611 . . . . 15.460000000000001 109.349 174.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -91.36 166.89 12.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.595 -0.275 . . . . 15.67 110.696 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -62.04 -40.19 94.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.513 0.673 . . . . 14.5 110.054 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.661 HG22 ' H ' ' A' ' 230' ' ' GLU . 87.9 mt -120.13 129.95 74.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.359 -0.837 . . . . 15.15 109.549 177.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 232' ' ' HIS . 47.1 mt-10 -95.5 -28.52 14.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.689 -0.232 . . . . 14.73 111.043 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 -69.58 -40.1 76.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.774 0.321 . . . . 16.379999999999999 111.469 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.661 ' H ' HG22 ' A' ' 227' ' ' ILE . 50.3 mt-10 -103.68 141.71 35.59 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.827 -0.435 . . . . 12.779999999999999 109.827 178.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 89.98 -9.99 75.44 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.667 -0.778 . . . . 11.1 111.703 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 228' ' ' GLU . 15.7 m-70 -122.16 132.89 54.69 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.685 -0.857 . . . . 12.26 108.685 175.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -150.0 170.1 19.65 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.309 0.576 . . . . 9.9900000000000002 111.392 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -128.32 48.0 2.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.119 -0.946 . . . . 10.43 109.073 173.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -56.5 129.42 40.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.403 -0.817 . . . . 6.29 111.65 -175.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.577 ' HD2' ' OE2' ' A' ' 258' ' ' GLU . 76.2 mtt180 -104.46 117.98 35.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.757 -0.656 . . . . 8.1500000000000004 110.141 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.444 HG21 ' HG3' ' A' ' 212' ' ' ARG . 54.2 t -69.93 -39.99 78.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.486 -0.779 . . . . 2.3999999999999999 110.942 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -162.06 155.11 26.27 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.429 -0.891 . . . . 1.27 112.117 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.457 HD21 ' HD3' ' A' ' 236' ' ' ARG . 90.7 mt -112.83 126.24 55.23 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.708 -0.478 . . . . 1.97 109.708 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -106.19 128.64 54.07 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.649 -0.5 . . . . 3.54 109.649 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -119.93 139.97 51.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.247 -0.433 . . . . 2.6400000000000001 110.89 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -111.67 116.05 4.06 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.962 -0.855 . . . . 1.3500000000000001 110.962 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 250' ' ' SER . 59.1 t80 -112.06 114.87 27.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.492 0.187 . . . . 4.3600000000000003 110.884 -177.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -101.34 115.7 31.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.233 0.54 . . . . 4.29 110.074 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -61.1 -49.88 75.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.877 -1.056 . . . . 6.6900000000000004 110.895 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -177.34 78.35 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.177 -0.465 . . . . 6.3700000000000001 110.825 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 49.8 t30 56.13 63.43 2.01 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.225 0.536 . . . . 5.8300000000000001 111.956 170.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 153.7 -42.73 0.63 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 119.829 -1.177 . . . . 2.6600000000000001 112.767 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 61.9 tp -99.21 108.69 21.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.875 0.369 . . . . 2.9700000000000002 110.021 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 243' ' ' TYR . 47.0 m -119.9 133.42 55.58 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.988 -0.551 . . . . 2.1699999999999999 110.227 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.9 t -119.34 133.06 67.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 116.017 -0.538 . . . . 1.79 110.095 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 22.9 t -98.55 129.83 45.11 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.005 -0.739 . . . . 1.6299999999999999 109.005 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 91.7 mt -118.86 128.42 54.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.314 -0.403 . . . . 2.96 110.782 -176.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.5 ' HB2' ' H ' ' A' ' 274' ' ' GLY . 97.5 mt-10 -101.45 114.42 28.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.948 -0.569 . . . . 4.0800000000000001 109.8 176.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -120.3 140.03 51.84 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.849 -0.341 . . . . 4.8399999999999999 110.771 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -114.97 1.07 13.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.151 -0.477 . . . . 3.5800000000000001 110.425 175.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -110.12 129.89 55.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.034 -0.53 . . . . 6.7699999999999996 111.01 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.577 ' OE2' ' HD2' ' A' ' 236' ' ' ARG . 55.6 mt-10 -120.11 170.38 9.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.108 -0.496 . . . . 8.5399999999999991 110.329 173.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 92.8 t90 -64.91 -39.95 94.31 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.907 -0.775 . . . . 11.9 108.907 170.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -69.98 -40.32 75.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.0 -1.0 . . . . 10.57 112.01 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -132.05 147.82 52.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.32 -0.4 . . . . 11.41 110.142 -171.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -119.53 143.11 47.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.617 -0.265 . . . . 11.98 111.018 -171.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.03 139.97 57.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.966 -0.561 . . . . 12.460000000000001 110.626 176.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -125.22 150.45 46.99 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.327 -0.62 . . . . 13.779999999999999 109.327 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 70.21 36.7 71.34 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.455 -0.878 . . . . 11.07 111.833 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -59.96 -36.55 77.37 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 122.575 0.35 . . . . 12.59 111.856 -176.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 53.2 m -60.15 -39.89 87.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.845 0.355 . . . . 10.92 110.967 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -84.96 -21.79 29.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.237 -0.438 . . . . 12.42 111.257 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -89.61 94.02 9.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.275 0.56 . . . . 11.59 110.697 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -70.03 -40.02 75.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.395 -0.821 . . . . 8.8300000000000001 111.57 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -91.94 82.35 5.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.854 0.359 . . . . 7.0199999999999996 110.25 -176.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -69.99 -44.42 69.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.561 0.696 . . . . 6.5999999999999996 110.144 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -147.29 160.27 42.7 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.167 -0.924 . . . . 1.9399999999999999 110.112 -176.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.5 ' H ' ' HB2' ' A' ' 254' ' ' GLU . . . -132.69 149.86 19.61 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.338 -0.705 . . . . 1.4199999999999999 111.338 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.56 143.31 40.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.698 0.285 . . . . 1.8100000000000001 110.597 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -139.89 130.58 4.75 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 111.205 -0.758 . . . . 1.3 111.205 174.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 63.2 t -110.13 120.71 61.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.871 0.336 . . . . 1.8300000000000001 110.383 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -127.73 119.95 26.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.068 0.461 . . . . 2.3100000000000001 111.044 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -103.72 122.06 44.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.775 -0.648 . . . . 4.75 109.266 175.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.7 t -111.34 129.69 55.92 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.069 -0.514 . . . . 1.6699999999999999 109.92 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 C--O 1.246 0.877 0 CA-C-O 118.407 -0.806 . . . . 3.6899999999999999 109.957 -179.379 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.6 t70 . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 120.923 0.392 . . . . 3.6099999999999999 111.092 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -99.64 130.45 45.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.331 -0.395 . . . . 3.3300000000000001 110.358 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -98.86 117.67 33.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.081 0.467 . . . . 3.2000000000000002 110.073 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -119.97 140.01 51.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.576 -0.738 . . . . 2.4900000000000002 110.569 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 14.3 t-20 -133.71 131.43 39.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.759 -0.655 . . . . 2.1299999999999999 110.2 174.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 84.7 mt -129.03 128.97 67.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.908 -0.587 . . . . 1.6000000000000001 109.577 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.08 135.61 11.77 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.482 -0.866 . . . . 0.88 111.347 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.02 135.33 54.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.082 0.441 . . . . 1.0800000000000001 110.516 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 94.6 mmm -136.99 149.97 47.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.757 -0.656 . . . . 2.3300000000000001 110.362 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.31 124.96 43.52 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.949 -0.76 . . . . 2.6099999999999999 108.949 174.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 N--CA 1.455 -0.219 0 C-N-CA 120.881 -0.327 . . . . 5.0899999999999999 111.101 -177.743 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HB2' ' HD2' ' A' ' 33' ' ' PRO . 11.9 pt-20 . . . . . 0 CA--C 1.53 0.203 0 N-CA-C 109.887 -0.412 . . . . 3.48 109.887 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 32' ' ' GLU . 31.7 Cg_endo -69.85 147.84 63.19 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 121.689 1.593 . . . . 1.8600000000000001 111.647 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.5 t -129.49 142.83 50.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.448 -0.342 . . . . 1.97 111.009 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.04 131.99 65.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.981 -0.554 . . . . 1.71 109.615 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 94.7 m-85 -110.02 131.26 55.21 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.883 -0.414 . . . . 4.0700000000000003 109.883 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.7 m-85 -112.99 128.07 56.4 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.927 -0.309 . . . . 2.8599999999999999 110.93 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 10' ' ' ASN . 48.8 m-80 -129.15 132.44 47.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.873 -0.603 . . . . 1.8899999999999999 109.981 175.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.54 143.36 37.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.593 -0.276 . . . . 1.0800000000000001 110.261 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.46 122.29 3.15 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.73 0.27 . . . . 1.3899999999999999 111.73 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.652 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 56.2 t30 -167.53 95.14 0.45 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.393 -0.595 . . . . 2.8599999999999999 109.393 171.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.23 -84.24 0.45 Allowed Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 110.921 -0.871 . . . . 1.6799999999999999 110.921 -173.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.652 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 24.4 Cg_endo -63.62 172.91 5.03 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.862 2.375 . . . . 1.6599999999999999 111.922 169.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -71.05 -174.86 1.03 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.95 -0.568 . . . . 3.3999999999999999 110.914 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -109.61 127.62 54.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.27 0.557 . . . . 3.1000000000000001 109.785 -171.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 72' ' ' LEU . 5.2 tt -127.3 135.24 63.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.856 -1.065 . . . . 1.8 110.876 -171.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -118.28 129.92 55.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.804 -0.635 . . . . 0.85999999999999999 110.264 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.3 tp -122.74 136.25 54.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.278 -0.419 . . . . 1.0600000000000001 110.788 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.32 159.94 42.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.738 -0.665 . . . . 1.1399999999999999 109.852 176.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -123.53 139.98 53.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.572 0.225 . . . . 4.0199999999999996 110.416 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -125.45 115.33 20.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 4.6100000000000003 110.926 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -112.28 129.06 56.41 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.844 -0.343 . . . . 3.3799999999999999 110.239 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.501 ' HB2' ' NH2' ' A' ' 69' ' ' ARG . 85.8 tt0 . . . . . 0 C--N 1.319 -0.72 0 CA-C-N 116.48 -0.327 . . . . 5.0499999999999998 110.468 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 96.2 m95 . . . . . 0 C--O 1.228 -0.059 0 CA-C-O 120.939 0.4 . . . . 5.6100000000000003 110.745 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -86.14 104.81 16.06 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.582 -0.896 . . . . 3.7799999999999998 108.582 170.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -141.86 147.06 36.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.505 -0.316 . . . . 2.4500000000000002 110.317 -166.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.59 ' HG3' ' HA ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -127.43 124.0 23.42 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 109.858 -0.423 . . . . 3.2400000000000002 109.858 172.315 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 67.0 Cg_endo -80.01 135.51 11.17 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.119 1.879 . . . . 1.1899999999999999 110.951 170.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.491 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 8.1 tp10 -115.35 120.0 38.16 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.406 -0.59 . . . . 2.1899999999999999 109.406 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.41 HD11 HD11 ' A' ' 46' ' ' ILE . 53.4 tp -134.54 129.54 35.21 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.267 -0.424 . . . . 1.1399999999999999 110.315 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -139.7 129.81 25.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.932 0.396 . . . . 2.1800000000000002 110.309 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.4 t -121.55 130.1 74.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.927 -0.579 . . . . 1.5600000000000001 109.773 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -108.81 137.43 46.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.049 0.452 . . . . 3.4399999999999999 110.915 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -119.91 139.89 51.73 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.472 -0.785 . . . . 4.7999999999999998 109.757 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -120.06 138.59 53.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.947 -0.39 . . . . 2.9399999999999999 109.947 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -125.5 127.64 46.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.287 0.565 . . . . 3.8999999999999999 110.496 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.7 tp . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 115.511 -0.768 . . . . 4.4800000000000004 110.097 -178.514 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.618 ' HA ' ' OD2' ' A' ' 120' ' ' ASP . 16.3 m . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.818 0.342 . . . . 2.5499999999999998 111.41 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -112.04 130.29 55.92 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.987 -0.375 . . . . 5.2999999999999998 109.987 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -154.76 156.35 26.83 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.545 -0.836 . . . . 1.3500000000000001 111.96 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 96.9 mt -132.84 136.89 46.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.821 0.343 . . . . 2.29 110.287 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 60.9 m -119.93 129.94 54.57 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.653 -0.499 . . . . 1.54 109.653 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.91 132.58 8.18 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.466 -0.873 . . . . 1.1699999999999999 111.528 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -125.07 128.5 6.67 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.762 -0.733 . . . . 1.1899999999999999 111.989 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -120.26 121.87 39.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.641 -0.503 . . . . 3.75 109.641 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.491 ' HD2' ' OE2' ' A' ' 71' ' ' GLU . 38.6 ttt180 -141.96 130.01 22.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.726 -0.472 . . . . 2.75 109.726 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.649 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 5.4 t30 -111.07 129.99 55.75 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.036 0.446 . . . . 1.8200000000000001 109.937 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.59 ' HA ' ' HG3' ' A' ' 69' ' ' ARG . 65.8 t80 -100.0 109.78 22.11 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.427 -0.582 . . . . 3.1400000000000001 109.427 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.674 0 C-N-CA 120.519 -0.848 . . . . 2.79 111.934 -175.206 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.442 -0.84 0 N-CA-C 108.819 -0.808 . . . . 3.2999999999999998 108.819 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -158.07 149.68 21.5 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.629 -0.508 . . . . 1.76 109.629 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -114.68 110.34 19.6 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.138 0.494 . . . . 2.5499999999999998 111.553 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.601 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 88.6 mtp -127.08 130.44 49.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.936 -0.764 . . . . 1.77 108.936 169.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.642 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 95.7 mt-30 -107.43 138.39 43.72 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.094 -0.642 . . . . 1.97 110.502 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 29.1 ttt180 -110.42 117.04 32.51 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.546 -0.539 . . . . 3.8500000000000001 109.546 171.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.564 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 61.4 m95 -108.5 127.42 53.91 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.735 -0.666 . . . . 2.2799999999999998 110.156 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -119.67 123.41 43.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.491 -0.322 . . . . 2.1400000000000001 110.795 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.6 mm -123.21 120.55 60.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.043 -0.725 . . . . 1.55 109.043 170.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -144.43 106.28 4.72 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 111.716 0.265 . . . . 1.1899999999999999 111.716 -177.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 87.8 Cg_endo -79.94 149.18 20.11 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.575 2.183 . . . . 1.3700000000000001 111.604 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -95.45 137.75 34.07 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.219 -0.66 . . . . 2.3500000000000001 109.219 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -135.98 130.49 33.72 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 111.957 0.355 . . . . 4.54 111.957 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.618 ' OD2' ' HA ' ' A' ' 85' ' ' SER . 13.0 m-20 -94.36 102.14 14.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.821 -0.807 . . . . 3.04 108.821 168.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 96.3 t -69.9 -42.73 79.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.142 -0.481 . . . . 4.2699999999999996 111.089 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -114.73 132.82 56.31 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.556 -0.535 . . . . 6.04 109.556 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.0 mt -107.19 24.84 12.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.202 -0.454 . . . . 4.5899999999999999 111.019 -173.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 17.4 p -108.89 142.57 39.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.12 -0.491 . . . . 3.6899999999999999 110.758 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -69.5 -39.96 77.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 5.1699999999999999 111.591 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -59.92 -40.11 87.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.006 -0.543 . . . . 3.71 111.248 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.6 tp -139.34 122.39 16.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.002 -0.544 . . . . 2.0499999999999998 109.745 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -119.16 136.29 54.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.991 0.424 . . . . 4.2400000000000002 110.54 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.413 ' CZ ' ' HB ' ' A' ' 156' ' ' THR . 89.1 t80 -139.58 130.87 26.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.826 -0.624 . . . . 3.5499999999999998 109.386 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -127.09 162.17 26.7 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.24 -0.436 . . . . 2.1099999999999999 110.958 -176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -161.39 140.51 6.68 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.276 -0.73 . . . . 1.1799999999999999 111.276 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.608 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 5.1 p90 -132.26 134.94 45.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.225 0.536 . . . . 4.2999999999999998 110.914 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.632 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 58.8 tp -104.46 124.46 49.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.163 -0.926 . . . . 2.2400000000000002 109.955 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.9 t -119.88 127.31 52.6 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.017 0.437 . . . . 1.6899999999999999 110.179 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 89.3 mtp -113.04 130.42 56.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.94 -0.573 . . . . 2.2400000000000002 110.043 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 113' ' ' TRP . 70.9 m-85 -121.58 139.98 52.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.92 0.39 . . . . 3.5600000000000001 111.676 -175.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 63.1 mttp -125.95 151.54 46.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.787 -0.642 . . . . 1.6699999999999999 109.7 169.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.642 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 87.8 m-85 -135.56 156.28 49.13 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.422 0.451 . . . . 3.23 110.53 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 110' ' ' MET . . . 60.05 -175.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.979 -0.555 . . . . 1.24 111.587 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -76.61 -33.69 58.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.487 0.66 . . . . 2.4700000000000002 109.766 168.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -60.11 -45.61 92.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.79 -1.095 . . . . 2.4100000000000001 112.421 -169.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 138' ' ' PHE . 9.4 mp -69.9 -30.11 67.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.826 0.345 . . . . 1.8300000000000001 110.88 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -67.38 -39.89 85.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.339 0.59 . . . . 2.0 109.955 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.1 m -66.94 -41.34 87.15 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.191 -0.913 . . . . 2.0499999999999998 111.665 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 34.7 p -80.58 -14.01 58.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.247 0.546 . . . . 1.5900000000000001 111.01 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.42 ' O ' ' HE3' ' A' ' 137' ' ' LYS . . . 71.3 -130.61 18.92 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.622 -0.717 . . . . 1.52 112.955 175.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.46 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 46.5 p90 -70.04 -16.15 63.11 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.53 0.196 . . . . 5.9400000000000004 111.53 -174.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.92 -48.68 80.69 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.208 0.448 . . . . 1.8300000000000001 112.208 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.449 ' HB3' ' HG ' ' A' ' 142' ' ' LEU . 51.3 m-20 -100.22 14.17 31.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.847 0.356 . . . . 2.6400000000000001 111.218 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.46 ' OG1' ' HA ' ' A' ' 147' ' ' TYR . 98.2 m -72.93 129.71 38.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.394 -0.366 . . . . 2.02 110.706 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -83.45 134.29 34.87 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.387 -0.598 . . . . 3.6699999999999999 109.387 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 63.0 t -119.6 124.24 72.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.002 0.43 . . . . 1.6399999999999999 110.746 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -127.39 136.18 51.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.63 -0.714 . . . . 2.5600000000000001 109.684 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 16.0 m -135.77 130.05 33.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.804 0.335 . . . . 1.3899999999999999 110.887 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.608 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 74.4 tt0 -120.29 136.89 54.53 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.525 -0.546 . . . . 2.04 109.525 175.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 172' ' ' TYR . 17.1 p -127.38 140.07 52.43 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.024 -0.535 . . . . 1.5600000000000001 110.375 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -125.02 130.1 7.25 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.694 -0.765 . . . . 1.04 112.211 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.8 tp -112.86 128.31 56.42 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 110.196 -0.298 . . . . 2.27 110.196 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -108.49 107.43 17.96 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.995 -0.372 . . . . 2.4100000000000001 109.995 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -121.01 130.08 53.65 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.414 -0.587 . . . . 4.5700000000000003 109.414 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.5 p -88.91 94.15 9.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.877 0.37 . . . . 1.46 110.523 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -61.1 -45.73 93.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.971 -0.559 . . . . 2.6299999999999999 111.271 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.413 ' HB2' HG22 ' A' ' 166' ' ' VAL . 19.6 m120 -99.95 7.65 44.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.589 -0.278 . . . . 2.4100000000000001 110.482 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 73.57 -46.01 0.62 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.708 0.803 . . . . 2.5800000000000001 111.201 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.4 p -73.88 -24.73 59.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.873 0.368 . . . . 2.2999999999999998 111.623 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' A' ' 163' ' ' ASN . 28.9 m -123.45 144.65 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.385 -0.37 . . . . 1.71 110.554 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.22 135.02 49.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.143 -0.48 . . . . 1.47 110.66 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 31.4 mt -104.2 134.53 47.28 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.416 -0.587 . . . . 1.6599999999999999 109.416 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.514 ' HD2' ' CE1' ' A' ' 197' ' ' TYR . 96.8 mtt180 -99.95 111.54 23.84 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.844 -0.428 . . . . 3.2999999999999998 109.844 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.11 119.95 60.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.146 -0.479 . . . . 1.3 109.812 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -107.83 128.44 54.6 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.205 0.526 . . . . 2.2200000000000002 110.792 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.562 ' HB2' ' OG1' ' A' ' 156' ' ' THR . 88.2 m-85 -106.81 128.52 54.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.457 -0.792 . . . . 4.6100000000000003 108.898 177.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -104.09 129.98 51.79 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.064 0.459 . . . . 3.98 110.697 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.513 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 54.2 tp -118.61 119.94 35.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.699 -0.682 . . . . 2.3799999999999999 110.549 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -122.91 149.24 44.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.182 -0.673 . . . . 3.3100000000000001 109.182 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 . . . . . 0 C--N 1.321 -0.635 0 C-N-CA 120.109 -0.637 . . . . 6.5300000000000002 110.417 178.25 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.838 -0.43 . . . . 4.4000000000000004 109.838 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 87.2 mt -104.09 116.08 47.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.368 -0.378 . . . . 2.21 110.089 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -107.61 125.28 51.13 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.182 -0.303 . . . . 3.54 110.182 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -122.85 140.3 53.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.64 0.257 . . . . 1.6699999999999999 111.137 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.514 ' CE1' ' HD2' ' A' ' 169' ' ' ARG . 28.5 p90 -149.73 157.67 43.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.273 -0.421 . . . . 5.8300000000000001 110.101 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.62 143.4 23.51 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.637 0.256 . . . . 2.5899999999999999 110.811 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -88.03 116.08 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.441 2.094 . . . . 1.77 112.168 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 55.0 tp -103.56 129.15 50.74 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.296 -0.631 . . . . 2.2599999999999998 109.296 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 27.4 m -95.67 116.72 29.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.955 0.407 . . . . 1.99 111.24 -176.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.1 mt -127.74 81.46 2.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.071 -0.714 . . . . 2.3100000000000001 109.071 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 75.83 -129.54 10.36 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.76 -0.733 . . . . 1.51 111.291 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -90.62 -0.42 57.68 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.057 -0.72 . . . . 2.5699999999999998 109.057 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 242' ' ' GLY . 33.3 m170 -102.95 117.4 34.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.679 -0.691 . . . . 2.6600000000000001 110.082 -176.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -96.02 132.88 40.91 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.877 -0.601 . . . . 1.6200000000000001 109.999 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.507 ' CG1' HD11 ' A' ' 239' ' ' LEU . 58.4 t -110.08 120.04 60.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.289 -0.634 . . . . 1.3799999999999999 109.289 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 45.1 m -131.01 91.95 34.95 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 120.776 0.322 . . . . 1.1799999999999999 111.569 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.06 147.77 18.95 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.314 2.009 . . . . 1.01 111.135 172.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.425 ' CE1' ' HA3' ' A' ' 238' ' ' GLY . 33.8 p90 -132.4 149.54 52.33 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.621 -0.511 . . . . 4.5 109.621 172.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.404 HG22 HG22 ' A' ' 237' ' ' VAL . 20.6 p -119.0 135.74 54.46 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.715 -0.675 . . . . 1.8899999999999999 109.626 177.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -60.1 -39.81 87.44 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.743 -0.662 . . . . 4.7999999999999998 110.259 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.444 -0.735 0 CA-C-N 115.861 -0.608 . . . . 4.5700000000000003 109.543 -179.579 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.404 HG22 HG22 ' A' ' 211' ' ' THR . 60.5 t . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 120.915 0.388 . . . . 2.3999999999999999 110.577 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.425 ' HA3' ' CE1' ' A' ' 210' ' ' TYR . . . -122.01 140.0 13.28 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.065 -0.814 . . . . 1.27 111.065 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.507 HD11 ' CG1' ' A' ' 207' ' ' VAL . 52.7 tp -120.58 124.4 45.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.928 0.364 . . . . 1.97 110.728 -176.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.487 ' CE1' ' HG2' ' A' ' 254' ' ' GLU . 96.3 m-85 -104.88 132.07 51.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.126 -0.488 . . . . 3.54 110.633 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -112.33 126.91 55.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.38 -0.373 . . . . 2.6400000000000001 110.22 171.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 205' ' ' HIS . . . -89.34 118.18 5.13 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.826 -0.91 . . . . 1.3500000000000001 110.826 174.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' TYR . . . . . 0.462 ' HB3' ' CG2' ' A' ' 251' ' ' VAL . 50.1 t80 -107.74 134.7 50.33 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.792 -0.447 . . . . 4.3600000000000003 109.792 -176.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -99.89 145.79 27.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.88 -0.6 . . . . 4.29 111.295 -174.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.68 139.9 52.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.842 -0.617 . . . . 6.6900000000000004 110.004 172.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -64.43 -26.41 68.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.288 -0.869 . . . . 6.3700000000000001 111.168 -174.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -59.82 -40.12 87.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.684 -0.689 . . . . 5.8300000000000001 110.808 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 130.8 21.74 1.09 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.83 -0.7 . . . . 2.6600000000000001 111.937 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 91.8 mt -110.99 151.52 27.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.747 0.308 . . . . 2.9700000000000002 110.351 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 52.8 m -130.07 139.77 50.92 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.703 -0.481 . . . . 2.1699999999999999 109.703 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.462 ' CG2' ' HB3' ' A' ' 243' ' ' TYR . 33.2 m -129.07 142.86 42.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.981 0.419 . . . . 1.79 110.827 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 4.2 p -100.07 120.74 40.31 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.999 -0.546 . . . . 1.6299999999999999 110.165 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 87.9 mt -99.96 125.94 46.04 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.052 -0.522 . . . . 2.96 110.154 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 273' ' ' ALA . 45.3 mt-10 -92.81 134.62 34.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.41 -0.359 . . . . 4.0800000000000001 111.018 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -137.04 138.88 40.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.987 -0.552 . . . . 4.8399999999999999 109.564 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.574 0 CA-C-O 120.603 0.24 . . . . 3.5800000000000001 110.432 177.75 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 254' ' ' GLU . . . . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 110.233 -0.284 . . . . 1.9399999999999999 110.233 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.468 ' H ' ' HB2' ' A' ' 254' ' ' GLU . . . -140.81 154.84 24.58 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.958 -0.639 . . . . 1.4199999999999999 111.571 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 58.2 t -119.99 127.98 75.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.13 0.49 . . . . 1.8100000000000001 110.982 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 251' ' ' VAL . . . -117.72 129.84 8.49 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.697 -0.961 . . . . 1.3 110.697 173.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.2 124.92 64.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 117.368 0.584 . . . . 1.8300000000000001 110.758 -175.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -117.43 127.35 53.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.275 0.56 . . . . 2.3100000000000001 111.111 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 44.2 t80 -113.89 119.57 37.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.361 -0.836 . . . . 4.75 109.106 171.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 53.4 m -129.98 129.61 43.97 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.752 0.311 . . . . 1.6699999999999999 110.337 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 49.8 t80 . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.319 -0.848 . . . . 3.6899999999999999 108.749 176.568 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 . . . . . 0 CA--C 1.519 -0.226 0 N-CA-C 109.785 -0.45 . . . . 3.6099999999999999 109.785 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -141.31 101.73 4.07 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.128 -0.694 . . . . 3.3300000000000001 109.128 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.446 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 44.7 m80 -119.98 137.88 53.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.014 0.435 . . . . 3.2000000000000002 111.119 -175.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -132.84 146.22 51.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.671 -0.695 . . . . 2.4900000000000002 110.85 -176.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -123.93 131.9 53.64 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.257 -0.428 . . . . 2.1299999999999999 109.969 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 279' ' ' TYR . 77.7 mt -130.0 129.97 65.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.309 -0.405 . . . . 1.6000000000000001 110.404 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -115.2 134.95 11.91 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.448 -0.882 . . . . 0.88 111.644 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.97 136.34 54.57 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.94 0.4 . . . . 1.0800000000000001 110.569 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.527 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 65.9 mtt -133.14 155.34 49.45 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.881 -0.599 . . . . 2.3300000000000001 109.769 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -111.33 114.49 27.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.769 -0.456 . . . . 2.6099999999999999 109.769 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 116.148 -0.478 . . . . 5.0899999999999999 111.445 -170.776 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.857 0.361 . . . . 3.48 110.229 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 14' ' ' MET . 74.4 Cg_endo -78.01 134.73 13.37 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.443 2.096 . . . . 1.8600000000000001 113.166 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.2 m -109.92 143.25 40.11 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.715 -0.846 . . . . 1.97 108.715 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.49 134.4 66.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.357 0.598 . . . . 1.71 111.615 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -114.08 134.24 55.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.473 -0.785 . . . . 4.0700000000000003 109.582 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -110.69 139.38 46.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.755 0.312 . . . . 2.8599999999999999 110.986 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.42 HD22 ' HB2' ' A' ' 47' ' ' ALA . 24.5 t-20 -149.79 140.54 22.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.689 -0.485 . . . . 1.8899999999999999 109.689 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.47 143.51 47.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.415 0.15 . . . . 1.0800000000000001 110.978 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.459 ' HB2' ' HG3' ' A' ' 45' ' ' ARG . . . -153.95 119.69 5.26 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.49 -0.323 . . . . 1.3899999999999999 111.338 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.55 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 13.0 p-10 -169.12 95.04 0.32 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.373 -0.376 . . . . 2.8599999999999999 111.046 176.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.06 -98.7 2.47 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.972 -0.633 . . . . 1.6799999999999999 112.034 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.55 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 88.6 Cg_exo -49.23 174.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.893 3.062 . . . . 1.6599999999999999 112.998 170.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.4 ' HZ3' ' O ' ' A' ' 77' ' ' GLN . 93.6 m95 -67.31 176.33 2.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.123 0.487 . . . . 3.3999999999999999 111.108 -172.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.459 ' HG3' ' HB2' ' A' ' 40' ' ' ALA . 21.6 ttm180 -110.41 126.79 54.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.988 0.423 . . . . 3.1000000000000001 110.421 -163.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 83.5 mt -117.18 136.86 52.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.774 -0.648 . . . . 1.8 110.715 -173.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.42 ' HB2' HD22 ' A' ' 38' ' ' ASN . . . -117.83 133.32 56.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.853 -0.612 . . . . 0.85999999999999999 110.423 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.9 tp -120.35 132.02 55.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.925 -0.58 . . . . 1.0600000000000001 110.257 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.8 165.08 29.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.172 -0.467 . . . . 1.1399999999999999 110.189 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -138.42 147.97 43.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.057 -0.349 . . . . 4.0199999999999996 110.057 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -124.55 129.82 51.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.276 0.56 . . . . 4.6100000000000003 110.803 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -110.29 155.78 21.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.276 -0.874 . . . . 3.3799999999999999 108.859 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 C--N 1.324 -0.514 0 CA-C-O 120.825 0.345 . . . . 5.0499999999999998 110.658 -175.529 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 88.1 m95 . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 120.875 0.369 . . . . 5.6100000000000003 111.224 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -110.51 135.33 51.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.031 -0.532 . . . . 3.7799999999999998 110.355 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -149.18 170.02 19.39 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.692 -0.485 . . . . 2.4500000000000002 109.692 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 94' ' ' ASN . 40.8 ttp180 -129.6 123.59 21.35 Favored Pre-proline 0 N--CA 1.451 -0.402 0 C-N-CA 120.682 -0.407 . . . . 3.2400000000000002 111.038 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.538 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 92.7 Cg_endo -87.78 152.07 7.36 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.938 2.425 . . . . 1.1899999999999999 110.802 167.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.46 ' OE2' ' HD3' ' A' ' 93' ' ' ARG . 52.7 mt-10 -134.5 125.72 27.94 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.807 -0.357 . . . . 2.1899999999999999 110.383 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.4 tp -133.7 129.96 37.49 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.893 -0.41 . . . . 1.1399999999999999 109.893 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -128.3 146.62 50.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.083 0.468 . . . . 2.1800000000000002 110.994 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.1 t -114.8 126.87 72.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.786 -0.82 . . . . 1.5600000000000001 108.786 171.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -110.85 119.82 40.36 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.298 -0.41 . . . . 3.4399999999999999 110.227 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -105.59 120.03 40.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.065 -0.516 . . . . 4.7999999999999998 110.429 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.4 ' O ' ' HZ3' ' A' ' 44' ' ' TRP . 53.8 mt-30 -109.45 120.16 41.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.789 -0.448 . . . . 2.9399999999999999 109.789 176.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -104.14 125.45 50.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.151 0.5 . . . . 3.8999999999999999 111.214 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.6 tp . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 115.43 -0.805 . . . . 4.4800000000000004 108.975 174.853 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 121.145 0.498 . . . . 2.5499999999999998 110.711 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -128.52 153.29 47.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.77 -0.65 . . . . 5.2999999999999998 109.816 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -151.62 166.28 30.73 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.499 -0.858 . . . . 1.3500000000000001 111.608 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 63.6 tp -146.49 120.09 9.14 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.908 0.385 . . . . 2.29 110.403 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.3 m -109.39 116.72 32.37 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.047 -0.524 . . . . 1.54 109.763 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -134.96 139.05 10.5 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.44 -0.886 . . . . 1.1699999999999999 111.266 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.78 161.67 32.47 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.072 -1.061 . . . . 1.1899999999999999 112.366 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -122.39 130.96 53.63 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.491 -0.559 . . . . 3.75 109.491 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.46 ' HD3' ' OE2' ' A' ' 71' ' ' GLU . 83.6 mtt180 -121.99 124.99 45.3 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.587 -0.894 . . . . 2.75 108.587 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.538 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 64.4 t30 -103.75 118.41 36.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.064 0.459 . . . . 1.8200000000000001 110.64 -173.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 109' ' ' ASN . 59.3 t80 -102.34 117.67 35.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.07 -0.514 . . . . 3.1400000000000001 110.452 -175.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.475 0 C-N-CA 120.635 -0.793 . . . . 2.79 113.478 173.334 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 110.228 -0.286 . . . . 3.2999999999999998 110.228 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -137.6 113.74 9.99 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.96 -0.296 . . . . 1.76 110.345 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 95' ' ' TYR . 3.5 t-20 -142.09 108.31 5.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.927 -0.579 . . . . 2.5499999999999998 109.677 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.465 ' HB2' ' HB3' ' A' ' 95' ' ' TYR . 88.4 mtp -111.27 125.69 54.1 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.733 -0.667 . . . . 1.77 109.343 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.575 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 81.1 mt-30 -91.66 119.87 31.92 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.527 -0.469 . . . . 1.97 109.88 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -106.29 113.06 26.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.873 -0.603 . . . . 3.8500000000000001 110.193 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 137' ' ' LYS . 86.3 m95 -115.81 125.31 52.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.882 -0.784 . . . . 2.2799999999999998 108.882 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -140.1 123.88 17.37 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.452 -0.573 . . . . 2.1400000000000001 109.452 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 134' ' ' SER . 87.4 mt -123.22 128.22 74.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.999 -0.546 . . . . 1.55 110.179 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -132.77 104.25 13.03 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.516 -0.311 . . . . 1.1899999999999999 111.278 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.18 141.13 11.44 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.091 2.527 . . . . 1.3700000000000001 111.356 172.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -93.42 138.51 31.67 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.064 -0.516 . . . . 2.3500000000000001 110.088 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -127.06 128.38 46.19 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.125 -0.324 . . . . 4.54 110.125 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -148.64 118.11 6.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.867 -0.42 . . . . 3.04 109.867 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 123' ' ' LEU . 61.1 t -124.6 130.01 73.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.001 0.429 . . . . 4.2699999999999996 111.105 -174.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -114.03 28.48 8.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 6.04 110.213 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.597 ' H ' HG12 ' A' ' 121' ' ' VAL . 61.3 tp -68.13 -22.77 64.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 4.5899999999999999 112.066 -171.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.0 p -108.15 143.84 36.38 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.081 0.467 . . . . 3.6899999999999999 111.789 -174.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -66.93 124.97 24.49 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.527 -0.76 . . . . 5.1699999999999999 110.823 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 60.25 15.6 5.45 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.86 0.725 . . . . 3.71 111.598 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.6 mt -129.25 119.53 24.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.207 -0.451 . . . . 2.0499999999999998 110.062 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.518 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 74.0 ttt180 -112.74 130.36 56.09 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.031 -0.531 . . . . 4.2400000000000002 110.062 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -107.24 125.81 51.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.066 -0.515 . . . . 3.5499999999999998 109.652 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -130.6 130.05 43.52 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.201 -0.666 . . . . 2.1099999999999999 109.201 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -137.53 144.55 16.01 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.139 -1.029 . . . . 1.1799999999999999 112.8 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 155' ' ' GLU . 61.0 t-105 -118.82 128.44 54.46 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.068 -0.716 . . . . 4.2999999999999998 109.068 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 60.9 tp -126.33 140.51 52.45 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.385 -0.598 . . . . 2.2400000000000002 109.385 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 29.3 t -156.72 169.97 23.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.418 -0.216 . . . . 1.6899999999999999 110.418 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 92.8 mtp -139.62 149.95 44.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.652 0.263 . . . . 2.2400000000000002 110.663 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -103.74 117.35 34.17 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.378 -0.374 . . . . 3.5600000000000001 111.207 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 113' ' ' TRP . 99.4 mttt -132.92 129.8 38.78 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.066 -0.716 . . . . 1.6699999999999999 109.066 170.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.575 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 51.1 p90 -157.02 161.04 39.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.473 -0.331 . . . . 3.23 110.618 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 74.72 -178.19 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 O-C-N 124.154 0.908 . . . . 1.24 110.678 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -74.47 -38.64 62.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.533 -0.303 . . . . 2.4700000000000002 111.019 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -59.86 -51.17 70.86 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.738 0.644 . . . . 2.4100000000000001 112.738 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.6 ' HA ' ' OG1' ' A' ' 145' ' ' THR . 44.2 mt -69.98 -30.01 67.25 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.776 -0.37 . . . . 1.8300000000000001 111.342 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -60.02 -42.16 93.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.029 0.442 . . . . 2.0 109.857 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 30.0 p -80.12 -31.37 39.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.011 -0.541 . . . . 2.0499999999999998 111.972 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.6 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 61.6 p -71.65 -32.38 67.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.147 0.499 . . . . 1.5900000000000001 110.95 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.414 ' O ' ' HE2' ' A' ' 137' ' ' LYS . . . 68.3 -120.09 11.31 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.692 -0.686 . . . . 1.52 112.61 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -89.89 -9.66 48.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.43 0.157 . . . . 5.9400000000000004 111.067 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.69 -52.97 47.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.874 0.369 . . . . 1.8300000000000001 110.663 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.417 ' O ' HD22 ' A' ' 142' ' ' LEU . 10.9 m-20 -118.11 110.05 17.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.867 -0.606 . . . . 2.6400000000000001 109.666 176.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.6 t -170.24 164.17 8.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.813 -0.63 . . . . 2.02 109.616 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 151' ' ' ARG . 49.9 mtm180 -119.89 143.98 47.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.645 0.259 . . . . 3.6699999999999999 110.478 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.0 143.51 25.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.146 -0.479 . . . . 1.6399999999999999 110.984 -172.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 134' ' ' SER . 34.9 mt-10 -110.61 125.5 53.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.56 -0.904 . . . . 2.5600000000000001 108.56 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.8 m -132.22 122.45 25.25 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.464 -0.494 . . . . 1.3899999999999999 110.97 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 132' ' ' TRP . 85.8 tt0 -119.91 111.98 18.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.301 -0.629 . . . . 2.04 109.301 174.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 31.7 m -108.57 120.32 42.1 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.072 -0.513 . . . . 1.5600000000000001 109.861 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -133.37 149.26 19.61 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 119.71 -1.233 . . . . 1.04 113.051 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 59.6 tp -122.47 130.42 53.04 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.983 -0.377 . . . . 2.27 109.983 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 51.3 tt0 -95.44 110.89 22.87 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.109 -0.7 . . . . 2.4100000000000001 109.109 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -122.85 130.08 52.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.566 -0.743 . . . . 4.5700000000000003 110.002 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.2 p -82.28 88.16 6.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.159 0.504 . . . . 1.46 109.94 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -60.47 -50.14 74.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.61 -0.723 . . . . 2.6299999999999999 111.323 -172.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -103.12 16.64 26.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.156 -0.475 . . . . 2.4100000000000001 111.18 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 72.92 -50.22 0.7 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.75 -0.659 . . . . 2.5800000000000001 111.868 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.1 p -74.21 -20.1 60.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.759 0.314 . . . . 2.2999999999999998 111.695 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -125.79 144.19 36.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.366 -0.379 . . . . 1.71 110.82 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -105.67 121.63 44.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.036 -0.529 . . . . 1.47 110.493 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -102.88 126.94 50.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.825 -0.625 . . . . 1.6599999999999999 109.761 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -98.11 111.78 23.98 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.303 -0.629 . . . . 3.2999999999999998 109.303 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.96 119.92 60.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.856 -0.611 . . . . 1.3 109.384 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -114.89 131.07 56.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.323 -0.399 . . . . 2.2200000000000002 111.157 -171.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -115.19 119.94 38.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.683 -0.689 . . . . 4.6100000000000003 109.255 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -106.91 130.7 54.54 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.831 0.348 . . . . 3.98 110.075 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 64.1 tp -99.5 119.92 38.8 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.982 -0.554 . . . . 2.3799999999999999 110.102 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -66.73 -40.05 88.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.264 -0.88 . . . . 3.3100000000000001 110.638 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 6.5300000000000002 109.766 -178.969 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 109.354 -0.609 . . . . 4.4000000000000004 109.354 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 85.2 mt -115.39 119.94 63.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.834 -0.432 . . . . 2.21 109.834 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 211' ' ' THR . 93.1 mtt180 -117.82 116.19 26.48 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.9 -0.407 . . . . 3.54 109.9 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -120.06 138.47 53.52 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.997 -0.547 . . . . 1.6699999999999999 110.178 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -136.82 140.75 42.68 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.348 0.594 . . . . 5.8300000000000001 111.362 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.41 HD12 ' HD2' ' A' ' 199' ' ' PRO . 55.5 tp -116.69 126.82 27.2 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 114.871 -1.059 . . . . 2.5899999999999999 109.399 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.41 ' HD2' HD12 ' A' ' 198' ' ' LEU . 21.8 Cg_exo -66.55 110.18 1.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.942 1.761 . . . . 1.77 111.078 174.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 60.0 tp -100.12 109.43 21.71 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.275 -0.639 . . . . 2.2599999999999998 109.275 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 78.5 m -121.34 130.07 53.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.331 0.586 . . . . 1.99 111.487 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 55.5 tp -133.6 83.86 2.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.507 -0.923 . . . . 2.3100000000000001 108.507 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.71 -117.79 9.14 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.504 -0.771 . . . . 1.51 112.063 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -79.89 -12.68 59.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.729 0.299 . . . . 2.5699999999999998 111.357 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -99.54 117.09 33.16 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.066 -0.346 . . . . 2.6600000000000001 110.066 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 28.6 t -132.57 138.14 47.35 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.724 -0.473 . . . . 1.6200000000000001 109.724 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.419 ' HB ' HD11 ' A' ' 239' ' ' LEU . 24.5 m -136.61 148.82 26.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.792 0.33 . . . . 1.3799999999999999 110.807 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 26.4 m -119.93 91.73 45.82 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.176 -0.465 . . . . 1.1799999999999999 110.412 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 2.6 Cg_endo -80.74 126.8 6.05 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.891 2.394 . . . . 1.01 112.455 177.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -95.27 140.07 30.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.234 -0.439 . . . . 4.5 110.0 175.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 195' ' ' ARG . 45.7 p -118.31 130.2 55.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.882 0.372 . . . . 1.8899999999999999 110.447 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 17.7 ttp85 -104.67 110.03 22.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.66 -0.7 . . . . 4.7999999999999998 109.704 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 30.4 pt . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.262 -0.426 . . . . 4.5700000000000003 110.586 -177.385 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.448 -0.56 0 CA-C-O 121.094 0.473 . . . . 2.3999999999999999 110.228 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -78.28 111.93 3.36 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.854 -0.898 . . . . 1.27 110.854 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.565 ' O ' ' HB3' ' A' ' 254' ' ' GLU . 47.7 tp -111.68 125.43 53.96 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.631 -0.507 . . . . 1.97 109.631 -175.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -124.83 133.34 53.14 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.993 -0.549 . . . . 3.54 109.776 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -98.11 131.15 44.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.972 0.415 . . . . 2.6400000000000001 110.471 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -121.12 118.45 3.8 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.726 -0.67 . . . . 1.3500000000000001 112.455 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -140.06 115.39 9.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.286 -0.635 . . . . 4.3600000000000003 109.286 174.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -120.06 130.29 54.61 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.995 -0.372 . . . . 4.29 109.995 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -139.92 129.67 24.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.034 -0.53 . . . . 6.6900000000000004 110.493 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -70.11 140.33 52.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.762 -0.653 . . . . 6.3700000000000001 110.307 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.97 39.63 19.86 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.449 0.468 . . . . 5.8300000000000001 110.984 -178.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -170.39 171.34 43.56 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.815 -0.707 . . . . 2.6600000000000001 111.74 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 86.7 mt -71.12 141.26 50.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.074 0.464 . . . . 2.9700000000000002 110.786 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.554 ' HB2' ' HB2' ' A' ' 278' ' ' ASN . 68.5 m -123.89 149.97 45.21 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.846 -0.615 . . . . 2.1699999999999999 109.972 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 66.7 t -123.15 135.15 64.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.645 0.26 . . . . 1.79 111.314 -172.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 22.7 t -136.44 152.98 51.17 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.078 -0.51 . . . . 1.6299999999999999 109.877 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 90.2 mt 73.23 -179.67 0.21 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.251 0.621 . . . . 2.96 111.05 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . 0.565 ' HB3' ' O ' ' A' ' 239' ' ' LEU . 38.2 tt0 -177.91 -86.11 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.293 0.042 . . . . 4.0800000000000001 110.991 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' TYR . . . . . 0.554 ' CD2' ' HG2' ' A' ' 254' ' ' GLU . 69.4 m-85 -120.02 135.96 54.73 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.91 -0.494 . . . . 4.8399999999999999 111.589 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.744 -0.662 . . . . 3.5800000000000001 110.248 176.514 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.426 -0.583 . . . . 1.9399999999999999 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -133.3 118.71 2.18 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 119.857 -1.163 . . . . 1.4199999999999999 111.601 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 63.1 t -126.97 130.05 71.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.966 0.413 . . . . 1.8100000000000001 110.428 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -116.15 160.23 13.47 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 111.167 -0.773 . . . . 1.3 111.167 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 250' ' ' SER . 19.0 m -123.25 139.8 48.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 120.919 0.39 . . . . 1.8300000000000001 110.556 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 250' ' ' SER . 94.1 m-20 -105.39 131.8 52.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.989 -0.551 . . . . 2.3100000000000001 110.936 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.405 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 91.9 m-85 -115.26 139.97 49.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.454 -0.943 . . . . 4.75 108.454 173.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 15.5 t -144.2 143.03 30.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.109 0.48 . . . . 1.6699999999999999 110.751 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 59.1 t80 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 117.901 -1.047 . . . . 3.6899999999999999 109.116 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.355 0 CA-C-O 121.242 0.544 . . . . 3.6099999999999999 111.713 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -134.85 129.42 34.43 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.314 -1.365 . . . . 3.3300000000000001 107.314 166.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.488 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 96.4 m-70 -124.58 137.04 54.42 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.953 -0.699 . . . . 3.2000000000000002 110.898 -172.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.45 ' CE2' ' HB3' ' A' ' 281' ' ' PHE . 50.4 p90 -140.0 160.61 39.53 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.637 -0.71 . . . . 2.4900000000000002 110.988 -176.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -134.12 129.85 36.52 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.777 -0.823 . . . . 2.1299999999999999 108.777 173.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.1 tt -130.1 130.05 65.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.962 -0.755 . . . . 1.6000000000000001 108.962 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.522 ' HA3' ' OD1' ' A' ' 278' ' ' ASN . . . -144.61 155.64 26.47 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 119.23 -1.462 . . . . 0.88 113.454 -173.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.423 ' HB2' HG22 ' A' ' 35' ' ' VAL . . . -118.1 135.14 54.39 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.583 -0.525 . . . . 1.0800000000000001 109.583 176.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.444 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 59.7 ttm -130.27 132.16 45.8 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.936 -0.575 . . . . 2.3300000000000001 110.003 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -84.51 120.34 26.22 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.532 -0.544 . . . . 2.6099999999999999 109.532 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 C--N 1.324 -0.537 0 CA-C-O 121.434 0.635 . . . . 5.0899999999999999 111.408 -174.579 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.768 0.318 . . . . 3.48 110.585 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 14' ' ' MET . 85.2 Cg_endo -79.92 134.83 10.88 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.678 2.252 . . . . 1.8600000000000001 112.832 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.3 m -113.32 142.68 45.56 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.292 -0.633 . . . . 1.97 109.292 172.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 59.4 t -115.93 134.5 59.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.701 0.286 . . . . 1.71 111.295 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -119.65 139.91 51.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.321 -0.399 . . . . 4.0700000000000003 110.056 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -110.59 129.87 55.7 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.567 -0.531 . . . . 2.8599999999999999 109.567 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.561 HD21 ' HD3' ' A' ' 45' ' ' ARG . 51.3 t30 -143.43 127.63 17.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.601 -0.272 . . . . 1.8899999999999999 110.295 -173.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -143.31 144.18 32.0 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.52 0.563 . . . . 1.0800000000000001 112.52 -175.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.437 ' HB2' ' CB ' ' A' ' 45' ' ' ARG . . . -163.09 144.53 9.78 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.363 -0.381 . . . . 1.3899999999999999 111.74 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.691 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 7.5 t30 -169.13 94.15 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 2.8599999999999999 110.14 166.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.57 -81.36 0.31 Allowed Glycine 0 CA--C 1.517 0.185 0 C-N-CA 120.878 -0.677 . . . . 1.6799999999999999 111.47 -176.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.691 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 22.9 Cg_endo -61.71 175.73 1.6 Allowed 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.326 2.684 . . . . 1.6599999999999999 111.776 170.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -68.21 174.72 3.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.968 0.413 . . . . 3.3999999999999999 110.159 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.561 ' HD3' HD21 ' A' ' 38' ' ' ASN . 39.0 ttm180 -110.56 124.84 52.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.24 0.543 . . . . 3.1000000000000001 111.078 -166.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.5 mm -113.09 130.01 67.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.414 -0.812 . . . . 1.8 110.599 -173.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 73' ' ' GLU . . . -117.95 129.95 55.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.274 -0.421 . . . . 0.85999999999999999 110.064 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.1 tp -128.14 133.98 49.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.112 -0.495 . . . . 1.0600000000000001 110.661 -176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.02 153.91 37.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.142 -0.481 . . . . 1.1399999999999999 110.244 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -120.11 139.97 51.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.782 0.325 . . . . 4.0199999999999996 110.684 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.614 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 71.1 t80 -99.9 129.96 46.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.088 -0.505 . . . . 4.6100000000000003 110.527 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -133.45 150.47 51.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.336 -0.847 . . . . 3.3799999999999999 109.049 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 . . . . . 0 C--N 1.322 -0.604 0 CA-C-O 120.952 0.406 . . . . 5.0499999999999998 110.627 -178.325 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 77.6 t90 . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.505 -0.554 . . . . 5.6100000000000003 109.505 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -150.26 159.95 44.06 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.212 -0.449 . . . . 3.7799999999999998 110.266 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -148.65 170.48 18.05 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.051 -0.722 . . . . 2.4500000000000002 109.051 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.614 ' HB3' ' HB3' ' A' ' 51' ' ' TYR . 29.0 ttp180 -135.0 122.16 15.06 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.648 -0.421 . . . . 3.2400000000000002 110.195 171.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.67 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 71.8 Cg_endo -81.91 146.2 14.51 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.756 2.304 . . . . 1.1899999999999999 111.47 169.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -136.57 120.08 17.05 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.699 -0.482 . . . . 2.1899999999999999 109.699 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 47' ' ' ALA . 40.6 tp -136.63 129.82 31.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.0 -0.545 . . . . 1.1399999999999999 110.338 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 99.8 mt-10 -117.93 142.18 47.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.176 -0.466 . . . . 2.1800000000000002 110.216 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.8 t -113.33 120.02 62.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.558 -0.904 . . . . 1.5600000000000001 108.558 173.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 15.3 m-70 -108.27 120.13 41.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.989 -0.55 . . . . 3.4399999999999999 109.769 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -99.14 141.44 31.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.155 -0.475 . . . . 4.7999999999999998 110.434 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -100.84 132.13 46.39 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.906 -0.405 . . . . 2.9399999999999999 109.906 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -120.02 99.8 6.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.768 0.318 . . . . 3.8999999999999999 111.662 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.6 tp . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 121.359 0.6 . . . . 4.4800000000000004 109.615 171.545 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.7 p . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 110.096 -0.335 . . . . 2.5499999999999998 110.096 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 52.9 t80 71.97 -76.75 0.06 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.982 -0.554 . . . . 5.2999999999999998 111.794 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.13 166.94 34.79 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 118.478 -1.82 . . . . 1.3500000000000001 114.853 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.1 tp -133.6 130.05 37.82 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.542 -0.91 . . . . 2.29 108.542 173.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.2 m -120.06 127.51 52.64 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.05 0.453 . . . . 1.54 110.555 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -132.07 132.57 6.74 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.83 -0.908 . . . . 1.1699999999999999 110.83 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -141.94 156.24 25.86 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.32 -0.943 . . . . 1.1899999999999999 112.343 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -139.31 149.34 44.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.073 0.463 . . . . 3.75 110.614 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.421 ' HB2' ' HB3' ' A' ' 112' ' ' ARG . 99.7 mtt180 -131.57 129.85 41.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.447 -0.797 . . . . 2.75 109.449 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.67 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 8.5 t30 -115.29 117.58 30.86 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.4 -0.592 . . . . 1.8200000000000001 109.4 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -111.76 120.3 41.55 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.607 0.241 . . . . 3.1400000000000001 110.529 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 108' ' ' ALA . . . . . . . . 0 N--CA 1.449 -0.436 0 C-N-CA 120.727 -0.749 . . . . 2.79 112.006 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.427 -0.583 . . . . 3.2999999999999998 109.427 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.4 ' O ' ' HA3' ' A' ' 96' ' ' GLY . . . -160.87 130.81 5.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.231 -0.285 . . . . 1.76 110.231 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -139.77 108.12 5.82 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.703 -0.48 . . . . 2.5499999999999998 109.703 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 89.7 mtp -116.98 128.1 54.85 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.243 -0.435 . . . . 1.77 109.917 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -110.22 133.52 53.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.03 0.443 . . . . 1.97 111.127 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 35.2 ttt180 -109.89 117.84 34.89 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.329 -0.619 . . . . 3.8500000000000001 109.329 172.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -113.6 136.32 52.95 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.503 -0.555 . . . . 2.2799999999999998 109.503 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 134' ' ' SER . 85.5 tttt -139.12 128.85 24.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.208 -0.451 . . . . 2.1400000000000001 110.817 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 87.0 mt -120.01 121.01 64.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.952 -0.759 . . . . 1.55 108.952 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -137.59 105.3 8.36 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.381 -0.372 . . . . 1.1899999999999999 111.051 -175.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 74.2 Cg_endo -79.64 139.99 14.56 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.075 1.85 . . . . 1.3700000000000001 110.614 173.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -95.57 136.6 35.75 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.773 -1.195 . . . . 2.3500000000000001 107.773 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -124.51 127.97 48.26 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.118 0.485 . . . . 4.54 111.349 -176.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -131.92 120.22 22.22 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.797 -0.816 . . . . 3.04 108.797 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.4 t -132.85 115.83 25.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.438 -0.346 . . . . 4.2699999999999996 110.329 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -107.76 86.45 2.3 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.268 0.556 . . . . 6.04 110.513 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.04 -39.95 90.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.437 -0.801 . . . . 4.5899999999999999 109.696 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 127' ' ' LEU . 24.4 p -129.87 164.01 25.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.218 -0.901 . . . . 3.6899999999999999 109.77 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -73.44 -47.1 44.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.722 0.296 . . . . 5.1699999999999999 111.17 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -70.07 -40.08 75.27 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.133 -0.485 . . . . 3.71 112.027 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.562 ' HB2' ' OG1' ' A' ' 124' ' ' THR . 6.1 mp -102.11 118.45 36.93 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.71 -0.478 . . . . 2.0499999999999998 109.71 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.425 ' HB2' ' HB2' ' A' ' 159' ' ' GLN . 90.6 mtt180 -122.94 134.88 54.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.005 -0.543 . . . . 4.2400000000000002 109.812 -174.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.419 ' CE1' HD13 ' A' ' 158' ' ' LEU . 97.1 m-85 -109.22 129.07 55.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.76 0.314 . . . . 3.5499999999999998 110.519 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -146.32 120.93 9.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.423 -0.584 . . . . 2.1099999999999999 109.423 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -157.13 172.18 34.6 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.565 -0.826 . . . . 1.1799999999999999 112.047 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.471 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 9.2 p90 -140.23 140.91 35.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.134 0.492 . . . . 4.2999999999999998 111.158 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 66.5 mt -109.41 133.75 52.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.023 -0.732 . . . . 2.2400000000000002 109.023 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.4 ' HB3' ' HE3' ' A' ' 114' ' ' LYS . 73.9 m -129.9 135.5 48.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.283 0.563 . . . . 1.6899999999999999 112.14 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 68.6 mtt -119.98 136.76 54.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.443 -0.799 . . . . 2.2400000000000002 108.872 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 96.1 m-85 -120.05 134.36 55.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.002 0.43 . . . . 3.5600000000000001 111.635 -176.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 98.4 mttt -128.18 138.82 52.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.56 -0.745 . . . . 1.6699999999999999 109.37 173.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.45 ' O ' HD23 ' A' ' 142' ' ' LEU . 96.1 m-85 -129.91 150.76 51.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.687 0.279 . . . . 3.23 111.09 -176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 58.99 -165.03 0.19 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.669 -0.696 . . . . 1.24 111.306 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -76.95 -32.81 57.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.29 0.567 . . . . 2.4700000000000002 110.254 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -60.01 -46.78 88.38 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.046 -0.979 . . . . 2.4100000000000001 113.176 -168.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 138' ' ' PHE . 4.1 mm? -69.92 -29.21 66.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.141 0.496 . . . . 1.8300000000000001 110.545 -177.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -69.76 -40.02 76.37 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.905 -0.589 . . . . 2.0 109.896 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.4 m -63.85 -40.12 95.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.098 -0.955 . . . . 2.0499999999999998 111.233 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.4 p -75.7 -23.63 56.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.821 0.343 . . . . 1.5900000000000001 111.615 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 60.43 -120.98 25.12 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.757 -0.656 . . . . 1.52 113.327 174.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -69.94 -30.6 68.03 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.4 0.28 . . . . 5.9400000000000004 111.727 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.7 -49.95 75.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 1.8300000000000001 112.054 -174.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -122.93 113.3 18.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.951 0.405 . . . . 2.6400000000000001 110.924 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.9 t -160.01 150.29 18.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.018 -0.734 . . . . 2.02 109.018 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.532 ' HB2' ' HB2' ' A' ' 136' ' ' TYR . 98.5 mtt180 -83.7 137.28 33.84 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.075 -0.343 . . . . 3.6699999999999999 110.075 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.6 119.95 60.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.337 -0.392 . . . . 1.6399999999999999 110.493 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -124.29 129.88 51.53 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.731 -0.84 . . . . 2.5600000000000001 108.731 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.404 HG23 ' CD2' ' A' ' 133' ' ' LEU . 50.8 m -136.71 130.17 31.68 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.623 -0.262 . . . . 1.3899999999999999 111.409 -174.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.471 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 82.4 tt0 -130.76 121.48 25.49 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.125 0.488 . . . . 2.04 109.818 175.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 40.7 p -119.33 139.17 52.38 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.596 -0.729 . . . . 1.5600000000000001 109.993 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -130.05 141.85 13.07 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.243 -0.98 . . . . 1.04 113.349 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.419 HD13 ' CE1' ' A' ' 129' ' ' PHE . 63.7 tp -122.21 128.58 51.36 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.733 -0.469 . . . . 2.27 109.733 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 168' ' ' LEU . 95.6 mt-30 -100.01 126.78 46.25 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.327 -0.62 . . . . 2.4100000000000001 109.327 173.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -126.06 128.81 47.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.388 -0.369 . . . . 4.5700000000000003 110.38 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 2.4 p -85.3 88.59 7.51 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.348 0.594 . . . . 1.46 111.071 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.414 ' HB2' HD11 ' A' ' 168' ' ' LEU . 58.2 t80 -60.07 -49.94 75.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.579 -0.737 . . . . 2.6299999999999999 111.618 -176.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.616 ' HB2' HG22 ' A' ' 166' ' ' VAL . 92.7 m-20 -102.61 14.55 31.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.535 -0.302 . . . . 2.4100000000000001 110.851 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 72.98 -49.03 0.7 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.893 0.746 . . . . 2.5800000000000001 110.487 -176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 27.2 m -72.86 -33.17 65.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.176 -0.465 . . . . 2.2999999999999998 111.037 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.616 HG22 ' HB2' ' A' ' 163' ' ' ASN . 13.7 m -108.75 138.63 34.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.861 0.362 . . . . 1.71 110.914 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -109.21 137.21 47.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.085 -0.507 . . . . 1.47 110.608 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 159' ' ' GLN . 16.2 mt -103.22 129.96 50.31 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.698 -0.482 . . . . 1.6599999999999999 109.698 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.421 ' HB2' ' HB2' ' A' ' 197' ' ' TYR . 99.1 mtt180 -94.11 105.43 17.43 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.529 -0.545 . . . . 3.2999999999999998 109.529 177.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.3 t -119.31 121.99 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.858 -0.423 . . . . 1.3 109.858 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.578 ' OD1' ' HB2' ' A' ' 195' ' ' ARG . 30.4 p30 -132.3 156.65 46.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.349 0.595 . . . . 2.2200000000000002 112.086 -177.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.555 ' CE1' ' HB3' ' A' ' 193' ' ' GLU . 67.8 t80 -124.3 131.42 53.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.992 -1.003 . . . . 4.6100000000000003 109.586 177.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -113.2 135.01 54.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.154 0.502 . . . . 3.98 110.42 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.7 tp -100.01 116.6 32.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.734 -0.666 . . . . 2.3799999999999999 109.608 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.517 ' OE2' ' HD2' ' A' ' 176' ' ' ARG . 31.7 tt0 -70.02 -40.76 75.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.962 -0.563 . . . . 3.3100000000000001 111.307 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.517 ' HD2' ' OE2' ' A' ' 175' ' ' GLU . 8.8 ptm180 . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.569 -0.741 . . . . 6.5300000000000002 110.525 -169.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.555 ' HB3' ' CE1' ' A' ' 172' ' ' TYR . 36.0 mt-10 . . . . . 0 C--O 1.233 0.234 0 CA-C-O 121.115 0.483 . . . . 4.4000000000000004 110.777 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 48.5 mm -105.76 127.89 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.616 -0.72 . . . . 2.21 110.646 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.578 ' HB2' ' OD1' ' A' ' 171' ' ' ASN . 25.2 mtm180 -110.87 129.32 55.9 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.549 -0.537 . . . . 3.54 109.549 174.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 169' ' ' ARG . . . -118.4 134.49 55.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.085 -0.507 . . . . 1.6699999999999999 110.924 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.421 ' HB2' ' HB2' ' A' ' 169' ' ' ARG . 87.6 m-85 -133.59 143.32 48.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.626 -0.715 . . . . 5.8300000000000001 109.56 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.623 ' O ' ' HA ' ' A' ' 208' ' ' THR . 42.3 tp -119.92 124.22 28.01 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.178 -0.675 . . . . 2.5899999999999999 109.178 171.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -93.28 105.41 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.905 1.737 . . . . 1.77 112.449 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.8 tp -96.11 121.89 38.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.043 -0.526 . . . . 2.2599999999999998 109.648 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 89.6 m -99.9 118.85 37.2 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.275 0.559 . . . . 1.99 110.845 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 94.4 mt -125.7 81.07 1.95 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.191 -1.04 . . . . 2.3100000000000001 108.191 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 74.35 -126.87 9.55 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.705 -0.958 . . . . 1.51 110.705 -172.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -95.08 -0.11 53.87 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.304 0.573 . . . . 2.5699999999999998 109.531 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -99.34 119.18 37.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.518 -0.764 . . . . 2.6600000000000001 109.554 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 32.1 t -112.49 139.93 47.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.935 0.398 . . . . 1.6200000000000001 110.525 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.92 123.12 70.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.658 -0.867 . . . . 1.3799999999999999 108.658 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 198' ' ' LEU . 42.6 m -126.86 93.02 43.18 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-O 120.788 0.327 . . . . 1.1799999999999999 110.721 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 29.0 Cg_endo -69.82 149.87 67.1 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.841 1.694 . . . . 1.01 111.378 175.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -126.0 138.05 53.71 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.729 -0.669 . . . . 4.5 109.987 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 59.2 p -130.01 143.57 50.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.204 -0.453 . . . . 1.8899999999999999 110.012 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -95.16 -15.35 23.38 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.939 -0.573 . . . . 4.7999999999999998 109.922 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.0 mt . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.73 -0.668 . . . . 4.5700000000000003 110.087 170.691 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 62.6 t . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.768 -0.456 . . . . 2.3999999999999999 109.768 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -85.47 138.85 16.83 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.327 -0.939 . . . . 1.27 110.987 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 255' ' ' TYR . 92.6 mt -119.69 129.48 54.56 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.494 -0.482 . . . . 1.97 110.013 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.453 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 65.2 t80 -107.37 131.19 54.52 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.361 -0.607 . . . . 3.54 109.361 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -120.0 140.12 51.46 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.824 -0.435 . . . . 2.6400000000000001 109.824 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -125.91 128.28 6.41 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.247 -0.978 . . . . 1.3500000000000001 112.48 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -111.39 117.0 31.89 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.507 -0.553 . . . . 4.3600000000000003 109.507 173.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.47 133.87 55.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.781 0.324 . . . . 4.29 110.307 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -119.93 139.92 51.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.337 -0.392 . . . . 6.6900000000000004 110.384 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -64.86 -13.24 55.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.757 -0.656 . . . . 6.3700000000000001 110.561 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -69.98 -10.93 60.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.712 -0.676 . . . . 5.8300000000000001 110.567 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 104.7 -2.54 42.06 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.696 -0.764 . . . . 2.6600000000000001 112.259 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 61.8 tp -95.18 120.02 34.68 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.015 -0.365 . . . . 2.9700000000000002 110.015 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 8.6 t -121.6 129.94 53.17 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.437 -0.579 . . . . 2.1699999999999999 109.437 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.6 t -124.37 132.54 71.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.026 0.441 . . . . 1.79 110.882 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 51.9 m -110.23 129.06 55.79 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.876 -0.602 . . . . 1.6299999999999999 109.865 178.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 75.0 mt -120.0 130.34 54.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.312 -0.403 . . . . 2.96 111.027 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -101.84 124.85 48.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.438 -0.347 . . . . 4.0800000000000001 110.073 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' TYR . . . . . 0.454 ' HB3' ' HB2' ' A' ' 239' ' ' LEU . 61.2 t80 -104.33 129.97 52.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.547 . . . . 4.8399999999999999 109.588 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.588 0 CA-C-N 116.371 -0.377 . . . . 3.5800000000000001 111.458 -176.12 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 109.833 -0.432 . . . . 1.9399999999999999 109.833 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.1 116.64 1.99 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.897 -1.144 . . . . 1.4199999999999999 111.895 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 62.6 t -129.92 130.0 66.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.638 0.256 . . . . 1.8100000000000001 110.826 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.09 126.97 5.41 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.807 -0.917 . . . . 1.3 110.807 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.6 t -118.19 120.05 63.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 117.099 0.449 . . . . 1.8300000000000001 110.954 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . 0.522 ' OD1' ' HA3' ' A' ' 12' ' ' GLY . 96.3 m-20 -119.3 129.98 55.16 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.579 -0.526 . . . . 2.3100000000000001 109.579 176.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -112.08 116.44 30.52 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.193 -0.669 . . . . 4.75 109.193 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 15.3 t -121.71 130.3 53.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.101 -0.499 . . . . 1.6699999999999999 110.382 -176.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 65.1 t80 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.245 -0.883 . . . . 3.6899999999999999 108.939 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 CA--C 1.523 -0.095 0 CA-C-O 120.799 0.333 . . . . 3.6099999999999999 110.698 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -77.56 121.57 24.08 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.598 -0.89 . . . . 3.3300000000000001 108.598 171.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.543 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 32.7 m170 -98.38 131.63 44.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.218 0.532 . . . . 3.2000000000000002 111.246 -174.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -139.65 159.91 41.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.642 -0.708 . . . . 2.4900000000000002 110.644 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.535 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 41.9 t30 -145.88 129.7 17.22 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.48 -0.563 . . . . 2.1299999999999999 109.48 172.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.4 mt -120.56 122.53 68.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.326 -0.62 . . . . 1.6000000000000001 109.326 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -130.15 137.3 9.42 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 119.85 -1.167 . . . . 0.88 112.827 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.57 136.29 54.84 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.789 -0.449 . . . . 1.0800000000000001 109.789 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 57.5 ttm -143.44 150.65 39.32 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.746 -0.464 . . . . 2.3300000000000001 109.746 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -106.69 119.99 40.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.115 -0.328 . . . . 2.6099999999999999 110.115 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 . . . . . 0 C--N 1.325 -0.497 0 CA-C-N 116.436 -0.347 . . . . 5.0899999999999999 110.209 -177.916 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 9.7 tp10 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.711 -0.477 . . . . 3.48 109.711 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 32' ' ' GLU . 26.8 Cg_exo -64.59 134.32 40.63 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.551 2.168 . . . . 1.8600000000000001 112.383 175.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 m -121.35 142.97 49.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.047 -0.524 . . . . 1.97 109.706 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.0 p -135.39 141.87 41.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.065 0.46 . . . . 1.71 110.943 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -137.85 147.61 44.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.979 -0.555 . . . . 4.0700000000000003 110.694 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -119.91 140.08 51.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.965 -0.562 . . . . 2.8599999999999999 111.238 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.535 ' HB2' ' HB3' ' A' ' 10' ' ' ASN . 28.6 m-80 -121.52 140.44 52.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.723 -0.671 . . . . 1.8899999999999999 110.095 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -137.87 140.93 40.69 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.987 -0.285 . . . . 1.0800000000000001 110.394 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.54 122.04 2.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.124 -0.489 . . . . 1.3899999999999999 110.669 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.694 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 43.4 t30 -149.95 92.12 1.86 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.23 -0.656 . . . . 2.8599999999999999 109.23 171.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.86 -78.96 0.28 Allowed Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.093 -0.803 . . . . 1.6799999999999999 111.093 -174.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.694 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 24.9 Cg_endo -61.96 175.57 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.526 2.817 . . . . 1.6599999999999999 112.94 171.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.454 ' HB3' ' O ' ' A' ' 75' ' ' HIS . 8.4 m-90 -69.41 -172.99 0.51 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.518 -0.765 . . . . 3.3999999999999999 111.15 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -106.64 122.34 46.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.779 0.8 . . . . 3.1000000000000001 111.237 -167.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 87.5 mt -111.81 136.09 49.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.417 -1.265 . . . . 1.8 109.895 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' A' ' 73' ' ' GLU . . . -117.22 132.48 56.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.087 -0.506 . . . . 0.85999999999999999 109.877 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.5 tp -119.49 131.7 55.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.059 -0.519 . . . . 1.0600000000000001 110.489 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.54 163.64 39.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.763 -0.653 . . . . 1.1399999999999999 109.537 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -157.05 150.6 24.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.644 0.259 . . . . 4.0199999999999996 110.396 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -130.04 150.02 51.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.911 -0.586 . . . . 4.6100000000000003 110.603 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -125.31 124.38 41.48 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.472 -0.785 . . . . 3.3799999999999999 109.301 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.727 -0.67 . . . . 5.0499999999999998 111.073 -175.577 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 75.8 m95 . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 120.963 0.411 . . . . 5.6100000000000003 110.85 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -120.02 140.02 51.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.839 -0.619 . . . . 3.7799999999999998 110.342 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -134.8 160.05 39.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.574 -0.739 . . . . 2.4500000000000002 109.861 -174.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 17.1 ptp180 -148.48 125.09 5.39 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.871 0.367 . . . . 3.2400000000000002 110.626 171.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.444 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 89.3 Cg_endo -93.02 153.77 2.65 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.941 2.428 . . . . 1.1899999999999999 112.313 171.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 93' ' ' ARG . 43.8 mt-10 -118.91 125.51 49.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.295 -0.411 . . . . 2.1899999999999999 110.123 175.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.412 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 64.0 tp -122.12 112.59 18.4 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.019 -0.537 . . . . 1.1399999999999999 109.981 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 80.0 mt-10 -108.5 132.72 53.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.003 0.43 . . . . 2.1800000000000002 111.28 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.42 124.59 72.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.894 -0.78 . . . . 1.5600000000000001 108.894 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' A' ' 44' ' ' TRP . 28.1 m-70 -106.32 119.1 38.36 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.84 -0.43 . . . . 3.4399999999999999 109.84 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 79.4 t80 -100.45 122.53 43.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.769 -0.65 . . . . 4.7999999999999998 110.35 -176.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -109.21 128.68 55.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.592 -0.731 . . . . 2.9399999999999999 109.693 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -143.37 129.95 20.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.069 -0.252 . . . . 3.8999999999999999 111.224 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 N--CA 1.465 0.309 0 CA-C-N 115.606 -0.724 . . . . 4.4800000000000004 111.703 177.67 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 120.878 0.37 . . . . 2.5499999999999998 110.747 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -123.06 148.33 45.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.056 -0.52 . . . . 5.2999999999999998 110.292 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.94 163.8 28.28 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.548 -0.834 . . . . 1.3500000000000001 111.959 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.502 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 65.1 tp -145.61 128.6 16.5 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.472 -0.566 . . . . 2.29 109.472 174.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 p -118.31 128.53 54.75 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.308 0.575 . . . . 1.54 110.9 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.84 132.63 8.48 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.571 -0.823 . . . . 1.1699999999999999 111.319 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -128.14 127.42 5.71 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 111.497 -0.641 . . . . 1.1899999999999999 111.497 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -111.09 130.28 55.66 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.888 0.375 . . . . 3.75 110.483 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.516 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 91.0 mtt180 -122.95 126.88 48.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.615 -0.72 . . . . 2.75 109.12 175.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 64.9 t30 -107.33 129.94 54.84 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.337 -0.616 . . . . 1.8200000000000001 109.337 -178.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.424 ' HB3' ' HB3' ' A' ' 110' ' ' MET . 54.5 t80 -137.05 146.05 44.74 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.416 -0.514 . . . . 3.1400000000000001 110.576 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.517 0 C-N-CA 120.622 -0.799 . . . . 2.79 112.495 177.7 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 109.591 -0.522 . . . . 3.2999999999999998 109.591 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.39 116.38 7.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.667 -0.242 . . . . 1.76 110.589 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -117.67 130.54 56.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.443 -0.344 . . . . 2.5499999999999998 110.085 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.611 ' HG3' ' H ' ' A' ' 139' ' ' ALA . 46.3 ttm -132.56 122.34 24.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.831 0.348 . . . . 1.77 111.624 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.517 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 56.7 mt-30 -103.54 118.71 37.35 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.036 -0.727 . . . . 1.97 109.036 170.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 31.4 ttm180 -113.77 120.73 41.8 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.124 0.488 . . . . 3.8500000000000001 110.168 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -119.14 139.62 51.5 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.728 -0.669 . . . . 2.2799999999999998 110.409 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 135' ' ' MET . 82.0 tttt -128.84 123.68 33.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.717 -0.674 . . . . 2.1400000000000001 109.559 172.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.9 mm -124.21 128.15 73.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.016 -0.538 . . . . 1.55 109.698 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -142.71 106.47 5.42 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 120.681 0.277 . . . . 1.1899999999999999 111.493 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.63 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 65.2 Cg_endo -76.8 132.53 13.16 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.977 1.784 . . . . 1.3700000000000001 110.467 172.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -92.38 137.31 32.47 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.538 -0.541 . . . . 2.3500000000000001 109.538 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -128.44 129.99 46.94 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.862 -0.422 . . . . 4.54 109.862 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -137.49 119.76 15.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.843 0.354 . . . . 3.04 110.481 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.9 t -129.56 128.28 65.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.732 -0.667 . . . . 4.2699999999999996 109.659 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -114.99 96.86 5.91 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.789 -0.448 . . . . 6.04 109.789 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.99 -33.24 71.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.557 0.694 . . . . 4.5899999999999999 109.683 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.459 ' HB ' ' H ' ' A' ' 127' ' ' LEU . 8.6 m -140.35 159.88 41.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.18 -0.918 . . . . 3.6899999999999999 108.75 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -60.14 -41.99 93.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.503 0.668 . . . . 5.1699999999999999 109.361 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -69.92 -40.03 75.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.763 -1.108 . . . . 3.71 111.946 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.459 ' H ' ' HB ' ' A' ' 124' ' ' THR . 84.9 mt -104.94 119.43 39.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 2.0499999999999998 110.814 -172.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.489 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 79.4 ttt180 -125.71 133.31 52.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.119 -0.491 . . . . 4.2400000000000002 111.453 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -108.98 119.99 41.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 3.5499999999999998 109.332 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -143.81 135.79 26.5 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.802 -0.444 . . . . 2.1099999999999999 109.802 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -171.8 172.13 44.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.445 -0.883 . . . . 1.1799999999999999 111.689 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -143.0 150.57 39.82 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.991 0.424 . . . . 4.2999999999999998 110.691 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.63 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 47.8 tp -106.0 111.61 24.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.933 -0.576 . . . . 2.2400000000000002 109.511 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.5 t -101.56 121.1 41.37 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.864 0.364 . . . . 1.6899999999999999 110.631 -173.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.423 ' O ' ' HA ' ' A' ' 114' ' ' LYS . 74.8 mtm -111.83 133.24 54.17 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.345 -0.389 . . . . 2.2400000000000002 110.08 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -118.98 134.88 54.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.95 0.405 . . . . 3.5600000000000001 111.411 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 97.3 mttt -138.55 148.35 44.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.078 -0.712 . . . . 1.6699999999999999 109.078 174.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.501 ' H ' HD22 ' A' ' 142' ' ' LEU . 54.8 p90 -150.83 160.02 44.15 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.974 -0.38 . . . . 3.23 109.974 175.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.611 ' H ' ' HG3' ' A' ' 110' ' ' MET . . . 72.16 -178.69 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.876 0.735 . . . . 1.24 110.334 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -76.82 -39.67 50.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.963 0.411 . . . . 2.4700000000000002 111.279 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.0 -49.61 77.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.715 -0.675 . . . . 2.4100000000000001 112.532 -171.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.501 HD22 ' H ' ' A' ' 138' ' ' PHE . 9.5 mp -62.59 -36.35 82.45 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.137 0.494 . . . . 1.8300000000000001 111.129 -177.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.517 ' ND2' ' HB2' ' A' ' 111' ' ' GLN . 94.0 m-20 -66.13 -39.93 90.26 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.24 0.543 . . . . 2.0 110.388 175.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 90.9 m -66.75 -42.25 86.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.367 -0.833 . . . . 2.0499999999999998 111.061 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 148' ' ' ALA . 33.9 p -72.72 -28.89 62.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.251 0.548 . . . . 1.5900000000000001 110.6 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.05 -118.05 7.84 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.531 -0.759 . . . . 1.52 113.041 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -70.11 -20.05 63.21 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.553 0.205 . . . . 5.9400000000000004 111.553 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.455 ' HB3' ' HB ' ' A' ' 145' ' ' THR . . . -66.25 -57.32 7.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.462 -0.336 . . . . 1.8300000000000001 111.851 -175.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -117.16 83.84 2.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.461 0.648 . . . . 2.6400000000000001 110.945 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.1 t -145.74 142.44 28.94 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.433 -0.803 . . . . 2.02 109.502 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.411 ' HB3' ' OE2' ' A' ' 153' ' ' GLU . 15.1 mtp180 -76.59 131.97 39.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.872 0.368 . . . . 3.6699999999999999 110.626 176.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.09 115.85 49.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.744 -0.662 . . . . 1.6399999999999999 109.499 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.411 ' OE2' ' HB3' ' A' ' 151' ' ' ARG . 17.8 mm-40 -113.03 129.1 56.62 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.08 -0.711 . . . . 2.5600000000000001 109.08 -177.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 174' ' ' LEU . 21.4 m -113.34 120.03 39.72 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 121.07 -0.252 . . . . 1.3899999999999999 110.745 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -116.45 122.13 43.88 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.741 -0.466 . . . . 2.04 109.741 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 55.3 m -119.58 128.22 53.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.182 -0.463 . . . . 1.5600000000000001 110.544 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -115.33 128.47 8.09 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.968 -0.56 . . . . 1.04 111.868 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 79.6 mt -118.27 134.66 54.84 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.634 -0.506 . . . . 2.27 109.634 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 63.1 tt0 -115.07 125.85 54.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.941 -0.392 . . . . 2.4100000000000001 109.941 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -130.3 133.79 46.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.252 -0.431 . . . . 4.5700000000000003 110.255 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.0 p -90.73 87.65 6.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.178 0.513 . . . . 1.46 109.617 171.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -60.33 -49.57 77.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.702 -0.681 . . . . 2.6299999999999999 111.367 -173.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.496 ' HB2' HG22 ' A' ' 166' ' ' VAL . 22.8 m120 -101.84 17.1 23.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.457 -0.338 . . . . 2.4100000000000001 110.499 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 72.4 -53.87 0.69 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 123.908 0.755 . . . . 2.5800000000000001 111.415 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.7 p -75.05 -15.96 60.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.348 -0.387 . . . . 2.2999999999999998 111.94 -176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.496 HG22 ' HB2' ' A' ' 163' ' ' ASN . 33.2 m -125.53 140.4 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.559 -0.291 . . . . 1.71 110.481 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.26 128.35 53.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.951 0.405 . . . . 1.47 110.48 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 22.1 mt -105.61 137.16 43.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.901 -0.591 . . . . 1.6599999999999999 109.476 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -110.64 116.12 30.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.961 0.41 . . . . 3.2999999999999998 110.264 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 63.0 t -124.01 129.87 74.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.886 -0.412 . . . . 1.3 109.886 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.411 ' OD1' ' HB2' ' A' ' 195' ' ' ARG . 25.9 p30 -134.09 156.09 48.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.875 0.369 . . . . 2.2200000000000002 110.969 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -145.34 150.02 35.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.183 -0.462 . . . . 4.6100000000000003 111.017 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -105.2 126.38 52.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.725 -0.671 . . . . 3.98 111.615 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.449 ' HB2' ' HB ' ' A' ' 154' ' ' THR . 93.3 mt -113.62 130.48 56.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.784 -0.644 . . . . 2.3799999999999999 110.151 175.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -100.39 128.87 46.35 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.272 -0.64 . . . . 3.3100000000000001 109.272 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 . . . . . 0 C--N 1.326 -0.437 0 CA-C-O 120.807 0.337 . . . . 6.5300000000000002 110.562 -179.297 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 121.251 0.548 . . . . 4.4000000000000004 110.892 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 82.2 mt -120.05 129.99 74.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.61 -0.723 . . . . 2.21 109.493 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.411 ' HB2' ' OD1' ' A' ' 171' ' ' ASN . 85.1 mtm180 -96.3 115.05 26.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.778 0.323 . . . . 3.54 110.6 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -108.39 124.02 49.73 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.599 -0.519 . . . . 1.6699999999999999 109.599 174.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -147.53 151.93 37.15 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.75 0.31 . . . . 5.8300000000000001 110.612 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 209' ' ' PRO . 1.8 pt? -129.66 128.37 23.03 Favored Pre-proline 0 C--N 1.321 -0.668 0 C-N-CA 120.98 -0.288 . . . . 2.5899999999999999 110.538 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.16 105.99 2.14 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.4 2.067 . . . . 1.77 111.427 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 56.9 tp -99.18 120.07 38.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.794 -0.639 . . . . 2.2599999999999998 109.512 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 19.6 p -99.95 123.93 44.73 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.943 0.401 . . . . 1.99 111.37 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 62.8 tp -130.29 81.84 2.03 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.032 -0.729 . . . . 2.3100000000000001 109.032 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 70.03 -125.2 15.29 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.409 -0.814 . . . . 1.51 112.283 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -86.82 -0.3 56.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.253 0.549 . . . . 2.5699999999999998 110.051 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -103.0 117.44 34.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.74 -0.664 . . . . 2.6600000000000001 110.112 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 63.3 m -107.9 123.75 49.08 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.779 -0.452 . . . . 1.6200000000000001 109.779 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 50.6 t -119.3 129.97 74.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 1.3799999999999999 109.854 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 25.3 m -126.62 91.29 47.73 Favored Pre-proline 0 C--N 1.318 -0.769 0 C-N-CA 120.965 -0.294 . . . . 1.1799999999999999 110.722 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 38.4 Cg_endo -70.8 146.33 53.49 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.128 1.885 . . . . 1.01 111.694 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -112.41 139.62 47.83 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.847 0.356 . . . . 4.5 110.344 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 21.1 p -134.58 125.25 26.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.762 -0.653 . . . . 1.8899999999999999 110.731 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -70.12 -36.12 74.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.255 -0.884 . . . . 4.7999999999999998 109.942 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 86.3 mt . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.399 -0.819 . . . . 4.5700000000000003 109.451 176.396 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.994 0.426 . . . . 2.3999999999999999 111.061 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -92.3 146.19 18.06 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.898 -0.668 . . . . 1.27 111.999 -177.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 89.3 mt -119.47 131.3 55.58 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.306 0.574 . . . . 1.97 111.129 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.416 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 61.9 t80 -108.75 130.16 55.37 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.413 -0.812 . . . . 3.54 109.767 173.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.51 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 96.1 m-85 -119.67 140.05 51.26 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.498 -0.927 . . . . 2.6400000000000001 108.498 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.44 167.05 33.42 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.64 -1.267 . . . . 1.3500000000000001 112.945 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -121.5 112.24 18.26 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.695 -0.483 . . . . 4.3600000000000003 109.695 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -120.87 13.88 11.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.242 0.544 . . . . 4.29 109.815 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.96 -40.33 88.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.356 -0.838 . . . . 6.6900000000000004 110.391 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -102.88 135.85 43.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.629 -0.714 . . . . 6.3700000000000001 109.747 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -70.01 -19.08 63.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 5.8300000000000001 111.535 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -96.66 2.81 62.66 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.704 -0.76 . . . . 2.6600000000000001 112.718 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 62.8 tp -131.2 129.94 42.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.818 0.342 . . . . 2.9700000000000002 110.648 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 48.9 m -134.94 130.4 35.78 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.399 -0.593 . . . . 2.1699999999999999 109.399 173.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.5 t -130.02 133.1 64.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 120.837 -0.345 . . . . 1.79 110.906 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 11.1 p -115.92 109.99 18.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.119 0.485 . . . . 1.6299999999999999 110.857 176.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 79.3 mt -105.54 120.06 40.69 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.049 -0.723 . . . . 2.96 109.049 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -113.64 112.83 24.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.548 -0.296 . . . . 4.0800000000000001 111.173 -172.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -127.15 110.08 12.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.039 -0.528 . . . . 4.8399999999999999 109.76 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.547 0 CA-C-O 120.832 0.349 . . . . 3.5800000000000001 111.619 179.083 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 110.178 -0.305 . . . . 1.9399999999999999 110.178 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -157.69 167.15 34.09 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.32 -0.943 . . . . 1.4199999999999999 112.399 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.452 HG12 HD22 ' A' ' 253' ' ' LEU . 34.7 m -128.9 140.01 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.94 0.4 . . . . 1.8100000000000001 111.133 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.92 140.01 11.41 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.321 -0.712 . . . . 1.3 111.321 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.4 t -128.01 129.94 69.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.908 0.354 . . . . 1.8300000000000001 110.884 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -126.42 130.56 50.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.026 -0.534 . . . . 2.3100000000000001 111.004 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -113.55 129.19 56.6 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.423 -0.584 . . . . 4.75 109.423 172.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 50.8 m -120.84 141.25 50.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.319 -0.4 . . . . 1.6699999999999999 110.485 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 91.0 m-85 . . . . . 0 C--O 1.247 0.96 0 CA-C-O 117.785 -1.103 . . . . 3.6899999999999999 109.584 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 . . . . . 0 CA--C 1.518 -0.267 0 CA-C-O 121.187 0.518 . . . . 3.6099999999999999 110.009 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.452 ' HA ' ' HB2' ' A' ' 41' ' ' ASN . 44.6 m95 -62.72 139.98 58.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.291 -0.868 . . . . 3.3300000000000001 111.471 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.35 135.64 36.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.125 -0.489 . . . . 3.2000000000000002 110.0 175.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.92 139.94 51.65 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.854 -0.612 . . . . 2.4900000000000002 110.683 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -126.64 129.83 49.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.276 -0.42 . . . . 2.1299999999999999 110.468 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.6 mt -121.0 120.09 61.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.058 -0.719 . . . . 1.6000000000000001 109.058 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.3 129.36 9.44 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.23 -0.986 . . . . 0.88 111.475 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.1 134.83 54.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.162 0.506 . . . . 1.0800000000000001 110.636 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 68.0 mtt -126.63 141.38 51.87 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.566 -0.743 . . . . 2.3300000000000001 109.492 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -119.32 127.93 53.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.619 -0.264 . . . . 2.6099999999999999 110.586 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 . . . . . 0 C--N 1.329 -0.302 0 O-C-N 123.804 0.69 . . . . 5.0899999999999999 111.26 172.431 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 C--O 1.236 0.348 0 CA-C-O 120.604 0.24 . . . . 3.48 110.559 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.2 135.87 15.6 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.883 2.389 . . . . 1.8600000000000001 111.211 170.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.1 t -140.45 149.88 43.12 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 121.097 -0.241 . . . . 1.97 110.848 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.2 m -126.56 139.93 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 1.71 110.824 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -119.75 147.04 45.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.989 -0.551 . . . . 4.0700000000000003 110.105 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -119.29 139.36 52.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.792 0.33 . . . . 2.8599999999999999 111.103 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -150.16 142.45 24.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.967 -0.56 . . . . 1.8899999999999999 110.266 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -148.29 143.73 27.13 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.959 -0.109 . . . . 1.0800000000000001 110.993 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.56 135.14 7.45 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.972 0.36 . . . . 1.3899999999999999 111.972 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.61 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 41.4 t30 -168.85 94.64 0.34 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.88 -0.6 . . . . 2.8599999999999999 110.096 170.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.85 -91.75 1.5 Allowed Glycine 0 CA--C 1.517 0.184 0 C-N-CA 120.901 -0.666 . . . . 1.6799999999999999 111.709 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 72.9 Cg_exo -50.44 176.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.608 2.872 . . . . 1.6599999999999999 113.456 169.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -67.1 170.8 6.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.621 -0.718 . . . . 3.3999999999999999 111.289 -171.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -113.11 130.03 56.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.8 -0.636 . . . . 3.1000000000000001 110.511 -173.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.5 tt -116.58 131.47 69.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.384 -0.825 . . . . 1.8 110.492 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -118.38 128.6 54.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.002 -0.544 . . . . 0.85999999999999999 110.697 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.8 tp -103.65 126.59 50.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.951 -0.568 . . . . 1.0600000000000001 110.242 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.0 168.39 19.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.098 0.475 . . . . 1.1399999999999999 110.928 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -164.31 160.01 20.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.867 -0.606 . . . . 4.0199999999999996 110.109 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.551 ' HB3' ' CG ' ' A' ' 69' ' ' ARG . 61.8 t80 -130.33 129.77 43.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.87 -0.419 . . . . 4.6100000000000003 109.87 177.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -130.85 159.74 36.49 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.972 -0.558 . . . . 3.3799999999999999 110.601 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 115.302 -0.863 . . . . 5.0499999999999998 109.174 176.719 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 95.2 m95 . . . . . 0 CA--C 1.517 -0.314 0 N-CA-C 110.095 -0.335 . . . . 5.6100000000000003 110.095 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -116.69 140.04 49.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.243 0.544 . . . . 3.7799999999999998 110.464 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -139.72 170.42 15.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.533 -0.758 . . . . 2.4500000000000002 109.373 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.551 ' CG ' ' HB3' ' A' ' 51' ' ' TYR . 3.2 ptp180 -129.98 125.95 22.23 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 120.419 -0.512 . . . . 3.2400000000000002 111.161 175.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.4 140.03 5.24 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.918 2.412 . . . . 1.1899999999999999 110.835 167.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.486 ' CD ' ' HE ' ' A' ' 93' ' ' ARG . 76.7 mt-10 -126.87 130.0 49.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.738 -0.468 . . . . 2.1899999999999999 109.738 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 47' ' ' ALA . 57.8 tp -133.54 120.85 21.3 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.562 -0.29 . . . . 1.1399999999999999 110.339 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -119.49 130.02 55.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.994 0.426 . . . . 2.1800000000000002 110.267 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 89' ' ' THR . 62.1 t -120.0 129.52 75.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.931 -0.577 . . . . 1.5600000000000001 110.062 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -113.99 122.26 46.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.155 -0.475 . . . . 3.4399999999999999 111.169 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -108.38 146.22 33.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.642 -0.708 . . . . 4.7999999999999998 109.705 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -117.14 137.39 52.35 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.029 -0.36 . . . . 2.9399999999999999 110.029 173.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.617 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 93.2 m-85 -134.87 91.01 2.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.208 -0.451 . . . . 3.8999999999999999 110.422 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 78' ' ' PHE . 10.0 mt . . . . . 0 N--CA 1.471 0.591 0 C-N-CA 124.786 1.234 . . . . 4.4800000000000004 109.354 171.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 121.0 0.428 . . . . 2.5499999999999998 111.574 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -110.17 150.18 29.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.614 -0.884 . . . . 5.2999999999999998 108.614 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -150.14 169.69 30.17 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.724 -1.227 . . . . 1.3500000000000001 112.818 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 97.4 mt -131.43 122.47 26.32 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.405 -0.591 . . . . 2.29 109.405 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 92.9 m -120.11 129.98 54.42 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.001 0.429 . . . . 1.54 110.254 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -121.67 133.57 9.52 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.771 -0.728 . . . . 1.1699999999999999 111.484 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.58 130.66 8.76 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.655 -0.783 . . . . 1.1899999999999999 112.462 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 68.3 m-85 -112.01 127.24 55.82 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.768 -0.456 . . . . 3.75 109.768 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.486 ' HE ' ' CD ' ' A' ' 71' ' ' GLU . 40.1 ttm180 -142.71 124.87 15.38 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.561 -0.163 . . . . 2.75 110.561 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.507 ' OD1' ' HA ' ' A' ' 111' ' ' GLN . 93.5 m-20 -132.65 129.83 39.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.293 -0.262 . . . . 1.8200000000000001 110.293 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -126.69 135.39 51.08 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.306 -0.627 . . . . 3.1400000000000001 109.306 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.439 0 C-N-CA 120.745 -0.74 . . . . 2.79 112.414 -178.364 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.5 p . . . . . 0 N--CA 1.447 -0.602 0 CA-C-O 120.951 0.405 . . . . 3.2999999999999998 110.514 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.16 160.94 33.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.793 -0.639 . . . . 1.76 109.775 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -120.12 129.99 54.42 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.572 -0.529 . . . . 2.5499999999999998 109.572 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 89.0 mtp -104.52 129.44 52.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.742 0.306 . . . . 1.77 110.413 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.507 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 99.5 mt-30 -95.66 123.14 39.08 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.823 -0.626 . . . . 1.97 111.047 -176.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 85.7 mtt180 -116.29 114.3 24.17 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.659 -0.497 . . . . 3.8500000000000001 109.659 173.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.457 ' NE1' ' HB3' ' A' ' 111' ' ' GLN . 83.8 m95 -107.44 136.88 46.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.68 -0.691 . . . . 2.2799999999999998 110.86 -173.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -120.53 123.36 42.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.823 -0.626 . . . . 2.1400000000000001 110.196 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 134' ' ' SER . 88.2 mt -120.07 120.35 62.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.077 -0.712 . . . . 1.55 109.077 174.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -145.76 108.05 4.36 Favored Pre-proline 0 C--N 1.325 -0.488 0 C-N-CA 120.723 -0.391 . . . . 1.1899999999999999 111.814 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.675 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 69.3 Cg_endo -77.64 139.93 18.4 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.067 1.845 . . . . 1.3700000000000001 110.185 171.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.88 137.44 32.36 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.229 -0.442 . . . . 2.3500000000000001 110.045 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -127.16 127.54 44.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.302 -0.408 . . . . 4.54 109.968 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -126.82 109.59 12.16 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.347 -0.612 . . . . 3.04 109.347 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.7 t -120.58 117.62 53.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.128 -0.487 . . . . 4.2699999999999996 110.321 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -117.34 96.09 5.26 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.651 -0.499 . . . . 6.04 109.651 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.42 -39.95 85.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.647 -0.706 . . . . 4.5899999999999999 110.694 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.1 t -149.71 170.0 19.74 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.381 -0.827 . . . . 3.6899999999999999 108.865 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.98 -39.24 85.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.404 0.621 . . . . 5.1699999999999999 110.046 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.15 -31.11 68.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.627 -1.169 . . . . 3.71 111.57 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 159' ' ' GLN . 85.0 mt -119.98 119.79 34.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 2.0499999999999998 112.061 -171.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.478 ' HB2' ' HB3' ' A' ' 159' ' ' GLN . 89.8 mtt180 -111.6 109.61 19.6 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.855 -0.794 . . . . 4.2400000000000002 108.855 170.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.41 ' C ' HD22 ' A' ' 130' ' ' ASN . 65.5 t80 -109.43 122.4 47.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.187 0.518 . . . . 3.5499999999999998 111.037 -177.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.41 HD22 ' C ' ' A' ' 129' ' ' PHE . 0.9 OUTLIER -125.12 139.91 53.35 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.764 -0.653 . . . . 2.1099999999999999 109.522 173.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -147.65 133.6 4.77 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.576 -0.821 . . . . 1.1799999999999999 111.573 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 29.3 m-90 -120.03 127.61 52.75 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.936 0.398 . . . . 4.2999999999999998 111.062 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.675 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 58.2 tp -101.3 118.57 37.24 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.438 -0.949 . . . . 2.2400000000000002 108.438 173.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 42.9 m -120.49 130.01 54.1 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.036 0.446 . . . . 1.6899999999999999 111.177 -175.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.649 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 76.5 mtm -106.3 130.24 54.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.595 -0.729 . . . . 2.2400000000000002 109.394 173.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -120.07 139.9 51.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.35 -0.386 . . . . 3.5600000000000001 111.346 -175.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 96.7 mttt -129.55 160.04 34.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.71 -0.677 . . . . 1.6699999999999999 109.271 174.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.462 ' H ' HD22 ' A' ' 142' ' ' LEU . 53.0 p90 -143.96 160.07 41.47 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.487 -0.56 . . . . 3.23 109.487 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 63.56 -178.57 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.893 0.746 . . . . 1.24 111.504 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -74.99 -39.93 60.98 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.117 0.484 . . . . 2.4700000000000002 111.343 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -59.98 -41.93 93.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.529 -0.759 . . . . 2.4100000000000001 113.034 -168.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.462 HD22 ' H ' ' A' ' 138' ' ' PHE . 9.4 mp -69.98 -30.13 67.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.878 0.37 . . . . 1.8300000000000001 111.352 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -70.03 -40.07 75.4 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.805 -0.358 . . . . 2.0 110.101 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 33.7 p -73.48 -31.15 63.6 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.569 0.581 . . . . 2.0499999999999998 112.569 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 35.1 p -79.46 -10.03 59.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.898 0.38 . . . . 1.5900000000000001 111.412 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 91.14 -137.06 13.66 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.689 -0.767 . . . . 1.52 112.449 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -89.93 -1.27 57.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.842 0.353 . . . . 5.9400000000000004 110.379 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.56 -47.7 82.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.934 -0.576 . . . . 1.8300000000000001 111.153 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -108.43 81.96 1.55 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.073 0.463 . . . . 2.6400000000000001 110.477 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.5 t -149.5 150.01 31.64 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.2 -0.455 . . . . 2.02 109.996 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 135' ' ' MET . 42.8 mtt180 -80.84 134.89 35.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.355 -0.384 . . . . 3.6699999999999999 110.309 174.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.83 102.85 14.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.055 -0.72 . . . . 1.6399999999999999 109.055 173.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.596 ' OE1' ' HD3' ' A' ' 151' ' ' ARG . 83.9 mt-10 -124.74 141.51 52.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.112 -0.495 . . . . 2.5600000000000001 110.248 -174.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 174' ' ' LEU . 21.8 m -130.08 139.91 50.89 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 121.014 -0.274 . . . . 1.3899999999999999 110.844 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -119.85 131.44 55.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.18 -0.674 . . . . 2.04 109.18 171.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.2 p -117.82 121.12 39.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.224 -0.444 . . . . 1.5600000000000001 110.906 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -113.38 120.1 5.05 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.123 -0.791 . . . . 1.04 111.123 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 68.8 tp -123.5 129.44 51.23 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.966 0.412 . . . . 2.27 110.941 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 128' ' ' ARG . 53.4 tt0 -102.87 118.37 36.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.718 -0.845 . . . . 2.4100000000000001 108.718 171.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -122.26 137.52 54.81 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.915 0.388 . . . . 4.5700000000000003 110.039 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . 1.6 m -98.26 89.22 4.4 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.33 0.586 . . . . 1.46 109.835 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -67.58 -48.75 65.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.377 -0.828 . . . . 2.6299999999999999 112.218 -171.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.477 ' HB2' HG22 ' A' ' 166' ' ' VAL . 93.6 m-20 -99.9 8.98 43.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.424 -0.353 . . . . 2.4100000000000001 110.98 -175.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 73.6 -39.71 0.44 Allowed 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.865 0.728 . . . . 2.5800000000000001 110.727 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.4 p -75.32 -40.13 58.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.194 -0.457 . . . . 2.2999999999999998 111.235 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.477 HG22 ' HB2' ' A' ' 163' ' ' ASN . 31.3 m -120.17 144.48 28.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.115 0.483 . . . . 1.71 111.536 -175.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 161' ' ' THR . . . -119.98 139.47 52.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.463 -0.789 . . . . 1.47 110.591 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 159' ' ' GLN . 3.1 mm? -108.49 130.49 55.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.828 -0.624 . . . . 1.6599999999999999 109.648 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -101.77 113.0 25.79 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.598 -0.519 . . . . 3.2999999999999998 109.598 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 195' ' ' ARG . 63.1 t -120.13 129.8 75.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.338 -0.392 . . . . 1.3 111.257 -177.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -110.88 126.36 54.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.906 -0.588 . . . . 2.2200000000000002 110.065 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -119.2 140.06 50.83 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.813 -0.631 . . . . 4.6100000000000003 109.941 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -97.52 137.0 37.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.057 0.456 . . . . 3.98 111.032 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.494 ' HB2' ' HB ' ' A' ' 154' ' ' THR . 3.4 mm? -106.73 120.02 40.86 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.131 -0.692 . . . . 2.3799999999999999 109.131 173.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.61 -42.55 97.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.603 -0.726 . . . . 3.3100000000000001 110.352 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 . . . . . 0 N--CA 1.446 -0.645 0 CA-C-N 115.136 -0.938 . . . . 6.5300000000000002 110.453 -178.566 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 C--O 1.234 0.277 0 CA-C-O 121.374 0.607 . . . . 4.4000000000000004 111.902 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 85.8 mt -119.98 120.54 63.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.226 -0.897 . . . . 2.21 109.831 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 72.3 mtm180 -102.86 120.15 40.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.752 -0.204 . . . . 3.54 110.745 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -117.26 128.7 55.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.657 0.265 . . . . 1.6699999999999999 110.498 175.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -150.05 159.95 44.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.152 -0.476 . . . . 5.8300000000000001 110.078 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.417 HD23 ' N ' ' A' ' 198' ' ' LEU . 1.8 pt? -147.05 128.5 7.3 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 110.233 -0.284 . . . . 2.5899999999999999 110.233 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.84 106.72 2.18 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.393 2.062 . . . . 1.77 111.89 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 62.6 tp -112.46 140.06 47.51 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.175 -0.676 . . . . 2.2599999999999998 109.175 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 28.6 p -119.97 140.43 50.94 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.466 -0.494 . . . . 1.99 111.658 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 58.9 tp -130.0 81.71 2.03 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.825 -0.806 . . . . 2.3100000000000001 108.825 176.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 75.72 -120.01 5.9 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.512 -0.767 . . . . 1.51 112.3 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -96.72 0.0 48.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.238 0.542 . . . . 2.5699999999999998 110.324 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -111.24 140.28 45.94 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.768 -0.651 . . . . 2.6600000000000001 109.367 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 19.6 p -114.77 151.74 33.26 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.528 -0.305 . . . . 1.6200000000000001 110.731 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 5.3 p -138.78 130.15 35.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.999 0.428 . . . . 1.3799999999999999 110.67 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 56.9 m -122.3 96.72 45.94 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 120.932 0.396 . . . . 1.1799999999999999 110.518 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -60.54 148.11 92.18 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.972 2.448 . . . . 1.01 112.62 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -119.9 139.95 51.62 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.357 -0.608 . . . . 4.5 109.357 174.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 14.0 t -159.41 173.59 16.0 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.591 -0.522 . . . . 1.8899999999999999 109.591 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 212' ' ' ARG . 50.9 mtt180 -126.71 129.57 48.67 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.884 -0.413 . . . . 4.7999999999999998 109.884 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 16.0 tt . . . . . 0 C--N 1.323 -0.571 0 CA-C-N 116.133 -0.485 . . . . 4.5700000000000003 110.355 -177.722 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 63.4 t . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 108.686 -0.857 . . . . 2.3999999999999999 108.686 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -150.25 166.45 30.05 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.005 -1.093 . . . . 1.27 112.098 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.4 mt -134.33 129.13 35.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.921 0.391 . . . . 1.97 110.749 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.496 ' HE2' ' OG ' ' A' ' 252' ' ' SER . 61.2 t80 -108.07 131.95 54.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.938 -0.574 . . . . 3.54 110.234 174.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -119.97 134.01 55.38 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.973 -0.38 . . . . 2.6400000000000001 109.973 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -110.13 121.76 6.09 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.754 -0.736 . . . . 1.3500000000000001 111.749 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' TYR . . . . . 0.441 ' CD1' HD12 ' A' ' 253' ' ' LEU . 91.9 m-85 -121.62 112.13 18.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.821 0.344 . . . . 4.3600000000000003 110.559 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -99.07 97.91 8.99 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.798 -0.445 . . . . 4.29 109.798 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -69.97 -37.0 75.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.015 -0.539 . . . . 6.6900000000000004 111.986 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 96.0 mt-30 -137.31 170.54 15.91 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.861 -0.422 . . . . 6.3700000000000001 109.861 -175.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -59.91 -40.17 87.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.159 0.504 . . . . 5.8300000000000001 111.003 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.19 10.9 51.44 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.742 -0.742 . . . . 2.6600000000000001 113.014 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 246' ' ' GLN . 58.5 tp -122.46 115.19 21.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.021 0.411 . . . . 2.9700000000000002 111.499 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 50.0 m -120.24 130.44 54.51 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.695 -0.684 . . . . 2.1699999999999999 109.814 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 99.2 t -113.26 132.14 62.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.189 0.519 . . . . 1.79 110.351 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . 0.496 ' OG ' ' HE2' ' A' ' 240' ' ' PHE . 42.5 t -101.33 118.77 37.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.242 -0.89 . . . . 1.6299999999999999 110.196 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.441 HD12 ' CD1' ' A' ' 243' ' ' TYR . 84.2 mt -119.6 100.96 7.59 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.0 -0.37 . . . . 2.96 110.0 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -109.5 130.04 55.53 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.034 -0.358 . . . . 4.0800000000000001 110.034 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.0 129.04 56.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.312 -0.404 . . . . 4.8399999999999999 110.405 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 3.5800000000000001 110.852 -179.398 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.833 0.349 . . . . 1.9399999999999999 111.182 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.66 131.54 6.23 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.588 -1.005 . . . . 1.4199999999999999 110.588 174.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.03 128.51 75.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.116 0.484 . . . . 1.8100000000000001 111.207 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -132.75 138.33 10.06 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.337 -0.705 . . . . 1.3 111.337 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.0 t -116.36 120.69 65.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.618 -0.512 . . . . 1.8300000000000001 109.618 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -116.21 129.94 56.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.139 0.495 . . . . 2.3100000000000001 111.069 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.44 ' CE2' HD13 ' A' ' 249' ' ' LEU . 97.8 m-85 -109.35 111.58 23.23 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.548 -0.908 . . . . 4.75 108.548 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.9 t -132.0 139.97 48.78 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.517 -0.473 . . . . 1.6699999999999999 110.683 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 57.5 t80 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.085 -0.959 . . . . 3.6899999999999999 108.784 178.825 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 109.12 -0.696 . . . . 3.6099999999999999 109.12 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 41' ' ' ASN . 82.9 m95 -69.88 119.83 14.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.956 0.408 . . . . 3.3300000000000001 111.549 -173.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -100.99 125.05 47.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.806 -0.634 . . . . 3.2000000000000002 109.661 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -114.92 139.68 49.6 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.26 -0.427 . . . . 2.4900000000000002 110.0 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -126.48 130.5 50.75 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.386 -0.598 . . . . 2.1299999999999999 109.386 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.1 mt -127.89 129.97 69.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.273 -0.421 . . . . 1.6000000000000001 110.681 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.29 140.0 11.46 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.173 -0.771 . . . . 0.88 111.173 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.4 135.58 54.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.014 0.407 . . . . 1.0800000000000001 110.947 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 96.6 mmm -130.1 157.09 43.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.496 -0.774 . . . . 2.3300000000000001 109.702 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -114.56 142.22 46.71 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.436 0.636 . . . . 2.6099999999999999 110.374 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 114.697 -1.138 . . . . 5.0899999999999999 111.754 -175.015 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 110.012 -0.366 . . . . 3.48 110.012 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.73 142.09 47.12 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.153 1.902 . . . . 1.8600000000000001 111.58 173.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.3 t -119.97 143.49 47.99 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.618 -0.512 . . . . 1.97 109.618 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.34 133.73 61.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.392 0.615 . . . . 1.71 111.453 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -111.64 126.2 54.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.275 -0.875 . . . . 4.0700000000000003 108.711 174.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -133.51 130.08 38.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.568 0.223 . . . . 2.8599999999999999 111.212 -174.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 9.9 p30 -145.59 156.48 43.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.513 -0.312 . . . . 1.8899999999999999 110.584 173.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 45' ' ' ARG . . . -137.01 143.94 43.01 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.966 -0.561 . . . . 1.0800000000000001 110.678 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.98 136.2 33.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.832 -0.622 . . . . 1.3899999999999999 110.766 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.613 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 40.8 t30 -165.95 95.37 0.59 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.023 -0.535 . . . . 2.8599999999999999 109.708 176.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.57 -98.62 1.41 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.051 -0.595 . . . . 1.6799999999999999 111.818 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 85.7 Cg_exo -45.12 175.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 124.12 3.213 . . . . 1.6599999999999999 114.078 168.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.561 ' HB2' ' O ' ' A' ' 75' ' ' HIS . 41.3 p90 -68.46 171.93 6.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.152 -0.931 . . . . 3.3999999999999999 112.054 -169.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 39' ' ' ALA . 57.7 ttp180 -113.1 133.32 55.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.839 -0.618 . . . . 3.1000000000000001 111.117 -168.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.2 mt -119.66 129.97 74.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.224 -0.898 . . . . 1.8 110.387 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . . . -118.09 144.42 45.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.012 -0.54 . . . . 0.85999999999999999 111.169 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.0 tp -133.41 134.91 44.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.248 -0.433 . . . . 1.0600000000000001 110.814 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.34 167.48 24.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.8 -0.636 . . . . 1.1399999999999999 109.4 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -134.04 148.71 51.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.339 . . . . 4.0199999999999996 111.639 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -132.1 149.94 52.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.834 -0.621 . . . . 4.6100000000000003 110.014 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -120.49 139.97 52.11 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.212 -0.292 . . . . 3.3799999999999999 110.212 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 67' ' ' PHE . 49.6 mt-10 . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.754 0.311 . . . . 5.0499999999999998 111.793 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 110.18 -0.304 . . . . 5.6100000000000003 110.18 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.574 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 93.8 m-85 -122.46 125.29 45.51 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.896 -0.779 . . . . 3.7799999999999998 108.896 174.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -156.41 160.41 39.59 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.077 0.465 . . . . 2.4500000000000002 110.907 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 94' ' ' ASN . 27.6 mtm180 -140.71 125.27 10.75 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 115.355 -0.839 . . . . 3.2400000000000002 110.565 175.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.63 140.18 11.65 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.848 2.365 . . . . 1.1899999999999999 112.096 174.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -106.06 120.09 40.88 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.858 -0.793 . . . . 2.1899999999999999 108.858 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.0 tp -128.03 106.67 9.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.848 0.356 . . . . 1.1399999999999999 110.363 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 46.5 mt-10 -101.61 128.68 47.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.144 -0.48 . . . . 2.1800000000000002 110.284 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.8 t -120.03 120.01 61.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.306 -0.627 . . . . 1.5600000000000001 109.306 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.561 ' O ' ' HB2' ' A' ' 44' ' ' TRP . 80.1 t60 -119.59 118.22 30.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.118 0.485 . . . . 3.4399999999999999 110.253 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -117.62 138.54 51.89 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.186 -0.916 . . . . 4.7999999999999998 109.9 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -130.09 149.17 51.92 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.855 -0.424 . . . . 2.9399999999999999 109.855 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -137.11 132.68 34.42 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.614 -0.513 . . . . 3.8999999999999999 109.614 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 C--N 1.322 -0.628 0 CA-C-N 116.416 -0.356 . . . . 4.4800000000000004 110.49 -178.152 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.2 p . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 120.915 0.388 . . . . 2.5499999999999998 110.552 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -135.84 160.06 39.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.318 -0.401 . . . . 5.2999999999999998 110.357 -175.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.97 176.88 41.87 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.393 -0.908 . . . . 1.3500000000000001 112.587 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.12 125.21 27.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.785 -0.45 . . . . 2.29 109.785 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.9 m -120.11 129.95 54.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.157 0.503 . . . . 1.54 110.183 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -131.59 146.76 18.24 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.556 -0.831 . . . . 1.1699999999999999 112.577 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -123.92 122.2 4.75 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.908 -0.877 . . . . 1.1899999999999999 110.908 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -111.54 122.22 47.24 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.234 -0.654 . . . . 3.75 109.234 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.614 ' HB2' ' HB2' ' A' ' 112' ' ' ARG . 97.8 mtt180 -134.97 137.36 42.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.914 0.388 . . . . 2.75 110.907 -173.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.593 ' O ' ' HG2' ' A' ' 69' ' ' ARG . 92.6 m-20 -114.51 130.13 56.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.071 -0.513 . . . . 1.8200000000000001 109.972 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.532 ' HA ' ' HG2' ' A' ' 69' ' ' ARG . 58.8 t80 -106.93 119.94 40.7 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.848 -0.427 . . . . 3.1400000000000001 109.848 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.511 0 C-N-CA 120.55 -0.833 . . . . 2.79 112.243 178.178 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.9 p . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 109.991 -0.374 . . . . 3.2999999999999998 109.991 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.41 148.56 47.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.583 0.23 . . . . 1.76 110.676 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -132.58 135.74 46.11 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.368 0.604 . . . . 2.5499999999999998 111.077 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.487 ' HB2' ' HB3' ' A' ' 95' ' ' TYR . 89.7 mtp -136.55 141.45 43.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.784 -1.191 . . . . 1.77 107.784 175.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 16.2 mm100 -108.95 139.97 43.08 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.022 -0.671 . . . . 1.97 111.546 -172.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.614 ' HB2' ' HB2' ' A' ' 93' ' ' ARG . 76.2 mtt180 -120.37 128.95 53.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.004 -0.544 . . . . 3.8500000000000001 109.864 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -127.72 133.03 49.54 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.004 -0.544 . . . . 2.2799999999999998 110.849 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -121.55 125.22 46.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.958 -0.565 . . . . 2.1400000000000001 109.947 171.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 86.6 mt -120.08 124.0 71.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.978 -0.556 . . . . 1.55 109.612 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -147.05 105.24 3.86 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.617 0.246 . . . . 1.1899999999999999 111.121 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.98 139.95 13.97 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.38 2.053 . . . . 1.3700000000000001 110.922 175.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.51 137.19 33.48 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.285 -0.416 . . . . 2.3500000000000001 109.916 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -130.88 129.79 42.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.445 -0.343 . . . . 4.54 110.493 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -94.28 113.87 25.85 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.17 -0.678 . . . . 3.04 109.17 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.6 t -120.08 119.99 61.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.778 -0.453 . . . . 4.2699999999999996 109.778 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 128' ' ' ARG . 36.4 mtmm -126.84 118.78 25.31 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.745 -0.465 . . . . 6.04 109.745 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.3 tp -90.15 -79.01 0.35 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 4.5899999999999999 110.79 -174.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 47.4 p -142.67 171.77 13.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.371 -0.377 . . . . 3.6899999999999999 110.662 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 62.37 26.27 15.69 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 124.057 0.848 . . . . 5.1699999999999999 112.071 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 57.82 33.54 23.34 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.046 -0.525 . . . . 3.71 110.692 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.1 mt -98.99 130.0 45.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.058 -0.519 . . . . 2.0499999999999998 109.983 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.522 ' HA ' ' HG2' ' A' ' 122' ' ' LYS . 47.9 ttt180 -105.07 127.83 53.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.207 0.527 . . . . 4.2400000000000002 111.02 -174.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.451 ' CE2' HD13 ' A' ' 158' ' ' LEU . 96.7 m-85 -108.18 129.09 55.2 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.521 -0.918 . . . . 3.5499999999999998 108.521 174.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -111.65 113.9 26.58 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.756 -0.831 . . . . 2.1099999999999999 108.756 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -123.1 137.72 11.26 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.204 -0.998 . . . . 1.1799999999999999 111.908 -175.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.526 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 8.8 p90 -134.45 140.91 46.58 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.115 0.484 . . . . 4.2999999999999998 110.315 177.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 64.3 tp -99.96 111.14 23.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.596 -0.729 . . . . 2.2400000000000002 109.258 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.8 m -100.83 118.0 36.04 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.306 0.574 . . . . 1.6899999999999999 111.121 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 87.1 mtp -101.09 125.39 47.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.195 -0.911 . . . . 2.2400000000000002 109.26 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 95.5 m-85 -109.94 127.59 54.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.93 0.395 . . . . 3.5600000000000001 110.988 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -129.9 144.62 51.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.787 -0.642 . . . . 1.6699999999999999 109.986 174.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.444 ' H ' HD22 ' A' ' 142' ' ' LEU . 46.9 p90 -148.01 165.52 30.49 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.063 -0.717 . . . . 3.23 109.063 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 110' ' ' MET . . . 64.42 170.09 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.673 0.608 . . . . 1.24 110.733 -174.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -76.05 -20.1 58.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.457 0.646 . . . . 2.4700000000000002 109.572 173.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -66.65 -49.53 65.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.022 -0.99 . . . . 2.4100000000000001 111.997 -175.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.464 ' HA ' ' OG1' ' A' ' 145' ' ' THR . 10.0 mp -68.38 -30.32 69.22 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.888 0.375 . . . . 1.8300000000000001 111.458 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -60.55 -40.21 90.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.394 0.616 . . . . 2.0 109.884 171.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 57.6 m -69.97 -40.38 75.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.956 -1.02 . . . . 2.0499999999999998 111.366 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.464 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 40.8 p -69.99 -36.57 75.26 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.959 0.409 . . . . 1.5900000000000001 110.632 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 62.19 -114.66 7.02 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.484 -0.78 . . . . 1.52 113.044 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -70.07 -31.3 68.82 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.549 0.34 . . . . 5.9400000000000004 111.149 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.9 -48.93 79.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.318 0.488 . . . . 1.8300000000000001 112.318 -172.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -138.98 111.72 7.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.132 0.491 . . . . 2.6400000000000001 110.738 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.3 t -160.01 149.66 18.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.341 -0.845 . . . . 2.02 109.102 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.499 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 67.5 ttt180 -79.55 125.24 29.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.778 0.323 . . . . 3.6699999999999999 110.26 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.461 ' CG1' HD11 ' A' ' 133' ' ' LEU . 62.1 t -119.92 120.1 62.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.928 -0.578 . . . . 1.6399999999999999 110.082 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -140.06 141.19 36.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.183 -0.303 . . . . 2.5600000000000001 110.183 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 m -115.24 128.39 56.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.683 0.278 . . . . 1.3899999999999999 110.766 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.526 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 83.3 tt0 -108.68 130.7 55.34 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.786 -0.45 . . . . 2.04 109.786 176.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 44.0 m -118.1 121.11 39.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.283 -0.417 . . . . 1.5600000000000001 110.18 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -111.02 118.12 4.79 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.938 -0.649 . . . . 1.04 111.903 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.451 HD13 ' CE2' ' A' ' 129' ' ' PHE . 41.5 tp -95.37 128.36 42.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.889 0.376 . . . . 2.27 110.68 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -101.8 108.98 20.64 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.276 -0.638 . . . . 2.4100000000000001 109.276 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -120.2 126.67 51.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.459 -0.791 . . . . 4.5700000000000003 109.244 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.1 p -99.21 88.81 4.03 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.279 -0.569 . . . . 1.46 110.225 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -60.24 -49.67 76.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.412 -0.813 . . . . 2.6299999999999999 111.292 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.503 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.0 m-20 -103.01 15.82 28.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.456 -0.338 . . . . 2.4100000000000001 110.824 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 72.52 -53.83 0.69 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.888 0.743 . . . . 2.5800000000000001 111.617 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.6 p -74.38 -18.77 60.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.372 -0.377 . . . . 2.2999999999999998 111.496 -177.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 163' ' ' ASN . 35.7 m -110.6 136.93 45.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.373 -0.376 . . . . 1.71 110.3 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.57 123.62 48.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.062 -0.517 . . . . 1.47 109.788 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 35.7 mt -102.48 127.43 49.53 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.265 -0.643 . . . . 1.6599999999999999 109.265 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -99.99 108.83 21.13 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.723 -0.473 . . . . 3.2999999999999998 109.723 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 195' ' ' ARG . 50.2 t -109.98 119.7 59.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.32 -0.622 . . . . 1.3 109.32 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.448 ' HB2' ' HD3' ' A' ' 195' ' ' ARG . 15.5 m120 -109.81 131.55 54.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.012 0.434 . . . . 2.2200000000000002 110.879 -172.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -119.88 139.6 52.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.88 -0.6 . . . . 4.6100000000000003 109.683 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -106.37 122.69 46.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.672 0.272 . . . . 3.98 110.387 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 55.7 tp -108.63 114.92 29.13 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.172 -0.467 . . . . 2.3799999999999999 109.963 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -108.59 138.52 44.77 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.013 -0.54 . . . . 3.3100000000000001 110.007 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 . . . . . 0 C--N 1.323 -0.566 0 N-CA-C 109.626 -0.509 . . . . 6.5300000000000002 109.626 177.064 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 110.044 -0.354 . . . . 4.4000000000000004 110.044 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 88.0 mt -100.62 120.04 49.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.986 0.422 . . . . 2.21 110.384 -176.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.448 ' HD3' ' HB2' ' A' ' 171' ' ' ASN . 31.4 ttt180 -98.93 119.37 37.59 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.692 -0.686 . . . . 3.54 110.754 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -119.6 123.46 43.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.916 0.389 . . . . 1.6699999999999999 110.72 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -130.86 118.75 21.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.615 -0.721 . . . . 5.8300000000000001 109.751 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 1.3 pt? -136.83 126.82 15.9 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.753 -0.379 . . . . 2.5899999999999999 111.103 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 198' ' ' LEU . 27.7 Cg_endo -94.49 117.44 0.25 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.965 2.443 . . . . 1.77 112.499 175.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 50.8 tp -104.31 116.41 32.1 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.19 -0.67 . . . . 2.2599999999999998 109.19 176.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 96.7 m -99.58 120.07 39.07 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.167 0.508 . . . . 1.99 110.881 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 89.7 mt -114.56 80.38 1.39 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.948 -0.76 . . . . 2.3100000000000001 108.948 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 72.59 -112.85 4.15 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.151 -0.931 . . . . 1.51 112.228 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -100.09 10.35 41.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.11 0.481 . . . . 2.5699999999999998 110.948 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -134.42 117.71 16.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.195 -0.457 . . . . 2.6600000000000001 109.864 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 74.3 m -102.66 134.19 46.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.197 0.522 . . . . 1.6200000000000001 111.227 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 59.1 t -115.45 122.67 69.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.575 -0.739 . . . . 1.3799999999999999 109.239 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 23.5 m -118.3 94.28 46.68 Favored Pre-proline 0 C--N 1.318 -0.767 0 C-N-CA 121.031 -0.268 . . . . 1.1799999999999999 111.37 -176.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 15.6 Cg_exo -69.41 139.97 42.8 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.902 2.401 . . . . 1.01 111.795 173.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.505 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . 64.9 t80 -137.68 140.23 40.68 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.074 -0.512 . . . . 4.5 110.408 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 28.7 p -135.34 147.73 49.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.268 -0.424 . . . . 1.8899999999999999 110.866 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -102.42 -0.03 33.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.437 0.637 . . . . 4.7999999999999998 109.995 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 48.5 mm . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.452 -0.795 . . . . 4.5700000000000003 109.505 175.825 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.434 -0.58 . . . . 2.3999999999999999 109.434 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -78.14 137.61 20.1 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.418 -0.896 . . . . 1.27 111.283 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 94.5 mt -134.45 124.47 25.67 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.759 -0.46 . . . . 1.97 109.759 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.509 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 64.5 t80 -118.52 118.4 31.59 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.158 -0.682 . . . . 3.54 109.158 175.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.422 ' HB2' ' HB3' ' A' ' 253' ' ' LEU . 92.9 m-85 -104.79 129.72 53.01 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.127 -0.488 . . . . 2.6400000000000001 110.379 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -114.45 143.34 17.99 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 115.576 -0.738 . . . . 1.3500000000000001 111.533 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -107.28 112.35 25.16 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.484 -0.562 . . . . 4.3600000000000003 109.484 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -105.42 28.4 7.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.337 -0.847 . . . . 4.29 110.31 -172.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -59.89 -40.12 87.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.013 -0.994 . . . . 6.6900000000000004 110.741 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . 0.44 ' OE1' ' HB3' ' A' ' 249' ' ' LEU . 62.4 tt0 -133.05 133.79 43.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.948 -0.569 . . . . 6.3700000000000001 110.358 -176.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -63.38 -39.86 95.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.788 -0.642 . . . . 5.8300000000000001 110.595 176.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -68.19 -50.07 42.02 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.539 -0.839 . . . . 2.6600000000000001 112.535 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.44 ' HB3' ' OE1' ' A' ' 246' ' ' GLN . 59.1 tp -118.51 124.15 46.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.94 0.4 . . . . 2.9700000000000002 111.046 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 46.9 p -126.78 148.21 49.94 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.91 -0.587 . . . . 2.1699999999999999 110.082 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 57.7 t -116.43 137.67 49.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.434 -0.348 . . . . 1.79 110.3 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 43.4 m -111.76 139.76 46.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.327 -0.397 . . . . 1.6299999999999999 110.628 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.427 ' HG ' ' HG3' ' A' ' 254' ' ' GLU . 59.3 tp -132.65 143.42 49.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.544 -0.298 . . . . 2.96 111.31 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . 0.427 ' HG3' ' HG ' ' A' ' 253' ' ' LEU . 43.9 mt-10 60.34 -159.99 0.3 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.886 0.741 . . . . 4.0800000000000001 111.108 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -144.47 137.05 26.66 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.05 0.453 . . . . 4.8399999999999999 111.529 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.505 ' HB1' ' HB2' ' A' ' 210' ' ' TYR . . . . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 115.637 -0.71 . . . . 3.5800000000000001 109.221 172.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.193 0 CA-C-O 120.503 0.192 . . . . 1.9399999999999999 110.516 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -138.4 158.62 24.99 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 119.529 -1.32 . . . . 1.4199999999999999 112.489 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.19 127.17 68.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.17 -0.678 . . . . 1.8100000000000001 109.17 176.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.68 157.23 21.74 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.757 -0.735 . . . . 1.3 111.638 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 6.2 p -119.96 121.31 65.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.116 0.484 . . . . 1.8300000000000001 110.344 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -122.21 123.71 42.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.895 -0.593 . . . . 2.3100000000000001 110.517 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -118.08 130.03 55.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.745 -0.465 . . . . 4.75 109.745 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 8.9 p -117.5 129.44 55.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.953 0.406 . . . . 1.6699999999999999 110.498 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 61.4 t80 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.395 -0.812 . . . . 3.6899999999999999 109.572 -176.986 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.866 0.365 . . . . 3.6099999999999999 110.811 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 41' ' ' ASN . 70.0 m95 -88.59 107.35 18.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.131 0.491 . . . . 3.3300000000000001 111.171 -176.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -94.87 130.44 41.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.619 -0.719 . . . . 3.2000000000000002 110.592 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.34 139.48 52.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.165 -0.925 . . . . 2.4900000000000002 110.244 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 15.6 m120 -122.67 132.03 54.07 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.94 -0.573 . . . . 2.1299999999999999 110.105 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.0 mt -120.06 119.83 61.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.021 -0.733 . . . . 1.6000000000000001 109.021 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.437 ' HA3' ' CZ ' ' A' ' 36' ' ' TYR . . . -115.77 134.43 11.49 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.103 -1.046 . . . . 0.88 112.453 -176.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -121.78 134.41 54.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.91 0.386 . . . . 1.0800000000000001 110.147 175.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 91.0 mtp -140.66 157.09 45.95 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.268 -0.641 . . . . 2.3300000000000001 109.268 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -100.19 121.98 42.3 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.834 -0.346 . . . . 2.6099999999999999 110.99 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--N 1.323 -0.568 0 N-CA-C 109.751 -0.462 . . . . 5.0899999999999999 109.751 178.232 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 41.1 mt-10 . . . . . 0 N--CA 1.451 -0.413 0 N-CA-C 110.083 -0.339 . . . . 3.48 110.083 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 32' ' ' GLU . 24.0 Cg_exo -63.9 134.0 41.39 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 121.914 1.743 . . . . 1.8600000000000001 111.132 173.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 28.3 t -124.59 142.4 51.38 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.603 -0.888 . . . . 1.97 108.603 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 62.5 t -130.01 133.61 64.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.893 0.378 . . . . 1.71 111.002 -174.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.437 ' CZ ' ' HA3' ' A' ' 12' ' ' GLY . 53.8 p90 -130.22 151.82 50.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.675 -0.491 . . . . 4.0700000000000003 109.675 175.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.563 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 93.2 m-85 -119.55 139.95 51.31 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.517 -0.31 . . . . 2.8599999999999999 111.051 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 18.5 m-80 -129.65 141.37 50.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.801 -0.636 . . . . 1.8899999999999999 109.995 174.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.11 142.67 38.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.68 -0.236 . . . . 1.0800000000000001 110.439 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 45' ' ' ARG . . . -159.61 139.21 11.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.197 0.443 . . . . 1.3899999999999999 112.197 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.663 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 34.3 t30 -167.68 94.14 0.41 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.346 -0.843 . . . . 2.8599999999999999 109.186 171.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.92 -91.89 1.73 Allowed Glycine 0 N--CA 1.454 -0.144 0 N-CA-C 111.276 -0.73 . . . . 1.6799999999999999 111.276 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.663 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 72.6 Cg_exo -50.51 173.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.331 2.687 . . . . 1.6599999999999999 113.06 167.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.519 ' CD1' HG13 ' A' ' 74' ' ' VAL . 48.9 p90 -68.4 176.65 2.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.737 -0.665 . . . . 3.3999999999999999 111.951 -170.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 17.1 ttm180 -112.83 129.31 56.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.515 -0.766 . . . . 3.1000000000000001 110.069 -173.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 45.6 pt -110.92 143.56 20.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.271 -0.422 . . . . 1.8 110.939 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 72' ' ' LEU . . . -118.52 127.12 53.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.746 -0.661 . . . . 0.85999999999999999 110.352 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.7 tp -119.95 128.75 53.87 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.889 0.376 . . . . 1.0600000000000001 111.176 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.53 157.1 42.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.589 -0.732 . . . . 1.1399999999999999 109.423 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -120.09 140.0 51.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.083 0.468 . . . . 4.0199999999999996 111.141 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -112.14 133.28 54.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.657 -0.701 . . . . 4.6100000000000003 111.289 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -122.56 127.04 48.95 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.38 -0.6 . . . . 3.3799999999999999 109.38 174.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.627 ' HB2' ' OH ' ' A' ' 95' ' ' TYR . 39.0 tt0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 121.238 0.542 . . . . 5.0499999999999998 110.021 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 78.1 m95 . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 121.287 0.565 . . . . 5.6100000000000003 111.517 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -139.99 137.43 34.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.205 -0.907 . . . . 3.7799999999999998 109.309 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -159.96 168.38 25.82 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.433 -0.349 . . . . 2.4500000000000002 110.518 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.516 ' HD2' ' HB3' ' A' ' 93' ' ' ARG . 58.6 ttp85 -142.43 123.73 8.59 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.817 -0.629 . . . . 3.2400000000000002 110.267 169.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.631 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 72.9 Cg_endo -80.07 139.98 13.85 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.14 1.893 . . . . 1.1899999999999999 110.54 167.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.505 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 33.5 tt0 -124.15 113.87 18.92 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.227 0.537 . . . . 2.1899999999999999 110.077 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 40.8 tp -120.21 119.73 34.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.172 -0.922 . . . . 1.1399999999999999 110.209 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 34.2 mt-10 -104.21 147.03 27.93 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.289 0.566 . . . . 2.1800000000000002 111.08 174.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.519 HG13 ' CD1' ' A' ' 44' ' ' TRP . 63.8 t -113.41 120.08 62.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.95 -1.023 . . . . 1.5600000000000001 108.83 174.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.576 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 93.4 m-70 -122.27 127.19 49.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.88 0.371 . . . . 3.4399999999999999 110.28 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.439 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 84.5 t80 -139.94 139.09 36.07 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.114 -0.493 . . . . 4.7999999999999998 110.43 -178.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -99.17 119.87 38.57 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.587 -0.523 . . . . 2.9399999999999999 109.587 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -100.02 120.03 39.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.289 -0.414 . . . . 3.8999999999999999 109.963 -174.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.9 tp . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 116.267 -0.424 . . . . 4.4800000000000004 112.077 -172.169 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.514 ' HB3' ' CD1' ' A' ' 119' ' ' TRP . 22.7 m . . . . . 0 N--CA 1.448 -0.554 0 CA-C-O 120.899 0.38 . . . . 2.5499999999999998 110.651 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -135.64 159.53 41.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.135 -0.484 . . . . 5.2999999999999998 110.257 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -141.0 -178.52 17.4 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.983 -1.247 . . . . 1.3500000000000001 109.983 174.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 75' ' ' HIS . 64.7 tp -140.18 121.78 15.24 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 117.515 0.657 . . . . 2.29 110.953 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.428 HG23 ' CE1' ' A' ' 75' ' ' HIS . 92.9 m -120.08 116.61 26.05 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.689 -0.687 . . . . 1.54 109.595 169.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 73' ' ' GLU . . . -125.99 154.63 18.88 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.837 -0.905 . . . . 1.1699999999999999 110.837 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.81 124.3 2.23 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.669 -0.777 . . . . 1.1899999999999999 112.102 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -111.35 121.77 46.09 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.843 -0.799 . . . . 3.75 108.843 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.516 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 34.8 mtm180 -142.59 126.87 17.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.392 -0.367 . . . . 2.75 111.208 -172.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.631 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 57.6 t30 -122.16 130.01 52.83 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.445 -0.576 . . . . 1.8200000000000001 109.445 174.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.627 ' OH ' ' HB2' ' A' ' 53' ' ' GLU . 3.3 t80 -121.95 115.95 23.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.804 -0.18 . . . . 3.1400000000000001 110.955 -172.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 C-N-CA 120.473 -0.87 . . . . 2.79 111.167 176.227 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.2 m . . . . . 0 N--CA 1.447 -0.605 0 CA-C-O 120.931 0.396 . . . . 3.2999999999999998 110.578 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.95 144.25 33.64 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.681 -0.859 . . . . 1.76 108.681 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.438 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 95.8 m-20 -129.06 127.0 40.65 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.87 0.367 . . . . 2.5499999999999998 110.739 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.478 ' HB3' ' HA ' ' A' ' 139' ' ' ALA . 41.8 mtm -108.59 130.03 55.31 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.043 -0.725 . . . . 1.77 109.043 175.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -102.99 137.22 41.48 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.093 -0.643 . . . . 1.97 111.241 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.505 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 53.7 mtp85 -119.98 109.97 16.14 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.978 -0.749 . . . . 3.8500000000000001 108.978 177.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -110.02 140.02 44.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.342 0.592 . . . . 2.2799999999999998 112.046 -175.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.401 ' HB2' ' NH2' ' A' ' 93' ' ' ARG . 87.0 tttt -129.03 124.42 34.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.588 -1.187 . . . . 2.1400000000000001 109.854 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 80.3 mt -140.46 120.03 12.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.471 -0.196 . . . . 1.55 110.471 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 134' ' ' SER . . . -155.38 106.24 2.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.649 -0.25 . . . . 1.1899999999999999 111.425 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.721 ' HD2' ' CD1' ' A' ' 132' ' ' TRP . 13.3 Cg_exo -71.48 88.06 0.76 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.461 2.108 . . . . 1.3700000000000001 111.045 168.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 119' ' ' TRP . 12.1 p-10 -108.5 139.38 43.34 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.211 0.449 . . . . 2.3500000000000001 112.211 -166.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.514 ' CD1' ' HB3' ' A' ' 85' ' ' SER . 7.3 t-105 176.61 -176.59 0.13 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.34 -0.845 . . . . 4.54 108.993 174.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.609 ' OD1' ' HB3' ' A' ' 128' ' ' ARG . 30.1 t70 -80.24 117.44 21.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.135 0.493 . . . . 3.04 111.277 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.4 t -107.01 120.04 57.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.019 -0.734 . . . . 4.2699999999999996 109.019 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -93.08 72.01 4.63 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.932 -0.577 . . . . 6.04 110.636 -171.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.2 tp -67.32 -40.04 85.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.753 -0.658 . . . . 4.5899999999999999 110.709 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 24.4 p -123.28 150.16 43.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.756 -0.657 . . . . 3.6899999999999999 110.03 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -69.93 -40.26 75.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.793 0.33 . . . . 5.1699999999999999 111.279 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -70.24 -40.26 74.57 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.103 -0.498 . . . . 3.71 112.212 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.0 mt -119.95 139.16 52.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.919 0.39 . . . . 2.0499999999999998 111.339 -171.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.609 ' HB3' ' OD1' ' A' ' 120' ' ' ASP . 62.0 mtt180 -103.26 139.26 38.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.013 -0.539 . . . . 4.2400000000000002 110.097 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -112.74 107.82 16.61 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.436 -0.579 . . . . 3.5499999999999998 109.436 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 2.9 t-20 -110.83 114.3 27.53 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 120.797 0.332 . . . . 2.1099999999999999 110.495 -174.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 142.52 -163.18 27.24 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.326 -0.71 . . . . 1.1799999999999999 111.326 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.721 ' CD1' ' HD2' ' A' ' 117' ' ' PRO . 47.8 t-105 -161.34 168.53 23.78 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.977 0.389 . . . . 4.2999999999999998 110.799 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 46.9 tp -100.5 119.93 39.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.741 -0.663 . . . . 2.2400000000000002 109.596 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.434 ' HB3' ' HB2' ' A' ' 116' ' ' ALA . 13.1 p -122.97 158.46 30.43 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.182 0.438 . . . . 1.6899999999999999 112.182 -172.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 75.0 mtm -118.39 136.74 53.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.047 -0.524 . . . . 2.2400000000000002 109.976 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -120.04 140.41 51.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.2 0.524 . . . . 3.5600000000000001 111.518 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -124.39 136.34 53.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.365 -0.834 . . . . 1.6699999999999999 109.503 176.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.505 ' H ' HD22 ' A' ' 142' ' ' LEU . 42.2 m-85 -128.46 146.65 50.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.155 -0.475 . . . . 3.23 110.1 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 110' ' ' MET . . . 59.99 -164.87 0.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.714 -0.675 . . . . 1.24 111.642 177.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -77.39 -31.33 54.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.033 0.444 . . . . 2.4700000000000002 110.766 172.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -60.0 -50.28 74.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.622 -0.717 . . . . 2.4100000000000001 112.328 -169.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.505 HD22 ' H ' ' A' ' 138' ' ' PHE . 8.8 mp -70.7 -29.91 66.33 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.769 -0.373 . . . . 1.8300000000000001 111.219 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -61.11 -43.61 98.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.857 0.36 . . . . 2.0 110.704 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.3 p -70.4 -31.1 68.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 2.0499999999999998 111.468 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 75.8 p -97.78 9.94 41.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.583 -0.28 . . . . 1.5900000000000001 110.542 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -60.0 -24.66 60.88 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.906 -0.588 . . . . 1.52 114.06 -172.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -69.87 -38.49 76.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.851 0.358 . . . . 5.9400000000000004 110.415 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -107.62 -55.93 2.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.451 0.537 . . . . 1.8300000000000001 112.451 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -109.2 117.41 34.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.424 0.631 . . . . 2.6400000000000001 111.963 -171.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 24.4 p -130.1 147.01 51.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.061 -0.972 . . . . 2.02 110.186 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -77.18 132.77 38.94 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.517 -0.549 . . . . 3.6699999999999999 109.517 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.99 129.57 64.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.297 -0.41 . . . . 1.6399999999999999 110.899 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.62 137.96 54.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.084 -0.507 . . . . 2.5600000000000001 110.397 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -133.38 101.04 5.01 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.281 -0.418 . . . . 1.3899999999999999 110.179 175.132 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -99.52 110.45 22.9 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.289 -1.004 . . . . 2.04 108.289 172.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 32.1 m -129.14 121.05 26.95 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.013 0.435 . . . . 1.5600000000000001 111.183 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 171' ' ' ASN . . . -101.12 120.1 6.76 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.896 -0.882 . . . . 1.04 110.896 174.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 92.5 mt -97.11 129.54 44.5 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.502 -0.555 . . . . 2.27 109.502 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.458 ' HG2' ' HG2' ' A' ' 169' ' ' ARG . 69.9 mt-30 -102.0 119.12 38.28 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.644 -0.422 . . . . 2.4100000000000001 110.625 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -118.81 133.11 56.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.513 -0.767 . . . . 4.5700000000000003 109.3 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.5 p -103.57 92.15 4.33 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.405 -0.518 . . . . 1.46 110.767 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -60.01 -48.96 79.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.593 -0.731 . . . . 2.6299999999999999 111.204 -176.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.456 ' HB2' HG22 ' A' ' 166' ' ' VAL . 10.9 m120 -101.96 13.18 35.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.486 -0.324 . . . . 2.4100000000000001 111.331 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 73.88 -53.41 0.69 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.367 0.667 . . . . 2.5800000000000001 111.915 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.5 p -74.51 -18.77 60.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.985 0.422 . . . . 2.2999999999999998 111.564 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 163' ' ' ASN . 16.7 m -119.93 144.48 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.297 -0.41 . . . . 1.71 110.175 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -114.83 132.74 56.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.3 -0.409 . . . . 1.47 111.127 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 27.3 mt -104.35 129.98 52.21 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.718 -0.845 . . . . 1.6599999999999999 108.718 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.458 ' HG2' ' HG2' ' A' ' 159' ' ' GLN . 81.0 mtt180 -110.08 112.81 25.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.994 0.426 . . . . 3.2999999999999998 110.633 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.57 119.75 60.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.975 -0.557 . . . . 1.3 109.87 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.441 ' HA ' ' HA2' ' A' ' 157' ' ' GLY . 47.9 t30 -119.51 133.9 55.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.0 0.428 . . . . 2.2200000000000002 110.674 -172.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -138.9 150.92 46.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.768 -0.651 . . . . 4.6100000000000003 110.835 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -106.29 129.7 54.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.024 -0.534 . . . . 3.98 110.381 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 154' ' ' THR . 86.6 mt -114.75 131.99 56.59 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.466 -0.568 . . . . 2.3799999999999999 109.466 171.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -113.47 177.21 4.71 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.564 -0.289 . . . . 3.3100000000000001 110.532 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 . . . . . 0 C--N 1.327 -0.407 0 CA-C-O 121.208 0.528 . . . . 6.5300000000000002 110.083 -178.714 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 121.273 0.559 . . . . 4.4000000000000004 109.718 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 32.4 mm -116.98 139.92 41.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.623 -0.717 . . . . 2.21 111.184 -164.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 48.3 mtm105 -114.02 139.98 48.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.334 -0.247 . . . . 3.54 110.334 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -132.22 137.99 47.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.776 0.322 . . . . 1.6699999999999999 110.653 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -150.16 160.01 43.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.35 -0.386 . . . . 5.8300000000000001 110.281 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -137.93 139.13 25.28 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 120.69 0.281 . . . . 2.5899999999999999 110.394 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.33 135.65 22.84 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.401 2.067 . . . . 1.77 112.43 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 67.3 tp -137.76 134.15 34.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.685 -0.689 . . . . 2.2599999999999998 109.559 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 85.4 m -119.92 129.56 54.4 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.814 0.34 . . . . 1.99 110.333 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.1 mt -131.45 81.71 2.0 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.283 0.563 . . . . 2.3100000000000001 109.523 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 71.42 -121.47 8.94 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.429 -0.805 . . . . 1.51 112.483 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -96.54 9.13 42.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.592 0.71 . . . . 2.5699999999999998 109.725 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -120.01 129.99 54.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.198 -0.91 . . . . 2.6600000000000001 109.615 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 7.0 p -103.71 146.28 28.84 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.297 -0.41 . . . . 1.6200000000000001 110.661 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 58.0 t -133.4 140.08 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 1.3799999999999999 110.119 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 46.1 m -138.49 95.48 10.14 Favored Pre-proline 0 C--N 1.319 -0.742 0 O-C-N 122.13 -0.356 . . . . 1.1799999999999999 110.533 173.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.11 139.97 90.11 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.43 2.087 . . . . 1.01 111.477 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -109.5 137.23 47.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.033 -0.53 . . . . 4.5 109.65 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 33.1 p -144.67 162.1 37.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.177 -0.465 . . . . 1.8899999999999999 110.731 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -138.29 142.02 39.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.26 -0.645 . . . . 4.7999999999999998 109.26 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 84.3 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 121.11 0.481 . . . . 4.5700000000000003 110.423 -178.436 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 62.4 t . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 120.791 0.329 . . . . 2.3999999999999999 110.886 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -85.51 165.98 39.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.781 -0.723 . . . . 1.27 111.438 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 89.4 mt -134.33 129.92 36.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.471 0.636 . . . . 1.97 112.04 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.517 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 57.5 t80 -100.67 131.29 46.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.333 -0.848 . . . . 3.54 109.845 171.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.462 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 91.0 m-85 -113.97 130.01 56.56 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.453 -0.573 . . . . 2.6400000000000001 109.453 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -123.3 134.24 9.35 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.7 -0.762 . . . . 1.3500000000000001 111.67 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.43 110.98 23.08 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.156 -0.683 . . . . 4.3600000000000003 109.156 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -107.06 102.12 11.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.908 -0.587 . . . . 4.29 110.37 -176.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 91.3 m-85 -120.0 135.98 54.72 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.13 -0.486 . . . . 6.6900000000000004 109.817 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -84.8 9.65 13.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.448 0.642 . . . . 6.3700000000000001 110.107 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -90.71 6.26 44.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.186 -0.916 . . . . 5.8300000000000001 110.268 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 99.94 5.13 55.22 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.791 -0.718 . . . . 2.6600000000000001 112.816 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 245' ' ' PHE . 65.9 tp -102.95 120.1 40.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.927 0.394 . . . . 2.9700000000000002 111.254 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 23.9 t -130.72 129.24 42.29 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.699 -0.852 . . . . 2.1699999999999999 108.699 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.51 133.17 64.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.932 -0.307 . . . . 1.79 110.643 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 15.5 m -116.65 120.1 37.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.069 -0.514 . . . . 1.6299999999999999 110.057 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 86.0 mt -125.2 127.51 46.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.753 -0.203 . . . . 2.96 110.515 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -120.55 111.33 17.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.854 0.359 . . . . 4.0800000000000001 110.487 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -120.1 140.09 51.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.963 0.411 . . . . 4.8399999999999999 111.316 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 115.899 -0.591 . . . . 3.5800000000000001 110.491 175.614 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.661 0.267 . . . . 1.9399999999999999 110.464 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.76 132.56 6.64 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.001 -0.619 . . . . 1.4199999999999999 111.698 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 29.6 m -138.01 140.17 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.862 0.363 . . . . 1.8100000000000001 111.103 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -163.96 140.58 6.55 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.7 -0.762 . . . . 1.3 112.394 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.5 t -120.29 130.07 74.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.728 0.299 . . . . 1.8300000000000001 110.3 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -118.59 126.37 51.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.25 -0.432 . . . . 2.3100000000000001 110.286 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -100.3 123.69 44.85 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.699 -0.852 . . . . 4.75 108.699 174.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 37.7 t -117.75 130.02 56.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.986 0.422 . . . . 1.6699999999999999 110.673 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.2 t80 . . . . . 0 C--O 1.243 0.724 0 CA-C-O 118.336 -0.84 . . . . 3.6899999999999999 109.182 176.836 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 . . . . . 0 CA--C 1.519 -0.228 0 CA-C-O 121.416 0.627 . . . . 3.6099999999999999 109.43 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -73.22 149.28 42.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.143 -0.935 . . . . 3.3300000000000001 110.534 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -104.08 131.08 51.71 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.96 -0.385 . . . . 3.2000000000000002 109.96 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.83 149.76 42.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.81 -0.632 . . . . 2.4900000000000002 111.791 -171.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -131.54 129.43 41.01 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.677 -0.86 . . . . 2.1299999999999999 108.677 166.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 85.4 mt -132.5 120.23 41.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.598 -0.519 . . . . 1.6000000000000001 109.598 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -117.08 147.8 18.87 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.352 -0.927 . . . . 0.88 112.505 -176.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -138.09 135.03 35.4 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.093 -0.336 . . . . 1.0800000000000001 110.093 175.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.662 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 67.8 mtt -134.0 146.42 50.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.406 -0.361 . . . . 2.3300000000000001 110.482 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -97.63 129.46 44.72 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.895 -0.78 . . . . 2.6099999999999999 108.895 177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 . . . . . 0 C--N 1.328 -0.355 0 N-CA-C 112.187 0.44 . . . . 5.0899999999999999 112.187 -173.365 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 N--CA 1.449 -0.519 0 CA-C-O 120.943 0.402 . . . . 3.48 110.326 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.662 ' HA ' ' O ' ' A' ' 14' ' ' MET . 73.8 Cg_endo -77.39 134.81 14.34 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.354 2.036 . . . . 1.8600000000000001 113.127 -177.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 34.8 p -84.42 157.71 21.3 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.992 -0.744 . . . . 1.97 108.992 171.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.99 132.56 69.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.213 0.53 . . . . 1.71 111.005 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 53.0 t80 -122.76 130.85 53.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.361 -0.836 . . . . 4.0700000000000003 110.303 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -120.02 135.24 55.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.764 0.316 . . . . 2.8599999999999999 110.75 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -149.9 127.96 11.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.243 -0.651 . . . . 1.8899999999999999 109.243 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.44 147.95 28.86 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.078 -0.249 . . . . 1.0800000000000001 111.316 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.72 139.12 9.96 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.131 -0.486 . . . . 1.3899999999999999 111.443 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.689 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 27.3 t-20 -168.28 94.97 0.39 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.963 -0.755 . . . . 2.8599999999999999 108.963 169.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.05 -85.62 0.55 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.93 -0.652 . . . . 1.6799999999999999 111.496 -173.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.689 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 19.6 Cg_endo -59.59 176.66 0.57 Allowed 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 123.643 2.895 . . . . 1.6599999999999999 112.55 171.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -67.77 175.25 3.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.932 -0.576 . . . . 3.3999999999999999 110.527 -173.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -110.99 117.08 32.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.478 0.656 . . . . 3.1000000000000001 109.706 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 84.3 mt -116.24 130.23 71.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.438 -1.256 . . . . 1.8 110.436 -170.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.22 130.7 56.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.261 -0.427 . . . . 0.85999999999999999 110.21 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 61.2 tp -130.59 132.57 45.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 1.0600000000000001 110.886 -177.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -146.59 168.92 20.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.56 -0.745 . . . . 1.1399999999999999 109.56 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -120.07 140.0 51.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.703 0.287 . . . . 4.0199999999999996 110.567 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -119.86 122.62 41.69 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.758 -0.46 . . . . 4.6100000000000003 109.758 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -123.1 139.98 53.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.941 0.401 . . . . 3.3799999999999999 110.091 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.685 -0.689 . . . . 5.0499999999999998 110.212 -179.608 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 . . . . . 0 N--CA 1.456 -0.161 0 CA-C-O 120.866 0.365 . . . . 5.6100000000000003 110.644 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -102.22 111.64 24.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.465 -0.569 . . . . 3.7799999999999998 109.465 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -125.34 169.96 11.81 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.267 -0.424 . . . . 2.4500000000000002 110.098 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.506 ' NE ' ' HB2' ' A' ' 95' ' ' TYR . 12.5 ttm180 -139.31 122.41 10.62 Favored Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 120.874 -0.33 . . . . 3.2400000000000002 110.134 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.508 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 85.3 Cg_endo -91.41 151.69 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.872 2.382 . . . . 1.1899999999999999 112.184 171.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.592 ' HA ' ' HG2' ' A' ' 93' ' ' ARG . 37.8 tt0 -118.04 115.61 25.21 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.17 -0.678 . . . . 2.1899999999999999 109.17 174.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.4 tp -132.56 114.74 14.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.883 -0.599 . . . . 1.1399999999999999 110.758 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.515 ' HG2' ' HA3' ' A' ' 91' ' ' GLY . 46.9 mt-10 -123.9 140.47 52.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.263 -0.426 . . . . 2.1800000000000002 110.108 174.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -123.03 129.8 74.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.203 -0.453 . . . . 1.5600000000000001 109.965 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -112.48 119.9 39.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.008 0.432 . . . . 3.4399999999999999 110.444 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.447 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . 64.8 t80 -93.08 129.14 39.14 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.554 -0.748 . . . . 4.7999999999999998 109.26 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -103.02 119.83 39.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.079 -0.509 . . . . 2.9399999999999999 110.099 -177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.453 ' CD2' ' HG ' ' A' ' 79' ' ' LEU . 69.7 t80 -120.1 119.35 33.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.522 -0.308 . . . . 3.8999999999999999 110.633 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.453 ' HG ' ' CD2' ' A' ' 78' ' ' PHE . 85.4 mt . . . . . 0 N--CA 1.466 0.336 0 O-C-N 124.136 0.897 . . . . 4.4800000000000004 112.817 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.402 ' OG ' ' HB ' ' A' ' 121' ' ' VAL . 21.3 t . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 109.996 -0.372 . . . . 2.5499999999999998 109.996 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -119.92 135.84 54.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.924 0.392 . . . . 5.2999999999999998 110.748 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.21 143.42 15.01 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.029 -0.828 . . . . 1.3500000000000001 111.029 175.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 76' ' ' TYR . 88.6 mt -120.27 113.72 20.82 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.767 -0.457 . . . . 2.29 109.767 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.1 m -116.58 122.64 45.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.05 0.452 . . . . 1.54 110.882 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -137.86 140.33 11.14 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.443 -0.663 . . . . 1.1699999999999999 111.443 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.515 ' HA3' ' HG2' ' A' ' 73' ' ' GLU . . . -169.63 170.03 42.44 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.219 -0.991 . . . . 1.1899999999999999 112.455 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 112' ' ' ARG . 53.3 p90 -156.75 160.01 38.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.986 0.422 . . . . 3.75 111.201 -176.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.592 ' HG2' ' HA ' ' A' ' 71' ' ' GLU . 30.1 mtm180 -121.27 127.96 51.89 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.743 -0.662 . . . . 2.75 109.228 169.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.508 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 52.0 t30 -107.3 119.13 38.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.189 -0.46 . . . . 1.8200000000000001 110.134 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.506 ' HB2' ' NE ' ' A' ' 69' ' ' ARG . 69.9 t80 -116.85 129.31 56.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.793 0.33 . . . . 3.1400000000000001 111.006 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 108' ' ' ALA . . . . . . . . 0 N--CA 1.444 -0.783 0 C-N-CA 120.333 -0.936 . . . . 2.79 113.179 172.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 109.4 -0.593 . . . . 3.2999999999999998 109.4 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.406 ' O ' ' HA3' ' A' ' 96' ' ' GLY . . . -164.78 129.12 2.52 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.632 -0.427 . . . . 1.76 111.159 -178.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -138.47 126.88 23.13 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.195 0.522 . . . . 2.5499999999999998 110.034 173.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 89.5 mtp -131.35 126.91 36.48 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.925 -0.579 . . . . 1.77 109.462 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.496 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 26.3 mt-30 -118.92 134.23 55.31 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.327 -0.549 . . . . 1.97 110.528 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 92' ' ' PHE . 47.3 ttt-85 -111.77 119.44 38.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.682 -0.69 . . . . 3.8500000000000001 109.439 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -119.94 140.21 51.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.545 -0.298 . . . . 2.2799999999999998 110.901 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 135' ' ' MET . 21.8 pttp -139.94 135.29 32.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.023 0.44 . . . . 2.1400000000000001 110.184 168.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 134' ' ' SER . 48.5 mm -120.02 119.85 61.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.827 -0.805 . . . . 1.55 108.827 173.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -140.55 106.58 6.5 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 120.553 0.216 . . . . 1.1899999999999999 111.197 -174.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.94 139.87 13.98 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.757 2.305 . . . . 1.3700000000000001 110.776 174.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -88.03 138.4 31.48 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.29 -0.634 . . . . 2.3500000000000001 109.29 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -125.86 132.32 52.21 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.547 0.203 . . . . 4.54 111.547 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 55.78 37.53 28.98 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.251 0.97 . . . . 3.04 112.451 171.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.402 ' HB ' ' OG ' ' A' ' 85' ' ' SER . 92.9 t -64.19 119.32 8.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.638 -0.255 . . . . 4.2699999999999996 110.926 -176.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 59.93 43.11 15.22 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.583 -0.735 . . . . 6.04 110.948 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.1 tp -60.15 -39.9 87.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.147 -0.479 . . . . 4.5899999999999999 111.872 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 127' ' ' LEU . 32.6 m -117.3 138.14 51.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.923 0.392 . . . . 3.6899999999999999 110.318 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -61.42 -44.66 96.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.147 -0.479 . . . . 5.1699999999999999 111.025 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -70.97 -40.83 71.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.794 -0.639 . . . . 3.71 111.492 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.535 ' O ' ' HB ' ' A' ' 124' ' ' THR . 86.5 mt -126.59 125.48 42.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.924 -0.58 . . . . 2.0499999999999998 110.523 -173.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.488 ' HD2' ' OE1' ' A' ' 159' ' ' GLN . 64.9 mtt180 -92.67 133.83 35.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.098 0.475 . . . . 4.2400000000000002 110.623 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.466 ' CD2' HD22 ' A' ' 158' ' ' LEU . 89.3 m-85 -119.8 122.0 40.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.367 -0.833 . . . . 3.5499999999999998 109.565 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 132' ' ' TRP . 94.4 m-20 -133.32 120.06 20.55 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.883 -0.414 . . . . 2.1099999999999999 109.883 174.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -148.18 140.27 8.25 Favored Glycine 0 CA--C 1.507 -0.416 0 C-N-CA 120.2 -1.0 . . . . 1.1799999999999999 111.43 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.462 ' CZ3' ' HB3' ' A' ' 130' ' ' ASN . 0.9 OUTLIER -142.72 147.67 36.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.302 0.573 . . . . 4.2999999999999998 112.153 -177.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 91.4 mt -104.43 120.01 40.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.987 -1.006 . . . . 2.2400000000000002 109.09 176.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 26.6 t -107.39 124.56 50.01 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.54 -0.464 . . . . 1.6899999999999999 110.974 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.472 ' O ' ' HA ' ' A' ' 114' ' ' LYS . 69.7 mtm -93.95 120.06 33.7 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.324 -0.991 . . . . 2.2400000000000002 108.324 171.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -115.12 132.61 56.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.167 0.508 . . . . 3.5600000000000001 112.208 -168.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -130.17 152.86 49.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.415 -0.812 . . . . 1.6699999999999999 109.908 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.459 ' O ' HD23 ' A' ' 142' ' ' LEU . 77.9 t80 -149.7 151.5 33.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.421 -0.354 . . . . 3.23 110.248 -177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 60.61 -163.44 0.25 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.546 0.529 . . . . 1.24 111.649 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -75.91 -41.39 52.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.967 0.413 . . . . 2.4700000000000002 111.786 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -60.14 -46.16 90.59 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.528 -0.76 . . . . 2.4100000000000001 112.959 -165.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 138' ' ' PHE . 3.8 mm? -69.88 -35.66 74.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.071 0.462 . . . . 1.8300000000000001 110.974 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' A' ' 111' ' ' GLN . 95.6 m-20 -70.78 -40.25 72.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.884 -0.598 . . . . 2.0 111.392 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.1 p -77.0 -35.05 57.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.504 -0.316 . . . . 2.0499999999999998 111.823 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 149' ' ' ASP . 23.2 p -69.9 -29.9 67.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.986 0.422 . . . . 1.5900000000000001 111.092 177.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 63.28 -109.83 2.98 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.694 -0.685 . . . . 1.52 113.071 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -70.02 -33.94 72.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.594 0.235 . . . . 5.9400000000000004 110.808 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.04 75.26 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.075 -0.512 . . . . 1.8300000000000001 112.256 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.428 ' HB2' ' OG1' ' A' ' 145' ' ' THR . 15.7 m-20 -122.51 127.1 49.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.212 0.53 . . . . 2.6400000000000001 111.003 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.1 t -160.23 157.73 28.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.853 -0.612 . . . . 2.02 110.113 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -120.16 148.2 43.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.917 -0.401 . . . . 3.6699999999999999 109.917 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.09 139.81 50.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.867 0.365 . . . . 1.6399999999999999 110.974 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -138.0 141.04 40.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.989 -0.551 . . . . 2.5600000000000001 109.523 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 24.5 m -122.91 131.36 53.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.735 0.302 . . . . 1.3899999999999999 111.346 -177.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -126.57 130.06 49.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.944 -0.571 . . . . 2.04 110.235 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 93.4 m -128.24 120.78 27.87 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.044 -0.525 . . . . 1.5600000000000001 110.538 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -111.69 117.73 4.56 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.657 -0.977 . . . . 1.04 110.657 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.466 HD22 ' CD2' ' A' ' 129' ' ' PHE . 77.4 mt -118.65 130.64 55.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.913 0.387 . . . . 2.27 111.024 -176.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.488 ' OE1' ' HD2' ' A' ' 128' ' ' ARG . 53.4 tt0 -100.14 113.43 26.07 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.901 -0.59 . . . . 2.4100000000000001 110.669 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.469 ' HA ' HD22 ' A' ' 127' ' ' LEU . 86.7 m-85 -120.16 139.8 52.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.889 -0.596 . . . . 4.5700000000000003 110.424 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 167' ' ' ALA . 24.4 p -94.25 100.26 12.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.963 0.411 . . . . 1.46 110.349 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -60.05 -49.07 79.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.939 -0.573 . . . . 2.6299999999999999 111.225 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.493 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.7 m-20 -101.09 10.09 41.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.222 -0.445 . . . . 2.4100000000000001 110.717 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 72.47 -46.92 0.66 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.634 0.774 . . . . 2.5800000000000001 111.235 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.4 p -74.71 -20.42 59.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.397 -0.365 . . . . 2.2999999999999998 111.788 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 163' ' ' ASN . 34.2 m -124.81 139.95 49.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.368 -0.378 . . . . 1.71 110.252 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.406 ' HA ' HG22 ' A' ' 161' ' ' THR . . . -106.83 131.55 53.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.959 0.409 . . . . 1.47 111.374 -175.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 31.1 mt -115.31 138.54 50.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.311 -0.626 . . . . 1.6599999999999999 109.311 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -112.17 122.02 46.58 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 110.075 -0.343 . . . . 3.2999999999999998 110.075 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.94 127.91 75.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.731 0.3 . . . . 1.3 110.547 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -107.05 126.69 52.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.249 0.547 . . . . 2.2200000000000002 110.782 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -99.42 124.42 44.54 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.11 -0.95 . . . . 4.6100000000000003 108.648 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -108.77 124.98 51.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.096 0.474 . . . . 3.98 110.923 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.501 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 62.0 tp -115.4 115.82 27.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.608 -0.723 . . . . 2.3799999999999999 111.21 -177.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -120.01 145.12 47.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.694 -0.685 . . . . 3.3100000000000001 110.116 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 . . . . . 0 C--N 1.321 -0.656 0 N-CA-C 109.546 -0.538 . . . . 6.5300000000000002 109.546 172.368 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 C--O 1.235 0.314 0 CA-C-O 120.635 0.255 . . . . 4.4000000000000004 110.521 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.491 ' O ' HG13 ' A' ' 194' ' ' ILE . 29.7 pt -93.92 90.72 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.66 0.743 . . . . 2.21 109.375 170.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.426 ' HG2' ' HA ' ' A' ' 212' ' ' ARG . 99.1 mtt180 -91.3 120.08 31.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.875 -0.602 . . . . 3.54 110.314 -173.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -109.36 147.23 33.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.95 -0.568 . . . . 1.6699999999999999 111.38 -174.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -155.97 160.02 39.72 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.492 -0.777 . . . . 5.8300000000000001 109.726 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 1.7 pt? -144.51 127.49 8.54 Favored Pre-proline 0 C--N 1.322 -0.619 0 C-N-CA 120.846 -0.342 . . . . 2.5899999999999999 111.006 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 198' ' ' LEU . 9.1 Cg_exo -73.28 127.38 11.88 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.462 2.108 . . . . 1.77 111.674 172.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 33.1 tp -130.83 148.57 52.62 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.565 -0.902 . . . . 2.2599999999999998 108.565 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 11.9 t -129.58 140.18 51.27 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.302 0.572 . . . . 1.99 110.954 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 60.0 tp -141.05 82.53 1.84 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.343 -0.844 . . . . 2.3100000000000001 109.149 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 69.22 -120.04 10.05 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.734 -0.666 . . . . 1.51 112.616 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -95.47 10.09 37.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.497 0.665 . . . . 2.5699999999999998 109.778 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -119.2 145.87 45.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.389 -0.823 . . . . 2.6600000000000001 109.399 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 241' ' ' TYR . 47.5 t -130.03 144.53 51.39 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.851 -0.426 . . . . 1.6200000000000001 109.851 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 47.9 t -119.92 129.95 74.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.639 -0.504 . . . . 1.3799999999999999 109.639 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 20.3 m -139.84 91.03 10.62 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-O 120.867 0.365 . . . . 1.1799999999999999 110.42 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.46 140.6 27.28 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 123.013 2.475 . . . . 1.01 111.826 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -118.99 139.88 50.94 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.858 -0.423 . . . . 4.5 109.858 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 61.1 p -133.07 146.15 51.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.789 -0.641 . . . . 1.8899999999999999 109.626 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.426 ' HA ' ' HG2' ' A' ' 195' ' ' ARG . 59.0 mtp180 -80.51 -9.97 59.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.035 0.445 . . . . 4.7999999999999998 110.255 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 46.5 pt . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.547 -0.751 . . . . 4.5700000000000003 109.932 179.18 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 109.832 -0.433 . . . . 2.3999999999999999 109.832 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -132.92 143.88 15.67 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.62 -0.8 . . . . 1.27 111.923 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 81.1 mt -116.94 121.78 42.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.7 0.286 . . . . 1.97 110.284 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -106.55 122.26 45.95 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.877 -0.416 . . . . 3.54 109.877 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 206' ' ' SER . 95.9 m-85 -112.2 120.37 41.54 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.066 -0.515 . . . . 2.6400000000000001 110.115 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -89.62 129.57 9.76 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.613 -0.803 . . . . 1.3500000000000001 111.533 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -107.58 127.19 53.42 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 110.004 -0.369 . . . . 4.3600000000000003 110.004 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -99.36 133.82 43.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.572 -0.74 . . . . 4.29 110.37 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -124.73 146.16 49.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.499 -0.556 . . . . 6.6900000000000004 109.499 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -56.49 -27.56 57.5 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.272 -0.876 . . . . 6.3700000000000001 112.816 -168.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.98 -34.97 74.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.364 0.602 . . . . 5.8300000000000001 110.742 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 116.2 1.94 20.25 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.21 -1.156 . . . . 2.6600000000000001 110.21 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 53.5 tp -91.08 130.41 36.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.579 -0.811 . . . . 2.9700000000000002 109.792 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 24.3 p -120.08 140.15 51.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.859 0.362 . . . . 2.1699999999999999 110.672 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.2 t -118.71 133.02 66.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.424 -0.353 . . . . 1.79 110.211 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 24.7 m -98.4 117.55 33.06 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.782 -0.451 . . . . 1.6299999999999999 109.782 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 68.6 mt -95.73 119.45 34.26 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.313 -0.625 . . . . 2.96 109.313 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -104.43 120.02 40.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.916 0.389 . . . . 4.0800000000000001 110.495 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -116.2 132.25 56.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.885 -0.598 . . . . 4.8399999999999999 110.675 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.474 0 CA-C-O 121.504 0.669 . . . . 3.5800000000000001 109.733 172.948 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.81 0.338 . . . . 1.9399999999999999 110.545 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.91 167.54 23.25 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.917 -0.658 . . . . 1.4199999999999999 111.844 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.05 140.0 39.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.149 0.499 . . . . 1.8100000000000001 111.06 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -126.77 137.08 9.76 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.033 -0.827 . . . . 1.3 111.033 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.99 119.99 60.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.857 -0.423 . . . . 1.8300000000000001 109.857 -176.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -128.25 129.77 46.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.154 0.502 . . . . 2.3100000000000001 111.627 -176.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -120.01 110.62 16.91 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.291 -0.633 . . . . 4.75 109.291 173.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 22.9 t -120.6 130.23 54.09 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.53 -0.544 . . . . 1.6699999999999999 109.53 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 46.2 t80 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.112 -0.946 . . . . 3.6899999999999999 109.462 -177.727 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 120.966 0.412 . . . . 3.6099999999999999 111.079 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -120.3 139.99 51.91 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.166 -0.679 . . . . 3.3300000000000001 109.166 172.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -131.83 130.78 42.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.812 0.339 . . . . 3.2000000000000002 110.182 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -137.06 150.35 47.99 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.089 -0.505 . . . . 2.4900000000000002 110.152 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -132.77 131.39 41.09 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.923 -0.769 . . . . 2.1299999999999999 108.923 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.8 pt -121.34 130.32 74.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.987 0.422 . . . . 1.6000000000000001 110.971 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -114.8 134.53 11.72 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.671 -0.776 . . . . 0.88 111.578 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -120.0 135.87 54.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.018 0.437 . . . . 1.0800000000000001 110.636 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 66.7 mtt -139.92 157.26 45.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.714 -0.675 . . . . 2.3300000000000001 109.734 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.02 112.32 24.75 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.007 -0.368 . . . . 2.6099999999999999 110.007 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 C--N 1.324 -0.536 0 CA-C-O 121.084 0.468 . . . . 5.0899999999999999 110.87 -176.789 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.591 0.234 . . . . 3.48 110.835 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.09 134.84 10.67 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.441 2.094 . . . . 1.8600000000000001 111.972 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 19.3 p -123.9 145.78 48.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.241 -0.436 . . . . 1.97 110.0 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 8.5 p -130.0 136.79 58.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.02 0.438 . . . . 1.71 110.791 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -117.97 143.66 46.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.033 -0.53 . . . . 4.0700000000000003 110.481 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 91.0 m-85 -102.71 129.28 49.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.976 -0.556 . . . . 2.8599999999999999 111.244 -176.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -119.88 137.43 54.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.137 -0.483 . . . . 1.8899999999999999 109.948 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -120.69 143.5 48.7 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.988 -0.375 . . . . 1.0800000000000001 109.988 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.49 117.98 6.97 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.537 0.523 . . . . 1.3899999999999999 111.226 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.631 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 37.4 t30 -167.24 96.01 0.48 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.01 -0.541 . . . . 2.8599999999999999 110.12 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.3 -98.78 1.89 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.017 -0.611 . . . . 1.6799999999999999 112.266 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.631 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 84.1 Cg_exo -47.82 175.0 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.956 3.104 . . . . 1.6599999999999999 113.644 169.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -69.72 -177.44 1.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.265 0.555 . . . . 3.3999999999999999 111.582 -170.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.7 mtp180 -111.97 140.58 46.52 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.609 0.719 . . . . 3.1000000000000001 112.331 -170.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.406 HG22 HG12 ' A' ' 74' ' ' VAL . 47.0 pt -126.52 146.66 32.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 114.397 -1.274 . . . . 1.8 110.892 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -119.73 131.22 55.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.791 -0.64 . . . . 0.85999999999999999 110.287 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.8 tp -119.92 131.84 55.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.166 -0.47 . . . . 1.0600000000000001 110.831 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 71' ' ' GLU . . . -151.98 157.8 42.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 1.1399999999999999 110.551 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -134.48 150.48 50.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.793 0.33 . . . . 4.0199999999999996 110.725 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -135.27 106.94 6.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.019 -0.537 . . . . 4.6100000000000003 111.589 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -98.87 135.84 39.73 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.457 -0.942 . . . . 3.3799999999999999 108.457 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 N--CA 1.462 0.149 0 CA-C-N 116.024 -0.535 . . . . 5.0499999999999998 111.059 -176.175 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 94.5 m95 . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 120.913 0.387 . . . . 5.6100000000000003 110.507 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -70.54 139.96 51.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.072 -0.513 . . . . 3.7799999999999998 110.804 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -130.65 144.26 51.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.67 -0.696 . . . . 2.4500000000000002 109.704 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.458 ' HD2' ' HB3' ' A' ' 93' ' ' ARG . 39.5 ttp180 -124.34 122.05 26.0 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.926 -0.579 . . . . 3.2400000000000002 110.07 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.478 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 2.9 Cg_endo -85.81 150.03 9.81 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.63 2.22 . . . . 1.1899999999999999 111.883 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 46.5 tt0 -128.11 128.95 45.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.054 0.454 . . . . 2.1899999999999999 110.211 173.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.4 tp -132.03 116.77 17.51 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.616 -0.72 . . . . 1.1399999999999999 109.442 173.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.472 ' HA ' ' HA2' ' A' ' 91' ' ' GLY . 40.5 tt0 -118.81 131.17 56.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.043 0.449 . . . . 2.1800000000000002 109.868 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.406 HG12 HG22 ' A' ' 46' ' ' ILE . 32.4 m -113.67 141.55 29.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.816 -0.629 . . . . 1.5600000000000001 109.999 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -120.97 127.01 51.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.097 -0.502 . . . . 3.4399999999999999 110.136 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.94 141.43 49.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.365 -0.38 . . . . 4.7999999999999998 110.074 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -114.65 139.91 49.26 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.851 -0.425 . . . . 2.9399999999999999 109.851 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -132.03 149.29 52.46 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.847 0.356 . . . . 3.8999999999999999 110.408 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.6 tp . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 116.039 -0.528 . . . . 4.4800000000000004 110.085 -179.788 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 120' ' ' ASP . 3.9 m . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 120.775 0.321 . . . . 2.5499999999999998 110.889 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -140.05 143.72 36.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.502 -0.555 . . . . 5.2999999999999998 109.502 174.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.65 176.36 23.08 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.255 -0.974 . . . . 1.3500000000000001 112.539 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 64.0 tp -126.83 130.04 49.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.912 0.387 . . . . 2.29 110.077 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.2 m -120.02 129.91 54.47 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.054 -0.521 . . . . 1.54 109.908 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 114' ' ' LYS . . . -138.97 133.6 6.3 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.615 -0.802 . . . . 1.1699999999999999 111.8 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 73' ' ' GLU . . . -135.03 147.99 19.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.591 -0.814 . . . . 1.1899999999999999 112.4 -178.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -129.36 137.74 51.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.957 0.408 . . . . 3.75 111.222 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 89.8 mtt180 -129.79 148.46 51.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.437 -0.801 . . . . 2.75 109.803 171.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.664 ' HA ' ' O ' ' A' ' 110' ' ' MET . 51.8 t-20 -139.55 118.43 12.47 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.094 -0.336 . . . . 1.8200000000000001 110.094 172.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.444 ' HB2' ' HD3' ' A' ' 69' ' ' ARG . 43.1 t80 -103.0 119.56 39.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.167 -0.309 . . . . 3.1400000000000001 110.167 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.517 0 C-N-CA 120.295 -0.955 . . . . 2.79 112.166 178.46 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.2 p . . . . . 0 N--CA 1.446 -0.645 0 N-CA-C 110.031 -0.359 . . . . 3.2999999999999998 110.031 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -128.98 133.24 47.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.894 0.378 . . . . 1.76 111.232 -174.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.518 ' HB2' ' OD1' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -149.41 149.46 30.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.789 -0.641 . . . . 2.5499999999999998 110.107 177.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.664 ' O ' ' HA ' ' A' ' 94' ' ' ASN . 87.1 mtp -116.07 116.3 27.62 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.025 -0.534 . . . . 1.77 110.353 -176.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -94.66 119.87 33.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.903 0.383 . . . . 1.97 110.279 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.61 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 55.3 ttt180 -116.9 125.6 51.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.217 -0.447 . . . . 3.8500000000000001 110.767 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -115.89 135.95 53.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.825 -0.625 . . . . 2.2799999999999998 110.239 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.483 ' O ' ' HA2' ' A' ' 90' ' ' GLY . 45.4 tttm -122.24 123.56 41.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.712 -0.676 . . . . 2.1400000000000001 109.97 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.5 mm -120.03 120.34 62.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 109.286 -0.635 . . . . 1.55 109.286 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -141.49 105.03 5.93 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 111.863 0.32 . . . . 1.1899999999999999 111.863 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 85.4 Cg_endo -84.44 157.04 12.53 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.93 2.42 . . . . 1.3700000000000001 111.263 171.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -126.21 146.77 49.85 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.908 -0.317 . . . . 2.3500000000000001 110.854 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -126.24 130.79 51.62 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.977 -0.556 . . . . 4.54 110.796 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 85' ' ' SER . 42.1 t0 -60.06 140.08 57.06 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.207 0.942 . . . . 3.04 111.319 -176.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.794 ' HA ' ' O ' ' A' ' 129' ' ' PHE . 35.9 m -76.5 -22.67 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.944 -1.025 . . . . 4.2699999999999996 111.444 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -82.4 83.52 7.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.79 0.328 . . . . 6.04 110.439 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.2 tp -90.39 -79.78 0.34 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.224 -0.444 . . . . 4.5899999999999999 111.284 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 69.4 p -145.14 158.11 43.91 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.9 -0.136 . . . . 3.6899999999999999 111.101 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 58.49 25.22 12.76 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.774 0.671 . . . . 5.1699999999999999 112.271 170.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.471 ' HA ' HH12 ' A' ' 128' ' ' ARG . 25.1 m-20 57.04 30.0 17.45 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.064 0.459 . . . . 3.71 111.908 -176.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.1 mt -99.02 139.58 34.45 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.231 -1.026 . . . . 2.0499999999999998 108.231 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.652 ' HA ' ' O ' ' A' ' 121' ' ' VAL . 50.7 mmt-85 -107.99 120.17 41.55 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.213 -0.595 . . . . 4.2400000000000002 110.624 -174.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.794 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 90.2 m-85 -118.47 125.11 49.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.6 -0.727 . . . . 3.5499999999999998 109.79 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.483 ' O ' ' HA ' ' A' ' 156' ' ' THR . 24.0 t30 -110.77 126.24 54.39 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.609 -0.268 . . . . 2.1099999999999999 110.282 -175.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.79 117.38 1.85 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.087 -1.054 . . . . 1.1799999999999999 112.357 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.536 ' HB3' ' HB3' ' A' ' 155' ' ' GLU . 52.8 t-105 -126.6 129.91 49.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.398 -0.593 . . . . 4.2999999999999998 109.398 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 84.3 mt -118.06 138.27 52.35 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.715 -0.476 . . . . 2.2400000000000002 109.715 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.489 ' OG ' ' HB2' ' A' ' 153' ' ' GLU . 3.2 p -134.99 117.19 15.51 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.475 0.655 . . . . 1.6899999999999999 111.153 175.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 95.1 mmm -106.12 134.83 48.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.183 -0.917 . . . . 2.2400000000000002 109.288 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -124.9 133.83 52.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.012 0.434 . . . . 3.5600000000000001 111.888 -173.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 97.7 mttt -118.5 132.66 56.22 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.681 -0.859 . . . . 1.6699999999999999 108.681 171.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.578 ' H ' HD12 ' A' ' 142' ' ' LEU . 54.3 m-85 -123.03 143.04 50.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.508 0.194 . . . . 3.23 110.908 -174.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 59.79 -160.19 0.29 Allowed 'General case' 0 C--O 1.226 -0.171 0 O-C-N 123.856 0.722 . . . . 1.24 111.446 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -76.02 -36.06 59.27 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.952 0.406 . . . . 2.4700000000000002 110.483 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -60.29 -49.74 76.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.379 -0.828 . . . . 2.4100000000000001 113.169 -167.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.578 HD12 ' H ' ' A' ' 138' ' ' PHE . 14.7 mt -70.41 -27.18 64.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.74 -0.384 . . . . 1.8300000000000001 111.371 -176.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -60.72 -39.92 90.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.114 0.483 . . . . 2.0 110.343 172.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 85.0 m -70.05 -41.02 74.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.617 -0.72 . . . . 2.0499999999999998 111.018 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.556 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 56.3 p -74.82 -26.09 59.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 1.5900000000000001 111.718 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 69.0 -112.96 4.91 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.845 -0.693 . . . . 1.52 112.345 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -106.21 -0.19 24.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.691 0.281 . . . . 5.9400000000000004 110.801 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.85 -40.18 75.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.103 0.478 . . . . 1.8300000000000001 110.547 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.454 ' O ' HD22 ' A' ' 142' ' ' LEU . 24.2 t70 -135.94 111.57 9.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.489 -0.778 . . . . 2.6400000000000001 109.083 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.6 t -165.7 147.15 7.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.932 -0.576 . . . . 2.02 110.114 -173.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.421 ' HD3' ' OE2' ' A' ' 153' ' ' GLU . 24.5 ttm180 -70.71 135.71 48.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.611 0.243 . . . . 3.6699999999999999 110.508 175.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.91 120.08 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.176 -0.466 . . . . 1.6399999999999999 110.058 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.489 ' HB2' ' OG ' ' A' ' 134' ' ' SER . 96.4 mt-10 -119.97 139.96 51.66 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.444 -0.576 . . . . 2.5600000000000001 109.444 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 89.5 m -139.97 134.41 31.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.972 0.415 . . . . 1.3899999999999999 111.493 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 132' ' ' TRP . 41.6 tt0 -113.35 127.81 56.25 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.298 -0.63 . . . . 2.04 109.298 173.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 130' ' ' ASN . 35.5 m -129.0 120.46 26.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.847 0.356 . . . . 1.5600000000000001 110.474 177.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -116.21 133.9 11.07 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.709 -0.758 . . . . 1.04 111.601 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.517 ' HB2' HG13 ' A' ' 170' ' ' VAL . 52.6 mt -121.28 133.07 55.13 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.508 -0.553 . . . . 2.27 109.508 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 128' ' ' ARG . 54.1 tt0 -120.03 120.38 36.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.458 -0.337 . . . . 2.4100000000000001 110.419 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -121.55 131.0 53.88 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.358 -0.608 . . . . 4.5700000000000003 109.358 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.405 ' HB ' ' HA ' ' A' ' 164' ' ' GLU . 15.1 p -99.49 89.81 4.3 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.466 -0.494 . . . . 1.46 110.138 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.07 -49.1 78.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.61 -0.723 . . . . 2.6299999999999999 111.441 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.498 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.1 m-20 -100.0 12.68 36.26 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 121.119 -0.232 . . . . 2.4100000000000001 110.454 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.405 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 42.2 tt0 71.15 -49.51 0.68 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.725 0.81 . . . . 2.5800000000000001 111.762 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.2 t -74.84 -16.22 60.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.73 0.3 . . . . 2.2999999999999998 111.488 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 163' ' ' ASN . 17.9 m -125.58 141.45 45.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.853 0.359 . . . . 1.71 110.439 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.423 ' O ' ' HD2' ' A' ' 199' ' ' PRO . . . -107.23 139.43 41.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 1.47 110.909 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 31.2 mt -104.42 136.8 43.32 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.651 -0.87 . . . . 1.6599999999999999 108.651 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -118.34 120.12 36.68 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.444 -0.502 . . . . 3.2999999999999998 110.477 -176.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.517 HG13 ' HB2' ' A' ' 158' ' ' LEU . 3.5 p -129.69 131.95 66.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.744 -0.662 . . . . 1.3 109.752 176.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.485 HD21 ' CG ' ' A' ' 155' ' ' GLU . 26.8 t-20 -127.84 130.05 47.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.002 -0.545 . . . . 2.2200000000000002 110.163 -176.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -101.01 121.67 42.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.009 -0.542 . . . . 4.6100000000000003 109.626 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -97.3 110.0 22.64 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.155 -0.683 . . . . 3.98 109.155 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.541 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 61.2 tp -103.63 115.67 30.92 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.084 -0.507 . . . . 2.3799999999999999 110.372 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -122.06 114.21 20.61 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.634 -0.876 . . . . 3.3100000000000001 108.634 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 116.261 -0.427 . . . . 6.5300000000000002 111.068 -176.349 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 . . . . . 0 CA--C 1.522 -0.107 0 CA-C-O 121.081 0.467 . . . . 4.4000000000000004 111.363 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.699 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 18.5 tt -149.27 146.57 17.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.976 -0.556 . . . . 2.21 109.645 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.517 ' HB3' ' HB3' ' A' ' 210' ' ' TYR . 96.6 mtt180 -121.93 110.08 15.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.723 0.297 . . . . 3.54 110.774 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -137.21 141.76 42.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.544 -0.298 . . . . 1.6699999999999999 111.186 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -163.53 174.99 11.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.647 -0.871 . . . . 5.8300000000000001 108.647 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 7.0 mp -98.64 125.61 42.03 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.045 -0.724 . . . . 2.5899999999999999 109.045 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' A' ' 167' ' ' ALA . 36.5 Cg_exo -60.07 138.75 83.83 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.1 1.867 . . . . 1.77 111.672 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 77.9 mt -116.94 131.81 56.86 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.183 -0.673 . . . . 2.2599999999999998 109.183 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 11.6 t -147.94 139.87 24.05 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.189 0.518 . . . . 1.99 110.838 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 57.2 tp -143.89 85.46 1.82 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.542 -0.754 . . . . 2.3100000000000001 109.354 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 75.92 -112.29 3.55 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.858 -0.686 . . . . 1.51 112.487 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -93.94 0.02 55.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.204 0.526 . . . . 2.5699999999999998 110.351 -177.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -110.56 116.56 31.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.725 -0.67 . . . . 2.6600000000000001 110.105 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 49.2 m -122.6 131.05 53.64 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.842 -0.429 . . . . 1.6200000000000001 109.842 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.27 130.01 72.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.044 -0.354 . . . . 1.3799999999999999 110.044 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.7 m -127.72 90.34 48.38 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-O 120.915 0.388 . . . . 1.1799999999999999 110.484 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 238' ' ' GLY . 5.8 Cg_exo -79.58 150.45 21.79 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.167 2.578 . . . . 1.01 112.081 175.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.517 ' HB3' ' HB3' ' A' ' 195' ' ' ARG . 80.9 m-85 -126.08 139.93 52.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.024 0.44 . . . . 4.5 111.316 173.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 7.0 t -154.43 169.22 24.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.368 -0.975 . . . . 1.8899999999999999 108.368 175.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.699 ' HA ' ' O ' ' A' ' 194' ' ' ILE . 67.3 ttt180 -60.29 -49.19 78.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.385 0.539 . . . . 4.7999999999999998 111.015 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.6 mt . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 109.584 -0.524 . . . . 4.5700000000000003 109.584 179.443 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 109.675 -0.491 . . . . 2.3999999999999999 109.675 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 209' ' ' PRO . . . -92.14 117.08 5.19 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.427 -0.892 . . . . 1.27 111.265 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.49 119.72 39.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.876 0.37 . . . . 1.97 110.305 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -99.89 119.92 38.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.76 -0.655 . . . . 3.54 109.287 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 252' ' ' SER . 91.1 m-85 -100.53 126.69 47.0 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.813 -0.44 . . . . 2.6400000000000001 109.813 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -116.25 121.46 5.21 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.798 -0.715 . . . . 1.3500000000000001 111.607 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' TYR . . . . . 0.442 ' HB2' ' HB ' ' A' ' 251' ' ' VAL . 89.7 m-85 -119.94 130.25 54.71 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.802 -0.444 . . . . 4.3600000000000003 109.802 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -112.65 128.7 56.46 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.456 -0.572 . . . . 4.29 109.456 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.92 140.19 51.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.159 0.505 . . . . 6.6900000000000004 110.391 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -60.0 -29.49 68.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.058 -0.974 . . . . 6.3700000000000001 112.24 -171.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -69.47 -20.01 63.75 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.607 0.241 . . . . 5.8300000000000001 111.486 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 116.22 0.0 20.76 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.548 -0.834 . . . . 2.6600000000000001 112.259 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.433 HD13 ' CD2' ' A' ' 279' ' ' TYR . 53.5 tp -74.98 129.96 38.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.869 0.366 . . . . 2.9700000000000002 110.256 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 25.8 t -122.06 130.26 53.12 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.261 -0.644 . . . . 2.1699999999999999 109.261 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 243' ' ' TYR . 62.9 t -119.99 132.85 68.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.42 -0.355 . . . . 1.79 110.666 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 241' ' ' TYR . 35.2 t -127.73 128.45 45.39 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.068 -0.716 . . . . 1.6299999999999999 109.068 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 81.6 mt -121.38 139.93 52.79 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.652 -0.249 . . . . 2.96 110.82 -178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -114.35 110.67 20.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.182 -0.463 . . . . 4.0800000000000001 110.536 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -131.92 148.67 52.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.35 -0.386 . . . . 4.8399999999999999 110.34 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.555 0 CA-C-O 121.24 0.543 . . . . 3.5800000000000001 110.087 175.803 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.607 -0.516 . . . . 1.9399999999999999 109.607 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.07 133.61 7.34 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.216 -0.992 . . . . 1.4199999999999999 112.343 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 61.8 t -127.86 129.82 69.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.956 -0.387 . . . . 1.8100000000000001 109.956 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -132.76 111.85 1.06 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.227 -0.749 . . . . 1.3 111.227 176.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 23.8 m -119.98 132.36 69.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.845 0.355 . . . . 1.8300000000000001 110.815 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -119.71 127.75 53.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.153 -0.476 . . . . 2.3100000000000001 110.368 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.433 ' CD2' HD13 ' A' ' 249' ' ' LEU . 89.6 m-85 -105.99 130.27 53.95 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.044 -0.725 . . . . 4.75 109.044 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.1 t -117.68 125.05 49.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.841 0.353 . . . . 1.6699999999999999 111.172 -172.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.281 -0.866 . . . . 3.6899999999999999 109.858 179.193 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 . . . . . 0 CA--C 1.518 -0.276 0 N-CA-C 109.816 -0.439 . . . . 3.6099999999999999 109.816 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -71.78 118.18 14.3 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.674 -0.491 . . . . 3.3300000000000001 109.674 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.468 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 96.4 m-70 -104.14 124.94 50.0 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.104 0.478 . . . . 3.2000000000000002 110.671 -176.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.97 139.94 51.7 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.422 -0.808 . . . . 2.4900000000000002 109.264 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -129.12 129.63 45.42 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.036 -0.728 . . . . 2.1299999999999999 109.036 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.6 mm -120.53 120.08 61.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.901 -0.407 . . . . 1.6000000000000001 109.901 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -102.74 137.69 13.53 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.065 -1.064 . . . . 0.88 111.331 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.17 135.36 54.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.921 0.391 . . . . 1.0800000000000001 110.248 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 59.4 ttm -134.6 130.95 37.24 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.696 -0.683 . . . . 2.3300000000000001 110.026 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -99.84 121.64 41.6 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.486 -0.561 . . . . 2.6099999999999999 109.486 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 5.0899999999999999 110.519 179.908 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.897 0.379 . . . . 3.48 111.278 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.38 133.59 28.68 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.088 1.859 . . . . 1.8600000000000001 110.679 171.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.8 m -128.45 147.25 50.65 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.561 -0.29 . . . . 1.97 110.654 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 19.5 m -120.13 146.69 24.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.382 -0.372 . . . . 1.71 110.475 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -119.96 142.65 48.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.03 -0.532 . . . . 4.0700000000000003 109.608 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 64.4 t80 -101.7 129.87 47.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.863 0.363 . . . . 2.8599999999999999 110.602 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -144.38 134.87 24.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.79 -0.641 . . . . 1.8899999999999999 109.351 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.74 146.7 39.87 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.309 -0.244 . . . . 1.0800000000000001 111.425 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 8' ' ' HIS . . . -154.95 122.53 5.7 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 111.936 0.347 . . . . 1.3899999999999999 111.936 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.656 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 53.8 t30 -167.87 95.56 0.43 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.391 -0.368 . . . . 2.8599999999999999 110.207 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.69 -94.72 2.02 Favored Glycine 0 C--O 1.23 -0.134 0 C-N-CA 121.012 -0.614 . . . . 1.6799999999999999 111.67 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.656 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 80.8 Cg_exo -47.19 175.74 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 123.912 3.075 . . . . 1.6599999999999999 113.357 167.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -66.1 176.68 1.62 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.428 0.632 . . . . 3.3999999999999999 111.441 -172.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.401 ' HG3' ' HB2' ' A' ' 40' ' ' ALA . 19.1 ttm180 -110.62 124.18 51.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.707 -0.678 . . . . 3.1000000000000001 109.649 -171.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.44 HG12 HG22 ' A' ' 74' ' ' VAL . 85.3 mt -119.58 130.01 74.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.664 -0.698 . . . . 1.8 110.915 -169.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -118.96 130.0 55.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.85999999999999999 110.419 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 72' ' ' LEU . 65.2 tp -124.57 135.66 53.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.138 -0.483 . . . . 1.0600000000000001 111.241 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.98 162.47 35.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.663 -0.699 . . . . 1.1399999999999999 110.121 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -137.42 146.87 44.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.821 0.344 . . . . 4.0199999999999996 110.345 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.436 ' HB2' ' HG3' ' A' ' 69' ' ' ARG . 96.1 m-85 -130.05 129.95 44.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.229 -0.441 . . . . 4.6100000000000003 111.306 -175.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -104.54 85.94 2.42 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.281 -0.637 . . . . 3.3799999999999999 109.281 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.552 ' CD ' HH21 ' A' ' 69' ' ' ARG . 42.2 mt-10 . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.857 -0.61 . . . . 5.0499999999999998 110.907 -173.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 87.6 m95 . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.637 0.256 . . . . 5.6100000000000003 110.616 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -125.66 138.65 53.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.459 -0.337 . . . . 3.7799999999999998 110.153 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -131.99 170.03 15.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.366 -0.379 . . . . 2.4500000000000002 110.173 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.552 HH21 ' CD ' ' A' ' 53' ' ' GLU . 27.9 ptt180 -141.84 125.7 9.96 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.979 0.418 . . . . 3.2400000000000002 111.196 171.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 90.9 Cg_endo -85.19 156.85 11.15 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.999 2.466 . . . . 1.1899999999999999 112.25 172.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.441 ' HG3' ' HE ' ' A' ' 93' ' ' ARG . 86.1 tt0 -127.09 120.77 29.7 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.123 -0.695 . . . . 2.1899999999999999 109.123 171.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.592 ' O ' ' HA3' ' A' ' 91' ' ' GLY . 64.3 tp -136.21 119.09 16.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.346 -0.388 . . . . 1.1399999999999999 110.208 -177.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.59 149.22 50.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.122 0.487 . . . . 2.1800000000000002 110.864 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 46' ' ' ILE . 50.6 t -119.96 130.04 74.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.447 -0.797 . . . . 1.5600000000000001 109.272 177.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -93.73 120.51 34.09 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.704 -0.48 . . . . 3.4399999999999999 109.704 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -108.2 134.85 50.47 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.105 -0.702 . . . . 4.7999999999999998 109.105 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -120.0 131.29 55.09 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.68 0.276 . . . . 2.9399999999999999 110.318 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -119.58 138.57 53.13 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.29 0.567 . . . . 3.8999999999999999 111.167 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.0 mt . . . . . 0 C--N 1.324 -0.522 0 N-CA-C 108.684 -0.858 . . . . 4.4800000000000004 108.684 177.433 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 CA--C 1.52 -0.21 0 CA-C-O 120.894 0.378 . . . . 2.5499999999999998 111.698 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -94.43 103.89 15.86 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.271 -0.572 . . . . 5.2999999999999998 109.65 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -113.97 125.65 6.99 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.979 -0.848 . . . . 1.3500000000000001 110.979 176.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 60.0 tp -119.64 130.53 55.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.837 0.351 . . . . 2.29 111.02 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.2 p -117.04 131.86 56.83 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.788 -0.819 . . . . 1.54 108.788 169.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.43 150.46 20.88 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.235 -0.983 . . . . 1.1699999999999999 111.585 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 72' ' ' LEU . . . -173.16 -169.96 36.23 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.632 -0.794 . . . . 1.1899999999999999 112.07 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -120.21 139.98 51.85 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.062 0.458 . . . . 3.75 110.819 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.441 ' HE ' ' HG3' ' A' ' 71' ' ' GLU . 98.2 mtt180 -121.04 127.21 51.5 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.492 -0.929 . . . . 2.75 108.492 172.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.553 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 10.4 t30 -132.25 124.61 29.26 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.78 -0.368 . . . . 1.8200000000000001 110.674 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.487 ' HA ' ' HB3' ' A' ' 69' ' ' ARG . 72.1 t80 -111.28 129.54 55.95 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.331 -0.395 . . . . 3.1400000000000001 110.435 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.541 0 C-N-CA 120.68 -0.772 . . . . 2.79 112.574 177.499 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.2 t . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 109.049 -0.723 . . . . 3.2999999999999998 109.049 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.62 113.25 7.02 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.623 -0.431 . . . . 1.76 110.864 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -147.02 138.56 24.19 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.045 -0.525 . . . . 2.5499999999999998 110.139 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.493 ' HG3' ' HA ' ' A' ' 139' ' ' ALA . 46.4 ttm -131.65 129.91 41.4 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.622 -0.717 . . . . 1.77 110.71 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -101.87 124.96 48.39 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.491 -0.559 . . . . 1.97 109.491 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.42 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 80.6 ttt180 -130.55 130.15 43.71 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.134 0.492 . . . . 3.8500000000000001 110.328 -175.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -112.2 141.73 45.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.742 -0.663 . . . . 2.2799999999999998 110.79 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -139.89 123.59 17.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.177 -0.465 . . . . 2.1400000000000001 110.424 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 88.0 mt -136.76 130.15 45.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.513 -0.767 . . . . 1.55 109.039 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -149.46 104.19 3.28 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.678 0.622 . . . . 1.1899999999999999 112.678 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 65.0 Cg_endo -94.43 159.77 1.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.463 2.775 . . . . 1.3700000000000001 113.036 170.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -120.6 142.51 49.33 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.379 -0.971 . . . . 2.3500000000000001 108.379 173.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -125.78 129.92 50.41 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.474 0.176 . . . . 4.54 111.474 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -84.1 120.89 26.7 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.576 -0.527 . . . . 3.04 109.576 170.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.57 ' O ' ' HB3' ' A' ' 129' ' ' PHE . 57.3 t -139.88 99.92 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.886 0.375 . . . . 4.2699999999999996 110.282 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -87.61 115.92 25.38 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.113 -0.328 . . . . 6.04 110.113 176.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.78 -39.81 95.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.413 0.625 . . . . 4.5899999999999999 109.322 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.0 p -141.4 169.92 16.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.873 -1.058 . . . . 3.6899999999999999 109.178 172.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.14 -45.44 93.05 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.839 0.311 . . . . 5.1699999999999999 111.839 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -64.94 -39.95 94.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 3.71 111.552 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.5 mt -76.16 142.57 41.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.43 0.634 . . . . 2.0499999999999998 112.11 -172.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.541 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 35.2 ttt180 -110.31 118.07 35.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.252 -0.886 . . . . 4.2400000000000002 109.248 175.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.57 ' HB3' ' O ' ' A' ' 121' ' ' VAL . 65.0 t80 -142.11 138.48 31.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.728 0.299 . . . . 3.5499999999999998 110.372 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -139.87 172.2 13.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 2.1099999999999999 109.913 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -148.23 121.99 1.44 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.776 -0.726 . . . . 1.1799999999999999 112.072 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -100.02 126.52 46.22 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.389 -0.597 . . . . 4.2999999999999998 109.389 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 42.6 tp -111.98 130.71 55.76 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.26 -0.427 . . . . 2.2400000000000002 110.117 -178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.1 m -127.0 129.99 49.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.901 0.382 . . . . 1.6899999999999999 110.308 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.613 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 72.0 mtm -122.91 125.19 44.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.849 -0.614 . . . . 2.2400000000000002 109.958 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -122.17 139.94 53.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.116 -0.493 . . . . 3.5600000000000001 111.774 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -135.78 149.98 49.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.323 -0.991 . . . . 1.6699999999999999 108.323 172.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.475 ' O ' HD23 ' A' ' 142' ' ' LEU . 46.2 p90 -140.5 165.93 26.1 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.095 -0.335 . . . . 3.23 110.095 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.493 ' HA ' ' HG3' ' A' ' 110' ' ' MET . . . 63.42 178.15 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.512 0.507 . . . . 1.24 111.018 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -76.1 -36.63 58.82 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.313 0.578 . . . . 2.4700000000000002 110.6 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -60.07 -40.02 88.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.253 -0.885 . . . . 2.4100000000000001 112.956 -171.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 138' ' ' PHE . 4.2 mm? -69.38 -33.4 72.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.696 0.284 . . . . 1.8300000000000001 111.535 -173.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -66.62 -39.93 88.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.365 0.602 . . . . 2.0 109.517 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 52.4 m -65.77 -39.95 91.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.2 -0.909 . . . . 2.0499999999999998 111.395 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 22.9 p -71.7 -9.87 58.91 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 111.89 0.33 . . . . 1.5900000000000001 111.89 -177.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 65.43 -120.34 17.19 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.786 -0.721 . . . . 1.52 111.857 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -103.29 10.09 37.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.854 0.327 . . . . 5.9400000000000004 111.016 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.48 -40.12 95.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.885 0.374 . . . . 1.8300000000000001 110.499 176.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -137.14 114.87 11.27 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.298 -0.631 . . . . 2.6400000000000001 109.298 175.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.1 t -159.95 150.05 18.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.918 0.39 . . . . 2.02 110.543 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 135' ' ' MET . 19.0 mtp180 -84.47 113.35 21.14 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.051 -0.351 . . . . 3.6699999999999999 110.051 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.9 t -111.15 103.7 15.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.98 -0.748 . . . . 1.6399999999999999 108.98 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -121.99 128.91 52.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.549 -0.75 . . . . 2.5600000000000001 110.016 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 72.7 m -128.49 130.22 47.2 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.033 0.444 . . . . 1.3899999999999999 111.527 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.403 ' CD ' HH22 ' A' ' 195' ' ' ARG . 37.2 tt0 -110.4 119.22 38.5 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.01 -0.737 . . . . 2.04 109.01 173.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 172' ' ' TYR . 22.7 p -101.36 141.67 33.89 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.726 -0.39 . . . . 1.5600000000000001 110.727 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 129' ' ' PHE . . . -116.7 120.02 4.69 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.723 -0.751 . . . . 1.04 112.095 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.6 tp -115.2 129.76 56.73 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.91 0.386 . . . . 2.27 110.151 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.541 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 30.1 tt0 -118.98 115.85 25.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.521 -0.548 . . . . 2.4100000000000001 109.521 174.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -125.39 130.53 52.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.795 -0.638 . . . . 4.5700000000000003 110.218 -175.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 3.7 p -87.58 93.9 9.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.064 0.459 . . . . 1.46 110.853 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.475 ' HB2' HD11 ' A' ' 168' ' ' LEU . 65.8 t80 -59.99 -49.82 76.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 2.6299999999999999 111.547 -176.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.423 ' HB2' HG22 ' A' ' 166' ' ' VAL . 93.0 m-20 -101.8 16.65 25.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.544 -0.298 . . . . 2.4100000000000001 110.861 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 163' ' ' ASN . 46.0 tt0 73.03 -50.19 0.7 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.763 0.664 . . . . 2.5800000000000001 111.419 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.1 p -74.78 -21.41 59.34 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.037 0.384 . . . . 2.2999999999999998 112.037 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 161' ' ' THR . 34.3 m -120.03 138.16 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.776 0.322 . . . . 1.71 110.724 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.0 134.4 50.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.215 -0.448 . . . . 1.47 110.29 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.475 HD11 ' HB2' ' A' ' 162' ' ' PHE . 43.8 mt -103.55 139.92 38.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.34 -0.391 . . . . 1.6599999999999999 110.024 -176.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 55.6 mtp180 -98.9 114.36 26.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.212 -0.449 . . . . 3.2999999999999998 109.882 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 195' ' ' ARG . 60.3 t -129.16 132.3 67.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 1.3 110.569 -177.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.435 ' O ' HG23 ' A' ' 194' ' ' ILE . 18.9 m120 -122.52 147.91 45.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.971 0.415 . . . . 2.2200000000000002 110.868 173.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.53 ' HB3' ' OG1' ' A' ' 156' ' ' THR . 64.5 t80 -129.09 147.09 50.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.487 -0.779 . . . . 4.6100000000000003 109.811 -173.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -96.63 125.49 41.14 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 120.757 0.313 . . . . 3.98 110.714 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 67.7 tp -120.83 114.02 20.99 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.257 -0.645 . . . . 2.3799999999999999 109.257 171.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -125.18 113.43 17.66 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.629 -0.508 . . . . 3.3100000000000001 109.629 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.063 0.459 . . . . 6.5300000000000002 111.021 -176.247 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.461 ' HA ' ' HG3' ' A' ' 212' ' ' ARG . 35.8 tt0 . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.077 -0.342 . . . . 4.4000000000000004 110.077 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 171' ' ' ASN . 87.3 mt -110.2 143.29 20.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 122.358 0.263 . . . . 2.21 111.188 -173.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.583 ' HB3' ' CD1' ' A' ' 210' ' ' TYR . 53.9 mtm-85 -98.41 102.84 14.7 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.904 -0.776 . . . . 3.54 108.904 169.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 169' ' ' ARG . . . -141.08 121.7 14.22 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.918 -0.313 . . . . 1.6699999999999999 111.014 177.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.405 ' HB3' ' O ' ' A' ' 209' ' ' PRO . 10.2 t80 -165.76 -179.11 5.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.648 -0.501 . . . . 5.8300000000000001 109.648 171.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.551 HD12 ' HD2' ' A' ' 199' ' ' PRO . 24.3 tp -99.44 126.58 37.09 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.315 -0.624 . . . . 2.5899999999999999 109.315 173.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.551 ' HD2' HD12 ' A' ' 198' ' ' LEU . 38.3 Cg_endo -70.06 145.79 56.46 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.139 1.892 . . . . 1.77 112.225 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 56.1 mt -118.41 130.72 56.13 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.085 -0.507 . . . . 2.2599999999999998 109.655 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 26.8 m -131.12 125.15 32.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.983 0.42 . . . . 1.99 110.996 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 91.8 mt -131.37 80.97 1.96 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.57 -0.741 . . . . 2.3100000000000001 109.47 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 68.62 -115.83 6.94 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.802 -0.713 . . . . 1.51 112.105 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -90.12 -0.59 57.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.209 0.528 . . . . 2.5699999999999998 110.117 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.435 ' CD2' ' HE2' ' A' ' 243' ' ' TYR . 75.7 m80 -99.9 117.23 33.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.539 -0.755 . . . . 2.6600000000000001 109.01 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 12.5 t -132.14 130.97 41.82 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.629 -0.428 . . . . 1.6200000000000001 110.24 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.8 p -137.56 134.98 46.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.408 0.623 . . . . 1.3799999999999999 110.862 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 29.0 m -128.95 91.78 41.74 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 115.667 -0.697 . . . . 1.1799999999999999 109.846 176.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.405 ' O ' ' HB3' ' A' ' 197' ' ' TYR . 14.4 Cg_exo -69.74 157.16 61.4 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.599 2.199 . . . . 1.01 110.664 174.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 195' ' ' ARG . 71.0 m-85 -129.29 139.79 51.66 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.997 -0.372 . . . . 4.5 109.997 175.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 39.5 p -124.25 140.02 53.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.987 0.422 . . . . 1.8899999999999999 110.385 176.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.461 ' HG3' ' HA ' ' A' ' 193' ' ' GLU . 37.7 ttt180 -64.27 -39.67 94.41 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 114.795 -1.093 . . . . 4.7999999999999998 112.748 -170.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.9 mt . . . . . 0 C--N 1.321 -0.643 0 CA-C-O 120.742 0.306 . . . . 4.5700000000000003 110.383 -174.917 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 210' ' ' TYR . 71.0 t . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 120.932 0.396 . . . . 2.3999999999999999 110.031 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -110.39 141.79 16.42 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.599 -0.81 . . . . 1.27 111.807 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 88.9 mt -109.72 117.65 34.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.158 -0.312 . . . . 1.97 110.158 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -101.09 120.11 39.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.205 -0.452 . . . . 3.54 109.95 175.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.555 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 86.8 m-85 -111.94 130.19 55.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.097 0.475 . . . . 2.6400000000000001 110.349 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -121.32 113.7 2.39 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 111.027 -0.829 . . . . 1.3500000000000001 111.027 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' TYR . . . . . 0.435 ' HE2' ' CD2' ' A' ' 205' ' ' HIS . 86.5 m-85 -119.96 135.25 54.98 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.178 0.513 . . . . 4.3600000000000003 111.501 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -110.0 100.82 9.71 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.408 -0.815 . . . . 4.29 109.077 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -77.55 -19.95 54.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.976 0.417 . . . . 6.6900000000000004 110.959 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -149.93 150.46 31.91 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.738 -0.838 . . . . 6.3700000000000001 108.738 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -66.97 121.68 16.06 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.423 -0.511 . . . . 5.8300000000000001 109.682 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 98.53 -9.71 62.65 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.778 -0.646 . . . . 2.6600000000000001 112.43 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 93.1 mt -124.23 133.0 53.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.721 0.296 . . . . 2.9700000000000002 110.616 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 33.7 m -129.98 149.96 51.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.368 -0.378 . . . . 2.1699999999999999 110.772 -176.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 8.5 p -127.41 134.07 66.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.17 0.51 . . . . 1.79 109.845 174.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 19.3 t -103.9 119.89 39.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.716 -0.674 . . . . 1.6299999999999999 109.747 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 77.9 mt -119.42 113.05 20.18 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.145 -0.479 . . . . 2.96 110.068 -178.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -109.05 129.55 55.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.945 0.402 . . . . 4.0800000000000001 111.036 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -128.14 151.3 49.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.823 -0.626 . . . . 4.8399999999999999 110.441 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 116.164 -0.471 . . . . 3.5800000000000001 110.568 -179.522 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 110.445 -0.206 . . . . 1.9399999999999999 110.445 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 177.69 -169.74 41.86 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.747 -0.739 . . . . 1.4199999999999999 112.333 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 63.2 t -110.12 128.89 65.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.867 0.365 . . . . 1.8100000000000001 110.667 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.86 141.21 12.46 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.508 -0.637 . . . . 1.3 111.508 176.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 61.6 t -120.02 129.96 74.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 117.093 0.447 . . . . 1.8300000000000001 110.162 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -108.11 109.33 20.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.935 0.398 . . . . 2.3100000000000001 110.058 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -100.02 107.9 19.96 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.872 -0.788 . . . . 4.75 108.872 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.6 m -119.54 132.27 55.71 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.998 0.428 . . . . 1.6699999999999999 111.248 -172.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 59.2 t80 . . . . . 0 C--O 1.241 0.617 0 CA-C-O 118.411 -0.804 . . . . 3.6899999999999999 109.225 176.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 121.162 0.506 . . . . 3.6099999999999999 111.322 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.517 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 71.0 m95 -119.79 147.24 44.88 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.151 -0.685 . . . . 3.3300000000000001 109.151 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.662 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 11.6 t-160 -96.44 113.37 24.94 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.624 -0.51 . . . . 3.2000000000000002 109.624 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.517 ' CE1' ' HB2' ' A' ' 7' ' ' TRP . 95.0 m-85 -110.41 158.88 18.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.904 -0.589 . . . . 2.4900000000000002 111.108 -176.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -141.42 132.3 25.93 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.809 -0.632 . . . . 2.1299999999999999 109.326 170.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.5 mt -119.8 114.09 43.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.974 -0.75 . . . . 1.6000000000000001 108.974 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.81 127.25 8.18 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.265 -0.969 . . . . 0.88 112.128 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -115.69 134.45 55.02 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 110.057 -0.349 . . . . 1.0800000000000001 110.057 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.607 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 94.8 mmm -124.31 131.03 53.5 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.859 -0.61 . . . . 2.3300000000000001 109.372 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -85.82 109.1 18.44 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.769 -0.456 . . . . 2.6099999999999999 109.769 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 C--N 1.325 -0.492 0 CA-C-O 121.145 0.498 . . . . 5.0899999999999999 110.706 -175.314 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.855 0.359 . . . . 3.48 111.026 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 14' ' ' MET . 76.9 Cg_endo -81.2 135.31 9.57 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.669 2.246 . . . . 1.8600000000000001 112.198 172.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 56.2 m -103.21 142.36 34.29 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.421 -0.585 . . . . 1.97 109.421 174.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 m -110.87 134.47 53.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.28 0.562 . . . . 1.71 111.309 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -119.9 132.08 55.43 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.59 -0.732 . . . . 4.0700000000000003 109.817 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 94.1 m-85 -105.37 127.95 53.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.031 -0.359 . . . . 2.8599999999999999 110.031 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.414 HD21 ' HD2' ' A' ' 45' ' ' ARG . 46.3 t30 -130.89 138.02 49.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.947 -0.39 . . . . 1.8899999999999999 109.947 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.57 143.13 50.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.711 -0.222 . . . . 1.0800000000000001 110.691 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.662 ' O ' ' HB3' ' A' ' 8' ' ' HIS . . . -154.14 117.37 4.54 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.366 -0.379 . . . . 1.3899999999999999 111.33 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.479 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 25.4 t-20 -163.49 95.42 0.82 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.642 -0.503 . . . . 2.8599999999999999 109.642 173.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.82 -97.59 2.31 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.037 -0.601 . . . . 1.6799999999999999 111.76 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 51.3 Cg_exo -55.3 174.16 0.26 Allowed 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.52 2.813 . . . . 1.6599999999999999 113.515 172.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.523 ' HB3' ' O ' ' A' ' 75' ' ' HIS . 24.4 m-90 -70.15 -176.24 1.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.551 -0.749 . . . . 3.3999999999999999 111.064 -175.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.536 ' HG2' ' HB2' ' A' ' 40' ' ' ALA . 36.7 mtm-85 -112.06 149.96 31.35 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.529 0.68 . . . . 3.1000000000000001 112.732 -163.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.497 HG22 HG12 ' A' ' 74' ' ' VAL . 47.5 pt -128.88 140.05 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 114.606 -1.179 . . . . 1.8 110.244 175.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -120.06 128.88 53.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.189 -0.46 . . . . 0.85999999999999999 110.09 177.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.6 tp -125.19 136.59 53.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.102 0.477 . . . . 1.0600000000000001 110.922 -176.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.76 168.15 20.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.456 -0.793 . . . . 1.1399999999999999 109.376 176.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -140.02 145.58 37.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.588 0.232 . . . . 4.0199999999999996 110.665 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.572 ' HB2' ' CG ' ' A' ' 69' ' ' ARG . 89.6 m-85 -135.75 148.97 49.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.307 -0.406 . . . . 4.6100000000000003 109.937 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -136.43 170.22 16.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.619 -0.264 . . . . 3.3799999999999999 111.323 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 115.938 -0.574 . . . . 5.0499999999999998 110.774 -179.514 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 35.6 p90 . . . . . 0 N--CA 1.455 -0.184 0 N-CA-C 109.83 -0.433 . . . . 5.6100000000000003 109.83 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.522 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 95.0 m-85 -109.2 127.64 54.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.039 0.447 . . . . 3.7799999999999998 111.057 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -97.2 166.45 11.56 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.761 -0.654 . . . . 2.4500000000000002 110.637 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.572 ' CG ' ' HB2' ' A' ' 51' ' ' TYR . 6.6 ptp180 -150.48 125.53 4.76 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 121.113 0.483 . . . . 3.2400000000000002 110.577 171.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 75.6 Cg_endo -89.41 158.78 5.47 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.005 2.47 . . . . 1.1899999999999999 112.268 172.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.651 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 39.5 tt0 -131.25 111.72 12.15 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.351 -0.611 . . . . 2.1899999999999999 109.351 173.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.8 tp -125.01 120.0 30.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.278 -0.419 . . . . 1.1399999999999999 110.424 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 39.0 tt0 -121.38 130.05 53.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.657 -0.497 . . . . 2.1800000000000002 109.657 177.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.497 HG12 HG22 ' A' ' 46' ' ' ILE . 29.6 m -112.67 136.38 49.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.986 0.422 . . . . 1.5600000000000001 109.961 -177.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.523 ' O ' ' HB3' ' A' ' 44' ' ' TRP . 63.2 m80 -116.64 119.6 36.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.081 -0.508 . . . . 3.4399999999999999 110.837 -171.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -113.62 126.08 54.88 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.099 -0.704 . . . . 4.7999999999999998 109.099 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -120.3 134.08 55.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.954 0.406 . . . . 2.9399999999999999 110.708 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -90.6 86.49 6.41 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.514 -0.766 . . . . 3.8999999999999999 109.158 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--N 1.32 -0.682 0 N-CA-C 108.439 -0.949 . . . . 4.4800000000000004 108.439 174.209 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.4 m . . . . . 0 N--CA 1.449 -0.496 0 CA-C-O 121.204 0.526 . . . . 2.5499999999999998 110.249 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -130.56 149.65 52.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.587 -0.894 . . . . 5.2999999999999998 108.587 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.23 154.13 21.84 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.033 -1.08 . . . . 1.3500000000000001 112.708 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.2 mt -134.93 129.87 34.97 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.172 -0.677 . . . . 2.29 109.172 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.1 t -133.96 139.47 46.12 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.111 0.481 . . . . 1.54 110.409 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 73' ' ' GLU . . . -132.96 132.79 6.71 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 111.34 -0.704 . . . . 1.1699999999999999 111.34 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.11 123.23 5.6 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.884 -0.674 . . . . 1.1899999999999999 111.892 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -112.01 122.12 46.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.633 0.254 . . . . 3.75 110.541 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.651 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 72.1 mtm180 -131.36 129.78 41.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.307 -0.406 . . . . 2.75 110.064 173.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.482 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 64.2 t30 -128.51 117.72 21.8 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.958 -0.386 . . . . 1.8200000000000001 109.958 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -109.84 126.67 54.06 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.742 0.306 . . . . 3.1400000000000001 110.372 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 67' ' ' PHE . . . . . . . . 0 N--CA 1.442 -0.947 0 C-N-CA 120.201 -0.999 . . . . 2.79 112.233 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 108.667 -0.864 . . . . 3.2999999999999998 108.667 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -119.39 115.29 23.79 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 120.631 -0.427 . . . . 1.76 110.921 -173.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -153.53 137.41 16.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.887 -0.597 . . . . 2.5499999999999998 111.593 -175.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 44.6 ttm -132.33 123.63 27.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.558 -0.746 . . . . 1.77 109.863 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.499 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 78.3 mt-30 -107.25 127.24 53.36 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 120.123 -0.631 . . . . 1.97 110.212 175.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.551 ' HB2' ' HB2' ' A' ' 93' ' ' ARG . 95.4 mtt180 -110.13 113.36 25.98 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.999 -0.741 . . . . 3.8500000000000001 108.999 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -107.4 122.56 46.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.965 -0.561 . . . . 2.2799999999999998 111.036 -176.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -114.71 123.77 50.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.651 -0.704 . . . . 2.1400000000000001 109.986 175.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 11.8 tt -131.12 129.82 63.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.932 -0.396 . . . . 1.55 109.932 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -149.93 121.16 4.03 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.558 -0.292 . . . . 1.1899999999999999 111.482 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -90.3 135.61 2.22 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 122.916 2.411 . . . . 1.3700000000000001 111.371 169.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -104.12 139.64 38.91 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.436 -0.579 . . . . 2.3500000000000001 109.436 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -132.21 140.66 48.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.377 0.608 . . . . 4.54 111.413 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -134.43 79.14 1.79 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.902 -1.045 . . . . 3.04 108.406 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.525 ' O ' ' HB3' ' A' ' 129' ' ' PHE . 63.1 t -129.99 125.39 60.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.758 -0.655 . . . . 4.2699999999999996 110.518 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.476 ' HD3' ' HB2' ' A' ' 129' ' ' PHE . 59.4 tptt -140.3 135.73 32.54 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.311 -0.626 . . . . 6.04 109.311 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.9 tp -60.52 -31.32 70.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.557 -0.747 . . . . 4.5899999999999999 111.921 -176.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.414 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 21.9 m -108.35 135.3 49.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.941 0.4 . . . . 3.6899999999999999 110.106 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -63.01 -39.79 95.81 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.28 -0.873 . . . . 5.1699999999999999 112.181 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -70.0 -15.47 63.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.906 -0.588 . . . . 3.71 111.234 -176.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.8 mt -111.82 154.22 25.43 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.908 -0.587 . . . . 2.0499999999999998 110.058 -173.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -130.88 136.88 49.03 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.539 -0.464 . . . . 4.2400000000000002 110.985 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.525 ' HB3' ' O ' ' A' ' 121' ' ' VAL . 65.2 t80 -123.31 120.42 33.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.79 -0.641 . . . . 3.5499999999999998 109.73 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -122.81 136.84 55.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.784 0.326 . . . . 2.1099999999999999 111.202 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -160.75 149.98 19.55 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.277 -0.729 . . . . 1.1799999999999999 111.277 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -148.33 148.03 29.94 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.119 -0.326 . . . . 4.2999999999999998 110.119 176.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 67.9 tp -116.79 117.93 31.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.332 -0.395 . . . . 2.2400000000000002 110.755 -175.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.5 t -104.99 118.41 36.45 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.805 0.336 . . . . 1.6899999999999999 110.577 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 64.6 mtt -108.86 121.63 45.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.226 -0.657 . . . . 2.2400000000000002 109.226 171.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.415 ' OH ' ' HD3' ' A' ' 112' ' ' ARG . 64.9 t80 -116.53 136.79 52.69 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.655 -0.702 . . . . 3.5600000000000001 111.068 -171.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -130.17 150.86 51.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.63 -0.713 . . . . 1.6699999999999999 109.813 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -139.55 159.94 41.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.571 0.224 . . . . 3.23 110.431 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 60.22 -177.03 0.1 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.552 -0.749 . . . . 1.24 111.001 -175.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -77.65 -24.67 49.37 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.087 0.47 . . . . 2.4700000000000002 110.515 172.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.95 -51.38 69.93 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.409 -0.814 . . . . 2.4100000000000001 112.575 -172.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.5 mp -70.17 -29.11 65.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.03 0.443 . . . . 1.8300000000000001 111.2 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.499 ' ND2' ' HB2' ' A' ' 111' ' ' GLN . 95.0 m-20 -68.79 -39.75 80.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.532 -0.304 . . . . 2.0 110.809 178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.3 p -70.11 -32.1 69.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.577 -0.283 . . . . 2.0499999999999998 111.481 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.4 p -80.36 -20.21 44.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.234 0.54 . . . . 1.5900000000000001 110.845 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.84 -114.35 5.26 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.694 -0.684 . . . . 1.52 112.381 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -99.98 3.65 44.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.566 0.222 . . . . 5.9400000000000004 111.162 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.82 -40.04 76.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.022 0.439 . . . . 1.8300000000000001 110.02 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -129.83 99.34 5.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.55 -0.75 . . . . 2.6400000000000001 109.788 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.9 t -148.81 159.06 44.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.06 -0.518 . . . . 2.02 109.833 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 135' ' ' MET . 42.1 ttm180 -93.68 123.38 36.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.204 -0.453 . . . . 3.6699999999999999 109.881 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.0 t -112.48 120.58 63.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.493 -0.321 . . . . 1.6399999999999999 110.58 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -143.17 130.03 20.49 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.0 -0.37 . . . . 2.5600000000000001 110.0 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.437 ' HB ' ' CD1' ' A' ' 133' ' ' LEU . 10.1 t -136.58 146.72 46.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.011 0.434 . . . . 1.3899999999999999 110.965 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -119.98 139.55 52.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.215 -0.448 . . . . 2.04 110.351 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 22.6 m -117.03 122.98 45.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.095 -0.502 . . . . 1.5600000000000001 110.297 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -117.79 121.86 5.23 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.722 -0.551 . . . . 1.04 111.722 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.432 ' HB3' ' CE2' ' A' ' 160' ' ' TYR . 92.2 mt -108.38 135.09 50.26 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 122.274 0.23 . . . . 2.27 110.382 -177.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 168' ' ' LEU . 63.8 tt0 -123.36 115.89 22.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.758 0.314 . . . . 2.4100000000000001 110.178 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 158' ' ' LEU . 82.9 m-85 -130.92 139.95 50.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.23 -0.441 . . . . 4.5700000000000003 110.867 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 22.9 p -96.93 92.76 6.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.09 -0.505 . . . . 1.46 110.973 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . 0.506 ' CD2' HD12 ' A' ' 168' ' ' LEU . 61.3 m-85 -70.04 -39.91 75.45 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.163 0.431 . . . . 2.6299999999999999 112.163 -176.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.533 ' HB2' HG22 ' A' ' 166' ' ' VAL . 88.7 m-20 -100.3 13.38 34.55 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.776 -0.37 . . . . 2.4100000000000001 110.908 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 73.12 -52.06 0.71 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.873 0.733 . . . . 2.5800000000000001 111.79 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.2 p -74.66 -20.58 59.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.715 0.293 . . . . 2.2999999999999998 111.705 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.533 HG22 ' HB2' ' A' ' 163' ' ' ASN . 35.8 m -116.68 137.91 48.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.89 0.376 . . . . 1.71 110.836 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.8 123.07 47.61 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.077 -0.51 . . . . 1.47 110.131 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.506 HD12 ' CD2' ' A' ' 162' ' ' PHE . 21.7 mt -103.8 140.53 37.51 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.72 -0.474 . . . . 1.6599999999999999 109.72 -177.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -115.18 125.46 53.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.935 0.398 . . . . 3.2999999999999998 110.383 -176.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.5 t -128.44 129.57 68.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.561 -0.533 . . . . 1.3 109.561 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.543 ' OD1' ' HB2' ' A' ' 195' ' ' ARG . 28.7 p-10 -133.74 148.72 51.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.302 0.572 . . . . 2.2200000000000002 111.575 -177.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -145.36 151.43 38.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.347 -0.842 . . . . 4.6100000000000003 110.071 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -101.18 128.91 47.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.428 0.632 . . . . 3.98 111.55 -173.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.423 ' HB3' HG23 ' A' ' 154' ' ' THR . 48.4 tp -120.06 124.24 45.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.327 -0.851 . . . . 2.3799999999999999 109.499 -176.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -70.01 -43.4 71.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.229 0.537 . . . . 3.3100000000000001 111.061 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.963 -0.562 . . . . 6.5300000000000002 109.979 -172.108 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.131 0.491 . . . . 4.4000000000000004 109.801 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 86.4 mt -117.26 131.54 69.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.968 -0.56 . . . . 2.21 110.855 -173.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.543 ' HB2' ' OD1' ' A' ' 171' ' ' ASN . 90.0 mtt180 -95.25 127.36 41.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.814 0.34 . . . . 3.54 110.419 176.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -117.78 130.53 56.36 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.571 -0.529 . . . . 1.6699999999999999 109.571 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -152.85 160.04 43.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.192 0.52 . . . . 5.8300000000000001 111.274 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.449 ' O ' ' HD2' ' A' ' 209' ' ' PRO . 2.5 pt? -137.95 134.25 17.94 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.126 -0.488 . . . . 2.5899999999999999 110.019 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.69 128.05 9.15 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.197 1.931 . . . . 1.77 112.708 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.8 tp -120.43 123.52 43.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.692 -0.686 . . . . 2.2599999999999998 109.538 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 22.7 m -104.9 119.96 40.28 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.454 -0.339 . . . . 1.99 110.7 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.92 80.26 1.8 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.472 -0.566 . . . . 2.3100000000000001 109.472 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.1 -117.26 8.9 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.714 -0.675 . . . . 1.51 112.298 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -90.48 0.09 57.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.372 0.606 . . . . 2.5699999999999998 109.651 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -114.69 120.1 38.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.506 -0.77 . . . . 2.6600000000000001 111.096 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 13.6 p -102.03 142.6 33.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.33 -0.396 . . . . 1.6200000000000001 110.453 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 49.8 t -129.13 129.98 67.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.307 -0.627 . . . . 1.3799999999999999 109.307 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 32.8 m -134.44 91.72 21.73 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-O 120.849 0.357 . . . . 1.1799999999999999 110.37 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.449 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 57.0 Cg_endo -74.57 138.47 24.21 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.273 1.982 . . . . 1.01 112.307 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -106.03 139.01 41.23 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.35 -0.611 . . . . 4.5 109.35 175.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 38.9 p -132.39 160.53 36.08 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.91 -0.404 . . . . 1.8899999999999999 109.91 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -66.24 -40.52 90.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.416 0.627 . . . . 4.7999999999999998 109.617 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 44.7 pt . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 115.484 -0.78 . . . . 4.5700000000000003 109.789 175.417 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.452 -0.342 0 CA-C-O 120.85 0.357 . . . . 2.3999999999999999 110.251 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -124.69 138.12 10.95 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.716 -0.754 . . . . 1.27 111.298 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.99 126.61 54.12 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.981 0.39 . . . . 1.97 110.527 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.503 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 61.7 t80 -99.56 124.42 44.74 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.318 -0.623 . . . . 3.54 109.318 173.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.526 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 81.7 m-85 -119.89 140.01 51.51 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.818 -0.438 . . . . 2.6400000000000001 109.818 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -136.77 151.87 21.08 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.074 -1.06 . . . . 1.3500000000000001 112.74 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' TYR . . . . . 0.408 ' HB2' HG22 ' A' ' 251' ' ' VAL . 96.3 m-85 -129.96 129.85 44.32 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.856 -0.794 . . . . 4.3600000000000003 108.856 172.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -128.1 130.38 48.09 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.193 -0.299 . . . . 4.29 110.193 -176.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -128.52 135.31 49.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.153 -0.476 . . . . 6.6900000000000004 110.429 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -60.09 -30.13 69.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.122 -0.944 . . . . 6.3700000000000001 111.684 -175.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -55.69 -33.64 64.34 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.303 -0.408 . . . . 5.8300000000000001 110.772 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 135.38 31.79 0.31 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.559 -0.829 . . . . 2.6600000000000001 112.797 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 53.0 tp -125.57 127.83 46.98 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.691 -0.3 . . . . 2.9700000000000002 110.4 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 6.1 t -140.09 129.31 23.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.642 -0.873 . . . . 2.1699999999999999 108.642 173.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 243' ' ' TYR . 33.1 m -129.94 159.81 41.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.91 0.386 . . . . 1.79 111.5 -176.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 35.3 p -131.34 139.96 49.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.523 -0.762 . . . . 1.6299999999999999 110.166 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 89.0 mt -125.7 135.61 52.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.003 -0.544 . . . . 2.96 109.986 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -110.59 120.92 43.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.125 -0.489 . . . . 4.0800000000000001 110.082 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -106.86 129.3 54.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.306 -0.406 . . . . 4.8399999999999999 110.787 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.733 -0.667 . . . . 3.5800000000000001 110.579 179.126 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 109.171 -0.678 . . . . 1.9399999999999999 109.171 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.75 136.05 8.55 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.224 -0.988 . . . . 1.4199999999999999 112.001 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 62.7 t -130.03 129.7 65.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.982 0.42 . . . . 1.8100000000000001 110.412 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.03 139.99 11.39 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.712 -0.955 . . . . 1.3 110.712 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.16 129.97 54.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 117.102 0.451 . . . . 1.8300000000000001 111.265 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -113.24 123.07 49.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.033 -0.531 . . . . 2.3100000000000001 110.004 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -99.97 107.27 19.19 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.932 -0.766 . . . . 4.75 108.932 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 25.6 m -102.12 124.05 47.05 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.144 0.497 . . . . 1.6699999999999999 111.043 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 88.9 m-85 . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.122 -0.942 . . . . 3.6899999999999999 108.722 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 CA--C 1.519 -0.217 0 N-CA-C 109.895 -0.409 . . . . 3.6099999999999999 109.895 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.53 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 20.3 m-90 -70.99 139.98 50.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.987 -0.551 . . . . 3.3300000000000001 110.981 -178.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -99.2 130.0 45.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.001 -0.545 . . . . 3.2000000000000002 110.544 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -115.77 140.31 49.33 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.866 -0.606 . . . . 2.4900000000000002 110.888 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 94.2 m-20 -121.86 132.33 54.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.556 -0.747 . . . . 2.1299999999999999 109.549 174.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.0 mt -119.76 120.02 62.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.372 -0.603 . . . . 1.6000000000000001 109.372 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.13 142.4 14.95 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.048 -1.072 . . . . 0.88 112.68 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.53 134.81 54.71 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.941 -0.762 . . . . 1.0800000000000001 108.941 174.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 49.0 tpp -129.93 129.67 44.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.061 -0.518 . . . . 2.3300000000000001 111.0 -173.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.469 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 56.3 m-85 -93.15 129.77 39.04 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.914 -1.143 . . . . 2.6099999999999999 107.914 169.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 C--N 1.317 -0.822 0 C-N-CA 120.328 -0.549 . . . . 5.0899999999999999 110.534 -177.497 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.649 -0.5 . . . . 3.48 109.649 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.469 ' HD3' ' CE2' ' A' ' 15' ' ' TYR . 59.6 Cg_endo -73.93 134.38 19.68 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.093 1.862 . . . . 1.8600000000000001 112.375 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.7 t -118.13 143.57 46.38 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.797 -0.816 . . . . 1.97 108.797 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.5 m -110.11 139.99 31.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.304 0.573 . . . . 1.71 111.639 -173.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 49' ' ' ALA . 34.6 p90 -135.72 149.77 49.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.425 -0.807 . . . . 4.0700000000000003 109.903 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -113.47 130.07 56.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.02 -0.536 . . . . 2.8599999999999999 110.729 -175.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 10' ' ' ASN . 77.6 m-20 -123.44 144.49 49.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.165 -0.471 . . . . 1.8899999999999999 109.952 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.41 142.34 45.62 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.074 -0.343 . . . . 1.0800000000000001 110.074 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.01 112.57 1.59 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.151 0.426 . . . . 1.3899999999999999 112.151 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 7' ' ' TRP . 24.5 t-20 -168.24 94.96 0.39 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.713 -0.477 . . . . 2.8599999999999999 109.713 166.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.89 -83.34 0.43 Allowed Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.212 -0.755 . . . . 1.6799999999999999 111.212 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.13 173.46 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.029 2.486 . . . . 1.6599999999999999 111.797 169.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.461 ' HB3' ' O ' ' A' ' 75' ' ' HIS . 45.3 m95 -70.75 -177.74 1.66 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.143 -0.481 . . . . 3.3999999999999999 110.064 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -109.6 120.42 42.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.657 0.741 . . . . 3.1000000000000001 109.976 -172.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.4 mt -109.94 136.29 46.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.378 -1.283 . . . . 1.8 110.326 -174.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.81 128.24 55.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.943 -0.572 . . . . 0.85999999999999999 110.158 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.1 tp -120.45 130.2 54.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.045 -0.525 . . . . 1.0600000000000001 110.494 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 36' ' ' TYR . . . -148.92 168.42 23.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.236 -0.438 . . . . 1.1399999999999999 110.524 178.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 45.2 p90 -142.4 160.03 41.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.357 -0.383 . . . . 4.0199999999999996 110.342 -177.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.429 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 64.3 t80 -134.28 130.02 36.45 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.82 -0.437 . . . . 4.6100000000000003 109.82 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -135.65 147.21 48.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.404 -0.362 . . . . 3.3799999999999999 110.412 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--N 1.321 -0.641 0 N-CA-C 108.967 -0.753 . . . . 5.0499999999999998 108.967 179.976 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.963 0.411 . . . . 5.6100000000000003 110.126 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -106.8 99.73 9.29 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.176 -0.676 . . . . 3.7799999999999998 109.176 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -134.23 170.63 15.42 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.511 -0.922 . . . . 2.4500000000000002 108.511 -171.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.523 ' HD3' ' CE1' ' A' ' 95' ' ' TYR . 39.4 ttp180 -119.14 123.01 29.12 Favored Pre-proline 0 C--N 1.318 -0.787 0 C-N-CA 120.326 -0.55 . . . . 3.2400000000000002 110.697 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -91.74 115.68 0.4 Allowed 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 122.126 1.884 . . . . 1.1899999999999999 110.767 169.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -103.26 112.74 25.76 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.903 -0.777 . . . . 2.1899999999999999 108.903 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.2 tp -124.53 118.66 27.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.652 -0.704 . . . . 1.1399999999999999 109.496 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -126.03 131.75 52.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.6 -0.518 . . . . 2.1800000000000002 109.6 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.22 121.88 68.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.869 0.366 . . . . 1.5600000000000001 110.116 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.461 ' O ' ' HB3' ' A' ' 44' ' ' TRP . 79.8 t60 -104.64 119.6 39.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.115 -0.493 . . . . 3.4399999999999999 110.503 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -97.16 120.74 38.07 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.984 -1.117 . . . . 4.7999999999999998 107.984 176.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.4 ' HG3' ' HA ' ' A' ' 86' ' ' PHE . 29.0 tt0 -127.31 113.78 16.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.174 0.511 . . . . 2.9399999999999999 111.671 -174.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -102.61 120.3 40.31 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.673 -0.694 . . . . 3.8999999999999999 109.38 175.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 C--N 1.323 -0.584 0 CA-C-O 121.122 0.486 . . . . 4.4800000000000004 110.777 179.326 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 120' ' ' ASP . 14.7 t . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 120.645 0.26 . . . . 2.5499999999999998 110.412 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.4 ' HA ' ' HG3' ' A' ' 77' ' ' GLN . 90.1 m-85 69.78 -100.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.512 -0.767 . . . . 5.2999999999999998 111.069 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.27 -82.06 0.35 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.012 -1.089 . . . . 1.3500000000000001 113.215 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 57.9 tp -144.13 131.25 20.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.22 0.51 . . . . 2.29 111.989 -173.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.5 m -121.36 130.08 53.42 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.575 -0.528 . . . . 1.54 109.575 170.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -145.45 141.92 10.26 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.145 -1.026 . . . . 1.1699999999999999 112.238 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.99 171.2 36.26 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.62 -0.8 . . . . 1.1899999999999999 111.993 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -148.47 159.95 43.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.092 0.472 . . . . 3.75 111.628 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -134.39 137.29 43.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.324 -0.853 . . . . 2.75 109.494 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 63.1 t30 -125.18 122.22 36.42 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.971 -0.381 . . . . 1.8200000000000001 109.971 175.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.523 ' CE1' ' HD3' ' A' ' 69' ' ' ARG . 95.2 m-85 -102.84 120.92 41.45 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.023 -0.362 . . . . 3.1400000000000001 110.023 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.788 0 C-N-CA 120.995 -0.621 . . . . 2.79 113.658 -176.135 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.1 p . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 112.267 0.469 . . . . 3.2999999999999998 112.267 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.72 119.13 33.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.725 0.774 . . . . 1.76 112.85 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -115.19 106.45 14.09 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.595 -0.891 . . . . 2.5499999999999998 108.595 171.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.539 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 89.5 mtp -139.85 117.05 11.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.527 -0.306 . . . . 1.77 110.799 -177.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.614 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 54.0 tt0 -117.21 117.96 31.0 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.627 -0.429 . . . . 1.97 110.182 176.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -105.6 123.53 48.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.869 -0.605 . . . . 3.8500000000000001 110.14 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -125.53 128.73 48.42 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.814 -0.81 . . . . 2.2799999999999998 108.814 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -130.15 126.03 36.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.408 . . . . 2.1400000000000001 110.558 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 134' ' ' SER . 88.2 mt -120.05 129.61 75.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.709 -0.678 . . . . 1.55 109.66 177.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 134' ' ' SER . . . -141.87 108.14 5.91 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 111.954 0.353 . . . . 1.1899999999999999 111.954 -176.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.721 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 61.4 Cg_endo -76.5 131.95 13.05 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.75 1.634 . . . . 1.3700000000000001 110.21 171.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -102.28 137.02 41.09 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.281 -0.637 . . . . 2.3500000000000001 109.281 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -135.45 129.98 34.05 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.99 -0.284 . . . . 4.54 110.942 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 32.5 t70 -126.25 122.09 34.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.172 -0.467 . . . . 3.04 109.856 174.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.4 t -120.05 120.49 63.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.09 -0.504 . . . . 4.2699999999999996 110.19 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.405 ' HE2' ' HD3' ' A' ' 128' ' ' ARG . 96.6 mttt -104.96 90.75 3.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.296 -0.411 . . . . 6.04 110.527 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.6 tp -60.28 -49.74 76.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.284 0.564 . . . . 4.5899999999999999 110.154 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.5 p -140.79 172.52 12.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.372 -0.831 . . . . 3.6899999999999999 109.358 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -60.16 -39.88 87.95 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.192 -0.603 . . . . 5.1699999999999999 109.605 172.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.1 -40.17 75.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.729 -0.669 . . . . 3.71 111.997 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.0 mt -111.12 119.65 39.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.285 0.564 . . . . 2.0499999999999998 111.436 -173.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.405 ' HD3' ' HE2' ' A' ' 122' ' ' LYS . 38.1 ttp180 -132.63 132.78 42.83 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.719 -0.673 . . . . 4.2400000000000002 110.681 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -111.97 100.03 8.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.326 -0.852 . . . . 3.5499999999999998 109.738 -176.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -113.8 114.65 26.59 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.022 -0.362 . . . . 2.1099999999999999 110.022 -178.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -144.82 152.75 24.71 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.994 -1.098 . . . . 1.1799999999999999 113.013 -175.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.536 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 56.5 p-90 -141.28 147.85 38.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.783 0.325 . . . . 4.2999999999999998 110.42 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.721 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 10.1 tt -126.27 131.98 51.78 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.314 -0.624 . . . . 2.2400000000000002 109.314 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.604 ' HB3' ' HB2' ' A' ' 116' ' ' ALA . 80.5 p -131.53 150.06 52.29 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.811 -0.355 . . . . 1.6899999999999999 111.548 -177.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 71.8 mtm -114.38 136.02 53.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.091 -0.504 . . . . 2.2400000000000002 110.415 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.428 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 49.5 m-85 -104.87 120.92 42.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.87 -0.605 . . . . 3.5600000000000001 111.674 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.68 121.79 29.32 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.134 -1.062 . . . . 1.6699999999999999 108.134 166.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.614 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 52.6 p90 -145.85 166.49 25.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.448 -0.342 . . . . 3.23 111.49 -171.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 110' ' ' MET . . . 60.0 -164.72 0.22 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.052 -0.976 . . . . 1.24 111.795 177.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -75.3 -39.79 59.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.102 -0.499 . . . . 2.4700000000000002 111.305 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.69 -54.2 49.11 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.438 0.533 . . . . 2.4100000000000001 112.438 -167.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.73 -40.11 84.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.2 0.524 . . . . 1.8300000000000001 110.492 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.438 HD22 ' C ' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -62.09 -39.38 92.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.783 -0.644 . . . . 2.0 109.96 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.8 m -68.66 -40.11 80.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.886 -0.597 . . . . 2.0499999999999998 111.912 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 148' ' ' ALA . 41.9 p -79.9 -20.04 46.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.169 0.509 . . . . 1.5900000000000001 110.865 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.02 -109.82 2.91 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.803 -0.635 . . . . 1.52 113.154 173.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -99.16 0.62 43.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.8 0.333 . . . . 5.9400000000000004 110.661 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' A' ' 145' ' ' THR . . . -70.04 -40.04 75.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 1.8300000000000001 111.489 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -118.96 124.68 47.62 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.566 -0.288 . . . . 2.6400000000000001 110.569 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.4 p -130.02 140.06 50.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.986 0.422 . . . . 2.02 110.9 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.428 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 42.5 ttm180 -113.06 129.98 56.32 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.337 -0.986 . . . . 3.6699999999999999 108.337 173.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.9 p -117.33 132.02 68.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.533 0.683 . . . . 1.6399999999999999 111.697 -173.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.421 ' OE1' ' HH2' ' A' ' 132' ' ' TRP . 38.3 tt0 -119.99 115.69 24.27 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.011 -0.995 . . . . 2.5600000000000001 109.126 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 21.7 m -129.74 127.21 39.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.77 0.319 . . . . 1.3899999999999999 111.283 -177.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.536 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 42.6 tt0 -122.34 134.49 54.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.966 -0.561 . . . . 2.04 110.032 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.5 m -128.27 120.26 26.78 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.857 0.361 . . . . 1.5600000000000001 110.094 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.72 106.8 3.36 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.861 -0.896 . . . . 1.04 110.861 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 82.7 mt -99.79 120.07 39.16 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.668 -0.493 . . . . 2.27 109.668 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -100.08 119.13 37.82 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.859 -0.61 . . . . 2.4100000000000001 110.014 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -121.55 137.94 54.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.532 -0.758 . . . . 4.5700000000000003 109.9 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 7.3 p -89.9 88.56 7.37 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.077 -0.712 . . . . 1.46 109.077 168.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.08 -48.97 79.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.023 -0.989 . . . . 2.6299999999999999 111.395 -170.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.416 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.6 m-20 -99.96 11.39 39.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.4 -0.364 . . . . 2.4100000000000001 110.52 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 71.88 -43.02 0.55 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.007 0.817 . . . . 2.5800000000000001 111.177 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.9 p -73.91 -26.66 60.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.286 -0.416 . . . . 2.2999999999999998 111.428 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 163' ' ' ASN . 33.7 m -119.16 143.61 29.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.119 -0.491 . . . . 1.71 110.678 -177.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.13 119.52 39.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.206 -0.452 . . . . 1.47 110.14 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 22.9 mt -111.57 134.73 52.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.355 -0.384 . . . . 1.6599999999999999 110.182 -175.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -100.06 122.02 42.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.798 -0.445 . . . . 3.2999999999999998 109.798 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 40.4 t -120.01 120.02 61.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.474 -0.49 . . . . 1.3 109.792 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -98.87 120.91 40.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.335 0.588 . . . . 2.2200000000000002 110.389 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -105.85 139.55 40.24 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.054 -0.975 . . . . 4.6100000000000003 109.253 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -113.15 129.79 56.4 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 110.074 -0.343 . . . . 3.98 110.074 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.498 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 61.5 tp -109.93 129.93 55.59 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.067 0.46 . . . . 2.3799999999999999 110.795 -174.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -112.62 179.45 3.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.393 -0.821 . . . . 3.3100000000000001 110.1 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 . . . . . 0 C--N 1.331 -0.216 0 CA-C-O 121.045 0.45 . . . . 6.5300000000000002 111.705 -179.261 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 120.832 0.348 . . . . 4.4000000000000004 110.669 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 88.0 mt -120.09 98.11 5.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.137 -1.061 . . . . 2.21 108.137 171.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.679 ' HA ' ' O ' ' A' ' 211' ' ' THR . 97.7 mtt180 -100.04 118.91 37.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.858 0.361 . . . . 3.54 111.173 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.589 ' O ' ' HA ' ' A' ' 210' ' ' TYR . . . -99.98 131.82 45.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.251 -0.431 . . . . 1.6699999999999999 110.916 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -127.69 129.41 47.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.752 -0.658 . . . . 5.8300000000000001 109.826 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 208' ' ' THR . 1.8 pt? -131.1 127.23 21.9 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.167 -0.309 . . . . 2.5899999999999999 110.167 174.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -89.55 120.31 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.664 2.243 . . . . 1.77 113.626 -177.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 84.1 mt -118.08 128.2 54.52 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.369 -0.604 . . . . 2.2599999999999998 109.369 172.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 24.0 m -100.51 120.13 39.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.807 0.337 . . . . 1.99 111.236 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 91.8 mt -122.57 80.78 1.77 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.525 -0.546 . . . . 2.3100000000000001 109.525 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 72.84 -122.98 8.5 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.65 -0.704 . . . . 1.51 111.861 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -93.83 3.56 55.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.293 0.568 . . . . 2.5699999999999998 110.2 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -118.59 130.01 55.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.915 -0.584 . . . . 2.6600000000000001 110.048 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 241' ' ' TYR . 5.4 p -111.13 139.82 46.19 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.774 -0.37 . . . . 1.6200000000000001 110.557 176.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.448 HG22 ' CE1' ' A' ' 241' ' ' TYR . 31.7 t -109.16 120.91 61.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.378 -0.601 . . . . 1.3799999999999999 109.378 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 198' ' ' LEU . 32.1 m -129.84 90.1 44.07 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.264 -0.426 . . . . 1.1799999999999999 110.0 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -63.17 146.05 93.89 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.45 2.1 . . . . 1.01 111.142 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 53.0 p90 -133.34 148.28 51.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.156 0.503 . . . . 4.5 110.204 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 195' ' ' ARG . 32.6 p -129.72 141.29 50.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.539 -0.755 . . . . 1.8899999999999999 110.57 -177.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -69.74 -38.92 77.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.649 -0.705 . . . . 4.7999999999999998 109.567 177.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.1 mt . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.229 -0.896 . . . . 4.5700000000000003 109.627 174.878 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 108.946 -0.761 . . . . 2.3999999999999999 108.946 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -80.15 134.6 13.72 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.088 -1.053 . . . . 1.27 111.737 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 87.0 mt -108.44 118.07 35.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.11 0.455 . . . . 1.97 110.627 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' A' ' 208' ' ' THR . 64.8 t80 -110.04 131.23 55.24 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.125 -0.695 . . . . 3.54 109.125 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . 0.562 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 96.2 m-85 -120.11 139.2 52.94 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.834 -0.432 . . . . 2.6400000000000001 109.834 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -110.95 129.04 9.03 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.527 -0.844 . . . . 1.3500000000000001 111.682 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -129.31 126.84 39.87 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.939 -0.393 . . . . 4.3600000000000003 109.939 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -120.0 131.7 55.23 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.918 0.389 . . . . 4.29 110.706 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 249' ' ' LEU . 52.2 t80 -102.34 129.95 48.93 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.941 -0.763 . . . . 6.6900000000000004 108.941 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -60.08 -37.17 79.14 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.583 0.957 . . . . 6.3700000000000001 113.583 -167.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -60.11 -39.98 88.09 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.622 0.249 . . . . 5.8300000000000001 111.559 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 151.65 42.04 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.868 -1.158 . . . . 2.6600000000000001 113.233 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 245' ' ' PHE . 49.9 tp -133.48 130.09 38.1 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.031 -0.359 . . . . 2.9700000000000002 110.031 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 21.6 t -117.04 130.03 56.41 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.227 -0.657 . . . . 2.1699999999999999 109.227 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.09 132.72 68.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.057 0.456 . . . . 1.79 110.426 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 52.6 m -114.19 128.7 56.49 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.532 -0.544 . . . . 1.6299999999999999 109.532 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 83.0 mt -118.98 133.57 55.74 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.378 -0.374 . . . . 2.96 110.541 -175.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -127.25 121.33 30.87 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.772 -0.455 . . . . 4.0800000000000001 109.772 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -122.97 139.24 54.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.928 0.394 . . . . 4.8399999999999999 111.631 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.673 -0.694 . . . . 3.5800000000000001 110.301 177.98 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.895 0.379 . . . . 1.9399999999999999 111.431 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.99 149.62 19.62 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.87 -0.604 . . . . 1.4199999999999999 112.285 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 61.5 t -130.04 130.07 65.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.673 0.273 . . . . 1.8100000000000001 110.719 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.48 134.69 8.91 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.041 -0.824 . . . . 1.3 111.041 176.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 28.0 m -128.71 139.5 51.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 117.431 0.615 . . . . 1.8300000000000001 111.375 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -129.4 124.31 33.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.855 -0.611 . . . . 2.3100000000000001 110.162 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.416 ' CD1' HD13 ' A' ' 249' ' ' LEU . 97.9 m-85 -96.69 127.92 43.14 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.45 -0.574 . . . . 4.75 109.45 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 49.1 m -111.32 124.95 53.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.723 0.297 . . . . 1.6699999999999999 110.73 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 72.6 t80 . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.58 -0.724 . . . . 3.6899999999999999 109.827 179.601 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 N--CA 1.449 -0.502 0 CA-C-O 120.694 0.283 . . . . 3.6099999999999999 110.397 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -119.4 138.52 53.03 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.038 -0.356 . . . . 3.3300000000000001 110.038 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -104.22 128.16 51.92 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.517 -0.549 . . . . 3.2000000000000002 109.517 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -103.23 144.89 30.74 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.687 -0.688 . . . . 2.4900000000000002 111.033 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 279' ' ' TYR . 35.4 m-80 -119.98 131.26 55.11 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.167 -0.924 . . . . 2.1299999999999999 108.926 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.6 mt -120.29 115.26 46.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 N-CA-C 109.204 -0.665 . . . . 1.6000000000000001 109.204 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -110.02 127.07 8.22 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.551 -0.833 . . . . 0.88 111.273 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -120.67 136.01 54.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.713 0.292 . . . . 1.0800000000000001 110.785 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . 0.405 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 91.4 mtp -135.35 156.93 48.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.852 -0.613 . . . . 2.3300000000000001 109.415 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -119.95 122.37 41.05 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.641 -0.503 . . . . 2.6099999999999999 109.641 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 C--N 1.34 0.153 0 CA-C-O 121.062 0.458 . . . . 5.0899999999999999 110.345 179.786 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.581 0.229 . . . . 3.48 110.948 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 14' ' ' MET . 36.3 Cg_endo -70.17 149.99 65.08 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.308 2.005 . . . . 1.8600000000000001 110.916 168.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 22.2 m -125.67 142.19 51.63 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.699 -0.482 . . . . 1.97 109.699 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.618 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 33.1 m -129.99 160.06 41.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.695 0.284 . . . . 1.71 110.512 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -140.2 149.95 43.56 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.68 -0.489 . . . . 4.0700000000000003 109.68 174.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 94.5 m-85 -109.45 128.79 55.42 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.465 -0.334 . . . . 2.8599999999999999 110.217 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -140.32 135.21 31.97 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.992 -0.549 . . . . 1.8899999999999999 109.753 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.6 141.39 51.14 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.762 -0.375 . . . . 1.0800000000000001 110.177 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . . . -160.17 125.82 4.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 1.3899999999999999 111.675 -177.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -167.46 93.47 0.42 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.507 -0.553 . . . . 2.8599999999999999 109.507 167.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.65 -94.78 1.34 Allowed Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.543 -0.837 . . . . 1.6799999999999999 112.003 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.76 172.95 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.605 2.87 . . . . 1.6599999999999999 113.114 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.8 p-90 -69.78 159.15 34.11 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.197 0.522 . . . . 3.3999999999999999 111.367 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.454 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 25.7 ptt-85 -115.72 146.85 41.52 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.249 0.833 . . . . 3.1000000000000001 113.249 -163.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.4 mm -122.88 131.26 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 114.495 -1.23 . . . . 1.8 111.03 -173.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -117.53 139.98 50.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.525 -0.307 . . . . 0.85999999999999999 110.719 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 56.4 tp -135.83 137.11 41.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 1.0600000000000001 111.046 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.04 166.94 28.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.743 -0.662 . . . . 1.1399999999999999 109.313 174.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -124.15 130.02 51.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.876 0.37 . . . . 4.0199999999999996 111.122 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.554 ' HB3' ' HB2' ' A' ' 69' ' ' ARG . 47.0 t80 -99.98 119.56 38.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.865 -0.607 . . . . 4.6100000000000003 110.073 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 -133.83 130.17 37.53 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.743 -0.465 . . . . 3.3799999999999999 109.743 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--N 1.323 -0.581 0 CA-C-O 121.015 0.436 . . . . 5.0499999999999998 110.981 177.625 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 97.1 m95 . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 109.032 -0.729 . . . . 5.6100000000000003 109.032 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.65 ' HB2' ' CZ ' ' A' ' 95' ' ' TYR . 64.8 m-85 -119.73 138.92 53.01 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.534 -0.543 . . . . 3.7799999999999998 109.534 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -123.82 164.94 18.19 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.194 -0.669 . . . . 2.4500000000000002 109.194 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.554 ' HB2' ' HB3' ' A' ' 51' ' ' TYR . 10.4 mtp180 -120.63 124.33 27.64 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.779 -0.452 . . . . 3.2400000000000002 109.779 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.548 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 69.9 Cg_endo -80.1 122.76 4.85 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.963 1.775 . . . . 1.1899999999999999 110.952 173.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 36.5 tt0 -99.96 113.03 25.32 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.557 -0.535 . . . . 2.1899999999999999 109.557 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.1 tp -121.9 123.41 41.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.269 -0.423 . . . . 1.1399999999999999 110.411 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -119.7 135.79 54.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.943 0.401 . . . . 2.1800000000000002 110.262 173.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.1 t -113.67 119.88 62.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.153 -1.054 . . . . 1.5600000000000001 108.153 172.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -117.38 117.38 29.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.752 -0.462 . . . . 3.4399999999999999 109.752 -176.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -120.45 131.2 54.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.815 -0.629 . . . . 4.7999999999999998 109.959 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -121.82 139.95 52.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.306 -0.406 . . . . 2.9399999999999999 110.369 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -116.63 97.92 6.26 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.849 -0.797 . . . . 3.8999999999999999 108.849 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.4 mt . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.842 -0.617 . . . . 4.4800000000000004 110.219 -175.374 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.849 0.356 . . . . 2.5499999999999998 111.657 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -131.56 150.2 52.24 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.948 -0.39 . . . . 5.2999999999999998 109.948 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.55 161.7 28.7 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.645 -0.788 . . . . 1.3500000000000001 111.828 176.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.0 tp -141.11 112.57 7.48 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.746 -0.464 . . . . 2.29 109.746 176.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.3 m -120.01 129.99 54.52 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.261 -0.427 . . . . 1.54 110.562 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -127.23 140.06 11.62 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.727 -0.749 . . . . 1.1699999999999999 111.571 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.47 119.86 1.76 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.631 -0.795 . . . . 1.1899999999999999 111.874 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -126.81 129.72 48.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.001 0.429 . . . . 3.75 110.933 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -141.34 134.84 29.84 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.102 -0.703 . . . . 2.75 109.102 175.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.548 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 8.6 p30 -134.87 151.65 51.08 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-O 120.468 0.175 . . . . 1.8200000000000001 110.981 -175.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.65 ' CZ ' ' HB2' ' A' ' 67' ' ' PHE . 65.2 t80 -118.74 130.01 55.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.547 -0.297 . . . . 3.1400000000000001 110.371 -176.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.233 0 C-N-CA 120.465 -0.874 . . . . 2.79 112.254 179.191 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 120.736 0.303 . . . . 3.2999999999999998 110.598 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -132.05 119.45 21.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.498 -0.319 . . . . 1.76 111.445 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' A' ' 95' ' ' TYR . 27.5 t-20 -151.8 124.62 8.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.779 -0.646 . . . . 2.5499999999999998 110.121 176.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.408 ' HG3' ' HA ' ' A' ' 139' ' ' ALA . 43.3 ttm -103.34 121.39 42.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.6 -0.727 . . . . 1.77 110.264 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -112.27 141.33 46.11 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.614 -0.434 . . . . 1.97 111.434 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.626 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 76.4 ttt180 -131.07 110.89 11.53 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.997 -0.742 . . . . 3.8500000000000001 108.997 168.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.563 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 83.2 m95 -98.76 119.95 38.38 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.879 -0.786 . . . . 2.2799999999999998 108.879 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.459 ' NZ ' ' HB2' ' A' ' 114' ' ' LYS . 10.2 mtmp? -121.74 123.81 42.73 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.785 -0.366 . . . . 2.1400000000000001 111.156 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 134' ' ' SER . 87.6 mt -120.62 126.22 74.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.032 -0.531 . . . . 1.55 109.976 174.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -138.92 105.78 7.42 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.425 -0.352 . . . . 1.1899999999999999 111.036 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.548 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 98.8 Cg_endo -80.06 160.03 23.77 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.98 2.453 . . . . 1.3700000000000001 111.158 173.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -116.19 137.19 52.35 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.248 -0.433 . . . . 2.3500000000000001 110.25 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -127.03 128.14 45.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.379 -0.373 . . . . 4.54 111.495 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.411 ' CG ' ' HE ' ' A' ' 128' ' ' ARG . 43.0 t0 -128.64 88.94 2.81 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.553 -0.536 . . . . 3.04 109.553 172.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.0 p -147.5 129.24 6.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.082 0.468 . . . . 4.2699999999999996 111.148 -177.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.711 ' HG3' ' H ' ' A' ' 124' ' ' THR . 55.8 tptt -144.31 142.91 30.72 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.217 -0.66 . . . . 6.04 109.217 177.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.3 mt -74.41 -6.77 50.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.137 0.494 . . . . 4.5899999999999999 110.904 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.711 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 26.3 m -119.96 135.7 54.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.637 -0.71 . . . . 3.6899999999999999 109.561 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -68.15 -39.93 82.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.873 -0.603 . . . . 5.1699999999999999 111.126 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -61.02 -40.27 92.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.244 -0.889 . . . . 3.71 112.078 -176.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -110.95 161.22 16.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.059 0.457 . . . . 2.0499999999999998 111.857 -171.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.541 ' HD2' ' OE1' ' A' ' 159' ' ' GLN . 20.3 ttm180 -125.51 133.66 52.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.88 -0.6 . . . . 4.2400000000000002 111.465 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.541 ' HB2' ' HD3' ' A' ' 122' ' ' LYS . 64.7 t80 -114.88 119.36 36.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.573 -0.739 . . . . 3.5499999999999998 109.21 175.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.412 ' OD1' ' HD3' ' A' ' 128' ' ' ARG . 17.4 m120 -118.45 130.05 55.74 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.018 -0.364 . . . . 2.1099999999999999 110.018 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -134.9 135.75 8.12 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.408 -0.901 . . . . 1.1799999999999999 111.688 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -124.0 128.28 49.14 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.668 -0.493 . . . . 4.2999999999999998 109.668 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.548 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 63.0 tp -109.95 110.93 22.03 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.188 -0.671 . . . . 2.2400000000000002 109.188 175.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 14.3 t -116.21 130.15 56.65 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.253 -0.579 . . . . 1.6899999999999999 110.533 -175.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 66.6 mtt -118.99 135.92 54.37 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.651 -0.87 . . . . 2.2400000000000002 108.651 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.563 ' HA ' ' O ' ' A' ' 113' ' ' TRP . 54.7 p90 -149.83 157.42 43.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.349 0.595 . . . . 3.5600000000000001 111.61 178.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 59.7 mttp -129.82 157.62 41.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.932 -1.031 . . . . 1.6699999999999999 109.849 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.745 ' H ' HD12 ' A' ' 142' ' ' LEU . 64.3 t80 -121.85 139.99 52.94 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.743 -0.662 . . . . 3.23 109.824 -173.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.408 ' HA ' ' HG3' ' A' ' 110' ' ' MET . . . 61.12 -175.91 0.12 Allowed 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.685 0.616 . . . . 1.24 110.745 -175.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 63.9 t30 -79.08 -21.63 46.47 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.211 -0.595 . . . . 2.4700000000000002 110.315 172.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.93 -47.39 85.98 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.496 -0.774 . . . . 2.4100000000000001 112.33 -172.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.745 HD12 ' H ' ' A' ' 138' ' ' PHE . 49.4 mt -69.87 -25.36 63.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.003 0.43 . . . . 1.8300000000000001 110.971 -178.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 140' ' ' ASN . 94.7 m-20 -59.91 -39.98 87.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.974 0.416 . . . . 2.0 110.007 175.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 80.9 p -78.1 -31.1 49.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.012 -0.54 . . . . 2.0499999999999998 111.54 -177.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.42 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 34.9 p -70.16 -25.03 63.26 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.105 0.478 . . . . 1.5900000000000001 110.912 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 64.93 -128.08 34.0 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.696 -0.684 . . . . 1.52 112.776 175.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -72.47 -20.69 61.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.514 0.19 . . . . 5.9400000000000004 111.514 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.02 97.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.827 0.346 . . . . 1.8300000000000001 111.155 -176.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -131.47 92.83 3.23 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.129 -0.693 . . . . 2.6400000000000001 109.129 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.2 t -144.85 146.69 32.18 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.048 -0.524 . . . . 2.02 110.153 -178.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 136' ' ' TYR . 32.8 tpt180 -99.77 119.05 37.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.39 -0.368 . . . . 3.6699999999999999 110.492 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.4 t -119.22 119.22 60.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 1.6399999999999999 109.875 178.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -123.49 140.01 53.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.929 0.395 . . . . 2.5600000000000001 111.009 -176.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 33.5 m -119.97 127.03 52.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.141 -0.482 . . . . 1.3899999999999999 109.737 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.526 ' HG3' HD21 ' A' ' 171' ' ' ASN . 31.0 tt0 -123.51 130.72 53.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.585 -0.524 . . . . 2.04 109.585 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 171' ' ' ASN . 88.3 m -122.07 121.83 37.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.855 0.359 . . . . 1.5600000000000001 111.614 -176.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -102.39 115.23 5.15 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 111.174 -0.77 . . . . 1.04 111.174 177.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 89.9 mt -100.34 122.61 43.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.829 0.347 . . . . 2.27 110.631 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.541 ' OE1' ' HD2' ' A' ' 128' ' ' ARG . 53.3 tt0 -100.01 107.97 20.05 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.065 -0.717 . . . . 2.4100000000000001 109.065 176.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -120.44 114.81 22.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.149 -0.478 . . . . 4.5700000000000003 109.714 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' A' ' 164' ' ' GLU . 6.8 p -88.85 90.5 8.44 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.269 0.557 . . . . 1.46 110.535 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -60.23 -49.28 78.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.582 -0.735 . . . . 2.6299999999999999 111.171 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.479 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.6 m-20 -101.77 13.13 35.76 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.983 -0.287 . . . . 2.4100000000000001 111.024 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.413 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 41.3 tt0 71.39 -48.7 0.68 Allowed 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.774 0.671 . . . . 2.5800000000000001 111.3 -178.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.7 p -74.69 -19.98 60.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.34 -0.391 . . . . 2.2999999999999998 111.642 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' A' ' 163' ' ' ASN . 33.4 m -121.46 140.0 46.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.326 -0.397 . . . . 1.71 110.266 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.488 ' O ' ' HD2' ' A' ' 199' ' ' PRO . . . -106.87 129.26 54.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.053 -0.522 . . . . 1.47 110.601 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 28.7 mt -103.72 129.22 51.05 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.291 -0.633 . . . . 1.6599999999999999 109.291 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -101.45 107.4 18.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.812 0.339 . . . . 3.2999999999999998 110.572 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.9 t -113.18 119.98 62.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 109.446 -0.576 . . . . 1.3 109.446 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.616 ' HB3' ' HB3' ' A' ' 195' ' ' ARG . 8.5 t30 -106.34 120.73 42.63 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.952 0.406 . . . . 2.2200000000000002 111.123 -176.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -103.18 129.96 50.23 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.562 -0.745 . . . . 4.6100000000000003 109.748 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -102.46 138.71 39.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.225 -0.443 . . . . 3.98 110.674 -177.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 62.8 tp -140.08 143.38 36.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.571 . . . . 2.3799999999999999 110.447 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -105.84 141.01 37.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.223 -0.288 . . . . 3.3100000000000001 110.223 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 . . . . . 0 C--N 1.324 -0.5 0 N-CA-C 109.983 -0.376 . . . . 6.5300000000000002 109.983 175.41 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.03 0.443 . . . . 4.4000000000000004 111.071 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 48.9 mm -113.83 125.53 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.781 -0.645 . . . . 2.21 110.24 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.616 ' HB3' ' HB3' ' A' ' 171' ' ' ASN . 35.2 ttm180 -99.96 109.37 21.73 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.553 -0.906 . . . . 3.54 108.553 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -123.63 131.44 53.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.834 0.349 . . . . 1.6699999999999999 111.695 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -158.22 165.75 34.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.934 -0.575 . . . . 5.8300000000000001 109.83 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.577 ' O ' ' HD2' ' A' ' 209' ' ' PRO . 1.5 pt? -143.64 137.29 14.31 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 121.126 -0.23 . . . . 2.5899999999999999 110.461 177.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' A' ' 167' ' ' ALA . 72.3 Cg_endo -79.77 129.67 8.28 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.451 2.101 . . . . 1.77 112.736 176.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 88.1 mt -128.05 135.21 49.55 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.35 -0.611 . . . . 2.2599999999999998 109.35 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 4.4 p -112.45 118.93 36.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.981 0.42 . . . . 1.99 111.149 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.9 mt -125.48 82.2 2.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.889 -0.782 . . . . 2.3100000000000001 108.889 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 69.49 -124.69 16.16 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.338 -0.846 . . . . 1.51 111.733 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -91.83 3.98 53.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.18 0.514 . . . . 2.5699999999999998 109.902 175.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -95.9 115.88 28.08 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.61 -0.885 . . . . 2.6600000000000001 108.61 174.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 47.5 t -100.61 120.37 39.94 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.938 -0.764 . . . . 1.6200000000000001 108.938 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.81 128.07 73.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.932 0.396 . . . . 1.3799999999999999 110.695 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 35.1 m -131.1 91.3 36.47 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-O 120.83 0.347 . . . . 1.1799999999999999 110.093 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.577 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 50.1 Cg_endo -70.41 140.58 40.54 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.269 1.979 . . . . 1.01 111.978 176.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -111.85 140.29 46.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.188 -0.46 . . . . 4.5 110.587 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 24.0 p -134.0 156.26 48.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 1.8899999999999999 110.314 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -116.57 120.33 38.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.045 0.45 . . . . 4.7999999999999998 110.656 -177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 84.8 mt . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.907 -0.588 . . . . 4.5700000000000003 110.259 -179.79 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 63.3 t . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 121.044 0.45 . . . . 2.3999999999999999 109.869 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -129.04 156.16 21.07 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.864 -0.684 . . . . 1.27 111.701 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.0 130.45 54.75 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.933 -0.395 . . . . 1.97 109.933 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -109.89 130.0 55.58 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.989 -0.745 . . . . 3.54 108.989 176.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -120.03 139.89 51.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.959 0.409 . . . . 2.6400000000000001 111.0 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -113.66 128.81 8.48 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.797 -0.921 . . . . 1.3500000000000001 110.797 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' TYR . . . . . 0.439 ' O ' ' HB ' ' A' ' 251' ' ' VAL . 73.3 m-85 -130.0 150.11 51.42 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.614 0.207 . . . . 4.3600000000000003 110.772 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 58.12 39.98 25.57 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.082 0.864 . . . . 4.29 110.666 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -77.56 114.06 16.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.554 -0.748 . . . . 6.6900000000000004 109.79 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -143.46 168.22 20.36 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.895 -1.048 . . . . 6.3700000000000001 108.26 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -59.97 -40.06 87.78 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.83 -0.348 . . . . 5.8300000000000001 110.794 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 280' ' ' SER . . . -99.83 -0.27 56.36 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.447 -0.883 . . . . 2.6600000000000001 113.967 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 59.4 tp -145.98 138.52 25.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.65 0.725 . . . . 2.9700000000000002 111.304 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 61.3 p -147.36 134.49 20.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.821 0.343 . . . . 2.1699999999999999 110.963 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.473 HG22 HG23 ' A' ' 277' ' ' VAL . 59.8 t -122.58 132.47 71.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.799 -0.445 . . . . 1.79 109.799 176.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 35.1 t -120.04 127.8 52.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.877 0.37 . . . . 1.6299999999999999 110.086 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 72.2 mt -117.15 129.24 55.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.112 -0.495 . . . . 2.96 110.259 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.12 119.95 41.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.053 -0.521 . . . . 4.0800000000000001 110.633 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -124.51 135.54 53.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.256 -0.429 . . . . 4.8399999999999999 110.465 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.504 0 CA-C-O 121.276 0.56 . . . . 3.5800000000000001 110.775 175.46 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 109.954 -0.387 . . . . 1.9399999999999999 109.954 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -137.8 144.46 15.8 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.552 -0.832 . . . . 1.4199999999999999 112.541 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 63.0 t -130.06 130.11 65.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.588 0.232 . . . . 1.8100000000000001 110.489 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -141.65 131.07 4.63 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.955 -0.64 . . . . 1.3 111.554 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.473 HG23 HG22 ' A' ' 251' ' ' VAL . 7.3 p -132.96 137.12 54.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.652 0.263 . . . . 1.8300000000000001 110.73 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -119.79 127.52 52.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 2.3100000000000001 110.31 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 89.5 m-85 -109.22 126.71 53.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.259 -0.645 . . . . 4.75 109.259 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . 0.498 ' HB2' ' HA2' ' A' ' 248' ' ' GLY . 37.7 m -114.17 129.35 56.63 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.903 0.383 . . . . 1.6699999999999999 110.554 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.178 -0.915 . . . . 3.6899999999999999 109.608 179.503 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 . . . . . 0 CA--C 1.517 -0.315 0 N-CA-C 109.609 -0.515 . . . . 3.6099999999999999 109.609 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.448 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 92.2 m95 -71.25 115.97 11.02 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.642 -0.708 . . . . 3.3300000000000001 110.053 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.427 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 53.1 t60 -114.57 122.16 45.67 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.071 -0.513 . . . . 3.2000000000000002 109.964 175.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' A' ' 7' ' ' TRP . 98.9 m-85 -120.21 140.07 51.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.944 -0.571 . . . . 2.4900000000000002 110.731 -178.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -122.0 129.47 52.49 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.078 -0.712 . . . . 2.1299999999999999 109.078 171.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.511 ' HB ' ' HB3' ' A' ' 279' ' ' TYR . 86.2 mt -125.12 129.37 73.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.292 -0.413 . . . . 1.6000000000000001 110.736 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.13 122.79 5.95 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.093 -0.803 . . . . 0.88 111.093 175.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -120.01 136.66 54.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.935 0.367 . . . . 1.0800000000000001 110.858 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 68.4 mtt -133.43 156.68 47.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.305 -0.407 . . . . 2.3300000000000001 110.347 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -114.65 139.93 49.25 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.782 -0.451 . . . . 2.6099999999999999 109.782 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 112.762 0.652 . . . . 5.0899999999999999 112.762 -175.276 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 109.796 -0.446 . . . . 3.48 109.796 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.97 150.01 66.32 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.347 2.031 . . . . 1.8600000000000001 112.267 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 14.3 p -124.46 143.67 50.51 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.038 -0.528 . . . . 1.97 109.733 175.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.0 m -129.96 139.23 52.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.19 0.519 . . . . 1.71 111.252 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -120.33 139.44 52.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.616 -0.72 . . . . 4.0700000000000003 109.631 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -119.9 138.34 53.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.882 0.373 . . . . 2.8599999999999999 111.625 -174.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -140.07 130.01 24.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.733 -0.667 . . . . 1.8899999999999999 109.222 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.62 143.46 49.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.884 0.373 . . . . 1.0800000000000001 111.573 -174.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.542 ' HB2' ' HG2' ' A' ' 45' ' ' ARG . . . -147.01 125.09 12.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.607 -0.724 . . . . 1.3899999999999999 111.354 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.602 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 27.8 p-10 -166.96 95.24 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.278 0.561 . . . . 2.8599999999999999 110.502 171.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.97 -95.52 2.1 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.05 -0.595 . . . . 1.6799999999999999 111.871 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.602 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 54.2 Cg_exo -52.5 174.47 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.624 2.883 . . . . 1.6599999999999999 113.178 171.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.605 ' HB2' ' O ' ' A' ' 75' ' ' HIS . 48.9 p90 -69.14 -176.02 0.84 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.83 -0.623 . . . . 3.3999999999999999 111.289 -175.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.542 ' HG2' ' HB2' ' A' ' 40' ' ' ALA . 83.3 mtm180 -111.0 136.37 50.1 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 121.786 0.803 . . . . 3.1000000000000001 112.42 -167.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 87.1 mt -120.06 129.95 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 114.113 -1.403 . . . . 1.8 109.931 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 73' ' ' GLU . . . -117.85 138.22 52.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.43 -0.35 . . . . 0.85999999999999999 110.065 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.0 tp -114.22 130.93 56.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.945 -0.57 . . . . 1.0600000000000001 110.423 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 71' ' ' GLU . . . -148.85 169.25 20.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.52 -0.764 . . . . 1.1399999999999999 109.332 177.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -139.75 157.52 45.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.642 0.258 . . . . 4.0199999999999996 110.386 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -120.42 131.71 54.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.114 -0.494 . . . . 4.6100000000000003 110.645 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -113.61 127.86 56.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.079 -0.51 . . . . 3.3799999999999999 109.816 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.455 ' CD ' HH12 ' A' ' 69' ' ' ARG . 93.6 mt-10 . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 116.308 -0.405 . . . . 5.0499999999999998 109.973 -178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 89.2 m95 . . . . . 0 CA--C 1.527 0.082 0 CA-C-O 120.793 0.33 . . . . 5.6100000000000003 110.863 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.425 ' CD2' ' HA2' ' A' ' 96' ' ' GLY . 37.2 m-85 -119.02 120.02 35.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.731 -0.47 . . . . 3.7799999999999998 109.731 173.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -145.05 150.82 37.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.866 -0.607 . . . . 2.4500000000000002 109.634 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.455 HH12 ' CD ' ' A' ' 53' ' ' GLU . 41.0 ttp180 -119.99 124.42 27.87 Favored Pre-proline 0 C--N 1.328 -0.341 0 C-N-CA 120.662 -0.415 . . . . 3.2400000000000002 110.98 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -84.02 149.15 12.18 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.843 2.362 . . . . 1.1899999999999999 112.921 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.468 ' CD ' ' HE ' ' A' ' 93' ' ' ARG . 3.7 tp10 -115.46 118.55 33.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.572 -0.899 . . . . 2.1899999999999999 108.572 168.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.462 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 59.5 tp -122.34 101.8 7.73 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.251 -0.431 . . . . 1.1399999999999999 110.15 -178.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 34.7 mt-10 -90.14 125.59 35.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.04 -0.527 . . . . 2.1800000000000002 111.31 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.8 m -114.0 121.99 67.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.524 -0.917 . . . . 1.5600000000000001 108.524 168.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.605 ' O ' ' HB2' ' A' ' 44' ' ' TRP . 63.0 m80 -109.67 118.11 35.69 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.662 -0.495 . . . . 3.4399999999999999 109.662 -174.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -114.52 130.07 56.72 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.859 -0.793 . . . . 4.7999999999999998 108.859 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -128.04 129.74 47.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.953 0.406 . . . . 2.9399999999999999 110.399 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 89.0 m-85 -100.23 109.54 21.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.95 -0.568 . . . . 3.8999999999999999 109.941 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 C--N 1.324 -0.541 0 N-CA-C 109.323 -0.621 . . . . 4.4800000000000004 109.323 177.258 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 108.407 -0.96 . . . . 2.5499999999999998 108.407 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 78' ' ' PHE . 98.9 m-85 -79.55 129.8 34.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.107 -0.497 . . . . 5.2999999999999998 110.344 -175.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.08 153.22 17.89 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.318 -0.944 . . . . 1.3500000000000001 111.903 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.8 tp -139.3 117.32 11.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.92 0.39 . . . . 2.29 110.079 176.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.6 m -110.8 117.65 34.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.138 -0.483 . . . . 1.54 110.368 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.57 133.9 10.8 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.508 -0.853 . . . . 1.1699999999999999 112.059 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -136.04 126.11 3.76 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.548 -0.621 . . . . 1.1899999999999999 111.548 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -112.35 131.29 55.61 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.054 -0.35 . . . . 3.75 110.054 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.468 ' HE ' ' CD ' ' A' ' 71' ' ' GLU . 85.8 mtt180 -135.28 131.33 36.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.088 -0.506 . . . . 2.75 110.177 -172.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -133.92 129.21 35.99 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.052 -0.259 . . . . 1.8200000000000001 110.958 175.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.411 ' HB2' ' HD3' ' A' ' 69' ' ' ARG . 71.4 t80 -114.85 125.13 53.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.525 -0.307 . . . . 3.1400000000000001 110.252 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.425 ' HA2' ' CD2' ' A' ' 67' ' ' PHE . . . . . . . . 0 N--CA 1.443 -0.856 0 C-N-CA 120.527 -0.845 . . . . 2.79 112.928 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 N--CA 1.445 -0.677 0 CA-C-O 121.155 0.502 . . . . 3.2999999999999998 110.835 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.64 124.67 16.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.928 -0.578 . . . . 1.76 110.095 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -139.54 107.93 5.83 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.245 -0.65 . . . . 2.5499999999999998 109.245 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 91.6 mtp -119.95 115.52 23.94 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.471 -0.331 . . . . 1.77 110.297 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.63 ' HB2' ' OD1' ' A' ' 143' ' ' ASN . 49.4 mt-30 -100.19 129.09 46.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.949 0.404 . . . . 1.97 110.113 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 40.5 ttm180 -120.24 111.02 17.28 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.87 -0.789 . . . . 3.8500000000000001 108.87 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -108.02 130.83 55.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.06 -0.518 . . . . 2.2799999999999998 109.703 -175.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 135' ' ' MET . 87.6 tttt -130.23 124.12 31.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.045 0.45 . . . . 2.1400000000000001 110.884 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 75.9 mt -129.82 130.03 66.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.022 -0.535 . . . . 1.55 109.557 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -134.01 116.41 13.42 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.393 -0.367 . . . . 1.1899999999999999 111.151 -177.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 87.3 Cg_endo -80.01 140.05 13.99 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.277 1.984 . . . . 1.3700000000000001 110.579 171.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -87.77 137.75 32.06 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.202 -0.454 . . . . 2.3500000000000001 110.985 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -101.13 127.53 47.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.24 -0.652 . . . . 4.54 109.24 172.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -71.43 160.39 32.82 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 124.092 0.87 . . . . 3.04 111.61 -171.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' A' ' 128' ' ' ARG . 34.6 m -115.04 173.94 3.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.304 -0.862 . . . . 4.2699999999999996 110.841 -173.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 60.13 39.07 19.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.854 -0.612 . . . . 6.04 111.576 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.7 tp -63.08 -40.19 96.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.759 -0.655 . . . . 4.5899999999999999 110.436 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.9 p -118.02 159.98 22.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.752 -0.658 . . . . 3.6899999999999999 110.446 177.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -70.27 129.91 40.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.061 -0.518 . . . . 5.1699999999999999 111.402 -174.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 59.86 28.37 17.85 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.081 -0.963 . . . . 3.71 111.368 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.8 mt -137.77 144.44 41.6 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.21 -0.663 . . . . 2.0499999999999998 109.21 175.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.5 ' HG3' ' HB ' ' A' ' 121' ' ' VAL . 56.8 ttt180 -130.2 128.99 42.81 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.427 -0.509 . . . . 4.2400000000000002 111.104 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.441 ' O ' HG12 ' A' ' 121' ' ' VAL . 90.0 m-85 -120.01 123.05 42.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.273 -0.876 . . . . 3.5499999999999998 108.882 176.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 156' ' ' THR . 21.8 m-80 -116.16 130.98 57.06 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.078 -0.712 . . . . 2.1099999999999999 109.078 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.36 129.61 4.62 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 118.965 -1.588 . . . . 1.1799999999999999 113.232 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -123.57 127.8 48.81 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.943 -0.392 . . . . 4.2999999999999998 109.943 173.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.627 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 87.9 mt -112.75 109.72 19.39 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.031 -0.729 . . . . 2.2400000000000002 109.031 174.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 152' ' ' VAL . 52.6 m -105.88 124.95 50.39 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.565 -0.454 . . . . 1.6899999999999999 111.469 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.661 ' O ' ' HA ' ' A' ' 114' ' ' LYS . 95.4 mmm -93.32 126.2 38.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.507 -0.77 . . . . 2.2400000000000002 109.295 176.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -120.68 126.14 49.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.177 0.513 . . . . 3.5600000000000001 111.953 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 61.7 mttp -130.31 143.72 50.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.387 -0.968 . . . . 1.6699999999999999 108.387 167.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.53 ' H ' HD22 ' A' ' 142' ' ' LEU . 53.1 p90 -141.48 160.0 41.06 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 121.201 -0.2 . . . . 3.23 110.76 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 62.75 178.66 0.14 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.94 0.775 . . . . 1.24 110.601 -177.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -75.73 -24.36 56.13 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.93 0.395 . . . . 2.4700000000000002 110.584 173.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -59.96 -50.85 72.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.951 -0.568 . . . . 2.4100000000000001 111.599 -174.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.53 HD22 ' H ' ' A' ' 138' ' ' PHE . 9.5 mp -70.81 -29.86 66.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.436 -0.347 . . . . 1.8300000000000001 111.24 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.63 ' OD1' ' HB2' ' A' ' 111' ' ' GLN . 12.7 m120 -61.58 -41.49 97.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.006 0.432 . . . . 2.0 110.456 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.1 p -80.22 -39.9 28.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.595 -0.73 . . . . 2.0499999999999998 111.832 -173.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 148' ' ' ALA . 24.6 p -74.07 -32.88 63.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.321 . . . . 1.5900000000000001 111.207 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.71 -108.75 2.59 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.933 -0.576 . . . . 1.52 113.149 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -59.97 -40.07 87.83 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 122.687 0.395 . . . . 5.9400000000000004 111.503 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' A' ' 145' ' ' THR . . . -60.04 -44.27 94.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.173 -0.467 . . . . 1.8300000000000001 111.857 -175.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.53 ' HB3' ' HG ' ' A' ' 142' ' ' LEU . 43.3 m-20 -118.01 98.25 6.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.125 0.488 . . . . 2.6400000000000001 110.966 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.5 t -149.93 144.56 25.96 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.406 -0.59 . . . . 2.02 109.406 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -110.16 151.71 26.94 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.335 -0.393 . . . . 3.6699999999999999 110.078 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.519 HG12 ' SD ' ' A' ' 135' ' ' MET . 16.1 m -136.41 134.4 49.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.984 0.421 . . . . 1.6399999999999999 111.504 -177.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -113.72 140.51 48.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.199 -0.455 . . . . 2.5600000000000001 109.832 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 78.6 m -128.42 118.63 23.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.163 -0.471 . . . . 1.3899999999999999 109.936 175.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -120.68 120.16 34.9 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.774 -0.454 . . . . 2.04 109.774 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 130' ' ' ASN . 27.0 m -108.3 119.93 40.92 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.669 -0.696 . . . . 1.5600000000000001 110.026 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.97 111.81 4.33 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.92 -0.872 . . . . 1.04 110.92 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 91.7 mt -104.23 129.98 52.03 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 110.263 -0.273 . . . . 2.27 110.263 -176.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 65.9 tt0 -114.92 113.55 24.31 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.832 -0.433 . . . . 2.4100000000000001 109.832 176.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -115.65 130.57 56.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.573 -0.74 . . . . 4.5700000000000003 109.458 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -92.58 90.18 7.02 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.404 0.621 . . . . 1.46 109.907 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -60.24 -49.62 76.88 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.934 -1.03 . . . . 2.6299999999999999 111.715 -171.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.418 ' C ' ' H ' ' A' ' 165' ' ' THR . 17.4 m120 -99.87 2.62 44.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.381 -0.372 . . . . 2.4100000000000001 110.353 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 71.88 -36.11 0.35 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.356 -0.838 . . . . 2.5800000000000001 111.263 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 163' ' ' ASN . 21.8 p -75.36 -34.97 61.19 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.859 0.362 . . . . 2.2999999999999998 111.206 174.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 163' ' ' ASN . 24.9 m -121.08 140.56 44.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 120.94 0.4 . . . . 1.71 110.734 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 161' ' ' THR . . . -107.74 139.94 41.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.928 -0.578 . . . . 1.47 111.237 -175.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 159' ' ' GLN . 17.9 mt -104.53 125.59 50.84 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.429 -0.582 . . . . 1.6599999999999999 109.429 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -109.22 115.72 30.54 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.727 -0.472 . . . . 3.2999999999999998 109.727 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.0 132.09 65.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.063 0.459 . . . . 1.3 110.855 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.475 ' O ' ' HB ' ' A' ' 194' ' ' ILE . 3.2 m-20 -107.23 122.57 46.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.048 0.451 . . . . 2.2200000000000002 111.025 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -98.28 121.51 40.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.512 -0.767 . . . . 4.6100000000000003 110.052 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -99.49 120.42 39.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.953 0.406 . . . . 3.98 110.119 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 63.9 tp -104.91 129.14 53.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.806 -0.634 . . . . 2.3799999999999999 110.95 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -98.68 138.63 35.57 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.641 -0.874 . . . . 3.3100000000000001 108.641 175.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.992 0.425 . . . . 6.5300000000000002 110.842 179.793 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 109.554 -0.535 . . . . 4.4000000000000004 109.554 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' A' ' 171' ' ' ASN . 28.5 pt -120.09 169.1 11.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.761 -0.654 . . . . 2.21 111.062 -172.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -101.68 119.94 39.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.85 -0.614 . . . . 3.54 110.553 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -112.87 129.44 56.46 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.512 -0.551 . . . . 1.6699999999999999 109.512 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 209' ' ' PRO . 31.1 p90 -145.42 149.93 35.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.264 0.554 . . . . 5.8300000000000001 111.528 -178.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.9 mp -112.26 127.74 26.44 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.689 -0.687 . . . . 2.5899999999999999 110.279 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' A' ' 167' ' ' ALA . 85.6 Cg_endo -81.22 106.23 1.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.287 1.991 . . . . 1.77 111.581 175.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 89.9 mt -114.47 140.09 49.0 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.941 -0.572 . . . . 2.2599999999999998 109.93 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 94.0 m -119.93 130.05 54.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.126 0.488 . . . . 1.99 111.134 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.1 mt -129.8 80.29 1.95 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.533 -0.914 . . . . 2.3100000000000001 108.533 173.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 70.06 -120.96 9.96 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.863 -0.684 . . . . 1.51 111.78 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -91.87 -0.03 57.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.259 0.552 . . . . 2.5699999999999998 109.536 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -93.67 118.98 32.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.327 -0.852 . . . . 2.6600000000000001 109.291 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 47.6 m -104.62 131.97 51.42 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.782 -0.451 . . . . 1.6200000000000001 109.782 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 63.2 t -120.07 130.03 74.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.908 -0.405 . . . . 1.3799999999999999 109.908 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 48.1 m -138.1 94.65 11.04 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 116.503 -0.317 . . . . 1.1799999999999999 110.987 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' A' ' 197' ' ' TYR . 16.5 Cg_exo -69.17 131.22 21.6 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.525 2.15 . . . . 1.01 111.635 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -108.43 139.97 42.4 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.823 -0.436 . . . . 4.5 109.823 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 11.1 t -168.53 166.93 11.9 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.191 -0.459 . . . . 1.8899999999999999 110.426 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -98.97 139.87 33.97 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.048 -1.093 . . . . 4.7999999999999998 108.048 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 83.7 mt . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.03 0.443 . . . . 4.5700000000000003 110.871 -175.74 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 C--O 1.233 0.234 0 N-CA-C 109.337 -0.616 . . . . 2.3999999999999999 109.337 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 172.43 177.03 41.59 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.024 -1.084 . . . . 1.27 112.995 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 83.0 mt -120.04 129.97 54.48 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.104 -0.332 . . . . 1.97 110.104 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -101.45 133.64 45.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.061 -0.348 . . . . 3.54 110.061 175.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -120.08 139.96 51.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.061 -0.518 . . . . 2.6400000000000001 110.262 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 251' ' ' VAL . . . -127.13 132.16 7.49 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.251 -0.739 . . . . 1.3500000000000001 111.251 176.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 250' ' ' SER . 91.3 m-85 -120.83 144.24 48.45 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.067 -0.346 . . . . 4.3600000000000003 110.067 -177.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 56.5 40.04 29.69 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.846 0.716 . . . . 4.29 110.507 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -62.72 -40.11 96.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.534 -0.757 . . . . 6.6900000000000004 110.867 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -111.21 129.99 55.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.636 -0.256 . . . . 6.3700000000000001 111.289 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 55.51 39.92 31.11 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.704 -0.68 . . . . 5.8300000000000001 112.229 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -161.82 -174.44 31.7 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.521 -0.632 . . . . 2.6600000000000001 111.521 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 86.2 mt -89.1 109.1 20.0 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.863 -0.791 . . . . 2.9700000000000002 108.863 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 243' ' ' TYR . 17.7 m -78.88 130.92 36.17 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.113 0.482 . . . . 2.1699999999999999 111.26 -169.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.42 ' O ' ' HA2' ' A' ' 242' ' ' GLY . 62.9 t -107.57 133.24 52.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.667 -0.697 . . . . 1.79 109.78 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 3.0 p -108.3 113.28 26.25 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.064 0.459 . . . . 1.6299999999999999 110.485 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 64.8 tp -119.57 115.73 24.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.087 -0.506 . . . . 2.96 110.635 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -101.77 115.47 30.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.181 -0.463 . . . . 4.0800000000000001 110.371 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -106.21 120.04 40.81 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 110.259 -0.275 . . . . 4.8399999999999999 110.259 175.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.684 0 N-CA-C 108.487 -0.931 . . . . 3.5800000000000001 108.487 172.62 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.467 0 N-CA-C 109.617 -0.512 . . . . 1.9399999999999999 109.617 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.35 137.57 9.54 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.937 -0.649 . . . . 1.4199999999999999 111.659 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 61.9 t -129.4 129.97 67.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.953 0.406 . . . . 1.8100000000000001 110.874 -175.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -152.44 163.66 30.36 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.873 -0.603 . . . . 1.3 111.686 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.19 140.01 32.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.885 0.374 . . . . 1.8300000000000001 110.163 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -113.5 127.01 55.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.196 0.522 . . . . 2.3100000000000001 110.929 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.511 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 65.0 t80 -105.96 124.71 50.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.655 -0.702 . . . . 4.75 109.402 176.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 7.7 p -117.44 130.51 56.51 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.037 0.446 . . . . 1.6699999999999999 110.858 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 59.2 t80 . . . . . 0 C--O 1.244 0.783 0 CA-C-O 118.508 -0.758 . . . . 3.6899999999999999 109.084 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 120.572 0.225 . . . . 3.6099999999999999 111.059 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -96.93 108.2 20.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.6 -0.889 . . . . 3.3300000000000001 108.6 171.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -110.7 137.16 48.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.341 0.591 . . . . 3.2000000000000002 111.778 -175.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -125.21 142.89 51.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.619 -1.173 . . . . 2.4900000000000002 109.536 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -120.98 129.99 53.64 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.962 -0.384 . . . . 2.1299999999999999 109.962 176.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.7 mt -120.03 122.52 68.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.921 -0.581 . . . . 1.6000000000000001 109.919 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.38 142.1 13.53 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 119.799 -1.191 . . . . 0.88 112.601 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.26 136.23 53.19 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.624 -0.509 . . . . 1.0800000000000001 109.624 176.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 70.1 mtm -127.75 151.28 49.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.184 -0.462 . . . . 2.3300000000000001 110.944 -175.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.444 ' CE1' ' HB3' ' A' ' 33' ' ' PRO . 59.3 m-85 -129.93 138.25 50.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.251 -0.886 . . . . 2.6099999999999999 108.69 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 121.124 0.488 . . . . 5.0899999999999999 110.049 176.841 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 120.548 0.213 . . . . 3.48 110.552 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HB3' ' CE1' ' A' ' 15' ' ' TYR . 87.8 Cg_endo -90.09 133.2 1.97 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.627 2.218 . . . . 1.8600000000000001 113.192 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.2 m -140.03 162.7 34.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.984 0.421 . . . . 1.97 111.619 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -125.19 134.91 65.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.791 -0.64 . . . . 1.71 110.775 -177.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -113.07 162.23 16.16 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.321 -0.622 . . . . 4.0700000000000003 109.321 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -139.87 146.72 39.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.056 0.455 . . . . 2.8599999999999999 111.231 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.6 ' OD1' ' HD3' ' A' ' 45' ' ' ARG . 11.3 p30 -151.4 160.86 43.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.773 -0.649 . . . . 1.8899999999999999 109.526 174.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.15 155.28 39.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.49 -0.323 . . . . 1.0800000000000001 110.576 -178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.37 146.03 16.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.369 -0.378 . . . . 1.3899999999999999 110.8 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.626 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 6.1 p-10 -167.08 94.73 0.47 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.773 -0.649 . . . . 2.8599999999999999 109.787 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.95 -94.07 1.95 Allowed Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 111.114 -0.794 . . . . 1.6799999999999999 111.114 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 77.0 Cg_exo -52.24 174.03 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.385 2.723 . . . . 1.6599999999999999 113.092 168.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.497 ' HB2' ' O ' ' A' ' 75' ' ' HIS . 48.9 p90 -70.07 -176.89 1.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.742 -0.663 . . . . 3.3999999999999999 112.155 -170.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.6 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 18.0 ttm180 -113.69 129.41 56.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.908 -0.587 . . . . 3.1000000000000001 111.29 -168.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.9 mt -113.22 129.92 68.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.37 -0.832 . . . . 1.8 110.274 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.499 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -118.9 132.14 56.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.492 -0.322 . . . . 0.85999999999999999 110.576 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.5 tp -124.23 131.0 53.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.777 0.322 . . . . 1.0600000000000001 110.413 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.37 160.87 42.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.846 -0.616 . . . . 1.1399999999999999 110.349 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -120.03 139.96 51.72 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.4 -0.593 . . . . 4.0199999999999996 109.4 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 45.4 t80 -98.89 128.16 45.0 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.651 0.738 . . . . 4.6100000000000003 111.808 -175.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -150.02 155.06 39.24 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.392 -1.707 . . . . 3.3799999999999999 106.392 171.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 . . . . . 0 C--N 1.317 -0.838 0 N-CA-C 109.393 -0.595 . . . . 5.0499999999999998 109.393 178.537 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 47.0 m95 . . . . . 0 CA--C 1.521 -0.173 0 N-CA-C 109.416 -0.587 . . . . 5.6100000000000003 109.416 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -119.1 119.95 35.72 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.58 -0.526 . . . . 3.7799999999999998 109.58 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -159.36 169.27 24.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.116 0.484 . . . . 2.4500000000000002 110.912 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 94' ' ' ASN . 41.5 ttp180 -149.87 123.24 4.43 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 115.293 -0.867 . . . . 3.2400000000000002 109.602 171.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.663 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 71.4 Cg_endo -79.81 140.56 14.66 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.292 1.995 . . . . 1.1899999999999999 110.733 169.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.544 ' CD ' ' HE ' ' A' ' 93' ' ' ARG . 72.2 tt0 -135.87 124.66 23.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.332 0.587 . . . . 2.1899999999999999 110.699 -178.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 47' ' ' ALA . 41.0 tp -120.17 130.02 54.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.408 -0.814 . . . . 1.1399999999999999 109.994 -178.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -125.04 128.02 47.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.019 0.438 . . . . 2.1800000000000002 110.1 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.03 129.93 74.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.172 -0.467 . . . . 1.5600000000000001 110.743 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 44' ' ' TRP . 64.4 m170 -116.61 120.08 37.53 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.786 0.327 . . . . 3.4399999999999999 110.636 177.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.403 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . 65.0 t80 -114.45 124.13 51.16 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.82 -0.627 . . . . 4.7999999999999998 109.38 174.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -119.55 137.97 53.49 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.27 -0.27 . . . . 2.9399999999999999 110.27 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -134.54 130.31 36.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.931 0.396 . . . . 3.8999999999999999 110.269 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.4 tp . . . . . 0 C--N 1.321 -0.647 0 N-CA-C 109.405 -0.591 . . . . 4.4800000000000004 109.405 177.145 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 120' ' ' ASP . 47.8 m . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 120.995 0.426 . . . . 2.5499999999999998 110.651 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -147.78 161.4 41.31 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.626 -0.509 . . . . 5.2999999999999998 109.626 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.61 176.94 34.62 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.463 -0.875 . . . . 1.3500000000000001 112.04 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 76' ' ' TYR . 92.3 mt -127.69 123.92 36.63 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.118 -0.327 . . . . 2.29 110.118 178.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.2 m -119.93 130.02 54.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.138 -0.483 . . . . 1.54 110.528 176.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -137.07 144.69 16.35 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.804 -0.713 . . . . 1.1699999999999999 111.768 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -137.66 143.98 15.23 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.987 -0.625 . . . . 1.1899999999999999 112.112 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 67.6 t80 -130.48 130.0 43.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.871 0.367 . . . . 3.75 110.753 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.544 ' HE ' ' CD ' ' A' ' 71' ' ' GLU . 99.3 mtt180 -130.29 127.36 39.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.738 -0.665 . . . . 2.75 109.809 175.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.663 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 61.2 t30 -111.27 117.95 34.57 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.441 -0.577 . . . . 1.8200000000000001 109.441 174.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -106.54 125.31 50.84 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.564 -0.289 . . . . 3.1400000000000001 110.881 -172.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.572 0 C-N-CA 120.0 -1.095 . . . . 2.79 111.584 175.486 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.874 -0.417 . . . . 3.2999999999999998 109.874 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.29 157.8 25.46 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.451 -0.203 . . . . 1.76 110.451 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -119.91 126.73 51.63 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.643 0.735 . . . . 2.5499999999999998 111.163 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 88.7 mtp -104.7 117.96 35.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.308 -0.86 . . . . 1.77 109.491 176.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 96.5 mt-30 -94.2 118.44 31.56 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.503 -0.479 . . . . 1.97 110.911 -174.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 84.4 mtt180 -105.5 115.94 31.1 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.012 -0.54 . . . . 3.8500000000000001 109.683 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 35.5 t-105 -118.35 120.8 38.69 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.999 -0.741 . . . . 2.2799999999999998 108.999 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.421 ' HE3' ' OG ' ' A' ' 134' ' ' SER . 87.8 tttt -126.32 130.01 49.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.445 -0.343 . . . . 2.1400000000000001 110.719 -176.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.2 pt -132.59 144.51 36.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.89 0.376 . . . . 1.55 110.953 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.47 123.84 3.17 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.775 -0.648 . . . . 1.1899999999999999 110.351 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.6 130.52 3.8 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.459 2.106 . . . . 1.3700000000000001 111.059 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -80.04 137.41 36.79 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.712 -0.477 . . . . 2.3500000000000001 109.712 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -132.91 128.41 36.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.008 0.432 . . . . 4.54 111.496 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 85' ' ' SER . 0.8 OUTLIER -103.57 110.26 22.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.795 -0.638 . . . . 3.04 109.461 171.172 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.73 119.98 61.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.145 0.498 . . . . 4.2699999999999996 110.817 -175.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -102.7 84.53 2.42 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.303 0.573 . . . . 6.04 110.137 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.02 -39.98 75.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.261 -0.881 . . . . 4.5899999999999999 111.598 -177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 81.5 m -123.8 139.18 54.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.073 -0.512 . . . . 3.6899999999999999 110.443 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -59.94 140.05 56.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.816 -0.629 . . . . 5.1699999999999999 111.272 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 66.1 14.31 9.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.271 -0.877 . . . . 3.71 111.964 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.6 mt -131.85 148.94 52.58 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.486 -0.561 . . . . 2.0499999999999998 109.486 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -130.81 137.58 49.49 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.719 -0.392 . . . . 4.2400000000000002 110.057 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -127.01 128.28 46.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.188 -0.46 . . . . 3.5499999999999998 109.78 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -119.77 129.91 54.7 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.473 -0.566 . . . . 2.1099999999999999 109.473 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -160.91 161.19 32.65 Favored Glycine 0 CA--C 1.504 -0.647 0 C-N-CA 119.908 -1.139 . . . . 1.1799999999999999 112.108 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -145.13 149.81 35.66 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.994 0.426 . . . . 4.2999999999999998 110.942 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.9 tp -101.34 120.98 41.09 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.925 -0.769 . . . . 2.2400000000000002 108.925 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.421 ' OG ' ' HE3' ' A' ' 114' ' ' LYS . 18.3 t -113.48 136.74 52.46 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.772 -0.649 . . . . 1.6899999999999999 111.099 -172.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 67.3 mtm -140.0 140.2 36.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.803 -0.635 . . . . 2.2400000000000002 109.727 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -145.29 156.52 43.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.271 0.558 . . . . 3.5600000000000001 111.555 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 62.2 mttp -130.95 157.0 44.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.879 -1.055 . . . . 1.6699999999999999 108.904 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 48.1 p90 -142.2 163.78 31.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.645 -0.252 . . . . 3.23 110.425 -175.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 65.09 -172.5 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.948 -0.569 . . . . 1.24 111.154 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -76.79 -47.34 21.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.169 0.509 . . . . 2.4700000000000002 110.89 174.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -60.17 -45.59 92.58 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.196 -0.911 . . . . 2.4100000000000001 113.455 -167.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 138' ' ' PHE . 3.1 mm? -62.02 -39.99 94.17 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.185 0.517 . . . . 1.8300000000000001 110.561 -176.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -67.36 -39.86 85.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.635 -0.711 . . . . 2.0 110.551 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.4 m -62.73 -44.36 96.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.675 -0.693 . . . . 2.0499999999999998 112.008 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 31.0 p -76.87 -19.9 56.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.992 0.425 . . . . 1.5900000000000001 111.156 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.21 -125.86 21.96 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.789 -0.641 . . . . 1.52 113.196 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -65.73 -19.39 65.88 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.647 0.24 . . . . 5.9400000000000004 111.647 -174.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.43 98.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.424 -0.353 . . . . 1.8300000000000001 111.675 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.503 ' O ' ' HE3' ' A' ' 137' ' ' LYS . 68.1 m-20 -119.69 117.18 27.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.044 0.45 . . . . 2.6400000000000001 110.572 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.4 t -154.3 153.92 32.5 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.863 -0.421 . . . . 2.02 109.863 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -108.27 140.06 42.07 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.742 -0.466 . . . . 3.6699999999999999 109.742 175.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.88 119.97 59.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.149 0.5 . . . . 1.6399999999999999 110.295 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -119.63 130.43 55.09 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.363 -0.835 . . . . 2.5600000000000001 109.122 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 21.8 m -129.54 129.79 44.94 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 121.923 -0.486 . . . . 1.3899999999999999 111.267 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -128.76 128.9 44.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.12 -0.491 . . . . 2.04 109.849 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 27.2 p -130.32 140.3 50.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.074 -0.512 . . . . 1.5600000000000001 110.773 -177.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -125.63 122.44 4.55 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.599 -0.601 . . . . 1.04 111.599 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.9 mt -102.29 128.25 48.92 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.988 -0.375 . . . . 2.27 109.988 -176.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -107.66 111.05 23.08 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.617 -0.433 . . . . 2.4100000000000001 110.379 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.98 139.8 51.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.737 -0.665 . . . . 4.5700000000000003 109.75 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.442 ' HB ' ' HA ' ' A' ' 164' ' ' GLU . 18.0 p -100.75 102.22 13.26 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.187 0.518 . . . . 1.46 110.368 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -60.01 -48.51 81.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.289 -0.869 . . . . 2.6299999999999999 110.992 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -102.64 9.77 39.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.336 -0.393 . . . . 2.4100000000000001 110.553 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.442 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 42.6 tt0 72.13 -42.93 0.55 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.597 0.759 . . . . 2.5800000000000001 111.131 -175.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.5 p -74.79 -24.44 58.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.448 -0.342 . . . . 2.2999999999999998 111.816 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.4 m -125.09 140.44 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.403 -0.362 . . . . 1.71 110.627 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.06 130.57 54.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.15 0.5 . . . . 1.47 111.389 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 21.9 mt -104.26 136.33 44.06 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.556 -0.905 . . . . 1.6599999999999999 108.556 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -114.07 113.45 24.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.169 0.509 . . . . 3.2999999999999998 110.7 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 63.2 t -115.05 120.11 63.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.5 -0.773 . . . . 1.3 110.217 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -104.69 124.08 48.74 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.01 0.433 . . . . 2.2200000000000002 110.773 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -105.17 130.39 53.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.785 -0.643 . . . . 4.6100000000000003 109.821 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.45 ' CE2' ' HD3' ' A' ' 195' ' ' ARG . 68.2 m-85 -110.99 136.65 49.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.971 -0.558 . . . . 3.98 110.468 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.5 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 61.5 tp -122.39 118.51 28.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.21 -0.45 . . . . 2.3799999999999999 110.398 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -120.11 179.98 4.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.889 -0.596 . . . . 3.3100000000000001 109.695 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 . . . . . 0 C--N 1.323 -0.546 0 C-N-CA 120.884 -0.326 . . . . 6.5300000000000002 111.042 -178.702 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.824 0.345 . . . . 4.4000000000000004 111.251 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 213' ' ' ILE . 86.4 mt -120.3 120.0 61.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.347 -0.388 . . . . 2.21 110.395 176.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.45 ' HD3' ' CE2' ' A' ' 173' ' ' TYR . 69.4 mtp180 -111.58 116.62 31.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.242 -0.651 . . . . 3.54 109.242 177.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -120.0 138.97 53.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.839 0.352 . . . . 1.6699999999999999 111.048 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -160.02 159.99 32.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.902 -0.59 . . . . 5.8300000000000001 110.425 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 198' ' ' LEU . 1.9 pt? -129.14 128.43 23.31 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.377 -0.374 . . . . 2.5899999999999999 110.116 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.83 133.04 11.08 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.414 2.076 . . . . 1.77 112.359 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 56.9 tp -135.66 131.14 35.35 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.027 -0.731 . . . . 2.2599999999999998 109.027 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 33.3 m -120.05 130.08 54.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.701 0.286 . . . . 1.99 110.548 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 58.3 tp -137.69 86.04 2.16 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.575 -0.528 . . . . 2.3100000000000001 109.575 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 69.93 -120.89 10.05 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.822 -0.704 . . . . 1.51 112.52 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -90.27 2.55 55.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 2.5699999999999998 110.248 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -112.65 130.08 56.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.099 -0.501 . . . . 2.6600000000000001 110.491 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 68.3 m -115.32 136.93 52.58 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.951 -0.568 . . . . 1.6200000000000001 109.73 173.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 45.9 t -119.93 130.01 74.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.751 -0.463 . . . . 1.3799999999999999 109.751 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.9 m -137.61 95.41 11.27 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-O 120.582 0.229 . . . . 1.1799999999999999 110.57 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.67 130.05 19.96 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.217 1.945 . . . . 1.01 110.659 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -110.79 138.66 46.9 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.287 -0.415 . . . . 4.5 110.171 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 71.1 p -133.68 151.66 51.7 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.133 -0.485 . . . . 1.8899999999999999 110.067 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.444 ' HG3' HG21 ' A' ' 237' ' ' VAL . 27.4 mtm180 -108.31 120.86 43.61 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.395 -0.595 . . . . 4.7999999999999998 109.395 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.514 ' O ' ' HB ' ' A' ' 194' ' ' ILE . 48.6 mm . . . . . 0 C--N 1.321 -0.662 0 N-CA-C 109.899 -0.408 . . . . 4.5700000000000003 109.899 -177.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.444 HG21 ' HG3' ' A' ' 212' ' ' ARG . 54.2 t . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 121.062 0.458 . . . . 2.3999999999999999 110.942 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -162.06 155.11 26.27 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.429 -0.891 . . . . 1.27 112.117 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 90.7 mt -112.83 126.24 55.23 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.708 -0.478 . . . . 1.97 109.708 176.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -106.19 128.64 54.07 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.649 -0.5 . . . . 3.54 109.649 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -119.93 139.97 51.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.247 -0.433 . . . . 2.6400000000000001 110.89 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -111.67 116.05 4.06 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.962 -0.855 . . . . 1.3500000000000001 110.962 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 250' ' ' SER . 59.1 t80 -112.06 114.87 27.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.492 0.187 . . . . 4.3600000000000003 110.884 -177.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -101.34 115.7 31.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.233 0.54 . . . . 4.29 110.074 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -61.1 -49.88 75.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.877 -1.056 . . . . 6.6900000000000004 110.895 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -177.34 78.35 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.177 -0.465 . . . . 6.3700000000000001 110.825 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 56.13 63.43 2.01 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.225 0.536 . . . . 5.8300000000000001 111.956 170.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 153.7 -42.73 0.63 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 119.829 -1.177 . . . . 2.6600000000000001 112.767 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 61.9 tp -99.21 108.69 21.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.875 0.369 . . . . 2.9700000000000002 110.021 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 243' ' ' TYR . 47.0 m -119.9 133.42 55.58 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.988 -0.551 . . . . 2.1699999999999999 110.227 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.9 t -119.34 133.06 67.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 116.017 -0.538 . . . . 1.79 110.095 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 22.9 t -98.55 129.83 45.11 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.005 -0.739 . . . . 1.6299999999999999 109.005 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 91.7 mt -118.86 128.42 54.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.314 -0.403 . . . . 2.96 110.782 -176.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' GLU . . . . . 0.5 ' HB2' ' H ' ' A' ' 274' ' ' GLY . 97.5 mt-10 -101.45 114.42 28.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.948 -0.569 . . . . 4.0800000000000001 109.8 176.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -120.3 140.03 51.84 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.849 -0.341 . . . . 4.8399999999999999 110.771 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.655 0 CA-C-N 116.151 -0.477 . . . . 3.5800000000000001 110.425 175.647 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 110.112 -0.329 . . . . 1.9399999999999999 110.112 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.5 ' H ' ' HB2' ' A' ' 254' ' ' GLU . . . -132.69 149.86 19.61 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.338 -0.705 . . . . 1.4199999999999999 111.338 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.56 143.31 40.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.698 0.285 . . . . 1.8100000000000001 110.597 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -139.89 130.58 4.75 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 111.205 -0.758 . . . . 1.3 111.205 174.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 63.2 t -110.13 120.71 61.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.871 0.336 . . . . 1.8300000000000001 110.383 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -127.73 119.95 26.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.068 0.461 . . . . 2.3100000000000001 111.044 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -103.72 122.06 44.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.775 -0.648 . . . . 4.75 109.266 175.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.7 t -111.34 129.69 55.92 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.069 -0.514 . . . . 1.6699999999999999 109.92 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 C--O 1.246 0.877 0 CA-C-O 118.407 -0.806 . . . . 3.6899999999999999 109.957 -179.379 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.5 ttm . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 110.212 -0.292 . . . . 11.85 110.212 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -60.1 -40.16 88.68 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.046 -0.525 . . . . 10.35 111.134 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.47 -39.8 92.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.783 -0.644 . . . . 9.3100000000000005 111.568 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -76.42 146.03 38.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.064 0.459 . . . . 8.8399999999999999 111.47 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -109.76 20.92 17.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.747 -0.661 . . . . 7.0099999999999998 110.569 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.95 -41.69 92.43 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.736 -0.666 . . . . 3.6099999999999999 111.092 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -99.64 130.45 45.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.331 -0.395 . . . . 3.3300000000000001 110.358 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -98.86 117.67 33.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.081 0.467 . . . . 3.2000000000000002 110.073 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -119.97 140.01 51.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.576 -0.738 . . . . 2.4900000000000002 110.569 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 14.3 t-20 -133.71 131.43 39.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.759 -0.655 . . . . 2.1299999999999999 110.2 174.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 84.7 mt -129.03 128.97 67.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.908 -0.587 . . . . 1.6000000000000001 109.577 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.08 135.61 11.77 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.482 -0.866 . . . . 0.88 111.347 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.02 135.33 54.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.082 0.441 . . . . 1.0800000000000001 110.516 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 94.6 mmm -136.99 149.97 47.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.757 -0.656 . . . . 2.3300000000000001 110.362 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -124.31 124.96 43.52 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.949 -0.76 . . . . 2.6099999999999999 108.949 174.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.427 ' OE1' ' HA ' ' A' ' 31' ' ' ALA . 46.2 mt-10 -70.15 -33.58 71.97 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 120.881 -0.327 . . . . 5.0899999999999999 111.101 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.1 tt -130.21 131.25 65.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.377 -0.374 . . . . 5.3300000000000001 110.552 174.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -120.64 141.46 50.34 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.389 0.614 . . . . 8.2799999999999994 110.732 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -86.14 0.25 54.01 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.542 -0.754 . . . . 9.6999999999999993 110.905 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.2 t -60.18 -50.89 78.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 11.09 111.224 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.551 ' OE1' ' HB3' ' A' ' 271' ' ' HIS . 62.2 mm-40 -70.5 -33.3 71.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.082 0.467 . . . . 13.1 111.257 177.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.11 8.34 56.75 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.68 -0.771 . . . . 11.94 112.652 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.0 140.01 45.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.738 0.304 . . . . 15.18 110.539 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.99 -156.92 9.08 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 121.011 -0.614 . . . . 12.0 111.981 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -132.71 172.26 12.78 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.6 -0.148 . . . . 12.82 110.6 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.76 -49.97 74.26 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.573 0.583 . . . . 10.81 112.573 -176.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 88.5 mtp -109.96 134.34 52.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.155 0.502 . . . . 10.050000000000001 112.268 -172.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -70.01 -39.97 75.52 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.185 -0.916 . . . . 8.0600000000000005 111.726 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.95 14.82 4.37 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-N 116.104 -0.498 . . . . 5.5800000000000001 113.713 -173.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.4 mt -109.88 -0.44 18.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.982 0.391 . . . . 5.5599999999999996 111.289 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.427 ' HA ' ' OE1' ' A' ' 16' ' ' GLU . . . -146.94 129.47 15.94 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 111.751 0.278 . . . . 3.0499999999999998 111.751 -176.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.415 ' HB2' ' HD2' ' A' ' 33' ' ' PRO . 11.9 pt-20 -150.42 160.3 33.2 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.887 -0.412 . . . . 3.48 109.887 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 32' ' ' GLU . 31.7 Cg_endo -69.85 147.84 63.19 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 121.689 1.593 . . . . 1.8600000000000001 111.647 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.5 t -129.49 142.83 50.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.448 -0.342 . . . . 1.97 111.009 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.1 t -130.04 131.99 65.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.981 -0.554 . . . . 1.71 109.615 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 94.7 m-85 -110.02 131.26 55.21 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.883 -0.414 . . . . 4.0700000000000003 109.883 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.7 m-85 -112.99 128.07 56.4 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.927 -0.309 . . . . 2.8599999999999999 110.93 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 10' ' ' ASN . 48.8 m-80 -129.15 132.44 47.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.873 -0.603 . . . . 1.8899999999999999 109.981 175.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.54 143.36 37.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.593 -0.276 . . . . 1.0800000000000001 110.261 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.46 122.29 3.15 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.73 0.27 . . . . 1.3899999999999999 111.73 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.652 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 56.2 t30 -167.53 95.14 0.45 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.393 -0.595 . . . . 2.8599999999999999 109.393 171.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.23 -84.24 0.45 Allowed Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 110.921 -0.871 . . . . 1.6799999999999999 110.921 -173.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.652 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 24.4 Cg_endo -63.62 172.91 5.03 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.862 2.375 . . . . 1.6599999999999999 111.922 169.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -71.05 -174.86 1.03 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.95 -0.568 . . . . 3.3999999999999999 110.914 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -109.61 127.62 54.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.27 0.557 . . . . 3.1000000000000001 109.785 -171.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 72' ' ' LEU . 5.2 tt -127.3 135.24 63.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.856 -1.065 . . . . 1.8 110.876 -171.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -118.28 129.92 55.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.804 -0.635 . . . . 0.85999999999999999 110.264 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.3 tp -122.74 136.25 54.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.278 -0.419 . . . . 1.0600000000000001 110.788 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.32 159.94 42.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.738 -0.665 . . . . 1.1399999999999999 109.852 176.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -123.53 139.98 53.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.572 0.225 . . . . 4.0199999999999996 110.416 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -125.45 115.33 20.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 4.6100000000000003 110.926 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -112.28 129.06 56.41 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.844 -0.343 . . . . 3.3799999999999999 110.239 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.501 ' HB2' ' NH2' ' A' ' 69' ' ' ARG . 85.8 tt0 -127.26 130.19 49.14 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.48 -0.327 . . . . 5.0499999999999998 110.468 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.434 ' HA2' ' HD2' ' A' ' 55' ' ' PRO . . . -112.27 100.64 1.16 Allowed Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.585 -0.817 . . . . 4.3700000000000001 112.122 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.434 ' HD2' ' HA2' ' A' ' 54' ' ' GLY . 23.3 Cg_endo -60.01 -26.56 82.75 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.631 2.221 . . . . 6.6799999999999997 111.034 175.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.8 t -128.4 130.08 69.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.623 -1.171 . . . . 8.1699999999999999 108.122 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -59.96 -32.28 70.66 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.838 0.351 . . . . 10.039999999999999 111.23 -176.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -65.78 -29.4 69.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.027 -0.533 . . . . 11.609999999999999 110.875 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.6 p -93.6 15.0 17.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.359 -0.382 . . . . 9.7899999999999991 111.359 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.53 143.65 34.34 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.895 -0.409 . . . . 8.5099999999999998 109.895 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.61 131.0 10.14 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.573 -0.822 . . . . 7.5599999999999996 112.688 -175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -69.87 -42.47 73.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.071 0.463 . . . . 10.0 110.429 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -70.22 -40.05 74.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.506 -0.77 . . . . 10.35 110.181 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.23 116.51 0.37 Allowed Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 114.812 -1.085 . . . . 5.3399999999999999 110.805 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 67' ' ' PHE . 21.7 m -70.69 130.97 43.16 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.998 0.428 . . . . 5.3200000000000003 111.039 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -65.2 -25.74 67.83 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.842 -0.617 . . . . 5.6100000000000003 110.745 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.582 ' H ' HG22 ' A' ' 65' ' ' THR . 91.6 m-85 -86.14 104.81 16.06 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.582 -0.896 . . . . 3.7799999999999998 108.582 170.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -141.86 147.06 36.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.505 -0.316 . . . . 2.4500000000000002 110.317 -166.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.59 ' HG3' ' HA ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -127.43 124.0 23.42 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 109.858 -0.423 . . . . 3.2400000000000002 109.858 172.315 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 67.0 Cg_endo -80.01 135.51 11.17 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.119 1.879 . . . . 1.1899999999999999 110.951 170.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.491 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 8.1 tp10 -115.35 120.0 38.16 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.406 -0.59 . . . . 2.1899999999999999 109.406 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.41 HD11 HD11 ' A' ' 46' ' ' ILE . 53.4 tp -134.54 129.54 35.21 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.267 -0.424 . . . . 1.1399999999999999 110.315 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -139.7 129.81 25.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.932 0.396 . . . . 2.1800000000000002 110.309 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.4 t -121.55 130.1 74.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.927 -0.579 . . . . 1.5600000000000001 109.773 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -108.81 137.43 46.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.049 0.452 . . . . 3.4399999999999999 110.915 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -119.91 139.89 51.73 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.472 -0.785 . . . . 4.7999999999999998 109.757 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -120.06 138.59 53.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.947 -0.39 . . . . 2.9399999999999999 109.947 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -125.5 127.64 46.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.287 0.565 . . . . 3.8999999999999999 110.496 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.7 tp -95.22 67.24 2.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.511 -0.768 . . . . 4.4800000000000004 110.097 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.599 ' HB2' ' CD1' ' A' ' 86' ' ' PHE . 45.3 mt-10 -89.97 -1.12 57.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.521 0.677 . . . . 6.1900000000000004 109.541 176.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -130.25 174.26 10.0 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.028 -1.101 . . . . 5.4500000000000002 108.028 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -60.05 -39.98 87.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 118.491 0.587 . . . . 5.2699999999999996 109.826 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -101.19 165.67 11.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.331 -0.849 . . . . 6.3300000000000001 109.467 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -79.22 66.67 4.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.028 0.442 . . . . 7.4800000000000004 110.281 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.618 ' HA ' ' OD2' ' A' ' 120' ' ' ASP . 16.3 m -80.0 -10.76 59.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.549 -0.75 . . . . 2.5499999999999998 111.41 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.599 ' CD1' ' HB2' ' A' ' 80' ' ' GLU . 97.8 m-85 -112.04 130.29 55.92 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.987 -0.375 . . . . 5.2999999999999998 109.987 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -154.76 156.35 26.83 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.545 -0.836 . . . . 1.3500000000000001 111.96 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 96.9 mt -132.84 136.89 46.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.821 0.343 . . . . 2.29 110.287 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 60.9 m -119.93 129.94 54.57 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.653 -0.499 . . . . 1.54 109.653 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -124.91 132.58 8.18 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.466 -0.873 . . . . 1.1699999999999999 111.528 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -125.07 128.5 6.67 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.762 -0.733 . . . . 1.1899999999999999 111.989 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -120.26 121.87 39.63 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.641 -0.503 . . . . 3.75 109.641 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.491 ' HD2' ' OE2' ' A' ' 71' ' ' GLU . 38.6 ttt180 -141.96 130.01 22.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.726 -0.472 . . . . 2.75 109.726 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.649 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 5.4 t30 -111.07 129.99 55.75 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.036 0.446 . . . . 1.8200000000000001 109.937 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.59 ' HA ' ' HG3' ' A' ' 69' ' ' ARG . 65.8 t80 -100.0 109.78 22.11 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.427 -0.582 . . . . 3.1400000000000001 109.427 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.9 -163.95 30.99 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.519 -0.848 . . . . 2.79 111.934 -175.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -130.9 152.77 49.87 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.372 -0.233 . . . . 7.6200000000000001 110.372 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -123.17 14.46 9.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.551 -0.295 . . . . 7.0800000000000001 111.345 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -70.15 -36.28 74.62 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.945 -0.302 . . . . 10.16 111.339 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.04 159.94 41.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.114 0.483 . . . . 9.8100000000000005 111.28 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -120.19 30.96 6.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.544 -0.753 . . . . 12.220000000000001 110.243 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.29 150.39 79.95 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.667 -0.697 . . . . 10.48 111.95 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -59.84 150.07 79.8 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.323 2.682 . . . . 9.0999999999999996 113.103 -177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.18 -26.97 12.37 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.825 -0.625 . . . . 6.46 111.748 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 59.8 33.54 21.72 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.145 0.578 . . . . 7.6699999999999999 112.062 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -76.21 -22.23 55.5 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.137 -1.06 . . . . 4.1399999999999997 108.137 170.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.5 m -96.4 131.93 42.46 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.457 -1.247 . . . . 3.2999999999999998 108.819 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -158.07 149.68 21.5 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.629 -0.508 . . . . 1.76 109.629 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -114.68 110.34 19.6 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.138 0.494 . . . . 2.5499999999999998 111.553 -176.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.601 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 88.6 mtp -127.08 130.44 49.89 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.936 -0.764 . . . . 1.77 108.936 169.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.642 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 95.7 mt-30 -107.43 138.39 43.72 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.094 -0.642 . . . . 1.97 110.502 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 29.1 ttt180 -110.42 117.04 32.51 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.546 -0.539 . . . . 3.8500000000000001 109.546 171.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.564 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 61.4 m95 -108.5 127.42 53.91 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.735 -0.666 . . . . 2.2799999999999998 110.156 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -119.67 123.41 43.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.491 -0.322 . . . . 2.1400000000000001 110.795 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.6 mm -123.21 120.55 60.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.043 -0.725 . . . . 1.55 109.043 170.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -144.43 106.28 4.72 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 111.716 0.265 . . . . 1.1899999999999999 111.716 -177.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 87.8 Cg_endo -79.94 149.18 20.11 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.575 2.183 . . . . 1.3700000000000001 111.604 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -95.45 137.75 34.07 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.219 -0.66 . . . . 2.3500000000000001 109.219 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -135.98 130.49 33.72 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 111.957 0.355 . . . . 4.54 111.957 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.618 ' OD2' ' HA ' ' A' ' 85' ' ' SER . 13.0 m-20 -94.36 102.14 14.11 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.821 -0.807 . . . . 3.04 108.821 168.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 96.3 t -69.9 -42.73 79.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.142 -0.481 . . . . 4.2699999999999996 111.089 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -114.73 132.82 56.31 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.556 -0.535 . . . . 6.04 109.556 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.0 mt -107.19 24.84 12.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.202 -0.454 . . . . 4.5899999999999999 111.019 -173.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 17.4 p -108.89 142.57 39.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.12 -0.491 . . . . 3.6899999999999999 110.758 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -69.5 -39.96 77.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 5.1699999999999999 111.591 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -59.92 -40.11 87.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.006 -0.543 . . . . 3.71 111.248 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.6 tp -139.34 122.39 16.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.002 -0.544 . . . . 2.0499999999999998 109.745 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -119.16 136.29 54.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.991 0.424 . . . . 4.2400000000000002 110.54 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.413 ' CZ ' ' HB ' ' A' ' 156' ' ' THR . 89.1 t80 -139.58 130.87 26.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.826 -0.624 . . . . 3.5499999999999998 109.386 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -127.09 162.17 26.7 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.24 -0.436 . . . . 2.1099999999999999 110.958 -176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -161.39 140.51 6.68 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.276 -0.73 . . . . 1.1799999999999999 111.276 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.608 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 5.1 p90 -132.26 134.94 45.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.225 0.536 . . . . 4.2999999999999998 110.914 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.632 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 58.8 tp -104.46 124.46 49.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.163 -0.926 . . . . 2.2400000000000002 109.955 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.9 t -119.88 127.31 52.6 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.017 0.437 . . . . 1.6899999999999999 110.179 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 89.3 mtp -113.04 130.42 56.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.94 -0.573 . . . . 2.2400000000000002 110.043 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' A' ' 113' ' ' TRP . 70.9 m-85 -121.58 139.98 52.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.92 0.39 . . . . 3.5600000000000001 111.676 -175.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 63.1 mttp -125.95 151.54 46.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.787 -0.642 . . . . 1.6699999999999999 109.7 169.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.642 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 87.8 m-85 -135.56 156.28 49.13 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.422 0.451 . . . . 3.23 110.53 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 110' ' ' MET . . . 60.05 -175.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.979 -0.555 . . . . 1.24 111.587 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -76.61 -33.69 58.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.487 0.66 . . . . 2.4700000000000002 109.766 168.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -60.11 -45.61 92.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.79 -1.095 . . . . 2.4100000000000001 112.421 -169.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 138' ' ' PHE . 9.4 mp -69.9 -30.11 67.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.826 0.345 . . . . 1.8300000000000001 110.88 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -67.38 -39.89 85.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.339 0.59 . . . . 2.0 109.955 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.1 m -66.94 -41.34 87.15 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.191 -0.913 . . . . 2.0499999999999998 111.665 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 34.7 p -80.58 -14.01 58.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.247 0.546 . . . . 1.5900000000000001 111.01 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.42 ' O ' ' HE3' ' A' ' 137' ' ' LYS . . . 71.3 -130.61 18.92 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.622 -0.717 . . . . 1.52 112.955 175.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.46 ' HA ' ' OG1' ' A' ' 150' ' ' THR . 46.5 p90 -70.04 -16.15 63.11 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.53 0.196 . . . . 5.9400000000000004 111.53 -174.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.92 -48.68 80.69 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.208 0.448 . . . . 1.8300000000000001 112.208 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.449 ' HB3' ' HG ' ' A' ' 142' ' ' LEU . 51.3 m-20 -100.22 14.17 31.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.847 0.356 . . . . 2.6400000000000001 111.218 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.46 ' OG1' ' HA ' ' A' ' 147' ' ' TYR . 98.2 m -72.93 129.71 38.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.394 -0.366 . . . . 2.02 110.706 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -83.45 134.29 34.87 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.387 -0.598 . . . . 3.6699999999999999 109.387 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 63.0 t -119.6 124.24 72.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.002 0.43 . . . . 1.6399999999999999 110.746 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -127.39 136.18 51.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.63 -0.714 . . . . 2.5600000000000001 109.684 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 16.0 m -135.77 130.05 33.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.804 0.335 . . . . 1.3899999999999999 110.887 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.608 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 74.4 tt0 -120.29 136.89 54.53 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.525 -0.546 . . . . 2.04 109.525 175.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 172' ' ' TYR . 17.1 p -127.38 140.07 52.43 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.024 -0.535 . . . . 1.5600000000000001 110.375 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -125.02 130.1 7.25 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.694 -0.765 . . . . 1.04 112.211 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.8 tp -112.86 128.31 56.42 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 110.196 -0.298 . . . . 2.27 110.196 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -108.49 107.43 17.96 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.995 -0.372 . . . . 2.4100000000000001 109.995 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -121.01 130.08 53.65 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.414 -0.587 . . . . 4.5700000000000003 109.414 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.5 p -88.91 94.15 9.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.877 0.37 . . . . 1.46 110.523 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -61.1 -45.73 93.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.971 -0.559 . . . . 2.6299999999999999 111.271 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.413 ' HB2' HG22 ' A' ' 166' ' ' VAL . 19.6 m120 -99.95 7.65 44.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.589 -0.278 . . . . 2.4100000000000001 110.482 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 73.57 -46.01 0.62 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.708 0.803 . . . . 2.5800000000000001 111.201 -177.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.4 p -73.88 -24.73 59.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.873 0.368 . . . . 2.2999999999999998 111.623 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' A' ' 163' ' ' ASN . 28.9 m -123.45 144.65 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.385 -0.37 . . . . 1.71 110.554 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.22 135.02 49.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.143 -0.48 . . . . 1.47 110.66 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 31.4 mt -104.2 134.53 47.28 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.416 -0.587 . . . . 1.6599999999999999 109.416 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.514 ' HD2' ' CE1' ' A' ' 197' ' ' TYR . 96.8 mtt180 -99.95 111.54 23.84 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.844 -0.428 . . . . 3.2999999999999998 109.844 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.4 t -110.11 119.95 60.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.146 -0.479 . . . . 1.3 109.812 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -107.83 128.44 54.6 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.205 0.526 . . . . 2.2200000000000002 110.792 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.562 ' HB2' ' OG1' ' A' ' 156' ' ' THR . 88.2 m-85 -106.81 128.52 54.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.457 -0.792 . . . . 4.6100000000000003 108.898 177.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -104.09 129.98 51.79 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.064 0.459 . . . . 3.98 110.697 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.513 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 54.2 tp -118.61 119.94 35.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.699 -0.682 . . . . 2.3799999999999999 110.549 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -122.91 149.24 44.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.182 -0.673 . . . . 3.3100000000000001 109.182 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -94.06 113.09 25.0 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.109 -0.637 . . . . 6.5300000000000002 110.417 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -110.07 -156.33 15.74 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 110.224 -1.15 . . . . 5.0599999999999996 110.224 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -69.99 -28.53 65.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.638 0.732 . . . . 7.3899999999999997 109.452 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 59.9 29.97 19.52 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.197 -1.365 . . . . 9.0700000000000003 111.12 174.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 75.2 mtm -125.62 133.42 52.25 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.562 -0.745 . . . . 10.869999999999999 109.713 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -70.77 146.47 49.76 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.053 -0.521 . . . . 10.449999999999999 110.377 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -137.8 144.91 41.76 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.172 -0.467 . . . . 13.06 109.753 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 19.2 p -70.01 -18.03 63.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 12.609999999999999 111.456 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -80.56 -10.17 59.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.019 -0.537 . . . . 15.19 110.648 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -102.83 122.06 43.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.949 -0.569 . . . . 13.18 109.699 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -70.74 -24.9 62.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.11 -0.496 . . . . 12.73 111.413 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 82.69 10.04 83.79 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.034 -0.603 . . . . 9.9800000000000004 111.743 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.32 -39.95 94.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.993 0.425 . . . . 10.699999999999999 110.857 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -107.85 146.4 32.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.797 -0.638 . . . . 10.5 110.135 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 32.2 p -81.26 147.84 29.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.084 0.469 . . . . 6.6399999999999997 110.77 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 23.4 p -70.06 -20.03 63.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.742 -0.663 . . . . 4.9800000000000004 111.056 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -127.25 149.85 49.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.852 -0.613 . . . . 7.0999999999999996 109.543 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -117.59 139.23 51.26 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.838 -0.43 . . . . 4.4000000000000004 109.838 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 87.2 mt -104.09 116.08 47.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.368 -0.378 . . . . 2.21 110.089 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -107.61 125.28 51.13 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.182 -0.303 . . . . 3.54 110.182 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -122.85 140.3 53.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.64 0.257 . . . . 1.6699999999999999 111.137 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.514 ' CE1' ' HD2' ' A' ' 169' ' ' ARG . 28.5 p90 -149.73 157.67 43.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.273 -0.421 . . . . 5.8300000000000001 110.101 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.62 143.4 23.51 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.637 0.256 . . . . 2.5899999999999999 110.811 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -88.03 116.08 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.441 2.094 . . . . 1.77 112.168 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 55.0 tp -103.56 129.15 50.74 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.296 -0.631 . . . . 2.2599999999999998 109.296 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 27.4 m -95.67 116.72 29.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.955 0.407 . . . . 1.99 111.24 -176.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.1 mt -127.74 81.46 2.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.071 -0.714 . . . . 2.3100000000000001 109.071 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 75.83 -129.54 10.36 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.76 -0.733 . . . . 1.51 111.291 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -90.62 -0.42 57.68 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.057 -0.72 . . . . 2.5699999999999998 109.057 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 242' ' ' GLY . 33.3 m170 -102.95 117.4 34.52 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.679 -0.691 . . . . 2.6600000000000001 110.082 -176.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 14.9 m -96.02 132.88 40.91 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.877 -0.601 . . . . 1.6200000000000001 109.999 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.507 ' CG1' HD11 ' A' ' 239' ' ' LEU . 58.4 t -110.08 120.04 60.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.289 -0.634 . . . . 1.3799999999999999 109.289 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 45.1 m -131.01 91.95 34.95 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 120.776 0.322 . . . . 1.1799999999999999 111.569 -176.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.06 147.77 18.95 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.314 2.009 . . . . 1.01 111.135 172.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.425 ' CE1' ' HA3' ' A' ' 238' ' ' GLY . 33.8 p90 -132.4 149.54 52.33 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.621 -0.511 . . . . 4.5 109.621 172.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.404 HG22 HG22 ' A' ' 237' ' ' VAL . 20.6 p -119.0 135.74 54.46 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.715 -0.675 . . . . 1.8899999999999999 109.626 177.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.425 ' HB3' ' H ' ' A' ' 236' ' ' ARG . 78.3 ttt180 -60.1 -39.81 87.44 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.743 -0.662 . . . . 4.7999999999999998 110.259 177.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.433 ' HB ' ' ND2' ' A' ' 235' ' ' ASN . 84.5 mt -119.91 118.9 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-N 115.861 -0.608 . . . . 4.5700000000000003 109.543 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -72.73 -43.4 43.02 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 121.153 -0.546 . . . . 4.9800000000000004 112.088 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 96.6 mt -120.04 104.82 10.45 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.498 -0.556 . . . . 8.1099999999999994 109.498 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -63.99 151.73 42.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.151 -0.477 . . . . 7.6500000000000004 110.921 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -60.79 -40.03 91.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 10.529999999999999 111.078 -177.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -132.26 161.12 34.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.147 -0.479 . . . . 11.56 110.396 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.2 p -60.86 -40.0 91.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.33 0.586 . . . . 10.06 111.035 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -160.05 -177.73 6.51 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.717 -1.216 . . . . 11.92 107.717 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -59.95 -39.38 85.35 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.421 -0.955 . . . . 14.01 108.421 168.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 50.99 47.04 25.57 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.727 0.642 . . . . 14.529999999999999 111.805 172.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -113.65 161.29 17.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.446 -0.797 . . . . 16.609999999999999 109.199 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -93.75 8.69 40.06 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.349 0.595 . . . . 15.460000000000001 109.998 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -146.23 119.96 9.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.944 -1.025 . . . . 15.67 108.936 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -126.81 145.75 50.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.912 0.387 . . . . 14.5 111.34 -172.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 86.1 mt -109.9 129.95 63.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.169 -0.678 . . . . 15.15 109.169 173.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -60.69 -38.53 85.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.701 -0.681 . . . . 14.73 111.699 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -94.38 119.21 32.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.994 0.426 . . . . 16.379999999999999 110.88 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -99.71 138.88 36.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.486 -0.779 . . . . 12.779999999999999 109.1 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -60.03 -39.99 96.44 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.379 -0.828 . . . . 11.1 113.224 -173.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -161.03 159.77 29.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.987 -0.375 . . . . 12.26 109.987 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -83.16 110.84 18.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.067 -0.515 . . . . 9.9900000000000002 110.209 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -69.31 -40.15 77.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.843 -0.617 . . . . 10.43 109.541 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.433 ' ND2' ' HB ' ' A' ' 213' ' ' ILE . 50.0 t-20 -111.19 109.89 20.14 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.399 -0.963 . . . . 6.29 108.399 174.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.425 ' H ' ' HB3' ' A' ' 212' ' ' ARG . 99.0 mtt180 -97.07 137.56 35.95 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.337 -0.392 . . . . 8.1500000000000004 110.626 -175.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.404 HG22 HG22 ' A' ' 211' ' ' THR . 60.5 t -120.17 124.88 73.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.977 -0.556 . . . . 2.3999999999999999 110.577 -174.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.425 ' HA3' ' CE1' ' A' ' 210' ' ' TYR . . . -122.01 140.0 13.28 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.065 -0.814 . . . . 1.27 111.065 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.507 HD11 ' CG1' ' A' ' 207' ' ' VAL . 52.7 tp -120.58 124.4 45.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.928 0.364 . . . . 1.97 110.728 -176.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.487 ' CE1' ' HG2' ' A' ' 254' ' ' GLU . 96.3 m-85 -104.88 132.07 51.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.126 -0.488 . . . . 3.54 110.633 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -112.33 126.91 55.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.38 -0.373 . . . . 2.6400000000000001 110.22 171.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 205' ' ' HIS . . . -89.34 118.18 5.13 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.826 -0.91 . . . . 1.3500000000000001 110.826 174.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' TYR . . . . . 0.462 ' HB3' ' CG2' ' A' ' 251' ' ' VAL . 50.1 t80 -107.74 134.7 50.33 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.792 -0.447 . . . . 4.3600000000000003 109.792 -176.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -99.89 145.79 27.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.88 -0.6 . . . . 4.29 111.295 -174.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.68 139.9 52.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.842 -0.617 . . . . 6.6900000000000004 110.004 172.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -64.43 -26.41 68.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.288 -0.869 . . . . 6.3700000000000001 111.168 -174.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -59.82 -40.12 87.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.684 -0.689 . . . . 5.8300000000000001 110.808 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 130.8 21.74 1.09 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.83 -0.7 . . . . 2.6600000000000001 111.937 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 91.8 mt -110.99 151.52 27.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.747 0.308 . . . . 2.9700000000000002 110.351 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 52.8 m -130.07 139.77 50.92 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.703 -0.481 . . . . 2.1699999999999999 109.703 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.462 ' CG2' ' HB3' ' A' ' 243' ' ' TYR . 33.2 m -129.07 142.86 42.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.981 0.419 . . . . 1.79 110.827 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 4.2 p -100.07 120.74 40.31 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.999 -0.546 . . . . 1.6299999999999999 110.165 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 87.9 mt -99.96 125.94 46.04 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.052 -0.522 . . . . 2.96 110.154 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 273' ' ' ALA . 45.3 mt-10 -92.81 134.62 34.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.41 -0.359 . . . . 4.0800000000000001 111.018 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -137.04 138.88 40.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.987 -0.552 . . . . 4.8399999999999999 109.564 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -111.84 129.67 56.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.603 0.24 . . . . 3.5800000000000001 110.432 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -119.95 139.5 52.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.598 -0.274 . . . . 6.7699999999999996 110.489 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -76.59 152.83 35.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.963 -0.562 . . . . 8.5399999999999991 110.077 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -60.13 -39.88 87.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 11.9 110.642 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -84.92 133.4 34.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.193 -0.458 . . . . 10.57 110.607 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.09 141.62 55.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.673 -0.694 . . . . 11.41 111.195 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -109.24 111.35 22.9 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.932 -0.576 . . . . 11.98 111.066 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -68.63 -39.84 80.6 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.091 -0.707 . . . . 12.460000000000001 109.091 172.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -100.12 101.51 12.57 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.104 -0.953 . . . . 13.779999999999999 110.044 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -82.43 -4.25 90.22 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.883 -0.675 . . . . 11.07 111.538 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -70.73 -20.65 62.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.549 -0.325 . . . . 12.59 111.58 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 33.5 t -140.04 122.15 15.76 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.082 -0.34 . . . . 10.92 110.082 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . 0.506 ' HB2' ' CE1' ' A' ' 271' ' ' HIS . 66.3 m-20 -130.04 151.04 51.02 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.564 -0.532 . . . . 12.42 109.564 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -69.91 -39.46 76.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.907 0.384 . . . . 11.59 110.925 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.36 149.97 52.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.047 -0.524 . . . . 8.8300000000000001 110.955 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . 0.551 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 22.4 m80 -138.85 103.33 4.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.005 -0.543 . . . . 7.0199999999999996 110.253 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -121.0 107.47 12.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.248 -0.433 . . . . 6.5999999999999996 110.236 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 254' ' ' GLU . . . -133.59 129.69 37.33 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.338 -0.392 . . . . 1.9399999999999999 110.233 176.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.468 ' H ' ' HB2' ' A' ' 254' ' ' GLU . . . -140.81 154.84 24.58 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.958 -0.639 . . . . 1.4199999999999999 111.571 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 58.2 t -119.99 127.98 75.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.13 0.49 . . . . 1.8100000000000001 110.982 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 251' ' ' VAL . . . -117.72 129.84 8.49 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.697 -0.961 . . . . 1.3 110.697 173.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.2 124.92 64.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 117.368 0.584 . . . . 1.8300000000000001 110.758 -175.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -117.43 127.35 53.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.275 0.56 . . . . 2.3100000000000001 111.111 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 44.2 t80 -113.89 119.57 37.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.361 -0.836 . . . . 4.75 109.106 171.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 53.4 m -129.98 129.61 43.97 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.752 0.311 . . . . 1.6699999999999999 110.337 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 49.8 t80 . . . . . 0 C--O 1.243 0.762 0 CA-C-O 118.319 -0.848 . . . . 3.6899999999999999 108.749 176.568 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.8 tpp . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 110.278 -0.267 . . . . 11.85 110.278 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -122.65 139.87 53.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.291 -0.413 . . . . 10.35 109.891 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -116.01 135.65 53.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.098 0.475 . . . . 9.3100000000000005 109.745 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 4' ' ' ARG . 13.0 ttp180 -68.55 -39.98 80.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.441 -0.8 . . . . 8.8399999999999999 111.691 -176.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -129.02 133.65 47.82 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.761 0.315 . . . . 7.0099999999999998 111.158 -175.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -74.52 143.66 44.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.982 -0.554 . . . . 3.6099999999999999 109.785 174.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -141.31 101.73 4.07 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.128 -0.694 . . . . 3.3300000000000001 109.128 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.446 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 44.7 m80 -119.98 137.88 53.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.014 0.435 . . . . 3.2000000000000002 111.119 -175.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -132.84 146.22 51.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.671 -0.695 . . . . 2.4900000000000002 110.85 -176.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -123.93 131.9 53.64 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.257 -0.428 . . . . 2.1299999999999999 109.969 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 279' ' ' TYR . 77.7 mt -130.0 129.97 65.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.309 -0.405 . . . . 1.6000000000000001 110.404 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -115.2 134.95 11.91 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.448 -0.882 . . . . 0.88 111.644 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.97 136.34 54.57 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.94 0.4 . . . . 1.0800000000000001 110.569 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.527 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 65.9 mtt -133.14 155.34 49.45 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.881 -0.599 . . . . 2.3300000000000001 109.769 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -111.33 114.49 27.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.769 -0.456 . . . . 2.6099999999999999 109.769 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -114.21 134.17 55.1 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.148 -0.478 . . . . 5.0899999999999999 111.445 -170.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.3 mt -117.04 129.93 72.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.626 -0.715 . . . . 5.3300000000000001 109.448 175.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.411 ' CD ' ' HD2' ' A' ' 55' ' ' PRO . 45.4 mt-10 -82.55 137.89 34.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.889 0.376 . . . . 8.2799999999999994 110.571 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -84.45 110.05 18.35 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.406 -0.59 . . . . 9.6999999999999993 109.406 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.9 t -70.16 -40.09 77.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.423 0.63 . . . . 11.09 110.489 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 59.93 23.1 12.16 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.597 -1.183 . . . . 13.1 111.81 176.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.02 -42.68 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.811 -0.709 . . . . 11.94 112.569 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -159.89 160.04 33.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.61 0.243 . . . . 15.18 110.397 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.1 23.05 53.4 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.574 -0.822 . . . . 12.0 112.168 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -60.03 -39.72 86.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.917 0.389 . . . . 12.82 111.431 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -60.22 -39.97 88.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.818 -0.628 . . . . 10.81 111.939 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 58.4 ttm -103.67 122.99 46.19 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.962 0.41 . . . . 10.050000000000001 111.172 -174.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -60.25 -39.86 88.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.662 -0.699 . . . . 8.0600000000000005 110.386 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.8 -143.79 16.79 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.839 -0.696 . . . . 5.5800000000000001 112.544 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.4 mt -119.59 140.84 49.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.129 -0.323 . . . . 5.5599999999999996 110.129 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.08 118.53 37.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.244 -0.435 . . . . 3.0499999999999998 110.96 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -85.55 138.51 35.9 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.857 0.361 . . . . 3.48 110.229 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 14' ' ' MET . 74.4 Cg_endo -78.01 134.73 13.37 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.443 2.096 . . . . 1.8600000000000001 113.166 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.2 m -109.92 143.25 40.11 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.715 -0.846 . . . . 1.97 108.715 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.49 134.4 66.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.357 0.598 . . . . 1.71 111.615 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -114.08 134.24 55.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.473 -0.785 . . . . 4.0700000000000003 109.582 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -110.69 139.38 46.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.755 0.312 . . . . 2.8599999999999999 110.986 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.42 HD22 ' HB2' ' A' ' 47' ' ' ALA . 24.5 t-20 -149.79 140.54 22.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.689 -0.485 . . . . 1.8899999999999999 109.689 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.47 143.51 47.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.415 0.15 . . . . 1.0800000000000001 110.978 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.459 ' HB2' ' HG3' ' A' ' 45' ' ' ARG . . . -153.95 119.69 5.26 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.49 -0.323 . . . . 1.3899999999999999 111.338 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.55 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 13.0 p-10 -169.12 95.04 0.32 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.373 -0.376 . . . . 2.8599999999999999 111.046 176.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.06 -98.7 2.47 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.972 -0.633 . . . . 1.6799999999999999 112.034 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.55 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 88.6 Cg_exo -49.23 174.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.893 3.062 . . . . 1.6599999999999999 112.998 170.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.4 ' HZ3' ' O ' ' A' ' 77' ' ' GLN . 93.6 m95 -67.31 176.33 2.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.123 0.487 . . . . 3.3999999999999999 111.108 -172.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.459 ' HG3' ' HB2' ' A' ' 40' ' ' ALA . 21.6 ttm180 -110.41 126.79 54.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.988 0.423 . . . . 3.1000000000000001 110.421 -163.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 83.5 mt -117.18 136.86 52.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.774 -0.648 . . . . 1.8 110.715 -173.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.42 ' HB2' HD22 ' A' ' 38' ' ' ASN . . . -117.83 133.32 56.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.853 -0.612 . . . . 0.85999999999999999 110.423 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.9 tp -120.35 132.02 55.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.925 -0.58 . . . . 1.0600000000000001 110.257 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -145.8 165.08 29.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.172 -0.467 . . . . 1.1399999999999999 110.189 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -138.42 147.97 43.92 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.057 -0.349 . . . . 4.0199999999999996 110.057 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -124.55 129.82 51.31 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.276 0.56 . . . . 4.6100000000000003 110.803 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -110.29 155.78 21.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.276 -0.874 . . . . 3.3799999999999999 108.859 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -59.98 -47.14 87.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.825 0.345 . . . . 5.0499999999999998 110.658 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -130.04 104.94 0.64 Allowed Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.79 -0.641 . . . . 4.3700000000000001 111.951 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.411 ' HD2' ' CD ' ' A' ' 18' ' ' GLU . 50.9 Cg_exo -55.69 -40.02 87.69 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.622 2.214 . . . . 6.6799999999999997 112.382 176.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.4 t -93.59 -29.97 4.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 8.1699999999999999 111.064 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -87.86 109.45 19.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.253 0.549 . . . . 10.039999999999999 110.615 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -97.86 119.24 36.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.884 -0.598 . . . . 11.609999999999999 110.664 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.5 p -78.35 126.65 31.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.931 -0.577 . . . . 9.7899999999999991 110.568 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.09 155.37 39.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.862 -0.608 . . . . 8.5099999999999998 109.519 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.94 18.18 73.05 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.693 -0.765 . . . . 7.5599999999999996 111.64 -177.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -129.01 144.6 51.24 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.136 -0.32 . . . . 10.0 110.136 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -125.89 131.49 52.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.698 0.285 . . . . 10.35 110.82 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.2 -160.89 30.45 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.796 -0.716 . . . . 5.3399999999999999 112.235 175.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.2 p -95.68 156.06 16.48 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.545 -0.539 . . . . 5.3200000000000003 109.545 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -131.35 160.02 36.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.875 0.369 . . . . 5.6100000000000003 111.224 -172.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -110.51 135.33 51.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.031 -0.532 . . . . 3.7799999999999998 110.355 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -149.18 170.02 19.39 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.692 -0.485 . . . . 2.4500000000000002 109.692 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 94' ' ' ASN . 40.8 ttp180 -129.6 123.59 21.35 Favored Pre-proline 0 N--CA 1.451 -0.402 0 C-N-CA 120.682 -0.407 . . . . 3.2400000000000002 111.038 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.538 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 92.7 Cg_endo -87.78 152.07 7.36 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.938 2.425 . . . . 1.1899999999999999 110.802 167.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.46 ' OE2' ' HD3' ' A' ' 93' ' ' ARG . 52.7 mt-10 -134.5 125.72 27.94 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.807 -0.357 . . . . 2.1899999999999999 110.383 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.4 tp -133.7 129.96 37.49 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.893 -0.41 . . . . 1.1399999999999999 109.893 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -128.3 146.62 50.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.083 0.468 . . . . 2.1800000000000002 110.994 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.1 t -114.8 126.87 72.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.786 -0.82 . . . . 1.5600000000000001 108.786 171.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -110.85 119.82 40.36 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.298 -0.41 . . . . 3.4399999999999999 110.227 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -105.59 120.03 40.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.065 -0.516 . . . . 4.7999999999999998 110.429 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.4 ' O ' ' HZ3' ' A' ' 44' ' ' TRP . 53.8 mt-30 -109.45 120.16 41.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.789 -0.448 . . . . 2.9399999999999999 109.789 176.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -104.14 125.45 50.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.151 0.5 . . . . 3.8999999999999999 111.214 -177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.6 tp -120.73 112.83 19.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.43 -0.805 . . . . 4.4800000000000004 108.975 174.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -113.74 170.35 8.32 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.88 -0.328 . . . . 6.1900000000000004 111.276 -173.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -60.51 -40.09 90.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.934 0.397 . . . . 5.4500000000000002 110.736 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -69.87 146.89 50.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.905 -0.589 . . . . 5.2699999999999996 109.497 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -79.98 66.68 5.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.797 0.808 . . . . 6.3300000000000001 110.32 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -138.61 150.54 46.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.863 -1.062 . . . . 7.4800000000000004 108.156 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.8 t -124.07 130.08 51.95 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.444 -0.503 . . . . 2.5499999999999998 110.711 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -128.52 153.29 47.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.77 -0.65 . . . . 5.2999999999999998 109.816 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -151.62 166.28 30.73 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.499 -0.858 . . . . 1.3500000000000001 111.608 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 63.6 tp -146.49 120.09 9.14 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.908 0.385 . . . . 2.29 110.403 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.3 m -109.39 116.72 32.37 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.047 -0.524 . . . . 1.54 109.763 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -134.96 139.05 10.5 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.44 -0.886 . . . . 1.1699999999999999 111.266 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.78 161.67 32.47 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.072 -1.061 . . . . 1.1899999999999999 112.366 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -122.39 130.96 53.63 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.491 -0.559 . . . . 3.75 109.491 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.46 ' HD3' ' OE2' ' A' ' 71' ' ' GLU . 83.6 mtt180 -121.99 124.99 45.3 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.587 -0.894 . . . . 2.75 108.587 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.538 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 64.4 t30 -103.75 118.41 36.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.064 0.459 . . . . 1.8200000000000001 110.64 -173.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 109' ' ' ASN . 59.3 t80 -102.34 117.67 35.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.07 -0.514 . . . . 3.1400000000000001 110.452 -175.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.46 -167.97 49.44 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.635 -0.793 . . . . 2.79 113.478 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -137.89 139.65 39.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.96 0.409 . . . . 7.6200000000000001 111.154 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -150.29 100.07 2.85 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.638 -0.875 . . . . 7.0800000000000001 108.638 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -99.51 126.39 45.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.978 0.418 . . . . 10.16 110.733 -176.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.7 t -70.24 -40.06 77.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.69 -0.686 . . . . 9.8100000000000005 110.491 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -65.12 -40.05 93.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.733 -0.667 . . . . 12.220000000000001 111.111 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -129.94 74.95 80.15 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.0 -0.545 . . . . 10.48 110.549 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -79.98 159.76 24.04 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.814 2.343 . . . . 9.0999999999999996 113.243 -176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -130.02 169.47 21.02 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.968 -0.853 . . . . 6.46 110.968 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -69.58 -40.02 76.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.32 0.56 . . . . 7.6699999999999999 110.174 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -111.55 109.98 20.17 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.846 -0.615 . . . . 4.1399999999999997 109.641 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.0 p -128.48 145.36 51.13 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.254 -0.43 . . . . 3.2999999999999998 110.228 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -137.6 113.74 9.99 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.96 -0.296 . . . . 1.76 110.345 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 95' ' ' TYR . 3.5 t-20 -142.09 108.31 5.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.927 -0.579 . . . . 2.5499999999999998 109.677 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.465 ' HB2' ' HB3' ' A' ' 95' ' ' TYR . 88.4 mtp -111.27 125.69 54.1 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.733 -0.667 . . . . 1.77 109.343 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.575 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 81.1 mt-30 -91.66 119.87 31.92 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.527 -0.469 . . . . 1.97 109.88 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -106.29 113.06 26.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.873 -0.603 . . . . 3.8500000000000001 110.193 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 137' ' ' LYS . 86.3 m95 -115.81 125.31 52.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.882 -0.784 . . . . 2.2799999999999998 108.882 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -140.1 123.88 17.37 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.452 -0.573 . . . . 2.1400000000000001 109.452 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 134' ' ' SER . 87.4 mt -123.22 128.22 74.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.999 -0.546 . . . . 1.55 110.179 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -132.77 104.25 13.03 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.516 -0.311 . . . . 1.1899999999999999 111.278 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.18 141.13 11.44 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.091 2.527 . . . . 1.3700000000000001 111.356 172.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -93.42 138.51 31.67 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.064 -0.516 . . . . 2.3500000000000001 110.088 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -127.06 128.38 46.19 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.125 -0.324 . . . . 4.54 110.125 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -148.64 118.11 6.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.867 -0.42 . . . . 3.04 109.867 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 123' ' ' LEU . 61.1 t -124.6 130.01 73.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.001 0.429 . . . . 4.2699999999999996 111.105 -174.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -114.03 28.48 8.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 6.04 110.213 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.597 ' H ' HG12 ' A' ' 121' ' ' VAL . 61.3 tp -68.13 -22.77 64.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 4.5899999999999999 112.066 -171.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.0 p -108.15 143.84 36.38 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.081 0.467 . . . . 3.6899999999999999 111.789 -174.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -66.93 124.97 24.49 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.527 -0.76 . . . . 5.1699999999999999 110.823 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 60.25 15.6 5.45 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.86 0.725 . . . . 3.71 111.598 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.6 mt -129.25 119.53 24.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.207 -0.451 . . . . 2.0499999999999998 110.062 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.518 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 74.0 ttt180 -112.74 130.36 56.09 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.031 -0.531 . . . . 4.2400000000000002 110.062 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -107.24 125.81 51.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.066 -0.515 . . . . 3.5499999999999998 109.652 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -130.6 130.05 43.52 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.201 -0.666 . . . . 2.1099999999999999 109.201 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -137.53 144.55 16.01 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.139 -1.029 . . . . 1.1799999999999999 112.8 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 155' ' ' GLU . 61.0 t-105 -118.82 128.44 54.46 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.068 -0.716 . . . . 4.2999999999999998 109.068 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 60.9 tp -126.33 140.51 52.45 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.385 -0.598 . . . . 2.2400000000000002 109.385 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 29.3 t -156.72 169.97 23.51 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.418 -0.216 . . . . 1.6899999999999999 110.418 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 92.8 mtp -139.62 149.95 44.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.652 0.263 . . . . 2.2400000000000002 110.663 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -103.74 117.35 34.17 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.378 -0.374 . . . . 3.5600000000000001 111.207 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 113' ' ' TRP . 99.4 mttt -132.92 129.8 38.78 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.066 -0.716 . . . . 1.6699999999999999 109.066 170.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.575 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 51.1 p90 -157.02 161.04 39.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.473 -0.331 . . . . 3.23 110.618 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 74.72 -178.19 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 O-C-N 124.154 0.908 . . . . 1.24 110.678 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -74.47 -38.64 62.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.533 -0.303 . . . . 2.4700000000000002 111.019 175.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -59.86 -51.17 70.86 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.738 0.644 . . . . 2.4100000000000001 112.738 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.6 ' HA ' ' OG1' ' A' ' 145' ' ' THR . 44.2 mt -69.98 -30.01 67.25 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.776 -0.37 . . . . 1.8300000000000001 111.342 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -60.02 -42.16 93.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.029 0.442 . . . . 2.0 109.857 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 30.0 p -80.12 -31.37 39.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.011 -0.541 . . . . 2.0499999999999998 111.972 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.6 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 61.6 p -71.65 -32.38 67.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.147 0.499 . . . . 1.5900000000000001 110.95 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.414 ' O ' ' HE2' ' A' ' 137' ' ' LYS . . . 68.3 -120.09 11.31 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.692 -0.686 . . . . 1.52 112.61 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -89.89 -9.66 48.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.43 0.157 . . . . 5.9400000000000004 111.067 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.69 -52.97 47.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.874 0.369 . . . . 1.8300000000000001 110.663 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.417 ' O ' HD22 ' A' ' 142' ' ' LEU . 10.9 m-20 -118.11 110.05 17.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.867 -0.606 . . . . 2.6400000000000001 109.666 176.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.6 t -170.24 164.17 8.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.813 -0.63 . . . . 2.02 109.616 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 151' ' ' ARG . 49.9 mtm180 -119.89 143.98 47.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.645 0.259 . . . . 3.6699999999999999 110.478 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.0 143.51 25.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.146 -0.479 . . . . 1.6399999999999999 110.984 -172.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 134' ' ' SER . 34.9 mt-10 -110.61 125.5 53.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.56 -0.904 . . . . 2.5600000000000001 108.56 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.8 m -132.22 122.45 25.25 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.464 -0.494 . . . . 1.3899999999999999 110.97 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 132' ' ' TRP . 85.8 tt0 -119.91 111.98 18.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.301 -0.629 . . . . 2.04 109.301 174.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 31.7 m -108.57 120.32 42.1 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.072 -0.513 . . . . 1.5600000000000001 109.861 -177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -133.37 149.26 19.61 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 119.71 -1.233 . . . . 1.04 113.051 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 59.6 tp -122.47 130.42 53.04 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.983 -0.377 . . . . 2.27 109.983 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 51.3 tt0 -95.44 110.89 22.87 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.109 -0.7 . . . . 2.4100000000000001 109.109 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -122.85 130.08 52.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.566 -0.743 . . . . 4.5700000000000003 110.002 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.2 p -82.28 88.16 6.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.159 0.504 . . . . 1.46 109.94 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -60.47 -50.14 74.75 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.61 -0.723 . . . . 2.6299999999999999 111.323 -172.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -103.12 16.64 26.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.156 -0.475 . . . . 2.4100000000000001 111.18 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 72.92 -50.22 0.7 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.75 -0.659 . . . . 2.5800000000000001 111.868 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.1 p -74.21 -20.1 60.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.759 0.314 . . . . 2.2999999999999998 111.695 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -125.79 144.19 36.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.366 -0.379 . . . . 1.71 110.82 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -105.67 121.63 44.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.036 -0.529 . . . . 1.47 110.493 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -102.88 126.94 50.23 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.825 -0.625 . . . . 1.6599999999999999 109.761 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -98.11 111.78 23.98 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.303 -0.629 . . . . 3.2999999999999998 109.303 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.96 119.92 60.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.856 -0.611 . . . . 1.3 109.384 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -114.89 131.07 56.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.323 -0.399 . . . . 2.2200000000000002 111.157 -171.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -115.19 119.94 38.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.683 -0.689 . . . . 4.6100000000000003 109.255 173.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -106.91 130.7 54.54 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.831 0.348 . . . . 3.98 110.075 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 64.1 tp -99.5 119.92 38.8 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.982 -0.554 . . . . 2.3799999999999999 110.102 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -66.73 -40.05 88.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.264 -0.88 . . . . 3.3100000000000001 110.638 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -173.85 135.23 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 6.5300000000000002 109.766 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 130.13 -144.77 16.02 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.324 -0.941 . . . . 5.0599999999999996 113.319 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -138.5 128.78 25.85 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.348 -0.612 . . . . 7.3899999999999997 109.348 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -60.2 -40.26 89.43 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.75 -0.659 . . . . 9.0700000000000003 111.655 -173.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.543 ' O ' ' HG3' ' A' ' 184' ' ' ARG . 98.9 mmm -70.0 -40.43 75.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.466 -0.334 . . . . 10.869999999999999 111.197 -178.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -77.0 -50.0 14.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.162 -0.472 . . . . 10.449999999999999 111.72 -176.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -62.82 -39.73 95.21 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.201 0.445 . . . . 13.06 112.201 -176.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.6 m -68.33 -14.81 63.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.635 0.255 . . . . 12.609999999999999 111.488 -177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 180' ' ' MET . 99.7 mtt180 -70.02 -31.54 69.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.967 0.413 . . . . 15.19 110.304 177.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -101.63 117.89 35.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.048 -0.524 . . . . 13.18 110.128 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -134.05 156.79 47.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.723 0.297 . . . . 12.73 110.371 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 162.04 -166.28 36.24 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.624 -0.798 . . . . 9.9800000000000004 112.096 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -60.21 -40.04 88.74 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.092 0.405 . . . . 10.699999999999999 112.092 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -90.7 -18.79 24.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.094 0.473 . . . . 10.5 110.803 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.3 m -89.96 65.24 6.54 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.108 -0.496 . . . . 6.6399999999999997 110.053 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 22.5 p -79.44 153.8 29.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.474 -0.785 . . . . 4.9800000000000004 112.107 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -129.48 154.94 46.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.647 -0.706 . . . . 7.0999999999999996 110.069 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -118.36 139.23 51.68 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.354 -0.609 . . . . 4.4000000000000004 109.354 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 85.2 mt -115.39 119.94 63.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 109.834 -0.432 . . . . 2.21 109.834 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 211' ' ' THR . 93.1 mtt180 -117.82 116.19 26.48 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.9 -0.407 . . . . 3.54 109.9 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -120.06 138.47 53.52 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.997 -0.547 . . . . 1.6699999999999999 110.178 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -136.82 140.75 42.68 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.348 0.594 . . . . 5.8300000000000001 111.362 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.41 HD12 ' HD2' ' A' ' 199' ' ' PRO . 55.5 tp -116.69 126.82 27.2 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 114.871 -1.059 . . . . 2.5899999999999999 109.399 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.41 ' HD2' HD12 ' A' ' 198' ' ' LEU . 21.8 Cg_exo -66.55 110.18 1.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.942 1.761 . . . . 1.77 111.078 174.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 60.0 tp -100.12 109.43 21.71 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.275 -0.639 . . . . 2.2599999999999998 109.275 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 78.5 m -121.34 130.07 53.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.331 0.586 . . . . 1.99 111.487 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 55.5 tp -133.6 83.86 2.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.507 -0.923 . . . . 2.3100000000000001 108.507 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.71 -117.79 9.14 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.504 -0.771 . . . . 1.51 112.063 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -79.89 -12.68 59.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.729 0.299 . . . . 2.5699999999999998 111.357 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -99.54 117.09 33.16 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.066 -0.346 . . . . 2.6600000000000001 110.066 -178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 28.6 t -132.57 138.14 47.35 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.724 -0.473 . . . . 1.6200000000000001 109.724 176.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.419 ' HB ' HD11 ' A' ' 239' ' ' LEU . 24.5 m -136.61 148.82 26.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.792 0.33 . . . . 1.3799999999999999 110.807 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 26.4 m -119.93 91.73 45.82 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.176 -0.465 . . . . 1.1799999999999999 110.412 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 2.6 Cg_endo -80.74 126.8 6.05 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.891 2.394 . . . . 1.01 112.455 177.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -95.27 140.07 30.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.234 -0.439 . . . . 4.5 110.0 175.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 195' ' ' ARG . 45.7 p -118.31 130.2 55.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.882 0.372 . . . . 1.8899999999999999 110.447 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.653 HH22 ' HG3' ' A' ' 264' ' ' GLU . 17.7 ttp85 -104.67 110.03 22.18 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.66 -0.7 . . . . 4.7999999999999998 109.704 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 30.4 pt -139.38 170.44 15.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.262 -0.426 . . . . 4.5700000000000003 110.586 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 125.29 -1.26 8.24 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.281 -0.962 . . . . 4.9800000000000004 113.473 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.0 mt -123.5 153.25 40.81 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.391 0.615 . . . . 8.1099999999999994 110.562 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -58.27 -35.43 71.77 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 114.545 -1.207 . . . . 7.6500000000000004 113.038 -166.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -59.81 -39.98 86.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.834 0.35 . . . . 10.529999999999999 110.878 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' TRP . . . . . 0.402 ' CH2' ' HB2' ' A' ' 236' ' ' ARG . 15.7 m95 -89.12 -11.44 43.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.973 0.415 . . . . 11.56 110.798 -176.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 42.1 m -74.6 -39.98 61.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.077 -0.51 . . . . 10.06 111.301 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -80.5 147.64 30.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.148 -0.478 . . . . 11.92 111.136 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -93.64 120.87 34.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.19 -0.459 . . . . 14.01 109.898 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -75.6 152.45 37.66 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.352 -0.61 . . . . 14.529999999999999 109.352 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -101.75 -0.01 35.14 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.834 0.309 . . . . 16.609999999999999 111.834 -171.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -95.93 116.68 29.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.912 0.386 . . . . 15.460000000000001 110.623 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -74.18 152.35 39.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.94 -0.573 . . . . 15.67 110.701 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -78.35 94.8 4.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.939 -0.573 . . . . 14.5 110.082 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 48.5 mm -70.1 -39.96 77.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.258 0.551 . . . . 15.15 109.883 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -94.64 42.62 1.09 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.675 -0.693 . . . . 14.73 109.77 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -66.24 126.04 27.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.059 -0.973 . . . . 16.379999999999999 110.367 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -70.15 -39.88 75.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.953 -0.567 . . . . 12.779999999999999 110.385 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 168.36 -129.41 1.88 Allowed Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.584 -0.735 . . . . 11.1 111.845 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -100.15 9.5 42.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.833 0.349 . . . . 12.26 110.397 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -80.77 134.25 35.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.922 -0.581 . . . . 9.9900000000000002 111.357 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -130.11 129.63 43.78 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.662 -0.496 . . . . 10.43 109.662 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -84.23 -23.61 30.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.656 -0.247 . . . . 6.29 111.42 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.402 ' HB2' ' CH2' ' A' ' 218' ' ' TRP . 36.9 ptt180 -75.55 -9.93 59.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.082 -0.508 . . . . 8.1500000000000004 111.795 -173.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 18.7 m -113.22 129.98 67.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.094 0.473 . . . . 2.3999999999999999 110.228 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -78.28 111.93 3.36 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.854 -0.898 . . . . 1.27 110.854 178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.565 ' O ' ' HB3' ' A' ' 254' ' ' GLU . 47.7 tp -111.68 125.43 53.96 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.631 -0.507 . . . . 1.97 109.631 -175.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -124.83 133.34 53.14 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.993 -0.549 . . . . 3.54 109.776 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -98.11 131.15 44.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.972 0.415 . . . . 2.6400000000000001 110.471 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -121.12 118.45 3.8 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.726 -0.67 . . . . 1.3500000000000001 112.455 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -140.06 115.39 9.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.286 -0.635 . . . . 4.3600000000000003 109.286 174.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -120.06 130.29 54.61 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.995 -0.372 . . . . 4.29 109.995 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -139.92 129.67 24.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.034 -0.53 . . . . 6.6900000000000004 110.493 -178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -70.11 140.33 52.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.762 -0.653 . . . . 6.3700000000000001 110.307 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.97 39.63 19.86 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.449 0.468 . . . . 5.8300000000000001 110.984 -178.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -170.39 171.34 43.56 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.815 -0.707 . . . . 2.6600000000000001 111.74 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 86.7 mt -71.12 141.26 50.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.074 0.464 . . . . 2.9700000000000002 110.786 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.554 ' HB2' ' HB2' ' A' ' 278' ' ' ASN . 68.5 m -123.89 149.97 45.21 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.846 -0.615 . . . . 2.1699999999999999 109.972 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 66.7 t -123.15 135.15 64.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.645 0.26 . . . . 1.79 111.314 -172.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 22.7 t -136.44 152.98 51.17 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.078 -0.51 . . . . 1.6299999999999999 109.877 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 90.2 mt 73.23 -179.67 0.21 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.251 0.621 . . . . 2.96 111.05 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.565 ' HB3' ' O ' ' A' ' 239' ' ' LEU . 38.2 tt0 -177.91 -86.11 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.293 0.042 . . . . 4.0800000000000001 110.991 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' TYR . . . . . 0.554 ' CD2' ' HG2' ' A' ' 254' ' ' GLU . 69.4 m-85 -120.02 135.96 54.73 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.91 -0.494 . . . . 4.8399999999999999 111.589 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -161.46 159.97 28.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.744 -0.662 . . . . 3.5800000000000001 110.248 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -113.77 139.98 48.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.923 0.392 . . . . 6.7699999999999996 110.393 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.77 -39.87 90.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.412 -0.813 . . . . 8.5399999999999991 110.935 175.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -127.48 136.13 51.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.329 -0.396 . . . . 11.9 110.423 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.436 ' NE2' ' HD3' ' A' ' 212' ' ' ARG . 97.7 mt-30 -69.74 -30.52 68.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.863 -0.608 . . . . 10.57 110.934 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.05 -39.91 87.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.86 -0.609 . . . . 11.41 110.277 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 270' ' ' PHE . 86.0 t60 -60.25 -38.48 83.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.413 -0.812 . . . . 11.98 111.32 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.53 -50.07 75.34 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.396 0.435 . . . . 12.460000000000001 111.861 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.653 ' HG3' HH22 ' A' ' 212' ' ' ARG . 41.6 mt-10 -70.09 -31.37 68.91 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 121.088 -0.245 . . . . 13.779999999999999 111.23 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -68.68 -65.07 2.77 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.897 -0.668 . . . . 11.07 113.001 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -160.02 140.18 11.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.736 0.268 . . . . 12.59 110.369 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 18.7 p -108.33 -9.88 15.41 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.361 0.504 . . . . 10.92 112.361 -174.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -109.97 -34.05 6.53 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.028 0.381 . . . . 12.42 112.028 -169.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -60.45 -40.12 90.02 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.401 -0.363 . . . . 11.59 110.364 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . 0.544 ' HB2' ' CE1' ' A' ' 262' ' ' HIS . 89.8 m-85 -133.68 130.0 37.59 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.127 -0.694 . . . . 8.8300000000000001 109.127 171.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -128.33 131.16 48.62 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.558 -0.534 . . . . 7.0199999999999996 109.558 -174.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -120.31 140.05 51.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.243 0.544 . . . . 6.5999999999999996 111.93 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -144.61 130.35 19.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.69 -0.686 . . . . 1.9399999999999999 109.426 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -133.3 118.71 2.18 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 119.857 -1.163 . . . . 1.4199999999999999 111.601 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 63.1 t -126.97 130.05 71.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.966 0.413 . . . . 1.8100000000000001 110.428 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -116.15 160.23 13.47 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 111.167 -0.773 . . . . 1.3 111.167 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 250' ' ' SER . 19.0 m -123.25 139.8 48.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 120.919 0.39 . . . . 1.8300000000000001 110.556 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 250' ' ' SER . 94.1 m-20 -105.39 131.8 52.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.989 -0.551 . . . . 2.3100000000000001 110.936 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.405 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 91.9 m-85 -115.26 139.97 49.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.454 -0.943 . . . . 4.75 108.454 173.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 15.5 t -144.2 143.03 30.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.109 0.48 . . . . 1.6699999999999999 110.751 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 59.1 t80 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 117.901 -1.047 . . . . 3.6899999999999999 109.116 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.2 mtm . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 110.789 -0.078 . . . . 11.85 110.789 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -60.07 -41.65 92.88 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.576 -0.898 . . . . 10.35 108.576 171.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -131.11 159.97 36.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.848 -1.069 . . . . 9.3100000000000005 108.723 170.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -109.24 140.09 43.32 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.682 0.277 . . . . 8.8399999999999999 110.26 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -95.89 102.82 14.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.084 -0.507 . . . . 7.0099999999999998 110.101 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.98 120.19 40.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.904 -0.589 . . . . 3.6099999999999999 111.713 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -134.85 129.42 34.43 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.314 -1.365 . . . . 3.3300000000000001 107.314 166.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.488 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 96.4 m-70 -124.58 137.04 54.42 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.953 -0.699 . . . . 3.2000000000000002 110.898 -172.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.45 ' CE2' ' HB3' ' A' ' 281' ' ' PHE . 50.4 p90 -140.0 160.61 39.53 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.637 -0.71 . . . . 2.4900000000000002 110.988 -176.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -134.12 129.85 36.52 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.777 -0.823 . . . . 2.1299999999999999 108.777 173.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.1 tt -130.1 130.05 65.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.962 -0.755 . . . . 1.6000000000000001 108.962 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.522 ' HA3' ' OD1' ' A' ' 278' ' ' ASN . . . -144.61 155.64 26.47 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 119.23 -1.462 . . . . 0.88 113.454 -173.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.423 ' HB2' HG22 ' A' ' 35' ' ' VAL . . . -118.1 135.14 54.39 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.583 -0.525 . . . . 1.0800000000000001 109.583 176.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.444 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 59.7 ttm -130.27 132.16 45.8 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.936 -0.575 . . . . 2.3300000000000001 110.003 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -84.51 120.34 26.22 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.532 -0.544 . . . . 2.6099999999999999 109.532 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -83.31 132.74 35.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.434 0.635 . . . . 5.0899999999999999 111.408 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 86.3 mt -117.57 130.11 72.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.058 -0.974 . . . . 5.3300000000000001 109.988 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -63.44 134.38 55.57 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.006 -0.543 . . . . 8.2799999999999994 111.151 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -107.59 114.81 29.05 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.356 -0.609 . . . . 9.6999999999999993 109.356 174.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.3 t -119.85 130.05 74.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.057 0.456 . . . . 11.09 109.96 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.89 -39.89 90.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.066 -0.97 . . . . 13.1 112.048 -174.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -152.46 178.68 29.5 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.509 -0.853 . . . . 11.94 112.481 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -87.67 6.69 33.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.787 0.327 . . . . 15.18 111.349 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.73 -10.07 70.55 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.918 -0.658 . . . . 12.0 113.329 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -139.95 141.2 36.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.097 0.448 . . . . 12.82 110.552 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -123.96 156.12 36.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.208 -0.451 . . . . 10.81 110.837 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 70.8 mtm -130.87 160.05 35.59 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.223 -0.658 . . . . 10.050000000000001 109.223 175.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -105.95 55.38 0.68 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.934 0.397 . . . . 8.0600000000000005 110.768 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.52 176.05 47.85 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.814 -0.708 . . . . 5.5800000000000001 112.604 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.6 tp -140.01 140.21 36.18 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.424 -0.584 . . . . 5.5599999999999996 109.424 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.21 76.0 3.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.027 0.441 . . . . 3.0499999999999998 110.814 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -101.26 147.23 33.47 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.816 -0.629 . . . . 3.48 110.585 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 14' ' ' MET . 85.2 Cg_endo -79.92 134.83 10.88 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.678 2.252 . . . . 1.8600000000000001 112.832 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.3 m -113.32 142.68 45.56 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.292 -0.633 . . . . 1.97 109.292 172.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 59.4 t -115.93 134.5 59.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.701 0.286 . . . . 1.71 111.295 -173.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -119.65 139.91 51.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.321 -0.399 . . . . 4.0700000000000003 110.056 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -110.59 129.87 55.7 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.567 -0.531 . . . . 2.8599999999999999 109.567 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.561 HD21 ' HD3' ' A' ' 45' ' ' ARG . 51.3 t30 -143.43 127.63 17.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.601 -0.272 . . . . 1.8899999999999999 110.295 -173.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -143.31 144.18 32.0 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.52 0.563 . . . . 1.0800000000000001 112.52 -175.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.437 ' HB2' ' CB ' ' A' ' 45' ' ' ARG . . . -163.09 144.53 9.78 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.363 -0.381 . . . . 1.3899999999999999 111.74 177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.691 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 7.5 t30 -169.13 94.15 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 2.8599999999999999 110.14 166.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.57 -81.36 0.31 Allowed Glycine 0 CA--C 1.517 0.185 0 C-N-CA 120.878 -0.677 . . . . 1.6799999999999999 111.47 -176.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.691 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 22.9 Cg_endo -61.71 175.73 1.6 Allowed 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.326 2.684 . . . . 1.6599999999999999 111.776 170.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -68.21 174.72 3.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.968 0.413 . . . . 3.3999999999999999 110.159 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.561 ' HD3' HD21 ' A' ' 38' ' ' ASN . 39.0 ttm180 -110.56 124.84 52.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.24 0.543 . . . . 3.1000000000000001 111.078 -166.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.5 mm -113.09 130.01 67.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.414 -0.812 . . . . 1.8 110.599 -173.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 73' ' ' GLU . . . -117.95 129.95 55.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.274 -0.421 . . . . 0.85999999999999999 110.064 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.1 tp -128.14 133.98 49.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.112 -0.495 . . . . 1.0600000000000001 110.661 -176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.02 153.91 37.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.142 -0.481 . . . . 1.1399999999999999 110.244 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -120.11 139.97 51.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.782 0.325 . . . . 4.0199999999999996 110.684 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.614 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 71.1 t80 -99.9 129.96 46.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.088 -0.505 . . . . 4.6100000000000003 110.527 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -133.45 150.47 51.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.336 -0.847 . . . . 3.3799999999999999 109.049 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -79.78 -9.95 59.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.952 0.406 . . . . 5.0499999999999998 110.627 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -149.89 167.35 29.94 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.6 -0.6 . . . . 4.3700000000000001 111.6 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -59.91 -28.9 88.19 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.136 2.557 . . . . 6.6799999999999997 112.257 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.96 160.14 40.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.885 -0.598 . . . . 8.1699999999999999 110.193 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -129.54 152.16 49.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.116 -0.493 . . . . 10.039999999999999 110.085 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -120.25 139.96 51.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.88 0.371 . . . . 11.609999999999999 110.633 -175.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.5 m -77.57 -13.95 59.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.03 -0.532 . . . . 9.7899999999999991 111.328 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -139.23 132.81 30.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.568 -0.287 . . . . 8.5099999999999998 110.35 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.87 160.02 28.05 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.517 -0.849 . . . . 7.5599999999999996 112.416 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -61.31 -40.04 92.7 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.762 0.425 . . . . 10.0 111.623 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -60.26 -39.91 88.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 10.35 110.653 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.25 -26.79 4.83 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.626 -0.716 . . . . 5.3399999999999999 112.345 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 29.4 m -83.33 121.54 27.28 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.272 -0.269 . . . . 5.3200000000000003 110.272 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -118.53 135.01 54.64 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.505 -0.554 . . . . 5.6100000000000003 109.505 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -150.26 159.95 44.06 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.212 -0.449 . . . . 3.7799999999999998 110.266 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -148.65 170.48 18.05 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.051 -0.722 . . . . 2.4500000000000002 109.051 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.614 ' HB3' ' HB3' ' A' ' 51' ' ' TYR . 29.0 ttp180 -135.0 122.16 15.06 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.648 -0.421 . . . . 3.2400000000000002 110.195 171.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.67 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 71.8 Cg_endo -81.91 146.2 14.51 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.756 2.304 . . . . 1.1899999999999999 111.47 169.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -136.57 120.08 17.05 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.699 -0.482 . . . . 2.1899999999999999 109.699 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 47' ' ' ALA . 40.6 tp -136.63 129.82 31.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.0 -0.545 . . . . 1.1399999999999999 110.338 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 99.8 mt-10 -117.93 142.18 47.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.176 -0.466 . . . . 2.1800000000000002 110.216 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.8 t -113.33 120.02 62.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.558 -0.904 . . . . 1.5600000000000001 108.558 173.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 15.3 m-70 -108.27 120.13 41.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.989 -0.55 . . . . 3.4399999999999999 109.769 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -99.14 141.44 31.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.155 -0.475 . . . . 4.7999999999999998 110.434 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -100.84 132.13 46.39 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.906 -0.405 . . . . 2.9399999999999999 109.906 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -120.02 99.8 6.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.768 0.318 . . . . 3.8999999999999999 111.662 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.6 tp -70.04 -39.99 75.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.359 0.6 . . . . 4.4800000000000004 109.615 171.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -92.03 137.08 32.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.157 -0.929 . . . . 6.1900000000000004 109.096 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.554 ' HA ' ' O ' ' A' ' 84' ' ' PHE . 82.4 m-20 -110.03 20.02 18.38 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.973 0.36 . . . . 5.4500000000000002 111.973 -169.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -67.91 -40.73 83.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.004 0.372 . . . . 5.2699999999999996 112.004 -174.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -106.09 -49.42 3.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.996 0.427 . . . . 6.3300000000000001 110.386 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 81' ' ' ASN . 97.0 m-85 -130.39 153.27 48.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.862 -0.608 . . . . 7.4800000000000004 109.622 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.7 p -120.03 143.49 48.06 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.096 -0.335 . . . . 2.5499999999999998 110.096 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 52.9 t80 71.97 -76.75 0.06 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.982 -0.554 . . . . 5.2999999999999998 111.794 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -159.13 166.94 34.79 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 118.478 -1.82 . . . . 1.3500000000000001 114.853 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.1 tp -133.6 130.05 37.82 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.542 -0.91 . . . . 2.29 108.542 173.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.2 m -120.06 127.51 52.64 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.05 0.453 . . . . 1.54 110.555 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -132.07 132.57 6.74 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.83 -0.908 . . . . 1.1699999999999999 110.83 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -141.94 156.24 25.86 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.32 -0.943 . . . . 1.1899999999999999 112.343 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -139.31 149.34 44.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.073 0.463 . . . . 3.75 110.614 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.421 ' HB2' ' HB3' ' A' ' 112' ' ' ARG . 99.7 mtt180 -131.57 129.85 41.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.447 -0.797 . . . . 2.75 109.449 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.67 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 8.5 t30 -115.29 117.58 30.86 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.4 -0.592 . . . . 1.8200000000000001 109.4 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -111.76 120.3 41.55 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.607 0.241 . . . . 3.1400000000000001 110.529 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 108' ' ' ALA . . . 92.83 -170.76 32.36 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.727 -0.749 . . . . 2.79 112.006 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -125.05 139.98 53.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.584 0.707 . . . . 7.6200000000000001 112.456 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.461 ' HB2' ' CB ' ' A' ' 109' ' ' ASN . 32.5 t60 -126.54 138.0 53.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.444 -1.253 . . . . 7.0800000000000001 108.108 173.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 63.6 t80 65.29 80.31 0.23 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.451 0.643 . . . . 10.16 109.412 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.31 129.95 74.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.558 -0.746 . . . . 9.8100000000000005 110.764 -171.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -68.13 -40.02 82.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.855 -0.611 . . . . 12.220000000000001 111.144 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -70.74 128.55 90.77 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.02 -0.536 . . . . 10.48 110.549 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.31 130.12 24.55 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.414 2.076 . . . . 9.0999999999999996 111.441 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -149.3 148.34 19.61 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.668 -0.777 . . . . 6.46 111.951 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -67.08 -40.08 86.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.849 0.357 . . . . 7.6699999999999999 110.998 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -120.11 133.99 55.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.363 0.601 . . . . 4.1399999999999997 111.56 -177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.3 p -132.42 139.9 48.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.406 -0.815 . . . . 3.2999999999999998 109.427 171.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.4 ' O ' ' HA3' ' A' ' 96' ' ' GLY . . . -160.87 130.81 5.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.231 -0.285 . . . . 1.76 110.231 -176.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.461 ' CB ' ' HB2' ' A' ' 98' ' ' HIS . 5.2 t30 -139.77 108.12 5.82 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.703 -0.48 . . . . 2.5499999999999998 109.703 -178.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 89.7 mtp -116.98 128.1 54.85 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.243 -0.435 . . . . 1.77 109.917 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -110.22 133.52 53.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.03 0.443 . . . . 1.97 111.127 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 35.2 ttt180 -109.89 117.84 34.89 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.329 -0.619 . . . . 3.8500000000000001 109.329 172.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -113.6 136.32 52.95 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.503 -0.555 . . . . 2.2799999999999998 109.503 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 134' ' ' SER . 85.5 tttt -139.12 128.85 24.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.208 -0.451 . . . . 2.1400000000000001 110.817 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 87.0 mt -120.01 121.01 64.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.952 -0.759 . . . . 1.55 108.952 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -137.59 105.3 8.36 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.381 -0.372 . . . . 1.1899999999999999 111.051 -175.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 74.2 Cg_endo -79.64 139.99 14.56 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.075 1.85 . . . . 1.3700000000000001 110.614 173.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -95.57 136.6 35.75 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.773 -1.195 . . . . 2.3500000000000001 107.773 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -124.51 127.97 48.26 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.118 0.485 . . . . 4.54 111.349 -176.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -131.92 120.22 22.22 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.797 -0.816 . . . . 3.04 108.797 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.4 t -132.85 115.83 25.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.438 -0.346 . . . . 4.2699999999999996 110.329 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -107.76 86.45 2.3 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.268 0.556 . . . . 6.04 110.513 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.04 -39.95 90.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.437 -0.801 . . . . 4.5899999999999999 109.696 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 127' ' ' LEU . 24.4 p -129.87 164.01 25.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.218 -0.901 . . . . 3.6899999999999999 109.77 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -73.44 -47.1 44.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.722 0.296 . . . . 5.1699999999999999 111.17 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -70.07 -40.08 75.27 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.133 -0.485 . . . . 3.71 112.027 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.562 ' HB2' ' OG1' ' A' ' 124' ' ' THR . 6.1 mp -102.11 118.45 36.93 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.71 -0.478 . . . . 2.0499999999999998 109.71 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.425 ' HB2' ' HB2' ' A' ' 159' ' ' GLN . 90.6 mtt180 -122.94 134.88 54.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.005 -0.543 . . . . 4.2400000000000002 109.812 -174.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.419 ' CE1' HD13 ' A' ' 158' ' ' LEU . 97.1 m-85 -109.22 129.07 55.5 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.76 0.314 . . . . 3.5499999999999998 110.519 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -146.32 120.93 9.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.423 -0.584 . . . . 2.1099999999999999 109.423 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -157.13 172.18 34.6 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.565 -0.826 . . . . 1.1799999999999999 112.047 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.471 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 9.2 p90 -140.23 140.91 35.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.134 0.492 . . . . 4.2999999999999998 111.158 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 66.5 mt -109.41 133.75 52.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.023 -0.732 . . . . 2.2400000000000002 109.023 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.4 ' HB3' ' HE3' ' A' ' 114' ' ' LYS . 73.9 m -129.9 135.5 48.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.283 0.563 . . . . 1.6899999999999999 112.14 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 68.6 mtt -119.98 136.76 54.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.443 -0.799 . . . . 2.2400000000000002 108.872 172.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 96.1 m-85 -120.05 134.36 55.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.002 0.43 . . . . 3.5600000000000001 111.635 -176.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 98.4 mttt -128.18 138.82 52.64 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.56 -0.745 . . . . 1.6699999999999999 109.37 173.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.45 ' O ' HD23 ' A' ' 142' ' ' LEU . 96.1 m-85 -129.91 150.76 51.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.687 0.279 . . . . 3.23 111.09 -176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 58.99 -165.03 0.19 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.669 -0.696 . . . . 1.24 111.306 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -76.95 -32.81 57.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.29 0.567 . . . . 2.4700000000000002 110.254 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -60.01 -46.78 88.38 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.046 -0.979 . . . . 2.4100000000000001 113.176 -168.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 138' ' ' PHE . 4.1 mm? -69.92 -29.21 66.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.141 0.496 . . . . 1.8300000000000001 110.545 -177.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -69.76 -40.02 76.37 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.905 -0.589 . . . . 2.0 109.896 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.4 m -63.85 -40.12 95.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.098 -0.955 . . . . 2.0499999999999998 111.233 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.4 p -75.7 -23.63 56.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.821 0.343 . . . . 1.5900000000000001 111.615 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 60.43 -120.98 25.12 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.757 -0.656 . . . . 1.52 113.327 174.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -69.94 -30.6 68.03 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.4 0.28 . . . . 5.9400000000000004 111.727 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.7 -49.95 75.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 1.8300000000000001 112.054 -174.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -122.93 113.3 18.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.951 0.405 . . . . 2.6400000000000001 110.924 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.9 t -160.01 150.29 18.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.018 -0.734 . . . . 2.02 109.018 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.532 ' HB2' ' HB2' ' A' ' 136' ' ' TYR . 98.5 mtt180 -83.7 137.28 33.84 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.075 -0.343 . . . . 3.6699999999999999 110.075 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.6 119.95 60.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.337 -0.392 . . . . 1.6399999999999999 110.493 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -124.29 129.88 51.53 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.731 -0.84 . . . . 2.5600000000000001 108.731 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.404 HG23 ' CD2' ' A' ' 133' ' ' LEU . 50.8 m -136.71 130.17 31.68 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.623 -0.262 . . . . 1.3899999999999999 111.409 -174.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.471 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 82.4 tt0 -130.76 121.48 25.49 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.125 0.488 . . . . 2.04 109.818 175.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 40.7 p -119.33 139.17 52.38 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.596 -0.729 . . . . 1.5600000000000001 109.993 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -130.05 141.85 13.07 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.243 -0.98 . . . . 1.04 113.349 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.419 HD13 ' CE1' ' A' ' 129' ' ' PHE . 63.7 tp -122.21 128.58 51.36 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.733 -0.469 . . . . 2.27 109.733 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 168' ' ' LEU . 95.6 mt-30 -100.01 126.78 46.25 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.327 -0.62 . . . . 2.4100000000000001 109.327 173.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -126.06 128.81 47.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.388 -0.369 . . . . 4.5700000000000003 110.38 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 2.4 p -85.3 88.59 7.51 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.348 0.594 . . . . 1.46 111.071 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.414 ' HB2' HD11 ' A' ' 168' ' ' LEU . 58.2 t80 -60.07 -49.94 75.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.579 -0.737 . . . . 2.6299999999999999 111.618 -176.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.616 ' HB2' HG22 ' A' ' 166' ' ' VAL . 92.7 m-20 -102.61 14.55 31.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.535 -0.302 . . . . 2.4100000000000001 110.851 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 72.98 -49.03 0.7 Allowed 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.893 0.746 . . . . 2.5800000000000001 110.487 -176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 27.2 m -72.86 -33.17 65.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.176 -0.465 . . . . 2.2999999999999998 111.037 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.616 HG22 ' HB2' ' A' ' 163' ' ' ASN . 13.7 m -108.75 138.63 34.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.861 0.362 . . . . 1.71 110.914 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -109.21 137.21 47.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.085 -0.507 . . . . 1.47 110.608 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 159' ' ' GLN . 16.2 mt -103.22 129.96 50.31 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.698 -0.482 . . . . 1.6599999999999999 109.698 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.421 ' HB2' ' HB2' ' A' ' 197' ' ' TYR . 99.1 mtt180 -94.11 105.43 17.43 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.529 -0.545 . . . . 3.2999999999999998 109.529 177.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.3 t -119.31 121.99 67.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.858 -0.423 . . . . 1.3 109.858 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.578 ' OD1' ' HB2' ' A' ' 195' ' ' ARG . 30.4 p30 -132.3 156.65 46.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.349 0.595 . . . . 2.2200000000000002 112.086 -177.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.555 ' CE1' ' HB3' ' A' ' 193' ' ' GLU . 67.8 t80 -124.3 131.42 53.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.992 -1.003 . . . . 4.6100000000000003 109.586 177.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -113.2 135.01 54.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.154 0.502 . . . . 3.98 110.42 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.7 tp -100.01 116.6 32.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.734 -0.666 . . . . 2.3799999999999999 109.608 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.517 ' OE2' ' HD2' ' A' ' 176' ' ' ARG . 31.7 tt0 -70.02 -40.76 75.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.962 -0.563 . . . . 3.3100000000000001 111.307 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.517 ' HD2' ' OE2' ' A' ' 175' ' ' GLU . 8.8 ptm180 -159.98 162.35 34.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.569 -0.741 . . . . 6.5300000000000002 110.525 -169.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.489 ' HA3' ' NH1' ' A' ' 184' ' ' ARG . . . 106.71 -158.85 15.09 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.616 -0.802 . . . . 5.0599999999999996 112.429 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -129.12 151.92 49.27 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.814 0.34 . . . . 7.3899999999999997 110.507 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -84.26 0.83 47.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.63 -0.714 . . . . 9.0700000000000003 110.126 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 56.1 ttm -60.08 -39.95 87.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.235 -0.893 . . . . 10.869999999999999 110.089 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -104.96 114.46 28.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.565 -0.743 . . . . 10.449999999999999 109.497 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -60.11 -39.95 88.02 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.862 -0.608 . . . . 13.06 111.343 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 51.2 m -139.72 149.98 44.27 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.968 -0.56 . . . . 12.609999999999999 109.51 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.489 ' NH1' ' HA3' ' A' ' 177' ' ' GLY . 22.8 mtm180 -123.19 133.46 54.23 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.824 0.345 . . . . 15.19 110.745 -175.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -78.76 -22.89 45.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.658 -0.701 . . . . 13.18 110.568 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -62.37 -40.01 95.03 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.927 -0.579 . . . . 12.73 111.743 -176.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -106.23 142.6 15.64 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.48 -0.867 . . . . 9.9800000000000004 112.776 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -79.29 130.08 35.1 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.667 -0.494 . . . . 10.699999999999999 109.667 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -72.14 129.81 39.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.316 -0.402 . . . . 10.5 110.49 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 46.5 p -124.54 150.2 46.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.175 -0.466 . . . . 6.6399999999999997 111.054 -177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 70.6 p -69.97 -19.97 63.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.843 -0.617 . . . . 4.9800000000000004 110.808 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -66.22 -24.23 66.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.802 -0.635 . . . . 7.0999999999999996 110.945 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.555 ' HB3' ' CE1' ' A' ' 172' ' ' TYR . 36.0 mt-10 -70.01 -18.93 63.33 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.463 -0.789 . . . . 4.4000000000000004 110.777 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 48.5 mm -105.76 127.89 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.616 -0.72 . . . . 2.21 110.646 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.578 ' HB2' ' OD1' ' A' ' 171' ' ' ASN . 25.2 mtm180 -110.87 129.32 55.9 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.549 -0.537 . . . . 3.54 109.549 174.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 169' ' ' ARG . . . -118.4 134.49 55.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.085 -0.507 . . . . 1.6699999999999999 110.924 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.421 ' HB2' ' HB2' ' A' ' 169' ' ' ARG . 87.6 m-85 -133.59 143.32 48.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.626 -0.715 . . . . 5.8300000000000001 109.56 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.623 ' O ' ' HA ' ' A' ' 208' ' ' THR . 42.3 tp -119.92 124.22 28.01 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.178 -0.675 . . . . 2.5899999999999999 109.178 171.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -93.28 105.41 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.905 1.737 . . . . 1.77 112.449 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.8 tp -96.11 121.89 38.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.043 -0.526 . . . . 2.2599999999999998 109.648 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 89.6 m -99.9 118.85 37.2 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.275 0.559 . . . . 1.99 110.845 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 94.4 mt -125.7 81.07 1.95 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.191 -1.04 . . . . 2.3100000000000001 108.191 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 74.35 -126.87 9.55 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.705 -0.958 . . . . 1.51 110.705 -172.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -95.08 -0.11 53.87 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.304 0.573 . . . . 2.5699999999999998 109.531 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -99.34 119.18 37.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.518 -0.764 . . . . 2.6600000000000001 109.554 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 32.1 t -112.49 139.93 47.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.935 0.398 . . . . 1.6200000000000001 110.525 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.92 123.12 70.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.658 -0.867 . . . . 1.3799999999999999 108.658 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 198' ' ' LEU . 42.6 m -126.86 93.02 43.18 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-O 120.788 0.327 . . . . 1.1799999999999999 110.721 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 29.0 Cg_endo -69.82 149.87 67.1 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.841 1.694 . . . . 1.01 111.378 175.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -126.0 138.05 53.71 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.729 -0.669 . . . . 4.5 109.987 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 59.2 p -130.01 143.57 50.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.204 -0.453 . . . . 1.8899999999999999 110.012 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -95.16 -15.35 23.38 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.939 -0.573 . . . . 4.7999999999999998 109.922 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.0 mt -70.41 -39.99 77.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.73 -0.668 . . . . 4.5700000000000003 110.087 170.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 97.71 -10.09 64.41 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.903 -0.665 . . . . 4.9800000000000004 113.447 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.6 tp -139.93 129.92 24.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.081 0.44 . . . . 8.1099999999999994 111.268 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -80.44 132.55 35.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.96 -0.564 . . . . 7.6500000000000004 110.024 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.05 -39.94 75.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.129 0.49 . . . . 10.529999999999999 110.035 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -105.38 133.6 49.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.6 -0.727 . . . . 11.56 109.96 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 23.3 t -97.73 135.96 38.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.528 -0.305 . . . . 10.06 110.207 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -101.76 130.0 48.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.008 0.432 . . . . 11.92 110.7 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -114.32 149.2 36.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.533 -0.758 . . . . 14.01 109.907 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.98 -19.9 63.33 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.151 -0.477 . . . . 14.529999999999999 110.396 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -66.29 -27.52 67.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.349 -0.841 . . . . 16.609999999999999 110.312 174.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -77.05 110.9 12.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.229 -0.442 . . . . 15.460000000000001 111.138 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -76.58 138.83 40.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.026 -0.534 . . . . 15.67 110.184 174.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -91.98 156.31 17.52 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.724 -0.473 . . . . 14.5 109.724 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 87.9 mt -119.96 126.56 75.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.27 -0.423 . . . . 15.15 110.017 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -60.11 -40.0 88.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.599 -0.728 . . . . 14.73 111.01 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -64.26 -39.96 95.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.698 -0.683 . . . . 16.379999999999999 110.909 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -70.73 136.19 48.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.737 -0.665 . . . . 12.779999999999999 111.292 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -117.73 150.68 18.26 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.553 -0.619 . . . . 11.1 111.553 176.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -119.79 134.52 55.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.846 0.355 . . . . 12.26 110.355 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -96.0 114.98 26.74 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.928 -0.578 . . . . 9.9900000000000002 110.423 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.465 ' HB3' ' HB ' ' A' ' 237' ' ' VAL . 96.4 m-85 -100.01 109.99 22.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.013 -0.54 . . . . 10.43 110.374 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -99.87 117.68 34.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.019 -0.537 . . . . 6.29 110.299 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.485 ' HA ' ' CE1' ' A' ' 257' ' ' PHE . 66.5 mtt180 52.19 39.17 26.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.793 -0.64 . . . . 8.1500000000000004 112.077 -177.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 234' ' ' PHE . 62.6 t -119.79 124.21 72.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.958 -0.565 . . . . 2.3999999999999999 109.768 176.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -85.47 138.85 16.83 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.327 -0.939 . . . . 1.27 110.987 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 255' ' ' TYR . 92.6 mt -119.69 129.48 54.56 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.494 -0.482 . . . . 1.97 110.013 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.453 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 65.2 t80 -107.37 131.19 54.52 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.361 -0.607 . . . . 3.54 109.361 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -120.0 140.12 51.46 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.824 -0.435 . . . . 2.6400000000000001 109.824 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -125.91 128.28 6.41 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.247 -0.978 . . . . 1.3500000000000001 112.48 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -111.39 117.0 31.89 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.507 -0.553 . . . . 4.3600000000000003 109.507 173.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -121.47 133.87 55.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.781 0.324 . . . . 4.29 110.307 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -119.93 139.92 51.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.337 -0.392 . . . . 6.6900000000000004 110.384 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -64.86 -13.24 55.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.757 -0.656 . . . . 6.3700000000000001 110.561 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -69.98 -10.93 60.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.712 -0.676 . . . . 5.8300000000000001 110.567 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 104.7 -2.54 42.06 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.696 -0.764 . . . . 2.6600000000000001 112.259 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 61.8 tp -95.18 120.02 34.68 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.015 -0.365 . . . . 2.9700000000000002 110.015 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 8.6 t -121.6 129.94 53.17 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.437 -0.579 . . . . 2.1699999999999999 109.437 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.6 t -124.37 132.54 71.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.026 0.441 . . . . 1.79 110.882 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 51.9 m -110.23 129.06 55.79 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.876 -0.602 . . . . 1.6299999999999999 109.865 178.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 75.0 mt -120.0 130.34 54.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.312 -0.403 . . . . 2.96 111.027 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -101.84 124.85 48.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.438 -0.347 . . . . 4.0800000000000001 110.073 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' TYR . . . . . 0.454 ' HB3' ' HB2' ' A' ' 239' ' ' LEU . 61.2 t80 -104.33 129.97 52.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.547 . . . . 4.8399999999999999 109.588 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -100.35 127.35 46.68 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.371 -0.377 . . . . 3.5800000000000001 111.458 -176.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . 0.485 ' CE1' ' HA ' ' A' ' 236' ' ' ARG . 51.6 p90 -70.07 -23.58 63.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.01 -0.541 . . . . 6.7699999999999996 109.633 175.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -60.62 -33.93 73.5 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 115.788 -0.642 . . . . 8.5399999999999991 110.753 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 61.0 t90 -69.52 -25.49 64.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.705 -0.68 . . . . 11.9 111.105 -178.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -68.18 116.31 8.63 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.346 -0.388 . . . . 10.57 111.335 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -85.43 130.01 34.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.208 0.528 . . . . 11.41 109.873 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -70.06 -39.94 75.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.53 -0.759 . . . . 11.98 112.827 -176.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -97.43 -176.98 3.66 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.934 -0.307 . . . . 12.460000000000001 111.267 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -60.06 -39.91 87.65 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.0 0.37 . . . . 13.779999999999999 112.0 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -73.75 80.16 0.81 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.994 -0.622 . . . . 11.07 113.096 -173.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -78.91 159.77 27.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.017 0.437 . . . . 12.59 110.987 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 12.1 p -119.98 137.71 53.91 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.56 0.695 . . . . 10.92 111.448 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -70.1 -39.93 75.23 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 114.942 -1.026 . . . . 12.42 111.695 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.87 139.58 58.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.218 -0.446 . . . . 11.59 110.796 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -99.01 117.1 32.76 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.177 -0.465 . . . . 8.8300000000000001 111.232 -174.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -59.93 -40.08 87.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.594 -0.73 . . . . 7.0199999999999996 111.046 173.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -145.33 137.45 25.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.905 -0.589 . . . . 6.5999999999999996 110.276 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -139.93 131.47 27.09 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.144 -0.48 . . . . 1.9399999999999999 109.833 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.1 116.64 1.99 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.897 -1.144 . . . . 1.4199999999999999 111.895 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 62.6 t -129.92 130.0 66.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.638 0.256 . . . . 1.8100000000000001 110.826 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.09 126.97 5.41 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.807 -0.917 . . . . 1.3 110.807 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.6 t -118.19 120.05 63.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 117.099 0.449 . . . . 1.8300000000000001 110.954 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . 0.522 ' OD1' ' HA3' ' A' ' 12' ' ' GLY . 96.3 m-20 -119.3 129.98 55.16 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.579 -0.526 . . . . 2.3100000000000001 109.579 176.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -112.08 116.44 30.52 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.193 -0.669 . . . . 4.75 109.193 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 15.3 t -121.71 130.3 53.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.101 -0.499 . . . . 1.6699999999999999 110.382 -176.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 65.1 t80 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.245 -0.883 . . . . 3.6899999999999999 108.939 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.8 mtm . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 121.664 0.745 . . . . 11.85 109.378 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -80.09 -9.57 59.71 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.944 -1.025 . . . . 10.35 111.217 -166.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -80.19 -9.97 59.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.255 -0.43 . . . . 9.3100000000000005 111.197 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 60.5 mtp85 -89.54 141.17 28.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.602 0.593 . . . . 8.8399999999999999 112.602 -177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -107.43 73.22 0.91 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.432 -0.804 . . . . 7.0099999999999998 109.363 170.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -60.27 -39.62 87.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 3.6099999999999999 110.698 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -77.56 121.57 24.08 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.598 -0.89 . . . . 3.3300000000000001 108.598 171.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.543 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 32.7 m170 -98.38 131.63 44.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.218 0.532 . . . . 3.2000000000000002 111.246 -174.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -139.65 159.91 41.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.642 -0.708 . . . . 2.4900000000000002 110.644 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.535 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 41.9 t30 -145.88 129.7 17.22 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.48 -0.563 . . . . 2.1299999999999999 109.48 172.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.4 mt -120.56 122.53 68.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.326 -0.62 . . . . 1.6000000000000001 109.326 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -130.15 137.3 9.42 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 119.85 -1.167 . . . . 0.88 112.827 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.57 136.29 54.84 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.789 -0.449 . . . . 1.0800000000000001 109.789 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 57.5 ttm -143.44 150.65 39.32 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.746 -0.464 . . . . 2.3300000000000001 109.746 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -106.69 119.99 40.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.115 -0.328 . . . . 2.6099999999999999 110.115 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -112.06 143.48 43.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.436 -0.347 . . . . 5.0899999999999999 110.209 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.7 pt -118.26 132.11 69.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.291 0.567 . . . . 5.3300000000000001 111.243 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -100.36 -0.57 38.05 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.692 -0.855 . . . . 8.2799999999999994 108.692 172.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -73.66 129.79 38.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.983 -1.008 . . . . 9.6999999999999993 110.947 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.9 p -139.99 145.84 25.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.513 -0.767 . . . . 11.09 109.382 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 64.81 39.86 5.89 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.659 0.6 . . . . 13.1 111.079 -176.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.56 -12.99 83.36 Favored Glycine 0 C--O 1.225 -0.409 0 CA-C-N 115.324 -0.853 . . . . 11.94 112.209 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -70.22 -30.12 67.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.903 0.382 . . . . 15.18 110.472 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.46 -43.78 76.26 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.144 -0.55 . . . . 12.0 113.089 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.472 ' HG2' ' H ' ' A' ' 27' ' ' MET . 41.4 tt0 -128.32 138.56 52.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.749 0.309 . . . . 12.82 110.261 -177.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -63.19 -16.38 59.94 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.695 -0.684 . . . . 10.81 112.397 -172.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.472 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 95.4 mmm -75.54 65.1 1.72 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.875 0.369 . . . . 10.050000000000001 111.349 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.65 140.19 58.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.017 -0.538 . . . . 8.0600000000000005 110.533 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.34 142.03 20.96 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.776 -0.726 . . . . 5.5800000000000001 112.226 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.5 tp -70.07 139.96 52.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.613 0.244 . . . . 5.5599999999999996 110.364 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.64 131.22 37.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.661 0.267 . . . . 3.0499999999999998 110.532 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 9.7 tp10 -90.52 125.03 61.01 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.711 -0.477 . . . . 3.48 109.711 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 32' ' ' GLU . 26.8 Cg_exo -64.59 134.32 40.63 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.551 2.168 . . . . 1.8600000000000001 112.383 175.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 m -121.35 142.97 49.46 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.047 -0.524 . . . . 1.97 109.706 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.0 p -135.39 141.87 41.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.065 0.46 . . . . 1.71 110.943 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -137.85 147.61 44.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.979 -0.555 . . . . 4.0700000000000003 110.694 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -119.91 140.08 51.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.965 -0.562 . . . . 2.8599999999999999 111.238 -177.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.535 ' HB2' ' HB3' ' A' ' 10' ' ' ASN . 28.6 m-80 -121.52 140.44 52.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.723 -0.671 . . . . 1.8899999999999999 110.095 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -137.87 140.93 40.69 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.987 -0.285 . . . . 1.0800000000000001 110.394 174.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.54 122.04 2.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.124 -0.489 . . . . 1.3899999999999999 110.669 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.694 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 43.4 t30 -149.95 92.12 1.86 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.23 -0.656 . . . . 2.8599999999999999 109.23 171.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.86 -78.96 0.28 Allowed Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 111.093 -0.803 . . . . 1.6799999999999999 111.093 -174.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.694 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 24.9 Cg_endo -61.96 175.57 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.526 2.817 . . . . 1.6599999999999999 112.94 171.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.454 ' HB3' ' O ' ' A' ' 75' ' ' HIS . 8.4 m-90 -69.41 -172.99 0.51 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.518 -0.765 . . . . 3.3999999999999999 111.15 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -106.64 122.34 46.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.779 0.8 . . . . 3.1000000000000001 111.237 -167.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 87.5 mt -111.81 136.09 49.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.417 -1.265 . . . . 1.8 109.895 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' A' ' 73' ' ' GLU . . . -117.22 132.48 56.63 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.087 -0.506 . . . . 0.85999999999999999 109.877 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.5 tp -119.49 131.7 55.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.059 -0.519 . . . . 1.0600000000000001 110.489 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.54 163.64 39.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.763 -0.653 . . . . 1.1399999999999999 109.537 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -157.05 150.6 24.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.644 0.259 . . . . 4.0199999999999996 110.396 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -130.04 150.02 51.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.911 -0.586 . . . . 4.6100000000000003 110.603 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -125.31 124.38 41.48 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.472 -0.785 . . . . 3.3799999999999999 109.301 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.83 -40.84 75.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.727 -0.67 . . . . 5.0499999999999998 111.073 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 47.15 59.91 5.41 Favored Glycine 0 CA--C 1.52 0.382 0 O-C-N 123.596 0.56 . . . . 4.3700000000000001 112.832 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.14 141.58 94.16 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.387 2.058 . . . . 6.6799999999999997 112.39 -174.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.99 119.96 61.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.033 -0.53 . . . . 8.1699999999999999 110.283 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.402 ' OD2' ' HD3' ' A' ' 62' ' ' LYS . 17.0 m-20 -79.2 159.49 27.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.136 -0.484 . . . . 10.039999999999999 110.155 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -65.99 -40.16 90.96 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.033 0.444 . . . . 11.609999999999999 110.356 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.6 m -81.44 139.18 35.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.825 -0.625 . . . . 9.7899999999999991 110.452 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.7 149.44 21.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.262 -0.427 . . . . 8.5099999999999998 110.924 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.4 10.73 37.93 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.748 -0.739 . . . . 7.5599999999999996 112.061 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.402 ' HD3' ' OD2' ' A' ' 57' ' ' ASP . 63.0 tttp -108.27 120.0 41.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.774 0.321 . . . . 10.0 110.513 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -70.03 -40.19 75.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.129 -0.487 . . . . 10.35 110.244 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.97 -147.84 50.78 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.292 -0.867 . . . . 5.3399999999999999 112.728 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.5 p -131.4 141.98 49.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.728 0.299 . . . . 5.3200000000000003 110.564 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -99.79 130.52 46.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.963 0.411 . . . . 5.6100000000000003 110.85 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -120.02 140.02 51.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.839 -0.619 . . . . 3.7799999999999998 110.342 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -134.8 160.05 39.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.574 -0.739 . . . . 2.4500000000000002 109.861 -174.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 94' ' ' ASN . 17.1 ptp180 -148.48 125.09 5.39 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.871 0.367 . . . . 3.2400000000000002 110.626 171.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.444 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 89.3 Cg_endo -93.02 153.77 2.65 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.941 2.428 . . . . 1.1899999999999999 112.313 171.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 93' ' ' ARG . 43.8 mt-10 -118.91 125.51 49.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.295 -0.411 . . . . 2.1899999999999999 110.123 175.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.412 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 64.0 tp -122.12 112.59 18.4 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.019 -0.537 . . . . 1.1399999999999999 109.981 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 80.0 mt-10 -108.5 132.72 53.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.003 0.43 . . . . 2.1800000000000002 111.28 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.42 124.59 72.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.894 -0.78 . . . . 1.5600000000000001 108.894 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' A' ' 44' ' ' TRP . 28.1 m-70 -106.32 119.1 38.36 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.84 -0.43 . . . . 3.4399999999999999 109.84 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 79.4 t80 -100.45 122.53 43.33 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.769 -0.65 . . . . 4.7999999999999998 110.35 -176.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -109.21 128.68 55.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.592 -0.731 . . . . 2.9399999999999999 109.693 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -143.37 129.95 20.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.069 -0.252 . . . . 3.8999999999999999 111.224 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.1 mt 60.12 42.21 15.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.606 -0.724 . . . . 4.4800000000000004 111.703 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -67.17 -37.76 84.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.132 0.491 . . . . 6.1900000000000004 110.815 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -87.31 0.1 55.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.77 -0.65 . . . . 5.4500000000000002 110.925 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -107.02 169.26 8.66 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.101 -0.5 . . . . 5.2699999999999996 110.913 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -60.3 -43.73 96.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.794 0.331 . . . . 6.3300000000000001 111.671 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -95.79 117.54 30.74 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.417 -0.356 . . . . 7.4800000000000004 110.402 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.6 p -99.86 123.95 44.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.345 -0.389 . . . . 2.5499999999999998 110.747 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -123.06 148.33 45.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.056 -0.52 . . . . 5.2999999999999998 110.292 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.94 163.8 28.28 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.548 -0.834 . . . . 1.3500000000000001 111.959 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.502 ' HB3' ' HB3' ' A' ' 76' ' ' TYR . 65.1 tp -145.61 128.6 16.5 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.472 -0.566 . . . . 2.29 109.472 174.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 p -118.31 128.53 54.75 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.308 0.575 . . . . 1.54 110.9 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -123.84 132.63 8.48 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.571 -0.823 . . . . 1.1699999999999999 111.319 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -128.14 127.42 5.71 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 111.497 -0.641 . . . . 1.1899999999999999 111.497 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -111.09 130.28 55.66 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.888 0.375 . . . . 3.75 110.483 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.516 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 91.0 mtt180 -122.95 126.88 48.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.615 -0.72 . . . . 2.75 109.12 175.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 64.9 t30 -107.33 129.94 54.84 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.337 -0.616 . . . . 1.8200000000000001 109.337 -178.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.424 ' HB3' ' HB3' ' A' ' 110' ' ' MET . 54.5 t80 -137.05 146.05 44.74 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.416 -0.514 . . . . 3.1400000000000001 110.576 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.81 169.66 36.85 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.622 -0.799 . . . . 2.79 112.495 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -145.86 157.26 43.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.28 0.562 . . . . 7.6200000000000001 111.656 -177.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -142.57 153.79 43.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.961 -1.018 . . . . 7.0800000000000001 108.69 171.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -134.06 100.02 4.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.861 0.362 . . . . 10.16 111.043 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 98.1 t -70.49 -39.85 76.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.216 0.532 . . . . 9.8100000000000005 109.902 175.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -60.09 -40.24 88.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.156 -0.929 . . . . 12.220000000000001 111.641 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -145.86 85.17 7.8 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.772 -0.455 . . . . 10.48 109.772 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.97 139.68 89.06 Favored 'Trans proline' 0 C--N 1.339 0.072 0 C-N-CA 122.89 2.394 . . . . 9.0999999999999996 112.498 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -104.19 179.06 24.78 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.735 -0.745 . . . . 6.46 112.08 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -60.06 -42.2 94.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.166 0.508 . . . . 7.6699999999999999 110.334 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -122.46 160.26 25.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.52 -0.764 . . . . 4.1399999999999997 110.471 -176.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.1 m -147.79 140.31 24.56 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.696 -0.684 . . . . 3.2999999999999998 109.591 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.39 116.38 7.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.667 -0.242 . . . . 1.76 110.589 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -117.67 130.54 56.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.443 -0.344 . . . . 2.5499999999999998 110.085 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.611 ' HG3' ' H ' ' A' ' 139' ' ' ALA . 46.3 ttm -132.56 122.34 24.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.831 0.348 . . . . 1.77 111.624 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.517 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 56.7 mt-30 -103.54 118.71 37.35 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.036 -0.727 . . . . 1.97 109.036 170.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 31.4 ttm180 -113.77 120.73 41.8 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.124 0.488 . . . . 3.8500000000000001 110.168 -178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -119.14 139.62 51.5 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.728 -0.669 . . . . 2.2799999999999998 110.409 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 135' ' ' MET . 82.0 tttt -128.84 123.68 33.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.717 -0.674 . . . . 2.1400000000000001 109.559 172.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.9 mm -124.21 128.15 73.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.016 -0.538 . . . . 1.55 109.698 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.593 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -142.71 106.47 5.42 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 120.681 0.277 . . . . 1.1899999999999999 111.493 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.63 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 65.2 Cg_endo -76.8 132.53 13.16 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 121.977 1.784 . . . . 1.3700000000000001 110.467 172.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -92.38 137.31 32.47 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.538 -0.541 . . . . 2.3500000000000001 109.538 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -128.44 129.99 46.94 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.862 -0.422 . . . . 4.54 109.862 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -137.49 119.76 15.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.843 0.354 . . . . 3.04 110.481 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.9 t -129.56 128.28 65.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.732 -0.667 . . . . 4.2699999999999996 109.659 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -114.99 96.86 5.91 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.789 -0.448 . . . . 6.04 109.789 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.99 -33.24 71.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.557 0.694 . . . . 4.5899999999999999 109.683 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.459 ' HB ' ' H ' ' A' ' 127' ' ' LEU . 8.6 m -140.35 159.88 41.2 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.18 -0.918 . . . . 3.6899999999999999 108.75 177.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -60.14 -41.99 93.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.503 0.668 . . . . 5.1699999999999999 109.361 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -69.92 -40.03 75.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.763 -1.108 . . . . 3.71 111.946 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.459 ' H ' ' HB ' ' A' ' 124' ' ' THR . 84.9 mt -104.94 119.43 39.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 2.0499999999999998 110.814 -172.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.489 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 79.4 ttt180 -125.71 133.31 52.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.119 -0.491 . . . . 4.2400000000000002 111.453 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -108.98 119.99 41.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 3.5499999999999998 109.332 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -143.81 135.79 26.5 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.802 -0.444 . . . . 2.1099999999999999 109.802 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -171.8 172.13 44.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.445 -0.883 . . . . 1.1799999999999999 111.689 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -143.0 150.57 39.82 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.991 0.424 . . . . 4.2999999999999998 110.691 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.63 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 47.8 tp -106.0 111.61 24.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.933 -0.576 . . . . 2.2400000000000002 109.511 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.5 t -101.56 121.1 41.37 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.864 0.364 . . . . 1.6899999999999999 110.631 -173.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.423 ' O ' ' HA ' ' A' ' 114' ' ' LYS . 74.8 mtm -111.83 133.24 54.17 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.345 -0.389 . . . . 2.2400000000000002 110.08 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -118.98 134.88 54.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.95 0.405 . . . . 3.5600000000000001 111.411 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 97.3 mttt -138.55 148.35 44.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.078 -0.712 . . . . 1.6699999999999999 109.078 174.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.501 ' H ' HD22 ' A' ' 142' ' ' LEU . 54.8 p90 -150.83 160.02 44.15 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.974 -0.38 . . . . 3.23 109.974 175.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.611 ' H ' ' HG3' ' A' ' 110' ' ' MET . . . 72.16 -178.69 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.876 0.735 . . . . 1.24 110.334 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -76.82 -39.67 50.57 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.963 0.411 . . . . 2.4700000000000002 111.279 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.0 -49.61 77.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.715 -0.675 . . . . 2.4100000000000001 112.532 -171.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.501 HD22 ' H ' ' A' ' 138' ' ' PHE . 9.5 mp -62.59 -36.35 82.45 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.137 0.494 . . . . 1.8300000000000001 111.129 -177.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.517 ' ND2' ' HB2' ' A' ' 111' ' ' GLN . 94.0 m-20 -66.13 -39.93 90.26 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.24 0.543 . . . . 2.0 110.388 175.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 90.9 m -66.75 -42.25 86.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.367 -0.833 . . . . 2.0499999999999998 111.061 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 148' ' ' ALA . 33.9 p -72.72 -28.89 62.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.251 0.548 . . . . 1.5900000000000001 110.6 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.05 -118.05 7.84 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.531 -0.759 . . . . 1.52 113.041 174.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -70.11 -20.05 63.21 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.553 0.205 . . . . 5.9400000000000004 111.553 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.455 ' HB3' ' HB ' ' A' ' 145' ' ' THR . . . -66.25 -57.32 7.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.462 -0.336 . . . . 1.8300000000000001 111.851 -175.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -117.16 83.84 2.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.461 0.648 . . . . 2.6400000000000001 110.945 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.1 t -145.74 142.44 28.94 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.433 -0.803 . . . . 2.02 109.502 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.411 ' HB3' ' OE2' ' A' ' 153' ' ' GLU . 15.1 mtp180 -76.59 131.97 39.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.872 0.368 . . . . 3.6699999999999999 110.626 176.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.09 115.85 49.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.744 -0.662 . . . . 1.6399999999999999 109.499 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.411 ' OE2' ' HB3' ' A' ' 151' ' ' ARG . 17.8 mm-40 -113.03 129.1 56.62 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.08 -0.711 . . . . 2.5600000000000001 109.08 -177.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 174' ' ' LEU . 21.4 m -113.34 120.03 39.72 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 121.07 -0.252 . . . . 1.3899999999999999 110.745 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -116.45 122.13 43.88 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.741 -0.466 . . . . 2.04 109.741 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 55.3 m -119.58 128.22 53.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.182 -0.463 . . . . 1.5600000000000001 110.544 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -115.33 128.47 8.09 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.968 -0.56 . . . . 1.04 111.868 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 79.6 mt -118.27 134.66 54.84 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.634 -0.506 . . . . 2.27 109.634 -179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 63.1 tt0 -115.07 125.85 54.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.941 -0.392 . . . . 2.4100000000000001 109.941 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -130.3 133.79 46.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.252 -0.431 . . . . 4.5700000000000003 110.255 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.0 p -90.73 87.65 6.77 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.178 0.513 . . . . 1.46 109.617 171.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -60.33 -49.57 77.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.702 -0.681 . . . . 2.6299999999999999 111.367 -173.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.496 ' HB2' HG22 ' A' ' 166' ' ' VAL . 22.8 m120 -101.84 17.1 23.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.457 -0.338 . . . . 2.4100000000000001 110.499 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 72.4 -53.87 0.69 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 123.908 0.755 . . . . 2.5800000000000001 111.415 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.7 p -75.05 -15.96 60.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.348 -0.387 . . . . 2.2999999999999998 111.94 -176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.496 HG22 ' HB2' ' A' ' 163' ' ' ASN . 33.2 m -125.53 140.4 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.559 -0.291 . . . . 1.71 110.481 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.26 128.35 53.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.951 0.405 . . . . 1.47 110.48 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 22.1 mt -105.61 137.16 43.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.901 -0.591 . . . . 1.6599999999999999 109.476 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -110.64 116.12 30.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.961 0.41 . . . . 3.2999999999999998 110.264 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 63.0 t -124.01 129.87 74.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.886 -0.412 . . . . 1.3 109.886 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.411 ' OD1' ' HB2' ' A' ' 195' ' ' ARG . 25.9 p30 -134.09 156.09 48.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.875 0.369 . . . . 2.2200000000000002 110.969 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.495 ' HB2' HG21 ' A' ' 191' ' ' THR . 52.1 p90 -145.34 150.02 35.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.183 -0.462 . . . . 4.6100000000000003 111.017 -177.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -105.2 126.38 52.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.725 -0.671 . . . . 3.98 111.615 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.449 ' HB2' ' HB ' ' A' ' 154' ' ' THR . 93.3 mt -113.62 130.48 56.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.784 -0.644 . . . . 2.3799999999999999 110.151 175.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -100.39 128.87 46.35 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.272 -0.64 . . . . 3.3100000000000001 109.272 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -94.29 129.14 41.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.807 0.337 . . . . 6.5300000000000002 110.562 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -154.53 178.1 31.5 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.863 -0.895 . . . . 5.0599999999999996 110.863 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -69.24 -27.7 65.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.708 0.289 . . . . 7.3899999999999997 110.488 -177.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -60.12 -40.2 88.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 9.0700000000000003 110.832 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 59.8 ttm -70.13 -41.2 74.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.509 -0.314 . . . . 10.869999999999999 111.043 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.06 -39.66 75.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.262 -0.426 . . . . 10.449999999999999 111.95 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -74.14 -7.49 52.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.665 0.269 . . . . 13.06 111.692 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 68.4 m -69.53 124.88 25.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.153 0.502 . . . . 12.609999999999999 110.373 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -70.04 -35.29 74.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.521 -0.763 . . . . 15.19 109.314 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -79.85 134.42 36.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.359 -0.837 . . . . 13.18 109.356 176.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -142.05 149.7 40.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.663 -0.244 . . . . 12.73 110.525 -175.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 102.58 -51.28 0.88 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.948 -0.644 . . . . 9.9800000000000004 112.737 176.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -100.03 116.79 32.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.0 0.429 . . . . 10.699999999999999 110.599 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -159.87 159.97 33.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.493 -0.776 . . . . 10.5 108.945 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 28.9 p -125.04 155.43 39.75 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.949 0.404 . . . . 6.6399999999999997 111.436 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.495 HG21 ' HB2' ' A' ' 172' ' ' TYR . 19.2 m -106.91 124.93 50.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.794 -0.639 . . . . 4.9800000000000004 109.867 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -61.07 -49.78 75.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.578 -0.737 . . . . 7.0999999999999996 112.21 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -112.4 108.22 17.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.251 0.548 . . . . 4.4000000000000004 110.892 -174.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 82.2 mt -120.05 129.99 74.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.61 -0.723 . . . . 2.21 109.493 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.411 ' HB2' ' OD1' ' A' ' 171' ' ' ASN . 85.1 mtm180 -96.3 115.05 26.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.778 0.323 . . . . 3.54 110.6 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -108.39 124.02 49.73 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.599 -0.519 . . . . 1.6699999999999999 109.599 174.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -147.53 151.93 37.15 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.75 0.31 . . . . 5.8300000000000001 110.612 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 209' ' ' PRO . 1.8 pt? -129.66 128.37 23.03 Favored Pre-proline 0 C--N 1.321 -0.668 0 C-N-CA 120.98 -0.288 . . . . 2.5899999999999999 110.538 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.16 105.99 2.14 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.4 2.067 . . . . 1.77 111.427 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 56.9 tp -99.18 120.07 38.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.794 -0.639 . . . . 2.2599999999999998 109.512 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 19.6 p -99.95 123.93 44.73 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.943 0.401 . . . . 1.99 111.37 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 62.8 tp -130.29 81.84 2.03 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.032 -0.729 . . . . 2.3100000000000001 109.032 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 70.03 -125.2 15.29 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.409 -0.814 . . . . 1.51 112.283 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -86.82 -0.3 56.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.253 0.549 . . . . 2.5699999999999998 110.051 177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -103.0 117.44 34.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.74 -0.664 . . . . 2.6600000000000001 110.112 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 63.3 m -107.9 123.75 49.08 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.779 -0.452 . . . . 1.6200000000000001 109.779 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 50.6 t -119.3 129.97 74.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.001 -0.545 . . . . 1.3799999999999999 109.854 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 25.3 m -126.62 91.29 47.73 Favored Pre-proline 0 C--N 1.318 -0.769 0 C-N-CA 120.965 -0.294 . . . . 1.1799999999999999 110.722 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 38.4 Cg_endo -70.8 146.33 53.49 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.128 1.885 . . . . 1.01 111.694 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -112.41 139.62 47.83 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.847 0.356 . . . . 4.5 110.344 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 21.1 p -134.58 125.25 26.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.762 -0.653 . . . . 1.8899999999999999 110.731 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -70.12 -36.12 74.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.255 -0.884 . . . . 4.7999999999999998 109.942 177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 86.3 mt -119.91 120.35 62.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.399 -0.819 . . . . 4.5700000000000003 109.451 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -91.72 138.35 14.22 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.651 -0.785 . . . . 4.9800000000000004 112.804 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.0 mt -114.72 145.9 41.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.166 0.508 . . . . 8.1099999999999994 109.85 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.547 ' HB3' ' CD1' ' A' ' 218' ' ' TRP . 14.2 m-20 -60.2 -40.12 88.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.138 -0.937 . . . . 7.6500000000000004 112.024 -175.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 57.86 70.67 0.63 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.715 0.769 . . . . 10.529999999999999 111.729 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' TRP . . . . . 0.547 ' CD1' ' HB3' ' A' ' 216' ' ' ASP . 52.4 m95 -103.38 139.79 38.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.515 -0.766 . . . . 11.56 109.908 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.8 p -76.17 131.03 39.12 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.634 -0.506 . . . . 10.06 109.634 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -86.43 169.14 13.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 111.898 0.333 . . . . 11.92 111.898 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -59.91 -49.89 75.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.351 -0.386 . . . . 14.01 111.307 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -114.99 156.31 25.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.299 0.571 . . . . 14.529999999999999 110.971 -175.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -70.04 -21.14 63.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.228 -0.896 . . . . 16.609999999999999 111.729 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -69.98 -29.1 66.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.615 -0.266 . . . . 15.460000000000001 110.894 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -67.49 -39.96 85.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 15.67 111.452 -176.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.19 131.59 34.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.198 -0.456 . . . . 14.5 110.809 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 87.3 mt -93.86 109.37 21.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.151 0.501 . . . . 15.15 110.606 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -70.18 -39.49 75.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.478 -0.783 . . . . 14.73 110.42 175.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -63.16 139.93 58.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.163 -0.926 . . . . 16.379999999999999 112.007 -172.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -79.81 149.39 31.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.291 -0.868 . . . . 12.779999999999999 109.546 175.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -107.67 -150.45 16.01 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.616 -0.802 . . . . 11.1 111.139 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 43.0 m170 -70.07 -36.32 74.87 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.687 -0.486 . . . . 12.26 109.687 173.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 50.03 62.83 2.46 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 124.0 0.812 . . . . 9.9900000000000002 111.596 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -60.55 -40.06 90.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.948 -1.024 . . . . 10.43 111.186 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -79.85 119.7 23.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.037 -0.528 . . . . 6.29 110.697 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -100.24 137.26 38.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.529 -0.305 . . . . 8.1500000000000004 110.192 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.1 m -106.75 151.76 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.244 -0.435 . . . . 2.3999999999999999 111.061 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -92.3 146.19 18.06 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.898 -0.668 . . . . 1.27 111.999 -177.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 89.3 mt -119.47 131.3 55.58 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.306 0.574 . . . . 1.97 111.129 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.416 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 61.9 t80 -108.75 130.16 55.37 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.413 -0.812 . . . . 3.54 109.767 173.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.51 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 96.1 m-85 -119.67 140.05 51.26 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.498 -0.927 . . . . 2.6400000000000001 108.498 175.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.44 167.05 33.42 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 119.64 -1.267 . . . . 1.3500000000000001 112.945 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -121.5 112.24 18.26 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.695 -0.483 . . . . 4.3600000000000003 109.695 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -120.87 13.88 11.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.242 0.544 . . . . 4.29 109.815 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.96 -40.33 88.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.356 -0.838 . . . . 6.6900000000000004 110.391 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -102.88 135.85 43.79 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.629 -0.714 . . . . 6.3700000000000001 109.747 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -70.01 -19.08 63.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.419 -0.355 . . . . 5.8300000000000001 111.535 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -96.66 2.81 62.66 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.704 -0.76 . . . . 2.6600000000000001 112.718 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 62.8 tp -131.2 129.94 42.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.818 0.342 . . . . 2.9700000000000002 110.648 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 48.9 m -134.94 130.4 35.78 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.399 -0.593 . . . . 2.1699999999999999 109.399 173.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.5 t -130.02 133.1 64.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 120.837 -0.345 . . . . 1.79 110.906 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 11.1 p -115.92 109.99 18.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.119 0.485 . . . . 1.6299999999999999 110.857 176.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 79.3 mt -105.54 120.06 40.69 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.049 -0.723 . . . . 2.96 109.049 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -113.64 112.83 24.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.548 -0.296 . . . . 4.0800000000000001 111.173 -172.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -127.15 110.08 12.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.039 -0.528 . . . . 4.8399999999999999 109.76 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -70.19 -29.55 66.44 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.832 0.349 . . . . 3.5800000000000001 111.619 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -132.89 159.68 39.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.296 -0.411 . . . . 6.7699999999999996 109.962 -176.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -97.19 140.14 32.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.95 0.405 . . . . 8.5399999999999991 110.913 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -69.89 -26.4 64.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.647 -0.706 . . . . 11.9 110.382 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -60.09 -40.0 88.11 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.814 -0.63 . . . . 10.57 111.279 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -84.47 152.31 24.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.397 -0.365 . . . . 11.41 110.15 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -83.67 75.01 10.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.054 0.454 . . . . 11.98 110.053 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -70.18 156.17 39.6 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.189 -0.914 . . . . 12.460000000000001 109.797 176.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -88.4 -0.04 56.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.75 -0.205 . . . . 13.779999999999999 111.237 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -75.61 168.37 54.79 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.97 -0.634 . . . . 11.07 112.75 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . 0.492 ' OD1' ' HD2' ' A' ' 269' ' ' LYS . 38.3 m-20 -70.08 130.84 43.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.802 0.334 . . . . 12.59 110.775 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 20.4 m -69.88 -22.64 63.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.849 -0.614 . . . . 10.92 111.121 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -99.82 10.54 41.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.098 -0.501 . . . . 12.42 111.324 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.492 ' HD2' ' OD1' ' A' ' 266' ' ' ASP . 94.5 mttt -131.21 160.01 36.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.922 -0.399 . . . . 11.59 109.922 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -107.46 97.23 7.0 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.054 -0.35 . . . . 8.8300000000000001 110.054 171.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -97.88 121.84 40.29 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.815 -0.809 . . . . 7.0199999999999996 108.815 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 60.72 40.08 16.68 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.212 0.529 . . . . 6.5999999999999996 111.169 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -140.28 130.12 24.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.606 -0.725 . . . . 1.9399999999999999 110.178 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -157.69 167.15 34.09 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.32 -0.943 . . . . 1.4199999999999999 112.399 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.452 HG12 HD22 ' A' ' 253' ' ' LEU . 34.7 m -128.9 140.01 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.94 0.4 . . . . 1.8100000000000001 111.133 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.92 140.01 11.41 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.321 -0.712 . . . . 1.3 111.321 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.4 t -128.01 129.94 69.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.908 0.354 . . . . 1.8300000000000001 110.884 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -126.42 130.56 50.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.026 -0.534 . . . . 2.3100000000000001 111.004 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -113.55 129.19 56.6 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.423 -0.584 . . . . 4.75 109.423 172.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 50.8 m -120.84 141.25 50.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.319 -0.4 . . . . 1.6699999999999999 110.485 -176.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 91.0 m-85 . . . . . 0 C--O 1.247 0.96 0 CA-C-O 117.785 -1.103 . . . . 3.6899999999999999 109.584 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.6 mtp . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.432 0.158 . . . . 11.85 110.821 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 55.66 38.31 29.99 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.492 0.663 . . . . 10.35 111.687 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -90.56 0.03 57.5 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.224 -0.898 . . . . 9.3100000000000005 110.262 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -90.18 8.77 31.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.198 -0.91 . . . . 8.8399999999999999 110.669 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -99.56 119.14 37.58 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.508 -0.553 . . . . 7.0099999999999998 109.508 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -69.88 -39.68 76.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.187 0.518 . . . . 3.6099999999999999 110.009 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.452 ' HA ' ' HB2' ' A' ' 41' ' ' ASN . 44.6 m95 -62.72 139.98 58.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.291 -0.868 . . . . 3.3300000000000001 111.471 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.35 135.64 36.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.125 -0.489 . . . . 3.2000000000000002 110.0 175.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.92 139.94 51.65 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.854 -0.612 . . . . 2.4900000000000002 110.683 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -126.64 129.83 49.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.276 -0.42 . . . . 2.1299999999999999 110.468 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.6 mt -121.0 120.09 61.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.058 -0.719 . . . . 1.6000000000000001 109.058 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.3 129.36 9.44 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.23 -0.986 . . . . 0.88 111.475 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.1 134.83 54.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.162 0.506 . . . . 1.0800000000000001 110.636 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 68.0 mtt -126.63 141.38 51.87 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.566 -0.743 . . . . 2.3300000000000001 109.492 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -119.32 127.93 53.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.619 -0.264 . . . . 2.6099999999999999 110.586 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.514 ' HG2' ' HB1' ' A' ' 31' ' ' ALA . 34.9 mt-10 59.78 40.0 20.07 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.804 0.69 . . . . 5.0899999999999999 111.26 172.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.5 mm -107.27 116.22 50.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.383 -0.371 . . . . 5.3300000000000001 110.625 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -85.67 87.43 7.4 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.511 -0.551 . . . . 8.2799999999999994 109.511 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.418 ' HB2' ' CE1' ' A' ' 51' ' ' TYR . 91.0 m-20 -60.17 -39.65 87.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.355 -0.839 . . . . 9.6999999999999993 111.775 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.0 t -105.78 120.15 56.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.837 0.351 . . . . 11.09 110.232 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.17 133.19 51.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.868 -0.605 . . . . 13.1 109.988 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.63 19.41 26.17 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.881 -0.676 . . . . 11.94 112.052 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -60.16 -39.84 87.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.87 0.367 . . . . 15.18 110.389 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.34 -30.08 69.58 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.104 -0.569 . . . . 12.0 112.906 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -100.97 7.78 43.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.648 0.261 . . . . 12.82 111.443 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 56.12 39.94 30.26 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.919 -0.582 . . . . 10.81 111.605 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 93.9 mmm -127.76 130.07 48.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.09 -0.505 . . . . 10.050000000000001 111.022 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -155.8 168.37 27.42 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.419 -0.586 . . . . 8.0600000000000005 109.419 176.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.47 28.78 18.54 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.491 -0.862 . . . . 5.5800000000000001 112.257 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.1 mt -100.89 131.79 46.6 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.473 -0.565 . . . . 5.5599999999999996 109.473 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.514 ' HB1' ' HG2' ' A' ' 16' ' ' GLU . . . -146.9 123.5 11.12 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.857 -0.337 . . . . 3.0499999999999998 111.803 -176.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.408 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 12.9 pt-20 -149.07 156.08 40.29 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 116.298 -0.41 . . . . 3.48 110.559 175.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.2 135.87 15.6 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.883 2.389 . . . . 1.8600000000000001 111.211 170.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.1 t -140.45 149.88 43.12 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 121.097 -0.241 . . . . 1.97 110.848 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.2 m -126.56 139.93 50.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 1.71 110.824 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -119.75 147.04 45.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.989 -0.551 . . . . 4.0700000000000003 110.105 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -119.29 139.36 52.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.792 0.33 . . . . 2.8599999999999999 111.103 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -150.16 142.45 24.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.967 -0.56 . . . . 1.8899999999999999 110.266 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -148.29 143.73 27.13 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.959 -0.109 . . . . 1.0800000000000001 110.993 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.56 135.14 7.45 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.972 0.36 . . . . 1.3899999999999999 111.972 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.61 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 41.4 t30 -168.85 94.64 0.34 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.88 -0.6 . . . . 2.8599999999999999 110.096 170.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.85 -91.75 1.5 Allowed Glycine 0 CA--C 1.517 0.184 0 C-N-CA 120.901 -0.666 . . . . 1.6799999999999999 111.709 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 72.9 Cg_exo -50.44 176.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.608 2.872 . . . . 1.6599999999999999 113.456 169.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 47.8 p90 -67.1 170.8 6.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.621 -0.718 . . . . 3.3999999999999999 111.289 -171.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -113.11 130.03 56.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.8 -0.636 . . . . 3.1000000000000001 110.511 -173.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.5 tt -116.58 131.47 69.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.384 -0.825 . . . . 1.8 110.492 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -118.38 128.6 54.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.002 -0.544 . . . . 0.85999999999999999 110.697 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.8 tp -103.65 126.59 50.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.951 -0.568 . . . . 1.0600000000000001 110.242 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -140.0 168.39 19.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.098 0.475 . . . . 1.1399999999999999 110.928 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -164.31 160.01 20.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.867 -0.606 . . . . 4.0199999999999996 110.109 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.551 ' HB3' ' CG ' ' A' ' 69' ' ' ARG . 61.8 t80 -130.33 129.77 43.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.87 -0.419 . . . . 4.6100000000000003 109.87 177.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -130.85 159.74 36.49 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.972 -0.558 . . . . 3.3799999999999999 110.601 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -110.04 23.22 14.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.302 -0.863 . . . . 5.0499999999999998 109.174 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.1 112.37 0.83 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 110.643 -0.983 . . . . 4.3700000000000001 110.643 -171.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.408 ' HD3' ' CB ' ' A' ' 32' ' ' GLU . 48.6 Cg_endo -69.98 168.23 22.45 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.736 2.29 . . . . 6.6799999999999997 112.828 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 95.6 t -59.87 -40.11 81.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.022 0.439 . . . . 8.1699999999999999 110.558 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -61.14 -35.6 77.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.863 -0.608 . . . . 10.039999999999999 111.473 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -59.99 -40.64 89.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 11.609999999999999 112.283 -173.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 t -129.95 139.98 51.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.031 0.443 . . . . 9.7899999999999991 111.299 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.99 -0.14 57.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.005 -0.543 . . . . 8.5099999999999998 110.499 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.62 73.88 2.34 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.941 -0.647 . . . . 7.5599999999999996 112.11 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -89.95 -2.5 58.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.599 0.238 . . . . 10.0 111.112 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -90.22 -0.86 57.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.706 0.288 . . . . 10.35 111.197 -175.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.08 173.69 25.67 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.9 -0.667 . . . . 5.3399999999999999 111.982 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.5 m -92.61 116.66 29.21 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.077 -0.342 . . . . 5.3200000000000003 110.077 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -120.07 143.19 48.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.187 -0.46 . . . . 5.6100000000000003 110.095 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -116.69 140.04 49.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.243 0.544 . . . . 3.7799999999999998 110.464 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -139.72 170.42 15.92 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.533 -0.758 . . . . 2.4500000000000002 109.373 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.551 ' CG ' ' HB3' ' A' ' 51' ' ' TYR . 3.2 ptp180 -129.98 125.95 22.23 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 120.419 -0.512 . . . . 3.2400000000000002 111.161 175.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -87.4 140.03 5.24 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.918 2.412 . . . . 1.1899999999999999 110.835 167.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.486 ' CD ' ' HE ' ' A' ' 93' ' ' ARG . 76.7 mt-10 -126.87 130.0 49.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.738 -0.468 . . . . 2.1899999999999999 109.738 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 47' ' ' ALA . 57.8 tp -133.54 120.85 21.3 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.562 -0.29 . . . . 1.1399999999999999 110.339 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -119.49 130.02 55.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.994 0.426 . . . . 2.1800000000000002 110.267 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 89' ' ' THR . 62.1 t -120.0 129.52 75.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.931 -0.577 . . . . 1.5600000000000001 110.062 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -113.99 122.26 46.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.155 -0.475 . . . . 3.4399999999999999 111.169 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -108.38 146.22 33.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.642 -0.708 . . . . 4.7999999999999998 109.705 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -117.14 137.39 52.35 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.029 -0.36 . . . . 2.9399999999999999 110.029 173.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.617 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 93.2 m-85 -134.87 91.01 2.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.208 -0.451 . . . . 3.8999999999999999 110.422 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 78' ' ' PHE . 10.0 mt 170.02 130.02 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.786 1.234 . . . . 4.4800000000000004 109.354 171.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -98.72 15.06 26.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.759 0.314 . . . . 6.1900000000000004 111.54 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.418 ' ND2' ' HB2' ' A' ' 83' ' ' ASP . 58.8 t30 -118.74 137.51 53.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.894 0.378 . . . . 5.4500000000000002 110.524 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -70.2 -22.3 62.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.815 -0.63 . . . . 5.2699999999999996 112.302 -176.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.418 ' HB2' ' ND2' ' A' ' 81' ' ' ASN . 59.5 m-20 -62.37 -45.15 94.47 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.821 0.343 . . . . 6.3300000000000001 111.792 -176.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -139.97 147.81 41.02 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.613 -0.514 . . . . 7.4800000000000004 109.613 -177.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.9 m -136.33 130.72 33.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.0 0.428 . . . . 2.5499999999999998 111.574 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -110.17 150.18 29.02 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.614 -0.884 . . . . 5.2999999999999998 108.614 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -150.14 169.69 30.17 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.724 -1.227 . . . . 1.3500000000000001 112.818 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 97.4 mt -131.43 122.47 26.32 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.405 -0.591 . . . . 2.29 109.405 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 92.9 m -120.11 129.98 54.42 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.001 0.429 . . . . 1.54 110.254 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -121.67 133.57 9.52 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.771 -0.728 . . . . 1.1699999999999999 111.484 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -118.58 130.66 8.76 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.655 -0.783 . . . . 1.1899999999999999 112.462 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 68.3 m-85 -112.01 127.24 55.82 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.768 -0.456 . . . . 3.75 109.768 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.486 ' HE ' ' CD ' ' A' ' 71' ' ' GLU . 40.1 ttm180 -142.71 124.87 15.38 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.561 -0.163 . . . . 2.75 110.561 177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.507 ' OD1' ' HA ' ' A' ' 111' ' ' GLN . 93.5 m-20 -132.65 129.83 39.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.293 -0.262 . . . . 1.8200000000000001 110.293 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -126.69 135.39 51.08 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.306 -0.627 . . . . 3.1400000000000001 109.306 176.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -72.3 125.94 11.07 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.745 -0.74 . . . . 2.79 112.414 -178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.468 ' CE2' ' HD1' ' A' ' 99' ' ' TYR . 64.8 t80 -87.19 124.57 33.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.93 0.395 . . . . 7.6200000000000001 111.04 -177.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -150.03 79.94 1.37 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.602 -0.726 . . . . 7.0800000000000001 109.745 172.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.468 ' HD1' ' CE2' ' A' ' 97' ' ' TYR . 67.6 m-85 -120.56 139.95 52.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.376 -0.601 . . . . 10.16 109.376 174.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.3 m -96.46 -2.76 10.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 112.0 0.37 . . . . 9.8100000000000005 112.0 -172.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -70.19 -40.05 74.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.051 0.453 . . . . 12.220000000000001 110.342 176.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -98.68 113.4 64.32 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.936 -0.575 . . . . 10.48 110.347 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.0 138.86 75.82 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.487 2.125 . . . . 9.0999999999999996 111.939 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.91 -117.04 0.75 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.62 -0.8 . . . . 6.46 112.463 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -105.37 127.47 52.99 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.978 0.418 . . . . 7.6699999999999999 110.853 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.08 -39.83 87.45 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.288 -0.869 . . . . 4.1399999999999997 111.232 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.5 p -116.29 130.09 56.6 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.951 0.405 . . . . 3.2999999999999998 110.514 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -160.16 160.94 33.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.793 -0.639 . . . . 1.76 109.775 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -120.12 129.99 54.42 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.572 -0.529 . . . . 2.5499999999999998 109.572 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 89.0 mtp -104.52 129.44 52.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.742 0.306 . . . . 1.77 110.413 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.507 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 99.5 mt-30 -95.66 123.14 39.08 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.823 -0.626 . . . . 1.97 111.047 -176.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 85.7 mtt180 -116.29 114.3 24.17 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.659 -0.497 . . . . 3.8500000000000001 109.659 173.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.457 ' NE1' ' HB3' ' A' ' 111' ' ' GLN . 83.8 m95 -107.44 136.88 46.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.68 -0.691 . . . . 2.2799999999999998 110.86 -173.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -120.53 123.36 42.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.823 -0.626 . . . . 2.1400000000000001 110.196 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 134' ' ' SER . 88.2 mt -120.07 120.35 62.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.077 -0.712 . . . . 1.55 109.077 174.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -145.76 108.05 4.36 Favored Pre-proline 0 C--N 1.325 -0.488 0 C-N-CA 120.723 -0.391 . . . . 1.1899999999999999 111.814 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.675 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 69.3 Cg_endo -77.64 139.93 18.4 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.067 1.845 . . . . 1.3700000000000001 110.185 171.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.88 137.44 32.36 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.229 -0.442 . . . . 2.3500000000000001 110.045 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -127.16 127.54 44.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.302 -0.408 . . . . 4.54 109.968 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -126.82 109.59 12.16 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.347 -0.612 . . . . 3.04 109.347 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.7 t -120.58 117.62 53.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.128 -0.487 . . . . 4.2699999999999996 110.321 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -117.34 96.09 5.26 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.651 -0.499 . . . . 6.04 109.651 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.42 -39.95 85.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.647 -0.706 . . . . 4.5899999999999999 110.694 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.1 t -149.71 170.0 19.74 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.381 -0.827 . . . . 3.6899999999999999 108.865 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.98 -39.24 85.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.404 0.621 . . . . 5.1699999999999999 110.046 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.15 -31.11 68.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.627 -1.169 . . . . 3.71 111.57 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 159' ' ' GLN . 85.0 mt -119.98 119.79 34.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 2.0499999999999998 112.061 -171.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.478 ' HB2' ' HB3' ' A' ' 159' ' ' GLN . 89.8 mtt180 -111.6 109.61 19.6 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.855 -0.794 . . . . 4.2400000000000002 108.855 170.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.41 ' C ' HD22 ' A' ' 130' ' ' ASN . 65.5 t80 -109.43 122.4 47.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.187 0.518 . . . . 3.5499999999999998 111.037 -177.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.41 HD22 ' C ' ' A' ' 129' ' ' PHE . 0.9 OUTLIER -125.12 139.91 53.35 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.764 -0.653 . . . . 2.1099999999999999 109.522 173.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -147.65 133.6 4.77 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.576 -0.821 . . . . 1.1799999999999999 111.573 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 29.3 m-90 -120.03 127.61 52.75 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.936 0.398 . . . . 4.2999999999999998 111.062 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.675 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 58.2 tp -101.3 118.57 37.24 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.438 -0.949 . . . . 2.2400000000000002 108.438 173.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 42.9 m -120.49 130.01 54.1 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.036 0.446 . . . . 1.6899999999999999 111.177 -175.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.649 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 76.5 mtm -106.3 130.24 54.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.595 -0.729 . . . . 2.2400000000000002 109.394 173.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -120.07 139.9 51.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.35 -0.386 . . . . 3.5600000000000001 111.346 -175.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 96.7 mttt -129.55 160.04 34.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.71 -0.677 . . . . 1.6699999999999999 109.271 174.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.462 ' H ' HD22 ' A' ' 142' ' ' LEU . 53.0 p90 -143.96 160.07 41.47 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.487 -0.56 . . . . 3.23 109.487 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 63.56 -178.57 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.893 0.746 . . . . 1.24 111.504 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -74.99 -39.93 60.98 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.117 0.484 . . . . 2.4700000000000002 111.343 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -59.98 -41.93 93.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.529 -0.759 . . . . 2.4100000000000001 113.034 -168.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.462 HD22 ' H ' ' A' ' 138' ' ' PHE . 9.4 mp -69.98 -30.13 67.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.878 0.37 . . . . 1.8300000000000001 111.352 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -70.03 -40.07 75.4 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.805 -0.358 . . . . 2.0 110.101 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 33.7 p -73.48 -31.15 63.6 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.569 0.581 . . . . 2.0499999999999998 112.569 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 35.1 p -79.46 -10.03 59.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.898 0.38 . . . . 1.5900000000000001 111.412 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 91.14 -137.06 13.66 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.689 -0.767 . . . . 1.52 112.449 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -89.93 -1.27 57.94 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.842 0.353 . . . . 5.9400000000000004 110.379 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.56 -47.7 82.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.934 -0.576 . . . . 1.8300000000000001 111.153 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -108.43 81.96 1.55 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.073 0.463 . . . . 2.6400000000000001 110.477 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.5 t -149.5 150.01 31.64 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.2 -0.455 . . . . 2.02 109.996 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 135' ' ' MET . 42.8 mtt180 -80.84 134.89 35.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.355 -0.384 . . . . 3.6699999999999999 110.309 174.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.83 102.85 14.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.055 -0.72 . . . . 1.6399999999999999 109.055 173.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.596 ' OE1' ' HD3' ' A' ' 151' ' ' ARG . 83.9 mt-10 -124.74 141.51 52.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.112 -0.495 . . . . 2.5600000000000001 110.248 -174.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 174' ' ' LEU . 21.8 m -130.08 139.91 50.89 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 121.014 -0.274 . . . . 1.3899999999999999 110.844 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -119.85 131.44 55.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.18 -0.674 . . . . 2.04 109.18 171.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.2 p -117.82 121.12 39.94 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.224 -0.444 . . . . 1.5600000000000001 110.906 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -113.38 120.1 5.05 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.123 -0.791 . . . . 1.04 111.123 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 68.8 tp -123.5 129.44 51.23 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.966 0.412 . . . . 2.27 110.941 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 128' ' ' ARG . 53.4 tt0 -102.87 118.37 36.67 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.718 -0.845 . . . . 2.4100000000000001 108.718 171.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -122.26 137.52 54.81 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.915 0.388 . . . . 4.5700000000000003 110.039 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . 1.6 m -98.26 89.22 4.4 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.33 0.586 . . . . 1.46 109.835 -176.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -67.58 -48.75 65.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.377 -0.828 . . . . 2.6299999999999999 112.218 -171.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.477 ' HB2' HG22 ' A' ' 166' ' ' VAL . 93.6 m-20 -99.9 8.98 43.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.424 -0.353 . . . . 2.4100000000000001 110.98 -175.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 73.6 -39.71 0.44 Allowed 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.865 0.728 . . . . 2.5800000000000001 110.727 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 21.4 p -75.32 -40.13 58.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.194 -0.457 . . . . 2.2999999999999998 111.235 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.477 HG22 ' HB2' ' A' ' 163' ' ' ASN . 31.3 m -120.17 144.48 28.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.115 0.483 . . . . 1.71 111.536 -175.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 161' ' ' THR . . . -119.98 139.47 52.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.463 -0.789 . . . . 1.47 110.591 178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 159' ' ' GLN . 3.1 mm? -108.49 130.49 55.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.828 -0.624 . . . . 1.6599999999999999 109.648 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -101.77 113.0 25.79 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.598 -0.519 . . . . 3.2999999999999998 109.598 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 195' ' ' ARG . 63.1 t -120.13 129.8 75.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.338 -0.392 . . . . 1.3 111.257 -177.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -110.88 126.36 54.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.906 -0.588 . . . . 2.2200000000000002 110.065 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -119.2 140.06 50.83 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.813 -0.631 . . . . 4.6100000000000003 109.941 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -97.52 137.0 37.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.057 0.456 . . . . 3.98 111.032 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.494 ' HB2' ' HB ' ' A' ' 154' ' ' THR . 3.4 mm? -106.73 120.02 40.86 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.131 -0.692 . . . . 2.3799999999999999 109.131 173.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.61 -42.55 97.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.603 -0.726 . . . . 3.3100000000000001 110.352 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -133.93 127.84 33.28 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.136 -0.938 . . . . 6.5300000000000002 110.453 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -98.84 122.66 7.63 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.675 -0.774 . . . . 5.0599999999999996 111.882 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -147.66 149.61 32.8 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.857 0.36 . . . . 7.3899999999999997 110.401 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -100.28 16.55 23.96 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.257 -0.429 . . . . 9.0700000000000003 110.844 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.9 ttm -60.86 -40.11 91.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.798 -0.637 . . . . 10.869999999999999 110.577 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -119.14 121.73 40.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.019 -0.537 . . . . 10.449999999999999 109.964 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -70.02 -39.96 75.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.019 -0.537 . . . . 13.06 110.815 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.9 m -104.67 134.85 47.14 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.104 -0.498 . . . . 12.609999999999999 110.707 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 184' ' ' ARG . 50.4 mtm180 -76.5 144.19 39.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.069 -0.514 . . . . 15.19 110.346 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.422 ' ND2' ' HG3' ' A' ' 188' ' ' GLU . 37.6 t30 -99.53 119.91 38.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.078 0.466 . . . . 13.18 111.194 -177.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -72.91 -20.05 61.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.574 -0.739 . . . . 12.73 111.434 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.49 -31.6 68.19 Favored Glycine 0 C--N 1.329 0.141 0 C-N-CA 121.165 -0.541 . . . . 9.9800000000000004 113.545 -174.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.422 ' HG3' ' ND2' ' A' ' 185' ' ' ASN . 36.0 mt-10 -85.93 146.72 26.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.187 0.517 . . . . 10.699999999999999 111.501 -176.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -95.79 149.06 21.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.714 -0.675 . . . . 10.5 111.314 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.3 p -140.03 154.09 47.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.731 -0.668 . . . . 6.6399999999999997 110.016 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 25.6 p -98.89 2.76 46.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.126 0.488 . . . . 4.9800000000000004 110.639 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -69.0 142.15 54.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.414 -0.812 . . . . 7.0999999999999996 110.987 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -80.07 153.01 29.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.624 -0.716 . . . . 4.4000000000000004 111.902 -173.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 85.8 mt -119.98 120.54 63.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.226 -0.897 . . . . 2.21 109.831 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 72.3 mtm180 -102.86 120.15 40.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.752 -0.204 . . . . 3.54 110.745 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -117.26 128.7 55.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.657 0.265 . . . . 1.6699999999999999 110.498 175.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -150.05 159.95 44.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.152 -0.476 . . . . 5.8300000000000001 110.078 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.417 HD23 ' N ' ' A' ' 198' ' ' LEU . 1.8 pt? -147.05 128.5 7.3 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 110.233 -0.284 . . . . 2.5899999999999999 110.233 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.84 106.72 2.18 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.393 2.062 . . . . 1.77 111.89 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 62.6 tp -112.46 140.06 47.51 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.175 -0.676 . . . . 2.2599999999999998 109.175 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 28.6 p -119.97 140.43 50.94 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.466 -0.494 . . . . 1.99 111.658 -177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 58.9 tp -130.0 81.71 2.03 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.825 -0.806 . . . . 2.3100000000000001 108.825 176.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 75.72 -120.01 5.9 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.512 -0.767 . . . . 1.51 112.3 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -96.72 0.0 48.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.238 0.542 . . . . 2.5699999999999998 110.324 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -111.24 140.28 45.94 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.768 -0.651 . . . . 2.6600000000000001 109.367 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 19.6 p -114.77 151.74 33.26 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.528 -0.305 . . . . 1.6200000000000001 110.731 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 5.3 p -138.78 130.15 35.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.999 0.428 . . . . 1.3799999999999999 110.67 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 56.9 m -122.3 96.72 45.94 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 120.932 0.396 . . . . 1.1799999999999999 110.518 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -60.54 148.11 92.18 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.972 2.448 . . . . 1.01 112.62 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -119.9 139.95 51.62 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.357 -0.608 . . . . 4.5 109.357 174.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 236' ' ' ARG . 14.0 t -159.41 173.59 16.0 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.591 -0.522 . . . . 1.8899999999999999 109.591 178.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 212' ' ' ARG . 50.9 mtt180 -126.71 129.57 48.67 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.884 -0.413 . . . . 4.7999999999999998 109.884 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 16.0 tt -110.77 141.71 25.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.133 -0.485 . . . . 4.5700000000000003 110.355 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 86.55 15.93 62.94 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.034 -0.603 . . . . 4.9800000000000004 111.626 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 65.3 tp -116.5 117.97 31.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.874 0.369 . . . . 8.1099999999999994 110.645 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -99.97 120.0 39.13 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.282 -0.636 . . . . 7.6500000000000004 109.282 174.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -60.6 -40.94 93.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.776 -0.647 . . . . 10.529999999999999 111.24 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -119.34 140.07 50.93 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.806 -0.442 . . . . 11.56 109.806 178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 50.4 m -131.47 146.88 52.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.201 -0.454 . . . . 10.06 110.475 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -70.56 -20.06 62.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.532 -0.758 . . . . 11.92 111.987 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.503 ' HB2' ' NE2' ' A' ' 224' ' ' GLN . 82.9 m95 -75.86 130.0 37.86 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.883 -0.414 . . . . 14.01 109.883 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -61.94 -40.03 94.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.199 -0.909 . . . . 14.529999999999999 112.645 -172.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 91.1 t90 -97.62 120.02 37.25 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.433 -0.507 . . . . 16.609999999999999 110.428 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.503 ' NE2' ' HB2' ' A' ' 221' ' ' TRP . 88.4 mm-40 -128.99 138.46 51.96 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.526 -0.761 . . . . 15.460000000000001 109.616 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -110.06 111.02 22.12 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.065 0.46 . . . . 15.67 109.928 177.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -146.56 165.73 28.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.538 -0.756 . . . . 14.5 109.562 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 86.7 mt -117.52 120.03 63.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.086 0.469 . . . . 15.15 110.84 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -110.5 137.92 47.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.748 -0.66 . . . . 14.73 109.366 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -108.86 167.08 10.34 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.263 -0.426 . . . . 16.379999999999999 110.134 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -67.9 -40.0 83.54 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.387 -0.597 . . . . 12.779999999999999 109.387 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.61 129.12 39.08 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.478 -0.783 . . . . 11.1 111.498 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -79.95 -8.65 59.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.63 0.252 . . . . 12.26 111.56 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -82.15 129.9 34.94 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.94 -0.393 . . . . 9.9900000000000002 109.94 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -136.64 159.79 40.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.611 -0.515 . . . . 10.43 109.611 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -105.11 32.48 4.18 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.47 -0.332 . . . . 6.29 111.261 -174.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 211' ' ' THR . 98.1 mtt180 -69.97 -39.98 75.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.443 -0.577 . . . . 8.1500000000000004 109.443 173.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 63.4 t -130.07 130.01 65.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.904 -1.044 . . . . 2.3999999999999999 108.686 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -150.25 166.45 30.05 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.005 -1.093 . . . . 1.27 112.098 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 96.4 mt -134.33 129.13 35.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.921 0.391 . . . . 1.97 110.749 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.496 ' HE2' ' OG ' ' A' ' 252' ' ' SER . 61.2 t80 -108.07 131.95 54.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.938 -0.574 . . . . 3.54 110.234 174.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -119.97 134.01 55.38 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.973 -0.38 . . . . 2.6400000000000001 109.973 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -110.13 121.76 6.09 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.754 -0.736 . . . . 1.3500000000000001 111.749 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' TYR . . . . . 0.441 ' CD1' HD12 ' A' ' 253' ' ' LEU . 91.9 m-85 -121.62 112.13 18.06 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.821 0.344 . . . . 4.3600000000000003 110.559 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -99.07 97.91 8.99 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.798 -0.445 . . . . 4.29 109.798 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -69.97 -37.0 75.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.015 -0.539 . . . . 6.6900000000000004 111.986 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 96.0 mt-30 -137.31 170.54 15.91 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.861 -0.422 . . . . 6.3700000000000001 109.861 -175.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -59.91 -40.17 87.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.159 0.504 . . . . 5.8300000000000001 111.003 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -104.19 10.9 51.44 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.742 -0.742 . . . . 2.6600000000000001 113.014 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 246' ' ' GLN . 58.5 tp -122.46 115.19 21.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.021 0.411 . . . . 2.9700000000000002 111.499 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 50.0 m -120.24 130.44 54.51 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.695 -0.684 . . . . 2.1699999999999999 109.814 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 99.2 t -113.26 132.14 62.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.189 0.519 . . . . 1.79 110.351 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.496 ' OG ' ' HE2' ' A' ' 240' ' ' PHE . 42.5 t -101.33 118.77 37.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.242 -0.89 . . . . 1.6299999999999999 110.196 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.441 HD12 ' CD1' ' A' ' 243' ' ' TYR . 84.2 mt -119.6 100.96 7.59 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.0 -0.37 . . . . 2.96 110.0 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -109.5 130.04 55.53 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.034 -0.358 . . . . 4.0800000000000001 110.034 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -116.0 129.04 56.19 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.312 -0.404 . . . . 4.8399999999999999 110.405 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -86.07 -32.32 21.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.92 -0.582 . . . . 3.5800000000000001 110.852 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -123.03 134.73 54.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.277 -0.42 . . . . 6.7699999999999996 110.407 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -84.67 138.65 32.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.085 -0.507 . . . . 8.5399999999999991 110.664 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . 0.437 ' CZ2' ' HB2' ' A' ' 266' ' ' ASP . 98.4 m95 -112.81 158.23 20.39 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.247 -0.433 . . . . 11.9 109.934 177.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -105.52 153.34 21.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.13 -0.486 . . . . 10.57 110.521 -173.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -68.26 -39.83 82.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.247 -0.433 . . . . 11.41 110.483 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . 0.428 ' HD2' ' OD1' ' A' ' 263' ' ' ASP . 65.2 t60 -67.74 -47.93 67.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.001 -0.545 . . . . 11.98 110.473 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.428 ' OD1' ' HD2' ' A' ' 262' ' ' HIS . 14.7 m-20 -114.71 103.94 11.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.915 0.388 . . . . 12.460000000000001 110.228 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -69.9 -38.58 76.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.708 -0.678 . . . . 13.779999999999999 111.097 -175.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 68.88 -128.54 23.41 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.888 -0.596 . . . . 11.07 112.672 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . 0.437 ' HB2' ' CZ2' ' A' ' 259' ' ' TRP . 2.7 m-20 -78.94 130.62 35.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.851 0.358 . . . . 12.59 110.56 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 25.2 m -122.99 132.3 54.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.177 -0.465 . . . . 10.92 110.875 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 60.09 30.45 19.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.604 -0.726 . . . . 12.42 111.496 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -91.58 149.11 21.82 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.229 -0.656 . . . . 11.59 109.229 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -92.83 1.04 57.5 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 111.827 0.306 . . . . 8.8300000000000001 111.827 -171.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 59.8 m170 -93.59 -40.78 10.1 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.185 -0.606 . . . . 7.0199999999999996 112.288 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -79.46 -10.87 59.89 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.463 -0.495 . . . . 6.5999999999999996 111.389 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -133.52 159.97 38.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.427 -0.351 . . . . 1.9399999999999999 111.182 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.66 131.54 6.23 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.588 -1.005 . . . . 1.4199999999999999 110.588 174.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.03 128.51 75.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.116 0.484 . . . . 1.8100000000000001 111.207 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -132.75 138.33 10.06 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.337 -0.705 . . . . 1.3 111.337 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.0 t -116.36 120.69 65.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.618 -0.512 . . . . 1.8300000000000001 109.618 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -116.21 129.94 56.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.139 0.495 . . . . 2.3100000000000001 111.069 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.44 ' CE2' HD13 ' A' ' 249' ' ' LEU . 97.8 m-85 -109.35 111.58 23.23 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.548 -0.908 . . . . 4.75 108.548 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 19.9 t -132.0 139.97 48.78 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.517 -0.473 . . . . 1.6699999999999999 110.683 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 57.5 t80 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.085 -0.959 . . . . 3.6899999999999999 108.784 178.825 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mmm . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.845 0.355 . . . . 11.85 110.365 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -87.96 72.92 9.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.375 0.607 . . . . 10.35 109.597 178.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -119.98 144.06 47.7 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.39 -0.823 . . . . 9.3100000000000005 110.359 -173.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -103.89 140.02 38.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.164 -0.471 . . . . 8.8399999999999999 112.068 -174.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 59.5 55.1 4.27 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.166 -0.924 . . . . 7.0099999999999998 111.29 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -121.44 139.03 53.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.528 -0.76 . . . . 3.6099999999999999 109.12 175.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 41' ' ' ASN . 82.9 m95 -69.88 119.83 14.69 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.956 0.408 . . . . 3.3300000000000001 111.549 -173.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -100.99 125.05 47.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.806 -0.634 . . . . 3.2000000000000002 109.661 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -114.92 139.68 49.6 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.26 -0.427 . . . . 2.4900000000000002 110.0 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -126.48 130.5 50.75 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.386 -0.598 . . . . 2.1299999999999999 109.386 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.1 mt -127.89 129.97 69.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.273 -0.421 . . . . 1.6000000000000001 110.681 -175.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.29 140.0 11.46 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.173 -0.771 . . . . 0.88 111.173 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.4 135.58 54.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.014 0.407 . . . . 1.0800000000000001 110.947 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 96.6 mmm -130.1 157.09 43.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.496 -0.774 . . . . 2.3300000000000001 109.702 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -114.56 142.22 46.71 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.436 0.636 . . . . 2.6099999999999999 110.374 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -59.83 -40.15 87.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.697 -1.138 . . . . 5.0899999999999999 111.754 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.433 ' HB ' ' HB2' ' A' ' 31' ' ' ALA . 48.1 mm -117.99 129.93 73.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.826 -0.435 . . . . 5.3300000000000001 109.826 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.548 ' OE2' ' HB3' ' A' ' 272' ' ' TYR . 98.6 mt-10 -65.73 138.01 57.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.087 0.47 . . . . 8.2799999999999994 111.152 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -83.69 139.82 32.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.551 -0.749 . . . . 9.6999999999999993 110.007 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.81 129.97 74.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.086 -0.506 . . . . 11.09 110.146 -177.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -76.8 106.57 8.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.231 0.538 . . . . 13.1 109.787 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.19 -162.52 9.49 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.519 -0.764 . . . . 11.94 111.284 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -106.7 10.16 31.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.893 0.346 . . . . 15.18 110.744 -176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -155.23 -168.54 18.54 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.716 -0.754 . . . . 12.0 112.581 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -133.69 159.55 40.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.244 -0.28 . . . . 12.82 110.244 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -119.75 129.05 54.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.423 -0.353 . . . . 10.81 110.317 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.632 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 67.3 mtt -68.05 -31.41 71.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.209 0.528 . . . . 10.050000000000001 110.121 176.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -70.17 -14.59 62.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.531 -0.759 . . . . 8.0600000000000005 110.994 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.93 19.33 42.51 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.053 -0.594 . . . . 5.5800000000000001 113.452 -175.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 27' ' ' MET . 90.4 mt -61.79 137.36 58.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 117.084 0.442 . . . . 5.5599999999999996 109.855 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.433 ' HB2' ' HB ' ' A' ' 17' ' ' ILE . . . -142.98 149.17 37.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.874 0.368 . . . . 3.0499999999999998 111.861 -174.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -99.63 129.99 27.68 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.863 -0.608 . . . . 3.48 110.012 172.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.73 142.09 47.12 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.153 1.902 . . . . 1.8600000000000001 111.58 173.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.3 t -119.97 143.49 47.99 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.618 -0.512 . . . . 1.97 109.618 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.34 133.73 61.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.392 0.615 . . . . 1.71 111.453 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -111.64 126.2 54.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.275 -0.875 . . . . 4.0700000000000003 108.711 174.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -133.51 130.08 38.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.568 0.223 . . . . 2.8599999999999999 111.212 -174.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 47' ' ' ALA . 9.9 p30 -145.59 156.48 43.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.513 -0.312 . . . . 1.8899999999999999 110.584 173.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 45' ' ' ARG . . . -137.01 143.94 43.01 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.966 -0.561 . . . . 1.0800000000000001 110.678 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.98 136.2 33.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.832 -0.622 . . . . 1.3899999999999999 110.766 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.613 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 40.8 t30 -165.95 95.37 0.59 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.023 -0.535 . . . . 2.8599999999999999 109.708 176.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.57 -98.62 1.41 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.051 -0.595 . . . . 1.6799999999999999 111.818 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 85.7 Cg_exo -45.12 175.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 124.12 3.213 . . . . 1.6599999999999999 114.078 168.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.561 ' HB2' ' O ' ' A' ' 75' ' ' HIS . 41.3 p90 -68.46 171.93 6.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.152 -0.931 . . . . 3.3999999999999999 112.054 -169.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 39' ' ' ALA . 57.7 ttp180 -113.1 133.32 55.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.839 -0.618 . . . . 3.1000000000000001 111.117 -168.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.2 mt -119.66 129.97 74.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.224 -0.898 . . . . 1.8 110.387 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . . . -118.09 144.42 45.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.012 -0.54 . . . . 0.85999999999999999 111.169 -177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.0 tp -133.41 134.91 44.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.248 -0.433 . . . . 1.0600000000000001 110.814 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.34 167.48 24.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.8 -0.636 . . . . 1.1399999999999999 109.4 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -134.04 148.71 51.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.339 . . . . 4.0199999999999996 111.639 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -132.1 149.94 52.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.834 -0.621 . . . . 4.6100000000000003 110.014 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -120.49 139.97 52.11 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.212 -0.292 . . . . 3.3799999999999999 110.212 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 67' ' ' PHE . 49.6 mt-10 -122.48 140.0 53.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.754 0.311 . . . . 5.0499999999999998 111.793 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.17 -177.79 10.65 Favored Glycine 0 C--N 1.331 0.268 0 CA-C-N 115.795 -0.638 . . . . 4.3700000000000001 113.822 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -70.07 138.52 37.03 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.884 2.389 . . . . 6.6799999999999997 111.357 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.03 159.83 41.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.299 -0.41 . . . . 8.1699999999999999 110.985 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -93.95 113.0 24.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.145 -0.48 . . . . 10.039999999999999 110.162 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -60.64 -42.54 97.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.323 -0.399 . . . . 11.609999999999999 111.105 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.0 m -62.82 138.69 58.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.242 -0.435 . . . . 9.7899999999999991 110.481 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.68 61.15 4.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.229 0.538 . . . . 8.5099999999999998 110.221 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.24 156.11 20.35 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.887 -0.673 . . . . 7.5599999999999996 112.134 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -70.11 -26.17 63.84 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.683 0.253 . . . . 10.0 111.683 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -89.92 0.01 57.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.912 0.387 . . . . 10.35 110.407 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.45 142.43 37.14 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.773 -0.649 . . . . 5.3399999999999999 111.865 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.4 m -118.36 129.98 55.74 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.025 0.44 . . . . 5.3200000000000003 110.212 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -129.44 136.15 49.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.029 -0.532 . . . . 5.6100000000000003 110.18 -176.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.574 ' HB2' ' O ' ' A' ' 53' ' ' GLU . 93.8 m-85 -122.46 125.29 45.51 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.896 -0.779 . . . . 3.7799999999999998 108.896 174.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -156.41 160.41 39.59 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.077 0.465 . . . . 2.4500000000000002 110.907 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 94' ' ' ASN . 27.6 mtm180 -140.71 125.27 10.75 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 115.355 -0.839 . . . . 3.2400000000000002 110.565 175.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.63 140.18 11.65 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.848 2.365 . . . . 1.1899999999999999 112.096 174.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -106.06 120.09 40.88 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.858 -0.793 . . . . 2.1899999999999999 108.858 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.0 tp -128.03 106.67 9.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.848 0.356 . . . . 1.1399999999999999 110.363 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 46.5 mt-10 -101.61 128.68 47.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.144 -0.48 . . . . 2.1800000000000002 110.284 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.8 t -120.03 120.01 61.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.306 -0.627 . . . . 1.5600000000000001 109.306 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.561 ' O ' ' HB2' ' A' ' 44' ' ' TRP . 80.1 t60 -119.59 118.22 30.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.118 0.485 . . . . 3.4399999999999999 110.253 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -117.62 138.54 51.89 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.186 -0.916 . . . . 4.7999999999999998 109.9 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -130.09 149.17 51.92 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.855 -0.424 . . . . 2.9399999999999999 109.855 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -137.11 132.68 34.42 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.614 -0.513 . . . . 3.8999999999999999 109.614 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.3 mt -107.54 118.63 37.24 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.416 -0.356 . . . . 4.4800000000000004 110.49 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -96.54 174.62 6.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.23 -0.441 . . . . 6.1900000000000004 110.813 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -69.85 -19.45 63.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.012 -0.54 . . . . 5.4500000000000002 110.284 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -74.33 158.41 34.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.747 -0.661 . . . . 5.2699999999999996 110.303 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -60.13 -40.4 89.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.421 -0.354 . . . . 6.3300000000000001 111.863 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -74.18 149.35 40.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.222 0.534 . . . . 7.4800000000000004 111.47 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.2 p -114.96 150.17 36.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.841 -0.618 . . . . 2.5499999999999998 110.552 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -135.84 160.06 39.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.318 -0.401 . . . . 5.2999999999999998 110.357 -175.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.97 176.88 41.87 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.393 -0.908 . . . . 1.3500000000000001 112.587 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.12 125.21 27.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.785 -0.45 . . . . 2.29 109.785 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.9 m -120.11 129.95 54.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.157 0.503 . . . . 1.54 110.183 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -131.59 146.76 18.24 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.556 -0.831 . . . . 1.1699999999999999 112.577 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -123.92 122.2 4.75 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.908 -0.877 . . . . 1.1899999999999999 110.908 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -111.54 122.22 47.24 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.234 -0.654 . . . . 3.75 109.234 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.614 ' HB2' ' HB2' ' A' ' 112' ' ' ARG . 97.8 mtt180 -134.97 137.36 42.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.914 0.388 . . . . 2.75 110.907 -173.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.593 ' O ' ' HG2' ' A' ' 69' ' ' ARG . 92.6 m-20 -114.51 130.13 56.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.071 -0.513 . . . . 1.8200000000000001 109.972 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.532 ' HA ' ' HG2' ' A' ' 69' ' ' ARG . 58.8 t80 -106.93 119.94 40.7 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.848 -0.427 . . . . 3.1400000000000001 109.848 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.95 178.59 51.75 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.55 -0.833 . . . . 2.79 112.243 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.732 ' O ' ' HB ' ' A' ' 107' ' ' THR . 58.3 t80 -139.96 146.41 39.1 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.333 -0.618 . . . . 7.6200000000000001 109.333 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.406 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 5.7 p80 -139.97 152.3 46.21 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.208 -0.293 . . . . 7.0800000000000001 110.208 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -101.63 120.09 39.79 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.733 -0.469 . . . . 10.16 109.733 176.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 88.2 t -70.13 -40.85 78.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.43 -0.805 . . . . 9.8100000000000005 110.696 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -70.07 -39.9 75.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.749 -0.659 . . . . 12.220000000000001 111.65 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -109.97 109.4 59.17 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.17 -0.468 . . . . 10.48 110.996 -174.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.89 149.92 66.75 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.791 2.328 . . . . 9.0999999999999996 112.732 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.2 150.86 5.94 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.049 -0.596 . . . . 6.46 112.145 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -90.05 1.94 55.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.699 0.285 . . . . 7.6699999999999999 111.029 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -60.19 -39.94 88.27 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.281 0.562 . . . . 4.1399999999999997 109.897 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.732 ' HB ' ' O ' ' A' ' 97' ' ' TYR . 32.9 p -105.66 145.96 30.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.488 -0.778 . . . . 3.2999999999999998 109.991 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.41 148.56 47.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.583 0.23 . . . . 1.76 110.676 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -132.58 135.74 46.11 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.368 0.604 . . . . 2.5499999999999998 111.077 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.487 ' HB2' ' HB3' ' A' ' 95' ' ' TYR . 89.7 mtp -136.55 141.45 43.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.784 -1.191 . . . . 1.77 107.784 175.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 16.2 mm100 -108.95 139.97 43.08 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.022 -0.671 . . . . 1.97 111.546 -172.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.614 ' HB2' ' HB2' ' A' ' 93' ' ' ARG . 76.2 mtt180 -120.37 128.95 53.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.004 -0.544 . . . . 3.8500000000000001 109.864 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -127.72 133.03 49.54 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.004 -0.544 . . . . 2.2799999999999998 110.849 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -121.55 125.22 46.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.958 -0.565 . . . . 2.1400000000000001 109.947 171.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 86.6 mt -120.08 124.0 71.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.978 -0.556 . . . . 1.55 109.612 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -147.05 105.24 3.86 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.617 0.246 . . . . 1.1899999999999999 111.121 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.98 139.95 13.97 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.38 2.053 . . . . 1.3700000000000001 110.922 175.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.51 137.19 33.48 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.285 -0.416 . . . . 2.3500000000000001 109.916 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -130.88 129.79 42.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.445 -0.343 . . . . 4.54 110.493 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -94.28 113.87 25.85 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.17 -0.678 . . . . 3.04 109.17 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.6 t -120.08 119.99 61.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.778 -0.453 . . . . 4.2699999999999996 109.778 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 128' ' ' ARG . 36.4 mtmm -126.84 118.78 25.31 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.745 -0.465 . . . . 6.04 109.745 177.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.3 tp -90.15 -79.01 0.35 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 4.5899999999999999 110.79 -174.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 47.4 p -142.67 171.77 13.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.371 -0.377 . . . . 3.6899999999999999 110.662 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 62.37 26.27 15.69 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 124.057 0.848 . . . . 5.1699999999999999 112.071 170.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 57.82 33.54 23.34 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.046 -0.525 . . . . 3.71 110.692 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.1 mt -98.99 130.0 45.31 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.058 -0.519 . . . . 2.0499999999999998 109.983 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.522 ' HA ' ' HG2' ' A' ' 122' ' ' LYS . 47.9 ttt180 -105.07 127.83 53.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.207 0.527 . . . . 4.2400000000000002 111.02 -174.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.451 ' CE2' HD13 ' A' ' 158' ' ' LEU . 96.7 m-85 -108.18 129.09 55.2 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.521 -0.918 . . . . 3.5499999999999998 108.521 174.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -111.65 113.9 26.58 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.756 -0.831 . . . . 2.1099999999999999 108.756 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -123.1 137.72 11.26 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.204 -0.998 . . . . 1.1799999999999999 111.908 -175.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.526 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 8.8 p90 -134.45 140.91 46.58 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.115 0.484 . . . . 4.2999999999999998 110.315 177.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 64.3 tp -99.96 111.14 23.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.596 -0.729 . . . . 2.2400000000000002 109.258 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.8 m -100.83 118.0 36.04 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.306 0.574 . . . . 1.6899999999999999 111.121 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 87.1 mtp -101.09 125.39 47.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.195 -0.911 . . . . 2.2400000000000002 109.26 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 95.5 m-85 -109.94 127.59 54.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.93 0.395 . . . . 3.5600000000000001 110.988 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -129.9 144.62 51.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.787 -0.642 . . . . 1.6699999999999999 109.986 174.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.444 ' H ' HD22 ' A' ' 142' ' ' LEU . 46.9 p90 -148.01 165.52 30.49 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.063 -0.717 . . . . 3.23 109.063 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 110' ' ' MET . . . 64.42 170.09 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.673 0.608 . . . . 1.24 110.733 -174.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -76.05 -20.1 58.05 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.457 0.646 . . . . 2.4700000000000002 109.572 173.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -66.65 -49.53 65.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.022 -0.99 . . . . 2.4100000000000001 111.997 -175.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.464 ' HA ' ' OG1' ' A' ' 145' ' ' THR . 10.0 mp -68.38 -30.32 69.22 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.888 0.375 . . . . 1.8300000000000001 111.458 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -60.55 -40.21 90.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.394 0.616 . . . . 2.0 109.884 171.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 57.6 m -69.97 -40.38 75.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.956 -1.02 . . . . 2.0499999999999998 111.366 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.464 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 40.8 p -69.99 -36.57 75.26 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.959 0.409 . . . . 1.5900000000000001 110.632 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 62.19 -114.66 7.02 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.484 -0.78 . . . . 1.52 113.044 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -70.07 -31.3 68.82 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.549 0.34 . . . . 5.9400000000000004 111.149 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.9 -48.93 79.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.318 0.488 . . . . 1.8300000000000001 112.318 -172.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.415 ' OD2' ' HG3' ' A' ' 180' ' ' MET . 17.5 t70 -138.98 111.72 7.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.132 0.491 . . . . 2.6400000000000001 110.738 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.3 t -160.01 149.66 18.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.341 -0.845 . . . . 2.02 109.102 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.499 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 67.5 ttt180 -79.55 125.24 29.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.778 0.323 . . . . 3.6699999999999999 110.26 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.461 ' CG1' HD11 ' A' ' 133' ' ' LEU . 62.1 t -119.92 120.1 62.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.928 -0.578 . . . . 1.6399999999999999 110.082 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -140.06 141.19 36.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.183 -0.303 . . . . 2.5600000000000001 110.183 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 21.4 m -115.24 128.39 56.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.683 0.278 . . . . 1.3899999999999999 110.766 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.526 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 83.3 tt0 -108.68 130.7 55.34 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.786 -0.45 . . . . 2.04 109.786 176.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 44.0 m -118.1 121.11 39.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.283 -0.417 . . . . 1.5600000000000001 110.18 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -111.02 118.12 4.79 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.938 -0.649 . . . . 1.04 111.903 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.451 HD13 ' CE2' ' A' ' 129' ' ' PHE . 41.5 tp -95.37 128.36 42.16 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.889 0.376 . . . . 2.27 110.68 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -101.8 108.98 20.64 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.276 -0.638 . . . . 2.4100000000000001 109.276 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -120.2 126.67 51.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.459 -0.791 . . . . 4.5700000000000003 109.244 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.1 p -99.21 88.81 4.03 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.279 -0.569 . . . . 1.46 110.225 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -60.24 -49.67 76.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.412 -0.813 . . . . 2.6299999999999999 111.292 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.503 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.0 m-20 -103.01 15.82 28.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.456 -0.338 . . . . 2.4100000000000001 110.824 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 72.52 -53.83 0.69 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.888 0.743 . . . . 2.5800000000000001 111.617 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.6 p -74.38 -18.77 60.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.372 -0.377 . . . . 2.2999999999999998 111.496 -177.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 163' ' ' ASN . 35.7 m -110.6 136.93 45.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.373 -0.376 . . . . 1.71 110.3 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.57 123.62 48.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.062 -0.517 . . . . 1.47 109.788 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 35.7 mt -102.48 127.43 49.53 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.265 -0.643 . . . . 1.6599999999999999 109.265 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -99.99 108.83 21.13 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.723 -0.473 . . . . 3.2999999999999998 109.723 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 195' ' ' ARG . 50.2 t -109.98 119.7 59.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.32 -0.622 . . . . 1.3 109.32 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.448 ' HB2' ' HD3' ' A' ' 195' ' ' ARG . 15.5 m120 -109.81 131.55 54.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.012 0.434 . . . . 2.2200000000000002 110.879 -172.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -119.88 139.6 52.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.88 -0.6 . . . . 4.6100000000000003 109.683 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -106.37 122.69 46.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.672 0.272 . . . . 3.98 110.387 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 55.7 tp -108.63 114.92 29.13 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.172 -0.467 . . . . 2.3799999999999999 109.963 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -108.59 138.52 44.77 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.013 -0.54 . . . . 3.3100000000000001 110.007 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -105.47 127.83 53.22 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.626 -0.509 . . . . 6.5300000000000002 109.626 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -70.13 153.17 51.8 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.086 -0.578 . . . . 5.0599999999999996 112.519 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.9 139.96 51.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.576 0.227 . . . . 7.3899999999999997 110.611 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -96.54 5.44 50.77 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.162 -0.472 . . . . 9.0700000000000003 110.727 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.415 ' HG3' ' OD2' ' A' ' 149' ' ' ASP . 98.1 mmm -68.66 -40.11 80.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.999 -0.546 . . . . 10.869999999999999 110.104 176.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -149.14 166.59 28.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.397 -0.82 . . . . 10.449999999999999 108.946 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -67.65 129.6 40.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.035 0.445 . . . . 13.06 111.29 -173.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 59.9 m -85.76 117.47 24.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.874 -0.603 . . . . 12.609999999999999 111.516 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -70.21 -39.9 74.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.001 -0.545 . . . . 15.19 111.884 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -76.79 -28.97 55.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.961 0.41 . . . . 13.18 111.406 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.442 ' HA ' ' OG ' ' A' ' 190' ' ' SER . 36.0 m-80 -103.3 120.47 40.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.099 -0.501 . . . . 12.73 111.188 -173.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -131.64 -140.69 4.6 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.424 -0.67 . . . . 9.9800000000000004 111.424 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -69.77 -40.21 76.2 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.493 -0.558 . . . . 10.699999999999999 109.493 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -140.0 132.03 27.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.334 -0.848 . . . . 10.5 109.376 173.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.442 ' OG ' ' HA ' ' A' ' 186' ' ' ASN . 70.6 m -119.36 156.78 29.44 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.897 0.379 . . . . 6.6399999999999997 110.321 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.1 t -128.26 161.48 29.26 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.949 0.404 . . . . 4.9800000000000004 110.293 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -128.29 144.11 51.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.807 -0.633 . . . . 7.0999999999999996 109.72 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.89 146.54 23.67 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.42 -0.355 . . . . 4.4000000000000004 110.044 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 88.0 mt -100.62 120.04 49.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.986 0.422 . . . . 2.21 110.384 -176.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.448 ' HD3' ' HB2' ' A' ' 171' ' ' ASN . 31.4 ttt180 -98.93 119.37 37.59 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.692 -0.686 . . . . 3.54 110.754 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -119.6 123.46 43.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.916 0.389 . . . . 1.6699999999999999 110.72 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -130.86 118.75 21.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.615 -0.721 . . . . 5.8300000000000001 109.751 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 1.3 pt? -136.83 126.82 15.9 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.753 -0.379 . . . . 2.5899999999999999 111.103 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 198' ' ' LEU . 27.7 Cg_endo -94.49 117.44 0.25 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.965 2.443 . . . . 1.77 112.499 175.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 50.8 tp -104.31 116.41 32.1 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.19 -0.67 . . . . 2.2599999999999998 109.19 176.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 96.7 m -99.58 120.07 39.07 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.167 0.508 . . . . 1.99 110.881 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 89.7 mt -114.56 80.38 1.39 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.948 -0.76 . . . . 2.3100000000000001 108.948 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 72.59 -112.85 4.15 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.151 -0.931 . . . . 1.51 112.228 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -100.09 10.35 41.41 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.11 0.481 . . . . 2.5699999999999998 110.948 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -134.42 117.71 16.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.195 -0.457 . . . . 2.6600000000000001 109.864 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 74.3 m -102.66 134.19 46.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.197 0.522 . . . . 1.6200000000000001 111.227 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 59.1 t -115.45 122.67 69.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.575 -0.739 . . . . 1.3799999999999999 109.239 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 23.5 m -118.3 94.28 46.68 Favored Pre-proline 0 C--N 1.318 -0.767 0 C-N-CA 121.031 -0.268 . . . . 1.1799999999999999 111.37 -176.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 15.6 Cg_exo -69.41 139.97 42.8 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.902 2.401 . . . . 1.01 111.795 173.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.63 ' OH ' ' HB2' ' A' ' 258' ' ' GLU . 64.9 t80 -137.68 140.23 40.68 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.074 -0.512 . . . . 4.5 110.408 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 28.7 p -135.34 147.73 49.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.268 -0.424 . . . . 1.8899999999999999 110.866 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -102.42 -0.03 33.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.437 0.637 . . . . 4.7999999999999998 109.995 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 48.5 mm -110.05 130.01 64.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.452 -0.795 . . . . 4.5700000000000003 109.505 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -73.37 129.36 12.32 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.779 -0.725 . . . . 4.9800000000000004 112.743 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.31 -40.35 89.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.899 0.38 . . . . 8.1099999999999994 111.0 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -70.06 -20.5 63.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 7.6500000000000004 111.603 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -69.03 -39.36 79.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.053 -0.521 . . . . 10.529999999999999 111.887 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -115.99 132.89 56.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.811 0.339 . . . . 11.56 111.175 -176.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 17.0 m -100.37 132.06 45.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.11 -0.495 . . . . 10.06 111.101 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -110.65 109.64 19.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.078 0.466 . . . . 11.92 109.857 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -70.48 -39.84 73.98 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.404 -0.817 . . . . 14.01 112.022 -176.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -89.9 138.9 31.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.991 0.424 . . . . 14.529999999999999 110.344 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -105.96 -18.41 14.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.931 -0.577 . . . . 16.609999999999999 110.48 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -60.13 -49.01 79.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.269 0.557 . . . . 15.460000000000001 110.092 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -154.62 161.02 41.78 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.361 -0.977 . . . . 15.67 108.361 174.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -145.69 179.6 7.33 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.742 -0.383 . . . . 14.5 111.325 -176.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 8.3 tp -60.2 -40.03 82.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.212 -0.449 . . . . 15.15 112.106 -174.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -67.66 -31.81 72.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.857 0.36 . . . . 14.73 110.695 -174.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -59.97 -39.6 86.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.156 -0.475 . . . . 16.379999999999999 111.043 -176.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -68.65 129.65 40.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.399 -0.364 . . . . 12.779999999999999 110.949 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 164.8 -171.17 40.16 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.346 -0.701 . . . . 11.1 111.346 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -92.67 -13.87 28.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.448 0.642 . . . . 12.26 109.783 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.595 ' H ' ' HD2' ' A' ' 236' ' ' ARG . 97.0 m-20 56.62 37.29 28.7 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.418 -1.264 . . . . 9.9900000000000002 112.502 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -109.48 97.69 7.22 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.741 -0.466 . . . . 10.43 109.741 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 55.7 39.91 30.85 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.339 -0.846 . . . . 6.29 111.666 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.595 ' HD2' ' H ' ' A' ' 233' ' ' ASP . 83.6 mtp180 -69.85 -39.98 76.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.594 -0.73 . . . . 8.1500000000000004 110.798 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.3 m -115.09 154.32 16.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.354 -0.839 . . . . 2.3999999999999999 109.434 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -78.14 137.61 20.1 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.418 -0.896 . . . . 1.27 111.283 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 94.5 mt -134.45 124.47 25.67 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.759 -0.46 . . . . 1.97 109.759 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.509 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 64.5 t80 -118.52 118.4 31.59 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.158 -0.682 . . . . 3.54 109.158 175.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.422 ' HB2' ' HB3' ' A' ' 253' ' ' LEU . 92.9 m-85 -104.79 129.72 53.01 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.127 -0.488 . . . . 2.6400000000000001 110.379 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -114.45 143.34 17.99 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 115.576 -0.738 . . . . 1.3500000000000001 111.533 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -107.28 112.35 25.16 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.484 -0.562 . . . . 4.3600000000000003 109.484 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -105.42 28.4 7.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.337 -0.847 . . . . 4.29 110.31 -172.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -59.89 -40.12 87.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.013 -0.994 . . . . 6.6900000000000004 110.741 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . 0.44 ' OE1' ' HB3' ' A' ' 249' ' ' LEU . 62.4 tt0 -133.05 133.79 43.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.948 -0.569 . . . . 6.3700000000000001 110.358 -176.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -63.38 -39.86 95.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.788 -0.642 . . . . 5.8300000000000001 110.595 176.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -68.19 -50.07 42.02 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.539 -0.839 . . . . 2.6600000000000001 112.535 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.44 ' HB3' ' OE1' ' A' ' 246' ' ' GLN . 59.1 tp -118.51 124.15 46.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.94 0.4 . . . . 2.9700000000000002 111.046 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 46.9 p -126.78 148.21 49.94 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.91 -0.587 . . . . 2.1699999999999999 110.082 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 57.7 t -116.43 137.67 49.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.434 -0.348 . . . . 1.79 110.3 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 43.4 m -111.76 139.76 46.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.327 -0.397 . . . . 1.6299999999999999 110.628 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.427 ' HG ' ' HG3' ' A' ' 254' ' ' GLU . 59.3 tp -132.65 143.42 49.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.544 -0.298 . . . . 2.96 111.31 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.427 ' HG3' ' HG ' ' A' ' 253' ' ' LEU . 43.9 mt-10 60.34 -159.99 0.3 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.886 0.741 . . . . 4.0800000000000001 111.108 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -144.47 137.05 26.66 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.05 0.453 . . . . 4.8399999999999999 111.529 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.505 ' HB1' ' HB2' ' A' ' 210' ' ' TYR . . . -123.67 44.25 2.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.637 -0.71 . . . . 3.5800000000000001 109.221 172.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -120.02 140.59 50.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.558 -0.747 . . . . 6.7699999999999996 110.669 -175.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.63 ' HB2' ' OH ' ' A' ' 210' ' ' TYR . 82.0 tt0 -60.12 -49.94 75.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.167 -0.924 . . . . 8.5399999999999991 110.862 175.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 55.4 p-90 -140.78 159.78 41.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.009 -0.996 . . . . 11.9 109.973 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -98.29 147.46 24.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.179 -0.464 . . . . 10.57 110.383 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -74.6 53.23 0.54 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.335 0.588 . . . . 11.41 110.792 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -136.45 148.16 47.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.762 -0.653 . . . . 11.98 109.738 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.2 -25.32 63.36 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.179 -0.464 . . . . 12.460000000000001 110.971 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -89.92 70.01 7.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.14 0.495 . . . . 13.779999999999999 109.737 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -165.27 43.29 0.29 Allowed Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.249 -0.887 . . . . 11.07 111.031 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -59.89 -40.1 87.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.186 0.517 . . . . 12.59 110.5 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . 0.408 ' HB3' ' HG3' ' A' ' 269' ' ' LYS . 24.4 m -88.87 -66.29 0.93 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.665 -0.698 . . . . 10.92 111.182 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 50.01 39.7 19.53 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.719 0.771 . . . . 12.42 111.113 -173.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.408 ' HG3' ' HB3' ' A' ' 267' ' ' SER . 94.8 mttt -84.43 -39.96 18.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.377 -0.829 . . . . 11.59 110.528 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -81.19 148.86 29.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.735 -0.666 . . . . 8.8300000000000001 110.278 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -84.34 145.33 28.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.186 -0.461 . . . . 7.0199999999999996 111.209 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . 0.548 ' HB3' ' OE2' ' A' ' 18' ' ' GLU . 93.8 m-85 -128.04 163.01 25.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.749 -0.659 . . . . 6.5999999999999996 109.999 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -140.15 125.6 19.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.503 0.192 . . . . 1.9399999999999999 110.516 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -138.4 158.62 24.99 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 119.529 -1.32 . . . . 1.4199999999999999 112.489 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.19 127.17 68.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.17 -0.678 . . . . 1.8100000000000001 109.17 176.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -129.68 157.23 21.74 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.757 -0.735 . . . . 1.3 111.638 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 6.2 p -119.96 121.31 65.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.116 0.484 . . . . 1.8300000000000001 110.344 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -122.21 123.71 42.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.895 -0.593 . . . . 2.3100000000000001 110.517 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -118.08 130.03 55.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.745 -0.465 . . . . 4.75 109.745 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 8.9 p -117.5 129.44 55.81 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.953 0.406 . . . . 1.6699999999999999 110.498 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 61.4 t80 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.395 -0.812 . . . . 3.6899999999999999 109.572 -176.986 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.888 0.375 . . . . 11.85 110.467 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.427 ' HB2' ' ND2' ' A' ' 5' ' ' ASN . 45.0 mt-10 -113.03 138.34 50.04 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.099 -0.5 . . . . 10.35 110.246 -178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -60.2 -36.53 77.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.527 -0.76 . . . . 9.3100000000000005 109.809 176.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -60.13 -39.42 86.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.897 -1.047 . . . . 8.8399999999999999 111.324 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.427 ' ND2' ' HB2' ' A' ' 2' ' ' GLU . 94.1 m-20 -69.4 -40.05 77.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.402 -0.363 . . . . 7.0099999999999998 111.091 -178.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -69.54 -47.24 64.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.366 -0.379 . . . . 3.6099999999999999 110.811 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 41' ' ' ASN . 70.0 m95 -88.59 107.35 18.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.131 0.491 . . . . 3.3300000000000001 111.171 -176.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -94.87 130.44 41.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.619 -0.719 . . . . 3.2000000000000002 110.592 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.34 139.48 52.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.165 -0.925 . . . . 2.4900000000000002 110.244 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 15.6 m120 -122.67 132.03 54.07 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.94 -0.573 . . . . 2.1299999999999999 110.105 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.0 mt -120.06 119.83 61.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.021 -0.733 . . . . 1.6000000000000001 109.021 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.437 ' HA3' ' CZ ' ' A' ' 36' ' ' TYR . . . -115.77 134.43 11.49 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.103 -1.046 . . . . 0.88 112.453 -176.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -121.78 134.41 54.92 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.91 0.386 . . . . 1.0800000000000001 110.147 175.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 91.0 mtp -140.66 157.09 45.95 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.268 -0.641 . . . . 2.3300000000000001 109.268 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -100.19 121.98 42.3 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.834 -0.346 . . . . 2.6099999999999999 110.99 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -112.92 143.09 44.79 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.751 -0.462 . . . . 5.0899999999999999 109.751 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 87.2 mt -103.83 127.47 57.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.908 0.385 . . . . 5.3300000000000001 111.275 -171.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.458 ' OE1' HG13 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -120.45 129.93 54.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.815 -0.63 . . . . 8.2799999999999994 109.626 179.347 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -165.23 35.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.399 . . . . 9.6999999999999993 110.688 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.458 HG13 ' OE1' ' A' ' 18' ' ' GLU . 27.8 m -69.3 -9.33 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.446 -0.343 . . . . 11.09 111.823 -177.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.16 -39.81 87.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 13.1 110.632 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -87.05 -168.78 45.22 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.826 -0.702 . . . . 11.94 112.275 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -69.17 -29.97 68.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.869 0.366 . . . . 15.18 111.058 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.26 2.29 74.13 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.8 -0.714 . . . . 12.0 112.538 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.9 -39.94 96.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.198 0.523 . . . . 12.82 110.401 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -114.61 142.01 47.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.517 -0.765 . . . . 10.81 109.118 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 53.0 ttm -102.37 120.07 39.88 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.005 0.431 . . . . 10.050000000000001 110.457 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -72.4 144.79 48.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.843 -0.617 . . . . 8.0600000000000005 110.259 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.31 26.2 5.79 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.086 -0.578 . . . . 5.5800000000000001 112.857 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.9 tp -99.75 119.9 38.87 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.334 -0.617 . . . . 5.5599999999999996 109.334 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.82 144.3 51.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.133 0.492 . . . . 3.0499999999999998 111.492 -175.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 41.1 mt-10 -97.42 137.72 21.13 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.524 -0.762 . . . . 3.48 110.083 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 32' ' ' GLU . 24.0 Cg_exo -63.9 134.0 41.39 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 121.914 1.743 . . . . 1.8600000000000001 111.132 173.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 28.3 t -124.59 142.4 51.38 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.603 -0.888 . . . . 1.97 108.603 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 62.5 t -130.01 133.61 64.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.893 0.378 . . . . 1.71 111.002 -174.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.437 ' CZ ' ' HA3' ' A' ' 12' ' ' GLY . 53.8 p90 -130.22 151.82 50.32 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.675 -0.491 . . . . 4.0700000000000003 109.675 175.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.563 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 93.2 m-85 -119.55 139.95 51.31 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.517 -0.31 . . . . 2.8599999999999999 111.051 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 18.5 m-80 -129.65 141.37 50.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.801 -0.636 . . . . 1.8899999999999999 109.995 174.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.11 142.67 38.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.68 -0.236 . . . . 1.0800000000000001 110.439 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 45' ' ' ARG . . . -159.61 139.21 11.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.197 0.443 . . . . 1.3899999999999999 112.197 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.663 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 34.3 t30 -167.68 94.14 0.41 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.346 -0.843 . . . . 2.8599999999999999 109.186 171.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.92 -91.89 1.73 Allowed Glycine 0 N--CA 1.454 -0.144 0 N-CA-C 111.276 -0.73 . . . . 1.6799999999999999 111.276 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.663 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 72.6 Cg_exo -50.51 173.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.331 2.687 . . . . 1.6599999999999999 113.06 167.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.519 ' CD1' HG13 ' A' ' 74' ' ' VAL . 48.9 p90 -68.4 176.65 2.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.737 -0.665 . . . . 3.3999999999999999 111.951 -170.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 17.1 ttm180 -112.83 129.31 56.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.515 -0.766 . . . . 3.1000000000000001 110.069 -173.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 38' ' ' ASN . 45.6 pt -110.92 143.56 20.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.271 -0.422 . . . . 1.8 110.939 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 72' ' ' LEU . . . -118.52 127.12 53.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.746 -0.661 . . . . 0.85999999999999999 110.352 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.7 tp -119.95 128.75 53.87 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.889 0.376 . . . . 1.0600000000000001 111.176 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.53 157.1 42.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.589 -0.732 . . . . 1.1399999999999999 109.423 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -120.09 140.0 51.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.083 0.468 . . . . 4.0199999999999996 111.141 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -112.14 133.28 54.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.657 -0.701 . . . . 4.6100000000000003 111.289 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -122.56 127.04 48.95 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.38 -0.6 . . . . 3.3799999999999999 109.38 174.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.627 ' HB2' ' OH ' ' A' ' 95' ' ' TYR . 39.0 tt0 -67.44 -39.94 85.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.238 0.542 . . . . 5.0499999999999998 110.021 178.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -126.69 79.98 0.37 Allowed Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 111.067 -0.813 . . . . 4.3700000000000001 111.067 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.83 149.96 80.36 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.271 2.648 . . . . 6.6799999999999997 111.968 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 58' ' ' TYR . 48.7 t -128.71 129.93 68.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.397 -0.365 . . . . 8.1699999999999999 110.067 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -59.86 -40.02 87.19 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.108 -0.496 . . . . 10.039999999999999 110.854 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.458 ' H ' HG12 ' A' ' 56' ' ' VAL . 98.3 m-85 -70.16 138.96 52.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.897 -0.592 . . . . 11.609999999999999 110.097 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.5 t -119.24 133.48 55.73 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.117 -0.492 . . . . 9.7899999999999991 109.839 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 60.86 40.05 16.22 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 123.657 0.598 . . . . 8.5099999999999998 110.928 -177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.69 -171.84 43.84 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.477 -0.783 . . . . 7.5599999999999996 111.602 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -86.78 118.55 26.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.882 0.372 . . . . 10.0 110.455 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -141.15 128.08 20.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.063 -0.517 . . . . 10.35 110.123 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -85.61 -38.01 9.16 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.023 -0.608 . . . . 5.3399999999999999 113.019 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 63.6 p -111.02 128.76 55.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.75 0.31 . . . . 5.3200000000000003 110.723 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -119.31 128.47 54.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.287 0.565 . . . . 5.6100000000000003 111.517 -176.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -139.99 137.43 34.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.205 -0.907 . . . . 3.7799999999999998 109.309 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -159.96 168.38 25.82 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.433 -0.349 . . . . 2.4500000000000002 110.518 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.516 ' HD2' ' HB3' ' A' ' 93' ' ' ARG . 58.6 ttp85 -142.43 123.73 8.59 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.817 -0.629 . . . . 3.2400000000000002 110.267 169.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.631 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 72.9 Cg_endo -80.07 139.98 13.85 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.14 1.893 . . . . 1.1899999999999999 110.54 167.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.505 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 33.5 tt0 -124.15 113.87 18.92 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.227 0.537 . . . . 2.1899999999999999 110.077 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 40.8 tp -120.21 119.73 34.08 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.172 -0.922 . . . . 1.1399999999999999 110.209 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 34.2 mt-10 -104.21 147.03 27.93 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.289 0.566 . . . . 2.1800000000000002 111.08 174.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.519 HG13 ' CD1' ' A' ' 44' ' ' TRP . 63.8 t -113.41 120.08 62.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.95 -1.023 . . . . 1.5600000000000001 108.83 174.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.576 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 93.4 m-70 -122.27 127.19 49.6 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.88 0.371 . . . . 3.4399999999999999 110.28 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.439 ' HB3' ' HB3' ' A' ' 88' ' ' LEU . 84.5 t80 -139.94 139.09 36.07 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.114 -0.493 . . . . 4.7999999999999998 110.43 -178.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -99.17 119.87 38.57 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.587 -0.523 . . . . 2.9399999999999999 109.587 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -100.02 120.03 39.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.289 -0.414 . . . . 3.8999999999999999 109.963 -174.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.9 tp -116.51 119.92 37.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.267 -0.424 . . . . 4.4800000000000004 112.077 -172.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -119.54 147.13 44.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.908 -0.587 . . . . 6.1900000000000004 110.169 173.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -89.85 1.21 56.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.229 -0.441 . . . . 5.4500000000000002 111.335 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -96.61 26.94 4.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.117 0.484 . . . . 5.2699999999999996 110.279 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 60.64 40.07 16.97 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.101 -0.954 . . . . 6.3300000000000001 112.279 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -108.91 129.94 55.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.062 -0.517 . . . . 7.4800000000000004 109.891 171.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.514 ' HB3' ' CD1' ' A' ' 119' ' ' TRP . 22.7 m -115.38 117.08 29.42 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.157 -0.474 . . . . 2.5499999999999998 110.651 -178.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -135.64 159.53 41.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.135 -0.484 . . . . 5.2999999999999998 110.257 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -141.0 -178.52 17.4 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.983 -1.247 . . . . 1.3500000000000001 109.983 174.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 75' ' ' HIS . 64.7 tp -140.18 121.78 15.24 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 117.515 0.657 . . . . 2.29 110.953 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.428 HG23 ' CE1' ' A' ' 75' ' ' HIS . 92.9 m -120.08 116.61 26.05 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.689 -0.687 . . . . 1.54 109.595 169.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 73' ' ' GLU . . . -125.99 154.63 18.88 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.837 -0.905 . . . . 1.1699999999999999 110.837 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.81 124.3 2.23 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.669 -0.777 . . . . 1.1899999999999999 112.102 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -111.35 121.77 46.09 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.843 -0.799 . . . . 3.75 108.843 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.516 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 34.8 mtm180 -142.59 126.87 17.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.392 -0.367 . . . . 2.75 111.208 -172.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.631 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 57.6 t30 -122.16 130.01 52.83 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.445 -0.576 . . . . 1.8200000000000001 109.445 174.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.627 ' OH ' ' HB2' ' A' ' 53' ' ' GLU . 3.3 t80 -121.95 115.95 23.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.804 -0.18 . . . . 3.1400000000000001 110.955 -172.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.71 129.85 16.83 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.473 -0.87 . . . . 2.79 111.167 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -127.57 138.54 52.91 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.194 -0.298 . . . . 7.6200000000000001 110.194 -174.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -130.09 170.14 14.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 7.0800000000000001 110.595 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.4 ' HB3' ' OD1' ' A' ' 101' ' ' ASP . 97.7 m-85 -119.87 139.96 51.58 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.878 -0.786 . . . . 10.16 108.878 174.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.9 t -70.1 -30.52 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.405 . . . . 9.8100000000000005 110.952 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' ' 99' ' ' TYR . 6.2 p-10 -69.58 -33.17 72.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.043 -0.526 . . . . 12.220000000000001 110.392 176.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -74.13 155.49 88.19 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.021 -0.536 . . . . 10.48 110.139 171.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -63.81 -13.8 39.19 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.408 2.738 . . . . 9.0999999999999996 113.853 -173.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.07 -7.49 81.54 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.622 -0.799 . . . . 6.46 112.154 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -89.87 4.12 50.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.537 0.684 . . . . 7.6699999999999999 109.372 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -79.16 170.54 16.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.687 -1.142 . . . . 4.1399999999999997 110.235 177.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.2 m -140.37 130.64 25.12 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.931 0.396 . . . . 3.2999999999999998 110.578 173.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.95 144.25 33.64 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.681 -0.859 . . . . 1.76 108.681 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.438 ' HB3' ' OD1' ' A' ' 94' ' ' ASN . 95.8 m-20 -129.06 127.0 40.65 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.87 0.367 . . . . 2.5499999999999998 110.739 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.478 ' HB3' ' HA ' ' A' ' 139' ' ' ALA . 41.8 mtm -108.59 130.03 55.31 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.043 -0.725 . . . . 1.77 109.043 175.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -102.99 137.22 41.48 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.093 -0.643 . . . . 1.97 111.241 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.505 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 53.7 mtp85 -119.98 109.97 16.14 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.978 -0.749 . . . . 3.8500000000000001 108.978 177.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -110.02 140.02 44.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.342 0.592 . . . . 2.2799999999999998 112.046 -175.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.401 ' HB2' ' NH2' ' A' ' 93' ' ' ARG . 87.0 tttt -129.03 124.42 34.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.588 -1.187 . . . . 2.1400000000000001 109.854 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 80.3 mt -140.46 120.03 12.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.471 -0.196 . . . . 1.55 110.471 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 134' ' ' SER . . . -155.38 106.24 2.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.649 -0.25 . . . . 1.1899999999999999 111.425 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.721 ' HD2' ' CD1' ' A' ' 132' ' ' TRP . 13.3 Cg_exo -71.48 88.06 0.76 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.461 2.108 . . . . 1.3700000000000001 111.045 168.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 119' ' ' TRP . 12.1 p-10 -108.5 139.38 43.34 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.211 0.449 . . . . 2.3500000000000001 112.211 -166.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.514 ' CD1' ' HB3' ' A' ' 85' ' ' SER . 7.3 t-105 176.61 -176.59 0.13 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.34 -0.845 . . . . 4.54 108.993 174.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.609 ' OD1' ' HB3' ' A' ' 128' ' ' ARG . 30.1 t70 -80.24 117.44 21.03 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.135 0.493 . . . . 3.04 111.277 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 62.4 t -107.01 120.04 57.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.019 -0.734 . . . . 4.2699999999999996 109.019 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -93.08 72.01 4.63 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.932 -0.577 . . . . 6.04 110.636 -171.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.2 tp -67.32 -40.04 85.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.753 -0.658 . . . . 4.5899999999999999 110.709 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 24.4 p -123.28 150.16 43.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.756 -0.657 . . . . 3.6899999999999999 110.03 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -69.93 -40.26 75.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.793 0.33 . . . . 5.1699999999999999 111.279 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -70.24 -40.26 74.57 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.103 -0.498 . . . . 3.71 112.212 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.0 mt -119.95 139.16 52.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.919 0.39 . . . . 2.0499999999999998 111.339 -171.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.609 ' HB3' ' OD1' ' A' ' 120' ' ' ASP . 62.0 mtt180 -103.26 139.26 38.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.013 -0.539 . . . . 4.2400000000000002 110.097 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -112.74 107.82 16.61 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.436 -0.579 . . . . 3.5499999999999998 109.436 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 2.9 t-20 -110.83 114.3 27.53 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 120.797 0.332 . . . . 2.1099999999999999 110.495 -174.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 142.52 -163.18 27.24 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.326 -0.71 . . . . 1.1799999999999999 111.326 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.721 ' CD1' ' HD2' ' A' ' 117' ' ' PRO . 47.8 t-105 -161.34 168.53 23.78 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.977 0.389 . . . . 4.2999999999999998 110.799 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 46.9 tp -100.5 119.93 39.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.741 -0.663 . . . . 2.2400000000000002 109.596 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.434 ' HB3' ' HB2' ' A' ' 116' ' ' ALA . 13.1 p -122.97 158.46 30.43 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.182 0.438 . . . . 1.6899999999999999 112.182 -172.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 75.0 mtm -118.39 136.74 53.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.047 -0.524 . . . . 2.2400000000000002 109.976 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -120.04 140.41 51.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.2 0.524 . . . . 3.5600000000000001 111.518 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -124.39 136.34 53.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.365 -0.834 . . . . 1.6699999999999999 109.503 176.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.505 ' H ' HD22 ' A' ' 142' ' ' LEU . 42.2 m-85 -128.46 146.65 50.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.155 -0.475 . . . . 3.23 110.1 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 110' ' ' MET . . . 59.99 -164.87 0.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.714 -0.675 . . . . 1.24 111.642 177.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -77.39 -31.33 54.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.033 0.444 . . . . 2.4700000000000002 110.766 172.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -60.0 -50.28 74.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.622 -0.717 . . . . 2.4100000000000001 112.328 -169.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.505 HD22 ' H ' ' A' ' 138' ' ' PHE . 8.8 mp -70.7 -29.91 66.33 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.769 -0.373 . . . . 1.8300000000000001 111.219 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -61.11 -43.61 98.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.857 0.36 . . . . 2.0 110.704 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.3 p -70.4 -31.1 68.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 2.0499999999999998 111.468 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 75.8 p -97.78 9.94 41.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.583 -0.28 . . . . 1.5900000000000001 110.542 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -60.0 -24.66 60.88 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.906 -0.588 . . . . 1.52 114.06 -172.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -69.87 -38.49 76.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.851 0.358 . . . . 5.9400000000000004 110.415 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -107.62 -55.93 2.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.451 0.537 . . . . 1.8300000000000001 112.451 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -109.2 117.41 34.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.424 0.631 . . . . 2.6400000000000001 111.963 -171.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 24.4 p -130.1 147.01 51.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.061 -0.972 . . . . 2.02 110.186 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -77.18 132.77 38.94 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.517 -0.549 . . . . 3.6699999999999999 109.517 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.99 129.57 64.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.297 -0.41 . . . . 1.6399999999999999 110.899 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -122.62 137.96 54.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.084 -0.507 . . . . 2.5600000000000001 110.397 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -133.38 101.04 5.01 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.281 -0.418 . . . . 1.3899999999999999 110.179 175.132 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -99.52 110.45 22.9 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.289 -1.004 . . . . 2.04 108.289 172.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 32.1 m -129.14 121.05 26.95 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.013 0.435 . . . . 1.5600000000000001 111.183 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 171' ' ' ASN . . . -101.12 120.1 6.76 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.896 -0.882 . . . . 1.04 110.896 174.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 92.5 mt -97.11 129.54 44.5 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.502 -0.555 . . . . 2.27 109.502 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.458 ' HG2' ' HG2' ' A' ' 169' ' ' ARG . 69.9 mt-30 -102.0 119.12 38.28 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.644 -0.422 . . . . 2.4100000000000001 110.625 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -118.81 133.11 56.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.513 -0.767 . . . . 4.5700000000000003 109.3 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.5 p -103.57 92.15 4.33 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.405 -0.518 . . . . 1.46 110.767 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -60.01 -48.96 79.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.593 -0.731 . . . . 2.6299999999999999 111.204 -176.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.456 ' HB2' HG22 ' A' ' 166' ' ' VAL . 10.9 m120 -101.96 13.18 35.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.486 -0.324 . . . . 2.4100000000000001 111.331 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 73.88 -53.41 0.69 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.367 0.667 . . . . 2.5800000000000001 111.915 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.5 p -74.51 -18.77 60.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.985 0.422 . . . . 2.2999999999999998 111.564 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 163' ' ' ASN . 16.7 m -119.93 144.48 28.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.297 -0.41 . . . . 1.71 110.175 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -114.83 132.74 56.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.3 -0.409 . . . . 1.47 111.127 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 27.3 mt -104.35 129.98 52.21 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.718 -0.845 . . . . 1.6599999999999999 108.718 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.458 ' HG2' ' HG2' ' A' ' 159' ' ' GLN . 81.0 mtt180 -110.08 112.81 25.04 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.994 0.426 . . . . 3.2999999999999998 110.633 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.57 119.75 60.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.975 -0.557 . . . . 1.3 109.87 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.441 ' HA ' ' HA2' ' A' ' 157' ' ' GLY . 47.9 t30 -119.51 133.9 55.47 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.0 0.428 . . . . 2.2200000000000002 110.674 -172.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -138.9 150.92 46.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.768 -0.651 . . . . 4.6100000000000003 110.835 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -106.29 129.7 54.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.024 -0.534 . . . . 3.98 110.381 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 154' ' ' THR . 86.6 mt -114.75 131.99 56.59 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.466 -0.568 . . . . 2.3799999999999999 109.466 171.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -113.47 177.21 4.71 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.564 -0.289 . . . . 3.3100000000000001 110.532 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -59.81 -40.16 87.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.208 0.528 . . . . 6.5300000000000002 110.083 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -173.86 157.43 25.62 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.348 -0.701 . . . . 5.0599999999999996 111.348 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -79.94 129.08 34.2 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.735 -0.469 . . . . 7.3899999999999997 109.735 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -109.62 153.4 24.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.32 -0.4 . . . . 9.0700000000000003 110.275 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 95.8 mmm -99.57 84.21 2.92 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.313 -0.403 . . . . 10.869999999999999 110.097 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -77.12 133.09 39.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.098 -0.501 . . . . 10.449999999999999 110.637 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -89.41 -0.07 57.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.118 -0.492 . . . . 13.06 110.019 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 34.7 t -61.93 -39.97 93.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.482 -0.781 . . . . 12.609999999999999 110.25 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -117.45 126.32 52.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.12 -0.491 . . . . 15.19 110.146 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -70.07 -39.89 75.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.471 0.653 . . . . 13.18 109.314 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -140.02 178.77 7.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.063 -0.971 . . . . 12.73 109.452 175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 142.05 -55.39 0.6 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.533 -0.841 . . . . 9.9800000000000004 111.502 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -88.8 119.98 29.79 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.155 -0.683 . . . . 10.699999999999999 109.155 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -104.49 -14.58 15.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.938 0.399 . . . . 10.5 111.113 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 52.3 m -140.31 148.64 41.67 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.759 -0.46 . . . . 6.6399999999999997 109.759 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 24.2 p -70.03 -22.05 63.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.135 -0.484 . . . . 4.9800000000000004 111.031 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -134.04 100.06 4.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.746 -0.661 . . . . 7.0999999999999996 109.369 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -99.13 128.45 45.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.273 0.559 . . . . 4.4000000000000004 109.718 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 32.4 mm -116.98 139.92 41.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.623 -0.717 . . . . 2.21 111.184 -164.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 48.3 mtm105 -114.02 139.98 48.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.334 -0.247 . . . . 3.54 110.334 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -132.22 137.99 47.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.776 0.322 . . . . 1.6699999999999999 110.653 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -150.16 160.01 43.99 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.35 -0.386 . . . . 5.8300000000000001 110.281 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -137.93 139.13 25.28 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-O 120.69 0.281 . . . . 2.5899999999999999 110.394 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.33 135.65 22.84 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.401 2.067 . . . . 1.77 112.43 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 67.3 tp -137.76 134.15 34.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.685 -0.689 . . . . 2.2599999999999998 109.559 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 85.4 m -119.92 129.56 54.4 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.814 0.34 . . . . 1.99 110.333 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.1 mt -131.45 81.71 2.0 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.283 0.563 . . . . 2.3100000000000001 109.523 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 71.42 -121.47 8.94 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.429 -0.805 . . . . 1.51 112.483 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -96.54 9.13 42.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.592 0.71 . . . . 2.5699999999999998 109.725 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -120.01 129.99 54.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.198 -0.91 . . . . 2.6600000000000001 109.615 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 7.0 p -103.71 146.28 28.84 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.297 -0.41 . . . . 1.6200000000000001 110.661 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 58.0 t -133.4 140.08 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.265 -0.425 . . . . 1.3799999999999999 110.119 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 46.1 m -138.49 95.48 10.14 Favored Pre-proline 0 C--N 1.319 -0.742 0 O-C-N 122.13 -0.356 . . . . 1.1799999999999999 110.533 173.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.11 139.97 90.11 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.43 2.087 . . . . 1.01 111.477 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -109.5 137.23 47.65 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.033 -0.53 . . . . 4.5 109.65 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 33.1 p -144.67 162.1 37.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.177 -0.465 . . . . 1.8899999999999999 110.731 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -138.29 142.02 39.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.26 -0.645 . . . . 4.7999999999999998 109.26 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 84.3 mt -60.65 -43.66 95.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.11 0.481 . . . . 4.5700000000000003 110.423 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 109.96 -110.12 2.83 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.885 -0.674 . . . . 4.9800000000000004 111.995 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.3 mt -139.67 159.76 41.42 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.336 -0.616 . . . . 8.1099999999999994 109.336 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -59.97 -40.14 88.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.203 0.525 . . . . 7.6500000000000004 110.732 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -67.47 -39.92 85.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.338 -0.846 . . . . 10.529999999999999 111.376 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 77.8 m95 -81.09 153.53 27.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.366 0.603 . . . . 11.56 112.009 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 50.4 m -140.01 153.57 46.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.694 -0.685 . . . . 10.06 109.588 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -94.68 125.64 39.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.823 -0.436 . . . . 11.92 109.823 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -119.81 139.88 51.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.376 -0.375 . . . . 14.01 110.276 -177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -71.65 -19.97 62.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.632 -0.713 . . . . 14.529999999999999 111.571 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 38.5 t90 -88.03 140.29 29.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.099 0.476 . . . . 16.609999999999999 110.825 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -75.32 131.93 40.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.482 -0.781 . . . . 15.460000000000001 110.593 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -60.6 -39.98 90.14 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.36 -0.836 . . . . 15.67 111.541 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -146.38 172.75 13.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.898 -0.592 . . . . 14.5 110.377 -177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 10.2 tp -74.43 -25.19 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.36 0.504 . . . . 15.15 112.36 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -89.91 67.2 7.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.161 0.505 . . . . 14.73 111.662 -173.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -69.84 137.15 51.51 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.272 -0.64 . . . . 16.379999999999999 109.272 174.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -60.18 -39.81 87.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.996 -0.547 . . . . 12.779999999999999 111.743 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 174.16 -175.69 46.59 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.53 -0.843 . . . . 11.1 112.141 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -66.05 -40.04 90.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.974 0.416 . . . . 12.26 110.098 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -72.9 136.83 45.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.003 -0.544 . . . . 9.9900000000000002 109.752 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -103.61 121.65 43.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.147 -0.479 . . . . 10.43 110.744 -174.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -69.8 -19.51 63.49 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.62 -0.718 . . . . 6.29 110.218 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -68.45 -26.73 65.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.346 -0.843 . . . . 8.1500000000000004 111.014 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 62.4 t -116.54 124.22 72.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.298 -0.41 . . . . 2.3999999999999999 110.886 -174.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -85.51 165.98 39.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.781 -0.723 . . . . 1.27 111.438 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 89.4 mt -134.33 129.92 36.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.471 0.636 . . . . 1.97 112.04 -177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.517 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 57.5 t80 -100.67 131.29 46.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.333 -0.848 . . . . 3.54 109.845 171.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.462 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 91.0 m-85 -113.97 130.01 56.56 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.453 -0.573 . . . . 2.6400000000000001 109.453 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -123.3 134.24 9.35 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.7 -0.762 . . . . 1.3500000000000001 111.67 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.43 110.98 23.08 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.156 -0.683 . . . . 4.3600000000000003 109.156 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -107.06 102.12 11.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.908 -0.587 . . . . 4.29 110.37 -176.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 91.3 m-85 -120.0 135.98 54.72 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.13 -0.486 . . . . 6.6900000000000004 109.817 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -84.8 9.65 13.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.448 0.642 . . . . 6.3700000000000001 110.107 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -90.71 6.26 44.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.186 -0.916 . . . . 5.8300000000000001 110.268 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 99.94 5.13 55.22 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.791 -0.718 . . . . 2.6600000000000001 112.816 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 245' ' ' PHE . 65.9 tp -102.95 120.1 40.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.927 0.394 . . . . 2.9700000000000002 111.254 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 23.9 t -130.72 129.24 42.29 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.699 -0.852 . . . . 2.1699999999999999 108.699 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.51 133.17 64.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.932 -0.307 . . . . 1.79 110.643 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 15.5 m -116.65 120.1 37.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.069 -0.514 . . . . 1.6299999999999999 110.057 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 86.0 mt -125.2 127.51 46.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.753 -0.203 . . . . 2.96 110.515 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -120.55 111.33 17.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.854 0.359 . . . . 4.0800000000000001 110.487 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -120.1 140.09 51.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.963 0.411 . . . . 4.8399999999999999 111.316 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -127.28 36.05 4.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.899 -0.591 . . . . 3.5800000000000001 110.491 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 59.84 34.55 21.82 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.843 -0.617 . . . . 6.7699999999999996 111.762 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 58.76 40.43 23.1 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.734 -0.666 . . . . 8.5399999999999991 111.436 176.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . 0.542 ' CD1' ' HB2' ' A' ' 261' ' ' ASP . 62.2 t-105 -95.87 129.24 43.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.035 -0.529 . . . . 11.9 111.018 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -83.34 124.53 30.72 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.947 -0.76 . . . . 10.57 108.947 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . 0.542 ' HB2' ' CD1' ' A' ' 259' ' ' TRP . 11.8 t70 -151.06 156.57 41.35 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.221 -0.592 . . . . 11.41 111.468 -174.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -69.65 -19.25 63.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.704 -1.134 . . . . 11.98 112.952 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -55.88 -30.79 62.09 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.247 0.546 . . . . 12.460000000000001 110.493 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -65.19 -30.97 71.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.196 -0.911 . . . . 13.779999999999999 112.292 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -61.81 134.81 46.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.831 -0.699 . . . . 11.07 113.389 -173.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 59.56 39.44 21.52 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.141 0.577 . . . . 12.59 111.068 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 37.3 t -129.46 148.44 51.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.677 -0.692 . . . . 10.92 109.803 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -78.26 -10.0 59.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.909 -0.587 . . . . 12.42 110.161 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -108.42 161.71 14.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.679 -0.691 . . . . 11.59 110.232 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -110.71 133.3 53.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.001 0.429 . . . . 8.8300000000000001 110.299 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -74.32 -35.01 63.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.536 -0.756 . . . . 7.0199999999999996 110.514 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -59.9 -50.06 75.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 6.5999999999999996 110.256 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -165.18 138.58 4.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.74 -0.664 . . . . 1.9399999999999999 110.464 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.76 132.56 6.64 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.001 -0.619 . . . . 1.4199999999999999 111.698 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 29.6 m -138.01 140.17 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.862 0.363 . . . . 1.8100000000000001 111.103 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -163.96 140.58 6.55 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.7 -0.762 . . . . 1.3 112.394 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 62.5 t -120.29 130.07 74.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.728 0.299 . . . . 1.8300000000000001 110.3 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -118.59 126.37 51.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.25 -0.432 . . . . 2.3100000000000001 110.286 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -100.3 123.69 44.85 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.699 -0.852 . . . . 4.75 108.699 174.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 37.7 t -117.75 130.02 56.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.986 0.422 . . . . 1.6699999999999999 110.673 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.2 t80 . . . . . 0 C--O 1.243 0.724 0 CA-C-O 118.336 -0.84 . . . . 3.6899999999999999 109.182 176.836 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.2 mtp . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.717 0.294 . . . . 11.85 111.475 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -60.12 -37.72 80.87 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.951 0.501 . . . . 10.35 111.988 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -51.21 -49.98 59.99 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.519 0.563 . . . . 9.3100000000000005 112.519 -173.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 58.89 49.15 10.14 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.481 0.658 . . . . 8.8399999999999999 110.055 -176.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -80.02 145.28 32.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.038 -0.983 . . . . 7.0099999999999998 110.892 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -69.87 -39.88 76.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.803 -0.635 . . . . 3.6099999999999999 109.43 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -73.22 149.28 42.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.143 -0.935 . . . . 3.3300000000000001 110.534 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -104.08 131.08 51.71 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.96 -0.385 . . . . 3.2000000000000002 109.96 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.83 149.76 42.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.81 -0.632 . . . . 2.4900000000000002 111.791 -171.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -131.54 129.43 41.01 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.677 -0.86 . . . . 2.1299999999999999 108.677 166.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 36' ' ' TYR . 85.4 mt -132.5 120.23 41.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.598 -0.519 . . . . 1.6000000000000001 109.598 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -117.08 147.8 18.87 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.352 -0.927 . . . . 0.88 112.505 -176.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -138.09 135.03 35.4 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.093 -0.336 . . . . 1.0800000000000001 110.093 175.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.662 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 67.8 mtt -134.0 146.42 50.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.406 -0.361 . . . . 2.3300000000000001 110.482 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.406 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 90.2 m-85 -97.63 129.46 44.72 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.895 -0.78 . . . . 2.6099999999999999 108.895 177.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -70.11 -32.56 70.64 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.187 0.44 . . . . 5.0899999999999999 112.187 -173.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.585 ' HB ' ' HB2' ' A' ' 31' ' ' ALA . 80.9 mt -110.3 130.03 64.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.774 0.321 . . . . 5.3300000000000001 110.461 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -63.59 139.98 58.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.922 -0.581 . . . . 8.2799999999999994 110.629 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -100.68 108.63 20.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.901 0.381 . . . . 9.6999999999999993 110.157 -175.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.9 t -119.13 130.01 74.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.096 -0.502 . . . . 11.09 109.788 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -88.68 119.94 29.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.933 0.397 . . . . 13.1 110.436 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.73 -171.76 39.45 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.926 -0.654 . . . . 11.94 111.82 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -140.4 130.88 25.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.723 0.296 . . . . 15.18 110.489 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -156.18 178.61 32.61 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.549 -0.62 . . . . 12.0 111.549 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.58 -43.12 97.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.946 0.403 . . . . 12.82 110.884 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -84.13 147.56 27.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.021 -0.536 . . . . 10.81 109.75 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 94.5 mtp -121.17 132.5 54.88 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.468 0.652 . . . . 10.050000000000001 110.654 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -60.16 -39.85 87.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.439 -1.255 . . . . 8.0600000000000005 112.105 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.26 -145.41 16.92 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.584 -0.817 . . . . 5.5800000000000001 111.749 -177.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.527 ' O ' HD12 ' A' ' 17' ' ' ILE . 59.0 tp -120.68 138.8 53.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.385 -0.598 . . . . 5.5599999999999996 109.385 175.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.585 ' HB2' ' HB ' ' A' ' 17' ' ' ILE . . . -119.99 107.07 12.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.816 0.341 . . . . 3.0499999999999998 110.892 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 57' ' ' ASP . 1.7 pm0 -103.25 140.79 21.39 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 116.249 -0.432 . . . . 3.48 110.326 177.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.662 ' HA ' ' O ' ' A' ' 14' ' ' MET . 73.8 Cg_endo -77.39 134.81 14.34 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.354 2.036 . . . . 1.8600000000000001 113.127 -177.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 34.8 p -84.42 157.71 21.3 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.992 -0.744 . . . . 1.97 108.992 171.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.99 132.56 69.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.213 0.53 . . . . 1.71 111.005 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 11' ' ' ILE . 53.0 t80 -122.76 130.85 53.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.361 -0.836 . . . . 4.0700000000000003 110.303 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -120.02 135.24 55.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.764 0.316 . . . . 2.8599999999999999 110.75 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -149.9 127.96 11.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.243 -0.651 . . . . 1.8899999999999999 109.243 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -149.44 147.95 28.86 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.078 -0.249 . . . . 1.0800000000000001 111.316 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.72 139.12 9.96 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.131 -0.486 . . . . 1.3899999999999999 111.443 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.689 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 27.3 t-20 -168.28 94.97 0.39 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.963 -0.755 . . . . 2.8599999999999999 108.963 169.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.05 -85.62 0.55 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.93 -0.652 . . . . 1.6799999999999999 111.496 -173.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.689 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 19.6 Cg_endo -59.59 176.66 0.57 Allowed 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 123.643 2.895 . . . . 1.6599999999999999 112.55 171.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -67.77 175.25 3.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.932 -0.576 . . . . 3.3999999999999999 110.527 -173.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -110.99 117.08 32.37 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.478 0.656 . . . . 3.1000000000000001 109.706 -174.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 84.3 mt -116.24 130.23 71.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.438 -1.256 . . . . 1.8 110.436 -170.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.22 130.7 56.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.261 -0.427 . . . . 0.85999999999999999 110.21 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 61.2 tp -130.59 132.57 45.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 1.0600000000000001 110.886 -177.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -146.59 168.92 20.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.56 -0.745 . . . . 1.1399999999999999 109.56 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -120.07 140.0 51.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.703 0.287 . . . . 4.0199999999999996 110.567 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -119.86 122.62 41.69 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.758 -0.46 . . . . 4.6100000000000003 109.758 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -123.1 139.98 53.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.941 0.401 . . . . 3.3799999999999999 110.091 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.58 -24.64 31.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.685 -0.689 . . . . 5.0499999999999998 110.212 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -133.2 71.23 0.5 Allowed Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.616 -0.72 . . . . 4.3700000000000001 111.342 174.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.03 141.11 47.22 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.393 2.728 . . . . 6.6799999999999997 113.363 -174.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.1 t -130.75 130.01 64.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.541 -0.754 . . . . 8.1699999999999999 109.096 174.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.548 ' HB2' ' HB3' ' A' ' 32' ' ' GLU . 20.9 t70 -60.02 -49.96 75.59 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.276 0.36 . . . . 10.039999999999999 111.524 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -152.2 150.4 29.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.78 0.324 . . . . 11.609999999999999 110.436 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 52.9 m -143.04 150.0 39.0 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.333 -0.394 . . . . 9.7899999999999991 110.346 176.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.77 120.04 41.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.517 -0.311 . . . . 8.5099999999999998 110.274 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.43 21.08 59.07 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.736 -0.745 . . . . 7.5599999999999996 111.756 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.657 ' HE3' ' O ' ' A' ' 64' ' ' GLY . 57.9 tptt -122.56 119.14 29.97 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.044 -0.354 . . . . 10.0 110.044 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -69.94 -39.74 75.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.27 -0.423 . . . . 10.35 111.354 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.657 ' O ' ' HE3' ' A' ' 62' ' ' LYS . . . 148.13 -150.33 22.52 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.923 -0.656 . . . . 5.3399999999999999 111.499 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 t -112.38 130.05 56.1 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.239 0.542 . . . . 5.3200000000000003 110.769 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -60.06 -40.05 88.13 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.262 -0.881 . . . . 5.6100000000000003 110.644 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -102.22 111.64 24.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.465 -0.569 . . . . 3.7799999999999998 109.465 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -125.34 169.96 11.81 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.267 -0.424 . . . . 2.4500000000000002 110.098 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.506 ' NE ' ' HB2' ' A' ' 95' ' ' TYR . 12.5 ttm180 -139.31 122.41 10.62 Favored Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 120.874 -0.33 . . . . 3.2400000000000002 110.134 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.508 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 85.3 Cg_endo -91.41 151.69 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.872 2.382 . . . . 1.1899999999999999 112.184 171.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.592 ' HA ' ' HG2' ' A' ' 93' ' ' ARG . 37.8 tt0 -118.04 115.61 25.21 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.17 -0.678 . . . . 2.1899999999999999 109.17 174.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.4 tp -132.56 114.74 14.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.883 -0.599 . . . . 1.1399999999999999 110.758 -175.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.515 ' HG2' ' HA3' ' A' ' 91' ' ' GLY . 46.9 mt-10 -123.9 140.47 52.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.263 -0.426 . . . . 2.1800000000000002 110.108 174.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.3 t -123.03 129.8 74.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.203 -0.453 . . . . 1.5600000000000001 109.965 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -112.48 119.9 39.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.008 0.432 . . . . 3.4399999999999999 110.444 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.447 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . 64.8 t80 -93.08 129.14 39.14 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.554 -0.748 . . . . 4.7999999999999998 109.26 176.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -103.02 119.83 39.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.079 -0.509 . . . . 2.9399999999999999 110.099 -177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.453 ' CD2' ' HG ' ' A' ' 79' ' ' LEU . 69.7 t80 -120.1 119.35 33.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.522 -0.308 . . . . 3.8999999999999999 110.633 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.453 ' HG ' ' CD2' ' A' ' 78' ' ' PHE . 85.4 mt 69.68 106.21 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 124.136 0.897 . . . . 4.4800000000000004 112.817 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -88.4 -7.17 57.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.477 -0.783 . . . . 6.1900000000000004 109.531 170.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -67.76 143.79 55.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.267 -0.879 . . . . 5.4500000000000002 110.462 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -70.14 -20.87 63.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.854 -0.612 . . . . 5.2699999999999996 112.177 -171.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -61.23 -39.95 92.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.018 0.377 . . . . 6.3300000000000001 112.018 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -138.08 155.36 48.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.856 0.36 . . . . 7.4800000000000004 110.815 -176.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.402 ' OG ' ' HB ' ' A' ' 121' ' ' VAL . 21.3 t -144.27 94.49 2.58 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.222 -0.445 . . . . 2.5499999999999998 109.996 -177.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -119.92 135.84 54.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.924 0.392 . . . . 5.2999999999999998 110.748 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.21 143.42 15.01 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.029 -0.828 . . . . 1.3500000000000001 111.029 175.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 76' ' ' TYR . 88.6 mt -120.27 113.72 20.82 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.767 -0.457 . . . . 2.29 109.767 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.1 m -116.58 122.64 45.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.05 0.452 . . . . 1.54 110.882 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -137.86 140.33 11.14 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.443 -0.663 . . . . 1.1699999999999999 111.443 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.515 ' HA3' ' HG2' ' A' ' 73' ' ' GLU . . . -169.63 170.03 42.44 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.219 -0.991 . . . . 1.1899999999999999 112.455 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 112' ' ' ARG . 53.3 p90 -156.75 160.01 38.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.986 0.422 . . . . 3.75 111.201 -176.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.592 ' HG2' ' HA ' ' A' ' 71' ' ' GLU . 30.1 mtm180 -121.27 127.96 51.89 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.743 -0.662 . . . . 2.75 109.228 169.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.508 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 52.0 t30 -107.3 119.13 38.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.189 -0.46 . . . . 1.8200000000000001 110.134 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.506 ' HB2' ' NE ' ' A' ' 69' ' ' ARG . 69.9 t80 -116.85 129.31 56.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.793 0.33 . . . . 3.1400000000000001 111.006 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 108' ' ' ALA . . . 99.73 166.89 29.54 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.333 -0.936 . . . . 2.79 113.179 172.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.454 ' O ' ' HB2' ' A' ' 98' ' ' HIS . 3.2 m-85 -118.69 157.67 27.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.637 -0.281 . . . . 7.6200000000000001 110.537 -176.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.498 ' HB3' ' O ' ' A' ' 101' ' ' ASP . 22.6 m-70 69.76 62.03 0.26 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 124.15 0.906 . . . . 7.0800000000000001 110.452 -169.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -70.07 -27.74 64.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.54 -0.755 . . . . 10.16 110.97 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 79.5 t -70.09 -40.98 79.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 9.8100000000000005 111.382 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' A' ' 98' ' ' HIS . 10.3 p-10 -139.3 136.87 35.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.133 0.492 . . . . 12.220000000000001 111.957 -173.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -129.89 71.18 82.23 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.833 -0.621 . . . . 10.48 110.067 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.02 -30.11 56.73 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.896 2.397 . . . . 9.0999999999999996 113.452 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -138.36 -177.3 15.17 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.61 -0.805 . . . . 6.46 112.261 -176.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -80.78 -16.12 54.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.686 0.279 . . . . 7.6699999999999999 111.16 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -69.92 -35.7 74.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.35 0.595 . . . . 4.1399999999999997 109.459 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.5 p -87.7 140.66 29.29 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.355 -0.839 . . . . 3.2999999999999998 109.4 172.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.406 ' O ' ' HA3' ' A' ' 96' ' ' GLY . . . -164.78 129.12 2.52 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.632 -0.427 . . . . 1.76 111.159 -178.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -138.47 126.88 23.13 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.195 0.522 . . . . 2.5499999999999998 110.034 173.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 89.5 mtp -131.35 126.91 36.48 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.925 -0.579 . . . . 1.77 109.462 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.496 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 26.3 mt-30 -118.92 134.23 55.31 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.327 -0.549 . . . . 1.97 110.528 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 92' ' ' PHE . 47.3 ttt-85 -111.77 119.44 38.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.682 -0.69 . . . . 3.8500000000000001 109.439 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -119.94 140.21 51.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.545 -0.298 . . . . 2.2799999999999998 110.901 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 135' ' ' MET . 21.8 pttp -139.94 135.29 32.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.023 0.44 . . . . 2.1400000000000001 110.184 168.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 134' ' ' SER . 48.5 mm -120.02 119.85 61.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.827 -0.805 . . . . 1.55 108.827 173.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -140.55 106.58 6.5 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 120.553 0.216 . . . . 1.1899999999999999 111.197 -174.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.94 139.87 13.98 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.757 2.305 . . . . 1.3700000000000001 110.776 174.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -88.03 138.4 31.48 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 109.29 -0.634 . . . . 2.3500000000000001 109.29 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -125.86 132.32 52.21 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 111.547 0.203 . . . . 4.54 111.547 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 55.78 37.53 28.98 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.251 0.97 . . . . 3.04 112.451 171.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.402 ' HB ' ' OG ' ' A' ' 85' ' ' SER . 92.9 t -64.19 119.32 8.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.638 -0.255 . . . . 4.2699999999999996 110.926 -176.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 59.93 43.11 15.22 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.583 -0.735 . . . . 6.04 110.948 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.1 tp -60.15 -39.9 87.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.147 -0.479 . . . . 4.5899999999999999 111.872 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 127' ' ' LEU . 32.6 m -117.3 138.14 51.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.923 0.392 . . . . 3.6899999999999999 110.318 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -61.42 -44.66 96.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.147 -0.479 . . . . 5.1699999999999999 111.025 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -70.97 -40.83 71.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.794 -0.639 . . . . 3.71 111.492 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.535 ' O ' ' HB ' ' A' ' 124' ' ' THR . 86.5 mt -126.59 125.48 42.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.924 -0.58 . . . . 2.0499999999999998 110.523 -173.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.488 ' HD2' ' OE1' ' A' ' 159' ' ' GLN . 64.9 mtt180 -92.67 133.83 35.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.098 0.475 . . . . 4.2400000000000002 110.623 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.466 ' CD2' HD22 ' A' ' 158' ' ' LEU . 89.3 m-85 -119.8 122.0 40.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.367 -0.833 . . . . 3.5499999999999998 109.565 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 132' ' ' TRP . 94.4 m-20 -133.32 120.06 20.55 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.883 -0.414 . . . . 2.1099999999999999 109.883 174.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -148.18 140.27 8.25 Favored Glycine 0 CA--C 1.507 -0.416 0 C-N-CA 120.2 -1.0 . . . . 1.1799999999999999 111.43 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.462 ' CZ3' ' HB3' ' A' ' 130' ' ' ASN . 0.9 OUTLIER -142.72 147.67 36.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.302 0.573 . . . . 4.2999999999999998 112.153 -177.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 91.4 mt -104.43 120.01 40.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.987 -1.006 . . . . 2.2400000000000002 109.09 176.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 26.6 t -107.39 124.56 50.01 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.54 -0.464 . . . . 1.6899999999999999 110.974 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.472 ' O ' ' HA ' ' A' ' 114' ' ' LYS . 69.7 mtm -93.95 120.06 33.7 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.324 -0.991 . . . . 2.2400000000000002 108.324 171.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -115.12 132.61 56.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.167 0.508 . . . . 3.5600000000000001 112.208 -168.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -130.17 152.86 49.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.415 -0.812 . . . . 1.6699999999999999 109.908 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.459 ' O ' HD23 ' A' ' 142' ' ' LEU . 77.9 t80 -149.7 151.5 33.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.421 -0.354 . . . . 3.23 110.248 -177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 60.61 -163.44 0.25 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.546 0.529 . . . . 1.24 111.649 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -75.91 -41.39 52.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.967 0.413 . . . . 2.4700000000000002 111.786 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -60.14 -46.16 90.59 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.528 -0.76 . . . . 2.4100000000000001 112.959 -165.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 138' ' ' PHE . 3.8 mm? -69.88 -35.66 74.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.071 0.462 . . . . 1.8300000000000001 110.974 -176.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' A' ' 111' ' ' GLN . 95.6 m-20 -70.78 -40.25 72.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.884 -0.598 . . . . 2.0 111.392 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.1 p -77.0 -35.05 57.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.504 -0.316 . . . . 2.0499999999999998 111.823 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 149' ' ' ASP . 23.2 p -69.9 -29.9 67.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.986 0.422 . . . . 1.5900000000000001 111.092 177.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 63.28 -109.83 2.98 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.694 -0.685 . . . . 1.52 113.071 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -70.02 -33.94 72.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.594 0.235 . . . . 5.9400000000000004 110.808 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.04 75.26 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.075 -0.512 . . . . 1.8300000000000001 112.256 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.428 ' HB2' ' OG1' ' A' ' 145' ' ' THR . 15.7 m-20 -122.51 127.1 49.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.212 0.53 . . . . 2.6400000000000001 111.003 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.1 t -160.23 157.73 28.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.853 -0.612 . . . . 2.02 110.113 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -120.16 148.2 43.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.917 -0.401 . . . . 3.6699999999999999 109.917 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.09 139.81 50.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.867 0.365 . . . . 1.6399999999999999 110.974 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -138.0 141.04 40.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.989 -0.551 . . . . 2.5600000000000001 109.523 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 24.5 m -122.91 131.36 53.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.735 0.302 . . . . 1.3899999999999999 111.346 -177.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -126.57 130.06 49.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.944 -0.571 . . . . 2.04 110.235 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 93.4 m -128.24 120.78 27.87 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.044 -0.525 . . . . 1.5600000000000001 110.538 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -111.69 117.73 4.56 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.657 -0.977 . . . . 1.04 110.657 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.466 HD22 ' CD2' ' A' ' 129' ' ' PHE . 77.4 mt -118.65 130.64 55.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.913 0.387 . . . . 2.27 111.024 -176.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.488 ' OE1' ' HD2' ' A' ' 128' ' ' ARG . 53.4 tt0 -100.14 113.43 26.07 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.901 -0.59 . . . . 2.4100000000000001 110.669 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.469 ' HA ' HD22 ' A' ' 127' ' ' LEU . 86.7 m-85 -120.16 139.8 52.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.889 -0.596 . . . . 4.5700000000000003 110.424 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 167' ' ' ALA . 24.4 p -94.25 100.26 12.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.963 0.411 . . . . 1.46 110.349 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -60.05 -49.07 79.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.939 -0.573 . . . . 2.6299999999999999 111.225 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.493 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.7 m-20 -101.09 10.09 41.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.222 -0.445 . . . . 2.4100000000000001 110.717 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 72.47 -46.92 0.66 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.634 0.774 . . . . 2.5800000000000001 111.235 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.4 p -74.71 -20.42 59.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.397 -0.365 . . . . 2.2999999999999998 111.788 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 163' ' ' ASN . 34.2 m -124.81 139.95 49.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.368 -0.378 . . . . 1.71 110.252 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.406 ' HA ' HG22 ' A' ' 161' ' ' THR . . . -106.83 131.55 53.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.959 0.409 . . . . 1.47 111.374 -175.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 31.1 mt -115.31 138.54 50.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.311 -0.626 . . . . 1.6599999999999999 109.311 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -112.17 122.02 46.58 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 110.075 -0.343 . . . . 3.2999999999999998 110.075 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.94 127.91 75.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.731 0.3 . . . . 1.3 110.547 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -107.05 126.69 52.68 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.249 0.547 . . . . 2.2200000000000002 110.782 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -99.42 124.42 44.54 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.11 -0.95 . . . . 4.6100000000000003 108.648 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -108.77 124.98 51.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.096 0.474 . . . . 3.98 110.923 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.501 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 62.0 tp -115.4 115.82 27.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.608 -0.723 . . . . 2.3799999999999999 111.21 -177.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -120.01 145.12 47.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.694 -0.685 . . . . 3.3100000000000001 110.116 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -140.35 130.07 24.39 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.546 -0.538 . . . . 6.5300000000000002 109.546 172.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -115.82 129.17 8.37 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.822 -0.704 . . . . 5.0599999999999996 112.051 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -70.01 -40.0 75.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.28 0.562 . . . . 7.3899999999999997 110.104 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -125.13 43.14 3.12 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.541 -0.754 . . . . 9.0700000000000003 110.011 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 54.8 ttm -60.22 -40.09 88.94 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.825 -0.625 . . . . 10.869999999999999 110.532 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -115.02 168.05 10.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.107 -0.497 . . . . 10.449999999999999 110.299 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -60.31 -40.2 89.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.015 0.436 . . . . 13.06 111.084 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.0 t -153.84 151.04 29.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.219 -0.446 . . . . 12.609999999999999 110.266 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -109.56 23.44 14.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.997 -0.547 . . . . 15.19 110.847 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -60.08 -40.13 88.49 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.78 0.324 . . . . 13.18 111.194 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -67.69 -38.38 83.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.166 0.507 . . . . 12.73 110.361 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 147.02 -166.63 28.41 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 111.152 -0.779 . . . . 9.9800000000000004 111.152 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -122.43 139.75 53.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.788 0.328 . . . . 10.699999999999999 110.364 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -142.49 155.52 45.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.246 -0.434 . . . . 10.5 110.225 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.1 p -154.77 159.15 40.44 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.838 -0.619 . . . . 6.6399999999999997 109.621 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 23.2 m -140.45 113.63 8.44 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.841 0.353 . . . . 4.9800000000000004 110.46 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.86 149.98 23.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.283 -0.417 . . . . 7.0999999999999996 110.08 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -104.61 126.57 51.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.518 -0.31 . . . . 4.4000000000000004 110.521 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.491 ' O ' HG13 ' A' ' 194' ' ' ILE . 29.7 pt -93.92 90.72 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.66 0.743 . . . . 2.21 109.375 170.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.426 ' HG2' ' HA ' ' A' ' 212' ' ' ARG . 99.1 mtt180 -91.3 120.08 31.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.875 -0.602 . . . . 3.54 110.314 -173.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -109.36 147.23 33.08 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.95 -0.568 . . . . 1.6699999999999999 111.38 -174.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -155.97 160.02 39.72 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.492 -0.777 . . . . 5.8300000000000001 109.726 175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 1.7 pt? -144.51 127.49 8.54 Favored Pre-proline 0 C--N 1.322 -0.619 0 C-N-CA 120.846 -0.342 . . . . 2.5899999999999999 111.006 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 198' ' ' LEU . 9.1 Cg_exo -73.28 127.38 11.88 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.462 2.108 . . . . 1.77 111.674 172.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 33.1 tp -130.83 148.57 52.62 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.565 -0.902 . . . . 2.2599999999999998 108.565 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 11.9 t -129.58 140.18 51.27 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.302 0.572 . . . . 1.99 110.954 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 60.0 tp -141.05 82.53 1.84 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.343 -0.844 . . . . 2.3100000000000001 109.149 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 69.22 -120.04 10.05 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.734 -0.666 . . . . 1.51 112.616 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -95.47 10.09 37.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.497 0.665 . . . . 2.5699999999999998 109.778 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -119.2 145.87 45.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.389 -0.823 . . . . 2.6600000000000001 109.399 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 241' ' ' TYR . 47.5 t -130.03 144.53 51.39 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.851 -0.426 . . . . 1.6200000000000001 109.851 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 47.9 t -119.92 129.95 74.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.639 -0.504 . . . . 1.3799999999999999 109.639 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 20.3 m -139.84 91.03 10.62 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-O 120.867 0.365 . . . . 1.1799999999999999 110.42 175.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.46 140.6 27.28 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 123.013 2.475 . . . . 1.01 111.826 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -118.99 139.88 50.94 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.858 -0.423 . . . . 4.5 109.858 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 61.1 p -133.07 146.15 51.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.789 -0.641 . . . . 1.8899999999999999 109.626 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.426 ' HA ' ' HG2' ' A' ' 195' ' ' ARG . 59.0 mtp180 -80.51 -9.97 59.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.035 0.445 . . . . 4.7999999999999998 110.255 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 46.5 pt -115.54 150.11 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.547 -0.751 . . . . 4.5700000000000003 109.932 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -109.45 -159.98 18.75 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.778 -0.725 . . . . 4.9800000000000004 112.193 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 84.2 mt -60.72 -40.11 91.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.018 0.437 . . . . 8.1099999999999994 110.966 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -84.33 102.72 12.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.906 -0.588 . . . . 7.6500000000000004 109.534 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -69.65 -37.93 76.93 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.883 -0.599 . . . . 10.529999999999999 109.942 -177.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -113.22 139.99 48.33 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.015 -0.735 . . . . 11.56 109.015 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 221' ' ' TRP . 23.0 m -107.56 156.67 18.76 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.596 -0.275 . . . . 10.06 110.379 -176.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -103.28 119.98 39.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.958 0.408 . . . . 11.92 110.262 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . 0.404 ' CZ2' ' HB2' ' A' ' 219' ' ' SER . 21.3 m-90 -114.01 142.33 46.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.836 -0.62 . . . . 14.01 110.035 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -90.52 8.33 34.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.935 -0.575 . . . . 14.529999999999999 110.302 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -104.4 157.0 17.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.788 -0.642 . . . . 16.609999999999999 110.374 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . 0.434 ' HB3' ' OD1' ' A' ' 226' ' ' ASP . 99.4 mt-30 -60.18 -53.08 61.95 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.191 0.307 . . . . 15.460000000000001 111.034 -176.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 49.92 40.01 19.9 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.47 0.481 . . . . 15.67 111.705 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.434 ' OD1' ' HB3' ' A' ' 224' ' ' GLN . 18.4 m-20 -70.02 -20.54 63.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.106 -0.497 . . . . 14.5 111.131 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 86.7 mt -120.03 119.95 61.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.396 -0.594 . . . . 15.15 109.396 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -115.11 149.84 36.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.083 -0.508 . . . . 14.73 110.731 -175.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -100.13 125.48 46.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.006 -0.738 . . . . 16.379999999999999 109.006 172.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -69.81 139.93 53.24 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.124 0.488 . . . . 12.779999999999999 110.744 -176.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -179.62 178.78 48.78 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.021 -0.832 . . . . 11.1 111.021 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 57.8 46.24 17.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.315 0.579 . . . . 12.26 109.762 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.08 -40.04 88.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.365 -0.834 . . . . 9.9900000000000002 110.474 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -123.54 140.0 53.44 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.61 -0.723 . . . . 10.43 109.944 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -96.43 116.21 28.69 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.811 -0.44 . . . . 6.29 109.811 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -100.21 141.34 33.19 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.383 -0.372 . . . . 8.1500000000000004 110.499 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.86 160.0 41.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.037 -0.529 . . . . 2.3999999999999999 109.832 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -132.92 143.88 15.67 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.62 -0.8 . . . . 1.27 111.923 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 81.1 mt -116.94 121.78 42.39 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.7 0.286 . . . . 1.97 110.284 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -106.55 122.26 45.95 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.877 -0.416 . . . . 3.54 109.877 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 206' ' ' SER . 95.9 m-85 -112.2 120.37 41.54 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.066 -0.515 . . . . 2.6400000000000001 110.115 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -89.62 129.57 9.76 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.613 -0.803 . . . . 1.3500000000000001 111.533 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -107.58 127.19 53.42 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 110.004 -0.369 . . . . 4.3600000000000003 110.004 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -99.36 133.82 43.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.572 -0.74 . . . . 4.29 110.37 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -124.73 146.16 49.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.499 -0.556 . . . . 6.6900000000000004 109.499 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -56.49 -27.56 57.5 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.272 -0.876 . . . . 6.3700000000000001 112.816 -168.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.98 -34.97 74.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.364 0.602 . . . . 5.8300000000000001 110.742 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 116.2 1.94 20.25 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.21 -1.156 . . . . 2.6600000000000001 110.21 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 53.5 tp -91.08 130.41 36.98 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.579 -0.811 . . . . 2.9700000000000002 109.792 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 24.3 p -120.08 140.15 51.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.859 0.362 . . . . 2.1699999999999999 110.672 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.2 t -118.71 133.02 66.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.424 -0.353 . . . . 1.79 110.211 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 24.7 m -98.4 117.55 33.06 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.782 -0.451 . . . . 1.6299999999999999 109.782 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 68.6 mt -95.73 119.45 34.26 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.313 -0.625 . . . . 2.96 109.313 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -104.43 120.02 40.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.916 0.389 . . . . 4.0800000000000001 110.495 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -116.2 132.25 56.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.885 -0.598 . . . . 4.8399999999999999 110.675 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -99.22 16.45 22.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.504 0.669 . . . . 3.5800000000000001 109.733 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . 0.431 ' HE2' ' CE2' ' A' ' 259' ' ' TRP . 53.2 p90 -150.06 167.4 26.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.205 -0.907 . . . . 6.7699999999999996 110.191 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -121.7 138.55 54.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.969 -0.559 . . . . 8.5399999999999991 109.878 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . 0.431 ' CE2' ' HE2' ' A' ' 257' ' ' PHE . 93.5 m95 -86.6 121.82 29.65 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.365 -0.976 . . . . 11.9 108.365 170.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -115.14 172.52 7.02 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 121.013 -0.275 . . . . 10.57 110.906 -171.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -60.01 -40.14 88.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.982 0.42 . . . . 11.41 110.562 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -127.64 109.67 11.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.751 -0.659 . . . . 11.98 110.33 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -119.98 130.02 54.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.183 -0.462 . . . . 12.460000000000001 110.132 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -109.67 143.63 39.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.964 0.411 . . . . 13.779999999999999 110.597 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -90.25 -158.24 34.29 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.744 -0.662 . . . . 11.07 112.064 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 54.3 39.05 30.54 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.939 0.399 . . . . 12.59 111.246 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 53.6 m -115.15 147.95 39.62 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.919 0.39 . . . . 10.92 110.182 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -89.96 -0.02 57.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.122 -0.49 . . . . 12.42 111.298 -174.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -87.32 70.03 9.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.24 -0.436 . . . . 11.59 110.072 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -66.17 139.69 58.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.986 -0.552 . . . . 8.8300000000000001 110.073 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -110.4 160.38 16.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.083 -0.508 . . . . 7.0199999999999996 111.638 -171.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -125.86 155.72 40.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.319 -0.855 . . . . 6.5999999999999996 109.904 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -150.02 149.82 30.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.324 -0.398 . . . . 1.9399999999999999 110.545 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.91 167.54 23.25 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.917 -0.658 . . . . 1.4199999999999999 111.844 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.05 140.0 39.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.149 0.499 . . . . 1.8100000000000001 111.06 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -126.77 137.08 9.76 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.033 -0.827 . . . . 1.3 111.033 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.99 119.99 60.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.857 -0.423 . . . . 1.8300000000000001 109.857 -176.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -128.25 129.77 46.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.154 0.502 . . . . 2.3100000000000001 111.627 -176.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -120.01 110.62 16.91 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.291 -0.633 . . . . 4.75 109.291 173.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 22.9 t -120.6 130.23 54.09 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.53 -0.544 . . . . 1.6699999999999999 109.53 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 46.2 t80 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.112 -0.946 . . . . 3.6899999999999999 109.462 -177.727 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.943 0.402 . . . . 11.85 110.489 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -98.73 90.79 4.82 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.073 -0.714 . . . . 10.35 109.073 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -123.82 144.62 49.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.542 -0.754 . . . . 9.3100000000000005 110.388 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -125.07 153.5 42.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.385 -0.37 . . . . 8.8399999999999999 110.753 -177.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -111.13 123.96 51.24 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.418 -0.586 . . . . 7.0099999999999998 109.418 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -59.93 -39.83 86.85 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.493 -0.776 . . . . 3.6099999999999999 111.079 -178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -120.3 139.99 51.91 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.166 -0.679 . . . . 3.3300000000000001 109.166 172.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -131.83 130.78 42.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.812 0.339 . . . . 3.2000000000000002 110.182 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -137.06 150.35 47.99 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.089 -0.505 . . . . 2.4900000000000002 110.152 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -132.77 131.39 41.09 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.923 -0.769 . . . . 2.1299999999999999 108.923 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.8 pt -121.34 130.32 74.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.987 0.422 . . . . 1.6000000000000001 110.971 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -114.8 134.53 11.72 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.671 -0.776 . . . . 0.88 111.578 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -120.0 135.87 54.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.018 0.437 . . . . 1.0800000000000001 110.636 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 66.7 mtt -139.92 157.26 45.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.714 -0.675 . . . . 2.3300000000000001 109.734 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.02 112.32 24.75 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.007 -0.368 . . . . 2.6099999999999999 110.007 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -99.39 133.28 43.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.084 0.468 . . . . 5.0899999999999999 110.87 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.0 pt -130.25 141.22 46.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.471 -0.786 . . . . 5.3300000000000001 110.033 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -119.9 140.05 51.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.764 0.316 . . . . 8.2799999999999994 110.28 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.481 ' ND2' ' HB2' ' A' ' 186' ' ' ASN . 54.4 t30 -80.73 117.38 21.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.909 -0.587 . . . . 9.6999999999999993 110.976 -177.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.99 124.55 72.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.964 -0.384 . . . . 11.09 109.964 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -138.87 140.04 38.3 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.615 -0.513 . . . . 13.1 109.615 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.94 -162.28 30.38 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.269 -0.967 . . . . 11.94 112.696 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -64.48 -28.78 69.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.855 0.359 . . . . 15.18 110.899 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.11 160.44 33.0 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.044 -0.598 . . . . 12.0 111.613 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -100.0 120.04 39.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.741 0.305 . . . . 12.82 110.42 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -82.85 -11.42 58.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 10.81 110.368 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 97.6 mmm -120.23 131.56 55.0 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.687 -0.688 . . . . 10.050000000000001 110.305 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -99.57 -0.05 41.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.066 -0.516 . . . . 8.0600000000000005 110.932 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.57 84.14 1.58 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.952 -0.642 . . . . 5.5800000000000001 112.296 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.31 -49.99 75.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.812 0.339 . . . . 5.5599999999999996 111.469 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -157.0 119.61 3.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.101 -0.499 . . . . 3.0499999999999998 110.927 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -128.71 145.18 55.17 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.515 -0.311 . . . . 3.48 110.835 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.09 134.84 10.67 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.441 2.094 . . . . 1.8600000000000001 111.972 173.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 19.3 p -123.9 145.78 48.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.241 -0.436 . . . . 1.97 110.0 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 8.5 p -130.0 136.79 58.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.02 0.438 . . . . 1.71 110.791 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -117.97 143.66 46.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.033 -0.53 . . . . 4.0700000000000003 110.481 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 91.0 m-85 -102.71 129.28 49.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.976 -0.556 . . . . 2.8599999999999999 111.244 -176.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -119.88 137.43 54.02 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.137 -0.483 . . . . 1.8899999999999999 109.948 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -120.69 143.5 48.7 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.988 -0.375 . . . . 1.0800000000000001 109.988 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.49 117.98 6.97 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.537 0.523 . . . . 1.3899999999999999 111.226 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.631 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 37.4 t30 -167.24 96.01 0.48 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.01 -0.541 . . . . 2.8599999999999999 110.12 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.3 -98.78 1.89 Allowed Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.017 -0.611 . . . . 1.6799999999999999 112.266 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.631 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 84.1 Cg_exo -47.82 175.0 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.956 3.104 . . . . 1.6599999999999999 113.644 169.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -69.72 -177.44 1.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.265 0.555 . . . . 3.3999999999999999 111.582 -170.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.7 mtp180 -111.97 140.58 46.52 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.609 0.719 . . . . 3.1000000000000001 112.331 -170.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.406 HG22 HG12 ' A' ' 74' ' ' VAL . 47.0 pt -126.52 146.66 32.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 114.397 -1.274 . . . . 1.8 110.892 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -119.73 131.22 55.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.791 -0.64 . . . . 0.85999999999999999 110.287 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.8 tp -119.92 131.84 55.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.166 -0.47 . . . . 1.0600000000000001 110.831 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 71' ' ' GLU . . . -151.98 157.8 42.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 1.1399999999999999 110.551 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -134.48 150.48 50.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.793 0.33 . . . . 4.0199999999999996 110.725 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -135.27 106.94 6.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.019 -0.537 . . . . 4.6100000000000003 111.589 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -98.87 135.84 39.73 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.457 -0.942 . . . . 3.3799999999999999 108.457 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -60.12 -34.0 72.9 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.024 -0.535 . . . . 5.0499999999999998 111.059 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -69.76 131.65 23.8 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.501 -0.856 . . . . 4.3700000000000001 111.262 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.32 168.2 8.24 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.061 2.507 . . . . 6.6799999999999997 113.123 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 65.4 t -60.17 -44.49 95.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.802 0.334 . . . . 8.1699999999999999 110.445 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -65.64 -40.13 92.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.741 -0.663 . . . . 10.039999999999999 111.246 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -124.98 100.04 6.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.584 -0.28 . . . . 11.609999999999999 111.05 -177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.1 t -64.39 -40.0 94.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.448 0.642 . . . . 9.7899999999999991 109.277 176.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.76 111.09 22.88 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.452 -0.794 . . . . 8.5099999999999998 110.258 176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.14 168.3 38.72 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.765 -0.731 . . . . 7.5599999999999996 112.008 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -60.15 -39.94 88.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.845 0.355 . . . . 10.0 110.663 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.9 mtm105 -69.74 -20.33 63.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 10.35 111.036 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.89 23.0 62.62 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.995 -0.621 . . . . 5.3399999999999999 113.145 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.1 p -84.94 131.86 34.44 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.215 0.531 . . . . 5.3200000000000003 111.169 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -119.95 29.7 7.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.749 -0.66 . . . . 5.6100000000000003 110.507 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -70.54 139.96 51.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.072 -0.513 . . . . 3.7799999999999998 110.804 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -130.65 144.26 51.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.67 -0.696 . . . . 2.4500000000000002 109.704 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.458 ' HD2' ' HB3' ' A' ' 93' ' ' ARG . 39.5 ttp180 -124.34 122.05 26.0 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 115.926 -0.579 . . . . 3.2400000000000002 110.07 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.478 ' O ' ' HA ' ' A' ' 93' ' ' ARG . 2.9 Cg_endo -85.81 150.03 9.81 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.63 2.22 . . . . 1.1899999999999999 111.883 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 46.5 tt0 -128.11 128.95 45.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.054 0.454 . . . . 2.1899999999999999 110.211 173.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.4 tp -132.03 116.77 17.51 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.616 -0.72 . . . . 1.1399999999999999 109.442 173.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.472 ' HA ' ' HA2' ' A' ' 91' ' ' GLY . 40.5 tt0 -118.81 131.17 56.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.043 0.449 . . . . 2.1800000000000002 109.868 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.406 HG12 HG22 ' A' ' 46' ' ' ILE . 32.4 m -113.67 141.55 29.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.816 -0.629 . . . . 1.5600000000000001 109.999 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -120.97 127.01 51.41 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.097 -0.502 . . . . 3.4399999999999999 110.136 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.94 141.43 49.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.365 -0.38 . . . . 4.7999999999999998 110.074 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -114.65 139.91 49.26 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.851 -0.425 . . . . 2.9399999999999999 109.851 177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -132.03 149.29 52.46 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.847 0.356 . . . . 3.8999999999999999 110.408 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.6 tp -133.22 129.66 38.03 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.039 -0.528 . . . . 4.4800000000000004 110.085 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -140.07 168.72 19.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.269 -0.641 . . . . 6.1900000000000004 109.269 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -60.0 -50.15 74.85 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.535 0.569 . . . . 5.4500000000000002 112.535 -171.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.72 -49.85 10.64 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.146 0.425 . . . . 5.2699999999999996 112.146 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -85.63 117.46 24.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.185 0.517 . . . . 6.3300000000000001 110.545 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -69.42 -47.85 62.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.36 -0.837 . . . . 7.4800000000000004 112.194 -173.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 120' ' ' ASP . 3.9 m -143.63 109.1 5.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.775 0.321 . . . . 2.5499999999999998 110.889 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -140.05 143.72 36.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.502 -0.555 . . . . 5.2999999999999998 109.502 174.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.65 176.36 23.08 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.255 -0.974 . . . . 1.3500000000000001 112.539 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 64.0 tp -126.83 130.04 49.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.912 0.387 . . . . 2.29 110.077 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.2 m -120.02 129.91 54.47 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.054 -0.521 . . . . 1.54 109.908 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 114' ' ' LYS . . . -138.97 133.6 6.3 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.615 -0.802 . . . . 1.1699999999999999 111.8 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 73' ' ' GLU . . . -135.03 147.99 19.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.591 -0.814 . . . . 1.1899999999999999 112.4 -178.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -129.36 137.74 51.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.957 0.408 . . . . 3.75 111.222 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 70' ' ' PRO . 89.8 mtt180 -129.79 148.46 51.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.437 -0.801 . . . . 2.75 109.803 171.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.664 ' HA ' ' O ' ' A' ' 110' ' ' MET . 51.8 t-20 -139.55 118.43 12.47 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.094 -0.336 . . . . 1.8200000000000001 110.094 172.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.444 ' HB2' ' HD3' ' A' ' 69' ' ' ARG . 43.1 t80 -103.0 119.56 39.06 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.167 -0.309 . . . . 3.1400000000000001 110.167 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 122.7 -174.68 16.37 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.295 -0.955 . . . . 2.79 112.166 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.502 ' O ' ' HB ' ' A' ' 107' ' ' THR . 95.2 m-85 -131.45 129.99 41.91 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.814 -0.439 . . . . 7.6200000000000001 109.814 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -120.16 123.83 44.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.576 -0.284 . . . . 7.0800000000000001 110.333 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -125.09 100.22 6.46 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.943 -0.392 . . . . 10.16 109.943 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.0 p -76.93 -10.16 13.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.174 0.511 . . . . 9.8100000000000005 110.389 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.85 -40.16 87.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.562 -0.745 . . . . 12.220000000000001 111.223 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -123.69 97.3 41.94 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.137 -0.483 . . . . 10.48 110.767 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.0 -12.15 35.0 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.901 2.4 . . . . 9.0999999999999996 112.597 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.42 -1.54 90.13 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.078 -0.582 . . . . 6.46 112.341 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -112.11 144.35 41.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.761 0.315 . . . . 7.6699999999999999 110.63 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -90.0 109.96 20.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.247 -0.433 . . . . 4.1399999999999997 109.979 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 97' ' ' TYR . 82.2 p -118.58 137.72 53.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.393 -0.367 . . . . 3.2999999999999998 110.031 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -128.98 133.24 47.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.894 0.378 . . . . 1.76 111.232 -174.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.518 ' HB2' ' OD1' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -149.41 149.46 30.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.789 -0.641 . . . . 2.5499999999999998 110.107 177.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.664 ' O ' ' HA ' ' A' ' 94' ' ' ASN . 87.1 mtp -116.07 116.3 27.62 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.025 -0.534 . . . . 1.77 110.353 -176.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -94.66 119.87 33.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.903 0.383 . . . . 1.97 110.279 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.61 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 55.3 ttt180 -116.9 125.6 51.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.217 -0.447 . . . . 3.8500000000000001 110.767 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -115.89 135.95 53.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.825 -0.625 . . . . 2.2799999999999998 110.239 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.483 ' O ' ' HA2' ' A' ' 90' ' ' GLY . 45.4 tttm -122.24 123.56 41.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.712 -0.676 . . . . 2.1400000000000001 109.97 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 48.5 mm -120.03 120.34 62.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 109.286 -0.635 . . . . 1.55 109.286 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -141.49 105.03 5.93 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 111.863 0.32 . . . . 1.1899999999999999 111.863 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 85.4 Cg_endo -84.44 157.04 12.53 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.93 2.42 . . . . 1.3700000000000001 111.263 171.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -126.21 146.77 49.85 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.908 -0.317 . . . . 2.3500000000000001 110.854 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -126.24 130.79 51.62 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.977 -0.556 . . . . 4.54 110.796 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 85' ' ' SER . 42.1 t0 -60.06 140.08 57.06 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.207 0.942 . . . . 3.04 111.319 -176.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.794 ' HA ' ' O ' ' A' ' 129' ' ' PHE . 35.9 m -76.5 -22.67 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 114.944 -1.025 . . . . 4.2699999999999996 111.444 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -82.4 83.52 7.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.79 0.328 . . . . 6.04 110.439 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.2 tp -90.39 -79.78 0.34 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.224 -0.444 . . . . 4.5899999999999999 111.284 -177.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 69.4 p -145.14 158.11 43.91 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.9 -0.136 . . . . 3.6899999999999999 111.101 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 58.49 25.22 12.76 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.774 0.671 . . . . 5.1699999999999999 112.271 170.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.471 ' HA ' HH12 ' A' ' 128' ' ' ARG . 25.1 m-20 57.04 30.0 17.45 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.064 0.459 . . . . 3.71 111.908 -176.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.1 mt -99.02 139.58 34.45 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.231 -1.026 . . . . 2.0499999999999998 108.231 170.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.652 ' HA ' ' O ' ' A' ' 121' ' ' VAL . 50.7 mmt-85 -107.99 120.17 41.55 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.213 -0.595 . . . . 4.2400000000000002 110.624 -174.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.794 ' O ' ' HA ' ' A' ' 121' ' ' VAL . 90.2 m-85 -118.47 125.11 49.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.6 -0.727 . . . . 3.5499999999999998 109.79 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.483 ' O ' ' HA ' ' A' ' 156' ' ' THR . 24.0 t30 -110.77 126.24 54.39 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.609 -0.268 . . . . 2.1099999999999999 110.282 -175.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.79 117.38 1.85 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.087 -1.054 . . . . 1.1799999999999999 112.357 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.536 ' HB3' ' HB3' ' A' ' 155' ' ' GLU . 52.8 t-105 -126.6 129.91 49.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.398 -0.593 . . . . 4.2999999999999998 109.398 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 84.3 mt -118.06 138.27 52.35 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.715 -0.476 . . . . 2.2400000000000002 109.715 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.489 ' OG ' ' HB2' ' A' ' 153' ' ' GLU . 3.2 p -134.99 117.19 15.51 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.475 0.655 . . . . 1.6899999999999999 111.153 175.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 95.1 mmm -106.12 134.83 48.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.183 -0.917 . . . . 2.2400000000000002 109.288 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -124.9 133.83 52.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.012 0.434 . . . . 3.5600000000000001 111.888 -173.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 97.7 mttt -118.5 132.66 56.22 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.681 -0.859 . . . . 1.6699999999999999 108.681 171.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.578 ' H ' HD12 ' A' ' 142' ' ' LEU . 54.3 m-85 -123.03 143.04 50.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.508 0.194 . . . . 3.23 110.908 -174.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 59.79 -160.19 0.29 Allowed 'General case' 0 C--O 1.226 -0.171 0 O-C-N 123.856 0.722 . . . . 1.24 111.446 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -76.02 -36.06 59.27 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.952 0.406 . . . . 2.4700000000000002 110.483 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -60.29 -49.74 76.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.379 -0.828 . . . . 2.4100000000000001 113.169 -167.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.578 HD12 ' H ' ' A' ' 138' ' ' PHE . 14.7 mt -70.41 -27.18 64.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.74 -0.384 . . . . 1.8300000000000001 111.371 -176.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -60.72 -39.92 90.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.114 0.483 . . . . 2.0 110.343 172.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 85.0 m -70.05 -41.02 74.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.617 -0.72 . . . . 2.0499999999999998 111.018 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.556 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 56.3 p -74.82 -26.09 59.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 1.5900000000000001 111.718 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 69.0 -112.96 4.91 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.845 -0.693 . . . . 1.52 112.345 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -106.21 -0.19 24.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.691 0.281 . . . . 5.9400000000000004 110.801 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.85 -40.18 75.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.103 0.478 . . . . 1.8300000000000001 110.547 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.454 ' O ' HD22 ' A' ' 142' ' ' LEU . 24.2 t70 -135.94 111.57 9.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.489 -0.778 . . . . 2.6400000000000001 109.083 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.6 t -165.7 147.15 7.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.932 -0.576 . . . . 2.02 110.114 -173.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.421 ' HD3' ' OE2' ' A' ' 153' ' ' GLU . 24.5 ttm180 -70.71 135.71 48.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.611 0.243 . . . . 3.6699999999999999 110.508 175.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.91 120.08 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.176 -0.466 . . . . 1.6399999999999999 110.058 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.489 ' HB2' ' OG ' ' A' ' 134' ' ' SER . 96.4 mt-10 -119.97 139.96 51.66 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.444 -0.576 . . . . 2.5600000000000001 109.444 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 89.5 m -139.97 134.41 31.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.972 0.415 . . . . 1.3899999999999999 111.493 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 132' ' ' TRP . 41.6 tt0 -113.35 127.81 56.25 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.298 -0.63 . . . . 2.04 109.298 173.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 130' ' ' ASN . 35.5 m -129.0 120.46 26.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.847 0.356 . . . . 1.5600000000000001 110.474 177.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -116.21 133.9 11.07 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.709 -0.758 . . . . 1.04 111.601 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.517 ' HB2' HG13 ' A' ' 170' ' ' VAL . 52.6 mt -121.28 133.07 55.13 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.508 -0.553 . . . . 2.27 109.508 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 128' ' ' ARG . 54.1 tt0 -120.03 120.38 36.14 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.458 -0.337 . . . . 2.4100000000000001 110.419 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -121.55 131.0 53.88 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.358 -0.608 . . . . 4.5700000000000003 109.358 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.405 ' HB ' ' HA ' ' A' ' 164' ' ' GLU . 15.1 p -99.49 89.81 4.3 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.466 -0.494 . . . . 1.46 110.138 177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.07 -49.1 78.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.61 -0.723 . . . . 2.6299999999999999 111.441 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.498 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.1 m-20 -100.0 12.68 36.26 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 121.119 -0.232 . . . . 2.4100000000000001 110.454 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.405 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 42.2 tt0 71.15 -49.51 0.68 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.725 0.81 . . . . 2.5800000000000001 111.762 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.2 t -74.84 -16.22 60.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.73 0.3 . . . . 2.2999999999999998 111.488 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 163' ' ' ASN . 17.9 m -125.58 141.45 45.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.853 0.359 . . . . 1.71 110.439 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.423 ' O ' ' HD2' ' A' ' 199' ' ' PRO . . . -107.23 139.43 41.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 1.47 110.909 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 31.2 mt -104.42 136.8 43.32 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.651 -0.87 . . . . 1.6599999999999999 108.651 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -118.34 120.12 36.68 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.444 -0.502 . . . . 3.2999999999999998 110.477 -176.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.517 HG13 ' HB2' ' A' ' 158' ' ' LEU . 3.5 p -129.69 131.95 66.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.744 -0.662 . . . . 1.3 109.752 176.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.485 HD21 ' CG ' ' A' ' 155' ' ' GLU . 26.8 t-20 -127.84 130.05 47.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.002 -0.545 . . . . 2.2200000000000002 110.163 -176.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -101.01 121.67 42.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.009 -0.542 . . . . 4.6100000000000003 109.626 175.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -97.3 110.0 22.64 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.155 -0.683 . . . . 3.98 109.155 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.541 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 61.2 tp -103.63 115.67 30.92 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.084 -0.507 . . . . 2.3799999999999999 110.372 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -122.06 114.21 20.61 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.634 -0.876 . . . . 3.3100000000000001 108.634 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -100.03 124.27 45.21 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.261 -0.427 . . . . 6.5300000000000002 111.068 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 141.35 89.45 0.15 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.813 -0.631 . . . . 5.0599999999999996 112.403 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -64.54 -39.71 94.27 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.218 -0.66 . . . . 7.3899999999999997 109.218 175.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -95.68 122.49 38.5 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.379 -0.971 . . . . 9.0700000000000003 108.379 172.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 90.3 mtp -79.23 151.12 31.37 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.05 -0.523 . . . . 10.869999999999999 111.3 -171.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -60.09 -43.42 95.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.34 0.591 . . . . 10.449999999999999 109.485 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.575 ' HB2' ' ND2' ' A' ' 185' ' ' ASN . 40.4 m-20 -130.01 130.01 44.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.115 -0.948 . . . . 13.06 109.213 174.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.8 p -73.81 -15.72 61.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.241 0.543 . . . . 12.609999999999999 109.946 175.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -69.76 -39.12 76.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.245 -0.889 . . . . 15.19 110.907 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.575 ' ND2' ' HB2' ' A' ' 182' ' ' ASP . 81.1 m-20 -64.65 134.82 55.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.993 -0.548 . . . . 13.18 110.19 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.481 ' HB2' ' ND2' ' A' ' 19' ' ' ASN . 10.9 t30 -107.18 119.99 40.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.776 0.322 . . . . 12.73 110.748 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -90.31 -177.5 44.54 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.963 -0.637 . . . . 9.9800000000000004 111.868 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -74.39 127.66 33.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.111 0.481 . . . . 10.699999999999999 109.959 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -70.18 -39.47 75.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.712 -0.676 . . . . 10.5 110.476 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 37.7 m -87.34 71.54 9.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.206 -0.452 . . . . 6.6399999999999997 110.18 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 27.3 m -64.6 128.89 37.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.788 -0.642 . . . . 4.9800000000000004 110.302 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -115.96 130.57 56.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.212 0.53 . . . . 7.0999999999999996 110.921 -175.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -59.78 -42.62 93.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.719 -1.128 . . . . 4.4000000000000004 111.363 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.699 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 18.5 tt -149.27 146.57 17.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.976 -0.556 . . . . 2.21 109.645 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.517 ' HB3' ' HB3' ' A' ' 210' ' ' TYR . 96.6 mtt180 -121.93 110.08 15.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.723 0.297 . . . . 3.54 110.774 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -137.21 141.76 42.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.544 -0.298 . . . . 1.6699999999999999 111.186 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -163.53 174.99 11.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.647 -0.871 . . . . 5.8300000000000001 108.647 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 7.0 mp -98.64 125.61 42.03 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.045 -0.724 . . . . 2.5899999999999999 109.045 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' A' ' 167' ' ' ALA . 36.5 Cg_exo -60.07 138.75 83.83 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.1 1.867 . . . . 1.77 111.672 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 77.9 mt -116.94 131.81 56.86 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.183 -0.673 . . . . 2.2599999999999998 109.183 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 11.6 t -147.94 139.87 24.05 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.189 0.518 . . . . 1.99 110.838 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 57.2 tp -143.89 85.46 1.82 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.542 -0.754 . . . . 2.3100000000000001 109.354 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 75.92 -112.29 3.55 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.858 -0.686 . . . . 1.51 112.487 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -93.94 0.02 55.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.204 0.526 . . . . 2.5699999999999998 110.351 -177.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -110.56 116.56 31.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.725 -0.67 . . . . 2.6600000000000001 110.105 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 49.2 m -122.6 131.05 53.64 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.842 -0.429 . . . . 1.6200000000000001 109.842 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.27 130.01 72.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.044 -0.354 . . . . 1.3799999999999999 110.044 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.7 m -127.72 90.34 48.38 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-O 120.915 0.388 . . . . 1.1799999999999999 110.484 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 238' ' ' GLY . 5.8 Cg_exo -79.58 150.45 21.79 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.167 2.578 . . . . 1.01 112.081 175.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.517 ' HB3' ' HB3' ' A' ' 195' ' ' ARG . 80.9 m-85 -126.08 139.93 52.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.024 0.44 . . . . 4.5 111.316 173.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 7.0 t -154.43 169.22 24.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.368 -0.975 . . . . 1.8899999999999999 108.368 175.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.699 ' HA ' ' O ' ' A' ' 194' ' ' ILE . 67.3 ttt180 -60.29 -49.19 78.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 118.385 0.539 . . . . 4.7999999999999998 111.015 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.6 mt -120.21 122.26 67.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.584 -0.524 . . . . 4.5700000000000003 109.584 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -86.72 39.06 3.08 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.835 -0.697 . . . . 4.9800000000000004 113.475 -174.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.8 tp -140.01 128.92 23.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.937 0.369 . . . . 8.1099999999999994 110.253 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -80.93 140.06 35.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.089 -0.505 . . . . 7.6500000000000004 111.565 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -131.4 151.9 51.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.439 -0.8 . . . . 10.529999999999999 109.353 173.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -111.68 131.22 55.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.597 -0.519 . . . . 11.56 109.597 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 222' ' ' ASP . 47.8 t -130.05 139.96 50.91 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.16 -0.473 . . . . 10.06 109.753 -176.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -69.25 -39.87 78.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.915 -0.584 . . . . 11.92 110.575 175.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -78.0 -39.91 40.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.513 -0.767 . . . . 14.01 111.901 -174.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 219' ' ' SER . 8.2 p-10 -131.77 150.08 52.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.116 0.484 . . . . 14.529999999999999 111.423 -175.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -132.66 158.76 41.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.768 -0.651 . . . . 16.609999999999999 110.478 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -70.02 -37.73 75.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.18 0.514 . . . . 15.460000000000001 109.761 172.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -60.12 -39.91 87.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.045 -0.98 . . . . 15.67 111.264 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -82.44 133.36 35.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.92 -0.582 . . . . 14.5 110.143 -177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.58 120.4 63.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.871 0.367 . . . . 15.15 110.687 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.22 125.8 33.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.841 -0.618 . . . . 14.73 110.472 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -63.18 -40.02 96.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.766 -0.652 . . . . 16.379999999999999 110.483 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -120.62 130.53 54.2 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.641 -0.709 . . . . 12.779999999999999 109.729 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -173.73 -173.18 39.73 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.505 -0.855 . . . . 11.1 112.317 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -70.0 -40.21 75.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.073 0.463 . . . . 12.26 110.657 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -151.05 167.81 26.54 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.776 -0.647 . . . . 9.9900000000000002 110.719 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -122.87 108.92 13.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.873 -0.603 . . . . 10.43 109.478 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -82.01 93.09 6.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.145 0.498 . . . . 6.29 110.58 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -99.29 139.26 35.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.829 -0.623 . . . . 8.1500000000000004 109.951 172.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 60.0 t -110.76 121.25 63.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.675 -0.491 . . . . 2.3999999999999999 109.675 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 209' ' ' PRO . . . -92.14 117.08 5.19 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.427 -0.892 . . . . 1.27 111.265 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.49 119.72 39.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.876 0.37 . . . . 1.97 110.305 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -99.89 119.92 38.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.76 -0.655 . . . . 3.54 109.287 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 252' ' ' SER . 91.1 m-85 -100.53 126.69 47.0 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.813 -0.44 . . . . 2.6400000000000001 109.813 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -116.25 121.46 5.21 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.798 -0.715 . . . . 1.3500000000000001 111.607 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' TYR . . . . . 0.442 ' HB2' ' HB ' ' A' ' 251' ' ' VAL . 89.7 m-85 -119.94 130.25 54.71 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.802 -0.444 . . . . 4.3600000000000003 109.802 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -112.65 128.7 56.46 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.456 -0.572 . . . . 4.29 109.456 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.92 140.19 51.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.159 0.505 . . . . 6.6900000000000004 110.391 -177.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -60.0 -29.49 68.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.058 -0.974 . . . . 6.3700000000000001 112.24 -171.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -69.47 -20.01 63.75 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.607 0.241 . . . . 5.8300000000000001 111.486 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 116.22 0.0 20.76 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.548 -0.834 . . . . 2.6600000000000001 112.259 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.433 HD13 ' CD2' ' A' ' 279' ' ' TYR . 53.5 tp -74.98 129.96 38.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.869 0.366 . . . . 2.9700000000000002 110.256 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 25.8 t -122.06 130.26 53.12 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.261 -0.644 . . . . 2.1699999999999999 109.261 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 243' ' ' TYR . 62.9 t -119.99 132.85 68.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.42 -0.355 . . . . 1.79 110.666 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 241' ' ' TYR . 35.2 t -127.73 128.45 45.39 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.068 -0.716 . . . . 1.6299999999999999 109.068 175.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 81.6 mt -121.38 139.93 52.79 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.652 -0.249 . . . . 2.96 110.82 -178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -114.35 110.67 20.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.182 -0.463 . . . . 4.0800000000000001 110.536 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -131.92 148.67 52.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.35 -0.386 . . . . 4.8399999999999999 110.34 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -111.66 19.97 17.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.24 0.543 . . . . 3.5800000000000001 110.087 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -126.84 113.99 17.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.812 -0.631 . . . . 6.7699999999999996 109.971 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.411 ' HG2' ' CD1' ' A' ' 259' ' ' TRP . 72.4 tt0 -70.18 -41.67 73.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.015 0.436 . . . . 8.5399999999999991 110.443 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . 0.411 ' CD1' ' HG2' ' A' ' 258' ' ' GLU . 90.5 m95 -133.77 93.98 3.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.977 -0.556 . . . . 11.9 110.544 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.59 ' HA ' ' OD1' ' A' ' 263' ' ' ASP . 97.9 mt-30 -59.85 -39.77 86.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.122 -0.49 . . . . 10.57 111.396 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -63.35 -21.54 66.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.972 -0.558 . . . . 11.41 111.611 -176.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -104.08 7.76 36.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.598 0.237 . . . . 11.98 111.41 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.59 ' OD1' ' HA ' ' A' ' 260' ' ' GLN . 10.4 m-20 -76.58 124.12 27.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.261 0.553 . . . . 12.460000000000001 111.49 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -70.03 -40.01 75.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.378 -0.828 . . . . 13.779999999999999 110.276 175.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 95.39 -22.4 39.02 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.737 -0.665 . . . . 11.07 112.816 176.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -70.03 -20.32 63.26 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.227 0.454 . . . . 12.59 112.227 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 51.8 m -59.95 -40.12 87.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.822 0.344 . . . . 10.92 111.681 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -127.01 132.79 50.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.297 -0.41 . . . . 12.42 110.03 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -70.12 -36.25 74.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.265 -0.425 . . . . 11.59 111.58 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -119.35 140.05 50.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.299 -0.409 . . . . 8.8300000000000001 110.179 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -130.04 138.17 50.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.145 -0.479 . . . . 7.0199999999999996 110.175 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -151.27 165.4 34.09 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.757 -0.46 . . . . 6.5999999999999996 109.757 176.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -138.94 170.55 15.79 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.607 -0.516 . . . . 1.9399999999999999 109.607 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.07 133.61 7.34 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.216 -0.992 . . . . 1.4199999999999999 112.343 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 61.8 t -127.86 129.82 69.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.956 -0.387 . . . . 1.8100000000000001 109.956 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -132.76 111.85 1.06 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.227 -0.749 . . . . 1.3 111.227 176.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 23.8 m -119.98 132.36 69.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.845 0.355 . . . . 1.8300000000000001 110.815 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -119.71 127.75 53.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.153 -0.476 . . . . 2.3100000000000001 110.368 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.433 ' CD2' HD13 ' A' ' 249' ' ' LEU . 89.6 m-85 -105.99 130.27 53.95 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.044 -0.725 . . . . 4.75 109.044 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.1 t -117.68 125.05 49.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.841 0.353 . . . . 1.6699999999999999 111.172 -172.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.281 -0.866 . . . . 3.6899999999999999 109.858 179.193 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.0 mtm . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 109.444 -0.576 . . . . 11.85 109.444 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.485 ' OE1' ' HB2' ' A' ' 4' ' ' ARG . 37.4 tt0 -151.01 143.94 24.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.048 0.451 . . . . 10.35 110.546 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.19 -39.88 88.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.387 -0.824 . . . . 9.3100000000000005 111.334 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.485 ' HB2' ' OE1' ' A' ' 2' ' ' GLU . 33.9 mtm180 -67.41 129.3 39.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.028 -0.533 . . . . 8.8399999999999999 110.663 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.418 ' HB3' ' OD1' ' A' ' 41' ' ' ASN . 13.4 m120 -127.31 109.18 11.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.898 -0.592 . . . . 7.0099999999999998 109.815 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -72.51 125.67 28.0 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.816 -0.439 . . . . 3.6099999999999999 109.816 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -71.78 118.18 14.3 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.674 -0.491 . . . . 3.3300000000000001 109.674 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.468 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 96.4 m-70 -104.14 124.94 50.0 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.104 0.478 . . . . 3.2000000000000002 110.671 -176.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.97 139.94 51.7 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.422 -0.808 . . . . 2.4900000000000002 109.264 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -129.12 129.63 45.42 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.036 -0.728 . . . . 2.1299999999999999 109.036 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.6 mm -120.53 120.08 61.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.901 -0.407 . . . . 1.6000000000000001 109.901 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -102.74 137.69 13.53 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.065 -1.064 . . . . 0.88 111.331 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.17 135.36 54.26 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.921 0.391 . . . . 1.0800000000000001 110.248 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 59.4 ttm -134.6 130.95 37.24 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.696 -0.683 . . . . 2.3300000000000001 110.026 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -99.84 121.64 41.6 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.486 -0.561 . . . . 2.6099999999999999 109.486 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.64 140.17 55.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 5.0899999999999999 110.519 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.0 tt -129.86 138.42 54.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.907 0.384 . . . . 5.3300000000000001 110.102 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -110.03 147.96 32.57 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.033 0.444 . . . . 8.2799999999999994 110.375 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -70.03 -20.59 63.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.322 -0.854 . . . . 9.6999999999999993 111.593 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.2 t -120.46 129.96 74.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.735 -0.469 . . . . 11.09 109.735 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.57 -39.8 92.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.364 -0.835 . . . . 13.1 111.183 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.24 151.86 17.94 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.711 -0.757 . . . . 11.94 111.842 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -84.9 122.31 29.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.177 0.513 . . . . 15.18 111.662 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.3 -176.6 38.98 Favored Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.471 -0.786 . . . . 12.0 111.415 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -69.78 -35.65 75.07 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.771 0.32 . . . . 12.82 110.862 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -70.11 -19.9 63.21 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.933 0.397 . . . . 10.81 111.087 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 91.3 mtp -91.38 139.97 30.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.892 -0.594 . . . . 10.050000000000001 111.064 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -156.14 151.94 27.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.082 -0.508 . . . . 8.0600000000000005 110.13 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.27 -177.9 30.1 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.014 -0.612 . . . . 5.5800000000000001 111.614 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.4 mt -134.57 148.6 50.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.814 0.307 . . . . 5.5599999999999996 110.644 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.42 114.49 25.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.092 -0.504 . . . . 3.0499999999999998 109.804 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -123.49 152.4 64.79 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 120.897 0.379 . . . . 3.48 111.278 -171.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.38 133.59 28.68 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.088 1.859 . . . . 1.8600000000000001 110.679 171.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.8 m -128.45 147.25 50.65 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.561 -0.29 . . . . 1.97 110.654 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 19.5 m -120.13 146.69 24.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.382 -0.372 . . . . 1.71 110.475 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -119.96 142.65 48.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.03 -0.532 . . . . 4.0700000000000003 109.608 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 64.4 t80 -101.7 129.87 47.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.863 0.363 . . . . 2.8599999999999999 110.602 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -144.38 134.87 24.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.79 -0.641 . . . . 1.8899999999999999 109.351 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.74 146.7 39.87 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.309 -0.244 . . . . 1.0800000000000001 111.425 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 8' ' ' HIS . . . -154.95 122.53 5.7 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 111.936 0.347 . . . . 1.3899999999999999 111.936 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.656 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 53.8 t30 -167.87 95.56 0.43 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.391 -0.368 . . . . 2.8599999999999999 110.207 173.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.69 -94.72 2.02 Favored Glycine 0 C--O 1.23 -0.134 0 C-N-CA 121.012 -0.614 . . . . 1.6799999999999999 111.67 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.656 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 80.8 Cg_exo -47.19 175.74 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 123.912 3.075 . . . . 1.6599999999999999 113.357 167.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -66.1 176.68 1.62 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.428 0.632 . . . . 3.3999999999999999 111.441 -172.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.401 ' HG3' ' HB2' ' A' ' 40' ' ' ALA . 19.1 ttm180 -110.62 124.18 51.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.707 -0.678 . . . . 3.1000000000000001 109.649 -171.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.44 HG12 HG22 ' A' ' 74' ' ' VAL . 85.3 mt -119.58 130.01 74.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.664 -0.698 . . . . 1.8 110.915 -169.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -118.96 130.0 55.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.85999999999999999 110.419 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 72' ' ' LEU . 65.2 tp -124.57 135.66 53.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.138 -0.483 . . . . 1.0600000000000001 111.241 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.98 162.47 35.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.663 -0.699 . . . . 1.1399999999999999 110.121 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -137.42 146.87 44.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.821 0.344 . . . . 4.0199999999999996 110.345 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.436 ' HB2' ' HG3' ' A' ' 69' ' ' ARG . 96.1 m-85 -130.05 129.95 44.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.229 -0.441 . . . . 4.6100000000000003 111.306 -175.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -104.54 85.94 2.42 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.281 -0.637 . . . . 3.3799999999999999 109.281 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.552 ' CD ' HH21 ' A' ' 69' ' ' ARG . 42.2 mt-10 -129.04 154.09 46.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.857 -0.61 . . . . 5.0499999999999998 110.907 -173.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 154.96 133.51 1.74 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.707 -0.759 . . . . 4.3700000000000001 112.454 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.21 145.44 60.31 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.328 2.019 . . . . 6.6799999999999997 111.649 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 61.4 t -130.0 129.94 65.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.353 -0.385 . . . . 8.1699999999999999 110.607 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -124.61 -174.75 3.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.54 -0.541 . . . . 10.039999999999999 109.54 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -60.01 -40.01 87.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.596 0.236 . . . . 11.609999999999999 111.07 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.484 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 10.2 m -63.45 -50.17 70.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.012 0.434 . . . . 9.7899999999999991 110.778 -178.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.25 -38.52 81.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.736 -0.665 . . . . 8.5099999999999998 111.36 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -60.03 -24.18 60.35 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 116.047 -0.524 . . . . 7.5599999999999996 113.523 -176.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' A' ' 59' ' ' SER . 55.1 mtmt -69.77 -26.31 64.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.544 0.211 . . . . 10.0 111.559 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -106.2 147.28 29.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.049 0.452 . . . . 10.35 110.806 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -86.99 46.3 3.54 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.586 -0.606 . . . . 5.3399999999999999 111.586 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.2 m -93.31 126.83 38.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.621 0.248 . . . . 5.3200000000000003 110.34 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -120.01 139.03 53.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.433 -0.349 . . . . 5.6100000000000003 110.616 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -125.66 138.65 53.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.459 -0.337 . . . . 3.7799999999999998 110.153 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -131.99 170.03 15.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.366 -0.379 . . . . 2.4500000000000002 110.173 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.552 HH21 ' CD ' ' A' ' 53' ' ' GLU . 27.9 ptt180 -141.84 125.7 9.96 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.979 0.418 . . . . 3.2400000000000002 111.196 171.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.553 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 90.9 Cg_endo -85.19 156.85 11.15 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.999 2.466 . . . . 1.1899999999999999 112.25 172.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.441 ' HG3' ' HE ' ' A' ' 93' ' ' ARG . 86.1 tt0 -127.09 120.77 29.7 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.123 -0.695 . . . . 2.1899999999999999 109.123 171.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.592 ' O ' ' HA3' ' A' ' 91' ' ' GLY . 64.3 tp -136.21 119.09 16.26 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.346 -0.388 . . . . 1.1399999999999999 110.208 -177.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -128.59 149.22 50.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.122 0.487 . . . . 2.1800000000000002 110.864 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 46' ' ' ILE . 50.6 t -119.96 130.04 74.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.447 -0.797 . . . . 1.5600000000000001 109.272 177.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -93.73 120.51 34.09 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.704 -0.48 . . . . 3.4399999999999999 109.704 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -108.2 134.85 50.47 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.105 -0.702 . . . . 4.7999999999999998 109.105 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -120.0 131.29 55.09 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.68 0.276 . . . . 2.9399999999999999 110.318 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -119.58 138.57 53.13 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.29 0.567 . . . . 3.8999999999999999 111.167 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 84' ' ' PHE . 37.0 mt -100.24 94.04 6.0 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.684 -0.858 . . . . 4.4800000000000004 108.684 177.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -90.02 -81.33 0.29 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.884 0.373 . . . . 6.1900000000000004 110.867 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -109.11 -40.01 5.1 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.994 -0.743 . . . . 5.4500000000000002 108.994 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -114.12 147.3 39.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.988 -1.006 . . . . 5.2699999999999996 108.966 174.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -71.34 125.03 25.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.081 -0.509 . . . . 6.3300000000000001 112.189 -173.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.483 ' H ' HD23 ' A' ' 79' ' ' LEU . 93.2 m-85 70.18 10.46 7.34 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.981 -1.008 . . . . 7.4800000000000004 112.4 172.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.3 m -60.38 -40.13 89.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.894 0.378 . . . . 2.5499999999999998 111.698 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -94.43 103.89 15.86 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.271 -0.572 . . . . 5.2999999999999998 109.65 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -113.97 125.65 6.99 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.979 -0.848 . . . . 1.3500000000000001 110.979 176.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 60.0 tp -119.64 130.53 55.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.837 0.351 . . . . 2.29 111.02 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.2 p -117.04 131.86 56.83 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.788 -0.819 . . . . 1.54 108.788 169.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.43 150.46 20.88 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.235 -0.983 . . . . 1.1699999999999999 111.585 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.592 ' HA3' ' O ' ' A' ' 72' ' ' LEU . . . -173.16 -169.96 36.23 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.632 -0.794 . . . . 1.1899999999999999 112.07 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -120.21 139.98 51.85 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.062 0.458 . . . . 3.75 110.819 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.441 ' HE ' ' HG3' ' A' ' 71' ' ' GLU . 98.2 mtt180 -121.04 127.21 51.5 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.492 -0.929 . . . . 2.75 108.492 172.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.553 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 10.4 t30 -132.25 124.61 29.26 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.78 -0.368 . . . . 1.8200000000000001 110.674 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.487 ' HA ' ' HB3' ' A' ' 69' ' ' ARG . 72.1 t80 -111.28 129.54 55.95 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.331 -0.395 . . . . 3.1400000000000001 110.435 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.3 -176.97 40.72 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.68 -0.772 . . . . 2.79 112.574 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -122.08 129.0 52.0 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.737 -0.468 . . . . 7.6200000000000001 109.737 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -70.27 -40.22 74.47 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.325 -0.62 . . . . 7.0800000000000001 109.325 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -107.67 124.25 49.7 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.364 -0.835 . . . . 10.16 109.525 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.66 HG12 ' H ' ' A' ' 102' ' ' GLU . 58.8 t -120.04 130.0 74.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.874 -0.417 . . . . 9.8100000000000005 109.874 -178.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -72.11 -10.05 59.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 12.220000000000001 112.123 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.66 ' H ' HG12 ' A' ' 100' ' ' VAL . 44.7 mt-10 -70.21 145.28 93.39 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.958 -0.386 . . . . 10.48 109.958 173.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.96 -10.59 28.77 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 C-N-CA 123.317 2.678 . . . . 9.0999999999999996 114.104 -172.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -74.65 141.57 28.71 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.455 -0.878 . . . . 6.46 112.331 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.62 -40.08 95.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.702 0.287 . . . . 7.6699999999999999 111.617 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -62.06 139.5 58.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.033 -0.53 . . . . 4.1399999999999997 111.17 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.2 t -141.51 173.51 11.43 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.522 -0.763 . . . . 3.2999999999999998 109.049 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.62 113.25 7.02 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.623 -0.431 . . . . 1.76 110.864 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -147.02 138.56 24.19 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.045 -0.525 . . . . 2.5499999999999998 110.139 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.493 ' HG3' ' HA ' ' A' ' 139' ' ' ALA . 46.4 ttm -131.65 129.91 41.4 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.622 -0.717 . . . . 1.77 110.71 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -101.87 124.96 48.39 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.491 -0.559 . . . . 1.97 109.491 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.42 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 80.6 ttt180 -130.55 130.15 43.71 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.134 0.492 . . . . 3.8500000000000001 110.328 -175.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -112.2 141.73 45.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.742 -0.663 . . . . 2.2799999999999998 110.79 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -139.89 123.59 17.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.177 -0.465 . . . . 2.1400000000000001 110.424 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 88.0 mt -136.76 130.15 45.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.513 -0.767 . . . . 1.55 109.039 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -149.46 104.19 3.28 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.678 0.622 . . . . 1.1899999999999999 112.678 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 65.0 Cg_endo -94.43 159.77 1.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.463 2.775 . . . . 1.3700000000000001 113.036 170.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -120.6 142.51 49.33 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.379 -0.971 . . . . 2.3500000000000001 108.379 173.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -125.78 129.92 50.41 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.474 0.176 . . . . 4.54 111.474 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -84.1 120.89 26.7 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.576 -0.527 . . . . 3.04 109.576 170.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.57 ' O ' ' HB3' ' A' ' 129' ' ' PHE . 57.3 t -139.88 99.92 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.886 0.375 . . . . 4.2699999999999996 110.282 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -87.61 115.92 25.38 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.113 -0.328 . . . . 6.04 110.113 176.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.78 -39.81 95.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.413 0.625 . . . . 4.5899999999999999 109.322 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.0 p -141.4 169.92 16.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.873 -1.058 . . . . 3.6899999999999999 109.178 172.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -60.14 -45.44 93.05 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.839 0.311 . . . . 5.1699999999999999 111.839 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -64.94 -39.95 94.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 3.71 111.552 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.5 mt -76.16 142.57 41.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.43 0.634 . . . . 2.0499999999999998 112.11 -172.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.541 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 35.2 ttt180 -110.31 118.07 35.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.252 -0.886 . . . . 4.2400000000000002 109.248 175.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.57 ' HB3' ' O ' ' A' ' 121' ' ' VAL . 65.0 t80 -142.11 138.48 31.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.728 0.299 . . . . 3.5499999999999998 110.372 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -139.87 172.2 13.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 2.1099999999999999 109.913 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -148.23 121.99 1.44 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.776 -0.726 . . . . 1.1799999999999999 112.072 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -100.02 126.52 46.22 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.389 -0.597 . . . . 4.2999999999999998 109.389 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 42.6 tp -111.98 130.71 55.76 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.26 -0.427 . . . . 2.2400000000000002 110.117 -178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.1 m -127.0 129.99 49.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.901 0.382 . . . . 1.6899999999999999 110.308 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.613 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 72.0 mtm -122.91 125.19 44.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.849 -0.614 . . . . 2.2400000000000002 109.958 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -122.17 139.94 53.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.116 -0.493 . . . . 3.5600000000000001 111.774 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -135.78 149.98 49.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.323 -0.991 . . . . 1.6699999999999999 108.323 172.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.475 ' O ' HD23 ' A' ' 142' ' ' LEU . 46.2 p90 -140.5 165.93 26.1 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.095 -0.335 . . . . 3.23 110.095 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.493 ' HA ' ' HG3' ' A' ' 110' ' ' MET . . . 63.42 178.15 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.512 0.507 . . . . 1.24 111.018 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -76.1 -36.63 58.82 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.313 0.578 . . . . 2.4700000000000002 110.6 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -60.07 -40.02 88.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.253 -0.885 . . . . 2.4100000000000001 112.956 -171.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 138' ' ' PHE . 4.2 mm? -69.38 -33.4 72.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.696 0.284 . . . . 1.8300000000000001 111.535 -173.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -66.62 -39.93 88.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.365 0.602 . . . . 2.0 109.517 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 52.4 m -65.77 -39.95 91.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.2 -0.909 . . . . 2.0499999999999998 111.395 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 22.9 p -71.7 -9.87 58.91 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 111.89 0.33 . . . . 1.5900000000000001 111.89 -177.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 65.43 -120.34 17.19 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.786 -0.721 . . . . 1.52 111.857 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -103.29 10.09 37.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.854 0.327 . . . . 5.9400000000000004 111.016 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.48 -40.12 95.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.885 0.374 . . . . 1.8300000000000001 110.499 176.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -137.14 114.87 11.27 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.298 -0.631 . . . . 2.6400000000000001 109.298 175.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.1 t -159.95 150.05 18.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.918 0.39 . . . . 2.02 110.543 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 135' ' ' MET . 19.0 mtp180 -84.47 113.35 21.14 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.051 -0.351 . . . . 3.6699999999999999 110.051 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.9 t -111.15 103.7 15.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.98 -0.748 . . . . 1.6399999999999999 108.98 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -121.99 128.91 52.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.549 -0.75 . . . . 2.5600000000000001 110.016 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 72.7 m -128.49 130.22 47.2 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.033 0.444 . . . . 1.3899999999999999 111.527 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.403 ' CD ' HH22 ' A' ' 195' ' ' ARG . 37.2 tt0 -110.4 119.22 38.5 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.01 -0.737 . . . . 2.04 109.01 173.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 172' ' ' TYR . 22.7 p -101.36 141.67 33.89 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 120.726 -0.39 . . . . 1.5600000000000001 110.727 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 129' ' ' PHE . . . -116.7 120.02 4.69 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.723 -0.751 . . . . 1.04 112.095 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.6 tp -115.2 129.76 56.73 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.91 0.386 . . . . 2.27 110.151 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.541 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 30.1 tt0 -118.98 115.85 25.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.521 -0.548 . . . . 2.4100000000000001 109.521 174.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -125.39 130.53 52.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.795 -0.638 . . . . 4.5700000000000003 110.218 -175.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 3.7 p -87.58 93.9 9.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.064 0.459 . . . . 1.46 110.853 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.475 ' HB2' HD11 ' A' ' 168' ' ' LEU . 65.8 t80 -59.99 -49.82 76.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.739 -0.664 . . . . 2.6299999999999999 111.547 -176.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.423 ' HB2' HG22 ' A' ' 166' ' ' VAL . 93.0 m-20 -101.8 16.65 25.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.544 -0.298 . . . . 2.4100000000000001 110.861 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 163' ' ' ASN . 46.0 tt0 73.03 -50.19 0.7 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.763 0.664 . . . . 2.5800000000000001 111.419 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.1 p -74.78 -21.41 59.34 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.037 0.384 . . . . 2.2999999999999998 112.037 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 161' ' ' THR . 34.3 m -120.03 138.16 51.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.776 0.322 . . . . 1.71 110.724 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.0 134.4 50.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.215 -0.448 . . . . 1.47 110.29 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.475 HD11 ' HB2' ' A' ' 162' ' ' PHE . 43.8 mt -103.55 139.92 38.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.34 -0.391 . . . . 1.6599999999999999 110.024 -176.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 196' ' ' ALA . 55.6 mtp180 -98.9 114.36 26.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.212 -0.449 . . . . 3.2999999999999998 109.882 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 195' ' ' ARG . 60.3 t -129.16 132.3 67.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 1.3 110.569 -177.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.435 ' O ' HG23 ' A' ' 194' ' ' ILE . 18.9 m120 -122.52 147.91 45.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.971 0.415 . . . . 2.2200000000000002 110.868 173.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.53 ' HB3' ' OG1' ' A' ' 156' ' ' THR . 64.5 t80 -129.09 147.09 50.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.487 -0.779 . . . . 4.6100000000000003 109.811 -173.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -96.63 125.49 41.14 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 120.757 0.313 . . . . 3.98 110.714 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 67.7 tp -120.83 114.02 20.99 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.257 -0.645 . . . . 2.3799999999999999 109.257 171.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -125.18 113.43 17.66 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.629 -0.508 . . . . 3.3100000000000001 109.629 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.494 ' HD3' ' OE2' ' A' ' 188' ' ' GLU . 47.7 ttp180 -157.17 98.37 1.72 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.063 0.459 . . . . 6.5300000000000002 111.021 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -111.59 -136.56 6.99 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.104 -0.798 . . . . 5.0599999999999996 111.104 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -88.1 130.0 35.14 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.744 -0.465 . . . . 7.3899999999999997 109.744 176.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -79.1 120.9 24.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.808 0.337 . . . . 9.0700000000000003 110.427 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 92.8 mtp -70.02 -40.02 75.47 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.661 -0.866 . . . . 10.869999999999999 108.661 173.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -143.0 109.78 5.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.783 -1.099 . . . . 10.449999999999999 109.202 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -60.89 128.94 38.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.972 0.415 . . . . 13.06 110.502 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 12.0 p -117.21 163.91 15.59 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.023 -0.535 . . . . 12.609999999999999 110.698 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -59.93 -40.18 88.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.272 0.558 . . . . 15.19 110.018 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -119.83 122.41 41.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.503 -0.771 . . . . 13.18 109.811 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -84.23 -23.62 30.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.262 0.553 . . . . 12.73 109.778 175.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 99.38 7.71 53.9 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.371 -0.831 . . . . 9.9800000000000004 111.479 -175.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.494 ' OE2' ' HD3' ' A' ' 176' ' ' ARG . 39.2 mt-10 -60.46 -39.98 89.57 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 122.593 0.357 . . . . 10.699999999999999 111.267 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -101.29 28.15 5.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.167 0.508 . . . . 10.5 110.995 -177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.7 t -139.73 159.97 40.96 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.134 -0.691 . . . . 6.6399999999999997 109.134 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.4 m -140.64 130.19 24.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.096 0.474 . . . . 4.9800000000000004 110.809 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -63.36 -40.68 97.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.617 -0.72 . . . . 7.0999999999999996 111.165 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.461 ' HA ' ' HG3' ' A' ' 212' ' ' ARG . 35.8 tt0 -158.94 131.13 6.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.299 -0.409 . . . . 4.4000000000000004 110.077 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 171' ' ' ASN . 87.3 mt -110.2 143.29 20.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 122.358 0.263 . . . . 2.21 111.188 -173.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.583 ' HB3' ' CD1' ' A' ' 210' ' ' TYR . 53.9 mtm-85 -98.41 102.84 14.7 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.904 -0.776 . . . . 3.54 108.904 169.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 169' ' ' ARG . . . -141.08 121.7 14.22 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.918 -0.313 . . . . 1.6699999999999999 111.014 177.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.405 ' HB3' ' O ' ' A' ' 209' ' ' PRO . 10.2 t80 -165.76 -179.11 5.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.648 -0.501 . . . . 5.8300000000000001 109.648 171.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.551 HD12 ' HD2' ' A' ' 199' ' ' PRO . 24.3 tp -99.44 126.58 37.09 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.315 -0.624 . . . . 2.5899999999999999 109.315 173.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.551 ' HD2' HD12 ' A' ' 198' ' ' LEU . 38.3 Cg_endo -70.06 145.79 56.46 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.139 1.892 . . . . 1.77 112.225 178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 56.1 mt -118.41 130.72 56.13 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.085 -0.507 . . . . 2.2599999999999998 109.655 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 26.8 m -131.12 125.15 32.34 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.983 0.42 . . . . 1.99 110.996 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 91.8 mt -131.37 80.97 1.96 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.57 -0.741 . . . . 2.3100000000000001 109.47 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 68.62 -115.83 6.94 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.802 -0.713 . . . . 1.51 112.105 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -90.12 -0.59 57.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.209 0.528 . . . . 2.5699999999999998 110.117 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.435 ' CD2' ' HE2' ' A' ' 243' ' ' TYR . 75.7 m80 -99.9 117.23 33.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.539 -0.755 . . . . 2.6600000000000001 109.01 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 12.5 t -132.14 130.97 41.82 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.629 -0.428 . . . . 1.6200000000000001 110.24 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.8 p -137.56 134.98 46.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.408 0.623 . . . . 1.3799999999999999 110.862 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 29.0 m -128.95 91.78 41.74 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 115.667 -0.697 . . . . 1.1799999999999999 109.846 176.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.405 ' O ' ' HB3' ' A' ' 197' ' ' TYR . 14.4 Cg_exo -69.74 157.16 61.4 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.599 2.199 . . . . 1.01 110.664 174.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 195' ' ' ARG . 71.0 m-85 -129.29 139.79 51.66 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.997 -0.372 . . . . 4.5 109.997 175.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 39.5 p -124.25 140.02 53.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.987 0.422 . . . . 1.8899999999999999 110.385 176.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.669 ' HD3' ' OD1' ' A' ' 235' ' ' ASN . 37.7 ttt180 -64.27 -39.67 94.41 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 114.795 -1.093 . . . . 4.7999999999999998 112.748 -170.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 87.9 mt -108.0 129.93 61.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.742 0.306 . . . . 4.5700000000000003 110.383 -174.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -70.44 94.87 0.5 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.92 -0.582 . . . . 4.9800000000000004 112.747 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 57.6 tp -60.23 -38.68 84.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.994 0.425 . . . . 8.1099999999999994 110.354 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -80.48 9.33 6.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.673 -0.694 . . . . 7.6500000000000004 111.491 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -115.77 139.9 49.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.952 0.406 . . . . 10.529999999999999 110.974 176.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -109.51 132.32 54.24 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.039 -0.528 . . . . 11.56 109.878 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 13.1 m -95.4 112.53 24.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.465 -0.334 . . . . 10.06 110.43 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -69.98 -37.28 75.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.318 0.58 . . . . 11.92 109.886 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 21.2 m-90 -120.93 153.02 37.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.648 -0.706 . . . . 14.01 110.218 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 60.25 39.51 19.02 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.882 0.739 . . . . 14.529999999999999 110.95 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -94.5 119.96 34.0 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.776 -0.824 . . . . 16.609999999999999 108.776 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -129.47 146.49 51.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.838 0.351 . . . . 15.460000000000001 111.096 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -60.95 -39.32 89.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.328 -0.851 . . . . 15.67 110.622 176.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -60.04 -39.97 87.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.685 -0.688 . . . . 14.5 111.386 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 88.7 mt -63.74 -25.31 37.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.39 -0.368 . . . . 15.15 111.356 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -59.97 -39.95 87.4 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.124 0.488 . . . . 14.73 111.22 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -118.17 137.71 52.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.962 -0.563 . . . . 16.379999999999999 110.526 -170.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.507 ' HG2' ' ND2' ' A' ' 235' ' ' ASN . 47.8 mt-10 -69.46 -34.44 74.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.206 -0.906 . . . . 12.779999999999999 111.134 -172.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 77.69 -132.57 12.07 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.624 -0.798 . . . . 11.1 112.501 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -70.1 -39.96 75.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.818 0.342 . . . . 12.26 111.284 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -89.97 160.16 16.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.09 -0.504 . . . . 9.9900000000000002 111.014 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -119.94 140.08 51.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.022 -0.536 . . . . 10.43 109.937 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.669 ' OD1' ' HD3' ' A' ' 212' ' ' ARG . 48.9 m-80 -79.1 136.75 37.24 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.777 -0.453 . . . . 6.29 109.777 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -73.0 121.75 20.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.254 0.55 . . . . 8.1500000000000004 111.251 -174.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 210' ' ' TYR . 71.0 t -113.58 129.34 69.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.285 -0.871 . . . . 2.3999999999999999 110.031 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -110.39 141.79 16.42 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.599 -0.81 . . . . 1.27 111.807 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 88.9 mt -109.72 117.65 34.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.158 -0.312 . . . . 1.97 110.158 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -101.09 120.11 39.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.205 -0.452 . . . . 3.54 109.95 175.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.555 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 86.8 m-85 -111.94 130.19 55.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.097 0.475 . . . . 2.6400000000000001 110.349 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -121.32 113.7 2.39 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 111.027 -0.829 . . . . 1.3500000000000001 111.027 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' TYR . . . . . 0.435 ' HE2' ' CD2' ' A' ' 205' ' ' HIS . 86.5 m-85 -119.96 135.25 54.98 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.178 0.513 . . . . 4.3600000000000003 111.501 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -110.0 100.82 9.71 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.408 -0.815 . . . . 4.29 109.077 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -77.55 -19.95 54.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.976 0.417 . . . . 6.6900000000000004 110.959 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -149.93 150.46 31.91 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.738 -0.838 . . . . 6.3700000000000001 108.738 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -66.97 121.68 16.06 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.423 -0.511 . . . . 5.8300000000000001 109.682 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 98.53 -9.71 62.65 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.778 -0.646 . . . . 2.6600000000000001 112.43 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 93.1 mt -124.23 133.0 53.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.721 0.296 . . . . 2.9700000000000002 110.616 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 33.7 m -129.98 149.96 51.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.368 -0.378 . . . . 2.1699999999999999 110.772 -176.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 8.5 p -127.41 134.07 66.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.17 0.51 . . . . 1.79 109.845 174.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 19.3 t -103.9 119.89 39.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.716 -0.674 . . . . 1.6299999999999999 109.747 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 77.9 mt -119.42 113.05 20.18 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.145 -0.479 . . . . 2.96 110.068 -178.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -109.05 129.55 55.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.945 0.402 . . . . 4.0800000000000001 111.036 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -128.14 151.3 49.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.823 -0.626 . . . . 4.8399999999999999 110.441 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -134.49 146.98 50.26 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.164 -0.471 . . . . 3.5800000000000001 110.568 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -78.77 159.94 27.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.092 -0.504 . . . . 6.7699999999999996 110.29 177.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 60.06 39.57 19.61 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.507 0.504 . . . . 8.5399999999999991 111.134 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -69.98 -30.02 67.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.766 -0.652 . . . . 11.9 112.467 -175.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -67.92 -40.75 83.32 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.647 0.261 . . . . 10.57 111.409 -173.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -104.32 114.89 29.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.911 -0.403 . . . . 11.41 109.911 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -93.6 74.03 4.37 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.144 -0.48 . . . . 11.98 111.438 -175.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -74.5 124.9 27.45 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.461 -0.57 . . . . 12.460000000000001 109.461 171.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -68.47 -40.0 81.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.637 -0.71 . . . . 13.779999999999999 110.985 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.85 17.32 68.03 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.523 -0.762 . . . . 11.07 111.972 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 60.04 39.38 19.92 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.305 0.574 . . . . 12.59 110.534 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 34.5 t -146.81 138.16 24.24 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.629 -0.714 . . . . 10.92 110.127 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -80.1 -10.17 59.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.282 0.563 . . . . 12.42 109.979 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -89.12 120.26 30.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.522 -0.763 . . . . 11.59 109.534 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -135.99 160.79 37.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.145 -0.479 . . . . 8.8300000000000001 110.695 -174.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -84.4 113.08 20.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.043 -0.526 . . . . 7.0199999999999996 110.92 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -82.73 130.09 35.07 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.064 -0.717 . . . . 6.5999999999999996 109.064 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -134.62 140.59 46.18 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.445 -0.206 . . . . 1.9399999999999999 110.445 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 177.69 -169.74 41.86 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.747 -0.739 . . . . 1.4199999999999999 112.333 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 63.2 t -110.12 128.89 65.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.867 0.365 . . . . 1.8100000000000001 110.667 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.86 141.21 12.46 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.508 -0.637 . . . . 1.3 111.508 176.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 61.6 t -120.02 129.96 74.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 117.093 0.447 . . . . 1.8300000000000001 110.162 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -108.11 109.33 20.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.935 0.398 . . . . 2.3100000000000001 110.058 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -100.02 107.9 19.96 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.872 -0.788 . . . . 4.75 108.872 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 39.6 m -119.54 132.27 55.71 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.998 0.428 . . . . 1.6699999999999999 111.248 -172.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 59.2 t80 . . . . . 0 C--O 1.241 0.617 0 CA-C-O 118.411 -0.804 . . . . 3.6899999999999999 109.225 176.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.425 0.155 . . . . 11.85 111.181 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -60.04 -39.55 86.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.392 0.615 . . . . 10.35 110.408 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -85.32 8.16 19.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.524 -0.762 . . . . 9.3100000000000005 111.547 -175.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -126.75 152.78 46.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.786 0.327 . . . . 8.8399999999999999 111.038 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -113.63 164.07 14.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.112 -0.494 . . . . 7.0099999999999998 110.892 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -60.85 -43.37 98.42 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.162 0.506 . . . . 3.6099999999999999 111.322 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.517 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 71.0 m95 -119.79 147.24 44.88 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.151 -0.685 . . . . 3.3300000000000001 109.151 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.662 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 11.6 t-160 -96.44 113.37 24.94 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.624 -0.51 . . . . 3.2000000000000002 109.624 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.517 ' CE1' ' HB2' ' A' ' 7' ' ' TRP . 95.0 m-85 -110.41 158.88 18.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.904 -0.589 . . . . 2.4900000000000002 111.108 -176.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -141.42 132.3 25.93 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.809 -0.632 . . . . 2.1299999999999999 109.326 170.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.5 mt -119.8 114.09 43.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.974 -0.75 . . . . 1.6000000000000001 108.974 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.81 127.25 8.18 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.265 -0.969 . . . . 0.88 112.128 -174.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -115.69 134.45 55.02 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 110.057 -0.349 . . . . 1.0800000000000001 110.057 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.607 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 94.8 mmm -124.31 131.03 53.5 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.859 -0.61 . . . . 2.3300000000000001 109.372 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -85.82 109.1 18.44 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.769 -0.456 . . . . 2.6099999999999999 109.769 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -96.2 114.37 26.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.145 0.498 . . . . 5.0899999999999999 110.706 -175.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 88.2 mt -119.87 121.31 65.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.401 -0.818 . . . . 5.3300000000000001 110.382 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -119.93 138.3 53.53 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.174 0.511 . . . . 8.2799999999999994 110.042 176.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -60.18 -39.91 88.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.101 -0.954 . . . . 9.6999999999999993 111.403 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.7 t -83.51 118.97 31.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.936 -0.575 . . . . 11.09 110.532 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -66.29 -39.87 89.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.271 -0.877 . . . . 13.1 109.975 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.22 -171.88 30.05 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.214 -0.903 . . . . 11.94 112.036 177.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -139.69 150.05 44.42 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.135 -0.32 . . . . 15.18 110.135 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 129.5 151.88 7.43 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.73 -0.748 . . . . 12.0 112.453 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -59.9 -40.06 87.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.853 0.359 . . . . 12.82 111.513 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -82.2 0.15 42.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.836 -0.62 . . . . 10.81 111.801 -173.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 93.6 mmm -100.63 109.33 21.39 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.829 0.347 . . . . 10.050000000000001 110.88 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -69.56 -39.68 77.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.967 -0.561 . . . . 8.0600000000000005 110.778 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.82 3.3 74.06 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.948 -0.644 . . . . 5.5800000000000001 111.916 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 90.4 mt -92.15 137.87 32.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.668 0.27 . . . . 5.5599999999999996 110.565 -178.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -78.43 133.9 37.43 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.445 -0.576 . . . . 3.0499999999999998 109.445 175.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -140.29 150.05 59.98 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-O 120.855 0.359 . . . . 3.48 111.026 -173.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 14' ' ' MET . 76.9 Cg_endo -81.2 135.31 9.57 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.669 2.246 . . . . 1.8600000000000001 112.198 172.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 56.2 m -103.21 142.36 34.29 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.421 -0.585 . . . . 1.97 109.421 174.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 m -110.87 134.47 53.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.28 0.562 . . . . 1.71 111.309 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -119.9 132.08 55.43 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.59 -0.732 . . . . 4.0700000000000003 109.817 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 94.1 m-85 -105.37 127.95 53.24 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.031 -0.359 . . . . 2.8599999999999999 110.031 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.414 HD21 ' HD2' ' A' ' 45' ' ' ARG . 46.3 t30 -130.89 138.02 49.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.947 -0.39 . . . . 1.8899999999999999 109.947 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.57 143.13 50.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.711 -0.222 . . . . 1.0800000000000001 110.691 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.662 ' O ' ' HB3' ' A' ' 8' ' ' HIS . . . -154.14 117.37 4.54 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.366 -0.379 . . . . 1.3899999999999999 111.33 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.479 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 25.4 t-20 -163.49 95.42 0.82 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.642 -0.503 . . . . 2.8599999999999999 109.642 173.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.82 -97.59 2.31 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.037 -0.601 . . . . 1.6799999999999999 111.76 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 51.3 Cg_exo -55.3 174.16 0.26 Allowed 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.52 2.813 . . . . 1.6599999999999999 113.515 172.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.523 ' HB3' ' O ' ' A' ' 75' ' ' HIS . 24.4 m-90 -70.15 -176.24 1.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.551 -0.749 . . . . 3.3999999999999999 111.064 -175.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.536 ' HG2' ' HB2' ' A' ' 40' ' ' ALA . 36.7 mtm-85 -112.06 149.96 31.35 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.529 0.68 . . . . 3.1000000000000001 112.732 -163.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.497 HG22 HG12 ' A' ' 74' ' ' VAL . 47.5 pt -128.88 140.05 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 CA-C-N 114.606 -1.179 . . . . 1.8 110.244 175.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -120.06 128.88 53.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.189 -0.46 . . . . 0.85999999999999999 110.09 177.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.6 tp -125.19 136.59 53.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.102 0.477 . . . . 1.0600000000000001 110.922 -176.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -144.76 168.15 20.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.456 -0.793 . . . . 1.1399999999999999 109.376 176.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -140.02 145.58 37.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.588 0.232 . . . . 4.0199999999999996 110.665 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.572 ' HB2' ' CG ' ' A' ' 69' ' ' ARG . 89.6 m-85 -135.75 148.97 49.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.307 -0.406 . . . . 4.6100000000000003 109.937 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -136.43 170.22 16.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.619 -0.264 . . . . 3.3799999999999999 111.323 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.91 -48.87 79.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.938 -0.574 . . . . 5.0499999999999998 110.774 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -169.19 155.83 26.5 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 111.247 -0.741 . . . . 4.3700000000000001 111.247 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.17 -48.45 11.95 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.631 2.221 . . . . 6.6799999999999997 112.033 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.02 130.12 65.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.935 -0.765 . . . . 8.1699999999999999 108.935 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -96.53 129.9 43.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.782 0.325 . . . . 10.039999999999999 110.728 -176.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -116.43 19.02 14.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.251 -0.431 . . . . 11.609999999999999 111.494 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.6 t -100.13 130.83 46.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.293 0.568 . . . . 9.7899999999999991 110.874 -176.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.64 0.03 57.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.883 -0.599 . . . . 8.5099999999999998 110.678 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.2 -11.15 84.66 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.79 -0.719 . . . . 7.5599999999999996 112.189 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -99.96 122.51 42.98 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.481 -0.562 . . . . 10.0 109.481 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -62.47 -40.0 95.24 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.66 -0.7 . . . . 10.35 112.114 -173.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.7 40.65 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.468 -0.872 . . . . 5.3399999999999999 112.09 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.4 t -159.98 151.2 19.46 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.123 -0.695 . . . . 5.3200000000000003 109.123 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 35.6 p90 -133.8 169.97 16.28 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.83 -0.433 . . . . 5.6100000000000003 109.83 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.522 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 95.0 m-85 -109.2 127.64 54.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.039 0.447 . . . . 3.7799999999999998 111.057 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -97.2 166.45 11.56 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.761 -0.654 . . . . 2.4500000000000002 110.637 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.572 ' CG ' ' HB2' ' A' ' 51' ' ' TYR . 6.6 ptp180 -150.48 125.53 4.76 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 121.113 0.483 . . . . 3.2400000000000002 110.577 171.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 75.6 Cg_endo -89.41 158.78 5.47 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.005 2.47 . . . . 1.1899999999999999 112.268 172.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.651 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 39.5 tt0 -131.25 111.72 12.15 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.351 -0.611 . . . . 2.1899999999999999 109.351 173.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.8 tp -125.01 120.0 30.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.278 -0.419 . . . . 1.1399999999999999 110.424 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 39.0 tt0 -121.38 130.05 53.39 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.657 -0.497 . . . . 2.1800000000000002 109.657 177.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.497 HG12 HG22 ' A' ' 46' ' ' ILE . 29.6 m -112.67 136.38 49.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 120.986 0.422 . . . . 1.5600000000000001 109.961 -177.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.523 ' O ' ' HB3' ' A' ' 44' ' ' TRP . 63.2 m80 -116.64 119.6 36.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.081 -0.508 . . . . 3.4399999999999999 110.837 -171.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -113.62 126.08 54.88 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.099 -0.704 . . . . 4.7999999999999998 109.099 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -120.3 134.08 55.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.954 0.406 . . . . 2.9399999999999999 110.708 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -90.6 86.49 6.41 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.514 -0.766 . . . . 3.8999999999999999 109.158 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.7 mt -108.28 15.83 23.73 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.439 -0.949 . . . . 4.4800000000000004 108.439 174.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.52 -39.82 94.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.056 -1.429 . . . . 6.1900000000000004 111.345 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -125.02 135.97 53.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.853 0.358 . . . . 5.4500000000000002 110.665 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -70.11 -19.01 63.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.614 -0.721 . . . . 5.2699999999999996 112.811 -174.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -60.04 -40.06 88.09 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.159 0.429 . . . . 6.3300000000000001 112.159 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -153.13 160.1 42.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.676 0.274 . . . . 7.4800000000000004 110.663 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.4 m -118.86 130.11 55.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.204 0.526 . . . . 2.5499999999999998 110.249 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -130.56 149.65 52.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.587 -0.894 . . . . 5.2999999999999998 108.587 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.23 154.13 21.84 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.033 -1.08 . . . . 1.3500000000000001 112.708 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.2 mt -134.93 129.87 34.97 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.172 -0.677 . . . . 2.29 109.172 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.1 t -133.96 139.47 46.12 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.111 0.481 . . . . 1.54 110.409 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 73' ' ' GLU . . . -132.96 132.79 6.71 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 111.34 -0.704 . . . . 1.1699999999999999 111.34 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.11 123.23 5.6 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.884 -0.674 . . . . 1.1899999999999999 111.892 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -112.01 122.12 46.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.633 0.254 . . . . 3.75 110.541 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.651 ' HD3' ' OE1' ' A' ' 71' ' ' GLU . 72.1 mtm180 -131.36 129.78 41.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.307 -0.406 . . . . 2.75 110.064 173.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.482 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 64.2 t30 -128.51 117.72 21.8 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.958 -0.386 . . . . 1.8200000000000001 109.958 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -109.84 126.67 54.06 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.742 0.306 . . . . 3.1400000000000001 110.372 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 67' ' ' PHE . . . 89.03 179.9 45.59 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.201 -0.999 . . . . 2.79 112.233 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -121.39 129.65 53.15 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.032 -0.358 . . . . 7.6200000000000001 110.032 -178.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.494 ' HB2' ' CB ' ' A' ' 109' ' ' ASN . 53.3 t-80 -108.44 110.02 21.44 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.297 -0.631 . . . . 7.0800000000000001 109.297 176.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -101.08 105.95 17.17 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.952 0.406 . . . . 10.16 110.94 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.7 t -76.28 -22.26 15.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.989 -0.745 . . . . 9.8100000000000005 108.989 174.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.522 ' C ' ' HD3' ' A' ' 103' ' ' PRO . 28.7 m-20 -69.95 -10.18 57.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.793 -1.094 . . . . 12.220000000000001 111.148 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -119.22 68.13 9.51 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.492 -0.322 . . . . 10.48 110.746 -176.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.522 ' HD3' ' C ' ' A' ' 101' ' ' ASP . 12.4 Cg_exo -70.18 134.22 26.59 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.511 2.141 . . . . 9.0999999999999996 111.545 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.03 -3.5 82.65 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.565 -0.826 . . . . 6.46 112.374 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -113.86 138.01 50.89 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.783 -0.451 . . . . 7.6699999999999999 109.783 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -64.71 132.36 49.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.097 0.475 . . . . 4.1399999999999997 110.894 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.4 t -131.85 143.56 50.26 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.667 -0.864 . . . . 3.2999999999999998 108.667 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -119.39 115.29 23.79 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 120.631 -0.427 . . . . 1.76 110.921 -173.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.494 ' CB ' ' HB2' ' A' ' 98' ' ' HIS . 29.0 t-20 -153.53 137.41 16.24 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.887 -0.597 . . . . 2.5499999999999998 111.593 -175.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 44.6 ttm -132.33 123.63 27.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.558 -0.746 . . . . 1.77 109.863 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.499 ' HB2' ' ND2' ' A' ' 143' ' ' ASN . 78.3 mt-30 -107.25 127.24 53.36 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 120.123 -0.631 . . . . 1.97 110.212 175.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.551 ' HB2' ' HB2' ' A' ' 93' ' ' ARG . 95.4 mtt180 -110.13 113.36 25.98 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.999 -0.741 . . . . 3.8500000000000001 108.999 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -107.4 122.56 46.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.965 -0.561 . . . . 2.2799999999999998 111.036 -176.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -114.71 123.77 50.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.651 -0.704 . . . . 2.1400000000000001 109.986 175.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 11.8 tt -131.12 129.82 63.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.932 -0.396 . . . . 1.55 109.932 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -149.93 121.16 4.03 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.558 -0.292 . . . . 1.1899999999999999 111.482 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -90.3 135.61 2.22 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 122.916 2.411 . . . . 1.3700000000000001 111.371 169.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -104.12 139.64 38.91 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.436 -0.579 . . . . 2.3500000000000001 109.436 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -132.21 140.66 48.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.377 0.608 . . . . 4.54 111.413 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -134.43 79.14 1.79 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.902 -1.045 . . . . 3.04 108.406 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.525 ' O ' ' HB3' ' A' ' 129' ' ' PHE . 63.1 t -129.99 125.39 60.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.758 -0.655 . . . . 4.2699999999999996 110.518 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.476 ' HD3' ' HB2' ' A' ' 129' ' ' PHE . 59.4 tptt -140.3 135.73 32.54 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.311 -0.626 . . . . 6.04 109.311 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.9 tp -60.52 -31.32 70.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.557 -0.747 . . . . 4.5899999999999999 111.921 -176.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.414 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 21.9 m -108.35 135.3 49.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.941 0.4 . . . . 3.6899999999999999 110.106 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -63.01 -39.79 95.81 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.28 -0.873 . . . . 5.1699999999999999 112.181 -174.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -70.0 -15.47 63.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.906 -0.588 . . . . 3.71 111.234 -176.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.8 mt -111.82 154.22 25.43 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.908 -0.587 . . . . 2.0499999999999998 110.058 -173.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -130.88 136.88 49.03 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.539 -0.464 . . . . 4.2400000000000002 110.985 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.525 ' HB3' ' O ' ' A' ' 121' ' ' VAL . 65.2 t80 -123.31 120.42 33.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.79 -0.641 . . . . 3.5499999999999998 109.73 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -122.81 136.84 55.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.784 0.326 . . . . 2.1099999999999999 111.202 -177.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -160.75 149.98 19.55 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.277 -0.729 . . . . 1.1799999999999999 111.277 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -148.33 148.03 29.94 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.119 -0.326 . . . . 4.2999999999999998 110.119 176.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 67.9 tp -116.79 117.93 31.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.332 -0.395 . . . . 2.2400000000000002 110.755 -175.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.5 t -104.99 118.41 36.45 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.805 0.336 . . . . 1.6899999999999999 110.577 -178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 151' ' ' ARG . 64.6 mtt -108.86 121.63 45.49 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.226 -0.657 . . . . 2.2400000000000002 109.226 171.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.415 ' OH ' ' HD3' ' A' ' 112' ' ' ARG . 64.9 t80 -116.53 136.79 52.69 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.655 -0.702 . . . . 3.5600000000000001 111.068 -171.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -130.17 150.86 51.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.63 -0.713 . . . . 1.6699999999999999 109.813 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -139.55 159.94 41.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.571 0.224 . . . . 3.23 110.431 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 60.22 -177.03 0.1 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.552 -0.749 . . . . 1.24 111.001 -175.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -77.65 -24.67 49.37 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.087 0.47 . . . . 2.4700000000000002 110.515 172.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.95 -51.38 69.93 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.409 -0.814 . . . . 2.4100000000000001 112.575 -172.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.5 mp -70.17 -29.11 65.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.03 0.443 . . . . 1.8300000000000001 111.2 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.499 ' ND2' ' HB2' ' A' ' 111' ' ' GLN . 95.0 m-20 -68.79 -39.75 80.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.532 -0.304 . . . . 2.0 110.809 178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.3 p -70.11 -32.1 69.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.577 -0.283 . . . . 2.0499999999999998 111.481 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.4 p -80.36 -20.21 44.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.234 0.54 . . . . 1.5900000000000001 110.845 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.84 -114.35 5.26 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.694 -0.684 . . . . 1.52 112.381 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -99.98 3.65 44.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.566 0.222 . . . . 5.9400000000000004 111.162 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.82 -40.04 76.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.022 0.439 . . . . 1.8300000000000001 110.02 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -129.83 99.34 5.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.55 -0.75 . . . . 2.6400000000000001 109.788 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.9 t -148.81 159.06 44.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.06 -0.518 . . . . 2.02 109.833 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 135' ' ' MET . 42.1 ttm180 -93.68 123.38 36.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.204 -0.453 . . . . 3.6699999999999999 109.881 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.0 t -112.48 120.58 63.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.493 -0.321 . . . . 1.6399999999999999 110.58 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -143.17 130.03 20.49 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.0 -0.37 . . . . 2.5600000000000001 110.0 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.437 ' HB ' ' CD1' ' A' ' 133' ' ' LEU . 10.1 t -136.58 146.72 46.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.011 0.434 . . . . 1.3899999999999999 110.965 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -119.98 139.55 52.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.215 -0.448 . . . . 2.04 110.351 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 22.6 m -117.03 122.98 45.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.095 -0.502 . . . . 1.5600000000000001 110.297 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -117.79 121.86 5.23 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.722 -0.551 . . . . 1.04 111.722 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.432 ' HB3' ' CE2' ' A' ' 160' ' ' TYR . 92.2 mt -108.38 135.09 50.26 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 122.274 0.23 . . . . 2.27 110.382 -177.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 168' ' ' LEU . 63.8 tt0 -123.36 115.89 22.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.758 0.314 . . . . 2.4100000000000001 110.178 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 158' ' ' LEU . 82.9 m-85 -130.92 139.95 50.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.23 -0.441 . . . . 4.5700000000000003 110.867 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 22.9 p -96.93 92.76 6.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.09 -0.505 . . . . 1.46 110.973 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . 0.506 ' CD2' HD12 ' A' ' 168' ' ' LEU . 61.3 m-85 -70.04 -39.91 75.45 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.163 0.431 . . . . 2.6299999999999999 112.163 -176.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.533 ' HB2' HG22 ' A' ' 166' ' ' VAL . 88.7 m-20 -100.3 13.38 34.55 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.776 -0.37 . . . . 2.4100000000000001 110.908 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 73.12 -52.06 0.71 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.873 0.733 . . . . 2.5800000000000001 111.79 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.2 p -74.66 -20.58 59.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.715 0.293 . . . . 2.2999999999999998 111.705 -179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.533 HG22 ' HB2' ' A' ' 163' ' ' ASN . 35.8 m -116.68 137.91 48.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.89 0.376 . . . . 1.71 110.836 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.8 123.07 47.61 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.077 -0.51 . . . . 1.47 110.131 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.506 HD12 ' CD2' ' A' ' 162' ' ' PHE . 21.7 mt -103.8 140.53 37.51 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.72 -0.474 . . . . 1.6599999999999999 109.72 -177.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -115.18 125.46 53.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.935 0.398 . . . . 3.2999999999999998 110.383 -176.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.5 t -128.44 129.57 68.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.561 -0.533 . . . . 1.3 109.561 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.543 ' OD1' ' HB2' ' A' ' 195' ' ' ARG . 28.7 p-10 -133.74 148.72 51.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.302 0.572 . . . . 2.2200000000000002 111.575 -177.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -145.36 151.43 38.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.347 -0.842 . . . . 4.6100000000000003 110.071 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -101.18 128.91 47.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.428 0.632 . . . . 3.98 111.55 -173.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.423 ' HB3' HG23 ' A' ' 154' ' ' THR . 48.4 tp -120.06 124.24 45.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.327 -0.851 . . . . 2.3799999999999999 109.499 -176.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -70.01 -43.4 71.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.229 0.537 . . . . 3.3100000000000001 111.061 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.434 ' NE ' HD21 ' A' ' 186' ' ' ASN . 90.7 mtt180 -134.29 129.3 35.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.963 -0.562 . . . . 6.5300000000000002 109.979 -172.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -70.03 -44.5 60.83 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.784 -0.644 . . . . 5.0599999999999996 112.321 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -160.06 160.03 32.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.746 0.308 . . . . 7.3899999999999997 110.355 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -159.95 149.69 18.17 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.248 -0.649 . . . . 9.0700000000000003 109.248 173.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 96.6 mmm -79.98 -12.9 59.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.297 -0.41 . . . . 10.869999999999999 111.17 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -70.45 -40.19 73.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.924 -0.58 . . . . 10.449999999999999 111.465 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 51.0 30.34 5.25 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.616 0.572 . . . . 13.06 111.0 -173.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 30.2 p -70.01 -38.22 75.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.71 -0.677 . . . . 12.609999999999999 111.337 -177.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 63.74 27.3 14.68 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.225 -0.898 . . . . 15.19 110.602 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -69.78 -14.42 62.77 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.692 -0.685 . . . . 13.18 111.291 -176.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.434 HD21 ' NE ' ' A' ' 176' ' ' ARG . 14.5 m120 -59.79 -35.09 73.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.77 -0.65 . . . . 12.73 110.084 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 100.55 -20.54 47.87 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.599 -0.728 . . . . 9.9800000000000004 111.781 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 59.09 32.44 22.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.299 0.571 . . . . 10.699999999999999 111.049 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -70.07 -39.85 75.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.487 -0.779 . . . . 10.5 110.078 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 80.1 p -62.89 -39.9 95.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.805 -0.634 . . . . 6.6399999999999997 110.877 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 6.4 p -74.74 -24.08 58.66 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.039 -0.528 . . . . 4.9800000000000004 111.478 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -70.16 -35.42 74.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.274 0.559 . . . . 7.0999999999999996 109.765 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -81.41 101.51 9.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.599 -0.728 . . . . 4.4000000000000004 109.801 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 86.4 mt -117.26 131.54 69.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.968 -0.56 . . . . 2.21 110.855 -173.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.543 ' HB2' ' OD1' ' A' ' 171' ' ' ASN . 90.0 mtt180 -95.25 127.36 41.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.814 0.34 . . . . 3.54 110.419 176.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -117.78 130.53 56.36 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.571 -0.529 . . . . 1.6699999999999999 109.571 174.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -152.85 160.04 43.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.192 0.52 . . . . 5.8300000000000001 111.274 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.449 ' O ' ' HD2' ' A' ' 209' ' ' PRO . 2.5 pt? -137.95 134.25 17.94 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.126 -0.488 . . . . 2.5899999999999999 110.019 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.69 128.05 9.15 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.197 1.931 . . . . 1.77 112.708 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.8 tp -120.43 123.52 43.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.692 -0.686 . . . . 2.2599999999999998 109.538 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 22.7 m -104.9 119.96 40.28 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.454 -0.339 . . . . 1.99 110.7 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 85.7 mt -123.92 80.26 1.8 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.472 -0.566 . . . . 2.3100000000000001 109.472 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 67.1 -117.26 8.9 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.714 -0.675 . . . . 1.51 112.298 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -90.48 0.09 57.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.372 0.606 . . . . 2.5699999999999998 109.651 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -114.69 120.1 38.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.506 -0.77 . . . . 2.6600000000000001 111.096 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 13.6 p -102.03 142.6 33.06 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.33 -0.396 . . . . 1.6200000000000001 110.453 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 49.8 t -129.13 129.98 67.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.307 -0.627 . . . . 1.3799999999999999 109.307 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 240' ' ' PHE . 32.8 m -134.44 91.72 21.73 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-O 120.849 0.357 . . . . 1.1799999999999999 110.37 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.449 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 57.0 Cg_endo -74.57 138.47 24.21 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.273 1.982 . . . . 1.01 112.307 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -106.03 139.01 41.23 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.35 -0.611 . . . . 4.5 109.35 175.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 38.9 p -132.39 160.53 36.08 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.91 -0.404 . . . . 1.8899999999999999 109.91 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.488 ' HD2' ' HA ' ' A' ' 235' ' ' ASN . 61.9 ttt180 -66.24 -40.52 90.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.416 0.627 . . . . 4.7999999999999998 109.617 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 44.7 pt -126.96 144.98 35.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.484 -0.78 . . . . 4.5700000000000003 109.789 175.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -116.99 -8.51 11.64 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.739 -0.743 . . . . 4.9800000000000004 112.335 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 61.8 tp -119.66 138.24 53.39 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.828 0.347 . . . . 8.1099999999999994 110.771 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -105.04 141.27 36.91 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.245 -0.65 . . . . 7.6500000000000004 109.245 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -120.04 134.81 55.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.233 0.539 . . . . 10.529999999999999 111.344 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 63.5 t-105 -69.99 -39.96 75.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.264 -0.88 . . . . 11.56 109.526 171.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 77.4 p -97.51 155.8 16.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.402 -0.817 . . . . 10.06 110.335 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 57.9 t30 58.35 40.02 24.83 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.488 0.661 . . . . 11.92 110.283 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -106.68 130.01 54.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.483 -0.78 . . . . 14.01 109.971 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -80.47 124.45 28.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.835 0.35 . . . . 14.529999999999999 110.369 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -106.82 -9.55 16.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.206 -0.452 . . . . 16.609999999999999 110.725 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -119.96 140.07 51.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.028 -0.533 . . . . 15.460000000000001 110.291 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -111.77 111.3 22.16 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.09 -0.337 . . . . 15.67 110.09 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -91.67 -6.54 51.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.083 0.468 . . . . 14.5 110.443 178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 45.7 pt -129.56 168.04 23.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.698 -0.683 . . . . 15.15 109.735 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -66.57 125.54 26.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.097 0.475 . . . . 14.73 110.032 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 59.2 mtp85 -63.09 -40.51 97.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.162 -0.926 . . . . 16.379999999999999 111.396 -176.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -72.18 -40.03 68.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.976 0.417 . . . . 12.779999999999999 110.97 176.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 56.35 -119.98 17.52 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.589 -0.732 . . . . 11.1 111.993 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -144.04 80.04 1.64 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.883 0.373 . . . . 12.26 110.03 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 58.23 35.44 24.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.322 -0.854 . . . . 9.9900000000000002 111.749 173.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -70.16 -39.94 75.03 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.048 0.451 . . . . 10.43 110.385 174.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.488 ' HA ' ' HD2' ' A' ' 212' ' ' ARG . 19.1 t-20 -90.25 97.4 11.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.284 -0.635 . . . . 6.29 109.284 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -98.92 118.56 35.97 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.85 -0.614 . . . . 8.1500000000000004 110.699 -175.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 62.1 t -110.28 120.72 61.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.65 -0.705 . . . . 2.3999999999999999 110.251 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -124.69 138.12 10.95 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.716 -0.754 . . . . 1.27 111.298 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.99 126.61 54.12 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.981 0.39 . . . . 1.97 110.527 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.503 ' HB3' ' HB ' ' A' ' 208' ' ' THR . 61.7 t80 -99.56 124.42 44.74 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.318 -0.623 . . . . 3.54 109.318 173.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.526 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 81.7 m-85 -119.89 140.01 51.51 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.818 -0.438 . . . . 2.6400000000000001 109.818 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -136.77 151.87 21.08 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.074 -1.06 . . . . 1.3500000000000001 112.74 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' TYR . . . . . 0.408 ' HB2' HG22 ' A' ' 251' ' ' VAL . 96.3 m-85 -129.96 129.85 44.32 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.856 -0.794 . . . . 4.3600000000000003 108.856 172.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -128.1 130.38 48.09 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 110.193 -0.299 . . . . 4.29 110.193 -176.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -128.52 135.31 49.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.153 -0.476 . . . . 6.6900000000000004 110.429 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -60.09 -30.13 69.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.122 -0.944 . . . . 6.3700000000000001 111.684 -175.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -55.69 -33.64 64.34 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.303 -0.408 . . . . 5.8300000000000001 110.772 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 135.38 31.79 0.31 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.559 -0.829 . . . . 2.6600000000000001 112.797 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 53.0 tp -125.57 127.83 46.98 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.691 -0.3 . . . . 2.9700000000000002 110.4 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 6.1 t -140.09 129.31 23.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.642 -0.873 . . . . 2.1699999999999999 108.642 173.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 243' ' ' TYR . 33.1 m -129.94 159.81 41.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.91 0.386 . . . . 1.79 111.5 -176.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 35.3 p -131.34 139.96 49.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.523 -0.762 . . . . 1.6299999999999999 110.166 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 89.0 mt -125.7 135.61 52.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.003 -0.544 . . . . 2.96 109.986 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -110.59 120.92 43.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.125 -0.489 . . . . 4.0800000000000001 110.082 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -106.86 129.3 54.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.306 -0.406 . . . . 4.8399999999999999 110.787 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -101.66 140.7 35.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.733 -0.667 . . . . 3.5800000000000001 110.579 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -69.93 -36.18 75.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.521 -0.763 . . . . 6.7699999999999996 111.369 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 261' ' ' ASP . 97.3 mt-10 50.11 40.4 21.61 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.909 0.707 . . . . 8.5399999999999991 112.909 172.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -69.85 -40.11 75.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.914 0.388 . . . . 11.9 110.553 176.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -59.89 -39.96 87.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.825 -0.625 . . . . 10.57 111.026 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . 0.435 ' HB3' ' HB3' ' A' ' 258' ' ' GLU . 28.2 t70 -69.17 145.9 52.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.456 -0.793 . . . . 11.41 111.649 -172.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -145.96 133.46 20.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.217 -0.901 . . . . 11.98 109.402 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -69.17 -10.48 57.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.399 0.618 . . . . 12.460000000000001 110.012 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -60.15 -39.8 87.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.992 -1.004 . . . . 13.779999999999999 111.336 174.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -94.07 165.66 26.78 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.848 -0.691 . . . . 11.07 113.495 -172.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -115.19 9.7 15.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.644 -0.278 . . . . 12.59 111.225 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 51.3 m -60.18 -39.93 88.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.291 0.567 . . . . 10.92 110.344 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -121.17 130.23 53.62 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.215 -1.031 . . . . 12.42 108.215 173.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -89.06 -12.61 40.78 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.746 0.647 . . . . 11.59 112.746 -173.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -149.24 151.4 34.19 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.744 -0.382 . . . . 8.8300000000000001 110.908 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -71.77 148.63 46.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.795 -0.639 . . . . 7.0199999999999996 109.946 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -102.76 128.26 49.57 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.343 0.592 . . . . 6.5999999999999996 111.561 -171.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -145.25 169.99 17.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.26 -0.882 . . . . 1.9399999999999999 109.171 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.75 136.05 8.55 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.224 -0.988 . . . . 1.4199999999999999 112.001 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 62.7 t -130.03 129.7 65.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.982 0.42 . . . . 1.8100000000000001 110.412 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -130.03 139.99 11.39 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.712 -0.955 . . . . 1.3 110.712 173.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.16 129.97 54.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 117.102 0.451 . . . . 1.8300000000000001 111.265 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -113.24 123.07 49.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.033 -0.531 . . . . 2.3100000000000001 110.004 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -99.97 107.27 19.19 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.932 -0.766 . . . . 4.75 108.932 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 25.6 m -102.12 124.05 47.05 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.144 0.497 . . . . 1.6699999999999999 111.043 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 88.9 m-85 . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.122 -0.942 . . . . 3.6899999999999999 108.722 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.4 mtp . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.711 0.291 . . . . 11.85 110.301 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -136.21 121.54 19.24 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.966 -0.383 . . . . 10.35 109.966 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -125.65 139.01 53.92 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.293 -0.412 . . . . 9.3100000000000005 109.997 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.454 ' HB3' ' OD2' ' A' ' 6' ' ' ASP . 17.6 mtp180 -99.85 133.21 44.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.038 0.447 . . . . 8.8399999999999999 111.269 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -108.53 61.89 0.61 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.685 -0.688 . . . . 7.0099999999999998 109.855 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.454 ' OD2' ' HB3' ' A' ' 4' ' ' ARG . 11.6 m-20 -74.79 110.16 8.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.811 -0.631 . . . . 3.6099999999999999 109.895 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.53 ' HA ' ' HB3' ' A' ' 41' ' ' ASN . 20.3 m-90 -70.99 139.98 50.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.987 -0.551 . . . . 3.3300000000000001 110.981 -178.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -99.2 130.0 45.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.001 -0.545 . . . . 3.2000000000000002 110.544 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -115.77 140.31 49.33 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.866 -0.606 . . . . 2.4900000000000002 110.888 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 94.2 m-20 -121.86 132.33 54.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.556 -0.747 . . . . 2.1299999999999999 109.549 174.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.0 mt -119.76 120.02 62.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.372 -0.603 . . . . 1.6000000000000001 109.372 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -122.13 142.4 14.95 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.048 -1.072 . . . . 0.88 112.68 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.53 134.81 54.71 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.941 -0.762 . . . . 1.0800000000000001 108.941 174.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 49.0 tpp -129.93 129.67 44.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.061 -0.518 . . . . 2.3300000000000001 111.0 -173.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.469 ' CE2' ' HD3' ' A' ' 33' ' ' PRO . 56.3 m-85 -93.15 129.77 39.04 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.914 -1.143 . . . . 2.6099999999999999 107.914 169.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -134.32 130.12 36.52 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.328 -0.549 . . . . 5.0899999999999999 110.534 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.45 HG21 ' CE1' ' A' ' 271' ' ' HIS . 80.3 mt -115.68 129.5 71.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.057 -0.52 . . . . 5.3300000000000001 110.385 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -80.56 153.71 27.9 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.876 -0.602 . . . . 8.2799999999999994 110.614 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -70.21 -20.29 63.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.892 -0.595 . . . . 9.6999999999999993 110.549 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.8 t -110.87 120.07 60.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.44 -0.8 . . . . 11.09 108.908 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -91.9 -9.11 44.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.041 0.448 . . . . 13.1 110.668 -177.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.4 -160.34 43.75 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.706 -0.759 . . . . 11.94 112.444 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -123.69 102.47 7.85 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.385 0.612 . . . . 15.18 111.148 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.99 26.53 67.45 Favored Glycine 0 C--N 1.329 0.162 0 CA-C-N 115.769 -0.651 . . . . 12.0 112.291 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -96.04 16.29 18.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.428 0.632 . . . . 12.82 110.706 -173.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.43 -28.27 65.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.87 -1.059 . . . . 10.81 109.986 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 94.7 mtp -59.9 -40.22 88.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.125 -0.943 . . . . 10.050000000000001 111.636 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -80.12 -50.25 10.58 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.627 -0.429 . . . . 8.0600000000000005 110.367 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.14 154.19 7.05 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.572 -0.823 . . . . 5.5800000000000001 112.436 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 93.4 mt -143.61 -26.87 0.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.592 0.234 . . . . 5.5599999999999996 111.475 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.411 ' HB2' HG12 ' A' ' 17' ' ' ILE . . . -154.86 70.71 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.08 0.466 . . . . 3.0499999999999998 110.616 -175.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -120.3 150.94 52.69 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 109.649 -0.5 . . . . 3.48 109.649 -175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.469 ' HD3' ' CE2' ' A' ' 15' ' ' TYR . 59.6 Cg_endo -73.93 134.38 19.68 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.093 1.862 . . . . 1.8600000000000001 112.375 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.7 t -118.13 143.57 46.38 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.797 -0.816 . . . . 1.97 108.797 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.5 m -110.11 139.99 31.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.304 0.573 . . . . 1.71 111.639 -173.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 49' ' ' ALA . 34.6 p90 -135.72 149.77 49.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.425 -0.807 . . . . 4.0700000000000003 109.903 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -113.47 130.07 56.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.02 -0.536 . . . . 2.8599999999999999 110.729 -175.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 10' ' ' ASN . 77.6 m-20 -123.44 144.49 49.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.165 -0.471 . . . . 1.8899999999999999 109.952 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.41 142.34 45.62 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.074 -0.343 . . . . 1.0800000000000001 110.074 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.01 112.57 1.59 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.151 0.426 . . . . 1.3899999999999999 112.151 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 7' ' ' TRP . 24.5 t-20 -168.24 94.96 0.39 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.713 -0.477 . . . . 2.8599999999999999 109.713 166.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.89 -83.34 0.43 Allowed Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.212 -0.755 . . . . 1.6799999999999999 111.212 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.13 173.46 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.029 2.486 . . . . 1.6599999999999999 111.797 169.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.461 ' HB3' ' O ' ' A' ' 75' ' ' HIS . 45.3 m95 -70.75 -177.74 1.66 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.143 -0.481 . . . . 3.3999999999999999 110.064 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -109.6 120.42 42.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.657 0.741 . . . . 3.1000000000000001 109.976 -172.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.4 mt -109.94 136.29 46.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.378 -1.283 . . . . 1.8 110.326 -174.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.81 128.24 55.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.943 -0.572 . . . . 0.85999999999999999 110.158 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.1 tp -120.45 130.2 54.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.045 -0.525 . . . . 1.0600000000000001 110.494 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 36' ' ' TYR . . . -148.92 168.42 23.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.236 -0.438 . . . . 1.1399999999999999 110.524 178.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 45.2 p90 -142.4 160.03 41.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.357 -0.383 . . . . 4.0199999999999996 110.342 -177.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.429 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 64.3 t80 -134.28 130.02 36.45 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.82 -0.437 . . . . 4.6100000000000003 109.82 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -135.65 147.21 48.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.404 -0.362 . . . . 3.3799999999999999 110.412 -177.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -111.61 144.37 40.98 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.967 -0.753 . . . . 5.0499999999999998 108.967 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 159.92 105.62 0.21 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.342 -1.409 . . . . 4.3700000000000001 113.391 -178.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.25 2.77 7.71 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 123.107 2.538 . . . . 6.6799999999999997 111.713 175.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.4 t -109.67 120.85 61.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.896 -0.593 . . . . 8.1699999999999999 110.478 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -70.29 -39.75 74.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.641 -0.709 . . . . 10.039999999999999 110.955 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -81.92 149.31 28.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.908 -0.587 . . . . 11.609999999999999 111.531 -173.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.8 p -119.65 149.2 42.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.918 -0.583 . . . . 9.7899999999999991 109.954 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -141.52 150.08 41.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.584 0.23 . . . . 8.5099999999999998 110.948 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.98 -93.2 1.59 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.823 -0.703 . . . . 7.5599999999999996 112.109 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -124.68 130.82 53.14 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.659 -0.497 . . . . 10.0 109.659 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -80.66 150.63 29.34 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.861 -0.422 . . . . 10.35 109.861 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.97 167.83 12.25 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 111.484 -0.646 . . . . 5.3399999999999999 111.484 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.9 m -129.55 109.46 11.05 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.004 -0.369 . . . . 5.3200000000000003 110.004 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -69.76 -40.06 76.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.203 -0.453 . . . . 5.6100000000000003 110.126 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 97' ' ' TYR . 53.2 m-85 -106.8 99.73 9.29 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.176 -0.676 . . . . 3.7799999999999998 109.176 177.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -134.23 170.63 15.42 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.511 -0.922 . . . . 2.4500000000000002 108.511 -171.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.523 ' HD3' ' CE1' ' A' ' 95' ' ' TYR . 39.4 ttp180 -119.14 123.01 29.12 Favored Pre-proline 0 C--N 1.318 -0.787 0 C-N-CA 120.326 -0.55 . . . . 3.2400000000000002 110.697 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -91.74 115.68 0.4 Allowed 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 122.126 1.884 . . . . 1.1899999999999999 110.767 169.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -103.26 112.74 25.76 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.903 -0.777 . . . . 2.1899999999999999 108.903 174.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.2 tp -124.53 118.66 27.1 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.652 -0.704 . . . . 1.1399999999999999 109.496 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -126.03 131.75 52.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.6 -0.518 . . . . 2.1800000000000002 109.6 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.22 121.88 68.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.869 0.366 . . . . 1.5600000000000001 110.116 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.461 ' O ' ' HB3' ' A' ' 44' ' ' TRP . 79.8 t60 -104.64 119.6 39.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.115 -0.493 . . . . 3.4399999999999999 110.503 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -97.16 120.74 38.07 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.984 -1.117 . . . . 4.7999999999999998 107.984 176.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.4 ' HG3' ' HA ' ' A' ' 86' ' ' PHE . 29.0 tt0 -127.31 113.78 16.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.174 0.511 . . . . 2.9399999999999999 111.671 -174.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -102.61 120.3 40.31 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.673 -0.694 . . . . 3.8999999999999999 109.38 175.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 91.3 mt -112.46 -29.84 7.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.122 0.486 . . . . 4.4800000000000004 110.777 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -118.44 -16.99 9.5 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.709 -0.678 . . . . 6.1900000000000004 111.525 -173.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -63.41 -49.99 71.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.529 -0.305 . . . . 5.4500000000000002 111.671 -174.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -146.98 -177.04 5.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 110.196 -0.298 . . . . 5.2699999999999996 110.196 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -60.01 -40.07 87.99 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.408 0.521 . . . . 6.3300000000000001 112.408 -176.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -74.43 138.43 43.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.208 0.528 . . . . 7.4800000000000004 111.324 -176.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 120' ' ' ASP . 14.7 t -95.43 159.56 14.94 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.856 -0.611 . . . . 2.5499999999999998 110.412 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.4 ' HA ' ' HG3' ' A' ' 77' ' ' GLN . 90.1 m-85 69.78 -100.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.512 -0.767 . . . . 5.2999999999999998 111.069 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.27 -82.06 0.35 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.012 -1.089 . . . . 1.3500000000000001 113.215 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 57.9 tp -144.13 131.25 20.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.22 0.51 . . . . 2.29 111.989 -173.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.5 m -121.36 130.08 53.42 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.575 -0.528 . . . . 1.54 109.575 170.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -145.45 141.92 10.26 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.145 -1.026 . . . . 1.1699999999999999 112.238 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.99 171.2 36.26 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.62 -0.8 . . . . 1.1899999999999999 111.993 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -148.47 159.95 43.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.092 0.472 . . . . 3.75 111.628 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -134.39 137.29 43.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.324 -0.853 . . . . 2.75 109.494 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 63.1 t30 -125.18 122.22 36.42 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.971 -0.381 . . . . 1.8200000000000001 109.971 175.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.523 ' CE1' ' HD3' ' A' ' 69' ' ' ARG . 95.2 m-85 -102.84 120.92 41.45 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.023 -0.362 . . . . 3.1400000000000001 110.023 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.6 152.59 52.48 Favored Glycine 0 CA--C 1.501 -0.788 0 C-N-CA 120.995 -0.621 . . . . 2.79 113.658 -176.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.794 ' HA ' ' H ' ' A' ' 108' ' ' ALA . 68.7 m-85 -48.52 82.46 0.0 OUTLIER 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 124.174 0.99 . . . . 7.6200000000000001 113.564 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.675 ' H ' ' HB3' ' A' ' 108' ' ' ALA . 30.9 p80 -114.17 170.36 8.34 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.231 -0.293 . . . . 7.0800000000000001 110.514 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -68.33 141.25 55.85 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.801 -0.444 . . . . 10.16 109.801 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.85 -177.03 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.651 -0.25 . . . . 9.8100000000000005 111.564 -175.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -60.25 -39.97 88.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.117 0.484 . . . . 12.220000000000001 110.473 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -72.7 115.48 40.18 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.416 -0.811 . . . . 10.48 110.229 -177.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.73 -19.62 53.26 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.707 2.272 . . . . 9.0999999999999996 112.671 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.56 2.4 85.65 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.834 -0.698 . . . . 6.46 112.68 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -139.54 119.96 13.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.966 0.412 . . . . 7.6699999999999999 110.553 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -96.93 0.25 48.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.947 -0.57 . . . . 4.1399999999999997 110.957 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.482 ' HB ' ' HB3' ' A' ' 97' ' ' TYR . 24.1 p -125.68 149.02 48.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.267 0.469 . . . . 3.2999999999999998 112.267 -175.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.794 ' H ' ' HA ' ' A' ' 97' ' ' TYR . . . -118.72 119.13 33.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.725 0.774 . . . . 1.76 112.85 177.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -115.19 106.45 14.09 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.595 -0.891 . . . . 2.5499999999999998 108.595 171.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.539 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 89.5 mtp -139.85 117.05 11.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.527 -0.306 . . . . 1.77 110.799 -177.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.614 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 54.0 tt0 -117.21 117.96 31.0 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.627 -0.429 . . . . 1.97 110.182 176.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -105.6 123.53 48.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.869 -0.605 . . . . 3.8500000000000001 110.14 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -125.53 128.73 48.42 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.814 -0.81 . . . . 2.2799999999999998 108.814 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -130.15 126.03 36.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.408 . . . . 2.1400000000000001 110.558 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 134' ' ' SER . 88.2 mt -120.05 129.61 75.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.709 -0.678 . . . . 1.55 109.66 177.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 134' ' ' SER . . . -141.87 108.14 5.91 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 111.954 0.353 . . . . 1.1899999999999999 111.954 -176.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.721 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 61.4 Cg_endo -76.5 131.95 13.05 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.75 1.634 . . . . 1.3700000000000001 110.21 171.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -102.28 137.02 41.09 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.281 -0.637 . . . . 2.3500000000000001 109.281 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -135.45 129.98 34.05 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.99 -0.284 . . . . 4.54 110.942 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 32.5 t70 -126.25 122.09 34.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.172 -0.467 . . . . 3.04 109.856 174.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.4 t -120.05 120.49 63.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.09 -0.504 . . . . 4.2699999999999996 110.19 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.405 ' HE2' ' HD3' ' A' ' 128' ' ' ARG . 96.6 mttt -104.96 90.75 3.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.296 -0.411 . . . . 6.04 110.527 -178.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.6 tp -60.28 -49.74 76.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.284 0.564 . . . . 4.5899999999999999 110.154 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.5 p -140.79 172.52 12.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.372 -0.831 . . . . 3.6899999999999999 109.358 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -60.16 -39.88 87.95 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.192 -0.603 . . . . 5.1699999999999999 109.605 172.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.1 -40.17 75.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.729 -0.669 . . . . 3.71 111.997 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.0 mt -111.12 119.65 39.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.285 0.564 . . . . 2.0499999999999998 111.436 -173.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.405 ' HD3' ' HE2' ' A' ' 122' ' ' LYS . 38.1 ttp180 -132.63 132.78 42.83 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.719 -0.673 . . . . 4.2400000000000002 110.681 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -111.97 100.03 8.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.326 -0.852 . . . . 3.5499999999999998 109.738 -176.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -113.8 114.65 26.59 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.022 -0.362 . . . . 2.1099999999999999 110.022 -178.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -144.82 152.75 24.71 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.994 -1.098 . . . . 1.1799999999999999 113.013 -175.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.536 ' NE1' ' HB3' ' A' ' 155' ' ' GLU . 56.5 p-90 -141.28 147.85 38.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.783 0.325 . . . . 4.2999999999999998 110.42 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.721 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 10.1 tt -126.27 131.98 51.78 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.314 -0.624 . . . . 2.2400000000000002 109.314 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.604 ' HB3' ' HB2' ' A' ' 116' ' ' ALA . 80.5 p -131.53 150.06 52.29 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.811 -0.355 . . . . 1.6899999999999999 111.548 -177.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 71.8 mtm -114.38 136.02 53.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.091 -0.504 . . . . 2.2400000000000002 110.415 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.428 ' HB2' ' HB3' ' A' ' 151' ' ' ARG . 49.5 m-85 -104.87 120.92 42.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.87 -0.605 . . . . 3.5600000000000001 111.674 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.68 121.79 29.32 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.134 -1.062 . . . . 1.6699999999999999 108.134 166.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.614 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 52.6 p90 -145.85 166.49 25.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.448 -0.342 . . . . 3.23 111.49 -171.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 110' ' ' MET . . . 60.0 -164.72 0.22 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.052 -0.976 . . . . 1.24 111.795 177.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -75.3 -39.79 59.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.102 -0.499 . . . . 2.4700000000000002 111.305 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -59.69 -54.2 49.11 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.438 0.533 . . . . 2.4100000000000001 112.438 -167.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.73 -40.11 84.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.2 0.524 . . . . 1.8300000000000001 110.492 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.438 HD22 ' C ' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -62.09 -39.38 92.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.783 -0.644 . . . . 2.0 109.96 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.8 m -68.66 -40.11 80.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.886 -0.597 . . . . 2.0499999999999998 111.912 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 148' ' ' ALA . 41.9 p -79.9 -20.04 46.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.169 0.509 . . . . 1.5900000000000001 110.865 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 74.02 -109.82 2.91 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.803 -0.635 . . . . 1.52 113.154 173.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -99.16 0.62 43.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.8 0.333 . . . . 5.9400000000000004 110.661 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' A' ' 145' ' ' THR . . . -70.04 -40.04 75.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 1.8300000000000001 111.489 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -118.96 124.68 47.62 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.566 -0.288 . . . . 2.6400000000000001 110.569 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.4 p -130.02 140.06 50.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.986 0.422 . . . . 2.02 110.9 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.428 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 42.5 ttm180 -113.06 129.98 56.32 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.337 -0.986 . . . . 3.6699999999999999 108.337 173.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.9 p -117.33 132.02 68.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.533 0.683 . . . . 1.6399999999999999 111.697 -173.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.421 ' OE1' ' HH2' ' A' ' 132' ' ' TRP . 38.3 tt0 -119.99 115.69 24.27 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.011 -0.995 . . . . 2.5600000000000001 109.126 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 21.7 m -129.74 127.21 39.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.77 0.319 . . . . 1.3899999999999999 111.283 -177.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.536 ' HB3' ' NE1' ' A' ' 132' ' ' TRP . 42.6 tt0 -122.34 134.49 54.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.966 -0.561 . . . . 2.04 110.032 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.5 m -128.27 120.26 26.78 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.857 0.361 . . . . 1.5600000000000001 110.094 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.72 106.8 3.36 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.861 -0.896 . . . . 1.04 110.861 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 82.7 mt -99.79 120.07 39.16 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.668 -0.493 . . . . 2.27 109.668 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -100.08 119.13 37.82 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.859 -0.61 . . . . 2.4100000000000001 110.014 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -121.55 137.94 54.52 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.532 -0.758 . . . . 4.5700000000000003 109.9 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 166' ' ' VAL . 7.3 p -89.9 88.56 7.37 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.077 -0.712 . . . . 1.46 109.077 168.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -60.08 -48.97 79.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.023 -0.989 . . . . 2.6299999999999999 111.395 -170.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.416 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.6 m-20 -99.96 11.39 39.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.4 -0.364 . . . . 2.4100000000000001 110.52 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 71.88 -43.02 0.55 Allowed 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.007 0.817 . . . . 2.5800000000000001 111.177 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.9 p -73.91 -26.66 60.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.286 -0.416 . . . . 2.2999999999999998 111.428 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 163' ' ' ASN . 33.7 m -119.16 143.61 29.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.119 -0.491 . . . . 1.71 110.678 -177.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.13 119.52 39.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.206 -0.452 . . . . 1.47 110.14 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 22.9 mt -111.57 134.73 52.94 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.355 -0.384 . . . . 1.6599999999999999 110.182 -175.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -100.06 122.02 42.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.798 -0.445 . . . . 3.2999999999999998 109.798 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 40.4 t -120.01 120.02 61.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 120.474 -0.49 . . . . 1.3 109.792 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -98.87 120.91 40.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.335 0.588 . . . . 2.2200000000000002 110.389 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -105.85 139.55 40.24 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.054 -0.975 . . . . 4.6100000000000003 109.253 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -113.15 129.79 56.4 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 110.074 -0.343 . . . . 3.98 110.074 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.498 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 61.5 tp -109.93 129.93 55.59 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.067 0.46 . . . . 2.3799999999999999 110.795 -174.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -112.62 179.45 3.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.393 -0.821 . . . . 3.3100000000000001 110.1 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -60.11 -40.01 88.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.045 0.45 . . . . 6.5300000000000002 111.705 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 83.17 22.69 56.71 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.811 -0.631 . . . . 5.0599999999999996 111.857 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -133.31 129.83 38.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.74 0.305 . . . . 7.3899999999999997 110.534 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . 0.551 HD21 ' HB2' ' A' ' 189' ' ' PHE . 5.9 m120 -100.36 118.43 36.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.031 -0.531 . . . . 9.0700000000000003 110.519 177.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 46.7 tpp -71.15 -30.0 65.92 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.549 -0.75 . . . . 10.869999999999999 110.262 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -79.93 169.99 17.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.444 -0.798 . . . . 10.449999999999999 111.591 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -114.21 130.34 56.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.598 -0.728 . . . . 13.06 110.958 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 46.9 t -131.14 146.46 52.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.059 -0.519 . . . . 12.609999999999999 110.094 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -89.88 -0.38 57.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.383 -0.372 . . . . 15.19 111.192 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -108.8 143.06 38.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.155 -0.475 . . . . 13.18 109.796 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -87.02 136.57 32.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.244 0.545 . . . . 12.73 110.841 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 150.26 -179.71 26.77 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 111.192 -0.763 . . . . 9.9800000000000004 111.192 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -114.33 139.98 49.01 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.604 -0.517 . . . . 10.699999999999999 109.604 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.551 ' HB2' HD21 ' A' ' 179' ' ' ASN . 94.9 m-85 -109.75 20.1 18.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.506 -0.316 . . . . 10.5 111.815 -172.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 16.1 m -61.01 142.81 56.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.438 -0.346 . . . . 6.6399999999999997 110.611 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 16.5 p -99.71 26.6 6.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.174 0.511 . . . . 4.9800000000000004 111.038 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -59.97 139.17 57.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.163 -0.926 . . . . 7.0999999999999996 111.694 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -111.84 154.17 25.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.881 -0.599 . . . . 4.4000000000000004 110.669 175.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 88.0 mt -120.09 98.11 5.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.137 -1.061 . . . . 2.21 108.137 171.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.679 ' HA ' ' O ' ' A' ' 211' ' ' THR . 97.7 mtt180 -100.04 118.91 37.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.858 0.361 . . . . 3.54 111.173 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.589 ' O ' ' HA ' ' A' ' 210' ' ' TYR . . . -99.98 131.82 45.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.251 -0.431 . . . . 1.6699999999999999 110.916 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -127.69 129.41 47.12 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.752 -0.658 . . . . 5.8300000000000001 109.826 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 208' ' ' THR . 1.8 pt? -131.1 127.23 21.9 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.167 -0.309 . . . . 2.5899999999999999 110.167 174.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -89.55 120.31 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.664 2.243 . . . . 1.77 113.626 -177.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 84.1 mt -118.08 128.2 54.52 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.369 -0.604 . . . . 2.2599999999999998 109.369 172.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 24.0 m -100.51 120.13 39.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.807 0.337 . . . . 1.99 111.236 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 91.8 mt -122.57 80.78 1.77 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.525 -0.546 . . . . 2.3100000000000001 109.525 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 72.84 -122.98 8.5 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.65 -0.704 . . . . 1.51 111.861 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -93.83 3.56 55.23 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.293 0.568 . . . . 2.5699999999999998 110.2 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -118.59 130.01 55.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.915 -0.584 . . . . 2.6600000000000001 110.048 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 241' ' ' TYR . 5.4 p -111.13 139.82 46.19 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.774 -0.37 . . . . 1.6200000000000001 110.557 176.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.448 HG22 ' CE1' ' A' ' 241' ' ' TYR . 31.7 t -109.16 120.91 61.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.378 -0.601 . . . . 1.3799999999999999 109.378 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 198' ' ' LEU . 32.1 m -129.84 90.1 44.07 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.264 -0.426 . . . . 1.1799999999999999 110.0 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -63.17 146.05 93.89 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.45 2.1 . . . . 1.01 111.142 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 53.0 p90 -133.34 148.28 51.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.156 0.503 . . . . 4.5 110.204 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 195' ' ' ARG . 32.6 p -129.72 141.29 50.92 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.539 -0.755 . . . . 1.8899999999999999 110.57 -177.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -69.74 -38.92 77.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.649 -0.705 . . . . 4.7999999999999998 109.567 177.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.408 HG22 ' H ' ' A' ' 215' ' ' LEU . 87.1 mt -120.24 119.96 61.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.229 -0.896 . . . . 4.5700000000000003 109.627 174.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -88.48 37.7 3.27 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 121.136 -0.554 . . . . 4.9800000000000004 112.558 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.408 ' H ' HG22 ' A' ' 213' ' ' ILE . 84.2 mt -126.67 131.14 51.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.579 -0.526 . . . . 8.1099999999999994 109.579 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -96.85 136.5 37.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.969 0.414 . . . . 7.6500000000000004 110.813 -177.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -113.08 107.79 16.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.997 -0.547 . . . . 10.529999999999999 111.432 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -71.77 -31.31 66.49 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.75 -0.833 . . . . 11.56 108.75 170.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 35.1 p -135.3 150.61 50.04 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.651 -1.159 . . . . 10.06 109.077 172.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -97.85 126.74 43.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.063 0.458 . . . . 11.92 111.17 -174.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -70.02 -31.16 68.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.391 -0.822 . . . . 14.01 110.021 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -82.76 139.97 33.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.795 -0.639 . . . . 14.529999999999999 110.123 178.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -117.62 138.61 51.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.116 0.484 . . . . 16.609999999999999 110.783 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -120.64 140.16 51.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.883 -0.598 . . . . 15.460000000000001 110.308 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -66.06 -39.92 90.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.751 -0.659 . . . . 15.67 109.84 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.46 -42.25 87.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.351 -0.841 . . . . 14.5 111.624 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 48.8 mm -120.07 118.45 56.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.396 -0.365 . . . . 15.15 111.164 -174.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -74.42 -39.89 62.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.905 -0.589 . . . . 14.73 110.86 177.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -161.5 158.96 27.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.93 -0.577 . . . . 16.379999999999999 110.321 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -107.93 124.97 50.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.249 -0.432 . . . . 12.779999999999999 110.554 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -71.2 -28.75 69.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.873 -0.68 . . . . 11.1 111.963 175.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 59.77 36.77 22.21 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 122.809 0.444 . . . . 12.26 111.111 -177.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -60.76 -40.11 91.27 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.479 0.657 . . . . 9.9900000000000002 109.498 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -122.64 140.05 53.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.845 -1.07 . . . . 10.43 108.616 171.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -120.08 151.08 39.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.74 0.305 . . . . 6.29 110.486 -175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -98.97 111.02 23.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.296 0.57 . . . . 8.1500000000000004 111.026 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.59 139.85 28.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.147 -0.933 . . . . 2.3999999999999999 108.946 176.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -80.15 134.6 13.72 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.088 -1.053 . . . . 1.27 111.737 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 87.0 mt -108.44 118.07 35.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.11 0.455 . . . . 1.97 110.627 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' A' ' 208' ' ' THR . 64.8 t80 -110.04 131.23 55.24 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.125 -0.695 . . . . 3.54 109.125 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . 0.562 ' HB2' ' HB2' ' A' ' 253' ' ' LEU . 96.2 m-85 -120.11 139.2 52.94 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.834 -0.432 . . . . 2.6400000000000001 109.834 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -110.95 129.04 9.03 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.527 -0.844 . . . . 1.3500000000000001 111.682 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -129.31 126.84 39.87 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.939 -0.393 . . . . 4.3600000000000003 109.939 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -120.0 131.7 55.23 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.918 0.389 . . . . 4.29 110.706 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 249' ' ' LEU . 52.2 t80 -102.34 129.95 48.93 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.941 -0.763 . . . . 6.6900000000000004 108.941 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -60.08 -37.17 79.14 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.583 0.957 . . . . 6.3700000000000001 113.583 -167.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -60.11 -39.98 88.09 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.622 0.249 . . . . 5.8300000000000001 111.559 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 151.65 42.04 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.868 -1.158 . . . . 2.6600000000000001 113.233 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 245' ' ' PHE . 49.9 tp -133.48 130.09 38.1 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.031 -0.359 . . . . 2.9700000000000002 110.031 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 21.6 t -117.04 130.03 56.41 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.227 -0.657 . . . . 2.1699999999999999 109.227 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.09 132.72 68.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.057 0.456 . . . . 1.79 110.426 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 52.6 m -114.19 128.7 56.49 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.532 -0.544 . . . . 1.6299999999999999 109.532 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 241' ' ' TYR . 83.0 mt -118.98 133.57 55.74 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.378 -0.374 . . . . 2.96 110.541 -175.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -127.25 121.33 30.87 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.772 -0.455 . . . . 4.0800000000000001 109.772 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -122.97 139.24 54.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.928 0.394 . . . . 4.8399999999999999 111.631 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -148.87 179.95 7.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.673 -0.694 . . . . 3.5800000000000001 110.301 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 60.26 48.5 8.04 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.542 0.526 . . . . 6.7699999999999996 112.262 177.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.17 -31.79 73.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.548 -0.296 . . . . 8.5399999999999991 110.839 173.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -67.09 140.17 57.58 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.763 -0.458 . . . . 11.9 109.763 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -77.52 113.57 15.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.378 -0.373 . . . . 10.57 110.636 -174.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.02 170.05 17.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.247 0.546 . . . . 11.41 110.764 176.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -101.69 29.9 4.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.828 -0.623 . . . . 11.98 110.331 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -112.68 179.5 3.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.131 -0.486 . . . . 12.460000000000001 109.939 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -121.05 144.04 48.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.574 0.226 . . . . 13.779999999999999 110.444 -177.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 70.2 31.59 69.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.564 -0.827 . . . . 11.07 112.105 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -63.73 -38.65 91.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.961 0.41 . . . . 12.59 110.564 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 48.9 m -60.32 -40.06 89.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.541 -0.754 . . . . 10.92 109.969 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -63.05 -38.03 89.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.576 -0.738 . . . . 12.42 111.361 177.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -60.01 134.23 56.85 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.092 -0.503 . . . . 11.59 111.223 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -83.65 -9.92 58.55 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.024 -0.534 . . . . 8.8300000000000001 110.211 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . 0.45 ' CE1' HG21 ' A' ' 17' ' ' ILE . 94.2 m-70 -61.17 -39.9 91.88 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 108.912 -0.773 . . . . 7.0199999999999996 108.912 169.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -62.38 -49.79 74.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.368 -1.287 . . . . 6.5999999999999996 111.283 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -149.27 148.98 30.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.895 0.379 . . . . 1.9399999999999999 111.431 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -132.99 149.62 19.62 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.87 -0.604 . . . . 1.4199999999999999 112.285 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 61.5 t -130.04 130.07 65.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.673 0.273 . . . . 1.8100000000000001 110.719 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -125.48 134.69 8.91 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.041 -0.824 . . . . 1.3 111.041 176.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 28.0 m -128.71 139.5 51.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 117.431 0.615 . . . . 1.8300000000000001 111.375 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -129.4 124.31 33.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.855 -0.611 . . . . 2.3100000000000001 110.162 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.416 ' CD1' HD13 ' A' ' 249' ' ' LEU . 97.9 m-85 -96.69 127.92 43.14 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.45 -0.574 . . . . 4.75 109.45 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 49.1 m -111.32 124.95 53.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.723 0.297 . . . . 1.6699999999999999 110.73 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 72.6 t80 . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.58 -0.724 . . . . 3.6899999999999999 109.827 179.601 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mmm . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.763 0.316 . . . . 11.85 110.659 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.549 ' HB2' ' ND2' ' A' ' 5' ' ' ASN . 48.0 mt-10 -107.9 131.32 54.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.74 0.305 . . . . 10.35 110.37 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -70.13 -28.02 65.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.918 -0.583 . . . . 9.3100000000000005 110.427 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -60.12 -40.16 88.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.53 . . . . 8.8399999999999999 110.743 175.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.549 ' ND2' ' HB2' ' A' ' 2' ' ' GLU . 88.7 m-20 -70.81 129.87 40.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.986 -0.552 . . . . 7.0099999999999998 109.689 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -119.91 119.47 33.58 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.098 -0.501 . . . . 3.6099999999999999 110.397 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -119.4 138.52 53.03 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.038 -0.356 . . . . 3.3300000000000001 110.038 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -104.22 128.16 51.92 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.517 -0.549 . . . . 3.2000000000000002 109.517 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -103.23 144.89 30.74 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.687 -0.688 . . . . 2.4900000000000002 111.033 -175.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 279' ' ' TYR . 35.4 m-80 -119.98 131.26 55.11 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.167 -0.924 . . . . 2.1299999999999999 108.926 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.6 mt -120.29 115.26 46.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 N-CA-C 109.204 -0.665 . . . . 1.6000000000000001 109.204 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -110.02 127.07 8.22 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.551 -0.833 . . . . 0.88 111.273 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -120.67 136.01 54.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.713 0.292 . . . . 1.0800000000000001 110.785 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.405 ' O ' ' HA ' ' A' ' 33' ' ' PRO . 91.4 mtp -135.35 156.93 48.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.852 -0.613 . . . . 2.3300000000000001 109.415 176.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -119.95 122.37 41.05 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.641 -0.503 . . . . 2.6099999999999999 109.641 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.23 -49.92 75.69 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 121.062 0.458 . . . . 5.0899999999999999 110.345 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 47.6 mm -119.95 120.33 62.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.915 -0.584 . . . . 5.3300000000000001 109.869 171.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -79.71 148.98 31.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.9 -0.591 . . . . 8.2799999999999994 111.028 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -122.52 110.02 15.06 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.12 -0.696 . . . . 9.6999999999999993 109.12 170.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.7 p -63.58 -29.97 48.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.259 -0.428 . . . . 11.09 111.492 -177.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -68.19 -40.02 82.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.1 -0.5 . . . . 13.1 110.669 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.32 127.08 1.13 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.086 -0.578 . . . . 11.94 111.917 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -69.47 126.15 28.89 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.883 0.373 . . . . 15.18 110.435 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.81 24.26 65.05 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.85 -0.69 . . . . 12.0 113.865 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.88 -39.91 94.28 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.754 0.777 . . . . 12.82 111.072 175.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -76.49 121.61 23.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 10.81 110.435 -177.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 59.9 ttp -69.86 -40.09 75.98 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.661 -0.699 . . . . 10.050000000000001 110.339 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -131.53 136.78 48.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.393 -0.821 . . . . 8.0600000000000005 110.106 -178.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -169.58 164.97 38.44 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.843 -0.694 . . . . 5.5800000000000001 111.688 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 96.9 mt -81.09 -9.95 59.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.696 0.284 . . . . 5.5599999999999996 110.771 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.75 137.58 53.85 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.113 -0.494 . . . . 3.0499999999999998 109.942 175.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -140.02 159.27 65.04 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.581 0.229 . . . . 3.48 110.948 -173.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 14' ' ' MET . 36.3 Cg_endo -70.17 149.99 65.08 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.308 2.005 . . . . 1.8600000000000001 110.916 168.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 22.2 m -125.67 142.19 51.63 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.699 -0.482 . . . . 1.97 109.699 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.618 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 33.1 m -129.99 160.06 41.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.695 0.284 . . . . 1.71 110.512 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -140.2 149.95 43.56 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.68 -0.489 . . . . 4.0700000000000003 109.68 174.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 94.5 m-85 -109.45 128.79 55.42 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.465 -0.334 . . . . 2.8599999999999999 110.217 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -140.32 135.21 31.97 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.992 -0.549 . . . . 1.8899999999999999 109.753 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.6 141.39 51.14 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.762 -0.375 . . . . 1.0800000000000001 110.177 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . . . -160.17 125.82 4.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.271 -0.422 . . . . 1.3899999999999999 111.675 -177.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -167.46 93.47 0.42 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.507 -0.553 . . . . 2.8599999999999999 109.507 167.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.65 -94.78 1.34 Allowed Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.543 -0.837 . . . . 1.6799999999999999 112.003 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.76 172.95 0.93 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.605 2.87 . . . . 1.6599999999999999 113.114 175.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.8 p-90 -69.78 159.15 34.11 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.197 0.522 . . . . 3.3999999999999999 111.367 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.454 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 25.7 ptt-85 -115.72 146.85 41.52 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.249 0.833 . . . . 3.1000000000000001 113.249 -163.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.4 mm -122.88 131.26 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 114.495 -1.23 . . . . 1.8 111.03 -173.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 37' ' ' PHE . . . -117.53 139.98 50.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.525 -0.307 . . . . 0.85999999999999999 110.719 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 71' ' ' GLU . 56.4 tp -135.83 137.11 41.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 1.0600000000000001 111.046 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.04 166.94 28.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.743 -0.662 . . . . 1.1399999999999999 109.313 174.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -124.15 130.02 51.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.876 0.37 . . . . 4.0199999999999996 111.122 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.554 ' HB3' ' HB2' ' A' ' 69' ' ' ARG . 47.0 t80 -99.98 119.56 38.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.865 -0.607 . . . . 4.6100000000000003 110.073 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 -133.83 130.17 37.53 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.743 -0.465 . . . . 3.3799999999999999 109.743 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -146.47 160.03 42.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.015 0.436 . . . . 5.0499999999999998 110.981 177.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.47 79.78 0.35 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.724 -0.671 . . . . 4.3700000000000001 112.157 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.93 149.91 66.48 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.46 2.107 . . . . 6.6799999999999997 111.627 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.0 p -69.9 -26.87 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.053 -0.521 . . . . 8.1699999999999999 110.862 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -66.68 -39.94 88.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.607 -0.724 . . . . 10.039999999999999 112.039 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -117.16 129.96 56.3 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.171 -0.307 . . . . 11.609999999999999 110.171 -173.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.3 p -125.97 149.18 48.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.815 0.34 . . . . 9.7899999999999991 111.24 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.34 -29.24 65.89 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.88 -0.6 . . . . 8.5099999999999998 110.812 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.82 -143.43 47.77 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.224 -0.898 . . . . 7.5599999999999996 113.814 172.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -69.99 -39.43 75.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.009 0.433 . . . . 10.0 110.709 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -59.94 -40.02 87.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.364 -0.834 . . . . 10.35 110.961 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.97 10.22 86.38 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.56 -0.745 . . . . 5.3399999999999999 112.17 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 19.0 p -79.01 129.36 34.36 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 120.93 0.395 . . . . 5.3200000000000003 111.326 -176.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -109.27 146.02 34.98 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.032 -0.729 . . . . 5.6100000000000003 109.032 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.65 ' HB2' ' CZ ' ' A' ' 95' ' ' TYR . 64.8 m-85 -119.73 138.92 53.01 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.534 -0.543 . . . . 3.7799999999999998 109.534 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -123.82 164.94 18.19 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.194 -0.669 . . . . 2.4500000000000002 109.194 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.554 ' HB2' ' HB3' ' A' ' 51' ' ' TYR . 10.4 mtp180 -120.63 124.33 27.64 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.779 -0.452 . . . . 3.2400000000000002 109.779 178.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.548 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 69.9 Cg_endo -80.1 122.76 4.85 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.963 1.775 . . . . 1.1899999999999999 110.952 173.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 36.5 tt0 -99.96 113.03 25.32 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.557 -0.535 . . . . 2.1899999999999999 109.557 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.1 tp -121.9 123.41 41.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.269 -0.423 . . . . 1.1399999999999999 110.411 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -119.7 135.79 54.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.943 0.401 . . . . 2.1800000000000002 110.262 173.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.1 t -113.67 119.88 62.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.153 -1.054 . . . . 1.5600000000000001 108.153 172.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -117.38 117.38 29.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.752 -0.462 . . . . 3.4399999999999999 109.752 -176.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -120.45 131.2 54.65 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.815 -0.629 . . . . 4.7999999999999998 109.959 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -121.82 139.95 52.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.306 -0.406 . . . . 2.9399999999999999 110.369 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -116.63 97.92 6.26 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.849 -0.797 . . . . 3.8999999999999999 108.849 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.611 HD22 ' O ' ' A' ' 83' ' ' ASP . 40.4 mt -114.7 18.35 16.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.842 -0.617 . . . . 4.4800000000000004 110.219 -175.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.84 -39.21 76.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.823 -0.626 . . . . 6.1900000000000004 111.789 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -73.03 -66.78 0.63 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.82 0.343 . . . . 5.4500000000000002 110.921 -178.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -127.1 -173.42 2.89 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.088 -0.505 . . . . 5.2699999999999996 109.646 177.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.611 ' O ' HD22 ' A' ' 79' ' ' LEU . 22.3 m-20 -59.92 -39.92 87.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.553 -0.536 . . . . 6.3300000000000001 109.553 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -132.75 139.26 47.5 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.82 -0.808 . . . . 7.4800000000000004 108.82 170.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.9 m -150.06 -74.45 0.16 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.849 0.356 . . . . 2.5499999999999998 111.657 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -131.56 150.2 52.24 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.948 -0.39 . . . . 5.2999999999999998 109.948 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.55 161.7 28.7 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.645 -0.788 . . . . 1.3500000000000001 111.828 176.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.0 tp -141.11 112.57 7.48 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.746 -0.464 . . . . 2.29 109.746 176.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.3 m -120.01 129.99 54.52 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.261 -0.427 . . . . 1.54 110.562 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -127.23 140.06 11.62 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.727 -0.749 . . . . 1.1699999999999999 111.571 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.47 119.86 1.76 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.631 -0.795 . . . . 1.1899999999999999 111.874 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -126.81 129.72 48.86 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.001 0.429 . . . . 3.75 110.933 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -141.34 134.84 29.84 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.102 -0.703 . . . . 2.75 109.102 175.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.548 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 8.6 p30 -134.87 151.65 51.08 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-O 120.468 0.175 . . . . 1.8200000000000001 110.981 -175.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.65 ' CZ ' ' HB2' ' A' ' 67' ' ' PHE . 65.2 t80 -118.74 130.01 55.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.547 -0.297 . . . . 3.1400000000000001 110.371 -176.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.9 -169.76 22.3 Favored Glycine 0 C--O 1.228 -0.233 0 C-N-CA 120.465 -0.874 . . . . 2.79 112.254 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -152.46 159.97 43.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.651 0.226 . . . . 7.6200000000000001 110.533 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -116.31 19.74 14.63 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.267 0.469 . . . . 7.0800000000000001 112.267 -175.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -110.55 125.4 53.32 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.288 -0.258 . . . . 10.16 110.557 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.97 160.16 41.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.558 -0.292 . . . . 9.8100000000000005 110.87 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -52.11 -61.56 2.19 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.382 0.427 . . . . 12.220000000000001 111.076 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -135.03 157.05 77.81 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.444 -0.798 . . . . 10.48 109.363 -178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.02 149.86 81.93 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.311 2.007 . . . . 9.0999999999999996 111.713 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.99 -9.96 37.11 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.793 -0.718 . . . . 6.46 111.768 -175.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -100.35 122.82 43.73 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.551 -0.537 . . . . 7.6699999999999999 109.551 174.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -64.5 130.26 43.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.052 -0.522 . . . . 4.1399999999999997 110.794 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.1 p -97.64 139.99 32.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.784 -0.643 . . . . 3.2999999999999998 110.598 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -132.05 119.45 21.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.498 -0.319 . . . . 1.76 111.445 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' A' ' 95' ' ' TYR . 27.5 t-20 -151.8 124.62 8.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.779 -0.646 . . . . 2.5499999999999998 110.121 176.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.408 ' HG3' ' HA ' ' A' ' 139' ' ' ALA . 43.3 ttm -103.34 121.39 42.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.6 -0.727 . . . . 1.77 110.264 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -112.27 141.33 46.11 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.614 -0.434 . . . . 1.97 111.434 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.626 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 76.4 ttt180 -131.07 110.89 11.53 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.997 -0.742 . . . . 3.8500000000000001 108.997 168.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.563 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 83.2 m95 -98.76 119.95 38.38 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.879 -0.786 . . . . 2.2799999999999998 108.879 -179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.459 ' NZ ' ' HB2' ' A' ' 114' ' ' LYS . 10.2 mtmp? -121.74 123.81 42.73 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.785 -0.366 . . . . 2.1400000000000001 111.156 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 134' ' ' SER . 87.6 mt -120.62 126.22 74.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.032 -0.531 . . . . 1.55 109.976 174.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -138.92 105.78 7.42 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.425 -0.352 . . . . 1.1899999999999999 111.036 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.548 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 98.8 Cg_endo -80.06 160.03 23.77 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.98 2.453 . . . . 1.3700000000000001 111.158 173.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -116.19 137.19 52.35 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.248 -0.433 . . . . 2.3500000000000001 110.25 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -127.03 128.14 45.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.379 -0.373 . . . . 4.54 111.495 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.411 ' CG ' ' HE ' ' A' ' 128' ' ' ARG . 43.0 t0 -128.64 88.94 2.81 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.553 -0.536 . . . . 3.04 109.553 172.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.0 p -147.5 129.24 6.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.082 0.468 . . . . 4.2699999999999996 111.148 -177.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.711 ' HG3' ' H ' ' A' ' 124' ' ' THR . 55.8 tptt -144.31 142.91 30.72 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.217 -0.66 . . . . 6.04 109.217 177.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.3 mt -74.41 -6.77 50.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.137 0.494 . . . . 4.5899999999999999 110.904 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.711 ' H ' ' HG3' ' A' ' 122' ' ' LYS . 26.3 m -119.96 135.7 54.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.637 -0.71 . . . . 3.6899999999999999 109.561 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -68.15 -39.93 82.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.873 -0.603 . . . . 5.1699999999999999 111.126 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -61.02 -40.27 92.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.244 -0.889 . . . . 3.71 112.078 -176.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -110.95 161.22 16.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.059 0.457 . . . . 2.0499999999999998 111.857 -171.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.541 ' HD2' ' OE1' ' A' ' 159' ' ' GLN . 20.3 ttm180 -125.51 133.66 52.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.88 -0.6 . . . . 4.2400000000000002 111.465 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.541 ' HB2' ' HD3' ' A' ' 122' ' ' LYS . 64.7 t80 -114.88 119.36 36.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.573 -0.739 . . . . 3.5499999999999998 109.21 175.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.412 ' OD1' ' HD3' ' A' ' 128' ' ' ARG . 17.4 m120 -118.45 130.05 55.74 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.018 -0.364 . . . . 2.1099999999999999 110.018 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -134.9 135.75 8.12 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.408 -0.901 . . . . 1.1799999999999999 111.688 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -124.0 128.28 49.14 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.668 -0.493 . . . . 4.2999999999999998 109.668 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.548 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 63.0 tp -109.95 110.93 22.03 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.188 -0.671 . . . . 2.2400000000000002 109.188 175.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 115' ' ' ILE . 14.3 t -116.21 130.15 56.65 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.253 -0.579 . . . . 1.6899999999999999 110.533 -175.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 66.6 mtt -118.99 135.92 54.37 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.651 -0.87 . . . . 2.2400000000000002 108.651 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.563 ' HA ' ' O ' ' A' ' 113' ' ' TRP . 54.7 p90 -149.83 157.42 43.18 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.349 0.595 . . . . 3.5600000000000001 111.61 178.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 59.7 mttp -129.82 157.62 41.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.932 -1.031 . . . . 1.6699999999999999 109.849 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.745 ' H ' HD12 ' A' ' 142' ' ' LEU . 64.3 t80 -121.85 139.99 52.94 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.743 -0.662 . . . . 3.23 109.824 -173.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.408 ' HA ' ' HG3' ' A' ' 110' ' ' MET . . . 61.12 -175.91 0.12 Allowed 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.685 0.616 . . . . 1.24 110.745 -175.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 143' ' ' ASN . 63.9 t30 -79.08 -21.63 46.47 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.211 -0.595 . . . . 2.4700000000000002 110.315 172.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.93 -47.39 85.98 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.496 -0.774 . . . . 2.4100000000000001 112.33 -172.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.745 HD12 ' H ' ' A' ' 138' ' ' PHE . 49.4 mt -69.87 -25.36 63.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.003 0.43 . . . . 1.8300000000000001 110.971 -178.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 140' ' ' ASN . 94.7 m-20 -59.91 -39.98 87.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.974 0.416 . . . . 2.0 110.007 175.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 80.9 p -78.1 -31.1 49.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.012 -0.54 . . . . 2.0499999999999998 111.54 -177.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.42 ' OG1' ' HA ' ' A' ' 142' ' ' LEU . 34.9 p -70.16 -25.03 63.26 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.105 0.478 . . . . 1.5900000000000001 110.912 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 64.93 -128.08 34.0 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.696 -0.684 . . . . 1.52 112.776 175.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -72.47 -20.69 61.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.514 0.19 . . . . 5.9400000000000004 111.514 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.02 97.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.827 0.346 . . . . 1.8300000000000001 111.155 -176.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -131.47 92.83 3.23 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.129 -0.693 . . . . 2.6400000000000001 109.129 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.2 t -144.85 146.69 32.18 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.048 -0.524 . . . . 2.02 110.153 -178.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 136' ' ' TYR . 32.8 tpt180 -99.77 119.05 37.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.39 -0.368 . . . . 3.6699999999999999 110.492 -177.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.4 t -119.22 119.22 60.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 1.6399999999999999 109.875 178.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -123.49 140.01 53.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.929 0.395 . . . . 2.5600000000000001 111.009 -176.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 33.5 m -119.97 127.03 52.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.141 -0.482 . . . . 1.3899999999999999 109.737 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.526 ' HG3' HD21 ' A' ' 171' ' ' ASN . 31.0 tt0 -123.51 130.72 53.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.585 -0.524 . . . . 2.04 109.585 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 171' ' ' ASN . 88.3 m -122.07 121.83 37.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.855 0.359 . . . . 1.5600000000000001 111.614 -176.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -102.39 115.23 5.15 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 111.174 -0.77 . . . . 1.04 111.174 177.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 89.9 mt -100.34 122.61 43.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.829 0.347 . . . . 2.27 110.631 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.541 ' OE1' ' HD2' ' A' ' 128' ' ' ARG . 53.3 tt0 -100.01 107.97 20.05 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.065 -0.717 . . . . 2.4100000000000001 109.065 176.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -120.44 114.81 22.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.149 -0.478 . . . . 4.5700000000000003 109.714 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' A' ' 164' ' ' GLU . 6.8 p -88.85 90.5 8.44 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.269 0.557 . . . . 1.46 110.535 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -60.23 -49.28 78.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.582 -0.735 . . . . 2.6299999999999999 111.171 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.479 ' HB2' HG22 ' A' ' 166' ' ' VAL . 94.6 m-20 -101.77 13.13 35.76 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.983 -0.287 . . . . 2.4100000000000001 111.024 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.413 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 41.3 tt0 71.39 -48.7 0.68 Allowed 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.774 0.671 . . . . 2.5800000000000001 111.3 -178.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 20.7 p -74.69 -19.98 60.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.34 -0.391 . . . . 2.2999999999999998 111.642 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' A' ' 163' ' ' ASN . 33.4 m -121.46 140.0 46.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.326 -0.397 . . . . 1.71 110.266 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.488 ' O ' ' HD2' ' A' ' 199' ' ' PRO . . . -106.87 129.26 54.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.053 -0.522 . . . . 1.47 110.601 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 28.7 mt -103.72 129.22 51.05 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.291 -0.633 . . . . 1.6599999999999999 109.291 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -101.45 107.4 18.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.812 0.339 . . . . 3.2999999999999998 110.572 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.9 t -113.18 119.98 62.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 109.446 -0.576 . . . . 1.3 109.446 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.616 ' HB3' ' HB3' ' A' ' 195' ' ' ARG . 8.5 t30 -106.34 120.73 42.63 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.952 0.406 . . . . 2.2200000000000002 111.123 -176.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -103.18 129.96 50.23 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.562 -0.745 . . . . 4.6100000000000003 109.748 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -102.46 138.71 39.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.225 -0.443 . . . . 3.98 110.674 -177.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 62.8 tp -140.08 143.38 36.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.571 . . . . 2.3799999999999999 110.447 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -105.84 141.01 37.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.223 -0.288 . . . . 3.3100000000000001 110.223 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -113.05 140.57 47.74 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.983 -0.376 . . . . 6.5300000000000002 109.983 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.459 ' O ' ' HG2' ' A' ' 180' ' ' MET . . . 103.1 -3.01 47.65 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.625 -0.798 . . . . 5.0599999999999996 111.732 -175.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.88 -40.08 87.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.178 0.513 . . . . 7.3899999999999997 110.013 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -58.62 -31.96 68.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.661 -0.7 . . . . 9.0700000000000003 111.331 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 177' ' ' GLY . 25.7 ptm -99.44 8.65 44.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.612 0.244 . . . . 10.869999999999999 111.218 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -89.19 95.55 10.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.664 -0.243 . . . . 10.449999999999999 110.372 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -60.12 -45.08 94.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.421 0.629 . . . . 13.06 109.868 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.2 p -160.05 150.26 18.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.211 -0.904 . . . . 12.609999999999999 108.984 173.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -103.28 113.23 26.56 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.343 0.592 . . . . 15.19 110.643 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -60.39 -39.94 89.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.521 -1.218 . . . . 13.18 111.826 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -69.69 -19.56 63.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.073 -0.512 . . . . 12.73 110.689 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 101.8 140.23 11.04 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.651 -0.704 . . . . 9.9800000000000004 111.479 -175.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.575 ' HG2' ' H ' ' A' ' 190' ' ' SER . 36.6 tt0 -104.59 130.47 52.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.836 0.35 . . . . 10.699999999999999 110.665 -177.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -75.41 -23.08 56.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.151 0.501 . . . . 10.5 110.251 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.575 ' H ' ' HG2' ' A' ' 188' ' ' GLU . 50.1 m 63.59 17.55 10.47 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.889 -1.051 . . . . 6.6399999999999997 112.293 174.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 7.0 p -140.35 150.04 43.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.592 -0.276 . . . . 4.9800000000000004 110.798 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -110.19 142.66 41.43 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.389 -0.967 . . . . 7.0999999999999996 108.389 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -107.52 150.96 26.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.03 0.443 . . . . 4.4000000000000004 111.071 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 48.9 mm -113.83 125.53 71.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.781 -0.645 . . . . 2.21 110.24 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.616 ' HB3' ' HB3' ' A' ' 171' ' ' ASN . 35.2 ttm180 -99.96 109.37 21.73 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.553 -0.906 . . . . 3.54 108.553 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -123.63 131.44 53.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.834 0.349 . . . . 1.6699999999999999 111.695 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -158.22 165.75 34.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.934 -0.575 . . . . 5.8300000000000001 109.83 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.577 ' O ' ' HD2' ' A' ' 209' ' ' PRO . 1.5 pt? -143.64 137.29 14.31 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 121.126 -0.23 . . . . 2.5899999999999999 110.461 177.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' A' ' 167' ' ' ALA . 72.3 Cg_endo -79.77 129.67 8.28 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.451 2.101 . . . . 1.77 112.736 176.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 88.1 mt -128.05 135.21 49.55 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.35 -0.611 . . . . 2.2599999999999998 109.35 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 4.4 p -112.45 118.93 36.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.981 0.42 . . . . 1.99 111.149 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.9 mt -125.48 82.2 2.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.889 -0.782 . . . . 2.3100000000000001 108.889 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 69.49 -124.69 16.16 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.338 -0.846 . . . . 1.51 111.733 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -91.83 3.98 53.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.18 0.514 . . . . 2.5699999999999998 109.902 175.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -95.9 115.88 28.08 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.61 -0.885 . . . . 2.6600000000000001 108.61 174.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 47.5 t -100.61 120.37 39.94 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.938 -0.764 . . . . 1.6200000000000001 108.938 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.81 128.07 73.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.932 0.396 . . . . 1.3799999999999999 110.695 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 35.1 m -131.1 91.3 36.47 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-O 120.83 0.347 . . . . 1.1799999999999999 110.093 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.577 ' HD2' ' O ' ' A' ' 198' ' ' LEU . 50.1 Cg_endo -70.41 140.58 40.54 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.269 1.979 . . . . 1.01 111.978 176.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -111.85 140.29 46.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.188 -0.46 . . . . 4.5 110.587 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 24.0 p -134.0 156.26 48.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 1.8899999999999999 110.314 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -116.57 120.33 38.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.045 0.45 . . . . 4.7999999999999998 110.656 -177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 84.8 mt -109.97 129.96 64.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.907 -0.588 . . . . 4.5700000000000003 110.259 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -102.09 -171.41 27.37 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.729 -0.748 . . . . 4.9800000000000004 112.451 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 91.1 mt -100.15 133.65 44.23 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.722 -0.473 . . . . 8.1099999999999994 109.722 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -69.93 -16.8 63.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 7.6500000000000004 111.725 -174.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -89.79 0.11 57.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.064 0.459 . . . . 10.529999999999999 111.051 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -125.52 149.42 48.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.835 -0.621 . . . . 11.56 109.347 178.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 46.1 m -76.98 -21.67 54.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.122 -0.49 . . . . 10.06 110.99 -176.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 59.98 25.69 14.91 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.255 -0.884 . . . . 11.92 112.3 170.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 85.6 m95 60.15 22.85 12.14 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.099 0.407 . . . . 14.01 112.099 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -99.5 137.16 38.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.333 -0.394 . . . . 14.529999999999999 109.995 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -118.85 122.02 41.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.771 0.32 . . . . 16.609999999999999 111.092 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -69.61 -21.16 63.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.999 -0.546 . . . . 15.460000000000001 109.964 175.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -60.54 -39.98 89.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.459 -0.792 . . . . 15.67 111.101 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -70.67 140.43 51.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.278 -0.419 . . . . 14.5 110.493 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 86.1 mt -110.04 130.09 63.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.823 -0.626 . . . . 15.15 110.691 -172.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -62.21 133.06 54.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.029 -0.532 . . . . 14.73 109.864 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 62.2 mtm180 -83.63 165.44 18.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.26 -0.427 . . . . 16.379999999999999 111.814 -173.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -59.95 -40.32 88.59 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.495 -0.557 . . . . 12.779999999999999 109.495 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -74.9 164.31 54.51 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.407 -0.815 . . . . 11.1 111.812 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -74.75 121.15 21.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.918 0.39 . . . . 12.26 111.692 -176.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -122.01 140.99 51.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.667 -0.697 . . . . 9.9900000000000002 109.867 174.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -134.72 149.86 50.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.827 0.346 . . . . 10.43 110.319 176.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -112.71 106.06 14.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.051 -0.522 . . . . 6.29 110.539 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 60.06 47.7 9.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.8 -0.636 . . . . 8.1500000000000004 111.675 174.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 63.3 t -109.9 129.7 64.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.604 -0.725 . . . . 2.3999999999999999 109.869 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -129.04 156.16 21.07 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.864 -0.684 . . . . 1.27 111.701 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.463 ' CD1' ' HA ' ' A' ' 258' ' ' GLU . 85.2 mt -120.0 130.45 54.75 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.933 -0.395 . . . . 1.97 109.933 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -109.89 130.0 55.58 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.989 -0.745 . . . . 3.54 108.989 176.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -120.03 139.89 51.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.959 0.409 . . . . 2.6400000000000001 111.0 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -113.66 128.81 8.48 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.797 -0.921 . . . . 1.3500000000000001 110.797 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' TYR . . . . . 0.439 ' O ' ' HB ' ' A' ' 251' ' ' VAL . 73.3 m-85 -130.0 150.11 51.42 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.614 0.207 . . . . 4.3600000000000003 110.772 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 58.12 39.98 25.57 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.082 0.864 . . . . 4.29 110.666 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -77.56 114.06 16.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.554 -0.748 . . . . 6.6900000000000004 109.79 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -143.46 168.22 20.36 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.895 -1.048 . . . . 6.3700000000000001 108.26 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -59.97 -40.06 87.78 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.83 -0.348 . . . . 5.8300000000000001 110.794 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 280' ' ' SER . . . -99.83 -0.27 56.36 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.447 -0.883 . . . . 2.6600000000000001 113.967 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 59.4 tp -145.98 138.52 25.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.65 0.725 . . . . 2.9700000000000002 111.304 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 61.3 p -147.36 134.49 20.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.821 0.343 . . . . 2.1699999999999999 110.963 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.473 HG22 HG23 ' A' ' 277' ' ' VAL . 59.8 t -122.58 132.47 71.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.799 -0.445 . . . . 1.79 109.799 176.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 35.1 t -120.04 127.8 52.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.877 0.37 . . . . 1.6299999999999999 110.086 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 72.2 mt -117.15 129.24 55.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.112 -0.495 . . . . 2.96 110.259 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -109.12 119.95 41.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.053 -0.521 . . . . 4.0800000000000001 110.633 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' TYR . . . . . 0.435 ' HD2' ' CZ ' ' A' ' 257' ' ' PHE . 92.6 m-85 -124.51 135.54 53.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.256 -0.429 . . . . 4.8399999999999999 110.465 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.644 ' HB3' ' H ' ' A' ' 272' ' ' TYR . . . -105.34 29.57 6.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.276 0.56 . . . . 3.5800000000000001 110.775 175.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . 0.435 ' CZ ' ' HD2' ' A' ' 255' ' ' TYR . 29.0 p90 -147.2 133.64 19.69 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.751 -0.658 . . . . 6.7699999999999996 110.174 177.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.463 ' HA ' ' CD1' ' A' ' 239' ' ' LEU . 56.3 mt-10 -69.86 -40.04 76.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.473 -0.785 . . . . 8.5399999999999991 111.174 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -121.05 154.63 35.83 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.834 -0.621 . . . . 11.9 109.71 -177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -86.96 109.01 19.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.0 0.429 . . . . 10.57 110.582 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -79.59 116.9 20.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.662 -0.699 . . . . 11.41 110.154 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -70.12 -19.94 63.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.031 -0.531 . . . . 11.98 111.775 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -80.75 168.53 18.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.623 -0.262 . . . . 12.460000000000001 111.069 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -60.1 -40.13 88.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.02 0.438 . . . . 13.779999999999999 111.05 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 136.55 167.18 11.09 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.903 -0.665 . . . . 11.07 111.649 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -120.35 134.09 55.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.971 -0.381 . . . . 12.59 109.971 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 12.6 p -69.99 -18.54 63.33 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.865 -0.607 . . . . 10.92 111.296 -178.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.2 -39.95 94.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.146 -0.479 . . . . 12.42 111.262 176.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -131.98 105.83 7.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.321 -0.4 . . . . 11.59 110.195 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -80.01 155.78 27.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.961 0.41 . . . . 8.8300000000000001 110.419 -177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -130.09 143.19 50.65 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.338 -0.392 . . . . 7.0199999999999996 110.619 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . 0.644 ' H ' ' HB3' ' A' ' 256' ' ' ALA . 91.9 m-85 -108.45 149.06 29.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.956 -0.565 . . . . 6.5999999999999996 110.158 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -137.57 130.25 29.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.834 -0.621 . . . . 1.9399999999999999 109.954 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -137.8 144.46 15.8 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.552 -0.832 . . . . 1.4199999999999999 112.541 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 63.0 t -130.06 130.11 65.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.588 0.232 . . . . 1.8100000000000001 110.489 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -141.65 131.07 4.63 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.955 -0.64 . . . . 1.3 111.554 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.473 HG23 HG22 ' A' ' 251' ' ' VAL . 7.3 p -132.96 137.12 54.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.652 0.263 . . . . 1.8300000000000001 110.73 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -119.79 127.52 52.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 2.3100000000000001 110.31 178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 10' ' ' ASN . 89.5 m-85 -109.22 126.71 53.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.259 -0.645 . . . . 4.75 109.259 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.498 ' HB2' ' HA2' ' A' ' 248' ' ' GLY . 37.7 m -114.17 129.35 56.63 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.903 0.383 . . . . 1.6699999999999999 110.554 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.178 -0.915 . . . . 3.6899999999999999 109.608 179.503 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.7 mtm . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 120.831 0.348 . . . . 11.85 110.976 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -117.02 112.97 21.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.087 0.47 . . . . 10.35 110.867 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -69.87 -40.02 75.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.53 -0.759 . . . . 9.3100000000000005 110.652 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -116.24 127.31 54.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.052 -0.522 . . . . 8.8399999999999999 109.969 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -120.04 130.59 54.77 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.093 -0.503 . . . . 7.0099999999999998 109.833 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -70.18 -29.4 66.27 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.609 -0.515 . . . . 3.6099999999999999 109.609 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.448 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 92.2 m95 -71.25 115.97 11.02 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.642 -0.708 . . . . 3.3300000000000001 110.053 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.427 ' HA ' ' O ' ' A' ' 281' ' ' PHE . 53.1 t60 -114.57 122.16 45.67 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.071 -0.513 . . . . 3.2000000000000002 109.964 175.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' A' ' 7' ' ' TRP . 98.9 m-85 -120.21 140.07 51.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.944 -0.571 . . . . 2.4900000000000002 110.731 -178.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -122.0 129.47 52.49 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.078 -0.712 . . . . 2.1299999999999999 109.078 171.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.511 ' HB ' ' HB3' ' A' ' 279' ' ' TYR . 86.2 mt -125.12 129.37 73.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.292 -0.413 . . . . 1.6000000000000001 110.736 -176.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.13 122.79 5.95 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.093 -0.803 . . . . 0.88 111.093 175.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 34' ' ' SER . . . -120.01 136.66 54.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.935 0.367 . . . . 1.0800000000000001 110.858 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 68.4 mtt -133.43 156.68 47.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.305 -0.407 . . . . 2.3300000000000001 110.347 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -114.65 139.93 49.25 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.782 -0.451 . . . . 2.6099999999999999 109.782 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 42.2 tt0 -60.34 -50.23 74.46 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.762 0.652 . . . . 5.0899999999999999 112.762 -175.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.8 tt -145.06 146.68 19.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.799 0.333 . . . . 5.3300000000000001 111.048 -174.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.532 ' HB3' HG13 ' A' ' 20' ' ' VAL . 40.5 mt-10 -61.75 -50.16 73.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.628 -0.715 . . . . 8.2799999999999994 112.317 -176.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 51.14 42.78 29.1 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.244 0.545 . . . . 9.6999999999999993 111.121 -174.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.532 HG13 ' HB3' ' A' ' 18' ' ' GLU . 16.5 m -80.1 -14.74 13.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.836 -0.62 . . . . 11.09 111.151 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.63 -30.1 67.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 13.1 110.993 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.6 178.56 28.24 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.733 -0.746 . . . . 11.94 112.218 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -130.02 159.97 35.1 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.501 -0.555 . . . . 15.18 109.501 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.19 -131.26 2.88 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.442 -0.885 . . . . 12.0 112.301 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -69.8 -35.75 75.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.495 0.664 . . . . 12.82 110.094 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 59.84 28.28 17.73 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 114.126 -1.397 . . . . 10.81 111.983 172.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 75.2 mtm -69.9 -40.04 75.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.291 -0.413 . . . . 10.050000000000001 111.369 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -70.18 149.27 47.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.963 0.411 . . . . 8.0600000000000005 111.026 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.73 97.98 0.51 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.988 -0.625 . . . . 5.5800000000000001 111.864 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.1 tp -139.94 140.77 36.43 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.635 -0.505 . . . . 5.5599999999999996 109.635 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 16' ' ' GLU . . . 64.27 63.09 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.623 0.577 . . . . 3.0499999999999998 111.506 176.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -100.82 130.7 24.72 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.953 -0.567 . . . . 3.48 109.796 175.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.97 150.01 66.32 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.347 2.031 . . . . 1.8600000000000001 112.267 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 14.3 p -124.46 143.67 50.51 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.038 -0.528 . . . . 1.97 109.733 175.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.0 m -129.96 139.23 52.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.19 0.519 . . . . 1.71 111.252 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -120.33 139.44 52.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.616 -0.72 . . . . 4.0700000000000003 109.631 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -119.9 138.34 53.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.882 0.373 . . . . 2.8599999999999999 111.625 -174.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -140.07 130.01 24.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.733 -0.667 . . . . 1.8899999999999999 109.222 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.62 143.46 49.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.884 0.373 . . . . 1.0800000000000001 111.573 -174.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.542 ' HB2' ' HG2' ' A' ' 45' ' ' ARG . . . -147.01 125.09 12.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.607 -0.724 . . . . 1.3899999999999999 111.354 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.602 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 27.8 p-10 -166.96 95.24 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.278 0.561 . . . . 2.8599999999999999 110.502 171.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.97 -95.52 2.1 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.05 -0.595 . . . . 1.6799999999999999 111.871 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.602 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 54.2 Cg_exo -52.5 174.47 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.624 2.883 . . . . 1.6599999999999999 113.178 171.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.605 ' HB2' ' O ' ' A' ' 75' ' ' HIS . 48.9 p90 -69.14 -176.02 0.84 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.83 -0.623 . . . . 3.3999999999999999 111.289 -175.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.542 ' HG2' ' HB2' ' A' ' 40' ' ' ALA . 83.3 mtm180 -111.0 136.37 50.1 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 121.786 0.803 . . . . 3.1000000000000001 112.42 -167.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 87.1 mt -120.06 129.95 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 114.113 -1.403 . . . . 1.8 109.931 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 73' ' ' GLU . . . -117.85 138.22 52.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.43 -0.35 . . . . 0.85999999999999999 110.065 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.0 tp -114.22 130.93 56.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.945 -0.57 . . . . 1.0600000000000001 110.423 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 71' ' ' GLU . . . -148.85 169.25 20.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.52 -0.764 . . . . 1.1399999999999999 109.332 177.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -139.75 157.52 45.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.642 0.258 . . . . 4.0199999999999996 110.386 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -120.42 131.71 54.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.114 -0.494 . . . . 4.6100000000000003 110.645 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -113.61 127.86 56.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.079 -0.51 . . . . 3.3799999999999999 109.816 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.641 ' O ' ' HE3' ' A' ' 62' ' ' LYS . 93.6 mt-10 -124.03 139.86 53.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.308 -0.405 . . . . 5.0499999999999998 109.973 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -102.12 164.31 17.04 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.703 -0.76 . . . . 4.3700000000000001 112.921 -173.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.98 -40.35 20.97 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.774 2.316 . . . . 6.6799999999999997 112.498 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.4 t -101.45 -60.04 3.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.962 0.41 . . . . 8.1699999999999999 110.232 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -83.98 129.78 34.91 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.183 -0.673 . . . . 10.039999999999999 109.183 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -61.37 -39.94 92.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.289 -0.869 . . . . 11.609999999999999 110.94 -172.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.2 t -112.31 100.13 8.56 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.888 -0.412 . . . . 9.7899999999999991 109.888 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.49 160.03 31.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.789 -0.641 . . . . 8.5099999999999998 109.517 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.28 116.96 5.6 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.342 -0.933 . . . . 7.5599999999999996 112.67 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.641 ' HE3' ' O ' ' A' ' 53' ' ' GLU . 97.6 mttt -78.16 146.63 34.95 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 175.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -68.35 -39.96 81.69 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.943 -0.391 . . . . 10.35 109.943 174.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -78.97 141.36 24.18 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.758 -0.734 . . . . 5.3399999999999999 111.923 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.8 p -108.61 19.98 19.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.956 0.408 . . . . 5.3200000000000003 111.003 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -60.04 -39.99 87.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.797 -0.638 . . . . 5.6100000000000003 110.863 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.425 ' CD2' ' HA2' ' A' ' 96' ' ' GLY . 37.2 m-85 -119.02 120.02 35.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.731 -0.47 . . . . 3.7799999999999998 109.731 173.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -145.05 150.82 37.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.866 -0.607 . . . . 2.4500000000000002 109.634 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.455 HH12 ' CD ' ' A' ' 53' ' ' GLU . 41.0 ttp180 -119.99 124.42 27.87 Favored Pre-proline 0 C--N 1.328 -0.341 0 C-N-CA 120.662 -0.415 . . . . 3.2400000000000002 110.98 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -84.02 149.15 12.18 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.843 2.362 . . . . 1.1899999999999999 112.921 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.468 ' CD ' ' HE ' ' A' ' 93' ' ' ARG . 3.7 tp10 -115.46 118.55 33.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.572 -0.899 . . . . 2.1899999999999999 108.572 168.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.462 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 59.5 tp -122.34 101.8 7.73 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.251 -0.431 . . . . 1.1399999999999999 110.15 -178.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . 34.7 mt-10 -90.14 125.59 35.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.04 -0.527 . . . . 2.1800000000000002 111.31 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 6.8 m -114.0 121.99 67.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.524 -0.917 . . . . 1.5600000000000001 108.524 168.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.605 ' O ' ' HB2' ' A' ' 44' ' ' TRP . 63.0 m80 -109.67 118.11 35.69 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.662 -0.495 . . . . 3.4399999999999999 109.662 -174.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -114.52 130.07 56.72 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.859 -0.793 . . . . 4.7999999999999998 108.859 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -128.04 129.74 47.17 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.953 0.406 . . . . 2.9399999999999999 110.399 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 86' ' ' PHE . 89.0 m-85 -100.23 109.54 21.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.95 -0.568 . . . . 3.8999999999999999 109.941 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -100.07 12.9 35.79 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.323 -0.621 . . . . 4.4800000000000004 109.323 177.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -59.98 -38.46 82.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.908 -1.042 . . . . 6.1900000000000004 111.05 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -109.92 130.06 55.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.01 -0.541 . . . . 5.4500000000000002 110.713 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -77.9 -13.73 59.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.247 0.546 . . . . 5.2699999999999996 109.598 172.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -59.97 -49.95 75.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.431 -0.804 . . . . 6.3300000000000001 110.3 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 86' ' ' PHE . 97.4 m-85 -142.83 141.62 31.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.604 -0.725 . . . . 7.4800000000000004 109.349 177.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.9 t -84.11 93.34 8.11 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.407 -0.96 . . . . 2.5499999999999998 108.407 172.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 78' ' ' PHE . 98.9 m-85 -79.55 129.8 34.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.107 -0.497 . . . . 5.2999999999999998 110.344 -175.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.08 153.22 17.89 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.318 -0.944 . . . . 1.3500000000000001 111.903 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.8 tp -139.3 117.32 11.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.92 0.39 . . . . 2.29 110.079 176.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.6 m -110.8 117.65 34.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.138 -0.483 . . . . 1.54 110.368 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.57 133.9 10.8 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.508 -0.853 . . . . 1.1699999999999999 112.059 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -136.04 126.11 3.76 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.548 -0.621 . . . . 1.1899999999999999 111.548 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -112.35 131.29 55.61 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.054 -0.35 . . . . 3.75 110.054 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.468 ' HE ' ' CD ' ' A' ' 71' ' ' GLU . 85.8 mtt180 -135.28 131.33 36.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.088 -0.506 . . . . 2.75 110.177 -172.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -133.92 129.21 35.99 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.052 -0.259 . . . . 1.8200000000000001 110.958 175.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.411 ' HB2' ' HD3' ' A' ' 69' ' ' ARG . 71.4 t80 -114.85 125.13 53.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.525 -0.307 . . . . 3.1400000000000001 110.252 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.425 ' HA2' ' CD2' ' A' ' 67' ' ' PHE . . . 102.32 178.84 27.4 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.527 -0.845 . . . . 2.79 112.928 175.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -136.65 140.01 42.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.056 0.455 . . . . 7.6200000000000001 110.106 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -77.0 -20.08 56.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.539 -0.755 . . . . 7.0800000000000001 109.74 177.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -116.5 134.17 55.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.782 -0.645 . . . . 10.16 109.98 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 28.5 m -136.96 -179.85 3.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 110.023 -0.362 . . . . 9.8100000000000005 110.023 177.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -59.88 -49.13 78.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.861 0.362 . . . . 12.220000000000001 111.067 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -131.15 78.59 72.51 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.071 -0.513 . . . . 10.48 110.481 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.28 118.44 5.32 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.572 2.181 . . . . 9.0999999999999996 112.867 -176.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -152.29 59.17 0.41 Allowed Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.596 -0.729 . . . . 6.46 111.38 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 63.03 19.97 11.99 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.213 0.53 . . . . 7.6699999999999999 111.025 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -100.94 1.05 39.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.766 -0.652 . . . . 4.1399999999999997 109.892 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.3 p -86.51 141.51 29.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.516 -0.765 . . . . 3.2999999999999998 110.835 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.64 124.67 16.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.928 -0.578 . . . . 1.76 110.095 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -139.54 107.93 5.83 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.245 -0.65 . . . . 2.5499999999999998 109.245 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 91.6 mtp -119.95 115.52 23.94 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.471 -0.331 . . . . 1.77 110.297 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.63 ' HB2' ' OD1' ' A' ' 143' ' ' ASN . 49.4 mt-30 -100.19 129.09 46.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.949 0.404 . . . . 1.97 110.113 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 40.5 ttm180 -120.24 111.02 17.28 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.87 -0.789 . . . . 3.8500000000000001 108.87 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -108.02 130.83 55.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.06 -0.518 . . . . 2.2799999999999998 109.703 -175.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 135' ' ' MET . 87.6 tttt -130.23 124.12 31.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.045 0.45 . . . . 2.1400000000000001 110.884 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 75.9 mt -129.82 130.03 66.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 116.022 -0.535 . . . . 1.55 109.557 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 133' ' ' LEU . . . -134.01 116.41 13.42 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.393 -0.367 . . . . 1.1899999999999999 111.151 -177.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 133' ' ' LEU . 87.3 Cg_endo -80.01 140.05 13.99 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.277 1.984 . . . . 1.3700000000000001 110.579 171.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -87.77 137.75 32.06 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.202 -0.454 . . . . 2.3500000000000001 110.985 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -101.13 127.53 47.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.24 -0.652 . . . . 4.54 109.24 172.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -71.43 160.39 32.82 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 124.092 0.87 . . . . 3.04 111.61 -171.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.5 ' HB ' ' HG3' ' A' ' 128' ' ' ARG . 34.6 m -115.04 173.94 3.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.304 -0.862 . . . . 4.2699999999999996 110.841 -173.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 60.13 39.07 19.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.854 -0.612 . . . . 6.04 111.576 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.7 tp -63.08 -40.19 96.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.759 -0.655 . . . . 4.5899999999999999 110.436 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.9 p -118.02 159.98 22.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.752 -0.658 . . . . 3.6899999999999999 110.446 177.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -70.27 129.91 40.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.061 -0.518 . . . . 5.1699999999999999 111.402 -174.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 59.86 28.37 17.85 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.081 -0.963 . . . . 3.71 111.368 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.8 mt -137.77 144.44 41.6 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.21 -0.663 . . . . 2.0499999999999998 109.21 175.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.5 ' HG3' ' HB ' ' A' ' 121' ' ' VAL . 56.8 ttt180 -130.2 128.99 42.81 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.427 -0.509 . . . . 4.2400000000000002 111.104 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.441 ' O ' HG12 ' A' ' 121' ' ' VAL . 90.0 m-85 -120.01 123.05 42.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.273 -0.876 . . . . 3.5499999999999998 108.882 176.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 156' ' ' THR . 21.8 m-80 -116.16 130.98 57.06 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.078 -0.712 . . . . 2.1099999999999999 109.078 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.36 129.61 4.62 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 118.965 -1.588 . . . . 1.1799999999999999 113.232 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -123.57 127.8 48.81 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.943 -0.392 . . . . 4.2999999999999998 109.943 173.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.627 ' O ' ' HD2' ' A' ' 117' ' ' PRO . 87.9 mt -112.75 109.72 19.39 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.031 -0.729 . . . . 2.2400000000000002 109.031 174.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 152' ' ' VAL . 52.6 m -105.88 124.95 50.39 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.565 -0.454 . . . . 1.6899999999999999 111.469 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.661 ' O ' ' HA ' ' A' ' 114' ' ' LYS . 95.4 mmm -93.32 126.2 38.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.507 -0.77 . . . . 2.2400000000000002 109.295 176.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -120.68 126.14 49.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.177 0.513 . . . . 3.5600000000000001 111.953 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 61.7 mttp -130.31 143.72 50.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.387 -0.968 . . . . 1.6699999999999999 108.387 167.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.53 ' H ' HD22 ' A' ' 142' ' ' LEU . 53.1 p90 -141.48 160.0 41.06 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 121.201 -0.2 . . . . 3.23 110.76 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 62.75 178.66 0.14 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.94 0.775 . . . . 1.24 110.601 -177.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -75.73 -24.36 56.13 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.93 0.395 . . . . 2.4700000000000002 110.584 173.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -59.96 -50.85 72.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.951 -0.568 . . . . 2.4100000000000001 111.599 -174.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.53 HD22 ' H ' ' A' ' 138' ' ' PHE . 9.5 mp -70.81 -29.86 66.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.436 -0.347 . . . . 1.8300000000000001 111.24 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.63 ' OD1' ' HB2' ' A' ' 111' ' ' GLN . 12.7 m120 -61.58 -41.49 97.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.006 0.432 . . . . 2.0 110.456 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.1 p -80.22 -39.9 28.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.595 -0.73 . . . . 2.0499999999999998 111.832 -173.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 148' ' ' ALA . 24.6 p -74.07 -32.88 63.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.321 . . . . 1.5900000000000001 111.207 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.71 -108.75 2.59 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.933 -0.576 . . . . 1.52 113.149 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -59.97 -40.07 87.83 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 122.687 0.395 . . . . 5.9400000000000004 111.503 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' A' ' 145' ' ' THR . . . -60.04 -44.27 94.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.173 -0.467 . . . . 1.8300000000000001 111.857 -175.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.53 ' HB3' ' HG ' ' A' ' 142' ' ' LEU . 43.3 m-20 -118.01 98.25 6.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.125 0.488 . . . . 2.6400000000000001 110.966 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.5 t -149.93 144.56 25.96 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.406 -0.59 . . . . 2.02 109.406 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -110.16 151.71 26.94 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.335 -0.393 . . . . 3.6699999999999999 110.078 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.519 HG12 ' SD ' ' A' ' 135' ' ' MET . 16.1 m -136.41 134.4 49.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.984 0.421 . . . . 1.6399999999999999 111.504 -177.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -113.72 140.51 48.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.199 -0.455 . . . . 2.5600000000000001 109.832 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 78.6 m -128.42 118.63 23.46 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.163 -0.471 . . . . 1.3899999999999999 109.936 175.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -120.68 120.16 34.9 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.774 -0.454 . . . . 2.04 109.774 176.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 130' ' ' ASN . 27.0 m -108.3 119.93 40.92 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.669 -0.696 . . . . 1.5600000000000001 110.026 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -97.97 111.81 4.33 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.92 -0.872 . . . . 1.04 110.92 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 91.7 mt -104.23 129.98 52.03 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 110.263 -0.273 . . . . 2.27 110.263 -176.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 65.9 tt0 -114.92 113.55 24.31 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.832 -0.433 . . . . 2.4100000000000001 109.832 176.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -115.65 130.57 56.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.573 -0.74 . . . . 4.5700000000000003 109.458 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . 0.2 OUTLIER -92.58 90.18 7.02 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.404 0.621 . . . . 1.46 109.907 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -60.24 -49.62 76.88 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 114.934 -1.03 . . . . 2.6299999999999999 111.715 -171.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.418 ' C ' ' H ' ' A' ' 165' ' ' THR . 17.4 m120 -99.87 2.62 44.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.381 -0.372 . . . . 2.4100000000000001 110.353 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 71.88 -36.11 0.35 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.356 -0.838 . . . . 2.5800000000000001 111.263 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 163' ' ' ASN . 21.8 p -75.36 -34.97 61.19 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.859 0.362 . . . . 2.2999999999999998 111.206 174.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 163' ' ' ASN . 24.9 m -121.08 140.56 44.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 120.94 0.4 . . . . 1.71 110.734 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 161' ' ' THR . . . -107.74 139.94 41.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.928 -0.578 . . . . 1.47 111.237 -175.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 159' ' ' GLN . 17.9 mt -104.53 125.59 50.84 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.429 -0.582 . . . . 1.6599999999999999 109.429 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -109.22 115.72 30.54 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.727 -0.472 . . . . 3.2999999999999998 109.727 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.0 132.09 65.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.063 0.459 . . . . 1.3 110.855 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.475 ' O ' ' HB ' ' A' ' 194' ' ' ILE . 3.2 m-20 -107.23 122.57 46.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.048 0.451 . . . . 2.2200000000000002 111.025 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -98.28 121.51 40.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.512 -0.767 . . . . 4.6100000000000003 110.052 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -99.49 120.42 39.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.953 0.406 . . . . 3.98 110.119 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 63.9 tp -104.91 129.14 53.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.806 -0.634 . . . . 2.3799999999999999 110.95 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -98.68 138.63 35.57 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.641 -0.874 . . . . 3.3100000000000001 108.641 175.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -60.25 -39.92 88.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.992 0.425 . . . . 6.5300000000000002 110.842 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -110.01 -159.03 17.41 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.866 -0.683 . . . . 5.0599999999999996 111.826 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -133.84 51.17 2.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.015 0.436 . . . . 7.3899999999999997 109.859 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -157.55 122.17 4.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.917 -0.583 . . . . 9.0700000000000003 110.445 -175.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 75.9 mtm -95.55 139.98 31.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.101 0.477 . . . . 10.869999999999999 110.608 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -62.05 -40.01 94.31 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.041 -0.982 . . . . 10.449999999999999 113.448 -169.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -73.66 117.2 15.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.931 0.396 . . . . 13.06 111.211 -172.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 13.2 p -104.0 -0.04 29.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.857 -0.611 . . . . 12.609999999999999 110.779 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -70.01 -40.0 75.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.425 0.631 . . . . 15.19 110.368 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -99.09 148.2 24.29 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.071 -0.968 . . . . 13.18 110.604 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -64.17 137.7 58.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.282 -0.636 . . . . 12.73 109.282 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -170.86 137.36 4.38 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 119.563 -1.304 . . . . 9.9800000000000004 113.561 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.2 145.59 51.34 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.99 -0.745 . . . . 10.699999999999999 108.99 170.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -70.07 -34.06 72.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 10.5 111.341 -172.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 53.0 m -125.05 130.07 51.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.753 0.311 . . . . 6.6399999999999997 110.277 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 9.9 t -158.2 154.77 27.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.328 -0.396 . . . . 4.9800000000000004 110.722 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.543 ' O ' ' HB3' ' A' ' 216' ' ' ASP . 48.7 tt0 -120.0 114.2 21.66 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.929 -0.578 . . . . 7.0999999999999996 109.721 175.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -140.77 111.05 6.68 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.554 -0.535 . . . . 4.4000000000000004 109.554 172.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' A' ' 171' ' ' ASN . 28.5 pt -120.09 169.1 11.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.761 -0.654 . . . . 2.21 111.062 -172.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -101.68 119.94 39.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.85 -0.614 . . . . 3.54 110.553 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -112.87 129.44 56.46 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.512 -0.551 . . . . 1.6699999999999999 109.512 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 209' ' ' PRO . 31.1 p90 -145.42 149.93 35.61 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.264 0.554 . . . . 5.8300000000000001 111.528 -178.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.9 mp -112.26 127.74 26.44 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.689 -0.687 . . . . 2.5899999999999999 110.279 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' A' ' 167' ' ' ALA . 85.6 Cg_endo -81.22 106.23 1.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.287 1.991 . . . . 1.77 111.581 175.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 89.9 mt -114.47 140.09 49.0 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.941 -0.572 . . . . 2.2599999999999998 109.93 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 94.0 m -119.93 130.05 54.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.126 0.488 . . . . 1.99 111.134 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 86.1 mt -129.8 80.29 1.95 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.533 -0.914 . . . . 2.3100000000000001 108.533 173.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 70.06 -120.96 9.96 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.863 -0.684 . . . . 1.51 111.78 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -91.87 -0.03 57.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.259 0.552 . . . . 2.5699999999999998 109.536 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -93.67 118.98 32.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.327 -0.852 . . . . 2.6600000000000001 109.291 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 47.6 m -104.62 131.97 51.42 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.782 -0.451 . . . . 1.6200000000000001 109.782 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 63.2 t -120.07 130.03 74.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.908 -0.405 . . . . 1.3799999999999999 109.908 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 48.1 m -138.1 94.65 11.04 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 116.503 -0.317 . . . . 1.1799999999999999 110.987 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' A' ' 197' ' ' TYR . 16.5 Cg_exo -69.17 131.22 21.6 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.525 2.15 . . . . 1.01 111.635 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -108.43 139.97 42.4 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.823 -0.436 . . . . 4.5 109.823 176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 11.1 t -168.53 166.93 11.9 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.191 -0.459 . . . . 1.8899999999999999 110.426 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -98.97 139.87 33.97 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.048 -1.093 . . . . 4.7999999999999998 108.048 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.466 ' HB ' ' OD2' ' A' ' 216' ' ' ASP . 83.7 mt -59.85 -40.2 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.03 0.443 . . . . 4.5700000000000003 110.871 -175.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 104.4 -30.28 10.42 Favored Glycine 0 CA--C 1.507 -0.438 0 C-N-CA 120.698 -0.763 . . . . 4.9800000000000004 111.908 176.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.1 tp -69.89 -24.01 63.33 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.922 -0.77 . . . . 8.1099999999999994 108.922 172.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 192' ' ' GLN . 17.0 m-20 -59.93 -50.06 75.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.638 -1.164 . . . . 7.6500000000000004 110.39 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -157.8 136.19 11.1 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.096 -0.956 . . . . 10.529999999999999 108.776 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -98.8 110.6 23.18 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.105 0.479 . . . . 11.56 110.705 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 84.3 p -146.53 159.49 43.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.775 -0.648 . . . . 10.06 109.567 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 15.2 m120 60.06 38.45 20.58 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.666 0.603 . . . . 11.92 111.179 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -61.74 -41.33 97.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.654 -0.703 . . . . 14.01 109.681 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -142.12 -179.61 6.34 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.13 -0.941 . . . . 14.529999999999999 109.251 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -75.16 99.11 3.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.394 0.616 . . . . 16.609999999999999 111.974 -175.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -70.03 147.95 49.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.925 -1.034 . . . . 15.460000000000001 109.569 175.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -100.09 14.05 32.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.821 0.343 . . . . 15.67 110.957 -177.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -67.01 150.19 49.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.887 -0.597 . . . . 14.5 110.934 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 10.7 tp -79.25 -7.58 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.738 0.78 . . . . 15.15 110.423 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 62.06 51.4 3.64 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.612 -1.176 . . . . 14.73 113.076 174.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -61.5 -34.22 75.13 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.044 -0.725 . . . . 16.379999999999999 109.044 171.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -63.6 -39.91 95.59 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.047 -0.978 . . . . 12.779999999999999 110.759 175.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 90.09 -12.7 66.92 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.974 -0.557 . . . . 11.1 114.239 173.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 25.6 m80 59.97 39.89 19.54 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 117.225 0.513 . . . . 12.26 111.346 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.8 -40.18 87.46 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.202 0.445 . . . . 9.9900000000000002 112.202 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -68.77 -39.85 80.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.669 0.271 . . . . 10.43 111.275 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -82.15 78.28 8.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.361 0.601 . . . . 6.29 109.53 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -119.14 135.93 54.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.567 -0.742 . . . . 8.1500000000000004 110.913 -176.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.424 HG23 ' HB3' ' A' ' 257' ' ' PHE . 33.1 m -130.03 159.99 41.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.337 -0.616 . . . . 2.3999999999999999 109.337 175.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 172.43 177.03 41.59 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.024 -1.084 . . . . 1.27 112.995 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 83.0 mt -120.04 129.97 54.48 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.104 -0.332 . . . . 1.97 110.104 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -101.45 133.64 45.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.061 -0.348 . . . . 3.54 110.061 175.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -120.08 139.96 51.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.061 -0.518 . . . . 2.6400000000000001 110.262 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 251' ' ' VAL . . . -127.13 132.16 7.49 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 111.251 -0.739 . . . . 1.3500000000000001 111.251 176.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 250' ' ' SER . 91.3 m-85 -120.83 144.24 48.45 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.067 -0.346 . . . . 4.3600000000000003 110.067 -177.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 56.5 40.04 29.69 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.846 0.716 . . . . 4.29 110.507 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -62.72 -40.11 96.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.534 -0.757 . . . . 6.6900000000000004 110.867 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -111.21 129.99 55.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.636 -0.256 . . . . 6.3700000000000001 111.289 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 55.51 39.92 31.11 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.704 -0.68 . . . . 5.8300000000000001 112.229 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -161.82 -174.44 31.7 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.521 -0.632 . . . . 2.6600000000000001 111.521 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 86.2 mt -89.1 109.1 20.0 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.863 -0.791 . . . . 2.9700000000000002 108.863 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 243' ' ' TYR . 17.7 m -78.88 130.92 36.17 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.113 0.482 . . . . 2.1699999999999999 111.26 -169.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.42 ' O ' ' HA2' ' A' ' 242' ' ' GLY . 62.9 t -107.57 133.24 52.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.667 -0.697 . . . . 1.79 109.78 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 3.0 p -108.3 113.28 26.25 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.064 0.459 . . . . 1.6299999999999999 110.485 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 64.8 tp -119.57 115.73 24.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.087 -0.506 . . . . 2.96 110.635 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -101.77 115.47 30.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.181 -0.463 . . . . 4.0800000000000001 110.371 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' TYR . . . . . 0.521 ' CE1' ' HA ' ' A' ' 257' ' ' PHE . 61.0 t80 -106.21 120.04 40.81 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 110.259 -0.275 . . . . 4.8399999999999999 110.259 175.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -80.04 123.34 27.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.487 -0.931 . . . . 3.5800000000000001 108.487 172.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . 0.521 ' HA ' ' CE1' ' A' ' 255' ' ' TYR . 49.2 t80 -71.32 118.46 14.15 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.859 0.361 . . . . 6.7699999999999996 110.546 -171.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -96.93 123.46 40.65 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 116.005 -0.543 . . . . 8.5399999999999991 110.151 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -80.05 155.65 27.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.756 -0.656 . . . . 11.9 111.218 -175.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -86.31 129.99 34.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.769 -0.65 . . . . 10.57 109.606 177.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -84.64 170.03 13.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.044 -0.526 . . . . 11.41 110.006 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -100.92 -18.09 16.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.613 -0.267 . . . . 11.98 111.216 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -85.22 122.9 30.07 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.407 0.623 . . . . 12.460000000000001 110.432 177.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.4 -40.1 93.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.716 -1.129 . . . . 13.779999999999999 111.674 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -60.32 119.37 18.19 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.105 -0.569 . . . . 11.07 112.671 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -61.45 132.24 52.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.292 0.567 . . . . 12.59 111.546 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 21.2 m -125.61 143.45 51.02 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.555 -0.748 . . . . 10.92 109.004 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.66 120.09 14.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.983 0.421 . . . . 12.42 109.929 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -119.58 140.08 51.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.784 -0.643 . . . . 11.59 110.113 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -80.67 129.33 34.46 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.217 0.532 . . . . 8.8300000000000001 110.319 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -98.1 133.19 42.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.51 -0.768 . . . . 7.0199999999999996 109.936 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -130.07 129.63 43.85 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.04 0.448 . . . . 6.5999999999999996 110.935 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -151.84 173.67 14.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.582 -0.735 . . . . 1.9399999999999999 109.617 174.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -131.35 137.57 9.54 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.937 -0.649 . . . . 1.4199999999999999 111.659 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 61.9 t -129.4 129.97 67.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.953 0.406 . . . . 1.8100000000000001 110.874 -175.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -152.44 163.66 30.36 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.873 -0.603 . . . . 1.3 111.686 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.19 140.01 32.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.885 0.374 . . . . 1.8300000000000001 110.163 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -113.5 127.01 55.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.196 0.522 . . . . 2.3100000000000001 110.929 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.511 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 65.0 t80 -105.96 124.71 50.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.655 -0.702 . . . . 4.75 109.402 176.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 7.7 p -117.44 130.51 56.51 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.037 0.446 . . . . 1.6699999999999999 110.858 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 8' ' ' HIS . 59.2 t80 . . . . . 0 C--O 1.244 0.783 0 CA-C-O 118.508 -0.758 . . . . 3.6899999999999999 109.084 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.4 mtp . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 120.689 0.28 . . . . 11.85 110.692 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -132.4 148.34 52.41 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.361 -0.607 . . . . 10.35 109.361 175.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -111.68 149.19 31.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.059 0.457 . . . . 9.3100000000000005 110.493 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -83.13 0.28 45.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.805 -0.634 . . . . 8.8399999999999999 111.092 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -126.72 140.71 52.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.067 -0.515 . . . . 7.0099999999999998 110.001 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.51 118.75 22.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.351 -0.386 . . . . 3.6099999999999999 111.059 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -96.93 108.2 20.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.6 -0.889 . . . . 3.3300000000000001 108.6 171.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -110.7 137.16 48.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.341 0.591 . . . . 3.2000000000000002 111.778 -175.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -125.21 142.89 51.22 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.619 -1.173 . . . . 2.4900000000000002 109.536 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -120.98 129.99 53.64 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.962 -0.384 . . . . 2.1299999999999999 109.962 176.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.7 mt -120.03 122.52 68.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.921 -0.581 . . . . 1.6000000000000001 109.919 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.38 142.1 13.53 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 119.799 -1.191 . . . . 0.88 112.601 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.26 136.23 53.19 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.624 -0.509 . . . . 1.0800000000000001 109.624 176.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 70.1 mtm -127.75 151.28 49.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.184 -0.462 . . . . 2.3300000000000001 110.944 -175.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.444 ' CE1' ' HB3' ' A' ' 33' ' ' PRO . 59.3 m-85 -129.93 138.25 50.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.251 -0.886 . . . . 2.6099999999999999 108.69 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 59.87 48.68 8.68 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.124 0.488 . . . . 5.0899999999999999 110.049 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.6 tp -70.02 -40.05 78.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.554 0.576 . . . . 5.3300000000000001 112.554 -169.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.564 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 36.4 tt0 -149.97 117.19 6.02 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.516 -0.473 . . . . 8.2799999999999994 110.897 -174.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -126.95 151.36 48.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.313 0.577 . . . . 9.6999999999999993 111.29 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 26' ' ' ASP . 62.7 t -129.97 135.74 60.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.459 -0.941 . . . . 11.09 108.459 176.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.92 -38.67 83.01 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.442 -0.799 . . . . 13.1 112.246 -169.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.87 86.82 0.15 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 119.654 -1.26 . . . . 11.94 113.977 174.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -69.96 -39.4 76.03 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.022 -1.103 . . . . 15.18 108.022 168.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -136.84 -89.3 0.24 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 109.621 -1.392 . . . . 12.0 109.621 172.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -128.61 96.72 4.47 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.751 -0.833 . . . . 12.82 108.751 168.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.43 ' HB3' ' HB ' ' A' ' 20' ' ' VAL . 15.9 m-20 -100.02 0.09 40.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.89 -0.595 . . . . 10.81 111.026 -177.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 70.3 mtm 60.15 47.09 9.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.978 -1.01 . . . . 10.050000000000001 111.747 175.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -59.97 -39.99 87.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.827 -0.624 . . . . 8.0600000000000005 111.339 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.11 18.1 24.17 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.756 -0.735 . . . . 5.5800000000000001 113.104 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.2 tp -137.83 131.16 30.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.901 0.351 . . . . 5.5599999999999996 110.404 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.07 161.95 36.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.6 -0.273 . . . . 3.0499999999999998 111.052 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.48 159.63 71.57 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.525 -0.307 . . . . 3.48 110.552 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HB3' ' CE1' ' A' ' 15' ' ' TYR . 87.8 Cg_endo -90.09 133.2 1.97 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.627 2.218 . . . . 1.8600000000000001 113.192 174.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.2 m -140.03 162.7 34.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.984 0.421 . . . . 1.97 111.619 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -125.19 134.91 65.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.791 -0.64 . . . . 1.71 110.775 -177.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -113.07 162.23 16.16 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.321 -0.622 . . . . 4.0700000000000003 109.321 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -139.87 146.72 39.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.056 0.455 . . . . 2.8599999999999999 111.231 -178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.6 ' OD1' ' HD3' ' A' ' 45' ' ' ARG . 11.3 p30 -151.4 160.86 43.54 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.773 -0.649 . . . . 1.8899999999999999 109.526 174.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.15 155.28 39.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.49 -0.323 . . . . 1.0800000000000001 110.576 -178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.37 146.03 16.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.369 -0.378 . . . . 1.3899999999999999 110.8 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.626 ' O ' ' HD2' ' A' ' 43' ' ' PRO . 6.1 p-10 -167.08 94.73 0.47 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.773 -0.649 . . . . 2.8599999999999999 109.787 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.95 -94.07 1.95 Allowed Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 111.114 -0.794 . . . . 1.6799999999999999 111.114 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' A' ' 41' ' ' ASN . 77.0 Cg_exo -52.24 174.03 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.385 2.723 . . . . 1.6599999999999999 113.092 168.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.497 ' HB2' ' O ' ' A' ' 75' ' ' HIS . 48.9 p90 -70.07 -176.89 1.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.742 -0.663 . . . . 3.3999999999999999 112.155 -170.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.6 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 18.0 ttm180 -113.69 129.41 56.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.908 -0.587 . . . . 3.1000000000000001 111.29 -168.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 86.9 mt -113.22 129.92 68.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.37 -0.832 . . . . 1.8 110.274 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.499 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -118.9 132.14 56.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.492 -0.322 . . . . 0.85999999999999999 110.576 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.5 tp -124.23 131.0 53.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.777 0.322 . . . . 1.0600000000000001 110.413 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.37 160.87 42.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.846 -0.616 . . . . 1.1399999999999999 110.349 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -120.03 139.96 51.72 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.4 -0.593 . . . . 4.0199999999999996 109.4 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.564 ' CE2' ' HB3' ' A' ' 18' ' ' GLU . 45.4 t80 -98.89 128.16 45.0 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.651 0.738 . . . . 4.6100000000000003 111.808 -175.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -150.02 155.06 39.24 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.392 -1.707 . . . . 3.3799999999999999 106.392 171.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -148.85 119.32 7.39 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.393 -0.595 . . . . 5.0499999999999998 109.393 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.04 -118.52 4.87 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.851 -0.69 . . . . 4.3700000000000001 112.347 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.96 150.34 66.85 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.822 2.348 . . . . 6.6799999999999997 112.79 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 58' ' ' TYR . 7.5 p -129.19 130.55 67.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.853 -0.612 . . . . 8.1699999999999999 110.307 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -70.59 -29.47 65.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.128 -0.487 . . . . 10.039999999999999 110.892 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.428 ' H ' HG22 ' A' ' 56' ' ' VAL . 41.1 m-85 -60.41 -15.04 22.51 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.462 0.542 . . . . 11.609999999999999 112.462 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.3 p -68.35 -19.85 64.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.855 0.359 . . . . 9.7899999999999991 110.879 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.35 128.32 55.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.351 -0.386 . . . . 8.5099999999999998 110.786 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.14 55.26 4.95 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.103 -0.799 . . . . 7.5599999999999996 111.103 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -127.08 158.95 35.64 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.962 0.41 . . . . 10.0 110.645 -173.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -92.2 120.18 32.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.793 -0.64 . . . . 10.35 109.998 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.47 -151.3 7.61 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.511 -0.852 . . . . 5.3399999999999999 112.057 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.2 p -82.59 140.7 33.08 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.699 0.285 . . . . 5.3200000000000003 110.864 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 47.0 m95 -120.23 134.18 55.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.416 -0.587 . . . . 5.6100000000000003 109.416 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -119.1 119.95 35.72 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.58 -0.526 . . . . 3.7799999999999998 109.58 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -159.36 169.27 24.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.116 0.484 . . . . 2.4500000000000002 110.912 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 94' ' ' ASN . 41.5 ttp180 -149.87 123.24 4.43 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 115.293 -0.867 . . . . 3.2400000000000002 109.602 171.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.663 ' HD2' ' O ' ' A' ' 94' ' ' ASN . 71.4 Cg_endo -79.81 140.56 14.66 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.292 1.995 . . . . 1.1899999999999999 110.733 169.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.544 ' CD ' ' HE ' ' A' ' 93' ' ' ARG . 72.2 tt0 -135.87 124.66 23.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.332 0.587 . . . . 2.1899999999999999 110.699 -178.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 47' ' ' ALA . 41.0 tp -120.17 130.02 54.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.408 -0.814 . . . . 1.1399999999999999 109.994 -178.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -125.04 128.02 47.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.019 0.438 . . . . 2.1800000000000002 110.1 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.03 129.93 74.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.172 -0.467 . . . . 1.5600000000000001 110.743 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 44' ' ' TRP . 64.4 m170 -116.61 120.08 37.53 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.786 0.327 . . . . 3.4399999999999999 110.636 177.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.403 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . 65.0 t80 -114.45 124.13 51.16 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.82 -0.627 . . . . 4.7999999999999998 109.38 174.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -119.55 137.97 53.49 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.27 -0.27 . . . . 2.9399999999999999 110.27 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -134.54 130.31 36.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.931 0.396 . . . . 3.8999999999999999 110.269 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.4 tp -106.69 119.99 40.78 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.405 -0.591 . . . . 4.4800000000000004 109.405 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -97.18 168.93 10.14 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.044 -0.354 . . . . 6.1900000000000004 110.044 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -60.08 -43.43 95.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.713 0.292 . . . . 5.4500000000000002 111.305 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -74.48 164.6 26.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 5.2699999999999996 110.785 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -75.98 36.52 0.14 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.297 -0.411 . . . . 6.3300000000000001 112.053 -177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.409 ' HA ' ' OD2' ' A' ' 120' ' ' ASP . 87.1 m-85 -119.94 140.02 51.54 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.186 -0.672 . . . . 7.4800000000000004 109.186 174.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 120' ' ' ASP . 47.8 m -124.67 149.43 47.18 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.995 0.426 . . . . 2.5499999999999998 110.651 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -147.78 161.4 41.31 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.626 -0.509 . . . . 5.2999999999999998 109.626 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.61 176.94 34.62 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.463 -0.875 . . . . 1.3500000000000001 112.04 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 76' ' ' TYR . 92.3 mt -127.69 123.92 36.63 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.118 -0.327 . . . . 2.29 110.118 178.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 94.2 m -119.93 130.02 54.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.138 -0.483 . . . . 1.54 110.528 176.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -137.07 144.69 16.35 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.804 -0.713 . . . . 1.1699999999999999 111.768 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 72' ' ' LEU . . . -137.66 143.98 15.23 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.987 -0.625 . . . . 1.1899999999999999 112.112 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 67.6 t80 -130.48 130.0 43.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.871 0.367 . . . . 3.75 110.753 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.544 ' HE ' ' CD ' ' A' ' 71' ' ' GLU . 99.3 mtt180 -130.29 127.36 39.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.738 -0.665 . . . . 2.75 109.809 175.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.663 ' O ' ' HD2' ' A' ' 70' ' ' PRO . 61.2 t30 -111.27 117.95 34.57 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.441 -0.577 . . . . 1.8200000000000001 109.441 174.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -106.54 125.31 50.84 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.564 -0.289 . . . . 3.1400000000000001 110.881 -172.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.77 109.99 2.92 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.0 -1.095 . . . . 2.79 111.584 175.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.403 ' HB3' ' HB3' ' A' ' 108' ' ' ALA . 64.2 t80 -85.48 119.27 25.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.027 0.441 . . . . 7.6200000000000001 109.817 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -109.98 98.22 7.56 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.999 -0.546 . . . . 7.0800000000000001 109.787 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.532 ' CD1' HG13 ' A' ' 100' ' ' VAL . 60.8 t80 -60.23 -50.14 74.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.89 -0.596 . . . . 10.16 111.522 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.532 HG13 ' CD1' ' A' ' 99' ' ' TYR . 34.3 m -131.93 161.13 41.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.527 -0.306 . . . . 9.8100000000000005 110.83 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -89.03 10.61 20.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 12.220000000000001 111.465 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -82.96 120.03 75.39 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.518 -0.31 . . . . 10.48 110.689 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -70.07 150.02 65.72 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.602 2.201 . . . . 9.0999999999999996 111.997 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.8 15.45 39.64 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.815 -0.707 . . . . 6.46 111.574 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -121.96 139.59 53.48 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.608 -0.516 . . . . 7.6699999999999999 109.608 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -65.17 136.45 56.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.994 0.426 . . . . 4.1399999999999997 110.842 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 m -87.97 157.88 18.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.793 -0.64 . . . . 3.2999999999999998 109.874 178.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 97' ' ' TYR . . . -117.29 157.8 25.46 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.451 -0.203 . . . . 1.76 110.451 -177.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -119.91 126.73 51.63 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.643 0.735 . . . . 2.5499999999999998 111.163 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 88.7 mtp -104.7 117.96 35.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.308 -0.86 . . . . 1.77 109.491 176.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 138' ' ' PHE . 96.5 mt-30 -94.2 118.44 31.56 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.503 -0.479 . . . . 1.97 110.911 -174.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 137' ' ' LYS . 84.4 mtt180 -105.5 115.94 31.1 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.012 -0.54 . . . . 3.8500000000000001 109.683 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 35.5 t-105 -118.35 120.8 38.69 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.999 -0.741 . . . . 2.2799999999999998 108.999 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.421 ' HE3' ' OG ' ' A' ' 134' ' ' SER . 87.8 tttt -126.32 130.01 49.97 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.445 -0.343 . . . . 2.1400000000000001 110.719 -176.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.2 pt -132.59 144.51 36.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.89 0.376 . . . . 1.55 110.953 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.47 123.84 3.17 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.775 -0.648 . . . . 1.1899999999999999 110.351 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.6 130.52 3.8 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.459 2.106 . . . . 1.3700000000000001 111.059 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -80.04 137.41 36.79 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.712 -0.477 . . . . 2.3500000000000001 109.712 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -132.91 128.41 36.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.008 0.432 . . . . 4.54 111.496 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 85' ' ' SER . 0.8 OUTLIER -103.57 110.26 22.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.795 -0.638 . . . . 3.04 109.461 171.172 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.73 119.98 61.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.145 0.498 . . . . 4.2699999999999996 110.817 -175.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -102.7 84.53 2.42 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.303 0.573 . . . . 6.04 110.137 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.02 -39.98 75.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.261 -0.881 . . . . 4.5899999999999999 111.598 -177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 81.5 m -123.8 139.18 54.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.073 -0.512 . . . . 3.6899999999999999 110.443 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -59.94 140.05 56.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.816 -0.629 . . . . 5.1699999999999999 111.272 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 66.1 14.31 9.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.271 -0.877 . . . . 3.71 111.964 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.6 mt -131.85 148.94 52.58 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.486 -0.561 . . . . 2.0499999999999998 109.486 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -130.81 137.58 49.49 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.719 -0.392 . . . . 4.2400000000000002 110.057 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -127.01 128.28 46.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.188 -0.46 . . . . 3.5499999999999998 109.78 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -119.77 129.91 54.7 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.473 -0.566 . . . . 2.1099999999999999 109.473 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -160.91 161.19 32.65 Favored Glycine 0 CA--C 1.504 -0.647 0 C-N-CA 119.908 -1.139 . . . . 1.1799999999999999 112.108 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -145.13 149.81 35.66 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.994 0.426 . . . . 4.2999999999999998 110.942 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.9 tp -101.34 120.98 41.09 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.925 -0.769 . . . . 2.2400000000000002 108.925 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.421 ' OG ' ' HE3' ' A' ' 114' ' ' LYS . 18.3 t -113.48 136.74 52.46 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.772 -0.649 . . . . 1.6899999999999999 111.099 -172.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 67.3 mtm -140.0 140.2 36.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.803 -0.635 . . . . 2.2400000000000002 109.727 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -145.29 156.52 43.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.271 0.558 . . . . 3.5600000000000001 111.555 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 112' ' ' ARG . 62.2 mttp -130.95 157.0 44.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.879 -1.055 . . . . 1.6699999999999999 108.904 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 111' ' ' GLN . 48.1 p90 -142.2 163.78 31.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.645 -0.252 . . . . 3.23 110.425 -175.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . 65.09 -172.5 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.948 -0.569 . . . . 1.24 111.154 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -76.79 -47.34 21.9 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.169 0.509 . . . . 2.4700000000000002 110.89 174.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -60.17 -45.59 92.58 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.196 -0.911 . . . . 2.4100000000000001 113.455 -167.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 138' ' ' PHE . 3.1 mm? -62.02 -39.99 94.17 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.185 0.517 . . . . 1.8300000000000001 110.561 -176.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -67.36 -39.86 85.74 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.635 -0.711 . . . . 2.0 110.551 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 94.4 m -62.73 -44.36 96.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.675 -0.693 . . . . 2.0499999999999998 112.008 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 31.0 p -76.87 -19.9 56.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.992 0.425 . . . . 1.5900000000000001 111.156 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.21 -125.86 21.96 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.789 -0.641 . . . . 1.52 113.196 173.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -65.73 -19.39 65.88 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.647 0.24 . . . . 5.9400000000000004 111.647 -174.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.43 98.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.424 -0.353 . . . . 1.8300000000000001 111.675 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.503 ' O ' ' HE3' ' A' ' 137' ' ' LYS . 68.1 m-20 -119.69 117.18 27.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.044 0.45 . . . . 2.6400000000000001 110.572 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.4 t -154.3 153.92 32.5 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.863 -0.421 . . . . 2.02 109.863 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -108.27 140.06 42.07 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.742 -0.466 . . . . 3.6699999999999999 109.742 175.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 62.0 t -108.88 119.97 59.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.149 0.5 . . . . 1.6399999999999999 110.295 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -119.63 130.43 55.09 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.363 -0.835 . . . . 2.5600000000000001 109.122 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 174' ' ' LEU . 21.8 m -129.54 129.79 44.94 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 121.923 -0.486 . . . . 1.3899999999999999 111.267 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -128.76 128.9 44.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.12 -0.491 . . . . 2.04 109.849 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 27.2 p -130.32 140.3 50.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.074 -0.512 . . . . 1.5600000000000001 110.773 -177.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -125.63 122.44 4.55 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.599 -0.601 . . . . 1.04 111.599 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.9 mt -102.29 128.25 48.92 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.988 -0.375 . . . . 2.27 109.988 -176.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -107.66 111.05 23.08 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.617 -0.433 . . . . 2.4100000000000001 110.379 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -119.98 139.8 51.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.737 -0.665 . . . . 4.5700000000000003 109.75 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.442 ' HB ' ' HA ' ' A' ' 164' ' ' GLU . 18.0 p -100.75 102.22 13.26 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.187 0.518 . . . . 1.46 110.368 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -60.01 -48.51 81.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.289 -0.869 . . . . 2.6299999999999999 110.992 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -102.64 9.77 39.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.336 -0.393 . . . . 2.4100000000000001 110.553 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.442 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 42.6 tt0 72.13 -42.93 0.55 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.597 0.759 . . . . 2.5800000000000001 111.131 -175.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.5 p -74.79 -24.44 58.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.448 -0.342 . . . . 2.2999999999999998 111.816 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.4 m -125.09 140.44 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.403 -0.362 . . . . 1.71 110.627 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -107.06 130.57 54.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.15 0.5 . . . . 1.47 111.389 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 21.9 mt -104.26 136.33 44.06 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.556 -0.905 . . . . 1.6599999999999999 108.556 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -114.07 113.45 24.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.169 0.509 . . . . 3.2999999999999998 110.7 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 63.2 t -115.05 120.11 63.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.5 -0.773 . . . . 1.3 110.217 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -104.69 124.08 48.74 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.01 0.433 . . . . 2.2200000000000002 110.773 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -105.17 130.39 53.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.785 -0.643 . . . . 4.6100000000000003 109.821 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.45 ' CE2' ' HD3' ' A' ' 195' ' ' ARG . 68.2 m-85 -110.99 136.65 49.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.971 -0.558 . . . . 3.98 110.468 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.5 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 61.5 tp -122.39 118.51 28.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.21 -0.45 . . . . 2.3799999999999999 110.398 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -120.11 179.98 4.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.889 -0.596 . . . . 3.3100000000000001 109.695 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 -67.11 -39.94 86.78 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.884 -0.326 . . . . 6.5300000000000002 111.042 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 66.45 78.33 0.25 Allowed Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.646 -0.788 . . . . 5.0599999999999996 112.643 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -70.05 -39.88 75.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.859 0.361 . . . . 7.3899999999999997 111.145 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -120.34 144.93 47.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.182 -0.463 . . . . 9.0700000000000003 110.285 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 70.6 mtm -120.4 -4.03 9.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.306 0.575 . . . . 10.869999999999999 109.668 171.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -122.83 35.38 4.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.127 -0.942 . . . . 10.449999999999999 111.112 -174.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -60.0 -40.09 88.03 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.246 -0.434 . . . . 13.06 110.487 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 59.6 m -130.46 135.81 48.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.818 -0.628 . . . . 12.609999999999999 109.881 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 83.7 mtm-85 -70.08 -28.59 65.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.49 . . . . 15.19 110.13 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -97.81 115.27 27.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.711 -0.677 . . . . 13.18 109.41 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -80.31 141.98 34.95 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.045 -0.525 . . . . 12.73 110.937 -174.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 102.12 -9.48 56.37 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.711 -0.757 . . . . 9.9800000000000004 112.738 178.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.44 -39.88 92.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.864 0.364 . . . . 10.699999999999999 111.084 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -118.29 139.06 51.91 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.743 -0.465 . . . . 10.5 109.743 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.493 ' OG ' ' HD2' ' A' ' 212' ' ' ARG . 4.7 t -95.48 111.4 23.3 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.135 0.493 . . . . 6.6399999999999997 109.984 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.2 p -76.33 -18.77 58.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.693 -0.685 . . . . 4.9800000000000004 111.143 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 59.56 34.68 22.47 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 114.895 -1.048 . . . . 7.0999999999999996 111.052 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -60.06 -40.8 90.71 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.747 -0.661 . . . . 4.4000000000000004 111.251 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 213' ' ' ILE . 86.4 mt -120.3 120.0 61.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.347 -0.388 . . . . 2.21 110.395 176.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.45 ' HD3' ' CE2' ' A' ' 173' ' ' TYR . 69.4 mtp180 -111.58 116.62 31.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.242 -0.651 . . . . 3.54 109.242 177.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -120.0 138.97 53.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.839 0.352 . . . . 1.6699999999999999 111.048 -176.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -160.02 159.99 32.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.902 -0.59 . . . . 5.8300000000000001 110.425 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 198' ' ' LEU . 1.9 pt? -129.14 128.43 23.31 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.377 -0.374 . . . . 2.5899999999999999 110.116 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.83 133.04 11.08 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.414 2.076 . . . . 1.77 112.359 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 56.9 tp -135.66 131.14 35.35 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.027 -0.731 . . . . 2.2599999999999998 109.027 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 33.3 m -120.05 130.08 54.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.701 0.286 . . . . 1.99 110.548 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 58.3 tp -137.69 86.04 2.16 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.575 -0.528 . . . . 2.3100000000000001 109.575 177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 69.93 -120.89 10.05 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.822 -0.704 . . . . 1.51 112.52 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -90.27 2.55 55.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.866 0.365 . . . . 2.5699999999999998 110.248 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -112.65 130.08 56.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.099 -0.501 . . . . 2.6600000000000001 110.491 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 68.3 m -115.32 136.93 52.58 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.951 -0.568 . . . . 1.6200000000000001 109.73 173.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 45.9 t -119.93 130.01 74.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.751 -0.463 . . . . 1.3799999999999999 109.751 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.9 m -137.61 95.41 11.27 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-O 120.582 0.229 . . . . 1.1799999999999999 110.57 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.67 130.05 19.96 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.217 1.945 . . . . 1.01 110.659 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -110.79 138.66 46.9 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.287 -0.415 . . . . 4.5 110.171 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 71.1 p -133.68 151.66 51.7 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.133 -0.485 . . . . 1.8899999999999999 110.067 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.493 ' HD2' ' OG ' ' A' ' 190' ' ' SER . 27.4 mtm180 -108.31 120.86 43.61 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.395 -0.595 . . . . 4.7999999999999998 109.395 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.514 ' O ' ' HB ' ' A' ' 194' ' ' ILE . 48.6 mm -110.05 129.97 64.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.899 -0.408 . . . . 4.5700000000000003 109.899 -177.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -119.62 -129.26 3.84 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.805 -0.712 . . . . 4.9800000000000004 111.876 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 64.6 tp -131.84 136.01 47.15 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.83 -0.433 . . . . 8.1099999999999994 109.83 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -64.68 132.49 49.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.147 -0.479 . . . . 7.6500000000000004 110.2 178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -69.8 -37.95 76.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.747 -0.66 . . . . 10.529999999999999 109.369 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -125.56 96.08 4.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.439 -0.8 . . . . 11.56 109.228 172.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 72.8 p -85.23 143.83 28.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.998 0.428 . . . . 10.06 110.672 -178.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.491 ' HB3' ' O ' ' A' ' 222' ' ' ASP . 94.8 m-20 -88.2 138.82 31.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.846 -0.616 . . . . 11.92 111.26 -177.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 26.7 m-90 -70.05 -36.39 74.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.436 -0.802 . . . . 14.01 109.158 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 220' ' ' ASN . 19.4 m-20 -116.0 127.52 54.99 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.962 -1.125 . . . . 14.529999999999999 107.962 170.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -83.92 37.82 0.62 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.059 0.457 . . . . 16.609999999999999 112.138 -170.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -124.09 114.53 19.83 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.349 -0.611 . . . . 15.460000000000001 109.349 174.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -91.36 166.89 12.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.595 -0.275 . . . . 15.67 110.696 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -62.04 -40.19 94.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.513 0.673 . . . . 14.5 110.054 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.661 HG22 ' H ' ' A' ' 230' ' ' GLU . 87.9 mt -120.13 129.95 74.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.359 -0.837 . . . . 15.15 109.549 177.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 232' ' ' HIS . 47.1 mt-10 -95.5 -28.52 14.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.689 -0.232 . . . . 14.73 111.043 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 -69.58 -40.1 76.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.774 0.321 . . . . 16.379999999999999 111.469 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.661 ' H ' HG22 ' A' ' 227' ' ' ILE . 50.3 mt-10 -103.68 141.71 35.59 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.827 -0.435 . . . . 12.779999999999999 109.827 178.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . 89.98 -9.99 75.44 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.667 -0.778 . . . . 11.1 111.703 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 228' ' ' GLU . 15.7 m-70 -122.16 132.89 54.69 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.685 -0.857 . . . . 12.26 108.685 175.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -150.0 170.1 19.65 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.309 0.576 . . . . 9.9900000000000002 111.392 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -128.32 48.0 2.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.119 -0.946 . . . . 10.43 109.073 173.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -56.5 129.42 40.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.403 -0.817 . . . . 6.29 111.65 -175.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.577 ' HD2' ' OE2' ' A' ' 258' ' ' GLU . 76.2 mtt180 -104.46 117.98 35.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.757 -0.656 . . . . 8.1500000000000004 110.141 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.444 HG21 ' HG3' ' A' ' 212' ' ' ARG . 54.2 t -69.93 -39.99 78.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.486 -0.779 . . . . 2.3999999999999999 110.942 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -162.06 155.11 26.27 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.429 -0.891 . . . . 1.27 112.117 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.457 HD21 ' HD3' ' A' ' 236' ' ' ARG . 90.7 mt -112.83 126.24 55.23 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.708 -0.478 . . . . 1.97 109.708 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -106.19 128.64 54.07 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.649 -0.5 . . . . 3.54 109.649 175.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -119.93 139.97 51.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.247 -0.433 . . . . 2.6400000000000001 110.89 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -111.67 116.05 4.06 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.962 -0.855 . . . . 1.3500000000000001 110.962 175.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 250' ' ' SER . 59.1 t80 -112.06 114.87 27.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.492 0.187 . . . . 4.3600000000000003 110.884 -177.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -101.34 115.7 31.11 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.233 0.54 . . . . 4.29 110.074 173.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -61.1 -49.88 75.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.877 -1.056 . . . . 6.6900000000000004 110.895 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -177.34 78.35 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.177 -0.465 . . . . 6.3700000000000001 110.825 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 56.13 63.43 2.01 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.225 0.536 . . . . 5.8300000000000001 111.956 170.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 153.7 -42.73 0.63 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 119.829 -1.177 . . . . 2.6600000000000001 112.767 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 61.9 tp -99.21 108.69 21.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.875 0.369 . . . . 2.9700000000000002 110.021 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 243' ' ' TYR . 47.0 m -119.9 133.42 55.58 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.988 -0.551 . . . . 2.1699999999999999 110.227 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 62.9 t -119.34 133.06 67.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 116.017 -0.538 . . . . 1.79 110.095 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 22.9 t -98.55 129.83 45.11 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.005 -0.739 . . . . 1.6299999999999999 109.005 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 91.7 mt -118.86 128.42 54.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.314 -0.403 . . . . 2.96 110.782 -176.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.5 ' HB2' ' H ' ' A' ' 274' ' ' GLY . 97.5 mt-10 -101.45 114.42 28.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.948 -0.569 . . . . 4.0800000000000001 109.8 176.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -120.3 140.03 51.84 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.849 -0.341 . . . . 4.8399999999999999 110.771 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -114.97 1.07 13.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.151 -0.477 . . . . 3.5800000000000001 110.425 175.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -110.12 129.89 55.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.034 -0.53 . . . . 6.7699999999999996 111.01 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.577 ' OE2' ' HD2' ' A' ' 236' ' ' ARG . 55.6 mt-10 -120.11 170.38 9.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.108 -0.496 . . . . 8.5399999999999991 110.329 173.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 92.8 t90 -64.91 -39.95 94.31 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.907 -0.775 . . . . 11.9 108.907 170.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -69.98 -40.32 75.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.0 -1.0 . . . . 10.57 112.01 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -132.05 147.82 52.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.32 -0.4 . . . . 11.41 110.142 -171.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -119.53 143.11 47.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.617 -0.265 . . . . 11.98 111.018 -171.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.03 139.97 57.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.966 -0.561 . . . . 12.460000000000001 110.626 176.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -125.22 150.45 46.99 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.327 -0.62 . . . . 13.779999999999999 109.327 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 70.21 36.7 71.34 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.455 -0.878 . . . . 11.07 111.833 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -59.96 -36.55 77.37 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 122.575 0.35 . . . . 12.59 111.856 -176.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 53.2 m -60.15 -39.89 87.92 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.845 0.355 . . . . 10.92 110.967 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -84.96 -21.79 29.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.237 -0.438 . . . . 12.42 111.257 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -89.61 94.02 9.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.275 0.56 . . . . 11.59 110.697 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -70.03 -40.02 75.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.395 -0.821 . . . . 8.8300000000000001 111.57 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -91.94 82.35 5.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.854 0.359 . . . . 7.0199999999999996 110.25 -176.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -69.99 -44.42 69.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.561 0.696 . . . . 6.5999999999999996 110.144 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -147.29 160.27 42.7 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.167 -0.924 . . . . 1.9399999999999999 110.112 -176.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.5 ' H ' ' HB2' ' A' ' 254' ' ' GLU . . . -132.69 149.86 19.61 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.338 -0.705 . . . . 1.4199999999999999 111.338 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.56 143.31 40.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.698 0.285 . . . . 1.8100000000000001 110.597 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -139.89 130.58 4.75 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 111.205 -0.758 . . . . 1.3 111.205 174.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 63.2 t -110.13 120.71 61.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.871 0.336 . . . . 1.8300000000000001 110.383 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -127.73 119.95 26.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.068 0.461 . . . . 2.3100000000000001 111.044 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -103.72 122.06 44.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.775 -0.648 . . . . 4.75 109.266 175.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 33.7 t -111.34 129.69 55.92 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.069 -0.514 . . . . 1.6699999999999999 109.92 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 68.1 t80 . . . . . 0 C--O 1.246 0.877 0 CA-C-O 118.407 -0.806 . . . . 3.6899999999999999 109.957 -179.379 . . . . . . . . 0 0 . 1 stop_ save_